<SEC-DOCUMENT>0000721371-20-000089.txt : 20200813
<SEC-HEADER>0000721371-20-000089.hdr.sgml : 20200813
<ACCEPTANCE-DATETIME>20200813100419
ACCESSION NUMBER:		0000721371-20-000089
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		136
CONFORMED PERIOD OF REPORT:	20200630
FILED AS OF DATE:		20200813
DATE AS OF CHANGE:		20200813

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARDINAL HEALTH INC
		CENTRAL INDEX KEY:			0000721371
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				310958666
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11373
		FILM NUMBER:		201097695

	BUSINESS ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147573033

	MAIL ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDINAL DISTRIBUTION INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>a20q410k063020form10-k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:6EACEE03E07F5CC4AD134205CB3BAB26,x:4096d48d63e34a18b576f26771407321-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:sheci="http://fasb.org/stm/sheci/2020-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2020-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2020-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2020-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2020-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2020-01-31" xmlns:equity="http://fasb.org/dis/equity/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:ides="http://fasb.org/dis/ides/2020-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2020-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2020-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2020-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2020-01-31" xmlns:ei="http://fasb.org/dis/ei/2020-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2020-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2020-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2020-01-31" xmlns:srt-all="http://fasb.org/srt-all/2020-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2020-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2020-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2020-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2020-01-31" xmlns:se="http://fasb.org/dis/se/2020-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2020-01-31" xmlns:hco="http://fasb.org/dis/hco/2020-01-31" xmlns:soi="http://fasb.org/stm/soi/2020-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2020-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:debt="http://fasb.org/dis/debt/2020-01-31" xmlns:spc="http://fasb.org/stm/spc/2020-01-31" xmlns:ts="http://fasb.org/dis/ts/2020-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:rd="http://fasb.org/dis/rd/2020-01-31" xmlns:sr="http://fasb.org/dis/sr/2020-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:edco="http://fasb.org/dis/edco/2020-01-31" xmlns:guar="http://fasb.org/dis/guar/2020-01-31" xmlns:te="http://fasb.org/dis/te/2020-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2020-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:ni="http://fasb.org/dis/ni/2020-01-31" xmlns:dr="http://fasb.org/dis/dr/2020-01-31" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2020-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2020-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2020-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2020-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2020-01-31" xmlns:iago="http://fasb.org/dis/iago/2020-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2020-01-31" xmlns:con="http://fasb.org/dis/con/2020-01-31" xmlns:leas="http://fasb.org/dis/leas/2020-01-31" xmlns:com="http://fasb.org/stm/com/2020-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2020-01-31" xmlns:inv="http://fasb.org/dis/inv/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2020-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2020-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2020-01-31" xmlns:oi="http://fasb.org/dis/oi/2020-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2020-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2020-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:cn-part="http://fasb.org/cn-part/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2020-01-31" xmlns:srt-std="http://fasb.org/srt-std/2020-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2020-01-31" xmlns:re="http://fasb.org/dis/re/2020-01-31" xmlns:ir="http://fasb.org/dis/ir/2020-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2020-01-31" xmlns:soc="http://fasb.org/stm/soc/2020-01-31" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2020-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2020-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2020-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2020-01-31" xmlns:regop="http://fasb.org/dis/regop/2020-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2020-01-31" xmlns:ero="http://fasb.org/dis/ero/2020-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2020-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2020-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:cah="http://www.cardinal.com/20200630" xmlns:invco="http://fasb.org/dis/invco/2020-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2020-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2020-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2020-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2020-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2020-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2020-01-31" xmlns:aro="http://fasb.org/dis/aro/2020-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2020-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2020-01-31" xmlns:pay="http://fasb.org/dis/pay/2020-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2020-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2020-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2020-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2020-01-31" xmlns:eps="http://fasb.org/dis/eps/2020-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2020-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2020-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:crcrb="http://fasb.org/dis/crcrb/2020-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2020-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2020-01-31" xmlns:lea="http://fasb.org/dis/lea/2020-01-31" xmlns:disops="http://fasb.org/dis/disops/2020-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2020-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2020-01-31" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2020-01-31" xmlns:nt="http://fasb.org/dis/nt/2020-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2020-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2020-01-31" xmlns:cce="http://fasb.org/dis/cce/2020-01-31" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2020-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2020-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2020-01-31" xmlns:acec="http://fasb.org/dis/acec/2020-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2020-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2020-01-31" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2020-01-31" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:cc="http://fasb.org/dis/cc/2020-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2020-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2020-01-31" xmlns:ru="http://fasb.org/dis/ru/2020-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2020-01-31" xmlns:foct="http://fasb.org/dis/foct/2020-01-31" xmlns:sec-re="http://fasb.org/dis/sec-re/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2020-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2020-01-31" xmlns:diha="http://fasb.org/dis/diha/2020-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ap="http://fasb.org/dis/ap/2020-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2020-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:eui="http://fasb.org/dis/eui/2020-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonFraction decimals="INF" unitRef="number" contextRef="FD2020Q4YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" name="cah:CommonStockVotingRightsVotes" id="Fact-E16BB84E9B5409A316AC284315A96F7E-wk-Fact-E16BB84E9B5409A316AC284315A96F7E">1</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="number" contextRef="FD2020Q4YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember" name="cah:CommonStockVotingRightsVotes" id="Fact-A855C44F344869CFCFE7284315B95464-wk-Fact-A855C44F344869CFCFE7284315B95464">0.2</ix:nonFraction><ix:nonFraction decimals="2" unitRef="number" contextRef="I2020Q4SD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" name="cah:PartnershipOwnership" id="Fact-D57577AEE0B557288649E01DDA4E0634-wk-Fact-D57577AEE0B557288649E01DDA4E0634">1.00</ix:nonFraction><ix:nonNumeric contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" name="cah:VestingPeriodinyearsforShares" id="Fact-EC6B57C071A328C01FDADE0DDE8A9B7F-wk-Fact-EC6B57C071A328C01FDADE0DDE8A9B7F">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="dei:AmendmentFlag" id="Fact-7EE2EF7FA7123C4011BD06666A6472B1-wk-Fact-7EE2EF7FA7123C4011BD06666A6472B1" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="dei:CurrentFiscalYearEndDate" id="Fact-BCB5B2A0B0B2546A6423284315E8066E-wk-Fact-BCB5B2A0B0B2546A6423284315E8066E">--06-30</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="dei:DocumentFiscalPeriodFocus" id="Fact-E0801A484E81674D2B3D284315DF4E99-wk-Fact-E0801A484E81674D2B3D284315DF4E99">FY</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="dei:DocumentFiscalYearFocus" id="Fact-BBDE103305CFAB43A4F6C4E57774E185-wk-Fact-BBDE103305CFAB43A4F6C4E57774E185">2020</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="dei:DocumentPeriodEndDate" id="Fact-A938400B46946745F04E065AB29B0470-wk-Fact-A938400B46946745F04E065AB29B0470">2020-06-30</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="dei:EntityCentralIndexKey" id="Fact-4902167BFF66B25CE475284315EC4DC8-wk-Fact-4902167BFF66B25CE475284315EC4DC8">0000721371</ix:nonNumeric><ix:nonFraction decimals="-6" unitRef="usd" contextRef="FD2019Q4YTD" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" id="Fact-F18397E4069F55E1BEF2EEFDF5A8B289-wk-Fact-F18397E4069F55E1BEF2EEFDF5A8B289">0</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesAuthorized" id="Fact-923370A2DAB955AAA46D2151A66718A7-wk-Fact-923370A2DAB955AAA46D2151A66718A7">755000000</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" name="us-gaap:CommonStockSharesAuthorized" id="Fact-0B88AD1EAE196AB9C5E8284315A83CB2-wk-Fact-0B88AD1EAE196AB9C5E8284315A83CB2">750000000</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember" name="us-gaap:CommonStockSharesAuthorized" id="Fact-613CDB2BC19AC5C1DC9E284315B80C94-wk-Fact-613CDB2BC19AC5C1DC9E284315B80C94">5000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FI2020Q4" name="us-gaap:CommonStockSharesAuthorized" id="Fact-A929D6785E3357D7A73F02688B24F63B-wk-Fact-A929D6785E3357D7A73F02688B24F63B">755000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesIssued" id="Fact-94AC3654F08A5D1395867A7025586BC3-wk-Fact-94AC3654F08A5D1395867A7025586BC3">327000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FI2020Q4" name="us-gaap:CommonStockSharesIssued" id="Fact-755B5B1B02805DBDBBF7A82ADC0764CE-wk-Fact-755B5B1B02805DBDBBF7A82ADC0764CE">327000000</ix:nonFraction><ix:nonFraction decimals="2" unitRef="number" contextRef="I2020Q4SD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" id="Fact-58F11AAB82755B2B98FC98B0C750D192-wk-Fact-58F11AAB82755B2B98FC98B0C750D192">0.40</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="usd" contextRef="FI2020Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" name="us-gaap:EquityMethodInvestments" id="Fact-5E16D6E38F505F259D6167F261D4237A-wk-Fact-5E16D6E38F505F259D6167F261D4237A">334000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="usd" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" id="Fact-F492BCA4EE4466E938C9284316123E25-wk-Fact-F492BCA4EE4466E938C9284316123E25">1372000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="usd" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" id="Fact-551AAB9C4149EBBA523B28431612E654-wk-Fact-551AAB9C4149EBBA523B28431612E654">829000000</ix:nonFraction><ix:nonFraction decimals="2" unitRef="number" contextRef="I2018Q1navi_srt_OwnershipAxis_cah_NaviOwnershipInterestDivestedMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" name="us-gaap:MinorityInterestOwnershipPercentageByParent" id="Fact-6CB2767ACECD5E8383E5836002164E4A-wk-Fact-6CB2767ACECD5E8383E5836002164E4A">0.98</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="segment" contextRef="FD2020Q4YTD" name="us-gaap:NumberOfReportableSegments" id="Fact-247C9A6E30A55B969DA5C7DEFE0A5EE8-wk-Fact-247C9A6E30A55B969DA5C7DEFE0A5EE8">2</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="usd" contextRef="FD2019Q4YTD" name="us-gaap:OtherComprehensiveIncomeLossTax" id="Fact-FDA3DCA53B1C9B7DF9F32843161A0750-wk-Fact-FDA3DCA53B1C9B7DF9F32843161A0750" sign="-">1000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="usd" contextRef="FD2020Q4YTD" name="us-gaap:OtherComprehensiveIncomeLossTax" id="Fact-62B4A22191FD5FD4276E2843161F9A82-wk-Fact-62B4A22191FD5FD4276E2843161F9A82" sign="-">4000000</ix:nonFraction><ix:nonFraction decimals="2" unitRef="number" contextRef="FI2019Q4" name="us-gaap:PercentageOfLIFOInventory" id="Fact-C8F54D5AD49941E92E4C28431461C297-wk-Fact-C8F54D5AD49941E92E4C28431461C297">0.56</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-889A095E4386594B95B682205A9D5F31-wk-Fact-889A095E4386594B95B682205A9D5F31">500000</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-FD29AD63C7261C32064A284315A95422-wk-Fact-FD29AD63C7261C32064A284315A95422">500000</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2020Q4" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-68C363828CF150ACB6FC5DAC7F200062-wk-Fact-68C363828CF150ACB6FC5DAC7F200062">500000</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesIssued" id="Fact-051CC501FFCC591AB826396AA2B50926-wk-Fact-051CC501FFCC591AB826396AA2B50926">0</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2020Q4" name="us-gaap:PreferredStockSharesIssued" id="Fact-623A5B55184A51C9A922D15DA7A3C6D9-wk-Fact-623A5B55184A51C9A922D15DA7A3C6D9">0</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:TreasuryStockShares" id="Fact-BFB8891058D35031A6577D8BE6205F1E-wk-Fact-BFB8891058D35031A6577D8BE6205F1E">28000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FI2020Q4" name="us-gaap:TreasuryStockShares" id="Fact-94416892BB7D5C43997E6DC34F8EE5E3-wk-Fact-94416892BB7D5C43997E6DC34F8EE5E3">34000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="usd" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PriorYearRecoveriesMember" name="us-gaap:ValuationAllowancesAndReservesRecoveries" id="Fact-A3B3C9E4A6044F48E26C28431636DDBB-wk-Fact-A3B3C9E4A6044F48E26C28431636DDBB">1000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="usd" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PriorYearRecoveriesMember" name="us-gaap:ValuationAllowancesAndReservesRecoveries" id="Fact-1C2AF9222CEF875281FA28431639098D-wk-Fact-1C2AF9222CEF875281FA28431639098D">1000000</ix:nonFraction><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock" id="Fact-2255A746672A5E2ED7AA2843161E6140-wk-Fact-2255A746672A5E2ED7AA2843161E6140" escape="true">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;. Investments&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In August 2018, we sold our &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;98 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; equity interest in naviHealth Holdings, LLC ("naviHealth") to investor entities controlled by Clayton, Dubilier &amp;amp; Rice in exchange for cash proceeds of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$737 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (after adjusting for certain fees and expenses) and a &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;40 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; equity interest in a partnership that owns &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;100 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of the equity interest of naviHealth. We also have certain call rights to reacquire naviHealth. We have accounted for this investment using the equity method of accounting and on a one-month reporting lag.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the fiscal year ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2019&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we recognized a pre-tax gain of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$508 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; related to this divestiture in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings/(loss). The carrying value of this investment was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$334 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; as of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2019&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In May 2020, we sold our &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;40 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; equity interest in a partnership that owns &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;100 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of the equity interest of naviHealth in exchange for cash proceeds of [] and recognized a gain of [] related to this disposal in gain on sale of naviHealth stock in our consolidated statements of earnings/(loss). During the three and twelve months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2020&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, our proportionate share of naviHealth&amp;#8217;s net loss, which was recorded in other (income)/ expense, net in the consolidated statements of earnings/(loss), was immaterial.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="cah-20200630.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="FD2020Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1SD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-07-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandBuildingsAndImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandBuildingsAndImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationnetoftaxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_MajorCustomersAxis_cah_GroupPurchasingOrganizationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_MajorCustomersAxis_cah_GroupPurchasingOrganizationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_MajorCustomersAxis_cah_GroupPurchasingOrganizationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1ASC842">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-07-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-08-01</xbrli:startDate>
			<xbrli:endDate>2018-08-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-08-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q1Jul29_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-29</xbrli:startDate>
			<xbrli:endDate>2017-07-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_cah_ContractTerminationAxis_cah_DistributorContractMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:ContractTerminationAxis">cah:DistributorContractMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q4SD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-05-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1navi_srt_OwnershipAxis_cah_NaviOwnershipInterestDivestedMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:OwnershipAxis">cah:NaviOwnershipInterestDivestedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-08-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:OperatingLeaseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:FinanceLeaseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q1SD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_srt_RangeAxis_srt_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_srt_RangeAxis_srt_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q1SD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cah_ASC842Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.4Notesdue2020Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.4Notesdue2020Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_dei_LegalEntityAxis_cah_AllegianceCorporationMember_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dei:LegalEntityAxis">cah:AllegianceCorporationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_CreditFacilityAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q2NotesPayable_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.4Notesdue2020Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-11-01</xbrli:startDate>
			<xbrli:endDate>2019-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4SD195notes_us-gaap_DebtInstrumentAxis_cah_OnePointNineFiveNotesdue2018Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:OnePointNineFiveNotesdue2018Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-06-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A1.948Notesdue2019Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A1.948Notesdue2019Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q4_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-08-11</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_LitigationCaseAxis_cah_OpioidLitigationCuyahogaandSummitCountiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q4_srt_LitigationCaseAxis_cah_OpioidLawsuitsStateDomain_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsStateDomain</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-08-11</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q4litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-28</xbrli:startDate>
			<xbrli:endDate>2020-07-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q4litigation_us-gaap_LossContingenciesByNatureOfContingencyAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-28</xbrli:startDate>
			<xbrli:endDate>2020-07-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q4litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:OtherJurisdictionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-28</xbrli:startDate>
			<xbrli:endDate>2020-07-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q4_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-08-11</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_MajorCustomersAxis_cah_CVSHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:GownRecallAxis">cah:SterileSurgicalGownRecallMemberDomain</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationlessCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationlessCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q4litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:AlamedaCountyMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-28</xbrli:startDate>
			<xbrli:endDate>2020-07-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q4_cah_LawsuitTypeAxis_cah_ClassActionLawsuitsMember_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:LawsuitTypeAxis">cah:ClassActionLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-08-11</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-04-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_cah_TaxMatterAxis_cah_CareFusionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_cah_TaxMatterAxis_cah_CareFusionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cah:DeferredIncomeTaxesandOtherLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cah:DeferredIncomeTaxesandOtherLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CrossCurrencyInterestRateContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CrossCurrencyInterestRateContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cah:DeferredIncomeTaxesandOtherLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cah:DeferredIncomeTaxesandOtherLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_cah_FixedRateDebtMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_cah_FixedRateDebtMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_cah_FixedRateDebtMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q3SD_us-gaap_ShareRepurchaseProgramAxis_cah_AcceleratedsharerepurchaseplanMember_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cah:AcceleratedsharerepurchaseplanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-02-14</xbrli:startDate>
			<xbrli:endDate>2018-03-21</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q4SD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:GownRecallAxis">cah:SterileSurgicalGownRecallMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeSolutionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeSolutionsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_AwardTypeAxis_cah_AwardsOtherThanStockOptionsMember_us-gaap_PlanNameAxis_cah_A2011LtipMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cah:AwardsOtherThanStockOptionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2011LtipMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_PlanNameAxis_cah_A2011LtipMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2011LtipMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_cah_A2011LtipMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2011LtipMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-04-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-10-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PricingDisputesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PricingDisputesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PricingDisputesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PriorYearRecoveriesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PriorYearRecoveriesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PriorYearRecoveriesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:unit id="number">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit><xbrli:unit id="organization">
		<xbrli:measure>cah:organization</xbrli:measure>
	</xbrli:unit><xbrli:unit id="StateAG">
		<xbrli:measure>cah:StateAG</xbrli:measure>
	</xbrli:unit><xbrli:unit id="segment">
		<xbrli:measure>cah:segment</xbrli:measure>
	</xbrli:unit><xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit><xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit><xbrli:unit id="plaintiff">
		<xbrli:measure>cah:plaintiff</xbrli:measure>
	</xbrli:unit><xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit><xbrli:unit id="lawsuit">
		<xbrli:measure>cah:lawsuit</xbrli:measure>
	</xbrli:unit><xbrli:unit id="eur">
		<xbrli:measure>iso4217:EUR</xbrli:measure>
	</xbrli:unit><xbrli:unit id="jpy">
		<xbrli:measure>iso4217:JPY</xbrli:measure>
	</xbrli:unit></ix:resources></ix:header></div><div><a id="s8687259D0016547D9BFBDC8AE0466320"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;color:#0000ff;text-decoration:underline;" href="#sF3DBCA2E656157EDB1A7D54CCD0EEA92"><span style="font-family:Arial Narrow;font-size:8pt;color:#0000ff;text-decoration:underline;">Table of Contents</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:100%;padding-bottom:4px;text-align:center;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:100%;padding-bottom:4px;text-align:center;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:100%;padding-bottom:0px;padding-top:8px;text-align:center;font-size:11pt;"><span style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Washington,&#160;D.C. 20549</span></div><div style="line-height:100%;padding-bottom:0px;padding-top:4px;text-align:center;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Form </span><span><ix:nonNumeric id="d9981211e2870-wk-Fact-CA2D1368291A72B449227FD1467351AF" name="dei:DocumentType" contextRef="FD2020Q4YTD"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">10-K</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial Unicode MS;font-size:10pt;"><span><ix:nonNumeric id="d9981211e2888-wk-Fact-8F565ED69BB77AAECC1B064BDDADCAFF" name="dei:DocumentAnnualReport" contextRef="FD2020Q4YTD" format="ixt-sec:boolballotbox">&#9745;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">For the fiscal year ended </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">or</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial Unicode MS;font-size:10pt;"><span><ix:nonNumeric id="d9981211e2918-wk-Fact-FF106948A018E3CD920F064C8668447C" name="dei:DocumentTransitionReport" contextRef="FD2020Q4YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">For the transition period from ________ to ________</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Commission File Number:&#160;</span><span><ix:nonNumeric id="d9981211e2931-wk-Fact-DE9E0385798492D3CA467FD288FE29FF" name="dei:EntityFileNumber" contextRef="FD2020Q4YTD"><span style="font-family:Arial Narrow;">1-11373</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:22pt;"><span><ix:nonNumeric id="d9981211e2940-wk-Fact-F80AF30E4312879AC61B7FD3132110BA" name="dei:EntityRegistrantName" contextRef="FD2020Q4YTD"><span style="font-family:Arial Narrow;font-size:22pt;font-weight:bold;">Cardinal Health, Inc.</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:22pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">(Exact name of registrant as specified in its charter)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:25%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d9981211e2966-wk-Fact-EF5C342B9A2713FF61DD7FDC9490F16F" name="dei:EntityIncorporationStateCountryCode" contextRef="FD2020Q4YTD" format="ixt-sec:stateprovnameen">Ohio</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d9981211e2996-wk-Fact-9AF59B375EE653BD2E5D7FD661C8113B" name="dei:EntityTaxIdentificationNumber" contextRef="FD2020Q4YTD">31-0958666</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">(State or other jurisdiction of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">incorporation or organization)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">(IRS Employer</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">Identification No.)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d9981211e3080-wk-Fact-1163E62A356F1F0A341C7FDE834470F3" name="dei:EntityAddressAddressLine1" contextRef="FD2020Q4YTD">7000 Cardinal Place</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d9981211e3090-wk-Fact-4F94A0EF44F975EA22597FDEC904EF04" name="dei:EntityAddressCityOrTown" contextRef="FD2020Q4YTD">Dublin</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d9981211e3100-wk-Fact-67D42E580C70383EFC557FDF004C04CB" name="dei:EntityAddressStateOrProvince" contextRef="FD2020Q4YTD" format="ixt-sec:stateprovnameen">Ohio</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d9981211e3110-wk-Fact-F6365580954346C7A6D67FDF3041895B" name="dei:EntityAddressPostalZipCode" contextRef="FD2020Q4YTD">43017</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">(Address of principal executive offices)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">(Zip Code)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d9981211e3207-wk-Fact-A10DA0CD4423AAA8DF977FDB85101EF0" name="dei:CityAreaCode" contextRef="FD2020Q4YTD">(614)</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d9981211e3217-wk-Fact-3F1E29A6893892E4B8AEA49604D23502" name="dei:LocalPhoneNumber" contextRef="FD2020Q4YTD">757-5000</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="7" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">(Registrant&#8217;s telephone number, including area code)</span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:37%;"></td><td style="width:26%;"></td><td style="width:37%;"></td></tr><tr><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Securities registered pursuant to Section 12(b) of the Act:</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">Title of each class</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">Trading Symbol(s)</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d9981211e3316-wk-Fact-520761B804068BADE292A499955F3D6D" name="dei:Security12bTitle" contextRef="FD2020Q4YTD">Common shares (without par value)</ix:nonNumeric></span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d9981211e3321-wk-Fact-43A52AEA7A23A86DC61DA499F4CDA4FC" name="dei:TradingSymbol" contextRef="FD2020Q4YTD">CAH</ix:nonNumeric></span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;"><span><ix:nonNumeric id="d9981211e3326-wk-Fact-1C36B619C4B6F98B0BD3A49A45B97A72" name="dei:SecurityExchangeName" contextRef="FD2020Q4YTD" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Securities registered pursuant to Section 12(g) of the Act: None</span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:9pt;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;&#160;&#160;&#160;</span><span><ix:nonNumeric id="d9981211e3362-wk-Fact-2719EDFE4A379D2FB8CE800B81FED78F" name="dei:EntityWellKnownSeasonedIssuer" contextRef="FD2020Q4YTD"><span style="font-family:Arial Narrow;font-size:9pt;">Yes</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:9pt;">&#160;&#160;</span><span style="font-family:Wingdings;font-size:9pt;">&#254;</span><span style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;</span><span style="font-family:Arial Narrow;font-size:9pt;">No</span><span style="font-family:inherit;font-size:9pt;">&#160;&#160;</span><span style="font-family:Wingdings;font-size:9pt;">o</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;</span><span style="font-family:inherit;font-size:9pt;">&#160;</span><span style="font-family:Wingdings;font-size:9pt;">o</span><span style="font-family:Arial Narrow;font-size:9pt;">&#160;&#160;&#160;&#160;</span><span><ix:nonNumeric id="d9981211e3386-wk-Fact-A1D37D04611C3CC6DBDB800C5CD2714F" name="dei:EntityVoluntaryFilers" contextRef="FD2020Q4YTD"><span style="font-family:Arial Narrow;font-size:9pt;">No</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:9pt;">&#160;&#160;</span><span style="font-family:Wingdings;font-size:9pt;">&#254;</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;</span><span><ix:nonNumeric id="d9981211e3396-wk-Fact-65E8A801B81091B28BC58002C357DBB8" name="dei:EntityCurrentReportingStatus" contextRef="FD2020Q4YTD"><span style="font-family:Arial Narrow;font-size:9pt;">Yes</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:9pt;">&#160;&#160;</span><span style="font-family:Wingdings;font-size:9pt;">&#254;</span><span style="font-family:Arial Narrow;font-size:9pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="font-family:Wingdings;font-size:9pt;">o</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;</span><span><ix:nonNumeric id="d9981211e3410-wk-Fact-7588CB319FE31124F557800FA6A919E9" name="dei:EntityInteractiveDataCurrent" contextRef="FD2020Q4YTD"><span style="font-family:Arial Narrow;font-size:9pt;">Yes</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:9pt;">&#160;</span><span style="font-family:inherit;font-size:9pt;">&#160;</span><span style="font-family:Wingdings;font-size:9pt;">&#254;</span><span style="font-family:Arial Narrow;font-size:9pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="font-family:Arial Unicode MS;font-size:9pt;">&#9744;</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:19%;"></td><td style="width:4%;"></td><td style="width:23%;"></td><td style="width:19%;"></td><td style="width:3%;"></td><td style="width:32%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><span><ix:nonNumeric id="d9981211e3443-wk-Fact-11300E29CB57C25158107FE4EA0F4821" name="dei:EntityFilerCategory" contextRef="FD2020Q4YTD" format="ixt-sec:entityfilercategoryen">Large accelerated filer</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Wingdings;font-size:9pt;">&#254;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Accelerated filer</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial Unicode MS;font-size:9pt;">&#9744;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Non-accelerated filer</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial Unicode MS;font-size:9pt;">&#9744;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Smaller&#160;reporting&#160;company</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial Unicode MS;font-size:10pt;"><span><ix:nonNumeric id="d9981211e3494-wk-Fact-AD48C20809F942643BAF06518361E584" name="dei:EntitySmallBusiness" contextRef="FD2020Q4YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Emerging growth&#160;company&#160;&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial Unicode MS;font-size:10pt;"><span><ix:nonNumeric id="d9981211e3524-wk-Fact-6DD83768D72B9BB3AAFB0651920A00FD" name="dei:EntityEmergingGrowthCompany" contextRef="FD2020Q4YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act </span><span style="font-family:Wingdings;font-size:9pt;">o</span></div></td></tr><tr><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="font-family:Wingdings;font-size:9pt;">&#254;</span></div><div style="font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes </span><span><ix:nonNumeric id="d9981211e3603-wk-Fact-6B3AB834130D5741C1AF0777BC1D4748" name="dei:EntityShellCompany" contextRef="FD2020Q4YTD" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:9pt;"> &#160;</span><span style="font-family:Arial Narrow;font-size:9pt;">No</span><span style="font-family:Arial Narrow;font-size:9pt;">&#160;</span><span style="font-family:inherit;font-size:9pt;">&#160;</span><span style="font-family:Wingdings;font-size:9pt;">&#254;</span><span style="font-family:inherit;font-size:9pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">The aggregate market value of voting stock held by non-affiliates on </span><span style="font-family:Arial Narrow;font-size:9pt;">December&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:9pt;">, was the following: </span><span style="font-family:Arial Narrow;font-size:9pt;"><span>$<ix:nonFraction id="d9981211e3626-wk-Fact-CE177E8A0E6F9C57635A284315E9690F" name="dei:EntityPublicFloat" contextRef="FI2020Q2" unitRef="usd" decimals="0" scale="0" format="ixt:numdotdecimal">14,729,138,108</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:9pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">The number of the registrant&#8217;s common shares, without par value, outstanding as of </span><span style="font-family:Arial Narrow;font-size:9pt;">July&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:9pt;">, was the following: </span><span style="font-family:Arial Narrow;font-size:9pt;"><span><ix:nonFraction id="d9981211e3638-wk-Fact-37EB97E6A91357D6BA639A8F32AC563F" name="dei:EntityCommonStockSharesOutstanding" contextRef="I2020Q1SD" unitRef="shares" decimals="0" scale="0" format="ixt:numdotdecimal">292,444,079</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:9pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="TextSelection-C968C0D54306DDF7B5360779C076D018-0-wk-Fact-BA8D36D66A1DE0F3E253077B23720715" escape="true"><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Documents Incorporated by Reference: </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Portions of the registrant&#8217;s Definitive Proxy Statement to be filed for its </span><span style="font-family:Arial Narrow;font-size:9pt;">2020</span><span style="font-family:Arial Narrow;font-size:9pt;"> Annual Meeting of Shareholders are incorporated by reference into the sections of this Form 10-K addressing the requirements of Part&#160;III of Form&#160;10-K.</span></div></ix:nonNumeric><div><br/></div><hr style="page-break-after:always"></hr><div><a id="sF3DBCA2E656157EDB1A7D54CCD0EEA92"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;font-weight:bold;color:#ee2724;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:18pt;font-weight:bold;color:#ee2724;">&#160;</span></div><div style="text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Fiscal 2020 Form 10-K                                                                                                                                   </span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Table of Contents</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:92%;"></td><td style="width:8%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Page</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sF8AF79492EBB5EFEB52BE55FA3BE82CC"><span style="font-family:Arial Narrow;font-size:10pt;">Introduction</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sF8AF79492EBB5EFEB52BE55FA3BE82CC">2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s8FE50BC6625E53A7A2EBD36A964A3F58"><span style="font-family:Arial Narrow;font-size:10pt;">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s8FE50BC6625E53A7A2EBD36A964A3F58">3</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s2B855D2F667B5A31AF19D34479AAEA66"><span style="font-family:Arial Narrow;font-size:10pt;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s2B855D2F667B5A31AF19D34479AAEA66">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sAD9595E6A7565841838053780BA1B0B4"><span style="font-family:Arial Narrow;font-size:10pt;">Selected Financial Data</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sAD9595E6A7565841838053780BA1B0B4">23</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s333C75A276DE55268DA27780A098DE09"><span style="font-family:Arial Narrow;font-size:10pt;">Quantitative and Qualitative Disclosures about Market Risk</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s333C75A276DE55268DA27780A098DE09">24</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s64B4883BB1AB5C45A2F86FABE0A8B842"><span style="font-family:Arial Narrow;font-size:10pt;">Business</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s64B4883BB1AB5C45A2F86FABE0A8B842">26</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sB887CB0119C25A08BEA9BE55BDBCD36D"><span style="font-family:Arial Narrow;font-size:10pt;">Risk Factors</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sB887CB0119C25A08BEA9BE55BDBCD36D">33</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s38B7FE605CD85F5ABED26E8E13F7E935"><span style="font-family:Arial Narrow;font-size:10pt;">Properties</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s38B7FE605CD85F5ABED26E8E13F7E935">40</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s2AE08030210259CCAE9BFFC1DD370010"><span style="font-family:Arial Narrow;font-size:10pt;">Legal Proceedings</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s2AE08030210259CCAE9BFFC1DD370010">40</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s38459D2E4A45535DA3214D65091BE252"><span style="font-family:Arial Narrow;font-size:10pt;">Market for Registrant's Common Equity</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s38459D2E4A45535DA3214D65091BE252">41</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s5B394966EB4C511684797CFE02614449"><span style="font-family:Arial Narrow;font-size:10pt;">Reports</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s5B394966EB4C511684797CFE02614449">43</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s7F3CE990DD1859BF8C1573967BC05AFD"><span style="font-family:Arial Narrow;font-size:10pt;">Financial Statements and Supplementary Data</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s7F3CE990DD1859BF8C1573967BC05AFD">48</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3C67236E06545A9EBF4D40D9E989AF63"><span style="font-family:Arial Narrow;font-size:10pt;">Directors, Executive Officers, and Corporate Governance</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s3C67236E06545A9EBF4D40D9E989AF63">79</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s836DADB5C449535FB68FD62583FB443E"><span style="font-family:Arial Narrow;font-size:10pt;">Exhibits</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s836DADB5C449535FB68FD62583FB443E">81</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s4FD952D373C65C1E8C00962F94F20840"><span style="font-family:Arial Narrow;font-size:10pt;">Form 10-K Cross Reference Index</span></a><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s4FD952D373C65C1E8C00962F94F20840">85</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sEF38C628ED485BCE881358888B51576D"><span style="font-family:Arial Narrow;font-size:10pt;">Signatures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sEF38C628ED485BCE881358888B51576D">86</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="sF8AF79492EBB5EFEB52BE55FA3BE82CC"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Introduction</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Introduction</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">References to Cardinal Health and Fiscal Years</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As used in this report, "we," "our," "us," "Cardinal Health" and similar pronouns refer to Cardinal Health, Inc. and its majority-owned subsidiaries, unless the context requires otherwise. Our fiscal year ends on June 30.&#160; References to fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2021</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2017</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2016</span><span style="font-family:Arial Narrow;font-size:10pt;"> are to the fiscal years ended </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2021</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2017</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2016</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. Except as otherwise specified, information in this report is provided as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Non-GAAP Financial Measures</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In this report, including in the "Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> Overview" section of Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&amp;A"), we use financial measures that are derived from consolidated financial data but are not presented in our financial statements that are prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). These measures are considered &#8220;non-GAAP financial measures&#8221; under the Securities and Exchange Commission (&#8220;SEC&#8221;) rules. The reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures are included in the &#8220;Explanation and Reconciliation of Non-GAAP Financial Measures&#8221; section following MD&amp;A in this report.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our MD&amp;A within this Form 10-K generally discusses fiscal 2020 and fiscal 2019 items and year-to-year comparisons between fiscal 2020 and fiscal 2019.&#160;Fiscal 2018 items and discussions of year-to-year comparisons between fiscal 2019 and fiscal 2018 that are not included in this Form 10-K can be found in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended June 30, 2019.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Important Information Regarding Forward-Looking Statements</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">This report (including information incorporated by reference) includes forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. Many forward-looking statements appear in MD&amp;A and Risk Factors, but there are others throughout this report, which may be identified by words such as &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; and similar expressions, and include statements reflecting future results or guidance, statements of outlook and expense accruals. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these risks and uncertainties are described in &#8220;Risk Factors&#8221; in this report and in Exhibit 99.1 to the Form 10-K included in this report. Forward-looking statements in this report speak only as of the date of this document. Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Available Information</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports are available free of charge on our website (www.cardinalhealth.com), under the &#8220;Investor Relations &#8212; Financial Reporting &#8212; SEC Filings&#8221; caption, as soon as reasonably practicable after we electronically file them with, or furnish them to, the SEC. The SEC also maintains a website (www.sec.gov) where you can search for annual, quarterly and current reports, proxy and information statements, and other information regarding us and other public companies.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">2</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s8FE50BC6625E53A7A2EBD36A964A3F58"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div></div><div><a id="s48CAD52991A55CC780F607C56A91E6BD"></a></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">About Cardinal Health</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Cardinal Health, Inc. is an Ohio corporation formed in 1979 and is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. We provide pharmaceuticals and medical products and cost-effective solutions that enhance supply chain efficiency. We connect patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. We manage our business and report our financial results in two segments: Pharmaceutical and Medical.</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Pharmaceutical Segment</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Medical Segment</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, this segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s1692EB648D025B4EA917C52A80E979F3"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Consolidated Results</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fiscal </span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> Overview</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Revenue</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Revenue for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$152.9 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">5 percent</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> increase from the prior year, primarily due to sales growth from pharmaceutical distribution and specialty solutions customers.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">GAAP and Non-GAAP Operating Earnings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP operating earnings/(loss)</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4,098</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2,060</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Surgical gown recall costs</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">85</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State opioid assessment related to prior fiscal years</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">122</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">125</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">524</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">621</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(488</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5,741</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">36</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP operating earnings</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,384</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2,353</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The sum of the components and certain computations may reflect rounding adjustments.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We had a GAAP operating loss of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$4.1 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> primarily due to a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax charge we recognized for the estimated liability associated with lawsuits and claims brought against us by states and political subdivisions relating to the distribution of prescription opioid pain medications as described in the Significant Developments in Fiscal 2020 and Trends section in this MD&amp;A and&#160;</span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;of the "Notes to Consolidated Financial Statements." GAAP operating earnings during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were favorably impacted by a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$508 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax gain from the divestiture of a majority interest in our naviHealth Holdings, LLC ("naviHealth") business.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in non-GAAP operating earnings was primarily due to the beneficial impact of enterprise-wide cost-savings measures, a higher contribution from branded pharmaceutical sales mix, the favorable year-over-year impact of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> charges related to an exclusive distribution agreement with a Medical segment supplier and growth from specialty solutions, partially offset by the adverse impact of Pharmaceutical segment customer contract renewals and the adverse impact of the pandemic associated with the novel strain of coronavirus (&#8220;COVID-19&#8221;). See the Significant Developments in Fiscal 2020 and Trends section of this MD&amp;A.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">GAAP and Non-GAAP Diluted EPS </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">($ per share)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020 </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2) (3)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019 </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP diluted EPS</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;(1)</sup></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(12.61</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.53</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Surgical gown recall costs</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.22</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State opioid assessment related to prior fiscal years</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.01</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.31</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.31</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1.34</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.57</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.02</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1.25</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">17.84</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.09</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss on early extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.04</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain on sale of equity interest in naviHealth</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(1.68</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Transitional tax benefit, net</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(0.01</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.03</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP diluted EPS </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5.45</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5.28</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The sum of the components and certain computations may reflect rounding adjustments.</span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted earnings/(loss) per share attributable to Cardinal Health, Inc. ("diluted EPS" or "diluted loss per share")</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The reconciling items are presented within this table net of tax. See quantification of tax effect of each reconciling item in our GAAP to Non-GAAP Reconciliations in the "Explanation and Reconciliation of Non-GAAP Financial Measures." </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">For fiscal </span><span style="font-family:Arial Narrow;font-size:8pt;">2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, GAAP diluted loss per share attributable to Cardinal Health, Inc. and the EPS impact from the GAAP to non-GAAP per share reconciling items are calculated using a weighted average of 293 million common shares, which excludes potentially dilutive securities from the denominator due to their anti-dilutive effects resulting from our GAAP net loss for the period. Fiscal 2020 non-GAAP diluted EPS is calculated using a weighted average of 295 million common shares, which includes potentially dilutive shares.</span></div></td></tr></table><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">4</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We had a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$12.61</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> GAAP diluted loss per share attributable to Cardinal Health, Inc. ("GAAP diluted EPS") during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> due to the charge we recognized for the estimated liability associated with lawsuits and claims brought against us by states and political subdivisions relating to the distribution of prescription opioid pain medications. The charge had a $(17.54) per share after tax impact on GAAP diluted EPS. GAAP diluted EPS during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was favorably impacted by a $1.68 per share gain from the sale of the remainder of our equity interest in naviHealth described further in Significant Developments in Fiscal 2020 and Trends section in this MD&amp;A and&#160;</span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s20ab24d9611f400f9fecc35ff4abdad4"><span style="font-family:Arial Narrow;font-size:10pt;">Note 2</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;of the "Notes to Consolidated Financial Statements". GAAP diluted EPS during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> included a $1.26 per share gain from the divestiture of our majority interest in naviHealth.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> non-GAAP diluted EPS increased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">3%</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.45</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. This increase was primarily due to the factors discussed above impacting non-GAAP operating earnings, as well as a lower share count as a result of share repurchases and lower interest expense due to&#160;less debt outstanding and lower interest rates. The year-over-year comparison was unfavorably impacted by a higher effective tax rate due to the benefit in the prior-year from discrete tax items, largely related to international legal entity changes.</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Cash and Equivalents</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our cash and equivalents balance was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$2.8 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> compared to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$2.5 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span><span style="font-family:Arial Narrow;font-size:10pt;">The increase in cash during</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> was due to net cash provided by operating activities of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$2.0 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$886 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of net cash proceeds from the sale of investments, offset by cash deployed of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1.4 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for debt repayments, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$569 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for dividends and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$350 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for share repurchases.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">5</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Significant Developments in Fiscal </span><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">2020</span><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> and Trends</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">COVID-19</span></div></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The COVID-19 pandemic continues to severely impact the U.S. and global economies. Our businesses have been impacted in a variety of ways beginning in the third quarter of fiscal 2020, as discussed in the following paragraphs and under &#8220;Results of Operations.&#8221; We estimate that the COVID-19 pandemic had a net negative impact to operating earnings/(loss) of approximately $100 million in fiscal 2020.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Within our manufacturing and distribution facilities, we have implemented sustained protocols designed to protect the safety of our employees and maintain continuity of our operations, and have generally continued to operate our distribution and manufacturing facilities in the ordinary course of business. Additionally, in line with various governmental recommendations to reduce large gatherings and practice social distancing, we have enabled most office-based employees to work remotely. These measures have created additional burdens on our infrastructure and information technology systems. Furthermore, if a significant number of our employees are unable to perform their duties for a period of time, we may experience difficulties in operating one or more of our facilities which could adversely impact our financial results.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Since the third quarter of fiscal 2020, our Medical segment has seen dramatically increased demand for certain personal protective equipment (&#8220;PPE&#8221;), such as masks, gowns and gloves. We manufacture, source and distribute some PPE products and distribute PPE manufactured by others. This increased demand resulted in an increase in sales volume for certain products in fiscal 2020. The cost to manufacture and source certain PPE products has also significantly increased, which had a slight negative impact on our margin for these products in fiscal 2020 and is expected to have a larger negative impact in fiscal 2021. We continue to seek alternate and additional sources for these products and otherwise mitigate cost increases. We also are increasing certain PPE product prices to reflect some of our higher costs and are seeking to modify affected customer contracts. If these efforts are unsuccessful, our margins may be adversely impacted even more significantly. In addition, we could experience decreased sales and customer disputes. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Federal, state and local governmental policies and orders and certain private initiatives designed to reduce the transmission of COVID-19 also resulted in, among other things, the cancellation or deferral of many elective medical procedures and some of our customers closing or severely curtailing their operations. As a result, our Medical segment has experienced decreased sales volume (apart from PPE products described above), which had a negative impact on Medical segment profit in fiscal 2020 and which we currently assume will have a negative impact in fiscal 2021. The decrease in elective procedures and physician office visits has also resulted in a significant decrease in sales by our Nuclear and Precision Health Solutions division in our Pharmaceutical segment in fiscal 2020. Fluctuating or decreasing elective procedure volume may have a greater or lesser adverse impact on the sales of these products and services than we anticipate.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Pharmaceutical Distribution and Specialty Solutions businesses experienced a temporary increase in sales volume during the third quarter of fiscal 2020, which we believe to be related to accelerated purchasing by some customers due to the COVID-19 pandemic and which was largely offset by a decrease in sales volume in the fourth quarter of fiscal 2020. We assume fiscal 2021 Pharmaceutical segment revenue will be negatively impacted by COVID-19, and we are uncertain when sales volume will return to pre-COVID-19 levels.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Political, legal or regulatory actions taken in response to the COVID-19 pandemic in certain jurisdictions where we manufacture, source or distribute products have created supply disruptions within both our Medical and, to a lesser extent, our Pharmaceutical segments and are likely to cause additional supply disruptions or shortages in the future. We cannot currently predict the frequency, duration or scope of these governmental actions and supply disruptions. For example, several countries have increased or instituted new restrictions on the export of medical or pharmaceutical products that we distribute or use in our businesses, including key components or raw materials. Additionally, governmental authorities in many countries, including the U.S., are considering enacting legislative or regulatory changes to address the impact of the pandemic, which may restrict or require changes in our operations, increase our costs, or otherwise adversely affect our operations. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In March 2020, the U.S enacted the Coronavirus Aid, Relief and Economic Security Act, which provided a variety of benefits for businesses as a result of the COVID-19 pandemic. During fiscal 2020, we received a cash flow benefit related to the deferral of payroll and income tax payments and a small tax benefit from the employee retention credit under this Act.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We currently anticipate that the COVID-19 pandemic will have a further negative impact on fiscal 2021 consolidated operating earnings and Medical segment profit. However, we cannot estimate the length or severity of the COVID-19 pandemic or of the related U.S. or global economic consequences on our business and operations, including whether and when historic economic and operating conditions will resume or the extent to which the disruption may impact our business, financial position, results of operations or cash flow, and its impact maybe greater or less than we anticipate.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">6</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Opioid Lawsuits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2019, we agreed in principle to a global settlement framework with a leadership group of state attorneys general that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions, but not private plaintiffs (the "Settlement Framework"). This Settlement Framework is subject to contingencies and uncertainties as to final terms, but is the basis for our negotiation of definitive terms and documentation. The Settlement Framework includes (1) a cash component, pursuant to which we would pay up to </span><span style="font-family:Arial Narrow;font-size:10pt;">$5.56 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> over </span><span style="font-family:Arial Narrow;font-size:10pt;">eighteen years</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, (2) development and participation in a program for free or rebated distribution of opioid abuse treatment medications for a period of ten years, and (3) to-be specified industry-wide changes to distributor controlled substance anti-diversion programs. We also agreed, with two other national distributors, to a $215 million settlement with two plaintiff counties. Our portion of that settlement was $66 million, which was paid in January 2020. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with these matters, we recorded a total pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.14 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> after tax) during fiscal year </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in litigation (recoveries)/charges, net, in the consolidated statement of earnings/(loss) for the cash component. We accrue for contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. Moreover, definitive terms for a settlement pursuant to the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. We regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Consolidated Financial Statements" for additional information. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Also in connection with these matters, we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$488 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$469 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid under the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> accrual taken in connection with the opioid litigation. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. Our assumptions and estimates around this benefit and uncertain tax position require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the U.S. Tax Cuts and Jobs Act (&#8220;Tax Act&#8221;). We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act. Further, it is possible that the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of tax benefit related to uncertain tax positions may differ materially from these estimates.  See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s002522EA8F5F5274B7487704BE70A9A8"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the &#8220;Notes to the Consolidated Financial Statements&#8221; for additional information.</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Gain on Sale of Equity Interest in naviHealth</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As described further in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s20ab24d9611f400f9fecc35ff4abdad4"><span style="font-family:Arial Narrow;font-size:10pt;">Note 2</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Consolidated Financial Statements," in May 2020 we sold the remainder of our equity interest in a partnership that owned naviHealth. We recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$579 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$493 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> after tax) from this disposal in gain on sale of equity interest in naviHealth in our consolidated statements of earnings/(loss).</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Trends</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition to the trends and uncertainties described above under the caption Significant Developments in Fiscal 2020 and Trends, the performance of our Pharmaceutical segment generics program, which includes generic pharmaceutical customer pricing changes and Red Oak Sourcing, adversely impacted Pharmaceutical segment profit in fiscal 2019 and fiscal 2018; however, in fiscal 2020 our generics program had a slightly favorable impact on Pharmaceutical segment profit. As is generally the case, the frequency, timing, magnitude and profit impact of generic pharmaceutical customer pricing changes, customer contract renewals, and branded and generic pharmaceutical manufacturer pricing changes remain uncertain and their impact on Pharmaceutical segment profit and consolidated operating earnings in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2021</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> could be more or less than we expect.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">7</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="sBD5C9A29CFA4566DA29D4AB545200550"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Results of Operations</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Revenue</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;"><img src="chart-df5fa58deb025709a81.jpg" alt="chart-df5fa58deb025709a81.jpg" style="height:209px;width:200px;"></img><img src="chart-148af8dedebd55ac9eb.jpg" alt="chart-148af8dedebd55ac9eb.jpg" style="height:209px;width:200px;"></img></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">137,495</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">129,917</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">15,444</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">15,633</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(1</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">152,939</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">145,550</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(17</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(16</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">152,922</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">145,534</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fiscal </span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020</span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> Compared to Fiscal </span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2019</span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Pharmaceutical Segment</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Pharmaceutical segment revenue grew primarily due to sales growth from pharmaceutical distribution and specialty solutions customers, which together increased revenue by </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$7.6 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Medical Segment</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> Medical segment revenue decreased due to the adverse impact of the COVID-19 pandemic, partially offset by sales growth from Cardinal Health at-Home Solutions.</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cost of Products Sold</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cost of products sold f</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">or fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">increased </span><span style="font-family:Arial Narrow;font-size:10pt;">$7.4 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;">5 percent</span><span style="font-family:Arial Narrow;font-size:10pt;">) due to the factors affecting the changes in revenue and gross margin.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">8</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Gross Margin</span></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><img src="chart-b8cf9d04cd0f5e60a69.jpg" alt="chart-b8cf9d04cd0f5e60a69.jpg" style="height:233px;width:200px;"></img><img src="chart-94d908f3201c52649e7.jpg" alt="chart-94d908f3201c52649e7.jpg" style="height:233px;width:200px;"></img><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Consolidated Gross Margin</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross margin</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,868</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">6,834</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fiscal</span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020</span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Compared to Fiscal</span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2019</span><span style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> consolidated gross margin is essentially flat with growth from pharmaceutical specialty solutions and higher contribution from branded pharmaceutical sales, mostly offset by the adverse impact of Pharmaceutical segment customer contract renewals. Gross margin comparison to the prior year benefitted from the fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> charges related to an exclusive distribution agreement with a Medical segment supplier.</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gross margin rate declined during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> mainly due to the adverse impact of pharmaceutical customer contract renewals and changes in pharmaceutical distribution product mix. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Distribution, Selling, General and Administrative ("SG&amp;A") Expenses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:center;font-size:14pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">SG&amp;A Expenses</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">SG&amp;A expenses</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4,572</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4,480</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:14pt;">            </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:center;font-size:2pt;"><span style="font-family:inherit;font-size:2pt;">&#160;</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fiscal</span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020</span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Compared to Fiscal</span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2019</span><span style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> SG&amp;A expenses increased due to higher costs to support sales growth and a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$37 million</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;charge in connection </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">with a voluntary recall for Association for the Advancement of Medical Instrumentation ("AAMI") Level 3 surgical gowns and a voluntary recall and field actions for surgical procedure packs containing affected gowns (together, the "Recalls"), as described further within</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Consolidated Financial Statements".</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">9</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Segment Profit</span></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluate segment performance based on segment profit, among other measures. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s4B6912BAF1A2559F8537A7BBB757540B"><span style="font-family:Arial Narrow;font-size:10pt;">Note 13</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Consolidated Financial Statements" for additional information on segment profit.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><img src="chart-785fc250b4225182a09.jpg" alt="chart-785fc250b4225182a09.jpg" style="height:240px;width:200px;"></img><img src="chart-460dfd3e426b549eabf.jpg" alt="chart-460dfd3e426b549eabf.jpg" style="height:240px;width:200px;"></img><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Segment Profit and Operating Earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,753</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,834</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">663</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">576</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">15</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,416</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2,410</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(6,514</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(350</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total consolidated operating earnings</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4,098</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2,060</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fiscal </span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020</span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> Compared to Fiscal </span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2019</span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Pharmaceutical Segment Profit</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Pharmaceutical segment profit decreased largely due to the adverse impact of customer contract renewals, partially offset by higher contribution from our branded pharmaceutical sales mix and growth from specialty solutions.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Pharmaceutical segment financial results do not include the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> charge associated with the opioid litigation. See Significant Developments in Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and Trends section in this MD&amp;A and&#160;</span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Medical Segment Profit</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Medical segment profit increased largely due to benefits from cost-savings measures and the favorable year-over-year impact of the fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> charges related to an exclusive distribution agreement with a Medical segment supplier</span><span style="font-family:Arial Narrow;font-size:10pt;">, partially offset by decreased sales resulting from the COVID-19 pandemic.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Medical segment financial results do not include the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$85 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> charge incurred during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in connection with the Recalls, as described further within </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Consolidated Financial Statements".</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Corporate</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The changes in Corporate during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> are due to the factors discussed in the Other Components of Consolidated Operating Earnings/(Loss) section that follows.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">10</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Components of Consolidated Operating Earnings/(Loss)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to revenue, gross margin, and SG&amp;A expenses discussed previously, consolidated operating earnings/(loss) were impacted by the following:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">122</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">125</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">524</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">621</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(488</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5,741</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">36</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Restructuring and Employee Severance</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, restructuring costs are primarily related to implementation of certain enterprise-wide cost-savings measures.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Amortization and Other Acquisition-Related Costs</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Amortization of acquisition-related intangible assets was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$512 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$531 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Transaction and integration costs associated with the acquisition of the Patient Recovery Business were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$7 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$75 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Impairments and (Gain)/Loss on Disposal of Assets, Net</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$508 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> related to the divestiture of our majority interest in naviHealth. See also &#8220;Gain on Sale of Equity Interest in naviHealth&#8221; below with respect to the sale of the remainder of our equity interest in naviHealth in fiscal 2020.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Litigation (Recoveries)/Charges, Net</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.14 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> after tax) associated with the opioid litigation. See Significant Developments in Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and Trends section in this MD&amp;A and&#160;</span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$103 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$117 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, of estimated losses and legal defense costs associated with inferior vena cava ("IVC") filter product liability claims.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized income of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$16 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$94 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, for</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">recoveries in class action antitrust lawsuits in which we were a class member.</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Components of Earnings/(Loss) Before Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition to the items discussed above, earnings/(loss) before income taxes was impacted by the following:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other (income)/expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(1</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">15</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Interest expense, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">238</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">294</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(19</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss on early extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">16</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain on sale of equity interest in naviHealth</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(579</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Interest Expense, Net</span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> interest expense decreased from fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> primarily due to lower debt outstanding and lower interest rates.</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Loss On Early Extinguishment Of Debt</span></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$16 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> loss in connection with the redemption and early debt repurchases as described further in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s90F282348F0354D781EEBCEFD3A04F7E"><span style="font-family:Arial Narrow;font-size:10pt;">Note 6</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Consolidated Financial Statements."</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Gain on Sale of Equity Interest in naviHealth</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;">$579 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> from the sale of our equity interest </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">in a partnership that owned naviHealth, as described further in the Significant Developments in Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and Trends section of this MD&amp;A and </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s20ab24d9611f400f9fecc35ff4abdad4"><span style="font-family:Arial Narrow;font-size:10pt;">Note 2</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Consolidated Financial Statements." See also &#8220;Impairments and (Gain)/Loss on Disposal of Assets, Net&#8221; above with respect to the fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> sale of our majority interest in naviHealth.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">11</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Provision for Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Generally, fluctuations in the effective tax rate are due to changes in the distribution of income among taxing jurisdictions with differing income tax rates and other reconciling items.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">A reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate from continuing operations is as follows</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">(see </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s002522EA8F5F5274B7487704BE70A9A8"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the "Notes to Consolidated Financial Statements" for additional information):</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:75%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020 (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019 (2)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Provision at Federal statutory rate</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">21.0</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">21.0</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State and local income taxes, net of federal benefit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Tax effect of foreign operations</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(0.7</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nondeductible/nontaxable items</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(0.1</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Tax Act</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.1</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(0.8</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Change in valuation allowances</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign tax credits</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.5</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1.0</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Legal entity reorganization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(3.6</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Opioid litigation</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(23.2</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(0.2</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(0.7</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effective income tax rate</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2.1</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">22.1</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The effective income tax rate for fiscal 2020 represents an income tax benefit tax rate.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The effective income tax rate for fiscal 2019 represents an income tax expense tax rate.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fiscal </span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020</span><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The fiscal 2020 effective income tax rate was impacted by </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">the Settlement Framework, as described further in the Significant Developments in Fiscal 2020 and Trends section in this MD&amp;A.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Ongoing Audits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2008 through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including U.S. Internal Revenue Service ("IRS") challenges to our international transfer pricing for the periods from 2008 to 2014, and it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">12</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s20C4F58445F6584F993BCF076689EB1D"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.40944881889764%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Liquidity and Capital Resources</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Liquidity and Capital Resources</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We currently believe that, based on available capital resources (cash on hand and committed credit facilities) and projected operating cash flow, we have adequate capital resources to fund working capital needs; currently anticipated capital expenditures; currently anticipated business growth and expansion; contractual obligations; tax payments; and current and projected debt service requirements, early extinguishment of debt, dividends and share repurchases as well as potential opioid litigation settlement payments associated with the Settlement Framework. If we decide to engage in one or more acquisitions, depending on the size and timing of such transactions, we may need to access capital markets for additional financing. To-date, the COVID-19 pandemic has not resulted in material changes to our liquidity and capital resources and has not impacted our ability to comply with financial commitments.</span></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash and Equivalents</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our cash and equivalents balance was </span><span style="font-family:Arial Narrow;font-size:10pt;">$2.8 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> compared to </span><span style="font-family:Arial Narrow;font-size:10pt;">$2.5 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. The increase in cash during</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> was due to net cash provided by operating activities of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$2.0 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which reflects increases to working capital associated with the timing of payments to vendors, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$886 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of net cash proceeds from the sale of investments, substantially all of which was related to the sale of our equity interest in naviHealth, offset by cash deployed of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1.4 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for debt repayments, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$569 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for dividends and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$350 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for share repurchases. </span><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, our cash and equivalents were held in cash depository accounts with major banks or invested in high quality, short-term liquid investments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, our cash and equivalents increased by $700 million due to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$2.7 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of net cash provided by operating activities and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$737 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of net cash proceeds from the sale of our majority interest in naviHealth, offset by </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1.1 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> paid for debt repayments, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$600 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> paid for share repurchases, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$577 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> paid in dividends and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$328 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> paid for capital expenditures.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Changes in working capital, which impact operating cash flow, can vary significantly depending on factors such as the timing of customer payments, inventory purchases, payments to vendors and tax </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">payments in the regular course of business, as well as fluctuating working capital needs driven by customer and product mix.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The cash and equivalents balance at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> included $476 million of cash and equivalents held by subsidiaries outside of the United States.  </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In June 2020, we returned $140 million of cash held by foreign subsidiaries to the U.S.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, foreign earnings of approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$800 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> are considered indefinitely reinvested for working capital and other offshore investment needs. The computation of tax required if those earnings are repatriated is not practicable. For amounts not considered indefinitely reinvested, we have recorded an immaterial amount of income tax expense in our financial statements in fiscal 2020.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Financing Arrangements and Financial Instruments</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Credit Facilities and Commercial Paper</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to cash and equivalents and operating cash flow, other sources of liquidity at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> include a </span><span style="font-family:Arial Narrow;font-size:10pt;">$2.0 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> commercial paper program, backed by a </span><span style="font-family:Arial Narrow;font-size:10pt;">$2.0 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> revolving credit facility. We also have a </span><span style="font-family:Arial Narrow;font-size:10pt;">$1.0 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> committed receivables sales facility. At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had no amounts outstanding under our commercial paper program, revolving credit facility or our committed receivables sales facility. During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, under our commercial paper program and our committed receivables program, we had maximum combined total daily amounts outstanding of </span><span style="font-family:Arial Narrow;font-size:10pt;">$1.7 billion</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;and an average combined daily amount outstanding of&#160;$</span><span style="font-family:Arial Narrow;font-size:10pt;">195 million</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">Our revolving credit and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter through December 2020, a consolidated net leverage ratio of no more than 4.00-to-1. The maximum permitted ratio will reduce to 3.75-to-1 in March 2021 and as of the end of every quarter thereafter</span><span style="font-family:Arial Narrow;font-size:10pt;">. As of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we were in compliance with this financial covenant. </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Long-Term Obligations</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had total long-term obligations, including the current portion and other short-term borrowings of </span><span style="font-family:Arial Narrow;font-size:10pt;">$6.8 billion</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In June 2020, we redeemed </span><span style="font-family:Arial Narrow;font-size:10pt;">$500 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> aggregate principle amount of 4.625% Notes due December 2020 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with the redemption, we recorded a </span><span style="font-family:Arial Narrow;font-size:10pt;">$7 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> loss on early extinguishment of debt. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In November 2019, we repaid the full principal of the 2.4% Notes due 2019 at maturity for&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$450 million</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">During fiscal 2020, we also early repurchased&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$247 million</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;2.616%&#160;Notes due 2022,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$11 million</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;3.2% Notes due 2022,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$20 million</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;Floating Rate Notes due 2022,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$104 million</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;3.41% Notes due 2027,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$6 million</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;4.6% Notes due 2043,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$5 million</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;4.9% Notes due 2045, and&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$35 million</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;4.368% Notes due 2047.&#160; In connection with these early debt </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">13</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.40944881889764%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Liquidity and Capital Resources</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">repurchases, we recognized a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$9 million</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;loss on early extinguishment of debt. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In fiscal 2019, we repaid </span><span style="font-family:Arial Narrow;font-size:10pt;">$1.0 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> of 1.948% notes at maturity and repurchased a total of </span><span style="font-family:Arial Narrow;font-size:10pt;">$100 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> of notes due in 2022 and 2027. The loss on early extinguishment of debt from the fiscal 2019 early repurchases was immaterial.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The redemption and repurchases were paid for with available cash and other short-term borrowings.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Risk Management</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We use interest rate swaps, foreign currency contracts and commodity contracts to manage our exposure to cash flow variability. </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We also use interest rate swaps to protect the value of our debt and use foreign currency forward contracts to protect the value of our existing and forecasted foreign currency assets and liabilities. See the "Quantitative and Qualitative Disclosures About Market Risk" section as well as </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sAF8B609C6A1B5242B7B172A7B9FB2416"><span style="font-family:Arial Narrow;font-size:10pt;">Note 1</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s138045C0A5375688972939C6B03E89B1"><span style="font-family:Arial Narrow;font-size:10pt;">Note 10</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for information regarding the use of financial instruments and derivatives as well as foreign currency, interest rate and commodity exposures.</span></div></div></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Capital Deployment</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Opioid Settlement Framework</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In October 2019, we agreed in principle to a Settlement Framework which includes a cash component, pursuant to which we would pay up to $5.56 billion over eighteen years. If a definitive agreement is reached, and subject to participation by states and political subdivisions, we expect payment amounts under the Settlement Framework to be spread through the 18-year period. We cannot currently predict when those payments might begin, and it is possible that they may ultimately be made over a different time period, or not at all. See </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Significant Developments in Fiscal 2020 and Trends section in this MD&amp;A </span><span style="font-family:Arial Narrow;font-size:10pt;">for additional information.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Capital Expenditures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Capital expenditures during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$375 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$328 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We expect capital expenditures in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2021</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to be between $400 million and $450 million and to be primarily for information technology and infrastructure projects.</span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Dividends</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we paid quarterly dividends totaling </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1.92</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> per share, an increase of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">1 percent</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> from fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">On May 11, 2020, our Board of Directors approved a quarterly dividend of $0.4859 per share, or $1.94 per share on an annualized basis, which was paid on July 15, 2020 to shareholders of record on July 1, 2020.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">On August 5, 2020, our Board of Directors approved a quarterly dividend of $0.4859 per share, payable on October 15, 2020 to shareholders of record on October 1, 2020.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Share Repurchases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$350 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$600 million</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, of our common shares. We funded the repurchases with available cash and short-term borrowing. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3D77F43D97875956BB9F5A04AD8753DD"><span style="font-family:Arial Narrow;font-size:10pt;">Note 11</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the "Notes to Consolidated Financial Statements" for additional information. At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> had </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$943 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> authorized for share repurchases r</span><span style="font-family:Arial Narrow;font-size:10pt;">emaining under all programs.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">14</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s465DB026D8AE58EAB5E73D7C0CD608EE"></a></div><div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Contractual Obligations</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, our contractual obligations, including estimated payments due by period, were as follows: </span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:32%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2022 to 2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2024 to 2025</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">There-after</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term debt and short-term borrowings (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,967</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,222</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3,552</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,741</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Interest on long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">226</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">411</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">336</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,671</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,644</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease obligations (2)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">18</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">6</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">36</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease obligations (3)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">117</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">168</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">95</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">123</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">503</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Purchase obligations and other payments (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">623</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">481</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">210</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">36</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,350</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:Arial Narrow;font-size:7.5pt;font-weight:bold;">Total contractual obligations (5) (6)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">976</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,045</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,869</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5,384</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">11,274</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Represents maturities of our long-term debt obligations and other short-term borrowings excluding finance lease obligations described below. See </span><a style="font-family:Arial Narrow;font-size:8pt;" href="#s90F282348F0354D781EEBCEFD3A04F7E"><span style="font-family:Arial Narrow;font-size:8pt;">Note 6</span></a><span style="font-family:Arial Narrow;font-size:8pt;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further information.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Represents minimum finance lease obligations included within long-term obligations in our consolidated balance sheet and further described in </span><a style="font-family:Arial Narrow;font-size:8pt;" href="#s1a0a81a45f964330b5b7b44b0dd06884"><span style="font-family:Arial Narrow;font-size:8pt;">Note 5</span></a><span style="font-family:Arial Narrow;font-size:8pt;"> of the &#8220;Notes to Consolidated Financial Statements.&#8221;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Represents minimum operating lease obligations included within other accrued liabilities and deferred income taxes and other liabilities in our consolidated balance sheet and further described in </span><a style="font-family:Arial Narrow;font-size:8pt;" href="#s1a0a81a45f964330b5b7b44b0dd06884"><span style="font-family:Arial Narrow;font-size:8pt;">Note 5</span></a><span style="font-family:Arial Narrow;font-size:8pt;"> of the &#8220;Notes to Consolidated Financial Statements.&#8221;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">A purchase obligation is defined as an agreement to purchase goods or services that is legally enforceable and specifies all significant terms, including fixed or </span></div></td></tr></table></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-left:24px;padding-bottom:4px;text-align:justify;"><span style="font-family:Arial Narrow;font-size:8pt;">minimum quantities to be purchased; fixed, minimum or variable price provisions; and approximate timing of the transaction. The purchase obligation amounts disclosed above represent estimates of the minimum for which we are obligated and the time period in which cash outflows will occur. Purchase orders and authorizations to purchase that involve no firm commitment from either party are excluded from the above table. In addition, contracts that can be unilaterally canceled with no termination fee or with proper notice are excluded from our total purchase obligations except for the amount of the termination fee or the minimum amount of goods that must be purchased during the requisite notice period. Purchase obligations and other payments also includes quarterly payments of $</span><span style="font-family:Arial Narrow;font-size:8pt;">45.6 million</span><span style="font-family:Arial Narrow;font-size:8pt;"> that we are required to pay CVS Health Corporation ("CVS") in connection with Red Oak Sourcing and will be in place for the remaining five years of the agreement. See </span><a style="font-family:Arial Narrow;font-size:8pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:8pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:8pt;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information.</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(5)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term liabilities, such as unrecognized tax benefits, deferred taxes and other tax liabilities, have been excluded from the above table due to the inherent uncertainty of the underlying tax positions or because of the inability to reasonably estimate the timing of any cash outflows. See </span><a style="font-family:Arial Narrow;font-size:8pt;" href="#s002522EA8F5F5274B7487704BE70A9A8"><span style="font-family:Arial Narrow;font-size:8pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:8pt;"> of the "Notes to Consolidated Financial Statements" for further discussion of income taxes.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(6)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total contractual obligations do not include payments that may be made in connection with the opioid litigation, as further described in Significant Developments in Fiscal </span><span style="font-family:Arial Narrow;font-size:8pt;">2020</span><span style="font-family:Arial Narrow;font-size:8pt;"> and Trends section in this MD&amp;A and&#160;</span><a style="font-family:Arial Narrow;font-size:8pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:8pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:8pt;">&#160;of the "Notes to Consolidated Financial Statements." If a definitive agreement is reached, and subject to participation by states and political subdivisions, we expect payment amounts under the Settlement Framework to be spread through the 18-year period. We cannot currently predict when those payments might begin, and it is possible that they may ultimately be made over a different time period, or not at all. See </span><a style="font-family:Arial Narrow;font-size:8pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:8pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:8pt;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information. </span></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></div></div><div><a id="s9BE74625C6A753219F5324517C4ED12E"></a></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Off-Balance Sheet Arrangements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We had no significant "off-balance sheet arrangements" at&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, as that term is defined in the SEC rules.</span></div><div><a id="sA220684FF9E95394A4A5BE0C895B26E6"></a></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Recent Financial Accounting Standards</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sAF8B609C6A1B5242B7B172A7B9FB2416"><span style="font-family:Arial Narrow;font-size:10pt;">Note 1</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for a discussion of recent financial accounting standards.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">15</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="sC1ADE4F0518352DE9F2C5B039A99DEE5"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.01574803149606%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Critical Accounting Policies and Sensitive Accounting Estimates</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Critical Accounting Policies and Sensitive Accounting Estimates</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Critical accounting policies are those accounting policies that (i)&#160;can have a significant impact on our financial condition and results of operations and (ii)&#160;require the use of complex and subjective estimates based upon past experience and management&#8217;s judgment. Other people applying reasonable judgment to the same facts and circumstances could develop different estimates. Because estimates are inherently uncertain, actual results may differ. In this section, we describe the significant policies applied in preparing our consolidated financial statements that management believes are the most dependent on estimates and assumptions. For further discussion of accounting policies for items within this section and of additional accounting policies, see </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sAF8B609C6A1B5242B7B172A7B9FB2416"><span style="font-family:Arial Narrow;font-size:10pt;">Note 1</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the &#8220;Notes to Consolidated Financial Statements.&#8221;</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The COVID-19 pandemic has severely impacted, and continues to severely impact the U.S. and global economies and, beginning in the third quarter of fiscal 2020, our businesses have been impacted in a variety of ways. We cannot estimate the length or severity of the COVID-19 pandemic or the related U.S. and global economic consequences on our business and operations, including whether and when normal economic and operating conditions will resume or the extent to which the disruption may impact our business, financial position, results of operations or cash flow. Our e</span><span style="font-family:Arial Narrow;font-size:10pt;">stimates, judgments and assumptions related to the COVID-19 pandemic could ultimately differ over time</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Allowance for Doubtful Accounts</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The allowance for doubtful accounts includes general and specific reserves. We determine our allowance for doubtful accounts by reviewing accounts receivable aging, industry trends, customer financial strength and credit standing, historical write-off trends and payment history. We regularly evaluate how changes in economic conditions, including the economic impact of the COVID-19 pandemic, may affect credit risks. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sAF8B609C6A1B5242B7B172A7B9FB2416"><span style="font-family:Arial Narrow;font-size:10pt;">Note 1</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further information on our policy for Receivables and Allowance for Doubtful Accounts.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">A hypothetical 0.1 percent increase or decrease in the reserve as a percentage of trade receivables at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, would result in an increase or decrease in bad debt expense of </span><span style="font-family:Arial Narrow;font-size:10pt;">$8 million</span><span style="font-family:Arial Narrow;font-size:10pt;">. We believe the reserve maintained and expenses recorded in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> are appropriate.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At this time, we are not aware of any analytical findings or customer issues that are likely to lead to a significant future increase in the allowance for doubtful accounts as a percentage of revenue. In addition, the </span><span style="font-family:Arial Narrow;font-size:10pt;">Financial Accounting Standards Board</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8217;s amended accounting guidance that requires entities to measure credit losses </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">on trade and other receivables using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts is effective for us in the first quarter of fiscal 2021.  We have evaluated the impact of adopting this new guidance and have determined it will not have a material impact on our consolidated financial statements or disclosures. The following table presents information regarding our allowance for doubtful accounts over the past three fiscal years:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:63%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except percentages)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Allowance for doubtful&#160;accounts at beginning of period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">193</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">139</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">137</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Charged to costs and expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">140</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">141</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">114</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Reduction&#160;to allowance&#160;for&#160;customer deductions&#160;and write-offs </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(127</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(87</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(111</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Allowance for doubtful accounts at end of period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">206</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">193</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">139</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Allowance&#160;as a&#160;percentage of customer receivables</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2.5</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.3</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.8</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Allowance&#160;as a&#160;percentage of revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.13</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.13</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.10</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The sum of the components may not equal the total due to rounding.</span></div></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Inventories</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">A substantial portion of our inventories (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">56 percent</span><span style="font-family:Arial Narrow;font-size:10pt;"> at both </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">)&#160;are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These are primarily merchandise inventories at the core pharmaceutical distribution facilities within our Pharmaceutical segment (&#8220;distribution facilities&#8221;). The LIFO impact on the consolidated statements of earnings/(loss) depends on pharmaceutical manufacturer price appreciation or deflation and our fiscal year-end inventory levels, which can be meaningfully influenced by customer buying behavior immediately preceding our fiscal year-end. Historically, prices for branded pharmaceuticals have generally tended to rise, resulting in an increase in cost of products sold, whereas prices for generic pharmaceuticals generally tend to decline, resulting in a decrease in cost of products sold. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sAF8B609C6A1B5242B7B172A7B9FB2416"><span style="font-family:Arial Narrow;font-size:10pt;">Note 1</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further information on our policy for Inventories.</span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Using LIFO, if there is a decrease in inventory levels that have experienced pharmaceutical price appreciation, the result generally will be a decrease in future cost of products sold as our older inventory is held at a lower cost. Conversely, if there is a decrease in inventory levels that have experienced a pharmaceutical price decline, the result generally will be an increase in future cost of products sold as our older inventory is held at a higher cost. </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">16</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.01574803149606%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Critical Accounting Policies and Sensitive Accounting Estimates</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within these distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation. At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, inventories valued at LIFO cost were </span><span style="font-family:Arial Narrow;font-size:10pt;">$411 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> and</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">$230 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> or </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our remaining inventory that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. Net realizable value is defined as </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were </span><span style="font-family:Arial Narrow;font-size:10pt;">$155 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">$171 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">If actual conditions are less favorable than our assumptions, additional inventory reserves may be required.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Goodwill and Other Indefinite-Lived Intangible Assets</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Purchased goodwill and intangible assets with indefinite lives are tested for impairment annually or when indicators of impairment exist. Goodwill impairment testing involves a comparison of the estimated fair value of reporting units to the respective carrying amount, which may be performed utilizing either a qualitative or quantitative assessment. </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for the annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. </span><span style="font-family:Arial Narrow;font-size:10pt;">A reporting unit is defined as an operating segment or </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">one level below an operating segment (also known as a component).</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (which are components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#8220;Medical Unit&#8221;); and Cardinal Health at-Home Solutions division. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Goodwill impairment testing involves judgment, including the identification of repo</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">rting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists and, if necessary,</span><span style="font-family:Arial Narrow;font-size:10pt;"> the estimation of the fair value of the applicable reporting </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">unit. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our determination of estimated fair value of our reporting units is based on a combination of the income-based and market-based approaches </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">(using discount rates ranging from </span><span style="font-family:Arial Narrow;font-size:10pt;">8.5 percent</span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;">10.5 percent</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">)</span><span style="font-family:Arial Narrow;font-size:10pt;">. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">internally-developed forecasts. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the market-based guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including actual operating results. The use of alternate estimates and assumptions, changes in the industry or peer groups,  or changes in weightings assigned to the discounted cash flow method, guideline public company method or guideline transaction method could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment. If a reporting unit fails to achieve expected earnings or operating cash flow, or otherwise fails to meet current financial plans, or if there were changes to any other key assumptions used in the tests, the reporting unit could incur a goodwill impairment in a future period. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We performed annual impairment testing in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;"> and, with the exception of our Medical Unit in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">For our annual impairment test in fiscal 2020, the fair value of our Medical Unit exceeded its carrying value of $10.1 billion by approximately 7 percent. For this test, we used a discount rate of 8.5 percent and a terminal growth rate of 2 percent. Additionally, we assigned a weighting of 80 percent to the discounted cash flow method, 10 percent to the guideline public company method, and 10 percent to the guideline transaction method. The goodwill balance for our Medical Unit was $4.2 billion at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Adverse changes in key assumptions, such as assumptions related to the COVID-19 pandemic which could cause a decrease in future cash flows; an increase in the discount rate; or a decrease in the terminal growth rate, among other things, could result in a goodwill impairment for the Medical Unit. For example, if we were to use a </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">17</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.01574803149606%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Critical Accounting Policies and Sensitive Accounting Estimates</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">discount rate of 9.5 percent, the carrying value would have exceeded the fair value for our Medical Unit by 5.0 percent for fiscal 2020. Similarly, if we were to use a terminal growth rate of 0.5 percent, the carrying value would have exceed the fair value for our Medical Unit by less than 1.0 percent for fiscal 2020. For any of our other reporting units, the fair value would not have been less than the carrying amount for fiscal 2020 if we increased the discount rate by 1.0 percentage point or decreased the terminal growth rate by 1.0 percentage point. As discussed further in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s0B8CFB5481FD5F8C92CD0E2191E456DF"><span style="font-family:Arial Narrow;font-size:10pt;">Note 1</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the "Notes to Consolidated Financial Statements," during the fourth quarter of fiscal 2018 we recognized a </span><span style="font-family:Arial Narrow;font-size:10pt;">$1.4 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> goodwill impairment charge related to our Medical Unit, which is included in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings/(loss). There was no tax benefit related to the goodwill impairment charge.</span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The impairment test for indefinite-lived intangibles other than goodwill (primarily IPR&amp;D) involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation </span><span style="font-family:Arial Narrow;font-size:10pt;">requires the use of estimates and significant judgments and</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sAF8B609C6A1B5242B7B172A7B9FB2416"><span style="font-family:Arial Narrow;font-size:10pt;">Note 1</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of "Notes to Consolidated Financial Statements" for additional information regarding goodwill and other intangible assets.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Loss Contingencies and Self-Insurance</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or outcomes can occur, assessing contingencies is highly subjective and requires judgments about future events.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We also self-insure for employee healthcare, certain product liability matters, auto liability, property and workers' compensation and maintain insurance for individual losses exceeding certain limits when available.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Self-insurance accruals include an estimate for expected settlements on pending claims, defense costs, administrative fees, claims adjustment costs and an estimate for claims incurred but not reported. For certain types of exposures, we develop the estimate of expected ultimate costs to settle each claim based on specific information related to each claim if available. Other estimates are based on an assessment of outstanding claims, historical analysis and current payment trends. For claims incurred but not reported, the liabilities are calculated and derived in accordance with generally accepted actuarial practices or using an estimated lag period.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We regularly review contingencies and self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Examples of such contingencies include various lawsuits related to the distribution of prescription opioid pain medications and the Cordis IVC filter lawsuits. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with the opioid litigation as described further in the Significant Developments in Fiscal 2020 and Trends section in this MD&amp;A, we recorded a pre-tax charge of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;(</span><span style="font-family:Arial Narrow;font-size:10pt;">$5.14 billion</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;after tax) during fiscal 2020. </span><span style="font-family:Arial Narrow;">Definitive terms of a settlement under the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied.  </span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">We develop and periodically update reserve estimates for the Cordis inferior vena cava ("Cordis IVC") claims, including those received to date and expected to be received in the future and related costs. To project future Cordis IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, sales data, implant and injury to report lag patterns and estimated defense costs. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The amount of loss may differ materially from these estimates. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information regarding loss contingencies and product liability lawsuits.</span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">18</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.01574803149606%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Critical Accounting Policies and Sensitive Accounting Estimates</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Provision for Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. Our income tax expense, deferred income tax assets and liabilities, and unrecognized tax benefits reflect management&#8217;s assessment of estimated future taxes to be paid on items in the consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents information about our tax position at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:74%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total deferred income tax assets (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,412</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">864</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Valuation allowance for deferred income tax assets (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(470</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(542</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Net deferred&#160;income&#160;tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">942</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">322</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total deferred income tax liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(2,161</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(2,035</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Net deferred income tax liability</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(1,219</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1,713</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total deferred income tax assets included </span><span style="font-family:Arial Narrow;font-size:8pt;">$589 million</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">$621 million</span><span style="font-family:Arial Narrow;font-size:8pt;"> of loss and tax credit carryforwards at </span><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;">, respectively.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The valuation allowance primarily relates to federal, state and international loss and credit carryforwards for which the ultimate realization of future benefits is uncertain.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Expiring or unusable loss and credit carryforwards and the required valuation allowances are adjusted quarterly when it is more likely than not that at least a portion of the respective deferred tax assets will not be realized. After applying the valuation allowances, we do not anticipate any limitations on our use of any of the other net deferred income tax assets described above. We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax charge for the opioid litigation, during fiscal year </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">,  we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$488 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$469 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the U.S. Tax Cuts and Jobs Act ("Tax Act"). Further, it is possible that the tax authorities </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s002522EA8F5F5274B7487704BE70A9A8"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2008 through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including IRS challenges to our international transfer pricing for the periods from 2008 to 2014, and it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our assumptions and estimates around uncertain tax positions require significant judgment; the actual amount of tax benefit related to uncertain tax positions may differ from these estimates. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s002522EA8F5F5274B7487704BE70A9A8"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information regarding unrecognized tax benefits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We believe that our estimates for the valuation allowances against deferred tax assets and unrecognized tax benefits are appropriate based on current facts and circumstances. The amount we ultimately pay when matters are resolved may differ from the amounts accrued. Changes in our current estimates due to unanticipated market conditions, tax law changes or other factors could have a material effect on our ability to utilize deferred tax assets. For a further discussion on Provision for Income Taxes, see </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s002522EA8F5F5274B7487704BE70A9A8"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the &#8220;Notes to the Consolidated Financial Statements.&#8221;</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The calculation of our tax liabilities includes estimates for uncertainties in the application of broad and complex changes to the U.S. tax code as per the Tax Act as enacted by the United States government on December 22, 2017. We have made reasonable estimates and recorded amounts based on management judgment and our current understanding of the Tax Act which is subject to further interpretation by the Internal Revenue Service ("IRS"). See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s002522EA8F5F5274B7487704BE70A9A8"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information regarding the Tax Act.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">19</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s2B855D2F667B5A31AF19D34479AAEA66"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:52%;"></td><td style="width:24%;"></td><td style="width:24%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">This report, including the "Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Overview" section within MD&amp;A, contains financial measures that are not calculated in accordance with GAAP. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">In addition to analyzing our business based on financial information prepared in accordance with GAAP, we use these non-GAAP financial measures internally to evaluate our performance, engage in financial and operational planning, and determine incentive compensation because we believe that these measures provide additional perspective on and, in some circumstances are more closely correlated to, the performance of our underlying, ongoing business. We provide these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on our financial and operating results on a year-over-year basis and in comparing our performance to that of our competitors. However, the non-GAAP financial measures that we use may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. The non-GAAP financial measures disclosed by us should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth below should be carefully evaluated.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Exclusions from Non-GAAP Financial Measures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Management believes it is useful to exclude the following items from the non-GAAP measures presented in this report for its own and for investors&#8217; assessment of the business for the reasons identified below:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;text-decoration:underline;">LIFO charges and credits</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;"> are excluded because the factors that drive last-in first-out ("LIFO") inventory charges or credits, such as pharmaceutical manufacturer price appreciation or deflation and year-end inventory levels (which can be meaningfully influenced by customer buying behavior immediately preceding our fiscal year-end), are largely out of our control and cannot be accurately predicted. The exclusion of LIFO charges and credits from non-GAAP metrics facilitates comparison of our current financial results to our historical financial results and to our peer group companies&#8217; financial results. We did not recognize any LIFO charges or credits during the periods presented.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Surgical gown recall costs</span><span style="font-family:Arial Narrow;"> includes inventory write-offs and certain remediation and supply disruption costs arising from the January 2020 recall of select Association for the Advancement of Medical Instrumentation ("AAMI") Level 3 surgical gowns and voluntary field actions (a recall of some packs and a corrective action allowing overlabeling of other packs) for Presource Procedure Packs containing affected gowns. We have excluded these costs from our non-GAAP metrics to allow investors to better understand the underlying operating results of the business and to facilitate comparison of our current financial results to our historical financial results and to our peer group companies&#8217; financial results.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">State opioid assessments related to prior fiscal years</span><span style="font-family:Arial Narrow;"> is the portion of state assessments for prescription opioid medications that were sold or distributed in periods prior to the fiscal year of the initial assessment. This portion is excluded from non-GAAP financial measures because it is retrospectively applied to sales in prior fiscal years and inclusion would obscure analysis of the current fiscal year results of our underlying, ongoing business. Additionally, while states' laws may require us to make payments on an ongoing basis, the portion of the assessment related to sales in prior periods are contemplated to be one-time, nonrecurring items. Reversals of these accruals have occurred when certain assessments were found by a Court unconstitutional</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;text-decoration:underline;">Restructuring and employee severance costs</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;"> are excluded because they are not part of the ongoing operations of our underlying business.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;text-decoration:underline;">Amortization and other acquisition-related costs</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">, which include transaction costs, integration costs, and changes in the fair value of contingent consideration obligations, are excluded because they are not part of the ongoing operations of our underlying business and to facilitate comparison of our current financial results to our historical financial results and to our peer group companies' financial results. Additionally, costs for amortization of acquisition-related intangible assets are non-cash amounts, which are variable in amount and frequency and are significantly impacted by the timing and size of acquisitions, so their exclusion facilitates comparison of historical, current and forecasted financial results. We also exclude other acquisition-related costs, which are directly related to an acquisition but do not meet the criteria to be recognized on the acquired entity&#8217;s initial balance sheet as part of the purchase price allocation. These costs are also significantly impacted by the timing, complexity and size of acquisitions.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;text-decoration:underline;">Impairments and gain or loss on disposal of assets</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">&#160;are excluded because they do not occur in or reflect the ordinary course of our ongoing business operations and are inherently unpredictable in timing and amount, and in the case of impairments, are non-cash amounts, so their exclusion facilitates comparison of historical, current and forecasted financial results.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;text-decoration:underline;">Litigation recoveries or charges, net</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;"> are excluded because they often relate to events that may have occurred in prior or multiple periods, do not occur in or reflect the ordinary course of our business and are inherently unpredictable in timing and amount.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">20</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:52%;"></td><td style="width:24%;"></td><td style="width:24%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;text-decoration:underline;">Loss on early extinguishment of debt</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;"> is excluded because it does not typically occur in the normal course of business and may obscure analysis of trends and financial performance. Additionally, the amount and frequency of this type of charge is not consistent and is significantly impacted by the timing and size of debt extinguishment transactions.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Gain on sale of equity interest in naviHealth</span><span style="font-family:Arial Narrow;"> was </span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">incurred in connection with the sale of our remaining equity interest in naviHealth in fiscal 2020. The equity interest was retained in connection with the initial sale of our majority interest in naviHealth during fiscal 2019. We exclude this significant gain because gains or losses on investments of this magnitude do not typically occur in the normal course of business and are similar in nature to a gain or loss from a divestiture of a majority interest, which we exclude from non-GAAP results. The gain on the initial sale of our majority interest in naviHealth in fiscal 2019 was also excluded from our non-GAAP measures. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;text-decoration:underline;">Transitional tax benefit, net</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;"> related to the Tax Cuts and Jobs Act is excluded because it results from the one-time impact of a very significant change in the U.S. federal corporate tax rate and, due to the significant size of the benefit, obscures analysis of trends and financial performance. The transitional tax benefit includes the initial estimate and subsequent adjustments for the re-measurement of deferred tax assets and liabilities due to the reduction of the U.S. federal corporate income tax rate and the repatriation tax on undistributed foreign earnings.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">  </span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">The tax effect for each of the items listed above, other than the transitional tax benefit item, is determined using the tax rate and other tax attributes applicable to the item and the jurisdiction(s) in which the item is recorded. The gross, tax and net impact of each item are presented with our GAAP to non-GAAP reconciliations. </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Definitions</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Growth rate calculation</span><span style="font-family:Arial Narrow;font-size:10pt;">: growth rates in this report are determined by dividing the difference between current period results and prior period results by prior period results.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Non-GAAP operating earnings</span><span style="font-family:Arial Narrow;">: operating earnings/(loss) excluding (1) LIFO charges/(credits), (2) surgical gown recall costs, (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, and (7) litigation (recoveries)/charges, net.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Non-GAAP earnings before income taxes</span><span style="font-family:Arial Narrow;">: earnings/(loss) before income taxes excluding (1) LIFO charges/(credits), (2) surgical gown recall costs, (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, (7) litigation (recoveries)/charges, net, (8) loss on early  extinguishment of debt and (9) gain on sale of equity interest in naviHealth.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Non-GAAP net earnings attributable to Cardinal Health, Inc.</span><span style="font-family:Arial Narrow;">: net earnings/(loss) attributable to Cardinal Health, Inc. excluding (1) LIFO charges/(credits), (2) surgical gown recall costs, (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, (7) litigation (recoveries)/charges, net, (8) loss on early extinguishment of debt and (9) gain on sale of equity interest in naviHealth, each net of tax, and (10) transitional tax benefit, net.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Non-GAAP effective tax rate</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">: provision for/(benefit from) income taxes adjusted for (1) LIFO charges/(credits), </span><span style="font-family:Arial Narrow;">(2) surgical gown recall costs, (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, (7) litigation (recoveries)/charges, net</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;">(8) loss on early extinguishment of debt and (9) gain on sale of equity interest in naviHealth, each net of tax, and (10) transitional tax benefit, net</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;"> divided by (earnings before income taxes adjusted for the first nine items).</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Non-GAAP diluted earnings per share attributable to Cardinal Health, Inc.</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">: non-GAAP net earnings attributable to Cardinal Health, Inc. divided by diluted weighted-average shares outstanding.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">21</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s86157E797BB25FF8AB6EF33A92777F40"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:52%;"></td><td style="width:24%;"></td><td style="width:24%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> GAAP to Non-GAAP Reconciliations</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"></td></tr><tr><td style="width:35%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Earnings/(Loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Earnings/(Loss) Growth Rate</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings/(Loss) Before Income Taxes</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Provision for/(Benefit From) Income Taxes</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net Earnings/(Loss)</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net Earnings/(Loss)</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;Growth Rate</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effective Tax Rate</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Diluted EPS</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1.2</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Diluted EPS</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;Growth Rate</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="23" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fiscal Year 2020</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4,098</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(3,772</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(79</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(3,696</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2.1</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(12.61</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Surgical gown recalls costs</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">85</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">85</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">22</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">63</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.22</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State opioid assessment related to prior fiscal years</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.01</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">122</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">122</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">29</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">93</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.31</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">524</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">524</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">130</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">394</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.34</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.02</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">3</sup></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5,741</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5,741</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">514</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5,227</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">17.84</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss on early extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">16</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">12</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.04</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain on sale of equity interest in naviHealth</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(579</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(86</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(493</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1.68</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Transitional tax benefit, net</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">4</sup></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(2</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(0.01</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,384</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,147</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">539</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,605</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">25.1</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5.45</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="23" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fiscal Year 2019</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">GAAP</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2,060</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,751</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">386</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,363</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">22.1</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.53</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">125</span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">125</span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">32</span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">93</span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.31</span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">621</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">621</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">148</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">473</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.57</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">5</sup></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(488</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(488</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(113</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(375</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1.25</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">36</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">36</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">26</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.09</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Transitional tax benefit, net</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">4</sup></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(9</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">9</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.03</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-GAAP</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2,353</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(9</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2,044</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">453</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,589</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">22.1</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5.28</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">6</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="23" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fiscal Year 2018</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">GAAP</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">126</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(94</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(228</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(487</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">256</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(80</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">213.8</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.81</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(80</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">176</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">176</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">25</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">151</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.48</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">707</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">707</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">176</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">531</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.69</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">6</sup></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,417</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,417</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(44</span></div></td><td style="vertical-align:middle;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,461</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.64</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">159</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">159</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">48</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">111</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.35</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss on early extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Transitional tax benefit, net</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">4</sup></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">936</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(936</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(2.97</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-GAAP</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2,585</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(7</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2,233</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">655</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,575</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(9</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">29.3</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5.00</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(7</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">1</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Attributable to Cardinal Health, Inc.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">2</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:8pt;">For fiscal 2020, GAAP diluted loss per share attributable to Cardinal Health, Inc. and the EPS impact from the GAAP to non-GAAP per share reconciling items are calculated using a weighted average of 293 million common shares, which excludes potentially dilutive securities from the denominator due to their anti-dilutive effects resulting from our GAAP net loss for the period. Fiscal 2020 non-GAAP diluted EPS is calculated using a weighted average of 295 million common shares, which includes potentially dilutive shares</span><span style="font-family:Arial Narrow;font-size:9pt;">.</span><span style="font-family:Arial Narrow;font-size:9pt;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">3</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net includes a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:8pt;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:8pt;"> (</span><span style="font-family:Arial Narrow;font-size:8pt;">$5.14 billion</span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax) recorded in the first quarter of fiscal 2020 related to the opioid litigation. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">4</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Reflects the net transitional benefit from the remeasurement of our deferred tax assets and liabilities partially offset by the repatriation tax on cash and earnings of foreign subsidiaries.&#160; See </span><a style="font-family:Arial Narrow;font-size:8pt;" href="#s002522EA8F5F5274B7487704BE70A9A8"><span style="font-family:Arial Narrow;font-size:8pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:8pt;"> of the "Notes to Consolidated Financial Statements" for more information on the Tax Act. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">5</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:8pt;">During fiscal 2019, we sold our majority interest in naviHealth and recognized a pre-tax gain of $508 million (</span><span style="font-family:Arial Narrow;font-size:8pt;">$378 million</span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax).</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">6</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fiscal year 2018 includes a goodwill impairment charge of $1.4 billion related to our Medical segment. There was no tax benefit related to this goodwill impairment charge. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">The sum of the components and certain computations may reflect rounding adjustments.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">We apply varying tax rates depending on the item's nature and tax jurisdiction where it is incurred.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">22</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sAD9595E6A7565841838053780BA1B0B4"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Selected Financial Data</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Selected Financial Data</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The consolidated financial data below includes all business combinations as of the date of acquisition that occurred during these periods. The following selected consolidated financial data should be read in conjunction with the consolidated financial statements and related notes and MD&amp;A.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:61%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1,2,3</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">4</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">5,6</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings Data:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">152,922</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">145,534</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">136,809</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">129,976</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">121,546</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4,098</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2,060</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">126</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2,120</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2,459</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(3,693</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,365</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">259</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,294</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,431</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(3</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(2</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(3</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(6</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(4</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net earnings/(loss) attributable to Cardinal Health, Inc. </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(3,696</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,363</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">256</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,288</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,427</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(12.61</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.55</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.82</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.06</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.36</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(12.61</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.53</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.81</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.03</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.32</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash dividends declared per common share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1.9292</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.9100</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.8635</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.8091</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.6099</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance Sheet Data:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">40,766</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">40,963</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">39,951</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">40,112</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">34,122</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term obligations, less current portion</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,765</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7,579</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">8,012</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">9,068</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4,952</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total Cardinal Health, Inc. shareholders' equity</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,789</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">6,328</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">6,059</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">6,808</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">6,554</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">During fiscal 2020, we recorded a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:8pt;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:8pt;"> (</span><span style="font-family:Arial Narrow;font-size:8pt;">$5.14 billion</span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax) related to the opioid litigation. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">2</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">During fiscal 2020, we recorded a total charge of $85 million in connection with the Recalls. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">3</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">During fiscal 2020, we sold the remainder of our equity interest in a partnership that owned naviHealth and recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:8pt;">$579 million</span><span style="font-family:Arial Narrow;font-size:8pt;"> (</span><span style="font-family:Arial Narrow;font-size:8pt;">$493 million</span><span style="font-family:Arial Narrow;font-size:8pt;"> million after tax) within net earnings/(loss). </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">4</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">During fiscal 2019, we sold our majority interest in naviHealth and recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:8pt;">$508 million</span><span style="font-family:Arial Narrow;font-size:8pt;"> (</span><span style="font-family:Arial Narrow;font-size:8pt;">$378 million</span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax) within operating earnings/(loss).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">5</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">During the fourth quarter of fiscal 2018, we recognized a non-cash goodwill impairment charge of </span><span style="font-family:Arial Narrow;font-size:8pt;">$1.4 billion</span><span style="font-family:Arial Narrow;font-size:8pt;"> related to our Medical segment. There was no tax benefit related to this goodwill impairment charge.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">6</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">During fiscal 2018, the United States enacted the Tax Cuts and Jobs Act. In fiscal 2018 we recognized a net transitional tax benefit of $936 million related to the enactment of the act. See </span><a style="font-family:Arial Narrow;font-size:8pt;" href="#s002522EA8F5F5274B7487704BE70A9A8"><span style="font-family:Arial Narrow;font-size:8pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:8pt;"> for more information. </span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">23</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s333C75A276DE55268DA27780A098DE09"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:25%;"></td><td style="width:75%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Disclosures about Market Risk</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are exposed to cash flow and earnings fluctuations as a result of certain market risks. These market risks primarily relate to foreign exchange, interest rate, and commodity price-related changes. We maintain a hedging program to manage volatility related to some of these market exposures which employs operational, economic, and derivative financial instruments in order to mitigate risk. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sAF8B609C6A1B5242B7B172A7B9FB2416"><span style="font-family:Arial Narrow;font-size:10pt;">Note 1</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s138045C0A5375688972939C6B03E89B1"><span style="font-family:Arial Narrow;font-size:10pt;">Note 10</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further discussion regarding our use of derivative instruments.</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Foreign Exchange Rate Sensitivity</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">By the nature of our global operations, we are exposed to cash flow and earnings fluctuations resulting from foreign exchange rate variation. These exposures are transactional and translational in nature. The following foreign currencies represent the principal drivers of our foreign exchange exposure: Canadian dollar, euro, Thai baht, Mexican peso, Chinese renminbi, Australian dollar, British pound and Japanese yen. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We apply a Value-At-Risk ("VAR") methodology to our transactional and translational exposures. The VAR model is a risk estimation tool and is not intended to represent actual losses in fair value that could be incurred.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Transactional Exposure</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Transactional exposure arises from the purchase and sale of goods and services in currencies other than our functional currency or the functional currency of our subsidiaries. At the end of each fiscal year </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">we perform sensitivity analyses on our forecasted transactional exposure for the upcoming fiscal year. These analyses include the estimated impact of our hedging program, which is designed to mitigate transactional exposure. Applying a VAR methodology to our transactional exposure and including the impact of our hedging program, the potential maximum loss in earnings for the upcoming fiscal year is estimated to be </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$12 million</span><span style="font-family:Arial Narrow;font-size:10pt;">, which is based on a one-year horizon and a 95 percent confidence level.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Translational Exposure</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have exposure related to the translation of financial statements of our foreign operations into U.S.&#160;dollars, our functional currency. Applying a VAR methodology to our translational exposure, the potential maximum loss in earnings for the upcoming fiscal year is estimated to be </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5 million</span><span style="font-family:Arial Narrow;font-size:10pt;">, which is based on a one-year horizon and a 95 percent confidence level. </span></div></div></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Interest Rate Sensitivity</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are exposed to changes in interest rates primarily as a result of our borrowing and investing activities to maintain liquidity and fund operations. The nature and amount of our long-term and short-term debt can be expected to fluctuate as a result of business requirements, market conditions and other factors. Our policy is to manage exposures to interest rates using a mix of fixed and floating rate debt as deemed appropriate by management. We utilize interest rate swap instruments to mitigate our exposure to interest rate movements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As part of our risk management program, we perform an annual sensitivity analysis on our forecasted exposure to interest rates for the upcoming fiscal year. This analysis assumes a hypothetical 50 basis point change in interest rates. At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, the potential increase or decrease in annual interest expense under this analysis as a result of this hypothetical change would be $5 million.  </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are also exposed to market risk from changes in interest rates related to our cash and cash equivalents, which includes marketable securities that are carried at fair value in the consolidated balance sheets. The fair value of our cash and cash equivalents is subject to change primarily as a result of changes in market interest rates and investment risk related to the issuers' credit worthiness. At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, a hypothetical increase or decrease of 50 basis points in interest rates would result in a hypothetical $5 million change in the estimated fair value.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">24</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:25%;"></td><td style="width:75%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Disclosures about Market Risk</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commodity Price Sensitivity</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are directly exposed to market price changes for certain commodities, including oil-based resins, nitrile, cotton, diesel fuel and latex. We typically purchase raw materials at either market prices or prices tied to a commodity index and some finished goods at prices based in part on a commodity price index. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As part of our risk management program, we perform sensitivity analysis on our forecasted direct commodity exposure for the upcoming fiscal year. Our forecasted direct commodity exposure at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> increased approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$10 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> from </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had hedged a portion of these direct commodity exposures (see </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s138045C0A5375688972939C6B03E89B1"><span style="font-family:Arial Narrow;font-size:10pt;">Note 10</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further discussion).</span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our forecasted direct commodity exposures for the upcoming fiscal year is </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$445 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span><span style="font-family:Arial Narrow;font-size:10pt;">The potential gain/loss given a hypothetical 10 percent fluctuation in commodity prices, assuming pricing collectively shifts in the same direction and we are unable to change customer pricing in response to those shifts or otherwise offset, for the upcoming fiscal year is </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$45 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> at June 30, 2020. The hypothetical offsetting impact of hedges in both periods was minimal. </span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">25</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s64B4883BB1AB5C45A2F86FABE0A8B842"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Business</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Business</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">General</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc. is a global integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. We provide medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. </span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Pharmaceutical Segment</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the United States, our Pharmaceutical segment:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">through its Pharmaceutical Distribution division, distributes branded and generic pharmaceutical and over-the-counter healthcare and consumer products to retailers (including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers), hospitals and other healthcare providers. This division:</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:12px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">maintains prime vendor relationships that streamline the purchasing process resulting in greater efficiency and lower costs for our retail, hospital and other healthcare provider customers;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:12px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">provides services to pharmaceutical manufacturers, including distribution, inventory management, data reporting, new product launch support and chargeback administration;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:12px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">through the connected care service offering, provides medication therapy management, telepharmacy and health messaging services and seeks to develop solutions to improve patient care through improved coordination of manufacturers, payers, pharmacies and patients;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:12px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">provides pharmacy management services to hospitals and operates pharmacies, including in community health centers; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:12px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">repackages generic pharmaceuticals and over-the-counter healthcare products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">through its Specialty Solutions division, distributes specialty pharmaceutical products to hospitals and other healthcare providers and provides consulting, patient support and other services for specialty pharmaceutical products to pharmaceutical manufacturers and healthcare providers; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">through its Nuclear and Precision Health Solutions division, operates nuclear pharmacies and manufacturing facilities, which manufacture, prepare and deliver radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and physician offices. This division also contract manufactures a radiopharmaceutical treatment (Xofigo) and holds the North American rights to manufacture and distribute Lymphoseek, a radiopharmaceutical diagnostic imaging agent.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s4B6912BAF1A2559F8537A7BBB757540B"><span style="font-family:Arial Narrow;font-size:10pt;">Note 15</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for Pharmaceutical segment revenue, profit and assets for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Pharmaceutical Distribution</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our Pharmaceutical Distribution division&#8217;s gross margin includes margin from our generic pharmaceutical program, from distribution services agreements with branded pharmaceutical manufacturers and from over-the-counter healthcare and consumer products. It also includes manufacturer cash discounts. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Margin from our generic pharmaceutical program includes price discounts and rebates from manufacturers and may in limited instances include price appreciation. Our earnings on generic pharmaceuticals are generally highest during the period immediately following the initial launch of a product, because generic pharmaceutical selling prices are generally highest during that period and tend to decline over time. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Margin from distribution services agreements with branded pharmaceutical manufacturers is derived from compensation we receive for providing a range of distribution and related services to manufacturers. Our compensation typically is a percentage of the wholesale acquisition cost that is set by manufacturers. In addition, under a limited number of agreements, branded pharmaceutical price appreciation, which is determined by the manufacturers, also serves as part of our compensation. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Sourcing Venture with CVS Health Corporation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In July 2014, we established Red Oak Sourcing, a U.S.-based generic pharmaceutical sourcing venture with CVS with an initial term of 10 years. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of both companies.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Specialty Pharmaceutical Products and Services</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We refer to products and services offered by our Specialty Solutions division as &#8220;specialty pharmaceutical products and services.&#8221; The Specialty Solutions division distributes oncology, rheumatology, urology, nephrology and other pharmaceutical products ("specialty pharmaceutical products") and human-derived plasma products to hospitals, dialysis clinics, physician offices and other healthcare providers; provides consulting, patient support, logistics, group purchasing and other services to pharmaceutical manufacturers and healthcare providers primarily supporting the development, marketing and distribution of specialty pharmaceutical products; and provides specialty pharmacy services. Our use of the terminology "specialty pharmaceutical products and services" may not be comparable to the terminology used by other industry participants.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">26</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Business</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Medical Segment</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our Medical segment manufactures and sources Cardinal Health branded general and specialty medical, surgical and laboratory products and devices. These products include exam and surgical gloves; needle, syringe and sharps disposal; compression; incontinence; nutritional delivery; wound care; cardiovascular and endovascular; single-use surgical drapes, gowns and apparel; fluid suction and collection systems; urology; operating room supply; and electrode product lines. Our Cardinal Health Brand products are sold directly or through third-party distributors in the United States, Canada, Europe, Asia and other markets. These products are generally higher-margin products. </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Medical segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada and this segment also assembles and sells sterile and non-sterile procedure kits. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Through Cardinal Health at-Home Solutions, this segment also distributes medical products to patients' homes in the United States. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Acquisitions and Divestitures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Acquisitions</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have acquired a number of businesses over the years that have enhanced our core strategic areas of Cardinal Health Brand medical products, generic pharmaceutical distribution and services, specialty pharmaceutical products and services, international and post-acute care. We expect to continue to pursue additional acquisitions in the future.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">During the last five fiscal years, we completed the following three large acquisitions:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:11%;"></td><td style="width:25%;"></td><td style="width:21%;"></td><td style="width:25%;"></td><td style="width:12%;"></td><td style="width:6%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">Company</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">Location</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Lines</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">of&#160;Business</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Acquisition</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Price</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">(in billions)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">07/17</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Patient Recovery Business of Medtronic, plc</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Mansfield, MA</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency</span></div></td><td colspan="2" style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$6.1</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10/15</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cordis business of Johnson &amp; Johnson</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fremont, CA</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardiovascular and endovascular products</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$1.9</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">07/15</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The Harvard Drug Group</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Livonia, MI</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical product distribution</span></div></td><td colspan="2" style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$1.1</span></div></td></tr></table></div></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We also completed several smaller acquisitions during the last five fiscal years, including, in fiscal 2017, the acquisition of the North </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">American rights to Lymphoseek, a radiopharmaceutical diagnostic imaging agent, from Navidea Biopharmaceuticals, Inc.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Divestitures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Over the past three fiscal years, we have also completed several divestitures. In February 2018, we completed the sale of our pharmaceutical and medical products distribution business in China to Shanghai Pharmaceuticals Holding Co., Ltd. for proceeds of $861 million (after adjusting for third party indebtedness and preliminary transaction adjustments).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In August 2018, we completed the sale of our equity interest in naviHealth, Inc. to investor entities controlled by CD&amp;R for proceeds of $737 million (after adjusting for certain fees and expenses) and a noncontrolling equity interest in a partnership that owned naviHealth. In May 2020, we sold the remainder of our equity interest in naviHealth.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We had acquired our equity interest in naviHealth through a series of transactions beginning in fiscal 2016, when we acquired a majority equity interest. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">27</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Business</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Customers</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our largest customers, CVS and OptumRx, accounted for </span><span style="font-family:Arial Narrow;font-size:10pt;">26 percent</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">14 percent</span><span style="font-family:Arial Narrow;font-size:10pt;"> of our fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> revenue, respectively. In the aggregate, our five largest customers, including CVS and OptumRx, accounted for </span><span style="font-family:Arial Narrow;font-size:10pt;">49 percent</span><span style="font-family:Arial Narrow;font-size:10pt;"> of our fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> revenue. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have agreements with group purchasing organizations (&#8220;GPOs&#8221;) that act as agents to negotiate vendor contracts on behalf of their </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">members. Our two largest GPO relationships in terms of  revenue are with Vizient, Inc. and Premier, Inc. Sales to members of these two GPOs, under numerous contracts across our businesses, collectively accounted for </span><span style="font-family:Arial Narrow;font-size:10pt;">16 percent</span><span style="font-family:Arial Narrow;font-size:10pt;"> of our revenue in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div></div></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Suppliers</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We rely on many different suppliers. Products obtained from our five largest suppliers accounted for an aggregate of </span><span style="font-family:Arial Narrow;font-size:10pt;">28 percent</span><span style="font-family:Arial Narrow;font-size:10pt;"> of our revenue during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, and our largest supplier&#8217;s products accounted for approximately </span><span style="font-family:Arial Narrow;font-size:10pt;">6 percent</span><span style="font-family:Arial Narrow;font-size:10pt;"> of revenue.</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Competition</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We operate in a highly competitive environment in the distribution of pharmaceuticals and consumer healthcare products. We also operate in a highly competitive environment in the manufacturing and distribution of medical devices and surgical products. We compete on many levels, including price, service offerings, support services, breadth of product lines and product quality and efficacy.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the Pharmaceutical segment, we compete with wholesale distributors with national reach, including McKesson Corporation and AmerisourceBergen Corporation, regional wholesale distributors, self-warehousing chains, specialty distributors, third-party logistics companies, companies that provide specialty pharmaceutical services and nuclear pharmacies, among others. In addition, the </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Pharmaceutical segment has experienced competition from a number of organizations offering generic pharmaceuticals, including telemarketers. We also compete with manufacturers that sell their products directly.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the Medical segment, we compete with many diversified healthcare companies and national medical product distributors, such as Medline Industries, Inc., Owens&#160;&amp; Minor, Inc. and Becton, Dickinson and Company, as well as regional medical product distributors and companies that are focused on specific product categories. We also compete with companies that distribute medical products to patients' homes and third-party logistics companies. </span></div></div></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Employees</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had approximately 30,000 employees in the United States and approximately 18,000 employees outside of the United States.</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Intellectual Property</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We rely on a combination of trade secret, patent, copyright and trademark laws, nondisclosure and other contractual provisions, and technical measures to protect our products, services and intangible assets. We hold patents, and continue to pursue patent protection throughout the world, relating to the manufacture, operation and use of various medical and surgical products, to certain distribution and logistics systems, to the production and distribution of our nuclear pharmacy products and to other service offerings. We also operate under licenses for certain proprietary technologies, and in certain instances we license our technologies to third parties.&#160; </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We believe that we have taken all necessary steps to protect our proprietary rights, but no assurance can be given that we will be able to successfully enforce or protect our rights in the event that they are infringed upon by a third party. While all of these proprietary rights are important to our operations, we do not consider any particular patent, trademark, license, franchise or concession to be material to our overall business.</span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">28</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Business</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Regulatory Matters</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our business is highly regulated in the United States, at both the federal and state level, and in foreign countries. Depending upon the specific business, we may be subject to regulation by government entities including:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;);</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">certain agencies within the U.S. Department of Health and Human Services, including the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), the Centers for Medicare and Medicaid Services, the Office of Inspector General and the Office for Civil Rights;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">state health departments, insurance departments, Medicaid departments or other comparable state agencies; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">state boards of pharmacy and other controlled substance authorities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">the U.S. Nuclear Regulatory Commission (the &#8220;NRC&#8221;);</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">the U.S. Federal Trade Commission (the "FTC");</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">U.S. Customs and Border Protection; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">agencies comparable to those listed above in markets outside the United States.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">These regulatory agencies have a variety of civil, administrative and criminal sanctions at their disposal for failure to comply with applicable legal or regulatory requirements. They can suspend our ability to manufacture and distribute products, require us to initiate product recalls, seize products or impose criminal, civil and administrative sanctions.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Distribution</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">State Boards of Pharmacy, FDA, DEA and various other state authorities regulate the marketing, purchase, storage and distribution of pharmaceutical and medical products under various federal and state statutes including the federal Prescription Drug Marketing Act of 1987, Drug Quality and Security Act of 2013 (the &#8220;DQSA&#8221;), and Controlled Substances Act (the "CSA"). The CSA governs the sale, packaging, storage and distribution of controlled substances. Wholesale distributors of controlled substances must hold valid DEA registrations and state-level licenses, meet various security and operating standards including effective anti-diversion programs, and comply with the CSA. They must also comply with state requirements relating to controlled substances that differ from state to state. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Manufacturing, Sourcing and Marketing</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We sell our manufactured products in the United States, Canada, Europe, Asia, Latin America and other markets. The FDA and other governmental agencies in the United States, as well as foreign governmental agencies, administer requirements that cover the design, testing, safety, effectiveness, manufacturing (including good manufacturing practices), quality systems, labeling, promotion and advertising (including restrictions on promoting or advertising a product other than for the product's cleared or approved uses), distribution, importation and post-market surveillance for most of our manufactured products. We are also responsible for compliance with </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">these requirements when we source certain Medical segment products from third-party manufacturers. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We need specific approval or clearance from, and registrations with, regulatory authorities before we can market and sell some products in the United States and certain other countries, including countries in the European Union ("EU"). </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the United States, authorization to commercially market a medical device is generally received in one of two ways. The first, known as pre-market notification or the 510(k) process, requires us to demonstrate that a medical device is substantially equivalent to a legally marketed medical device. The second more rigorous process, known as pre-market approval (&#8220;PMA&#8221;), requires us to independently demonstrate that a medical device is safe and effective. Many of our Medical segment branded products are cleared through the 510(k) process and certain products must be approved through the PMA process.</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the EU, we are required to comply with the Medical Device Directive ("MDD") and obtain CE Mark Certification in order to market medical devices. In 2017, EU regulatory bodies finalized a new Medical Device Regulation ("MDR") which will replace the MDD when it is implemented in May 2021. Under the MDR, medical devices marketed in the EU will require significant additional pre-market and post-market requirements, except that devices with valid CE Mark issued before May 2020 can be marketed until May 2024. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">It can be costly and time-consuming to obtain regulatory approvals, clearances and registrations of medical devices, and they might not be granted on a timely basis, if at all. Even after we obtain approval or clearance to market a product or obtain product registrations, the product and our manufacturing processes are subject to continued regulatory oversight, including periodic inspection of manufacturing facilities by FDA and other regulatory authorities both in the United States and internationally. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we may determine that products we manufacture or market do not meet our specifications, regulatory requirements or published standards. When we or a regulatory agency identify a quality or regulatory issue, we investigate and take appropriate corrective action, which may include recalling the product, correcting the product at the customer location, revising product labeling and notifying customers. For example, in January, 2020, we issued a voluntary recall for 9.1 million AAMI Level 3 surgical gowns and two voluntary field actions (a recall of some packs and a corrective action allowing overlabeling of other packs) for 2.9 million Presource Procedure Packs containing affected gowns because one of our FDA-registered suppliers in China had shifted production of some gowns to unapproved sites with uncontrolled environments, resulting in us being unable to assure the sterility of the gowns. </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">29</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Business</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Any adverse regulatory action, depending on its magnitude, may limit our ability to effectively manufacture, source, market and sell our products, limit our ability to obtain future premarket approvals or result in a substantial modification to our business practices and operations. For additional information, please see our Risk Factor entitled</span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"> "Our business is subject to rigorous regulatory and licensing requirements."</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Privacy and Data Protection </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are subject to various and evolving privacy laws and regulations in many jurisdictions. Because we collect, handle and maintain patient-identifiable health information, we are subject to laws that require specified privacy and security measures and that regulate the use and disclosure of such information, including the U.S. Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), as augmented by the Health Information Technology for Economic and Clinical Health Act as well as state laws, in the United States. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We also collect, handle, and maintain other sensitive personal and financial information. Within the U.S., these activities are regulated by certain federal and state laws. For example, the new California Consumer Privacy Act became effective in January 2020 and grants specified rights to consumers over the use of their personal information, including increased transparency. Other states are considering adopting similar or different comprehensive privacy laws. Internationally, we are also subject to privacy and data protection laws that require significant compliance efforts, including the EU's General Data Protection Regulation (GDPR), Canada's Personal Information Protection and Electronic Documents Act (PIPEDA) and Japan's Act on the Protection of Personal Information (APPI), among many others. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Nuclear Pharmacies and Related Businesses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our nuclear pharmacies and radiopharmaceutical manufacturing facilities (including for Xofigo) require licenses or permits and must abide by regulations issued by the NRC, applicable state boards of pharmacy and the radiologic health agency or department of health of each state in which we operate, including pharmacy sterile compounding standards and practices. In addition, our radiopharmaceutical manufacturing facilities also must comply with FDA regulations, including good manufacturing practices.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Product Tracing and Supply Chain Integrity</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Title II of the DQSA, known as the Drug Supply Chain Security Act or "Track and Trace," establishes a phased-in national system for tracing pharmaceutical products through the pharmaceutical distribution supply chain to detect, prevent and rapidly respond to the introduction of drugs that may be counterfeit, diverted, stolen, adulterated, subject of a fraudulent transaction or otherwise unfit for distribution. The first phase of implementation began in 2015, and upon full implementation in 2023, we and other supply chain stakeholders will participate in an electronic, interoperable, prescription drug tracing system. In addition, the FDA also has issued regulations requiring most medical device labeling to bear a unique device identifier. These&#160;regulations are being phased in through 2020. The MDR, described above, also introduces a new unique device identifier requirement.</span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Government Healthcare Programs</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are subject to U.S. federal healthcare fraud and abuse laws. These laws generally prohibit persons from soliciting, offering, receiving or paying any compensation in order to induce someone to order, recommend or purchase products or services that are in any way paid for by Medicare, Medicaid or other federally-funded healthcare programs. They also prohibit submitting any fraudulent claim for payment by the federal government. There are similar state healthcare fraud and abuse laws that apply to Medicaid and other state-funded healthcare programs. Violations of these laws may result in criminal or civil penalties, as well as breach of contract claims and </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> actions (false claims cases initiated by private parties purporting to act on behalf of federal or state governments).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Some businesses within each of our segments are Medicare-certified suppliers or participate in other federal and state healthcare </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">programs, such as state Medicaid programs and the federal 340B drug pricing program. These businesses are subject to accreditation and quality standards and other rules and regulations, including applicable reporting, billing, payment and record-keeping requirements. Other businesses within each segment manufacture pharmaceutical or medical products or repackage pharmaceuticals that are purchased or reimbursed through, or are otherwise governed by, federal or state healthcare programs. Failure to comply with applicable eligibility requirements, standards and regulations could result in civil or criminal sanctions, including the loss of our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our U.S. federal and state government contracts are subject to specific procurement requirements. Failure to comply with applicable rules or regulations or with contractual or other requirements may result in monetary damages and criminal or civil penalties as well as termination of our government contracts or our suspension or debarment from government contract work.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Environmental, Health and Safety Laws</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the United States and other countries, we are subject to various federal, state and local environmental laws, including laws regulating the production or use of hazardous substances, as well as laws relating to safe working conditions and laboratory practices.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Antitrust Laws</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The U.S. federal government, most U.S. states and many foreign countries have laws that prohibit certain types of conduct deemed to be anti-competitive. Violations of these laws can result in various sanctions, including criminal and civil penalties. Private plaintiffs also could bring civil lawsuits against us in the United States for alleged antitrust law violations, including claims for treble damages. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Laws Relating to Foreign Trade and Operations</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">U.S. and foreign laws require us to abide by standards relating to the import and export of finished goods, raw materials and supplies and the handling of information. We also must comply with various export control and trade embargo laws, which may require licenses or other authorizations for transactions within some countries or with some counterparties.</span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">30</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Business</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Similarly, we are subject to U.S. and foreign laws concerning the conduct of our foreign operations, including the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and other foreign anti-bribery laws. Among other things, these laws generally prohibit companies and their intermediaries from offering, promising or making payments to officials of foreign governments for the purpose of obtaining or retaining business. For example, in February 2020, we paid approximately $8.4 million to the Securities and Exchange Commission to settle charges that our internal controls were not sufficient to detect improper payments made by employees of our former China distribution business. </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Business</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Information</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Although our agreements with manufacturers sometimes require us to maintain inventory levels within specified ranges, our distribution businesses are generally not required by our customers to maintain particular inventory levels other than as needed to meet service level requirements. Certain customer contracts require us to maintain sufficient inventory to meet emergency demands, but we do not believe those requirements materially affect inventory levels.</span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return product for credit that can be added back to inventory and resold at full value, or that can be returned to vendors for credit.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We offer market payment terms to our customers.</span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">32</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sB887CB0119C25A08BEA9BE55BDBCD36D"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:11%;"></td><td style="width:21%;"></td><td style="width:68%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Risk Factors</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Risk Factors </span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The risks described below could materially and adversely affect our results of operations, financial condition, liquidity or cash flows. These are not the only risks we face. Our businesses also could be affected by risks that we are not presently aware of or that we currently consider immaterial to our operations. In addition to the effects of the COVID-19 pandemic and resulting global disruptions on our business and operations discussed in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and in the risk factors below, additional or unforeseen effects from the COVID-19 pandemic and the global economic climate may arise or may amplify many of the risks discussed below.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">We have been and expect to continue to be negatively affected by the ongoing COVID-19 pandemic.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#212529;">See the description of the actual and possible effects of the COVID-19 pandemic and resulting disruptions on our business and operations discussed above in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; In addition to the adverse impacts and uncertainties from the COVID-19 pandemic identified there, we face additional possible adverse impacts, including those described below. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#212529;">The cost to manufacture and source certain PPE products has significantly increased, which negatively impacted our margins for these products in fiscal 2020 and is expected to negatively impact our Medical segment profit in fiscal 2021. While we are seeking alternate and additional sources for these products and otherwise seeking to mitigate cost increases, as well as increasing certain PPE product prices to reflect some of our higher costs and seeking to modify affected customer contracts, our segment profit may be adversely impacted more significantly than we expect to the extent these efforts are not successful. In addition, we could experience decreased sales and customer disputes. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#212529;">Federal, state and local government policies and initiatives designed to reduce the transmission of COVID-19 also resulted in the cancellation or deferral of many elective medical procedures and some of our customers closing or severely curtailing their operations. If demand for these procedures does not return, or if these policies remain effective over a sustained period we could experience a greater decrease in sales for the affected products and services than we currently expect. Additionally, sustained changes in the manner in which patients access healthcare may result in shifts in consumer preferences that may not be favorable to us. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Political, legal or regulatory actions as a result of the COVID-19 pandemic in jurisdictions where we manufacture, source or distribute products have created supply disruptions within both our Medical and, currently to a lesser extent, our Pharmaceutical segments and from time to time may cause additional supply disruptions or shortages in the future. We cannot currently predict the frequency, duration or scope of these governmental actions and supply disruptions. For example, several countries, including India and China, have increased or instituted new restrictions on the export of medical or pharmaceutical products that we distribute or use in our businesses, including key components or raw materials.</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">Additionally, </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">governmental authorities in many countries, including the U.S., are enacting legislative or regulatory changes to address the impact of the pandemic, which may restrict or require changes in our operations, increase our costs, or otherwise have an adverse effect on our operations.</span><span style="font-family:inherit;font-size:10pt;">  </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#212529;">As a critical player in the global healthcare supply chain, we participated in industry-wide collaboration with the U.S. government and other distributors intended to increase the availability of PPE in the U.S. In connection with these efforts, we, along with other distributor participants, have received information requests from several members of the U.S. Congress.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#212529;">Also, we may become subject to claims or lawsuits by employees, customers, suppliers or other parties regarding actions we take in our operations in response to the pandemic. Financial hardship to our customers and others could adversely impact the timing and collectability of payments to us from customers and require an increase in reserves against our accounts receivable. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#212529;">We cannot estimate the length or severity of the COVID-19 pandemic or the related consequences on the U.S. and global economy and our business and operations, including whether and when normal economic and operating conditions will resume or the extent to which the disruption may impact our business, financial position, results of operations or cash flow. The COVID-19 pandemic also may give rise to new risks or heighten many of the risks we have previously identified, including risks associated with competitive pressures, supplier relationships, international operations, regulatory and licensing, changes to the U.S. healthcare environment, cyber security, and access to capital markets. COVID-19 may also adversely affect our operating and financial results in a manner that is not currently known to us or that we do not currently consider a significant risk. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">We could continue to suffer the adverse effects of competitive pressures.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As described in greater detail in the "Business" section, we operate in markets that are highly competitive and dynamic. In addition, competitive pressures in our pharmaceutical and medical segments may be increased by new business models, new entrants, new regulations, changes in consumer demand or general competitive dynamics. Our businesses face continued pricing pressure from these factors, which adversely affects our margins. If we are unable to offset margin reductions caused by these pricing pressures through steps such as sourcing or cost control measures, additional service offerings and sales of higher margin products, our results of operations could continue to be adversely affected.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Our Pharmaceutical segment&#8217;s generic pharmaceutical program may be adversely affected by pricing changes and fewer product launches.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The performance of our Pharmaceutical segment&#8217;s generic pharmaceutical program declined in fiscal 2019, 2018 and 2017 and increased in fiscal 2020. Declines in earlier years were  due, in large part, to generic pharmaceutical customer pricing deflation and less incremental benefit from new generic pharmaceutical launches, </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">33</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:11%;"></td><td style="width:21%;"></td><td style="width:68%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Risk Factors</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">which more than offset the benefits from sourcing generic pharmaceuticals through our Red Oak Sourcing venture with CVS.&#160; If performance of our generic pharmaceutical program declines in future fiscal years and we are unable to offset the decline, our Pharmaceutical segment profit and consolidated operating earnings will be adversely affected.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The extent and magnitude of generic pharmaceutical pricing changes is uncertain in future fiscal years and may vary from what we anticipate. Similarly, the number of new generic pharmaceutical launches also varies from year to year, and the margin impact of these launches varies from product to product. Finally, the benefit from Red Oak Sourcing could be less than we anticipate.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Changes in manufacturer approaches to pricing branded pharmaceutical products could have an adverse effect on our Pharmaceutical segment&#8217;s margins.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Compensation under our contractual arrangements with manufacturers for the purchase of branded pharmaceutical products is generally based on the wholesale acquisition cost set by the manufacturer. Sales prices of branded pharmaceutical products to our customers generally are a percentage discount from wholesale acquisition cost.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Historically, pharmaceutical manufacturers have generally increased the wholesale acquisition cost of their branded pharmaceuticals each year. However, the U.S. government has announced plans to, among other things, adopt policies to encourage manufacturers to limit increases in (or reduce) wholesale acquisition cost. In fiscal 2019 and fiscal 2020, manufacturers, in the aggregate, increased prices less than in prior years. If manufacturers change their historical approach to setting and increasing wholesale acquisition cost and we are unable to negotiate alternative ways to be compensated by manufacturers or customers for the value of our services, our Pharmaceutical segment profit and consolidated operating earnings could be adversely affected.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Also, almost all of our distribution services agreements with branded pharmaceutical manufacturers generally provide that we receive fees from the manufacturers to compensate us for services we provide them.&#160; However, under a limited number of agreements, branded pharmaceutical price appreciation, which is determined by the manufacturers also serves as a part of our compensation. If manufacturers decide to reduce prices, not to increase prices or to implement only small increases and we are unable to negotiate alternative ways to be compensated by manufacturers or customers for the value of our services, our margins could be adversely affected.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">The public health crisis involving the abuse of prescription opioid pain medication and our efforts to resolve related claims could have additional or unexpected material negative effects on our business</span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our Pharmaceutical segment distributes prescription opioid pain medications. In recent years, the abuse of prescription opioid pain medication has become a public health crisis.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">A significant number of states, counties, municipalities and other public plaintiffs, have filed lawsuits against pharmaceutical manufacturers, pharmaceutical wholesale distributors (including us), </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">retail chains and others relating to the manufacturing, marketing or distribution of prescription opioid pain medications and additional public plaintiffs are likely to file similar lawsuits. In addition, we are currently being sued by private plaintiffs, such as unions, other health and welfare funds, hospital systems and other healthcare providers, for the same activities and could be named as a defendant in additional lawsuits. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have also received federal grand jury subpoenas issued in connection with investigations being conducted by the U.S. Attorney&#8217;s Office for the Eastern District of New York  and by the Fraud Section of the U.S. Department of Justice (DOJ).  The subpoenas seek documents and, with respect to the DOJ investigation, testimony relating to our anti-diversion policies and procedures, and our distribution of certain controlled substances. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In October 2019, we agreed in principle to a Settlement Framework that would resolve pending and future lawsuits and claims brought by states and political subdivisions. In connection with this development we recorded a pre-tax accrual of $5.56 billion in  fiscal  2020. This Settlement Framework is subject to contingencies but is the basis for our negotiation of definitive terms and documentation. Definitive terms of a settlement under the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. The amount of ultimate loss may differ materially from this accrual. See&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">Note 7</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the "Notes to Consolidated Financial Statements" for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The defense and resolution of current and future lawsuits and events relating to these lawsuits are subject to uncertainty and could have a material adverse effect on our results of operations, financial condition, cash flows, liquidity, or our ability to pay dividends or repurchase our shares, beyond the amounts accrued.  In addition, they could have adverse reputational or operational effects on our business.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Other legislative, regulatory or industry measures related to the public health crisis involving the abuse of prescription opioid pain medication and the distribution of these medications could affect our business in ways that we may not be able to predict. For example, several states have now adopted taxes or other fees on the sale of opioids, and several other states have proposed similar legislative initiatives. These laws and proposals vary in the tax amounts imposed and the means of calculation. Liabilities for taxes or assessments under any such laws could have an adverse impact on our results of operations unless we are able to mitigate them through operational changes or commercial arrangements where permitted.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Ongoing unfavorable publicity regarding the abuse or misuse of prescription opioid pain medications and the role of wholesale distributors in the supply chain of such prescription medications, as well as the continued proliferation of the opioid lawsuits, investigations, regulations and legislative actions, and unfavorable publicity in relation to those lawsuits could have a material adverse effect on our reputation or results of operations.</span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">34</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:11%;"></td><td style="width:21%;"></td><td style="width:68%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Risk Factors</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Products that we manufacture, source and market are subject to strict quality and regulatory requirements. The recalls of certain surgical gowns and related Presource Procedure Packs had a negative impact on our financial results in fiscal 2020 and may have additional negative financial and operational impacts.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As described in greater detail in the "Business" section, products that we manufacture, source, distribute or market must comply with quality and regulatory requirements. Noncompliance or concerns over noncompliance, including noncompliance by third-party contract manufacturers, may result in suspension of our ability to distribute, import, manufacture or source products, as well as product bans, recalls, safety alerts or seizures, or criminal or civil sanctions, which, in turn, could result in product liability claims and lawsuits, including class actions. In addition, it can be costly and time-consuming to obtain regulatory approvals or product registrations to market a medical device or other product, and such approvals or registrations might not be granted on a timely basis, if at all.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In January, 2020, we issued a voluntary recall for 9.1 million AAMI Level 3 surgical gowns and two voluntary field actions (a recall of some packs and a corrective action allowing overlabeling of other packs) for 2.9 million Presource Procedure Packs containing affected gowns (together, the "Recalls") because one of our FDA-registered suppliers in China had shifted production of some gowns to unapproved sites with uncontrolled environments. Because of this, we could not assure sterility of the gowns.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with the Recalls, in fiscal year 2020, we recorded a total charge of </span><span style="font-family:Arial Narrow;font-size:10pt;">$85 million</span><span style="font-family:Arial Narrow;font-size:10pt;">, of which </span><span style="font-family:Arial Narrow;font-size:10pt;">$48 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> is within cost of products sold and </span><span style="font-family:Arial Narrow;font-size:10pt;">$37 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> is within SG&amp;A in the consolidated statements of earnings/(loss). See&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">Note 7</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the "Notes to Consolidated Financial Statements" for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition, the Recalls may have other negative impacts, which could include government investigations and enforcement actions by the U.S. Food and Drug Administration or other regulators or U.S. or international governmental bodies, which could possibly result in the suspension or revocation of the authority to produce, distribute and sell products and other civil or criminal sanctions or penalties.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Our business is subject to other rigorous regulatory and licensing requirements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to regulatory requirements relating to manufacturing, sourcing and marketing our products described in the Risk Factor immediately above and as described in greater detail in the "Business" section, our business is highly regulated in the United States, at both the federal and state level, and in foreign countries. If we fail to comply with regulatory requirements, or if allegations are made that we fail to comply, our results of operations and financial condition could be adversely affected.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">To lawfully operate our businesses, we are required to obtain and hold permits, product registrations, licenses and other regulatory approvals from, and to comply with operating and security standards of, numerous governmental bodies. For example, as a wholesale distributor of controlled substances, we must hold valid DEA registrations and state-level licenses, meet various security and </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">operating standards, and comply with the CSA. Failure to maintain or renew necessary permits, product registrations, licenses or approvals, or to comply with required standards, could have an adverse effect on our results of operations and financial condition.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We collect, handle and maintain patient-identifiable health information and other sensitive personal and financial information which are subject to federal, state and foreign laws that regulate the use and disclosure of such information. Regulations currently in place continue to evolve, and new laws in this area could further restrict our ability to collect, handle and maintain personal or patient information, or could require us to incur additional compliance costs, either of which could have an adverse impact on our results of operations. Violations of federal, state or foreign laws concerning privacy and data protection could subject us to civil or criminal penalties, breach of contract claims, costs for remediation and harm to our reputation.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are required to comply with laws relating to healthcare fraud and abuse. The requirements of these laws are complex and subject to varying interpretations. From time to time, regulatory authorities investigate our policies or practices, and may challenge them. If we fail to comply with these laws, we could be subject to federal or state government investigations or </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> actions (false claims cases initiated by private parties purporting to act on behalf of federal or state governments), which could result in civil or criminal sanctions, including the loss of licenses or the ability to participate in Medicare, Medicaid and other federal and state healthcare programs. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Some businesses within each of our segments are Medicare-certified suppliers or participate in other federal and state healthcare programs, such as state Medicaid program and the federal 340B drug pricing program. In addition, some businesses manufacture pharmaceutical or medical products or repackage pharmaceuticals that are purchased or reimbursed through, or are otherwise governed by, federal or state healthcare programs. Failure to comply with applicable eligibility requirements, standards and regulations could result in civil or criminal sanctions, including the loss of our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our government contracts are subject to specific procurement requirements. Failure to comply with applicable rules or regulations or with contractual or other requirements may result in monetary damages and criminal or civil penalties as well as termination of our government contracts or our suspension or debarment from government contract work.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our global operations are required to comply with the U.S. Foreign Corrupt Practices Act ("FCPA"), the U.K. Bribery Act and similar anti-bribery laws in other jurisdictions and U.S. and foreign export control, trade embargo and customs laws. If we fail to comply, or are alleged to fail to comply, with any of these laws, we could suffer civil or criminal sanctions. For example, in February 2020, we paid approximately $8.4 million to the Securities and Exchange Commission to settle charges that our internal controls were not sufficient to detect improper payments made by employees of our former China distribution business.</span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">35</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:11%;"></td><td style="width:21%;"></td><td style="width:68%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Risk Factors</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">We could be subject to adverse changes in the tax laws or challenges to our tax positions.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are a large multinational corporation with operations in the United States and many foreign countries. As a result, we are subject to the tax laws of many jurisdictions.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, initiatives are proposed in the United States and other jurisdictions in which we operate that could adversely affect our tax positions, effective tax rate or tax payments. Specific initiatives that may impact us include possible increases in U.S. or foreign corporate income tax rates or other changes in tax law to raise revenue, the repeal of the LIFO (last-in, first-out) method of inventory accounting for income tax purposes, the establishment or increase in taxation at the U.S. state level on the basis of gross revenues, recommendations of the recently completed base erosion and profit shifting project undertaken by the Organization for Economic Cooperation and Development and the European Commission&#8217;s investigation into illegal state aid.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Additionally, in connection with the $5.63 billion pre-tax charge for the opioid litigation, in the fiscal year ended June 30, 2020, we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$488 million</span><span style="font-family:Arial Narrow;font-size:10pt;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$469 million</span><span style="font-family:Arial Narrow;font-size:10pt;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the Tax Act.  Further, the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><span style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">Note 7</span><span style="font-family:Arial Narrow;font-size:10pt;"> of the "Notes to Consolidated Financial Statements" for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2008 through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including IRS challenges to our international transfer pricing for the periods from 2008 to 2014, and it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Changes to the U.S. healthcare environment may not be favorable to us.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Over a number of years, the U.S. healthcare industry has undergone significant changes designed to increase access to medical care, improve safety and patient outcomes, contain costs and increase efficiencies. These changes include a general decline in Medicare and Medicaid reimbursement levels, efforts by healthcare insurance companies to limit or reduce payments to pharmacies and providers, the basis for payments beginning to transition from a fee-for-service model to value-based payments and risk-sharing models, and the </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">industry shifting away from traditional healthcare venues like hospitals and into clinics, physician offices and patients&#8217; homes.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We expect the U.S. healthcare industry to continue to change significantly in the future. Possible changes include further reduction or limitations on governmental funding at the state or federal level, efforts by healthcare insurance companies to further limit payments for products and services or changes in legislation or regulations governing prescription pharmaceutical pricing, healthcare services or mandated benefits. These possible changes, and the uncertainty surrounding these possible changes, may adversely affect us.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Our business and operations depend on the proper functioning of information systems, critical facilities and distribution networks.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We rely on our and third-party service providers' information systems for a wide variety of critical operations, including to obtain, rapidly process, analyze and manage data to:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">facilitate the purchase and distribution of inventory items from numerous distribution centers;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">receive, process and ship orders on a timely basis;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">manage accurate billing and collections for thousands of customers;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">process payments to suppliers;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">facilitate manufacturing and assembly of medical products; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">generate financial information.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our business also depends on the proper functioning of our and our suppliers' critical facilities, including our national logistics center, and our distribution networks. Our results of operations could be adversely affected if our or a service provider's information systems, critical facilities or distribution networks are disrupted (including disruption of access), are damaged or fail, whether due to physical disruptions, such as fire, natural disaster, pandemic or power outage, or due to cyber-security incidents, ransomware or other actions of third parties, including labor strikes, political unrest and terrorist attacks. Manufacturing disruptions also can occur due to regulatory action, production quality deviations, safety issues or raw material shortages or defects, or because a key product or component is manufactured at a single manufacturing facility with limited alternate facilities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, our businesses perform business process improvements or infrastructure modernizations or use service providers for key systems and processes, such as receiving and processing customer orders, customer service and accounts payable. For example, our Pharmaceutical segment is currently engaged in a multi-year project to implement a replacement of certain finance and operating information systems. If any of these initiatives are not successfully or efficiently implemented or maintained, they could adversely affect our business and our internal control over financial reporting.</span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">36</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:11%;"></td><td style="width:21%;"></td><td style="width:68%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Risk Factors</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Our business and results of operations could be adversely affected if we experience a cyber-attack or other systems breach.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our business relies on the secure transmission, storage and hosting of patient-identifiable health information, financial information and other sensitive protected information relating to our customers, company and workforce. We have programs in place to detect, contain and respond to information security incidents. However, because the techniques used to obtain unauthorized access, disable or degrade service or sabotage systems change frequently and may be difficult to detect for long periods of time, we may be unable to anticipate these techniques or to implement adequate preventative measures. In addition, hardware, software or applications developed internally or procured from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise information security.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Unauthorized parties have gained access and will continue to attempt to gain access to our or a service provider's systems or facilities through fraud, trickery or other forms of deception. We have been the target of cyber attacks, including incidents where certain customer account information was accessed. Although we do not believe these incidents had a material impact on us, similar incidents or events in the future may negatively impact our business, reputation or financial results.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Any compromise of our or a service provider's information systems, including unauthorized access to or use or disclosure of sensitive information, could adversely impact our operations, results of operations or our ability to satisfy legal or regulatory requirements, including the California Consumer Privacy Act (CCPA), the new EU general data protection regulation (GDPR) and those related to patient-identifiable health information as further described in the Risk Factor titled &#8220;Our business is subject to rigorous regulatory and licensing requirements,&#8221; above.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">We depend on direct and indirect suppliers to make their products and raw materials available to us and are subject to fluctuations in costs and availability of products and raw materials.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We depend on others to manufacture some products that we market and distribute. Our operations are also dependent on various components, compounds, raw materials and energy supplied by others. We purchase many of these components, raw materials and energy, and source certain products from numerous suppliers in various countries. In some instances, for reasons of quality assurance, cost effectiveness, or availability, we procure certain components and raw materials from a sole supplier. Any of our supplier relationships could be interrupted,  become less favorable to us or be terminated and the supply of these components, compounds, raw materials or products could be interrupted or become insufficient. These risks are currently heightened with respect to certain PPE products due to the current and expected future demand for such products. These supply interruptions or other disruptions in manufacturing processes could be caused by events beyond our control, including natural disasters, supplier facility shut-downs, defective raw materials, the impact of epidemics or </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">pandemics, such as COVID-19, and actions by U.S. or international governments, including export restrictions or  tariffs. In addition, due to the stringent regulatory requirements regarding the manufacture and sourcing of our products, we may not be able to quickly establish additional or replacement sources for certain components,  materials or products. A sustained supply reduction or interruption, and an inability to develop alternative and additional sources for such supply, could result in lost sales, increased cost, damage to our reputation, and may have an adverse effect on our business.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our manufacturing businesses use oil-based resins, pulp, cotton, latex and other commodities as raw materials in many products. Prices of oil and gas also affect our distribution and transportation costs. Prices of these commodities are volatile and can fluctuate significantly, causing our costs to produce and distribute our products to fluctuate. Due to competitive dynamics and contractual limitations, we may be unable to pass along cost increases through higher prices. If we cannot fully offset cost increases through other cost reductions, or recover these costs through price increases or surcharges, our results of operations could be adversely affected.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Changes or uncertainty in U.S. or international trade policies   and exposure to economic, political and currency risks, could disrupt our global operations or negatively impact our financial results.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We conduct our operations in various regions of the world outside of the United States, including Europe, Asia and Latin America. Global developments can affect our business in many ways. Our global operations are affected by local economic environments, including inflation, recession and competition. Additionally, divergent or unfamiliar regulatory systems and labor markets can increase the risks and burdens of operating in numerous countries.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our foreign operations expose us to a number of risks related to trade protection laws, tariffs, excise or other border taxes on goods sourced from certain countries or on the importation or exportation of products or raw materials. Changes or uncertainty in U.S. or international trade policies or tariffs could impact our global operations, as well as our customers and suppliers. We may be required to spend more money to source certain products or materials that we need or to manufacture certain of our products. This could adversely impact our business and results of operations.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As a result of the COVID-19 pandemic, many governments, including the U.S., China and India have, or have considered, restrictions on exports of medical and pharmaceutical products. If these restrictions are implemented or not lifted, we may experience a significant disruption in our ability to source pharmaceutical and medical products and could experience increased prices and lost sales. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition, we conduct our business in U.S. dollars and various functional currencies of our foreign subsidiaries. Changes in foreign currency exchange rates could adversely affect our financial results, which are reported in U.S. dollars. We may not be able to hedge to protect us against these exposures, and any hedges may not successfully mitigate these exposures.</span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">37</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:11%;"></td><td style="width:21%;"></td><td style="width:68%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Risk Factors</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Our sales and credit concentration is significant.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">CVS is a large customer that generates a significant amount of our revenue. CVS accounted for </span><span style="font-family:Arial Narrow;font-size:10pt;">26</span><span style="font-family:Arial Narrow;font-size:10pt;"> percent of our fiscal 2020 revenue and </span><span style="font-family:Arial Narrow;font-size:10pt;">26</span><span style="font-family:Arial Narrow;font-size:10pt;"> percent of our gross trade receivable balance at June&#160;30, 2020. If CVS does not renew our agreements, terminates the agreements due to an alleged default by us, defaults in payment or significantly reduces its purchases from us, our results of operations and financial condition could be adversely affected.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Consolidation in the U.S. healthcare industry may negatively impact our results of operations.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In recent years, U.S. healthcare industry participants, including distributors, manufacturers, suppliers, healthcare providers, insurers and pharmacy chains, have consolidated or formed strategic alliances. Consolidations create larger enterprises with greater negotiating power, and also could result in the possible loss of a customer where the combined enterprise selects one distributor from two incumbents. If this consolidation trend continues, it could adversely affect our results of operations.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Legal proceedings could adversely impact our cash flows or results of operations.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Due to the nature of our business, which includes the distribution of controlled substances and other pharmaceutical products and the sourcing, marketing and manufacturing of medical products, we regularly become involved in disputes, litigation and regulatory matters. Litigation is inherently unpredictable and the unfavorable outcome of one or more of these legal proceedings could adversely affect our results of operations or financial condition.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">For example, we are subject to a number of lawsuits and investigations related to the national health crisis involving the abuse of opioid pain medication as described above in the Risk Factor titled "The public health crisis involving the abuse of prescription opioid pain medication and our efforts to resolve related claims could have additional or unexpected material negative effects on our business" and in </span><span style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">Note 7</span><span style="font-family:Arial Narrow;font-size:10pt;"> to the "Notes to Consolidated Financial Statements."</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Additionally, some of the products that we distribute or manufacture have been and may in the future be alleged to cause personal injury, subjecting us to product liability claims. For example, we are a defendant in product liability lawsuits that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products and in lawsuits alleging impurities in the active pharmaceutical ingredients in certain pharmaceutical products. In addition, product liability insurance for these types of claims is becoming more limited and may not be available to us at amounts that we historically have obtained or that we would like to obtain. It is possible that a settlement of or judgment for a product liability claim may not be covered by insurance or exceed available insurance recoveries. If this happens, and if any such settlement or judgment is in excess of any prior accruals, our results of operations and financial condition could be adversely affected.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We also operate in an industry characterized by extensive intellectual property litigation. Patent litigation can result in significant damage awards and injunctions that could prevent the manufacture and sale </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">of affected products or force us to make royalty payments in order to continue selling the affected products.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Our results of operations could be adversely impacted if we fail to manage and complete divestitures.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We regularly evaluate our portfolio of businesses to determine whether an asset or business may no longer help us meet our objectives or whether there may be a more advantaged owner for that business. For example, in the past few years, we divested our pharmaceutical and medical products distribution business in China and our ownership interest in naviHealth, Inc. When we decide to sell assets or a business, we may encounter difficulty finding buyers or alternative exit strategies, which could delay the achievement of our strategic objectives. We could also experience greater dis-synergies than expected and the impact of the divestiture on our results of operations could be greater than anticipated.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Our ability to manage and complete acquisitions could impact our strategic objectives and financial condition.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">An important element of our growth strategy has been to acquire other businesses that expand or complement our existing businesses. Completion of acquisitions and the integration of acquired businesses involve a number of risks, including the following: we may overpay for a business or fail to realize the synergies and other benefits we expect from the acquisition; our management&#8217;s attention may be diverted to integration efforts; we may fail to retain key personnel of the acquired business; future developments may impair the value of our purchased goodwill or intangible assets; we may face difficulties or delays establishing, integrating or combining operations and systems, including manufacturing facilities; we may assume liabilities related to legal proceedings involving the acquired business; we may face challenges retaining the customers of the acquired business; or we may encounter unforeseen internal control, regulatory or compliance issues.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">We may not realize the expected benefits from planned cost-savings and business improvement initiatives.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As a part of an ongoing effort to optimize and simplify our operating model, we expect to transition portions of our finance operations to a global professional services firm and we are making structural changes to certain other functional and commercial areas of our organization as well. Additionally, our Pharmaceutical segment is in a multi-year project to implement a replacement of certain finance and operating information systems. These initiatives, and any similar initiatives identified and implemented in the future, could result in unexpected charges and expenses that negatively impact our financial results and we could fail to achieve the desired efficiencies and estimated cost savings. In addition, if we are not able to effectively implement these initiatives, or if they fail to operate as intended, our internal control over financial reporting could be adversely affected.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Additionally, these types of initiatives could yield unintended consequences such as distraction of management and employees, business disruption, an inability to attract or retain key personnel, which could negatively affect our business or financial condition and results of operations.</span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">38</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:11%;"></td><td style="width:21%;"></td><td style="width:68%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Risk Factors</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">If we are not able to effectively develop, implement and manage our outsourcing or similar third-party relationships, we may experience operational difficulties and increased costs, which may adversely affect our results of operations.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Our goodwill may be further impaired, which would require us to record a significant charge to earnings in accordance with generally accepted accounting principles.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">U.S. GAAP requires us to test our goodwill for impairment on an annual basis, or more frequently if indicators for potential impairment exist. In the fourth quarter of fiscal year 2018, we recorded a $1.4 billion impairment to goodwill within our Medical segment. The testing required by GAAP involves estimates and significant judgments by management. Although we believe our assumptions and estimates are reasonable and appropriate, any changes in key assumptions, including a failure to meet business plans or other unanticipated events and circumstances such as a rise in interest rates, may affect the accuracy or validity of such estimates. It is possible that we may record significant charges related to other reporting units or we may record additional charges in our Medical segment, which charge or charges could adversely affect our results of operations. See "Critical Accounting Policies and Sensitive Accounting Estimates" in MD&amp;A above for more information regarding goodwill impairment testing.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">39</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s38B7FE605CD85F5ABED26E8E13F7E935"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:27%;"></td><td style="width:51%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Properties and Legal Proceedings</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Properties</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the United States, at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, the Pharmaceutical segment operated one national logistics center; a number of primary pharmaceutical and specialty distribution facilities as well as nuclear pharmacy and radiopharmaceutical manufacturing facilities.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ff0000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">The Medical segment operated medical-surgical distribution, assembly, manufacturing and other operating facilities in the United States. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, our Medical segment operated manufacturing facilities in the United States, including Puerto Rico, Canada, Costa Rica, the Dominican Republic, Germany, Ireland, Japan, Malaysia, Malta, Mexico and Thailand.</span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our principal executive offices are headquartered in an owned building located at 7000 Cardinal Place in Dublin, Ohio.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We consider our operating properties to be in satisfactory condition and adequate to meet our present needs. However, we regularly evaluate operating properties and may make further additions and improvements or consolidate locations as we seek opportunities to expand or enhance the efficiency of our business.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><a id="s2AE08030210259CCAE9BFFC1DD370010"></a></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Legal Proceedings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to the proceedings described below, the legal proceedings described in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the "Notes to Consolidated Financial Statements" are incorporated in this "Legal Proceedings" section by reference.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In June 2019, Melissa Cohen, a purported shareholder, filed an action on behalf of Cardinal Health, Inc. in the U.S. District Court for the Southern District of Ohio against certain current and former members of our Board of Directors alleging that the defendants breached their fiduciary duties by failing to effectively monitor Cardinal Health's distribution of controlled substances. In December 2019 and January 2020, similar complaints were filed in the U.S. District Court for the Southern District of Ohio by purported shareholders, Stanley M. Malone and Michael Splaine, respectively. In January, 2020, the court consolidated the derivative cases under the caption In re Cardinal Health, Inc. Derivative Litigation and in March 2020, plaintiffs filed an amended complaint. The amended consolidated derivative complaint seeks, among other things, unspecified money damages against the defendants and an award of attorneys' fees. In June 2020, the defendants filed a motion to dismiss the complaint. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">40</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s38459D2E4A45535DA3214D65091BE252"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:32%;"></td><td style="width:32%;"></td><td style="width:36%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Market for Registrant's Common Equity</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities </span></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our common shares are listed on the New York Stock Exchange under the symbol &#8220;CAH.&#8221; </span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At July&#160;31, 2020 there were approximately </span><span style="font-family:Arial Narrow;font-size:10pt;">7,324</span><span style="font-family:Arial Narrow;font-size:10pt;"> shareholders of record of our common shares.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We anticipate that we will continue to pay quarterly cash dividends in the future. The payment and amount of future dividends remain, however, within the discretion of our Board of Directors and will depend upon our future earnings, financial condition, capital requirements and other factors. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Issuer Purchases of Equity Securities</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:26%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total Number<br/>of Shares<br/>Purchased&#160;(1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Average Price Paid&#160;per Share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total Number of Shares<br/>Purchased<br/>as Part of Publicly Announced Programs&#160;(2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Approximate</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Dollar Value of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Shares That May</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Yet be Purchased</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Under the Programs&#160;(2)</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">April 2020</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,406</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">49.91</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">943</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">May 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">325</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">51.44</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">943</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">217</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">52.38</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">943</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,948</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">50.44</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">943</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Reflects </span><span style="font-family:Arial Narrow;font-size:8pt;">1,406</span><span style="font-family:Arial Narrow;font-size:8pt;">, </span><span style="font-family:Arial Narrow;font-size:8pt;">325</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">217</span><span style="font-family:Arial Narrow;font-size:8pt;"> common shares purchased in April, May and June </span><span style="font-family:Arial Narrow;font-size:8pt;">2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, respectively, through a rabbi trust as investments of participants in our Deferred Compensation Plan.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">On November 7, 2018, our Board of Directors approved a $1.0 billion share repurchase program that expires on December 31, 2021. As of June 30, 2020, we have </span><span style="font-family:Arial Narrow;font-size:8pt;">$943 million</span><span style="font-family:Arial Narrow;font-size:8pt;"> authorized for share repurchases remaining under this program.</span></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">41</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:32%;"></td><td style="width:32%;"></td><td style="width:36%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Market for Registrant's Common Equity</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Five Year Performance Graph</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following line graph compares the cumulative total return of our common shares with the cumulative total return of the Standard &amp; Poor&#8217;s Composite&#8212;500 Stock Index (the "S&amp;P 500 Index") and the Standard &amp; Poor's Composite&#8212;500 Healthcare Index (the "S&amp;P 500 Healthcare Index"). The line graph assumes, in each case, an initial investment of $100 invested at the closing price on June 30, 2015, and is based on the market prices at the end of each fiscal year through and including </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, and reinvestment of dividends. The S&amp;P 500 Index and S&amp;P 500 Healthcare Index investments are weighted on the basis of market capitalization at the beginning of each period.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;"><img src="chart-262f3986bd9a95f0107.jpg" alt="chart-262f3986bd9a95f0107.jpg" style="height:464px;width:672px;"></img></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19"></td></tr><tr><td style="width:28%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="18" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">June 30</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">2015</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">2016</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">2017</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">2018</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">2019</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health, Inc.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">100.00</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">95.12</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">97.26</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">62.90</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">63.11</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">72.70</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">S&amp;P 500 Index</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">100.00</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">103.99</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">122.60</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">140.23</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">154.83</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">166.45</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">S&amp;P 500 Healthcare Index</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">100.00</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">97.98</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">110.19</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">118.02</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">133.35</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">147.89</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;">                                </span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">42</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s5B394966EB4C511684797CFE02614449"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:6px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:30%;"></td><td style="width:35%;"></td><td style="width:35%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Reports</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Management Reports</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Evaluation of Disclosure Controls and Procedures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We evaluated, with the participation of our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")) as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">. Based on this evaluation, our principal executive officer and principal financial officer has concluded that our disclosure controls and procedures were effective as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> to provide reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. Our internal control system is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, controls deemed effective now may become inadequate in the future because of changes in conditions, or because compliance with policies or procedures has deteriorated or been circumvented.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Management assessed the effectiveness of our internal control over financial reporting as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">. In making this assessment, management used the criteria established in the Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the &#8220;COSO criteria&#8221;). Based on management&#8217;s assessment and the COSO criteria, management believes that our internal control over financial reporting was effective as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our independent registered public accounting firm, Ernst&#160;&amp; Young LLP, has issued a report on our internal control over financial reporting. Ernst&#160;&amp; Young LLP&#8217;s report appears following this "Management Reports" section and expresses an unqualified opinion on the effectiveness of our internal control over financial reporting.</span></div><div style="line-height:120%;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Changes in Internal Control Over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">There were no changes in our internal control over financial reporting during the quarter ended </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Implementation of Business Improvement Initiatives </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have certain business improvement initiatives underway that we expect to affect internal control over financial reporting in fiscal year 2021.  During fiscal year 2021, as a part of an ongoing effort to optimize and simplify our operating model, we expect to transition portions of our finance operations to a global professional services firm. Additionally, the Pharmaceutical segment is in a multi-year project to implement a replacement of certain finance and operating information systems. If either of these initiatives are not effectively implemented, or fail to operate as intended, it could adversely affect our internal control over financial reporting. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">43</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s7722655C098C5A06A2C9C69B95AF7908"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:6px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:30%;"></td><td style="width:35%;"></td><td style="width:35%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Reports</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The Shareholders and the Board of Directors of Cardinal Health, Inc.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Opinion on Internal Control over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We have audited Cardinal Health, Inc. and subsidiaries&#8217; internal control over financial reporting as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Cardinal Health, Inc. and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, based on the COSO criteria.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the related consolidated statements of earnings/(loss), comprehensive income/(loss), shareholders' equity and cash flows for each of the three years in the period ended </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and the related notes and the financial statement schedule listed in the Index at Item 15(a)(2) and our report dated </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">August&#160;13, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> expressed an unqualified opinion thereon.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis for Opinion</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying &#8220;Management&#8217;s Report on Internal Control Over Financial Reporting.&#8221; Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.35802469135803%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">/s/ Ernst&#160;&amp; Young LLP</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Grandview Heights, Ohio</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">August&#160;13, 2020</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">44</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sFCC8A07843265B68B2E3B6073F4495AF"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:6px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:30%;"></td><td style="width:35%;"></td><td style="width:35%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Reports</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Report of Independent Registered Public Accounting Firm</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">To the Shareholders and the Board of Directors of Cardinal Health, Inc.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Opinion on the Financial Statements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have audited the accompanying consolidated balance sheets of Cardinal Health, Inc. and subsidiaries (the Company) as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, the related consolidated statements of earnings/(loss), comprehensive income/(loss), shareholders' equity and cash flows for each of the three years in the period ended </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, and the related notes and the financial statement schedule listed in the Index at Item 15(a)(2) (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, and the results of its operations and its cash flows for each of the three years in the period ended </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, in conformity with U.S. generally accepted accounting principles.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">August&#160;13, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> expressed an unqualified opinion thereon.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis for Opinion</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Critical Audit Matters</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:10%;"></td><td style="width:90%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Medical Unit Goodwill</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;">Description of the Matter<br/></span></div></td><td style="vertical-align:top;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">At June 30, 2020, goodwill related to the Company&#8217;s Medical segment, including the Medical Unit was $5.7 billion. As discussed in </span><a style="font-family:Arial Narrow;font-size:9.5pt;" href="#sAF8B609C6A1B5242B7B172A7B9FB2416"><span style="font-family:Arial Narrow;font-size:9.5pt;">Note 1</span></a><span style="font-family:Arial Narrow;font-size:9.5pt;">&#160;to the consolidated financial statements, goodwill is tested for impairment at least annually at the reporting unit level. </span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;"><br/></span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">Auditing management&#8217;s goodwill impairment test for the Medical Unit was challenging because there is significant judgement required in determining the fair value of the reporting unit. In particular, the fair value estimate was sensitive to significant judgmental assumptions including the revenue growth rate, gross margin, distribution, selling, general and administrative expenses, and company specific risk premium, which are affected by expectations about future market or economic conditions.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;border-bottom:1px solid #ffffff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;">How We Addressed the Matter in Our Audit<br/></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;border-bottom:1px solid #ffffff;"><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s goodwill impairment review process. For example, we tested controls over management&#8217;s review of significant judgmental assumptions, including the revenue growth rate, gross margin, distribution, selling, general and administrative expenses, and company specific risk premium, among other assumptions.   </span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;"><br/></span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">To test the estimated fair value of the Medical Unit, we performed audit procedures that included, among others, evaluating methodologies used, involving our valuation specialists in testing the significant assumptions described above and testing the underlying data used by the Company in its analysis for completeness and accuracy. We compared the significant assumptions used by management to current industry and economic trends, recent historical performance, changes to the reporting unit&#8217;s business model, customer base or product mix and other relevant factors. We assessed the historical accuracy of management&#8217;s estimates and performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the reporting unit that would result from changes in the assumptions. We evaluated the incorporation of the applicable assumptions into the model and tested the model&#8217;s computational accuracy. In addition, we inspected the Company&#8217;s reconciliation of the fair value of all reporting units to the market capitalization of the Company and assessed the result.</span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;"><br/></span></div><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">45</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:6px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:30%;"></td><td style="width:35%;"></td><td style="width:35%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Reports</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:10%;"></td><td style="width:90%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Product Liability Lawsuits</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;">Description of the Matter</span></div><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">As described in </span><a style="font-family:Arial Narrow;font-size:9.5pt;" href="#sAF8B609C6A1B5242B7B172A7B9FB2416"><span style="font-family:Arial Narrow;font-size:9.5pt;">Note 1</span></a><span style="font-family:Arial Narrow;font-size:9.5pt;">&#160;and </span><a style="font-family:Arial Narrow;font-size:9.5pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:9.5pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:9.5pt;">&#160;to the consolidated financial statements, the Company is a defendant in various product liability claims in which individuals seek damages associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. The Company accrues for losses and defense costs related to product liability at the time a loss is probable and the amount of loss can be reasonably estimated. The methodology used by the Company to project future Cordis IVC claim costs is based largely on recent experience, including claim filing rates, indemnity severity by claim type, sales data, implant and injury to report lag patterns, and defense costs. The Company periodically reviews such estimates and records adjustments for changes in reserves in the period in which the change in estimate occurs.  At June 30, 2020, the Company&#8217;s product liability reserve balance related to the Cordis IVC lawsuits totaled $468 million, net of estimated insurance recoveries. The Company believes there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, the Company has accrued the minimum amount in the range. The Company estimates the high end of the range to be approximately $919 million, net of estimated insurance recoveries.</span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">&#160;</span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">Auditing management&#8217;s accounting for and disclosure of loss contingencies related to the Cordis IVC product liability lawsuits was challenging due to the significant judgment required to develop the key assumptions utilized in the model and the nature of information available given the early stages of these lawsuits and the limited claims history. </span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;">How We Addressed the Matter in Our Audit</span></div><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over management&#8217;s evaluation of the product liability litigation reserve.  For example, we tested controls over management&#8217;s review of the model used to estimate the product liability reserve amount and the significant assumptions as described above used within the model. We also tested management&#8217;s controls over the completeness and accuracy of the data used in the model.</span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;"><br/></span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">To test management&#8217;s assessment of the probability of occurrence of a loss and whether the loss was reasonably estimable, we evaluated, for example, claims data of the Company, we evaluated the legal letters obtained from internal and external legal counsel, and we discussed with internal and external legal counsel of the plaintiffs&#8217; claims. Among other procedures we performed to test the measurement of the product liability litigation reserve, we evaluated the method of measuring the reserve for claims including analyses to determine the range of possible losses, obtained and performed audit procedures relative to the analysis, tested the accuracy and completeness of the data, and evaluated new or contrary information affecting the estimate. In addition, we involved internal actuarial specialists to assist with our procedures related to the measurement of the product liability reserve. We have also assessed the adequacy of the Company&#8217;s disclosures included in </span><a style="font-family:Arial Narrow;font-size:9.5pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:9.5pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:9.5pt;">&#160;in relation to these matters.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Uncertain Tax Positions</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;">Description of the Matter </span></div><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">As described in </span><a style="font-family:Arial Narrow;font-size:9.5pt;" href="#s002522EA8F5F5274B7487704BE70A9A8"><span style="font-family:Arial Narrow;font-size:9.5pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:9.5pt;">&#160;to the consolidated financial statements, the Company&#8217;s unrecognized tax benefits related to its uncertain tax positions were approximately $998 million at June 30, 2020. Uncertain tax positions may arise as tax laws are subject to interpretation. The Company uses significant judgment in (1) determining if the tax position is more likely than not to be sustained upon examination, based on the technical merits of the position and (2) measuring the amount of tax benefit that qualifies for recognition. </span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;"><br/></span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">Auditing management's estimate of the amount of tax benefit related to the Company's uncertain tax positions that qualified for recognition was challenging because management's estimate required significant judgment in evaluating the technical merits of the positions, including interpretations of applicable tax laws and regulations. </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;border-bottom:1px solid #ffffff;"><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;">How We Addressed the Matter in Our Audit</span></div><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;border-bottom:1px solid #ffffff;"><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over the Company&#8217;s process to assess the technical merits of its uncertain tax positions, including the Company&#8217;s assessment as to whether a tax position is more likely than not to be sustained and management&#8217;s process to measure the benefit of its tax positions.</span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">&#160;</span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">We involved our international tax, transfer pricing, and national tax professionals in assessing the technical merits of certain of the Company&#8217;s tax positions. Depending on the nature of the specific tax position and, where applicable, developments with the relevant tax authorities relating thereto, our procedures included obtaining and examining the Company&#8217;s analysis.  For example, we evaluated the underlying facts upon which the tax positions are based, and, where applicable, obtained the Company&#8217;s correspondence with local tax authorities.  We used our knowledge of international and local income tax laws, as well as historical settlement activity, where applicable, with local income tax authorities, to evaluate the Company&#8217;s accounting for its uncertain tax positions. We evaluated developments in the applicable tax jurisdictions to assess potential effects on the Company&#8217;s positions. We analyzed the Company&#8217;s assumptions and data used to evaluate the appropriateness of the Company&#8217;s measurement of tax benefits. We have also evaluated the Company&#8217;s income tax disclosures in relation to these matters.</span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;"><br/></span></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">46</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:6px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:30%;"></td><td style="width:35%;"></td><td style="width:35%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Reports</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:10%;"></td><td style="width:90%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Opioid Lawsuits</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;">Description of the Matter<br/></span></div></td><td style="vertical-align:top;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">As discussed in </span><a style="font-family:Arial Narrow;font-size:9.5pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:9.5pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:9.5pt;">&#160;to the consolidated financial statements, the Company is a defendant in numerous lawsuits brought by certain state governments and other political subdivisions related to opioid matters.  The Company accrues for losses related to legal matters at the time a loss is probable and the amount of loss can be reasonably estimated.  In October 2019, the Company agreed in principal to a global settlement framework (the &#8220;Settlement Framework&#8221;). The Settlement Framework is subject to contingencies and uncertainties as to final terms, however, it is the basis for the Company&#8217;s negotiation of definitive terms. The Company has accrued $5.56 billion pretax under the cash component of the Settlement Framework as of June 30, 2020 and is unable to reasonably estimate the liability associated with other components. Additionally, management is unable to estimate the range of possible loss associated with these matters. </span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;"><br/></span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">Auditing the Company&#8217;s accounting for, and disclosure of, loss contingencies related to the opioid lawsuits was challenging due to the significant judgment required to evaluate management&#8217;s assessment of the likelihood of a loss being incurred and management&#8217;s determination of whether a reasonable estimate of the range of loss can be made.</span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;">How We Addressed the Matter in Our Audit</span></div><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;border-bottom:1px solid #ffffff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;border-right:1px solid #ffffff;border-top:1px solid #ffffff;"><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the identification and evaluation of this legal contingency. For example, we tested controls over management&#8217;s review of the assessment of the probability of occurrence of a loss and whether the loss was reasonably estimable and whether the assessment considered all relevant facts.</span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;"><br/></span></div><div style="text-align:justify;font-size:9.5pt;"><span style="font-family:Arial Narrow;font-size:9.5pt;">To test the Company&#8217;s assessment of the probability of a loss and whether the loss was reasonably estimable, among other procedures, we read the Settlement Framework, requested and received internal and external legal counsel confirmation letters, met with internal counsel to discuss the status of the proceedings and negotiations of the Settlement Framework, and evaluated the reasonableness of management&#8217;s assessment regarding whether an unfavorable outcome is reasonably possible or probable and reasonably estimable. We also assessed the adequacy and the sufficiency of the Company&#8217;s disclosures included in </span><a style="font-family:Arial Narrow;font-size:9.5pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:9.5pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:9.5pt;">&#160;in relation to these matters.</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.5925925925926%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">/s/ Ernst&#160;&amp; Young LLP</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have served as the Company's auditor since 2002.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Grandview Heights, Ohio</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">August&#160;13, 2020</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">47</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s7F3CE990DD1859BF8C1573967BC05AFD"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Financial Statements and Supplementary Data </span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:95%;"></td><td style="width:5%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Page</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Consolidated Financial Statements and Schedule:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sF7156E578CEB5B2ABF0435CD8BB4D517"><span style="font-family:Arial Narrow;font-size:10pt;">Consolidated Statements of Earnings/(Loss) for the Fiscal Years Ended June&#160;30, 2020, 2019 and 2018</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sF7156E578CEB5B2ABF0435CD8BB4D517">49</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sF50126044E6258F3BDCB7683EEDB8C61"><span style="font-family:Arial Narrow;font-size:10pt;">Consolidated Statements of Comprehensive Income/(Loss) for the Fiscal Years Ended June&#160;30, 2020, 2019 and 2018</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sF50126044E6258F3BDCB7683EEDB8C61">50</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3FA194F7CCCE56278BB2C27FF79EE72B"><span style="font-family:Arial Narrow;font-size:10pt;">Consolidated Balance Sheets at June&#160;30, 2020 and 2019</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s3FA194F7CCCE56278BB2C27FF79EE72B">51</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s2E03441EBB675479ADBCB3C557531AA6"><span style="font-family:Arial Narrow;font-size:10pt;">Consolidated Statements of Shareholders&#8217; Equity for the Fiscal Years Ended June&#160; 30, 2020, 2019, and 2018</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s2E03441EBB675479ADBCB3C557531AA6">52</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sA741D5B2B3175E01B66914E8B178C0CC"><span style="font-family:Arial Narrow;font-size:10pt;">Consolidated Statements of Cash Flows for the Fiscal Years Ended June&#160;30, 2020, 2019 and 2018</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sA741D5B2B3175E01B66914E8B178C0CC">53</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s7F5EE3762E4F50C7A352513C3AD9C48A"><span style="font-family:Arial Narrow;font-size:10pt;">Notes to Consolidated Financial Statements</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s7F5EE3762E4F50C7A352513C3AD9C48A">54</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">48</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sF7156E578CEB5B2ABF0435CD8BB4D517"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Consolidated Statements of Earnings/(Loss)</span><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10058038e2945-wk-Fact-EC673078FA4FB89EE7BA2843162A4DFB" name="us-gaap:Revenues" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">152,922</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e2964-wk-Fact-BD3D8FD103E378282798284316187DCD" name="us-gaap:Revenues" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">145,534</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e2983-wk-Fact-DB142B6DA98C5A50ADCB2843162D4777" name="us-gaap:Revenues" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">136,809</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cost of products sold</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10058038e2999-wk-Fact-08D8FAD9B3F5C3D052732843162D2B32" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">146,054</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3018-wk-Fact-FB042132871FCB3D9C1E28431619AA15" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">138,700</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3037-wk-Fact-938179D878F2BDCAB52E2843162143E0" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">129,628</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross margin</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10058038e3058-wk-Fact-7702ECF6E01FE01E12C72843162E9BF9" name="us-gaap:GrossProfit" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,868</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3077-wk-Fact-7A3ED88AB6960E25F46428431625A4F6" name="us-gaap:GrossProfit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,834</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3096-wk-Fact-4C9A9B4C81AF004FC3DA284316183FAB" name="us-gaap:GrossProfit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7,181</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating expenses:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Distribution, selling, general and administrative expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10058038e3241-wk-Fact-8AB5B3C56F6B6AF3ABA72843161BFCAD" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4,572</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3260-wk-Fact-BD206D2DED90DE4C83362843162529EE" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4,480</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3279-wk-Fact-A490E01F9D9CAAD7D1FD284316409849" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4,596</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10058038e3300-wk-Fact-B1C11A87F92A34B823FC2843162C8B54" name="us-gaap:RestructuringCharges" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">122</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3319-wk-Fact-3F8673AEAFD4719F9AD028431460FC93" name="us-gaap:RestructuringCharges" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">125</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3338-wk-Fact-138BB9B6057862937C5C2843145D0C42" name="us-gaap:RestructuringCharges" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">176</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10058038e3359-wk-Fact-AAAFD56F8BBBC5A01AF9284316438C07" name="cah:Amortizationandotheracquisitionrelatedcosts" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">524</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3378-wk-Fact-B29D1409AC87B910C1CC2843161DD8F4" name="cah:Amortizationandotheracquisitionrelatedcosts" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">621</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3397-wk-Fact-10BD70A944A8FF63ED792843161DD9A1" name="cah:Amortizationandotheracquisitionrelatedcosts" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">707</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10058038e3418-wk-Fact-81DD573C26D385689CC62843162E7B18" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10058038e3437-wk-Fact-7F41BBDEA2F421FA4BBB2843162FC07D" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">488</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3457-wk-Fact-6306BF99352252989396284316404B2E" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1,417</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10058038e3478-wk-Fact-3C0DFB838F3D17105D392843162D2A0E" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5,741</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3497-wk-Fact-076617D8C843032BCAA828431620ECB6" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">36</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3516-wk-Fact-4BC6C845B993548189E6284316426089" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">159</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10058038e3538-wk-Fact-A7B59A36E5F72A058365284316403890" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,098</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3558-wk-Fact-F255B30F4DA9D01D31CE2843162EC039" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,060</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3577-wk-Fact-7CFC054F72252BD96EDA2843162CDB72" name="us-gaap:OperatingIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">126</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other (income)/expense, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10058038e3660-wk-Fact-A4380AD6A9E884B496312843161E59F8" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3680-wk-Fact-40A961CF50FB552837DF28431629E64D" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">15</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3699-wk-Fact-DD444C85DE5746491EF52843162A2860" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">23</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Interest expense, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10058038e3720-wk-Fact-84F1F9CB5E981909167F28431620F264" name="us-gaap:InterestExpense" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">238</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3739-wk-Fact-33EFFE55AA531DFAB8B32843162FAB66" name="us-gaap:InterestExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">294</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3758-wk-Fact-38B78A53A6BA2DFBA47B284316270872" name="us-gaap:InterestExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">329</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss on early extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10058038e3779-wk-Fact-04EBBE90C0E8A84B4F0D284316412812" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3798-wk-Fact-E27CFF974E808DDEC6EE284316279CA1" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3817-wk-Fact-9A932B4A1F36871979202843161AD9CD" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain on sale of equity interest in naviHealth</span></div><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10058038e3840-wk-Fact-89E3224004987E7C3321A58ABB8E4B0F" name="us-gaap:GainOnSaleOfInvestments" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">579</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3860-wk-Fact-26DBFAAC3970F2B06B92E2EE19D9C158" name="us-gaap:GainOnSaleOfInvestments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3879-wk-Fact-0315A7D6D42179F39666E2EE6489D3CB" name="us-gaap:GainOnSaleOfInvestments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Earnings/(loss) before income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10058038e3900-wk-Fact-8029B570251D776CB89B2843162B2728" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3,772</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e3920-wk-Fact-5027B60DD37A44F7AA932843161E0815" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,751</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10058038e3939-wk-Fact-867F273B7C9665AD5CF328431621C9DA" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">228</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Provision for/(benefit from) income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10058038e4023-wk-Fact-1F76A9CA55BDEBE5013228431626E45F" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4043-wk-Fact-32C8EE70D1FD77AC3B30284316197236" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">386</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10058038e4062-wk-Fact-55DB262DD0862713240F2843161FBB12" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">487</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10058038e4084-wk-Fact-9AE3E593FCE6335F39752843162378C6" name="us-gaap:ProfitLoss" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3,693</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4104-wk-Fact-DA8A9DB84161C8826F8428431624E0AF" name="us-gaap:ProfitLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,365</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4123-wk-Fact-CB17DEC5A4D0E06152A128431645C61E" name="us-gaap:ProfitLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">259</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10058038e4207-wk-Fact-59D860CFE7EAD17DA86F284314604AB7" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10058038e4227-wk-Fact-40DF87BBE9A82CD4A06E2843164157A9" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10058038e4247-wk-Fact-2FA51944D462B903C3502843161C2311" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net earnings/(loss) attributable to Cardinal Health, Inc. </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10058038e4274-wk-Fact-D376E4CF10C84B75E68E2843162F9636" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3,696</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4294-wk-Fact-A6793123A202F02F7DDF2843161A0AE7" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,363</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4313-wk-Fact-278090E7B9D1E914F887284316449146" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">256</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings/(loss) per common share attributable to Cardinal Health, Inc.</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10058038e4458-wk-Fact-AA245B061237350EEC15284316290C1D" name="us-gaap:EarningsPerShareBasic" contextRef="FD2020Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">12.61</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4478-wk-Fact-2F9983D6B6AF648F50342843162BDF25" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">4.55</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4497-wk-Fact-94E9FF2EC52DA96189682843145D91AD" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.82</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10058038e4513-wk-Fact-DA6F10378D87161DA776284316273F14" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2020Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">12.61</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4533-wk-Fact-EAD48A09FC8087EFCA5D284316228D5C" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">4.53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4552-wk-Fact-0A9184B91DD77CD592422843162338C6" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.81</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average number of common shares outstanding:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Basic</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10058038e4697-wk-Fact-43211921D8B5D431B24928431628CAD3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2020Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">293</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4716-wk-Fact-F05B0CAA787082C1A64D28431622E9C2" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">300</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4735-wk-Fact-4251EE951E11F5191C4528431624F81D" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">313</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10058038e4756-wk-Fact-8196072F7E42FDFF1191284314623FA4" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2020Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">293</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4775-wk-Fact-3EE9D56C6B63748AD0EF2843161B9246" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">301</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10058038e4794-wk-Fact-45955312A229A57570A7284316286CCF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">315</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The accompanying notes are an integral part of these consolidated statements.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">49</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="sF50126044E6258F3BDCB7683EEDB8C61"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Consolidated Statements of Comprehensive Income/(Loss)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10060662e2943-wk-Fact-9AE3E593FCE6335F39752843162378C6" name="us-gaap:ProfitLoss" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3,693</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10060662e2963-wk-Fact-DA8A9DB84161C8826F8428431624E0AF" name="us-gaap:ProfitLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,365</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10060662e2982-wk-Fact-CB17DEC5A4D0E06152A128431645C61E" name="us-gaap:ProfitLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">259</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Other comprehensive income/(loss):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10060662e3122-wk-Fact-5316A4A73620A5AF7ECF284315D3DD68" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10060662e3141-wk-Fact-3A39C2DF5EB81751D1CC284315D4046B" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10060662e3160-wk-Fact-2D414D3CEDB2E79177EC284315C441FF" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">58</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10060662e3181-wk-Fact-85030439EC03F1534084284315CC5288" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10060662e3200-wk-Fact-E4296D3CF67F6722D94C284315CBF28C" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10060662e3219-wk-Fact-B04AA3DD5566649C483F284315CD4212" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">23</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net unrealized gain/(loss) on derivative instruments, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10060662e3241-wk-Fact-54A1F40EDCA3AF5248D4284315CEC5A8" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">28</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10060662e3261-wk-Fact-AB1C3AE31F896456B19D284315C76F27" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10060662e3281-wk-Fact-A879646321F72E27A773284315D0C796" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total other comprehensive income/(loss), net of tax</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10060662e3303-wk-Fact-A6397626AEF8DA99ACC7284315D1A7E0" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">25</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10060662e3323-wk-Fact-25A84D589EE05D58C780284315C6C941" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10060662e3342-wk-Fact-9B6DDE0F0577529DB145284315CB02AF" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total comprehensive income/(loss)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10060662e3425-wk-Fact-7121B1BE87B991F317A7284315CCBB0C" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3,718</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10060662e3445-wk-Fact-FDF73F682E589F2446E4284315CD974C" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,378</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10060662e3464-wk-Fact-6946D48C42759534E9DC284315CB8981" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">292</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: comprehensive income attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10060662e3548-wk-Fact-59D860CFE7EAD17DA86F284314604AB7" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10060662e3568-wk-Fact-40DF87BBE9A82CD4A06E2843164157A9" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10060662e3588-wk-Fact-2FA51944D462B903C3502843161C2311" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total comprehensive income/(loss) attributable to Cardinal Health, Inc. </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10060662e3615-wk-Fact-2DEA4357B65473DD265A284315CF337B" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3,721</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10060662e3635-wk-Fact-B198A5E9EAA82361E700284315C925CD" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,376</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10060662e3654-wk-Fact-4F3901E30A3C4968CCD8284315C4684A" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">289</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The accompanying notes are an integral part of these consolidated statements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">50</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s3FA194F7CCCE56278BB2C27FF79EE72B"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Consolidated Balance Sheets</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">June 30</span></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Current assets:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash and equivalents</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3039-wk-Fact-9A4D6F4B89355C9FAAA69392AD203FAB" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,771</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3058-wk-Fact-97315FFE5C1057E198DE11BA3705027F" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,531</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trade receivables, net</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3073-wk-Fact-E1B36F938B8E51A8838E512551CAF5CA" name="us-gaap:ReceivablesNetCurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,264</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3092-wk-Fact-40FF9FC6A63B586482E86B0955C58DAC" name="us-gaap:ReceivablesNetCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,448</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inventories, net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3112-wk-Fact-0774C5FC68CB52D4A0A2F3FB9811F7AC" name="us-gaap:InventoryNet" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13,198</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3131-wk-Fact-FB3483C9F0A65999AA748E5902724A82" name="us-gaap:InventoryNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12,822</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Prepaid expenses and other</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3151-wk-Fact-71B7A2799AF850CC9451EC25C1581E45" name="us-gaap:OtherAssetsCurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,707</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3170-wk-Fact-849FE785EBB55F7481A0567941258C90" name="us-gaap:OtherAssetsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,946</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total current assets</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3190-wk-Fact-FE16BD49BBCC5B57B33DFB2B786F7B13" name="us-gaap:AssetsCurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">25,940</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3209-wk-Fact-2389389C28A15477ADDF98E434B9029C" name="us-gaap:AssetsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">25,747</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Property and equipment, net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3270-wk-Fact-022AFBD3623650148594C8C3580F78AF" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,366</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3289-wk-Fact-65BAC2AADAAF5CD58F3560A3DA72CCD6" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,356</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill and other intangibles, net</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3310-wk-Fact-FAEE6BDABBFD57E9AC5917B6BC97FF27" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11,275</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3329-wk-Fact-572710A9966E5A7692E1FB9328CFF598" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11,808</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3349-wk-Fact-D25985F5AC10538786292CAF43C7D242" name="us-gaap:OtherAssetsNoncurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,185</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3368-wk-Fact-7A22140B18905DF0927FE02E33E1FAC1" name="us-gaap:OtherAssetsNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,052</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3393-wk-Fact-0D1C1049F30C5252BA4FAD5427DE72B3" name="us-gaap:Assets" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40,766</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3412-wk-Fact-45315210045352E49355E81E393FAF22" name="us-gaap:Assets" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40,963</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities and Shareholders&#8217; Equity</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Current liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accounts payable</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3555-wk-Fact-76945333943153788398655228951E9B" name="us-gaap:AccountsPayableCurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">21,374</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3574-wk-Fact-604A1E19365D5FDFA607BE920789BA99" name="us-gaap:AccountsPayableCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">21,535</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Current portion of long-term obligations and other short-term borrowings</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3589-wk-Fact-AEE6885C79795EC8BD6D2D94473CEAC3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3608-wk-Fact-65E8671C68655ED487958DD7FF10BC0C" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">452</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other accrued liabilities</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3628-wk-Fact-5E727B9213B95603B761A4CB95A7537E" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,231</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3647-wk-Fact-C7552CB5C5B255C3847147086BBC9F25" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,122</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total current liabilities</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3667-wk-Fact-9A4F183F036E5452B4A40486E478ED8C" name="us-gaap:LiabilitiesCurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">23,615</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3686-wk-Fact-9FD3D1F2A7265466A86AF5C8D35F059B" name="us-gaap:LiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">24,109</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term obligations, less current portion</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3748-wk-Fact-1AC0DDF0A60D5B1AA8B9E0BB56255504" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,765</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3767-wk-Fact-19FEF4F9B77450E896FB33A6F288C5A4" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7,579</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Deferred income taxes and other liabilities</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3787-wk-Fact-883A6A6F96ED510087CC37F98F3E57BD" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,594</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3806-wk-Fact-A52DF61150E95F73832F36AC1129ED3C" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,945</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Shareholders&#8217; equity:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Preferred shares, without par value:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Authorized&#8212;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">500&#160;thousand</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;shares, Issued&#8212;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">none</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e3955-wk-Fact-9FD0126AA2EF554EA618B33C7C2E0FC0" name="us-gaap:PreferredStockValue" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e3974-wk-Fact-C47A359CEEFC5C3EBB25B3A59D934879" name="us-gaap:PreferredStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Common shares, without par value:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Authorized&#8212;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">755&#160;million</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;shares, Issued&#8212;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">327 million</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;shares at </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">June 30, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;and 2019, respectively</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e4047-wk-Fact-D65F4D5D73615E618749D976EF4D4B7A" name="us-gaap:CommonStockValue" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,789</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e4066-wk-Fact-2CCA681560405AB6B3E953CEB62780D4" name="us-gaap:CommonStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Retained earnings</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e4086-wk-Fact-B6B8CFAB9013559F936ECDA4294C99ED" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,170</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e4105-wk-Fact-C04CBA9C6747500E83BDC09CEB5A099D" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,434</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Common shares in treasury, at cost: </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">34 million</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;shares and 28&#160;million shares at </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">June 30, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;and 2019, respectively</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10065441e4133-wk-Fact-68FCC0F9C85255D8821CC559BCC642CE" name="us-gaap:TreasuryStockValue" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,066</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10065441e4153-wk-Fact-9708B384A9A7572EB8E763C902F377DF" name="us-gaap:TreasuryStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,790</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated other comprehensive loss</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10065441e4174-wk-Fact-7FFCFB000E8859C6A73419BF99BFA506" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">104</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10065441e4194-wk-Fact-8895C7DD90EF54278F4E9A7F73C5D3AA" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total Cardinal Health, Inc. shareholders' equity</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e4216-wk-Fact-D6763D183153576D9EDE85F64E34DB3A" name="us-gaap:StockholdersEquity" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,789</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e4235-wk-Fact-9C18192299EC589EA09EB952F3A0B10D" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,328</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e4255-wk-Fact-F8D041B04DEA55D58F83B33CA5318C35" name="us-gaap:MinorityInterest" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e4274-wk-Fact-658886C5E1F9554CA0F6FCC484DDEDCE" name="us-gaap:MinorityInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total shareholders&#8217; equity</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e4294-wk-Fact-EE27D00AF623506B8D26814FF00D04C0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,792</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e4313-wk-Fact-88F8D7D7B8D15C6F9DF0260592476564" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,330</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total liabilities and shareholders&#8217; equity</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10065441e4338-wk-Fact-2C7A02EA1BEF5C059EA78A827965BFD6" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40,766</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10065441e4357-wk-Fact-F734184A7A235162B1FC16685EB03445" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40,963</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;">The accompanying notes are an integral part of these consolidated statements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">51</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s2E03441EBB675479ADBCB3C557531AA6"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Consolidated Statements of Shareholders' Equity</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"></td></tr><tr><td style="width:26%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Common Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Treasury Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated Other<br/>Comprehensive<br/>Loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Noncontrolling Interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total<br/>Shareholders&#8217;<br/>Equity</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Shares Issued</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Retained<br/>Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e3200-wk-Fact-E64CD996901E80E3033C2843148CDF69" name="us-gaap:CommonStockSharesIssued" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e3219-wk-Fact-EEF0D2681C1188CD3DC128431598EBE3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,697</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e3238-wk-Fact-3A445377EED55020ACE12843159D415E" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4,967</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e3253-wk-Fact-74853BF3418DBF0E562D284314764576" name="us-gaap:TreasuryStockShares" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e3273-wk-Fact-E6E2D01694BAA965335E28431470C2A6" name="us-gaap:TreasuryStockValue" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">731</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e3293-wk-Fact-9B135615A0EB75B1EE512843159B846A" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">125</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e3314-wk-Fact-12ECD40C5D2A080F219F284314890DBE" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e3333-wk-Fact-58BE4933D46E97F28F6028431483A379" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2017Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,828</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e3383-wk-Fact-E0208F68272ACC5F53622843148195B9" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">256</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e3459-wk-Fact-0E88BEFAEB209943633828431597DFA3" name="us-gaap:ProfitLoss" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e3479-wk-Fact-21B6DB1FAC42C4E72E5A28431489147A" name="cah:NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">255</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e3590-wk-Fact-A274C204689E9F9A0A872843146CA0F2" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e3630-wk-Fact-12249A8F821549C30BD6284315961B3C" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Purchase of noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e3762-wk-Fact-2DC758A05D1AAE5A148E28431484957F" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e3782-wk-Fact-CC6909D8B3252EDD177A2843147897EB" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock plans activity, including tax benefit of $10&#160;million</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e3817-wk-Fact-6D466FC9259178EBE5EB2843146B4C0B" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e3857-wk-Fact-75A5AAF374A73D779E1128431474D10E" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e3871-wk-Fact-EA455C917E5AD8A31C6D2843147A759A" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">57</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e3931-wk-Fact-EF7C121786857F74FD5628431477F529" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">90</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share repurchase program activity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e4007-wk-Fact-9771E1CF2C5E612D2FEB28431482AAEA" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e4022-wk-Fact-C268C3032B53ABAFA8A428431599DDFC" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">550</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e4083-wk-Fact-36F7F96137A9E46A0CB82843146DFDA5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">550</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividends declared</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e4139-wk-Fact-3748AA0E5E4DDE1D27682843146ED7BE" name="us-gaap:Dividends" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">584</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e4236-wk-Fact-760830E9A75D54047DBB2843148337DE" name="us-gaap:Dividends" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">584</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e4292-wk-Fact-9266E704C691615915002843147D6048" name="us-gaap:StockholdersEquityOther" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e4368-wk-Fact-B3E6841820718F4D6B44284315A16006" name="us-gaap:StockholdersEquityOther" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e4387-wk-Fact-5E48569B3317A503A5612843159A6AA3" name="us-gaap:StockholdersEquityOther" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e4407-wk-Fact-9A053AD09EA150119F5F7E802DD4D24A" name="us-gaap:CommonStockSharesIssued" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e4421-wk-Fact-5EB3015CA2EA5420B5CBB80767459469" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,730</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e4440-wk-Fact-081F05C09EC25B78B48D8F5ABC9DAEA5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4,645</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e4460-wk-Fact-BCB2B42D9765580C9596E554363B4C9A" name="us-gaap:TreasuryStockShares" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e4475-wk-Fact-56B19E5DA22F5A748539ED433809907D" name="us-gaap:TreasuryStockValue" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,224</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e4495-wk-Fact-D8E8AFD70315541DAB84B9798AABD625" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">92</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e4516-wk-Fact-97CFACFE7E7D5765A17ECB779F5EEC79" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e4535-wk-Fact-9C91F74A71C3576D9AB14EF164472262" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,059</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e4591-wk-Fact-A6793123A202F02F7DDF2843161A0AE7" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,363</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e4667-wk-Fact-8E9EEC27995A58BF9A8A91F7E1D73525" name="us-gaap:ProfitLoss" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e4686-wk-Fact-DA8A9DB84161C8826F8428431624E0AF" name="us-gaap:ProfitLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,365</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e4797-wk-Fact-5098069C0A2452C487D09C0036D8B533" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e4837-wk-Fact-EDC2EA4378D0553CAA139A21A4864150" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock plans activity, net of shares withheld for employee taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e4871-wk-Fact-22AFC1E0274F5427BFF810D80D2E8C88" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e4911-wk-Fact-D714E9EBF54C5A02A5172DD56A90CEB7" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e4925-wk-Fact-D8993BC3552F5B77A402E353B8D05265" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">34</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e4985-wk-Fact-EBFED96D21A052B99CC122087818E248" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">67</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share repurchase program activity</span></div><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e5063-wk-Fact-DDD310F7665D5FBE90DAA36019186D6C" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e5078-wk-Fact-2760FFF59B935E778B43CBEDECAED277" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e5139-wk-Fact-6C4833ABCB64549088514B473B3B623B" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividends declared</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e5195-wk-Fact-39663EF132EF55F384BE6E987102ABBD" name="us-gaap:Dividends" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">575</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e5292-wk-Fact-BEFD301F710B59AF88490E9722414D9A" name="us-gaap:Dividends" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">575</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e5348-wk-Fact-D8120BE8C13A57D99E9154065C9B6DA2" name="us-gaap:StockholdersEquityOther" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e5443-wk-Fact-429B34B7595C5A23A5D7D8BF7568AFAC" name="us-gaap:StockholdersEquityOther" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e5463-wk-Fact-567C4336224A5237A1BBEA2E9CBFDAAE" name="us-gaap:CommonStockSharesIssued" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e5477-wk-Fact-0346FC711B445AD68D95EB0049AA6CF3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e5496-wk-Fact-AD803AC849C1593199D80B6BD6D0E100" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,434</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e5516-wk-Fact-A92D2B68D2DC5A27BBFA377C2DF1D80A" name="us-gaap:TreasuryStockShares" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">28</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e5531-wk-Fact-CAD332DD03BC525FA0EC561ABAF7FC61" name="us-gaap:TreasuryStockValue" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,790</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10072770e5551-wk-Fact-53FE35BCC48B59D8B4B22A283001343A" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10072770e5572-wk-Fact-75D677F3CF515C73B370A96683F6A9AC" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e5591-wk-Fact-88F8D7D7B8D15C6F9DF0260592476564" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,330</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e5646-wk-Fact-D376E4CF10C84B75E68E2843162F9636" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3,696</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e5723-wk-Fact-F4165ED7FD5857A48D79CE61364FFB17" name="us-gaap:ProfitLoss" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e5742-wk-Fact-9AE3E593FCE6335F39752843162378C6" name="us-gaap:ProfitLoss" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3,693</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e5854-wk-Fact-FD89153856515D78A20181F5156EF4E8" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e5895-wk-Fact-6FBCCE1C5FCA57F1BF127506005DDA77" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock plans activity, net of shares withheld for employee taxes</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e5930-wk-Fact-7D98484CF591519996174147BB57824B" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">26</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e5970-wk-Fact-58AC83CF8F42518C853CC139AA6824EB" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e5984-wk-Fact-1FB46825630E5CCEAD5B32356133151D" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">74</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e6044-wk-Fact-80EC858E39D250ADBB26172E4029FC22" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">100</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share repurchase program activity</span></div><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e6122-wk-Fact-D840DE3AEA4A533CB5D84C740417EC22" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e6137-wk-Fact-B56DFE89D6255492B027056E16831EE2" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e6198-wk-Fact-0FFD88740F0A5843A18003D7D25D0B9D" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividends declared</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e6255-wk-Fact-65AF2ACE299F510B9378E06634316BFD" name="us-gaap:Dividends" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">570</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e6352-wk-Fact-117688CB52E85103BCD2A4701D673ADC" name="us-gaap:Dividends" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">570</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e6408-wk-Fact-E5F62C13DDB957DB835AF247E64BB446" name="us-gaap:StockholdersEquityOther" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e6484-wk-Fact-8B2AF363073B58B4B39F8ED07050EA13" name="us-gaap:StockholdersEquityOther" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e6504-wk-Fact-CEDBB8E5DDE354DFA0894AF5E4E228DE" name="us-gaap:StockholdersEquityOther" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e6524-wk-Fact-6A5599DCEFD655C3B7B90E7F5B486288" name="us-gaap:CommonStockSharesIssued" contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e6543-wk-Fact-6B21B74568FA5E188A38A7498A800A13" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,789</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e6562-wk-Fact-437ADE4D67FC53579D3FC0C3362B033E" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,170</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e6577-wk-Fact-86C13BA5B0B75AFDA6E220A4DFA83944" name="us-gaap:TreasuryStockShares" contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e6597-wk-Fact-F2B4418B5F725907B478D74139E8B580" name="us-gaap:TreasuryStockValue" contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,066</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10072770e6617-wk-Fact-1179AEBAD93252BAA89002DD34E515A8" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">104</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e6638-wk-Fact-675835789CE35BBB880D42BFDE0318B3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10072770e6657-wk-Fact-EE27D00AF623506B8D26814FF00D04C0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,792</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The accompanying notes are an integral part of these consolidated statements.</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">52</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sA741D5B2B3175E01B66914E8B178C0CC"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Consolidated Statements of Cash Flows</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:0%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash flows from operating activities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e3015-wk-Fact-9AE3E593FCE6335F39752843162378C6" name="us-gaap:ProfitLoss" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3,693</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3040-wk-Fact-DA8A9DB84161C8826F8428431624E0AF" name="us-gaap:ProfitLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,365</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3060-wk-Fact-CB17DEC5A4D0E06152A128431645C61E" name="us-gaap:ProfitLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">259</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e3142-wk-Fact-57EDF83A615A6AD362F8284314743364" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">913</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3166-wk-Fact-83DDAE6665350772F68628431483662C" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3185-wk-Fact-025EC02EAF19C052A2972843148966C8" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,032</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and loss on sale of other investments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e3206-wk-Fact-EC9F947B59F7626A70CF2843146B9E71" name="us-gaap:LossOnSaleOfInvestments" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3230-wk-Fact-9EA3BD11D620361DFA272843159E2BD2" name="us-gaap:LossOnSaleOfInvestments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3249-wk-Fact-9F1501F9157CD71B18A5284314690ED4" name="us-gaap:LossOnSaleOfInvestments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain on sale of equity interest in naviHealth</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e3270-wk-Fact-89E3224004987E7C3321A58ABB8E4B0F" name="us-gaap:GainOnSaleOfInvestments" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">579</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3294-wk-Fact-26DBFAAC3970F2B06B92E2EE19D9C158" name="us-gaap:GainOnSaleOfInvestments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3313-wk-Fact-0315A7D6D42179F39666E2EE6489D3CB" name="us-gaap:GainOnSaleOfInvestments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and loss/(gain) on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e3334-wk-Fact-81DD573C26D385689CC62843162E7B18" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e3358-wk-Fact-7F41BBDEA2F421FA4BBB2843162FC07D" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">488</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3378-wk-Fact-6306BF99352252989396284316404B2E" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1,417</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss on early extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e3399-wk-Fact-04EBBE90C0E8A84B4F0D284316412812" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3423-wk-Fact-E27CFF974E808DDEC6EE284316279CA1" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3442-wk-Fact-9A932B4A1F36871979202843161AD9CD" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e3463-wk-Fact-6B97C04F43AD8F4BA5032843148C7315" name="us-gaap:ShareBasedCompensation" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">90</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3487-wk-Fact-7FB0ECBA1306D3E53A882843146EE777" name="us-gaap:ShareBasedCompensation" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">82</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3506-wk-Fact-AEFF1AA99AAB022A1C882843147AB65C" name="us-gaap:ShareBasedCompensation" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">85</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Provision for/(benefit from) deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e3527-wk-Fact-2A3D5D1ADB9EB2D73D3C2843148BB1D8" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">961</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e3552-wk-Fact-07BADBE2FC7BA806CDA82843146F9B0B" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">83</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e3572-wk-Fact-5608F2B71E98868ABA9E2843147BAB8F" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1,012</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Provision for bad debts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e3595-wk-Fact-F9CDE76EB3BE3850444D2843159F4F68" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">106</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3619-wk-Fact-AC6643F37D3C0AB3438E2843159781FA" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">88</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3638-wk-Fact-4BC0ABA7AFCE2F416134284315975397" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">74</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Change in fair value of contingent consideration obligation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e3659-wk-Fact-926D85D304C76ABBB48E28431598350D" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3683-wk-Fact-B6C7F21C06C789A24A94284314886CB9" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e3702-wk-Fact-298610F29606204AD83A284315A430AC" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Decrease/(increase) in trade receivables</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e3791-wk-Fact-C206A9FC403A31B9459528431477911F" name="us-gaap:IncreaseDecreaseInReceivables" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">82</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e3815-wk-Fact-5E44DCDE1DEE2B4D449A284314799B27" name="us-gaap:IncreaseDecreaseInReceivables" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">751</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e3835-wk-Fact-F071FDA9F10B84A0C1F328431478D98A" name="us-gaap:IncreaseDecreaseInReceivables" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">871</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Increase in inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e3857-wk-Fact-41C2E16BA36EF7107E5E284315A972BF" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">409</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e3882-wk-Fact-48C8D11568AE6920F8632843159EC82E" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">551</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e3902-wk-Fact-BBFEFD82C1AFF44C57EF28431476D2B6" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,211</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Increase/(decrease) in accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e3924-wk-Fact-0C572275D583D859E8C9284314820435" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">162</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3949-wk-Fact-7502EB01DF17E69D19C2284315A65EF7" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,864</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e3968-wk-Fact-7D66E3030956AE7CAAA8284314643C57" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,574</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other accrued liabilities and operating items, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e3989-wk-Fact-90157E909AEC8FF565E4284314874ECC" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">6,550</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4013-wk-Fact-D175EEF287E4518EFB2F28431472C825" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">193</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4032-wk-Fact-3BDE26F7F847B4E11203284315A72C4D" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">415</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net cash provided by operating activities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e4053-wk-Fact-571F873ECD44339BC0D028431470C631" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,960</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4077-wk-Fact-30C76AE19077EA9AFAE028431470E2CC" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,722</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4096-wk-Fact-2ABD408F7ADB6960BDF32843148BC49F" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,768</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash flows from investing activities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Acquisition of subsidiaries, net of cash acquired</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e4184-wk-Fact-770DE458ED772EF50FD7284315A55B60" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e4208-wk-Fact-CF15DEC65EA7E9FB846C284314794A7D" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">82</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e4228-wk-Fact-EB5DCB839DF68C9EB5082843159DD461" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,142</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions to property and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e4250-wk-Fact-5569821F2C7BF16C54C3284315A0F77A" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">375</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e4275-wk-Fact-53BD6795C0FB005E6EB728431488D90A" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">328</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e4295-wk-Fact-08E32C846E584979DCB328431474D5E4" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">384</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Purchase of other investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e4318-wk-Fact-BFF3E0EF6372C222C614284315A0979F" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e4343-wk-Fact-F36F20139036E1B413FD284314660A32" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e4363-wk-Fact-0F3C41D083F60406D9FA284314664E6A" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Proceeds from sale of investments and available-for-sale securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e4385-wk-Fact-02AAA7B2AF60BA9D64122843148C8A73" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">886</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4409-wk-Fact-1887130A343B4DAA253028431484533B" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4428-wk-Fact-9924846590D2B5D015902843159A6CEA" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">65</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Proceeds from divestitures, net of cash sold, and disposal of property and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e4449-wk-Fact-6A96DF999DC05C1281802843159C2431" name="cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4473-wk-Fact-D37085A4CB3D82F4FD8A2843147812F6" name="cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4492-wk-Fact-546F76E4454FADF3C8DB28431476600E" name="cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">862</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net cash provided by/(used in) investing activities </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e4513-wk-Fact-0FBE0B8AD07F0424DC4C284315A45060" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">493</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4537-wk-Fact-6B403F908E603683C7F9284315A34670" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">338</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e4556-wk-Fact-20DEA545AF91B94229ED2843146A0633" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5,608</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash flows from financing activities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payment of contingent consideration obligation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e4645-wk-Fact-569F036927A6BDCDF5A72843147F758A" name="cah:PaymentofContingentConsideration" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4669-wk-Fact-F09B5682345E2C6C93FA2843148D4850" name="cah:PaymentofContingentConsideration" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e4688-wk-Fact-19B1BFB019D5B0DE8B0F2843159B8C7B" name="cah:PaymentofContingentConsideration" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net change in short-term borrowings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e4710-wk-Fact-AF0D9C803BE9CA0F690D284315A7CA64" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4735-wk-Fact-AD00958FAA234B35B77028431479B47E" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e4754-wk-Fact-21FF4CD54B0DAF8F2A5C284314891A78" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">50</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Purchase of noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e4776-wk-Fact-0ED92021AA90104F0249284315A44151" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4800-wk-Fact-845ACBB7A62AE3CB76D82843147325C0" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e4819-wk-Fact-EA086A3F2F89313B4E1E284315A6A302" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">106</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Proceeds from interest rate swap terminations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e4841-wk-Fact-987680E5982123EFCB1528431476810F" name="us-gaap:PaymentsForProceedsFromHedgeFinancingActivities" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">112</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4865-wk-Fact-07F7075B24DD534A7E31284315A268BF" name="us-gaap:PaymentsForProceedsFromHedgeFinancingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4884-wk-Fact-4999FEB3B223F8C1A30E284315967563" name="us-gaap:PaymentsForProceedsFromHedgeFinancingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Proceeds from long-term obligations, net of issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e4905-wk-Fact-49E6320CBFFD032EF4DFA4CC94B290D3" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4929-wk-Fact-5ABC4D049B16BAE1B67CA4CC94D5F58C" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e4948-wk-Fact-942FB965171F2F36DAE6A4CC94D17533" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Reduction of long-term obligations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e4969-wk-Fact-70A6C0DC9C07CB66A7CE284314689E0A" name="us-gaap:RepaymentsOfLongTermDebt" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,399</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e4994-wk-Fact-523D62DE7B3141125A4628431478FF09" name="us-gaap:RepaymentsOfLongTermDebt" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,102</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e5014-wk-Fact-F06C9E17689D954643B528431597DCB0" name="us-gaap:RepaymentsOfLongTermDebt" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">954</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net tax proceeds/(withholding) from share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e5037-wk-Fact-64C7379686385DF6989728431472DBF1" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e5061-wk-Fact-5BE562853545F2035DD1284314678173" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">14</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e5081-wk-Fact-778B23D82A70E693C5652843159D0301" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividends on common shares</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e5103-wk-Fact-D6E3DA2146864945E79E28431489211B" name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">569</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e5128-wk-Fact-6ED7CFC41F80247E31DA2843147CAE6C" name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">577</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e5148-wk-Fact-C54FF9A86D54D57F463C2843146BCE98" name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">581</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Purchase of treasury shares</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e5170-wk-Fact-642F443511C39C8A05F8284315A3168A" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e5195-wk-Fact-78812F29DED41077567028431482749D" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e5215-wk-Fact-EBEA51C4749354D630FF284315A0004A" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">550</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net cash used in financing activities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e5237-wk-Fact-896A6A76D236AB83CCF82843148A7052" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2,200</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e5262-wk-Fact-B92070DDB4C0594BB9572843148073B9" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2,293</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e5282-wk-Fact-69487A3B4B4E4D65CD9B2843147E58B2" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2,276</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Effect of exchange rates changes on cash and equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10082224e5304-wk-Fact-375DF60AEFB9DF93D9B2284315961EA5" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e5329-wk-Fact-C9D8DB1D67C5FF1F48E5284315A1DC05" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e5348-wk-Fact-D6405475ECFD56A7E1A328431483A543" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash reclassified to assets held for sale</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e5369-wk-Fact-B5A1D20BCD939F88CFEC2843146E0B68" name="cah:CashReclassifiedtoAssetsHeldforSale" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e5393-wk-Fact-F88AF0548449C0549F612843147B440A" name="cah:CashReclassifiedtoAssetsHeldforSale" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e5412-wk-Fact-FC26E79659256BE02BC7284314895EDF" name="cah:CashReclassifiedtoAssetsHeldforSale" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net increase/(decrease) in cash and equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e5434-wk-Fact-7D3ABECE6780F84C3525284314670088" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">240</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e5458-wk-Fact-B9B56A456A7CAE047A122843146D994D" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">768</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10082224e5477-wk-Fact-B92B6E817708DCD3F2EF2843148DBAC0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5,116</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash and equivalents at beginning of period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e5499-wk-Fact-97315FFE5C1057E198DE11BA3705027F" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,531</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e5523-wk-Fact-BAD91DFF7A447392749D28431481678A" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e5542-wk-Fact-0D3D8DB6197E471A2D8A28431469E823" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2017Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,879</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash and equivalents at end of period</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e5568-wk-Fact-9A4D6F4B89355C9FAAA69392AD203FAB" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,771</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e5592-wk-Fact-97315FFE5C1057E198DE11BA3705027F" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,531</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e5612-wk-Fact-BAD91DFF7A447392749D28431481678A" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Supplemental Information:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash payments for interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e5699-wk-Fact-D1860AF0038635CEB7242843148677EC" name="us-gaap:InterestPaidNet" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">226</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e5723-wk-Fact-6B4CD19380184837615A2843147E29F2" name="us-gaap:InterestPaidNet" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">285</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e5743-wk-Fact-40C6E36DA783033D550A284315A7907B" name="us-gaap:InterestPaidNet" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">320</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash payments for income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10082224e5759-wk-Fact-1019F891E21A3D1246CE2843146E35A3" name="us-gaap:IncomeTaxesPaidNet" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">368</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e5783-wk-Fact-70B62F71FE6431572BD228431598C9EC" name="us-gaap:IncomeTaxesPaidNet" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">311</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10082224e5802-wk-Fact-4E9BDA73D620A55397822843147131E7" name="us-gaap:IncomeTaxesPaidNet" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">425</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The accompanying notes are an integral part of these consolidated statements.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">53</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s7F5EE3762E4F50C7A352513C3AD9C48A"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Notes to Consolidated Financial Statements </span></div><div style="line-height:120%;padding-bottom:1px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div><a id="sAF8B609C6A1B5242B7B172A7B9FB2416"></a></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="TextSelection-D2F85451D5D8AC126E34284316618231-0-wk-Fact-A6E21350279767F6FFA9284314853D1B" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">1. Basis of Presentation and Summary of Significant Accounting Policies</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc. is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. We provide medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. References to &#8220;we&#8221;, &#8220;our&#8221; and similar pronouns in these consolidated financial statements are to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context otherwise requires.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our fiscal year ends on June&#160;30. References to fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;"> in these consolidated financial statements are to the fiscal years ended </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="TextSelection-DC06C886645E5ADEC3FA2843165E660A-0-wk-Fact-41D2489D0FDC755648A028431468FFA3" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis of Presentation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:UseOfEstimates" id="TextSelection-BEBF39E558B1BF1F41842843165F2902-0-wk-Fact-60DA110BF97234222F5F28431488C5A7" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts could ultimately differ from these estimated amounts.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The outbreak of the novel strain of coronavirus (&#8220;COVID-19&#8221;) has severely impacted, and continues to severely impact the U.S. and global economies, and beginning in the third quarter of fiscal 2020, our businesses have been impacted in a variety of ways. We cannot estimate the length or severity of the COVID-19 pandemic or the related U.S. and global economic consequences on our business and operations, including whether and when historic economic and operating conditions will resume or the extent to which the disruption may impact our business, financial position, results of operations or cash flow. Our e</span><span style="font-family:Arial Narrow;font-size:10pt;">stimates, judgments and assumptions related to COVID-19 could ultimately differ over time</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="TextSelection-11FDF4A20B3A08D6C1042843165E35FB-0-wk-Fact-99B46EED41FF449277F7284314725A13" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash Equivalents</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.</span></div></ix:nonNumeric></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-1" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-2"><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ReceivablesPolicyTextBlock" id="TextSelection-C57247C3F98E4752B0B82843165FFDEC-0-wk-Fact-07DB15014C72C5E98C6D28431476E012" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Receivables and Allowance for Doubtful Accounts</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Trade receivables are presented net of an allowance for doubtful accounts of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3175-wk-Fact-F38380296049D80EEE54284315D7BE2E" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">206</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3179-wk-Fact-F77B919A29D45CF279F8284314635DD1" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">193</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. An account is considered past due on the first day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to cover potential losses, which are based primarily on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We provide financing to various customers. Such financing arrangements range from </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d10103707e3194-wk-Fact-BA9AFE78465914E7A11928431482BA2F" name="cah:ReceivableFinancingAgreementTerm" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember" format="ixt-sec:duryear">1</ix:nonNumeric> year</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d10103707e3198-wk-Fact-8D0D706F7D641A3AA92F2843145F6E96" name="cah:ReceivableFinancingAgreementTerm" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember" format="ixt-sec:duryear">5</ix:nonNumeric> years</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3202-wk-Fact-F7D43D7DA9D3E9EF660928431488CB90" name="us-gaap:NotesReceivableNet" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">104</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> (current portion </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3206-wk-Fact-0F31C25762DA60BF5F032843146CF956" name="us-gaap:NotesAndLoansReceivableNetCurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">) and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3210-wk-Fact-AF981ECDF0A7984CE4DF284314866025" name="us-gaap:NotesReceivableNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">103</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> (current portion </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3215-wk-Fact-197BBCF35735ED553A8A284315D582B7" name="us-gaap:NotesAndLoansReceivableNetCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">) at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3227-wk-Fact-560ECF7266B4A2A76257A5D9FD574F9A" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">27</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3231-wk-Fact-B0FEA8F4C381D289FFAC28431479A023" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">14</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ConcentrationRiskCreditRisk" id="TextSelection-6A2C7D4D18DE440AB757284316600377-0-wk-Fact-BE5B003B42D683606817284314708EA5" continuedAt="TextSelection-6A2C7D4D18DE440AB757284316600377-1" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Concentrations of Credit Risk</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.</span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><ix:continuation id="TextSelection-6A2C7D4D18DE440AB757284316600377-1">Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#8217; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts. </ix:continuation> </span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:MajorCustomersPolicyPolicyTextBlock" id="TextSelection-A910EF4BB28FC63256BE28431660BAE1-0-wk-Fact-AC1E6CD4306E994FD3FA2843146698FF" continuedAt="TextSelection-A910EF4BB28FC63256BE28431660BAE1-1" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Major Customers</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">CVS Health Corporation ("CVS") and OptumRx, are our only customers that individually account for at least 10 percent of revenue </span></div></ix:nonNumeric></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">54</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-2" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-3"><ix:continuation id="TextSelection-A910EF4BB28FC63256BE28431660BAE1-1" continuedAt="TextSelection-A910EF4BB28FC63256BE28431660BAE1-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="TextSelection-2D576EFA8CB72577A32F2843165F4768-0-wk-Fact-8D09C9B7DACB24EE37F5284314770498" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:34%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Percent of Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">CVS</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103707e3476-wk-Fact-C5F3AD6BE114A0D11E8E2843162C5A0D" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2020Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">26</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103707e3491-wk-Fact-2360AADDAF69ADE14DD92843162E6685" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">26</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103707e3506-wk-Fact-723CCEC70FB50E2F1CCA2843162FFD96" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103707e3521-wk-Fact-3269E37177B70AD365832843162C0AB0" name="cah:GrossTradeReceivablesMajorCustomerPercentage" contextRef="FI2020Q4_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">26</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103707e3537-wk-Fact-F7B4ACA67A078B6A24D72843162D1CF1" name="cah:GrossTradeReceivablesMajorCustomerPercentage" contextRef="FI2019Q4_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">24</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">OptumRx</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103707e3553-wk-Fact-52B1B312600AB8822EB22843162E040C" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2020Q4YTD_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">14</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103707e3568-wk-Fact-71ECA709A0B512352D392843162C0F01" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103707e3583-wk-Fact-AF1EE5556E4C721C23BB2843162D6F89" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103707e3598-wk-Fact-8724E6C25FEC44467F8B2843162F3CA6" name="cah:GrossTradeReceivablesMajorCustomerPercentage" contextRef="FI2020Q4_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103707e3614-wk-Fact-08AC220879783786BEB12843162DE124" name="cah:GrossTradeReceivablesMajorCustomerPercentage" contextRef="FI2019Q4_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><ix:continuation id="TextSelection-A910EF4BB28FC63256BE28431660BAE1-2" continuedAt="TextSelection-A910EF4BB28FC63256BE28431660BAE1-3"><span style="font-family:Arial Narrow;font-size:10pt;">We have entered into agreements with group purchasing organizations (&#8220;GPOs&#8221;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10103707e3631-wk-Fact-B50E8914FBA19FFFBE062843146495A2" name="cah:ConcentrationRiskLargestGroupPurchasingOrganizations" contextRef="FD2020Q4YTD" unitRef="organization" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> largest GPO member relationships in terms of revenue. Sales to members of these </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10103707e3635-wk-Fact-B50E8914FBA19FFFBE062843146495A2" name="cah:ConcentrationRiskLargestGroupPurchasingOrganizations" contextRef="FD2020Q4YTD" unitRef="organization" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> GPOs collectively accounted for </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10103707e3639-wk-Fact-79EFF11ECDDE56FA789628431462D3E0" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2020Q4YTD_srt_MajorCustomersAxis_cah_GroupPurchasingOrganizationsMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">16</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10103707e3643-wk-Fact-D3B55CFBC0B8289DDC672843146AB4A1" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_cah_GroupPurchasingOrganizationsMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">22</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10103707e3647-wk-Fact-1BA8568AEF077C18BD8F284315D9107C" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_cah_GroupPurchasingOrganizationsMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">22</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of revenue for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span></ix:continuation><span style="font-family:Arial Narrow;font-size:10pt;"><ix:continuation id="TextSelection-A910EF4BB28FC63256BE28431660BAE1-3">, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements</ix:continuation>.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:InventoryPolicyTextBlock" id="TextSelection-353A333F90EDCC7DCBF3284316622C51-0-wk-Fact-8DF6B1AA9F5295104BC42843148A28FB" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Inventories</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">A substantial portion of our inventories (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10103707e3683-wk-Fact-BD683EDA0AEE5870E91B284315D8C671" name="us-gaap:PercentageOfLIFOInventory" contextRef="FI2020Q4" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">56</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at both </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#8220;distribution facilities&#8221;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, inventories valued at LIFO cost were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3706-wk-Fact-9CF1D6C21AB3DA50F852284314801D79" name="us-gaap:InventoryLIFOReserve" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">411</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3712-wk-Fact-AA4ACC711C964B3461612843147591E1" name="us-gaap:InventoryLIFOReserve" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">230</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> or </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our remaining inventory that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Net realizable value is defined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3735-wk-Fact-629FD4D05E43FD8C8F5D2843146E5E13" name="us-gaap:InventoryValuationReserves" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">155</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3739-wk-Fact-AD9598010FD7593F09222843148243EF" name="us-gaap:InventoryValuationReserves" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">171</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies.</span></div></ix:nonNumeric></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-3" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-4"><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:CashDiscountsPolicyTextBlock" id="TextSelection-A1E804E92E2ABBD6C6AF2843165FF7FD-0-wk-Fact-393768B3D8BE4F5BA8B22843145E3FFC" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash Discounts</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="TextSelection-245A49A4CFC655C719562843165FB61E-0-wk-Fact-26C1462A401AFDEA12862843145F57C7" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Property and Equipment</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#8212;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d10103707e3788-wk-Fact-DEF1BA72BAFBF304F0AB284315D6EB62" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" format="ixt-sec:duryear">3</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d10103707e3792-wk-Fact-49758C091034E482F96D2843147F7E4A" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" format="ixt-sec:duryear">39</ix:nonNumeric> years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">; machinery and equipment&#8212;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d10103707e3796-wk-Fact-C47BC0FCBAC05D04BBB42843147EE4F3" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear">3</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d10103707e3800-wk-Fact-B6CBC82046843AE018EA28431467A2B9" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear">20</ix:nonNumeric> years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">; and furniture and fixtures&#8212;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d10103707e3804-wk-Fact-432EC347B61AA13563972843146FECB8" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear">3</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d10103707e3809-wk-Fact-D97609E3BF6B6C47FFA6284314807B9B" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear">7</ix:nonNumeric> years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. We recorded depreciation and amortization expense of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3813-wk-Fact-23E914573FCFE351A6B62843147EA8B0" name="us-gaap:Depreciation" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">405</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3817-wk-Fact-B11D0A2E32E9AF10481F2843146108D1" name="us-gaap:Depreciation" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">455</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e3821-wk-Fact-1FCDC13508AA54B84620284314660F87" name="us-gaap:Depreciation" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">446</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="TextSelection-E1619307AD69A5DDBE30284316606799-0-wk-Fact-A014B7BBFFC5797046C828431482756C" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents the components of property and equipment, net at June&#160;30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:64%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Land, building and improvements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103707e3917-wk-Fact-A9B6407D1DA8AA43C157284315F3C4FD" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandBuildingsAndImprovementsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,185</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103707e3936-wk-Fact-CEA6A6C112E331B9B11F2843159B0B53" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandBuildingsAndImprovementsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,992</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Machinery and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103707e3951-wk-Fact-190F4B5FC5FBA163F8D7284315FBF880" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,008</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103707e3970-wk-Fact-B33797CAC569F57F0EE1284315F60096" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,038</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Furniture and fixtures</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103707e3990-wk-Fact-8D18F5153BDF9F294C4F284315EF1A21" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">138</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103707e4009-wk-Fact-0927281AC0B8789107F9284314727850" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">138</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total property and equipment, at cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103707e4029-wk-Fact-001B380544AB8CA6924428431599F67B" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,331</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103707e4048-wk-Fact-95892F9A964E3A0EB83C284315FB6DF3" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,168</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10103707e4068-wk-Fact-25ED03FB64CAC316DE4D2843163C5855" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,965</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10103707e4088-wk-Fact-6C5E47F4D1DDF71DA8AA284315F7D2DA" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,812</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Property and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103707e4114-wk-Fact-022AFBD3623650148594C8C3580F78AF" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,366</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103707e4133-wk-Fact-65BAC2AADAAF5CD58F3560A3DA72CCD6" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,356</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term obligations, which was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10103707e4148-wk-Fact-25AE72DEE3E1FCEB2FB6284314738402" name="us-gaap:LongtermDebtWeightedAverageInterestRate" contextRef="FI2020Q4" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">3</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">. The amount of capitalized interest was immaterial for all periods presented.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="TextSelection-3F21A07CBB2FC31581B7284316611B18-0-wk-Fact-24D932B3AA88B377E54728431468FFBB" continuedAt="TextSelection-3F21A07CBB2FC31581B7284316611B18-1" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Goodwill and Other Intangible Assets</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. </span></div></ix:nonNumeric></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">55</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-3F21A07CBB2FC31581B7284316611B18-1" continuedAt="TextSelection-3F21A07CBB2FC31581B7284316611B18-2"><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-4" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-5"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10103707e4196-wk-Fact-B90E114593CC51829C3D13F56F7DEC04" name="us-gaap:NumberOfOperatingSegments" contextRef="FD2020Q4YTD" unitRef="segment" decimals="0" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#8220;Medical Unit&#8221;); and Cardinal Health at-Home Solutions division. Our Nuclear and Precision Health Solutions division was formerly referred to as our Nuclear Pharmacy Services division and our Cardinal Health at-Home Solutions division was formerly referred to as our Cardinal Health at Home division.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10103707e4203-wk-Fact-F8F58562574D4E36970C2843146D8E78" name="cah:DiscountRatefairvalueinputs" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">8.5</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10103707e4207-wk-Fact-D759DB0E19B67115786928431462387E" name="cah:DiscountRatefairvalueinputs" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">10.5</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We performed annual impairment testing in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;"> and with the exception of our Medical Unit in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In conjunction with the preparation of our consolidated financial statements for fiscal 2018, we completed our annual quantitative goodwill impairment test, which we perform annually in the fourth quarter. Using a combination of income and market-based approaches (using a discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10103707e4233-wk-Fact-E6971E7F1C62A6722280284315BEE91C" name="cah:DiscountRatefairvalueinputs" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">8.5</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">), the carrying value </span></div></ix:continuation></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-5" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-6"><ix:continuation id="TextSelection-3F21A07CBB2FC31581B7284316611B18-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">exceeded the fair value and resulted in an impairment charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10103707e4240-wk-Fact-804F9E1FB0E76481C72C2843147F8E0C" name="us-gaap:GoodwillImpairmentLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">1.4</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> related to our Medical Unit, which is included in impairments and loss on disposal of assets in our consolidated statements of earnings/(loss). Our fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The impairment was primarily driven by inventory and cost challenges within our Cordis business which furthered in the fourth quarter of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. This impairment charge did not impact our liquidity, cash flows from operations, or compliance with debt covenants. There was no tax benefit related to the goodwill impairment charge. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The impairment test for indefinite-lived intangibles other than goodwill (primarily IPR&amp;D) involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation </span><span style="font-family:Arial Narrow;font-size:10pt;">requires the use of estimates and significant judgments and</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.</span></div></ix:continuation><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:AssetsHeldforSalePolicyPolicyTextBlock" id="TextSelection-8DD2D08D84B5306E0AD4284316607FF4-0-wk-Fact-44439DF0BFF23ECD829828431474A61A" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Assets Held for Sale</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We classify assets and liabilities (the &#8220;disposal group&#8221;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.</span></div></ix:nonNumeric></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">56</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-6" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-7"><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:InvestmentPolicyTextBlock" id="TextSelection-E567518D0870022A33BA2843165F6999-0-wk-Fact-8069B854B6D26B8C25A7284315D8F4B5" continuedAt="TextSelection-E567518D0870022A33BA2843165F6999-1" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Investments</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:CostofSalesVendorReservesPolicyPolicyTextBlock" id="TextSelection-90C13FB0AE4EF12A961628431662849E-0-wk-Fact-8317A7DEEF65F12A265A2843146A374E" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"><ix:continuation id="TextSelection-E567518D0870022A33BA2843165F6999-1"></ix:continuation>Vendor Reserves</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically refine our methodology by updating the reserve estimate percentages to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues, such as bankruptcies. Vendor reserves were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4306-wk-Fact-438805A6985F78A2D7552843147D72D9" name="cah:VendorReserves" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">77</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4310-wk-Fact-A27DD312E56DD3035D7C2843146B21B6" name="cah:VendorReserves" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">53</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" id="TextSelection-86D2665D0D56DCEBBEF628431662A68B-0-wk-Fact-6ACB5E04E18B9132B112284314833F5B" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Distribution Services Agreement and Other Vendor Fees</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#8217; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#8217;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.</span></div></ix:nonNumeric></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-7" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-8"><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="TextSelection-D1F289BB5BABC5241B232843165FAB4A-0-wk-Fact-26E350BBDE9E574DCBEE28431483FB78" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Loss Contingencies and Self-Insurance</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with the opioid litigation as described further in the </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;">, we recorded a pre-tax charge of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4363-wk-Fact-7BEE7B16CCFA59729DF5EFBDE17CAEA0" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-6" scale="9" sign="-" format="ixt:numdotdecimal">5.63</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;(</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4367-wk-Fact-3BA3C56106F25C3CBCB9EB04F56E6EB3" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember" unitRef="usd" decimals="-6" scale="9" sign="-" format="ixt:numdotdecimal">5.14</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;after tax) during fiscal 2020. </span><span style="font-family:Arial Narrow;">Definitive terms of a settlement under the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied.  </span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">We develop and periodically update reserve estimates for the Cordis inferior vena cava ("Cordis IVC") claims, including those received to date and expected to be received in the future and related costs. To project future Cordis IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, sales data, implant and injury to report lag patterns and estimated defense costs. </span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We also self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The amount of ultimate loss may differ materially from these estimates.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). </span><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding loss contingencies and product liability lawsuits.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies" id="TextSelection-373C08E18EE088AC0CC3B65F6C3F9410-0-wk-Fact-E2C75B9818811CD480D9B660A5780421" continuedAt="TextSelection-373C08E18EE088AC0CC3B65F6C3F9410-1" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Guarantees</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material </span></div></ix:nonNumeric></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">57</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-8" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-9"><ix:continuation id="TextSelection-373C08E18EE088AC0CC3B65F6C3F9410-1" continuedAt="TextSelection-373C08E18EE088AC0CC3B65F6C3F9410-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">liability being triggered under these indemnification obligations is not probable.</span></div></ix:continuation><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><ix:continuation id="TextSelection-373C08E18EE088AC0CC3B65F6C3F9410-2" continuedAt="TextSelection-373C08E18EE088AC0CC3B65F6C3F9410-3"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were </span><span style="font-family:Arial Narrow;font-size:10pt;">no</span><span style="font-family:Arial Narrow;font-size:10pt;"> material obligations at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span></ix:continuation><span style="font-family:Arial Narrow;font-size:10pt;"><ix:continuation id="TextSelection-373C08E18EE088AC0CC3B65F6C3F9410-3">.</ix:continuation> </span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:IncomeTaxPolicyTextBlock" id="TextSelection-3CC2F6FE5BED6001E977284316617C9A-0-wk-Fact-900A279E07625B9E25E12843145EA4E8" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amoun</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">t of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s002522EA8F5F5274B7487704BE70A9A8"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding income taxes.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:OtherAccruedLiabilitiesPolicyPolicyTextBlock" id="TextSelection-FDB4FD894B2E12A70B72284316606C52-0-wk-Fact-316BE2B12D0EC60FA69428431487B5A2" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Accrued Liabilities</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ConsolidationPolicyTextBlock" id="TextSelection-372D8F071B6A6F5D7D8C28431661ACEE-0-wk-Fact-1B7ADDC9BE32B18B55D628431479CCC5" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Noncontrolling Interests</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Noncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc. </span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="TextSelection-88A4CBDE7750E2C09105284316613ECE-0-wk-Fact-CC4F9C19CFF4BB98911E2843148994E7" continuedAt="TextSelection-88A4CBDE7750E2C09105284316613ECE-1" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Share-Based Compensation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The </span></div></ix:nonNumeric></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-9" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-10"><ix:continuation id="TextSelection-88A4CBDE7750E2C09105284316613ECE-1"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD47735F83E5151799C861160A959DEB5"><span style="font-family:Arial Narrow;font-size:10pt;">Note 14</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding share-based compensation.</span></div></ix:continuation><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:DividendsPolicyPolicyTextBlock" id="TextSelection-488A5961E3A6D68D214828431661C190-0-wk-Fact-CAD0E45E43F3CFFEE784284314738616" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Dividends</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We paid cash dividends per common share of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4531-wk-Fact-6B1B040B9173325E8E06B6007A5A5AF4" name="us-gaap:CommonStockDividendsPerShareCashPaid" contextRef="FD2020Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.92</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4535-wk-Fact-35CC992E94F54CCA9ED5B60BECD23041" name="us-gaap:CommonStockDividendsPerShareCashPaid" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.91</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4539-wk-Fact-D5C615BE5C79AC55B2E52843147BA996" name="us-gaap:CommonStockDividendsPerShareCashPaid" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.85</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="TextSelection-172A044ECE0505509D0328431662384C-0-wk-Fact-1C763DE5C42D2F26AC1B28431465BA0D" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Revenue Recognition</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both </span><span style="font-family:Arial Narrow;font-size:10pt;">manufactured and sourced products, and</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer. </span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:SalesreturnsPolicyTextBlock" id="TextSelection-888404E1830B69AD8FD92843165F2580-0-wk-Fact-DE4697F9FD1280EE343428431481587D" continuedAt="TextSelection-888404E1830B69AD8FD92843165F2580-1" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Sales Returns and Allowances</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical data. </span><span style="font-family:Arial Narrow;font-size:10pt;">Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#8220;merchantable product&#8221;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.</span></div></ix:nonNumeric></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">58</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-10" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-11"><ix:continuation id="TextSelection-888404E1830B69AD8FD92843165F2580-1"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At both </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, the accrual for estimated sales returns and allowances was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4609-wk-Fact-462A02C7F02674BE3563284315D782CC" name="cah:RevenueRecognitionReserveforSalesReturnsandAllowances" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">495</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4613-wk-Fact-7F943A5A5E8BB2E68678284314616BBB" name="cah:RevenueRecognitionReserveforSalesReturnsandAllowances" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">479</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, the impact of which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4617-wk-Fact-4DECE9C6449C9C85435428431477268A" name="us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">2.3</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4622-wk-Fact-9D21DD4838679D65AE90284314740019" name="us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">2.2</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4626-wk-Fact-9291C172CB3388EABEFF2843146D70D2" name="us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">2.4</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Third-Party Returns</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.</span></div></ix:continuation><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:ShippingandHandlingCostsPolicyTextBlock" id="TextSelection-2638F03ED5A82FE46A2C28431660B9AF-0-wk-Fact-A7B83BEDD3E0790147C128431473A9E8" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Shipping and Handling</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Shipping and handling costs are primarily included in SG&amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4678-wk-Fact-4516DFBB47E04A95CD35284314635808" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2020Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">620</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4682-wk-Fact-2B686B6AAC7C583839D1284314617979" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">622</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10103707e4686-wk-Fact-FCC89FFD8B4930C984222843147AD541" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">543</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. </span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="TextSelection-E0D5A0E182B1D61F333528431661223F-0-wk-Fact-9DBED0B62F51F572454D2843147ACC84" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Restructuring and Employee Severance</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are employee severance costs that are not incurred in connection with a restructuring activity. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sF72C50E68F165E22A368883CF79808D0"><span style="font-family:Arial Narrow;font-size:10pt;">Note 3</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding our restructuring activities.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" id="TextSelection-5E6440FFEE24B3413D7A28431662B57D-0-wk-Fact-B2565DC47B26E1B329A928431460676B" continuedAt="TextSelection-5E6440FFEE24B3413D7A28431662B57D-1" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Amortization and Other Acquisition-Related Costs</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration </span></div></ix:nonNumeric></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-11" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-12"><ix:continuation id="TextSelection-5E6440FFEE24B3413D7A28431662B57D-1"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s0B8CFB5481FD5F8C92CD0E2191E456DF"><span style="font-family:Arial Narrow;font-size:10pt;">Note 4</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding amortization of acquisition-related intangible assets. </span></div></ix:continuation><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="TextSelection-D8429A9C3755E52D0CD62843165EF3B6-0-wk-Fact-376E5928A1EA89F3C95F284314715155" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Translation of Foreign Currencies</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#8217; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The foreign currency translation gains/(losses) included in AOCI at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> are presented in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3D77F43D97875956BB9F5A04AD8753DD"><span style="font-family:Arial Narrow;font-size:10pt;">Note 11</span></a><span style="font-family:Arial Narrow;font-size:10pt;">. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives" id="TextSelection-337EDF02C0082790FCBA284316611165-0-wk-Fact-C083ED1B5BFA04CB27E528431469D98E" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Interest Rate, Currency and Commodity Risk</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#8217; equity through AOCI, net of tax.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#8217;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments received from the cross currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s138045C0A5375688972939C6B03E89B1"><span style="font-family:Arial Narrow;font-size:10pt;">Note 10</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow and economic hedges.</span></div></ix:nonNumeric></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">59</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-12" continuedAt="TextSelection-D2F85451D5D8AC126E34284316618231-13"><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="TextSelection-9144F1271823662A0DDD284316618394-0-wk-Fact-86596244DF88938AC7A82843147EC13B" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value Measurements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">Level 1 -</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Observable prices in active markets for identical assets and liabilities.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">Level 2 -</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Observable inputs other than quoted prices in active markets for identical assets and liabilities.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">Level 3 -</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sC842095C866F51CEAB114318376AF314"><span style="font-family:Arial Narrow;font-size:10pt;">Note 9</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding fair value measurements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="TextSelection-E588FA6609B98BBF617F2843165F9550-0-wk-Fact-1BAFB1FD7AC8372E533B2843147ADB7F" continuedAt="TextSelection-E588FA6609B98BBF617F2843165F9550-1" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Adopted Financial Accounting Standards</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Derivatives and Hedging </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2018, the </span><span style="font-family:Arial Narrow;font-size:10pt;">Financial Accounting Standards Board ("FASB")</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a benchmark interest rate for hedge accounting purposes. This guidance was effective beginning the first quarter of fiscal 2020. The adoption did not have a material impact on our consolidated financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Leases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and elected the transition option which allows us to apply the guidance prospectively. The initial adoption in the first quarter of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> resulted in the recognition of lease liabilities in the amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10103707e4929-wk-Fact-D0B6E47994415F8E8BF4E87CEDA52D1B" name="cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" contextRef="I2020Q1ASC842" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">422</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. See&#160;</span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s1a0a81a45f964330b5b7b44b0dd06884"><span style="font-family:Arial Narrow;font-size:10pt;">Note 5</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for additional information regarding leases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Issued Financial Accounting Standards Not Yet Adopted</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers </span></div></ix:nonNumeric></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-E588FA6609B98BBF617F2843165F9550-1"><ix:continuation id="TextSelection-D2F85451D5D8AC126E34284316618231-13"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This&#160;guidance will be effective for us in the first quarter of fiscal 2021. The adoption of this guidance will not have a material impact on our consolidated financial statements or disclosures.</span></div></ix:continuation></ix:continuation><div><a id="s20ab24d9611f400f9fecc35ff4abdad4"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">2. Divestitures and Acquisitions</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Divestitures</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">naviHealth</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In August 2018, we sold our  majority ownership interest in naviHealth, which operated within our Medical segment in exchange for cash proceeds of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2856-wk-Fact-138C1BF43F005E833E38A591045BA0DB" name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">737</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (after adjusting for certain fees and expenses) and a noncontrolling equity interest in a partnership that owned naviHealth. We also had certain call rights to reacquire naviHealth. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As a result of this divestiture, during the fiscal year ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2867-wk-Fact-7976D9DD094654FB9A6538D502E6B761" name="cah:PreTaxGainonDivestiture" contextRef="FD2019Q4YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">508</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings/(loss). This gain included our initial recognition of an equity method investment for </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2871-wk-Fact-B4FF5E8009214658C790A594DDDE901E" name="us-gaap:EquityMethodInvestments" contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">358</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and the derecognition of redeemable noncontrolling interests of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2875-wk-Fact-F505F51AA1F48F8561EBA65873B56D1F" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The fiscal 2019 tax expense as a result of this transaction was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2879-wk-Fact-686B0D1781EDAA9B07E2A65972C596C1" name="cah:Provisionaltaxbenefitrelatedtotransaction" contextRef="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">130</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We determined that the sale of the naviHealth business did not meet the criteria to be classified as discontinued operations.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">I</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">n May 2020 we sold the remainder of our noncontrolling equity interest in a partnership that owned naviHealth. We recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2888-wk-Fact-A4954187376CE474EA85A65DF290D3F7" name="us-gaap:GainOnSaleOfInvestments" contextRef="FD2020Q4QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">579</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> from this disposal in gain on sale of equity interest in naviHealth in our consolidated statements of earnings/(loss).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our proportionate share of naviHealth&#8217;s results, which was recorded in other (income)/expense, net in the consolidated statements of earnings/(loss), was income of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2895-wk-Fact-4FC134107CD4E9624DB5A663AE0FB074" name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and a loss of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2899-wk-Fact-1F89DB3D81D9601CA562A6647A37199C" name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">China </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In February 2018, we sold our pharmaceutical and medical</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"> </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">products distribution business in China ("China distribution business") for proceeds of </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"><span>$<ix:nonFraction id="d10085457e2921-wk-Fact-F755AFFA48301931E6C6A5FDF071D681" name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="FD2018Q4YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">861</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"> (after adjusting for third party indebtedness and preliminary transaction adjustments).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We determined that the sale of the China distribution business did not meet the criteria to be classified as discontinued operations. The China distribution business primarily operated within our Pharmaceutical segment, and a smaller portion operated within our Medical segment. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the fiscal year ended 2018, we recognized a pre-tax loss of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2931-wk-Fact-51C1408F11F94F55A3FCA5FFA94BE15A" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" contextRef="FD2018Q4YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">41</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> related to this divestiture. </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">60</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Acquisitions</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We did not complete any acquisitions d</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">uring fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span><span style="font-family:Arial Narrow;font-size:10pt;">While we completed several small acquisitions d</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">uring fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the pro forma results of operations and the results of operations for acquired businesses since the acquisition dates have not been separately disclosed because the effects were not significant compared to the consolidated financial statements, individually or in the aggregate. The cash paid for these acquisitions, net of cash acquired was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2956-wk-Fact-CF15DEC65EA7E9FB846C284314794A7D" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">82</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Patient Recovery Business</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">On July 29, 2017, we acquired the Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses (the "Patient Recovery Business") from Medtronic plc for </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2971-wk-Fact-3E3F92B70752DCF3285FB47B371C7B11" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="D2018Q1Jul29_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">6.1</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in cash. The acquisition further expanded the Medical segment's portfolio of self-manufactured products.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Transaction and integration costs associated with the acquisition of the Patient Recovery Business were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2978-wk-Fact-92D18CDB87B5572483C2A58233E9C0BA" name="cah:BusinessCombinationTransactionandintegrationcosts" contextRef="FD2020Q4YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">,  </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2982-wk-Fact-A755742BD5C20B963B54A583739B9174" name="cah:BusinessCombinationTransactionandintegrationcosts" contextRef="FD2019Q4YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">75</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and  </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10085457e2986-wk-Fact-B386B6404E9E8BBC5E65A5839861DD77" name="cah:BusinessCombinationTransactionandintegrationcosts" contextRef="FD2018Q4YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">109</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the fiscal years ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">,  </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and  </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. These costs are included in amortization and other acquisition-related costs in the consolidated statement of earnings/(loss).  </span></div><div><a id="sF72C50E68F165E22A368883CF79808D0"></a></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="TextSelection-562197F0F2B9437A7404284316644A12-0-wk-Fact-88BEA3FC66D1DE091AB0284315F4C750" continuedAt="TextSelection-562197F0F2B9437A7404284316644A12-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">3. Restructuring and Employee Severance</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="TextSelection-F31694C66F193D71DD8D2843166465C7-0-wk-Fact-033A3BBBE7A01409DBAA284315F74ED1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize restructuring and employee severance costs:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:57%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10089436e2996-wk-Fact-43E427D08D6EB02F90AB284315F1190A" name="us-gaap:SeveranceCosts1" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">66</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3015-wk-Fact-D791146DB19754C04600284315EDEE91" name="us-gaap:SeveranceCosts1" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">95</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3034-wk-Fact-16B20E13B90499334C2C284315EE117E" name="us-gaap:SeveranceCosts1" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">34</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10089436e3050-wk-Fact-E7335B6128A04626E52B284315EE5B90" name="cah:FacilityExitAndOtherCosts" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">56</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3069-wk-Fact-88B953838E9F841E7109284315F068BB" name="cah:FacilityExitAndOtherCosts" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">30</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3088-wk-Fact-31EF1809098F2CE63C9F284315F04A13" name="cah:FacilityExitAndOtherCosts" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">142</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10089436e3114-wk-Fact-B1C11A87F92A34B823FC2843162C8B54" name="us-gaap:RestructuringCharges" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">122</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3133-wk-Fact-3F8673AEAFD4719F9AD028431460FC93" name="us-gaap:RestructuringCharges" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">125</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3152-wk-Fact-138BB9B6057862937C5C2843145D0C42" name="us-gaap:RestructuringCharges" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">176</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods. Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, vendor transition fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.</span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, restructuring costs are primarily related to implementation of certain enterprise-wide cost-savings measures.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered into an agreement to transition the distribution of our Medical segment's surgeon gloves in certain international markets from a third-party distribution arrangement to a direct distribution model. The costs associated with this restructuring included </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10089436e3217-wk-Fact-5F1DDF755B856A4970D0284315F69F2C" name="cah:FacilityExitAndOtherCosts" contextRef="FD2018Q4YTD_cah_ContractTerminationAxis_cah_DistributorContractMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">125</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, on a pre-tax basis, in contract termination costs that were paid during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These costs are reflected in restructuring and employee severance in the consolidated statements of earnings/(loss) during the fiscal year ended 2018. </span></div></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="TextSelection-5A1070052AB1984C57BF28431664C841-0-wk-Fact-0294BE220A66BB119B1E284315F6C321" escape="true"><ix:continuation id="TextSelection-562197F0F2B9437A7404284316644A12-1"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:20%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Related Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility Exit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">and Other Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3341-wk-Fact-377EBE6DA140D145195A2843163FA8DF" name="us-gaap:RestructuringReserve" contextRef="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">24</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3360-wk-Fact-F159F3A5449D769CF7BF2843163E1B49" name="us-gaap:RestructuringReserve" contextRef="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10089436e3379-wk-Fact-3F90E746928D8C3DE9D52843163F525B" name="us-gaap:RestructuringReserve" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">28</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3395-wk-Fact-86D35A11339AAE78885E284316428015" name="us-gaap:RestructuringCosts" contextRef="FD2019Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">84</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3414-wk-Fact-BBECBC22896BAE2B184E2843145E345A" name="us-gaap:RestructuringCosts" contextRef="FD2019Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10089436e3433-wk-Fact-70A423E2A3F2B4DD44942843145D55C3" name="us-gaap:RestructuringCosts" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">92</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10089436e3454-wk-Fact-FDA8B0365FF9E005E65D28431642B756" name="us-gaap:PaymentsForRestructuring" contextRef="FD2019Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">44</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10089436e3474-wk-Fact-59D790580800F1796C9F2843163F3EEE" name="us-gaap:PaymentsForRestructuring" contextRef="FD2019Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10089436e3494-wk-Fact-D194D51A1D17C16784DA284316435680" name="us-gaap:PaymentsForRestructuring" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">48</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3516-wk-Fact-14653DD4524D56A4B6BCC218F61E13FF" name="us-gaap:RestructuringReserve" contextRef="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">64</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3535-wk-Fact-2A8D8FBFD079524FA2C907A53E8279B4" name="us-gaap:RestructuringReserve" contextRef="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10089436e3554-wk-Fact-AECF643BFDFD5BF2896F9A04E349E892" name="us-gaap:RestructuringReserve" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">72</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3575-wk-Fact-680925DC14F5589B99A852BF3979CFB6" name="us-gaap:RestructuringCosts" contextRef="FD2020Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">85</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10089436e3594-wk-Fact-54EF291F4D7D546BBD78AE5116791C22" name="us-gaap:RestructuringCosts" contextRef="FD2020Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">24</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10089436e3613-wk-Fact-71213E057E48500EADE834D9ABDA25F7" name="us-gaap:RestructuringCosts" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">109</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10089436e3634-wk-Fact-344A568FA30B59C0B45059117B296C40" name="us-gaap:PaymentsForRestructuring" contextRef="FD2020Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">81</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10089436e3654-wk-Fact-A6DAC566F6315D1693C4DD812E955855" name="us-gaap:PaymentsForRestructuring" contextRef="FD2020Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10089436e3674-wk-Fact-431788301B5F5042AC6391668D577B59" name="us-gaap:PaymentsForRestructuring" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">85</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10089436e3701-wk-Fact-F13A5E509ADD53858D6DE2C0122C476E" name="us-gaap:RestructuringReserve" contextRef="FI2020Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">68</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10089436e3720-wk-Fact-A89463AFD4045586A4A7077C716EC500" name="us-gaap:RestructuringReserve" contextRef="FI2020Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">28</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10089436e3739-wk-Fact-B0B291C0232D50598B30A5437E7C78A2" name="us-gaap:RestructuringReserve" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">96</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:continuation></ix:nonNumeric><div><a id="s0B8CFB5481FD5F8C92CD0E2191E456DF"></a></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="TextSelection-9896D7A085152D3AB91D28431665F8DA-0-wk-Fact-CD97AD1C06572F099852284315C5ADBE" continuedAt="TextSelection-9896D7A085152D3AB91D28431665F8DA-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">4. Goodwill and Other Intangible Assets</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Goodwill</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfGoodwillTextBlock" id="TextSelection-5794193DAA6F48E32CA2284316641B84-0-wk-Fact-689752128944BE8B460A284315CAAE8A" continuedAt="TextSelection-5794193DAA6F48E32CA2284316641B84-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:42%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e2973-wk-Fact-6EC83C828FDAC41140F9284315AA927F" name="us-gaap:Goodwill" contextRef="FI2018Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,621</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e2992-wk-Fact-D9174860956E0961F193284315AD9B3A" name="us-gaap:Goodwill" contextRef="FI2018Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,695</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3011-wk-Fact-13C0F9F31849E3D5336F284315B3A619" name="us-gaap:Goodwill" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,316</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e3027-wk-Fact-BE43D2F7D7542BC5290E284315A5E85F" name="us-gaap:GoodwillTransfers" contextRef="FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">45</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e3046-wk-Fact-09E0D254262A56EE2932284315C1D19D" name="us-gaap:GoodwillTransfers" contextRef="FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3065-wk-Fact-E71C2F8343FBDC26BA72284315A69B0A" name="us-gaap:GoodwillTransfers" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">52</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10103689e3086-wk-Fact-8D2661396854D1306516284315B7A13E" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e3106-wk-Fact-1B0EEF0CF6A10818D017284315B8EC26" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3125-wk-Fact-B934E5418EF43BBD9CF7284315AB1A53" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e3146-wk-Fact-5BE38993DC8E55A7AE6ABFB91134D31F" name="us-gaap:Goodwill" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,663</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e3165-wk-Fact-AB71997628ED5EA4AA25372BAA082898" name="us-gaap:Goodwill" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,715</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3184-wk-Fact-CFEC5930BF2F53CAAAC4F6E423AD054C" name="us-gaap:Goodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,378</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10103689e3205-wk-Fact-0D89141EAD1957F6AC801BB1A09A3593" name="us-gaap:GoodwillTransfers" contextRef="FD2020Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3225-wk-Fact-AC7D27C5FFD258C793CD10B00B9478D2" name="us-gaap:GoodwillTransfers" contextRef="FD2020Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10103689e3244-wk-Fact-F739C8C1BD725CF99D4CF7033912F783" name="us-gaap:GoodwillTransfers" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10103689e3266-wk-Fact-387A9EF0F6D450B1865361D2FE42E627" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10103689e3286-wk-Fact-5664924CDB305D779564B5D1CF84C379" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">15</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10103689e3306-wk-Fact-D30ACE11804454029773B456B296B4D3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3333-wk-Fact-8AF842D9000652B99A8C49C8739EF898" name="us-gaap:Goodwill" contextRef="FI2020Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,657</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3352-wk-Fact-E074F7A6E74F530C834DEFBDDC316B91" name="us-gaap:Goodwill" contextRef="FI2020Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,700</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3371-wk-Fact-DB90080FE62156838ABA5E1498FD0735" name="us-gaap:Goodwill" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,357</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">At </span><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;">, the Pharmaceutical segment accumulated goodwill impairment loss was </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10103689e3401-wk-Fact-A555357B33DA99105109284315C82BEA" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" contextRef="FI2020Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">829</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;">.</span></div></td></tr></table></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-5794193DAA6F48E32CA2284316641B84-1" continuedAt="TextSelection-5794193DAA6F48E32CA2284316641B84-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-5794193DAA6F48E32CA2284316641B84-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">At </span><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;">, the Medical segment accumulated goodwill impairment loss was </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10103689e3424-wk-Fact-82D4200A4D51B87C4DB5284315C1F341" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" contextRef="FI2020Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">1.4</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:8pt;">. </span></div></ix:continuation></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">61</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-9896D7A085152D3AB91D28431665F8DA-1" continuedAt="TextSelection-9896D7A085152D3AB91D28431665F8DA-2"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Intangible Assets</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="TextSelection-DC5E8DB9640841B311A628431664EF87-0-wk-Fact-423C709BA7A48DADCE86284315BED6CC" escape="true"><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="TextSelection-50D128247EFC249417962843166431DF-0-wk-Fact-1473582E2A2E6CCAAE54284315C53BB9" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at June&#160;30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:22%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted- Average Remaining Amortization Period (Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3714-wk-Fact-F1ACE23082C95F0AAB5E4DE0DD7081B7" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">23</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3752-wk-Fact-F1ACE23082C95F0AAB5E4DE0DD7081B7" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">23</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3778-wk-Fact-3DCFA1679BAB5EA382F99AF7B1F41CE2" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">23</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3816-wk-Fact-3DCFA1679BAB5EA382F99AF7B1F41CE2" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">23</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3919-wk-Fact-4217866368495E53A293011883C22067" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,554</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3938-wk-Fact-3D20FB655AE256548A2258397A7F36B1" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,828</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3957-wk-Fact-FA7C8FCAFB0C586C86F24425256A7B57" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,726</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d10103689e3977-wk-Fact-B6505909076D54F997C2E848063CED7D" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="FD2020Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear">13</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e3988-wk-Fact-E865BBF54D2F582B809BCEAFAC29373C" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">673</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e4007-wk-Fact-CB2BA626D59055D9B817EAACC763B5CC" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">341</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e4026-wk-Fact-557B190521DD53ADAFF57662C8400144" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">332</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d10103689e4046-wk-Fact-21FFEDA80671579688C17A5E032525B8" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="FD2020Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" format="ixt-sec:duryear">13</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e4057-wk-Fact-13187A58CB3D5B8997378B1596E647C0" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,604</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e4076-wk-Fact-3877656628E05EFA97B16B48DAE258EF" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">767</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e4095-wk-Fact-D77EE9184D8F5E8293926ABE63E77B34" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">837</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d10103689e4115-wk-Fact-AFAAFB11DE725513BAD67518FAB942D2" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="FD2020Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" format="ixt-sec:duryear">11</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e4126-wk-Fact-4C06ACD6CDE15D738950DA8F383BD057" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,831</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e4145-wk-Fact-9DB2FF85DF225BE89EDD1C33278E8376" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,936</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e4164-wk-Fact-BECC0D0D87B75C19893FF47EEFD3A526" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,895</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d10103689e4184-wk-Fact-53CC052C6E875B0CAA9EF9CA902CCD2D" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="FD2020Q4YTD" format="ixt-sec:duryear">12</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e4200-wk-Fact-400777A7ADC25350A435B9FD891BB776" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,854</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e4219-wk-Fact-9DB2FF85DF225BE89EDD1C33278E8376" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,936</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10103689e4238-wk-Fact-EF222D5B5F055691AD794EDD34366343" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,918</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4483-wk-Fact-C78B0F8AC8525A00886655D573EA3F45" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4521-wk-Fact-C78B0F8AC8525A00886655D573EA3F45" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4537-wk-Fact-6B765AD6C57C5FB492FB1C40E1C1C7B3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4575-wk-Fact-6B765AD6C57C5FB492FB1C40E1C1C7B3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4658-wk-Fact-F0C879342C705B8FA6E1DDFD04C864B5" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,562</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4677-wk-Fact-C1953452B1EB5D9E9D48F755694D8490" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,517</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4696-wk-Fact-AB9BCE352E0C587EA93D88C44FEDCC7D" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,045</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4717-wk-Fact-AE3B3CCD8F7D5F298AD82A0891BEDF28" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">672</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4736-wk-Fact-24C3653AD7175971AF1530A3723FCA69" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">295</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4755-wk-Fact-CB14A9B6D96A5113B209A9C98BE20407" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">377</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4776-wk-Fact-A93C982DBBBA5EB0BC55A7CF383B732D" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,602</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4795-wk-Fact-F054E99347D55845B057AC3A07CAB2EC" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">616</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4814-wk-Fact-0EBE64AE59E551F4BB22D0A05C89FFB8" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">986</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4835-wk-Fact-F13B95D07A7B561CA8C2536FD1B1449E" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,836</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4854-wk-Fact-E5424B236E175115A7AD8A3842FFEAB6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,428</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4873-wk-Fact-B5C20F3553385C70A045F69A8794546A" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,408</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4899-wk-Fact-94559B23276C5319AA1C6C2270635B6B" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,858</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4918-wk-Fact-E5424B236E175115A7AD8A3842FFEAB6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,428</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10103689e4937-wk-Fact-03E7792CD4905F4C87900979220E9673" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,430</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><ix:continuation id="TextSelection-9896D7A085152D3AB91D28431665F8DA-2" continuedAt="TextSelection-9896D7A085152D3AB91D28431665F8DA-3"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Total amortization of intangible assets was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10103689e4967-wk-Fact-935B8C1D46CE99D2216A284315CFDF0C" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">512</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10103689e4971-wk-Fact-B532A228B3C06CDB4931284315C29834" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">531</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10103689e4975-wk-Fact-E13DE713EFAB2F001514284315CD3183" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">574</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. The estimated annual amortization for intangible assets for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2021</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> through </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2025</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> is as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10103689e5003-wk-Fact-B77C822A66005786A96C082F6E40AD6F" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">442</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10103689e5007-wk-Fact-53501F973DEA5E329E05872FFB2B0A7D" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">408</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10103689e5011-wk-Fact-80109984808E553BBCC51E411A638FC9" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">358</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10103689e5016-wk-Fact-6D16D914A74C5A5D8EB0EB242EC101CD" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">329</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10103689e5020-wk-Fact-B37C51C7EF9A5A65930406EB8E59C3B4" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">277</ix:nonFraction> million</span></span></ix:continuation><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-9896D7A085152D3AB91D28431665F8DA-3">.</ix:continuation> </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a id="s1a0a81a45f964330b5b7b44b0dd06884"></a></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:LeasesTextBlock" id="TextSelection-8AFE88E318663B6C9D17941EADD41A0D-0-wk-Fact-5892642C657792BAB173941F0289AA40" continuedAt="TextSelection-8AFE88E318663B6C9D17941EADD41A0D-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">5. Leases</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operating leases are primarily for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at its inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Beginning July 1, 2019, operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our consolidated balance sheet at lease commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our lease agreements contain lease components and non-lease components. For all asset classes, we have elected to account for both of these components as a single lease component.  We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the consolidated financial statements at or for the fiscal year ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in fiscal 2020 was not material. In addition, upon adoption of the new lease standard, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing 1) whether any contracts are leases or contain leases, 2) lease classification and 3) initial direct costs. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our leases have remaining lease terms from less than </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d10094005e2869-wk-Fact-1FF72909DA53581B9AF9B424323FD8C7" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="FI2020Q4_srt_RangeAxis_srt_MinimumMember" format="ixt-sec:duryear">1</ix:nonNumeric> year</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> up to approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d10094005e2873-wk-Fact-C556AC05D58E563D85DE63F903B35975" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="FI2020Q4_srt_RangeAxis_srt_MaximumMember" format="ixt-sec:duryear">22</ix:nonNumeric> years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option. </span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:LeaseCostTableTextBlock" id="TextSelection-453BEB7775627F1806C6940F4687940B-0-wk-Fact-AD5B900794CC6D82D38A940FC293DB7F" continuedAt="TextSelection-453BEB7775627F1806C6940F4687940B-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the components of lease cost:       </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e2927-wk-Fact-D29CEE2F3D2954E2AB77E404313E4669" name="us-gaap:OperatingLeaseCost" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">134</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e2942-wk-Fact-9E31BB57ADC850729E006DA9C6F05682" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Variable lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e2962-wk-Fact-CF6DF23E4032770DB578A4C556257267" name="us-gaap:VariableLeaseCost" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e2987-wk-Fact-A7E36D1FCBA8D33880C9E2926EBBFB8C" name="us-gaap:LeaseCost" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">164</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-453BEB7775627F1806C6940F4687940B-1">Variable lease cost primarily includes payments for property taxes, maintenance and insurance. </ix:continuation>Our rental expense relating to operating leases&#160;was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10094005e2998-wk-Fact-47894BC1F938E6572E8D28431598499D" name="us-gaap:LeaseAndRentalExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">153</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10094005e3002-wk-Fact-410567B6D95CECC545292843159EC333" name="us-gaap:LeaseAndRentalExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">172</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </span></div></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">62</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8015873015873%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-8AFE88E318663B6C9D17941EADD41A0D-1" continuedAt="TextSelection-8AFE88E318663B6C9D17941EADD41A0D-2"><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:LeasesSupplementalBalanceSheetInformationTableTextBlock" id="TextSelection-E62BA2C0D9B798C266CD9410DDCC0DDA-0-wk-Fact-45075A23A46600885DA494116788D7FE" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes supplemental balance sheet information related to leases at June&#160;30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:27%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3086-wk-Fact-F4E5D9F3F808500CA4D0602B93C115F3" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">426</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Current portion of operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3122-wk-Fact-E15D29793650526991A5F308CE5588EF" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">104</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Long-term operating lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3142-wk-Fact-199EC984E0AC5C2FBAAABB2B996A25F0" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">341</ix:nonFraction></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3163-wk-Fact-ED6DACE125C086C0FFB6E2F7634A3ACD" name="us-gaap:OperatingLeaseLiability" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">445</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease right-of-use assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3225-wk-Fact-D16A356C7DB65A83B6494BD5D33988A3" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Current portion of finance lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3267-wk-Fact-75A3F16B4792529BAEC2C8523A38B257" name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term finance lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3287-wk-Fact-63F29DBC87915E2DA310D85D70FF8187" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3312-wk-Fact-0FED789CA64892187603E2F7B5075D76" name="us-gaap:FinanceLeaseLiability" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">34</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our consolidated balance sheet. Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our consolidated balance sheet. </span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:LeasePaymentsTableTextBlock" id="TextSelection-54D2BE6F692341EA3257941BA800778F-0-wk-Fact-8E1A7FF1DEBE1CD07D07941C1129206F" continuedAt="TextSelection-54D2BE6F692341EA3257941BA800778F-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarizes supplemental cash flow information related to leases:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:27%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash paid for lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating cash flows paid for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3395-wk-Fact-94519B021AD359A4B410E41819280520" name="us-gaap:OperatingLeasePayments" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">125</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Financing cash flows paid for finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3410-wk-Fact-8953F2B9C1F55EFDAAB82AF3AACADE1F" name="us-gaap:FinanceLeasePrincipalPayments" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3451-wk-Fact-CD48E450816A56EC939BC0EF8C154364" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">150</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3471-wk-Fact-CD46892E183F5AC3AD59A7A04AE0216F" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amended lease standard adoption impact as of July 1, 2019 </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3495-wk-Fact-833C0F21A7C5CBC8DE80A4C535509FC3" name="cah:Impactofadoptionofnewaccountingstandard" contextRef="D2020Q1SD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cah_ASC842Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">400</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-54D2BE6F692341EA3257941BA800778F-1" continuedAt="TextSelection-54D2BE6F692341EA3257941BA800778F-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></ix:continuation></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><ix:continuation id="TextSelection-54D2BE6F692341EA3257941BA800778F-2" continuedAt="TextSelection-54D2BE6F692341EA3257941BA800778F-3"><span style="font-family:Arial Narrow;font-size:8pt;">Includes the effect of </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10094005e3513-wk-Fact-70D0394C1E5C3C142E1A54B51A7F1779" name="cah:ReclassificationofdeferredrentinaccordancewithASC842" contextRef="D2020Q1SD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction> million</span></span></ix:continuation><span style="font-family:Arial Narrow;font-size:8pt;"><ix:continuation id="TextSelection-54D2BE6F692341EA3257941BA800778F-3"> from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance.</ix:continuation> </span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operating leases had a weighted-average remaining lease term of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d10094005e3522-wk-Fact-F8F86975C6B25209B1BD88EB92071244" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="FI2020Q4" format="ixt-sec:duryear">6.4</ix:nonNumeric> years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and a weighted-average discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10094005e3526-wk-Fact-5F4DAF181CE35385A025110FC7F3F9E7" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="FI2020Q4" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">2.9</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Our finance leases had a weighted-average remaining lease term of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d10094005e3530-wk-Fact-15E9E77BF9010C0994CCA5CEF4A999F4" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" contextRef="FI2020Q4" format="ixt-sec:duryear">4.3</ix:nonNumeric> years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and a weighted-average discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10094005e3534-wk-Fact-0F9927B57C4213E54940A5D00035C371" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="FI2020Q4" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">2.4</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> . </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-8AFE88E318663B6C9D17941EADD41A0D-2"><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="TextSelection-BB45401D58C4CDA9270F941CBF064B34-0-wk-Fact-401820EC22D37B828D43941D29632A67" continuedAt="TextSelection-BB45401D58C4CDA9270F941CBF064B34-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Future lease payments under non-cancellable leases as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> were as follows:</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">                          </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:51%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3644-wk-Fact-CC6271E0296556C8AF6D1AC803361D49" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">117</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3663-wk-Fact-1A8779ABB7AD5487A0B8B2E28020F950" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3682-wk-Fact-9C742072AC0B54188BB8EEA3A1D343AD" name="cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">127</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3698-wk-Fact-28413AC191E554179C124229CF6EC777" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">96</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3717-wk-Fact-C46545D4988F5C7EB388D6240FECB85B" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3736-wk-Fact-38D322AF086F515899FCC8A7AD9BCE61" name="cah:LesseeLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">105</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3757-wk-Fact-CA74593AD1935B36ABDE2CA42C40450E" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">72</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3776-wk-Fact-CFB206162CC55548B221A19140F3F6DD" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3795-wk-Fact-A7BE57CAEC4652AB9BF9F6DD704B73ED" name="cah:LesseeLeaseLiabilityPaymentsDueYearThree" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">81</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3816-wk-Fact-4818A5C54B6C5F01BAEB8E6AB351D9BD" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">51</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3835-wk-Fact-B8CC0BABA54A53199E8057343EB8C167" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3854-wk-Fact-893B6F2EA2645CD7AF0359887F5E8953" name="cah:LesseeLeaseLiabilityPaymentsDueYearFour" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">55</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2025</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3875-wk-Fact-27B91ACEAAB35C02B50B4A84D5BFAD0E" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">44</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3894-wk-Fact-2C1CA7E33D5F595BB6192190FA41D5D8" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3913-wk-Fact-CC49054E4FCB5E33A10B6F527B41BDB7" name="cah:LesseeLeaseLiabilityPaymentsDueYearFive" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">46</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3934-wk-Fact-65E559578F145C589DF193037B8B179E" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">123</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3953-wk-Fact-7E6425FF91F85634A2D59BB030D295C8" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e3972-wk-Fact-208DF7B657AD5E7BB17FA04B4A8CAFF1" name="cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">125</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e3993-wk-Fact-1B157BD921A75D5DBEE210C43DBA4C6D" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">503</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e4012-wk-Fact-59FE7F248D55533C95AF805CCE33F98B" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">36</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e4031-wk-Fact-42A4436E89AA5A9DB5EE4F0129069BDB" name="cah:TotalLeaseLiabilityPaymentsDue" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">539</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: leases not yet commenced </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e4056-wk-Fact-A2E7D77B7E0158B0BF8786CF2DCF7D13" name="cah:LesseeOperatingLeaseLiabilityNotYetCommencedAmount" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e4075-wk-Fact-BBE57EC26B535CDBA90BE9C019ED5C40" name="cah:LesseeFinanceLeaseLiabilityNotYetCommencedAmount" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e4094-wk-Fact-428E72E3D7065F54A2C4F3305DF84431" name="cah:TotalLeaseLiabilityNotYetCommencedAmount" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e4115-wk-Fact-27FD9A02F69C5357B20AB6AA12D22D22" name="cah:OperatingLeaseImputedInterest" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">54</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e4134-wk-Fact-893198D2FBE352449E10424860A1F302" name="cah:FinanceLeaseImputedInterest" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e4153-wk-Fact-DD76697FC7F6560F8FC746F0B78B456C" name="cah:TotalLeaseLiabilityUndiscountedExcessAmount" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">56</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e4179-wk-Fact-2B273AFABE0F5A3C9ABEA5D08EC84F1A" name="us-gaap:OperatingLeaseLiability" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">445</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10094005e4198-wk-Fact-D879A5B19B1C56BF82794EE6625CC797" name="us-gaap:FinanceLeaseLiability" contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">34</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10094005e4217-wk-Fact-AB1B09137E295A458BF3DCAE8F9A6C5A" name="cah:TotalLeaseLiability" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">479</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-BB45401D58C4CDA9270F941CBF064B34-1" continuedAt="TextSelection-BB45401D58C4CDA9270F941CBF064B34-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-BB45401D58C4CDA9270F941CBF064B34-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">As of </span><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the consolidated balance sheet. </span></div></ix:continuation></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The future minimum rental payments for operating leases&#160;having initial or remaining non-cancelable lease terms in excess of one year at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> for fiscal 2020 through 2024 and thereafter were as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10094005e4243-wk-Fact-5BDFC3A1686B1ED760B054B51A7FFD9A" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">126</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10094005e4247-wk-Fact-57F12B10BCAEDFFFB8D654B51B2989E4" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">100</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10094005e4251-wk-Fact-DCE5995520BBE9E2F97954B51B22107F" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">76</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10094005e4255-wk-Fact-2E8E6B739775003C52BC54B51B0D31F1" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">54</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10094005e4260-wk-Fact-C8FB2AABFA729C12234A54B51B2413F5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10094005e4264-wk-Fact-0E28B44946A3B30B2EAE54B51A81ADCE" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">94</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div></ix:continuation><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><a id="s90F282348F0354D781EEBCEFD3A04F7E"></a></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:DebtDisclosureTextBlock" id="TextSelection-9BE4C58C6D094B6DCE3A28431665ED32-0-wk-Fact-C2E78A137CDACF7ACBE5284316077780" continuedAt="TextSelection-9BE4C58C6D094B6DCE3A28431665ED32-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">6. Long-Term Obligations and Other Short-Term Borrowings</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfDebtTableTextBlock" id="TextSelection-8FD28214F0771ED335CE28431665F83A-0-wk-Fact-A9AC983CE221C70B469F284316032ABF" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes long-term obligations and other short-term borrowings at June 30:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:58%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions) (1)</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.4% Notes due 2019</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e2931-wk-Fact-FA7A04C5186E5725A99D33A728378540" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e2950-wk-Fact-783CBE09F2735960A70552634DD6943B" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">450</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.625%&#160;Notes due 2020</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e2965-wk-Fact-28841080EA3F5240B410CF9A06648B79" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e2984-wk-Fact-5EEC6C1340D65150BF6324267464F69E" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">508</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.616% Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3004-wk-Fact-78E2DB28A5D254A3B2BA7172AB40DC2E" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">834</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3023-wk-Fact-C8B1B803E0BA54FDA54E3D19F24A66F1" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,079</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2% Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3043-wk-Fact-134BD797E4ED503E8AE96B246002C3EC" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">236</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3062-wk-Fact-FB8328D9008C5AA7BDB0F5F48425D2E6" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">247</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Floating Rate Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3082-wk-Fact-6F8E9F26B52359C4A20BB3E9DFA87DEB" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">321</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3101-wk-Fact-CB181FE7D0735E59840BE5CD9FFD04F7" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">340</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2% Notes due 2023</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3121-wk-Fact-A47489877A785137A6575161011B3EE2" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">576</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3140-wk-Fact-774D3727FEF4565A933647F341ADBE56" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">551</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.079% Notes due 2024</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3160-wk-Fact-53B1AF8785A05D45856192F8D114B899" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">809</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3179-wk-Fact-FF1FE4E200A05667A704A25512125CE6" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">781</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.5% Notes due 2024</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3199-wk-Fact-7CB156375A255DA083E882E6429E989D" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">413</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3218-wk-Fact-E3A9D83663A05C18B6A2DBF9E665DC3C" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">402</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.75% Notes due 2025</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3238-wk-Fact-58B86DE147825EB2BA3B6CE89E532A4F" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">529</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3257-wk-Fact-C2B2E64183915C5FB19DD45CFDC98BFD" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">494</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.41% Notes due 2027</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3277-wk-Fact-996824975C9054ED883E9A355BEA5ABC" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,215</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3296-wk-Fact-1B6143F2BB885125811A830774EBC686" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,318</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.6% Notes due 2043</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3317-wk-Fact-57D62AC6CDBE5714A87FFC3BB1EF2F02" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">340</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3336-wk-Fact-81761FC22E5B55A78ADFB12140FDE321" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">346</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.5% Notes due 2044</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3356-wk-Fact-9FA9B0340A9B58DD97F8CFDF9F9D293A" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">342</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3375-wk-Fact-D97433900EFD5D3EA1E722F51C3CE210" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">342</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.9% Notes due 2045</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3395-wk-Fact-78BDA8DEC9A9555F9FCBEF1FFED9DADB" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">441</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3414-wk-Fact-BD56768C53FE507D98B3B1E46442526A" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">445</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.368% Notes due 2047</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3434-wk-Fact-86263AC3CF3C531CAAB0C4116598A1DE" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">560</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3453-wk-Fact-F8439A8590B15F45AA22BF775C0DE25B" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">594</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7.0%&#160;Debentures due 2026</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3473-wk-Fact-8FAAD6C41FAD55A29293FE11268FC89B" name="us-gaap:NotesPayable" contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">124</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3492-wk-Fact-BFF6821DB20054EA8AD10789B45D1107" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">124</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other Obligations</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3512-wk-Fact-181981B23BBF57169C5A09E380550C88" name="us-gaap:OtherBorrowings" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3531-wk-Fact-CF6A6D11A95A520CA8CCE9E69188DD5C" name="us-gaap:OtherBorrowings" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3551-wk-Fact-9DA8E8BB8C8F5C549572884EE1EA482D" name="us-gaap:DebtAndCapitalLeaseObligations" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,775</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3570-wk-Fact-94C2B7ADE99F539DB0231B2DC19C1620" name="us-gaap:DebtAndCapitalLeaseObligations" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,031</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: current portion of long-term obligations and other short-term borrowings</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3590-wk-Fact-AEE6885C79795EC8BD6D2D94473CEAC3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3609-wk-Fact-65E8671C68655ED487958DD7FF10BC0C" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">452</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;&#160;&#160;Long-term obligations, less current portion</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10107867e3634-wk-Fact-1AC0DDF0A60D5B1AA8B9E0BB56255504" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,765</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10107867e3653-wk-Fact-19FEF4F9B77450E896FB33A6F288C5A4" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7,579</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)      Maturities are presented on a calendar year basis. </span></div></ix:nonNumeric></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">63</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-9BE4C58C6D094B6DCE3A28431665ED32-1" continuedAt="TextSelection-9BE4C58C6D094B6DCE3A28431665ED32-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Maturities of existing long-term obligations and other short-term borrowings for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2021</span><span style="font-family:Arial Narrow;font-size:10pt;"> through </span><span style="font-family:Arial Narrow;font-size:10pt;">2025</span><span style="font-family:Arial Narrow;font-size:10pt;"> and thereafter are as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3679-wk-Fact-4FB450083541D7BCAA58284316088E7F" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3683-wk-Fact-6016D8E4FF39BD67BAA42843160AA9D1" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">1.4</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3687-wk-Fact-87524B13B4AF9F281C44284316110452" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">585</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3692-wk-Fact-0BC639FB74B28C5FFACE2843160E7E24" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">814</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3696-wk-Fact-1301E97ECBBA91A149A22843160BF64D" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">414</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3700-wk-Fact-36C86E37DA329B627E5E284316029947" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">3.6</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Long-Term Debt</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. The </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10107867e3710-wk-Fact-8938FEE674980423E69128431609C597" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2020Q4_dei_LegalEntityAxis_cah_AllegianceCorporationMember_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">7.0</ix:nonFraction>%</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> Debentures represent unsecured obligations of Allegiance Corporation (a wholly-owned subsidiary), which Cardinal Health, Inc. has guaranteed. None of these obligations are subject to a sinking fund and the Allegiance obligations are not redeemable prior to maturity. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3714-wk-Fact-29CF716DBEE25839A6737A9DA31469C4" name="us-gaap:AccountsPayableCurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">21.4</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In June 2020, we redeemed </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3721-wk-Fact-0E01340FEA849A26B9F7B6452EE02B20" name="cah:NotesPayableRepurchased" contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">500</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> aggregate principle amount of 4.625% Notes due December 2020 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with the redemption, we recorded a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3725-wk-Fact-9A26BE4AD65B862A239DB6181A88D47B" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> loss on early extinguishment of debt. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">During fiscal 2020, we also early repurchased&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3732-wk-Fact-840A572B44E450F5859ADDB349D7BC8F" name="cah:NotesPayableRepurchased" contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">247</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;2.616%&#160;Notes due 2022,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3736-wk-Fact-60C67F50EEAE5D03B2FABA2A828B4487" name="cah:NotesPayableRepurchased" contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;3.2% Notes due 2022,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3740-wk-Fact-40BC2DDBCFED554DBDAEF5FB7B6A432F" name="cah:NotesPayableRepurchased" contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;Floating Rate Notes due 2022,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3744-wk-Fact-66AADD9234FC5B99B05DE9237A65B10F" name="cah:NotesPayableRepurchased" contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">104</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;3.41% Notes due 2027,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3748-wk-Fact-E7E53EE2A5445787B318D1ADFAEC52FE" name="cah:NotesPayableRepurchased" contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;4.6% Notes due 2043,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3753-wk-Fact-A18EC9E8DBFC5C54B0CE9709E694EAF1" name="cah:NotesPayableRepurchased" contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;4.9% Notes due 2045, and&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3757-wk-Fact-113DB8463AB75E838ED8EB31929E67DB" name="cah:NotesPayableRepurchased" contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;4.368% Notes due 2047.&#160; In connection with the early debt repurchases, we recognized a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3761-wk-Fact-6C1D5F13968A0EC7F5A2B619EBFA7507" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;loss on early extinguishment of debt. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In November 2019, we repaid the full principal of the 2.4% Notes due 2019 at maturity for&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3768-wk-Fact-33CAF7D006ACD940E14BB61B40B1666F" name="us-gaap:RepaymentsOfNotesPayable" contextRef="D2020Q2NotesPayable_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">450</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The redemption and repurchases were paid for with available cash and other short-term borrowings.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In fiscal 2019, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3778-wk-Fact-E7A7E9210E01F4547A41B61ED132FCC0" name="cah:NotesPayableRepurchased" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">67</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the 2.616% Notes due 2022, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3782-wk-Fact-633737ED3D2CB3797635B6403E1181F7" name="cah:NotesPayableRepurchased" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the 3.2% Notes due 2022, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10107867e3786-wk-Fact-AEAF04A031F1429E37E9B61F7E5966D8" name="cah:NotesPayableRepurchased" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the Floating Rate Notes due 2022, and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3790-wk-Fact-D506E0B80FAEBD5027F9B61FE09B321A" name="cah:NotesPayableRepurchased" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">24</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the 3.41% Notes due 2027 for a total of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3794-wk-Fact-193369BFF4FA49F61A87B639A5A02C54" name="cah:NotesPayableRepurchased" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">100</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. The repurchases were paid for with available cash. The loss on early extinguishment of debt in connection with these early repurchases was immaterial. We also paid off the </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3799-wk-Fact-76CEA39F5722215AB74FB63D8753C624" name="cah:NotesPayableRepurchased" contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A1.948Notesdue2019Member" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">1.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> 1.948% Notes due 2019 as they became due with available cash.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In June 2018, we repaid the full principal of the 1.95% Notes due 2018 at maturity for </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3807-wk-Fact-C5F8A24668EC8DC941B3A66E546F658D" name="us-gaap:ProceedsFromRepaymentsOfNotesPayable" contextRef="D2018Q4SD195notes_us-gaap_DebtInstrumentAxis_cah_OnePointNineFiveNotesdue2018Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">550</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">If we undergo a change of control, as defined in the notes, and if the notes receive specified ratings below investment grade by each of Standard &amp; Poors Ratings Services, Moody&#8217;s Investors Services and Fitch Ratings, any holder of the notes, excluding the debentures, can require with respect to the notes owned by such holder, or we can offer, to repurchase the notes at </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10107867e3814-wk-Fact-F898D1C7866E46DCDE6D2843160A3F70" name="cah:OfferAsPercentageOfPrincipalAmount" contextRef="FD2020Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">101</ix:nonFraction>%</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the principal amount plus accrued and unpaid interest.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Financing Arrangements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3824-wk-Fact-7D45EA3096315D529AA3BF326D0BDFDC" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">2.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;commercial paper program </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-9BE4C58C6D094B6DCE3A28431665ED32-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">backed by a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3831-wk-Fact-024DBDB8A5655BAFBEFBE8FB34CA5B1B" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">2.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;revolving credit facility. We also have a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3835-wk-Fact-74A5727D1EF6591A933CDB136522BA33" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2020Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">1.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;committed receivables sales facility.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through September 30, 2022. CHF was organized for</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">Our revolving credit and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter through December 2020, a consolidated net leverage ratio of no more than 4.00-to-1. The maximum permitted ratio will reduce to 3.75-to-1 in March 2021 and as of the end of every quarter thereafter</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. As of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we were in compliance with this financial covenant.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had no amounts outstanding under the revolving credit facility; however, availability was reduced by outstanding letters of credit of  </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3867-wk-Fact-6D5418BCA11D9AC5AF742843160B511A" name="us-gaap:LineOfCredit" contextRef="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3871-wk-Fact-EE53C84463CDBC12C1C3A66FEA42DFC1" name="us-gaap:LineOfCredit" contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">24</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at  </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Under our committed receivables sales facility program, we had a maximum amount outstanding of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3887-wk-Fact-B0599BCF11243290FD3CA67185B97D85" name="us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" contextRef="FD2020Q4YTD_us-gaap_CreditFacilityAxis_cah_CommittedReceivablesSalesFacilityProgramMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">700</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and an average daily amount outstanding of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3891-wk-Fact-03CFAD8EBC60D48B6382A672C1EB38C6" name="us-gaap:LineOfCreditFacilityAverageOutstandingAmount" contextRef="FD2020Q4YTD_us-gaap_CreditFacilityAxis_cah_CommittedReceivablesSalesFacilityProgramMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">. We also had no amounts outstanding under the committed receivables sales facility program; however, availability was reduced by outstanding standby letters of credit of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3899-wk-Fact-FBF9CAAF04A45A1CC9282843160D4EF2" name="us-gaap:LineOfCredit" contextRef="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">29</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3903-wk-Fact-094C8F068F4FB43203742843160FF9B1" name="us-gaap:LineOfCredit" contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">30</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Under our commercial paper program we had a maximum amount outstanding of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3919-wk-Fact-0F79EF30E1EC300872B1A6745BEBC61F" name="us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" contextRef="FD2020Q4YTD_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">1.7</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and an average daily amount outstanding of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3923-wk-Fact-3F95231F3937E6A494DFA6750F7E00C5" name="us-gaap:LineOfCreditFacilityAverageOutstandingAmount" contextRef="FD2020Q4YTD_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">183</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">. We had no amounts outstanding under the commercial paper program as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We also maintain other short-term credit facilities and an unsecured line of credit that allowed for borrowings up to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3942-wk-Fact-C57AAC7F1D52FC7BF5A9284316105DF7" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2020Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3946-wk-Fact-3A1D8170067CC74F35DE2843160DCB67" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. The </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3958-wk-Fact-181981B23BBF57169C5A09E380550C88" name="us-gaap:OtherBorrowings" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10107867e3963-wk-Fact-CF6A6D11A95A520CA8CCE9E69188DD5C" name="us-gaap:OtherBorrowings" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> balance of other obligations at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, consisted of short-term borrowings and finance leases.</span></div></ix:continuation><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><a id="sD2716397D81358C69DCBB2A8D6E9CCCE"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">7. Commitments, Contingent Liabilities and Litigation</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commitments</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Generic Sourcing Venture with CVS Healt<ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="TextSelection-EA085B351F09AB1CD3AA2843166658F5-0-wk-Fact-231F5D65E6EBC51A78B42843159B25E7" continuedAt="TextSelection-EA085B351F09AB1CD3AA2843166658F5-1" escape="true">h Corporation ("CVS Health")</ix:nonNumeric></span></div><ix:continuation id="TextSelection-EA085B351F09AB1CD3AA2843166658F5-1" continuedAt="TextSelection-EA085B351F09AB1CD3AA2843166658F5-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Red Oak Sourcing, LLC ("Red Oak Sourcing") is a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term through June 2024. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. Due to the achievement of predetermined milestones, we are required to make quarterly payments of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10111338e2871-wk-Fact-133E85DA714658D4855E16F9A784C02F" name="cah:MaximumQuarterlyPayment" contextRef="FD2020Q4YTD_srt_MajorCustomersAxis_cah_CVSHealthMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">45.6</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to CVS Health for the initial term.</span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">64</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-EA085B351F09AB1CD3AA2843166658F5-2" continuedAt="TextSelection-EA085B351F09AB1CD3AA2843166658F5-3"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Contingencies</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">New York Opioid Stewardship Act</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In April 2018, the State of New York passed a budget which included the Opioid Stewardship Act (the "OSA"). The OSA created an aggregate $100 million annual assessment on all manufacturers and distributors licensed to sell or distribute opioids in New York. Under the OSA, each licensed manufacturer and distributor would be required to pay a portion of the assessment based on its share of the total morphine milligram equivalents sold or distributed in New York during the applicable calendar year, beginning in 2017.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In December 2018, the U.S. District Court for the Southern District of New York ruled that the OSA is unconstitutional and enjoined its enforcement (the "Ruling"). In January 2019, the State filed notice of its intent to appeal the Ruling. In April 2019, the State, among other things, amended the OSA so that the assessment would only cover opioid sales in 2017 and 2018, subject to the State's pending appeal of the Ruling. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We accrue contingencies if it is probable that a liability has been incurred and the amount can be estimated. At June 30, 2020, we have no amounts accrued for the OSA because we do not believe it is probable that a liability has been incurred. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Legal Proceedings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We become involved from time to time in disputes, litigation and regulatory matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we determine that products we source, manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions have led to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, product liability claims and lawsuits and can lead to action by regulators. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information could directly or indirectly lead to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We may be named from time to time in </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-EA085B351F09AB1CD3AA2843166658F5-3" continuedAt="TextSelection-EA085B351F09AB1CD3AA2843166658F5-4"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">a </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our consolidated statements of earnings/(loss).</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Opioid Lawsuits and Investigations</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Pharmaceutical wholesale distributors, including us, have been named as defendants in over </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10111338e2937-wk-Fact-720FAE897D63652E4D84D9F63E69A1CA" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q4_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="number" decimals="0" scale="0" format="ixt:numdotdecimal">3,000</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits relating to the distribution of prescription opioid pain medications. The lawsuits seek equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as public nuisance, negligence and unjust enrichment as well as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. These lawsuits also name pharmaceutical manufacturers, retail pharmacy chains and other entities as defendants.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">States &amp; Political Subdivisions</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10111338e2947-wk-Fact-FDA0BC7079475FD4B44FD7E0DE83BCDD" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q4_srt_LitigationCaseAxis_cah_OpioidLawsuitsStateDomain_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="number" decimals="0" scale="0" format="ixt:numdotdecimal">2,800</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of these lawsuits have been filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The vast majority of these lawsuits were filed in U.S. federal court and have been transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#8220;MDL&#8221;).  </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In January 2020, the complaints of Cabell County and City of Huntington, West Virginia were remanded from the MDL to U.S. District Court in West Virginia.  A trial date has been set for October 2020.  In addition, the complaints of San Francisco, California and the Cherokee Nation have been remanded to their original district courts.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10111338e2958-wk-Fact-57FC158950C25CBB81C08952396C0849" name="cah:NumberofStateAttorneysGeneralfilinglawsuits" contextRef="I2020Q4_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="StateAG" decimals="0" scale="0" format="ixt:numdotdecimal">25</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> state attorneys general have filed lawsuits against distributors, including us, in various state courts.  A trial in New York for cases brought by the New York Attorney General and Nassau and Suffolk counties was scheduled to begin in March 2020, but was deferred due to the COVID-19 pandemic. A trial is scheduled to begin in Madison County, Ohio, in October 2020 for the case brought by the Ohio Attorney General. A state court trial in a case brought by </span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">65</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-EA085B351F09AB1CD3AA2843166658F5-4" continuedAt="TextSelection-EA085B351F09AB1CD3AA2843166658F5-5"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">certain West Virginia political subdivisions is scheduled for March 2021.  Additionally, we have received requests, civil investigative demands, subpoenas or requests for information from additional state attorneys general offices and governmental authorities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In October 2019, we agreed in principle to a global settlement framework with a leadership group of state attorneys general that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions (the "Settlement Framework"). This Settlement Framework is subject to contingencies and uncertainties as to final terms, but is the basis for our negotiation of definitive terms and documentation.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Settlement Framework includes (1) a cash </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">component</span><span style="font-family:Arial Narrow;font-size:10pt;">, pursuant to which we would pay up to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10111338e2975-wk-Fact-A0BA3C98E766574492379451719F070A" name="us-gaap:LitigationReserve" contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" unitRef="usd" decimals="-7" scale="9" format="ixt:numdotdecimal">5.56</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> over </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d10111338e2979-wk-Fact-AF2082243E7C57E7ADD86F94B9E23E83" name="cah:CashComponentForSettlementFrameworkTerm" contextRef="FD2020Q4YTD_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" format="ixt-sec:durwordsen">eighteen years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;">, (2) development and participation in a program for  distribution of opioid abuse treatment medications for a period of ten years, and (3) to-be specified industry-wide changes to controlled substance anti-diversion programs. Definitive terms for a settlement pursuant to the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. In connection with these matters, we have </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10111338e2983-wk-Fact-A0BA3C98E766574492379451719F070A" name="us-gaap:LitigationReserve" contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" unitRef="usd" decimals="-7" scale="9" format="ixt:numdotdecimal">5.56</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> accrued at June 30, 2020, included in deferred income taxes and other liabilities in the consolidated balance sheets, which represents the cash component. We are unable to estimate the range of possible loss associated with these matters. We are unable to reasonably estimate the liability or cost associated with the other components of the Settlement Framework, the potential distribution of treatment medications and any incremental costs for changes to our controlled substance anti-diversion program that we may agree to.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the fiscal year ended June 30, 2020, we along with two other national distributors entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10111338e2990-wk-Fact-224A68188626581F9A30152BDAEEC882" name="cah:OpioidTotalSettlementCuyahogaandSummitCounties" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">215</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> settlement with two Ohio counties, Cuyahoga and Summit, to resolve all claims in the first bellwether trial in the MDL, which had been set for trial for October 2019. In connection with this settlement, we incurred </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10111338e2994-wk-Fact-9DF8B72E3AD55366A8818DF2C78B9655" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q4YTD_srt_LitigationCaseAxis_cah_OpioidLitigationCuyahogaandSummitCountiesMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">66</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> within litigation (recoveries)/charges, net during the fiscal year ended June 30, 2020. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with these matters (including the settlement with two Ohio counties), we recorded a total pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10111338e3001-wk-Fact-7BEE7B16CCFA59729DF5EFBDE17CAEA0" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-6" scale="9" sign="-" format="ixt:numdotdecimal">5.63</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10111338e3005-wk-Fact-3BA3C56106F25C3CBCB9EB04F56E6EB3" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember" unitRef="usd" decimals="-6" scale="9" sign="-" format="ixt:numdotdecimal">5.14</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> after tax) during the fiscal year ended June 30, 2020 in litigation (recoveries)/charges, net, in the consolidated statement of earnings/(loss) for the cash component. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual. We continue to strongly dispute the allegations made in these lawsuits and reaching an agreement in principle on a global settlement framework is not an admission of liability or wrongdoing.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Private Plaintiffs</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Settlement Framework does not address claims by private plaintiffs, which includes unions and other health and welfare funds, hospital systems and other healthcare providers, businesses and </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-EA085B351F09AB1CD3AA2843166658F5-5" continuedAt="TextSelection-EA085B351F09AB1CD3AA2843166658F5-6"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">individuals. Private plaintiffs had brought approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10111338e3018-wk-Fact-D0087EAEB2735294BE2DBC7CFE363464" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q4_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="lawsuit" decimals="0" scale="0" format="ixt:numdotdecimal">400</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits as of July 28, 2020. Of these, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10111338e3022-wk-Fact-39B4B1A9302C5B5BBCB10269D42810B4" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q4_cah_LawsuitTypeAxis_cah_ClassActionLawsuitsMember_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="lawsuit" decimals="0" scale="0" format="ixt:numdotdecimal">106</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs relating to the distribution of controlled substances. We are vigorously defending ourselves in these matters.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Department of Justice Investigations</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have received federal grand jury subpoenas issued in connection with investigations being conducted by the U.S. Attorney's Office for the Eastern District of New York and the Fraud Section of the U.S. Department of Justice ("DOJ"). The subpoenas seek documents  relating to our anti-diversion policies, procedures and program, and our distribution of certain controlled substances. We are cooperating with these requests.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Product Liability Lawsuits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As of July 28, 2020, we are named as a defendant in </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10111338e3039-wk-Fact-F6E8E4604D74536EB840D7E9E2CCBBC3" name="us-gaap:LossContingencyNewClaimsFiledNumber" contextRef="D2020Q4litigation_us-gaap_LossContingenciesByNatureOfContingencyAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="lawsuit" decimals="0" scale="0" format="ixt:numdotdecimal">334</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10111338e3043-wk-Fact-2C3C76B47B3B591483086FAF42D4165E" name="us-gaap:LossContingencyNumberOfPlaintiffs" contextRef="D2020Q4litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="plaintiff" decimals="0" scale="0" format="ixt:numdotdecimal">4,280</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. Another </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10111338e3047-wk-Fact-64B85656AC9D5E98984142913D64F743" name="us-gaap:LossContingencyNewClaimsFiledNumber" contextRef="D2020Q4litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="lawsuit" decimals="0" scale="0" format="ixt:numdotdecimal">31</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits involving similar claims by approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10111338e3051-wk-Fact-24509F9E4186583A8B83AC5497ABD0E1" name="us-gaap:LossContingencyNumberOfPlaintiffs" contextRef="D2020Q4litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="plaintiff" decimals="0" scale="0" format="ixt:numdotdecimal">36</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. We continue to vigorously defend ourselves in these lawsuits and have begun to engage in preliminary resolution discussions with plaintiffs.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#5b9bd5;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At June&#160;30, 2020, we had a total of </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"><span>$<ix:nonFraction id="d10111338e3060-wk-Fact-F3A003C5CE3950F4B16BDDDECCEB65A8" name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="FI2020Q4_srt_RangeAxis_srt_MinimumMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">468</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, net of estimated insurance recoveries, accrued for losses and legal defense costs related to the Cordis IVC filter lawsuits which are presented on a gross basis in the consolidated balance sheets. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range to be approximately </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"><span>$<ix:nonFraction id="d10111338e3064-wk-Fact-9A65C6907A01594E82BE43D64A281412" name="us-gaap:LossContingencyEstimateOfPossibleLoss" contextRef="FI2020Q4_srt_RangeAxis_srt_MaximumMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">919</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, net of estimated insurance recoveries.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Shareholder Securities Litigation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In August 2019, the Louisiana Sheriffs' Pension &amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. The complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. In June 2020, the court appointed 1199 SEIU Health Care Employees Pension Fund as lead plaintiff. We believe that the claims asserted in this complaint are without merit and intend to vigorously defend against them. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Surgical Gown Recalls</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In January 2020, we issued a voluntary recall for </span><span style="font-family:Arial Narrow;font-size:10pt;">9.1 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> AAMI Level 3 surgical gowns and two voluntary field actions (a recall of some packs and a corrective action allowing overlabeling of other packs) for 2.9 million Presource Procedure Packs containing affected </span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">66</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-EA085B351F09AB1CD3AA2843166658F5-6" continuedAt="TextSelection-EA085B351F09AB1CD3AA2843166658F5-7"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">gowns (together, the "Recalls"). These Recalls were necessary because we discovered in December 2019 that one of our FDA-registered suppliers in China had shifted production of some gowns to unapproved sites with uncontrolled manufacturing environments. Because of this, we could not assure sterility of the gowns. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with these Recalls, in the fiscal year ended June 30, 2020, we recorded total charges of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10111338e3090-wk-Fact-621E6CE68D105FF193008BB558E45E0E" name="us-gaap:InventoryRecallExpense" contextRef="FD2020Q4YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">85</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, of which </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10111338e3094-wk-Fact-8AFA4400637F516FB6BB805933517039" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2020Q4YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">48</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> is within cost of products sold and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10111338e3098-wk-Fact-ABE67A811E1C530886BC04B4E600D3DF" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2020Q4YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> is within SG&amp;A in the consolidated statements of earnings/(loss). This charge represents our best estimate of costs for the Recalls and includes inventory write-off costs and certain remediation and supply disruption costs, such as costs to replace recalled products. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Civil Litigation </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Generic Pharmaceutical Pricing Antitrust Litigation </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In December 2019, pharmaceutical distributors including us were added as defendants in a civil class action lawsuit filed by indirect purchasers of generic drugs, such as hospitals and retail pharmacies. The indirect purchaser case is part of a multidistrict litigation consisting of multiple individual class action matters consolidated in the Eastern District of Pennsylvania. The indirect purchaser plaintiffs allege that pharmaceutical distributors encouraged manufacturers to increase prices, provided anti-competitive pricing information to manufacturers and improperly engaged in customer allocation. We have filed a motion to dismiss the complaints and we intend to vigorously defend ourselves in this matter. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Active Pharmaceutical Ingredient Impurity Litigation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Many participants in the pharmaceutical supply chain, including active pharmaceutical ingredient ("API") manufacturers, finished dose manufacturers, repackagers (including us), distributors (including us), and retailers have been named as defendants in lawsuits arising out of recalls of certain medications due to alleged impurities in the active pharmaceutical ingredients or finished product. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In February 2019, a Multidistrict Litigation was created in the U.S. District Court for the District of New Jersey (the &#8220;Sartan MDL&#8221;) alleging API impurities in certain generic blood pressure medications. We were recently named as a defendant in a Multidistrict Litigation alleging API impurities in Zantac and its generic form, ranitidine. We intend to vigorously defend ourselves in these matters.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Antitrust Litigation Proceeds</span></div></ix:continuation><div style="line-height:120%;text-align:justify;font-size:10pt;"><ix:continuation id="TextSelection-EA085B351F09AB1CD3AA2843166658F5-7" continuedAt="TextSelection-EA085B351F09AB1CD3AA2843166658F5-8"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">We received and recognized income resulting from settlements of lawsuits in which we were a class member or plaintiff of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10111338e3127-wk-Fact-FEF658AB85BAAF779BB4D8D2A6AC7DE6" name="cah:IncomefromSettlementsofClassActionLawsuits" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;">,</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"><span>$<ix:nonFraction id="d10111338e3131-wk-Fact-6AD77896BFBCB7B0A0F8D8D321B6E6EC" name="cah:IncomefromSettlementsofClassActionLawsuits" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">94</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"><span>$<ix:nonFraction id="d10111338e3135-wk-Fact-AE56D34829BE7F85D1D5D8D340210D24" name="cah:IncomefromSettlementsofClassActionLawsuits" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">  during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">, </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">,  and </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">2018</span></ix:continuation><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"><ix:continuation id="TextSelection-EA085B351F09AB1CD3AA2843166658F5-8">, respectively.</ix:continuation> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a id="s002522EA8F5F5274B7487704BE70A9A8"></a></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:IncomeTaxDisclosureTextBlock" id="TextSelection-FFCF7B493C2126F1B3A3284316656C68-0-wk-Fact-2576FDA57101ACE0EE21284315D24342" continuedAt="TextSelection-FFCF7B493C2126F1B3A3284316656C68-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">8. Income Taxes</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Earnings/(Loss) before Income Taxes and Provision for/(Benefit From) Income Taxes</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="TextSelection-CAF3258FE243E274D06B284316664F48-0-wk-Fact-7BFD59D23731E9571A5D284315DFA06E" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes earnings/(loss) before income taxes:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:53%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">U.S. operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e3006-wk-Fact-0248E185BA170A31AEAC28431601AA41" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,056</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3026-wk-Fact-7F86C4678AC49828A758952EBBCBA77B" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,478</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3045-wk-Fact-383DE7FE678CF8A79E1F952EBBC168E7" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">391</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-U.S. operations</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e3061-wk-Fact-1D9D584817790BA4E571284316032AA3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">284</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3080-wk-Fact-6C4D4B198110CDF3C020952EBBD5ACD1" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">273</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e3099-wk-Fact-555A2A1277094A6A03DD952EBBBC213D" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">619</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings/(loss) before income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e3126-wk-Fact-8029B570251D776CB89B2843162B2728" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3,772</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3146-wk-Fact-5027B60DD37A44F7AA932843161E0815" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,751</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e3165-wk-Fact-867F273B7C9665AD5CF328431621C9DA" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">228</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="TextSelection-DBE1EA43A32D972D8A33284316659C15-0-wk-Fact-5F9A57BDA20510645506284315E98986" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the components of provision for/(benefit from) income taxes:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:54%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Current:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e3345-wk-Fact-55339C044840A183E4CA284316117276" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">659</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3364-wk-Fact-BEC86B32DF5523928C92952ECE6F9EAA" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">295</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3383-wk-Fact-53E5608CBFD2326CCEED952ECDF8C95E" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">341</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State and local</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e3399-wk-Fact-866D164EA7D1E334CFC128431608BA8B" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">154</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3418-wk-Fact-72723772EFD749252972952ECE41D150" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">89</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3437-wk-Fact-65ED9098F57364D0959D952ECDC4B847" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">41</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-U.S.</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e3458-wk-Fact-37CB45D9E6BCACC7043728431613EA28" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">69</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3477-wk-Fact-AF5100CC0F1D5D58B497952ECD68CB30" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">85</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3496-wk-Fact-2C4D67578B5E21BC12EE952ECE89A9EB" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">143</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total current</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e3522-wk-Fact-185A8B9515C2D90362102843160ABB69" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">882</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3541-wk-Fact-0C152A668754C3FB6AF8952ECD075984" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">469</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3560-wk-Fact-DA15813AA0B51A9CBF84952ECDDD7FE4" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">525</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Deferred:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e3705-wk-Fact-976C6AA098962A1E2DFA284316065DDF" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">822</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e3725-wk-Fact-ABD89E3D19DB63DA1E27952ECDB061D3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">28</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e3745-wk-Fact-267F00EB5C0F51E2BCF5952ECE27EA8F" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1,003</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State and local</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e3762-wk-Fact-19A2E169F25C7191D661284316109A72" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">127</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e3782-wk-Fact-422A9E00C16DB4AC7DF8952ECD7CBA2A" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">37</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3802-wk-Fact-C9FF4F1A2B7220674842952ECCF30896" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-U.S.</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e3823-wk-Fact-5411A2D5E0C4FF15F5D728431612D0BC" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e3843-wk-Fact-29FC465E7F75F160F215952ECD219F09" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e3863-wk-Fact-609ADB09A87073412682952ECE5A88CC" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total deferred</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e3886-wk-Fact-2A3D5D1ADB9EB2D73D3C2843148BB1D8" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">961</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e3906-wk-Fact-07BADBE2FC7BA806CDA82843146F9B0B" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">83</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e3926-wk-Fact-5608F2B71E98868ABA9E2843147BAB8F" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1,012</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Provision for/(benefit from) income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e3953-wk-Fact-1F76A9CA55BDEBE5013228431626E45F" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e3973-wk-Fact-32C8EE70D1FD77AC3B30284316197236" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">386</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e3992-wk-Fact-55DB262DD0862713240F2843161FBB12" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">487</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Effective Tax Rate</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="TextSelection-7895133F7434327CE5AF2843166544C3-0-wk-Fact-50B797CD80B14ED1D5BE284315E3F5B6" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:54%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020 (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019 (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018 (1)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Provision at Federal statutory rate</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4088-wk-Fact-9B8BF3D3579184D9F840284315E11843" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4103-wk-Fact-38DFF9B65C5B6BD2B7A4284315C65F05" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4118-wk-Fact-4F39EE8BAA91F4A4CF9B284315B9C4DA" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">28.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State and local income taxes, net of federal benefit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4134-wk-Fact-C7B25AD2CE503E4F70C0284315C28F37" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">2.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4148-wk-Fact-218181C31302F3522F55284315C1923F" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e4162-wk-Fact-9F26557324A6247AFD35284315B8BE7C" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">16.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Tax effect of foreign operations</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4178-wk-Fact-CF2D098D2D4473C20EA7284315B7AADA" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e4192-wk-Fact-C04F46B204C46ACA7916284315B6D42C" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e4207-wk-Fact-B3A819A4C81F7E9C57AA284315C45200" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">48.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nondeductible/nontaxable items</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e4223-wk-Fact-1A38CB563D51606D2CF6284315B49093" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4238-wk-Fact-7AE8192BB4D3CE5D3683284315C7D7F2" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">2.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e4252-wk-Fact-5DEC7B61E65E3D1B0BD8284315BE73FA" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">10.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill impairment</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4268-wk-Fact-2B64D6DF81CC9BB72ED2284315BBF319" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4282-wk-Fact-422388AF7520A3597708284315C5BA6C" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e4296-wk-Fact-84F41314A6C6FBD609E1284315C2B5F4" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">124.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Tax Act</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4312-wk-Fact-214716403DB3268E19D5284315BEF21E" name="cah:EffectiveIncomeTaxRateReconciliationTaxAct2018" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e4326-wk-Fact-E975813B148C6970D211284315C4E82D" name="cah:EffectiveIncomeTaxRateReconciliationTaxAct2018" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4341-wk-Fact-850AA5C58B392F438E32284315B6B7E3" name="cah:EffectiveIncomeTaxRateReconciliationTaxAct2018" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">410.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Change in valuation allowances</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4356-wk-Fact-CA955AE8C6568F5AB77C284315BC26CF" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4370-wk-Fact-2831E9B8715AC1AE2534284315BF907B" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">4.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e4384-wk-Fact-1820949393ADF9E66E3E284315C38CE5" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">76.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign tax credits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4400-wk-Fact-6622C59C0394BCB78CF1284315B46084" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e4414-wk-Fact-E9E9542C455415AA370D284315B73637" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4429-wk-Fact-6767BB6FC39BA55A057F284315BC0E23" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">27.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">China tax related to divestiture</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4444-wk-Fact-163385C3EB2A0E27C517284315C317D0" name="cah:EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4458-wk-Fact-A99E66E70A4537D9352B284315BA031B" name="cah:EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e4472-wk-Fact-3E6E8B3E31FF1B666066284315BB43C2" name="cah:EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">25.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Legal entity reorganization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4488-wk-Fact-767882B6A3BD49155BA6284315C34E0E" name="cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e4502-wk-Fact-6098A5F4B553329E4113284315BF3B21" name="cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">3.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4517-wk-Fact-1DECE176A923F3EC2B6B284315B58074" name="cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">71.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Opioid litigation</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e4533-wk-Fact-6365FC22484F6DC92A35C57729EACB5E" name="cah:EffectiveIncomeTaxReconciliationOpioidLitigation" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">23.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4548-wk-Fact-8C647E0B45E9B2819FDFC5785BA34367" name="cah:EffectiveIncomeTaxReconciliationOpioidLitigation" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4562-wk-Fact-4F6A05C53D0D3D6280CDC5786D8C7614" name="cah:EffectiveIncomeTaxReconciliationOpioidLitigation" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e4577-wk-Fact-9ED7956EA513DD3F80E1284315BF3FE0" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e4592-wk-Fact-5B029CD900301E71FDD7284315B662FF" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e4607-wk-Fact-6B0D33291A8CBC057D1C284315B55B30" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" sign="-" format="ixt:numdotdecimal">21.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effective income tax rate</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4623-wk-Fact-A98288A60614D42B5E15284315CCEC31" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">2.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4638-wk-Fact-7115304A0C3857B5AE7C284315D830E5" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">22.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4653-wk-Fact-B97F7E881AFFCAFCDD6D284315D18F9E" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">213.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1) </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The effective income tax rate for fiscal 2020 and 2018 represents an income tax benefit tax rate.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2) </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The effective income tax rate for fiscal 2019 represents an income tax expense tax rate. </span></div></td></tr></table></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">67</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-FFCF7B493C2126F1B3A3284316656C68-1" continuedAt="TextSelection-FFCF7B493C2126F1B3A3284316656C68-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The income tax benefit rate was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10126096e4683-wk-Fact-A98288A60614D42B5E15284315CCEC31" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">2.1</ix:nonFraction>%</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10126096e4687-wk-Fact-B97F7E881AFFCAFCDD6D284315D18F9E" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">213.8</ix:nonFraction>%</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;"> compared to an income tax expense rate of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10126096e4699-wk-Fact-7115304A0C3857B5AE7C284315D830E5" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">22.1</ix:nonFraction>%</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. Fluctuations in the effective tax rates are primarily due to the impact of opioid litigation in fiscal 2020 and the impact of the U.S. Tax Cuts and Jobs Act ("Tax Act") in fiscal 2018, both described further below, as well as the Medical Unit goodwill impairment in fiscal 2018, as described in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sAF8B609C6A1B5242B7B172A7B9FB2416"><span style="font-family:Arial Narrow;font-size:10pt;">Note 1</span></a><span style="font-family:Arial Narrow;font-size:10pt;">. There were also changes in valuation allowances related to capital losses, credit carryforwards and net operating loss carryforwards in U.S. federal, U.S. state and international jurisdictions.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10126096e4717-wk-Fact-C827D709C763425D03DB54B51A88875B" name="us-gaap:LitigationReserve" contextRef="FI2020Q3_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-7" scale="9" format="ixt:numdotdecimal">5.63</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax charge for the opioid litigation, we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10126096e4721-wk-Fact-CE5AE3BF363D5D54B93DB630543D5E28" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2020Q4YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">488</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">,</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10126096e4735-wk-Fact-0C8F754D81135B46A8B5BB023ACA6ECE" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextRef="FI2020Q4_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">469</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the tax law; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the Tax Act. Further, it is possible that the tax authorities could challenge our interpretation of the currently enacted tax law or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our effective tax rate has benefits from negotiated lower than statutory tax rates in select foreign jurisdictions which individually are not material to our effective tax rate but in aggregate have a favorable tax impact of approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e4748-wk-Fact-3E6A12D310DE121B480D284315CE2429" name="cah:EffectiveTaxRateImpactFromCertainForeignJurisdictions" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">17</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> during fiscal 2020.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">On December 22, 2017, the United States enacted the Tax Act. The Tax Act made broad and comp</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">lex changes to the U.S. tax code that affected fiscal 2018 and incrementally affected our fiscal year 2019 financial results in several ways. First, the U.S. statutory tax rate in fiscal 2019 was reduced to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10126096e4757-wk-Fact-9B8BF3D3579184D9F840284315E11843" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="FD2020Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">21.0</ix:nonFraction>%</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Second, the Tax Act established new tax provisions that affected us beginning July 1, 2018 including, (1) eliminating the U.S. manufacturing deduction; (2) establishing new limitations on deductible interest expense and certain executive compensation; (3) eliminating the corporate alternative minimum tax; (4) creating the base erosion anti-abuse tax; (5) creating a new provision designed to tax global intangible low-tax income (&#8220;GILTI&#8221;) and allow for a deduction related to foreign derived intangible income ("FDII"); (6) generally eliminating U.S. federal income taxes on dividends from foreign subsidiaries; and (7) changing rules related to uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Regarding the new GILTI tax rules, we elected to treat taxes due on future GILTI inclusions in U.S. taxable income as a current period expense when incurred.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, foreign earnings of approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10126096e4771-wk-Fact-FFCA1A7BE54F9FB2E89B284315D1BF8E" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">800</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> are considered indefinitely reinvested for working capital and other offshore investment needs. The computation of tax required if those earnings are repatriated is not practicable. For amounts not </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-FFCF7B493C2126F1B3A3284316656C68-2" continuedAt="TextSelection-FFCF7B493C2126F1B3A3284316656C68-3"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">considered indefinitely reinvested, we have recorded an immaterial amount of income tax expense in our financial statements in fiscal 2020. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Deferred Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities and operating loss and tax credit carryforwards for tax purposes. </span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="TextSelection-8CB597CA87FAACB3F6C42843166683D0-0-wk-Fact-CCEE629D25ACAB38B4EA284315CCFD24" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents the components of the deferred income tax assets and liabilities at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Deferred income tax assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Receivable basis difference</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4903-wk-Fact-7D65AF42FAA9F7737780284315C6356E" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4922-wk-Fact-BCB74967C3C5ABC63DC9952EDD41A400" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4937-wk-Fact-4894D38A5EF0693E049C284315B184C2" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">607</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4956-wk-Fact-130B7573F08AB08F0ADA952EDEA0DA2D" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">133</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e4976-wk-Fact-4D96278DA4E81B2C5307284315B6F120" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">38</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e4995-wk-Fact-95EC459A8E60F39A644E952EDD466994" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss and tax credit carryforwards</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e5015-wk-Fact-3511AD9B3388391AA471284315E63EDE" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">589</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e5034-wk-Fact-1655DACE3DCD3F14BEA0952EDEAE9A31" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">621</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Deferred tax assets related to uncertain tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e5054-wk-Fact-6C143BA513EE7388E276284315B39AE0" name="cah:DeferredTaxAssetsRelatedtouncertaintaxpositions" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">52</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e5073-wk-Fact-28B7B11F422E397814F1952EDE918EF7" name="cah:DeferredTaxAssetsRelatedtouncertaintaxpositions" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">30</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e5093-wk-Fact-18269E9F1A66A46BC4B9284315B9004E" name="us-gaap:DeferredTaxAssetsOther" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">87</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e5112-wk-Fact-4772480247B4051E8540952EDE8C317A" name="us-gaap:DeferredTaxAssetsOther" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total deferred income tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e5132-wk-Fact-08E1BCD50DB0DB34FF9D284315B33ED8" name="us-gaap:DeferredTaxAssetsGross" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,412</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e5151-wk-Fact-EDC6EE95CCAAE675D486952EDEA95B75" name="us-gaap:DeferredTaxAssetsGross" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">864</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Valuation allowance for deferred income tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e5171-wk-Fact-DBAA4EDE76CFA5ED2EA6284315BA8366" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">470</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e5191-wk-Fact-407B40A9B5EB9A49B112952EDEA57E4A" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">542</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net deferred income tax assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e5217-wk-Fact-66FFFDB89E5518A4C227284315BA0F5F" name="us-gaap:DeferredTaxAssetsNet" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">942</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e5236-wk-Fact-D80AF8B4309618B61BDE284315BDA038" name="us-gaap:DeferredTaxAssetsNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">322</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Deferred income tax liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inventory basis differences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e5339-wk-Fact-37D785AA65EF8106530A284315BD360A" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,083</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e5359-wk-Fact-6E821CE7A5ED868EF8A3952EDE9BF92C" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,056</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Property-related</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e5375-wk-Fact-F422B5BE7BD2CEC33CF0284315B9BD64" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e5395-wk-Fact-6EDD581FDF6C8E91B1B8952EDE97A649" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">171</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill and other intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e5416-wk-Fact-B5D6ACAAE1F22F34017F284315C1E10C" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">751</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e5436-wk-Fact-68FBAE0DF6325A2B05E0952EDD4B71D6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">808</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total deferred income tax liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e5464-wk-Fact-2BACE29F9D1C21E49757284315CA328C" name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,161</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e5484-wk-Fact-3D88C2C626816139D7D1952EDD3C86A3" name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,035</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net deferred income tax liability</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e5505-wk-Fact-C6B8A7AE79EFC264CAE4284315F911C0" name="us-gaap:DeferredTaxLiabilities" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,219</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e5525-wk-Fact-F6B12155F05213B57D56952EC2F92F17" name="us-gaap:DeferredTaxLiabilities" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,713</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" id="TextSelection-21D3B8017C8F030B297C284316650332-0-wk-Fact-49B519DB2CE122D2BF1F284315D5176B" continuedAt="TextSelection-21D3B8017C8F030B297C284316650332-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Noncurrent deferred income tax asset (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e5619-wk-Fact-5BA44FD505745B13799F284315FA6D78" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e5638-wk-Fact-D08105063DFB4DE2A3CE952EC2C94CAE" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">36</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Noncurrent deferred income tax liability (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e5653-wk-Fact-B4F4111163280DABBBCB284315F876B9" name="us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,258</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e5673-wk-Fact-4099A83C9BCCD1CA6EB4952EC2DFCEE8" name="us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,749</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net deferred income tax liability</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e5699-wk-Fact-C6B8A7AE79EFC264CAE4284315F911C0" name="us-gaap:DeferredTaxLiabilities" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,219</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e5719-wk-Fact-F6B12155F05213B57D56952EC2F92F17" name="us-gaap:DeferredTaxLiabilities" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,713</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in other assets in the consolidated balance sheets.</span></div></td></tr></table></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-21D3B8017C8F030B297C284316650332-1" continuedAt="TextSelection-21D3B8017C8F030B297C284316650332-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-21D3B8017C8F030B297C284316650332-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div></ix:continuation></td></tr></table><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> we had gross federal, state and international loss and credit carryforwards of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e5774-wk-Fact-6C10D2C3C2D86CC67ADB284315D631AE" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="FI2020Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">123</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e5778-wk-Fact-327DABBA8D67B8D26EDC284315D4E7B3" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="FI2020Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">2.4</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e5782-wk-Fact-B1689030D322A7696D10284315E8947D" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="FI2020Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">2.2</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, the tax effect of which is an aggregate deferred tax asset of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e5786-wk-Fact-3511AD9B3388391AA471284315E63EDE" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">589</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. Substantially all of these carryforwards are available for at least three years. Approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e5791-wk-Fact-500B7CF63F31BFAD6F13284315DB57F1" name="us-gaap:OperatingLossCarryforwardsValuationAllowance" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">461</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the valuation allowance at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> applies to certain federal, state and international loss carryforwards that, in our opinion, are more likely than not to expire unutilized. However, to the extent that tax benefits related</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">to these carryforwards are realized in the future, the reduction in the valuation allowance would reduce income tax expense.</span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">68</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-FFCF7B493C2126F1B3A3284316656C68-3" continuedAt="TextSelection-FFCF7B493C2126F1B3A3284316656C68-4"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Unrecognized Tax Benefits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We had </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e5809-wk-Fact-D89E93BBF064CAEF2575284315E20A89" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">998</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e5813-wk-Fact-822B7E99A1DB5AB0A313E733A910F08B" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">456</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e5817-wk-Fact-26A1AD8EC14D0CDDC244284315CD2241" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">423</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of unrecognized tax benefits at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. The </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;"> balances include </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e5846-wk-Fact-088DB6725E9B8EB1B705284315D04FE7" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">753</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e5850-wk-Fact-8972CBB1C17D53EF8DE613FABD7A6962" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">303</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e5855-wk-Fact-77DBA4F04BDFCC015FC0284315CCEC9F" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">262</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate. The remaining unrecognized tax benefits relate to tax positions for which ultimate deductibility is highly certain but for which there is uncertainty as to the timing of such deductibility. Recognition of these tax benefits would not affect our effective tax rate. We include the full amount of unrecognized tax benefits in deferred income taxes and other liabilities in the consolidated balance<ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="TextSelection-12B97FD8334CE931932D284316650AEC-0-wk-Fact-FE6F70A6A9C4B66308C0284315D314A4" continuedAt="TextSelection-12B97FD8334CE931932D284316650AEC-1" escape="true"> sheets. The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:</ix:nonNumeric></span></div><ix:continuation id="TextSelection-12B97FD8334CE931932D284316650AEC-1" continuedAt="TextSelection-12B97FD8334CE931932D284316650AEC-2"><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:54%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at beginning of fiscal year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e5963-wk-Fact-822B7E99A1DB5AB0A313E733A910F08B" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">456</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e5982-wk-Fact-26A1AD8EC14D0CDDC244284315CD2241" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">423</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e6001-wk-Fact-D376313F2A07F64C267E284315B8ED58" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2017Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">417</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions for tax positions of the current year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e6017-wk-Fact-19FA88F5C183E0B0CF4F284315B2E0B7" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">500</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e6036-wk-Fact-683470D6FF9F59806568284315AE6FC6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">24</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e6055-wk-Fact-BDA0BF0D7BE0AF9E537F284315B489A6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions for tax positions of prior years (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e6076-wk-Fact-9C26CE231C0997451AA8284315B500CB" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">78</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e6095-wk-Fact-1403F95CD9E8276D6C47284315B7A3C8" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e6114-wk-Fact-4925BC65CCCDDBAD0653284315B8DFB0" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">141</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Reductions for tax positions of prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e6135-wk-Fact-3E1A9E42D8D07D8793B0284315B3AB2E" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">27</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e6155-wk-Fact-92721D09E1774FE36DF3284315B75C58" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e6175-wk-Fact-6DB4FE2D34DF9C8E27FA284315B6F0E7" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Settlements with tax authorities (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e6197-wk-Fact-A731738A344E51369F9F284315B17F51" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e6217-wk-Fact-91F822905754229847A0284315B1E1EE" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e6237-wk-Fact-DA6FA005CC96251E062C284315AF0F93" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">99</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Expiration of the statute of limitations (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10126096e6259-wk-Fact-28C37AD50E44C26B04F4284315B04C20" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e6279-wk-Fact-8B20F719AFE7E9D49321284315B00102" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10126096e6298-wk-Fact-73B13634DE9522FE05F2284315B58B31" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at end of fiscal year</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10126096e6325-wk-Fact-D89E93BBF064CAEF2575284315E20A89" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">998</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e6344-wk-Fact-822B7E99A1DB5AB0A313E733A910F08B" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">456</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10126096e6363-wk-Fact-26A1AD8EC14D0CDDC244284315CD2241" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">423</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:continuation><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-12B97FD8334CE931932D284316650AEC-2" continuedAt="TextSelection-12B97FD8334CE931932D284316650AEC-3"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-12B97FD8334CE931932D284316650AEC-3"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in fiscal 2018 additions for tax positions of prior years is </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10126096e6379-wk-Fact-12DAB65A20C7E4B86EB5284315CFF3AC" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2018Q4YTD_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">110</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> related to exposures acquired as part of the Patient Recovery Business for which we are fully indemnified. Also for fiscal 2018 are settlements of </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10126096e6383-wk-Fact-7268B6BE07522BEB02A4284315E864B1" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" contextRef="FD2018Q4YTD_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">81</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> related to the Patient Recovery Business as well as </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10126096e6387-wk-Fact-CF0B115FC3F9E1DA64BB284315E65773" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" contextRef="FD2018Q4YTD_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> of statute expirations. </span></div></ix:continuation></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of audit issues, reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations.</span><span style="font-family:Arial Narrow;font-size:10pt;"> We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is a net decrease of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e6399-wk-Fact-65D42A798CC9D259CD5C284315CEC405" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" contextRef="FI2020Q4_srt_RangeAxis_srt_MinimumMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">0</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e6403-wk-Fact-EDB83EF8173353DD843EA21548FF1761" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" contextRef="FI2020Q4_srt_RangeAxis_srt_MaximumMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">370</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, exclusive of penalties and interest.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e6422-wk-Fact-460C6E0274685B78997087EB6C0BE55C" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">146</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e6426-wk-Fact-3ABE8DAC48EF7FB3E0DC284315E7DB07" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">122</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e6431-wk-Fact-1AD9B44443585B6FA8707DC89F4B17C4" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">110</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, accrued for the payment of interest and penalties. These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the consolidated balance sheets. During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;"> we recognized </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e6447-wk-Fact-3CAD6F80DEE9F537CE5D284315E17BD0" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e6451-wk-Fact-638BB968C8474D0A8475284315D4386E" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e6456-wk-Fact-8014A2B9BE399BC9CF2A284315E96641" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of expense for interest and penalties in income tax expense, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Tax Matters</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state and local jurisdictions, and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2008 through the current fiscal year. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), which has been acquired by Becton, Dickinson and Company. Under the tax matters agreement, </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-FFCF7B493C2126F1B3A3284316656C68-4"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e6473-wk-Fact-37787FD6909A5502BFD05B7D6D97C92F" name="cah:IndemnificationReceivable" contextRef="FI2020Q4_cah_TaxMatterAxis_cah_CareFusionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">176</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10126096e6477-wk-Fact-BAA7B8857F1D25F9DE66284315DF9546" name="cah:IndemnificationReceivable" contextRef="FI2019Q4_cah_TaxMatterAxis_cah_CareFusionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">165</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, and is included in other assets in the consolidated balance sheets.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition under the purchase agreement. The indemnification receivable was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10126096e6535-wk-Fact-E5A531A4C45D54AEAAA61C642ECA0D06" name="cah:IndemnificationReceivable" contextRef="FI2020Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">19</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10126096e6539-wk-Fact-E20F0DD2FF17955AE8E5284315EC90E6" name="cah:IndemnificationReceivable" contextRef="FI2019Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and is included in other assets in the consolidated balance sheets.</span></div></ix:continuation><div><a id="sC842095C866F51CEAB114318376AF314"></a></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="TextSelection-15D901CB49DCDC7AE77728431666A425-0-wk-Fact-9452A0A9983AF3E2155428431614AA72" continuedAt="TextSelection-15D901CB49DCDC7AE77728431666A425-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">9. Fair Value Measurements</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="TextSelection-9E3593418D6EF4EAB4F428431666C1D6-0-wk-Fact-ED1BB6F3682B36163B3A284316148B8F" continuedAt="TextSelection-9E3593418D6EF4EAB4F428431666C1D6-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10115540e3159-wk-Fact-478D2137315459C79FBB2BDDBBD35B17" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">721</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10115540e3178-wk-Fact-000CC1CA2134517DA056B2016A5EA65D" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10115540e3197-wk-Fact-BEE4724C85E45E7198C6EA7C6F445980" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10115540e3217-wk-Fact-FDA945F80F3650BF9857942B6ED4F990" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2020Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">721</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10115540e3232-wk-Fact-32C31CD8487C54B38D9B68E0144835ED" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">114</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10115540e3251-wk-Fact-2103811B975352B798F7B4E5829FEEE8" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10115540e3270-wk-Fact-885F2EC1EC1A5E2688705644FAE0A2B8" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10115540e3290-wk-Fact-1DA285435331501E9AFEB8D73B70B5D4" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">114</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10115540e3310-wk-Fact-14B0667DE4415F40B60DBD061D592537" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10115540e3329-wk-Fact-2C6BED4D67235C609B8FA158389990CD" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10115540e3348-wk-Fact-F32D20651D8256B2B77A8061864B29C3" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10115540e3368-wk-Fact-BDAA57BB75105940BCE79CFC2A8AAFB6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2020Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10115540e3662-wk-Fact-FDD5F9C1E95D5A55B3F2EF71F0209857" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">297</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10115540e3681-wk-Fact-7A73469B094F5FD7AC0AA7DE4A115E0D" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10115540e3700-wk-Fact-88D34EAFBE575A82AA3B2F574E75D0BB" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10115540e3720-wk-Fact-C0C895B85F9C5B558F91F0635E3993A8" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">297</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10115540e3735-wk-Fact-1C9621A5C32F590B9268C4EE648F542C" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">118</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10115540e3754-wk-Fact-1F4133A131AA5ACE8A99C7A56A6D1C9F" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10115540e3773-wk-Fact-94AABB68AC135BB88BE04ABC6A5F6239" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10115540e3793-wk-Fact-1D3DCE01961053BE8366D7A99C7605A3" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">118</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10115540e3813-wk-Fact-38A2E1AE543D529A98D50A4F2F43B68E" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10115540e3832-wk-Fact-A92BE58186ED5B9C9C3B9072D0FE6813" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10115540e3851-wk-Fact-32CB648696335B66957F2B6B781762AF" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10115540e3871-wk-Fact-7A9FA06361605262BCD6BD71D5BD181D" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div></td></tr></table></ix:nonNumeric></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-9E3593418D6EF4EAB4F428431666C1D6-1" continuedAt="TextSelection-9E3593418D6EF4EAB4F428431666C1D6-2"><ix:continuation id="TextSelection-15D901CB49DCDC7AE77728431666A425-1" continuedAt="TextSelection-15D901CB49DCDC7AE77728431666A425-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></ix:continuation></ix:continuation></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><ix:continuation id="TextSelection-15D901CB49DCDC7AE77728431666A425-2"><ix:continuation id="TextSelection-9E3593418D6EF4EAB4F428431666C1D6-2">The</ix:continuation> fair value of interest rate swaps, foreign currency contracts, net investment hedges and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows.<ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="TextSelection-C3650DCD87CA370894F72843166631F6-0-wk-Fact-97A0687D102C2195C4212843161533FD" escape="true"> The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.</ix:nonNumeric></ix:continuation> </span></div></td></tr></table><div><a id="s138045C0A5375688972939C6B03E89B1"></a></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="TextSelection-DD2CD71E9FDDD6038F3C28431668D305-0-wk-Fact-8A9B4857CCE041A248102843161C5C3C" continuedAt="TextSelection-DD2CD71E9FDDD6038F3C28431668D305-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">10. Financial Instruments</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to current fair value through earnings at the end of each period. </span><span style="font-family:Arial Narrow;font-size:10pt;">We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are rated investment grade or better. We do not have significant exposure to any one counterparty and we believe </span></div></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">69</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-DD2CD71E9FDDD6038F3C28431668D305-1" continuedAt="TextSelection-DD2CD71E9FDDD6038F3C28431668D305-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">the risk of loss is remote. Additionally, we do not require collateral under these agreements.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Interest Rate Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes in interest rates. In addition, we enter into interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Currency Exchange Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce earnings and cash flow volatility associated with foreign exchange rate changes to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commodity Price Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="TextSelection-6F05C90816002F7092032843166878FA-0-wk-Fact-424FF33460EF4206E5FE28431621C906" continuedAt="TextSelection-6F05C90816002F7092032843166878FA-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:70%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e3043-wk-Fact-200A503D2BD641043332284315A62682" name="us-gaap:DerivativeFairValueOfDerivativeAsset" contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">27</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e3062-wk-Fact-DB8B09BAEB1FE4E6D84D284315A1FF87" name="us-gaap:DerivativeFairValueOfDerivativeAsset" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">46</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cross-currency swap (1) </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e3077-wk-Fact-B9893E5BEACE0A87794F284315A33582" name="us-gaap:DerivativeFairValueOfDerivativeAsset" contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CrossCurrencyInterestRateContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">47</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e3096-wk-Fact-E691965F46693E44600B284315A7ED4A" name="us-gaap:DerivativeFairValueOfDerivativeAsset" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CrossCurrencyInterestRateContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e3116-wk-Fact-D3AD943B2632D3A0D4F02843159FAD2D" name="us-gaap:DerivativeFairValueOfDerivativeAsset" contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e3135-wk-Fact-35EEF3279D45A8A3EE54284315A53CF2" name="us-gaap:DerivativeFairValueOfDerivativeAsset" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e3160-wk-Fact-037C86DDD9F4CDAD320A284315A16241" name="us-gaap:DerivativeFairValueOfDerivativeAsset" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">74</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e3179-wk-Fact-4A457CB25699BE0458412843159DF00B" name="us-gaap:DerivativeFairValueOfDerivativeAsset" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">64</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps (3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e3281-wk-Fact-9E7C8FDF080C4B04224B284315A17C7E" name="us-gaap:DerivativeFairValueOfDerivativeLiability" contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e3300-wk-Fact-9212D5C8D80D902E0E252843159E1ACE" name="us-gaap:DerivativeFairValueOfDerivativeLiability" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (4)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e3315-wk-Fact-5CB6BA663B4F48B39C36284315A68EA6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e3334-wk-Fact-27ECD6BB19B2ED03085F284315A0EBC4" name="us-gaap:DerivativeFairValueOfDerivativeLiability" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps (3)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e3354-wk-Fact-30A295E9C879654F6E5228431460ABEC" name="us-gaap:DerivativeFairValueOfDerivativeLiability" contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e3373-wk-Fact-C19583C9783E385BEB3628431462D925" name="us-gaap:DerivativeFairValueOfDerivativeLiability" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e3394-wk-Fact-9C1F60165374F4660D18284315A2C70E" name="us-gaap:DerivativeFairValueOfDerivativeLiability" contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e3413-wk-Fact-83E49AC604A3982F7FF2284315A513C1" name="us-gaap:DerivativeFairValueOfDerivativeLiability" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e3438-wk-Fact-0581FA5F55E19F0928532843159F6F20" name="us-gaap:DerivativeFairValueOfDerivativeLiability" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">21</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e3457-wk-Fact-974B58B20B1ABA8D7972284315A437A4" name="us-gaap:DerivativeFairValueOfDerivativeLiability" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in other assets in the consolidated balance sheets.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in prepaid expenses and other in the consolidated balance sheets.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div></td></tr></table></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-6F05C90816002F7092032843166878FA-1" continuedAt="TextSelection-6F05C90816002F7092032843166878FA-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-6F05C90816002F7092032843166878FA-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in other accrued liabilities in the consolidated balance sheets.</span></div></ix:continuation></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-DD2CD71E9FDDD6038F3C28431668D305-2" continuedAt="TextSelection-DD2CD71E9FDDD6038F3C28431668D305-3"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense, net in the consolidated statements of earnings/(loss). D</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">uring fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, there was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10136988e3526-wk-Fact-340F0A1B46C553F8AA2D52F4211D6D27" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> gain or loss recorded to interest expense as changes in the market value of our derivative instruments offset changes in the market value of the underlying debt.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In May </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we unwound certain interest rate swap contracts. In connection with the unwind of these contracts, we received cash proceeds of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10136988e3537-wk-Fact-800D7B5B215EE3D6C31CB585A617A26D" name="us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">112</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The related gain will be recognized in interest expense, net in our statement of earnings/(loss) over the remaining term of the related debt agreements, which ranged from 48 months to 63 months at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the debt repayment as described in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s90F282348F0354D781EEBCEFD3A04F7E"><span style="font-family:Arial Narrow;font-size:10pt;">Note 6</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, two pay-floating interest rate swaps with notional amounts of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10136988e3553-wk-Fact-6262A45A34F655438910490228581C45" name="cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">200</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> matured in the second quarter of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">During fiscal&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we terminated notional amounts of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10136988e3568-wk-Fact-3B1696958DD2F458A9D72843162261D9" name="cah:DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">163</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of pay-floating interest rate swaps in connection with the debt repurchases in&#160;fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;described in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s90F282348F0354D781EEBCEFD3A04F7E"><span style="font-family:Arial Narrow;font-size:10pt;">Note 6</span></a><span style="font-family:Arial Narrow;font-size:10pt;">. These swaps were previously designated as fair value hedges.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> we entered into pay-floating interest rate swaps with total notional amounts of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10136988e3588-wk-Fact-F0597385CF13B0DDBE3D284316227163" name="us-gaap:DerivativeAssetNotionalAmount" contextRef="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">1.1</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These swaps have been designated as fair value hedges of our fixed rate debt and are included in deferred income taxes and other liabilities in the consolidated balance sheets. During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10136988e3596-wk-Fact-1D0B89F6969E47488BFC28431624F26E" name="cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" contextRef="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">550</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of pay-floating interest rate swaps matured.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="TextSelection-C7B6944FD4BFAAA3BF21284316677704-0-wk-Fact-8FCA07E82217C6647488284316242DFD" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:26%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:11%;"></td><td style="width:4%;"></td><td style="width:12%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Maturity&#160;Date</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e3719-wk-Fact-8F6AFF218E0A7D4241D628431461629F" name="us-gaap:DerivativeAssetNotionalAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">550</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Mar 2023</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:44%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:11%;"></td><td style="width:4%;"></td><td style="width:12%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Maturity&#160;Date</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e3855-wk-Fact-0C9C89855E0A4D43225C284316213844" name="us-gaap:DerivativeAssetNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,150</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nov 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">-</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Sep 2025</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="TextSelection-5109584BA3C94173A5B3284316679E04-0-wk-Fact-A249B11A88C4C244DD67284316214BD4" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:54%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e3991-wk-Fact-C200B9F32AA14DECA3B32843159DFD2C" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">106</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e4010-wk-Fact-EBEA863AF431288B0C622843159FA0C4" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e4029-wk-Fact-891A8C676DE1016183F02843159F1121" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fixed-rate debt (1)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10136988e4045-wk-Fact-575B66D54376C587B63A284315A27E75" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_cah_FixedRateDebtMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">106</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10136988e4065-wk-Fact-65546CC868A8D2006F0C284315A01B69" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_cah_FixedRateDebtMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10136988e4085-wk-Fact-0E647F82F745A4E8717E284315A0856D" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_cah_FixedRateDebtMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1) Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash Flow Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted </span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">70</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-DD2CD71E9FDDD6038F3C28431668D305-3" continuedAt="TextSelection-DD2CD71E9FDDD6038F3C28431668D305-4"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive loss and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered into forward interest rate swaps with a total notional amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10136988e4129-wk-Fact-825D10F27F465E1EA8700FF967AA5E86" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">200</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to hedge probable, but not firmly committed, future transactions associated with our debt.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">All gains and losses currently included within accumulated other comprehensive loss associated with our cash flow hedges that are expected to be reclassified into net earnings within the next 12 months are immaterial.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We enter into foreign currency contracts to protect the value of anticipated foreign currency revenues and expenses. At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we held contracts to hedge probable, but not firmly committed, revenue and expenses. The principal currencies hedged are the Canadian dollar, Mexican peso, euro, Thai baht, Chinese renminbi, Japanese yen, Australian dollar, and British pound.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We enter into commodity contracts to manage the price risk associated with forecasted purchases of certain commodities used in our Medical segment.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="TextSelection-DE548948F8CA9045BCE028431666BE1A-0-wk-Fact-9B7A50853A9A39128FD5284316235DBE" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarize the outstanding cash flow hedges at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:40%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:14%;"></td><td style="width:4%;"></td><td style="width:14%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Maturity&#160;Date</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e4270-wk-Fact-87E3DF80700DE3D26154284315AE1713" name="us-gaap:DerivativeAssetNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">200</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jun 2022</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e4305-wk-Fact-838D34F076DE98A4514A284315DFEE2C" name="us-gaap:DerivativeAssetNotionalAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">328</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jul 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">-</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jun 2021</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e4345-wk-Fact-66D0FBB2C3EF04AE64BE284315D9413A" name="us-gaap:DerivativeAssetNotionalAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jul 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">-</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jun 2021</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:40%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:14%;"></td><td style="width:4%;"></td><td style="width:14%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Maturity&#160;Date</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e4486-wk-Fact-25195DB65F1E9216679FAB01BB4C1CB1" name="us-gaap:DerivativeAssetNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">381</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jul 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">-</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jun 2020</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e4521-wk-Fact-8334FB61D99EA268C61EAB01BACEAD64" name="us-gaap:DerivativeAssetNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jul 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">-</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jun 2020</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" id="TextSelection-AB4EA973AACD973DF69D28431668B61B-0-wk-Fact-6BD4F596B55D3CAC3E84284316204DA2" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:47%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10136988e4663-wk-Fact-E96101B8EC06BC4640FCB569C11F1430" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e4683-wk-Fact-BFA79BC4277CF35DA676B569C6A653B0" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e4702-wk-Fact-E4987D49B38892EDA85CB569CB43A6F1" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e4718-wk-Fact-5F7C94828F978958BD8E2843148C5CF0" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10136988e4737-wk-Fact-F5C79D89561257ED9F98284315A5FA19" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e4757-wk-Fact-B5DF809A1BFFA5600B5EB56937D1DBB5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10136988e4778-wk-Fact-B2AEA65500695E360BE42843159D6BCF" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e4798-wk-Fact-0A3C987AB738ABC4857D2843148C1F38" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10136988e4817-wk-Fact-57C8E77DA17C7B08A06DB5693C45448D" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="TextSelection-15DE37986BFFE3B9B4C528431668734C-0-wk-Fact-885EE46AAB2B9DA000632843162410B5" continuedAt="TextSelection-15DE37986BFFE3B9B4C528431668734C-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e4940-wk-Fact-0A954131919C69A44F112843160D13A1" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e4959-wk-Fact-4C815D07C9874800A6322843160B2CF2" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e4978-wk-Fact-6F309016821D37520F002843160F3667" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e4994-wk-Fact-2FEF4FCA426C2A0907022843160D1601" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e5013-wk-Fact-BC708BC4A504E7A0FF8D2843160A8F84" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e5032-wk-Fact-137FB8A05FD9DDFBF3C92843160D8274" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (3)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e5053-wk-Fact-9D85849FE52D109D103D2843160E139E" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e5072-wk-Fact-B97A8EA64D62AA0501F42843160E0BD6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10136988e5091-wk-Fact-10A97C8F8DEEC600DD852843160D93E5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps (4)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e5113-wk-Fact-45525065FEC795B66D84B56A85067C95" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e5132-wk-Fact-4941A4D4A67F7FD0D51BB56A8C3242A5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e5151-wk-Fact-BBDCEBC6F615DC1CDBCEB56A930C7A2A" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts (3)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10136988e5172-wk-Fact-0F3E8D608C8641ECD16628431612934E" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e5192-wk-Fact-876BD845FE26987C70442843160DD0B5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e5211-wk-Fact-3D85CC1C91D93B9669672843160DBFED" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in revenue in the consolidated statements of earnings/(loss).</span></div></td></tr></table></ix:nonNumeric></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-DD2CD71E9FDDD6038F3C28431668D305-4" continuedAt="TextSelection-DD2CD71E9FDDD6038F3C28431668D305-5"><ix:continuation id="TextSelection-15DE37986BFFE3B9B4C528431668734C-1" continuedAt="TextSelection-15DE37986BFFE3B9B4C528431668734C-2"><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in cost of products sold in the consolidated statements of earnings/(loss).</span></div></td></tr></table></ix:continuation><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-15DE37986BFFE3B9B4C528431668734C-2" continuedAt="TextSelection-15DE37986BFFE3B9B4C528431668734C-3"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-15DE37986BFFE3B9B4C528431668734C-3"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in SG&amp;A expenses in the consolidated statements of earnings/(loss).</span></div></ix:continuation></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4) </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Net Investment Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In August 2019, we entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>&#165;<ix:nonFraction id="d10136988e5272-wk-Fact-28327CA0E23F5099AAB45137214A079C" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="jpy" decimals="-6" scale="9" format="ixt:numdotdecimal">64</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10136988e5276-wk-Fact-9C51B897DD8952D19FA742CC2105B7D2" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">) cross-currency swap maturing in </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2022</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In </span><span style="font-family:Arial Narrow;font-size:10pt;">September 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>&#8364;<ix:nonFraction id="d10136988e5291-wk-Fact-CD0972EE3F585FD59B10B5C2B1BD64CB" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="eur" decimals="-6" scale="6" format="ixt:numdotdecimal">200</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10136988e5295-wk-Fact-A0A76C80F740512FA4E0E2B74A32C8BB" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">233</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">) cross-currency swap maturing in </span><span style="font-family:Arial Narrow;font-size:10pt;">2023</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive loss until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Pre-tax gain from net investment hedges recorded in other  foreign currency translation was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10136988e5309-wk-Fact-2C907640E605560309C6B5750BC40E64" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10136988e5313-wk-Fact-83D542563B5CFDFCADE9B58182C2621F" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. Gain recognized in interest expense, net in the consolidated statements of earnings/(loss) for the portion of the net investment hedges excluded from the assessment of hedge effectiveness was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10136988e5325-wk-Fact-F3C9F8154B0C8FABCC20B581CD7DB6F5" name="us-gaap:InterestIncomeExpenseNonoperatingNet" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">17</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10136988e5332-wk-Fact-AD37A13EF3042CCEF8A8B58340B26E17" name="us-gaap:InterestIncomeExpenseNonoperatingNet" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Economic (Non-Designated) Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. The principal currency managed through foreign currency contracts is the euro, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Canadian dollar, British pound, Japanese yen, and Chinese renminbi.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="TextSelection-A487D09C0A0C58647E752843166713A8-0-wk-Fact-23D2DA6DA7D549CE8600284316223FD2" continuedAt="TextSelection-A487D09C0A0C58647E752843166713A8-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:40%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:14%;"></td><td style="width:4%;"></td><td style="width:14%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Maturity Date</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e5471-wk-Fact-0C1B0B3AAA48A29090192843160B35D1" name="us-gaap:DerivativeAssetNotionalAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">325</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">July 2020</span></div></td></tr></table></div></div></ix:nonNumeric></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">71</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-DD2CD71E9FDDD6038F3C28431668D305-5"><ix:continuation id="TextSelection-A487D09C0A0C58647E752843166713A8-1"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:40%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:14%;"></td><td style="width:4%;"></td><td style="width:14%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Maturity Date</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e5607-wk-Fact-39290C7C39E2E6BAA95E284315F039F2" name="us-gaap:DerivativeAssetNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">488</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jul 2019</span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:continuation><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="TextSelection-51D544CC56D9E3A9E80A28431667E802-0-wk-Fact-20F6FE1794F029551B4A28431622D480" continuedAt="TextSelection-51D544CC56D9E3A9E80A28431667E802-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (1)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10136988e5743-wk-Fact-1D33DA171E8156EFB3E92BB7F8E00C7C" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10136988e5763-wk-Fact-0EF18BAB860C55509545FDF3B280DA9B" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10136988e5783-wk-Fact-ADC6C8E7B1DD7751F04428431608E19F" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div></div></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-51D544CC56D9E3A9E80A28431667E802-1" continuedAt="TextSelection-51D544CC56D9E3A9E80A28431667E802-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-51D544CC56D9E3A9E80A28431667E802-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in other income, net in the consolidated statements of earnings/(loss).</span></div></ix:continuation></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value of Financial Instruments</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The carrying amounts of cash and equivalents, trade receivables, net, accounts payable, and other accrued liabilities at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> approximate fair value due to their short-term maturities.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="TextSelection-D839E1E497E734116A1A28431666FD76-0-wk-Fact-0E3E6FAC4EB8D1AE033E284316237C3D" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Estimated fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e5897-wk-Fact-264C7E2128C951DF9D9A0F0D1C876167" name="us-gaap:DebtInstrumentFairValue" contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7,273</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e5916-wk-Fact-26B9E9CEDAB4513DBF89BA65718F4581" name="us-gaap:DebtInstrumentFairValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,065</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Carrying amount</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e5931-wk-Fact-3DC5D901384F5A19AC7ECF33074D2088" name="cah:CarryingAmountofLongTermandotherShortTermBorrowings" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,775</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e5950-wk-Fact-7D46BB0398C557D8B2BCBF1B13C9D791" name="cah:CarryingAmountofLongTermandotherShortTermBorrowings" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,031</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" id="TextSelection-12C0EDD31AA7DFCFD0DB2843166741D8-0-wk-Fact-EB84AAF02467A07A30C228431624C25D" escape="true"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:</span></div><div style="line-height:100%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:32%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Notional<br/>Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fair&#160;Value<br/>Gain/(Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Notional<br/>Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fair&#160;Value<br/>Gain/(Loss)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e6219-wk-Fact-024078DE68EF497C4632284315D82FE1" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">550</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e6238-wk-Fact-EA5C1AA4C88915DF1C13284315A885BC" name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">27</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e6257-wk-Fact-FCDD73E63AAB50617AB82843159C5DF6" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,150</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e6277-wk-Fact-56C15295755994B4196B284315AD721E" name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e6292-wk-Fact-FD531D015C98CF8DD45F284315A48EDD" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">653</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10136988e6311-wk-Fact-102DCB5ADCEF25DE3D7F284315D48D8E" name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e6331-wk-Fact-8EE26FC7D152C581DC67284315D53460" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">869</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e6351-wk-Fact-7679F7A5C9DFBCEE90E6284315A7131E" name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e6371-wk-Fact-67C4D82337385D4715B3B565AFE1C0D5" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">200</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10136988e6390-wk-Fact-FE2515E22322E0AEB060B565B3165AAA" name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e6410-wk-Fact-A9E74B5F26ADDE24CB48B565B689CED7" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e6430-wk-Fact-30504F66B9BC256DA07EB565B9CA4ECE" name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cross-currency swap</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e6450-wk-Fact-2B8C592D38FE3454A7B0B565BC666D34" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">833</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e6469-wk-Fact-264ECF038D6464334180B565BF54D3BA" name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">47</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e6488-wk-Fact-67FBCCF018DE237A99D0B565C295F6AC" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">233</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e6508-wk-Fact-6F491AE48C7C7F1E778CB565C5F7D426" name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10136988e6528-wk-Fact-A07999AAFD668BE233E42843159C46E5" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10136988e6547-wk-Fact-7AFAE128EFF6FEE8473E2843159C9484" name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10136988e6567-wk-Fact-9C74D46BAB983F90329E284315A330F4" name="us-gaap:DerivativeNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10136988e6587-wk-Fact-0C55E12F79572A03ADAD284315AABF67" name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><a id="s3D77F43D97875956BB9F5A04AD8753DD"></a></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="TextSelection-D02F0981FD28C7ED5F9E28431668D169-0-wk-Fact-1D9F4283039D37F400702843146AE2E1" continuedAt="TextSelection-D02F0981FD28C7ED5F9E28431668D169-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">11. Shareholders' Equity</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, authorized capital shares consisted of the following: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10119396e2870-wk-Fact-E19E1ECF8D8DAE6610002843163B5D9D" name="us-gaap:CommonStockSharesAuthorized" contextRef="FI2020Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">750</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> Class A common shares, without par value; </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10119396e2875-wk-Fact-220E38A33B9E163CA7902843146F5F5D" name="us-gaap:CommonStockSharesAuthorized" contextRef="FI2020Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> Class B common shares, without par value; and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d10119396e2879-wk-Fact-15921F8E736AD525E6102843146A0B3B" name="us-gaap:PreferredStockSharesAuthorized" contextRef="FI2020Q4" unitRef="shares" decimals="INF" scale="3" format="ixt:numdotdecimal">500</ix:nonFraction> thousand</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> non-voting preferred shares, without par value. The Class A common shares and Class B common shares are collectively referred to below as &#8220;common shares&#8221;. Holders of common shares are entitled to share equally in any dividends declared by the Board of Directors and to participate equally in all distributions of assets upon liquidation. Generally, the holders of Class A common shares are entitled to </span><span style="font-family:Arial Narrow;font-size:10pt;">one vote</span><span style="font-family:Arial Narrow;font-size:10pt;"> per share, and the holders of Class B common shares are entitled to </span><span style="font-family:Arial Narrow;font-size:10pt;">one-fifth of one vote</span><span style="font-family:Arial Narrow;font-size:10pt;"> per share on proposals presented to shareholders for vote. Under certain circumstances, the </span></div></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-D02F0981FD28C7ED5F9E28431668D169-1"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">holders of Class B common shares are entitled to vote as a separate class. Only Class A common shares were outstanding at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10119396e2905-wk-Fact-854B6F5BE299DDC465202843163B4391" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="D2020Q4SD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">1.5</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of our common shares, in the aggregate, through share repurchase programs during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, as described below. We funded the repurchases with available cash and short term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10119396e2928-wk-Fact-B215055D30B85C1CA125EFB04AF2D1CE" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">7.3</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10119396e2932-wk-Fact-3936BCD4D87F534A8A416398BE9277F2" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10119396e2936-wk-Fact-B154173D9EB456EBA8E06B04DFA3CB1F" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">48.00</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These repurchases were made under an accelerated share repurchase ("ASR") program, which began on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">August&#160;20, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and was completed on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">December&#160;4, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10119396e2956-wk-Fact-EA577AD26B465F41888DF858FBE664C0" name="cah:TreasuryStockAcquiredShares" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">11.5</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10119396e2960-wk-Fact-2760FFF59B935E778B43CBEDECAED277" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10119396e2964-wk-Fact-ED2FDEB445955D35BF5C87D8D19E7913" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">52.32</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These repurchases were made under ASR program, which began on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">August&#160;16, 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and was completed on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">October&#160;25, 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10119396e2984-wk-Fact-43C75448B18784DE476A28431463A701" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">8.4</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10119396e2988-wk-Fact-C268C3032B53ABAFA8A428431599DDFC" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">550</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10119396e2992-wk-Fact-204F4B5B852B26E5CBD12843146825AC" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">65.30</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These repurchases include&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10119396e2996-wk-Fact-8072A27A17EF1439060228431462EA03" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="D2018Q3SD_us-gaap_ShareRepurchaseProgramAxis_cah_AcceleratedsharerepurchaseplanMember_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">300</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> purchased under an ASR program, which began on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">February&#160;14, 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and was completed on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;21, 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We repurchased&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10119396e3009-wk-Fact-917D2352F472CCA97ECA28431466F792" name="us-gaap:TreasuryStockSharesAcquired" contextRef="D2018Q3SD_us-gaap_ShareRepurchaseProgramAxis_cah_AcceleratedsharerepurchaseplanMember_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">4.3</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;shares under the ASR at an average price paid per share of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10119396e3013-wk-Fact-85121CC8221C6B2B683C28431467F904" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="D2018Q3SD_us-gaap_ShareRepurchaseProgramAxis_cah_AcceleratedsharerepurchaseplanMember_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">69.26</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Accumulated Other Comprehensive Loss</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="TextSelection-CF729509B5A86AC8BD6A28431669C108-0-wk-Fact-2E894C93FF9041F4B16C284314668155" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:38%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Currency</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Translation</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Adjustments and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain/(Loss) on</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Derivatives,</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Comprehensive</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Loss</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10119396e3153-wk-Fact-CB930A102123859086E92843161732C7" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">113</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10119396e3173-wk-Fact-40627DDF112ADA9E984A28431614DA39" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">21</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10119396e3192-wk-Fact-D8E8AFD70315541DAB84B9798AABD625" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">92</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), net before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10119396e3209-wk-Fact-24EC87234A8D8A3ED2952843161ADF5A" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10119396e3228-wk-Fact-67C3C8CC86EA78380877284316139317" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10119396e3247-wk-Fact-07C63015B5C7C925363B284316177F32" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10119396e3268-wk-Fact-169A10C08CAA0346D1F82843161544F6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10119396e3287-wk-Fact-BE2B857FC0767ED81761284316228DEA" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10119396e3307-wk-Fact-EB43C3887B14E0B998BE28431616C690" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total other comprehensive loss attributable to Cardinal Health, Inc., net of tax of $1 million</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10119396e3329-wk-Fact-169839F20C352024684B2843161045F6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10119396e3348-wk-Fact-6903EBC6F135F3EF5805284316165DFC" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10119396e3368-wk-Fact-5098069C0A2452C487D09C0036D8B533" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10119396e3389-wk-Fact-A6D0AFA11D6B5262973B842E0CCEBA87" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">95</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10119396e3409-wk-Fact-FEB9D27E8B005BBDA69D3FB3DAA25BAC" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10119396e3428-wk-Fact-E7F2C96EB3DC5850A31A36053B97CD6A" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10119396e3450-wk-Fact-343BD056547F52BC8AE3275F2122E5AF" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10119396e3469-wk-Fact-D84CDDF413065882A5A3430B74DE4806" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">23</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10119396e3489-wk-Fact-9651BCE6CB2D526484C5BD61BD71CE69" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10119396e3511-wk-Fact-8CC044C216A95639AF7B6F23C5795A59" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10119396e3530-wk-Fact-54FC3F572B125C07AD6C7E092A17258B" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10119396e3550-wk-Fact-9D053A10F30C501AB1419C51196C985C" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10119396e3572-wk-Fact-2DC9B07F23F53F067A9928431616BC98" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10119396e3591-wk-Fact-B234F583FBDD8979E3F52843161BC07A" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">28</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10119396e3611-wk-Fact-FD89153856515D78A20181F5156EF4E8" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10119396e3638-wk-Fact-7638EBBE5CD856F5BF4C2378BCAC0B97" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">92</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10119396e3658-wk-Fact-A85339E44D995E78A5238B1751D2C751" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10119396e3678-wk-Fact-06D9310609A658858A4EC9F315B685D5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">104</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">72</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s21F643CE4B9755B98C227B05257F54E6"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:EarningsPerShareTextBlock" id="TextSelection-0BC7E70850C47F71D10A2843166920A5-0-wk-Fact-B1D1A521756624C6BF9328431623CC67" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">12. Earnings/(Loss) Per Share Attributable to Cardinal Health, Inc.</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="TextSelection-52C26D66429C9BB1092328431669BAA7-0-wk-Fact-AA7E17C207306814CE9C28431625DA11" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:61%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10130008e2975-wk-Fact-9AE3E593FCE6335F39752843162378C6" name="us-gaap:ProfitLoss" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3,693</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e2995-wk-Fact-DA8A9DB84161C8826F8428431624E0AF" name="us-gaap:ProfitLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,365</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3014-wk-Fact-CB17DEC5A4D0E06152A128431645C61E" name="us-gaap:ProfitLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">259</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings attributable to noncontrolling interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10130008e3030-wk-Fact-59D860CFE7EAD17DA86F284314604AB7" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10130008e3050-wk-Fact-40DF87BBE9A82CD4A06E2843164157A9" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10130008e3070-wk-Fact-2FA51944D462B903C3502843161C2311" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10130008e3097-wk-Fact-D376E4CF10C84B75E68E2843162F9636" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3,696</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3117-wk-Fact-A6793123A202F02F7DDF2843161A0AE7" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,363</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3136-wk-Fact-278090E7B9D1E914F887284316449146" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">256</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10130008e3152-wk-Fact-43211921D8B5D431B24928431628CAD3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2020Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">293</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3171-wk-Fact-F05B0CAA787082C1A64D28431622E9C2" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">300</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3190-wk-Fact-4251EE951E11F5191C4528431624F81D" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">313</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units, and performance share units</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10130008e3273-wk-Fact-4F725EA64F7161215B8677CB8530234E" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="FD2020Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3292-wk-Fact-64785481744F008D89D4284315B047BA" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3311-wk-Fact-F4680ABA2B815576BA3E284315BB5E27" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10130008e3332-wk-Fact-8196072F7E42FDFF1191284314623FA4" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2020Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">293</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3351-wk-Fact-3EE9D56C6B63748AD0EF2843161B9246" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">301</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3370-wk-Fact-45955312A229A57570A7284316286CCF" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">315</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10130008e3396-wk-Fact-AA245B061237350EEC15284316290C1D" name="us-gaap:EarningsPerShareBasic" contextRef="FD2020Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">12.61</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3416-wk-Fact-2F9983D6B6AF648F50342843162BDF25" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">4.55</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3435-wk-Fact-94E9FF2EC52DA96189682843145D91AD" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.82</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10130008e3451-wk-Fact-DA6F10378D87161DA776284316273F14" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2020Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">12.61</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3471-wk-Fact-EAD48A09FC8087EFCA5D284316228D5C" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">4.53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10130008e3490-wk-Fact-0A9184B91DD77CD592422843162338C6" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.81</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10130008e3524-wk-Fact-A2EC6F0B0F972BF53BDE2843162BBA82" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2020Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10130008e3528-wk-Fact-83256237D1255C868538F4145DE8C92E" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10130008e3533-wk-Fact-03DCC59C9A74AB4F47D3A6787B458B32" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, there were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10130008e3541-wk-Fact-EE851B67A763B4E1786077CCF7F90B00" name="cah:Sharesthatwouldbeantidilutiveasaresultofnetloss" contextRef="FD2020Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> potentially dilutive employee stock options, restricted share units and performance share units not included in the computation of diluted loss per common share attributable to Cardinal Health, Inc. because their effect would be anti-dilutive as a result of the net loss for the fiscal year.</span></div></ix:nonNumeric><div><a id="s4B6912BAF1A2559F8537A7BBB757540B"></a></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:SegmentReportingDisclosureTextBlock" id="TextSelection-FD075778DBFAF028C5B4284316692353-0-wk-Fact-05CAEDB77BA89E601629284315FC756F" continuedAt="TextSelection-FD075778DBFAF028C5B4284316692353-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">13. Segment Information</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operations are principally managed on a products and services basis and are comprised of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10148527e2863-wk-Fact-B90E114593CC51829C3D13F56F7DEC04" name="us-gaap:NumberOfOperatingSegments" contextRef="FD2020Q4YTD" unitRef="segment" decimals="0" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Revenue</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates pharmacies, including pharmacies in community health centers, nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, </span></div></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-FD075778DBFAF028C5B4284316692353-1" continuedAt="TextSelection-FD075778DBFAF028C5B4284316692353-2"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">this segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="TextSelection-4E8A090E4A4C4F62827FB50BE49C01A2-0-wk-Fact-74D883C5AAFA9CC3D6FDB50DECC05263" continuedAt="TextSelection-4E8A090E4A4C4F62827FB50BE49C01A2-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue for each reportable segment and Corporate:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:56%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e2983-wk-Fact-C3CDF5C17E6CE10AC8E2951AD4FE36CD" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">137,495</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3002-wk-Fact-6BDEF3281D14D51D97DB9520B43D8899" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">129,917</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3021-wk-Fact-F9D6CA3722064C40B42177CFF220537E" name="us-gaap:Revenues" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">121,241</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3037-wk-Fact-8BA9924FB83D6BC37D26951AD4F6E02E" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15,444</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3056-wk-Fact-34FE0312A02DF0B9523B9520C670168A" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15,633</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3075-wk-Fact-B6867D55E92FEB22F69477D03ADA1622" name="us-gaap:Revenues" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15,581</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3096-wk-Fact-BBAB069DCED743CC7106951AD50F3F1A" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">152,939</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3115-wk-Fact-6D6D9868D1D895A6B1B99520CB13C2A4" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">145,550</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3134-wk-Fact-5AECB952E15DB893D65B77D074446AC1" name="us-gaap:Revenues" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">136,822</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10148527e3155-wk-Fact-773AC6DE960689BFE64B951AD528B3B7" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148527e3175-wk-Fact-3A18C428483A74D9BE3D9520CE0F51C2" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148527e3195-wk-Fact-7E80463645138BBE56E077D0A40E06C1" name="us-gaap:Revenues" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3222-wk-Fact-EC673078FA4FB89EE7BA2843162A4DFB" name="us-gaap:Revenues" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">152,922</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3241-wk-Fact-BD3D8FD103E378282798284316187DCD" name="us-gaap:Revenues" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">145,534</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3260-wk-Fact-DB142B6DA98C5A50ADCB2843162D4777" name="us-gaap:Revenues" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">136,809</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-4E8A090E4A4C4F62827FB50BE49C01A2-1" continuedAt="TextSelection-4E8A090E4A4C4F62827FB50BE49C01A2-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-4E8A090E4A4C4F62827FB50BE49C01A2-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:continuation></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="TextSelection-11F801B19DE243644D6028431669DCE5-0-wk-Fact-ACA56CE8637CE11FF675284315DD77A5" continuedAt="TextSelection-11F801B19DE243644D6028431669DCE5-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="TextSelection-C30188B16B7D77136C042843166A12E6-0-wk-Fact-AB9B64C1F7995090DDC1284315E9D7EA" continuedAt="TextSelection-C30188B16B7D77136C042843166A12E6-1" escape="true"><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:66%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3367-wk-Fact-3EE08EC6A096ECD7C0AB951AD508F9A6" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">136,693</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3381-wk-Fact-A0632A0EFAFD24E9D69D9520A36B85E6" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">129,067</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3396-wk-Fact-C8179CCA6F45B58AEFA2951AD51B4976" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">802</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3410-wk-Fact-B70413B78D9852DB482D9520ACF3D907" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">850</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3430-wk-Fact-C3CDF5C17E6CE10AC8E2951AD4FE36CD" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">137,495</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3444-wk-Fact-6BDEF3281D14D51D97DB9520B43D8899" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">129,917</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (3)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3464-wk-Fact-97C72595945FC33A0715951AD5224F19" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13,429</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3478-wk-Fact-B8E03B5E6B87953031039520B95CFAC0" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13,833</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3498-wk-Fact-37C629CCB6EEDB38B4E6951AD5141C28" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeSolutionsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,015</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3512-wk-Fact-518318057F7EA92950609520C0329AF2" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeSolutionsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,800</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3532-wk-Fact-8BA9924FB83D6BC37D26951AD4F6E02E" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15,444</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3546-wk-Fact-34FE0312A02DF0B9523B9520C670168A" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15,633</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3566-wk-Fact-BBAB069DCED743CC7106951AD50F3F1A" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">152,939</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3580-wk-Fact-6D6D9868D1D895A6B1B99520CB13C2A4" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">145,550</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10148527e3600-wk-Fact-773AC6DE960689BFE64B951AD528B3B7" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148527e3615-wk-Fact-3A18C428483A74D9BE3D9520CE0F51C2" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3641-wk-Fact-EC673078FA4FB89EE7BA2843162A4DFB" name="us-gaap:Revenues" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">152,922</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3655-wk-Fact-BD3D8FD103E378282798284316187DCD" name="us-gaap:Revenues" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">145,534</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services"</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division</span></div></td></tr></table></ix:nonNumeric></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-C30188B16B7D77136C042843166A12E6-1" continuedAt="TextSelection-C30188B16B7D77136C042843166A12E6-2"><ix:continuation id="TextSelection-11F801B19DE243644D6028431669DCE5-1" continuedAt="TextSelection-11F801B19DE243644D6028431669DCE5-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4)</span></div></ix:continuation></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-C30188B16B7D77136C042843166A12E6-2"><ix:continuation id="TextSelection-11F801B19DE243644D6028431669DCE5-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:continuation></ix:continuation></td></tr></table><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="TextSelection-1D18CEFFA8009BB395C4284316695E85-0-wk-Fact-826F847B26F1938F3A8B284315EBC66A" continuedAt="TextSelection-1D18CEFFA8009BB395C4284316695E85-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue by geographic area:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3814-wk-Fact-4ACFB677EF1D3EFF0562284316035233" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">148,707</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3833-wk-Fact-5765A4CE69F83AB6DE2C284315FDC2CF" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">141,479</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3852-wk-Fact-6B450C52911DA389F9B4284315FF537B" name="us-gaap:Revenues" contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">132,539</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3868-wk-Fact-E7A5400131127CE5952D284316054BD1" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4,232</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3887-wk-Fact-1E4BC42AB3FB4AA9866F28431605CB13" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4,071</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3906-wk-Fact-DC7868D2D021593925AF284316019D4B" name="us-gaap:Revenues" contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4,283</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total  segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e3927-wk-Fact-BBAB069DCED743CC7106951AD50F3F1A" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">152,939</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3946-wk-Fact-6D6D9868D1D895A6B1B99520CB13C2A4" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">145,550</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e3965-wk-Fact-5AECB952E15DB893D65B77D074446AC1" name="us-gaap:Revenues" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">136,822</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10148527e3986-wk-Fact-773AC6DE960689BFE64B951AD528B3B7" name="us-gaap:Revenues" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148527e4006-wk-Fact-3A18C428483A74D9BE3D9520CE0F51C2" name="us-gaap:Revenues" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148527e4026-wk-Fact-7E80463645138BBE56E077D0A40E06C1" name="us-gaap:Revenues" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e4053-wk-Fact-EC673078FA4FB89EE7BA2843162A4DFB" name="us-gaap:Revenues" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">152,922</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4072-wk-Fact-BD3D8FD103E378282798284316187DCD" name="us-gaap:Revenues" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">145,534</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4091-wk-Fact-DB142B6DA98C5A50ADCB2843162D4777" name="us-gaap:Revenues" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">136,809</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-1D18CEFFA8009BB395C4284316695E85-1" continuedAt="TextSelection-1D18CEFFA8009BB395C4284316695E85-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-1D18CEFFA8009BB395C4284316695E85-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:continuation></td></tr></table></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">73</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-FD075778DBFAF028C5B4284316692353-2" continuedAt="TextSelection-FD075778DBFAF028C5B4284316692353-3"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Segment Profit</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general, and administrative ("SG&amp;A") expenses. Segment SG&amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial and customer care shared services, human resources, information technology, legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We do not allocate the following items to our segments: last-in first-out, or ("LIFO"), inventory charges/(credits); surgical gown recall costs; state opioid assessment related to prior fiscal years; restructuring and employee severance; amortization and other acquisition-related costs; impairments and (gain)/loss on disposal of assets; litigation (recoveries)/charges, net; other (income)/expense, net; interest expense, net; loss on early extinguishment of debt; gain on sale of equity interest in naviHealth and provision for/(benefit from) income taxes. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10148527e4120-wk-Fact-7A1A7490B3B257D38B13B9C6D34DB933" name="cah:ProjectCostsOnInvestmentAndOtherSpending" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">69</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10148527e4124-wk-Fact-ECFD7929BBBE59A891CD76A63E01F7D0" name="cah:ProjectCostsOnInvestmentAndOtherSpending" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">55</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10148527e4129-wk-Fact-A04483053512E1BC4D65284315F8E21F" name="cah:ProjectCostsOnInvestmentAndOtherSpending" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">43</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the opioid litigation as discussed further in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10148527e4154-wk-Fact-7BEE7B16CCFA59729DF5EFBDE17CAEA0" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-6" scale="9" sign="-" format="ixt:numdotdecimal">5.63</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> which was retained at Corporate. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the surgical gown recall as discussed further in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD2716397D81358C69DCBB2A8D6E9CCCE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10148527e4170-wk-Fact-731D1329BF8F5295AB242044B0F32C30" name="us-gaap:InventoryRecallExpense" contextRef="FD2020Q4YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">85</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> which was retained at Corporate. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the naviHealth divestiture discussed in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s20ab24d9611f400f9fecc35ff4abdad4"><span style="font-family:Arial Narrow;font-size:10pt;">Note 2</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10148527e4186-wk-Fact-4E5C63720C372A7C7130284315F7388D" name="cah:PreTaxGainonDivestiture" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">508</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> which was retained at Corporate.</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the sale of our remaining equity interest in a partnership that owned naviHealth as discussed in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s20ab24d9611f400f9fecc35ff4abdad4"><span style="font-family:Arial Narrow;font-size:10pt;">Note 2</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10148527e4202-wk-Fact-A4954187376CE474EA85A65DF290D3F7" name="us-gaap:GainOnSaleOfInvestments" contextRef="FD2020Q4QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">579</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax gain (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10148527e4206-wk-Fact-F43E5915F710A356B389B477FD2C18A3" name="cah:GainonDivestitureAfterTax" contextRef="FD2020Q4QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">493</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> after tax) during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is included in gain on sale of equity interest naviHealth in the </span><span style="font-family:Arial Narrow;font-size:10pt;">consolidated statements of earnings/(loss) and did not impact segment profit or operating earnings</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="TextSelection-B72C5461438D05FFF94E28431669470D-0-wk-Fact-B011CB9F8B7DEF68A810284315F7A12A" continuedAt="TextSelection-B72C5461438D05FFF94E28431669470D-1" escape="true"><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present segment profit by reportable segment and Corporate:</span></div></ix:nonNumeric></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-FD075778DBFAF028C5B4284316692353-3"><ix:continuation id="TextSelection-B72C5461438D05FFF94E28431669470D-1"><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e4365-wk-Fact-78BB278EF419BD44A0BF951ACA99DA7D" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,753</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4384-wk-Fact-D24F8581ED10E7D0094A951ACAB03F45" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,834</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4403-wk-Fact-BB3DC3CF575F73A3DDC928431600E665" name="us-gaap:OperatingIncomeLoss" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,992</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e4419-wk-Fact-D9EF8167B4D7F596F24B951ACA8DF4F4" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">663</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4438-wk-Fact-F8DFBE5B5F8903585277951ACA93C9F6" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">576</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4457-wk-Fact-3BC18EBC286EA15945B8284315FA0EE3" name="us-gaap:OperatingIncomeLoss" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">662</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e4478-wk-Fact-5AD125C436A3BC5D2110951ACAAA2C60" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,416</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4497-wk-Fact-E9D57FA3E09FC76BE54D951ACAA5D4FD" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,410</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4516-wk-Fact-55EC1B93270CB1529099284315FA1D1F" name="us-gaap:OperatingIncomeLoss" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,654</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10148527e4537-wk-Fact-3010C5009A5F530DA628951ACA871E4B" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">6,514</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148527e4557-wk-Fact-DCF6276FA8829B1CCD8B951ACA8175FD" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148527e4577-wk-Fact-2C6710A80E615781366E284315FEAD9B" name="us-gaap:OperatingIncomeLoss" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2,528</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10148527e4604-wk-Fact-A7B59A36E5F72A058365284316403890" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,098</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4624-wk-Fact-F255B30F4DA9D01D31CE2843162EC039" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,060</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4643-wk-Fact-7CFC054F72252BD96EDA2843162CDB72" name="us-gaap:OperatingIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">126</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:continuation><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" id="TextSelection-61BAE07CEC5EE88710FC2843166ACF77-0-wk-Fact-1436F2F39711A5238125284315DE907D" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e4760-wk-Fact-B3DDF038D48B1D32DF91284315EC7A46" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">135</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4779-wk-Fact-35C2FAF2B5405206C16D284315F66619" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">147</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4798-wk-Fact-8BC09ACB1EDF39D764F0284315E0DD18" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">156</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e4814-wk-Fact-F2E892895AB4DDACB181284315F40628" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">243</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4833-wk-Fact-14127CA03D4668103C7C2843146C4894" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">288</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4852-wk-Fact-22CF41B99E473A9CDE1D284315F33C63" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">278</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e4873-wk-Fact-2CD757E8766C91ABC040284315E9167F" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">535</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4892-wk-Fact-378193F31A22716DED3F284315F0BA73" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">565</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4911-wk-Fact-AC6D7E4087C79593C4BF284315F60ECD" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">598</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total depreciation and amortization</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e4937-wk-Fact-57EDF83A615A6AD362F8284314743364" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">913</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4956-wk-Fact-83DDAE6665350772F68628431483662C" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e4975-wk-Fact-025EC02EAF19C052A2972843148966C8" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,032</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e5078-wk-Fact-A9A23B253F2D6A0AF3D728431630AEC0" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">47</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5097-wk-Fact-D75EC5FACAD4A11E1C6A2843162E6D8F" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5116-wk-Fact-E9B36B52E20B3A8F2A8E2843162F191D" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">58</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e5132-wk-Fact-83D82EBF49DA837E4F392843162D46A3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">86</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5151-wk-Fact-C36A95106E2C8FD312052843162F0D00" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">74</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5170-wk-Fact-C7548E0FB167A43877952843162D4EE5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">127</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e5191-wk-Fact-47CD19C57FE018295D182843162BD36B" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">242</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5210-wk-Fact-D8A6018247D50A4A4E6A2843162E5ED9" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">219</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5229-wk-Fact-4EF6E23E176A95FBF9252843162FA258" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">199</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total additions to property and equipment</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e5255-wk-Fact-5569821F2C7BF16C54C3284315A0F77A" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">375</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5274-wk-Fact-53BD6795C0FB005E6EB728431488D90A" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">328</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5293-wk-Fact-08E32C846E584979DCB328431474D5E4" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">384</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="TextSelection-FA6B32ACB13AE3269CEB28431669E41A-0-wk-Fact-58CD5D0D45E89F5813DB284315E6DFFE" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents total assets for each reportable segment and Corporate at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e5415-wk-Fact-FAE7C86BDC1659AB8D601372A8155930" name="us-gaap:Assets" contextRef="FI2020Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22,398</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5434-wk-Fact-305835B199AD52EDBF4714879B2E1D67" name="us-gaap:Assets" contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22,446</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5453-wk-Fact-1047E59FEE41FF77BE752843146DF82F" name="us-gaap:Assets" contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">21,421</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e5469-wk-Fact-6E2E26B230245966A13702DAACD45126" name="us-gaap:Assets" contextRef="FI2020Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">14,691</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5488-wk-Fact-5042E86A83995598A18C1F623DC4236A" name="us-gaap:Assets" contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15,284</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5507-wk-Fact-44D4F4C302C687030F85284314684258" name="us-gaap:Assets" contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16,066</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e5528-wk-Fact-C0849739F4185EF79795DF2E9F3D0167" name="us-gaap:Assets" contextRef="FI2020Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,677</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5547-wk-Fact-2EE07113D015563AB23B6BA07BA2D4E7" name="us-gaap:Assets" contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,233</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5566-wk-Fact-ABCC7559ED4B4B3A85C32843147090E6" name="us-gaap:Assets" contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,464</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e5592-wk-Fact-0D1C1049F30C5252BA4FAD5427DE72B3" name="us-gaap:Assets" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40,766</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5611-wk-Fact-45315210045352E49355E81E393FAF22" name="us-gaap:Assets" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40,963</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5630-wk-Fact-59FEF2AF6F38D3CD414928431471643F" name="us-gaap:Assets" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39,951</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="TextSelection-4723FF77A2B5913F395D2843166A6302-0-wk-Fact-86F11EA2F277DDDE0DE0284315EAB6AF" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables present property and equipment, net by geographic area:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e5747-wk-Fact-61BE44E966CACD8EE805284315F7A755" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2020Q4_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,880</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5766-wk-Fact-7A42B5A3DE13628584AC284315F3053C" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2019Q4_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,846</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5785-wk-Fact-CC5B1B3B0ED37C56D41F284315EA9796" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2018Q4_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,950</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e5801-wk-Fact-8E63A66DD5F9AE814DB3284315F4EA77" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2020Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">486</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5820-wk-Fact-B68D6FF3317AFA6E355D284315F21A4B" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2019Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">510</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5839-wk-Fact-EE82EEF39305D20F5CFD284315ECE45F" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2018Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">537</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Property and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148527e5865-wk-Fact-022AFBD3623650148594C8C3580F78AF" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,366</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5884-wk-Fact-65BAC2AADAAF5CD58F3560A3DA72CCD6" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,356</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148527e5903-wk-Fact-1EB985FB43D05687F27E284315EEA3C6" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,487</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">74</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sD47735F83E5151799C861160A959DEB5"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8015873015873%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="TextSelection-0E9745B85081B8609E292843166B35F2-0-wk-Fact-02BA9C4BBD21FAC95BAB284315AD6880" continuedAt="TextSelection-0E9745B85081B8609E292843166B35F2-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">14. Share-Based Compensation</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We maintain stock incentive plans (collectively, the &#8220;Plans&#8221;) for the benefit of certain of our officers, directors and employees. At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10159911e2868-wk-Fact-413FF77BE05F667068E0284315B1899B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="FI2020Q4_us-gaap_PlanNameAxis_cah_A2011LtipMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> shares remain available for future grants under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan ("2011 LTIP"). Under the 2011 LTIP's fungible share counting provisions, stock options are counted against the plan as </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">one share for every share issued</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">; awards other than stock options are counted against the plan as </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">two and one-half shares for every share issued</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. This means that only </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10159911e2880-wk-Fact-635B483F96B811A73D13284315AD3995" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="FI2020Q4_us-gaap_AwardTypeAxis_cah_AwardsOtherThanStockOptionsMember_us-gaap_PlanNameAxis_cah_A2011LtipMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> shares could be issued under awards other than stock options while </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10159911e2885-wk-Fact-DFE567A44F49AE81C07F284315AADF32" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_cah_A2011LtipMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> shares could be issued under stock options. Shares are issued out of treasury shares when stock options are exercised and when restricted share units and performance share units vest. </span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="TextSelection-E52CD5EC49FF451857672843166C8507-0-wk-Fact-93A12674EA31D3B36E4E284315F73D55" continuedAt="TextSelection-E52CD5EC49FF451857672843166C8507-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides total share-based compensation expense by type of award:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:60%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e3005-wk-Fact-150E6B1604EC8921D76B284315B7DBC9" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">70</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3024-wk-Fact-B964489CB1C5CF7D76DF284315C0DE04" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">63</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3043-wk-Fact-53DF133EE0C38DC55C87284315CB7018" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">73</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e3059-wk-Fact-C20350B9EAC990CE8683284315BCA3C4" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3078-wk-Fact-CDF04E28835826530798284315B41AA2" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3097-wk-Fact-F757E5A1A8A438D22623284315C63B70" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e3118-wk-Fact-930200C250DEB4034780284315B75B7E" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3137-wk-Fact-5CC63477C4560BABEDF5284315C7F0A1" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10159911e3156-wk-Fact-AEBF175479F690002AE1284315CFBE23" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation expense</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e3183-wk-Fact-7DB978ED2CBE3D24705B284315C09EB3" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">90</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3202-wk-Fact-A36DC376E5C3914563D0284315C3FD92" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">82</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3221-wk-Fact-7C5E9A2BC2446656EC2A284315BD8E16" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">85</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-E52CD5EC49FF451857672843166C8507-1"></ix:continuation>The total tax benefit related to share-based compensation was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10159911e3241-wk-Fact-2FAAA9E46F074CCB0570284315A8B9B7" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10159911e3245-wk-Fact-F5168AAC48A2C5A0FBB1284315AA429D" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d10159911e3249-wk-Fact-9871BB0649BD6135B628284315B09CBC" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">23</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Restricted Share Units</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Restricted share units granted under the Plans generally vest in equal annual installments over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d10159911e3272-wk-Fact-ABD67E191A7A536091BF27BB0A6DCE19" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="TextSelection-5CB15943F843B755FDAA2843166B0B06-0-wk-Fact-86E2D3537E6083207695284315A75FD8" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:52%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Restricted Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3348-wk-Fact-75F7E839E03CC9C8C66E284316325EE7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3367-wk-Fact-89FA4997F35CEE3C55392843163C6AE3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">71.58</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3382-wk-Fact-1862A7713002520980DC2843162CD56A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3396-wk-Fact-8F43E5A0495C5F7963DF284315F8110D" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">50.13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10159911e3416-wk-Fact-10393C06DB042EBF5ED2284316307C72" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3431-wk-Fact-F12B9A5EFB74AF39DB02284316195776" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">74.52</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10159911e3451-wk-Fact-93D3BC066EDE8284066B2843161DB56B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3466-wk-Fact-C6FE4E7F8C1C0C13C21E284315FA3B77" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">62.32</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3486-wk-Fact-C9509EDD7C4953C487EE049CC8D660BF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3500-wk-Fact-4725BFDBB4D752D28E860244A9AB22A1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">51.65</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3520-wk-Fact-7D1041A39BB455699F468480FE79BE2C" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3534-wk-Fact-F7CB85A6AC7C59269B18B8A99DA024B9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">42.71</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10159911e3554-wk-Fact-32184EA33E675E579FC8382BD3C81533" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3569-wk-Fact-54906FE9EBE650959B07815C86D1124B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">60.21</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3589-wk-Fact-005D077437F05DC487E41EBA177AB30B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3603-wk-Fact-F69541D02F7D5E72A9246B119E76FF07" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e3623-wk-Fact-B78A4574EF8A5ACE91538162F008C752" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e3642-wk-Fact-142CCBE7B4065DA9A51DC3AC2A769A0B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">45.92</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-0E9745B85081B8609E292843166B35F2-1" continuedAt="TextSelection-0E9745B85081B8609E292843166B35F2-2"><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" id="TextSelection-E5741612AFBF8CBDACA02843166CBB4A-0-wk-Fact-6B13C65EBD6C42241DA1284315A62F9E" escape="true"><div style="line-height:120%;padding-bottom:5px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table provides additional data related to restricted share unit activity:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:54%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e3756-wk-Fact-5FBC12CE3E685BAF9488D69BBCCFD7DA" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">77</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3775-wk-Fact-7261A945DAAA88875B5C284315FC63D1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">75</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3794-wk-Fact-FF4E7D68FFC9FC0033F8284315FA4416" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">78</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d10159911e3810-wk-Fact-BBD672F6F87351E5A50DB36FDC15A86B" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" format="ixt-sec:duryear">2</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d10159911e3829-wk-Fact-64399945F2E5496E8962284315F6F14D" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" format="ixt-sec:duryear">2</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d10159911e3848-wk-Fact-95DFE17B6221B469CAA7284315F87828" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" format="ixt-sec:duryear">2</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total fair value of shares vested during the year</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e3874-wk-Fact-DE55300541A2EA6DD92B2843160222EA" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">57</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3893-wk-Fact-6483A927284060CFE6F0284315EF60AD" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">68</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e3912-wk-Fact-A2B7267AC2ABC31A918F284315F01E2A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">65</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Stock Options</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Employee stock options granted under the Plans generally vest in equal annual installments over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d10159911e3931-wk-Fact-737B4542D202515C8431F534FC0ABAE6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and are exercisable for a period up to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d10159911e3935-wk-Fact-FD4B81DBE0595C05A542853A316EDCD6" name="cah:ExercisablePeriodOfPlansInYears" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen">ten years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="TextSelection-0E2CC69691E2DE2E422D2843166B0866-0-wk-Fact-ADEAFA84547A466DECFB284315AC4DDC" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all stock option transactions under the Plans:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:57%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Stock</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercise Price per</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Common Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4022-wk-Fact-04FA5693206397C6AC83284315FA94C7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="FI2018Q4" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4041-wk-Fact-93FD3E598F6B428106AC284315F461F5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="FI2018Q4" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">64.50</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4056-wk-Fact-6B3028C20F60A3A90CFF284315F265F3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4070-wk-Fact-E70794C0381D918E8238284315F0C581" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Exercised</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4090-wk-Fact-E7C0F02D471ED9621B21284315FB01EE" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4104-wk-Fact-4F419441803F010317FF284315F24011" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10159911e4124-wk-Fact-D8D931679DBF6900D993284315FDC222" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4139-wk-Fact-A63A16459032782E5753284315FD157E" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">72.54</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4159-wk-Fact-210EAA4DEB3B59B5BDD004953B98F0F6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="FI2019Q4" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4173-wk-Fact-596963E6C2AE5BFA88190462F822D2CC" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="FI2019Q4" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">63.78</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4193-wk-Fact-2BF2751BC7945B6C8366E9F12A437B4F" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="FD2020Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4207-wk-Fact-A8C77787AEE65F4FB6511C0D46B2C93B" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="FD2020Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Exercised</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10159911e4227-wk-Fact-D4E723AAA1BE52A9BB93F0DAC6758EDF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="FD2020Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4242-wk-Fact-54D2509E64F855AEA0021DF97EC6A76D" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="FD2020Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">42.36</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4262-wk-Fact-ACA2B7F003D05E69918AAA2CA4770369" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="FD2020Q4YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4276-wk-Fact-9921B5308FCE5F34AEDCF7178D0F88B0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="FD2020Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Outstanding at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e4296-wk-Fact-5CB45B06BC335CA699C70E942DB31484" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="FI2020Q4" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e4315-wk-Fact-0968FF6934155F67ABE0E6F02D2CE9BA" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="FI2020Q4" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">65.15</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercisable at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e4330-wk-Fact-084C8C1418725006B340F593378FC527" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="FI2020Q4" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e4349-wk-Fact-35C34FF1FB675C46A09A955ACD4185FE" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="FI2020Q4" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">65.25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">75</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8015873015873%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-0E9745B85081B8609E292843166B35F2-2" continuedAt="TextSelection-0E9745B85081B8609E292843166B35F2-3"><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:AdditionalStockOptionPlanDataTableTextBlock" id="TextSelection-7E52B2F0E833E770D4152843166B4746-0-wk-Fact-BFCBA056F1CC9BEE5A79284315AF93A3" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides additional detail related to stock options:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:54%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of outstanding options at period end</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e4474-wk-Fact-F8F4ECBE2347532493DA653C07925C45" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4493-wk-Fact-68962932DD115F39B00658DC307D9DE4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4512-wk-Fact-313F156E1C2C1E9CB5B2284315B595D4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercisable options at period end</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e4528-wk-Fact-2BC887C14988580CB603442FF8199396" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4547-wk-Fact-D2A211314ECC5F6D80D1D3F94F4161B8" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4566-wk-Fact-CB4D0D661C1227EA452028431633B194" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercised options</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e4587-wk-Fact-498891F51D1471D07042284315BE58F7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4606-wk-Fact-292EF46C0DF6022CE9E3284315B103EB" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4625-wk-Fact-1B4031EF6A6B1E117E0328431630DB5E" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">14</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net proceeds/(withholding) from share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e4646-wk-Fact-F284F4582DCDA497FAB1284315B0F219" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">26</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4665-wk-Fact-B862D3094785AD4260AF284315B0B248" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10159911e4684-wk-Fact-642AB5ED58644BD2D12628431631AE9C" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Excess tax benefits from share based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e4706-wk-Fact-8058EEC86F4C8DFEA51E284315BAE892" name="us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4725-wk-Fact-C36C12B512DA4F4F3879284315B3140F" name="us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4744-wk-Fact-9C9D76181A80B41D74B5284315AEDE35" name="us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e4765-wk-Fact-0379BBB58BD25DA5B2B31CB19DFE7230" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4784-wk-Fact-91C4F9E14B8D6FA9AA6928431632A925" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4803-wk-Fact-B3A6FDD10E471E54DD79284316301B49" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total fair value of shares vested during the year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e4824-wk-Fact-55BE7AB76C15A491A1EB28431630A963" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4843-wk-Fact-DC3230356880F95B731F2843162CECE4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4862-wk-Fact-F35B51F08392D8EA0277284316252BED" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average grant date fair value per stock option</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e4888-wk-Fact-FAC8D718ACF686DA61E8284315ACC307" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">8.26</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4907-wk-Fact-2E8B2A8F57AACDE928D728431630FC94" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">8.34</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e4926-wk-Fact-B113C6E90D581942217C28431627DE1A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">13.50</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:RemainingStockOptionPlanDataTableTextBlock" id="TextSelection-9CFBD5538B1B821360A82843166B80D3-0-wk-Fact-BC125AF2B7E2A84A1D39284315A75D9F" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:66%;"></td><td style="width:10%;"></td><td style="width:2%;"></td><td style="width:10%;"></td><td style="width:2%;"></td><td style="width:10%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in years)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of outstanding options</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d10159911e4996-wk-Fact-681EAA3CCC7A597084D5940F78374968" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d10159911e5006-wk-Fact-C978030C8276581FA810CFA857D4CCC9" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d10159911e5016-wk-Fact-B04CC475EAC8FF6CC5BC284316323567" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">7</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of exercisable options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d10159911e5027-wk-Fact-2B882F85D49258838C0B4715F4396E2E" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d10159911e5037-wk-Fact-AEB7914FB9A45387A1B51068393668DF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d10159911e5047-wk-Fact-BA221B7A81B19EEB30E528431631A140" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average period over which stock option compensation cost is expected to be recognized</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d10159911e5058-wk-Fact-320CDF4B825F58B8A586B112DD375363" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">1</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d10159911e5068-wk-Fact-49E3C4B7CD3BFF574F1A28431632C84E" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">1</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d10159911e5078-wk-Fact-C46435AF8B3E34A078C128431630B0ED" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">2</ix:nonNumeric></span></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Until the end of fiscal 2018, stock options were granted to our officers and certain employees. The fair values were estimated on the grant date using a lattice valuation model. We believe the lattice model provides reasonable estimates because it has the ability to take into account individual exercise patterns based on changes in our stock price and other variables, and it provides for a range of input assumptions, which are disclosed in the table below. The risk-free rate is based on the U.S. Treasury yield curve at the time of the grant. We analyzed historical data to estimate option exercise behaviors and employee terminations to be used within the lattice model. The expected life of the options granted was calculated from the option valuation model and represents the length of time in years that the options granted are expected to be outstanding. Expected volatilities are based on implied volatility from traded options on our common shares and historical volatility over a period of time commensurate with the contractual term of the option grant (up to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d10159911e5095-wk-Fact-C505AA130D680F117B00284315A4D4E5" name="cah:ExercisablePeriodOfPlansInYears" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen">ten years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;">). </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">There were no stock options granted to employees during fiscal year </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> or </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. <ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="TextSelection-37106044D6F99D0222372843166C9265-0-wk-Fact-A729FA8FDA20E4C55329284315AB7F2A" continuedAt="TextSelection-37106044D6F99D0222372843166C9265-1" escape="true">The following table provides the range of assumptions used to estimate the fair value of stock options:</ix:nonNumeric></span></div><ix:continuation id="TextSelection-37106044D6F99D0222372843166C9265-1"><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.12345679012346%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:76%;"></td><td style="width:10%;"></td><td style="width:4%;"></td><td style="width:10%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Risk-free interest rate</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5186-wk-Fact-F6FBE752F5E655A22802284315B4BF56" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">2.1</ix:nonFraction>%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Expected volatility</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5207-wk-Fact-0301073A2E1D6184062B284315C2BCF1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">25</ix:nonFraction>%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividend yield</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5228-wk-Fact-59C6F6BAAEE2D98E696D284315BBA094" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">2.7</ix:nonFraction>%</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">-</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5238-wk-Fact-B0667923EA120693BBE6284314606962" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">2.8</ix:nonFraction>%</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Expected life in years</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d10159911e5249-wk-Fact-6C8A338B2A34529740D3284315AEFB22" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">7</ix:nonNumeric></span></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;"><br/></span></div></ix:continuation></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-0E9745B85081B8609E292843166B35F2-3"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Performance Share Units</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Performance share units generally vest over a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">three</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10159911e5314-wk-Fact-9C08A77BDF7C543A90547D25A6115F5E" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="number" decimals="2" scale="-2" format="ixt-sec:numwordsen">zero</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d10159911e5318-wk-Fact-1458231810045FE9BF79B7E5A1A8891D" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">240</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="TextSelection-458A5D6795BEA9FED75E2843166B4257-0-wk-Fact-D48FE830EF3A6FB70285284315A66172" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:51%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Performance</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5420-wk-Fact-6C4748E5D23E7546507C284315C417AB" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5439-wk-Fact-D129CF2F36899B379ABE284315D4AEC4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">66.13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5454-wk-Fact-58AB46548D125763BAE9284315C4300E" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5468-wk-Fact-9947D4B3FA37690D44E0284315D33103" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">50.96</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5488-wk-Fact-F36426B17F3930B3FA4A284315C5AAA6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5502-wk-Fact-3D55CB364E0559E6BC2D284315D96A99" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10159911e5522-wk-Fact-279712A35FE5C2DC9067284315D4F15B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5537-wk-Fact-A7CCFC69D837024E06CC284315CD861A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">52.20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5557-wk-Fact-3F35DCDC64F75101B99DF7951E8F1401" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5571-wk-Fact-7116820D176758BEBEA8981C89AB130B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">51.45</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5591-wk-Fact-EFE975B0095159F7B7A203A26E3765E0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5605-wk-Fact-CF021A229C9D58ABAF258CCAAA1AD015" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">44.03</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10159911e5625-wk-Fact-BDE8A9A3DABC5812913BC664C4F3A995" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5640-wk-Fact-4B74E52F9C9C5DB9B8E48DFB53F196A0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">48.40</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10159911e5660-wk-Fact-48D0DA9A9C015FBE9282755F3A595DFD" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5675-wk-Fact-A6135A848EEB5DD6BABEE20FEAF2713A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">50.92</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e5695-wk-Fact-8AA3D43BF6D4563FA7D9FB69C0B6F024" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e5714-wk-Fact-768171E09C535230907B059EED38413A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">54.24</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q4YTD" name="cah:AdditionalPerformanceShareUnitsDataTableTextBlock" id="TextSelection-035483CD28D067EDEDB52843166B5B03-0-wk-Fact-D2EBDFBC76C29E5C31F0284315A4C0AD" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table provides additional data related to performance share unit activity:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:60%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e5851-wk-Fact-3DF7DD887BFD502EA5D9D540E7E92D50" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">29</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5870-wk-Fact-5EBF16AAECC38C0375D7284315EC14F6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5889-wk-Fact-B73CCC31C12F848DF70D284315F1CA4F" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d10159911e5905-wk-Fact-53CD132D9DB85DB3BB1878D432E4903B" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" format="ixt-sec:duryear">2</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d10159911e5924-wk-Fact-87145B08C4722A640446284315EF63FF" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" format="ixt-sec:duryear">2</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d10159911e5943-wk-Fact-FFB1BD5F6DA8E5AF7F16284315F2C5DA" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" format="ixt-sec:duryear">2</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total fair value of shares vested during the year</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10159911e5969-wk-Fact-CCCFBB6F6AA748441264284315EDCFDA" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e5988-wk-Fact-3D5D3182F33E61C6300C284315EC954D" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10159911e6007-wk-Fact-EE5A8BA232F3F98A6881284315F22588" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">14</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Employee Retirement Savings Plans</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Substantially all of our domestic non-union employees are eligible to be enrolled in our company-sponsored contributory retirement savings plans, which include features under Section 401(k) of the Internal Revenue Code of 1986, and provide for matching and discretionary contributions by us. The total expense for our employee retirement savings plans was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10159911e6026-wk-Fact-D847A36CDF8CC991F1C1284315A92F13" name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">66</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10159911e6030-wk-Fact-278F4D25D7DA6B08912A284315A8B60A" name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">99</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d10159911e6034-wk-Fact-D7BF134819BB98F4F23E284315A3482B" name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">129</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">76</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s502164B9C2795450BCB4EA550B7B3EC3"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8015873015873%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="TextSelection-FD211B76A9FB756DF2322843166C04F5-0-wk-Fact-15D310389967ACB4E64428431638D0B3" continuedAt="TextSelection-FD211B76A9FB756DF2322843166C04F5-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ff0000;font-weight:bold;">15. Selected Quarterly Financial Data (Unaudited)</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ff0000;font-weight:bold;"> </span></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="TextSelection-73E2EB373AB1C5FB8A552843166C1630-0-wk-Fact-8FDA74F56F5598CE02D528431631BBC9" continuedAt="TextSelection-73E2EB373AB1C5FB8A552843166C1630-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following is selected quarterly financial data for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. The sum of the quarters may not equal year-to-date due to rounding.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:40%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">First<br/>Quarter (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Second<br/>Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Third<br/>Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fourth<br/>Quarter (2)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fiscal 2020</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3074-wk-Fact-9F333D5389E65F858DA8284314721358" name="us-gaap:Revenues" contextRef="FD2020Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37,341</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3093-wk-Fact-779FF2039DE032B70B0E284315B0C4E9" name="us-gaap:Revenues" contextRef="FD2020Q2QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39,735</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3112-wk-Fact-85B1CB06276AC43C7F94284316096427" name="us-gaap:Revenues" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39,157</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148526e3132-wk-Fact-926A0DAC21B65AD3AFA151E8E1850C4C" name="us-gaap:Revenues" contextRef="FD2020Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">36,689</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross margin</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3147-wk-Fact-84FA1AB96E2F559DD2A8284316024978" name="us-gaap:GrossProfit" contextRef="FD2020Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,679</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3166-wk-Fact-A2772F7C28D77EB27FC7284314645298" name="us-gaap:GrossProfit" contextRef="FD2020Q2QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,714</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3185-wk-Fact-924020C06DAB730BA1DE284315FCA9C3" name="us-gaap:GrossProfit" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,885</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148526e3205-wk-Fact-65A256B3A08F5E61991D35C9124C0EF4" name="us-gaap:GrossProfit" contextRef="FD2020Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,590</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Distribution, selling, general and administrative expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3225-wk-Fact-9DDD113631F5915A066F2843160870FF" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2020Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,107</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3244-wk-Fact-FD941D4856399AB4C3CF284316005DA5" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2020Q2QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,163</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3263-wk-Fact-BDFE552D487CA424261928431476A913" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,165</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148526e3283-wk-Fact-35E870AF90A55A1C83376EE7FE7B821F" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2020Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,137</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148526e3303-wk-Fact-42B6A32CF1D251009E7B2843160DF85C" name="us-gaap:ProfitLoss" contextRef="FD2020Q1QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,921</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3323-wk-Fact-7144DB4988456ED6C419284316067884" name="us-gaap:ProfitLoss" contextRef="FD2020Q2QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">220</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3342-wk-Fact-B1B38AA9932E76ABD0E32843160D3B25" name="us-gaap:ProfitLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">351</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148526e3362-wk-Fact-1FFCB5FB71275D0F854F493A060AC8C4" name="us-gaap:ProfitLoss" contextRef="FD2020Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">657</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148526e3382-wk-Fact-A909CF9ECCA08491B00328431600D12D" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q1QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3402-wk-Fact-6F3378926DD61B1402B228431477FC70" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q2QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148526e3421-wk-Fact-3809AC150355D1E7B05C28431601A1D5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148526e3442-wk-Fact-575D921A1C0955A3957261704DC9345C" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148526e3463-wk-Fact-4C1788D14931EE035A12284315FB99EA" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q1QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,922</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3483-wk-Fact-D8E7EB0A28B7F1ACD4B8284316118CC5" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q2QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">220</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3502-wk-Fact-ACB834C6B87307952470284315F930CD" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148526e3522-wk-Fact-518C75E08EC4558E9B768F1132044091" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">656</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148526e3711-wk-Fact-6F68CA0AEB4307E338EF284315F11DCE" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="FD2020Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">16.65</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3731-wk-Fact-0E31400111E08726AA0F284315B22D87" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="FD2020Q2QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.75</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3750-wk-Fact-21598021607A7FB6BB7E284315FDA46C" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="FD2020Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148526e3770-wk-Fact-B37E75F1F7FDA5B08788A67A746CA411" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="FD2020Q4QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">2.25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148526e3786-wk-Fact-BFEA375997F21A7AC9B12843147389C7" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="FD2020Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">16.65</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3806-wk-Fact-7AC138190F9644A2F69A284316038C0C" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="FD2020Q2QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.75</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e3825-wk-Fact-039801FAAB67D89E384D284315FADFCE" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="FD2020Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10148526e3845-wk-Fact-92888785DC2936E0946BA67A7537FB13" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="FD2020Q4QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">2.23</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes a </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10148526e3865-wk-Fact-7BEE7B16CCFA59729DF5EFBDE17CAEA0" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-6" scale="9" sign="-" format="ixt:numdotdecimal">5.63</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> pre-tax charge for the opioid litigation (</span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10148526e3869-wk-Fact-3BA3C56106F25C3CBCB9EB04F56E6EB3" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember" unitRef="usd" decimals="-6" scale="9" sign="-" format="ixt:numdotdecimal">5.14</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax). </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes a </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10148526e3880-wk-Fact-A4954187376CE474EA85A65DF290D3F7" name="us-gaap:GainOnSaleOfInvestments" contextRef="FD2020Q4QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">579</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> pre-tax gain (</span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10148526e3884-wk-Fact-F43E5915F710A356B389B477FD2C18A3" name="cah:GainonDivestitureAfterTax" contextRef="FD2020Q4QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">493</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax) in connection with the sale of our remaining equity interest in a partnership that owned naviHealth.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">First<br/>Quarter (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Second<br/>Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Third<br/>Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fourth<br/>Quarter</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fiscal 2019</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4090-wk-Fact-A9D13AFEC9B2FB77D5F828431628505B" name="us-gaap:Revenues" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,213</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4109-wk-Fact-A614E4BD35E45AE2029328431634C20B" name="us-gaap:Revenues" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37,740</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4128-wk-Fact-9DF0D77000B43DFFCC3E2843163855DA" name="us-gaap:Revenues" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,228</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4148-wk-Fact-E7294A8D52405715BC70284314825C7E" name="us-gaap:Revenues" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37,353</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross margin</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4163-wk-Fact-7F1B9B03859768714CAF28431634E21F" name="us-gaap:GrossProfit" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,667</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4182-wk-Fact-9B1A59E0CBC1A3FAFDCC28431631E17C" name="us-gaap:GrossProfit" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,730</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4201-wk-Fact-34D1D7F926C08E5D0A0F284316310380" name="us-gaap:GrossProfit" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,764</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4221-wk-Fact-41DFD00F86411243B76B284316333117" name="us-gaap:GrossProfit" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,674</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Distribution, selling, general and administrative expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4241-wk-Fact-D9158987ADD5433149D12843163468C9" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,155</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4260-wk-Fact-6AD1C589EA74ADC36B4B28431631AC25" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,064</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4279-wk-Fact-A9AABF28B8463E1F5E3A28431633900A" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,097</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4299-wk-Fact-67F296DAB6FA545946C4284315CFAB1E" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,168</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4319-wk-Fact-9DD5337DE48CE56B1363284316308657" name="us-gaap:ProfitLoss" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">594</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4338-wk-Fact-7AE3D5F2DF0C880EF1A8284316363393" name="us-gaap:ProfitLoss" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">281</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4357-wk-Fact-1F757B849937A3FA5D94284316373E3F" name="us-gaap:ProfitLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">296</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4377-wk-Fact-6B98451C47F4F9B39EAA284316362BFE" name="us-gaap:ProfitLoss" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">194</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148526e4397-wk-Fact-D56EF4E6221F6D57BC4F2843163BB234" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10148526e4417-wk-Fact-22551189A97AA637189B284315DC0631" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4437-wk-Fact-4FE20A66245B6CE8C573284316332567" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4457-wk-Fact-6B9AD00563D22853B00A284315D06831" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4477-wk-Fact-BD087FF9909400CF599328431636D82B" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">593</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4496-wk-Fact-2EB20EEB4539A2656022284316370ADD" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">280</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4515-wk-Fact-1685DCCF87FEC6E8AD4928431637A84E" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">296</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4535-wk-Fact-9D64CB9F433201288F302843163477C1" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">194</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4724-wk-Fact-38FA669F0541645B7D8728431631E615" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="FD2019Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.95</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4743-wk-Fact-01E5621503272C101959284316330D85" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="FD2019Q2QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.94</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4762-wk-Fact-50E546EA701EF4115DA3284315D8232A" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="FD2019Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.99</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4782-wk-Fact-A91D9FFF296CF4DB81C628431633AB21" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="FD2019Q4QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.65</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted (3)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4798-wk-Fact-1323B6C40D2E49A606DE28431635CB9C" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="FD2019Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.94</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4817-wk-Fact-266B724350EE75B8A54328431632878F" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="FD2019Q2QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.93</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4836-wk-Fact-F0F09B7D1ED9406C230B28431632F348" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="FD2019Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.99</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10148526e4856-wk-Fact-87A943E4F63ACBE6032928431638B8FA" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="FD2019Q4QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.65</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-73E2EB373AB1C5FB8A552843166C1630-1" continuedAt="TextSelection-73E2EB373AB1C5FB8A552843166C1630-2"><ix:continuation id="TextSelection-FD211B76A9FB756DF2322843166C04F5-1" continuedAt="TextSelection-FD211B76A9FB756DF2322843166C04F5-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></ix:continuation></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-73E2EB373AB1C5FB8A552843166C1630-2"><ix:continuation id="TextSelection-FD211B76A9FB756DF2322843166C04F5-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes a </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10148526e4874-wk-Fact-E1DE1AFCDED5C394D1942843163CB78A" name="cah:PreTaxGainonDivestiture" contextRef="FD2019Q1QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">508</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> gain (</span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10148526e4878-wk-Fact-B8CA76FE5068617C65522843163254B4" name="cah:GainonDivestitureAfterTax" contextRef="FD2019Q1QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">378</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax) related to the naviHealth divestiture.</span></div></ix:continuation></ix:continuation></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">77</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s925BF423E66F57549092D3B86D837E48"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.60317460317461%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Schedule II</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Valuation and Qualifying Accoun</span><span style="font-family:Arial Narrow;font-size:10pt;">ts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:nonNumeric contextRef="FD2020Q4YTD" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="TextSelection-91371D9B7EF18E5DA1512843166C0C7C-0-wk-Fact-72699077A983AECC94BD284315FEDA40" continuedAt="TextSelection-91371D9B7EF18E5DA1512843166C0C7C-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Cardinal Health, Inc. and Subsidiaries</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ff0000;font-weight:bold;">Schedule&#160;II - Valuation and Qualifying Accounts </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:29%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance&#160;at</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Beginning of Period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Charged&#160;to Costs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">and Expenses (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Charged&#160;to</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Other Accounts&#160;(2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Deductions&#160;(3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance&#160;at</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">End of Period</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fiscal 2020</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3113-wk-Fact-F77B919A29D45CF279F8284314635DD1" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">193</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3132-wk-Fact-AFB8CEEAD599B76D323D284315DF579B" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">139</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3151-wk-Fact-4088C845BB43D141593F284315EBCD9F" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10161388e3171-wk-Fact-CF67913C27010DC1EFD628431461472F" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">127</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3191-wk-Fact-F38380296049D80EEE54284315D7BE2E" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">206</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance notes receivable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3206-wk-Fact-B0FEA8F4C381D289FFAC28431479A023" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">14</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3225-wk-Fact-C39DCA928D715F12DA93284315DC94D0" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3244-wk-Fact-9DAD7279BAE1F1CE14D52843162BBF7B" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10161388e3264-wk-Fact-F94C4A1F2DE49CC7AC3928431600B72F" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3284-wk-Fact-560ECF7266B4A2A76257A5D9FD574F9A" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">27</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Sales returns and allowances</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3304-wk-Fact-BEC461849D59104D167E284315E052AF" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">479</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3323-wk-Fact-D83C3E160B892EA8A121284315EBB733" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,253</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3342-wk-Fact-43964B0893A450C82EA528431623ACC7" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10161388e3362-wk-Fact-4491094BD68EE9CDF032284315E514F9" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,237</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3382-wk-Fact-2E309E3F3DD5685386D7284315FFF7EA" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">495</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3402-wk-Fact-31FE6D702B1FBE19D9262843161A5A69" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3421-wk-Fact-28B8C061BCB2383A1F15284315EC1B4F" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3440-wk-Fact-B24ADF0176D341156E07284315E91603" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3460-wk-Fact-C39FE1F174389A15B034284316178175" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3479-wk-Fact-FAA95DFBDAD40473FCA2284315D2EF19" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3504-wk-Fact-46831EDF60EF5DDA9D9A2843161C2BB3" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">687</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3523-wk-Fact-6AA5D952C48C05E9296F28431621B2D4" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,407</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3542-wk-Fact-ACA38F6BA1AEAAFBC095284315DD7C67" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d10161388e3562-wk-Fact-4156B603948078D3560228431623F100" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2020Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,366</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d10161388e3582-wk-Fact-768F2B010B148561326728431621C191" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2020Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">729</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fiscal 2019</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e3806-wk-Fact-2DCB09F6D4C2F3A216F82843162AD6DC" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">139</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e3825-wk-Fact-64F6A80CE4C195DF9A47284315D1DC5A" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">140</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e3844-wk-Fact-D83321AA5B3FB94586A12843160AD4C4" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10161388e3864-wk-Fact-BD085E701D2D9D98368A28431603833E" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">87</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e3884-wk-Fact-F77B919A29D45CF279F8284314635DD1" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">193</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance notes receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e3899-wk-Fact-CE711DF92741B13D379C28431629855F" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e3918-wk-Fact-202D8A23CBEFFA79F1562843162B030E" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e3937-wk-Fact-2D790080FF4701D5C121284315EEBAA9" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10161388e3957-wk-Fact-8CD9EE34C55518C60F2B284315DEB78C" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e3977-wk-Fact-B0FEA8F4C381D289FFAC28431479A023" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">14</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Sales returns and allowances</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e3998-wk-Fact-022084EAC061078ABF7B2843162ACF35" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">479</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4017-wk-Fact-4E465F78B4EEB0D8564B284315CDB0BC" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,205</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4036-wk-Fact-309CBB863A5D99D6E3A52843161E77EF" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10161388e4056-wk-Fact-5F5A07B27AB522AD829F284315E5E8C3" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,205</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4076-wk-Fact-BEC461849D59104D167E284315E052AF" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">479</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4096-wk-Fact-C2F1C1BF2968A3CEBD702843161EC354" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4115-wk-Fact-2AC5B86AF1D632A0708A284315F5B487" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4134-wk-Fact-742B1623FDD6FBABCE0928431624775A" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4154-wk-Fact-E0D94B245766B5545E48284316040B34" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4173-wk-Fact-31FE6D702B1FBE19D9262843161A5A69" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4198-wk-Fact-74E83E48928278AD4FF628431619DE74" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">626</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4217-wk-Fact-4F90DFB0A3F3BCC5E5D3284315E11589" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,353</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4236-wk-Fact-82905ED475C09D718D32284314633167" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10161388e4256-wk-Fact-FC869AAEFDAC48574905284315D08358" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,293</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4276-wk-Fact-46831EDF60EF5DDA9D9A2843161C2BB3" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">687</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fiscal 2018</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4500-wk-Fact-58350DE1E6285ECE1F76284315F8981A" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">137</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4519-wk-Fact-BFF5EF877CD544AB7887284315F9DECA" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">113</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4538-wk-Fact-CF3ACCF5B07B2F1AD18928431618C270" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10161388e4558-wk-Fact-5514592FB1CAFF278ADC2843161D0DDD" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">111</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4578-wk-Fact-2DCB09F6D4C2F3A216F82843162AD6DC" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">139</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance notes receivable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4593-wk-Fact-CEEE9711EE585694D3BD284315DE3392" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10161388e4612-wk-Fact-3391634CA8E227C1E2A62843160782DB" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4632-wk-Fact-8DF2BD4E92C2D27DFAC2284315F2B76B" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4652-wk-Fact-2717026EE586038A5C10284315E388C3" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4671-wk-Fact-CE711DF92741B13D379C28431629855F" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Sales returns and allowances</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4691-wk-Fact-CC02F4DFDDB20B714901284315D6DDCF" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">347</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4710-wk-Fact-5780789841126AD0B394284315E60A55" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,402</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4729-wk-Fact-66AC025BA37F49ED429C284315EC919F" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10161388e4749-wk-Fact-B9A7838D43E7A92F4890284315EF2C70" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,270</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4769-wk-Fact-022084EAC061078ABF7B2843162ACF35" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">479</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4789-wk-Fact-047FC05B62074A188FA22843160E80DD" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4808-wk-Fact-33DED8A28EB733EB6834284315EA4391" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4827-wk-Fact-DE415946A73BB291B79928431617F5FD" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4847-wk-Fact-07DA0F0D2D9E48DF5DF1284315E7B303" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4866-wk-Fact-C2F1C1BF2968A3CEBD702843161EC354" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4891-wk-Fact-1E6F492F070DE6B213BE284315E9654E" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2017Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">494</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4910-wk-Fact-C70BE7C8CB07DDF08C9B2843160EBA70" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,513</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4929-wk-Fact-0BD01C429C3000A35914284315D5A228" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d10161388e4949-wk-Fact-14E78EFF785842D8DC49284315D80BA3" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,381</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d10161388e4969-wk-Fact-74E83E48928278AD4FF628431619DE74" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">626</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fiscal </span><span style="font-family:Arial Narrow;font-size:8pt;">2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, </span><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">2018</span><span style="font-family:Arial Narrow;font-size:8pt;"> include </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10161388e4997-wk-Fact-BC42DF7DEDEF0A0745E2284315FDBDB3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PricingDisputesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">49</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;">, </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10161388e5001-wk-Fact-C6AFE77CA22B6BE89FD3284315F44528" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PricingDisputesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">60</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10161388e5006-wk-Fact-C85076BA4FEB9A7CA944284315EF00F8" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PricingDisputesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;">, respectively, for reserves related to service charges and customer pricing disputes, excluded from provision for bad debts on the consolidated statements of cash flows and classified as a reduction in revenue in the consolidated statements of earnings/(loss).</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Recoveries of amounts provided for or written off in prior years was </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d10161388e5019-wk-Fact-AB40FC6AFB8AE36D164D284315F30170" name="us-gaap:ValuationAllowancesAndReservesRecoveries" contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PriorYearRecoveriesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> in each fiscal year </span><span style="font-family:Arial Narrow;font-size:8pt;">2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, </span><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">2018</span><span style="font-family:Arial Narrow;font-size:8pt;">.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Write-off of uncollectible accounts or actual sales returns.</span></div></td></tr></table></ix:nonNumeric><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><ix:continuation id="TextSelection-91371D9B7EF18E5DA1512843166C0C7C-1">The sum of the components may not equal the total due to rounding.</ix:continuation> </span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">78</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s3C67236E06545A9EBF4D40D9E989AF63"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:45%;"></td><td style="width:34%;"></td><td style="width:21%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Directors, Executive Officers, and Corporate Governance</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Directors, Executive Officers and Corporate Governance</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Information About Our Executive Officers</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following is a list of our executive officers:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:31%;"></td><td style="width:4%;"></td><td style="width:65%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">Name</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">Age</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">Position</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Michael C. Kaufmann</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">57</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Chief Executive Officer</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jason M. Hollar</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">47</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Chief Financial Officer</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Victor L. Crawford</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">59</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Chief Executive Officer, Pharmaceutical segment</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Stephen M. Mason</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">49</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Chief Executive Officer, Medical segment</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Michele A. M. Holcomb</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">52</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Executive Vice President, Strategy and Corporate Development</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Ola M. Snow</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">53</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Chief Human Resources Officer</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jessica L. Mayer</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">51</span></div></td><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Chief Legal and Compliance Officer</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Brian S. Rice</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">57</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Executive Vice President, Chief Information Officer and Customer Support Services</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The business experience summaries provided below for our executive officers describe positions held during the last five years (unless otherwise indicated).</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Mr.&#160;Kaufmann has served as Chief Executive Officer since January 2018. In August 2019, he was also appointed to serve as Interim Chief Financial Officer, and served in that position until September 1, 2019. From November 2014 through December 2017, Mr. Kaufmann served as Chief Financial Officer. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Mr. Hollar has served as Chief Financial Officer since May 2020. Mr. Hollar joined us from Tenneco Inc. ("Tenneco") where he was Executive Vice President and Chief Financial Officer from July 2018. From June 2017 to June 2018, Mr. Hollar served as Senior Vice President Finance at Tenneco. Prior to that, Mr. Hollar served as Chief Financial Officer of Sears Holding Corporation ("Sears") from October 2016 to April 2017 and was Senior Vice President, Finance, at Sears beginning in October 2014. Sears filed for Chapter 11 bankruptcy in October 2018.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Mr. Crawford has served as Chief Executive Officer, Pharmaceutical segment since November 2018. From September 2012 until November 2018, Mr. Crawford served as the Chief Operating Officer, Healthcare, Education, Business Dining for Aramark Corporation.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Mr.&#160;Mason has served as Chief Executive Officer, Medical segment since August 2019. From September 2016 through August 2019, he served as President of our Cardinal Health at-Home Solutions within our Medical segment and from June 2013 until August 2016, he served as the President of our Kinray pharmaceutical distribution business. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Ms. Holcomb has served as Executive Vice President, Strategy and Corporate Development since January 2017. She joined us from Teva Pharmaceutical Industries Ltd., where she served as Senior Vice President, Strategy, Portfolio, Search, and Partnerships and Chief Operating Officer, Global R&amp;D from October 2015 to December 2016 and Senior Vice President, Chief Operating Officer, Global R&amp;D from September 2012 to September 2015.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Ms. Snow has served as Chief Human Resources Officer since October 2018. From January 2016 through September 2018, Ms. Snow served as Senior Vice President, Human Resources, Total Rewards, Talent Acquisition and Corporate Business Partner. From November 2012 to January 2016, she served as the Senior Vice President of Human Resources for the Medical segment.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Ms. Mayer has served as Chief Legal and Compliance Officer since March 2019. Ms. Mayer served as Executive Vice President, Deputy General Counsel and Secretary from September 2017 through March 2019. From December 2015 through September 2017, Ms. Mayer served as Senior Vice President, Deputy General Counsel, and from June 2008 to December 2015, she was Vice President, Managing Counsel.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Mr. Rice has served as Executive Vice President, Chief Information Officer and Customer Support Services since February 2019. From 2009 until the beginning of 2019, Mr. Rice served as Senior Vice President, Chief Information Officer &amp; Global and Business Services for Kellogg Company.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Directors and Corporate Governance</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have adopted </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Standards of Business Conduct</span><span style="font-family:Arial Narrow;font-size:10pt;"> that apply to all of our directors, officers and employees. The </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Standards of Business Conduct</span><span style="font-family:Arial Narrow;font-size:10pt;"> outline our corporate values and standards of integrity and behavior and are designed to protect and promote our reputation. The full text of the </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Standards of Business Conduct</span><span style="font-family:Arial Narrow;font-size:10pt;"> is posted on our website at www.cardinalhealth.com under &#8220;About Us &#8212; Ethics and Compliance.&#8221; </span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">79</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:45%;"></td><td style="width:34%;"></td><td style="width:21%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Directors, Executive Officers, and Corporate Governance</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Any waiver of the </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Standards of Business Conduct</span><span style="font-family:Arial Narrow;font-size:10pt;"> for directors or executive officers must be approved by the Audit Committee. As required under SEC and New York Stock Exchange rules, we will disclose future amendments to our </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Standards of Business Conduct</span><span style="font-family:Arial Narrow;font-size:10pt;"> and waivers from the </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Standards of Business Conduct</span><span style="font-family:Arial Narrow;font-size:10pt;"> for our principal executive officer, principal financial officer, and principal accounting officer, or persons performing similar functions, and our other executive officers and directors on our website within four business days following the date of the amendment or waiver.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The other information called for by Item&#160;10 of Form 10-K is incorporated by reference to our Definitive Proxy Statement (which will be filed with the SEC pursuant to Regulation 14A under the Exchange Act) relating to our 2020 Annual Meeting of Shareholders (our &#8220;2020 Proxy Statement&#8221;) under the captions &#8220;Corporate Governance&#8221; and &#8220;Share Ownership Information.&#8221;</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The other information called for by Item 12 of Form 10-K is incorporated by reference to our 2020 Proxy Statement under the caption "Share Ownership Information."</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">80</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s836DADB5C449535FB68FD62583FB443E"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Exhibits</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;-sec-extract:summary;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Exhibits, Financial Statement Schedules</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">(a)(1) The following financial statements are included in the "Financial Statements" section of this report:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:95%;"></td><td style="width:5%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Page</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Consolidated Financial Statements and Schedule:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s7F3CE990DD1859BF8C1573967BC05AFD">48</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sF7156E578CEB5B2ABF0435CD8BB4D517"><span style="font-family:Arial Narrow;font-size:10pt;">Consolidated Statements of Earnings/(Loss) for the Fiscal Years Ended June&#160;30, 2020, 2019 and 2018</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sF7156E578CEB5B2ABF0435CD8BB4D517">49</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sF50126044E6258F3BDCB7683EEDB8C61"><span style="font-family:Arial Narrow;font-size:10pt;">Consolidated Statements of Comprehensive Income/(Loss) for the Fiscal Years Ended June&#160;30, 2020, 2019 and 2018</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sF50126044E6258F3BDCB7683EEDB8C61">50</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3FA194F7CCCE56278BB2C27FF79EE72B"><span style="font-family:Arial Narrow;font-size:10pt;">Consolidated Balance Sheets at June&#160;30, 2020 and 2019</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s3FA194F7CCCE56278BB2C27FF79EE72B">51</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s2E03441EBB675479ADBCB3C557531AA6"><span style="font-family:Arial Narrow;font-size:10pt;">Consolidated Statements of Shareholders&#8217; Equity for the Fiscal Years Ended June&#160; 30, 2020, 2019 and 2018</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s2E03441EBB675479ADBCB3C557531AA6">52</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sA741D5B2B3175E01B66914E8B178C0CC"><span style="font-family:Arial Narrow;font-size:10pt;">Consolidated Statements of Cash Flows for the Fiscal Years Ended June&#160;30, 2020, 2019 and 2018</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sA741D5B2B3175E01B66914E8B178C0CC">53</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s7F5EE3762E4F50C7A352513C3AD9C48A"><span style="font-family:Arial Narrow;font-size:10pt;">Notes to Consolidated Financial Statements</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s7F5EE3762E4F50C7A352513C3AD9C48A">54</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">(a)(2) The following Supplemental Schedule is included in this report:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:95%;"></td><td style="width:5%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Page</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s925BF423E66F57549092D3B86D837E48"><span style="font-family:Arial Narrow;font-size:10pt;">Schedule II - Valuation and Qualifying Accounts</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s925BF423E66F57549092D3B86D837E48">78</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">All other schedules not listed above have been omitted as not applicable or because the required information is included in the Consolidated Financial Statements or in the Notes thereto.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;text-align:justify;">Exhibit</span></div><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;text-align:justify;">Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">Exhibit Description</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.1.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517127390/d380332dex21.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Stock and Asset Purchase Agreement, dated April 18, 2017, between Cardinal Health, Inc. and Medtronic plc (incorporated by reference to Exhibit 2.1 to Cardinal Health's Current Report on Form 8-K filed on April 18, 2017, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.1.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit222.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Amendment No. 1, dated as of July 28, 2017, to Stock and Asset Purchase Agreement, dated April 18, 2017, between Cardinal Health, Inc. and Medtronic plc (incorporated by reference to Exhibit 2.2.2 to Cardinal Health's Annual Report on Form 10-K for the year ended June 30, 2017, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312508230011/dex31.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Amended and Restated Articles of Incorporation of Cardinal Health, Inc., as amended (incorporated by reference to Exhibit 3.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137119000129/exhibit32-restatedcode.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health, Inc. Restated Code of Regulations (incorporated by reference to Exhibit 3.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 12, 2019, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000095015201504123/l89994aex4-01.txt"><span style="font-family:Arial Narrow;font-size:8pt;">Specimen Certificate for Common Shares of Cardinal Health, Inc. (incorporated by reference to Exhibit 4.01 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2001, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000095015208004364/l31811aexv4w1.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Indenture, dated as of June 2, 2008, between Cardinal Health, Inc. and The Bank of New York Trust Company, N.A. (incorporated by reference to Exhibit 4.1 to Cardinal Health&#8217;s Current Report on Form 8-K filed on June 2, 2008, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312512241732/d351025dex42.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of 3.200% Notes due 2022 (incorporated by reference to Exhibit 4.2 to Cardinal Health's Current Report on Form 8-K filed on May 21, 2012, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312513071020/d490312dex42.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of 3.200% Notes due 2023 (incorporated by reference to Exhibit 4.2 to Cardinal Health's Current Report on Form 8-K filed on February 22, 2013, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.4</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312513071020/d490312dex43.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of 4.600% Notes due 2043 (incorporated by reference to Exhibit 4.3 to Cardinal Health's Current Report on Form 8-K filed on February 22, 2013, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.5</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000270/ex41formof2019note.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of 2.400% Notes due 2019 (incorporated by reference to Exhibit 4.1 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 19, 2014, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.6</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000270/ex42formof2024note.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of 3.500% Notes due 2024 (incorporated by reference to Exhibit 4.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 19, 2014, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.7</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000270/ex43formof2044note.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of 4.500% Notes due 2044 (incorporated by reference to Exhibit 4.3 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 19, 2014, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.8</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312515232063/d941651dex42.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of 3.750% Notes due 2025 (incorporated by reference to Exhibit 4.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on June 23, 2015, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.9</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312515232063/d941651dex43.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of 4.900% Notes due 2045 (incorporated by reference to Exhibit 4.3 to Cardinal Health&#8217;s Current Report on Form 8-K filed on June 23, 2015, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.10</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex42.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of 2.616% notes due 2022 (incorporated by reference to Exhibit 4.2 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.11</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex43.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Floating rate notes due 2022 (incorporated by reference to Exhibit 4.3 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.12</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex44.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of 3.079% notes due 2024 (incorporated by reference to Exhibit 4.4 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.13</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex45.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of 3.410% notes due 2027 (incorporated by reference to Exhibit 4.5 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.2.14</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex46.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of 4.368% notes due 2047 (incorporated by reference to Exhibit 4.6 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</span></a></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">81</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Exhibits</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000095015205007585/l15839aexv4w07.txt"><span style="font-family:Arial Narrow;font-size:8pt;">Agreement to furnish to the Securities and Exchange Commission upon request a copy of instruments defining the rights of holders of certain long-term debt of Cardinal Health, Inc. and consolidated subsidiaries (incorporated by reference to Exhibit 4.07 to Cardinal Health&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended June 30, 2005, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.4</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137119000090/a19q4_10-kx63019xexhibit44.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Description of Securities (incorporated by reference to Exhibit 4.4 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2019, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.1.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312511296273/d241126dex101.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Current Report on Form 8-K/A filed on November 4, 2011, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.1.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000181/a14q4_10kx063014xexhibit1012.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment to Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.2 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2014)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.1.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312511296273/d241126dex102.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Nonqualified Stock Option Agreement under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2 to Cardinal Health&#8217;s Current Report on Form 8-K/A filed on November 4, 2011, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.1.4</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137112000069/a10-kexhibit1013nqso.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Nonqualified Stock Option Agreement under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.3 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2012, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.1.5</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000181/a14q4_10kx063014xexhibit1018.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Restricted Share Units Agreement under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.8 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2014)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.1.6</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312511296273/d241126dex104.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Performance Share Units Agreement under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4 to Cardinal Health's Current Report on Form 8-K/A filed on November 4, 2011, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.1.7</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000154/a13q4_10kx063013xex1019.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Amendment to Stock Option and Restricted Share Units Agreements under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan, the Cardinal Health, Inc. 2005 Long-Term Incentive Plan and the Cardinal Health, Inc. 2007 Nonemployee Directors Equity Incentive Plan (incorporated by reference to Exhibit 10.1.9 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2013, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.2.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137116000353/exhibit101-amendedcardinal.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on November 7, 2016, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.2.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1022.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment to Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2.2 to Cardinal Health's Annual Report on Form 10-K  for the fiscal year end June 30, 2017, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.2.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit102.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Second Amendment to the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 3019, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.2.4</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1023.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Nonqualified Stock Option Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan  (incorporated by reference to Exhibit 10.2.3 to Cardinal Health's Annual Report on Form 10-K  for the fiscal year end June 30, 2017, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.2.5</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1024.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Restricted Share Units Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan  (incorporated by reference to Exhibit 10.2.4 to Cardinal Health's Annual Report on Form 10-K  for the fiscal year end June 30, 2017, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.2.6</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit103.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Restricted Share Units Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporate by reference to Exhibit 10.3 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2019, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.2.7</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1025.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Performance Share Units Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan  (incorporated by reference to Exhibit 10.2.5 to Cardinal Health's Annual Report on Form 10-K  for the fiscal year end June 30, 2017, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.2.8</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000010/a19q2_10qx123118xexhibit104.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Directors Restricted Share Units Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2018, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.3.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312508230011/dex101.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.3.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509229321/dex1011.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment to Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2009, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.3.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509229321/dex1012.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Second Amendment to Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.2 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2009, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.3.4</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000181/a14q4_10kx063014xexhibit1024.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Third Amendment to Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2.4 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2014)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.3.5</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312510198300/dex10111.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Nonqualified Stock Option Agreement under the Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.11 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2010, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.4.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312508020700/dex104.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health, Inc. 2007 Nonemployee Directors Equity Incentive Plan (incorporated by reference to Exhibit 10.4 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December&#160;31, 2007, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.4.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509229321/dex1021.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment to Cardinal Health, Inc. 2007 Nonemployee Directors Equity Incentive Plan (incorporated by reference to Exhibit 10.2.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2009, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.4.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312512042612/d263502dex105.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Second Amendment to the Cardinal Health, Inc. 2007 Nonemployee Directors Equity Incentive Plan (incorporated by reference to Exhibit 10.5 to Cardinal Health's Quarterly Report on Form 10-Q for the Quarter ended December 31, 2011, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.5.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137116000207/a16q2_10qx123115xexhibit101.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Deferred Compensation Plan, as amended and restated effective January 1, 2016 (incorporated by reference to Exhibit 10.1 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2015, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.5.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit101.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment to the Cardinal Health Deferred Compensation Plan, as amended and restated effective as of January 1, 2016 (incorporated by reference to Exhibit 10.1 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.5.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137118000020/a18q2_10qx123117xexhibit102.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Second Amendment, effective as of January 1, 2018, to the Cardinal Health Deferred Compensation Plan, as amended and restated effective as of January 1, 2016 (incorporated by reference to Exhibit 10.2 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2017, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.5.4</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000010/a19q2_10qx123118xexhibit103.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Third Amendment, effective as of April 1, 2018, to the Cardinal Health Deferred Compensation Plan, as amended and restated effective January 1, 2016 (incorporated by reference to Exhibit 10.3 to Cardinal Health's Quarterly Report on Form 10-Q for the Quarter ended December 31, 2018)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.5.6</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit1.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Deferred Compensation Plan, Amended and Restated effective January 1, 2020 (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2019, File No. 1-11373)*</span></a></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">82</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Exhibits</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.6.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137118000088/exhibit101-seniorexecutive.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health, Inc. Senior Executive Severance Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on September 26, 2018, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.6.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit101.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment to the Cardinal Health, Inc. Senior Executive Severance Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2019, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.7</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000095015206006573/l21691aexv10w09.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health, Inc. Policy Regarding Shareholder Approval of Severance Agreements (incorporated by reference to Exhibit 10.09 to Cardinal Health&#8217;s Current Report on Form 8-K filed on August&#160;7, 2006, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.8.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312510198300/dex1015.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Confidentiality and Business Protection Agreement, effective as of February 15, 2010, between Cardinal Health, Inc. and Michael C. Kaufmann (incorporated by reference to Exhibit 10.15 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2010, File&#160;No.&#160;1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.8.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:10px;text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137118000038/a18q3_10qx033118xexhibit102.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Aircraft Time Sharing Agreement, effective as of February 8, 2018, by and between Cardinal Health, Inc. and Michael C. Kaufmann (incorporated by reference to Exhibit 10.2 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.9</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000235/a15q1_10qx093014xexhibit101.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Confidentiality and Business Protection Agreement, effective as of September 9, 2014, between Cardinal Health, Inc. and Jon L. Giacomin (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.10</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137118000020/a18q2_10qx123117xexhibit104.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Confidentiality and Business Protection Agreement, effective as of November 6, 2017, between Cardinal Health, Inc. and Jorge M. Gomez (incorporated by reference to Exhibit 10.4 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2017 , File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.11.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000090/exhibit10131.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Confidentiality and Business Protection Agreement, effective as of November 1, 2018, between Cardinal Health, Inc. and Victor L. Crawford (incorporated by reference to Exhibit 10.13.1 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2019, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.11.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000090/exhibit10132.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Letter Agreement, dated October 30, 2018, between Cardinal Health, Inc. and Victor L. Crawford (incorporated by reference to Exhibit 10.13.2 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2019, File No. 1-11373) *</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.11.4</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000033/exhibit101cfoofferlett.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Letter Agreement, dated March 9, 2020, between Cardinal Health, Inc. and Jason Hollar (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on March 19, 2020, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.11.5</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000033/exhibit102cfocbpagreem.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Confidentiality and Business Protection Agreement, effective as of April 27, 2020, between Cardinal Health, Inc. and Jason Hollar (incorporated by reference to Exhibit 10.2 to Cardinal Health's Current Report on Form 8-K filed on March 19, 2020, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.12</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000095015204007635/l09353bexv10w38.txt"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Indemnification Agreement between Cardinal Health, Inc. and certain individual directors (incorporated by reference to Exhibit 10.38 to Cardinal Health&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended June 30, 2004, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1001.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Issuing and Paying Agency Agreement, dated August 9, 2006, between Cardinal Health, Inc. and The Bank of New York (incorporated by reference to Exhibit 10.01 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2006, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1001.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment to Issuing and Paying Agency Agreement, dated February 28, 2007, between Cardinal Health, Inc. and The Bank of New York (incorporated by reference to Exhibit 10.01 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March 6, 2007, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit102.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Second Amendment to Issuing and Paying Agency Agreement, effective as of December 1, 2016, between Cardinal Health, Inc. and The Bank of New York (incorporated by reference to Exhibit 10.2 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.4</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000145/a18q1_10qx93017xexhibit102.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Third Amendment to Issuing and Paying Agency Agreement, dated September 15, 2017, between Cardinal Health, Inc. and The Bank of New York (incorporated by reference to Exhibit 10.2 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.5</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1002.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Commercial Paper Dealer Agreement, dated August&#160;9, 2006, between Cardinal Health, Inc. and J.P.&#160;Morgan Securities Inc. (incorporated by reference to Exhibit 10.02 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2006, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.6</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1002.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment to Commercial Paper Dealer Agreement, dated February 28, 2007, between Cardinal Health, Inc. and J.P. Morgan Securities Inc. (incorporated by reference to Exhibit 10.02 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March 6, 2007, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.7</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit104.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Second Amendment to Commercial Paper Dealer Agreement, effective as of December 31, 2012, between Cardinal Health, Inc. and J.P. Morgan Securities LLC (formerly known as J.P. Morgan Securities Inc.) (incorporated by reference to Exhibit 10.4 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.8</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit106.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and J.P. Morgan Securities LLC, effective as of December 1, 2016 (incorporated by reference to Exhibit 10.6 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.9</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1003.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Commercial Paper Dealer Agreement, dated August 9, 2006, between Cardinal Health, Inc. and Banc of America Securities LLC (incorporated by reference to Exhibit 10.03 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2006, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.10</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1003.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment to Commercial Paper Dealer Agreement, dated February&#160;28, 2007, between Cardinal Health, Inc. and Banc of America Securities LLC (incorporated by reference to Exhibit&#160;10.03 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March&#160;6, 2007, File&#160;No.&#160;1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.11</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit105.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Second Amendment to Commercial Paper Dealer Agreement, effective as of December 31, 2012, between Cardinal Health, Inc. and Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, f/k/a Banc of America Securities LLC (incorporated by reference to Exhibit 10.5 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.12</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit103.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, effective as of December 1, 2016 (incorporated by reference to Exhibit 10.3 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.13</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1004.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Commercial Paper Dealer Agreement, dated August 9, 2006, between Cardinal Health, Inc. and Wachovia Capital Markets, LLC (incorporated by reference to Exhibit 10.04 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2006, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.14</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1004.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment to Commercial Paper Dealer Agreement, dated February 28, 2007, between Cardinal Health, Inc. and Wachovia Capital Markets, LLC (incorporated by reference to Exhibit&#160;10.04 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March 6, 2007, File&#160;No.&#160;1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.15</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit106.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Second Amendment to Commercial Paper Dealer Agreement, effective as of December 31, 2012, between Cardinal Health, Inc. and Wells Fargo Securities, LLC, as successor in interest to Wachovia Capital Markets, LLC (incorporated by reference to Exhibit 10.6 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.16</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit105.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and Wells Fargo Securities, LLC, effective as of December 1, 2016 (incorporated by reference to Exhibit 10.5 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.17</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1005.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Commercial Paper Dealer Agreement, dated August&#160;9, 2006, between Cardinal Health, Inc. and Goldman, Sachs &amp; Co. (incorporated by reference to Exhibit 10.05 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2006, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.18</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1005.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment to Commercial Paper Dealer Agreement, dated February 28, 2007, between Cardinal Health, Inc. and Goldman, Sachs &amp; Co. (incorporated by reference to Exhibit 10.05 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March 6, 2007, File No. 1-11373)</span></a></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">83</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Exhibits</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.19</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit107.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Second Amendment to Commercial Paper Dealer Agreement, effective as of December 31, 2012, between Cardinal Health, Inc. and Goldman, Sachs &amp; Co. (incorporated by reference to Exhibit 10.7 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.20</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit104.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and Goldman Sachs &amp; Co., effective as of December 1, 2016 (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.21</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509083079/dex102.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of Commercial Paper Dealer Agreement between Cardinal Health, Inc. and SunTrust Robinson Humphrey, Inc. (incorporated by reference to Exhibit 10.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on April 21, 2009, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.22</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit108.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Form of First Amendment to Commercial Paper Dealer Agreement between Cardinal Health, Inc. and SunTrust Robinson Humphrey, Inc. (incorporated by reference to Exhibit 10.8 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.13.23</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit107.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and SunTrust Robinson Humphrey, Inc., effective as of December 1, 2016 (incorporated by reference to Exhibit 10.7 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.14</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000042/ex101secondamendedandresta.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Second Amended and Restated Five-Year Credit Agreement, dated as of June 27, 2019, among JPMorgan Chase Bank, N.A. as Administrative Agent, Joint Lead Arranger and Joint Book Manager, Bank of America, N.A. as Syndication Agent, MUFG Bank, Ltd. as Syndication Agent, Joint Lead Arranger and Joint Book Manager, Barclays Bank PLC, Deutsche Bank AG New York Branch, Goldman Sachs Bank USA, HSBC Bank USA, N.A. and Wells Fargo Bank, N.A., as Documentation Agents, and BOFA Securities, Inc., as Joint Lead Arranger and Joint Book Manager (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on June 28, 2019, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.15.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000179/a14q1_10qx093013xexhibit101.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013, among Cardinal Health Funding, LLC, as Seller, Griffin Capital, LLC, as Servicer, the Conduits party thereto, the Financial Institutions Party thereto, the Managing Agents party thereto, and LC Banks party thereto and the Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the Agent (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.15.2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000235/a15q1_10qx093014xexhibit103.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment and Joinder, dated as of November 3, 2014, to the Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013 (incorporated by reference to Exhibit 10.3 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.15.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:10px;text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000145/a18q1_10qx093017xexhibit1043.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Second Amendment, dated as of November 14, 2016, to the Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013 (incorporated by reference to Exhibit 10.4.3 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.15.4</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000110/a83117_8kxex101.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Third Amendment, dated as of August 30, 2017, to the Fourth Amended and Receivables Purchase Agreement, dated as of November 1, 2013 (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on August 31, 2017, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.15.5</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137119000109/ex101_4thamendmentjoindert.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Fourth Amendment and Joinder, dated September 30, 2019, to the Fourth Amended and Restated Receivables Purchase Agreement (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on October 2, 2019, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.16.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000145/a18q1_10qx093017xexhibit1051.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Seventh Amended and Restated Performance Guaranty, dated as of November 14, 2016, executed by Cardinal Health, Inc. in favor of Cardinal Health Funding, LLC (incorporated by reference to Exhibit 10.5.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.16.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000145/a18q1_10qx93017xexhibit1052.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Amendment No. 1 to Seventh Amended and Restated Performance Guaranty, dated as of November 14, 2016 (incorporated by reference to Exhibit 10.5.2 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, File No. 1-11373</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.16.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137118000100/a19q1_10qx93018xexhibit104.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Amendment No. 2 to Seventh Amended and Restated Performance Guaranty, dated as of November 6, 2018 (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report on Form 10-Q for the Quarter ended September 30, 2018, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.16.4</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137119000109/ex102_3rdamendmentto7tharp.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Amendment No. 3 to Seventh Amended and Restated Performance Guaranty (incorporated by reference to Exhibit 10.2 to Cardinal Health's Current Report on Form 8-K filed October 2, 2019, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.17.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509187778/dex103.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Tax Matters Agreement, dated as of August 31, 2009, by and between Cardinal Health, Inc. and CareFusion Corporation (incorporated by reference to Exhibit 10.3 to Cardinal Health&#8217;s Current Report on Form 8-K filed on September 4, 2009, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.17.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137112000069/a10-kexhibit102021stamendt.htm"><span style="font-family:Arial Narrow;font-size:8pt;">First Amendment to Tax Matters Agreement, dated as of May 28, 2012, by and between Cardinal Health, Inc. and CareFusion Corporation (incorporated by reference to Exhibit 10.20.2 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2012, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">21.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q410k63020exhibit211.htm"><span style="font-family:Arial Narrow;font-size:8pt;">List of Subsidiaries of Cardinal Health, Inc.</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">23.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q410k63020exhibit231.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Consent of Independent Registered Public Accounting Firm</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">31.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q410k63020exhibit311.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">31.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q410k63020exhibit312.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">32.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q410k63020exhibit321.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">99.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q410k63020exhibit991.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Statement Regarding Forward-Looking Information</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.INS</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Instance Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.SCH</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Extension Schema Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.CAL</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.DEF</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Definition Linkbase Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.LAB</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.PRE</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">104</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cover Page Interactive Data File - formatted in Inline XBRL (included as Exhibit 101)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">* Management contract or compensatory plan or arrangement.</span></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">84</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s4FD952D373C65C1E8C00962F94F20840"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:29%;"></td><td style="width:47%;"></td><td style="width:24%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Form 10-K Cross Reference Index</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Form 10-K Cross Reference Index</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:5%;"></td><td style="width:88%;"></td><td style="width:7%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Item</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Page(s)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Part 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s64B4883BB1AB5C45A2F86FABE0A8B842"><span style="font-family:Arial Narrow;font-size:10pt;">Business</span></a><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s64B4883BB1AB5C45A2F86FABE0A8B842">26</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">1A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sB887CB0119C25A08BEA9BE55BDBCD36D"><span style="font-family:Arial Narrow;font-size:10pt;">Risk Factors</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sB887CB0119C25A08BEA9BE55BDBCD36D">33</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">1B</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Unresolved Staff Comments </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s38B7FE605CD85F5ABED26E8E13F7E935"><span style="font-family:Arial Narrow;font-size:10pt;">Properties</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s38B7FE605CD85F5ABED26E8E13F7E935">40</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s2AE08030210259CCAE9BFFC1DD370010"><span style="font-family:Arial Narrow;font-size:10pt;">Legal Proceedings</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s2AE08030210259CCAE9BFFC1DD370010">40</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">4</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Mine Safety Disclosures </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Part II</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">5</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s38459D2E4A45535DA3214D65091BE252"><span style="font-family:Arial Narrow;font-size:10pt;">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s38459D2E4A45535DA3214D65091BE252">41</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">6</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sAD9595E6A7565841838053780BA1B0B4"><span style="font-family:Arial Narrow;font-size:10pt;">Selected Financial Data</span></a><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sAD9595E6A7565841838053780BA1B0B4">23</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">7</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s8FE50BC6625E53A7A2EBD36A964A3F58"><span style="font-family:Arial Narrow;font-size:10pt;">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s8FE50BC6625E53A7A2EBD36A964A3F58">3</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">7A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s333C75A276DE55268DA27780A098DE09"><span style="font-family:Arial Narrow;font-size:10pt;">Quantitative and Qualitative Disclosures about Market Risk</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s333C75A276DE55268DA27780A098DE09">24</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">8</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s7F3CE990DD1859BF8C1573967BC05AFD"><span style="font-family:Arial Narrow;font-size:10pt;">Financial Statements and Supplementary Data</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s7F3CE990DD1859BF8C1573967BC05AFD">48</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">9</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">9A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s5B394966EB4C511684797CFE02614449"><span style="font-family:Arial Narrow;font-size:10pt;">Controls and Procedures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s5B394966EB4C511684797CFE02614449">43</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">9B</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Other Information </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Part III</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">10</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3C67236E06545A9EBF4D40D9E989AF63"><span style="font-family:Arial Narrow;font-size:10pt;">Directors, Executive Officers and Corporate Governance </span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s3C67236E06545A9EBF4D40D9E989AF63">79</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">11</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Executive Compensation </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">(a)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">12</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">(b)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">13</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Certain Relationships and Related Transactions, and Director Independence </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">(c)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">14</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Principal Accounting Fees and Services</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">(d)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Part IV</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">15</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s836DADB5C449535FB68FD62583FB443E"><span style="font-family:Arial Narrow;font-size:10pt;">Exhibits, Financial Statement Schedules</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s836DADB5C449535FB68FD62583FB443E">81</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">16</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Form 10-K Summary</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sEF38C628ED485BCE881358888B51576D"><span style="font-family:Arial Narrow;font-size:10pt;">Signatures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sEF38C628ED485BCE881358888B51576D">86</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:4%;"></td><td style="width:48%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Not applicable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(a)</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The information called for by Item 11 of Form 10-K is incorporated by reference to our 2020 Proxy Statement under the captions &#8220;Corporate Governance&#8221; and &#8220;Executive Compensation.&#8221;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(b)</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The information called for by Item 12 of Form 10-K is incorporated by reference to our 2020 Proxy Statement under the caption "Executive Compensation."</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(c)</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The information called for by Item 13 of Form 10-K is incorporated by reference to our 2020 Proxy Statement under the caption "Corporate Governance."</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(d)</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The information called for by Item 14 of Form 10-K is incorporated by reference to our 2020 Proxy Statement under the caption &#8220;Audit Committee Matters.&#8221;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">85</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="sEF38C628ED485BCE881358888B51576D"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.40944881889764%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Signatures</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Signatures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on </span><span style="font-family:Arial Narrow;font-size:10pt;">August&#160;13, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:55%;"></td><td style="width:4%;"></td><td style="width:41%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">By:</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;MICHAEL C. KAUFMANN</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Michael C. Kaufmann</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Chief Executive Officer </span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed below by the following persons on behalf of the registrant and in the capacities indicated on </span><span style="font-family:Arial Narrow;font-size:10pt;">August&#160;13, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:672px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:248px;"></td><td style="width:24px;"></td><td style="width:400px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;text-decoration:underline;">Name</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;text-decoration:underline;">Title</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;&#160;MICHAEL C. KAUFMANN</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Chief Executive Officer and Director (principal executive officer)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Michael C. Kaufmann</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="text-align:justify;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;&#160;JASON M. HOLLAR</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Chief Financial Officer (principal financial officer)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Jason M. Hollar</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;&#160;STUART G. LAWS</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Senior Vice President and Chief Accounting Officer (principal accounting officer)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Stuart G. Laws</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:20px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;&#160;COLLEEN F. ARNOLD</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Director</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:20px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Colleen F. Arnold</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/ CARRIE S. COX</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Director</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Carrie S. Cox</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;&#160;CALVIN DARDEN</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Director</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Calvin Darden</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;&#160;BRUCE L. DOWNEY</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Director</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Bruce L. Downey</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;DAVID C. EVANS</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Director</span></div><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">David C. Evans</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;&#160;PATRICIA A. HEMINGWAY HALL</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Director</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Patricia A. Hemingway Hall</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;&#160;AKHIL JOHRI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Director</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Akhil Johri</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;GREGORY B. KENNY</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Director</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Gregory B. Kenny</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/    NANCY KILLEFER</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Director</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Nancy Killefer</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;&#160;J. MICHAEL LOSH</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Director</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">J. Michael Losh</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;&#160;DEAN A. SCARBOROUGH</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Director</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Dean A. Scarborough</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">/s/&#160;&#160;&#160;&#160;JOHN H. WEILAND</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Director</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">John H. Weiland</span></div><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Fiscal 2020 Form 10-K</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">86</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>a20q410k63020exhibit211.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sBA24816442FB5FAD92975D8F4CCA144B"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 21.1</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Subsidiaries of the Registrant</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Listed below are majority-owned subsidiaries of Cardinal Health, Inc. as of </font><font style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</font><font style="font-family:Arial Narrow;font-size:10pt;">.  Subsidiaries excluded from the list below would not, considered in the aggregate as a single subsidiary, constitute a &#8220;significant subsidiary&#8221; of Cardinal Health, Inc. as that term is defined in Rule 1-02(w) of SEC Regulation S-X.</font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:317px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:228px;"></td><td style="width:5px;"></td><td style="width:84px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Subsidiary Name</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">State/Jurisdiction</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">of Incorporation</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">A+ Secure Packaging, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Tennessee</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Access Closure, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">California</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Aero-Med, Ltd.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Connecticut</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Allegiance Corporation</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">AssuraMed, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 2, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nevada</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 3, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 5, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 6, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nevada</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 7, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 100, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Indiana</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 104 LP</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ohio</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 105, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ohio</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 107, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ohio</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 108, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 110, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 112, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 113, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Wisconsin</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 114, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 115, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ohio</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 116, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 118, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 119, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 121, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 122, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 123, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 124, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 126, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 127, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Kansas</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 200, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 201, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 222 (Thailand) Ltd.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Thailand</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 247, Inc. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Colorado</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 249, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health 414, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Australia 503 Pty. Ltd.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Australia</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Austria 504 GmbH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Austria</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Belgium 505 BVBA</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Belgium</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Canada Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Canada</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Canada Holdings Cooperative U.A.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Netherlands</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Chile Limitada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Chile</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Colombia S.A.S.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Colombia</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health do Brasil Ltd.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Brazil</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health D.R. 203 II Ltd.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Bermuda</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Denmark ApS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Denmark</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Finland Oy</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Finland</font></div></td></tr></table></div></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:317px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:228px;"></td><td style="width:5px;"></td><td style="width:84px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Subsidiary Name</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">State/Jurisdiction</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">of Incorporation</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Foundation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ohio</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health France 506 SAS</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">France</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Funding, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nevada</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Germany 507 GmbH</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Germany</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Germany Manufacturing GmbH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Germany</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health International Philippines, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Philippines</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health IPS, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Ireland 419 Designated Activity Company</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ireland</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Ireland 508 Limited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ireland</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Ireland Unlimited Company</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ireland</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Italy 509 Srl</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Italy</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Japan G.K.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Japan</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Korea Limited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Korea</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Malaysia 211 Sdn. Bhd.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Malaysia</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Malta 212 Limited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Malta</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Managed Care Services, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Medical Products India Private Limited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">India</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Mexico 244 S. de R.L. de C.V.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Mexico</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Mexico 514 S. de R.L. de C.V.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Mexico</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Middle East FZ-LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">United Arab Emirates</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Netherlands 502 B.V.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Netherlands</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Norway AS</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Norway</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Pharmaceutical Contracting, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Pharmacy Services, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Poland Sp&#243;&#322;lka z ograniczon&#261;a odpowiedzialno&#347;sci&#261;a</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Poland</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Portugal 513 Unipessoal Lda.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Portugal</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health P.R. 120, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Puerto Rico</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health P.R. 218, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Puerto Rico</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health P.R. 220, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Puerto Rico</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Singapore 225 Pte. Ltd.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Singapore</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Spain 511 S.L.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Spain</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Specialty Pharmacy, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Sweden 512 A.B.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Sweden</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Switzerland 515 GmbH</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Switzerland</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Systems, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ohio</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Technologies, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nevada</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Technologies Switzerland GmbH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Switzerland</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health U.K. 432 Limited</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">United Kingdom</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Medical Equipment Consulting (Shanghai) Co., Ltd.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">China</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cirpro de Delicias S.A. de C.V.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Mexico</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Convertors de Mexico S.A. de C.V.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Mexico</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cordis Cashel Company Unlimited</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ireland</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cordis Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Florida</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cordis (Shanghai) Medical Devices Co., Ltd.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">China</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cornerstone Partners G.P.O., L.P.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Tennessee</font></div></td></tr></table></div></div></div></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><br></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:317px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:228px;"></td><td style="width:5px;"></td><td style="width:84px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Subsidiary Name</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">State/Jurisdiction</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">of Incorporation</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Covidien Manufacturing Solutions, S.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Costa Rica</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Curaspan Health Group, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">EPIC Insurance Company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Vermont</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Especialidades Medicas Kenmex S.A. de C.V.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Mexico</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Griffin Capital, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nevada</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Innovative Therapies, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Instant Diagnostic Systems, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Alabama</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Kendall Patient Recovery BVBA</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Belgiuum</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Kendall-Gammatron Limited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Thailand</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">KPR Australia Pty. Ltd.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Australia</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">KPR Italia S.r.l.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Italy</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">KPR Switzerland Sales Gmbh</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Switzerland</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">KPR U.S., LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Leader Drugstores, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Limited Liability Company "Cardinal Health Russia"</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Russian Federation</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ludlow Technical Products Canada, Ltd.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Canada</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Marin Apothecaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">California</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medicine Shoppe International, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Mediquip Sdn. Bhd.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Malaysia</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Mirixa Corporation</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">mscripts, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">mscripts Systems India Private Limited</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">India</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nippon Covidien Ltd.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Japan</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">One Cloverleaf, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Outcomes Incorporated</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Iowa</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pinnacle Intellectual Property Services, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nevada</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pinnacle Intellectual Property Services-International, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nevada</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Post-Acute Care Center for Research, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Quiroproductos de Cuauhtemoc S. de R.L. de C.V.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Mexico</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">R Cubed, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Tennessee</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">RainTree GPO, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Renal Purchasing Group, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Tennessee</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">RGH Enterprises, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ohio</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Rxealtime, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nevada</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Sonexus Health, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Texas</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">TelePharm, LLC</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Iowa</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The Harvard Drug Group, L.L.C.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Michigan</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Tradex International, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#acacac;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Ohio</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">WaveMark, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Delaware</font></div></td></tr></table></div></div></div></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>a20q410k63020exhibit231.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sF7ED75D1B1CE59B5B6F25675AE6BF3EE"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 23.1</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Consent of Independent Registered Public Accounting Firm </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We consent to the incorporation by reference in the following Registration Statements: </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Registration Statement on Form S-3 No.&#160;333-233377 of Cardinal Health, Inc., </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Registration Statements on Form S-4 No.&#160;333-62938 and No.&#160;333-74761 of Cardinal Health, Inc., and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Registration Statements on Form S-8 No.&#160;33-42357, No.&#160;333-90423, No.&#160;333-38192, No.&#160;333-38198, No.&#160;333-56010, No.&#160;333-129725, No.&#160;333-149107, No.&#160;333-155156, No.&#160;333-163128, No.&#160;333-164736, No. 333-177728, No. 333-183471, No.&#160;333-206339, No.&#160;333-206340, No. 333-214412, No. 333-219892, and 333-233380 of Cardinal Health, Inc.; </font></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">of our reports dated </font><font style="font-family:Arial Narrow;font-size:10pt;">August&#160;13, 2020</font><font style="font-family:Arial Narrow;font-size:10pt;">, with respect to the consolidated financial statements and schedule of Cardinal Health, Inc. and subsidiaries and the effectiveness of internal control over financial reporting of Cardinal Health, Inc. and subsidiaries, included in this Annual Report (Form 10-K) of Cardinal Health, Inc. and subsidiaries for the year ended June&#160;30, 2020.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.81481481481482%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:37%;"></td><td style="width:63%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ Ernst&#160;&amp; Young LLP</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Grandview Heights, Ohio</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">August&#160;13, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>a20q410k63020exhibit311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sD5C56FCB79BE552ABAC43BE328E22B86"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 31.1</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I, </font><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann</font><font style="font-family:Arial Narrow;font-size:10pt;">, certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I have reviewed this Form 10-K of Cardinal Health, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Date: </font><font style="font-family:Arial Narrow;font-size:10pt;">August&#160;13, 2020</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:627px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:198px;"></td><td style="width:428px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ MICHAEL C. KAUFMANN</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Executive Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>a20q410k63020exhibit312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s044F34F1444153C787EBABBEE5F94A7A"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 31.2</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I, Jason M. Hollar, certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I have reviewed this Form 10-K of Cardinal Health, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Date: </font><font style="font-family:Arial Narrow;font-size:10pt;">August&#160;13, 2020</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:184px;"></td><td style="width:498px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/</font><font style="font-family:Arial Narrow;font-size:9pt;">&#160;JASON M. HOLLAR</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Jason M. Hollar</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Financial Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>a20q410k63020exhibit321.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s1AA02D9D005F54C7BA83807E4149D7F4"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 32.1</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Certification of the Chief Executive Officer and the Chief Financial Officer Pursuant to 18 U.S.C. Section&#160;1350, as Adopted </font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann, Chief Executive Officer of Cardinal Health, Inc. (the &#8220;Company&#8221;) and Jason M. Hollar, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the Annual Report on Form 10-K for the fiscal year ended June 30, 2020 containing the financial statements of the Company (the &#8220;Periodic Report&#8221;), which this statement accompanies, fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Dated: </font><font style="font-family:Arial Narrow;font-size:10pt;">August&#160;13, 2020</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:70%;"></td><td style="width:30%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ MICHAEL C. KAUFMANN</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Executive Officer </font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:70%;"></td><td style="width:30%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ JASON M. HOLLAR</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Jason M. Hollar</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>a20q410k63020exhibit991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s5E14AF1CBCA9551995B584B8E792CDA9"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 99.1</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;font-weight:bold;">Statement Regarding Forward-Looking Information </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">As used in this exhibit, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and similar pronouns refer to Cardinal Health, Inc. and its subsidiaries, unless the context requires otherwise. Our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2020 (the &#8220;2020 Form 10-K&#8221;), our quarterly reports on Form 10-Q, and our current reports on Form 8-K (along with any exhibits and amendments to such reports), as well as our news releases or any other written or oral statements made by or on behalf of us, including materials posted on our website, may include, directly or by incorporation by reference, forward-looking statements that reflect our current view (as of the date the forward-looking statement is first made) about future events, prospects, projections or financial performance. The matters discussed in these forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied in or by such statements. These risks and uncertainties include:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from the COVID-19 pandemic, including the possibility that our manufacturing or distribution facilities will be required to cease operations, whether from government regulation in the United States or internationally, or from reduction in available workforce due to illness; the possibility that we could experience significant  delays or disruptions in our supply of medical or pharmaceutical products resulting in an inability to fulfill customer demand; the risk that we will not be able to offset significant cost increases or that and price increases for these products could result in lost sales or customer losses or disputes; the possibility that the widespread required cancellation or deferral of elective medical procedures will result in a sustained reduction in demand for our products; and the potential for us to receive negative publicity resulting from prolonged supply shortages or our participation in industry-wide collaboration to increase the supply of personal protective equipment in the United States; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">competitive pressures in the markets in which we operate, including pricing pressures;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to the pricing of generic pharmaceuticals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to the timing, frequency and profitability of generic pharmaceutical launches;  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to maintain the benefits of our generic pharmaceutical sourcing venture with CVS Health Corporation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">with respect to our distribution services agreements with branded pharmaceutical manufacturers, changes in the amount of service fees we receive or, in cases where part of our compensation under these agreements is based on branded pharmaceutical price appreciation, changes in the frequency or magnitude of such price appreciation; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in manufacturer approaches to pricing branded pharmaceutical products and risks related to our compensation under contractual arrangements with manufacturers being set as a percentage of the wholesale acquisition cost of branded pharmaceuticals; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in the timing or frequency of the introduction of branded pharmaceuticals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with the resolution and defense of the lawsuits and investigations in which we have been or will be named relating to the distribution of prescription opioid pain medication, including the risk that the outcome of these lawsuits and investigations could have a material adverse effect on our results of operations, financial condition, cash flows or liquidity;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">potential damage to our reputation, adverse operational impacts or other effects that may result from the national opioid epidemic, the allegations that have been made about our role in such epidemic and the ongoing unfavorable publicity surrounding the lawsuits and investigations against us;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with the ongoing discussions regarding a potential global settlement of certain opioid lawsuits and investigations against us, including the risk that we could fail to reach a final settlement, that any final settlement reached could require us to pay more than we currently anticipate or could have a negative effect on our liquidity or ability to return money to shareholders and the risk that any injunctive or non-monetary remedies we may agree to could have unintended consequences;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">potential adverse impact to our financial results from enacted and proposed state taxes or other assessments on the sale or distribution of opioid medications;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our high sales concentration with certain key customers, including CVS Health Corporation and OptumRx;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">costs or claims resulting from a quality issue related to the manufacture of some of our sterile surgical gowns, or other potential errors or defects in our manufacturing of medical devices or other products or in our compounding, repackaging, information systems or pharmacy management services that may injure persons or damage property or operations, including costs from recalls, remediation efforts, and related product liability claims and lawsuits, including class action lawsuits;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">actions of regulatory bodies and other governmental authorities, including the U.S. Drug Enforcement Administration, certain agencies within the U.S. Department of Health and Human Services (including the U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services, the Office of Inspector General and the Office for Civil Rights), the U.S. Nuclear Regulatory Commission, the U.S. Federal Trade Commission, the U.S. Customs and Border Protection, various state boards of pharmacy, state controlled substance authorities, state health departments, state insurance departments, state Medicaid departments or comparable regulatory bodies or governmental authorities or foreign equivalents that, in each case, could delay, limit or suspend product development, manufacturing, distribution, importation or sales or result in warning letters, recalls, seizures, injunctions or monetary sanctions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any compromise of our information systems or of those of a third-party service provider, including unauthorized access to or use or disclosure of company or customer information, disruption of access and ancillary risks associated with our ability to effectively manage any issues arising from any such compromise or disruption;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties related to our Medical segment's Cardinal Health Brand products, including our ability to manage cost, infrastructure and to retain margin or improve its performance;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with the realignment of our Medical segment's supply chain and other businesses, including our ability to achieve the expected benefits from such realignment; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties with respect to our cost-savings initiatives or IT infrastructure activities, including the ability to achieve the expected benefits from such initiatives, the risk that we could incur unexpected charges, and the risk that we may fail to retain key personnel; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">difficulties or delays in the development, production, manufacturing, sourcing and marketing of new or existing products and services, including difficulties or delays associated with obtaining or maintaining requisite regulatory consents, whether our own or third parties', or approvals associated with those activities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">manufacturing disruptions, whether due to regulatory action, production quality deviations, safety issues or raw material shortages or defects, or because a key product is manufactured at a single manufacturing facility with limited alternate facilities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from possible violations of healthcare fraud and abuse laws;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from possible violations of the U.S. Foreign Corrupt Practices Act and other similar anti-corruption laws in other jurisdictions and U.S. and foreign export control, trade embargo and customs laws;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from our collecting, handling and maintaining patient-identifiable health information and other sensitive personal and financial information, which are subject to federal, state and foreign laws that regulate the use and disclosure of such information;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from certain of our businesses being Medicare-certified suppliers or participating in other federal and state healthcare programs, such as state Medicaid programs and the federal 340B drug pricing program, which businesses are subject to accreditation and quality standards and other rules and regulations, including applicable reporting, billing, payment and record-keeping requirements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from certain of our businesses manufacturing pharmaceutical and medical products or repackaging pharmaceuticals that are purchased or reimbursed through, or are otherwise governed by, federal or state healthcare programs, which businesses are subject to federal and state laws that establish eligibility for reimbursement by such programs and other applicable standards and regulations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in laws or changes in the interpretation or application of laws or regulations, as well as possible failures to comply with applicable laws or regulations, including as a result of possible misinterpretations or misapplications;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">material reductions in purchases, pricing changes, non-renewal, early termination, or delinquencies or defaults under contracts with key customers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">unfavorable changes to the terms or with our ability to meet contractual obligations of key customer or supplier relationships, or changes in customer mix;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from changes in U.S. or foreign tax laws and unfavorable challenges to our tax positions and payments to settle these challenges, which may adversely affect our effective tax rate or tax payments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties due to possible government healthcare reform, including proposals related to Medicare drug rebate arrangements, possible repeal or replacement of major parts of the Patient Protection and Affordable Care Act, proposals related to prescription drug pricing transparency and the possible adoption of Medicare-For-All;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">reductions or limitations on governmental funding at the state or federal level or efforts by healthcare insurance companies to limit payments for products and services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in manufacturers' pricing, selling, inventory, distribution or supply policies or practices;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in legislation or regulations governing prescription drug pricing, healthcare services or mandated benefits;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in hospital buying groups or hospital buying practices;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in distribution or sourcing models for pharmaceutical and medical and surgical products, including an increase in direct and limited distribution;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes to the prescription drug reimbursement formula and related reporting requirements for generic pharmaceuticals under Medicaid;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">continuing consolidation in the healthcare industry, which could give the resulting enterprises greater bargaining power and may increase pressure on prices for our products and services or result in the loss of customers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">disruption, damage or lack of access to, or failure of, our or our third-party service providers' information systems, our critical facilities, including our national logistics center, or our distribution networks;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks to our business and information and controls systems in the event that business process improvements, infrastructure modernizations or initiatives to use third-party service providers for key systems and processes are not effectively implemented;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the results, costs, effects or timing of any commercial disputes, government contract compliance matters, patent infringement claims, </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;actions, government investigations, shareholder lawsuits or other legal proceedings;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">possible losses relating to product liability lawsuits and claims regarding products for which we cannot obtain product liability insurance or for which such insurance may not be adequate to cover our losses, including the product liability lawsuits we are currently defending relating to alleged personal injuries associated with the use of Cordis inferior vena cava filter products;</font></div></td></tr></table><div><br></div><hr style="page-break-after:always"><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to maintain adequate intellectual property protections;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the costs, difficulties and uncertainties related to the integration of acquired businesses, including liabilities relating to the operations or activities of such businesses prior to their acquisition, and uncertainties relating to our ability to achieve the anticipated results from acquisitions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to manage and complete divestitures or other strategic business combination transactions, including our ability to find buyers or other strategic exit opportunities and risks associated with the possibility that we could experience greater dis-synergies than anticipated or otherwise fail to achieve our strategic objectives;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">increased costs for commodities and other materials used in the Medical segment manufacturing, including various components, compounds, raw materials or energy such as oil-based resins, pulp, cotton, latex and other commodities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">shortages in commodities, components, compounds, raw materials or energy used by our businesses, including supply disruptions of radioisotopes;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the loss of, or default by, one or more key suppliers for which alternative suppliers may not be readily available;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">bankruptcy, insolvency or other credit failure of a customer or supplier that owes us a substantial amount;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with global operations, including the effect of local economic environments, inflation, recession, currency volatility and global competition, in addition to risks associated with compliance with U.S. and international laws relating to global operations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties with respect to U.S. or international trade policies, tariffs, excise or border taxes and their impact on our ability to source products or materials that we need to conduct our business;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with our use of and reliance on the global capital and credit markets, including our ability to access credit and our cost of credit, which may adversely affect our ability to efficiently fund our operations or undertake certain expenditures;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to introduce and market new products and our ability to keep pace with advances in technology;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">significant charges to earnings if goodwill or intangible assets become impaired; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to general political, business, industry, regulatory and market conditions; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">other factors described in the &#8220;Risk Factors&#8221; section of the 2020 Form 10-K.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The words &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; and similar expressions generally identify &#8220;forward-looking statements,&#8221; which speak only as of the date the statements were made, and also include statements reflecting future results or guidance, statements of outlook and expense accruals. We undertake no obligation to update or revise any forward-looking statements, except to the extent required by applicable law.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>cah-20200630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cardinal.com/20200630" xmlns:cah="http://www.cardinal.com/20200630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20200630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20200630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20200630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20200630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies">
        <link:definition>2101100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails">
        <link:definition>2401408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails">
        <link:definition>2401416 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails">
        <link:definition>2401412 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails">
        <link:definition>2401409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails">
        <link:definition>2401406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInvestmentsDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInvestmentsDetails">
        <link:definition>2401410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Investments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails">
        <link:definition>2401405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails">
        <link:definition>2401407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails">
        <link:definition>2401403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails">
        <link:definition>2401415 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails">
        <link:definition>2401413 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails">
        <link:definition>2401414 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails">
        <link:definition>2401411 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>2201201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails">
        <link:definition>2401404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>2301302 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingentLiabilitiesAndLitigation" roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation">
        <link:definition>2112100 - Disclosure - Commitments, Contingent Liabilities and Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingentLiabilitiesAndLitigationDetails" roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails">
        <link:definition>2412401 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets">
        <link:definition>1003000 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1003501 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows">
        <link:definition>1014000 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfComprehensiveIncome" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome">
        <link:definition>1002000 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfComprehensiveIncomeCalc2" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncomeCalc2">
        <link:definition>1002000 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfEarnings" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings">
        <link:definition>1001000 - Statement - Consolidated Statements of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfShareholdersEquity" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity">
        <link:definition>1013000 - Statement - Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresAndAcquisitions" roleURI="http://www.cardinal.com/role/DivestituresAndAcquisitions">
        <link:definition>2102100 - Disclosure - Divestitures and Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresAndAcquisitionsNarrativeDetails" roleURI="http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails">
        <link:definition>2402402 - Disclosure - Divestitures and Acquisitions (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresAndAcquisitionsTables" roleURI="http://www.cardinal.com/role/DivestituresAndAcquisitionsTables">
        <link:definition>2302301 - Disclosure - Divestitures and Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DocumentAndEntityInformation" roleURI="http://www.cardinal.com/role/DocumentAndEntityInformation">
        <link:definition>0001000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthInc" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc">
        <link:definition>2118100 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails">
        <link:definition>2418403 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails">
        <link:definition>2418402 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthIncTables" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables">
        <link:definition>2318301 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.cardinal.com/role/FairValueMeasurements">
        <link:definition>2114100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails">
        <link:definition>2414402 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details">
        <link:definition>2414403 - Disclosure - Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables">
        <link:definition>2314301 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.cardinal.com/role/FinancialInstruments">
        <link:definition>2115100 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>2415403 - Disclosure - Financial Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails">
        <link:definition>2415412 - Disclosure - Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails">
        <link:definition>2415402 - Disclosure - Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails">
        <link:definition>2415407 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails">
        <link:definition>2415408 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails">
        <link:definition>2415410 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails">
        <link:definition>2415405 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails">
        <link:definition>2415406 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails">
        <link:definition>2415409 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails">
        <link:definition>2415404 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails">
        <link:definition>2415411 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables">
        <link:definition>2315301 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssets" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets">
        <link:definition>2105100 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsNarrativeDetails" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails">
        <link:definition>2405404 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails">
        <link:definition>2405402 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails">
        <link:definition>2405403 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsTables" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables">
        <link:definition>2305301 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Guarantees" roleURI="http://www.cardinal.com/role/Guarantees">
        <link:definition>2113100 - Disclosure - Guarantees</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cardinal.com/role/IncomeTaxes">
        <link:definition>2111100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2411405 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails">
        <link:definition>2411403 - Disclosure - Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails">
        <link:definition>2411407 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>2411406 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails">
        <link:definition>2411404 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails">
        <link:definition>2411402 - Disclosure - Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails">
        <link:definition>2411408 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.cardinal.com/role/IncomeTaxesTables">
        <link:definition>2311301 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.cardinal.com/role/Investments">
        <link:definition>2108100 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDetails" roleURI="http://www.cardinal.com/role/InvestmentsDetails">
        <link:definition>2408401 - Disclosure - Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.cardinal.com/role/Leases">
        <link:definition>2101100 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.cardinal.com/role/LeasesDetails">
        <link:definition>2401402 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleOfFutureLeasePaymentsDetails" roleURI="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails">
        <link:definition>2401406 - Disclosure - Leases Schedule of Future Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleOfLeaseCostsDetails" roleURI="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails">
        <link:definition>2401403 - Disclosure - Leases Schedule of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleOfLeaseCostsDetailsCalc2" roleURI="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetailsCalc2">
        <link:definition>2401403 - Disclosure - Leases Schedule of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>2401404 - Disclosure - Leases Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>2401405 - Disclosure - Leases Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.cardinal.com/role/LeasesTables">
        <link:definition>2301301 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowings" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings">
        <link:definition>2110100 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails">
        <link:definition>2410404 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails">
        <link:definition>2410403 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails">
        <link:definition>2410405 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails">
        <link:definition>2410402 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowingsTables" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables">
        <link:definition>2310301 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeverance" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance">
        <link:definition>2103100 - Disclosure - Restructuring and Employee Severance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails">
        <link:definition>2403402 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails">
        <link:definition>2403403 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceNarrativeDetails" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails">
        <link:definition>2403404 - Disclosure - Restructuring and Employee Severance Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceTables" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables">
        <link:definition>2303301 - Disclosure - Restructuring and Employee Severance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIiValuationsAndQualifyingAccounts" roleURI="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccounts">
        <link:definition>2123100 - Schedule - Schedule II - Valuations and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIiValuationsAndQualifyingAccountsDetails" roleURI="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails">
        <link:definition>2423401 - Schedule - Schedule II - Valuations and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.cardinal.com/role/SegmentInformation">
        <link:definition>2119100 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationAssetsByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails">
        <link:definition>2419406 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails">
        <link:definition>2419405 - Disclosure - Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails">
        <link:definition>2419402 - Disclosure - Segment Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails" roleURI="http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails">
        <link:definition>2419407 - Disclosure - Segment Information  Property and Equipment, net by Geographic Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationRevenueByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails">
        <link:definition>2419403 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentProfitByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails">
        <link:definition>2419404 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.cardinal.com/role/SegmentInformationTables">
        <link:definition>2319301 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SelectedQuarterlyFinancialDataUnaudited" roleURI="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnaudited">
        <link:definition>2121100 - Disclosure - Selected Quarterly Financial Data (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SelectedQuarterlyFinancialDataUnauditedDetails" roleURI="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails">
        <link:definition>2421402 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SelectedQuarterlyFinancialDataUnauditedTables" roleURI="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedTables">
        <link:definition>2321301 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.cardinal.com/role/ShareBasedCompensation">
        <link:definition>2120100 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails">
        <link:definition>2420411 - Disclosure - Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails">
        <link:definition>2420409 - Disclosure - Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>2420402 - Disclosure - Share-Based Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails">
        <link:definition>2420405 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails">
        <link:definition>2420404 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails">
        <link:definition>2420410 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails">
        <link:definition>2420408 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails">
        <link:definition>2420407 - Disclosure - Share-Based Compensation (Schedule of the Range of Assumptions Used to Estimate the Fair Value of Stock Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails">
        <link:definition>2420406 - Disclosure - Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails">
        <link:definition>2420403 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables">
        <link:definition>2320301 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cardinal.com/role/ShareholdersEquity">
        <link:definition>2117100 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2417403 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>2417402 - Disclosure - Shareholders' Equity (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.cardinal.com/role/ShareholdersEquityTables">
        <link:definition>2317301 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="cah_A1.948Notesdue2019Member" name="A1.948Notesdue2019Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A2.4Notesdue2020Member" name="A2.4Notesdue2020Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" name="A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A2.616Notesdue2022Member" name="A2.616Notesdue2022Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A2011LtipMember" name="A2011LtipMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.079Notesdue2024Member" name="A3.079Notesdue2024Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.2Notesdue2022Member" name="A3.2Notesdue2022Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.2Notesdue2023Member" name="A3.2Notesdue2023Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.41Notesdue2027Member" name="A3.41Notesdue2027Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.5Notesdue2025Member" name="A3.5Notesdue2025Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.75Notesdue2026Member" name="A3.75Notesdue2026Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A4.368Notesdue2047Member" name="A4.368Notesdue2047Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A4.5Notesdue2044Member" name="A4.5Notesdue2044Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A4.625Notesdue2021Member" name="A4.625Notesdue2021Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A4.6Notesdue2043Member" name="A4.6Notesdue2043Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A4.9Notesdue2045Member" name="A4.9Notesdue2045Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A7.0Debenturesduefiscal2027Member" name="A7.0Debenturesduefiscal2027Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ASC842Member" name="ASC842Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_AcceleratedsharerepurchaseplanMember" name="AcceleratedsharerepurchaseplanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_AdditionalPerformanceShareUnitsDataTableTextBlock" name="AdditionalPerformanceShareUnitsDataTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" name="AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_AdditionalStockOptionPlanDataTableTextBlock" name="AdditionalStockOptionPlanDataTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_AlamedaCountyMember" name="AlamedaCountyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_AllegianceCorporationMember" name="AllegianceCorporationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" name="AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Amortizationandotheracquisitionrelatedcosts" name="Amortizationandotheracquisitionrelatedcosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_AssetsHeldforSalePolicyPolicyTextBlock" name="AssetsHeldforSalePolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_AwardsOtherThanStockOptionsMember" name="AwardsOtherThanStockOptionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_BusinessCombinationTransactionandintegrationcosts" name="BusinessCombinationTransactionandintegrationcosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CVSCaremarkCorporationMember" name="CVSCaremarkCorporationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CVSHealthMember" name="CVSHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CardinalHealthAtHomeSolutionsMember" name="CardinalHealthAtHomeSolutionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CareFusionMember" name="CareFusionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_CarryingAmountofLongTermandotherShortTermBorrowings" name="CarryingAmountofLongTermandotherShortTermBorrowings" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_CashComponentForSettlementFrameworkTerm" name="CashComponentForSettlementFrameworkTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_CashDiscountsPolicyTextBlock" name="CashDiscountsPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_CashReclassifiedtoAssetsHeldforSale" name="CashReclassifiedtoAssetsHeldforSale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember" name="ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ClassActionLawsuitsMember" name="ClassActionLawsuitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CommittedReceivablesSalesFacilityProgramMember" name="CommittedReceivablesSalesFacilityProgramMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_CommonStockVotingRightsVotes" name="CommonStockVotingRightsVotes" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ConcentrationRiskLargestGroupPurchasingOrganizations" name="ConcentrationRiskLargestGroupPurchasingOrganizations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ContractTerminationAxis" name="ContractTerminationAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ContractTerminationDomain" name="ContractTerminationDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_CostofSalesVendorReservesPolicyPolicyTextBlock" name="CostofSalesVendorReservesPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_DeferredIncomeTaxesandOtherLiabilitiesMember" name="DeferredIncomeTaxesandOtherLiabilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" name="DeferredTaxAssetsRelatedtouncertaintaxpositions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" name="DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" name="DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cah_DiscountRatefairvalueinputs" name="DiscountRatefairvalueinputs" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" name="DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_DistributorContractMember" name="DistributorContractMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_DividendsPolicyPolicyTextBlock" name="DividendsPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" name="EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_EffectiveIncomeTaxRateReconciliationTaxAct2018" name="EffectiveIncomeTaxRateReconciliationTaxAct2018" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_EffectiveIncomeTaxReconciliationOpioidLitigation" name="EffectiveIncomeTaxReconciliationOpioidLitigation" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" name="EffectiveTaxRateImpactFromCertainForeignJurisdictions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture" name="EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ExercisablePeriodOfPlansInYears" name="ExercisablePeriodOfPlansInYears" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_FacilityExitAndOtherCosts" name="FacilityExitAndOtherCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_FinanceLeaseImputedInterest" name="FinanceLeaseImputedInterest" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_FinanceLeaseMember" name="FinanceLeaseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_FixedRateDebtMember" name="FixedRateDebtMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_FloatingRateNotesdue2022Member" name="FloatingRateNotesdue2022Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_GainonDivestitureAfterTax" name="GainonDivestitureAfterTax" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_GoodsandservicessoldLineItems" name="GoodsandservicessoldLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_GoodsandservicessoldTable" name="GoodsandservicessoldTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_GoodwillAndIntangibleAssetsLineItems" name="GoodwillAndIntangibleAssetsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_GoodwillAndIntangibleAssetsTable" name="GoodwillAndIntangibleAssetsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_GownRecallAxis" name="GownRecallAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_GownRecallDomain" name="GownRecallDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_GrossTradeReceivablesMajorCustomerPercentage" name="GrossTradeReceivablesMajorCustomerPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_GroupPurchasingOrganizationsMember" name="GroupPurchasingOrganizationsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_IPRDTrademarksandOtherMember" name="IPRDTrademarksandOtherMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Impactofadoptionofnewaccountingstandard" name="Impactofadoptionofnewaccountingstandard" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cah_IncomefromSettlementsofClassActionLawsuits" name="IncomefromSettlementsofClassActionLawsuits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_IndemnificationReceivable" name="IndemnificationReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_LawsuitTypeAxis" name="LawsuitTypeAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_LawsuitTypeDomain" name="LawsuitTypeDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" name="LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LeasePaymentsTableTextBlock" name="LeasePaymentsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" name="LeasesSupplementalBalanceSheetInformationTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LeasesTextBlock" name="LeasesTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" name="LesseeFinanceLeaseLiabilityNotYetCommencedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" name="LesseeLeaseLiabilityPaymentsDueAfterYearFive" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueYearFive" name="LesseeLeaseLiabilityPaymentsDueYearFive" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueYearFour" name="LesseeLeaseLiabilityPaymentsDueYearFour" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueYearThree" name="LesseeLeaseLiabilityPaymentsDueYearThree" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueYearTwo" name="LesseeLeaseLiabilityPaymentsDueYearTwo" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" name="LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" name="LesseeOperatingLeaseLiabilityNotYetCommencedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_LitigationTypeAxis" name="LitigationTypeAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_LitigationTypeDomain" name="LitigationTypeDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LossContingencyLawsuitsNumber" name="LossContingencyLawsuitsNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="cah_MaximumQuarterlyPayment" name="MaximumQuarterlyPayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_MedicalMember" name="MedicalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_MedicalReportingUnitMember" name="MedicalReportingUnitMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_MedicaldistributionandproductsMember" name="MedicaldistributionandproductsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_NaviHealthMember" name="NaviHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_NaviOwnershipInterestDivestedMember" name="NaviOwnershipInterestDivestedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" name="NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cah_Netproceedstaxwithholdingsfromsharebasedcompensation" name="Netproceedstaxwithholdingsfromsharebasedcompensation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_NotesPayableRepurchased" name="NotesPayableRepurchased" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_NuclearPrecisionHealthServicesMember" name="NuclearPrecisionHealthServicesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_NumberofStateAttorneysGeneralfilinglawsuits" name="NumberofStateAttorneysGeneralfilinglawsuits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="cah_OfferAsPercentageOfPrincipalAmount" name="OfferAsPercentageOfPrincipalAmount" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OnePointNineFiveNotesdue2018Member" name="OnePointNineFiveNotesdue2018Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_OperatingLeaseImputedInterest" name="OperatingLeaseImputedInterest" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_OperatingLeaseMember" name="OperatingLeaseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLawsuitsMember" name="OpioidLawsuitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLawsuitsStateDomain" name="OpioidLawsuitsStateDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLitigationAxis" name="OpioidLitigationAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLitigationCuyahogaandSummitCountiesMember" name="OpioidLitigationCuyahogaandSummitCountiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLitigationDomain" name="OpioidLitigationDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" name="OpioidLitigationlessCuyahogaandSummitCountiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_OpioidTotalSettlementCuyahogaandSummitCounties" name="OpioidTotalSettlementCuyahogaandSummitCounties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_OptumRxMember" name="OptumRxMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" name="OtherAccruedLiabilitiesPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OtherJurisdictionsMember" name="OtherJurisdictionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_PartnershipOwnership" name="PartnershipOwnership" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_PatientRecoveryBusinessMember" name="PatientRecoveryBusinessMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_PaymentofContingentConsideration" name="PaymentofContingentConsideration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PharmaceuticalDistributionandSpecialtyMember" name="PharmaceuticalDistributionandSpecialtyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PharmaceuticalMember" name="PharmaceuticalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PlaintiffTypeAxis" name="PlaintiffTypeAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PlaintiffTypeDomain" name="PlaintiffTypeDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_PreTaxGainonDivestiture" name="PreTaxGainonDivestiture" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PricingDisputesMember" name="PricingDisputesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PriorYearRecoveriesMember" name="PriorYearRecoveriesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PrivatePartiesMember" name="PrivatePartiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" name="Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" name="Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ProductLiabilityLawsuitsMember" name="ProductLiabilityLawsuitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ProjectCostsOnInvestmentAndOtherSpending" name="ProjectCostsOnInvestmentAndOtherSpending" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_Provisionaltaxbenefitrelatedtotransaction" name="Provisionaltaxbenefitrelatedtotransaction" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_Purchaseofavailableforsalesecuritiesandotherinvestments" name="Purchaseofavailableforsalesecuritiesandotherinvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cah_ReceivableFinancingAgreementTerm" name="ReceivableFinancingAgreementTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ReclassificationofdeferredrentinaccordancewithASC842" name="ReclassificationofdeferredrentinaccordancewithASC842" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_RemainingStockOptionPlanDataTableTextBlock" name="RemainingStockOptionPlanDataTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_RetirementofTreasurySharesMember" name="RetirementofTreasurySharesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_RevenueRecognitionReserveforSalesReturnsandAllowances" name="RevenueRecognitionReserveforSalesReturnsandAllowances" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_SalesreturnsPolicyTextBlock" name="SalesreturnsPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ScheduleIIAbstract" name="ScheduleIIAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" name="ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" name="ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" name="Sharesthatwouldbeantidilutiveasaresultofnetloss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ShippingandHandlingCostsPolicyTextBlock" name="ShippingandHandlingCostsPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ShortTermCreditFacilitiesMember" name="ShortTermCreditFacilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_SterileSurgicalGownRecallMember" name="SterileSurgicalGownRecallMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_SterileSurgicalGownRecallMemberDomain" name="SterileSurgicalGownRecallMemberDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_TaxExpenseasaResultofSaleofInvestment" name="TaxExpenseasaResultofSaleofInvestment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TaxMatterAxis" name="TaxMatterAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TaxMatterDomain" name="TaxMatterDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_TotalLeaseLiability" name="TotalLeaseLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_TotalLeaseLiabilityNotYetCommencedAmount" name="TotalLeaseLiabilityNotYetCommencedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_TotalLeaseLiabilityPaymentsDue" name="TotalLeaseLiabilityPaymentsDue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_TotalLeaseLiabilityUndiscountedExcessAmount" name="TotalLeaseLiabilityUndiscountedExcessAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_TotalOpioidLitigationMember" name="TotalOpioidLitigationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TotalOpioidLitigationnetoftaxMember" name="TotalOpioidLitigationnetoftaxMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TrademarksAndPatentsMember" name="TrademarksAndPatentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_TreasuryStockAcquiredShares" name="TreasuryStockAcquiredShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_VendorReserves" name="VendorReserves" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cah_VestingPeriodinyearsforShares" name="VestingPeriodinyearsforShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>cah-20200630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:href="cah-20200630.xsd#CommitmentsContingentLiabilitiesAndLitigation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:href="cah-20200630.xsd#CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:href="cah-20200630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cah-20200630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncomeCalc2" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfComprehensiveIncomeCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfEarnings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresAndAcquisitions" xlink:href="cah-20200630.xsd#DivestituresAndAcquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails" xlink:href="cah-20200630.xsd#DivestituresAndAcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresAndAcquisitionsTables" xlink:href="cah-20200630.xsd#DivestituresAndAcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DocumentAndEntityInformation" xlink:href="cah-20200630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:href="cah-20200630.xsd#EarningsPerShareAttributableToCardinalHealthInc" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:href="cah-20200630.xsd#EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:href="cah-20200630.xsd#EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:href="cah-20200630.xsd#EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:href="cah-20200630.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="cah-20200630.xsd#FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:href="cah-20200630.xsd#FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:href="cah-20200630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:href="cah-20200630.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:href="cah-20200630.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Guarantees" xlink:href="cah-20200630.xsd#Guarantees" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:href="cah-20200630.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:href="cah-20200630.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesTables" xlink:href="cah-20200630.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Investments" xlink:href="cah-20200630.xsd#Investments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/InvestmentsDetails" xlink:href="cah-20200630.xsd#InvestmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Leases" xlink:href="cah-20200630.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesDetails" xlink:href="cah-20200630.xsd#LeasesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" xlink:href="cah-20200630.xsd#LeasesScheduleOfFutureLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails" xlink:href="cah-20200630.xsd#LeasesScheduleOfLeaseCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetailsCalc2" xlink:href="cah-20200630.xsd#LeasesScheduleOfLeaseCostsDetailsCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="cah-20200630.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:href="cah-20200630.xsd#LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesTables" xlink:href="cah-20200630.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeverance" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeveranceTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccounts" xlink:href="cah-20200630.xsd#ScheduleIiValuationsAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails" xlink:href="cah-20200630.xsd#ScheduleIiValuationsAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:href="cah-20200630.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:href="cah-20200630.xsd#SegmentInformationAssetsByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails" xlink:href="cah-20200630.xsd#SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:href="cah-20200630.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails" xlink:href="cah-20200630.xsd#SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:href="cah-20200630.xsd#SegmentInformationRevenueByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:href="cah-20200630.xsd#SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:href="cah-20200630.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnaudited" xlink:href="cah-20200630.xsd#SelectedQuarterlyFinancialDataUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" xlink:href="cah-20200630.xsd#SelectedQuarterlyFinancialDataUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedTables" xlink:href="cah-20200630.xsd#SelectedQuarterlyFinancialDataUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:href="cah-20200630.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:href="cah-20200630.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:href="cah-20200630.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="cah-20200630.xsd#ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:href="cah-20200630.xsd#ShareholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:href="cah-20200630.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bf545d72-755b-f46c-4176-2eeaac0328d1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0f02ac25-d0ba-9aaf-434b-6901724c980e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_bf545d72-755b-f46c-4176-2eeaac0328d1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0f02ac25-d0ba-9aaf-434b-6901724c980e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_da8328db-6eed-8982-00a4-561b118e61c9" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_bf545d72-755b-f46c-4176-2eeaac0328d1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_da8328db-6eed-8982-00a4-561b118e61c9" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:to="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26247a2d-7bac-8834-3dc5-06c993b10b2c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26247a2d-7bac-8834-3dc5-06c993b10b2c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_02eb9f27-cc70-d84a-60be-0ebfa9ad27e5" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:to="loc_us-gaap_ReceivablesNetCurrent_02eb9f27-cc70-d84a-60be-0ebfa9ad27e5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_aa7cc103-d668-cf3b-6875-81c99ffeac19" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:to="loc_us-gaap_InventoryNet_aa7cc103-d668-cf3b-6875-81c99ffeac19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_be6829f0-538a-891f-48bc-46140655594e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:to="loc_us-gaap_OtherAssetsCurrent_be6829f0-538a-891f-48bc-46140655594e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bf545d72-755b-f46c-4176-2eeaac0328d1" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_bf545d72-755b-f46c-4176-2eeaac0328d1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_459a5f08-8f16-fffd-523f-f6e6ee19e90a" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_459a5f08-8f16-fffd-523f-f6e6ee19e90a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_17a41c51-6fe7-c037-64c3-3ef6c9692a94" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_17a41c51-6fe7-c037-64c3-3ef6c9692a94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:to="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_95fe5c6d-e90e-6d2c-8e9a-8339666be1b8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:to="loc_us-gaap_AccountsPayableCurrent_95fe5c6d-e90e-6d2c-8e9a-8339666be1b8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c8e34a68-78cf-1f0f-d260-cfd03835a0ac" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c8e34a68-78cf-1f0f-d260-cfd03835a0ac" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_13159f86-b20a-f641-5cfd-65a0553fc694" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_13159f86-b20a-f641-5cfd-65a0553fc694" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_18cd02df-c342-1135-80a4-128981b71541" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_18cd02df-c342-1135-80a4-128981b71541" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_585ced85-cbc5-11e0-dac8-d6a197e5d990" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_585ced85-cbc5-11e0-dac8-d6a197e5d990" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:to="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_844e7c43-dfe0-790d-4f5e-8b1150390e12" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:to="loc_us-gaap_PreferredStockValue_844e7c43-dfe0-790d-4f5e-8b1150390e12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_130b8997-2f7a-8192-a853-ff9fb4629d95" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:to="loc_us-gaap_CommonStockValue_130b8997-2f7a-8192-a853-ff9fb4629d95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_18ff0284-4873-6ef0-806f-4fb76051c01f" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_18ff0284-4873-6ef0-806f-4fb76051c01f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_af531fdd-0099-f49a-729d-64bccce3d7cd" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:to="loc_us-gaap_TreasuryStockValue_af531fdd-0099-f49a-729d-64bccce3d7cd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_355fc088-038d-3905-0784-91db0d020a77" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_444cfce6-fc59-0d4d-1ade-0fdec3499b08" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_355fc088-038d-3905-0784-91db0d020a77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_02ec7b38-4afa-636c-3b62-de1bd1bf96c1" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:to="loc_us-gaap_MinorityInterest_02ec7b38-4afa-636c-3b62-de1bd1bf96c1" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e98a0be-51ae-18d0-54bf-b32eca8c5c1d" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e98a0be-51ae-18d0-54bf-b32eca8c5c1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_fb4a1534-3ea3-3150-f601-42486b71bc63" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_fb4a1534-3ea3-3150-f601-42486b71bc63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_9574e099-407d-f499-a4f7-37e06c5ca226" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_LossOnSaleOfInvestments_9574e099-407d-f499-a4f7-37e06c5ca226" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_f1665cc9-2278-4ae5-1778-cb7c3961fee4" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_f1665cc9-2278-4ae5-1778-cb7c3961fee4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0d10caa9-02ca-dfff-16b0-b48af0dbe41a" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0d10caa9-02ca-dfff-16b0-b48af0dbe41a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_8e70545b-e41a-5c88-3aeb-15f273c05266" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_ShareBasedCompensation_8e70545b-e41a-5c88-3aeb-15f273c05266" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_282d8de6-1466-4351-6593-66c6a3dfd2f5" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_282d8de6-1466-4351-6593-66c6a3dfd2f5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_62c92b83-f76e-68ff-4453-8ab3478d0029" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_62c92b83-f76e-68ff-4453-8ab3478d0029" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6dc01ea6-0e0e-5657-9826-e795d04445b1" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6dc01ea6-0e0e-5657-9826-e795d04445b1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_2720b568-6d18-ebd1-f8c5-59e8401a86fb" xlink:type="locator" />
    <link:calculationArc order="10" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_2720b568-6d18-ebd1-f8c5-59e8401a86fb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_660d037d-5031-2fde-c0d3-d2b6978292ac" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_660d037d-5031-2fde-c0d3-d2b6978292ac" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1aefa3b7-6b7a-d481-5bdc-6b8b587c627e" xlink:type="locator" />
    <link:calculationArc order="12" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1aefa3b7-6b7a-d481-5bdc-6b8b587c627e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4392a9aa-12d6-0a02-3bb4-a001e4753188" xlink:type="locator" />
    <link:calculationArc order="13" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4392a9aa-12d6-0a02-3bb4-a001e4753188" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11843925-b604-1b74-cbbb-bea6e3ba6b7e" xlink:type="locator" />
    <link:calculationArc order="14" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11843925-b604-1b74-cbbb-bea6e3ba6b7e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e98a0be-51ae-18d0-54bf-b32eca8c5c1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c7e64fd7-0b56-e309-1408-1e90657554b0" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c7e64fd7-0b56-e309-1408-1e90657554b0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ca48a49a-2cde-cf3d-6904-e8f08b6e1fbb" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ca48a49a-2cde-cf3d-6904-e8f08b6e1fbb" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_cab8a6dd-a29f-61af-763a-54b5341882f1" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_cab8a6dd-a29f-61af-763a-54b5341882f1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_56b5177b-1beb-5c9c-aed9-54b532fdd715" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_56b5177b-1beb-5c9c-aed9-54b532fdd715" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" xlink:label="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_48e461f9-21ca-d5f9-b102-54b535786f26" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_48e461f9-21ca-d5f9-b102-54b535786f26" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e98a0be-51ae-18d0-54bf-b32eca8c5c1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PaymentofContingentConsideration" xlink:label="loc_cah_PaymentofContingentConsideration_8dc6f8bd-10b9-bf10-50fc-28433797dd90" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_cah_PaymentofContingentConsideration_8dc6f8bd-10b9-bf10-50fc-28433797dd90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_9fc9e483-8e3b-7514-ceac-50d930424fe0" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_9fc9e483-8e3b-7514-ceac-50d930424fe0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_339aab3b-6949-79f7-284e-647d6ec5fab0" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_339aab3b-6949-79f7-284e-647d6ec5fab0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_7f9580a9-3805-cc3a-42fd-74ab6d116d7a" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_7f9580a9-3805-cc3a-42fd-74ab6d116d7a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_d162839c-cd69-2681-f443-1d2b8d098863" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_d162839c-cd69-2681-f443-1d2b8d098863" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_8ae074eb-80ea-dbd0-38c7-8d7fe3904bdb" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_8ae074eb-80ea-dbd0-38c7-8d7fe3904bdb" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_b2cc977c-eaa3-c1f6-1b9f-54b535bd7fad" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_b2cc977c-eaa3-c1f6-1b9f-54b535bd7fad" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_d9ad3f49-2983-0520-055e-f1b6b7b8718e" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_d9ad3f49-2983-0520-055e-f1b6b7b8718e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_d5388628-04a8-f9f2-f1f1-9af34cf68c6b" xlink:type="locator" />
    <link:calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_d5388628-04a8-f9f2-f1f1-9af34cf68c6b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5438f733-2c2e-cb8b-518a-eb0b0108364e" xlink:type="locator" />
    <link:calculationArc order="10" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5438f733-2c2e-cb8b-518a-eb0b0108364e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5a50c8d2-c551-fe84-870a-29975db72587" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e98a0be-51ae-18d0-54bf-b32eca8c5c1d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5a50c8d2-c551-fe84-870a-29975db72587" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CashReclassifiedtoAssetsHeldforSale" xlink:label="loc_cah_CashReclassifiedtoAssetsHeldforSale_5b6eebbc-bf31-e5a8-60ae-284333b1be4a" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e98a0be-51ae-18d0-54bf-b32eca8c5c1d" xlink:to="loc_cah_CashReclassifiedtoAssetsHeldforSale_5b6eebbc-bf31-e5a8-60ae-284333b1be4a" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_61cff5eb-6380-0a99-0b9f-2aa494c88658" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b648d0ef-16fe-7d60-a025-6e0cc8ac751c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_61cff5eb-6380-0a99-0b9f-2aa494c88658" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b648d0ef-16fe-7d60-a025-6e0cc8ac751c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b648d0ef-16fe-7d60-a025-6e0cc8ac751c" xlink:to="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec9c3aab-da5b-a831-3f37-62a3ea3b00ff" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b648d0ef-16fe-7d60-a025-6e0cc8ac751c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec9c3aab-da5b-a831-3f37-62a3ea3b00ff" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d954d1a3-69c6-9ed8-87ac-70ab0eca24d0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec9c3aab-da5b-a831-3f37-62a3ea3b00ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d954d1a3-69c6-9ed8-87ac-70ab0eca24d0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_b6d34176-e5c4-1bea-2919-8d8743b54529" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec9c3aab-da5b-a831-3f37-62a3ea3b00ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_b6d34176-e5c4-1bea-2919-8d8743b54529" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_cebe8cd2-dfa5-f0b2-fced-53d6c831f16c" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec9c3aab-da5b-a831-3f37-62a3ea3b00ff" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_cebe8cd2-dfa5-f0b2-fced-53d6c831f16c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_63bbe84c-b938-87b9-5103-68b80738d584" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_61cff5eb-6380-0a99-0b9f-2aa494c88658" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_63bbe84c-b938-87b9-5103-68b80738d584" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncomeCalc2" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:to="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_da1a9111-3960-6334-38ac-32be56368293" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_us-gaap_GrossProfit_da1a9111-3960-6334-38ac-32be56368293" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_0bbe8f4f-d085-9302-fa93-9512411ebfc0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_da1a9111-3960-6334-38ac-32be56368293" xlink:to="loc_us-gaap_Revenues_0bbe8f4f-d085-9302-fa93-9512411ebfc0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_01f4f849-ade5-f04f-1204-64d74a0c2886" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_da1a9111-3960-6334-38ac-32be56368293" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_01f4f849-ade5-f04f-1204-64d74a0c2886" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89404ae6-0808-876c-4ac7-0c429ea9ed38" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89404ae6-0808-876c-4ac7-0c429ea9ed38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_0e117598-5e59-61cf-d7cd-38957b1c7098" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_us-gaap_RestructuringCharges_0e117598-5e59-61cf-d7cd-38957b1c7098" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Amortizationandotheracquisitionrelatedcosts" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_ff8c1a7b-e054-a484-6efc-54b532e5bca3" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_cah_Amortizationandotheracquisitionrelatedcosts_ff8c1a7b-e054-a484-6efc-54b532e5bca3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0d10caa9-02ca-dfff-16b0-b48af0dbe41a" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0d10caa9-02ca-dfff-16b0-b48af0dbe41a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_f8b165ba-23a3-ed13-0d25-fe63b9165d30" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_f8b165ba-23a3-ed13-0d25-fe63b9165d30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_497f98e6-8a11-3c53-7076-ee6aaae664ce" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_497f98e6-8a11-3c53-7076-ee6aaae664ce" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_70961961-6a13-30f4-732a-8e29cef0bea0" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:to="loc_us-gaap_InterestExpense_70961961-6a13-30f4-732a-8e29cef0bea0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11843925-b604-1b74-cbbb-bea6e3ba6b7e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11843925-b604-1b74-cbbb-bea6e3ba6b7e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_f1665cc9-2278-4ae5-1778-cb7c3961fee4" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_f1665cc9-2278-4ae5-1778-cb7c3961fee4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_aaf4fade-f652-62f8-cf02-c59447905641" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aaf4fade-f652-62f8-cf02-c59447905641" xlink:to="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_63bbe84c-b938-87b9-5103-68b80738d584" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aaf4fade-f652-62f8-cf02-c59447905641" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_63bbe84c-b938-87b9-5103-68b80738d584" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/DivestituresAndAcquisitions" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/DivestituresAndAcquisitionsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3b4f95d0-4de5-2b2f-e2ec-91daf63ca50c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f60858b4-cb31-daa2-3699-140a0e3df912" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3b4f95d0-4de5-2b2f-e2ec-91daf63ca50c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f60858b4-cb31-daa2-3699-140a0e3df912" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7595492d-e98c-ec24-3583-0c7237508f48" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3b4f95d0-4de5-2b2f-e2ec-91daf63ca50c" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7595492d-e98c-ec24-3583-0c7237508f48" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/Guarantees" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6a75c878-dfaf-e368-936e-ce293fe86f6f" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e64ce807-b602-bc51-7ea1-c0d1711761a2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6a75c878-dfaf-e368-936e-ce293fe86f6f" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e64ce807-b602-bc51-7ea1-c0d1711761a2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1a6d40f3-7f00-0153-1ee4-4e2445fbaeef" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e64ce807-b602-bc51-7ea1-c0d1711761a2" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1a6d40f3-7f00-0153-1ee4-4e2445fbaeef" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_43dfa6b1-2e6b-dd2e-63a9-d4afa4720eb3" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e64ce807-b602-bc51-7ea1-c0d1711761a2" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_43dfa6b1-2e6b-dd2e-63a9-d4afa4720eb3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_fdac4e70-772b-30b7-3f72-25bbd5a5cb16" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e64ce807-b602-bc51-7ea1-c0d1711761a2" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_fdac4e70-772b-30b7-3f72-25bbd5a5cb16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_282d8de6-1466-4351-6593-66c6a3dfd2f5" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6a75c878-dfaf-e368-936e-ce293fe86f6f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_282d8de6-1466-4351-6593-66c6a3dfd2f5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_26aba821-ee13-ac43-8c55-58ad3425d5df" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_282d8de6-1466-4351-6593-66c6a3dfd2f5" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_26aba821-ee13-ac43-8c55-58ad3425d5df" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b9f6e110-c74a-c0ab-a0d7-5b9e884703dc" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_282d8de6-1466-4351-6593-66c6a3dfd2f5" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b9f6e110-c74a-c0ab-a0d7-5b9e884703dc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_19b176a6-0274-96d9-c4cb-ed631a679351" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_282d8de6-1466-4351-6593-66c6a3dfd2f5" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_19b176a6-0274-96d9-c4cb-ed631a679351" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_aaf42fc7-a6ad-75e4-2d48-6e59cc297b47" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_a4c0ee4c-af27-869a-012a-d2f30d9bd2f4" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_aaf42fc7-a6ad-75e4-2d48-6e59cc297b47" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_a4c0ee4c-af27-869a-012a-d2f30d9bd2f4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_6971e943-29d9-e3ce-dab3-c8e93edd2007" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_aaf42fc7-a6ad-75e4-2d48-6e59cc297b47" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_6971e943-29d9-e3ce-dab3-c8e93edd2007" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_aaf42fc7-a6ad-75e4-2d48-6e59cc297b47" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1e1d56b4-3bdf-2fac-470b-de317df367a4" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_aaf42fc7-a6ad-75e4-2d48-6e59cc297b47" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_1e1d56b4-3bdf-2fac-470b-de317df367a4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_7e41d511-b24a-32b9-b40b-50e97bc073c8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_1e1d56b4-3bdf-2fac-470b-de317df367a4" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_7e41d511-b24a-32b9-b40b-50e97bc073c8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_62c3c5a2-308c-6038-2a4e-9ddb5796c793" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7e41d511-b24a-32b9-b40b-50e97bc073c8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_62c3c5a2-308c-6038-2a4e-9ddb5796c793" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_53350f8d-fede-aaab-bd80-c66bd44979d1" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7e41d511-b24a-32b9-b40b-50e97bc073c8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_53350f8d-fede-aaab-bd80-c66bd44979d1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_5e9d5f9f-1caf-4154-2abb-b30812ff970e" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7e41d511-b24a-32b9-b40b-50e97bc073c8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_5e9d5f9f-1caf-4154-2abb-b30812ff970e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_2c39651a-6266-5aee-51d4-82e58f7e57df" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7e41d511-b24a-32b9-b40b-50e97bc073c8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_2c39651a-6266-5aee-51d4-82e58f7e57df" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:label="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_0ddb3399-a01c-f06c-eaad-284336bdc1c3" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7e41d511-b24a-32b9-b40b-50e97bc073c8" xlink:to="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_0ddb3399-a01c-f06c-eaad-284336bdc1c3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_ab30b1c3-0732-1175-5d2a-89d3c944de53" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7e41d511-b24a-32b9-b40b-50e97bc073c8" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_ab30b1c3-0732-1175-5d2a-89d3c944de53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ddb893c9-1cf8-2a42-9640-0f52c0535a5f" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_1e1d56b4-3bdf-2fac-470b-de317df367a4" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ddb893c9-1cf8-2a42-9640-0f52c0535a5f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_21ae8ad8-f66d-202f-9d71-5681f4f2b7ef" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_aaf42fc7-a6ad-75e4-2d48-6e59cc297b47" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_21ae8ad8-f66d-202f-9d71-5681f4f2b7ef" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_4d0d0249-7f43-8eb1-1909-80241b27c420" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_21ae8ad8-f66d-202f-9d71-5681f4f2b7ef" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_4d0d0249-7f43-8eb1-1909-80241b27c420" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a424eec6-2004-55ec-732e-55fca0e0a962" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_21ae8ad8-f66d-202f-9d71-5681f4f2b7ef" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a424eec6-2004-55ec-732e-55fca0e0a962" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_d6a290fd-0c9d-30b4-efec-10f442b2e6e6" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_21ae8ad8-f66d-202f-9d71-5681f4f2b7ef" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_d6a290fd-0c9d-30b4-efec-10f442b2e6e6" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_88432fd7-7b7a-9b90-1335-815c18b74343" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_88432fd7-7b7a-9b90-1335-815c18b74343" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_47023b39-ec79-3ba9-fb53-521ae5f47554" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_47023b39-ec79-3ba9-fb53-521ae5f47554" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_d4bd6cb1-4348-69b2-c613-e89f35f1df8f" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_d4bd6cb1-4348-69b2-c613-e89f35f1df8f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_0200a9d2-1aea-7af8-7758-37fd0ccda2b2" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_0200a9d2-1aea-7af8-7758-37fd0ccda2b2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_7f59a15f-8198-f0cb-1612-a188783a6dec" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_7f59a15f-8198-f0cb-1612-a188783a6dec" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveIncomeTaxRateReconciliationTaxAct2018" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_915d195e-21b4-b992-2d19-284333bcbab5" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_915d195e-21b4-b992-2d19-284333bcbab5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_ec89a76d-6f94-3882-5908-bc13d198d223" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_ec89a76d-6f94-3882-5908-bc13d198d223" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_1d21e416-f240-ff5e-b002-ecf6ecbebcea" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_1d21e416-f240-ff5e-b002-ecf6ecbebcea" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture" xlink:label="loc_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_7cc1a684-6c29-16c8-9536-284333d78882" xlink:type="locator" />
    <link:calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:to="loc_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_7cc1a684-6c29-16c8-9536-284333d78882" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_1426746b-9e39-2fac-a9f6-284333c3fe4d" xlink:type="locator" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_1426746b-9e39-2fac-a9f6-284333c3fe4d" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:label="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_8D9E8EA17901E7041E66C587C3612E14" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:to="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_8D9E8EA17901E7041E66C587C3612E14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_e15e0e78-fc2d-829f-b8e2-54886e0a929b" xlink:type="locator" />
    <link:calculationArc order="12" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_93fd3edf-6334-eee5-46a3-8cd2bed4e1cb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_e15e0e78-fc2d-829f-b8e2-54886e0a929b" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e5f086c5-191b-e277-32f6-cb8b016c6b86" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e5f086c5-191b-e277-32f6-cb8b016c6b86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_46c9f2cc-79e5-baaf-803d-d7debfb02013" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_46c9f2cc-79e5-baaf-803d-d7debfb02013" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/Investments" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/InvestmentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/Leases" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_77713e2c-39c0-2928-ada1-44468992f16e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_255ac63d-d319-d16f-1081-3af76186230c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_77713e2c-39c0-2928-ada1-44468992f16e" xlink:to="loc_us-gaap_VariableLeaseCost_255ac63d-d319-d16f-1081-3af76186230c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_33693773-864e-1cc1-3236-0c5155be3c52" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_77713e2c-39c0-2928-ada1-44468992f16e" xlink:to="loc_us-gaap_OperatingLeaseCost_33693773-864e-1cc1-3236-0c5155be3c52" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetailsCalc2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_ECA611DEF5CBD69492FDE4222A9DB962_77713e2c-39c0-2928-ada1-44468992f16e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_ECA611DEF5CBD69492FDE4222A9DB962_33693773-864e-1cc1-3236-0c5155be3c52" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ECA611DEF5CBD69492FDE4222A9DB962_77713e2c-39c0-2928-ada1-44468992f16e" xlink:to="loc_us-gaap_OperatingLeaseCost_ECA611DEF5CBD69492FDE4222A9DB962_33693773-864e-1cc1-3236-0c5155be3c52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_ECA611DEF5CBD69492FDE4222A9DB962_7f54c327-2f55-648a-30dd-b75d1935dcb8" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ECA611DEF5CBD69492FDE4222A9DB962_77713e2c-39c0-2928-ada1-44468992f16e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_ECA611DEF5CBD69492FDE4222A9DB962_7f54c327-2f55-648a-30dd-b75d1935dcb8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_ECA611DEF5CBD69492FDE4222A9DB962_255ac63d-d319-d16f-1081-3af76186230c" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ECA611DEF5CBD69492FDE4222A9DB962_77713e2c-39c0-2928-ada1-44468992f16e" xlink:to="loc_us-gaap_VariableLeaseCost_ECA611DEF5CBD69492FDE4222A9DB962_255ac63d-d319-d16f-1081-3af76186230c" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_a31684ed-2356-0d85-eb54-e1db259dd282" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1b26ed2d-89b9-5574-412a-b48bbaf33fe0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_a31684ed-2356-0d85-eb54-e1db259dd282" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_1b26ed2d-89b9-5574-412a-b48bbaf33fe0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3c3e63f4-630c-b98c-78f0-49ca0fb25e96" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_a31684ed-2356-0d85-eb54-e1db259dd282" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3c3e63f4-630c-b98c-78f0-49ca0fb25e96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_a8b66d7f-72c7-4ff2-7f1f-84b93ba048de" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f5d89653-9412-3469-28ee-c3579ebc0767" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a8b66d7f-72c7-4ff2-7f1f-84b93ba048de" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f5d89653-9412-3469-28ee-c3579ebc0767" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7098604a-0754-f0ec-28b7-b5aa73ca65d5" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a8b66d7f-72c7-4ff2-7f1f-84b93ba048de" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7098604a-0754-f0ec-28b7-b5aa73ca65d5" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_7e92022d-1815-a8c6-f9d4-6ea045534cf5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c8e34a68-78cf-1f0f-d260-cfd03835a0ac" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_7e92022d-1815-a8c6-f9d4-6ea045534cf5" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c8e34a68-78cf-1f0f-d260-cfd03835a0ac" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_18cd02df-c342-1135-80a4-128981b71541" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_7e92022d-1815-a8c6-f9d4-6ea045534cf5" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_18cd02df-c342-1135-80a4-128981b71541" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_0e117598-5e59-61cf-d7cd-38957b1c7098" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_bc82456d-8f04-6add-4452-4fd7d3855aa8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_0e117598-5e59-61cf-d7cd-38957b1c7098" xlink:to="loc_us-gaap_SeveranceCosts1_bc82456d-8f04-6add-4452-4fd7d3855aa8" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_c70e8c4d-38ea-e44f-6db5-54b535c9d208" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_0e117598-5e59-61cf-d7cd-38957b1c7098" xlink:to="loc_cah_FacilityExitAndOtherCosts_c70e8c4d-38ea-e44f-6db5-54b535c9d208" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccounts" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnaudited" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>cah-20200630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:href="cah-20200630.xsd#CommitmentsContingentLiabilitiesAndLitigation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:href="cah-20200630.xsd#CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:href="cah-20200630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cah-20200630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfEarnings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresAndAcquisitions" xlink:href="cah-20200630.xsd#DivestituresAndAcquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails" xlink:href="cah-20200630.xsd#DivestituresAndAcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresAndAcquisitionsTables" xlink:href="cah-20200630.xsd#DivestituresAndAcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DocumentAndEntityInformation" xlink:href="cah-20200630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:href="cah-20200630.xsd#EarningsPerShareAttributableToCardinalHealthInc" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:href="cah-20200630.xsd#EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:href="cah-20200630.xsd#EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:href="cah-20200630.xsd#EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:href="cah-20200630.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="cah-20200630.xsd#FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:href="cah-20200630.xsd#FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:href="cah-20200630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:href="cah-20200630.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:href="cah-20200630.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Guarantees" xlink:href="cah-20200630.xsd#Guarantees" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:href="cah-20200630.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:href="cah-20200630.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesTables" xlink:href="cah-20200630.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Investments" xlink:href="cah-20200630.xsd#Investments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/InvestmentsDetails" xlink:href="cah-20200630.xsd#InvestmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Leases" xlink:href="cah-20200630.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesDetails" xlink:href="cah-20200630.xsd#LeasesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" xlink:href="cah-20200630.xsd#LeasesScheduleOfFutureLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails" xlink:href="cah-20200630.xsd#LeasesScheduleOfLeaseCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="cah-20200630.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:href="cah-20200630.xsd#LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesTables" xlink:href="cah-20200630.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeverance" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeveranceTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccounts" xlink:href="cah-20200630.xsd#ScheduleIiValuationsAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails" xlink:href="cah-20200630.xsd#ScheduleIiValuationsAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:href="cah-20200630.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:href="cah-20200630.xsd#SegmentInformationAssetsByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails" xlink:href="cah-20200630.xsd#SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:href="cah-20200630.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails" xlink:href="cah-20200630.xsd#SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:href="cah-20200630.xsd#SegmentInformationRevenueByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:href="cah-20200630.xsd#SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:href="cah-20200630.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnaudited" xlink:href="cah-20200630.xsd#SelectedQuarterlyFinancialDataUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" xlink:href="cah-20200630.xsd#SelectedQuarterlyFinancialDataUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedTables" xlink:href="cah-20200630.xsd#SelectedQuarterlyFinancialDataUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:href="cah-20200630.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:href="cah-20200630.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:href="cah-20200630.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="cah-20200630.xsd#ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:href="cah-20200630.xsd#ShareholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:href="cah-20200630.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:to="loc_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1" xlink:to="loc_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1" xlink:to="loc_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_EEEAB1F7CAB617067545064EB39DF635" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:to="loc_srt_MaximumMember_EEEAB1F7CAB617067545064EB39DF635" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_69C47B255EA92E3BF6A3064EB39DD7F3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:to="loc_srt_MinimumMember_69C47B255EA92E3BF6A3064EB39DD7F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_ECEEA1892692362A6C26064EB39E9529" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_ECEEA1892692362A6C26064EB39E9529" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_CC42FE05B275D140A1A6064EB39EB62C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_CC42FE05B275D140A1A6064EB39EB62C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_31A1AB580CB3D9003138064EB39F3667" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_31A1AB580CB3D9003138064EB39F3667" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_A1B5A8461122662AA477064EB39F69D6" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_A1B5A8461122662AA477064EB39F69D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9541103BEE1433EA2477064EB39FE301" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9541103BEE1433EA2477064EB39FE301" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_24DC60AF119D74F9C5BC064EB39F9954" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_NumberOfOperatingSegments_24DC60AF119D74F9C5BC064EB39F9954" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_B65D516B0BF0AF25AAF2064EB39FDD5E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_B65D516B0BF0AF25AAF2064EB39FDD5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_69C143D626DEBDD76915064EB3A09ADA" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_69C143D626DEBDD76915064EB3A09ADA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_FBDE385EB2EB3A1F9DA1064EB3A07B66" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_FBDE385EB2EB3A1F9DA1064EB3A07B66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_EF21E9F0F7FA500D31C5064EB3A09766" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_EF21E9F0F7FA500D31C5064EB3A09766" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_0724C8D2B09CED11ED6DC4ECD055B1C3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_A026CFDEE36B4C0D3CEAC4ECD054B87F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_0724C8D2B09CED11ED6DC4ECD055B1C3" xlink:to="loc_us-gaap_LossContingenciesTable_A026CFDEE36B4C0D3CEAC4ECD054B87F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_BFABB8494199F2623209C4ECD05486A1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_A026CFDEE36B4C0D3CEAC4ECD054B87F" xlink:to="loc_cah_OpioidLitigationAxis_BFABB8494199F2623209C4ECD05486A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F352B98D67D7092EF0E3C4ECD0543A32" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_BFABB8494199F2623209C4ECD05486A1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F352B98D67D7092EF0E3C4ECD0543A32" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_47936590FCCE8800E6BBC4ECD0554BDF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F352B98D67D7092EF0E3C4ECD0543A32" xlink:to="loc_cah_TotalOpioidLitigationMember_47936590FCCE8800E6BBC4ECD0554BDF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_596C8DF3F04B0B7AE5D9C4ECD0555FC3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F352B98D67D7092EF0E3C4ECD0543A32" xlink:to="loc_cah_TotalOpioidLitigationnetoftaxMember_596C8DF3F04B0B7AE5D9C4ECD0555FC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_9B458BF12E73BB593D2EC4ECD055996F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0724C8D2B09CED11ED6DC4ECD055B1C3" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_9B458BF12E73BB593D2EC4ECD055996F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodwillAndIntangibleAssetsLineItems" xlink:label="loc_cah_GoodwillAndIntangibleAssetsLineItems_1AFDA89340C0C9391EDDB5FF91F62743" xlink:type="locator" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodwillAndIntangibleAssetsTable" xlink:label="loc_cah_GoodwillAndIntangibleAssetsTable_594FBE0DBDF2CE8BCE25B5FF91EEA021" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_1AFDA89340C0C9391EDDB5FF91F62743" xlink:to="loc_cah_GoodwillAndIntangibleAssetsTable_594FBE0DBDF2CE8BCE25B5FF91EEA021" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9611934B650493242A6AB5FF91EF9B38" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_594FBE0DBDF2CE8BCE25B5FF91EEA021" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9611934B650493242A6AB5FF91EF9B38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_0DBCA902B1F7632D3D03B5FF91EF68EF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9611934B650493242A6AB5FF91EF9B38" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_0DBCA902B1F7632D3D03B5FF91EF68EF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_0DBCA902B1F7632D3D03B5FF91EF68EF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9611934B650493242A6AB5FF91EF9B38" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_0DBCA902B1F7632D3D03B5FF91EF68EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_F82F75CAC2E0DCB1A766B5FF91F01BAB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_0DBCA902B1F7632D3D03B5FF91EF68EF" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_F82F75CAC2E0DCB1A766B5FF91F01BAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_8D429DE48395183185FEB5FF91F03889" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_594FBE0DBDF2CE8BCE25B5FF91EEA021" xlink:to="loc_srt_RangeAxis_8D429DE48395183185FEB5FF91F03889" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_D02B98140C8FDA3E85ABB5FF91F5B4AD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8D429DE48395183185FEB5FF91F03889" xlink:to="loc_srt_RangeMember_D02B98140C8FDA3E85ABB5FF91F5B4AD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_D02B98140C8FDA3E85ABB5FF91F5B4AD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8D429DE48395183185FEB5FF91F03889" xlink:to="loc_srt_RangeMember_D02B98140C8FDA3E85ABB5FF91F5B4AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_92D4588D769DB90694B2B5FF91F685D2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_D02B98140C8FDA3E85ABB5FF91F5B4AD" xlink:to="loc_srt_MinimumMember_92D4588D769DB90694B2B5FF91F685D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_F41402059CFB23046FCFB5FF91F60941" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_D02B98140C8FDA3E85ABB5FF91F5B4AD" xlink:to="loc_srt_MaximumMember_F41402059CFB23046FCFB5FF91F60941" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_5016A167D467D3FC9F90B5FF91F6AB13" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_1AFDA89340C0C9391EDDB5FF91F62743" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_5016A167D467D3FC9F90B5FF91F6AB13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_7E3032E7F71F25499228B5FF91F7680A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_1AFDA89340C0C9391EDDB5FF91F62743" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_7E3032E7F71F25499228B5FF91F7680A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DiscountRatefairvalueinputs" xlink:label="loc_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_1AFDA89340C0C9391EDDB5FF91F62743" xlink:to="loc_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_BEE47AE99F308C23FBF7B5FF91F7F04F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_1AFDA89340C0C9391EDDB5FF91F62743" xlink:to="loc_us-gaap_NumberOfOperatingSegments_BEE47AE99F308C23FBF7B5FF91F7F04F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:to="loc_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_BC8B7317AA71C52331FC064EB3AD64D1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071" xlink:to="loc_srt_MajorCustomersAxis_BC8B7317AA71C52331FC064EB3AD64D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_740FE08DD09C2DF1187D064EB3AED872_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_BC8B7317AA71C52331FC064EB3AD64D1" xlink:to="loc_srt_NameOfMajorCustomerDomain_740FE08DD09C2DF1187D064EB3AED872_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_740FE08DD09C2DF1187D064EB3AED872" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_BC8B7317AA71C52331FC064EB3AD64D1" xlink:to="loc_srt_NameOfMajorCustomerDomain_740FE08DD09C2DF1187D064EB3AED872" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GroupPurchasingOrganizationsMember" xlink:label="loc_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_740FE08DD09C2DF1187D064EB3AED872" xlink:to="loc_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:label="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:to="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_CC4AADCDF766CE3B8E10064EB3AF3AE2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_CC4AADCDF766CE3B8E10064EB3AF3AE2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6AD952CFFC7812AEFDE0064EB3A79B03" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5DEA1A20F1870E4573F4064EB3A4ADC3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6AD952CFFC7812AEFDE0064EB3A79B03" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5DEA1A20F1870E4573F4064EB3A4ADC3" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ADEA82A83E3111F22693064EB3A5B353" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5DEA1A20F1870E4573F4064EB3A4ADC3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ADEA82A83E3111F22693064EB3A5B353" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17381C5079B341FD3689064EB3A51586_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ADEA82A83E3111F22693064EB3A5B353" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17381C5079B341FD3689064EB3A51586_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17381C5079B341FD3689064EB3A51586" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ADEA82A83E3111F22693064EB3A5B353" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17381C5079B341FD3689064EB3A51586" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_AB561E399CD191A39875064EB3A540EA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17381C5079B341FD3689064EB3A51586" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_AB561E399CD191A39875064EB3A540EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_EEE4294E0E45C82B9287064EB3A563D3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17381C5079B341FD3689064EB3A51586" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_EEE4294E0E45C82B9287064EB3A563D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_B63CAE2C595674203A0D064EB3A6D82B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17381C5079B341FD3689064EB3A51586" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_B63CAE2C595674203A0D064EB3A6D82B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_EEF6E63D362C707C1245064EB3A694CE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5DEA1A20F1870E4573F4064EB3A4ADC3" xlink:to="loc_srt_RangeAxis_EEF6E63D362C707C1245064EB3A694CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_AAA8072C8179A2822EE3064EB3A65C28_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_EEF6E63D362C707C1245064EB3A694CE" xlink:to="loc_srt_RangeMember_AAA8072C8179A2822EE3064EB3A65C28_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_AAA8072C8179A2822EE3064EB3A65C28" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_EEF6E63D362C707C1245064EB3A694CE" xlink:to="loc_srt_RangeMember_AAA8072C8179A2822EE3064EB3A65C28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_ABB1A32DDB6B0C23EB6D064EB3A68C5C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_AAA8072C8179A2822EE3064EB3A65C28" xlink:to="loc_srt_MinimumMember_ABB1A32DDB6B0C23EB6D064EB3A68C5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9B31D27B43304C58248D064EB3A6C535" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_AAA8072C8179A2822EE3064EB3A65C28" xlink:to="loc_srt_MaximumMember_9B31D27B43304C58248D064EB3A6C535" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7B4F19EA7F1631BA5BF5064EB3A741C0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6AD952CFFC7812AEFDE0064EB3A79B03" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7B4F19EA7F1631BA5BF5064EB3A741C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_FCD3F566815411FCF720064EB3A7835F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6AD952CFFC7812AEFDE0064EB3A79B03" xlink:to="loc_us-gaap_Depreciation_FCD3F566815411FCF720064EB3A7835F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_121C963EBFCEBCE17E01064EB3B83306" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_121C963EBFCEBCE17E01064EB3B83306" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_76062F4F8A22F148455B064EB3B821AE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_121C963EBFCEBCE17E01064EB3B83306" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_76062F4F8A22F148455B064EB3B821AE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_76062F4F8A22F148455B064EB3B821AE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_121C963EBFCEBCE17E01064EB3B83306" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_76062F4F8A22F148455B064EB3B821AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_9B9758844D9C4E6C523C064EB3B9B1E8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_76062F4F8A22F148455B064EB3B821AE" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_9B9758844D9C4E6C523C064EB3B9B1E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_29A64E1798EA2B0665AE064EB3B9DD69" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_76062F4F8A22F148455B064EB3B821AE" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_29A64E1798EA2B0665AE064EB3B9DD69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_8B46ACC3864D5B8F45C1064EB3B96165" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:to="loc_srt_RangeAxis_8B46ACC3864D5B8F45C1064EB3B96165" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_B7047A76368F3D0CF6B6064EB3B9E340_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8B46ACC3864D5B8F45C1064EB3B96165" xlink:to="loc_srt_RangeMember_B7047A76368F3D0CF6B6064EB3B9E340_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_B7047A76368F3D0CF6B6064EB3B9E340" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8B46ACC3864D5B8F45C1064EB3B96165" xlink:to="loc_srt_RangeMember_B7047A76368F3D0CF6B6064EB3B9E340" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1DC9DD832B5E2817AF5E064EB3BA550E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_B7047A76368F3D0CF6B6064EB3B9E340" xlink:to="loc_srt_MinimumMember_1DC9DD832B5E2817AF5E064EB3BA550E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_C4F7CA967C40B01E84D9064EB3BA04EF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_B7047A76368F3D0CF6B6064EB3B9E340" xlink:to="loc_srt_MaximumMember_C4F7CA967C40B01E84D9064EB3BA04EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_CA4D52CF732D4D810511064EB3BA4DC6" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_CA4D52CF732D4D810511064EB3BA4DC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaap_ReceivableTypeDomain_CFE29001504C3047DA21064EB3BA8830_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_CA4D52CF732D4D810511064EB3BA4DC6" xlink:to="loc_us-gaap_ReceivableTypeDomain_CFE29001504C3047DA21064EB3BA8830_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaap_ReceivableTypeDomain_CFE29001504C3047DA21064EB3BA8830" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_CA4D52CF732D4D810511064EB3BA4DC6" xlink:to="loc_us-gaap_ReceivableTypeDomain_CFE29001504C3047DA21064EB3BA8830" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_205C8E6B83881DA3DC4A064EB3BB24AB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_205C8E6B83881DA3DC4A064EB3BB24AB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ReceivableFinancingAgreementTerm" xlink:label="loc_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:to="loc_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableNet" xlink:label="loc_us-gaap_NotesReceivableNet_E494DFB69F6E5233A534064EB3BB5405" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:to="loc_us-gaap_NotesReceivableNet_E494DFB69F6E5233A534064EB3BB5405" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_68B4563223042ADD5D53064EB3BBD944" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_68B4563223042ADD5D53064EB3BBD944" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6D204303806E79C2015FDD8506135B62" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6D204303806E79C2015FDD8506135B62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_932C1C3A0684010B2D93DD850613F3E1_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6D204303806E79C2015FDD8506135B62" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_932C1C3A0684010B2D93DD850613F3E1_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_932C1C3A0684010B2D93DD850613F3E1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6D204303806E79C2015FDD8506135B62" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_932C1C3A0684010B2D93DD850613F3E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_35FE7C4155323B696E15DD8506142434" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_35FE7C4155323B696E15DD8506142434" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_A6E3C82709E95B33D8BCDD850614188D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_35FE7C4155323B696E15DD8506142434" xlink:to="loc_us-gaap_TypeOfAdoptionMember_A6E3C82709E95B33D8BCDD850614188D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_A6E3C82709E95B33D8BCDD850614188D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_35FE7C4155323B696E15DD8506142434" xlink:to="loc_us-gaap_TypeOfAdoptionMember_A6E3C82709E95B33D8BCDD850614188D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:to="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_7E3AA3DE7A68D45C1771DD850615713A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_7E3AA3DE7A68D45C1771DD850615713A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" xlink:label="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:to="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails" xlink:type="extended">
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodsandservicessoldLineItems" xlink:label="loc_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3" xlink:type="locator" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodsandservicessoldTable" xlink:label="loc_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3" xlink:to="loc_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:to="loc_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811" xlink:to="loc_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811" xlink:to="loc_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaap_ShippingAndHandlingMember_BADD039969B7627346AF064EB38BEA05" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B" xlink:to="loc_us-gaap_ShippingAndHandlingMember_BADD039969B7627346AF064EB38BEA05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_BAFC52764AA23A12BBB7064EB38B6EA5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_BAFC52764AA23A12BBB7064EB38B6EA5" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_160DBEC11BAC1997CBD1064EB3B22ABA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_160DBEC11BAC1997CBD1064EB3B22ABA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_B87CEC7F240A2E55B5A5064EB3B2EA0B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_160DBEC11BAC1997CBD1064EB3B22ABA" xlink:to="loc_us-gaap_SegmentDomain_B87CEC7F240A2E55B5A5064EB3B2EA0B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_B87CEC7F240A2E55B5A5064EB3B2EA0B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_160DBEC11BAC1997CBD1064EB3B22ABA" xlink:to="loc_us-gaap_SegmentDomain_B87CEC7F240A2E55B5A5064EB3B2EA0B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_43AC0EE9CE5D04C2F0C0064EB3B3FCDA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_B87CEC7F240A2E55B5A5064EB3B2EA0B" xlink:to="loc_cah_PharmaceuticalMember_43AC0EE9CE5D04C2F0C0064EB3B3FCDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:to="loc_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9" xlink:to="loc_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9" xlink:to="loc_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CVSCaremarkCorporationMember" xlink:label="loc_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:to="loc_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OptumRxMember" xlink:label="loc_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:to="loc_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_653E1BCC90973C8125E9064EB3B4F442" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_653E1BCC90973C8125E9064EB3B4F442" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:label="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:to="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LawsuitTypeAxis" xlink:label="loc_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LawsuitTypeDomain" xlink:label="loc_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:to="loc_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LawsuitTypeDomain" xlink:label="loc_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:to="loc_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ClassActionLawsuitsMember" xlink:label="loc_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005" xlink:to="loc_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PlaintiffTypeAxis" xlink:label="loc_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PlaintiffTypeDomain" xlink:label="loc_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:to="loc_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PlaintiffTypeDomain" xlink:label="loc_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:to="loc_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PrivatePartiesMember" xlink:label="loc_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993" xlink:to="loc_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_D2C1FBE521F533A10EDBE4F266FA47FC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_cah_OpioidLitigationAxis_D2C1FBE521F533A10EDBE4F266FA47FC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_A504A74EC1C9BF3F1499E4F266FA15CC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_D2C1FBE521F533A10EDBE4F266FA47FC" xlink:to="loc_cah_OpioidLitigationDomain_A504A74EC1C9BF3F1499E4F266FA15CC_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_A504A74EC1C9BF3F1499E4F266FA15CC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_D2C1FBE521F533A10EDBE4F266FA47FC" xlink:to="loc_cah_OpioidLitigationDomain_A504A74EC1C9BF3F1499E4F266FA15CC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_63817EA92916BF43C36FE4F266FB3418" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_A504A74EC1C9BF3F1499E4F266FA15CC" xlink:to="loc_cah_TotalOpioidLitigationnetoftaxMember_63817EA92916BF43C36FE4F266FB3418" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_E69840A55A12CF56F7AAE4F266FBA0FB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_A504A74EC1C9BF3F1499E4F266FA15CC" xlink:to="loc_cah_TotalOpioidLitigationMember_E69840A55A12CF56F7AAE4F266FBA0FB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GownRecallAxis" xlink:label="loc_cah_GownRecallAxis_8B5FB66D9A9B544A9841E4F266FB2391" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_cah_GownRecallAxis_8B5FB66D9A9B544A9841E4F266FB2391" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_F896145E7A29E704195DE4F266FBCB74_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_GownRecallAxis_8B5FB66D9A9B544A9841E4F266FB2391" xlink:to="loc_cah_GownRecallDomain_F896145E7A29E704195DE4F266FBCB74_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_F896145E7A29E704195DE4F266FBCB74" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_GownRecallAxis_8B5FB66D9A9B544A9841E4F266FB2391" xlink:to="loc_cah_GownRecallDomain_F896145E7A29E704195DE4F266FBCB74" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_SterileSurgicalGownRecallMemberDomain" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_GownRecallAxis_8B5FB66D9A9B544A9841E4F266FB2391" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_808E9655A39C7E768E11E4F266FC3C3C" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_srt_RangeAxis_808E9655A39C7E768E11E4F266FC3C3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_3BC1B89A16F9A70668BBE4F266FCFAED_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_808E9655A39C7E768E11E4F266FC3C3C" xlink:to="loc_srt_RangeMember_3BC1B89A16F9A70668BBE4F266FCFAED_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_3BC1B89A16F9A70668BBE4F266FCFAED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_808E9655A39C7E768E11E4F266FC3C3C" xlink:to="loc_srt_RangeMember_3BC1B89A16F9A70668BBE4F266FCFAED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_568429AB002BFF7986C3E4F266FCDB14" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3BC1B89A16F9A70668BBE4F266FCFAED" xlink:to="loc_srt_MinimumMember_568429AB002BFF7986C3E4F266FCDB14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_B7D8479E7DE7853D15E8E4F266FC2626" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3BC1B89A16F9A70668BBE4F266FCFAED" xlink:to="loc_srt_MaximumMember_B7D8479E7DE7853D15E8E4F266FC2626" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119" xlink:to="loc_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119" xlink:to="loc_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:to="loc_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LitigationTypeAxis" xlink:label="loc_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LitigationTypeDomain" xlink:label="loc_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:to="loc_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LitigationTypeDomain" xlink:label="loc_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:to="loc_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ClassActionLawsuitsMember" xlink:label="loc_cah_ClassActionLawsuitsMember_29CEE1701BA5DCFD3B63E4F26703B575" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32" xlink:to="loc_cah_ClassActionLawsuitsMember_29CEE1701BA5DCFD3B63E4F26703B575" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_3C3B6FB2C3400F0423A3E4F267032903" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_srt_StatementGeographicalAxis_3C3B6FB2C3400F0423A3E4F267032903" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_CCC1E62FFB5378990F00E4F267043CA4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_3C3B6FB2C3400F0423A3E4F267032903" xlink:to="loc_srt_SegmentGeographicalDomain_CCC1E62FFB5378990F00E4F267043CA4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_CCC1E62FFB5378990F00E4F267043CA4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_3C3B6FB2C3400F0423A3E4F267032903" xlink:to="loc_srt_SegmentGeographicalDomain_CCC1E62FFB5378990F00E4F267043CA4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AlamedaCountyMember" xlink:label="loc_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_CCC1E62FFB5378990F00E4F267043CA4" xlink:to="loc_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OtherJurisdictionsMember" xlink:label="loc_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_CCC1E62FFB5378990F00E4F267043CA4" xlink:to="loc_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_2FC144582B23A455E70FE4F267059E80" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_srt_MajorCustomersAxis_2FC144582B23A455E70FE4F267059E80" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_7537FCE576797D252904E4F267053B11_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_2FC144582B23A455E70FE4F267059E80" xlink:to="loc_srt_NameOfMajorCustomerDomain_7537FCE576797D252904E4F267053B11_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_7537FCE576797D252904E4F267053B11" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_2FC144582B23A455E70FE4F267059E80" xlink:to="loc_srt_NameOfMajorCustomerDomain_7537FCE576797D252904E4F267053B11" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_1DC9707C8EB1AD664CBCE4F26705D4C9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7537FCE576797D252904E4F267053B11" xlink:to="loc_cah_CVSHealthMember_1DC9707C8EB1AD664CBCE4F26705D4C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C" xlink:to="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C" xlink:to="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:to="loc_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLawsuitsStateDomain" xlink:label="loc_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:to="loc_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_E367C047E2AF5768E4EEE4F2670CC4A4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_E367C047E2AF5768E4EEE4F2670CC4A4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:to="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:to="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_EA94F10A738D69BE0183E4F2670DD1D0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926" xlink:to="loc_us-gaap_SubsequentEventMember_EA94F10A738D69BE0183E4F2670DD1D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_B004444270C90B6B1D3CE4F2670D711E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_LitigationReserve_B004444270C90B6B1D3CE4F2670D711E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CashComponentForSettlementFrameworkTerm" xlink:label="loc_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRecallExpense" xlink:label="loc_us-gaap_InventoryRecallExpense_A8AAF1D270B5D0BA7AA4E4F2670EAA54" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_InventoryRecallExpense_A8AAF1D270B5D0BA7AA4E4F2670EAA54" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MaximumQuarterlyPayment" xlink:label="loc_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_BC24CF81B273875EF0CBE4F2670E7850" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_BC24CF81B273875EF0CBE4F2670E7850" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_E84F61A0453080425FBFE4F2670FC998" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_E84F61A0453080425FBFE4F2670FC998" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2A4A50E8E0AC74FD6AD8E4F2670F78B2" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2A4A50E8E0AC74FD6AD8E4F2670F78B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_845630B1D6547349B991E4F26F33B679" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_845630B1D6547349B991E4F26F33B679" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_IncomefromSettlementsofClassActionLawsuits" xlink:label="loc_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_8081B88345B6152E519AE4F267149D0B" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_8081B88345B6152E519AE4F267149D0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8C5FD0D4943FAB06E2C5E4F26714157E" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8C5FD0D4943FAB06E2C5E4F26714157E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidTotalSettlementCuyahogaandSummitCounties" xlink:label="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_F958C6569E1677C1DA36E4F267158030" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_F958C6569E1677C1DA36E4F267158030" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LossContingencyLawsuitsNumber" xlink:label="loc_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:label="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_59FA159A28AB19B1489FE457F1C4966C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_AF24462AFA43B4C92FACE457F1C17562" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_59FA159A28AB19B1489FE457F1C4966C" xlink:to="loc_us-gaap_StatementTable_AF24462AFA43B4C92FACE457F1C17562" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_AF24462AFA43B4C92FACE457F1C17562" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD" xlink:to="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD" xlink:to="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_C9CB369BD92D9ED19984E457F1C2F2AC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:to="loc_us-gaap_CommonStockMember_C9CB369BD92D9ED19984E457F1C2F2AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_7956F1A400BB6D849480E457F1C3F751" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:to="loc_us-gaap_RetainedEarningsMember_7956F1A400BB6D849480E457F1C3F751" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_2E3BCB4817923CC7D3A3E457F1C39D21" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:to="loc_us-gaap_TreasuryStockMember_2E3BCB4817923CC7D3A3E457F1C39D21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7CC217BC102F4D5F9BE2E457F1C3464E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7CC217BC102F4D5F9BE2E457F1C3464E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9B142BF7EF0B34A82C13E457F1C323D7" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:to="loc_us-gaap_NoncontrollingInterestMember_9B142BF7EF0B34A82C13E457F1C323D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_152AF61C5544993318ADE457F1C4B053" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_59FA159A28AB19B1489FE457F1C4966C" xlink:to="loc_us-gaap_NetIncomeLoss_152AF61C5544993318ADE457F1C4B053" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_59FA159A28AB19B1489FE457F1C4966C" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_467DFB0A6993C5EA8A18E457F1C4A352" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_CommonStockSharesIssued_467DFB0A6993C5EA8A18E457F1C4A352" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_800D1504D356630A72A2E457F1C42A4F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_800D1504D356630A72A2E457F1C42A4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_769844D0342F4F1CF4D4E457F1C5C6C3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_TreasuryStockShares_769844D0342F4F1CF4D4E457F1C5C6C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_AC0E80F38FB51C6485BAE457F1C502B0" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_TreasuryStockValue_AC0E80F38FB51C6485BAE457F1C502B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_29FD05C31B317E1A7A42E457F1C54AFA" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_ProfitLoss_29FD05C31B317E1A7A42E457F1C54AFA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:label="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A2BEAB627C30195BE794E457F1C51F9C" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A2BEAB627C30195BE794E457F1C51F9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_87297F5B7109C9F38DE4E457F1C5AB90" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_87297F5B7109C9F38DE4E457F1C5AB90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1B438BC40B223F92851FE457F1C68714" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1B438BC40B223F92851FE457F1C68714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_B1E875A89524AA21F814E457F1C6E4BC" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_B1E875A89524AA21F814E457F1C6E4BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_F12BF709787E2DFD1B16E457F1C6C3DE" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_F12BF709787E2DFD1B16E457F1C6C3DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_CE6E1D3866943017BD77E457F1C6503D" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_CE6E1D3866943017BD77E457F1C6503D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_C17FF57DBE6FF325EA6EE457F1C6513A" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_Dividends_C17FF57DBE6FF325EA6EE457F1C6513A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="loc_us-gaap_StockholdersEquityOther_3056893B0F030C51AD62E457F1C6A1B6" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_StockholdersEquityOther_3056893B0F030C51AD62E457F1C6A1B6" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/DivestituresAndAcquisitions" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:to="loc_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04" xlink:to="loc_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04" xlink:to="loc_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviOwnershipInterestDivestedMember" xlink:label="loc_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568" xlink:to="loc_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87818BAA480F8062B875E438CD3FB651" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87818BAA480F8062B875E438CD3FB651" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7AB3BE35C898214169D6E438CD3FE69C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87818BAA480F8062B875E438CD3FB651" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7AB3BE35C898214169D6E438CD3FE69C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7AB3BE35C898214169D6E438CD3FE69C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87818BAA480F8062B875E438CD3FB651" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7AB3BE35C898214169D6E438CD3FE69C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember" xlink:label="loc_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7AB3BE35C898214169D6E438CD3FE69C" xlink:to="loc_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_9E34F005ECFF422B4DEFE438CD3FCC78" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7AB3BE35C898214169D6E438CD3FE69C" xlink:to="loc_cah_NaviHealthMember_9E34F005ECFF422B4DEFE438CD3FCC78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_F881ACC08521EE1356DAE438CD40EE80" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_F881ACC08521EE1356DAE438CD40EE80" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_CECA96EE052C37AB7DB0E438CD4081A7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_F881ACC08521EE1356DAE438CD40EE80" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_CECA96EE052C37AB7DB0E438CD4081A7_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_CECA96EE052C37AB7DB0E438CD4081A7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_F881ACC08521EE1356DAE438CD40EE80" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_CECA96EE052C37AB7DB0E438CD4081A7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_CE91806E0D86644C00FBE438CD405892" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_CECA96EE052C37AB7DB0E438CD4081A7" xlink:to="loc_cah_PatientRecoveryBusinessMember_CE91806E0D86644C00FBE438CD405892" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_84696551568311F83776E438CD41017C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:to="loc_srt_RangeAxis_84696551568311F83776E438CD41017C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_48085023287076CA58FBE438CD418AB1_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_84696551568311F83776E438CD41017C" xlink:to="loc_srt_RangeMember_48085023287076CA58FBE438CD418AB1_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_48085023287076CA58FBE438CD418AB1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_84696551568311F83776E438CD41017C" xlink:to="loc_srt_RangeMember_48085023287076CA58FBE438CD418AB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_607BC68423FE7B3C4B5DE438CD41E89E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_607BC68423FE7B3C4B5DE438CD41E89E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_607BC68423FE7B3C4B5DE438CD41E89E" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_607BC68423FE7B3C4B5DE438CD41E89E" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_F8A66132E056219273A7E438CD42D6C5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0" xlink:to="loc_cah_PatientRecoveryBusinessMember_F8A66132E056219273A7E438CD42D6C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_22181AD30FA19356BD44E438CD42D1A3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_22181AD30FA19356BD44E438CD42D1A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_C974BF5C311D27320708E438CD435715" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_C974BF5C311D27320708E438CD435715" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4591EADCD4943F8B9015E438CD4308B4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4591EADCD4943F8B9015E438CD4308B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_6A4D96F6C076B40F401FE438CD43CBCB" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_6A4D96F6C076B40F401FE438CD43CBCB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PartnershipOwnership" xlink:label="loc_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_6A1964F55350C67D5F89E438CD440716" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_cah_PreTaxGainonDivestiture_6A1964F55350C67D5F89E438CD440716" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7B2D851E8940AB497F9CE438CD44F4C2" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7B2D851E8940AB497F9CE438CD44F4C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1858C9D62FAA8E0968E3E438CD44B849" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1858C9D62FAA8E0968E3E438CD44B849" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_BusinessCombinationTransactionandintegrationcosts" xlink:label="loc_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_330B61B60CC93512830BE438CD444E82" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_EquityMethodInvestments_330B61B60CC93512830BE438CD444E82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8426AC05673F269990A6E438D27388A1" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8426AC05673F269990A6E438D27388A1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Provisionaltaxbenefitrelatedtotransaction" xlink:label="loc_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_B9D3CEA04F31DECD0CC7E438CD455DA2" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_B9D3CEA04F31DECD0CC7E438CD455DA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_0C3185266062ECFBD549E438CD45E4FF" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_0C3185266062ECFBD549E438CD45E4FF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TaxExpenseasaResultofSaleofInvestment" xlink:label="loc_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6445D6630A03A26FE704E438CD4512CC" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6445D6630A03A26FE704E438CD4512CC" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/DivestituresAndAcquisitionsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_AF5A2E06CCA03057F906064EB2253BB6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_AF5A2E06CCA03057F906064EB2253BB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_95E44859CD52A5E41833064EB2267776" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_95E44859CD52A5E41833064EB2267776" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8349386C845F16779A7C064EB226C272" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8349386C845F16779A7C064EB226C272" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_24A754A45B4FB7520981064EB2261EE4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_24A754A45B4FB7520981064EB2261EE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_89CE0C1F1574E1A27079064EB227006C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_89CE0C1F1574E1A27079064EB227006C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_FD05F81FE8215A9397A3064EB227FFB2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_FD05F81FE8215A9397A3064EB227FFB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_E489A5D3F918DA6EF617064EB22753BE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_E489A5D3F918DA6EF617064EB22753BE" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_D79AB4811CA0845BA19F077B0201DDA4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_D79AB4811CA0845BA19F077B0201DDA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98E9A3A51CFC7C6FAA80077B02010601_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_D79AB4811CA0845BA19F077B0201DDA4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98E9A3A51CFC7C6FAA80077B02010601_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98E9A3A51CFC7C6FAA80077B02010601" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_D79AB4811CA0845BA19F077B0201DDA4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98E9A3A51CFC7C6FAA80077B02010601" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3B0739383EF6E5679043077B0202D81D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98E9A3A51CFC7C6FAA80077B02010601" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3B0739383EF6E5679043077B0202D81D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_D4C6B147228365F4C162077B0202AEE8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98E9A3A51CFC7C6FAA80077B02010601" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_D4C6B147228365F4C162077B0202AEE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_B43E415EB66632E21AE0077B0202FCEF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98E9A3A51CFC7C6FAA80077B02010601" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_B43E415EB66632E21AE0077B0202FCEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_09BE1DBF3D0CEA40B103077B0202C037" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_09BE1DBF3D0CEA40B103077B0202C037" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3DB1F71DE5ED53A890CC077B0202C50C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_09BE1DBF3D0CEA40B103077B0202C037" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3DB1F71DE5ED53A890CC077B0202C50C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3DB1F71DE5ED53A890CC077B0202C50C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_09BE1DBF3D0CEA40B103077B0202C037" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3DB1F71DE5ED53A890CC077B0202C50C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5A90B479E72F4A4B974B077B0203F0DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3DB1F71DE5ED53A890CC077B0202C50C" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5A90B479E72F4A4B974B077B0203F0DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_58C519A3F3BD3EF8DFBD077B020478F2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_58C519A3F3BD3EF8DFBD077B020478F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_FA113901F2DA96D0EEE9077B02045EDA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_FA113901F2DA96D0EEE9077B02045EDA" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:to="loc_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1" xlink:to="loc_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1" xlink:to="loc_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_B7A4B2F154845583F62BDE51401BF8EA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_B7A4B2F154845583F62BDE51401BF8EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0" xlink:to="loc_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0" xlink:to="loc_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_E90CC3E563DB57D7B851DE51401C50FA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:to="loc_us-gaap_FairValueHedgingMember_E90CC3E563DB57D7B851DE51401C50FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_033D019D18C7A670A864DE51401DB617" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:to="loc_us-gaap_CashFlowHedgingMember_033D019D18C7A670A864DE51401DB617" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_B49F07B5A6F8E9725C3DDE51401E37F9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:to="loc_us-gaap_InterestRateSwapMember_B49F07B5A6F8E9725C3DDE51401E37F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_1D3219008EEBBAD58BA2DE51401E4D2A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:to="loc_us-gaap_CurrencySwapMember_1D3219008EEBBAD58BA2DE51401E4D2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2063C6DE70FC070C7CF8DE51401F32A6" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:to="loc_us-gaap_ForeignExchangeContractMember_2063C6DE70FC070C7CF8DE51401F32A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:to="loc_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_5964184582E648169555DE514020F598" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_5964184582E648169555DE514020F598" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_476DE8FBCE90D46DA294DE51402017F6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_476DE8FBCE90D46DA294DE51402017F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_85BD0AF9721464296371DE5149685707" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_85BD0AF9721464296371DE5149685707" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_E4C8B39E60D801A80B33DE579BD9CFC1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_E4C8B39E60D801A80B33DE579BD9CFC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_6D2962D1BA7439879AF2DE51402085FB" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_6D2962D1BA7439879AF2DE51402085FB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_8B6572DDB9C166611BB3C141C69E4DA5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_EABBC3789B8FFAED077EC141C69BF840" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_8B6572DDB9C166611BB3C141C69E4DA5" xlink:to="loc_us-gaap_DerivativeTable_EABBC3789B8FFAED077EC141C69BF840" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_531A654D95F7ACE7392CC141C69B6286" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_EABBC3789B8FFAED077EC141C69BF840" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_531A654D95F7ACE7392CC141C69B6286" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_F9423A34AA9FA3BC2880C141C69CBE22_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_531A654D95F7ACE7392CC141C69B6286" xlink:to="loc_us-gaap_HedgingRelationshipDomain_F9423A34AA9FA3BC2880C141C69CBE22_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_F9423A34AA9FA3BC2880C141C69CBE22" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_531A654D95F7ACE7392CC141C69B6286" xlink:to="loc_us-gaap_HedgingRelationshipDomain_F9423A34AA9FA3BC2880C141C69CBE22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_6CB40A27D1DD7AE8E30DC141C69C47EA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_F9423A34AA9FA3BC2880C141C69CBE22" xlink:to="loc_us-gaap_FairValueHedgingMember_6CB40A27D1DD7AE8E30DC141C69C47EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_B185B1D2CAA6C1F16A03C141C69C7EE4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_F9423A34AA9FA3BC2880C141C69CBE22" xlink:to="loc_us-gaap_CashFlowHedgingMember_B185B1D2CAA6C1F16A03C141C69C7EE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_B717681E1C18744EF9F7C141C69C41A1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_EABBC3789B8FFAED077EC141C69BF840" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_B717681E1C18744EF9F7C141C69C41A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_B717681E1C18744EF9F7C141C69C41A1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_B717681E1C18744EF9F7C141C69C41A1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_FE63B4A325D1E035A741C141C69D35F8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:to="loc_us-gaap_InterestRateSwapMember_FE63B4A325D1E035A741C141C69D35F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_EA974B5675BB49F2F923C141C69DF77D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:to="loc_us-gaap_ForeignExchangeContractMember_EA974B5675BB49F2F923C141C69DF77D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember" xlink:label="loc_us-gaap_ForwardContractsMember_6238286375496738DD5CC141C69D4A5E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:to="loc_us-gaap_ForwardContractsMember_6238286375496738DD5CC141C69D4A5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_A470C6F459CABEC28F9AC141C69E4EB3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:to="loc_us-gaap_CurrencySwapMember_A470C6F459CABEC28F9AC141C69E4EB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaap_CommodityContractMember_210BD55CA9F13F484C30C141C69E76DC" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:to="loc_us-gaap_CommodityContractMember_210BD55CA9F13F484C30C141C69E76DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="loc_us-gaap_DerivativeNotionalAmount_39E297BF6A5F558BF4B9C144202F72A1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8B6572DDB9C166611BB3C141C69E4DA5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_39E297BF6A5F558BF4B9C144202F72A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_3ADD341D40B7AC99BED9C141C69E67AB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8B6572DDB9C166611BB3C141C69E4DA5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_3ADD341D40B7AC99BED9C141C69E67AB" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_A2D0D9E29BBCB207EF85064EB20AE10F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:to="loc_us-gaap_HedgingDesignationAxis_A2D0D9E29BBCB207EF85064EB20AE10F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_696EC7AC71ACF755F36C064EB20BFBE2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_A2D0D9E29BBCB207EF85064EB20AE10F" xlink:to="loc_us-gaap_HedgingDesignationDomain_696EC7AC71ACF755F36C064EB20BFBE2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_696EC7AC71ACF755F36C064EB20BFBE2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_A2D0D9E29BBCB207EF85064EB20AE10F" xlink:to="loc_us-gaap_HedgingDesignationDomain_696EC7AC71ACF755F36C064EB20BFBE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_419C9E6871F0E5260D5E064EB20BEBBC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_696EC7AC71ACF755F36C064EB20BFBE2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_419C9E6871F0E5260D5E064EB20BEBBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_957135AFD139D13D878F064EB20BDDA8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_957135AFD139D13D878F064EB20BDDA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_F493876053DD0F680B9B064EB20B177C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_957135AFD139D13D878F064EB20BDDA8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_F493876053DD0F680B9B064EB20B177C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_F493876053DD0F680B9B064EB20B177C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_957135AFD139D13D878F064EB20BDDA8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_F493876053DD0F680B9B064EB20B177C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_7A6CCAF6C942C3783976064EB20CB7F9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_F493876053DD0F680B9B064EB20B177C" xlink:to="loc_us-gaap_CashFlowHedgingMember_7A6CCAF6C942C3783976064EB20CB7F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_DB4101AEF3CF3986719E064EB20C5480" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_F493876053DD0F680B9B064EB20B177C" xlink:to="loc_us-gaap_FairValueHedgingMember_DB4101AEF3CF3986719E064EB20C5480" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_100730B1EDDEFA2DE625064EB20C58AD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_100730B1EDDEFA2DE625064EB20C58AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_100730B1EDDEFA2DE625064EB20C58AD" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_100730B1EDDEFA2DE625064EB20C58AD" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1DA88162BFD01BF3A10D064EB20D1374" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1DA88162BFD01BF3A10D064EB20D1374" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_99CBA30FDE3005F8A972064EB20D07A6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4" xlink:to="loc_us-gaap_InterestRateSwapMember_99CBA30FDE3005F8A972064EB20D07A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_66D1C2F40240457C37B6064EB20D1945" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_66D1C2F40240457C37B6064EB20D1945" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaap_CommodityContractMember_8D4130C3737B362C3DDB064EB20D4F34" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4" xlink:to="loc_us-gaap_CommodityContractMember_8D4130C3737B362C3DDB064EB20D4F34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_B8365E7C98A6AD853FC8064EB20E0818" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:to="loc_us-gaap_OtherAssetsMember_B8365E7C98A6AD853FC8064EB20E0818" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0BC29F5AFF4BD797A28E064EB20E2B1F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0BC29F5AFF4BD797A28E064EB20E2B1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_3E86411DF0B01CFBC5AD064EB20E334A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_3E86411DF0B01CFBC5AD064EB20E334A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DeferredIncomeTaxesandOtherLiabilitiesMember" xlink:label="loc_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:to="loc_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_D10F828DADE441D12263064EB20F3433" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_D10F828DADE441D12263064EB20F3433" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7491BF822C9A752C1C68064EB20F9222" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7491BF822C9A752C1C68064EB20F9222" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_5F4A0D1F56718993C7CEB5681FF9729B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_FB3B3A723691D644C749B5681FF69B02" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_5F4A0D1F56718993C7CEB5681FF9729B" xlink:to="loc_us-gaap_DerivativeTable_FB3B3A723691D644C749B5681FF69B02" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_95682FA99AEDE34D9320B5681FF68A0D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_FB3B3A723691D644C749B5681FF69B02" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_95682FA99AEDE34D9320B5681FF68A0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_C7F8A74D08838B4426A3B5681FF7ACA5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_95682FA99AEDE34D9320B5681FF68A0D" xlink:to="loc_us-gaap_HedgingRelationshipDomain_C7F8A74D08838B4426A3B5681FF7ACA5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_C7F8A74D08838B4426A3B5681FF7ACA5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_95682FA99AEDE34D9320B5681FF68A0D" xlink:to="loc_us-gaap_HedgingRelationshipDomain_C7F8A74D08838B4426A3B5681FF7ACA5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_17BC08A5BD1CBB682F85B5681FF75D06" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_C7F8A74D08838B4426A3B5681FF7ACA5" xlink:to="loc_us-gaap_CashFlowHedgingMember_17BC08A5BD1CBB682F85B5681FF75D06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8FEB151CED8E0FC5DD03B5681FF7A10D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_FB3B3A723691D644C749B5681FF69B02" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8FEB151CED8E0FC5DD03B5681FF7A10D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8FEB151CED8E0FC5DD03B5681FF7A10D" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8FEB151CED8E0FC5DD03B5681FF7A10D" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember" xlink:label="loc_us-gaap_ForwardContractsMember_0F126400AD0335FB2B3DB56A4514F96A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66" xlink:to="loc_us-gaap_ForwardContractsMember_0F126400AD0335FB2B3DB56A4514F96A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_D8F994A5922FF2661E5FB5681FF84A4F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66" xlink:to="loc_us-gaap_InterestRateSwapMember_D8F994A5922FF2661E5FB5681FF84A4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaap_CommodityContractMember_7DAEA8DB5B526EB469EAB5681FF819F8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66" xlink:to="loc_us-gaap_CommodityContractMember_7DAEA8DB5B526EB469EAB5681FF819F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_29D7C2CFE40E878C665EB5681FF85505" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66" xlink:to="loc_us-gaap_ForeignExchangeContractMember_29D7C2CFE40E878C665EB5681FF85505" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_81930D56F9AAA2AE13B6B5681FF913D2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5F4A0D1F56718993C7CEB5681FF9729B" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_81930D56F9AAA2AE13B6B5681FF913D2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_A2436C6BD982E0652410DE7650269637" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_22A138D9B19C1DA11ECADE765022F2CB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_A2436C6BD982E0652410DE7650269637" xlink:to="loc_us-gaap_DerivativeTable_22A138D9B19C1DA11ECADE765022F2CB" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C5BAB4CC8342D8D0B96EDE7650237EBC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_22A138D9B19C1DA11ECADE765022F2CB" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C5BAB4CC8342D8D0B96EDE7650237EBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_FDF5F72EC5594C797A50DE7650231AA4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C5BAB4CC8342D8D0B96EDE7650237EBC" xlink:to="loc_us-gaap_HedgingRelationshipDomain_FDF5F72EC5594C797A50DE7650231AA4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_FDF5F72EC5594C797A50DE7650231AA4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C5BAB4CC8342D8D0B96EDE7650237EBC" xlink:to="loc_us-gaap_HedgingRelationshipDomain_FDF5F72EC5594C797A50DE7650231AA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_C4026F83AC1BD8E92FC9DE765023FF05" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_FDF5F72EC5594C797A50DE7650231AA4" xlink:to="loc_us-gaap_CashFlowHedgingMember_C4026F83AC1BD8E92FC9DE765023FF05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3AB29C99D67285E13AFCDE765024117A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_22A138D9B19C1DA11ECADE765022F2CB" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3AB29C99D67285E13AFCDE765024117A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_163D4AFD4A452D9E6BCCDE765024C700_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3AB29C99D67285E13AFCDE765024117A" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_163D4AFD4A452D9E6BCCDE765024C700_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_163D4AFD4A452D9E6BCCDE765024C700" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3AB29C99D67285E13AFCDE765024117A" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_163D4AFD4A452D9E6BCCDE765024C700" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_EE82D8C87DEAE6E78AA6DE765024FC14" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_163D4AFD4A452D9E6BCCDE765024C700" xlink:to="loc_us-gaap_ForeignExchangeContractMember_EE82D8C87DEAE6E78AA6DE765024FC14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember" xlink:label="loc_us-gaap_ForwardContractsMember_A9C472195480FB0406D4DE765025718E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_163D4AFD4A452D9E6BCCDE765024C700" xlink:to="loc_us-gaap_ForwardContractsMember_A9C472195480FB0406D4DE765025718E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaap_CommodityContractMember_2AE824A5810EE7C67EEEDE765025520C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_163D4AFD4A452D9E6BCCDE765024C700" xlink:to="loc_us-gaap_CommodityContractMember_2AE824A5810EE7C67EEEDE765025520C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7D531114B0EC57BC7689DE765025F448" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_22A138D9B19C1DA11ECADE765022F2CB" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7D531114B0EC57BC7689DE765025F448" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7D531114B0EC57BC7689DE765025F448" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7D531114B0EC57BC7689DE765025F448" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember_721101DD2BA28DCC9A0FDE765025C273" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556" xlink:to="loc_us-gaap_SalesMember_721101DD2BA28DCC9A0FDE765025C273" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_822E070734E1DF720988DE765026C3BF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556" xlink:to="loc_us-gaap_CostOfSalesMember_822E070734E1DF720988DE765026C3BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0020C039FF809F66CEE5DE7650269628" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0020C039FF809F66CEE5DE7650269628" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_A6EC90C8900595DBA420DE765026B61C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556" xlink:to="loc_us-gaap_InterestExpenseMember_A6EC90C8900595DBA420DE765026B61C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2C454ACE3FB39AAB1911DE7650262655" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_A2436C6BD982E0652410DE7650269637" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2C454ACE3FB39AAB1911DE7650262655" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_D6D52805B4ECDA47550E064EB1954BC4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_CB5400A5DE843CE346E1064EB193A062" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_D6D52805B4ECDA47550E064EB1954BC4" xlink:to="loc_us-gaap_DerivativeTable_CB5400A5DE843CE346E1064EB193A062" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_3238C8ADF3DFDB7740DA064EB19353BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_CB5400A5DE843CE346E1064EB193A062" xlink:to="loc_us-gaap_HedgingDesignationAxis_3238C8ADF3DFDB7740DA064EB19353BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_4991457DA5C8D57FA6D3064EB1938F46_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_3238C8ADF3DFDB7740DA064EB19353BB" xlink:to="loc_us-gaap_HedgingDesignationDomain_4991457DA5C8D57FA6D3064EB1938F46_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_4991457DA5C8D57FA6D3064EB1938F46" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_3238C8ADF3DFDB7740DA064EB19353BB" xlink:to="loc_us-gaap_HedgingDesignationDomain_4991457DA5C8D57FA6D3064EB1938F46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_403BA32C7DEAD389C1E9064EB1938D45" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_4991457DA5C8D57FA6D3064EB1938F46" xlink:to="loc_us-gaap_NondesignatedMember_403BA32C7DEAD389C1E9064EB1938D45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_A8E4B10ACC90908CDECE064EB19406B1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_CB5400A5DE843CE346E1064EB193A062" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_A8E4B10ACC90908CDECE064EB19406B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5E16AABAF09CD3A50E41064EB1948F41_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_A8E4B10ACC90908CDECE064EB19406B1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5E16AABAF09CD3A50E41064EB1948F41_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5E16AABAF09CD3A50E41064EB1948F41" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_A8E4B10ACC90908CDECE064EB19406B1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5E16AABAF09CD3A50E41064EB1948F41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_96A838CCB248FB70F4DA064EB1944999" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5E16AABAF09CD3A50E41064EB1948F41" xlink:to="loc_us-gaap_ForeignExchangeContractMember_96A838CCB248FB70F4DA064EB1944999" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1058EBFEDE149F8AD97A064EB194822E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_CB5400A5DE843CE346E1064EB193A062" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1058EBFEDE149F8AD97A064EB194822E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3AC7FC468C4B8AAED01F064EB1955FC6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1058EBFEDE149F8AD97A064EB194822E" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3AC7FC468C4B8AAED01F064EB1955FC6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3AC7FC468C4B8AAED01F064EB1955FC6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1058EBFEDE149F8AD97A064EB194822E" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3AC7FC468C4B8AAED01F064EB1955FC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_DCB928F876FD07865D96064EB1953986" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3AC7FC468C4B8AAED01F064EB1955FC6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_DCB928F876FD07865D96064EB1953986" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_FCBB534680F140539CEF064EB195E21F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_D6D52805B4ECDA47550E064EB1954BC4" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_FCBB534680F140539CEF064EB195E21F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_19B24FEF196D86DA49D0064EB1F5FC32" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_160F8A6A0845A03E33E6064EB1EF7A98" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_19B24FEF196D86DA49D0064EB1F5FC32" xlink:to="loc_us-gaap_DerivativeTable_160F8A6A0845A03E33E6064EB1EF7A98" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_20E5255515A450613D11064EB1EFD2DD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_160F8A6A0845A03E33E6064EB1EF7A98" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_20E5255515A450613D11064EB1EFD2DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_043313DCFC0C4E2D5C8D064EB1EF4119_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_20E5255515A450613D11064EB1EFD2DD" xlink:to="loc_us-gaap_HedgingRelationshipDomain_043313DCFC0C4E2D5C8D064EB1EF4119_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_043313DCFC0C4E2D5C8D064EB1EF4119" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_20E5255515A450613D11064EB1EFD2DD" xlink:to="loc_us-gaap_HedgingRelationshipDomain_043313DCFC0C4E2D5C8D064EB1EF4119" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_655C56BBFA2AFAD78E30064EB1F0B154" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_043313DCFC0C4E2D5C8D064EB1EF4119" xlink:to="loc_us-gaap_FairValueHedgingMember_655C56BBFA2AFAD78E30064EB1F0B154" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_E3E562C8ED86ADBB6509064EB1F0BAD6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_160F8A6A0845A03E33E6064EB1EF7A98" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_E3E562C8ED86ADBB6509064EB1F0BAD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_B51BC3B98636ECDF130E064EB1F0FC83_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_E3E562C8ED86ADBB6509064EB1F0BAD6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_B51BC3B98636ECDF130E064EB1F0FC83_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_B51BC3B98636ECDF130E064EB1F0FC83" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_E3E562C8ED86ADBB6509064EB1F0BAD6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_B51BC3B98636ECDF130E064EB1F0FC83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_CB3C9544D03FBE2469B0064EB1F048A5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_B51BC3B98636ECDF130E064EB1F0FC83" xlink:to="loc_us-gaap_InterestRateSwapMember_CB3C9544D03FBE2469B0064EB1F048A5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FixedRateDebtMember" xlink:label="loc_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_B51BC3B98636ECDF130E064EB1F0FC83" xlink:to="loc_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_160F8A6A0845A03E33E6064EB1EF7A98" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_39CF7377A649BAC47B88064EB1F10554" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF" xlink:to="loc_us-gaap_InterestExpenseMember_39CF7377A649BAC47B88064EB1F10554" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_582B623A1A26D258A960064EB1F5604B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_19B24FEF196D86DA49D0064EB1F5FC32" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_582B623A1A26D258A960064EB1F5604B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_90DF3E8516F47846BBB9C4ECCD38908B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_90DF3E8516F47846BBB9C4ECCD38908B" xlink:to="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_9BA82437FACD745DB8EAC4ECCD2E2F21" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:to="loc_us-gaap_HedgingDesignationAxis_9BA82437FACD745DB8EAC4ECCD2E2F21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_1E09D3EE84C99C7603A1C4ECCD2FD552_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_9BA82437FACD745DB8EAC4ECCD2E2F21" xlink:to="loc_us-gaap_HedgingDesignationDomain_1E09D3EE84C99C7603A1C4ECCD2FD552_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_1E09D3EE84C99C7603A1C4ECCD2FD552" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_9BA82437FACD745DB8EAC4ECCD2E2F21" xlink:to="loc_us-gaap_HedgingDesignationDomain_1E09D3EE84C99C7603A1C4ECCD2FD552" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_131014EA533B32BE8E47C4ECCD2FE8D3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_1E09D3EE84C99C7603A1C4ECCD2FD552" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_131014EA533B32BE8E47C4ECCD2FE8D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0B077E4E60331FA2B0A2C4ECCD2F6F51" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0B077E4E60331FA2B0A2C4ECCD2F6F51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_B073BE561CC5B73FC17EC4ECCD30CB53_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0B077E4E60331FA2B0A2C4ECCD2F6F51" xlink:to="loc_us-gaap_HedgingRelationshipDomain_B073BE561CC5B73FC17EC4ECCD30CB53_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_B073BE561CC5B73FC17EC4ECCD30CB53" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0B077E4E60331FA2B0A2C4ECCD2F6F51" xlink:to="loc_us-gaap_HedgingRelationshipDomain_B073BE561CC5B73FC17EC4ECCD30CB53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_4CB316E79A649DF627DFC4ECCD3046FB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_B073BE561CC5B73FC17EC4ECCD30CB53" xlink:to="loc_us-gaap_FairValueHedgingMember_4CB316E79A649DF627DFC4ECCD3046FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_16E5201821E3F3B8BE1EC4ECCD31B1FB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_B073BE561CC5B73FC17EC4ECCD30CB53" xlink:to="loc_us-gaap_CashFlowHedgingMember_16E5201821E3F3B8BE1EC4ECCD31B1FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_02E7F94DC80F84B0C9ABC4ECCD31E4D8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_02E7F94DC80F84B0C9ABC4ECCD31E4D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_02E7F94DC80F84B0C9ABC4ECCD31E4D8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_02E7F94DC80F84B0C9ABC4ECCD31E4D8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_57AC5682CC46FEC5646AC4ECCD365656" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6" xlink:to="loc_us-gaap_InterestRateSwapMember_57AC5682CC46FEC5646AC4ECCD365656" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_8FCA73D0976F6355CDC7C4ECCD363D1A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_8FCA73D0976F6355CDC7C4ECCD363D1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaap_CommodityContractMember_66DD3C0DA01570FF61CEC4ECCD36FDDF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6" xlink:to="loc_us-gaap_CommodityContractMember_66DD3C0DA01570FF61CEC4ECCD36FDDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_8074221AD114CB216588C4ECCD374766" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6" xlink:to="loc_us-gaap_CashFlowHedgingMember_8074221AD114CB216588C4ECCD374766" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_A56FD3CA5C5D5FCA6BACC4ECCD37AB86" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:to="loc_srt_RangeAxis_A56FD3CA5C5D5FCA6BACC4ECCD37AB86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_834218E75440313C2966C4ECCD375A43_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_A56FD3CA5C5D5FCA6BACC4ECCD37AB86" xlink:to="loc_srt_RangeMember_834218E75440313C2966C4ECCD375A43_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_834218E75440313C2966C4ECCD375A43" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_A56FD3CA5C5D5FCA6BACC4ECCD37AB86" xlink:to="loc_srt_RangeMember_834218E75440313C2966C4ECCD375A43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_BFF73B7A12BAAAC061C7C4ECCD379D82" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_834218E75440313C2966C4ECCD375A43" xlink:to="loc_srt_MinimumMember_BFF73B7A12BAAAC061C7C4ECCD379D82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_436A1348DEB855276707C4ECCD382FF8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_834218E75440313C2966C4ECCD375A43" xlink:to="loc_srt_MaximumMember_436A1348DEB855276707C4ECCD382FF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_A50A80DE3D63DB48D765C4ECCD3833FD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_90DF3E8516F47846BBB9C4ECCD38908B" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_A50A80DE3D63DB48D765C4ECCD3833FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_5A62F688B86A2236E717C4ECCD386F17" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_90DF3E8516F47846BBB9C4ECCD38908B" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_5A62F688B86A2236E717C4ECCD386F17" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BE141BDB859D2D3FE594C4ECCD397422" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_90DF3E8516F47846BBB9C4ECCD38908B" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BE141BDB859D2D3FE594C4ECCD397422" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_ADE28FFF219C04D56DB8C4ECCCECD7EF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_85ABEA010DF354382525C4ECCCE96930" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_ADE28FFF219C04D56DB8C4ECCCECD7EF" xlink:to="loc_us-gaap_DerivativeTable_85ABEA010DF354382525C4ECCCE96930" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_55CB21C271343C866310C4ECCCE98640" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_85ABEA010DF354382525C4ECCCE96930" xlink:to="loc_srt_RangeAxis_55CB21C271343C866310C4ECCCE98640" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1DBE334C29D11ACD259CC4ECCCE90BB6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_55CB21C271343C866310C4ECCCE98640" xlink:to="loc_srt_RangeMember_1DBE334C29D11ACD259CC4ECCCE90BB6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1DBE334C29D11ACD259CC4ECCCE90BB6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_55CB21C271343C866310C4ECCCE98640" xlink:to="loc_srt_RangeMember_1DBE334C29D11ACD259CC4ECCCE90BB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_C7FDA7126421D42921AAC4ECCCEA62EB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1DBE334C29D11ACD259CC4ECCCE90BB6" xlink:to="loc_srt_MinimumMember_C7FDA7126421D42921AAC4ECCCEA62EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_C77D598B6BF6A96B9838C4ECCCEAE211" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1DBE334C29D11ACD259CC4ECCCE90BB6" xlink:to="loc_srt_MaximumMember_C77D598B6BF6A96B9838C4ECCCEAE211" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_65BA34425473709EBC50C4ECCCEAC1E4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_85ABEA010DF354382525C4ECCCE96930" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_65BA34425473709EBC50C4ECCCEAC1E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_DF4D8F938F8C6A068D28C4ECCCEAE46B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_65BA34425473709EBC50C4ECCCEAC1E4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_DF4D8F938F8C6A068D28C4ECCCEAE46B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_DF4D8F938F8C6A068D28C4ECCCEAE46B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_65BA34425473709EBC50C4ECCCEAC1E4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_DF4D8F938F8C6A068D28C4ECCCEAE46B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_19975C47E43D02D3E4A1C4ECCCEB3AB6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_DF4D8F938F8C6A068D28C4ECCCEAE46B" xlink:to="loc_us-gaap_ForeignExchangeContractMember_19975C47E43D02D3E4A1C4ECCCEB3AB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_37EB4E79E42020A5272DC4ECCCEBC06D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_85ABEA010DF354382525C4ECCCE96930" xlink:to="loc_us-gaap_HedgingDesignationAxis_37EB4E79E42020A5272DC4ECCCEBC06D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_728A0453B8D91734E067C4ECCCEC789D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_37EB4E79E42020A5272DC4ECCCEBC06D" xlink:to="loc_us-gaap_HedgingDesignationDomain_728A0453B8D91734E067C4ECCCEC789D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_728A0453B8D91734E067C4ECCCEC789D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_37EB4E79E42020A5272DC4ECCCEBC06D" xlink:to="loc_us-gaap_HedgingDesignationDomain_728A0453B8D91734E067C4ECCCEC789D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_758D8158D97AE24AF9F7C4ECCCECB5D9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_728A0453B8D91734E067C4ECCCEC789D" xlink:to="loc_us-gaap_NondesignatedMember_758D8158D97AE24AF9F7C4ECCCECB5D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_F21ECF549D34A1C60F70C4ECCCEDE2B8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ADE28FFF219C04D56DB8C4ECCCECD7EF" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_F21ECF549D34A1C60F70C4ECCCEDE2B8" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_20288F505E3E92FF267FC4ECCD65E1A5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_20288F505E3E92FF267FC4ECCD65E1A5" xlink:to="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_67CBEAE6B5EF0A385D80C4ECCD5C45E2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:to="loc_us-gaap_HedgingDesignationAxis_67CBEAE6B5EF0A385D80C4ECCD5C45E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_AA7FA9109E5439930CADC4ECCD5DB1EB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_67CBEAE6B5EF0A385D80C4ECCD5C45E2" xlink:to="loc_us-gaap_HedgingDesignationDomain_AA7FA9109E5439930CADC4ECCD5DB1EB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_AA7FA9109E5439930CADC4ECCD5DB1EB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_67CBEAE6B5EF0A385D80C4ECCD5C45E2" xlink:to="loc_us-gaap_HedgingDesignationDomain_AA7FA9109E5439930CADC4ECCD5DB1EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_41D1D4A5A0FE302D26E7C4ECCD5D4F96" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_AA7FA9109E5439930CADC4ECCD5DB1EB" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_41D1D4A5A0FE302D26E7C4ECCD5D4F96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E8B88B103FC9491A31F9C4ECCD5DFBF8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E8B88B103FC9491A31F9C4ECCD5DFBF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_299842E8F230B261EDA2C4ECCD5E180D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E8B88B103FC9491A31F9C4ECCD5DFBF8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_299842E8F230B261EDA2C4ECCD5E180D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_299842E8F230B261EDA2C4ECCD5E180D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E8B88B103FC9491A31F9C4ECCD5DFBF8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_299842E8F230B261EDA2C4ECCD5E180D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_00598A164800C8F496E1C4ECCD5E20BD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_299842E8F230B261EDA2C4ECCD5E180D" xlink:to="loc_us-gaap_FairValueHedgingMember_00598A164800C8F496E1C4ECCD5E20BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_F4C7EBCBBFA884A09750C4ECCD5ECA5F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_F4C7EBCBBFA884A09750C4ECCD5ECA5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_BEE02290A05A33FBCFB7C4ECCD5E7FE4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_F4C7EBCBBFA884A09750C4ECCD5ECA5F" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_BEE02290A05A33FBCFB7C4ECCD5E7FE4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_BEE02290A05A33FBCFB7C4ECCD5E7FE4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_F4C7EBCBBFA884A09750C4ECCD5ECA5F" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_BEE02290A05A33FBCFB7C4ECCD5E7FE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_1BE287D102C9ED2EF9E4C4ECCD64B75C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_BEE02290A05A33FBCFB7C4ECCD5E7FE4" xlink:to="loc_us-gaap_InterestRateSwapMember_1BE287D102C9ED2EF9E4C4ECCD64B75C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_E9A49621CFA2C6548D6CC4ECCD64DE30" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:to="loc_srt_RangeAxis_E9A49621CFA2C6548D6CC4ECCD64DE30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_6E77F683F42ACED8CBC4C4ECCD64CA27_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_E9A49621CFA2C6548D6CC4ECCD64DE30" xlink:to="loc_srt_RangeMember_6E77F683F42ACED8CBC4C4ECCD64CA27_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_6E77F683F42ACED8CBC4C4ECCD64CA27" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_E9A49621CFA2C6548D6CC4ECCD64DE30" xlink:to="loc_srt_RangeMember_6E77F683F42ACED8CBC4C4ECCD64CA27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_33ACC4D1E31A006B0C40C4ECCD65D3A0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6E77F683F42ACED8CBC4C4ECCD64CA27" xlink:to="loc_srt_MinimumMember_33ACC4D1E31A006B0C40C4ECCD65D3A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_D9DAF4925F5251175460C4ECCD65570F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_20288F505E3E92FF267FC4ECCD65E1A5" xlink:to="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_D9DAF4925F5251175460C4ECCD65570F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_8BEEF5A366133A6CD0F2C4ECCD6502D7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_20288F505E3E92FF267FC4ECCD65E1A5" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_8BEEF5A366133A6CD0F2C4ECCD6502D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_2960AD956102F03D0D2AC4ECCD65293C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_20288F505E3E92FF267FC4ECCD65E1A5" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_2960AD956102F03D0D2AC4ECCD65293C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9462BC4618D056276249B5576F9DA2B5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9462BC4618D056276249B5576F9DA2B5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_10C2A82FD88896AA3FDDB5576F99DB7F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_10C2A82FD88896AA3FDDB5576F99DB7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_10C2A82FD88896AA3FDDB5576F99DB7F" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_10C2A82FD88896AA3FDDB5576F99DB7F" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_04AB712FE8F8DB4C4274B5576F9A756E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6" xlink:to="loc_us-gaap_InterestRateSwapMember_04AB712FE8F8DB4C4274B5576F9A756E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_B9C8ECEB6486BAA78A3DB5576F9AF766" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:to="loc_us-gaap_HedgingDesignationAxis_B9C8ECEB6486BAA78A3DB5576F9AF766" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_5681FD3850E80C99885BB5576F9A431A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_B9C8ECEB6486BAA78A3DB5576F9AF766" xlink:to="loc_us-gaap_HedgingDesignationDomain_5681FD3850E80C99885BB5576F9A431A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_5681FD3850E80C99885BB5576F9A431A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_B9C8ECEB6486BAA78A3DB5576F9AF766" xlink:to="loc_us-gaap_HedgingDesignationDomain_5681FD3850E80C99885BB5576F9A431A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_608790E8F083515FDB63B5576F9AD88E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5681FD3850E80C99885BB5576F9A431A" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_608790E8F083515FDB63B5576F9AD88E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_AD70C33D31F4671FC563B5576F9B5181" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_AD70C33D31F4671FC563B5576F9B5181" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_B0354AF89C9CD9ACA4BCB5576F9BB1B5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_AD70C33D31F4671FC563B5576F9B5181" xlink:to="loc_us-gaap_HedgingRelationshipDomain_B0354AF89C9CD9ACA4BCB5576F9BB1B5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_B0354AF89C9CD9ACA4BCB5576F9BB1B5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_AD70C33D31F4671FC563B5576F9B5181" xlink:to="loc_us-gaap_HedgingRelationshipDomain_B0354AF89C9CD9ACA4BCB5576F9BB1B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_B61AF075A07A0257CFDCB5576F9B7EDD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_B0354AF89C9CD9ACA4BCB5576F9BB1B5" xlink:to="loc_us-gaap_FairValueHedgingMember_B61AF075A07A0257CFDCB5576F9B7EDD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_45CC8387C1B9791854C4B5576F9C69BD" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_45CC8387C1B9791854C4B5576F9C69BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C0C501DDBE417569E37EB5576F9C7F46_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_45CC8387C1B9791854C4B5576F9C69BD" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C0C501DDBE417569E37EB5576F9C7F46_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C0C501DDBE417569E37EB5576F9C7F46" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_45CC8387C1B9791854C4B5576F9C69BD" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C0C501DDBE417569E37EB5576F9C7F46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_B6261751BFAD268B0683B5576F9C451E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C0C501DDBE417569E37EB5576F9C7F46" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_B6261751BFAD268B0683B5576F9C451E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_25B789B37F62A579DAC1B5576F9D5E2C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9462BC4618D056276249B5576F9DA2B5" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_25B789B37F62A579DAC1B5576F9D5E2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_E8300C95EEA64F6B6945B5576F9D36AE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9462BC4618D056276249B5576F9DA2B5" xlink:to="loc_us-gaap_DebtInstrumentFairValue_E8300C95EEA64F6B6945B5576F9D36AE" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:label="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9462BC4618D056276249B5576F9DA2B5" xlink:to="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_C497C3C14099D7F076C4B5576F9D628C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9462BC4618D056276249B5576F9DA2B5" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_C497C3C14099D7F076C4B5576F9D628C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_6FE1734A50DB62A0A3AF064EB2165129" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_BD37C5AAF6BF3F876434064EB2142262" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_6FE1734A50DB62A0A3AF064EB2165129" xlink:to="loc_us-gaap_DerivativeTable_BD37C5AAF6BF3F876434064EB2142262" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_67332E56EFBE78BA0383064EB214B9D3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_BD37C5AAF6BF3F876434064EB2142262" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_67332E56EFBE78BA0383064EB214B9D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9EF67AC46FCE24726356064EB2144B48_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_67332E56EFBE78BA0383064EB214B9D3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9EF67AC46FCE24726356064EB2144B48_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9EF67AC46FCE24726356064EB2144B48" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_67332E56EFBE78BA0383064EB214B9D3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9EF67AC46FCE24726356064EB2144B48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_9A8E6E26B1B8675177E3064EB215246F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9EF67AC46FCE24726356064EB2144B48" xlink:to="loc_us-gaap_FairValueHedgingMember_9A8E6E26B1B8675177E3064EB215246F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_29E47410E6379B094F57064EB215E555" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9EF67AC46FCE24726356064EB2144B48" xlink:to="loc_us-gaap_CashFlowHedgingMember_29E47410E6379B094F57064EB215E555" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_8B1AA5DE51906E563A0D064EB215FDF5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_BD37C5AAF6BF3F876434064EB2142262" xlink:to="loc_us-gaap_HedgingDesignationAxis_8B1AA5DE51906E563A0D064EB215FDF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_1E70313B31ABBB4DB077064EB215FCAD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_8B1AA5DE51906E563A0D064EB215FDF5" xlink:to="loc_us-gaap_HedgingDesignationDomain_1E70313B31ABBB4DB077064EB215FCAD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_1E70313B31ABBB4DB077064EB215FCAD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_8B1AA5DE51906E563A0D064EB215FDF5" xlink:to="loc_us-gaap_HedgingDesignationDomain_1E70313B31ABBB4DB077064EB215FCAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_D779AB8113744D9199A7064EB215C9F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_1E70313B31ABBB4DB077064EB215FCAD" xlink:to="loc_us-gaap_NondesignatedMember_D779AB8113744D9199A7064EB215C9F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_DFC37C9D22A8F7453135064EB2165C2E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6FE1734A50DB62A0A3AF064EB2165129" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_DFC37C9D22A8F7453135064EB2165C2E" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6DEF9E9BF1793892B167DD85E61E0502" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6DEF9E9BF1793892B167DD85E61E0502" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5626FE57320A6714CD7DDD85E61F3698_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6DEF9E9BF1793892B167DD85E61E0502" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5626FE57320A6714CD7DDD85E61F3698_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5626FE57320A6714CD7DDD85E61F3698" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6DEF9E9BF1793892B167DD85E61E0502" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5626FE57320A6714CD7DDD85E61F3698" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember" xlink:label="loc_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_E126F570852817A84912DD85E61FBF8B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5626FE57320A6714CD7DDD85E61F3698" xlink:to="loc_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_E126F570852817A84912DD85E61FBF8B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_0E4FE26D852050E4B7CFDD85E61FB47C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5626FE57320A6714CD7DDD85E61F3698" xlink:to="loc_cah_NaviHealthMember_0E4FE26D852050E4B7CFDD85E61FB47C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5D789C201AA6AD6F26D2DD85E620A34C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5D789C201AA6AD6F26D2DD85E620A34C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_37181042756ED704D137DD85E6208C69_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5D789C201AA6AD6F26D2DD85E620A34C" xlink:to="loc_us-gaap_SegmentDomain_37181042756ED704D137DD85E6208C69_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_37181042756ED704D137DD85E6208C69" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5D789C201AA6AD6F26D2DD85E620A34C" xlink:to="loc_us-gaap_SegmentDomain_37181042756ED704D137DD85E6208C69" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalReportingUnitMember" xlink:label="loc_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_37181042756ED704D137DD85E6208C69" xlink:to="loc_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis" xlink:label="loc_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:to="loc_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9" xlink:to="loc_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9" xlink:to="loc_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalReportingUnitMember" xlink:label="loc_cah_MedicalReportingUnitMember_302CA1C3E4B03627C3FFDD85E621D5CA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F" xlink:to="loc_cah_MedicalReportingUnitMember_302CA1C3E4B03627C3FFDD85E621D5CA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DiscountRatefairvalueinputs" xlink:label="loc_cah_DiscountRatefairvalueinputs_EDC048AE80E8D4201841DD85E62124AE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_cah_DiscountRatefairvalueinputs_EDC048AE80E8D4201841DD85E62124AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_D3E27DD15F574DEC1A03DD85E621A0F5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_D3E27DD15F574DEC1A03DD85E621A0F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_03A3BADE403A345D4547DD85E622D72C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_Goodwill_03A3BADE403A345D4547DD85E622D72C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_97110EB56CE16140457BDD85E622C02B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_97110EB56CE16140457BDD85E622C02B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9FCE732D3E7BB829A585DD85E6229021" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9FCE732D3E7BB829A585DD85E6229021" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33189D6901CC59C740A5DD85E622B752" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33189D6901CC59C740A5DD85E622B752" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_922B2ED18FD93200BC94DD85E6226159" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_922B2ED18FD93200BC94DD85E6226159" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1369D261D5BBFD90D1B1DD85E622A713" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1369D261D5BBFD90D1B1DD85E622A713" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_11C900B8558504E06815DD85E6238B7D" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_11C900B8558504E06815DD85E6238B7D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182" xlink:to="loc_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182" xlink:to="loc_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:to="loc_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:to="loc_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers" xlink:label="loc_us-gaap_GoodwillTransfers_9F51FFEA3FBBE32EB262E412BFCE916D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:to="loc_us-gaap_GoodwillTransfers_9F51FFEA3FBBE32EB262E412BFCE916D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:to="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_A3934E12D59CAFCE9341E412B9C495B3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:to="loc_us-gaap_Goodwill_A3934E12D59CAFCE9341E412B9C495B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73D288E492E2E1163D64E412B9C8E7F6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73D288E492E2E1163D64E412B9C8E7F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_D81A8A7C59D361C98EC1E412B9C8D00A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_D81A8A7C59D361C98EC1E412B9C8D00A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_656C2BB71796CA3246BAE412B9C9892B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_656C2BB71796CA3246BAE412B9C9892B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_IPRDTrademarksandOtherMember" xlink:label="loc_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37" xlink:to="loc_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_E9ABB0E16C330B09D59C064EB33FD193" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_E9ABB0E16C330B09D59C064EB33FD193" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3B318B325A3266C9810D064EB3407BCB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3B318B325A3266C9810D064EB3407BCB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TrademarksAndPatentsMember" xlink:label="loc_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:to="loc_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_BAA80E6C06E7E1AEBC0D064EB341A607" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_BAA80E6C06E7E1AEBC0D064EB341A607" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_DFB6EBC87AB4BF3E17F6064EB3416A99" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_DFB6EBC87AB4BF3E17F6064EB3416A99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_87E22CB079B4C5D56723064EB341B920" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_87E22CB079B4C5D56723064EB341B920" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A03798C7E0231B3DA0B064EB34267B0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A03798C7E0231B3DA0B064EB34267B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_355EF849C74CB1B2992B064EB342EE48" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_355EF849C74CB1B2992B064EB342EE48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_F9F8D7D4374EF7AD7B99064EB342E2EC" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_F9F8D7D4374EF7AD7B99064EB342E2EC" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/Guarantees" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_9C9B0B783AA8757C71D4CA007278FAA6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_cah_OpioidLitigationAxis_9C9B0B783AA8757C71D4CA007278FAA6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_83D1354AC2C9129D2952CA1BC505128C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_9C9B0B783AA8757C71D4CA007278FAA6" xlink:to="loc_cah_OpioidLitigationDomain_83D1354AC2C9129D2952CA1BC505128C_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_83D1354AC2C9129D2952CA1BC505128C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_9C9B0B783AA8757C71D4CA007278FAA6" xlink:to="loc_cah_OpioidLitigationDomain_83D1354AC2C9129D2952CA1BC505128C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_79BDFAA280E245375304CA197D2D057D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_83D1354AC2C9129D2952CA1BC505128C" xlink:to="loc_cah_TotalOpioidLitigationMember_79BDFAA280E245375304CA197D2D057D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TaxMatterAxis" xlink:label="loc_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TaxMatterDomain" xlink:label="loc_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:to="loc_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TaxMatterDomain" xlink:label="loc_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:to="loc_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:to="loc_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CareFusionMember" xlink:label="loc_cah_CareFusionMember_5789E786440FB550550ACA007278DB36" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:to="loc_cah_CareFusionMember_5789E786440FB550550ACA007278DB36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_26F70DAB7E122B1CD4AACA00727F825D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_26F70DAB7E122B1CD4AACA00727F825D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82E38AD86AD772351642CA00727FCC4F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_26F70DAB7E122B1CD4AACA00727F825D" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82E38AD86AD772351642CA00727FCC4F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82E38AD86AD772351642CA00727FCC4F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_26F70DAB7E122B1CD4AACA00727F825D" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82E38AD86AD772351642CA00727FCC4F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_3B80148D5FB855EE4E82CA00727F35ED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82E38AD86AD772351642CA00727FCC4F" xlink:to="loc_cah_PatientRecoveryBusinessMember_3B80148D5FB855EE4E82CA00727F35ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_D73A31326D9CCFCDFA92CA0072805DCB" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_D73A31326D9CCFCDFA92CA0072805DCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_D197736A810DC014D4B4CA007280EFE4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_D73A31326D9CCFCDFA92CA0072805DCB" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_D197736A810DC014D4B4CA007280EFE4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_D197736A810DC014D4B4CA007280EFE4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_D73A31326D9CCFCDFA92CA0072805DCB" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_D197736A810DC014D4B4CA007280EFE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_ACBD9D51BA1F1C388097CA0072811D78" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_ACBD9D51BA1F1C388097CA0072811D78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_9FE9497467FB50D9D863CA007281D784" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_9FE9497467FB50D9D863CA007281D784" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_414189AE5BCB1C075968CA0072816731" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:to="loc_us-gaap_ForeignCountryMember_414189AE5BCB1C075968CA0072816731" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1BAE8C15670E1F820039CA0072815C76" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_srt_RangeAxis_1BAE8C15670E1F820039CA0072815C76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_EE3A96E0694FDC49419ACA00728111BC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1BAE8C15670E1F820039CA0072815C76" xlink:to="loc_srt_RangeMember_EE3A96E0694FDC49419ACA00728111BC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_EE3A96E0694FDC49419ACA00728111BC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1BAE8C15670E1F820039CA0072815C76" xlink:to="loc_srt_RangeMember_EE3A96E0694FDC49419ACA00728111BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_A6F20076C004171B479BCA0072820A84" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_EE3A96E0694FDC49419ACA00728111BC" xlink:to="loc_srt_MinimumMember_A6F20076C004171B479BCA0072820A84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_403A223D3C287D2096E4CA007282A624" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_EE3A96E0694FDC49419ACA00728111BC" xlink:to="loc_srt_MaximumMember_403A223D3C287D2096E4CA007282A624" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_BF2B7E768062CD3D4A03CA0072876493" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_BF2B7E768062CD3D4A03CA0072876493" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_1BE9813F6519916B31D0CA0072889766" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_LitigationReserve_1BE9813F6519916B31D0CA0072889766" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3FAB93880BFF7C724843CA007288CAB7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3FAB93880BFF7C724843CA007288CAB7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:label="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_BA1D701181C56A051845CA007288F7D9" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_BA1D701181C56A051845CA007288F7D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_F21494E97DECA6BFBA0FCA0072886109" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_F21494E97DECA6BFBA0FCA0072886109" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_7E4ADA472D8F1E0E0BECCA0072888589" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_7E4ADA472D8F1E0E0BECCA0072888589" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_30DBC6DB59FF50EC762ECA0072894A2B" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_30DBC6DB59FF50EC762ECA0072894A2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_DA69C0E373966F39660ACA007289A233" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_DA69C0E373966F39660ACA007289A233" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2C85A009EE8181097E9CCA0072892951" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2C85A009EE8181097E9CCA0072892951" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_98713B61E988B374098DCA00728912D4" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_98713B61E988B374098DCA00728912D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_356195757A0D6769D42ACA00728979D0" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_356195757A0D6769D42ACA00728979D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_C1DA5A00CE4D34A856EFCA00728AE932" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_C1DA5A00CE4D34A856EFCA00728AE932" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_E90814F2B01563FB9030CA00728A391E" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_E90814F2B01563FB9030CA00728A391E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8274BBF0B5BE0BF0126CCA00728A9EC7" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8274BBF0B5BE0BF0126CCA00728A9EC7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_EE0EE6364CC904886246CA00728AF60A" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_EE0EE6364CC904886246CA00728AF60A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_A60936AB3CFD6D6BC62ECA00728ADA36" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_A60936AB3CFD6D6BC62ECA00728ADA36" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_IndemnificationReceivable" xlink:label="loc_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_1655E5B09BC16352B7E1CA00728BE298" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_1655E5B09BC16352B7E1CA00728BE298" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2F228BD13C672EEFBE0EC1427618A4D4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2F228BD13C672EEFBE0EC1427618A4D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_293B21C4FAB4D4EF2519C1427618B877_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2F228BD13C672EEFBE0EC1427618A4D4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_293B21C4FAB4D4EF2519C1427618B877_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_293B21C4FAB4D4EF2519C1427618B877" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2F228BD13C672EEFBE0EC1427618A4D4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_293B21C4FAB4D4EF2519C1427618B877" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_06A11252E0CCBDCA7EB8C1427618E210" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_293B21C4FAB4D4EF2519C1427618B877" xlink:to="loc_cah_PatientRecoveryBusinessMember_06A11252E0CCBDCA7EB8C1427618E210" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:to="loc_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386" xlink:to="loc_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386" xlink:to="loc_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4F870BAFE50570459471C142761A9436" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4F870BAFE50570459471C142761A9436" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_796A5D3E7D518E0FC5A8C142761A48D7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_796A5D3E7D518E0FC5A8C142761A48D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9CDAC9D2589202A6AAD3C142761AB326" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9CDAC9D2589202A6AAD3C142761AB326" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_D97C31181747972BF88BC142761A1739" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_D97C31181747972BF88BC142761A1739" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3AC8375A8BADB40C0404C142761AD2FF" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3AC8375A8BADB40C0404C142761AD2FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3BD4ABB1A89EAB9F7194C142761B8491" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3BD4ABB1A89EAB9F7194C142761B8491" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_71A35028291CA5B86F57C142761B3FA9" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_71A35028291CA5B86F57C142761B3FA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4DC26D65F28E335491D6C142761B22DA" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4DC26D65F28E335491D6C142761B22DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_07432BCF6C21CBD35811C142761B1250" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_07432BCF6C21CBD35811C142761B1250" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1364F251829A3AA7DA36C142761B2084" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1364F251829A3AA7DA36C142761B2084" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DA9E9290C0CE6E53125C142761CBCC8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DA9E9290C0CE6E53125C142761CBCC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_092CA76C422A7BF7DBC5C142761CE950" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_092CA76C422A7BF7DBC5C142761CE950" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_E91D2CDE6DFB7B884625C142761CBC81" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_E91D2CDE6DFB7B884625C142761CBC81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4E096B00601D8DDFFB42C142761CE598" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4E096B00601D8DDFFB42C142761CE598" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_CF87D39B9E8A54CBC2FBC142761CBE50" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_CF87D39B9E8A54CBC2FBC142761CBE50" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/Investments" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/InvestmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_D63F17ED12F74D7BEBD1E42C99E4D693" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:to="loc_srt_OwnershipAxis_D63F17ED12F74D7BEBD1E42C99E4D693" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_CE501980EEEEC535E335E42C99E49E3B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_D63F17ED12F74D7BEBD1E42C99E4D693" xlink:to="loc_srt_OwnershipDomain_CE501980EEEEC535E335E42C99E49E3B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_CE501980EEEEC535E335E42C99E49E3B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_D63F17ED12F74D7BEBD1E42C99E4D693" xlink:to="loc_srt_OwnershipDomain_CE501980EEEEC535E335E42C99E49E3B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviOwnershipInterestDivestedMember" xlink:label="loc_cah_NaviOwnershipInterestDivestedMember_42AB87D5F401820DB15EE42C99E5A68F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_CE501980EEEEC535E335E42C99E49E3B" xlink:to="loc_cah_NaviOwnershipInterestDivestedMember_42AB87D5F401820DB15EE42C99E5A68F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_356D6F29EF3388A535F0E42C99E5DBAE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_356D6F29EF3388A535F0E42C99E5DBAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_BDB4EE72473BD528539DE42C99E50CFA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_356D6F29EF3388A535F0E42C99E5DBAE" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_BDB4EE72473BD528539DE42C99E50CFA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_BDB4EE72473BD528539DE42C99E50CFA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_356D6F29EF3388A535F0E42C99E5DBAE" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_BDB4EE72473BD528539DE42C99E50CFA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_5139899E6141FBC2F55CE42C99E5E7A0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_BDB4EE72473BD528539DE42C99E50CFA" xlink:to="loc_cah_NaviHealthMember_5139899E6141FBC2F55CE42C99E5E7A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_665C4E62B645F228EAAEE42C99E6C731" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_665C4E62B645F228EAAEE42C99E6C731" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_0916593D46C777349E63E42C99E68B1F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_0916593D46C777349E63E42C99E68B1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_80CBDFB759B816D077F4E42C99E6E15B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_80CBDFB759B816D077F4E42C99E6E15B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_DB0F7C174C846D352A2EE42C99E6C1B2" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_us-gaap_EquityMethodInvestments_DB0F7C174C846D352A2EE42C99E6C1B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_A3C054E4FCF2AAF17D94E42C99E7C0EB" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_A3C054E4FCF2AAF17D94E42C99E7C0EB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PartnershipOwnership" xlink:label="loc_cah_PartnershipOwnership_C21D6D4CC111A003453AE42C99E7BED7" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_cah_PartnershipOwnership_C21D6D4CC111A003453AE42C99E7BED7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_FFD9950635080300F09AE42C99E71B44" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_cah_PreTaxGainonDivestiture_FFD9950635080300F09AE42C99E71B44" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/Leases" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_8F6BF18C8B48FB170C24DA07310A6D8B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_StatementTable_8F6BF18C8B48FB170C24DA07310A6D8B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_ED931191FC71D0473A96DA07310ABF95" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8F6BF18C8B48FB170C24DA07310A6D8B" xlink:to="loc_srt_RangeAxis_ED931191FC71D0473A96DA07310ABF95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_72C311E82506DCE820B6DA07310A641C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ED931191FC71D0473A96DA07310ABF95" xlink:to="loc_srt_RangeMember_72C311E82506DCE820B6DA07310A641C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_72C311E82506DCE820B6DA07310A641C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ED931191FC71D0473A96DA07310ABF95" xlink:to="loc_srt_RangeMember_72C311E82506DCE820B6DA07310A641C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_7E7FD4C16D4A8B92C3FFDA07310BE2BE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_72C311E82506DCE820B6DA07310A641C" xlink:to="loc_srt_MinimumMember_7E7FD4C16D4A8B92C3FFDA07310BE2BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_C6108ECB3D953031DB07DA07310BDB2F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_72C311E82506DCE820B6DA07310A641C" xlink:to="loc_srt_MaximumMember_C6108ECB3D953031DB07DA07310BDB2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_5BD450D9CC5C24F53CB7DA0747ED6B2D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_LeaseAndRentalExpense_5BD450D9CC5C24F53CB7DA0747ED6B2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3DC595DC5C62EBAF2917DA07310B112E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3DC595DC5C62EBAF2917DA07310B112E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_68F9F17C9A1CFCD67320DA07310CCF6F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_68F9F17C9A1CFCD67320DA07310CCF6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_7B8762045FF62F7C63E7DA07310CDB4D" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_7B8762045FF62F7C63E7DA07310CDB4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1702A5D7664968D481B7DA07310C0913" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1702A5D7664968D481B7DA07310C0913" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_6E34038D529ACC78CC62DA07310C894D" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_6E34038D529ACC78CC62DA07310C894D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_B092BF3FB86CAEAB2453DA07310D0E7A" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_B092BF3FB86CAEAB2453DA07310D0E7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_04A5264C3326DB5EDA27DA07310D2827" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_04A5264C3326DB5EDA27DA07310D2827" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_754C441D89DA484B3CA2DA07310DF0E2" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_754C441D89DA484B3CA2DA07310DF0E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_26B8FA4C2A489F23F593DA07310DCB73" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_26B8FA4C2A489F23F593DA07310DCB73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_858EF78DEFDFAE458624DA07310D91F7" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_858EF78DEFDFAE458624DA07310D91F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_058B1CB701D23487AC4EDA07310D3AB2" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_058B1CB701D23487AC4EDA07310D3AB2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DE1035AD7D5C62645107C0931EDAAFF2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DE1035AD7D5C62645107C0931EDAAFF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_368287E7B197A2028685C0931EDAF385_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DE1035AD7D5C62645107C0931EDAAFF2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_368287E7B197A2028685C0931EDAF385_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_368287E7B197A2028685C0931EDAF385" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DE1035AD7D5C62645107C0931EDAAFF2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_368287E7B197A2028685C0931EDAF385" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OperatingLeaseMember" xlink:label="loc_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_368287E7B197A2028685C0931EDAF385" xlink:to="loc_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FinanceLeaseMember" xlink:label="loc_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_368287E7B197A2028685C0931EDAF385" xlink:to="loc_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48EDC5E0F0A4630D39C5C0931EDBD417" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48EDC5E0F0A4630D39C5C0931EDBD417" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_DFCDA61FF528C3065F74C0931EDC2C48" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_DFCDA61FF528C3065F74C0931EDC2C48" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7769A8018645A9846E03C0931EDC7253" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7769A8018645A9846E03C0931EDC7253" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_76B70A8017068AEBE457C0931EDC3DA7" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_76B70A8017068AEBE457C0931EDC3DA7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_001353955AA549878D6EC0931EDC7463" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_001353955AA549878D6EC0931EDC7463" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_20B6B50FAFA729CCEE59C0931EDC3610" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_20B6B50FAFA729CCEE59C0931EDC3610" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0D600E7FF47D4C430799C0931EDDDDBF" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0D600E7FF47D4C430799C0931EDDDDBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_760948BECBD61079332FC0931EDD4A1E" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_760948BECBD61079332FC0931EDD4A1E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_EAF9CB6F8E92F06BE6BFC0931EDDFE32" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_EAF9CB6F8E92F06BE6BFC0931EDDFE32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_33265FBAB7882A94105BC0931EDE818F" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_33265FBAB7882A94105BC0931EDE818F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798408633149076E3710C0931EDE4938" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798408633149076E3710C0931EDE4938" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_DC7268E5F661418111E4C0931EDEB646" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_DC7268E5F661418111E4C0931EDEB646" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0CF6A7FBB13E260744BDC0931EDEA659" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0CF6A7FBB13E260744BDC0931EDEA659" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_24644C33FF0EEEE2B97BC0931EDED2AB" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_24644C33FF0EEEE2B97BC0931EDED2AB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalLeaseLiabilityPaymentsDue" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59" xlink:type="locator" />
    <link:definitionArc order="23" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9" xlink:type="locator" />
    <link:definitionArc order="24" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OperatingLeaseImputedInterest" xlink:label="loc_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6" xlink:type="locator" />
    <link:definitionArc order="25" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FinanceLeaseImputedInterest" xlink:label="loc_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B" xlink:type="locator" />
    <link:definitionArc order="26" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3" xlink:type="locator" />
    <link:definitionArc order="27" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_C0790FF26CC75D9FDD96C0931EE00011" xlink:type="locator" />
    <link:definitionArc order="28" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_OperatingLeaseLiability_C0790FF26CC75D9FDD96C0931EE00011" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_3DE17E958A8931063D95C0931EE01357" xlink:type="locator" />
    <link:definitionArc order="29" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiability_3DE17E958A8931063D95C0931EE01357" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalLeaseLiability" xlink:label="loc_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D" xlink:type="locator" />
    <link:definitionArc order="30" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_A98C0FF6728C4EF4A752C0931EE8B11D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_661536C2ADBFC7CFCDD4C0931EE7F451" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_A98C0FF6728C4EF4A752C0931EE8B11D" xlink:to="loc_us-gaap_StatementTable_661536C2ADBFC7CFCDD4C0931EE7F451" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_661536C2ADBFC7CFCDD4C0931EE7F451" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ASC842Member" xlink:label="loc_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E" xlink:to="loc_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Impactofadoptionofnewaccountingstandard" xlink:label="loc_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_A98C0FF6728C4EF4A752C0931EE8B11D" xlink:to="loc_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_FC3BBA810F8F1A5D8481DE6EC1FAE151" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_DebtInstrumentTable_FC3BBA810F8F1A5D8481DE6EC1FAE151" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_8B595A761FF6E719E06FDE6EC1FA85CF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_FC3BBA810F8F1A5D8481DE6EC1FAE151" xlink:to="loc_us-gaap_CreditFacilityAxis_8B595A761FF6E719E06FDE6EC1FA85CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_C36AC219176909051620DE6EC1FB3859_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_8B595A761FF6E719E06FDE6EC1FA85CF" xlink:to="loc_us-gaap_CreditFacilityDomain_C36AC219176909051620DE6EC1FB3859_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_C36AC219176909051620DE6EC1FB3859" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_8B595A761FF6E719E06FDE6EC1FA85CF" xlink:to="loc_us-gaap_CreditFacilityDomain_C36AC219176909051620DE6EC1FB3859" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_76183A91EE87A99E32F6DE6EC1FBDB72" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_FC3BBA810F8F1A5D8481DE6EC1FAE151" xlink:to="loc_us-gaap_DebtInstrumentAxis_76183A91EE87A99E32F6DE6EC1FBDB72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_76183A91EE87A99E32F6DE6EC1FBDB72" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_76183A91EE87A99E32F6DE6EC1FBDB72" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A1.948Notesdue2019Member" xlink:label="loc_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.616Notesdue2022Member" xlink:label="loc_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.079Notesdue2024Member" xlink:label="loc_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.41Notesdue2027Member" xlink:label="loc_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.368Notesdue2047Member" xlink:label="loc_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FloatingRateNotesdue2022Member" xlink:label="loc_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OnePointNineFiveNotesdue2018Member" xlink:label="loc_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.4Notesdue2020Member" xlink:label="loc_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.2Notesdue2022Member" xlink:label="loc_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.2Notesdue2023Member" xlink:label="loc_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.5Notesdue2025Member" xlink:label="loc_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.75Notesdue2026Member" xlink:label="loc_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.5Notesdue2044Member" xlink:label="loc_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.6Notesdue2043Member" xlink:label="loc_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.625Notesdue2021Member" xlink:label="loc_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.9Notesdue2045Member" xlink:label="loc_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A7.0Debenturesduefiscal2027Member" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_FC3BBA810F8F1A5D8481DE6EC1FAE151" xlink:to="loc_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2" xlink:to="loc_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11_default" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2" xlink:to="loc_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AllegianceCorporationMember" xlink:label="loc_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11" xlink:to="loc_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1A00D4CFC4FAB7AF41F4DE6EC2004003" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1A00D4CFC4FAB7AF41F4DE6EC2004003" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_571F81A1F9CF2A390B80DE6EC200BAA6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_AccountsPayableCurrent_571F81A1F9CF2A390B80DE6EC200BAA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfNotesPayable_90006F84DCE5913063F7DE6EC20022A9" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfNotesPayable_90006F84DCE5913063F7DE6EC20022A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AB52731F2A4C89916704DE6EC2000816" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AB52731F2A4C89916704DE6EC2000816" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OfferAsPercentageOfPrincipalAmount" xlink:label="loc_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_73F7A4B98A81F9D2FB95DE6EC201C508" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_LineOfCredit_73F7A4B98A81F9D2FB95DE6EC201C508" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2DE109C8C816F40E55FFDE6EC2013C03" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2DE109C8C816F40E55FFDE6EC2013C03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_1C592CD51FB608884FC8DE6EC201E267" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_1C592CD51FB608884FC8DE6EC201E267" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NotesPayableRepurchased" xlink:label="loc_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_A555FD2A7878974A625BDD83F3779488" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_A555FD2A7878974A625BDD83F3779488" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84DF2024C6A7F683398ADD83F377A72B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A555FD2A7878974A625BDD83F3779488" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84DF2024C6A7F683398ADD83F377A72B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84DF2024C6A7F683398ADD83F377A72B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A555FD2A7878974A625BDD83F3779488" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84DF2024C6A7F683398ADD83F377A72B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_C9B622FB0F33B596ECB9DD83F378E4CD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:to="loc_us-gaap_DebtInstrumentAxis_C9B622FB0F33B596ECB9DD83F378E4CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_C9B622FB0F33B596ECB9DD83F378E4CD" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_C9B622FB0F33B596ECB9DD83F378E4CD" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.616Notesdue2022Member" xlink:label="loc_cah_A2.616Notesdue2022Member_B0A9B918FC9D41C12A33DD83F378187C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A2.616Notesdue2022Member_B0A9B918FC9D41C12A33DD83F378187C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.2Notesdue2023Member" xlink:label="loc_cah_A3.2Notesdue2023Member_6391D432F3AAB65535CCDD83F3799A5C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A3.2Notesdue2023Member_6391D432F3AAB65535CCDD83F3799A5C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FloatingRateNotesdue2022Member" xlink:label="loc_cah_FloatingRateNotesdue2022Member_741D0635BAC46B409806DD83F379B9B4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_FloatingRateNotesdue2022Member_741D0635BAC46B409806DD83F379B9B4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.41Notesdue2027Member" xlink:label="loc_cah_A3.41Notesdue2027Member_52A199EA44CDE7CB91E8DD83F3794D78" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A3.41Notesdue2027Member_52A199EA44CDE7CB91E8DD83F3794D78" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.6Notesdue2043Member" xlink:label="loc_cah_A4.6Notesdue2043Member_D3E5F86DA085F1524A49DD83F379A08E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A4.6Notesdue2043Member_D3E5F86DA085F1524A49DD83F379A08E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.9Notesdue2045Member" xlink:label="loc_cah_A4.9Notesdue2045Member_F8867EBD60C4E834F768DD83F37A1D77" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A4.9Notesdue2045Member_F8867EBD60C4E834F768DD83F37A1D77" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.368Notesdue2047Member" xlink:label="loc_cah_A4.368Notesdue2047Member_E8E6E594309767EF74CEDD83F37AE56B" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A4.368Notesdue2047Member_E8E6E594309767EF74CEDD83F37AE56B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OnePointNineFiveNotesdue2018Member" xlink:label="loc_cah_OnePointNineFiveNotesdue2018Member_8C4069C77EBC2F2C6959DD83F37AE46C" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_OnePointNineFiveNotesdue2018Member_8C4069C77EBC2F2C6959DD83F37AE46C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_338F394F3093EA209C6FDD83F37AA4E5" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_338F394F3093EA209C6FDD83F37AA4E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_BC2CEB101EA7751CB129DD83F37B36B7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:to="loc_us-gaap_CreditFacilityAxis_BC2CEB101EA7751CB129DD83F37B36B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_BC2CEB101EA7751CB129DD83F37B36B7" xlink:to="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_BC2CEB101EA7751CB129DD83F37B36B7" xlink:to="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_2CBE1173C37EBC04175ADD83F37B0470" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:to="loc_us-gaap_LetterOfCreditMember_2CBE1173C37EBC04175ADD83F37B0470" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_94BD35603F9A5EBB0184DD83F37CE804" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_94BD35603F9A5EBB0184DD83F37CE804" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_23C8F7709BE856465D4BDD83F37CF220" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_23C8F7709BE856465D4BDD83F37CF220" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_FCAB1B1FE65AB34F9A6EDD83F37C5F08" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:to="loc_us-gaap_CommercialPaperMember_FCAB1B1FE65AB34F9A6EDD83F37C5F08" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_CB6FA5511D09AB671A97DD83F37C46AA" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_CB6FA5511D09AB671A97DD83F37C46AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_066111107A2AB6893E24DD83F37C6A9C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_LineOfCredit_066111107A2AB6893E24DD83F37C6A9C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_5474A154365EC664813DDD83F37D1713" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_dei_DocumentFiscalYearFocus_5474A154365EC664813DDD83F37D1713" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_D2241E67D08C37E0ABCFDD83F37D7511" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_AccountsPayableCurrent_D2241E67D08C37E0ABCFDD83F37D7511" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NotesPayableRepurchased" xlink:label="loc_cah_NotesPayableRepurchased_1EC4BB319D2E162A130CDD83F37D76B5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_cah_NotesPayableRepurchased_1EC4BB319D2E162A130CDD83F37D76B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_C089ED29F4DEA9460899DD83F37EB9BE" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_C089ED29F4DEA9460899DD83F37EB9BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:label="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_0A876BBE98A1BEA46240DD83F37E187C" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_0A876BBE98A1BEA46240DD83F37E187C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfNotesPayable_29387C9FD0CFBC74F43FDD83F37E8769" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfNotesPayable_29387C9FD0CFBC74F43FDD83F37E8769" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AACAF2DFF9D11B55980EDD83F37EC2A6" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AACAF2DFF9D11B55980EDD83F37EC2A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaap_OtherBorrowings_EB0D2A785D2F120D736EDD83F37E706F" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_OtherBorrowings_EB0D2A785D2F120D736EDD83F37E706F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_12EC5C4E4DB0C14D7378DD83F37EABA6" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_12EC5C4E4DB0C14D7378DD83F37EABA6" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:to="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:to="loc_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB" xlink:to="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB" xlink:to="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_39006DA89D7982E2EF27064EB2C04AF6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_39006DA89D7982E2EF27064EB2C04AF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_368D4B9C9EBDA4E70ABA064EB2C00941" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:to="loc_us-gaap_LetterOfCreditMember_368D4B9C9EBDA4E70ABA064EB2C00941" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_335C603C19F403D6EE94064EB2C1D298" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:to="loc_us-gaap_CommercialPaperMember_335C603C19F403D6EE94064EB2C1D298" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_B2FF73E26ECFF923C6D9064EB2C12F2C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:to="loc_us-gaap_DebtInstrumentAxis_B2FF73E26ECFF923C6D9064EB2C12F2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_539F892E5749765DC63C064EB2C1BBE0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_B2FF73E26ECFF923C6D9064EB2C12F2C" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_539F892E5749765DC63C064EB2C1BBE0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_539F892E5749765DC63C064EB2C1BBE0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_B2FF73E26ECFF923C6D9064EB2C12F2C" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_539F892E5749765DC63C064EB2C1BBE0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_539F892E5749765DC63C064EB2C1BBE0" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_ECEF4DA63E91B6B1F813064EB2C2040E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:to="loc_srt_RangeAxis_ECEF4DA63E91B6B1F813064EB2C2040E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9EC47D174D3AA49C923E064EB2C2E591_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ECEF4DA63E91B6B1F813064EB2C2040E" xlink:to="loc_srt_RangeMember_9EC47D174D3AA49C923E064EB2C2E591_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9EC47D174D3AA49C923E064EB2C2E591" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ECEF4DA63E91B6B1F813064EB2C2040E" xlink:to="loc_srt_RangeMember_9EC47D174D3AA49C923E064EB2C2E591" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_77B984AC55F7EBDF394F064EB2C252F9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_77B984AC55F7EBDF394F064EB2C252F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_328A671E496F400F08CE064EB2C2685C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:to="loc_us-gaap_LineOfCredit_328A671E496F400F08CE064EB2C2685C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:label="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_F21BA5300ECD31413EC9064EB2C364E1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:to="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_F21BA5300ECD31413EC9064EB2C364E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaap_OtherBorrowings_6F46C8465FE9AE46D0F2064EB2C3921C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:to="loc_us-gaap_OtherBorrowings_6F46C8465FE9AE46D0F2064EB2C3921C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_824E8F2AAB15F283FC9DC9F58AD4B5A7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_DebtInstrumentTable_824E8F2AAB15F283FC9DC9F58AD4B5A7" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_FABDC027D29E2335851FC9F58AD47AF8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_824E8F2AAB15F283FC9DC9F58AD4B5A7" xlink:to="loc_us-gaap_DebtInstrumentAxis_FABDC027D29E2335851FC9F58AD47AF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_FABDC027D29E2335851FC9F58AD47AF8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_FABDC027D29E2335851FC9F58AD47AF8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A1.948Notesdue2019Member" xlink:label="loc_cah_A1.948Notesdue2019Member_0E49FBFCAA213597D767C9F58AD59614" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A1.948Notesdue2019Member_0E49FBFCAA213597D767C9F58AD59614" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.4Notesdue2020Member" xlink:label="loc_cah_A2.4Notesdue2020Member_5AA696BE4FE52303F364C9F58AD5CFA4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A2.4Notesdue2020Member_5AA696BE4FE52303F364C9F58AD5CFA4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.625Notesdue2021Member" xlink:label="loc_cah_A4.625Notesdue2021Member_C734C5BEDD89BCF21906C9F58AD52261" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A4.625Notesdue2021Member_C734C5BEDD89BCF21906C9F58AD52261" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.616Notesdue2022Member" xlink:label="loc_cah_A2.616Notesdue2022Member_C9514F7CC09C6F3C7154C9F58AD62C1B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A2.616Notesdue2022Member_C9514F7CC09C6F3C7154C9F58AD62C1B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.2Notesdue2022Member" xlink:label="loc_cah_A3.2Notesdue2022Member_798CCEB80AEB53136994C9F58AD6BF45" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A3.2Notesdue2022Member_798CCEB80AEB53136994C9F58AD6BF45" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FloatingRateNotesdue2022Member" xlink:label="loc_cah_FloatingRateNotesdue2022Member_0CC469B039D26C908692C9F58AD61DC7" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_FloatingRateNotesdue2022Member_0CC469B039D26C908692C9F58AD61DC7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.2Notesdue2023Member" xlink:label="loc_cah_A3.2Notesdue2023Member_222C272F6FB60CFCFAABC9F58AD6C4D2" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A3.2Notesdue2023Member_222C272F6FB60CFCFAABC9F58AD6C4D2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.079Notesdue2024Member" xlink:label="loc_cah_A3.079Notesdue2024Member_3BD2A9579E59C9810C17C9F58AD63EE3" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A3.079Notesdue2024Member_3BD2A9579E59C9810C17C9F58AD63EE3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.5Notesdue2025Member" xlink:label="loc_cah_A3.5Notesdue2025Member_55A108E32EFC5C1B67FDC9F58AD6A106" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A3.5Notesdue2025Member_55A108E32EFC5C1B67FDC9F58AD6A106" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.75Notesdue2026Member" xlink:label="loc_cah_A3.75Notesdue2026Member_988E642AB1BBFC27261EC9F58AD6D8BD" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A3.75Notesdue2026Member_988E642AB1BBFC27261EC9F58AD6D8BD" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.41Notesdue2027Member" xlink:label="loc_cah_A3.41Notesdue2027Member_BE07669BF049546ABDF4C9F58AD7A991" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A3.41Notesdue2027Member_BE07669BF049546ABDF4C9F58AD7A991" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.6Notesdue2043Member" xlink:label="loc_cah_A4.6Notesdue2043Member_3BBCB6B37B6B73CCB5EBC9F58AD72AD0" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A4.6Notesdue2043Member_3BBCB6B37B6B73CCB5EBC9F58AD72AD0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.5Notesdue2044Member" xlink:label="loc_cah_A4.5Notesdue2044Member_9222C23290D73B5D6029C9F58AD75415" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A4.5Notesdue2044Member_9222C23290D73B5D6029C9F58AD75415" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.9Notesdue2045Member" xlink:label="loc_cah_A4.9Notesdue2045Member_98B8ECBD92E022F9DF69C9F58AD72A4A" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A4.9Notesdue2045Member_98B8ECBD92E022F9DF69C9F58AD72A4A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.368Notesdue2047Member" xlink:label="loc_cah_A4.368Notesdue2047Member_B1130ACE7146A87A04F6C9F58AD7E0C3" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A4.368Notesdue2047Member_B1130ACE7146A87A04F6C9F58AD7E0C3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A7.0Debenturesduefiscal2027Member" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_F4F555E1A261038DC811C9F58ADDE0CD" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_F4F555E1A261038DC811C9F58ADDE0CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_2524BDB427C5D627CDF2C9F799A384D7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_AccountsPayableCurrent_2524BDB427C5D627CDF2C9F799A384D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_82BA4D81DD123904578DC9F58ADDBEF0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_NotesPayable_82BA4D81DD123904578DC9F58ADDBEF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaap_OtherBorrowings_419A41D0CA7CE7314214C9F58ADD9E98" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_OtherBorrowings_419A41D0CA7CE7314214C9F58ADD9E98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_424FAEDE087CB69F6A40C9F58ADEF9DE" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_424FAEDE087CB69F6A40C9F58ADEF9DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_C4A503556652A5FCF9DFC9F58ADE0D6E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_C4A503556652A5FCF9DFC9F58ADE0D6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8C9326659FF4B1405ADBC9F58ADED039" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8C9326659FF4B1405ADBC9F58ADED039" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_367C6B342013EBA36EB6064EB35830A6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:to="loc_us-gaap_EmployeeSeveranceMember_367C6B342013EBA36EB6064EB35830A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_076A494B3AC9F72537C5064EB359BBA4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:to="loc_us-gaap_FacilityClosingMember_076A494B3AC9F72537C5064EB359BBA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE" xlink:to="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_A11FAAB7CEF17708668C064EB359797C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:to="loc_us-gaap_RestructuringReserve_A11FAAB7CEF17708668C064EB359797C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_95A2B16C83C98DE173E4064EB35AAC35" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:to="loc_us-gaap_RestructuringCosts_95A2B16C83C98DE173E4064EB35AAC35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_73AD08C6D4D9CBB5744C064EB35A2363" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:to="loc_us-gaap_PaymentsForRestructuring_73AD08C6D4D9CBB5744C064EB35A2363" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_382B7DF65845AE3D7692B48EFB9AEE61" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_EF07083E094D75EA9891B48EFB98C51A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_382B7DF65845AE3D7692B48EFB9AEE61" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_EF07083E094D75EA9891B48EFB98C51A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_EF07083E094D75EA9891B48EFB98C51A" xlink:to="loc_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D" xlink:to="loc_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D" xlink:to="loc_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ContractTerminationAxis" xlink:label="loc_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_EF07083E094D75EA9891B48EFB98C51A" xlink:to="loc_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:to="loc_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:to="loc_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DistributorContractMember" xlink:label="loc_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D" xlink:to="loc_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_452D6E34CF1ED220C6DEB48EFB9ADF21" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_382B7DF65845AE3D7692B48EFB9AEE61" xlink:to="loc_us-gaap_RestructuringCosts_452D6E34CF1ED220C6DEB48EFB9ADF21" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_382B7DF65845AE3D7692B48EFB9AEE61" xlink:to="loc_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccounts" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C" xlink:to="loc_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C" xlink:to="loc_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PricingDisputesMember" xlink:label="loc_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="loc_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_175517EED0B56A00C4B6DE7834850405" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_175517EED0B56A00C4B6DE7834850405" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PriorYearRecoveriesMember" xlink:label="loc_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="loc_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_C5C8EFD3035627BE1D8DDE783485117C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_C5C8EFD3035627BE1D8DDE783485117C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesReturnsAndAllowancesMember" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_3DA2CBCBBBBBF478AB2DDE7834854C78" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="loc_us-gaap_SalesReturnsAndAllowancesMember_3DA2CBCBBBBBF478AB2DDE7834854C78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_CB371EB49934956454C6DE78348579E9" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_CB371EB49934956454C6DE78348579E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_2605EDC60B9C5D34A188DE783486596F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_2605EDC60B9C5D34A188DE783486596F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_382AF8651B5DFAEFF84FDE7834865F71" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_382AF8651B5DFAEFF84FDE7834865F71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5933B14FBA65BDBC0F71DE7834862444" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5933B14FBA65BDBC0F71DE7834862444" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4775AC1450FEEC3B8E6DDE783486C9C1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4775AC1450FEEC3B8E6DDE783486C9C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_477DF9CB0679745B0682DE783487B417" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_477DF9CB0679745B0682DE783487B417" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_F66CB789A726650B8974DE7834873229" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_F66CB789A726650B8974DE7834873229" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1FC6C910714C3EB2E5D5064EB0607F14" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_589EDF1DA75A89745F43064EB05D56EA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1FC6C910714C3EB2E5D5064EB0607F14" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_589EDF1DA75A89745F43064EB05D56EA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_124454BF8EF7A82A52AA064EB05E5EA4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_589EDF1DA75A89745F43064EB05D56EA" xlink:to="loc_srt_ConsolidationItemsAxis_124454BF8EF7A82A52AA064EB05E5EA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_48EF0394F3B8D51D9400064EB05EE414_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_124454BF8EF7A82A52AA064EB05E5EA4" xlink:to="loc_srt_ConsolidationItemsDomain_48EF0394F3B8D51D9400064EB05EE414_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_48EF0394F3B8D51D9400064EB05EE414" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_124454BF8EF7A82A52AA064EB05E5EA4" xlink:to="loc_srt_ConsolidationItemsDomain_48EF0394F3B8D51D9400064EB05EE414" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_36A896FE51E824723970064EB05E1F32" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_48EF0394F3B8D51D9400064EB05EE414" xlink:to="loc_us-gaap_OperatingSegmentsMember_36A896FE51E824723970064EB05E1F32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_D7F211FB1D2F5AEFF129064EB05ED9EC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_48EF0394F3B8D51D9400064EB05EE414" xlink:to="loc_us-gaap_CorporateNonSegmentMember_D7F211FB1D2F5AEFF129064EB05ED9EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9180577FB8327F495BD4064EB05FD94A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_589EDF1DA75A89745F43064EB05D56EA" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9180577FB8327F495BD4064EB05FD94A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_BACCD9FC6A6A67463002064EB05FE584_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9180577FB8327F495BD4064EB05FD94A" xlink:to="loc_us-gaap_SegmentDomain_BACCD9FC6A6A67463002064EB05FE584_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_BACCD9FC6A6A67463002064EB05FE584" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9180577FB8327F495BD4064EB05FD94A" xlink:to="loc_us-gaap_SegmentDomain_BACCD9FC6A6A67463002064EB05FE584" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_4B000C4B7197A404EA68064EB05FF451" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_BACCD9FC6A6A67463002064EB05FE584" xlink:to="loc_cah_PharmaceuticalMember_4B000C4B7197A404EA68064EB05FF451" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_FE4CEC9CEA14CCE89815064EB05FD003" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_BACCD9FC6A6A67463002064EB05FE584" xlink:to="loc_cah_MedicalMember_FE4CEC9CEA14CCE89815064EB05FD003" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_D8E97C4B76152619F086064EB06098D7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1FC6C910714C3EB2E5D5064EB0607F14" xlink:to="loc_us-gaap_Assets_D8E97C4B76152619F086064EB06098D7" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_110FB6FEFD9BEF1F8D84064EB06FEF35" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0C0A616D1FAED93DFCE2064EB06D7279" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_110FB6FEFD9BEF1F8D84064EB06FEF35" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0C0A616D1FAED93DFCE2064EB06D7279" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_99CC1809621AB8118F98064EB06D92F5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0C0A616D1FAED93DFCE2064EB06D7279" xlink:to="loc_srt_ConsolidationItemsAxis_99CC1809621AB8118F98064EB06D92F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_E25E87509308628BA354064EB06D63AA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_99CC1809621AB8118F98064EB06D92F5" xlink:to="loc_srt_ConsolidationItemsDomain_E25E87509308628BA354064EB06D63AA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_E25E87509308628BA354064EB06D63AA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_99CC1809621AB8118F98064EB06D92F5" xlink:to="loc_srt_ConsolidationItemsDomain_E25E87509308628BA354064EB06D63AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_C48465B782B0584B5345064EB06E7885" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_E25E87509308628BA354064EB06D63AA" xlink:to="loc_us-gaap_OperatingSegmentsMember_C48465B782B0584B5345064EB06E7885" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_C83070548E20E6F6AC4D064EB06E0B97" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_E25E87509308628BA354064EB06D63AA" xlink:to="loc_us-gaap_CorporateNonSegmentMember_C83070548E20E6F6AC4D064EB06E0B97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_E74F563A538841E9A7C3064EB06ECD72" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0C0A616D1FAED93DFCE2064EB06D7279" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_E74F563A538841E9A7C3064EB06ECD72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_93001C9A7245B8A2A909064EB06E1C6F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_E74F563A538841E9A7C3064EB06ECD72" xlink:to="loc_us-gaap_SegmentDomain_93001C9A7245B8A2A909064EB06E1C6F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_93001C9A7245B8A2A909064EB06E1C6F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_E74F563A538841E9A7C3064EB06ECD72" xlink:to="loc_us-gaap_SegmentDomain_93001C9A7245B8A2A909064EB06E1C6F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_786A5CD8B275F04CB503064EB06E6305" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_93001C9A7245B8A2A909064EB06E1C6F" xlink:to="loc_cah_PharmaceuticalMember_786A5CD8B275F04CB503064EB06E6305" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_F97ACBBAFA6C20A6DB6E064EB06F9FBB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_93001C9A7245B8A2A909064EB06E1C6F" xlink:to="loc_cah_MedicalMember_F97ACBBAFA6C20A6DB6E064EB06F9FBB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_B2054D3E244F17FE1A9E064EB06F0B63" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_110FB6FEFD9BEF1F8D84064EB06FEF35" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_B2054D3E244F17FE1A9E064EB06F0B63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_E273D2CBE7D160F61AEC064EB06FCBD9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_110FB6FEFD9BEF1F8D84064EB06FEF35" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_E273D2CBE7D160F61AEC064EB06FCBD9" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:to="loc_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:to="loc_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:to="loc_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839" xlink:to="loc_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GownRecallAxis" xlink:label="loc_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:to="loc_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:to="loc_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:to="loc_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_SterileSurgicalGownRecallMember" xlink:label="loc_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE" xlink:to="loc_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C" xlink:to="loc_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GainonDivestitureAfterTax" xlink:label="loc_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_C731FD4880B77B650CA1C5281BA93E07" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_us-gaap_NumberOfReportableSegments_C731FD4880B77B650CA1C5281BA93E07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_8ED963C4FFD9079D270BC5281BAA1DAC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_us-gaap_NumberOfOperatingSegments_8ED963C4FFD9079D270BC5281BAA1DAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRecallExpense" xlink:label="loc_us-gaap_InventoryRecallExpense_72B2A0898268A8793A90C5281BAAEFA2" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_us-gaap_InventoryRecallExpense_72B2A0898268A8793A90C5281BAAEFA2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_800FDEAD59F15391D9E0C5281BAA88F0" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_800FDEAD59F15391D9E0C5281BAA88F0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_0215FDA112570E8AB365064EB04FBEEB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328" xlink:to="loc_srt_StatementGeographicalAxis_0215FDA112570E8AB365064EB04FBEEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_C69A5F6F33D953EFE6B7064EB04F755B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0215FDA112570E8AB365064EB04FBEEB" xlink:to="loc_srt_SegmentGeographicalDomain_C69A5F6F33D953EFE6B7064EB04F755B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_C69A5F6F33D953EFE6B7064EB04F755B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0215FDA112570E8AB365064EB04FBEEB" xlink:to="loc_srt_SegmentGeographicalDomain_C69A5F6F33D953EFE6B7064EB04F755B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_country_US_7BDB4F7ADAC72A1C9752064EB04F7652" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_C69A5F6F33D953EFE6B7064EB04F755B" xlink:to="loc_country_US_7BDB4F7ADAC72A1C9752064EB04F7652" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_A9AD5F29017D326CECFE064EB04F2CFF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_C69A5F6F33D953EFE6B7064EB04F755B" xlink:to="loc_us-gaap_NonUsMember_A9AD5F29017D326CECFE064EB04F2CFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_B1235D0F5436BC4E4E9F064EB0500DD2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_B1235D0F5436BC4E4E9F064EB0500DD2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_EF2AC3B615434EDFED6FC0931BA72C7D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_EF2AC3B615434EDFED6FC0931BA72C7D" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:to="loc_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659" xlink:to="loc_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659" xlink:to="loc_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_C17B9EE8A1F98BF104F4C0931BA3CB06" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:to="loc_us-gaap_OperatingSegmentsMember_C17B9EE8A1F98BF104F4C0931BA3CB06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_6534A0DCF79D7B1548C5C0931BA43E28" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:to="loc_us-gaap_CorporateNonSegmentMember_6534A0DCF79D7B1548C5C0931BA43E28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_E55DE2CC4ECDA83587DAC0931BA45299" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_E55DE2CC4ECDA83587DAC0931BA45299" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_D32036E84A3999F40330C0931BA47986_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_E55DE2CC4ECDA83587DAC0931BA45299" xlink:to="loc_us-gaap_SegmentDomain_D32036E84A3999F40330C0931BA47986_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_D32036E84A3999F40330C0931BA47986" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_E55DE2CC4ECDA83587DAC0931BA45299" xlink:to="loc_us-gaap_SegmentDomain_D32036E84A3999F40330C0931BA47986" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_21EFD10D2E72419B1AB2C0931BA42791" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_D32036E84A3999F40330C0931BA47986" xlink:to="loc_cah_PharmaceuticalMember_21EFD10D2E72419B1AB2C0931BA42791" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_18036A9BBFB308757EDFC0931BA55C25" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_D32036E84A3999F40330C0931BA47986" xlink:to="loc_cah_MedicalMember_18036A9BBFB308757EDFC0931BA55C25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:to="loc_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D" xlink:to="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D" xlink:to="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalDistributionandSpecialtyMember" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NuclearPrecisionHealthServicesMember" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicaldistributionandproductsMember" xlink:label="loc_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:to="loc_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CardinalHealthAtHomeSolutionsMember" xlink:label="loc_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:to="loc_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:to="loc_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251" xlink:to="loc_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251" xlink:to="loc_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_C6EEEDB7E197B8F6E6DEC0931BA72893" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:to="loc_us-gaap_NonUsMember_C6EEEDB7E197B8F6E6DEC0931BA72893" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_country_US_BE5C30E11E8EE1F32F8BC0931BA79DC3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:to="loc_country_US_BE5C30E11E8EE1F32F8BC0931BA79DC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_F286121EFF3FC668C949C0931BA77C01" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_EF2AC3B615434EDFED6FC0931BA72C7D" xlink:to="loc_us-gaap_Revenues_F286121EFF3FC668C949C0931BA77C01" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_9EAC3978E0E6E12BB6CC064EB07D373D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:to="loc_srt_ConsolidationItemsAxis_9EAC3978E0E6E12BB6CC064EB07D373D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_7FDA309E4A813C3C6DD0064EB07EE2EE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_9EAC3978E0E6E12BB6CC064EB07D373D" xlink:to="loc_srt_ConsolidationItemsDomain_7FDA309E4A813C3C6DD0064EB07EE2EE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_7FDA309E4A813C3C6DD0064EB07EE2EE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_9EAC3978E0E6E12BB6CC064EB07D373D" xlink:to="loc_srt_ConsolidationItemsDomain_7FDA309E4A813C3C6DD0064EB07EE2EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_2D9D35BDE71406069BF8064EB07E6741" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7FDA309E4A813C3C6DD0064EB07EE2EE" xlink:to="loc_us-gaap_OperatingSegmentsMember_2D9D35BDE71406069BF8064EB07E6741" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_6BD5B8A26C2A82DCF0D1064EB07E4BF6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7FDA309E4A813C3C6DD0064EB07EE2EE" xlink:to="loc_us-gaap_CorporateNonSegmentMember_6BD5B8A26C2A82DCF0D1064EB07E4BF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_43A5D8054B3AC85CDBDA064EB07F5956" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_43A5D8054B3AC85CDBDA064EB07F5956" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_F83A4E68BAF97A4FC90E064EB07F18BB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_43A5D8054B3AC85CDBDA064EB07F5956" xlink:to="loc_us-gaap_SegmentDomain_F83A4E68BAF97A4FC90E064EB07F18BB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_F83A4E68BAF97A4FC90E064EB07F18BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_43A5D8054B3AC85CDBDA064EB07F5956" xlink:to="loc_us-gaap_SegmentDomain_F83A4E68BAF97A4FC90E064EB07F18BB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_B2BE9D1B828B4EE951CD064EB07FB35A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_F83A4E68BAF97A4FC90E064EB07F18BB" xlink:to="loc_cah_PharmaceuticalMember_B2BE9D1B828B4EE951CD064EB07FB35A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_FE8A7D77FD1E47CB6E30064EB07FAC37" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_F83A4E68BAF97A4FC90E064EB07F18BB" xlink:to="loc_cah_MedicalMember_FE8A7D77FD1E47CB6E30064EB07FAC37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_1673BF2B941B1C8006F9064EB080F5D4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A" xlink:to="loc_us-gaap_OperatingIncomeLoss_1673BF2B941B1C8006F9064EB080F5D4" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" xlink:type="extended">
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodwillAndIntangibleAssetsLineItems" xlink:label="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:type="locator" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodwillAndIntangibleAssetsTable" xlink:label="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:to="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_5DE65C4D4B550DDA34BAD9796910629F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:to="loc_cah_OpioidLitigationAxis_5DE65C4D4B550DDA34BAD9796910629F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_6CC9EB62B3AEF54F28B1D97B2C60BD5B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_5DE65C4D4B550DDA34BAD9796910629F" xlink:to="loc_cah_OpioidLitigationDomain_6CC9EB62B3AEF54F28B1D97B2C60BD5B_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_6CC9EB62B3AEF54F28B1D97B2C60BD5B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_5DE65C4D4B550DDA34BAD9796910629F" xlink:to="loc_cah_OpioidLitigationDomain_6CC9EB62B3AEF54F28B1D97B2C60BD5B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_7BAB613D6B724BC799B1D97B2C61CC18" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_6CC9EB62B3AEF54F28B1D97B2C60BD5B" xlink:to="loc_cah_TotalOpioidLitigationMember_7BAB613D6B724BC799B1D97B2C61CC18" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_D638479EC43FF2604787D97C618C98AF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_6CC9EB62B3AEF54F28B1D97B2C60BD5B" xlink:to="loc_cah_TotalOpioidLitigationnetoftaxMember_D638479EC43FF2604787D97C618C98AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_885359EE3E4F507B5C61D97969114894" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_885359EE3E4F507B5C61D97969114894" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_864D01DF175FF7F8AE0AD9796911555F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_885359EE3E4F507B5C61D97969114894" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_864D01DF175FF7F8AE0AD9796911555F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_864D01DF175FF7F8AE0AD9796911555F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_885359EE3E4F507B5C61D97969114894" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_864D01DF175FF7F8AE0AD9796911555F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_6768A921FA020C144F30D9796911A177" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_864D01DF175FF7F8AE0AD9796911555F" xlink:to="loc_cah_NaviHealthMember_6768A921FA020C144F30D9796911A177" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_96C4996CE5882E6C5E8DD9796912197F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_96C4996CE5882E6C5E8DD9796912197F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_96C4996CE5882E6C5E8DD9796912197F" xlink:to="loc_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_96C4996CE5882E6C5E8DD9796912197F" xlink:to="loc_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_0BE29DB9420FAC2D8D9CD97969120B21" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9" xlink:to="loc_cah_MedicalMember_0BE29DB9420FAC2D8D9CD97969120B21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_840E1BB30C20E9F52A9ED9796912C332" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_840E1BB30C20E9F52A9ED9796912C332" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_2318AD5D2C83F8D23948D9796913946D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_2318AD5D2C83F8D23948D9796913946D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_0A6637D0146917758FECD979691370BA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:to="loc_cah_PreTaxGainonDivestiture_0A6637D0146917758FECD979691370BA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GainonDivestitureAfterTax" xlink:label="loc_cah_GainonDivestitureAfterTax_E1D5EA029656CCD595D5D9796913572F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:to="loc_cah_GainonDivestitureAfterTax_E1D5EA029656CCD595D5D9796913572F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_97F0328435FC79F5B702D97969132182" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_97F0328435FC79F5B702D97969132182" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94C3CD1A31E6DB93F0C1064EAFFDBE85" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68777257C7D1E3C2E5E1064EAFFC41BC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94C3CD1A31E6DB93F0C1064EAFFDBE85" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68777257C7D1E3C2E5E1064EAFFC41BC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_B9A409156C7DFBED0B14064EAFFC193C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68777257C7D1E3C2E5E1064EAFFC41BC" xlink:to="loc_us-gaap_AwardTypeAxis_B9A409156C7DFBED0B14064EAFFC193C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EDBB35EB65C95FA7FB0C064EAFFC235D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_B9A409156C7DFBED0B14064EAFFC193C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EDBB35EB65C95FA7FB0C064EAFFC235D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EDBB35EB65C95FA7FB0C064EAFFC235D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_B9A409156C7DFBED0B14064EAFFC193C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EDBB35EB65C95FA7FB0C064EAFFC235D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_8DFEFB4ED98CDA1B7EA4064EAFFD73B8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EDBB35EB65C95FA7FB0C064EAFFC235D" xlink:to="loc_us-gaap_PerformanceSharesMember_8DFEFB4ED98CDA1B7EA4064EAFFD73B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7A01A915E6AB5C237E02064EAFFDFA00" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94C3CD1A31E6DB93F0C1064EAFFDBE85" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7A01A915E6AB5C237E02064EAFFDFA00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_48CDF4D099E39332C0D8064EAFFDF589" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94C3CD1A31E6DB93F0C1064EAFFDBE85" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_48CDF4D099E39332C0D8064EAFFDF589" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_C2D6F04B9DC8CA6E0775064EAFFD7AA0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94C3CD1A31E6DB93F0C1064EAFFDBE85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_C2D6F04B9DC8CA6E0775064EAFFD7AA0" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E6081F5583AC6ADEBFA064EB00A295A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47983B0AF423B7D018EB064EB008486F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E6081F5583AC6ADEBFA064EB00A295A" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47983B0AF423B7D018EB064EB008486F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2ED30AA81B85C58BBD0F064EB0090FFF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47983B0AF423B7D018EB064EB008486F" xlink:to="loc_us-gaap_AwardTypeAxis_2ED30AA81B85C58BBD0F064EB0090FFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A9B09893428DF1D9AAFB064EB009134E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2ED30AA81B85C58BBD0F064EB0090FFF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A9B09893428DF1D9AAFB064EB009134E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A9B09893428DF1D9AAFB064EB009134E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2ED30AA81B85C58BBD0F064EB0090FFF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A9B09893428DF1D9AAFB064EB009134E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5FE169E1C0D6351F2769064EB00933BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A9B09893428DF1D9AAFB064EB009134E" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5FE169E1C0D6351F2769064EB00933BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_F7FB883589F9D804E65C064EB0092A03" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A9B09893428DF1D9AAFB064EB009134E" xlink:to="loc_us-gaap_PerformanceSharesMember_F7FB883589F9D804E65C064EB0092A03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9F17621C8F4339B36086064EB00A4167" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E6081F5583AC6ADEBFA064EB00A295A" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9F17621C8F4339B36086064EB00A4167" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C247B2B75F89375D4866064EB00AE319" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E6081F5583AC6ADEBFA064EB00A295A" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C247B2B75F89375D4866064EB00AE319" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_31BBC975ACA8F0422A6A064EB00AF96D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E6081F5583AC6ADEBFA064EB00A295A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_31BBC975ACA8F0422A6A064EB00AF96D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_557D9306602A1427C9E7DE0D6FADE5D0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_557D9306602A1427C9E7DE0D6FADE5D0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_557D9306602A1427C9E7DE0D6FADE5D0" xlink:to="loc_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A" xlink:to="loc_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A" xlink:to="loc_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2011LtipMember" xlink:label="loc_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE" xlink:to="loc_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_0710AB13F07E10EA83D2DE0D6FAEC89D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_557D9306602A1427C9E7DE0D6FADE5D0" xlink:to="loc_us-gaap_AwardTypeAxis_0710AB13F07E10EA83D2DE0D6FAEC89D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0710AB13F07E10EA83D2DE0D6FAEC89D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0710AB13F07E10EA83D2DE0D6FAEC89D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AwardsOtherThanStockOptionsMember" xlink:label="loc_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9" xlink:to="loc_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_860343C66F7C70053D9FDE0D6FAF59F9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_860343C66F7C70053D9FDE0D6FAF59F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0D8DA4EE0CB173C0E15BDE0D6FAFD217" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0D8DA4EE0CB173C0E15BDE0D6FAFD217" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_BC029B396BB38729C73FDE0D6FAF7FF9" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9" xlink:to="loc_us-gaap_PerformanceSharesMember_BC029B396BB38729C73FDE0D6FAF7FF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_8547CE61818AF8CAA009DE0D6FAFF24F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_557D9306602A1427C9E7DE0D6FADE5D0" xlink:to="loc_srt_RangeAxis_8547CE61818AF8CAA009DE0D6FAFF24F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_F7E4EA4987C8E97773AEDE0D6FB0FC93_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8547CE61818AF8CAA009DE0D6FAFF24F" xlink:to="loc_srt_RangeMember_F7E4EA4987C8E97773AEDE0D6FB0FC93_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_F7E4EA4987C8E97773AEDE0D6FB0FC93" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8547CE61818AF8CAA009DE0D6FAFF24F" xlink:to="loc_srt_RangeMember_F7E4EA4987C8E97773AEDE0D6FB0FC93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_46E9A8CE44DF499CA621DE0D6FB01A2C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_F7E4EA4987C8E97773AEDE0D6FB0FC93" xlink:to="loc_srt_MinimumMember_46E9A8CE44DF499CA621DE0D6FB01A2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9E1113F3DFB58E51563EDE0D6FB0E9A1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_F7E4EA4987C8E97773AEDE0D6FB0FC93" xlink:to="loc_srt_MaximumMember_9E1113F3DFB58E51563EDE0D6FB0E9A1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_VestingPeriodinyearsforShares" xlink:label="loc_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C2237067A658A9C111CDE0D6FB1E346" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C2237067A658A9C111CDE0D6FB1E346" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_F4C7387D1E1F48EB1A92DE0D6FB1A2DD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_F4C7387D1E1F48EB1A92DE0D6FB1A2DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_E7CBE9C9E3FFAE1C1E8CDE0D6FB19882" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_E7CBE9C9E3FFAE1C1E8CDE0D6FB19882" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ExercisablePeriodOfPlansInYears" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_F768628F938C0BD6C893DE0D6FB14D70" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_F768628F938C0BD6C893DE0D6FB14D70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_998FA33686F69414AE6CDE0D6FB2E80A" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_998FA33686F69414AE6CDE0D6FB2E80A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2EA1836B827C58BB9E14064EB021983C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2EA1836B827C58BB9E14064EB021983C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_7A74C4762C83663D3B79064EB0215976" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2EA1836B827C58BB9E14064EB021983C" xlink:to="loc_us-gaap_AwardTypeAxis_7A74C4762C83663D3B79064EB0215976" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BA601090560F797E9CE3064EB022C006_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7A74C4762C83663D3B79064EB0215976" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BA601090560F797E9CE3064EB022C006_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BA601090560F797E9CE3064EB022C006" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7A74C4762C83663D3B79064EB0215976" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BA601090560F797E9CE3064EB022C006" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_477E80E83FE5EFC56241064EB0227FFA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BA601090560F797E9CE3064EB022C006" xlink:to="loc_us-gaap_EmployeeStockOptionMember_477E80E83FE5EFC56241064EB0227FFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7F9D007CBEE4911733E6064EB02214C0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7F9D007CBEE4911733E6064EB02214C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E5FD4180E043D72F1149064EB0230D27" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E5FD4180E043D72F1149064EB0230D27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_BB86FE2C124A1D7C4A5B064EB023EBBA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_BB86FE2C124A1D7C4A5B064EB023EBBA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_B67A31EAC03EE1C01F08064EB0232433" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_B67A31EAC03EE1C01F08064EB0232433" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_9D6C02A2C01601D853CC064EB023AAC6" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_9D6C02A2C01601D853CC064EB023AAC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_DCFA7F2026EA74CBCC41064EB0236DEA" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_DCFA7F2026EA74CBCC41064EB0236DEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9457A4CF5283DE050DAF064EB0238FD2" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9457A4CF5283DE050DAF064EB0238FD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_B49AE6B236CC2C18C231064EB0235713" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_B49AE6B236CC2C18C231064EB0235713" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216" xlink:to="loc_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_80D47757AC837CA3BE1F064EB0029F6A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D" xlink:to="loc_us-gaap_PerformanceSharesMember_80D47757AC837CA3BE1F064EB0029F6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_55C50C20207CF6B2DEEE064EB003D658" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_55C50C20207CF6B2DEEE064EB003D658" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_00E98CC9B2EAED295E2E064EB003DA43" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_00E98CC9B2EAED295E2E064EB003DA43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_EB4857F217D21B4A1160064EB003D6E3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_EB4857F217D21B4A1160064EB003D6E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2ACA1D091F320523594C064EB0033EEB" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2ACA1D091F320523594C064EB0033EEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_814300961413DCB5681C064EB004F31A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_814300961413DCB5681C064EB004F31A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_D326C3D928BA2063894F064EB004FCA9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_D326C3D928BA2063894F064EB004FCA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1846DF5F2AB9ED40F037064EB00432A8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1846DF5F2AB9ED40F037064EB00432A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76EC03B657E934F90932064EB004D388" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76EC03B657E934F90932064EB004D388" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8764D9B254F4144D3966064EB0052CE5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8764D9B254F4144D3966064EB0052CE5" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0A2F187C25D370E09177064EB00F41BD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3C279287E9BB5DC0CD10064EB00EA590" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0A2F187C25D370E09177064EB00F41BD" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3C279287E9BB5DC0CD10064EB00EA590" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_ED41E22460C8ADAE7470064EB00EDE84" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3C279287E9BB5DC0CD10064EB00EA590" xlink:to="loc_us-gaap_AwardTypeAxis_ED41E22460C8ADAE7470064EB00EDE84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02BC78F78AF36AA6C8ED064EB00FCF4F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ED41E22460C8ADAE7470064EB00EDE84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02BC78F78AF36AA6C8ED064EB00FCF4F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02BC78F78AF36AA6C8ED064EB00FCF4F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ED41E22460C8ADAE7470064EB00EDE84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02BC78F78AF36AA6C8ED064EB00FCF4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_A479A3A196E8BC589F4B064EB00FD222" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02BC78F78AF36AA6C8ED064EB00FCF4F" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_A479A3A196E8BC589F4B064EB00FD222" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0A2F187C25D370E09177064EB00F41BD" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8B07469606800836B7F9064EB0109A13" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8B07469606800836B7F9064EB0109A13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27F021D61899B11B6D03064EB0104CE6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27F021D61899B11B6D03064EB0104CE6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_FC970A941820BDA59437064EB010D269" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_FC970A941820BDA59437064EB010D269" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2EF0A012B75FE9203C26064EB01074AE" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2EF0A012B75FE9203C26064EB01074AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0A2F187C25D370E09177064EB00F41BD" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_23362E45B3788F9AEC9E064EB010E404" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_23362E45B3788F9AEC9E064EB010E404" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_BFF54658551AC91CF3E7064EB01140E6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_BFF54658551AC91CF3E7064EB01140E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_FBD90DABCC4AAFCB245B064EB011B6CB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_FBD90DABCC4AAFCB245B064EB011B6CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_735E3A38AD3B7C7742AD064EB0115A72" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_735E3A38AD3B7C7742AD064EB0115A72" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1A15565AD4C210E3101CDD8B84F26C65" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BF0133C2EEDDF1249639DD8B84EF4356" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1A15565AD4C210E3101CDD8B84F26C65" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BF0133C2EEDDF1249639DD8B84EF4356" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_36AAB2C109E9A07404EFDD8B84F09540" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BF0133C2EEDDF1249639DD8B84EF4356" xlink:to="loc_us-gaap_AwardTypeAxis_36AAB2C109E9A07404EFDD8B84F09540" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_FD3ED7642861A5E824CADD8B84F0F4BC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_36AAB2C109E9A07404EFDD8B84F09540" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_FD3ED7642861A5E824CADD8B84F0F4BC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_FD3ED7642861A5E824CADD8B84F0F4BC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_36AAB2C109E9A07404EFDD8B84F09540" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_FD3ED7642861A5E824CADD8B84F0F4BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_954E90C317D1CD197502DD8B84F0A0F5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_FD3ED7642861A5E824CADD8B84F0F4BC" xlink:to="loc_us-gaap_EmployeeStockOptionMember_954E90C317D1CD197502DD8B84F0A0F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_6340CE05D9D327E332BBDD8B84F11645" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BF0133C2EEDDF1249639DD8B84EF4356" xlink:to="loc_srt_RangeAxis_6340CE05D9D327E332BBDD8B84F11645" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_BC24528F003BB0FEA1A1DD8B84F1147D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6340CE05D9D327E332BBDD8B84F11645" xlink:to="loc_srt_RangeMember_BC24528F003BB0FEA1A1DD8B84F1147D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_BC24528F003BB0FEA1A1DD8B84F1147D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6340CE05D9D327E332BBDD8B84F11645" xlink:to="loc_srt_RangeMember_BC24528F003BB0FEA1A1DD8B84F1147D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_3E7114191C57A8C0A008DD8B84F19606" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_BC24528F003BB0FEA1A1DD8B84F1147D" xlink:to="loc_srt_MinimumMember_3E7114191C57A8C0A008DD8B84F19606" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_16C739AA4BEBFDB7EF40DD8B84F1F47B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_BC24528F003BB0FEA1A1DD8B84F1147D" xlink:to="loc_srt_MaximumMember_16C739AA4BEBFDB7EF40DD8B84F1F47B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_79DC5B77D39EBDA54231DD8B84F2C5BE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1A15565AD4C210E3101CDD8B84F26C65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_79DC5B77D39EBDA54231DD8B84F2C5BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_947A20F3E29B5DF3DC02DD8B84F2B277" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1A15565AD4C210E3101CDD8B84F26C65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_947A20F3E29B5DF3DC02DD8B84F2B277" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2153C91BF9CDB8204D88DD8B84F2A1BB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1A15565AD4C210E3101CDD8B84F26C65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2153C91BF9CDB8204D88DD8B84F2A1BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_DA605096AF860E4AA054DD8B84F2C128" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1A15565AD4C210E3101CDD8B84F26C65" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_DA605096AF860E4AA054DD8B84F2C128" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90CDA3A25035715D0591064EB01D3094" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DA9C9E98F31A01BA004A064EB01C1670" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90CDA3A25035715D0591064EB01D3094" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DA9C9E98F31A01BA004A064EB01C1670" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_F96F8EB5E982DCE2DC3F064EB01C8E35" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DA9C9E98F31A01BA004A064EB01C1670" xlink:to="loc_us-gaap_AwardTypeAxis_F96F8EB5E982DCE2DC3F064EB01C8E35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0DFF94D467E3A3D04085064EB01D953D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_F96F8EB5E982DCE2DC3F064EB01C8E35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0DFF94D467E3A3D04085064EB01D953D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0DFF94D467E3A3D04085064EB01D953D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_F96F8EB5E982DCE2DC3F064EB01C8E35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0DFF94D467E3A3D04085064EB01D953D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_C42EF881A95B51F8561C064EB01DC28E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0DFF94D467E3A3D04085064EB01D953D" xlink:to="loc_us-gaap_EmployeeStockOptionMember_C42EF881A95B51F8561C064EB01DC28E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_B02303C4E11F04C1379B064EB01D4270" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90CDA3A25035715D0591064EB01D3094" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_B02303C4E11F04C1379B064EB01D4270" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2AB3EA17EF3401841A4C064EB01E5566" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90CDA3A25035715D0591064EB01D3094" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2AB3EA17EF3401841A4C064EB01E5566" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_843FF8F064E86C704A6B064EB01EA4C3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90CDA3A25035715D0591064EB01D3094" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_843FF8F064E86C704A6B064EB01EA4C3" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_657C0E67F6998B0BCE30064EB02FA9C5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_FF49E821D93AC851D952064EB02E5445" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_657C0E67F6998B0BCE30064EB02FA9C5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_FF49E821D93AC851D952064EB02E5445" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_CBFC7B05BF3D6F15585E064EB02E7932" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_FF49E821D93AC851D952064EB02E5445" xlink:to="loc_us-gaap_AwardTypeAxis_CBFC7B05BF3D6F15585E064EB02E7932" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09707CD650FFC3C1073D064EB02E0DEC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_CBFC7B05BF3D6F15585E064EB02E7932" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09707CD650FFC3C1073D064EB02E0DEC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09707CD650FFC3C1073D064EB02E0DEC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_CBFC7B05BF3D6F15585E064EB02E7932" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09707CD650FFC3C1073D064EB02E0DEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4D88D739035A76C72682064EB02E1AE5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09707CD650FFC3C1073D064EB02E0DEC" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4D88D739035A76C72682064EB02E1AE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_F293773F0CE703D0F69A064EB02FF113" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09707CD650FFC3C1073D064EB02E0DEC" xlink:to="loc_us-gaap_EmployeeStockOptionMember_F293773F0CE703D0F69A064EB02FF113" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_5C2B0D30A61607E3F02F064EB02F51AE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09707CD650FFC3C1073D064EB02E0DEC" xlink:to="loc_us-gaap_PerformanceSharesMember_5C2B0D30A61607E3F02F064EB02F51AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4AC51A950DEB6A2BE79C064EB02FFBA8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_657C0E67F6998B0BCE30064EB02FA9C5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4AC51A950DEB6A2BE79C064EB02FFBA8" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_34D40CC2EFCED3DBD5D3B49CFBA4AE49" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_34D40CC2EFCED3DBD5D3B49CFBA4AE49" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_34D40CC2EFCED3DBD5D3B49CFBA4AE49" xlink:to="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_34D40CC2EFCED3DBD5D3B49CFBA4AE49" xlink:to="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_AAF230A07E7E31550B4EB49CFBA5120C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_AAF230A07E7E31550B4EB49CFBA5120C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_93B0E1B81D56364692F0B49CFBA5E14F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_93B0E1B81D56364692F0B49CFBA5E14F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_FAFABE4FF7BC7F218682B49CFBA5BBE5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_FAFABE4FF7BC7F218682B49CFBA5BBE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_35B786E77969B7F9D595B49CFBA657F5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_35B786E77969B7F9D595B49CFBA657F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_90CC2DBDF286CAB8DA5BB49CFBA683AF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_90CC2DBDF286CAB8DA5BB49CFBA683AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5E66ADBEC1587E1DA25CB49CFBA601E6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5E66ADBEC1587E1DA25CB49CFBA601E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_FDB2DFB0C0DFAD3CD269B49CFBA795F0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_FDB2DFB0C0DFAD3CD269B49CFBA795F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_9D7AF11AFBC0F5BB4BA9B49CFBA77CA5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_9D7AF11AFBC0F5BB4BA9B49CFBA77CA5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A229ABA478145D0FA7ACB49CFBA7012C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A229ABA478145D0FA7ACB49CFBA7012C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AcceleratedsharerepurchaseplanMember" xlink:label="loc_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23" xlink:to="loc_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:to="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_RetirementofTreasurySharesMember" xlink:label="loc_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411" xlink:to="loc_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A" xlink:to="loc_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A" xlink:to="loc_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_A131CEEB2C70491410FEDD84B209EE9C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:to="loc_us-gaap_CommonClassAMember_A131CEEB2C70491410FEDD84B209EE9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_DF3BF7E221CCE351C98EDD84B20A175D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:to="loc_us-gaap_CommonClassBMember_DF3BF7E221CCE351C98EDD84B20A175D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_C52FD2C34D9889D81EFFDD84B20A3C8C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_C52FD2C34D9889D81EFFDD84B20A3C8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_D5C5C03FD0E2FC1FA4B2DD84B20A250D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_C52FD2C34D9889D81EFFDD84B20A3C8C" xlink:to="loc_us-gaap_EquityComponentDomain_D5C5C03FD0E2FC1FA4B2DD84B20A250D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_D5C5C03FD0E2FC1FA4B2DD84B20A250D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_C52FD2C34D9889D81EFFDD84B20A3C8C" xlink:to="loc_us-gaap_EquityComponentDomain_D5C5C03FD0E2FC1FA4B2DD84B20A250D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_3B09B5448F64A5B4F922DD84B20AD190" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_D5C5C03FD0E2FC1FA4B2DD84B20A250D" xlink:to="loc_us-gaap_TreasuryStockMember_3B09B5448F64A5B4F922DD84B20AD190" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_D6A15D7DE85033904790DD84B20BA6CF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_D6A15D7DE85033904790DD84B20BA6CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_5A835E5694377A71B819DD84B20B9F5C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_5A835E5694377A71B819DD84B20B9F5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5125901CD457D3DE33E1DD84B20B5BDB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5125901CD457D3DE33E1DD84B20B5BDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_8E12941CB25F2CF13979DD84B20B0D70" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_8E12941CB25F2CF13979DD84B20B0D70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_24B1DC087B02D1F52716DD84B20C07CF" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_24B1DC087B02D1F52716DD84B20C07CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6DC801689C16205EEDA0DD84B20C6C21" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6DC801689C16205EEDA0DD84B20C6C21" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TreasuryStockAcquiredShares" xlink:label="loc_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84E4663FFD1D2185602BDD84B20D1D0A" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84E4663FFD1D2185602BDD84B20D1D0A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CommonStockVotingRightsVotes" xlink:label="loc_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>cah-20200630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SegmentReportingAbstract_5D6318F8EDA21C95155B064EB0BD480C_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract_5D6318F8EDA21C95155B064EB0BD480C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_5D6318F8EDA21C95155B064EB0BD480C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_5D6318F8EDA21C95155B064EB0BD480C" xlink:to="lab_us-gaap_SegmentReportingAbstract_5D6318F8EDA21C95155B064EB0BD480C" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_9B98A2518008DD151ADC064EB0BD006E_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_9B98A2518008DD151ADC064EB0BD006E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_9B98A2518008DD151ADC064EB0BD006E_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_9B98A2518008DD151ADC064EB0BD006E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_9B98A2518008DD151ADC064EB0BD006E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_9B98A2518008DD151ADC064EB0BD006E" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_9B98A2518008DD151ADC064EB0BD006E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_16BAD739DE3D606E64F6DE514012D3DB_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_16BAD739DE3D606E64F6DE514012D3DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_16BAD739DE3D606E64F6DE514012D3DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_16BAD739DE3D606E64F6DE514012D3DB" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_16BAD739DE3D606E64F6DE514012D3DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC_label_en-US" xlink:label="lab_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:to="lab_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1" xlink:to="lab_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044" xlink:to="lab_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044" xlink:type="arc" />
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_B7A4B2F154845583F62BDE51401BF8EA_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_B7A4B2F154845583F62BDE51401BF8EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_B7A4B2F154845583F62BDE51401BF8EA_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_B7A4B2F154845583F62BDE51401BF8EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_B7A4B2F154845583F62BDE51401BF8EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember_B7A4B2F154845583F62BDE51401BF8EA" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember_B7A4B2F154845583F62BDE51401BF8EA" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:to="lab_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueHedgingMember_E90CC3E563DB57D7B851DE51401C50FA_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember_E90CC3E563DB57D7B851DE51401C50FA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_E90CC3E563DB57D7B851DE51401C50FA_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember_E90CC3E563DB57D7B851DE51401C50FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_E90CC3E563DB57D7B851DE51401C50FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember_E90CC3E563DB57D7B851DE51401C50FA" xlink:to="lab_us-gaap_FairValueHedgingMember_E90CC3E563DB57D7B851DE51401C50FA" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashFlowHedgingMember_033D019D18C7A670A864DE51401DB617_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember_033D019D18C7A670A864DE51401DB617" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_033D019D18C7A670A864DE51401DB617_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember_033D019D18C7A670A864DE51401DB617" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_033D019D18C7A670A864DE51401DB617" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember_033D019D18C7A670A864DE51401DB617" xlink:to="lab_us-gaap_CashFlowHedgingMember_033D019D18C7A670A864DE51401DB617" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:to="lab_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestRateSwapMember_B49F07B5A6F8E9725C3DDE51401E37F9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember_B49F07B5A6F8E9725C3DDE51401E37F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_B49F07B5A6F8E9725C3DDE51401E37F9_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember_B49F07B5A6F8E9725C3DDE51401E37F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_B49F07B5A6F8E9725C3DDE51401E37F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember_B49F07B5A6F8E9725C3DDE51401E37F9" xlink:to="lab_us-gaap_InterestRateSwapMember_B49F07B5A6F8E9725C3DDE51401E37F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrencySwapMember_1D3219008EEBBAD58BA2DE51401E4D2A_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember_1D3219008EEBBAD58BA2DE51401E4D2A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_1D3219008EEBBAD58BA2DE51401E4D2A_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember_1D3219008EEBBAD58BA2DE51401E4D2A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_1D3219008EEBBAD58BA2DE51401E4D2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember_1D3219008EEBBAD58BA2DE51401E4D2A" xlink:to="lab_us-gaap_CurrencySwapMember_1D3219008EEBBAD58BA2DE51401E4D2A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_2063C6DE70FC070C7CF8DE51401F32A6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember_2063C6DE70FC070C7CF8DE51401F32A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_2063C6DE70FC070C7CF8DE51401F32A6_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember_2063C6DE70FC070C7CF8DE51401F32A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2063C6DE70FC070C7CF8DE51401F32A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember_2063C6DE70FC070C7CF8DE51401F32A6" xlink:to="lab_us-gaap_ForeignExchangeContractMember_2063C6DE70FC070C7CF8DE51401F32A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054" xlink:to="lab_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="lab_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_5964184582E648169555DE514020F598_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_5964184582E648169555DE514020F598" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_5964184582E648169555DE514020F598_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_5964184582E648169555DE514020F598" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_5964184582E648169555DE514020F598" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_5964184582E648169555DE514020F598" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_5964184582E648169555DE514020F598" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_476DE8FBCE90D46DA294DE51402017F6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount_476DE8FBCE90D46DA294DE51402017F6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_476DE8FBCE90D46DA294DE51402017F6_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount_476DE8FBCE90D46DA294DE51402017F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_476DE8FBCE90D46DA294DE51402017F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount_476DE8FBCE90D46DA294DE51402017F6" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount_476DE8FBCE90D46DA294DE51402017F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_85BD0AF9721464296371DE5149685707_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_85BD0AF9721464296371DE5149685707" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_85BD0AF9721464296371DE5149685707_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_85BD0AF9721464296371DE5149685707" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_85BD0AF9721464296371DE5149685707" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_85BD0AF9721464296371DE5149685707" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_85BD0AF9721464296371DE5149685707" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_E4C8B39E60D801A80B33DE579BD9CFC1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_E4C8B39E60D801A80B33DE579BD9CFC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_E4C8B39E60D801A80B33DE579BD9CFC1_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_E4C8B39E60D801A80B33DE579BD9CFC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_E4C8B39E60D801A80B33DE579BD9CFC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_E4C8B39E60D801A80B33DE579BD9CFC1" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_E4C8B39E60D801A80B33DE579BD9CFC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_6D2962D1BA7439879AF2DE51402085FB_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount_6D2962D1BA7439879AF2DE51402085FB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_6D2962D1BA7439879AF2DE51402085FB_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount_6D2962D1BA7439879AF2DE51402085FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_6D2962D1BA7439879AF2DE51402085FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount_6D2962D1BA7439879AF2DE51402085FB" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount_6D2962D1BA7439879AF2DE51402085FB" xlink:type="arc" />
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D_terseLabel_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives, terminated notional amounts</link:label>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D_label_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount</link:label>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D_documentation_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D" xlink:to="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D" xlink:type="arc" />
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F_terseLabel_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives, matured notional amounts</link:label>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F_label_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</link:label>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F_documentation_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F" xlink:to="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_1DEBA3F7DC4FC1894D6E064EB3AABC8A_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_1DEBA3F7DC4FC1894D6E064EB3AABC8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1DEBA3F7DC4FC1894D6E064EB3AABC8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1DEBA3F7DC4FC1894D6E064EB3AABC8A" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_1DEBA3F7DC4FC1894D6E064EB3AABC8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_D929ED28DD2207754751064EB3AAFDB3_terseLabel_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory_D929ED28DD2207754751064EB3AAFDB3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Portion of inventories held at LIFO, percentage</link:label>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_D929ED28DD2207754751064EB3AAFDB3_label_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory_D929ED28DD2207754751064EB3AAFDB3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of LIFO Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PercentageOfLIFOInventory" xlink:label="loc_us-gaap_PercentageOfLIFOInventory_D929ED28DD2207754751064EB3AAFDB3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PercentageOfLIFOInventory_D929ED28DD2207754751064EB3AAFDB3" xlink:to="lab_us-gaap_PercentageOfLIFOInventory_D929ED28DD2207754751064EB3AAFDB3" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryLIFOReserve_A2DD491DA4ED198A27CF064EB3AAD06D_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve_A2DD491DA4ED198A27CF064EB3AAD06D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories valued at LIFO amount higher than average cost value</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_A2DD491DA4ED198A27CF064EB3AAD06D_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve_A2DD491DA4ED198A27CF064EB3AAD06D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, LIFO Reserve</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReserve" xlink:label="loc_us-gaap_InventoryLIFOReserve_A2DD491DA4ED198A27CF064EB3AAD06D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReserve_A2DD491DA4ED198A27CF064EB3AAD06D" xlink:to="lab_us-gaap_InventoryLIFOReserve_A2DD491DA4ED198A27CF064EB3AAD06D" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryValuationReserves_4729B519285950342455064EB3AA63AB_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves_4729B519285950342455064EB3AA63AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reserves for excess and obsolete inventory</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_4729B519285950342455064EB3AA63AB_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves_4729B519285950342455064EB3AA63AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaap_InventoryValuationReserves_4729B519285950342455064EB3AA63AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves_4729B519285950342455064EB3AA63AB" xlink:to="lab_us-gaap_InventoryValuationReserves_4729B519285950342455064EB3AA63AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:type="arc" />
    <link:label id="lab_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1_terseLabel_en-US" xlink:label="lab_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1_label_en-US" xlink:label="lab_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1" xlink:to="lab_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1" xlink:type="arc" />
    <link:label id="lab_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72_terseLabel_en-US" xlink:label="lab_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72_label_en-US" xlink:label="lab_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:to="lab_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:type="arc" />
    <link:label id="lab_srt_MaximumMember_EEEAB1F7CAB617067545064EB39DF635_terseLabel_en-US" xlink:label="lab_srt_MaximumMember_EEEAB1F7CAB617067545064EB39DF635" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_EEEAB1F7CAB617067545064EB39DF635_label_en-US" xlink:label="lab_srt_MaximumMember_EEEAB1F7CAB617067545064EB39DF635" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_EEEAB1F7CAB617067545064EB39DF635" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_EEEAB1F7CAB617067545064EB39DF635" xlink:to="lab_srt_MaximumMember_EEEAB1F7CAB617067545064EB39DF635" xlink:type="arc" />
    <link:label id="lab_srt_MinimumMember_69C47B255EA92E3BF6A3064EB39DD7F3_terseLabel_en-US" xlink:label="lab_srt_MinimumMember_69C47B255EA92E3BF6A3064EB39DD7F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_69C47B255EA92E3BF6A3064EB39DD7F3_label_en-US" xlink:label="lab_srt_MinimumMember_69C47B255EA92E3BF6A3064EB39DD7F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_69C47B255EA92E3BF6A3064EB39DD7F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_69C47B255EA92E3BF6A3064EB39DD7F3" xlink:to="lab_srt_MinimumMember_69C47B255EA92E3BF6A3064EB39DD7F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:type="arc" />
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_ECEEA1892692362A6C26064EB39E9529_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember_ECEEA1892692362A6C26064EB39E9529" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Building and Improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_ECEEA1892692362A6C26064EB39E9529_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember_ECEEA1892692362A6C26064EB39E9529" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_ECEEA1892692362A6C26064EB39E9529" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember_ECEEA1892692362A6C26064EB39E9529" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember_ECEEA1892692362A6C26064EB39E9529" xlink:type="arc" />
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_CC42FE05B275D140A1A6064EB39EB62C_terseLabel_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember_CC42FE05B275D140A1A6064EB39EB62C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land, building and improvements</link:label>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_CC42FE05B275D140A1A6064EB39EB62C_label_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember_CC42FE05B275D140A1A6064EB39EB62C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land, Buildings and Improvements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_CC42FE05B275D140A1A6064EB39EB62C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandBuildingsAndImprovementsMember_CC42FE05B275D140A1A6064EB39EB62C" xlink:to="lab_us-gaap_LandBuildingsAndImprovementsMember_CC42FE05B275D140A1A6064EB39EB62C" xlink:type="arc" />
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_31A1AB580CB3D9003138064EB39F3667_verboseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember_31A1AB580CB3D9003138064EB39F3667" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_31A1AB580CB3D9003138064EB39F3667_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember_31A1AB580CB3D9003138064EB39F3667" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_31A1AB580CB3D9003138064EB39F3667" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember_31A1AB580CB3D9003138064EB39F3667" xlink:to="lab_us-gaap_MachineryAndEquipmentMember_31A1AB580CB3D9003138064EB39F3667" xlink:type="arc" />
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_A1B5A8461122662AA477064EB39F69D6_verboseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember_A1B5A8461122662AA477064EB39F69D6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_A1B5A8461122662AA477064EB39F69D6_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember_A1B5A8461122662AA477064EB39F69D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_A1B5A8461122662AA477064EB39F69D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember_A1B5A8461122662AA477064EB39F69D6" xlink:to="lab_us-gaap_FurnitureAndFixturesMember_A1B5A8461122662AA477064EB39F69D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_9541103BEE1433EA2477064EB39FE301_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_9541103BEE1433EA2477064EB39FE301" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_9541103BEE1433EA2477064EB39FE301_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_9541103BEE1433EA2477064EB39FE301" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9541103BEE1433EA2477064EB39FE301" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9541103BEE1433EA2477064EB39FE301" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_9541103BEE1433EA2477064EB39FE301" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_24DC60AF119D74F9C5BC064EB39F9954_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_24DC60AF119D74F9C5BC064EB39F9954" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_24DC60AF119D74F9C5BC064EB39F9954_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_24DC60AF119D74F9C5BC064EB39F9954" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_24DC60AF119D74F9C5BC064EB39F9954" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments_24DC60AF119D74F9C5BC064EB39F9954" xlink:to="lab_us-gaap_NumberOfOperatingSegments_24DC60AF119D74F9C5BC064EB39F9954" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_B65D516B0BF0AF25AAF2064EB39FDD5E_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_B65D516B0BF0AF25AAF2064EB39FDD5E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_B65D516B0BF0AF25AAF2064EB39FDD5E_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_B65D516B0BF0AF25AAF2064EB39FDD5E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_B65D516B0BF0AF25AAF2064EB39FDD5E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_B65D516B0BF0AF25AAF2064EB39FDD5E" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_B65D516B0BF0AF25AAF2064EB39FDD5E" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_69C143D626DEBDD76915064EB3A09ADA_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_69C143D626DEBDD76915064EB3A09ADA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_69C143D626DEBDD76915064EB3A09ADA_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_69C143D626DEBDD76915064EB3A09ADA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_69C143D626DEBDD76915064EB3A09ADA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_69C143D626DEBDD76915064EB3A09ADA" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross_69C143D626DEBDD76915064EB3A09ADA" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_FBDE385EB2EB3A1F9DA1064EB3A07B66_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_FBDE385EB2EB3A1F9DA1064EB3A07B66" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_FBDE385EB2EB3A1F9DA1064EB3A07B66_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_FBDE385EB2EB3A1F9DA1064EB3A07B66" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_FBDE385EB2EB3A1F9DA1064EB3A07B66" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_FBDE385EB2EB3A1F9DA1064EB3A07B66" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_FBDE385EB2EB3A1F9DA1064EB3A07B66" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_EF21E9F0F7FA500D31C5064EB3A09766_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_EF21E9F0F7FA500D31C5064EB3A09766" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_EF21E9F0F7FA500D31C5064EB3A09766_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_EF21E9F0F7FA500D31C5064EB3A09766" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_EF21E9F0F7FA500D31C5064EB3A09766" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_EF21E9F0F7FA500D31C5064EB3A09766" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_EF21E9F0F7FA500D31C5064EB3A09766" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestRateSwapMember_FE63B4A325D1E035A741C141C69D35F8_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember_FE63B4A325D1E035A741C141C69D35F8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Swaps</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_FE63B4A325D1E035A741C141C69D35F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember_FE63B4A325D1E035A741C141C69D35F8" xlink:to="lab_us-gaap_InterestRateSwapMember_FE63B4A325D1E035A741C141C69D35F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForwardContractsMember_6238286375496738DD5CC141C69D4A5E_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember_6238286375496738DD5CC141C69D4A5E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_6238286375496738DD5CC141C69D4A5E_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember_6238286375496738DD5CC141C69D4A5E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember" xlink:label="loc_us-gaap_ForwardContractsMember_6238286375496738DD5CC141C69D4A5E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember_6238286375496738DD5CC141C69D4A5E" xlink:to="lab_us-gaap_ForwardContractsMember_6238286375496738DD5CC141C69D4A5E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommodityContractMember_210BD55CA9F13F484C30C141C69E76DC_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityContractMember_210BD55CA9F13F484C30C141C69E76DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commodity Contracts</link:label>
    <link:label id="lab_us-gaap_CommodityContractMember_210BD55CA9F13F484C30C141C69E76DC_label_en-US" xlink:label="lab_us-gaap_CommodityContractMember_210BD55CA9F13F484C30C141C69E76DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commodity Contract [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaap_CommodityContractMember_210BD55CA9F13F484C30C141C69E76DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityContractMember_210BD55CA9F13F484C30C141C69E76DC" xlink:to="lab_us-gaap_CommodityContractMember_210BD55CA9F13F484C30C141C69E76DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_39E297BF6A5F558BF4B9C144202F72A1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount_39E297BF6A5F558BF4B9C144202F72A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_39E297BF6A5F558BF4B9C144202F72A1_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount_39E297BF6A5F558BF4B9C144202F72A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="loc_us-gaap_DerivativeNotionalAmount_39E297BF6A5F558BF4B9C144202F72A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount_39E297BF6A5F558BF4B9C144202F72A1" xlink:to="lab_us-gaap_DerivativeNotionalAmount_39E297BF6A5F558BF4B9C144202F72A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_3ADD341D40B7AC99BED9C141C69E67AB_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet_3ADD341D40B7AC99BED9C141C69E67AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Gain/(Loss)</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_3ADD341D40B7AC99BED9C141C69E67AB_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet_3ADD341D40B7AC99BED9C141C69E67AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_3ADD341D40B7AC99BED9C141C69E67AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet_3ADD341D40B7AC99BED9C141C69E67AB" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet_3ADD341D40B7AC99BED9C141C69E67AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_D9DAF4925F5251175460C4ECCD65570F_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_D9DAF4925F5251175460C4ECCD65570F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</link:label>
    <link:label id="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_D9DAF4925F5251175460C4ECCD65570F_label_en-US" xlink:label="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_D9DAF4925F5251175460C4ECCD65570F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_D9DAF4925F5251175460C4ECCD65570F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_D9DAF4925F5251175460C4ECCD65570F" xlink:to="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_D9DAF4925F5251175460C4ECCD65570F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_2960AD956102F03D0D2AC4ECCD65293C_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount_2960AD956102F03D0D2AC4ECCD65293C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_2960AD956102F03D0D2AC4ECCD65293C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount_2960AD956102F03D0D2AC4ECCD65293C" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount_2960AD956102F03D0D2AC4ECCD65293C" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_A0D8B2FA980081536A83E412B9B631BA_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_A0D8B2FA980081536A83E412B9B631BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_A0D8B2FA980081536A83E412B9B631BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_A0D8B2FA980081536A83E412B9B631BA" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_A0D8B2FA980081536A83E412B9B631BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating and Reportable Segment</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618_label_en-US" xlink:label="lab_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:to="lab_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:type="arc" />
    <link:label id="lab_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pharmaceutical</link:label>
    <link:label id="lab_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532_label_en-US" xlink:label="lab_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmaceutical Member</link:label>
    <link:label id="lab_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532_documentation_en-US" xlink:label="lab_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharmaceutical [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532" xlink:to="lab_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532" xlink:type="arc" />
    <link:label id="lab_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C_terseLabel_en-US" xlink:label="lab_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C_label_en-US" xlink:label="lab_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Member</link:label>
    <link:label id="lab_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C_documentation_en-US" xlink:label="lab_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C" xlink:to="lab_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:to="lab_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillTransfers_9F51FFEA3FBBE32EB262E412BFCE916D_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers_9F51FFEA3FBBE32EB262E412BFCE916D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_9F51FFEA3FBBE32EB262E412BFCE916D_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers_9F51FFEA3FBBE32EB262E412BFCE916D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers" xlink:label="loc_us-gaap_GoodwillTransfers_9F51FFEA3FBBE32EB262E412BFCE916D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers_9F51FFEA3FBBE32EB262E412BFCE916D" xlink:to="lab_us-gaap_GoodwillTransfers_9F51FFEA3FBBE32EB262E412BFCE916D" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:to="lab_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_A3934E12D59CAFCE9341E412B9C495B3_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill_A3934E12D59CAFCE9341E412B9C495B3" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_A3934E12D59CAFCE9341E412B9C495B3_label_en-US" xlink:label="lab_us-gaap_Goodwill_A3934E12D59CAFCE9341E412B9C495B3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_A3934E12D59CAFCE9341E412B9C495B3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_A3934E12D59CAFCE9341E412B9C495B3" xlink:to="lab_us-gaap_Goodwill_A3934E12D59CAFCE9341E412B9C495B3" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73D288E492E2E1163D64E412B9C8E7F6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73D288E492E2E1163D64E412B9C8E7F6" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73D288E492E2E1163D64E412B9C8E7F6_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73D288E492E2E1163D64E412B9C8E7F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73D288E492E2E1163D64E412B9C8E7F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73D288E492E2E1163D64E412B9C8E7F6" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73D288E492E2E1163D64E412B9C8E7F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_D81A8A7C59D361C98EC1E412B9C8D00A_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_D81A8A7C59D361C98EC1E412B9C8D00A" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_D81A8A7C59D361C98EC1E412B9C8D00A_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_D81A8A7C59D361C98EC1E412B9C8D00A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_D81A8A7C59D361C98EC1E412B9C8D00A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss_D81A8A7C59D361C98EC1E412B9C8D00A" xlink:to="lab_us-gaap_GoodwillImpairmentLoss_D81A8A7C59D361C98EC1E412B9C8D00A" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_B2F7F2E518F7FC74352BE412B9C8EB2B_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill_B2F7F2E518F7FC74352BE412B9C8EB2B" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B2F7F2E518F7FC74352BE412B9C8EB2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_B2F7F2E518F7FC74352BE412B9C8EB2B" xlink:to="lab_us-gaap_Goodwill_B2F7F2E518F7FC74352BE412B9C8EB2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_656C2BB71796CA3246BAE412B9C9892B_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_656C2BB71796CA3246BAE412B9C9892B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated goodwill impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_656C2BB71796CA3246BAE412B9C9892B_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_656C2BB71796CA3246BAE412B9C9892B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_656C2BB71796CA3246BAE412B9C9892B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_656C2BB71796CA3246BAE412B9C9892B" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_656C2BB71796CA3246BAE412B9C9892B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2246B73CFB5456618025064EB214D6AB_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2246B73CFB5456618025064EB214D6AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2246B73CFB5456618025064EB214D6AB_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2246B73CFB5456618025064EB214D6AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2246B73CFB5456618025064EB214D6AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2246B73CFB5456618025064EB214D6AB" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2246B73CFB5456618025064EB214D6AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_NondesignatedMember_D779AB8113744D9199A7064EB215C9F4_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember_D779AB8113744D9199A7064EB215C9F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_D779AB8113744D9199A7064EB215C9F4_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember_D779AB8113744D9199A7064EB215C9F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_D779AB8113744D9199A7064EB215C9F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember_D779AB8113744D9199A7064EB215C9F4" xlink:to="lab_us-gaap_NondesignatedMember_D779AB8113744D9199A7064EB215C9F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_DFC37C9D22A8F7453135064EB2165C2E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_DFC37C9D22A8F7453135064EB2165C2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Outstanding Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_DFC37C9D22A8F7453135064EB2165C2E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_DFC37C9D22A8F7453135064EB2165C2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_DFC37C9D22A8F7453135064EB2165C2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_DFC37C9D22A8F7453135064EB2165C2E" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_DFC37C9D22A8F7453135064EB2165C2E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_E2554AB5441990B34599064EB216DA4A_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_E2554AB5441990B34599064EB216DA4A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_E2554AB5441990B34599064EB216DA4A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_E2554AB5441990B34599064EB216DA4A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_E2554AB5441990B34599064EB216DA4A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_E2554AB5441990B34599064EB216DA4A" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_E2554AB5441990B34599064EB216DA4A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_458D6C08D6E24783B6B9064EB2163285_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_458D6C08D6E24783B6B9064EB2163285" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_458D6C08D6E24783B6B9064EB2163285_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_458D6C08D6E24783B6B9064EB2163285" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_458D6C08D6E24783B6B9064EB2163285" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_458D6C08D6E24783B6B9064EB2163285" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_458D6C08D6E24783B6B9064EB2163285" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_230E90E71C6C3EBE45C8064EB2170163_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_230E90E71C6C3EBE45C8064EB2170163" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_230E90E71C6C3EBE45C8064EB2170163_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_230E90E71C6C3EBE45C8064EB2170163" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_230E90E71C6C3EBE45C8064EB2170163" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_230E90E71C6C3EBE45C8064EB2170163" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_230E90E71C6C3EBE45C8064EB2170163" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2799996BE6E2C8490659064EB2176475_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2799996BE6E2C8490659064EB2176475" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Gain/(Loss) Recognized in Earnings for Economic (Non-designated) Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2799996BE6E2C8490659064EB2176475_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2799996BE6E2C8490659064EB2176475" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2799996BE6E2C8490659064EB2176475" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2799996BE6E2C8490659064EB2176475" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2799996BE6E2C8490659064EB2176475" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6E411A653BFDBD003FE4064EB2174719_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6E411A653BFDBD003FE4064EB2174719" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6E411A653BFDBD003FE4064EB2174719_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6E411A653BFDBD003FE4064EB2174719" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6E411A653BFDBD003FE4064EB2174719" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6E411A653BFDBD003FE4064EB2174719" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6E411A653BFDBD003FE4064EB2174719" xlink:type="arc" />
    <link:label id="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_B9620BED67C919FC65C3064EB217AED4_terseLabel_en-US" xlink:label="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_B9620BED67C919FC65C3064EB217AED4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Gain/(Loss) Derivative Instrument</link:label>
    <link:label id="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_B9620BED67C919FC65C3064EB217AED4_label_en-US" xlink:label="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_B9620BED67C919FC65C3064EB217AED4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Fair Value Gain Loss Derivative Instrument [Table Text Block]</link:label>
    <link:label id="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_B9620BED67C919FC65C3064EB217AED4_documentation_en-US" xlink:label="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_B9620BED67C919FC65C3064EB217AED4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summarizes the fair value and notional amounts of derivative instruments held as of the balance sheet date.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:label="loc_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_B9620BED67C919FC65C3064EB217AED4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_B9620BED67C919FC65C3064EB217AED4" xlink:to="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_B9620BED67C919FC65C3064EB217AED4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4593551B539EA05DC35C064EB0014841_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4593551B539EA05DC35C064EB0014841" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4593551B539EA05DC35C064EB0014841" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4593551B539EA05DC35C064EB0014841" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4593551B539EA05DC35C064EB0014841" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216" xlink:type="arc" />
    <link:label id="lab_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F" xlink:to="lab_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_80D47757AC837CA3BE1F064EB0029F6A_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_80D47757AC837CA3BE1F064EB0029F6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_80D47757AC837CA3BE1F064EB0029F6A_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_80D47757AC837CA3BE1F064EB0029F6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_80D47757AC837CA3BE1F064EB0029F6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_80D47757AC837CA3BE1F064EB0029F6A" xlink:to="lab_us-gaap_PerformanceSharesMember_80D47757AC837CA3BE1F064EB0029F6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_55C50C20207CF6B2DEEE064EB003D658_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_55C50C20207CF6B2DEEE064EB003D658" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_55C50C20207CF6B2DEEE064EB003D658_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_55C50C20207CF6B2DEEE064EB003D658" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_55C50C20207CF6B2DEEE064EB003D658" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_55C50C20207CF6B2DEEE064EB003D658" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_55C50C20207CF6B2DEEE064EB003D658" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_00E98CC9B2EAED295E2E064EB003DA43_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_00E98CC9B2EAED295E2E064EB003DA43" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_00E98CC9B2EAED295E2E064EB003DA43_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_00E98CC9B2EAED295E2E064EB003DA43" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_00E98CC9B2EAED295E2E064EB003DA43" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_00E98CC9B2EAED295E2E064EB003DA43" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_00E98CC9B2EAED295E2E064EB003DA43" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_EB4857F217D21B4A1160064EB003D6E3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_EB4857F217D21B4A1160064EB003D6E3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_EB4857F217D21B4A1160064EB003D6E3_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_EB4857F217D21B4A1160064EB003D6E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_EB4857F217D21B4A1160064EB003D6E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_EB4857F217D21B4A1160064EB003D6E3" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_EB4857F217D21B4A1160064EB003D6E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2ACA1D091F320523594C064EB0033EEB_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2ACA1D091F320523594C064EB0033EEB" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2ACA1D091F320523594C064EB0033EEB_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2ACA1D091F320523594C064EB0033EEB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2ACA1D091F320523594C064EB0033EEB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2ACA1D091F320523594C064EB0033EEB" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2ACA1D091F320523594C064EB0033EEB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4F98ECDE7CA30296E3A4064EB0031535_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4F98ECDE7CA30296E3A4064EB0031535" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4F98ECDE7CA30296E3A4064EB0031535" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4F98ECDE7CA30296E3A4064EB0031535" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4F98ECDE7CA30296E3A4064EB0031535" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_814300961413DCB5681C064EB004F31A_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_814300961413DCB5681C064EB004F31A" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_814300961413DCB5681C064EB004F31A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_814300961413DCB5681C064EB004F31A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_814300961413DCB5681C064EB004F31A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_814300961413DCB5681C064EB004F31A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_814300961413DCB5681C064EB004F31A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_D326C3D928BA2063894F064EB004FCA9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_D326C3D928BA2063894F064EB004FCA9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_D326C3D928BA2063894F064EB004FCA9_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_D326C3D928BA2063894F064EB004FCA9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_D326C3D928BA2063894F064EB004FCA9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_D326C3D928BA2063894F064EB004FCA9" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_D326C3D928BA2063894F064EB004FCA9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1846DF5F2AB9ED40F037064EB00432A8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1846DF5F2AB9ED40F037064EB00432A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1846DF5F2AB9ED40F037064EB00432A8_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1846DF5F2AB9ED40F037064EB00432A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1846DF5F2AB9ED40F037064EB00432A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1846DF5F2AB9ED40F037064EB00432A8" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1846DF5F2AB9ED40F037064EB00432A8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76EC03B657E934F90932064EB004D388_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76EC03B657E934F90932064EB004D388" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76EC03B657E934F90932064EB004D388_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76EC03B657E934F90932064EB004D388" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76EC03B657E934F90932064EB004D388" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76EC03B657E934F90932064EB004D388" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76EC03B657E934F90932064EB004D388" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_CCAF181B5947865CBE7F064EB004E4B9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_CCAF181B5947865CBE7F064EB004E4B9" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (in usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_CCAF181B5947865CBE7F064EB004E4B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_CCAF181B5947865CBE7F064EB004E4B9" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_CCAF181B5947865CBE7F064EB004E4B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8764D9B254F4144D3966064EB0052CE5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8764D9B254F4144D3966064EB0052CE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Target performance goal (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8764D9B254F4144D3966064EB0052CE5_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8764D9B254F4144D3966064EB0052CE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8764D9B254F4144D3966064EB0052CE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8764D9B254F4144D3966064EB0052CE5" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8764D9B254F4144D3966064EB0052CE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_91E3A9D724F89FB91497064EB3BEE323_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_91E3A9D724F89FB91497064EB3BEE323" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Revenue and Gross Trade Receivables Percentage by Major Customers</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_91E3A9D724F89FB91497064EB3BEE323_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_91E3A9D724F89FB91497064EB3BEE323" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_91E3A9D724F89FB91497064EB3BEE323" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_91E3A9D724F89FB91497064EB3BEE323" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_91E3A9D724F89FB91497064EB3BEE323" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_1396FDC82E3826E79A7E064EB3BE08D1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_1396FDC82E3826E79A7E064EB3BE08D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_1396FDC82E3826E79A7E064EB3BE08D1_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_1396FDC82E3826E79A7E064EB3BE08D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1396FDC82E3826E79A7E064EB3BE08D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1396FDC82E3826E79A7E064EB3BE08D1" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_1396FDC82E3826E79A7E064EB3BE08D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_72F9CAB232095F521B2C064EB22A242F_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_72F9CAB232095F521B2C064EB22A242F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_72F9CAB232095F521B2C064EB22A242F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_72F9CAB232095F521B2C064EB22A242F" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_72F9CAB232095F521B2C064EB22A242F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_596AED684AC2F4FD59CC064EB22AA925_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_596AED684AC2F4FD59CC064EB22AA925" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_596AED684AC2F4FD59CC064EB22AA925_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_596AED684AC2F4FD59CC064EB22AA925" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_596AED684AC2F4FD59CC064EB22AA925" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_596AED684AC2F4FD59CC064EB22AA925" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_596AED684AC2F4FD59CC064EB22AA925" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2F7525616256AC5ACDBB064EB22AB54C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2F7525616256AC5ACDBB064EB22AB54C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2F7525616256AC5ACDBB064EB22AB54C_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2F7525616256AC5ACDBB064EB22AB54C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2F7525616256AC5ACDBB064EB22AB54C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2F7525616256AC5ACDBB064EB22AB54C" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2F7525616256AC5ACDBB064EB22AB54C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_160DBEC11BAC1997CBD1064EB3B22ABA_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_160DBEC11BAC1997CBD1064EB3B22ABA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_160DBEC11BAC1997CBD1064EB3B22ABA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_160DBEC11BAC1997CBD1064EB3B22ABA" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_160DBEC11BAC1997CBD1064EB3B22ABA" xlink:type="arc" />
    <link:label id="lab_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9_label_en-US" xlink:label="lab_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9" xlink:to="lab_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9" xlink:type="arc" />
    <link:label id="lab_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:to="lab_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:type="arc" />
    <link:label id="lab_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2_terseLabel_en-US" xlink:label="lab_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CVS Health</link:label>
    <link:label id="lab_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2_label_en-US" xlink:label="lab_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CVS Caremark Corporation [Member]</link:label>
    <link:label id="lab_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2_documentation_en-US" xlink:label="lab_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CVS Caremark Corporation [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_CVSCaremarkCorporationMember" xlink:label="loc_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2" xlink:to="lab_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2" xlink:type="arc" />
    <link:label id="lab_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967_terseLabel_en-US" xlink:label="lab_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OptumRx [Member]</link:label>
    <link:label id="lab_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967_label_en-US" xlink:label="lab_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OptumRx [Member]</link:label>
    <link:label id="lab_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967_documentation_en-US" xlink:label="lab_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">OptumRx [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OptumRxMember" xlink:label="loc_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967" xlink:to="lab_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967" xlink:type="arc" />
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_653E1BCC90973C8125E9064EB3B4F442_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_653E1BCC90973C8125E9064EB3B4F442" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Percent of Revenue</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_653E1BCC90973C8125E9064EB3B4F442_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_653E1BCC90973C8125E9064EB3B4F442" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_653E1BCC90973C8125E9064EB3B4F442" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1_653E1BCC90973C8125E9064EB3B4F442" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1_653E1BCC90973C8125E9064EB3B4F442" xlink:type="arc" />
    <link:label id="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035_terseLabel_en-US" xlink:label="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of Gross Trade Receivables</link:label>
    <link:label id="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035_label_en-US" xlink:label="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Trade Receivables, Major Customer Percentage</link:label>
    <link:label id="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035_documentation_en-US" xlink:label="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gross Trade Receivables, Major Customer Percentage</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:label="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035" xlink:to="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeasesAbstract_C07FEE0E58E9B1E1E26CC0931EFC2FE0_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract_C07FEE0E58E9B1E1E26CC0931EFC2FE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_C07FEE0E58E9B1E1E26CC0931EFC2FE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract_C07FEE0E58E9B1E1E26CC0931EFC2FE0" xlink:to="lab_us-gaap_LeasesAbstract_C07FEE0E58E9B1E1E26CC0931EFC2FE0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_AE5A669D33B81606DD57C0931EFD848F_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_AE5A669D33B81606DD57C0931EFD848F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_AE5A669D33B81606DD57C0931EFD848F_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_AE5A669D33B81606DD57C0931EFD848F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_AE5A669D33B81606DD57C0931EFD848F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock_AE5A669D33B81606DD57C0931EFD848F" xlink:to="lab_us-gaap_LeaseCostTableTextBlock_AE5A669D33B81606DD57C0931EFD848F" xlink:type="arc" />
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_CE51F63359972E1CE97DC0931EFD2EE8_terseLabel_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_CE51F63359972E1CE97DC0931EFD2EE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_CE51F63359972E1CE97DC0931EFD2EE8_label_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_CE51F63359972E1CE97DC0931EFD2EE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">LeasesSupplementalBalanceSheetInformation [Table Text Block]</link:label>
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_CE51F63359972E1CE97DC0931EFD2EE8_documentation_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_CE51F63359972E1CE97DC0931EFD2EE8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:label="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_CE51F63359972E1CE97DC0931EFD2EE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_CE51F63359972E1CE97DC0931EFD2EE8" xlink:to="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_CE51F63359972E1CE97DC0931EFD2EE8" xlink:type="arc" />
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_0E4DC971543366195759C0931EFDE8D7_terseLabel_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock_0E4DC971543366195759C0931EFDE8D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases Supplemental Cash Flow Information</link:label>
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_0E4DC971543366195759C0931EFDE8D7_label_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock_0E4DC971543366195759C0931EFDE8D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Payments [Table Text Block]</link:label>
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_0E4DC971543366195759C0931EFDE8D7_documentation_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock_0E4DC971543366195759C0931EFDE8D7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Table Text Block] for Lease Payments [Table]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LeasePaymentsTableTextBlock" xlink:label="loc_cah_LeasePaymentsTableTextBlock_0E4DC971543366195759C0931EFDE8D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasePaymentsTableTextBlock_0E4DC971543366195759C0931EFDE8D7" xlink:to="lab_cah_LeasePaymentsTableTextBlock_0E4DC971543366195759C0931EFDE8D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_3E32629E1748D0DE9169C0931EFDFF4E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_3E32629E1748D0DE9169C0931EFDFF4E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Future Lease Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_3E32629E1748D0DE9169C0931EFDFF4E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_3E32629E1748D0DE9169C0931EFDFF4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_3E32629E1748D0DE9169C0931EFDFF4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_3E32629E1748D0DE9169C0931EFDFF4E" xlink:to="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_3E32629E1748D0DE9169C0931EFDFF4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Litigation [Axis]</link:label>
    <link:label id="lab_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878_label_en-US" xlink:label="lab_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Litigation [Axis]</link:label>
    <link:label id="lab_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878_documentation_en-US" xlink:label="lab_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Litigation</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:to="lab_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Litigation [Domain]</link:label>
    <link:label id="lab_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839_label_en-US" xlink:label="lab_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Litigation [Domain]</link:label>
    <link:label id="lab_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839_documentation_en-US" xlink:label="lab_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Litigation [Domain]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839" xlink:to="lab_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839" xlink:type="arc" />
    <link:label id="lab_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717_terseLabel_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717_label_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717_documentation_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717" xlink:to="lab_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717" xlink:type="arc" />
    <link:label id="lab_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4_terseLabel_en-US" xlink:label="lab_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4_label_en-US" xlink:label="lab_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4_documentation_en-US" xlink:label="lab_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gown Recall [Axis]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_GownRecallAxis" xlink:label="loc_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:to="lab_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:type="arc" />
    <link:label id="lab_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE_terseLabel_en-US" xlink:label="lab_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE_label_en-US" xlink:label="lab_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE_documentation_en-US" xlink:label="lab_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Gown Recall [Axis]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE" xlink:to="lab_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE" xlink:type="arc" />
    <link:label id="lab_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630_terseLabel_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Member]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630_label_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Member]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630_documentation_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_SterileSurgicalGownRecallMember" xlink:label="loc_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630" xlink:to="lab_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C" xlink:type="arc" />
    <link:label id="lab_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920_terseLabel_en-US" xlink:label="lab_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:label id="lab_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920_label_en-US" xlink:label="lab_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:label id="lab_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920_documentation_en-US" xlink:label="lab_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920" xlink:to="lab_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:type="arc" />
    <link:label id="lab_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0_terseLabel_en-US" xlink:label="lab_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on Divestiture After Tax</link:label>
    <link:label id="lab_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0_label_en-US" xlink:label="lab_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain on Divestiture After Tax</link:label>
    <link:label id="lab_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0_documentation_en-US" xlink:label="lab_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain on Divestiture After Tax</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_GainonDivestitureAfterTax" xlink:label="loc_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0" xlink:to="lab_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfReportableSegments_C731FD4880B77B650CA1C5281BA93E07_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_C731FD4880B77B650CA1C5281BA93E07" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_C731FD4880B77B650CA1C5281BA93E07_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_C731FD4880B77B650CA1C5281BA93E07" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_C731FD4880B77B650CA1C5281BA93E07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments_C731FD4880B77B650CA1C5281BA93E07" xlink:to="lab_us-gaap_NumberOfReportableSegments_C731FD4880B77B650CA1C5281BA93E07" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryRecallExpense_72B2A0898268A8793A90C5281BAAEFA2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense_72B2A0898268A8793A90C5281BAAEFA2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:label id="lab_us-gaap_InventoryRecallExpense_72B2A0898268A8793A90C5281BAAEFA2_label_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense_72B2A0898268A8793A90C5281BAAEFA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRecallExpense" xlink:label="loc_us-gaap_InventoryRecallExpense_72B2A0898268A8793A90C5281BAAEFA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRecallExpense_72B2A0898268A8793A90C5281BAAEFA2" xlink:to="lab_us-gaap_InventoryRecallExpense_72B2A0898268A8793A90C5281BAAEFA2" xlink:type="arc" />
    <link:label id="lab_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778_terseLabel_en-US" xlink:label="lab_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-Tax Gain on Divestiture</link:label>
    <link:label id="lab_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778_label_en-US" xlink:label="lab_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Tax Gain on Divestiture</link:label>
    <link:label id="lab_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778_documentation_en-US" xlink:label="lab_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Tax Gain on Divestiture</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778" xlink:to="lab_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_800FDEAD59F15391D9E0C5281BAA88F0_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement_800FDEAD59F15391D9E0C5281BAA88F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_800FDEAD59F15391D9E0C5281BAA88F0_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement_800FDEAD59F15391D9E0C5281BAA88F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_800FDEAD59F15391D9E0C5281BAA88F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement_800FDEAD59F15391D9E0C5281BAA88F0" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement_800FDEAD59F15391D9E0C5281BAA88F0" xlink:type="arc" />
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A_terseLabel_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Project costs on investment and other spending</link:label>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A_label_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Project Costs On Investment And Other Spending</link:label>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A_documentation_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A" xlink:to="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_EF1B3AA40C62E6ED903A064EB2F0405A_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract_EF1B3AA40C62E6ED903A064EB2F0405A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_EF1B3AA40C62E6ED903A064EB2F0405A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_EF1B3AA40C62E6ED903A064EB2F0405A" xlink:to="lab_us-gaap_DebtDisclosureAbstract_EF1B3AA40C62E6ED903A064EB2F0405A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_6BC56C64EA2C477D87F4064EB2F12EF0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_6BC56C64EA2C477D87F4064EB2F12EF0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Obligations and Other Short-Term Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_6BC56C64EA2C477D87F4064EB2F12EF0_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_6BC56C64EA2C477D87F4064EB2F12EF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_6BC56C64EA2C477D87F4064EB2F12EF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock_6BC56C64EA2C477D87F4064EB2F12EF0" xlink:to="lab_us-gaap_DebtDisclosureTextBlock_6BC56C64EA2C477D87F4064EB2F12EF0" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_CEFDF59E3084160B2605C56FB75EACF7_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_CEFDF59E3084160B2605C56FB75EACF7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_CEFDF59E3084160B2605C56FB75EACF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_CEFDF59E3084160B2605C56FB75EACF7" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_CEFDF59E3084160B2605C56FB75EACF7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_E252EF1A31BB180431B6C56FB77519A5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_E252EF1A31BB180431B6C56FB77519A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable basis difference</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_E252EF1A31BB180431B6C56FB77519A5_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_E252EF1A31BB180431B6C56FB77519A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_E252EF1A31BB180431B6C56FB77519A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_E252EF1A31BB180431B6C56FB77519A5" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_E252EF1A31BB180431B6C56FB77519A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_BC574AC47A83FF7712A5C56FB77718D4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_BC574AC47A83FF7712A5C56FB77718D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_BC574AC47A83FF7712A5C56FB77718D4_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_BC574AC47A83FF7712A5C56FB77718D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_BC574AC47A83FF7712A5C56FB77718D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_BC574AC47A83FF7712A5C56FB77718D4" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_BC574AC47A83FF7712A5C56FB77718D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_95D5A04B6969AF5AFEE2C56FB779972D_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_95D5A04B6969AF5AFEE2C56FB779972D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_95D5A04B6969AF5AFEE2C56FB779972D_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_95D5A04B6969AF5AFEE2C56FB779972D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_95D5A04B6969AF5AFEE2C56FB779972D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_95D5A04B6969AF5AFEE2C56FB779972D" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_95D5A04B6969AF5AFEE2C56FB779972D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_FB490BE471D5BFBD3E14C56FB779E2AB_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_FB490BE471D5BFBD3E14C56FB779E2AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss and tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_FB490BE471D5BFBD3E14C56FB779E2AB_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_FB490BE471D5BFBD3E14C56FB779E2AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_FB490BE471D5BFBD3E14C56FB779E2AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_FB490BE471D5BFBD3E14C56FB779E2AB" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_FB490BE471D5BFBD3E14C56FB779E2AB" xlink:type="arc" />
    <link:label id="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_D62B39F4662DDFE00823C56FB77ADD24_terseLabel_en-US" xlink:label="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_D62B39F4662DDFE00823C56FB77ADD24" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets related to uncertain tax positions</link:label>
    <link:label id="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_D62B39F4662DDFE00823C56FB77ADD24_label_en-US" xlink:label="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_D62B39F4662DDFE00823C56FB77ADD24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Related to uncertain tax positions</link:label>
    <link:label id="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_D62B39F4662DDFE00823C56FB77ADD24_documentation_en-US" xlink:label="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_D62B39F4662DDFE00823C56FB77ADD24" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax assets related to uncertain tax positions</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:label="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_D62B39F4662DDFE00823C56FB77ADD24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_D62B39F4662DDFE00823C56FB77ADD24" xlink:to="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_D62B39F4662DDFE00823C56FB77ADD24" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_2DBA479C3792727BEEA2C56FB77AF43E_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther_2DBA479C3792727BEEA2C56FB77AF43E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_2DBA479C3792727BEEA2C56FB77AF43E_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther_2DBA479C3792727BEEA2C56FB77AF43E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_2DBA479C3792727BEEA2C56FB77AF43E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther_2DBA479C3792727BEEA2C56FB77AF43E" xlink:to="lab_us-gaap_DeferredTaxAssetsOther_2DBA479C3792727BEEA2C56FB77AF43E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_778D7F1CB0CBE53A9FAFC56FB77B0B4E_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_778D7F1CB0CBE53A9FAFC56FB77B0B4E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_778D7F1CB0CBE53A9FAFC56FB77B0B4E_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_778D7F1CB0CBE53A9FAFC56FB77B0B4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_778D7F1CB0CBE53A9FAFC56FB77B0B4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_778D7F1CB0CBE53A9FAFC56FB77B0B4E" xlink:to="lab_us-gaap_DeferredTaxAssetsGross_778D7F1CB0CBE53A9FAFC56FB77B0B4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_35D36D1260ECC755D481C56FB77B05B7_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_35D36D1260ECC755D481C56FB77B05B7" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance for deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_35D36D1260ECC755D481C56FB77B05B7_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_35D36D1260ECC755D481C56FB77B05B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_35D36D1260ECC755D481C56FB77B05B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_35D36D1260ECC755D481C56FB77B05B7" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_35D36D1260ECC755D481C56FB77B05B7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_60FC9F330F391F976BA2C56FB77BCA17_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_60FC9F330F391F976BA2C56FB77BCA17" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_60FC9F330F391F976BA2C56FB77BCA17_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_60FC9F330F391F976BA2C56FB77BCA17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_60FC9F330F391F976BA2C56FB77BCA17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_60FC9F330F391F976BA2C56FB77BCA17" xlink:to="lab_us-gaap_DeferredTaxAssetsNet_60FC9F330F391F976BA2C56FB77BCA17" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_2105FC134F42EAF17674C56FB77C6891_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_2105FC134F42EAF17674C56FB77C6891" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventory basis differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_2105FC134F42EAF17674C56FB77C6891_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_2105FC134F42EAF17674C56FB77C6891" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_2105FC134F42EAF17674C56FB77C6891" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_2105FC134F42EAF17674C56FB77C6891" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_2105FC134F42EAF17674C56FB77C6891" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_A93C65D22DDDEE03B931C56FB77C406C_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_A93C65D22DDDEE03B931C56FB77C406C" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Property-related</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_A93C65D22DDDEE03B931C56FB77C406C_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_A93C65D22DDDEE03B931C56FB77C406C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_A93C65D22DDDEE03B931C56FB77C406C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_A93C65D22DDDEE03B931C56FB77C406C" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_A93C65D22DDDEE03B931C56FB77C406C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_79DED02E4EEDCC15281CC56FB77D0585_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_79DED02E4EEDCC15281CC56FB77D0585" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Goodwill and other intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_79DED02E4EEDCC15281CC56FB77D0585_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_79DED02E4EEDCC15281CC56FB77D0585" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_79DED02E4EEDCC15281CC56FB77D0585" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_79DED02E4EEDCC15281CC56FB77D0585" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_79DED02E4EEDCC15281CC56FB77D0585" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_9FE7A06FF8333D0B1710C56FB77DBE9E_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities_9FE7A06FF8333D0B1710C56FB77DBE9E" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_9FE7A06FF8333D0B1710C56FB77DBE9E_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities_9FE7A06FF8333D0B1710C56FB77DBE9E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_9FE7A06FF8333D0B1710C56FB77DBE9E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_9FE7A06FF8333D0B1710C56FB77DBE9E" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities_9FE7A06FF8333D0B1710C56FB77DBE9E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_230EE51B7FF7BCFC2374C56FB77D309F_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities_230EE51B7FF7BCFC2374C56FB77D309F" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net deferred income tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_230EE51B7FF7BCFC2374C56FB77D309F_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities_230EE51B7FF7BCFC2374C56FB77D309F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_230EE51B7FF7BCFC2374C56FB77D309F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities_230EE51B7FF7BCFC2374C56FB77D309F" xlink:to="lab_us-gaap_DeferredTaxLiabilities_230EE51B7FF7BCFC2374C56FB77D309F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893_label_en-US" xlink:label="lab_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893" xlink:to="lab_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893" xlink:type="arc" />
    <link:label id="lab_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7_terseLabel_en-US" xlink:label="lab_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7_label_en-US" xlink:label="lab_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease [Member]</link:label>
    <link:label id="lab_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7_documentation_en-US" xlink:label="lab_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OperatingLeaseMember" xlink:label="loc_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7" xlink:to="lab_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7" xlink:type="arc" />
    <link:label id="lab_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D_terseLabel_en-US" xlink:label="lab_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D_label_en-US" xlink:label="lab_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:label id="lab_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D_documentation_en-US" xlink:label="lab_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_FinanceLeaseMember" xlink:label="loc_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D" xlink:to="lab_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE_label_en-US" xlink:label="lab_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="lab_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48EDC5E0F0A4630D39C5C0931EDBD417_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48EDC5E0F0A4630D39C5C0931EDBD417" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2020</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48EDC5E0F0A4630D39C5C0931EDBD417_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48EDC5E0F0A4630D39C5C0931EDBD417" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48EDC5E0F0A4630D39C5C0931EDBD417" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48EDC5E0F0A4630D39C5C0931EDBD417" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48EDC5E0F0A4630D39C5C0931EDBD417" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_DFCDA61FF528C3065F74C0931EDC2C48_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_DFCDA61FF528C3065F74C0931EDC2C48" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2020</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_DFCDA61FF528C3065F74C0931EDC2C48_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_DFCDA61FF528C3065F74C0931EDC2C48" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_DFCDA61FF528C3065F74C0931EDC2C48" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_DFCDA61FF528C3065F74C0931EDC2C48" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_DFCDA61FF528C3065F74C0931EDC2C48" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2020</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Remainder Of Fiscal Year</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Remainder Of Fiscal Year</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7769A8018645A9846E03C0931EDC7253_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7769A8018645A9846E03C0931EDC7253" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7769A8018645A9846E03C0931EDC7253_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7769A8018645A9846E03C0931EDC7253" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7769A8018645A9846E03C0931EDC7253" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7769A8018645A9846E03C0931EDC7253" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7769A8018645A9846E03C0931EDC7253" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_76B70A8017068AEBE457C0931EDC3DA7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_76B70A8017068AEBE457C0931EDC3DA7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_76B70A8017068AEBE457C0931EDC3DA7_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_76B70A8017068AEBE457C0931EDC3DA7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_76B70A8017068AEBE457C0931EDC3DA7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_76B70A8017068AEBE457C0931EDC3DA7" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_76B70A8017068AEBE457C0931EDC3DA7" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Two</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Two</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_001353955AA549878D6EC0931EDC7463_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_001353955AA549878D6EC0931EDC7463" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_001353955AA549878D6EC0931EDC7463_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_001353955AA549878D6EC0931EDC7463" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_001353955AA549878D6EC0931EDC7463" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_001353955AA549878D6EC0931EDC7463" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_001353955AA549878D6EC0931EDC7463" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_20B6B50FAFA729CCEE59C0931EDC3610_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_20B6B50FAFA729CCEE59C0931EDC3610" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_20B6B50FAFA729CCEE59C0931EDC3610_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_20B6B50FAFA729CCEE59C0931EDC3610" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_20B6B50FAFA729CCEE59C0931EDC3610" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_20B6B50FAFA729CCEE59C0931EDC3610" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_20B6B50FAFA729CCEE59C0931EDC3610" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Three</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Three</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0D600E7FF47D4C430799C0931EDDDDBF_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0D600E7FF47D4C430799C0931EDDDDBF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0D600E7FF47D4C430799C0931EDDDDBF_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0D600E7FF47D4C430799C0931EDDDDBF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0D600E7FF47D4C430799C0931EDDDDBF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0D600E7FF47D4C430799C0931EDDDDBF" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0D600E7FF47D4C430799C0931EDDDDBF" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_760948BECBD61079332FC0931EDD4A1E_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_760948BECBD61079332FC0931EDD4A1E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_760948BECBD61079332FC0931EDD4A1E_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_760948BECBD61079332FC0931EDD4A1E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_760948BECBD61079332FC0931EDD4A1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_760948BECBD61079332FC0931EDD4A1E" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_760948BECBD61079332FC0931EDD4A1E" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Four</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Four</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_EAF9CB6F8E92F06BE6BFC0931EDDFE32_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_EAF9CB6F8E92F06BE6BFC0931EDDFE32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_EAF9CB6F8E92F06BE6BFC0931EDDFE32_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_EAF9CB6F8E92F06BE6BFC0931EDDFE32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_EAF9CB6F8E92F06BE6BFC0931EDDFE32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_EAF9CB6F8E92F06BE6BFC0931EDDFE32" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_EAF9CB6F8E92F06BE6BFC0931EDDFE32" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_33265FBAB7882A94105BC0931EDE818F_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_33265FBAB7882A94105BC0931EDE818F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_33265FBAB7882A94105BC0931EDE818F_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_33265FBAB7882A94105BC0931EDE818F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_33265FBAB7882A94105BC0931EDE818F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_33265FBAB7882A94105BC0931EDE818F" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_33265FBAB7882A94105BC0931EDE818F" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Five</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Five</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798408633149076E3710C0931EDE4938_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798408633149076E3710C0931EDE4938" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798408633149076E3710C0931EDE4938_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798408633149076E3710C0931EDE4938" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798408633149076E3710C0931EDE4938" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798408633149076E3710C0931EDE4938" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798408633149076E3710C0931EDE4938" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_DC7268E5F661418111E4C0931EDEB646_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_DC7268E5F661418111E4C0931EDEB646" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_DC7268E5F661418111E4C0931EDEB646_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_DC7268E5F661418111E4C0931EDEB646" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_DC7268E5F661418111E4C0931EDEB646" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_DC7268E5F661418111E4C0931EDEB646" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_DC7268E5F661418111E4C0931EDEB646" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due After Year Five</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due After Year Five</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0CF6A7FBB13E260744BDC0931EDEA659_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0CF6A7FBB13E260744BDC0931EDEA659" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0CF6A7FBB13E260744BDC0931EDEA659_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0CF6A7FBB13E260744BDC0931EDEA659" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0CF6A7FBB13E260744BDC0931EDEA659" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0CF6A7FBB13E260744BDC0931EDEA659" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0CF6A7FBB13E260744BDC0931EDEA659" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_24644C33FF0EEEE2B97BC0931EDED2AB_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_24644C33FF0EEEE2B97BC0931EDED2AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_24644C33FF0EEEE2B97BC0931EDED2AB_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_24644C33FF0EEEE2B97BC0931EDED2AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_24644C33FF0EEEE2B97BC0931EDED2AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_24644C33FF0EEEE2B97BC0931EDED2AB" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_24644C33FF0EEEE2B97BC0931EDED2AB" xlink:type="arc" />
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Lease Liability Payments Due</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total undiscounted Lease Liability Payments Due for both operating and financing leases</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalLeaseLiabilityPaymentsDue" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD" xlink:to="lab_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD" xlink:type="arc" />
    <link:label id="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A_terseLabel_en-US" xlink:label="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: leases not yet commenced (1)</link:label>
    <link:label id="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A_label_en-US" xlink:label="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Operating Lease Liability Not Yet Commenced, Amount</link:label>
    <link:label id="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A_documentation_en-US" xlink:label="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Operating Lease Liability Not Yet Commenced, Amount</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A" xlink:to="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A" xlink:type="arc" />
    <link:label id="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59_terseLabel_en-US" xlink:label="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: leases not yet commenced (1)</link:label>
    <link:label id="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59_label_en-US" xlink:label="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Finance Lease Liability Not Yet Commenced, Amount</link:label>
    <link:label id="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59_documentation_en-US" xlink:label="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Finance Lease Liability Not Yet Commenced, Amount</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59" xlink:to="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59" xlink:type="arc" />
    <link:label id="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: leases not yet commenced (1)</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Lease Liability Not Yet Commenced, Amount</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Lease Liability Not Yet Commenced, Amount</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9" xlink:to="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9" xlink:type="arc" />
    <link:label id="lab_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6_terseLabel_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6_label_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease Imputed Interest</link:label>
    <link:label id="lab_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6_documentation_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease Imputed Interest</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OperatingLeaseImputedInterest" xlink:label="loc_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6" xlink:to="lab_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6" xlink:type="arc" />
    <link:label id="lab_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B_terseLabel_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B_label_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease Imputed Interest</link:label>
    <link:label id="lab_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B_documentation_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease Imputed Interest</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_FinanceLeaseImputedInterest" xlink:label="loc_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B" xlink:to="lab_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B" xlink:type="arc" />
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3" xlink:to="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_C0790FF26CC75D9FDD96C0931EE00011_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_C0790FF26CC75D9FDD96C0931EE00011" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_C0790FF26CC75D9FDD96C0931EE00011_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_C0790FF26CC75D9FDD96C0931EE00011" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_C0790FF26CC75D9FDD96C0931EE00011" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_C0790FF26CC75D9FDD96C0931EE00011" xlink:to="lab_us-gaap_OperatingLeaseLiability_C0790FF26CC75D9FDD96C0931EE00011" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiability_3DE17E958A8931063D95C0931EE01357_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_3DE17E958A8931063D95C0931EE01357" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_3DE17E958A8931063D95C0931EE01357_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_3DE17E958A8931063D95C0931EE01357" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_3DE17E958A8931063D95C0931EE01357" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability_3DE17E958A8931063D95C0931EE01357" xlink:to="lab_us-gaap_FinanceLeaseLiability_3DE17E958A8931063D95C0931EE01357" xlink:type="arc" />
    <link:label id="lab_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Lease Liability</link:label>
    <link:label id="lab_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D_label_en-US" xlink:label="lab_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Lease Liability</link:label>
    <link:label id="lab_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Lease Liability</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalLeaseLiability" xlink:label="loc_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D" xlink:to="lab_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D" xlink:type="arc" />
    <link:label id="lab_cah_LeasesTextBlock_6A48A37B90CB14F578C6C0931EFFC794_terseLabel_en-US" xlink:label="lab_cah_LeasesTextBlock_6A48A37B90CB14F578C6C0931EFFC794" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_cah_LeasesTextBlock_6A48A37B90CB14F578C6C0931EFFC794_label_en-US" xlink:label="lab_cah_LeasesTextBlock_6A48A37B90CB14F578C6C0931EFFC794" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Text Block]</link:label>
    <link:label id="lab_cah_LeasesTextBlock_6A48A37B90CB14F578C6C0931EFFC794_documentation_en-US" xlink:label="lab_cah_LeasesTextBlock_6A48A37B90CB14F578C6C0931EFFC794" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leases [Text Block]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LeasesTextBlock" xlink:label="loc_cah_LeasesTextBlock_6A48A37B90CB14F578C6C0931EFFC794" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasesTextBlock_6A48A37B90CB14F578C6C0931EFFC794" xlink:to="lab_cah_LeasesTextBlock_6A48A37B90CB14F578C6C0931EFFC794" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_18CDBB1659F6386FA471DDA1F606B239_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_18CDBB1659F6386FA471DDA1F606B239" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_18CDBB1659F6386FA471DDA1F606B239" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_18CDBB1659F6386FA471DDA1F606B239" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_18CDBB1659F6386FA471DDA1F606B239" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_1033C8834694F1780E4FDDA1F606CBAC_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_1033C8834694F1780E4FDDA1F606CBAC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_1033C8834694F1780E4FDDA1F606CBAC_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_1033C8834694F1780E4FDDA1F606CBAC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1033C8834694F1780E4FDDA1F606CBAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized_1033C8834694F1780E4FDDA1F606CBAC" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized_1033C8834694F1780E4FDDA1F606CBAC" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_F5DA07283F6B4609552DDDA1F6065A2A_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_F5DA07283F6B4609552DDDA1F6065A2A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_F5DA07283F6B4609552DDDA1F6065A2A_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_F5DA07283F6B4609552DDDA1F6065A2A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_F5DA07283F6B4609552DDDA1F6065A2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued_F5DA07283F6B4609552DDDA1F6065A2A" xlink:to="lab_us-gaap_PreferredStockSharesIssued_F5DA07283F6B4609552DDDA1F6065A2A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_AC05C48DECCCE37E4054DDA1F607C41F_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_AC05C48DECCCE37E4054DDA1F607C41F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares, authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_AC05C48DECCCE37E4054DDA1F607C41F_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_AC05C48DECCCE37E4054DDA1F607C41F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_AC05C48DECCCE37E4054DDA1F607C41F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_AC05C48DECCCE37E4054DDA1F607C41F" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_AC05C48DECCCE37E4054DDA1F607C41F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_5CB7E50BA0FA777C7C6CDDA1F607D449_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_5CB7E50BA0FA777C7C6CDDA1F607D449" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares, issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_5CB7E50BA0FA777C7C6CDDA1F607D449_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_5CB7E50BA0FA777C7C6CDDA1F607D449" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_5CB7E50BA0FA777C7C6CDDA1F607D449" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_5CB7E50BA0FA777C7C6CDDA1F607D449" xlink:to="lab_us-gaap_CommonStockSharesIssued_5CB7E50BA0FA777C7C6CDDA1F607D449" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_02A56F2BCE546D2BDF12DDA1F6074431_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_02A56F2BCE546D2BDF12DDA1F6074431" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares in treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_02A56F2BCE546D2BDF12DDA1F6074431_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_02A56F2BCE546D2BDF12DDA1F6074431" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_02A56F2BCE546D2BDF12DDA1F6074431" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_02A56F2BCE546D2BDF12DDA1F6074431" xlink:to="lab_us-gaap_TreasuryStockShares_02A56F2BCE546D2BDF12DDA1F6074431" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:type="arc" />
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_66D1C2F40240457C37B6064EB20D1945_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember_66D1C2F40240457C37B6064EB20D1945" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_66D1C2F40240457C37B6064EB20D1945_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember_66D1C2F40240457C37B6064EB20D1945" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_66D1C2F40240457C37B6064EB20D1945" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember_66D1C2F40240457C37B6064EB20D1945" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember_66D1C2F40240457C37B6064EB20D1945" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2" xlink:to="lab_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:to="lab_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsMember_B8365E7C98A6AD853FC8064EB20E0818_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember_B8365E7C98A6AD853FC8064EB20E0818" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_B8365E7C98A6AD853FC8064EB20E0818_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember_B8365E7C98A6AD853FC8064EB20E0818" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_B8365E7C98A6AD853FC8064EB20E0818" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember_B8365E7C98A6AD853FC8064EB20E0818" xlink:to="lab_us-gaap_OtherAssetsMember_B8365E7C98A6AD853FC8064EB20E0818" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0BC29F5AFF4BD797A28E064EB20E2B1F_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0BC29F5AFF4BD797A28E064EB20E2B1F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid Expenses and Other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0BC29F5AFF4BD797A28E064EB20E2B1F_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0BC29F5AFF4BD797A28E064EB20E2B1F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0BC29F5AFF4BD797A28E064EB20E2B1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0BC29F5AFF4BD797A28E064EB20E2B1F" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0BC29F5AFF4BD797A28E064EB20E2B1F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_3E86411DF0B01CFBC5AD064EB20E334A_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember_3E86411DF0B01CFBC5AD064EB20E334A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_3E86411DF0B01CFBC5AD064EB20E334A_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember_3E86411DF0B01CFBC5AD064EB20E334A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_3E86411DF0B01CFBC5AD064EB20E334A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember_3E86411DF0B01CFBC5AD064EB20E334A" xlink:to="lab_us-gaap_AccruedLiabilitiesMember_3E86411DF0B01CFBC5AD064EB20E334A" xlink:type="arc" />
    <link:label id="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B_terseLabel_en-US" xlink:label="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Other Liabilities</link:label>
    <link:label id="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B_label_en-US" xlink:label="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Other Liabilities [Member]</link:label>
    <link:label id="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B_documentation_en-US" xlink:label="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Other Liabilities [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_DeferredIncomeTaxesandOtherLiabilitiesMember" xlink:label="loc_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B" xlink:to="lab_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:to="lab_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_D10F828DADE441D12263064EB20F3433_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_D10F828DADE441D12263064EB20F3433" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_D10F828DADE441D12263064EB20F3433_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_D10F828DADE441D12263064EB20F3433" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_D10F828DADE441D12263064EB20F3433" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_D10F828DADE441D12263064EB20F3433" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_D10F828DADE441D12263064EB20F3433" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_7491BF822C9A752C1C68064EB20F9222_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_7491BF822C9A752C1C68064EB20F9222" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_7491BF822C9A752C1C68064EB20F9222_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_7491BF822C9A752C1C68064EB20F9222" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7491BF822C9A752C1C68064EB20F9222" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7491BF822C9A752C1C68064EB20F9222" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_7491BF822C9A752C1C68064EB20F9222" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_0B4E41AB36C2475CD536A678C2127BD1_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_0B4E41AB36C2475CD536A678C2127BD1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0B4E41AB36C2475CD536A678C2127BD1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0B4E41AB36C2475CD536A678C2127BD1" xlink:to="lab_us-gaap_EarningsPerShareAbstract_0B4E41AB36C2475CD536A678C2127BD1" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_F30A4250C2272D509AEEA678C213F653_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_F30A4250C2272D509AEEA678C213F653" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_F30A4250C2272D509AEEA678C213F653_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_F30A4250C2272D509AEEA678C213F653" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_F30A4250C2272D509AEEA678C213F653" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_F30A4250C2272D509AEEA678C213F653" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_F30A4250C2272D509AEEA678C213F653" xlink:type="arc" />
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_545255E540EADDA21436A678C213F687_terseLabel_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_545255E540EADDA21436A678C213F687" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_545255E540EADDA21436A678C213F687_label_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_545255E540EADDA21436A678C213F687" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_545255E540EADDA21436A678C213F687_documentation_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_545255E540EADDA21436A678C213F687" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:label="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_545255E540EADDA21436A678C213F687" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_545255E540EADDA21436A678C213F687" xlink:to="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_545255E540EADDA21436A678C213F687" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_F231C5F272FD25C2A7C0064EB2AEC321_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit_F231C5F272FD25C2A7C0064EB2AEC321" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_F231C5F272FD25C2A7C0064EB2AEC321_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit_F231C5F272FD25C2A7C0064EB2AEC321" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_F231C5F272FD25C2A7C0064EB2AEC321" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit_F231C5F272FD25C2A7C0064EB2AEC321" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit_F231C5F272FD25C2A7C0064EB2AEC321" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C5C6CE77F42AB205B510064EB2AFFE67_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C5C6CE77F42AB205B510064EB2AFFE67" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C5C6CE77F42AB205B510064EB2AFFE67_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C5C6CE77F42AB205B510064EB2AFFE67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C5C6CE77F42AB205B510064EB2AFFE67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C5C6CE77F42AB205B510064EB2AFFE67" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C5C6CE77F42AB205B510064EB2AFFE67" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_7BE65B0A9C2A2956DB42064EB2AF2F64_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit_7BE65B0A9C2A2956DB42064EB2AF2F64" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-U.S.</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_7BE65B0A9C2A2956DB42064EB2AF2F64_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit_7BE65B0A9C2A2956DB42064EB2AF2F64" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7BE65B0A9C2A2956DB42064EB2AF2F64" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7BE65B0A9C2A2956DB42064EB2AF2F64" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit_7BE65B0A9C2A2956DB42064EB2AF2F64" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_E6A9A76ABFC685129E9A064EB2AFF1AA_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_E6A9A76ABFC685129E9A064EB2AFF1AA" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_E6A9A76ABFC685129E9A064EB2AFF1AA_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_E6A9A76ABFC685129E9A064EB2AFF1AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_E6A9A76ABFC685129E9A064EB2AFF1AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_E6A9A76ABFC685129E9A064EB2AFF1AA" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_E6A9A76ABFC685129E9A064EB2AFF1AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_BCADBC5F7C4EF6FEC62E064EB2AFDF32_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_BCADBC5F7C4EF6FEC62E064EB2AFDF32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_BCADBC5F7C4EF6FEC62E064EB2AFDF32_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_BCADBC5F7C4EF6FEC62E064EB2AFDF32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_BCADBC5F7C4EF6FEC62E064EB2AFDF32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_BCADBC5F7C4EF6FEC62E064EB2AFDF32" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_BCADBC5F7C4EF6FEC62E064EB2AFDF32" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_D7FF5CD5A47A7EEDE550064EB2B076D7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_D7FF5CD5A47A7EEDE550064EB2B076D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_D7FF5CD5A47A7EEDE550064EB2B076D7_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_D7FF5CD5A47A7EEDE550064EB2B076D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_D7FF5CD5A47A7EEDE550064EB2B076D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_D7FF5CD5A47A7EEDE550064EB2B076D7" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_D7FF5CD5A47A7EEDE550064EB2B076D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1F0A963A66D7658E6896064EB2B0A285_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1F0A963A66D7658E6896064EB2B0A285" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-U.S.</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1F0A963A66D7658E6896064EB2B0A285_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1F0A963A66D7658E6896064EB2B0A285" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1F0A963A66D7658E6896064EB2B0A285" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1F0A963A66D7658E6896064EB2B0A285" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1F0A963A66D7658E6896064EB2B0A285" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0A7441396D5CF8BA1E69064EB2B03454_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0A7441396D5CF8BA1E69064EB2B03454" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0A7441396D5CF8BA1E69064EB2B03454_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0A7441396D5CF8BA1E69064EB2B03454" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0A7441396D5CF8BA1E69064EB2B03454" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0A7441396D5CF8BA1E69064EB2B03454" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0A7441396D5CF8BA1E69064EB2B03454" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5552E6E9311A5D9468C1064EB2B06F0A_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_5552E6E9311A5D9468C1064EB2B06F0A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Provision for/(benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5552E6E9311A5D9468C1064EB2B06F0A_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_5552E6E9311A5D9468C1064EB2B06F0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5552E6E9311A5D9468C1064EB2B06F0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_5552E6E9311A5D9468C1064EB2B06F0A" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_5552E6E9311A5D9468C1064EB2B06F0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_4AA68EE936146355B22BD979690E943C_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues_4AA68EE936146355B22BD979690E943C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_4AA68EE936146355B22BD979690E943C_label_en-US" xlink:label="lab_us-gaap_Revenues_4AA68EE936146355B22BD979690E943C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_4AA68EE936146355B22BD979690E943C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_4AA68EE936146355B22BD979690E943C" xlink:to="lab_us-gaap_Revenues_4AA68EE936146355B22BD979690E943C" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_0BD450AE1DBD21CF0F2FD979690E7268_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_0BD450AE1DBD21CF0F2FD979690E7268" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_0BD450AE1DBD21CF0F2FD979690E7268_label_en-US" xlink:label="lab_us-gaap_GrossProfit_0BD450AE1DBD21CF0F2FD979690E7268" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_0BD450AE1DBD21CF0F2FD979690E7268" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_0BD450AE1DBD21CF0F2FD979690E7268" xlink:to="lab_us-gaap_GrossProfit_0BD450AE1DBD21CF0F2FD979690E7268" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_AF20E8DBE1637BD78266D979690FC80A_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_AF20E8DBE1637BD78266D979690FC80A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution, selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_AF20E8DBE1637BD78266D979690FC80A_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_AF20E8DBE1637BD78266D979690FC80A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_AF20E8DBE1637BD78266D979690FC80A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_AF20E8DBE1637BD78266D979690FC80A" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense_AF20E8DBE1637BD78266D979690FC80A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_9D38FE9E353628DD8B54D979690FE173_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_9D38FE9E353628DD8B54D979690FE173" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_9D38FE9E353628DD8B54D979690FE173_label_en-US" xlink:label="lab_us-gaap_ProfitLoss_9D38FE9E353628DD8B54D979690FE173" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_9D38FE9E353628DD8B54D979690FE173" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_9D38FE9E353628DD8B54D979690FE173" xlink:to="lab_us-gaap_ProfitLoss_9D38FE9E353628DD8B54D979690FE173" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_F5119758A83C2A0C631AD979690F8110_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_F5119758A83C2A0C631AD979690F8110" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Net earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_F5119758A83C2A0C631AD979690F8110_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_F5119758A83C2A0C631AD979690F8110" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_F5119758A83C2A0C631AD979690F8110" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_F5119758A83C2A0C631AD979690F8110" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_F5119758A83C2A0C631AD979690F8110" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_3013F1DE1461E03215F7D979690F3396_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_3013F1DE1461E03215F7D979690F3396" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net earnings attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3013F1DE1461E03215F7D979690F3396_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_3013F1DE1461E03215F7D979690F3396" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_3013F1DE1461E03215F7D979690F3396" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_3013F1DE1461E03215F7D979690F3396" xlink:to="lab_us-gaap_NetIncomeLoss_3013F1DE1461E03215F7D979690F3396" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_63F00625FF15CFC27D6FD979690F2846_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_63F00625FF15CFC27D6FD979690F2846" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_63F00625FF15CFC27D6FD979690F2846_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_63F00625FF15CFC27D6FD979690F2846" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_63F00625FF15CFC27D6FD979690F2846" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_63F00625FF15CFC27D6FD979690F2846" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_63F00625FF15CFC27D6FD979690F2846" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_D0FB503112D9FD084DC0D979690FC485_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_D0FB503112D9FD084DC0D979690FC485" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_D0FB503112D9FD084DC0D979690FC485_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_D0FB503112D9FD084DC0D979690FC485" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_D0FB503112D9FD084DC0D979690FC485" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_D0FB503112D9FD084DC0D979690FC485" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_D0FB503112D9FD084DC0D979690FC485" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6333C7ACD100D596149BD9796910EBD8_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6333C7ACD100D596149BD9796910EBD8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6333C7ACD100D596149BD9796910EBD8_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6333C7ACD100D596149BD9796910EBD8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6333C7ACD100D596149BD9796910EBD8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6333C7ACD100D596149BD9796910EBD8" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6333C7ACD100D596149BD9796910EBD8" xlink:type="arc" />
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED_terseLabel_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets [Table]</link:label>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED_label_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets [Table]</link:label>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED_documentation_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets [Table]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodwillAndIntangibleAssetsTable" xlink:label="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:to="lab_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:type="arc" />
    <link:label id="lab_cah_TotalOpioidLitigationnetoftaxMember_D638479EC43FF2604787D97C618C98AF_terseLabel_en-US" xlink:label="lab_cah_TotalOpioidLitigationnetoftaxMember_D638479EC43FF2604787D97C618C98AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation, net of tax [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationnetoftaxMember_D638479EC43FF2604787D97C618C98AF_label_en-US" xlink:label="lab_cah_TotalOpioidLitigationnetoftaxMember_D638479EC43FF2604787D97C618C98AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation, net of tax [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationnetoftaxMember_D638479EC43FF2604787D97C618C98AF_documentation_en-US" xlink:label="lab_cah_TotalOpioidLitigationnetoftaxMember_D638479EC43FF2604787D97C618C98AF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation, net of tax</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_D638479EC43FF2604787D97C618C98AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalOpioidLitigationnetoftaxMember_D638479EC43FF2604787D97C618C98AF" xlink:to="lab_cah_TotalOpioidLitigationnetoftaxMember_D638479EC43FF2604787D97C618C98AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9" xlink:to="lab_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9" xlink:type="arc" />
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8_terseLabel_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets [Line Items]</link:label>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8_label_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets [Line Items]</link:label>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8_documentation_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodwillAndIntangibleAssetsLineItems" xlink:label="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:to="lab_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainOnSaleOfInvestments_2318AD5D2C83F8D23948D9796913946D_terseLabel_en-US" xlink:label="lab_us-gaap_GainOnSaleOfInvestments_2318AD5D2C83F8D23948D9796913946D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_GainOnSaleOfInvestments_2318AD5D2C83F8D23948D9796913946D_label_en-US" xlink:label="lab_us-gaap_GainOnSaleOfInvestments_2318AD5D2C83F8D23948D9796913946D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain on Sale of Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_2318AD5D2C83F8D23948D9796913946D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainOnSaleOfInvestments_2318AD5D2C83F8D23948D9796913946D" xlink:to="lab_us-gaap_GainOnSaleOfInvestments_2318AD5D2C83F8D23948D9796913946D" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_97F0328435FC79F5B702D97969132182_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_97F0328435FC79F5B702D97969132182" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_97F0328435FC79F5B702D97969132182" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss_97F0328435FC79F5B702D97969132182" xlink:to="lab_us-gaap_GoodwillImpairmentLoss_97F0328435FC79F5B702D97969132182" xlink:type="arc" />
    <link:label id="lab_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659" xlink:to="lab_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659" xlink:type="arc" />
    <link:label id="lab_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:to="lab_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingSegmentsMember_C17B9EE8A1F98BF104F4C0931BA3CB06_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember_C17B9EE8A1F98BF104F4C0931BA3CB06" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_C17B9EE8A1F98BF104F4C0931BA3CB06_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember_C17B9EE8A1F98BF104F4C0931BA3CB06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_C17B9EE8A1F98BF104F4C0931BA3CB06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember_C17B9EE8A1F98BF104F4C0931BA3CB06" xlink:to="lab_us-gaap_OperatingSegmentsMember_C17B9EE8A1F98BF104F4C0931BA3CB06" xlink:type="arc" />
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_6534A0DCF79D7B1548C5C0931BA43E28_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember_6534A0DCF79D7B1548C5C0931BA43E28" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_6534A0DCF79D7B1548C5C0931BA43E28_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember_6534A0DCF79D7B1548C5C0931BA43E28" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_6534A0DCF79D7B1548C5C0931BA43E28" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember_6534A0DCF79D7B1548C5C0931BA43E28" xlink:to="lab_us-gaap_CorporateNonSegmentMember_6534A0DCF79D7B1548C5C0931BA43E28" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D" xlink:to="lab_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:to="lab_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:type="arc" />
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62_label_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62_documentation_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalDistributionandSpecialtyMember" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62" xlink:to="lab_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62" xlink:type="arc" />
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3_terseLabel_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3_label_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3_documentation_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_NuclearPrecisionHealthServicesMember" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3" xlink:to="lab_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3" xlink:type="arc" />
    <link:label id="lab_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784_terseLabel_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:label id="lab_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784_label_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:label id="lab_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784_documentation_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicaldistributionandproductsMember" xlink:label="loc_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784" xlink:to="lab_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784" xlink:type="arc" />
    <link:label id="lab_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8_terseLabel_en-US" xlink:label="lab_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cardinal Health At Home Solutions [Member]</link:label>
    <link:label id="lab_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8_label_en-US" xlink:label="lab_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cardinal Health At Home Solutions [Member]</link:label>
    <link:label id="lab_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8_documentation_en-US" xlink:label="lab_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cardinal Health At Home Solutions [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_CardinalHealthAtHomeSolutionsMember" xlink:label="loc_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8" xlink:to="lab_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E" xlink:type="arc" />
    <link:label id="lab_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251" xlink:to="lab_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251" xlink:type="arc" />
    <link:label id="lab_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:to="lab_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonUsMember_C6EEEDB7E197B8F6E6DEC0931BA72893_verboseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember_C6EEEDB7E197B8F6E6DEC0931BA72893" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_C6EEEDB7E197B8F6E6DEC0931BA72893_label_en-US" xlink:label="lab_us-gaap_NonUsMember_C6EEEDB7E197B8F6E6DEC0931BA72893" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_C6EEEDB7E197B8F6E6DEC0931BA72893" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember_C6EEEDB7E197B8F6E6DEC0931BA72893" xlink:to="lab_us-gaap_NonUsMember_C6EEEDB7E197B8F6E6DEC0931BA72893" xlink:type="arc" />
    <link:label id="lab_country_US_BE5C30E11E8EE1F32F8BC0931BA79DC3_terseLabel_en-US" xlink:label="lab_country_US_BE5C30E11E8EE1F32F8BC0931BA79DC3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_BE5C30E11E8EE1F32F8BC0931BA79DC3_label_en-US" xlink:label="lab_country_US_BE5C30E11E8EE1F32F8BC0931BA79DC3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_country_US_BE5C30E11E8EE1F32F8BC0931BA79DC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_BE5C30E11E8EE1F32F8BC0931BA79DC3" xlink:to="lab_country_US_BE5C30E11E8EE1F32F8BC0931BA79DC3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A" xlink:to="lab_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE" xlink:to="lab_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE" xlink:type="arc" />
    <link:label id="lab_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886_terseLabel_en-US" xlink:label="lab_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2011 LTIP</link:label>
    <link:label id="lab_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886_label_en-US" xlink:label="lab_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2011 LTIP [Member]</link:label>
    <link:label id="lab_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886_documentation_en-US" xlink:label="lab_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2011 LTIP [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A2011LtipMember" xlink:label="loc_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886" xlink:to="lab_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886" xlink:type="arc" />
    <link:label id="lab_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995_terseLabel_en-US" xlink:label="lab_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Other than Stock Options</link:label>
    <link:label id="lab_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995_label_en-US" xlink:label="lab_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Other than Stock Options [Member]</link:label>
    <link:label id="lab_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995_documentation_en-US" xlink:label="lab_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Awards Other than Stock Options [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_AwardsOtherThanStockOptionsMember" xlink:label="loc_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995" xlink:to="lab_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_860343C66F7C70053D9FDE0D6FAF59F9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_860343C66F7C70053D9FDE0D6FAF59F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_860343C66F7C70053D9FDE0D6FAF59F9_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_860343C66F7C70053D9FDE0D6FAF59F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_860343C66F7C70053D9FDE0D6FAF59F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_860343C66F7C70053D9FDE0D6FAF59F9" xlink:to="lab_us-gaap_EmployeeStockOptionMember_860343C66F7C70053D9FDE0D6FAF59F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_0D8DA4EE0CB173C0E15BDE0D6FAFD217_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_0D8DA4EE0CB173C0E15BDE0D6FAFD217" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Share Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_0D8DA4EE0CB173C0E15BDE0D6FAFD217_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_0D8DA4EE0CB173C0E15BDE0D6FAFD217" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0D8DA4EE0CB173C0E15BDE0D6FAFD217" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_0D8DA4EE0CB173C0E15BDE0D6FAFD217" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_0D8DA4EE0CB173C0E15BDE0D6FAFD217" xlink:type="arc" />
    <link:label id="lab_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2_terseLabel_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:label id="lab_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2_label_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:label id="lab_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2_documentation_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_VestingPeriodinyearsforShares" xlink:label="loc_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2" xlink:to="lab_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C2237067A658A9C111CDE0D6FB1E346_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C2237067A658A9C111CDE0D6FB1E346" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares available for grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C2237067A658A9C111CDE0D6FB1E346_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C2237067A658A9C111CDE0D6FB1E346" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C2237067A658A9C111CDE0D6FB1E346" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C2237067A658A9C111CDE0D6FB1E346" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C2237067A658A9C111CDE0D6FB1E346" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_F4C7387D1E1F48EB1A92DE0D6FB1A2DD_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_F4C7387D1E1F48EB1A92DE0D6FB1A2DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax benefit related to share-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_F4C7387D1E1F48EB1A92DE0D6FB1A2DD_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_F4C7387D1E1F48EB1A92DE0D6FB1A2DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_F4C7387D1E1F48EB1A92DE0D6FB1A2DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_F4C7387D1E1F48EB1A92DE0D6FB1A2DD" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_F4C7387D1E1F48EB1A92DE0D6FB1A2DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_E7CBE9C9E3FFAE1C1E8CDE0D6FB19882_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_E7CBE9C9E3FFAE1C1E8CDE0D6FB19882" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_E7CBE9C9E3FFAE1C1E8CDE0D6FB19882_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_E7CBE9C9E3FFAE1C1E8CDE0D6FB19882" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_E7CBE9C9E3FFAE1C1E8CDE0D6FB19882" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_E7CBE9C9E3FFAE1C1E8CDE0D6FB19882" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_E7CBE9C9E3FFAE1C1E8CDE0D6FB19882" xlink:type="arc" />
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F_terseLabel_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable period of plans (in years)</link:label>
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F_label_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercisable period of plans, in years</link:label>
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F_documentation_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The instrument's contractual term.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ExercisablePeriodOfPlansInYears" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F" xlink:to="lab_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_998FA33686F69414AE6CDE0D6FB2E80A_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized_998FA33686F69414AE6CDE0D6FB2E80A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total expense on employee retirement savings plans</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_998FA33686F69414AE6CDE0D6FB2E80A_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized_998FA33686F69414AE6CDE0D6FB2E80A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_998FA33686F69414AE6CDE0D6FB2E80A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized_998FA33686F69414AE6CDE0D6FB2E80A" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized_998FA33686F69414AE6CDE0D6FB2E80A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:to="lab_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB" xlink:to="lab_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:to="lab_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_39006DA89D7982E2EF27064EB2C04AF6_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_39006DA89D7982E2EF27064EB2C04AF6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_39006DA89D7982E2EF27064EB2C04AF6_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_39006DA89D7982E2EF27064EB2C04AF6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_39006DA89D7982E2EF27064EB2C04AF6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_39006DA89D7982E2EF27064EB2C04AF6" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember_39006DA89D7982E2EF27064EB2C04AF6" xlink:type="arc" />
    <link:label id="lab_us-gaap_LetterOfCreditMember_368D4B9C9EBDA4E70ABA064EB2C00941_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember_368D4B9C9EBDA4E70ABA064EB2C00941" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_368D4B9C9EBDA4E70ABA064EB2C00941_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember_368D4B9C9EBDA4E70ABA064EB2C00941" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_368D4B9C9EBDA4E70ABA064EB2C00941" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember_368D4B9C9EBDA4E70ABA064EB2C00941" xlink:to="lab_us-gaap_LetterOfCreditMember_368D4B9C9EBDA4E70ABA064EB2C00941" xlink:type="arc" />
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567_terseLabel_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short Term Credit Facilities</link:label>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567_label_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short Term Credit Facilities Member</link:label>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567_documentation_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other short-term credit facilities and an unsecured line of credit</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567" xlink:to="lab_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommercialPaperMember_335C603C19F403D6EE94064EB2C1D298_verboseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember_335C603C19F403D6EE94064EB2C1D298" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_335C603C19F403D6EE94064EB2C1D298_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember_335C603C19F403D6EE94064EB2C1D298" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_335C603C19F403D6EE94064EB2C1D298" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember_335C603C19F403D6EE94064EB2C1D298" xlink:to="lab_us-gaap_CommercialPaperMember_335C603C19F403D6EE94064EB2C1D298" xlink:type="arc" />
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86_terseLabel_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Committed Receivables Sales Facility Program</link:label>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86_label_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Committed Receivables Sales Facility Program [Member]</link:label>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86_documentation_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Committed receivables sales facility program that exists largely to provide liquidity by selling interests in trade receivables.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86" xlink:to="lab_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:to="lab_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_77B984AC55F7EBDF394F064EB2C252F9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_77B984AC55F7EBDF394F064EB2C252F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_77B984AC55F7EBDF394F064EB2C252F9_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_77B984AC55F7EBDF394F064EB2C252F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_77B984AC55F7EBDF394F064EB2C252F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_77B984AC55F7EBDF394F064EB2C252F9" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_77B984AC55F7EBDF394F064EB2C252F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCredit_328A671E496F400F08CE064EB2C2685C_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit_328A671E496F400F08CE064EB2C2685C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_328A671E496F400F08CE064EB2C2685C_label_en-US" xlink:label="lab_us-gaap_LineOfCredit_328A671E496F400F08CE064EB2C2685C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_328A671E496F400F08CE064EB2C2685C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit_328A671E496F400F08CE064EB2C2685C" xlink:to="lab_us-gaap_LineOfCredit_328A671E496F400F08CE064EB2C2685C" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_F21BA5300ECD31413EC9064EB2C364E1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_F21BA5300ECD31413EC9064EB2C364E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_F21BA5300ECD31413EC9064EB2C364E1_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_F21BA5300ECD31413EC9064EB2C364E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Average Outstanding Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:label="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_F21BA5300ECD31413EC9064EB2C364E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_F21BA5300ECD31413EC9064EB2C364E1" xlink:to="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_F21BA5300ECD31413EC9064EB2C364E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherBorrowings_6F46C8465FE9AE46D0F2064EB2C3921C_terseLabel_en-US" xlink:label="lab_us-gaap_OtherBorrowings_6F46C8465FE9AE46D0F2064EB2C3921C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other obligations</link:label>
    <link:label id="lab_us-gaap_OtherBorrowings_6F46C8465FE9AE46D0F2064EB2C3921C_label_en-US" xlink:label="lab_us-gaap_OtherBorrowings_6F46C8465FE9AE46D0F2064EB2C3921C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Borrowings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaap_OtherBorrowings_6F46C8465FE9AE46D0F2064EB2C3921C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherBorrowings_6F46C8465FE9AE46D0F2064EB2C3921C" xlink:to="lab_us-gaap_OtherBorrowings_6F46C8465FE9AE46D0F2064EB2C3921C" xlink:type="arc" />
    <link:label id="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_33664A39C1FA7B3BA564064EB38E9D39_terseLabel_en-US" xlink:label="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_33664A39C1FA7B3BA564064EB38E9D39" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrual for estimated sales returns and allowances</link:label>
    <link:label id="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_33664A39C1FA7B3BA564064EB38E9D39_label_en-US" xlink:label="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_33664A39C1FA7B3BA564064EB38E9D39" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Reserve for Sales Returns and Allowances</link:label>
    <link:label id="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_33664A39C1FA7B3BA564064EB38E9D39_documentation_en-US" xlink:label="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_33664A39C1FA7B3BA564064EB38E9D39" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Reserve for Sales Returns and Allowances</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:label="loc_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_33664A39C1FA7B3BA564064EB38E9D39" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_33664A39C1FA7B3BA564064EB38E9D39" xlink:to="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_33664A39C1FA7B3BA564064EB38E9D39" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_C149F2EF1B3BB15A62B7064EB38E5778_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_C149F2EF1B3BB15A62B7064EB38E5778" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Sales Returns, Reserve for Sales Returns</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_C149F2EF1B3BB15A62B7064EB38E5778_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_C149F2EF1B3BB15A62B7064EB38E5778" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Sales Returns, Reserve for Sales Returns</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns" xlink:label="loc_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_C149F2EF1B3BB15A62B7064EB38E5778" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_C149F2EF1B3BB15A62B7064EB38E5778" xlink:to="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_C149F2EF1B3BB15A62B7064EB38E5778" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_97B95FB5DCBAD98879F2064EB04046EA_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_97B95FB5DCBAD98879F2064EB04046EA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_97B95FB5DCBAD98879F2064EB04046EA_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_97B95FB5DCBAD98879F2064EB04046EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_97B95FB5DCBAD98879F2064EB04046EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_97B95FB5DCBAD98879F2064EB04046EA" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_97B95FB5DCBAD98879F2064EB04046EA" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_EA4DF5E1864307031609DE78348369A2_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract_EA4DF5E1864307031609DE78348369A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_EA4DF5E1864307031609DE78348369A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_EA4DF5E1864307031609DE78348369A2" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract_EA4DF5E1864307031609DE78348369A2" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90" xlink:to="lab_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:type="arc" />
    <link:label id="lab_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41_terseLabel_en-US" xlink:label="lab_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pricing Disputes [Member]</link:label>
    <link:label id="lab_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41_label_en-US" xlink:label="lab_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pricing Disputes [Member]</link:label>
    <link:label id="lab_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41_documentation_en-US" xlink:label="lab_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expense related to pricing disputes, excluded from provision for bad debts in the consolidated statements of cash flows and recorded as a reduction in gross margin  in the consolidated statements of earnings.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_PricingDisputesMember" xlink:label="loc_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41" xlink:to="lab_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_175517EED0B56A00C4B6DE7834850405_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember_175517EED0B56A00C4B6DE7834850405" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_175517EED0B56A00C4B6DE7834850405_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember_175517EED0B56A00C4B6DE7834850405" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_175517EED0B56A00C4B6DE7834850405" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember_175517EED0B56A00C4B6DE7834850405" xlink:to="lab_us-gaap_AllowanceForCreditLossMember_175517EED0B56A00C4B6DE7834850405" xlink:type="arc" />
    <link:label id="lab_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED_terseLabel_en-US" xlink:label="lab_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year Recoveries</link:label>
    <link:label id="lab_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED_label_en-US" xlink:label="lab_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year Recoveries [Member]</link:label>
    <link:label id="lab_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED_documentation_en-US" xlink:label="lab_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prior Year Recoveries [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_PriorYearRecoveriesMember" xlink:label="loc_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED" xlink:to="lab_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_C5C8EFD3035627BE1D8DDE783485117C_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_C5C8EFD3035627BE1D8DDE783485117C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</link:label>
    <link:label id="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_C5C8EFD3035627BE1D8DDE783485117C_label_en-US" xlink:label="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_C5C8EFD3035627BE1D8DDE783485117C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_C5C8EFD3035627BE1D8DDE783485117C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_C5C8EFD3035627BE1D8DDE783485117C" xlink:to="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_C5C8EFD3035627BE1D8DDE783485117C" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesReturnsAndAllowancesMember_3DA2CBCBBBBBF478AB2DDE7834854C78_terseLabel_en-US" xlink:label="lab_us-gaap_SalesReturnsAndAllowancesMember_3DA2CBCBBBBBF478AB2DDE7834854C78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales Returns and Allowances [Member]</link:label>
    <link:label id="lab_us-gaap_SalesReturnsAndAllowancesMember_3DA2CBCBBBBBF478AB2DDE7834854C78_label_en-US" xlink:label="lab_us-gaap_SalesReturnsAndAllowancesMember_3DA2CBCBBBBBF478AB2DDE7834854C78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Returns and Allowances [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesReturnsAndAllowancesMember" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_3DA2CBCBBBBBF478AB2DDE7834854C78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesReturnsAndAllowancesMember_3DA2CBCBBBBBF478AB2DDE7834854C78" xlink:to="lab_us-gaap_SalesReturnsAndAllowancesMember_3DA2CBCBBBBBF478AB2DDE7834854C78" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember_CB371EB49934956454C6DE78348579E9_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember_CB371EB49934956454C6DE78348579E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]</link:label>
    <link:label id="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember_CB371EB49934956454C6DE78348579E9_label_en-US" xlink:label="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember_CB371EB49934956454C6DE78348579E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_CB371EB49934956454C6DE78348579E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_CB371EB49934956454C6DE78348579E9" xlink:to="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember_CB371EB49934956454C6DE78348579E9" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_2605EDC60B9C5D34A188DE783486596F_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_2605EDC60B9C5D34A188DE783486596F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_2605EDC60B9C5D34A188DE783486596F_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_2605EDC60B9C5D34A188DE783486596F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_2605EDC60B9C5D34A188DE783486596F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_2605EDC60B9C5D34A188DE783486596F" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_2605EDC60B9C5D34A188DE783486596F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_382AF8651B5DFAEFF84FDE7834865F71_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_382AF8651B5DFAEFF84FDE7834865F71" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_382AF8651B5DFAEFF84FDE7834865F71_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_382AF8651B5DFAEFF84FDE7834865F71" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_382AF8651B5DFAEFF84FDE7834865F71" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_382AF8651B5DFAEFF84FDE7834865F71" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_382AF8651B5DFAEFF84FDE7834865F71" xlink:type="arc" />
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5933B14FBA65BDBC0F71DE7834862444_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5933B14FBA65BDBC0F71DE7834862444" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5933B14FBA65BDBC0F71DE7834862444_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5933B14FBA65BDBC0F71DE7834862444" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5933B14FBA65BDBC0F71DE7834862444" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5933B14FBA65BDBC0F71DE7834862444" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5933B14FBA65BDBC0F71DE7834862444" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4775AC1450FEEC3B8E6DDE783486C9C1_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4775AC1450FEEC3B8E6DDE783486C9C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4775AC1450FEEC3B8E6DDE783486C9C1_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4775AC1450FEEC3B8E6DDE783486C9C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4775AC1450FEEC3B8E6DDE783486C9C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4775AC1450FEEC3B8E6DDE783486C9C1" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4775AC1450FEEC3B8E6DDE783486C9C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_477DF9CB0679745B0682DE783487B417_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_477DF9CB0679745B0682DE783487B417" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_477DF9CB0679745B0682DE783487B417_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_477DF9CB0679745B0682DE783487B417" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_477DF9CB0679745B0682DE783487B417" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_477DF9CB0679745B0682DE783487B417" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_477DF9CB0679745B0682DE783487B417" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_F66CB789A726650B8974DE7834873229_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions_F66CB789A726650B8974DE7834873229" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_F66CB789A726650B8974DE7834873229_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions_F66CB789A726650B8974DE7834873229" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_F66CB789A726650B8974DE7834873229" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions_F66CB789A726650B8974DE7834873229" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions_F66CB789A726650B8974DE7834873229" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_3F51D1EF87A174193010064EAFF7FFCE_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_3F51D1EF87A174193010064EAFF7FFCE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Selected Quarterly Financial Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_3F51D1EF87A174193010064EAFF7FFCE_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_3F51D1EF87A174193010064EAFF7FFCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_3F51D1EF87A174193010064EAFF7FFCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_3F51D1EF87A174193010064EAFF7FFCE" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_3F51D1EF87A174193010064EAFF7FFCE" xlink:type="arc" />
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_816EBB17F7AB4CD39551064EAFF974DE_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock_816EBB17F7AB4CD39551064EAFF974DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selected Quarterly Financial Data (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_816EBB17F7AB4CD39551064EAFF974DE_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock_816EBB17F7AB4CD39551064EAFF974DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_816EBB17F7AB4CD39551064EAFF974DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock_816EBB17F7AB4CD39551064EAFF974DE" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock_816EBB17F7AB4CD39551064EAFF974DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071" xlink:to="lab_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071" xlink:type="arc" />
    <link:label id="lab_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0_terseLabel_en-US" xlink:label="lab_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Group Purchasing Organizations</link:label>
    <link:label id="lab_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0_label_en-US" xlink:label="lab_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Group Purchasing Organizations [Member]</link:label>
    <link:label id="lab_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0_documentation_en-US" xlink:label="lab_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Group Purchasing Organizations [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_GroupPurchasingOrganizationsMember" xlink:label="loc_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0" xlink:to="lab_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:to="lab_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:type="arc" />
    <link:label id="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985_terseLabel_en-US" xlink:label="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Largest group purchasing organizations</link:label>
    <link:label id="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985_label_en-US" xlink:label="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Largest Group Purchasing Organizations</link:label>
    <link:label id="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985_documentation_en-US" xlink:label="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Concentration Risk, Largest Group Purchasing Organizations</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:label="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985" xlink:to="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_CC4AADCDF766CE3B8E10064EB3AF3AE2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_CC4AADCDF766CE3B8E10064EB3AF3AE2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, major customer, percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_CC4AADCDF766CE3B8E10064EB3AF3AE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1_CC4AADCDF766CE3B8E10064EB3AF3AE2" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1_CC4AADCDF766CE3B8E10064EB3AF3AE2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_DB19793119633BA1A11A064EB03CAED8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_DB19793119633BA1A11A064EB03CAED8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Total Share-based Compensation Expense by Type of Award</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_DB19793119633BA1A11A064EB03CAED8_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_DB19793119633BA1A11A064EB03CAED8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_DB19793119633BA1A11A064EB03CAED8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_DB19793119633BA1A11A064EB03CAED8" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_DB19793119633BA1A11A064EB03CAED8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_194991B5B22A084D8EAD064EB03CD32F_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_194991B5B22A084D8EAD064EB03CD32F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Transactions Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_194991B5B22A084D8EAD064EB03CD32F_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_194991B5B22A084D8EAD064EB03CD32F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_194991B5B22A084D8EAD064EB03CD32F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_194991B5B22A084D8EAD064EB03CD32F" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_194991B5B22A084D8EAD064EB03CD32F" xlink:type="arc" />
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_A8F9E585769C88233CED064EB03C6C59_terseLabel_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_A8F9E585769C88233CED064EB03C6C59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Additional Data Related to Stock Option Activity</link:label>
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_A8F9E585769C88233CED064EB03C6C59_label_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_A8F9E585769C88233CED064EB03C6C59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Stock Option Plan Data [Table Text Block]</link:label>
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_A8F9E585769C88233CED064EB03C6C59_documentation_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_A8F9E585769C88233CED064EB03C6C59" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">A disclosure of additional data related to all stock option activity</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:label="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_A8F9E585769C88233CED064EB03C6C59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_A8F9E585769C88233CED064EB03C6C59" xlink:to="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_A8F9E585769C88233CED064EB03C6C59" xlink:type="arc" />
    <link:label id="lab_cah_RemainingStockOptionPlanDataTableTextBlock_45295D34F87DDF2BC1D3064EB03C2D10_terseLabel_en-US" xlink:label="lab_cah_RemainingStockOptionPlanDataTableTextBlock_45295D34F87DDF2BC1D3064EB03C2D10" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Remaining Stock Option Plan Data</link:label>
    <link:label id="lab_cah_RemainingStockOptionPlanDataTableTextBlock_45295D34F87DDF2BC1D3064EB03C2D10_label_en-US" xlink:label="lab_cah_RemainingStockOptionPlanDataTableTextBlock_45295D34F87DDF2BC1D3064EB03C2D10" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remaining Stock Option Plan Data [Table Text Block]</link:label>
    <link:label id="lab_cah_RemainingStockOptionPlanDataTableTextBlock_45295D34F87DDF2BC1D3064EB03C2D10_documentation_en-US" xlink:label="lab_cah_RemainingStockOptionPlanDataTableTextBlock_45295D34F87DDF2BC1D3064EB03C2D10" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Table Text Block] for Remaining Stock Option Plan Data [Table]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_RemainingStockOptionPlanDataTableTextBlock" xlink:label="loc_cah_RemainingStockOptionPlanDataTableTextBlock_45295D34F87DDF2BC1D3064EB03C2D10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_RemainingStockOptionPlanDataTableTextBlock_45295D34F87DDF2BC1D3064EB03C2D10" xlink:to="lab_cah_RemainingStockOptionPlanDataTableTextBlock_45295D34F87DDF2BC1D3064EB03C2D10" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_275FFCCA4576396D7F3E064EB03C8B70_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_275FFCCA4576396D7F3E064EB03C8B70" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Range of Assumptions Used to Estimate Fair Value of Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_275FFCCA4576396D7F3E064EB03C8B70_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_275FFCCA4576396D7F3E064EB03C8B70" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_275FFCCA4576396D7F3E064EB03C8B70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_275FFCCA4576396D7F3E064EB03C8B70" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_275FFCCA4576396D7F3E064EB03C8B70" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_643A430D66EAB26DFE37064EB03DBEDA_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_643A430D66EAB26DFE37064EB03DBEDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Transactions Related to Restricted Share Units Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_643A430D66EAB26DFE37064EB03DBEDA_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_643A430D66EAB26DFE37064EB03DBEDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_643A430D66EAB26DFE37064EB03DBEDA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_643A430D66EAB26DFE37064EB03DBEDA" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_643A430D66EAB26DFE37064EB03DBEDA" xlink:type="arc" />
    <link:label id="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_0A71D01001CBD9FF43F6064EB03D6CDC_terseLabel_en-US" xlink:label="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_0A71D01001CBD9FF43F6064EB03D6CDC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Restricted Shares and Restricted Share Units Activity</link:label>
    <link:label id="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_0A71D01001CBD9FF43F6064EB03D6CDC_label_en-US" xlink:label="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_0A71D01001CBD9FF43F6064EB03D6CDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Restricted Shares And Restricted Share Units Data [Table Text Block]</link:label>
    <link:label id="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_0A71D01001CBD9FF43F6064EB03D6CDC_documentation_en-US" xlink:label="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_0A71D01001CBD9FF43F6064EB03D6CDC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additional Restricted Shares And Restricted Share Units Data [Table Text Block]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:label="loc_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_0A71D01001CBD9FF43F6064EB03D6CDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_0A71D01001CBD9FF43F6064EB03D6CDC" xlink:to="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_0A71D01001CBD9FF43F6064EB03D6CDC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_EE3BC24D388586F412A4064EB03D066F_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_EE3BC24D388586F412A4064EB03D066F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Transactions Related to Performance Share Units Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_EE3BC24D388586F412A4064EB03D066F_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_EE3BC24D388586F412A4064EB03D066F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_EE3BC24D388586F412A4064EB03D066F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_EE3BC24D388586F412A4064EB03D066F" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_EE3BC24D388586F412A4064EB03D066F" xlink:type="arc" />
    <link:label id="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_FB289595BE8D27944373064EB03D1FE5_terseLabel_en-US" xlink:label="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_FB289595BE8D27944373064EB03D1FE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Data Related to Performance Share Units Activity</link:label>
    <link:label id="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_FB289595BE8D27944373064EB03D1FE5_label_en-US" xlink:label="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_FB289595BE8D27944373064EB03D1FE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Performance Share Units Data [Table Text Block]</link:label>
    <link:label id="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_FB289595BE8D27944373064EB03D1FE5_documentation_en-US" xlink:label="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_FB289595BE8D27944373064EB03D1FE5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additional Performance Share Units Data [Table Text Block]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:label="loc_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_FB289595BE8D27944373064EB03D1FE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_FB289595BE8D27944373064EB03D1FE5" xlink:to="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_FB289595BE8D27944373064EB03D1FE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_A9EAC9A01C075FCB26ECE2F768DF511B_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_A9EAC9A01C075FCB26ECE2F768DF511B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_A9EAC9A01C075FCB26ECE2F768DF511B_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_A9EAC9A01C075FCB26ECE2F768DF511B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_A9EAC9A01C075FCB26ECE2F768DF511B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_A9EAC9A01C075FCB26ECE2F768DF511B" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_A9EAC9A01C075FCB26ECE2F768DF511B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_22183FAD2AA18A345E07E2F768DF9CFA_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_22183FAD2AA18A345E07E2F768DF9CFA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_22183FAD2AA18A345E07E2F768DF9CFA_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_22183FAD2AA18A345E07E2F768DF9CFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_22183FAD2AA18A345E07E2F768DF9CFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_22183FAD2AA18A345E07E2F768DF9CFA" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_22183FAD2AA18A345E07E2F768DF9CFA" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6EBE7605A5FCB291805CE2F768DF8271_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_6EBE7605A5FCB291805CE2F768DF8271" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6EBE7605A5FCB291805CE2F768DF8271_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_6EBE7605A5FCB291805CE2F768DF8271" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6EBE7605A5FCB291805CE2F768DF8271" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_6EBE7605A5FCB291805CE2F768DF8271" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_6EBE7605A5FCB291805CE2F768DF8271" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_F6F827C8736DD54DDB21E2F768DF6914_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_F6F827C8736DD54DDB21E2F768DF6914" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_F6F827C8736DD54DDB21E2F768DF6914" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_F6F827C8736DD54DDB21E2F768DF6914" xlink:to="lab_us-gaap_OperatingLeaseLiability_F6F827C8736DD54DDB21E2F768DF6914" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiability_D41FD5B8FE645D219B68E2F768DF89E0_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_D41FD5B8FE645D219B68E2F768DF89E0" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_D41FD5B8FE645D219B68E2F768DF89E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability_D41FD5B8FE645D219B68E2F768DF89E0" xlink:to="lab_us-gaap_FinanceLeaseLiability_D41FD5B8FE645D219B68E2F768DF89E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_5441F55A04FC81DF4A6AE2F768E02A04_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset_5441F55A04FC81DF4A6AE2F768E02A04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_5441F55A04FC81DF4A6AE2F768E02A04_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset_5441F55A04FC81DF4A6AE2F768E02A04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_5441F55A04FC81DF4A6AE2F768E02A04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_5441F55A04FC81DF4A6AE2F768E02A04" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset_5441F55A04FC81DF4A6AE2F768E02A04" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_087C037B555ECFC2CEEEE2F768E01864_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent_087C037B555ECFC2CEEEE2F768E01864" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_087C037B555ECFC2CEEEE2F768E01864_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent_087C037B555ECFC2CEEEE2F768E01864" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_087C037B555ECFC2CEEEE2F768E01864" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent_087C037B555ECFC2CEEEE2F768E01864" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent_087C037B555ECFC2CEEEE2F768E01864" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_E43BA21E7D27BC3E8999E2F768E0755B_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_E43BA21E7D27BC3E8999E2F768E0755B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_E43BA21E7D27BC3E8999E2F768E0755B_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_E43BA21E7D27BC3E8999E2F768E0755B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_E43BA21E7D27BC3E8999E2F768E0755B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_E43BA21E7D27BC3E8999E2F768E0755B" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_E43BA21E7D27BC3E8999E2F768E0755B" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_5BD450D9CC5C24F53CB7DA0747ED6B2D_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense_5BD450D9CC5C24F53CB7DA0747ED6B2D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_5BD450D9CC5C24F53CB7DA0747ED6B2D_label_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense_5BD450D9CC5C24F53CB7DA0747ED6B2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_5BD450D9CC5C24F53CB7DA0747ED6B2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseAndRentalExpense_5BD450D9CC5C24F53CB7DA0747ED6B2D" xlink:to="lab_us-gaap_LeaseAndRentalExpense_5BD450D9CC5C24F53CB7DA0747ED6B2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_3DC595DC5C62EBAF2917DA07310B112E_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_3DC595DC5C62EBAF2917DA07310B112E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_3DC595DC5C62EBAF2917DA07310B112E_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_3DC595DC5C62EBAF2917DA07310B112E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3DC595DC5C62EBAF2917DA07310B112E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3DC595DC5C62EBAF2917DA07310B112E" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract_3DC595DC5C62EBAF2917DA07310B112E" xlink:type="arc" />
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21_terseLabel_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21_label_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21_documentation_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21" xlink:to="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_68F9F17C9A1CFCD67320DA07310CCF6F_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_68F9F17C9A1CFCD67320DA07310CCF6F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_68F9F17C9A1CFCD67320DA07310CCF6F_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_68F9F17C9A1CFCD67320DA07310CCF6F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_68F9F17C9A1CFCD67320DA07310CCF6F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_68F9F17C9A1CFCD67320DA07310CCF6F" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_68F9F17C9A1CFCD67320DA07310CCF6F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_7B8762045FF62F7C63E7DA07310CDB4D_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_7B8762045FF62F7C63E7DA07310CDB4D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future minimum rental payments for operating leases - 2020</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_7B8762045FF62F7C63E7DA07310CDB4D_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_7B8762045FF62F7C63E7DA07310CDB4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_7B8762045FF62F7C63E7DA07310CDB4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_7B8762045FF62F7C63E7DA07310CDB4D" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_7B8762045FF62F7C63E7DA07310CDB4D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1702A5D7664968D481B7DA07310C0913_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1702A5D7664968D481B7DA07310C0913" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future minimum rental payments for operating leases - 2021</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1702A5D7664968D481B7DA07310C0913_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1702A5D7664968D481B7DA07310C0913" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1702A5D7664968D481B7DA07310C0913" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1702A5D7664968D481B7DA07310C0913" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1702A5D7664968D481B7DA07310C0913" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_6E34038D529ACC78CC62DA07310C894D_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_6E34038D529ACC78CC62DA07310C894D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_6E34038D529ACC78CC62DA07310C894D_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_6E34038D529ACC78CC62DA07310C894D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_6E34038D529ACC78CC62DA07310C894D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_6E34038D529ACC78CC62DA07310C894D" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_6E34038D529ACC78CC62DA07310C894D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_B092BF3FB86CAEAB2453DA07310D0E7A_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_B092BF3FB86CAEAB2453DA07310D0E7A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_B092BF3FB86CAEAB2453DA07310D0E7A_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_B092BF3FB86CAEAB2453DA07310D0E7A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_B092BF3FB86CAEAB2453DA07310D0E7A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_B092BF3FB86CAEAB2453DA07310D0E7A" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_B092BF3FB86CAEAB2453DA07310D0E7A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_04A5264C3326DB5EDA27DA07310D2827_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_04A5264C3326DB5EDA27DA07310D2827" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_04A5264C3326DB5EDA27DA07310D2827_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_04A5264C3326DB5EDA27DA07310D2827" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_04A5264C3326DB5EDA27DA07310D2827" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_04A5264C3326DB5EDA27DA07310D2827" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_04A5264C3326DB5EDA27DA07310D2827" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_754C441D89DA484B3CA2DA07310DF0E2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_754C441D89DA484B3CA2DA07310DF0E2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_754C441D89DA484B3CA2DA07310DF0E2_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_754C441D89DA484B3CA2DA07310DF0E2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_754C441D89DA484B3CA2DA07310DF0E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_754C441D89DA484B3CA2DA07310DF0E2" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_754C441D89DA484B3CA2DA07310DF0E2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_26B8FA4C2A489F23F593DA07310DCB73_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_26B8FA4C2A489F23F593DA07310DCB73" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_26B8FA4C2A489F23F593DA07310DCB73_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_26B8FA4C2A489F23F593DA07310DCB73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_26B8FA4C2A489F23F593DA07310DCB73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_26B8FA4C2A489F23F593DA07310DCB73" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_26B8FA4C2A489F23F593DA07310DCB73" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_858EF78DEFDFAE458624DA07310D91F7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_858EF78DEFDFAE458624DA07310D91F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_858EF78DEFDFAE458624DA07310D91F7_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_858EF78DEFDFAE458624DA07310D91F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_858EF78DEFDFAE458624DA07310D91F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_858EF78DEFDFAE458624DA07310D91F7" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_858EF78DEFDFAE458624DA07310D91F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_058B1CB701D23487AC4EDA07310D3AB2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_058B1CB701D23487AC4EDA07310D3AB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_058B1CB701D23487AC4EDA07310D3AB2_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_058B1CB701D23487AC4EDA07310D3AB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_058B1CB701D23487AC4EDA07310D3AB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_058B1CB701D23487AC4EDA07310D3AB2" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_058B1CB701D23487AC4EDA07310D3AB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_3B417D7C9E2359EF5ECC064EB3623440_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract_3B417D7C9E2359EF5ECC064EB3623440" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_3B417D7C9E2359EF5ECC064EB3623440" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract_3B417D7C9E2359EF5ECC064EB3623440" xlink:to="lab_us-gaap_RestructuringChargesAbstract_3B417D7C9E2359EF5ECC064EB3623440" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_78D293BB1E29C06C75F7064EB3627770_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_78D293BB1E29C06C75F7064EB3627770" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_78D293BB1E29C06C75F7064EB3627770_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_78D293BB1E29C06C75F7064EB3627770" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_78D293BB1E29C06C75F7064EB3627770" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_78D293BB1E29C06C75F7064EB3627770" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_78D293BB1E29C06C75F7064EB3627770" xlink:type="arc" />
    <link:label id="lab_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2_terseLabel_en-US" xlink:label="lab_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed-Rate Debt</link:label>
    <link:label id="lab_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2_label_en-US" xlink:label="lab_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fixed Rate Debt [Member]</link:label>
    <link:label id="lab_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2_documentation_en-US" xlink:label="lab_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fixed Rate Debt [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_FixedRateDebtMember" xlink:label="loc_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2" xlink:to="lab_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpenseMember_39CF7377A649BAC47B88064EB1F10554_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember_39CF7377A649BAC47B88064EB1F10554" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Expense, Net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_39CF7377A649BAC47B88064EB1F10554_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember_39CF7377A649BAC47B88064EB1F10554" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_39CF7377A649BAC47B88064EB1F10554" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember_39CF7377A649BAC47B88064EB1F10554" xlink:to="lab_us-gaap_InterestExpenseMember_39CF7377A649BAC47B88064EB1F10554" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_582B623A1A26D258A960064EB1F5604B_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet_582B623A1A26D258A960064EB1F5604B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain/(loss) on derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_582B623A1A26D258A960064EB1F5604B_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet_582B623A1A26D258A960064EB1F5604B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_582B623A1A26D258A960064EB1F5604B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet_582B623A1A26D258A960064EB1F5604B" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet_582B623A1A26D258A960064EB1F5604B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseCost_6FD066B6DB56420E346FE42134FB0D44_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost_6FD066B6DB56420E346FE42134FB0D44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_6FD066B6DB56420E346FE42134FB0D44_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost_6FD066B6DB56420E346FE42134FB0D44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_6FD066B6DB56420E346FE42134FB0D44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost_6FD066B6DB56420E346FE42134FB0D44" xlink:to="lab_us-gaap_OperatingLeaseCost_6FD066B6DB56420E346FE42134FB0D44" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4D31964AD828EDC81CC8E42134FC7548_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4D31964AD828EDC81CC8E42134FC7548" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4D31964AD828EDC81CC8E42134FC7548_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4D31964AD828EDC81CC8E42134FC7548" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4D31964AD828EDC81CC8E42134FC7548" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4D31964AD828EDC81CC8E42134FC7548" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4D31964AD828EDC81CC8E42134FC7548" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableLeaseCost_5501E7F7D4C7F699C54BE42134FC05A1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost_5501E7F7D4C7F699C54BE42134FC05A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_5501E7F7D4C7F699C54BE42134FC05A1_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost_5501E7F7D4C7F699C54BE42134FC05A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_5501E7F7D4C7F699C54BE42134FC05A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost_5501E7F7D4C7F699C54BE42134FC05A1" xlink:to="lab_us-gaap_VariableLeaseCost_5501E7F7D4C7F699C54BE42134FC05A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCost_C9070CE34127EABDD051E42134FC7659_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost_C9070CE34127EABDD051E42134FC7659" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_C9070CE34127EABDD051E42134FC7659_label_en-US" xlink:label="lab_us-gaap_LeaseCost_C9070CE34127EABDD051E42134FC7659" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_C9070CE34127EABDD051E42134FC7659" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost_C9070CE34127EABDD051E42134FC7659" xlink:to="lab_us-gaap_LeaseCost_C9070CE34127EABDD051E42134FC7659" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_E1830F17203B36A3D059C0922B05995F_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_E1830F17203B36A3D059C0922B05995F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_E1830F17203B36A3D059C0922B05995F_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_E1830F17203B36A3D059C0922B05995F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_E1830F17203B36A3D059C0922B05995F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_E1830F17203B36A3D059C0922B05995F" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_E1830F17203B36A3D059C0922B05995F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_E0AD0A32BACCFA5536C4C0922B0520CA_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_E0AD0A32BACCFA5536C4C0922B0520CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_E0AD0A32BACCFA5536C4C0922B0520CA_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_E0AD0A32BACCFA5536C4C0922B0520CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_E0AD0A32BACCFA5536C4C0922B0520CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_E0AD0A32BACCFA5536C4C0922B0520CA" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_E0AD0A32BACCFA5536C4C0922B0520CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_B08D2E1880B08247ECC6C0922B057403_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_B08D2E1880B08247ECC6C0922B057403" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_B08D2E1880B08247ECC6C0922B057403_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_B08D2E1880B08247ECC6C0922B057403" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_B08D2E1880B08247ECC6C0922B057403" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_B08D2E1880B08247ECC6C0922B057403" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_B08D2E1880B08247ECC6C0922B057403" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_FD165F03CA69AB24D47FC0922B067553_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_FD165F03CA69AB24D47FC0922B067553" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_FD165F03CA69AB24D47FC0922B067553_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_FD165F03CA69AB24D47FC0922B067553" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_FD165F03CA69AB24D47FC0922B067553" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_FD165F03CA69AB24D47FC0922B067553" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_FD165F03CA69AB24D47FC0922B067553" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F327A67A746FB40ECAE7C0922B068FFF_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F327A67A746FB40ECAE7C0922B068FFF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Profit by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F327A67A746FB40ECAE7C0922B068FFF_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F327A67A746FB40ECAE7C0922B068FFF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F327A67A746FB40ECAE7C0922B068FFF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F327A67A746FB40ECAE7C0922B068FFF" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F327A67A746FB40ECAE7C0922B068FFF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_3924CFFA41BE06B9480BC0922B06FC26_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_3924CFFA41BE06B9480BC0922B06FC26" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_3924CFFA41BE06B9480BC0922B06FC26_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_3924CFFA41BE06B9480BC0922B06FC26" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_3924CFFA41BE06B9480BC0922B06FC26" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_3924CFFA41BE06B9480BC0922B06FC26" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_3924CFFA41BE06B9480BC0922B06FC26" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_3B50FA994BB8F6D62D8DC0922B06C313_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_3B50FA994BB8F6D62D8DC0922B06C313" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_3B50FA994BB8F6D62D8DC0922B06C313_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_3B50FA994BB8F6D62D8DC0922B06C313" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_3B50FA994BB8F6D62D8DC0922B06C313" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_3B50FA994BB8F6D62D8DC0922B06C313" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_3B50FA994BB8F6D62D8DC0922B06C313" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_8CA2C77982F571EF61A8C0922B07568B_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_8CA2C77982F571EF61A8C0922B07568B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment, Net by Geographic Area</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_8CA2C77982F571EF61A8C0922B07568B_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_8CA2C77982F571EF61A8C0922B07568B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_8CA2C77982F571EF61A8C0922B07568B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_8CA2C77982F571EF61A8C0922B07568B" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_8CA2C77982F571EF61A8C0922B07568B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_27F5470913FDAB047ADF064EB2EF1509_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_27F5470913FDAB047ADF064EB2EF1509" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_27F5470913FDAB047ADF064EB2EF1509_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_27F5470913FDAB047ADF064EB2EF1509" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_27F5470913FDAB047ADF064EB2EF1509" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock_27F5470913FDAB047ADF064EB2EF1509" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock_27F5470913FDAB047ADF064EB2EF1509" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_079F33318E4A0C7593D8B5FF8B4F07C9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid_079F33318E4A0C7593D8B5FF8B4F07C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash dividends per common share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_079F33318E4A0C7593D8B5FF8B4F07C9_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid_079F33318E4A0C7593D8B5FF8B4F07C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_079F33318E4A0C7593D8B5FF8B4F07C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid_079F33318E4A0C7593D8B5FF8B4F07C9" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid_079F33318E4A0C7593D8B5FF8B4F07C9" xlink:type="arc" />
    <link:label id="lab_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92_terseLabel_en-US" xlink:label="lab_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.948% Notes due 2019</link:label>
    <link:label id="lab_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92_label_en-US" xlink:label="lab_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">1.948% Notes due 2019 [Member]</link:label>
    <link:label id="lab_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92_documentation_en-US" xlink:label="lab_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">1.948% Notes due 2019</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A1.948Notesdue2019Member" xlink:label="loc_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92" xlink:to="lab_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92" xlink:type="arc" />
    <link:label id="lab_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208_terseLabel_en-US" xlink:label="lab_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2.616% Notes due fiscal 2022</link:label>
    <link:label id="lab_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208_label_en-US" xlink:label="lab_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2.616% Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208_documentation_en-US" xlink:label="lab_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2.616% Notes due 2022</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.616Notesdue2022Member" xlink:label="loc_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208" xlink:to="lab_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208" xlink:type="arc" />
    <link:label id="lab_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637_terseLabel_en-US" xlink:label="lab_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.079% Notes due fiscal 2024</link:label>
    <link:label id="lab_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637_label_en-US" xlink:label="lab_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.079% Notes due 2024 [Member]</link:label>
    <link:label id="lab_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637_documentation_en-US" xlink:label="lab_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.079% Notes due 2024</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.079Notesdue2024Member" xlink:label="loc_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637" xlink:to="lab_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637" xlink:type="arc" />
    <link:label id="lab_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49_terseLabel_en-US" xlink:label="lab_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.41% Notes due fiscal 2027</link:label>
    <link:label id="lab_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49_label_en-US" xlink:label="lab_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.41% Notes due 2027 [Member]</link:label>
    <link:label id="lab_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49_documentation_en-US" xlink:label="lab_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.41% Notes due 2027</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.41Notesdue2027Member" xlink:label="loc_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49" xlink:to="lab_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49" xlink:type="arc" />
    <link:label id="lab_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B_terseLabel_en-US" xlink:label="lab_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.368% Notes due fiscal 2047</link:label>
    <link:label id="lab_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B_label_en-US" xlink:label="lab_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.368% Notes due 2047 [Member]</link:label>
    <link:label id="lab_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B_documentation_en-US" xlink:label="lab_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.368% Notes due 2047</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.368Notesdue2047Member" xlink:label="loc_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B" xlink:to="lab_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B" xlink:type="arc" />
    <link:label id="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997_terseLabel_en-US" xlink:label="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</link:label>
    <link:label id="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997_label_en-US" xlink:label="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</link:label>
    <link:label id="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997_documentation_en-US" xlink:label="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997" xlink:to="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997" xlink:type="arc" />
    <link:label id="lab_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6_terseLabel_en-US" xlink:label="lab_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Floating Rate Notes due fiscal 2022</link:label>
    <link:label id="lab_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6_label_en-US" xlink:label="lab_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Floating Rate Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6_documentation_en-US" xlink:label="lab_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Floating Rate Notes due 2022</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_FloatingRateNotesdue2022Member" xlink:label="loc_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6" xlink:to="lab_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6" xlink:type="arc" />
    <link:label id="lab_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF_terseLabel_en-US" xlink:label="lab_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.95% Notes due 2018</link:label>
    <link:label id="lab_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF_label_en-US" xlink:label="lab_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One Point Nine Five % Notes due 2018 [Member]</link:label>
    <link:label id="lab_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF_documentation_en-US" xlink:label="lab_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">One Point Nine Five % Notes due 2018 [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OnePointNineFiveNotesdue2018Member" xlink:label="loc_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF" xlink:to="lab_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF" xlink:type="arc" />
    <link:label id="lab_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6_terseLabel_en-US" xlink:label="lab_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2.4% Notes due 2019</link:label>
    <link:label id="lab_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6_label_en-US" xlink:label="lab_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2.4% Notes due 2020 [Member]</link:label>
    <link:label id="lab_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6_documentation_en-US" xlink:label="lab_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2.4% Notes due 2020</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.4Notesdue2020Member" xlink:label="loc_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6" xlink:to="lab_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6" xlink:type="arc" />
    <link:label id="lab_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526_terseLabel_en-US" xlink:label="lab_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.2% Notes due 2022</link:label>
    <link:label id="lab_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526_label_en-US" xlink:label="lab_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.2% Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526_documentation_en-US" xlink:label="lab_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.2% Notes due 2022</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.2Notesdue2022Member" xlink:label="loc_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526" xlink:to="lab_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526" xlink:type="arc" />
    <link:label id="lab_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56_terseLabel_en-US" xlink:label="lab_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.2% Notes due 2023</link:label>
    <link:label id="lab_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56_label_en-US" xlink:label="lab_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.2% Notes due 2023 [Member]</link:label>
    <link:label id="lab_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56_documentation_en-US" xlink:label="lab_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.2% Notes due 2023</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.2Notesdue2023Member" xlink:label="loc_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56" xlink:to="lab_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56" xlink:type="arc" />
    <link:label id="lab_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7_terseLabel_en-US" xlink:label="lab_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.5% Notes due fiscal 2025</link:label>
    <link:label id="lab_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7_label_en-US" xlink:label="lab_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.5% Notes due 2025 [Member]</link:label>
    <link:label id="lab_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7_documentation_en-US" xlink:label="lab_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.5% Notes due 2025</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.5Notesdue2025Member" xlink:label="loc_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7" xlink:to="lab_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7" xlink:type="arc" />
    <link:label id="lab_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353_terseLabel_en-US" xlink:label="lab_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.75% Notes due 2025</link:label>
    <link:label id="lab_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353_label_en-US" xlink:label="lab_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.75% Notes due 2026 [Member]</link:label>
    <link:label id="lab_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353_documentation_en-US" xlink:label="lab_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.75% Notes due 2026</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.75Notesdue2026Member" xlink:label="loc_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353" xlink:to="lab_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353" xlink:type="arc" />
    <link:label id="lab_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0_terseLabel_en-US" xlink:label="lab_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.5% Notes due 2044</link:label>
    <link:label id="lab_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0_label_en-US" xlink:label="lab_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.5% Notes due 2044 [Member]</link:label>
    <link:label id="lab_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0_documentation_en-US" xlink:label="lab_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.5% Notes due 2044</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.5Notesdue2044Member" xlink:label="loc_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0" xlink:to="lab_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0" xlink:type="arc" />
    <link:label id="lab_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3_terseLabel_en-US" xlink:label="lab_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.6% Notes due 2043</link:label>
    <link:label id="lab_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3_label_en-US" xlink:label="lab_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.6% Notes due 2043 [Member]</link:label>
    <link:label id="lab_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3_documentation_en-US" xlink:label="lab_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.6% Notes due 2043</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.6Notesdue2043Member" xlink:label="loc_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3" xlink:to="lab_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3" xlink:type="arc" />
    <link:label id="lab_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E_terseLabel_en-US" xlink:label="lab_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.625% Notes due 2020</link:label>
    <link:label id="lab_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E_label_en-US" xlink:label="lab_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.625% Notes due 2021 [Member]</link:label>
    <link:label id="lab_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E_documentation_en-US" xlink:label="lab_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.625% Notes due 2021</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.625Notesdue2021Member" xlink:label="loc_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E" xlink:to="lab_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E" xlink:type="arc" />
    <link:label id="lab_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35_terseLabel_en-US" xlink:label="lab_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.9% Notes due 2045</link:label>
    <link:label id="lab_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35_label_en-US" xlink:label="lab_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.9% Notes due 2045 [Member]</link:label>
    <link:label id="lab_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35_documentation_en-US" xlink:label="lab_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.9% Notes due 2045</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.9Notesdue2045Member" xlink:label="loc_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35" xlink:to="lab_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35" xlink:type="arc" />
    <link:label id="lab_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59_terseLabel_en-US" xlink:label="lab_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">7.0% Debentures due 2026</link:label>
    <link:label id="lab_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59_label_en-US" xlink:label="lab_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">7.0% Debentures due fiscal 2027 [Member]</link:label>
    <link:label id="lab_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59_documentation_en-US" xlink:label="lab_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">7.0% Debentures due fiscal 2027</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_A7.0Debenturesduefiscal2027Member" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59" xlink:to="lab_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59" xlink:type="arc" />
    <link:label id="lab_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2_label_en-US" xlink:label="lab_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2" xlink:to="lab_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2" xlink:type="arc" />
    <link:label id="lab_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11_terseLabel_en-US" xlink:label="lab_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11_label_en-US" xlink:label="lab_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11" xlink:to="lab_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11" xlink:type="arc" />
    <link:label id="lab_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587_terseLabel_en-US" xlink:label="lab_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allegiance Corporation</link:label>
    <link:label id="lab_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587_label_en-US" xlink:label="lab_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allegiance Corporation [Member]</link:label>
    <link:label id="lab_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587_documentation_en-US" xlink:label="lab_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Allegiance Corporation [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_AllegianceCorporationMember" xlink:label="loc_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587" xlink:to="lab_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1A00D4CFC4FAB7AF41F4DE6EC2004003_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1A00D4CFC4FAB7AF41F4DE6EC2004003" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1A00D4CFC4FAB7AF41F4DE6EC2004003_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1A00D4CFC4FAB7AF41F4DE6EC2004003" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1A00D4CFC4FAB7AF41F4DE6EC2004003" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1A00D4CFC4FAB7AF41F4DE6EC2004003" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1A00D4CFC4FAB7AF41F4DE6EC2004003" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableCurrent_571F81A1F9CF2A390B80DE6EC200BAA6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_571F81A1F9CF2A390B80DE6EC200BAA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_571F81A1F9CF2A390B80DE6EC200BAA6_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_571F81A1F9CF2A390B80DE6EC200BAA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_571F81A1F9CF2A390B80DE6EC200BAA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_571F81A1F9CF2A390B80DE6EC200BAA6" xlink:to="lab_us-gaap_AccountsPayableCurrent_571F81A1F9CF2A390B80DE6EC200BAA6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfNotesPayable_90006F84DCE5913063F7DE6EC20022A9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfNotesPayable_90006F84DCE5913063F7DE6EC20022A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Notes Payable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfNotesPayable_90006F84DCE5913063F7DE6EC20022A9_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfNotesPayable_90006F84DCE5913063F7DE6EC20022A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Notes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfNotesPayable_90006F84DCE5913063F7DE6EC20022A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfNotesPayable_90006F84DCE5913063F7DE6EC20022A9" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfNotesPayable_90006F84DCE5913063F7DE6EC20022A9" xlink:type="arc" />
    <link:label id="lab_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F_terseLabel_en-US" xlink:label="lab_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offer as percentage of principal amount</link:label>
    <link:label id="lab_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F_label_en-US" xlink:label="lab_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offer As Percentage Of Principal Amount</link:label>
    <link:label id="lab_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F_documentation_en-US" xlink:label="lab_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of principal amount that the company is required to offer to purchase certain notes, under certain circumstances.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OfferAsPercentageOfPrincipalAmount" xlink:label="loc_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F" xlink:to="lab_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_2DE109C8C816F40E55FFDE6EC2013C03_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_2DE109C8C816F40E55FFDE6EC2013C03" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_2DE109C8C816F40E55FFDE6EC2013C03_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_2DE109C8C816F40E55FFDE6EC2013C03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2DE109C8C816F40E55FFDE6EC2013C03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2DE109C8C816F40E55FFDE6EC2013C03" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_2DE109C8C816F40E55FFDE6EC2013C03" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_1C592CD51FB608884FC8DE6EC201E267_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable_1C592CD51FB608884FC8DE6EC201E267" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_1C592CD51FB608884FC8DE6EC201E267_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable_1C592CD51FB608884FC8DE6EC201E267" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_1C592CD51FB608884FC8DE6EC201E267" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable_1C592CD51FB608884FC8DE6EC201E267" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable_1C592CD51FB608884FC8DE6EC201E267" xlink:type="arc" />
    <link:label id="lab_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A_terseLabel_en-US" xlink:label="lab_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable Repurchased</link:label>
    <link:label id="lab_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A_label_en-US" xlink:label="lab_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable Repurchased</link:label>
    <link:label id="lab_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A_documentation_en-US" xlink:label="lab_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Principal Amount of Notes Payable Repurchased during the year</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_NotesPayableRepurchased" xlink:label="loc_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A" xlink:to="lab_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_16B0E1ED4A9E2849CDC0A57610232439_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_16B0E1ED4A9E2849CDC0A57610232439" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_16B0E1ED4A9E2849CDC0A57610232439" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_16B0E1ED4A9E2849CDC0A57610232439" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_16B0E1ED4A9E2849CDC0A57610232439" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income/(loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_FF089B484F91FD3AB7A2A57610238D44_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_FF089B484F91FD3AB7A2A57610238D44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_FF089B484F91FD3AB7A2A57610238D44_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_FF089B484F91FD3AB7A2A57610238D44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_FF089B484F91FD3AB7A2A57610238D44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_FF089B484F91FD3AB7A2A57610238D44" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_FF089B484F91FD3AB7A2A57610238D44" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_76BFE5CA939EE1ABF540A57610241282_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_76BFE5CA939EE1ABF540A57610241282" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amounts reclassified to earnings</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_76BFE5CA939EE1ABF540A57610241282_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_76BFE5CA939EE1ABF540A57610241282" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_76BFE5CA939EE1ABF540A57610241282" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_76BFE5CA939EE1ABF540A57610241282" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_76BFE5CA939EE1ABF540A57610241282" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_F75F041699A8C9BA2035A5761024FA12_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_F75F041699A8C9BA2035A5761024FA12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net unrealized gain/(loss) on derivative instruments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_F75F041699A8C9BA2035A5761024FA12_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_F75F041699A8C9BA2035A5761024FA12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_F75F041699A8C9BA2035A5761024FA12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_F75F041699A8C9BA2035A5761024FA12" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_F75F041699A8C9BA2035A5761024FA12" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5BC0998A4F6C690F515BA5761024578C_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5BC0998A4F6C690F515BA5761024578C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other comprehensive income/(loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5BC0998A4F6C690F515BA5761024578C_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5BC0998A4F6C690F515BA5761024578C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5BC0998A4F6C690F515BA5761024578C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5BC0998A4F6C690F515BA5761024578C" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5BC0998A4F6C690F515BA5761024578C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ED0B98A23B715AA1F912A57610258518_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ED0B98A23B715AA1F912A57610258518" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income/(loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ED0B98A23B715AA1F912A57610258518_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ED0B98A23B715AA1F912A57610258518" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ED0B98A23B715AA1F912A57610258518" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ED0B98A23B715AA1F912A57610258518" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ED0B98A23B715AA1F912A57610258518" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1AEC59C21939C41C39C4A57610250117_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1AEC59C21939C41C39C4A57610250117" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1AEC59C21939C41C39C4A57610250117" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1AEC59C21939C41C39C4A57610250117" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1AEC59C21939C41C39C4A57610250117" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_DD7ED5646E48C5BB39A9A5761025DFD2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_DD7ED5646E48C5BB39A9A5761025DFD2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_DD7ED5646E48C5BB39A9A5761025DFD2_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_DD7ED5646E48C5BB39A9A5761025DFD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_DD7ED5646E48C5BB39A9A5761025DFD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_DD7ED5646E48C5BB39A9A5761025DFD2" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_DD7ED5646E48C5BB39A9A5761025DFD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesMember_721101DD2BA28DCC9A0FDE765025C273_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember_721101DD2BA28DCC9A0FDE765025C273" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesMember_721101DD2BA28DCC9A0FDE765025C273_label_en-US" xlink:label="lab_us-gaap_SalesMember_721101DD2BA28DCC9A0FDE765025C273" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember_721101DD2BA28DCC9A0FDE765025C273" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember_721101DD2BA28DCC9A0FDE765025C273" xlink:to="lab_us-gaap_SalesMember_721101DD2BA28DCC9A0FDE765025C273" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfSalesMember_822E070734E1DF720988DE765026C3BF_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember_822E070734E1DF720988DE765026C3BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of Products Sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_822E070734E1DF720988DE765026C3BF_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember_822E070734E1DF720988DE765026C3BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_822E070734E1DF720988DE765026C3BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember_822E070734E1DF720988DE765026C3BF" xlink:to="lab_us-gaap_CostOfSalesMember_822E070734E1DF720988DE765026C3BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0020C039FF809F66CEE5DE7650269628_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0020C039FF809F66CEE5DE7650269628" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SG&amp;A Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0020C039FF809F66CEE5DE7650269628_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0020C039FF809F66CEE5DE7650269628" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0020C039FF809F66CEE5DE7650269628" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0020C039FF809F66CEE5DE7650269628" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0020C039FF809F66CEE5DE7650269628" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2C454ACE3FB39AAB1911DE7650262655_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2C454ACE3FB39AAB1911DE7650262655" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2C454ACE3FB39AAB1911DE7650262655_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2C454ACE3FB39AAB1911DE7650262655" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2C454ACE3FB39AAB1911DE7650262655" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2C454ACE3FB39AAB1911DE7650262655" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2C454ACE3FB39AAB1911DE7650262655" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsAbstract_5C66418D40E204891329064EB33015D8_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract_5C66418D40E204891329064EB33015D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_5C66418D40E204891329064EB33015D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract_5C66418D40E204891329064EB33015D8" xlink:to="lab_us-gaap_InvestmentsAbstract_5C66418D40E204891329064EB33015D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_6038934F725933EF18AC064EB330A425_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_6038934F725933EF18AC064EB330A425" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_6038934F725933EF18AC064EB330A425_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_6038934F725933EF18AC064EB330A425" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Holdings, Schedule of Investments [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_6038934F725933EF18AC064EB330A425" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_6038934F725933EF18AC064EB330A425" xlink:to="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_6038934F725933EF18AC064EB330A425" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Share Units</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3879354E099AEAAD8FCCE4F266F3A891_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3879354E099AEAAD8FCCE4F266F3A891" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3879354E099AEAAD8FCCE4F266F3A891" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3879354E099AEAAD8FCCE4F266F3A891" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3879354E099AEAAD8FCCE4F266F3A891" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="lab_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:type="arc" />
    <link:label id="lab_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256_terseLabel_en-US" xlink:label="lab_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:label id="lab_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256_label_en-US" xlink:label="lab_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:label id="lab_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256_documentation_en-US" xlink:label="lab_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LawsuitTypeAxis" xlink:label="loc_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:to="lab_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:type="arc" />
    <link:label id="lab_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005_terseLabel_en-US" xlink:label="lab_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Domain]</link:label>
    <link:label id="lab_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005_label_en-US" xlink:label="lab_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Domain]</link:label>
    <link:label id="lab_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005_documentation_en-US" xlink:label="lab_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Lawsuit Type [Axis]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LawsuitTypeDomain" xlink:label="loc_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005" xlink:to="lab_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005" xlink:type="arc" />
    <link:label id="lab_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1_terseLabel_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1_label_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1_documentation_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ClassActionLawsuitsMember" xlink:label="loc_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1" xlink:to="lab_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1" xlink:type="arc" />
    <link:label id="lab_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609_terseLabel_en-US" xlink:label="lab_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:label id="lab_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609_label_en-US" xlink:label="lab_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:label id="lab_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609_documentation_en-US" xlink:label="lab_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_PlaintiffTypeAxis" xlink:label="loc_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:to="lab_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:type="arc" />
    <link:label id="lab_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993_terseLabel_en-US" xlink:label="lab_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Domain]</link:label>
    <link:label id="lab_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993_label_en-US" xlink:label="lab_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Domain]</link:label>
    <link:label id="lab_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993_documentation_en-US" xlink:label="lab_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Plaintiff Type [Axis]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_PlaintiffTypeDomain" xlink:label="loc_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993" xlink:to="lab_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993" xlink:type="arc" />
    <link:label id="lab_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4_terseLabel_en-US" xlink:label="lab_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:label id="lab_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4_label_en-US" xlink:label="lab_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:label id="lab_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4_documentation_en-US" xlink:label="lab_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_PrivatePartiesMember" xlink:label="loc_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4" xlink:to="lab_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4" xlink:type="arc" />
    <link:label id="lab_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1_terseLabel_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Member] [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1_label_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Member] [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1_documentation_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Member] [Domain]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_SterileSurgicalGownRecallMemberDomain" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1" xlink:to="lab_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:to="lab_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:type="arc" />
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B_terseLabel_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Liability Lawsuits</link:label>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B_label_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B_documentation_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B" xlink:to="lab_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B" xlink:type="arc" />
    <link:label id="lab_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6_terseLabel_en-US" xlink:label="lab_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CVS Health</link:label>
    <link:label id="lab_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6_label_en-US" xlink:label="lab_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CVS Health [Member]</link:label>
    <link:label id="lab_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6_documentation_en-US" xlink:label="lab_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CVS Health [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6" xlink:to="lab_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6" xlink:type="arc" />
    <link:label id="lab_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8_terseLabel_en-US" xlink:label="lab_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Type [Axis]</link:label>
    <link:label id="lab_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8_label_en-US" xlink:label="lab_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Type [Axis]</link:label>
    <link:label id="lab_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8_documentation_en-US" xlink:label="lab_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Litigation Type [Axis]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LitigationTypeAxis" xlink:label="loc_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:to="lab_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:type="arc" />
    <link:label id="lab_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32_terseLabel_en-US" xlink:label="lab_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Type [Domain]</link:label>
    <link:label id="lab_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32_label_en-US" xlink:label="lab_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Type [Domain]</link:label>
    <link:label id="lab_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32_documentation_en-US" xlink:label="lab_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Litigation Type [Axis]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LitigationTypeDomain" xlink:label="loc_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32" xlink:to="lab_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32" xlink:type="arc" />
    <link:label id="lab_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706_terseLabel_en-US" xlink:label="lab_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:label id="lab_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706_label_en-US" xlink:label="lab_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:label id="lab_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706_documentation_en-US" xlink:label="lab_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_AlamedaCountyMember" xlink:label="loc_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706" xlink:to="lab_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706" xlink:type="arc" />
    <link:label id="lab_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC_terseLabel_en-US" xlink:label="lab_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:label id="lab_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC_label_en-US" xlink:label="lab_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:label id="lab_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC_documentation_en-US" xlink:label="lab_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OtherJurisdictionsMember" xlink:label="loc_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC" xlink:to="lab_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967" xlink:type="arc" />
    <link:label id="lab_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C_label_en-US" xlink:label="lab_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C" xlink:to="lab_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C" xlink:type="arc" />
    <link:label id="lab_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case Type</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:to="lab_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5_terseLabel_en-US" xlink:label="lab_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits</link:label>
    <link:label id="lab_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5_label_en-US" xlink:label="lab_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5_documentation_en-US" xlink:label="lab_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5" xlink:to="lab_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29_terseLabel_en-US" xlink:label="lab_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits State [Domain]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29_label_en-US" xlink:label="lab_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits State [Domain]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29_documentation_en-US" xlink:label="lab_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits State and Political Subdivisions [Domain]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLawsuitsStateDomain" xlink:label="loc_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29" xlink:to="lab_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Litigation, less Cuyahoga and Summit Counties [Member]</link:label>
    <link:label id="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04_label_en-US" xlink:label="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Litigation, less Cuyahoga and Summit Counties [Member]</link:label>
    <link:label id="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04_documentation_en-US" xlink:label="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Litigation, less Cuyahoga and Summit Counties</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04" xlink:to="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Litigation, Cuyahoga and Summit Counties [Member]</link:label>
    <link:label id="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8_label_en-US" xlink:label="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Litigation, Cuyahoga and Summit Counties [Member]</link:label>
    <link:label id="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8_documentation_en-US" xlink:label="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Litigation, Cuyahoga and Summit Counties</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8" xlink:to="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventMember_EA94F10A738D69BE0183E4F2670DD1D0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_EA94F10A738D69BE0183E4F2670DD1D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_EA94F10A738D69BE0183E4F2670DD1D0_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_EA94F10A738D69BE0183E4F2670DD1D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_EA94F10A738D69BE0183E4F2670DD1D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_EA94F10A738D69BE0183E4F2670DD1D0" xlink:to="lab_us-gaap_SubsequentEventMember_EA94F10A738D69BE0183E4F2670DD1D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="lab_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationReserve_B004444270C90B6B1D3CE4F2670D711E_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve_B004444270C90B6B1D3CE4F2670D711E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_B004444270C90B6B1D3CE4F2670D711E_label_en-US" xlink:label="lab_us-gaap_LitigationReserve_B004444270C90B6B1D3CE4F2670D711E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_B004444270C90B6B1D3CE4F2670D711E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve_B004444270C90B6B1D3CE4F2670D711E" xlink:to="lab_us-gaap_LitigationReserve_B004444270C90B6B1D3CE4F2670D711E" xlink:type="arc" />
    <link:label id="lab_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3_terseLabel_en-US" xlink:label="lab_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Component For Settlement Framework, Term</link:label>
    <link:label id="lab_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3_label_en-US" xlink:label="lab_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Component For Settlement Framework, Term</link:label>
    <link:label id="lab_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3_documentation_en-US" xlink:label="lab_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Component For Settlement Framework, Term</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_CashComponentForSettlementFrameworkTerm" xlink:label="loc_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3" xlink:to="lab_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3" xlink:type="arc" />
    <link:label id="lab_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834_terseLabel_en-US" xlink:label="lab_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum quarterly payment</link:label>
    <link:label id="lab_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834_label_en-US" xlink:label="lab_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Quarterly Payment</link:label>
    <link:label id="lab_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834_documentation_en-US" xlink:label="lab_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_MaximumQuarterlyPayment" xlink:label="loc_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834" xlink:to="lab_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_BC24CF81B273875EF0CBE4F2670E7850_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber_BC24CF81B273875EF0CBE4F2670E7850" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of lawsuits filed</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_BC24CF81B273875EF0CBE4F2670E7850_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber_BC24CF81B273875EF0CBE4F2670E7850" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_BC24CF81B273875EF0CBE4F2670E7850" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber_BC24CF81B273875EF0CBE4F2670E7850" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber_BC24CF81B273875EF0CBE4F2670E7850" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_E84F61A0453080425FBFE4F2670FC998_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs_E84F61A0453080425FBFE4F2670FC998" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_E84F61A0453080425FBFE4F2670FC998_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs_E84F61A0453080425FBFE4F2670FC998" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_E84F61A0453080425FBFE4F2670FC998" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs_E84F61A0453080425FBFE4F2670FC998" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs_E84F61A0453080425FBFE4F2670FC998" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_2A4A50E8E0AC74FD6AD8E4F2670F78B2_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue_2A4A50E8E0AC74FD6AD8E4F2670F78B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_2A4A50E8E0AC74FD6AD8E4F2670F78B2_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue_2A4A50E8E0AC74FD6AD8E4F2670F78B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2A4A50E8E0AC74FD6AD8E4F2670F78B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2A4A50E8E0AC74FD6AD8E4F2670F78B2" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue_2A4A50E8E0AC74FD6AD8E4F2670F78B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_845630B1D6547349B991E4F26F33B679_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_845630B1D6547349B991E4F26F33B679" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_845630B1D6547349B991E4F26F33B679_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_845630B1D6547349B991E4F26F33B679" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_845630B1D6547349B991E4F26F33B679" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_845630B1D6547349B991E4F26F33B679" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_845630B1D6547349B991E4F26F33B679" xlink:type="arc" />
    <link:label id="lab_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36_terseLabel_en-US" xlink:label="lab_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income from Settlements of Class Action Lawsuits</link:label>
    <link:label id="lab_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36_label_en-US" xlink:label="lab_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income from Settlements of Class Action Lawsuits</link:label>
    <link:label id="lab_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36_documentation_en-US" xlink:label="lab_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income from Settlements of Class Action Lawsuits</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_IncomefromSettlementsofClassActionLawsuits" xlink:label="loc_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36" xlink:to="lab_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_8081B88345B6152E519AE4F267149D0B_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_8081B88345B6152E519AE4F267149D0B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_8081B88345B6152E519AE4F267149D0B_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_8081B88345B6152E519AE4F267149D0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_8081B88345B6152E519AE4F267149D0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_8081B88345B6152E519AE4F267149D0B" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold_8081B88345B6152E519AE4F267149D0B" xlink:type="arc" />
    <link:label id="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863_terseLabel_en-US" xlink:label="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Total Settlement, Cuyahoga and Summit Counties</link:label>
    <link:label id="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863_label_en-US" xlink:label="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Total Settlement, Cuyahoga and Summit Counties</link:label>
    <link:label id="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863_documentation_en-US" xlink:label="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Total Settlement, Cuyahoga and Summit Counties</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidTotalSettlementCuyahogaandSummitCounties" xlink:label="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863" xlink:to="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863" xlink:type="arc" />
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC_terseLabel_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC_label_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC_documentation_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LossContingencyLawsuitsNumber" xlink:label="loc_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC" xlink:to="lab_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC" xlink:type="arc" />
    <link:label id="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49_terseLabel_en-US" xlink:label="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of State Attorneys General filing lawsuits</link:label>
    <link:label id="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49_label_en-US" xlink:label="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of State Attorneys General filing lawsuits</link:label>
    <link:label id="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49_documentation_en-US" xlink:label="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of State Attorneys General filing lawsuits</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:label="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49" xlink:to="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_B02303C4E11F04C1379B064EB01D4270_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_B02303C4E11F04C1379B064EB01D4270" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining contractual life of outstanding options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_B02303C4E11F04C1379B064EB01D4270_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_B02303C4E11F04C1379B064EB01D4270" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_B02303C4E11F04C1379B064EB01D4270" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_B02303C4E11F04C1379B064EB01D4270" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_B02303C4E11F04C1379B064EB01D4270" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2AB3EA17EF3401841A4C064EB01E5566_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2AB3EA17EF3401841A4C064EB01E5566" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining contractual life of exercisable options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2AB3EA17EF3401841A4C064EB01E5566_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2AB3EA17EF3401841A4C064EB01E5566" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2AB3EA17EF3401841A4C064EB01E5566" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2AB3EA17EF3401841A4C064EB01E5566" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2AB3EA17EF3401841A4C064EB01E5566" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_843FF8F064E86C704A6B064EB01EA4C3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_843FF8F064E86C704A6B064EB01EA4C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average period over which stock option compensation cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_843FF8F064E86C704A6B064EB01EA4C3_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_843FF8F064E86C704A6B064EB01EA4C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_843FF8F064E86C704A6B064EB01EA4C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_843FF8F064E86C704A6B064EB01EA4C3" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_843FF8F064E86C704A6B064EB01EA4C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37" xlink:type="arc" />
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0_terseLabel_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IPR&amp;D, trademarks and other</link:label>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0_label_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IPR&amp;D,TrademarksandOther [Member]</link:label>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0_documentation_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Includes in process investigation of new knowledge useful in developing new product or service or new process or techniques or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for the improvements to existing product or process and rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_IPRDTrademarksandOtherMember" xlink:label="loc_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0" xlink:to="lab_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_E9ABB0E16C330B09D59C064EB33FD193_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_E9ABB0E16C330B09D59C064EB33FD193" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Intangible</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_E9ABB0E16C330B09D59C064EB33FD193_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_E9ABB0E16C330B09D59C064EB33FD193" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_E9ABB0E16C330B09D59C064EB33FD193" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_E9ABB0E16C330B09D59C064EB33FD193" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_E9ABB0E16C330B09D59C064EB33FD193" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_3B318B325A3266C9810D064EB3407BCB_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_3B318B325A3266C9810D064EB3407BCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_3B318B325A3266C9810D064EB3407BCB_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_3B318B325A3266C9810D064EB3407BCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3B318B325A3266C9810D064EB3407BCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_3B318B325A3266C9810D064EB3407BCB" xlink:to="lab_us-gaap_CustomerRelationshipsMember_3B318B325A3266C9810D064EB3407BCB" xlink:type="arc" />
    <link:label id="lab_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7_terseLabel_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks, trade names and patents</link:label>
    <link:label id="lab_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7_label_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks And Patents Member</link:label>
    <link:label id="lab_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7_documentation_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_TrademarksAndPatentsMember" xlink:label="loc_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7" xlink:to="lab_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_BAA80E6C06E7E1AEBC0D064EB341A607_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_BAA80E6C06E7E1AEBC0D064EB341A607" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Developed technology and other</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_BAA80E6C06E7E1AEBC0D064EB341A607_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_BAA80E6C06E7E1AEBC0D064EB341A607" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_BAA80E6C06E7E1AEBC0D064EB341A607" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember_BAA80E6C06E7E1AEBC0D064EB341A607" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember_BAA80E6C06E7E1AEBC0D064EB341A607" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_DFB6EBC87AB4BF3E17F6064EB3416A99_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_DFB6EBC87AB4BF3E17F6064EB3416A99" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_DFB6EBC87AB4BF3E17F6064EB3416A99_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_DFB6EBC87AB4BF3E17F6064EB3416A99" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_DFB6EBC87AB4BF3E17F6064EB3416A99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_DFB6EBC87AB4BF3E17F6064EB3416A99" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_DFB6EBC87AB4BF3E17F6064EB3416A99" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_87E22CB079B4C5D56723064EB341B920_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_87E22CB079B4C5D56723064EB341B920" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Intangible</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_87E22CB079B4C5D56723064EB341B920_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_87E22CB079B4C5D56723064EB341B920" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_87E22CB079B4C5D56723064EB341B920" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross_87E22CB079B4C5D56723064EB341B920" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross_87E22CB079B4C5D56723064EB341B920" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A03798C7E0231B3DA0B064EB34267B0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A03798C7E0231B3DA0B064EB34267B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A03798C7E0231B3DA0B064EB34267B0_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A03798C7E0231B3DA0B064EB34267B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A03798C7E0231B3DA0B064EB34267B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A03798C7E0231B3DA0B064EB34267B0" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A03798C7E0231B3DA0B064EB34267B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_355EF849C74CB1B2992B064EB342EE48_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_355EF849C74CB1B2992B064EB342EE48" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Intangible</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_355EF849C74CB1B2992B064EB342EE48_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_355EF849C74CB1B2992B064EB342EE48" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_355EF849C74CB1B2992B064EB342EE48" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_355EF849C74CB1B2992B064EB342EE48" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_355EF849C74CB1B2992B064EB342EE48" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_F9F8D7D4374EF7AD7B99064EB342E2EC_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_F9F8D7D4374EF7AD7B99064EB342E2EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_F9F8D7D4374EF7AD7B99064EB342E2EC_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_F9F8D7D4374EF7AD7B99064EB342E2EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_F9F8D7D4374EF7AD7B99064EB342E2EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_F9F8D7D4374EF7AD7B99064EB342E2EC" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_F9F8D7D4374EF7AD7B99064EB342E2EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_948D89A32C053B453F08064EB3423A9F_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_948D89A32C053B453F08064EB3423A9F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Intangible, Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_948D89A32C053B453F08064EB3423A9F_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_948D89A32C053B453F08064EB3423A9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_948D89A32C053B453F08064EB3423A9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_948D89A32C053B453F08064EB3423A9F" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_948D89A32C053B453F08064EB3423A9F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2859770A03BE1DE63A77064EB3428200_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2859770A03BE1DE63A77064EB3428200" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Intangible, Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2859770A03BE1DE63A77064EB3428200_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2859770A03BE1DE63A77064EB3428200" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2859770A03BE1DE63A77064EB3428200" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2859770A03BE1DE63A77064EB3428200" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2859770A03BE1DE63A77064EB3428200" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6703C0D4DE207AFAEEC5064EB0281A73_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6703C0D4DE207AFAEEC5064EB0281A73" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6703C0D4DE207AFAEEC5064EB0281A73_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6703C0D4DE207AFAEEC5064EB0281A73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6703C0D4DE207AFAEEC5064EB0281A73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6703C0D4DE207AFAEEC5064EB0281A73" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6703C0D4DE207AFAEEC5064EB0281A73" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_E83C1D18F9AB33D5F6FD064EB028FF6D_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_E83C1D18F9AB33D5F6FD064EB028FF6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_E83C1D18F9AB33D5F6FD064EB028FF6D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_E83C1D18F9AB33D5F6FD064EB028FF6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_E83C1D18F9AB33D5F6FD064EB028FF6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_E83C1D18F9AB33D5F6FD064EB028FF6D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_E83C1D18F9AB33D5F6FD064EB028FF6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC6ABD5365E8B7C81DC3064EB0281E72_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC6ABD5365E8B7C81DC3064EB0281E72" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC6ABD5365E8B7C81DC3064EB0281E72_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC6ABD5365E8B7C81DC3064EB0281E72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC6ABD5365E8B7C81DC3064EB0281E72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC6ABD5365E8B7C81DC3064EB0281E72" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC6ABD5365E8B7C81DC3064EB0281E72" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_E1BC0130A2C2B35F33F1064EB02905CE_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_E1BC0130A2C2B35F33F1064EB02905CE" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_E1BC0130A2C2B35F33F1064EB02905CE_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_E1BC0130A2C2B35F33F1064EB02905CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_E1BC0130A2C2B35F33F1064EB02905CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_E1BC0130A2C2B35F33F1064EB02905CE" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_E1BC0130A2C2B35F33F1064EB02905CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_04C18287125088E33CA2064EB029AA6A_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_04C18287125088E33CA2064EB029AA6A" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_04C18287125088E33CA2064EB029AA6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_04C18287125088E33CA2064EB029AA6A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_04C18287125088E33CA2064EB029AA6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_608E9088F3D1E71A7EF7064EB029D56A_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_608E9088F3D1E71A7EF7064EB029D56A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_608E9088F3D1E71A7EF7064EB029D56A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_608E9088F3D1E71A7EF7064EB029D56A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_608E9088F3D1E71A7EF7064EB029D56A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_608E9088F3D1E71A7EF7064EB029D56A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_608E9088F3D1E71A7EF7064EB029D56A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price per Common Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7786E48645328E6B4DBF064EB0298D7B_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7786E48645328E6B4DBF064EB0298D7B" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7786E48645328E6B4DBF064EB0298D7B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7786E48645328E6B4DBF064EB0298D7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7786E48645328E6B4DBF064EB0298D7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7786E48645328E6B4DBF064EB0298D7B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7786E48645328E6B4DBF064EB0298D7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_C7ABDB024C88B9FAEFCB064EB0292254_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_C7ABDB024C88B9FAEFCB064EB0292254" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_C7ABDB024C88B9FAEFCB064EB0292254_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_C7ABDB024C88B9FAEFCB064EB0292254" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_C7ABDB024C88B9FAEFCB064EB0292254" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_C7ABDB024C88B9FAEFCB064EB0292254" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_C7ABDB024C88B9FAEFCB064EB0292254" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9F89B5249846BE90C5C6064EB0296C78_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9F89B5249846BE90C5C6064EB0296C78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9F89B5249846BE90C5C6064EB0296C78_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9F89B5249846BE90C5C6064EB0296C78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9F89B5249846BE90C5C6064EB0296C78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9F89B5249846BE90C5C6064EB0296C78" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9F89B5249846BE90C5C6064EB0296C78" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E773183CC4753EDE9926064EB02AF7DF_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E773183CC4753EDE9926064EB02AF7DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E773183CC4753EDE9926064EB02AF7DF_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E773183CC4753EDE9926064EB02AF7DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E773183CC4753EDE9926064EB02AF7DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E773183CC4753EDE9926064EB02AF7DF" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E773183CC4753EDE9926064EB02AF7DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_009695AF83AE21FD8E21064EB02A444D_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_009695AF83AE21FD8E21064EB02A444D" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_009695AF83AE21FD8E21064EB02A444D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_009695AF83AE21FD8E21064EB02A444D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_009695AF83AE21FD8E21064EB02A444D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_CD78816AC39418BC2745064EB02A07C7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_CD78816AC39418BC2745064EB02A07C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_CD78816AC39418BC2745064EB02A07C7_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_CD78816AC39418BC2745064EB02A07C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_CD78816AC39418BC2745064EB02A07C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_CD78816AC39418BC2745064EB02A07C7" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_CD78816AC39418BC2745064EB02A07C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_8D35D8640DB73C2FC094064EB34DF896_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_8D35D8640DB73C2FC094064EB34DF896" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_8D35D8640DB73C2FC094064EB34DF896_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_8D35D8640DB73C2FC094064EB34DF896" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_8D35D8640DB73C2FC094064EB34DF896" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock_8D35D8640DB73C2FC094064EB34DF896" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock_8D35D8640DB73C2FC094064EB34DF896" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2899107A01FBAB407B8D064EB34D8BBD_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2899107A01FBAB407B8D064EB34D8BBD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2899107A01FBAB407B8D064EB34D8BBD_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2899107A01FBAB407B8D064EB34D8BBD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2899107A01FBAB407B8D064EB34D8BBD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2899107A01FBAB407B8D064EB34D8BBD" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2899107A01FBAB407B8D064EB34D8BBD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_EE6A9857E697F0AA47D4064EB34D566D_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_EE6A9857E697F0AA47D4064EB34D566D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_EE6A9857E697F0AA47D4064EB34D566D_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_EE6A9857E697F0AA47D4064EB34D566D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_EE6A9857E697F0AA47D4064EB34D566D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_EE6A9857E697F0AA47D4064EB34D566D" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_EE6A9857E697F0AA47D4064EB34D566D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_402DB2DA737E87229881064EB2B8AE77_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_402DB2DA737E87229881064EB2B8AE77" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Income Before Income Tax, Domestic and Foreign</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_402DB2DA737E87229881064EB2B8AE77_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_402DB2DA737E87229881064EB2B8AE77" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_402DB2DA737E87229881064EB2B8AE77" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_402DB2DA737E87229881064EB2B8AE77" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_402DB2DA737E87229881064EB2B8AE77" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_F2FED6BA52C4F5BF2C05064EB2B90536_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_F2FED6BA52C4F5BF2C05064EB2B90536" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit), Current and Deferred</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_F2FED6BA52C4F5BF2C05064EB2B90536_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_F2FED6BA52C4F5BF2C05064EB2B90536" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_F2FED6BA52C4F5BF2C05064EB2B90536" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_F2FED6BA52C4F5BF2C05064EB2B90536" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_F2FED6BA52C4F5BF2C05064EB2B90536" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0A46EA67A0329DFA003E064EB2B91564_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0A46EA67A0329DFA003E064EB2B91564" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0A46EA67A0329DFA003E064EB2B91564_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0A46EA67A0329DFA003E064EB2B91564" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0A46EA67A0329DFA003E064EB2B91564" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0A46EA67A0329DFA003E064EB2B91564" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0A46EA67A0329DFA003E064EB2B91564" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_E201A3A933BB51D3B528064EB2B949A4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_E201A3A933BB51D3B528064EB2B949A4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_E201A3A933BB51D3B528064EB2B949A4_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_E201A3A933BB51D3B528064EB2B949A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_E201A3A933BB51D3B528064EB2B949A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_E201A3A933BB51D3B528064EB2B949A4" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_E201A3A933BB51D3B528064EB2B949A4" xlink:type="arc" />
    <link:label id="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_40955FDB6775EE8FC131064EB2B9562F_terseLabel_en-US" xlink:label="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_40955FDB6775EE8FC131064EB2B9562F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities after Netting by Tax Jurisdiction</link:label>
    <link:label id="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_40955FDB6775EE8FC131064EB2B9562F_label_en-US" xlink:label="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_40955FDB6775EE8FC131064EB2B9562F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]</link:label>
    <link:label id="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_40955FDB6775EE8FC131064EB2B9562F_documentation_en-US" xlink:label="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_40955FDB6775EE8FC131064EB2B9562F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:label="loc_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_40955FDB6775EE8FC131064EB2B9562F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_40955FDB6775EE8FC131064EB2B9562F" xlink:to="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_40955FDB6775EE8FC131064EB2B9562F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_4D1129EFB0C88BC537D0064EB2B98E35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_4D1129EFB0C88BC537D0064EB2B98E35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_4D1129EFB0C88BC537D0064EB2B98E35_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_4D1129EFB0C88BC537D0064EB2B98E35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_4D1129EFB0C88BC537D0064EB2B98E35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_4D1129EFB0C88BC537D0064EB2B98E35" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_4D1129EFB0C88BC537D0064EB2B98E35" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonUsMember_A9AD5F29017D326CECFE064EB04F2CFF_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember_A9AD5F29017D326CECFE064EB04F2CFF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_A9AD5F29017D326CECFE064EB04F2CFF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember_A9AD5F29017D326CECFE064EB04F2CFF" xlink:to="lab_us-gaap_NonUsMember_A9AD5F29017D326CECFE064EB04F2CFF" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_B1235D0F5436BC4E4E9F064EB0500DD2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_B1235D0F5436BC4E4E9F064EB0500DD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_B1235D0F5436BC4E4E9F064EB0500DD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_B1235D0F5436BC4E4E9F064EB0500DD2" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_B1235D0F5436BC4E4E9F064EB0500DD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A3AE88F8AD7F561F2B70DE783AD65BCD_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A3AE88F8AD7F561F2B70DE783AD65BCD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A3AE88F8AD7F561F2B70DE783AD65BCD_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A3AE88F8AD7F561F2B70DE783AD65BCD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A3AE88F8AD7F561F2B70DE783AD65BCD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A3AE88F8AD7F561F2B70DE783AD65BCD" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A3AE88F8AD7F561F2B70DE783AD65BCD" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_E33A2F78C15346563145DE783AD7F606_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_E33A2F78C15346563145DE783AD7F606" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_E33A2F78C15346563145DE783AD7F606_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_E33A2F78C15346563145DE783AD7F606" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_E33A2F78C15346563145DE783AD7F606" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_E33A2F78C15346563145DE783AD7F606" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_E33A2F78C15346563145DE783AD7F606" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossOnSaleOfInvestments_33B9AD2FF775B32A7AD2DE783AD76268_terseLabel_en-US" xlink:label="lab_us-gaap_LossOnSaleOfInvestments_33B9AD2FF775B32A7AD2DE783AD76268" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_LossOnSaleOfInvestments_33B9AD2FF775B32A7AD2DE783AD76268_label_en-US" xlink:label="lab_us-gaap_LossOnSaleOfInvestments_33B9AD2FF775B32A7AD2DE783AD76268" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss on Sale of Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_33B9AD2FF775B32A7AD2DE783AD76268" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossOnSaleOfInvestments_33B9AD2FF775B32A7AD2DE783AD76268" xlink:to="lab_us-gaap_LossOnSaleOfInvestments_33B9AD2FF775B32A7AD2DE783AD76268" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainOnSaleOfInvestments_6E5E731447196AFC87CFDE783AD76985_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainOnSaleOfInvestments_6E5E731447196AFC87CFDE783AD76985" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on Sale of Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_6E5E731447196AFC87CFDE783AD76985" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainOnSaleOfInvestments_6E5E731447196AFC87CFDE783AD76985" xlink:to="lab_us-gaap_GainOnSaleOfInvestments_6E5E731447196AFC87CFDE783AD76985" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_01841B9F13BA2FEC7642DE783AD7297F_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_01841B9F13BA2FEC7642DE783AD7297F" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairments and (gain)/loss on disposal of assets, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_01841B9F13BA2FEC7642DE783AD7297F_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_01841B9F13BA2FEC7642DE783AD7297F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_01841B9F13BA2FEC7642DE783AD7297F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_01841B9F13BA2FEC7642DE783AD7297F" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_01841B9F13BA2FEC7642DE783AD7297F" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_6A27E4D01BD2A66C14EBDE783AD83E1E_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_6A27E4D01BD2A66C14EBDE783AD83E1E" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6A27E4D01BD2A66C14EBDE783AD83E1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6A27E4D01BD2A66C14EBDE783AD83E1E" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_6A27E4D01BD2A66C14EBDE783AD83E1E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_1FF0DB4901BA29324FD1DE783AD820AD_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_1FF0DB4901BA29324FD1DE783AD820AD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_1FF0DB4901BA29324FD1DE783AD820AD_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_1FF0DB4901BA29324FD1DE783AD820AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_1FF0DB4901BA29324FD1DE783AD820AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_1FF0DB4901BA29324FD1DE783AD820AD" xlink:to="lab_us-gaap_ShareBasedCompensation_1FF0DB4901BA29324FD1DE783AD820AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_22E2AAF25B04C5096414DE783AD886B7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_22E2AAF25B04C5096414DE783AD886B7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for/(benefit from) deferred income taxes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_22E2AAF25B04C5096414DE783AD886B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_22E2AAF25B04C5096414DE783AD886B7" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_22E2AAF25B04C5096414DE783AD886B7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_08F753E93DA4CDBC4EC4DE783ADD46C6_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_08F753E93DA4CDBC4EC4DE783ADD46C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for bad debts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_08F753E93DA4CDBC4EC4DE783ADD46C6_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_08F753E93DA4CDBC4EC4DE783ADD46C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_08F753E93DA4CDBC4EC4DE783ADD46C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts_08F753E93DA4CDBC4EC4DE783ADD46C6" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts_08F753E93DA4CDBC4EC4DE783ADD46C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E6FE367E2BB7AD8025BBDE783ADD8FE7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E6FE367E2BB7AD8025BBDE783ADD8FE7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of contingent consideration obligation</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E6FE367E2BB7AD8025BBDE783ADD8FE7_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E6FE367E2BB7AD8025BBDE783ADD8FE7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E6FE367E2BB7AD8025BBDE783ADD8FE7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E6FE367E2BB7AD8025BBDE783ADD8FE7" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E6FE367E2BB7AD8025BBDE783ADD8FE7" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_E843BCD256C4E0F64780DE783ADE9082_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables_E843BCD256C4E0F64780DE783ADE9082" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease/(increase) in trade receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_E843BCD256C4E0F64780DE783ADE9082_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables_E843BCD256C4E0F64780DE783ADE9082" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_E843BCD256C4E0F64780DE783ADE9082" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables_E843BCD256C4E0F64780DE783ADE9082" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables_E843BCD256C4E0F64780DE783ADE9082" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_C027BB595681EF7AF942DE783ADE199C_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_C027BB595681EF7AF942DE783ADE199C" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_C027BB595681EF7AF942DE783ADE199C_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_C027BB595681EF7AF942DE783ADE199C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_C027BB595681EF7AF942DE783ADE199C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_C027BB595681EF7AF942DE783ADE199C" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_C027BB595681EF7AF942DE783ADE199C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_292C7AA6AA550E61380BDE783ADEDDEB_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_292C7AA6AA550E61380BDE783ADEDDEB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase/(decrease) in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_292C7AA6AA550E61380BDE783ADEDDEB_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_292C7AA6AA550E61380BDE783ADEDDEB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_292C7AA6AA550E61380BDE783ADEDDEB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable_292C7AA6AA550E61380BDE783ADEDDEB" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable_292C7AA6AA550E61380BDE783ADEDDEB" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1B269A72DFE8C3CCA2DBDE783ADE1631_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1B269A72DFE8C3CCA2DBDE783ADE1631" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities and operating items, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1B269A72DFE8C3CCA2DBDE783ADE1631_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1B269A72DFE8C3CCA2DBDE783ADE1631" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1B269A72DFE8C3CCA2DBDE783ADE1631" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1B269A72DFE8C3CCA2DBDE783ADE1631" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1B269A72DFE8C3CCA2DBDE783ADE1631" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_28E0106398D675EFBB8BDE783ADF6090_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_28E0106398D675EFBB8BDE783ADF6090" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_28E0106398D675EFBB8BDE783ADF6090_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_28E0106398D675EFBB8BDE783ADF6090" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_28E0106398D675EFBB8BDE783ADF6090" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_28E0106398D675EFBB8BDE783ADF6090" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_28E0106398D675EFBB8BDE783ADF6090" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_AA9C2FFE201244ED4655DE783ADF753C_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_AA9C2FFE201244ED4655DE783ADF753C" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Acquisition of subsidiaries, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_AA9C2FFE201244ED4655DE783ADF753C_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_AA9C2FFE201244ED4655DE783ADF753C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_AA9C2FFE201244ED4655DE783ADF753C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_AA9C2FFE201244ED4655DE783ADF753C" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_AA9C2FFE201244ED4655DE783ADF753C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0059BD1BFE376E922F72DE783ADF9566_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0059BD1BFE376E922F72DE783ADF9566" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Additions to property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0059BD1BFE376E922F72DE783ADF9566_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0059BD1BFE376E922F72DE783ADF9566" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0059BD1BFE376E922F72DE783ADF9566" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0059BD1BFE376E922F72DE783ADF9566" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0059BD1BFE376E922F72DE783ADF9566" xlink:type="arc" />
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_A4F7E263AD123A75BC25DE783ADF1E33_negatedLabel_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_A4F7E263AD123A75BC25DE783ADF1E33" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of other investments</link:label>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_A4F7E263AD123A75BC25DE783ADF1E33_label_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_A4F7E263AD123A75BC25DE783ADF1E33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_A4F7E263AD123A75BC25DE783ADF1E33_documentation_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_A4F7E263AD123A75BC25DE783ADF1E33" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow from purchases of available-for-sale securities and other investments.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_A4F7E263AD123A75BC25DE783ADF1E33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_A4F7E263AD123A75BC25DE783ADF1E33" xlink:to="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_A4F7E263AD123A75BC25DE783ADF1E33" xlink:type="arc" />
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_98FFEEDBFDB173C18ADBDE783AE06E7F_terseLabel_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_98FFEEDBFDB173C18ADBDE783AE06E7F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of investments and available-for-sale securities</link:label>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_98FFEEDBFDB173C18ADBDE783AE06E7F_label_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_98FFEEDBFDB173C18ADBDE783AE06E7F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sale of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_98FFEEDBFDB173C18ADBDE783AE06E7F_documentation_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_98FFEEDBFDB173C18ADBDE783AE06E7F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash inflow from sales of available-for-sale securities and other investments.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_98FFEEDBFDB173C18ADBDE783AE06E7F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_98FFEEDBFDB173C18ADBDE783AE06E7F" xlink:to="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_98FFEEDBFDB173C18ADBDE783AE06E7F" xlink:type="arc" />
    <link:label id="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_D61410D64B86462AACE5DE783AE0CC15_terseLabel_en-US" xlink:label="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_D61410D64B86462AACE5DE783AE0CC15" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from divestitures, net of cash sold, and disposal of property and equipment</link:label>
    <link:label id="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_D61410D64B86462AACE5DE783AE0CC15_label_en-US" xlink:label="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_D61410D64B86462AACE5DE783AE0CC15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from divestitures and disposal of property and equipment and held for sale assets</link:label>
    <link:label id="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_D61410D64B86462AACE5DE783AE0CC15_documentation_en-US" xlink:label="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_D61410D64B86462AACE5DE783AE0CC15" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds from divestitures and disposal of property and equipment and held for sale assets</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" xlink:label="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_D61410D64B86462AACE5DE783AE0CC15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_D61410D64B86462AACE5DE783AE0CC15" xlink:to="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_D61410D64B86462AACE5DE783AE0CC15" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2E76DC30B0AD497D9B81DE783AE0D9D7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2E76DC30B0AD497D9B81DE783AE0D9D7" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by/(used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2E76DC30B0AD497D9B81DE783AE0D9D7_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2E76DC30B0AD497D9B81DE783AE0D9D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2E76DC30B0AD497D9B81DE783AE0D9D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2E76DC30B0AD497D9B81DE783AE0D9D7" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2E76DC30B0AD497D9B81DE783AE0D9D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:type="arc" />
    <link:label id="lab_cah_PaymentofContingentConsideration_C22895BC4E679B6B7952DE783AE0F2C7_negatedTerseLabel_en-US" xlink:label="lab_cah_PaymentofContingentConsideration_C22895BC4E679B6B7952DE783AE0F2C7" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of contingent consideration obligation</link:label>
    <link:label id="lab_cah_PaymentofContingentConsideration_C22895BC4E679B6B7952DE783AE0F2C7_label_en-US" xlink:label="lab_cah_PaymentofContingentConsideration_C22895BC4E679B6B7952DE783AE0F2C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment of Contingent Consideration</link:label>
    <link:label id="lab_cah_PaymentofContingentConsideration_C22895BC4E679B6B7952DE783AE0F2C7_documentation_en-US" xlink:label="lab_cah_PaymentofContingentConsideration_C22895BC4E679B6B7952DE783AE0F2C7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow from a settlement payment of contingent consideration assumed in a business combination.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_PaymentofContingentConsideration" xlink:label="loc_cah_PaymentofContingentConsideration_C22895BC4E679B6B7952DE783AE0F2C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PaymentofContingentConsideration_C22895BC4E679B6B7952DE783AE0F2C7" xlink:to="lab_cah_PaymentofContingentConsideration_C22895BC4E679B6B7952DE783AE0F2C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_14C584F90426B2179AB4DE783AE130A9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_14C584F90426B2179AB4DE783AE130A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net change in short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_14C584F90426B2179AB4DE783AE130A9_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_14C584F90426B2179AB4DE783AE130A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_14C584F90426B2179AB4DE783AE130A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_14C584F90426B2179AB4DE783AE130A9" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_14C584F90426B2179AB4DE783AE130A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_F5C035BEFA36A87E4976DF5037A810C6_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_F5C035BEFA36A87E4976DF5037A810C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses and Interest in Affiliates</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_F5C035BEFA36A87E4976DF5037A810C6_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_F5C035BEFA36A87E4976DF5037A810C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_F5C035BEFA36A87E4976DF5037A810C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_F5C035BEFA36A87E4976DF5037A810C6" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_F5C035BEFA36A87E4976DF5037A810C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_4D45B23F4CDA2998D6F8DE783AE1BE05_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_4D45B23F4CDA2998D6F8DE783AE1BE05" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reduction of long-term obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_4D45B23F4CDA2998D6F8DE783AE1BE05_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_4D45B23F4CDA2998D6F8DE783AE1BE05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_4D45B23F4CDA2998D6F8DE783AE1BE05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt_4D45B23F4CDA2998D6F8DE783AE1BE05" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt_4D45B23F4CDA2998D6F8DE783AE1BE05" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_9EC077F0BA1DF954ED4CDE783AE6603E_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_9EC077F0BA1DF954ED4CDE783AE6603E" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from interest rate swap terminations</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_9EC077F0BA1DF954ED4CDE783AE6603E_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_9EC077F0BA1DF954ED4CDE783AE6603E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Hedge, Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_9EC077F0BA1DF954ED4CDE783AE6603E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_9EC077F0BA1DF954ED4CDE783AE6603E" xlink:to="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_9EC077F0BA1DF954ED4CDE783AE6603E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_1162FE5A94705586C97FDE783AE6BD57_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_1162FE5A94705586C97FDE783AE6BD57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from long-term obligations, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_1162FE5A94705586C97FDE783AE6BD57_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_1162FE5A94705586C97FDE783AE6BD57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_1162FE5A94705586C97FDE783AE6BD57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_1162FE5A94705586C97FDE783AE6BD57" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_1162FE5A94705586C97FDE783AE6BD57" xlink:type="arc" />
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_871D94758FBDF479534EDE783AE7DDF1_terseLabel_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_871D94758FBDF479534EDE783AE7DDF1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net tax proceeds/(withholding) from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_871D94758FBDF479534EDE783AE7DDF1_label_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_871D94758FBDF479534EDE783AE7DDF1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net proceeds/(tax withholdings) from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_871D94758FBDF479534EDE783AE7DDF1_documentation_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_871D94758FBDF479534EDE783AE7DDF1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_871D94758FBDF479534EDE783AE7DDF1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_871D94758FBDF479534EDE783AE7DDF1" xlink:to="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_871D94758FBDF479534EDE783AE7DDF1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_4964FF3C1BE4F8D6E3F8DE783AE77E2B_terseLabel_en-US" xlink:label="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_4964FF3C1BE4F8D6E3F8DE783AE77E2B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Excess tax benefits from share-based compensation</link:label>
    <link:label id="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_4964FF3C1BE4F8D6E3F8DE783AE77E2B_label_en-US" xlink:label="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_4964FF3C1BE4F8D6E3F8DE783AE77E2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Excess Tax Benefit from Share-based Compensation, Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_4964FF3C1BE4F8D6E3F8DE783AE77E2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_4964FF3C1BE4F8D6E3F8DE783AE77E2B" xlink:to="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_4964FF3C1BE4F8D6E3F8DE783AE77E2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_FC2C57A19F52DC52CEBFDE783AE7A42E_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock_FC2C57A19F52DC52CEBFDE783AE7A42E" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Dividends on common shares</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_FC2C57A19F52DC52CEBFDE783AE7A42E_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock_FC2C57A19F52DC52CEBFDE783AE7A42E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_FC2C57A19F52DC52CEBFDE783AE7A42E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock_FC2C57A19F52DC52CEBFDE783AE7A42E" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock_FC2C57A19F52DC52CEBFDE783AE7A42E" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_006D17C19F48FEAC951DDE783AE7FCC5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_006D17C19F48FEAC951DDE783AE7FCC5" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of treasury shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_006D17C19F48FEAC951DDE783AE7FCC5_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_006D17C19F48FEAC951DDE783AE7FCC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_006D17C19F48FEAC951DDE783AE7FCC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_006D17C19F48FEAC951DDE783AE7FCC5" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_006D17C19F48FEAC951DDE783AE7FCC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_7346B4AA501F2233DE8FDE783AE7A58F_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_7346B4AA501F2233DE8FDE783AE7A58F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_7346B4AA501F2233DE8FDE783AE7A58F_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_7346B4AA501F2233DE8FDE783AE7A58F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7346B4AA501F2233DE8FDE783AE7A58F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7346B4AA501F2233DE8FDE783AE7A58F" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_7346B4AA501F2233DE8FDE783AE7A58F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_A5AAB08A95EF38FA5A19DE783AE7B73A_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_A5AAB08A95EF38FA5A19DE783AE7B73A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rates changes on cash and equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_A5AAB08A95EF38FA5A19DE783AE7B73A_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_A5AAB08A95EF38FA5A19DE783AE7B73A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_A5AAB08A95EF38FA5A19DE783AE7B73A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_A5AAB08A95EF38FA5A19DE783AE7B73A" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_A5AAB08A95EF38FA5A19DE783AE7B73A" xlink:type="arc" />
    <link:label id="lab_cah_CashReclassifiedtoAssetsHeldforSale_05D98B053BAD3EF9D4D8DE783AE83854_terseLabel_en-US" xlink:label="lab_cah_CashReclassifiedtoAssetsHeldforSale_05D98B053BAD3EF9D4D8DE783AE83854" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash reclassified to assets held for sale</link:label>
    <link:label id="lab_cah_CashReclassifiedtoAssetsHeldforSale_05D98B053BAD3EF9D4D8DE783AE83854_label_en-US" xlink:label="lab_cah_CashReclassifiedtoAssetsHeldforSale_05D98B053BAD3EF9D4D8DE783AE83854" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CashReclassifiedtoAssetsHeldforSale</link:label>
    <link:label id="lab_cah_CashReclassifiedtoAssetsHeldforSale_05D98B053BAD3EF9D4D8DE783AE83854_documentation_en-US" xlink:label="lab_cah_CashReclassifiedtoAssetsHeldforSale_05D98B053BAD3EF9D4D8DE783AE83854" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CashReclassifiedtoAssetsHeldforSale</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_CashReclassifiedtoAssetsHeldforSale" xlink:label="loc_cah_CashReclassifiedtoAssetsHeldforSale_05D98B053BAD3EF9D4D8DE783AE83854" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CashReclassifiedtoAssetsHeldforSale_05D98B053BAD3EF9D4D8DE783AE83854" xlink:to="lab_cah_CashReclassifiedtoAssetsHeldforSale_05D98B053BAD3EF9D4D8DE783AE83854" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_D1FA0366DFB4E3197F04DF2FC817CA89_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_D1FA0366DFB4E3197F04DF2FC817CA89" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_D1FA0366DFB4E3197F04DF2FC817CA89_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_D1FA0366DFB4E3197F04DF2FC817CA89" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_D1FA0366DFB4E3197F04DF2FC817CA89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_D1FA0366DFB4E3197F04DF2FC817CA89" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_D1FA0366DFB4E3197F04DF2FC817CA89" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_75569104994D7519E817DE783AE82537_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_75569104994D7519E817DE783AE82537" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_75569104994D7519E817DE783AE82537_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_75569104994D7519E817DE783AE82537" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_75569104994D7519E817DE783AE82537" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_75569104994D7519E817DE783AE82537" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_75569104994D7519E817DE783AE82537" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_E33D32C636F411AFD600DE783AE8A468_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_E33D32C636F411AFD600DE783AE8A468" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_E33D32C636F411AFD600DE783AE8A468" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_E33D32C636F411AFD600DE783AE8A468" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_E33D32C636F411AFD600DE783AE8A468" xlink:type="arc" />
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_225B08A0CE00F5DAAA80DE783AE86208_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_225B08A0CE00F5DAAA80DE783AE86208" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_225B08A0CE00F5DAAA80DE783AE86208_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_225B08A0CE00F5DAAA80DE783AE86208" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_225B08A0CE00F5DAAA80DE783AE86208" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_225B08A0CE00F5DAAA80DE783AE86208" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract_225B08A0CE00F5DAAA80DE783AE86208" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestPaidNet_EE3D112327F4F54FC81ADE783AE844FE_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet_EE3D112327F4F54FC81ADE783AE844FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payments for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_EE3D112327F4F54FC81ADE783AE844FE_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet_EE3D112327F4F54FC81ADE783AE844FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_EE3D112327F4F54FC81ADE783AE844FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet_EE3D112327F4F54FC81ADE783AE844FE" xlink:to="lab_us-gaap_InterestPaidNet_EE3D112327F4F54FC81ADE783AE844FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_58FF4821FA36AA83A7F6DE783AE9FEBD_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet_58FF4821FA36AA83A7F6DE783AE9FEBD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payments for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_58FF4821FA36AA83A7F6DE783AE9FEBD_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet_58FF4821FA36AA83A7F6DE783AE9FEBD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_58FF4821FA36AA83A7F6DE783AE9FEBD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet_58FF4821FA36AA83A7F6DE783AE9FEBD" xlink:to="lab_us-gaap_IncomeTaxesPaidNet_58FF4821FA36AA83A7F6DE783AE9FEBD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_79DC5B77D39EBDA54231DD8B84F2C5BE_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_79DC5B77D39EBDA54231DD8B84F2C5BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate (minimum)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_79DC5B77D39EBDA54231DD8B84F2C5BE_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_79DC5B77D39EBDA54231DD8B84F2C5BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_79DC5B77D39EBDA54231DD8B84F2C5BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_79DC5B77D39EBDA54231DD8B84F2C5BE" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_79DC5B77D39EBDA54231DD8B84F2C5BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_947A20F3E29B5DF3DC02DD8B84F2B277_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_947A20F3E29B5DF3DC02DD8B84F2B277" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_947A20F3E29B5DF3DC02DD8B84F2B277_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_947A20F3E29B5DF3DC02DD8B84F2B277" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_947A20F3E29B5DF3DC02DD8B84F2B277" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_947A20F3E29B5DF3DC02DD8B84F2B277" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_947A20F3E29B5DF3DC02DD8B84F2B277" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2153C91BF9CDB8204D88DD8B84F2A1BB_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2153C91BF9CDB8204D88DD8B84F2A1BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2153C91BF9CDB8204D88DD8B84F2A1BB_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2153C91BF9CDB8204D88DD8B84F2A1BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2153C91BF9CDB8204D88DD8B84F2A1BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2153C91BF9CDB8204D88DD8B84F2A1BB" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2153C91BF9CDB8204D88DD8B84F2A1BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_DA605096AF860E4AA054DD8B84F2C128_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_DA605096AF860E4AA054DD8B84F2C128" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected life in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_DA605096AF860E4AA054DD8B84F2C128_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_DA605096AF860E4AA054DD8B84F2C128" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_DA605096AF860E4AA054DD8B84F2C128" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_DA605096AF860E4AA054DD8B84F2C128" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_DA605096AF860E4AA054DD8B84F2C128" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_F9434EF6FB04FEF5F4B3064EB3CC669E_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_F9434EF6FB04FEF5F4B3064EB3CC669E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_F9434EF6FB04FEF5F4B3064EB3CC669E_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_F9434EF6FB04FEF5F4B3064EB3CC669E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_F9434EF6FB04FEF5F4B3064EB3CC669E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_F9434EF6FB04FEF5F4B3064EB3CC669E" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_F9434EF6FB04FEF5F4B3064EB3CC669E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_D20FAFBC20FCD6405B66064EB22C60CB_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_D20FAFBC20FCD6405B66064EB22C60CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_D20FAFBC20FCD6405B66064EB22C60CB_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_D20FAFBC20FCD6405B66064EB22C60CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_D20FAFBC20FCD6405B66064EB22C60CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_D20FAFBC20FCD6405B66064EB22C60CB" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_D20FAFBC20FCD6405B66064EB22C60CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_93EEF3E3A6C1483638A77736CB9DF229_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_93EEF3E3A6C1483638A77736CB9DF229" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_93EEF3E3A6C1483638A77736CB9DF229" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_93EEF3E3A6C1483638A77736CB9DF229" xlink:to="lab_us-gaap_ProfitLoss_93EEF3E3A6C1483638A77736CB9DF229" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7AD328932813074C42F57736CB9D9765_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7AD328932813074C42F57736CB9D9765" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net earnings attributable to noncontrolling interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7AD328932813074C42F57736CB9D9765" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7AD328932813074C42F57736CB9D9765" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7AD328932813074C42F57736CB9D9765" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_1D90A24F299A9ECBF4B67736CB9EE431_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_1D90A24F299A9ECBF4B67736CB9EE431" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1D90A24F299A9ECBF4B67736CB9EE431" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_1D90A24F299A9ECBF4B67736CB9EE431" xlink:to="lab_us-gaap_NetIncomeLoss_1D90A24F299A9ECBF4B67736CB9EE431" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C345821368C5EE2C530B7736CB9E54CB_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C345821368C5EE2C530B7736CB9E54CB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares&#8211;basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C345821368C5EE2C530B7736CB9E54CB_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C345821368C5EE2C530B7736CB9E54CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C345821368C5EE2C530B7736CB9E54CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C345821368C5EE2C530B7736CB9E54CB" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C345821368C5EE2C530B7736CB9E54CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_60BF238A8ED2C097AE817736CB9EA399_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_60BF238A8ED2C097AE817736CB9EA399" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_60BF238A8ED2C097AE817736CB9EA399_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_60BF238A8ED2C097AE817736CB9EA399" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_60BF238A8ED2C097AE817736CB9EA399" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_60BF238A8ED2C097AE817736CB9EA399" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_60BF238A8ED2C097AE817736CB9EA399" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_75A637EFF79CB13A26AD7736CB9E86F9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_75A637EFF79CB13A26AD7736CB9E86F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee stock options, restricted share units, and performance share units (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_75A637EFF79CB13A26AD7736CB9E86F9_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_75A637EFF79CB13A26AD7736CB9E86F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_75A637EFF79CB13A26AD7736CB9E86F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_75A637EFF79CB13A26AD7736CB9E86F9" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_75A637EFF79CB13A26AD7736CB9E86F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E5B8AF4A617A9DB7DC307736CB9E8AAB_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E5B8AF4A617A9DB7DC307736CB9E8AAB" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares&#8211;diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E5B8AF4A617A9DB7DC307736CB9E8AAB_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E5B8AF4A617A9DB7DC307736CB9E8AAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E5B8AF4A617A9DB7DC307736CB9E8AAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E5B8AF4A617A9DB7DC307736CB9E8AAB" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E5B8AF4A617A9DB7DC307736CB9E8AAB" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_142917831E1ACD3A1CD27736CB9F0EC6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract_142917831E1ACD3A1CD27736CB9F0EC6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings/(loss) per common share attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_142917831E1ACD3A1CD27736CB9F0EC6_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract_142917831E1ACD3A1CD27736CB9F0EC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_142917831E1ACD3A1CD27736CB9F0EC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_142917831E1ACD3A1CD27736CB9F0EC6" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract_142917831E1ACD3A1CD27736CB9F0EC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_7C50A469CAD4BA1A7D347736CB9FAACA_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract_7C50A469CAD4BA1A7D347736CB9FAACA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per common share attributable to Cardinal Health, Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_7C50A469CAD4BA1A7D347736CB9FAACA_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract_7C50A469CAD4BA1A7D347736CB9FAACA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_7C50A469CAD4BA1A7D347736CB9FAACA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_7C50A469CAD4BA1A7D347736CB9FAACA" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract_7C50A469CAD4BA1A7D347736CB9FAACA" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasic_72AAF0776742605367307736CB9FE2AB_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_72AAF0776742605367307736CB9FE2AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_72AAF0776742605367307736CB9FE2AB_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_72AAF0776742605367307736CB9FE2AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_72AAF0776742605367307736CB9FE2AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_72AAF0776742605367307736CB9FE2AB" xlink:to="lab_us-gaap_EarningsPerShareBasic_72AAF0776742605367307736CB9FE2AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_D55E22FF127D1F8ACCA77736CB9FE372_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_D55E22FF127D1F8ACCA77736CB9FE372" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_D55E22FF127D1F8ACCA77736CB9FE372_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_D55E22FF127D1F8ACCA77736CB9FE372" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_D55E22FF127D1F8ACCA77736CB9FE372" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_D55E22FF127D1F8ACCA77736CB9FE372" xlink:to="lab_us-gaap_EarningsPerShareDiluted_D55E22FF127D1F8ACCA77736CB9FE372" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_EB53EF43BAC6A0A204BEDDA1874E2090_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_EB53EF43BAC6A0A204BEDDA1874E2090" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_EB53EF43BAC6A0A204BEDDA1874E2090_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_EB53EF43BAC6A0A204BEDDA1874E2090" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_EB53EF43BAC6A0A204BEDDA1874E2090" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_EB53EF43BAC6A0A204BEDDA1874E2090" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_EB53EF43BAC6A0A204BEDDA1874E2090" xlink:type="arc" />
    <link:label id="lab_us-gaap_UseOfEstimates_5774E2F19BEE6219EC8CDDA1874FAF89_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates_5774E2F19BEE6219EC8CDDA1874FAF89" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_5774E2F19BEE6219EC8CDDA1874FAF89_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates_5774E2F19BEE6219EC8CDDA1874FAF89" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_5774E2F19BEE6219EC8CDDA1874FAF89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_5774E2F19BEE6219EC8CDDA1874FAF89" xlink:to="lab_us-gaap_UseOfEstimates_5774E2F19BEE6219EC8CDDA1874FAF89" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_BD2F055D2D21D7C1C853DDA1874F52B9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_BD2F055D2D21D7C1C853DDA1874F52B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_BD2F055D2D21D7C1C853DDA1874F52B9_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_BD2F055D2D21D7C1C853DDA1874F52B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_BD2F055D2D21D7C1C853DDA1874F52B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_BD2F055D2D21D7C1C853DDA1874F52B9" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_BD2F055D2D21D7C1C853DDA1874F52B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_AEE055263865F0B6CEE4DDA1874F686E_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock_AEE055263865F0B6CEE4DDA1874F686E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_AEE055263865F0B6CEE4DDA1874F686E_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock_AEE055263865F0B6CEE4DDA1874F686E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_AEE055263865F0B6CEE4DDA1874F686E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock_AEE055263865F0B6CEE4DDA1874F686E" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock_AEE055263865F0B6CEE4DDA1874F686E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_62364E0488B8B6F07D3EDDA1874FC0A9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk_62364E0488B8B6F07D3EDDA1874FC0A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentrations of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_62364E0488B8B6F07D3EDDA1874FC0A9_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk_62364E0488B8B6F07D3EDDA1874FC0A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_62364E0488B8B6F07D3EDDA1874FC0A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk_62364E0488B8B6F07D3EDDA1874FC0A9" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk_62364E0488B8B6F07D3EDDA1874FC0A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_6F433AEEEA47E76A486DDDA18750CD2D_terseLabel_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_6F433AEEEA47E76A486DDDA18750CD2D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major Customers</link:label>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_6F433AEEEA47E76A486DDDA18750CD2D_label_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_6F433AEEEA47E76A486DDDA18750CD2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Customers, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_6F433AEEEA47E76A486DDDA18750CD2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_6F433AEEEA47E76A486DDDA18750CD2D" xlink:to="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_6F433AEEEA47E76A486DDDA18750CD2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_14678DCE50383D842248DDA18750FF14_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock_14678DCE50383D842248DDA18750FF14" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_14678DCE50383D842248DDA18750FF14_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock_14678DCE50383D842248DDA18750FF14" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_14678DCE50383D842248DDA18750FF14" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock_14678DCE50383D842248DDA18750FF14" xlink:to="lab_us-gaap_InventoryPolicyTextBlock_14678DCE50383D842248DDA18750FF14" xlink:type="arc" />
    <link:label id="lab_cah_CashDiscountsPolicyTextBlock_8BA3A49CE126825D6888DDA187509F52_terseLabel_en-US" xlink:label="lab_cah_CashDiscountsPolicyTextBlock_8BA3A49CE126825D6888DDA187509F52" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Discounts</link:label>
    <link:label id="lab_cah_CashDiscountsPolicyTextBlock_8BA3A49CE126825D6888DDA187509F52_label_en-US" xlink:label="lab_cah_CashDiscountsPolicyTextBlock_8BA3A49CE126825D6888DDA187509F52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Discounts [Policy Text Block]</link:label>
    <link:label id="lab_cah_CashDiscountsPolicyTextBlock_8BA3A49CE126825D6888DDA187509F52_documentation_en-US" xlink:label="lab_cah_CashDiscountsPolicyTextBlock_8BA3A49CE126825D6888DDA187509F52" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Discounts [Policy Text Block]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_CashDiscountsPolicyTextBlock" xlink:label="loc_cah_CashDiscountsPolicyTextBlock_8BA3A49CE126825D6888DDA187509F52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CashDiscountsPolicyTextBlock_8BA3A49CE126825D6888DDA187509F52" xlink:to="lab_cah_CashDiscountsPolicyTextBlock_8BA3A49CE126825D6888DDA187509F52" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0F59B88EF928803769DBDDA18750BB8A_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0F59B88EF928803769DBDDA18750BB8A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0F59B88EF928803769DBDDA18750BB8A_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0F59B88EF928803769DBDDA18750BB8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0F59B88EF928803769DBDDA18750BB8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0F59B88EF928803769DBDDA18750BB8A" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0F59B88EF928803769DBDDA18750BB8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_9DC6375CE8583BAB2455DDA18750AC9D_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_9DC6375CE8583BAB2455DDA18750AC9D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_9DC6375CE8583BAB2455DDA18750AC9D_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_9DC6375CE8583BAB2455DDA18750AC9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_9DC6375CE8583BAB2455DDA18750AC9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_9DC6375CE8583BAB2455DDA18750AC9D" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_9DC6375CE8583BAB2455DDA18750AC9D" xlink:type="arc" />
    <link:label id="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_831FAA570F6D4E701B7FDDA18751B472_terseLabel_en-US" xlink:label="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_831FAA570F6D4E701B7FDDA18751B472" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets Held for Sale, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_831FAA570F6D4E701B7FDDA18751B472_label_en-US" xlink:label="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_831FAA570F6D4E701B7FDDA18751B472" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets Held for Sale, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_831FAA570F6D4E701B7FDDA18751B472_documentation_en-US" xlink:label="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_831FAA570F6D4E701B7FDDA18751B472" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets Held for Sale, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:label="loc_cah_AssetsHeldforSalePolicyPolicyTextBlock_831FAA570F6D4E701B7FDDA18751B472" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AssetsHeldforSalePolicyPolicyTextBlock_831FAA570F6D4E701B7FDDA18751B472" xlink:to="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_831FAA570F6D4E701B7FDDA18751B472" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_04199747E6410ECF14D8DDA187511A71_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock_04199747E6410ECF14D8DDA187511A71" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_04199747E6410ECF14D8DDA187511A71_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock_04199747E6410ECF14D8DDA187511A71" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_04199747E6410ECF14D8DDA187511A71" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock_04199747E6410ECF14D8DDA187511A71" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock_04199747E6410ECF14D8DDA187511A71" xlink:type="arc" />
    <link:label id="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5867B236276DEC3D127ADDA187517C73_terseLabel_en-US" xlink:label="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5867B236276DEC3D127ADDA187517C73" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vendor Reserves</link:label>
    <link:label id="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5867B236276DEC3D127ADDA187517C73_label_en-US" xlink:label="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5867B236276DEC3D127ADDA187517C73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales, Vendor Reserves, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5867B236276DEC3D127ADDA187517C73_documentation_en-US" xlink:label="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5867B236276DEC3D127ADDA187517C73" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for allowances received from a vendor. The disclosure differentiates between those allowances that are recorded as a reduction in the price of the vendors' products or services (that is, the entity's inventory) and which ultimately will be recorded as a reduction in the entity's cost of sales and those that are not.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:label="loc_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5867B236276DEC3D127ADDA187517C73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5867B236276DEC3D127ADDA187517C73" xlink:to="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5867B236276DEC3D127ADDA187517C73" xlink:type="arc" />
    <link:label id="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_1DF3167D5532DD5492E9DDA18751ADAF_terseLabel_en-US" xlink:label="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_1DF3167D5532DD5492E9DDA18751ADAF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution Service Agreement and Other Vendor Fees</link:label>
    <link:label id="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_1DF3167D5532DD5492E9DDA18751ADAF_label_en-US" xlink:label="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_1DF3167D5532DD5492E9DDA18751ADAF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distribution Service Agreement And Other Vendor Fees [Policy Text Block]</link:label>
    <link:label id="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_1DF3167D5532DD5492E9DDA18751ADAF_documentation_en-US" xlink:label="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_1DF3167D5532DD5492E9DDA18751ADAF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Describes an entity's accounting policy for fees received from distribution service agreements and other fees received from vendors related to the purchase or distribution of the vendor's inventory. Such fees are recognized as a reduction of inventory when those fees have been earned and the entity is entitled to payment.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:label="loc_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_1DF3167D5532DD5492E9DDA18751ADAF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_1DF3167D5532DD5492E9DDA18751ADAF" xlink:to="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_1DF3167D5532DD5492E9DDA18751ADAF" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_DD36B48405AB8D51CEDBDDA18752545F_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_DD36B48405AB8D51CEDBDDA18752545F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_DD36B48405AB8D51CEDBDDA18752545F_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_DD36B48405AB8D51CEDBDDA18752545F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_DD36B48405AB8D51CEDBDDA18752545F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_DD36B48405AB8D51CEDBDDA18752545F" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_DD36B48405AB8D51CEDBDDA18752545F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_B89DD0AC72F11578C503DDA18752BE0D_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_B89DD0AC72F11578C503DDA18752BE0D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_B89DD0AC72F11578C503DDA18752BE0D_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_B89DD0AC72F11578C503DDA18752BE0D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_B89DD0AC72F11578C503DDA18752BE0D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock_B89DD0AC72F11578C503DDA18752BE0D" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock_B89DD0AC72F11578C503DDA18752BE0D" xlink:type="arc" />
    <link:label id="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_A1016052F2BB6BB2D342DDA18752C4AB_terseLabel_en-US" xlink:label="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_A1016052F2BB6BB2D342DDA18752C4AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_A1016052F2BB6BB2D342DDA18752C4AB_label_en-US" xlink:label="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_A1016052F2BB6BB2D342DDA18752C4AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_A1016052F2BB6BB2D342DDA18752C4AB_documentation_en-US" xlink:label="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_A1016052F2BB6BB2D342DDA18752C4AB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:label="loc_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_A1016052F2BB6BB2D342DDA18752C4AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_A1016052F2BB6BB2D342DDA18752C4AB" xlink:to="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_A1016052F2BB6BB2D342DDA18752C4AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_60339C8FCD06F51EF1FCDDA187521551_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_60339C8FCD06F51EF1FCDDA187521551" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interests and Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_60339C8FCD06F51EF1FCDDA187521551_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_60339C8FCD06F51EF1FCDDA187521551" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_60339C8FCD06F51EF1FCDDA187521551" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock_60339C8FCD06F51EF1FCDDA187521551" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock_60339C8FCD06F51EF1FCDDA187521551" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7FCF891D2524F8664EABDDA18752025D_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7FCF891D2524F8664EABDDA18752025D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7FCF891D2524F8664EABDDA18752025D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7FCF891D2524F8664EABDDA18752025D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7FCF891D2524F8664EABDDA18752025D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7FCF891D2524F8664EABDDA18752025D" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7FCF891D2524F8664EABDDA18752025D" xlink:type="arc" />
    <link:label id="lab_cah_DividendsPolicyPolicyTextBlock_E4803F6DCFD21F7CEC0ADDA18752B7A3_terseLabel_en-US" xlink:label="lab_cah_DividendsPolicyPolicyTextBlock_E4803F6DCFD21F7CEC0ADDA18752B7A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_DividendsPolicyPolicyTextBlock_E4803F6DCFD21F7CEC0ADDA18752B7A3_label_en-US" xlink:label="lab_cah_DividendsPolicyPolicyTextBlock_E4803F6DCFD21F7CEC0ADDA18752B7A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_DividendsPolicyPolicyTextBlock_E4803F6DCFD21F7CEC0ADDA18752B7A3_documentation_en-US" xlink:label="lab_cah_DividendsPolicyPolicyTextBlock_E4803F6DCFD21F7CEC0ADDA18752B7A3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dividends, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_DividendsPolicyPolicyTextBlock" xlink:label="loc_cah_DividendsPolicyPolicyTextBlock_E4803F6DCFD21F7CEC0ADDA18752B7A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DividendsPolicyPolicyTextBlock_E4803F6DCFD21F7CEC0ADDA18752B7A3" xlink:to="lab_cah_DividendsPolicyPolicyTextBlock_E4803F6DCFD21F7CEC0ADDA18752B7A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_B0CE098229AD1DDC92A7DDA187532143_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock_B0CE098229AD1DDC92A7DDA187532143" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_B0CE098229AD1DDC92A7DDA187532143_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock_B0CE098229AD1DDC92A7DDA187532143" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_B0CE098229AD1DDC92A7DDA187532143" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock_B0CE098229AD1DDC92A7DDA187532143" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock_B0CE098229AD1DDC92A7DDA187532143" xlink:type="arc" />
    <link:label id="lab_cah_SalesreturnsPolicyTextBlock_E341C9E1C233D03C13AADDA187533B41_terseLabel_en-US" xlink:label="lab_cah_SalesreturnsPolicyTextBlock_E341C9E1C233D03C13AADDA187533B41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales Returns and Allowances</link:label>
    <link:label id="lab_cah_SalesreturnsPolicyTextBlock_E341C9E1C233D03C13AADDA187533B41_label_en-US" xlink:label="lab_cah_SalesreturnsPolicyTextBlock_E341C9E1C233D03C13AADDA187533B41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">sales returns [Policy Text Block]</link:label>
    <link:label id="lab_cah_SalesreturnsPolicyTextBlock_E341C9E1C233D03C13AADDA187533B41_documentation_en-US" xlink:label="lab_cah_SalesreturnsPolicyTextBlock_E341C9E1C233D03C13AADDA187533B41" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">sales returns [Policy Text Block]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_SalesreturnsPolicyTextBlock" xlink:label="loc_cah_SalesreturnsPolicyTextBlock_E341C9E1C233D03C13AADDA187533B41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SalesreturnsPolicyTextBlock_E341C9E1C233D03C13AADDA187533B41" xlink:to="lab_cah_SalesreturnsPolicyTextBlock_E341C9E1C233D03C13AADDA187533B41" xlink:type="arc" />
    <link:label id="lab_cah_ShippingandHandlingCostsPolicyTextBlock_7E098F802CE8A64BB9BDDDA18753B147_terseLabel_en-US" xlink:label="lab_cah_ShippingandHandlingCostsPolicyTextBlock_7E098F802CE8A64BB9BDDDA18753B147" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shipping and Handling</link:label>
    <link:label id="lab_cah_ShippingandHandlingCostsPolicyTextBlock_7E098F802CE8A64BB9BDDDA18753B147_label_en-US" xlink:label="lab_cah_ShippingandHandlingCostsPolicyTextBlock_7E098F802CE8A64BB9BDDDA18753B147" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ShippingandHandlingCosts [Policy Text Block]</link:label>
    <link:label id="lab_cah_ShippingandHandlingCostsPolicyTextBlock_7E098F802CE8A64BB9BDDDA18753B147_documentation_en-US" xlink:label="lab_cah_ShippingandHandlingCostsPolicyTextBlock_7E098F802CE8A64BB9BDDDA18753B147" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ShippingandHandlingCosts [Policy Text Block]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ShippingandHandlingCostsPolicyTextBlock" xlink:label="loc_cah_ShippingandHandlingCostsPolicyTextBlock_7E098F802CE8A64BB9BDDDA18753B147" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ShippingandHandlingCostsPolicyTextBlock_7E098F802CE8A64BB9BDDDA18753B147" xlink:to="lab_cah_ShippingandHandlingCostsPolicyTextBlock_7E098F802CE8A64BB9BDDDA18753B147" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0E3B0ED68E6C6A21E9BBDDA18753D7C0_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0E3B0ED68E6C6A21E9BBDDA18753D7C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0E3B0ED68E6C6A21E9BBDDA18753D7C0_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0E3B0ED68E6C6A21E9BBDDA18753D7C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0E3B0ED68E6C6A21E9BBDDA18753D7C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0E3B0ED68E6C6A21E9BBDDA18753D7C0" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0E3B0ED68E6C6A21E9BBDDA18753D7C0" xlink:type="arc" />
    <link:label id="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_7A018B16891B16F4D149DDA187539848_terseLabel_en-US" xlink:label="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_7A018B16891B16F4D149DDA187539848" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization and Other Acquisition-Related Costs</link:label>
    <link:label id="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_7A018B16891B16F4D149DDA187539848_label_en-US" xlink:label="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_7A018B16891B16F4D149DDA187539848" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization and Other Acquisition Related Costs Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_7A018B16891B16F4D149DDA187539848_documentation_en-US" xlink:label="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_7A018B16891B16F4D149DDA187539848" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for the costs incurred during and relating to an acquisition. These costs specifically include transaction and integration costs; changes in fair value of contingent consideration obligations and amortization of acquisition-related intangible assets, and are recorded within amortization and other acquisition-related costs.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:label="loc_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_7A018B16891B16F4D149DDA187539848" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_7A018B16891B16F4D149DDA187539848" xlink:to="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_7A018B16891B16F4D149DDA187539848" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_F0A18ECF74F374652FFBDDA187538796_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_F0A18ECF74F374652FFBDDA187538796" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Translation of Foreign Currencies</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_F0A18ECF74F374652FFBDDA187538796_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_F0A18ECF74F374652FFBDDA187538796" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_F0A18ECF74F374652FFBDDA187538796" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_F0A18ECF74F374652FFBDDA187538796" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_F0A18ECF74F374652FFBDDA187538796" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_0E8FB532E1648C56298DDDA187530ABA_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_0E8FB532E1648C56298DDDA187530ABA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate, Currency and Commodity Risk</link:label>
    <link:label id="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_0E8FB532E1648C56298DDDA187530ABA_label_en-US" xlink:label="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_0E8FB532E1648C56298DDDA187530ABA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Methods of Accounting, Hedging Derivatives [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:label="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_0E8FB532E1648C56298DDDA187530ABA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_0E8FB532E1648C56298DDDA187530ABA" xlink:to="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_0E8FB532E1648C56298DDDA187530ABA" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4CE8C40A395B83B28AEBDDA187541A4C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4CE8C40A395B83B28AEBDDA187541A4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4CE8C40A395B83B28AEBDDA187541A4C_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4CE8C40A395B83B28AEBDDA187541A4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4CE8C40A395B83B28AEBDDA187541A4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4CE8C40A395B83B28AEBDDA187541A4C" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4CE8C40A395B83B28AEBDDA187541A4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_47BA20482B5848F0F275DDA187548A3E_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_47BA20482B5848F0F275DDA187548A3E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Financial Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_47BA20482B5848F0F275DDA187548A3E_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_47BA20482B5848F0F275DDA187548A3E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_47BA20482B5848F0F275DDA187548A3E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_47BA20482B5848F0F275DDA187548A3E" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_47BA20482B5848F0F275DDA187548A3E" xlink:type="arc" />
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_D0CD7F2D5884639B99D2DDA187543E5B_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_D0CD7F2D5884639B99D2DDA187543E5B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_D0CD7F2D5884639B99D2DDA187543E5B_label_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_D0CD7F2D5884639B99D2DDA187543E5B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_D0CD7F2D5884639B99D2DDA187543E5B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_D0CD7F2D5884639B99D2DDA187543E5B" xlink:to="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_D0CD7F2D5884639B99D2DDA187543E5B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:to="lab_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_367C6B342013EBA36EB6064EB35830A6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember_367C6B342013EBA36EB6064EB35830A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee- Related Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_367C6B342013EBA36EB6064EB35830A6_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember_367C6B342013EBA36EB6064EB35830A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_367C6B342013EBA36EB6064EB35830A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember_367C6B342013EBA36EB6064EB35830A6" xlink:to="lab_us-gaap_EmployeeSeveranceMember_367C6B342013EBA36EB6064EB35830A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FacilityClosingMember_076A494B3AC9F72537C5064EB359BBA4_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember_076A494B3AC9F72537C5064EB359BBA4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_076A494B3AC9F72537C5064EB359BBA4_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember_076A494B3AC9F72537C5064EB359BBA4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_076A494B3AC9F72537C5064EB359BBA4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember_076A494B3AC9F72537C5064EB359BBA4" xlink:to="lab_us-gaap_FacilityClosingMember_076A494B3AC9F72537C5064EB359BBA4" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:to="lab_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_A11FAAB7CEF17708668C064EB359797C_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_A11FAAB7CEF17708668C064EB359797C" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_A11FAAB7CEF17708668C064EB359797C_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve_A11FAAB7CEF17708668C064EB359797C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_A11FAAB7CEF17708668C064EB359797C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_A11FAAB7CEF17708668C064EB359797C" xlink:to="lab_us-gaap_RestructuringReserve_A11FAAB7CEF17708668C064EB359797C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCosts_95A2B16C83C98DE173E4064EB35AAC35_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts_95A2B16C83C98DE173E4064EB35AAC35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_95A2B16C83C98DE173E4064EB35AAC35_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts_95A2B16C83C98DE173E4064EB35AAC35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_95A2B16C83C98DE173E4064EB35AAC35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts_95A2B16C83C98DE173E4064EB35AAC35" xlink:to="lab_us-gaap_RestructuringCosts_95A2B16C83C98DE173E4064EB35AAC35" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRestructuring_73AD08C6D4D9CBB5744C064EB35A2363_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_73AD08C6D4D9CBB5744C064EB35A2363" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments and other adjustments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_73AD08C6D4D9CBB5744C064EB35A2363_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_73AD08C6D4D9CBB5744C064EB35A2363" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_73AD08C6D4D9CBB5744C064EB35A2363" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring_73AD08C6D4D9CBB5744C064EB35A2363" xlink:to="lab_us-gaap_PaymentsForRestructuring_73AD08C6D4D9CBB5744C064EB35A2363" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_C106418A696A672B8FE2064EB35AFBD9_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_C106418A696A672B8FE2064EB35AFBD9" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_C106418A696A672B8FE2064EB35AFBD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_C106418A696A672B8FE2064EB35AFBD9" xlink:to="lab_us-gaap_RestructuringReserve_C106418A696A672B8FE2064EB35AFBD9" xlink:type="arc" />
    <link:label id="lab_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E_terseLabel_en-US" xlink:label="lab_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">goods and services sold [Table]</link:label>
    <link:label id="lab_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E_label_en-US" xlink:label="lab_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">goods and services sold [Table]</link:label>
    <link:label id="lab_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E_documentation_en-US" xlink:label="lab_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">goods and services sold [Table]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodsandservicessoldTable" xlink:label="loc_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:to="lab_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:type="arc" />
    <link:label id="lab_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811" xlink:to="lab_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811" xlink:type="arc" />
    <link:label id="lab_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B" xlink:to="lab_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_BADD039969B7627346AF064EB38BEA05_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember_BADD039969B7627346AF064EB38BEA05" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_BADD039969B7627346AF064EB38BEA05_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember_BADD039969B7627346AF064EB38BEA05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaap_ShippingAndHandlingMember_BADD039969B7627346AF064EB38BEA05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember_BADD039969B7627346AF064EB38BEA05" xlink:to="lab_us-gaap_ShippingAndHandlingMember_BADD039969B7627346AF064EB38BEA05" xlink:type="arc" />
    <link:label id="lab_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3_terseLabel_en-US" xlink:label="lab_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">goods and services sold [Line Items]</link:label>
    <link:label id="lab_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3_label_en-US" xlink:label="lab_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">goods and services sold [Line Items]</link:label>
    <link:label id="lab_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3_documentation_en-US" xlink:label="lab_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Line Items] for goods and services sold [Table]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodsandservicessoldLineItems" xlink:label="loc_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3" xlink:to="lab_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_9C13A764E06669B1CA6DCA8BC0A2E80D_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_9C13A764E06669B1CA6DCA8BC0A2E80D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_9C13A764E06669B1CA6DCA8BC0A2E80D_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_9C13A764E06669B1CA6DCA8BC0A2E80D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_9C13A764E06669B1CA6DCA8BC0A2E80D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_9C13A764E06669B1CA6DCA8BC0A2E80D" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_9C13A764E06669B1CA6DCA8BC0A2E80D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_6C463B092ECBFFB5B84FCA8A24074841_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_6C463B092ECBFFB5B84FCA8A24074841" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_6C463B092ECBFFB5B84FCA8A24074841_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_6C463B092ECBFFB5B84FCA8A24074841" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_6C463B092ECBFFB5B84FCA8A24074841" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_6C463B092ECBFFB5B84FCA8A24074841" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_6C463B092ECBFFB5B84FCA8A24074841" xlink:type="arc" />
    <link:label id="lab_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915_terseLabel_en-US" xlink:label="lab_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount Rate, fair value inputs</link:label>
    <link:label id="lab_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915_label_en-US" xlink:label="lab_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discount Rate, fair value inputs</link:label>
    <link:label id="lab_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915_documentation_en-US" xlink:label="lab_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discount Rate, fair value inputs</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_DiscountRatefairvalueinputs" xlink:label="loc_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915" xlink:to="lab_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_1203A2301D8D52CA13B6064EB2B58D2E_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_1203A2301D8D52CA13B6064EB2B58D2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_1203A2301D8D52CA13B6064EB2B58D2E_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_1203A2301D8D52CA13B6064EB2B58D2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_1203A2301D8D52CA13B6064EB2B58D2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_1203A2301D8D52CA13B6064EB2B58D2E" xlink:to="lab_dei_DocumentFiscalYearFocus_1203A2301D8D52CA13B6064EB2B58D2E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1FA796F3960EB547052D064EB2B50358_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1FA796F3960EB547052D064EB2B50358" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1FA796F3960EB547052D064EB2B50358_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1FA796F3960EB547052D064EB2B50358" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1FA796F3960EB547052D064EB2B50358" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1FA796F3960EB547052D064EB2B50358" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1FA796F3960EB547052D064EB2B50358" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_33A38BDD379A3BF29051064EB2B5975F_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_33A38BDD379A3BF29051064EB2B5975F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-U.S. operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_33A38BDD379A3BF29051064EB2B5975F_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_33A38BDD379A3BF29051064EB2B5975F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_33A38BDD379A3BF29051064EB2B5975F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_33A38BDD379A3BF29051064EB2B5975F" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_33A38BDD379A3BF29051064EB2B5975F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_06B868EB1C62B7452F98064EB2B5A907_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_06B868EB1C62B7452F98064EB2B5A907" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Earnings/(loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_06B868EB1C62B7452F98064EB2B5A907_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_06B868EB1C62B7452F98064EB2B5A907" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_06B868EB1C62B7452F98064EB2B5A907" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_06B868EB1C62B7452F98064EB2B5A907" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_06B868EB1C62B7452F98064EB2B5A907" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_29D53F01A8CFDB78CABE064EB0E6FD5A_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_29D53F01A8CFDB78CABE064EB0E6FD5A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share Attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_29D53F01A8CFDB78CABE064EB0E6FD5A_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_29D53F01A8CFDB78CABE064EB0E6FD5A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_29D53F01A8CFDB78CABE064EB0E6FD5A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_29D53F01A8CFDB78CABE064EB0E6FD5A" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_29D53F01A8CFDB78CABE064EB0E6FD5A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_9BF778FD944CB540AE7A064EB360EC66_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_9BF778FD944CB540AE7A064EB360EC66" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_9BF778FD944CB540AE7A064EB360EC66_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_9BF778FD944CB540AE7A064EB360EC66" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_9BF778FD944CB540AE7A064EB360EC66" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_9BF778FD944CB540AE7A064EB360EC66" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_9BF778FD944CB540AE7A064EB360EC66" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_C7CC23DDBAB9CB07AD7B064EB3608400_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_C7CC23DDBAB9CB07AD7B064EB3608400" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_C7CC23DDBAB9CB07AD7B064EB3608400_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_C7CC23DDBAB9CB07AD7B064EB3608400" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_C7CC23DDBAB9CB07AD7B064EB3608400" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_C7CC23DDBAB9CB07AD7B064EB3608400" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_C7CC23DDBAB9CB07AD7B064EB3608400" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_8881FAC34A4ED831BA62B48EFB97754E_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_8881FAC34A4ED831BA62B48EFB97754E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8881FAC34A4ED831BA62B48EFB97754E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8881FAC34A4ED831BA62B48EFB97754E" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_8881FAC34A4ED831BA62B48EFB97754E" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D" xlink:to="lab_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB" xlink:to="lab_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB" xlink:type="arc" />
    <link:label id="lab_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552_terseLabel_en-US" xlink:label="lab_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract Termination [Axis]</link:label>
    <link:label id="lab_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552_label_en-US" xlink:label="lab_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Termination [Axis]</link:label>
    <link:label id="lab_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552_documentation_en-US" xlink:label="lab_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract Termination [Axis]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ContractTerminationAxis" xlink:label="loc_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:to="lab_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:type="arc" />
    <link:label id="lab_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D_terseLabel_en-US" xlink:label="lab_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract Termination [Domain]</link:label>
    <link:label id="lab_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D_label_en-US" xlink:label="lab_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Termination [Domain]</link:label>
    <link:label id="lab_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D_documentation_en-US" xlink:label="lab_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Contract Termination [Axis]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D" xlink:to="lab_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D" xlink:type="arc" />
    <link:label id="lab_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E_terseLabel_en-US" xlink:label="lab_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distributor Contract [Member]</link:label>
    <link:label id="lab_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E_label_en-US" xlink:label="lab_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distributor Contract [Member]</link:label>
    <link:label id="lab_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E_documentation_en-US" xlink:label="lab_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Distributor Contract [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_DistributorContractMember" xlink:label="loc_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E" xlink:to="lab_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCosts_452D6E34CF1ED220C6DEB48EFB9ADF21_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts_452D6E34CF1ED220C6DEB48EFB9ADF21" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_452D6E34CF1ED220C6DEB48EFB9ADF21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts_452D6E34CF1ED220C6DEB48EFB9ADF21" xlink:to="lab_us-gaap_RestructuringCosts_452D6E34CF1ED220C6DEB48EFB9ADF21" xlink:type="arc" />
    <link:label id="lab_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380_terseLabel_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380_label_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380_documentation_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380" xlink:to="lab_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_7B4F19EA7F1631BA5BF5064EB3A741C0_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_7B4F19EA7F1631BA5BF5064EB3A741C0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Useful life of property and equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7B4F19EA7F1631BA5BF5064EB3A741C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7B4F19EA7F1631BA5BF5064EB3A741C0" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_7B4F19EA7F1631BA5BF5064EB3A741C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_Depreciation_FCD3F566815411FCF720064EB3A7835F_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation_FCD3F566815411FCF720064EB3A7835F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_FCD3F566815411FCF720064EB3A7835F_label_en-US" xlink:label="lab_us-gaap_Depreciation_FCD3F566815411FCF720064EB3A7835F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_FCD3F566815411FCF720064EB3A7835F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation_FCD3F566815411FCF720064EB3A7835F" xlink:to="lab_us-gaap_Depreciation_FCD3F566815411FCF720064EB3A7835F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_93C2DDCB4E21BDC6821D064EB3A7BAD5_verboseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_93C2DDCB4E21BDC6821D064EB3A7BAD5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest rate on long-term projects (approximates weighted-average on long-term obligations)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_93C2DDCB4E21BDC6821D064EB3A7BAD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_93C2DDCB4E21BDC6821D064EB3A7BAD5" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_93C2DDCB4E21BDC6821D064EB3A7BAD5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_29A64E1798EA2B0665AE064EB3B9DD69_verboseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_29A64E1798EA2B0665AE064EB3B9DD69" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_29A64E1798EA2B0665AE064EB3B9DD69" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_29A64E1798EA2B0665AE064EB3B9DD69" xlink:to="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_29A64E1798EA2B0665AE064EB3B9DD69" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:type="arc" />
    <link:label id="lab_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704_terseLabel_en-US" xlink:label="lab_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable financing agreement term</link:label>
    <link:label id="lab_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704_label_en-US" xlink:label="lab_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable Financing Agreement Term</link:label>
    <link:label id="lab_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704_documentation_en-US" xlink:label="lab_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Receivable Financing Agreement Term</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ReceivableFinancingAgreementTerm" xlink:label="loc_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704" xlink:to="lab_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704" xlink:type="arc" />
    <link:label id="lab_us-gaap_NotesReceivableNet_E494DFB69F6E5233A534064EB3BB5405_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet_E494DFB69F6E5233A534064EB3BB5405" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance notes and related accrued interest, net, total</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_E494DFB69F6E5233A534064EB3BB5405_label_en-US" xlink:label="lab_us-gaap_NotesReceivableNet_E494DFB69F6E5233A534064EB3BB5405" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableNet" xlink:label="loc_us-gaap_NotesReceivableNet_E494DFB69F6E5233A534064EB3BB5405" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableNet_E494DFB69F6E5233A534064EB3BB5405" xlink:to="lab_us-gaap_NotesReceivableNet_E494DFB69F6E5233A534064EB3BB5405" xlink:type="arc" />
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_68B4563223042ADD5D53064EB3BBD944_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent_68B4563223042ADD5D53064EB3BBD944" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance notes and related accrued interest, net, current</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_68B4563223042ADD5D53064EB3BBD944_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent_68B4563223042ADD5D53064EB3BBD944" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_68B4563223042ADD5D53064EB3BBD944" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent_68B4563223042ADD5D53064EB3BBD944" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetCurrent_68B4563223042ADD5D53064EB3BBD944" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_B2054D3E244F17FE1A9E064EB06F0B63_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_B2054D3E244F17FE1A9E064EB06F0B63" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total depreciation and amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_B2054D3E244F17FE1A9E064EB06F0B63" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_B2054D3E244F17FE1A9E064EB06F0B63" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_B2054D3E244F17FE1A9E064EB06F0B63" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_E273D2CBE7D160F61AEC064EB06FCBD9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_E273D2CBE7D160F61AEC064EB06FCBD9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total additions to property and equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_E273D2CBE7D160F61AEC064EB06FCBD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_E273D2CBE7D160F61AEC064EB06FCBD9" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_E273D2CBE7D160F61AEC064EB06FCBD9" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_81930D56F9AAA2AE13B6B5681FF913D2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_81930D56F9AAA2AE13B6B5681FF913D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain/(loss) included in AOCI for derivative instruments designated as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_81930D56F9AAA2AE13B6B5681FF913D2_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_81930D56F9AAA2AE13B6B5681FF913D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_81930D56F9AAA2AE13B6B5681FF913D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_81930D56F9AAA2AE13B6B5681FF913D2" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_81930D56F9AAA2AE13B6B5681FF913D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34" xlink:to="lab_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819" xlink:to="lab_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7C6AFF8514B3E5C9F119DDA1B14DD1A3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7C6AFF8514B3E5C9F119DDA1B14DD1A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7C6AFF8514B3E5C9F119DDA1B14DD1A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7C6AFF8514B3E5C9F119DDA1B14DD1A3" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7C6AFF8514B3E5C9F119DDA1B14DD1A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_54DE0F981FF44CC43388DDA1B14DA5F0_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent_54DE0F981FF44CC43388DDA1B14DA5F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_54DE0F981FF44CC43388DDA1B14DA5F0_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent_54DE0F981FF44CC43388DDA1B14DA5F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_54DE0F981FF44CC43388DDA1B14DA5F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent_54DE0F981FF44CC43388DDA1B14DA5F0" xlink:to="lab_us-gaap_ReceivablesNetCurrent_54DE0F981FF44CC43388DDA1B14DA5F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_8D4374F9FDDA481A0005DDA1B14E33DC_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_8D4374F9FDDA481A0005DDA1B14E33DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_8D4374F9FDDA481A0005DDA1B14E33DC_label_en-US" xlink:label="lab_us-gaap_InventoryNet_8D4374F9FDDA481A0005DDA1B14E33DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_8D4374F9FDDA481A0005DDA1B14E33DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_8D4374F9FDDA481A0005DDA1B14E33DC" xlink:to="lab_us-gaap_InventoryNet_8D4374F9FDDA481A0005DDA1B14E33DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsCurrent_2EA5E843C669CF0F2F44DDA1B14EE57E_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_2EA5E843C669CF0F2F44DDA1B14EE57E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_2EA5E843C669CF0F2F44DDA1B14EE57E_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_2EA5E843C669CF0F2F44DDA1B14EE57E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_2EA5E843C669CF0F2F44DDA1B14EE57E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent_2EA5E843C669CF0F2F44DDA1B14EE57E" xlink:to="lab_us-gaap_OtherAssetsCurrent_2EA5E843C669CF0F2F44DDA1B14EE57E" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_E1824EB36274E31C46DEDDA1B14E896D_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_E1824EB36274E31C46DEDDA1B14E896D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_E1824EB36274E31C46DEDDA1B14E896D_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_E1824EB36274E31C46DEDDA1B14E896D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_E1824EB36274E31C46DEDDA1B14E896D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_E1824EB36274E31C46DEDDA1B14E896D" xlink:to="lab_us-gaap_AssetsCurrent_E1824EB36274E31C46DEDDA1B14E896D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_F0ECA4CDAE6706062BB4DDA1B14E42FE_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_F0ECA4CDAE6706062BB4DDA1B14E42FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and other intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_F0ECA4CDAE6706062BB4DDA1B14E42FE_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_F0ECA4CDAE6706062BB4DDA1B14E42FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_F0ECA4CDAE6706062BB4DDA1B14E42FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_F0ECA4CDAE6706062BB4DDA1B14E42FE" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_F0ECA4CDAE6706062BB4DDA1B14E42FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_305C5012468D842940BDDDA1B14F2833_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_305C5012468D842940BDDDA1B14F2833" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_305C5012468D842940BDDDA1B14F2833_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_305C5012468D842940BDDDA1B14F2833" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_305C5012468D842940BDDDA1B14F2833" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_305C5012468D842940BDDDA1B14F2833" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_305C5012468D842940BDDDA1B14F2833" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_990F71900491ADC40353DDA1B14FECB0_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_990F71900491ADC40353DDA1B14FECB0" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_990F71900491ADC40353DDA1B14FECB0_label_en-US" xlink:label="lab_us-gaap_Assets_990F71900491ADC40353DDA1B14FECB0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_990F71900491ADC40353DDA1B14FECB0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_990F71900491ADC40353DDA1B14FECB0" xlink:to="lab_us-gaap_Assets_990F71900491ADC40353DDA1B14FECB0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_26151C1412A32BC03F1FDDA1B151E609_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_26151C1412A32BC03F1FDDA1B151E609" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of long-term obligations and other short-term borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_26151C1412A32BC03F1FDDA1B151E609_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_26151C1412A32BC03F1FDDA1B151E609" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_26151C1412A32BC03F1FDDA1B151E609" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_26151C1412A32BC03F1FDDA1B151E609" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_26151C1412A32BC03F1FDDA1B151E609" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4571A9485109560CEE72DDA1B1516D44_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4571A9485109560CEE72DDA1B1516D44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4571A9485109560CEE72DDA1B1516D44_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4571A9485109560CEE72DDA1B1516D44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4571A9485109560CEE72DDA1B1516D44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4571A9485109560CEE72DDA1B1516D44" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4571A9485109560CEE72DDA1B1516D44" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_CB6B79CE20576BBA13A8DDA1B1519893_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_CB6B79CE20576BBA13A8DDA1B1519893" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_CB6B79CE20576BBA13A8DDA1B1519893_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_CB6B79CE20576BBA13A8DDA1B1519893" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_CB6B79CE20576BBA13A8DDA1B1519893" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_CB6B79CE20576BBA13A8DDA1B1519893" xlink:to="lab_us-gaap_LiabilitiesCurrent_CB6B79CE20576BBA13A8DDA1B1519893" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_3058F02A9956BDF16DF7DDA1B151DE16_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_3058F02A9956BDF16DF7DDA1B151DE16" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term obligations, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_3058F02A9956BDF16DF7DDA1B151DE16_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_3058F02A9956BDF16DF7DDA1B151DE16" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_3058F02A9956BDF16DF7DDA1B151DE16" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_3058F02A9956BDF16DF7DDA1B151DE16" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_3058F02A9956BDF16DF7DDA1B151DE16" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_804EA0990000473440BADDA1B1512268_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_804EA0990000473440BADDA1B1512268" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes and other liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_804EA0990000473440BADDA1B1512268_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_804EA0990000473440BADDA1B1512268" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax and Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_804EA0990000473440BADDA1B1512268" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_804EA0990000473440BADDA1B1512268" xlink:to="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_804EA0990000473440BADDA1B1512268" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:to="lab_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_41AE489696C3A7BF0B47DDA1B1518342_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_41AE489696C3A7BF0B47DDA1B1518342" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, without par value:</link:label>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_41AE489696C3A7BF0B47DDA1B1518342_label_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_41AE489696C3A7BF0B47DDA1B1518342" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_41AE489696C3A7BF0B47DDA1B1518342" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_41AE489696C3A7BF0B47DDA1B1518342" xlink:to="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_41AE489696C3A7BF0B47DDA1B1518342" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockValue_2383A25C5E9F4EE14DB7DDA1B1519F25_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue_2383A25C5E9F4EE14DB7DDA1B1519F25" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized&#8212;500 thousand shares, Issued&#8212;none</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_2383A25C5E9F4EE14DB7DDA1B1519F25_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue_2383A25C5E9F4EE14DB7DDA1B1519F25" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_2383A25C5E9F4EE14DB7DDA1B1519F25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue_2383A25C5E9F4EE14DB7DDA1B1519F25" xlink:to="lab_us-gaap_PreferredStockValue_2383A25C5E9F4EE14DB7DDA1B1519F25" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_7DD2CFDA7C96C888C6D3DDA1B151AFA3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_7DD2CFDA7C96C888C6D3DDA1B151AFA3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares, without par value:</link:label>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_7DD2CFDA7C96C888C6D3DDA1B151AFA3_label_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_7DD2CFDA7C96C888C6D3DDA1B151AFA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_7DD2CFDA7C96C888C6D3DDA1B151AFA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_7DD2CFDA7C96C888C6D3DDA1B151AFA3" xlink:to="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_7DD2CFDA7C96C888C6D3DDA1B151AFA3" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValue_C589590279FB79C741FFDDA1B1529CA6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue_C589590279FB79C741FFDDA1B1529CA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized&#8212;755 million shares, Issued&#8212;327 million shares at June 30, 2020 and 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_C589590279FB79C741FFDDA1B1529CA6_label_en-US" xlink:label="lab_us-gaap_CommonStockValue_C589590279FB79C741FFDDA1B1529CA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_C589590279FB79C741FFDDA1B1529CA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_C589590279FB79C741FFDDA1B1529CA6" xlink:to="lab_us-gaap_CommonStockValue_C589590279FB79C741FFDDA1B1529CA6" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3E0F5EE17860B0F3976FDDA1B1524E2C_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3E0F5EE17860B0F3976FDDA1B1524E2C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3E0F5EE17860B0F3976FDDA1B1524E2C_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3E0F5EE17860B0F3976FDDA1B1524E2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3E0F5EE17860B0F3976FDDA1B1524E2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3E0F5EE17860B0F3976FDDA1B1524E2C" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3E0F5EE17860B0F3976FDDA1B1524E2C" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_3D140956AC52D6DB6567DDA1B152401E_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_3D140956AC52D6DB6567DDA1B152401E" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Common shares in treasury, at cost: 34 million shares and 28 million shares at June 30, 2020 and 2019, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_3D140956AC52D6DB6567DDA1B152401E_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_3D140956AC52D6DB6567DDA1B152401E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_3D140956AC52D6DB6567DDA1B152401E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_3D140956AC52D6DB6567DDA1B152401E" xlink:to="lab_us-gaap_TreasuryStockValue_3D140956AC52D6DB6567DDA1B152401E" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4EAA541681FCCE8D7866DDA1B1520B1C_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4EAA541681FCCE8D7866DDA1B1520B1C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4EAA541681FCCE8D7866DDA1B1520B1C_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4EAA541681FCCE8D7866DDA1B1520B1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4EAA541681FCCE8D7866DDA1B1520B1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4EAA541681FCCE8D7866DDA1B1520B1C" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4EAA541681FCCE8D7866DDA1B1520B1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_6BAF34F08D59F1926775DDA1B1529C94_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_6BAF34F08D59F1926775DDA1B1529C94" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Cardinal Health, Inc. shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_6BAF34F08D59F1926775DDA1B1529C94_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity_6BAF34F08D59F1926775DDA1B1529C94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_6BAF34F08D59F1926775DDA1B1529C94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_6BAF34F08D59F1926775DDA1B1529C94" xlink:to="lab_us-gaap_StockholdersEquity_6BAF34F08D59F1926775DDA1B1529C94" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterest_E746029CF90BE2703139DDA1B153E773_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest_E746029CF90BE2703139DDA1B153E773" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_E746029CF90BE2703139DDA1B153E773_label_en-US" xlink:label="lab_us-gaap_MinorityInterest_E746029CF90BE2703139DDA1B153E773" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_E746029CF90BE2703139DDA1B153E773" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest_E746029CF90BE2703139DDA1B153E773" xlink:to="lab_us-gaap_MinorityInterest_E746029CF90BE2703139DDA1B153E773" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_96907104661768C07984DDA1B1530AE3_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_96907104661768C07984DDA1B1530AE3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_96907104661768C07984DDA1B1530AE3_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_96907104661768C07984DDA1B1530AE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_96907104661768C07984DDA1B1530AE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_96907104661768C07984DDA1B1530AE3" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_96907104661768C07984DDA1B1530AE3" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_FE1099F94BBFE47B4159DDA1B1538A80_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_FE1099F94BBFE47B4159DDA1B1538A80" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_FE1099F94BBFE47B4159DDA1B1538A80_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_FE1099F94BBFE47B4159DDA1B1538A80" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_FE1099F94BBFE47B4159DDA1B1538A80" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_FE1099F94BBFE47B4159DDA1B1538A80" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_FE1099F94BBFE47B4159DDA1B1538A80" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_D8E97C4B76152619F086064EB06098D7_terseLabel_en-US" xlink:label="lab_us-gaap_Assets_D8E97C4B76152619F086064EB06098D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_D8E97C4B76152619F086064EB06098D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_D8E97C4B76152619F086064EB06098D7" xlink:to="lab_us-gaap_Assets_D8E97C4B76152619F086064EB06098D7" xlink:type="arc" />
    <link:label id="lab_cah_VendorReserves_B628E9AD1C2EA94D8D79064EB392DF24_terseLabel_en-US" xlink:label="lab_cah_VendorReserves_B628E9AD1C2EA94D8D79064EB392DF24" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vendor reserves</link:label>
    <link:label id="lab_cah_VendorReserves_B628E9AD1C2EA94D8D79064EB392DF24_label_en-US" xlink:label="lab_cah_VendorReserves_B628E9AD1C2EA94D8D79064EB392DF24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vendor Reserves</link:label>
    <link:label id="lab_cah_VendorReserves_B628E9AD1C2EA94D8D79064EB392DF24_documentation_en-US" xlink:label="lab_cah_VendorReserves_B628E9AD1C2EA94D8D79064EB392DF24" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total of reserves, relating to vendor disputes or deductions, that are netted against vendor liabilities in the ordinary course of business.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_VendorReserves" xlink:label="loc_cah_VendorReserves_B628E9AD1C2EA94D8D79064EB392DF24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_VendorReserves_B628E9AD1C2EA94D8D79064EB392DF24" xlink:to="lab_cah_VendorReserves_B628E9AD1C2EA94D8D79064EB392DF24" xlink:type="arc" />
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BE141BDB859D2D3FE594C4ECCD397422_verboseLabel_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BE141BDB859D2D3FE594C4ECCD397422" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BE141BDB859D2D3FE594C4ECCD397422" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BE141BDB859D2D3FE594C4ECCD397422" xlink:to="lab_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BE141BDB859D2D3FE594C4ECCD397422" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8CC0548D71CCB00356ED064EB278AB41_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8CC0548D71CCB00356ED064EB278AB41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments, Contingent Liabilities and Litigation</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8CC0548D71CCB00356ED064EB278AB41_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8CC0548D71CCB00356ED064EB278AB41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8CC0548D71CCB00356ED064EB278AB41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8CC0548D71CCB00356ED064EB278AB41" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8CC0548D71CCB00356ED064EB278AB41" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="lab_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:type="arc" />
    <link:label id="lab_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC_terseLabel_en-US" xlink:label="lab_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:label id="lab_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC_label_en-US" xlink:label="lab_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:label id="lab_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC_documentation_en-US" xlink:label="lab_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_TaxMatterAxis" xlink:label="loc_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:to="lab_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:type="arc" />
    <link:label id="lab_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A_terseLabel_en-US" xlink:label="lab_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Matter [Domain]</link:label>
    <link:label id="lab_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A_label_en-US" xlink:label="lab_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Matter [Domain]</link:label>
    <link:label id="lab_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A_documentation_en-US" xlink:label="lab_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Tax Matter [Axis]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_TaxMatterDomain" xlink:label="loc_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:to="lab_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:type="arc" />
    <link:label id="lab_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7_terseLabel_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7_label_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7_documentation_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7" xlink:to="lab_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7" xlink:type="arc" />
    <link:label id="lab_cah_CareFusionMember_5789E786440FB550550ACA007278DB36_terseLabel_en-US" xlink:label="lab_cah_CareFusionMember_5789E786440FB550550ACA007278DB36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:label id="lab_cah_CareFusionMember_5789E786440FB550550ACA007278DB36_label_en-US" xlink:label="lab_cah_CareFusionMember_5789E786440FB550550ACA007278DB36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:label id="lab_cah_CareFusionMember_5789E786440FB550550ACA007278DB36_documentation_en-US" xlink:label="lab_cah_CareFusionMember_5789E786440FB550550ACA007278DB36" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_CareFusionMember" xlink:label="loc_cah_CareFusionMember_5789E786440FB550550ACA007278DB36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CareFusionMember_5789E786440FB550550ACA007278DB36" xlink:to="lab_cah_CareFusionMember_5789E786440FB550550ACA007278DB36" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:type="arc" />
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_ACBD9D51BA1F1C388097CA0072811D78_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember_ACBD9D51BA1F1C388097CA0072811D78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_ACBD9D51BA1F1C388097CA0072811D78_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember_ACBD9D51BA1F1C388097CA0072811D78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_ACBD9D51BA1F1C388097CA0072811D78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember_ACBD9D51BA1F1C388097CA0072811D78" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember_ACBD9D51BA1F1C388097CA0072811D78" xlink:type="arc" />
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_9FE9497467FB50D9D863CA007281D784_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_9FE9497467FB50D9D863CA007281D784" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and Local</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_9FE9497467FB50D9D863CA007281D784_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_9FE9497467FB50D9D863CA007281D784" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_9FE9497467FB50D9D863CA007281D784" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember_9FE9497467FB50D9D863CA007281D784" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember_9FE9497467FB50D9D863CA007281D784" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCountryMember_414189AE5BCB1C075968CA0072816731_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember_414189AE5BCB1C075968CA0072816731" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_414189AE5BCB1C075968CA0072816731_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember_414189AE5BCB1C075968CA0072816731" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_414189AE5BCB1C075968CA0072816731" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember_414189AE5BCB1C075968CA0072816731" xlink:to="lab_us-gaap_ForeignCountryMember_414189AE5BCB1C075968CA0072816731" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="lab_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_BF2B7E768062CD3D4A03CA0072876493_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_BF2B7E768062CD3D4A03CA0072876493" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_BF2B7E768062CD3D4A03CA0072876493_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_BF2B7E768062CD3D4A03CA0072876493" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_BF2B7E768062CD3D4A03CA0072876493" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_BF2B7E768062CD3D4A03CA0072876493" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_BF2B7E768062CD3D4A03CA0072876493" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3FAB93880BFF7C724843CA007288CAB7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_3FAB93880BFF7C724843CA007288CAB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3FAB93880BFF7C724843CA007288CAB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3FAB93880BFF7C724843CA007288CAB7" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_3FAB93880BFF7C724843CA007288CAB7" xlink:type="arc" />
    <link:label id="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36_negatedTerseLabel_en-US" xlink:label="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Effective Tax Rate Impact From Certain Foreign Jurisdictions</link:label>
    <link:label id="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36_label_en-US" xlink:label="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Tax Rate Impact From Certain Foreign Jurisdictions</link:label>
    <link:label id="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36_documentation_en-US" xlink:label="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Tax Rate Impact From Certain Foreign Jurisdictions</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:label="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36" xlink:to="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_BA1D701181C56A051845CA007288F7D9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_BA1D701181C56A051845CA007288F7D9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision at Federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_BA1D701181C56A051845CA007288F7D9_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_BA1D701181C56A051845CA007288F7D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_BA1D701181C56A051845CA007288F7D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_BA1D701181C56A051845CA007288F7D9" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_BA1D701181C56A051845CA007288F7D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_F21494E97DECA6BFBA0FCA0072886109_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_F21494E97DECA6BFBA0FCA0072886109" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_F21494E97DECA6BFBA0FCA0072886109" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_F21494E97DECA6BFBA0FCA0072886109" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_F21494E97DECA6BFBA0FCA0072886109" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_7E4ADA472D8F1E0E0BECCA0072888589_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount_7E4ADA472D8F1E0E0BECCA0072888589" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_7E4ADA472D8F1E0E0BECCA0072888589_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount_7E4ADA472D8F1E0E0BECCA0072888589" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_7E4ADA472D8F1E0E0BECCA0072888589" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount_7E4ADA472D8F1E0E0BECCA0072888589" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount_7E4ADA472D8F1E0E0BECCA0072888589" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_30DBC6DB59FF50EC762ECA0072894A2B_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_30DBC6DB59FF50EC762ECA0072894A2B" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets on tax credit carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_30DBC6DB59FF50EC762ECA0072894A2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_30DBC6DB59FF50EC762ECA0072894A2B" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_30DBC6DB59FF50EC762ECA0072894A2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_DA69C0E373966F39660ACA007289A233_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_DA69C0E373966F39660ACA007289A233" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance on operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_DA69C0E373966F39660ACA007289A233_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_DA69C0E373966F39660ACA007289A233" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_DA69C0E373966F39660ACA007289A233" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_DA69C0E373966F39660ACA007289A233" xlink:to="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_DA69C0E373966F39660ACA007289A233" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2C85A009EE8181097E9CCA0072892951_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2C85A009EE8181097E9CCA0072892951" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2C85A009EE8181097E9CCA0072892951_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2C85A009EE8181097E9CCA0072892951" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2C85A009EE8181097E9CCA0072892951" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2C85A009EE8181097E9CCA0072892951" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2C85A009EE8181097E9CCA0072892951" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_98713B61E988B374098DCA00728912D4_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_98713B61E988B374098DCA00728912D4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_98713B61E988B374098DCA00728912D4_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_98713B61E988B374098DCA00728912D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_98713B61E988B374098DCA00728912D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_98713B61E988B374098DCA00728912D4" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_98713B61E988B374098DCA00728912D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_356195757A0D6769D42ACA00728979D0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_356195757A0D6769D42ACA00728979D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_356195757A0D6769D42ACA00728979D0_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_356195757A0D6769D42ACA00728979D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_356195757A0D6769D42ACA00728979D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_356195757A0D6769D42ACA00728979D0" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_356195757A0D6769D42ACA00728979D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_C1DA5A00CE4D34A856EFCA00728AE932_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_C1DA5A00CE4D34A856EFCA00728AE932" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_C1DA5A00CE4D34A856EFCA00728AE932_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_C1DA5A00CE4D34A856EFCA00728AE932" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_C1DA5A00CE4D34A856EFCA00728AE932" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_C1DA5A00CE4D34A856EFCA00728AE932" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_C1DA5A00CE4D34A856EFCA00728AE932" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_E90814F2B01563FB9030CA00728A391E_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_E90814F2B01563FB9030CA00728A391E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_E90814F2B01563FB9030CA00728A391E_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_E90814F2B01563FB9030CA00728A391E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_E90814F2B01563FB9030CA00728A391E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_E90814F2B01563FB9030CA00728A391E" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_E90814F2B01563FB9030CA00728A391E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8274BBF0B5BE0BF0126CCA00728A9EC7_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8274BBF0B5BE0BF0126CCA00728A9EC7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated range of decrease in unrecognized tax benefits within the next 12 months</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8274BBF0B5BE0BF0126CCA00728A9EC7_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8274BBF0B5BE0BF0126CCA00728A9EC7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8274BBF0B5BE0BF0126CCA00728A9EC7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8274BBF0B5BE0BF0126CCA00728A9EC7" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8274BBF0B5BE0BF0126CCA00728A9EC7" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_EE0EE6364CC904886246CA00728AF60A_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_EE0EE6364CC904886246CA00728AF60A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, interest and penalties accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_EE0EE6364CC904886246CA00728AF60A_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_EE0EE6364CC904886246CA00728AF60A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_EE0EE6364CC904886246CA00728AF60A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_EE0EE6364CC904886246CA00728AF60A" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_EE0EE6364CC904886246CA00728AF60A" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_A60936AB3CFD6D6BC62ECA00728ADA36_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_A60936AB3CFD6D6BC62ECA00728ADA36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_A60936AB3CFD6D6BC62ECA00728ADA36_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_A60936AB3CFD6D6BC62ECA00728ADA36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_A60936AB3CFD6D6BC62ECA00728ADA36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_A60936AB3CFD6D6BC62ECA00728ADA36" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_A60936AB3CFD6D6BC62ECA00728ADA36" xlink:type="arc" />
    <link:label id="lab_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF_terseLabel_en-US" xlink:label="lab_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority</link:label>
    <link:label id="lab_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF_label_en-US" xlink:label="lab_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indemnification Receivable</link:label>
    <link:label id="lab_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF_documentation_en-US" xlink:label="lab_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_IndemnificationReceivable" xlink:label="loc_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF" xlink:to="lab_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_1655E5B09BC16352B7E1CA00728BE298_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_1655E5B09BC16352B7E1CA00728BE298" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_1655E5B09BC16352B7E1CA00728BE298_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_1655E5B09BC16352B7E1CA00728BE298" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_1655E5B09BC16352B7E1CA00728BE298" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_1655E5B09BC16352B7E1CA00728BE298" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_1655E5B09BC16352B7E1CA00728BE298" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_AF5A2E06CCA03057F906064EB2253BB6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_AF5A2E06CCA03057F906064EB2253BB6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_AF5A2E06CCA03057F906064EB2253BB6_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_AF5A2E06CCA03057F906064EB2253BB6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_AF5A2E06CCA03057F906064EB2253BB6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember_AF5A2E06CCA03057F906064EB2253BB6" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember_AF5A2E06CCA03057F906064EB2253BB6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_95E44859CD52A5E41833064EB2267776_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_95E44859CD52A5E41833064EB2267776" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_95E44859CD52A5E41833064EB2267776_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_95E44859CD52A5E41833064EB2267776" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_95E44859CD52A5E41833064EB2267776" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_95E44859CD52A5E41833064EB2267776" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_95E44859CD52A5E41833064EB2267776" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_8349386C845F16779A7C064EB226C272_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_8349386C845F16779A7C064EB226C272" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_8349386C845F16779A7C064EB226C272_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_8349386C845F16779A7C064EB226C272" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8349386C845F16779A7C064EB226C272" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_8349386C845F16779A7C064EB226C272" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_8349386C845F16779A7C064EB226C272" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_24A754A45B4FB7520981064EB2261EE4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_24A754A45B4FB7520981064EB2261EE4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_24A754A45B4FB7520981064EB2261EE4_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_24A754A45B4FB7520981064EB2261EE4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_24A754A45B4FB7520981064EB2261EE4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_24A754A45B4FB7520981064EB2261EE4" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_24A754A45B4FB7520981064EB2261EE4" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_89CE0C1F1574E1A27079064EB227006C_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_89CE0C1F1574E1A27079064EB227006C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_89CE0C1F1574E1A27079064EB227006C_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_89CE0C1F1574E1A27079064EB227006C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_89CE0C1F1574E1A27079064EB227006C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_89CE0C1F1574E1A27079064EB227006C" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_89CE0C1F1574E1A27079064EB227006C" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_FD05F81FE8215A9397A3064EB227FFB2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_FD05F81FE8215A9397A3064EB227FFB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_FD05F81FE8215A9397A3064EB227FFB2_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_FD05F81FE8215A9397A3064EB227FFB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_FD05F81FE8215A9397A3064EB227FFB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure_FD05F81FE8215A9397A3064EB227FFB2" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure_FD05F81FE8215A9397A3064EB227FFB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_E489A5D3F918DA6EF617064EB22753BE_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_E489A5D3F918DA6EF617064EB22753BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forward contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_E489A5D3F918DA6EF617064EB22753BE_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_E489A5D3F918DA6EF617064EB22753BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_E489A5D3F918DA6EF617064EB22753BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_E489A5D3F918DA6EF617064EB22753BE" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_E489A5D3F918DA6EF617064EB22753BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_5799E8AEC468239D282EE438CD3D9C03_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract_5799E8AEC468239D282EE438CD3D9C03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_5799E8AEC468239D282EE438CD3D9C03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_5799E8AEC468239D282EE438CD3D9C03" xlink:to="lab_us-gaap_BusinessCombinationsAbstract_5799E8AEC468239D282EE438CD3D9C03" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:type="arc" />
    <link:label id="lab_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04_label_en-US" xlink:label="lab_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04" xlink:to="lab_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04" xlink:type="arc" />
    <link:label id="lab_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568_label_en-US" xlink:label="lab_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568" xlink:to="lab_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568" xlink:type="arc" />
    <link:label id="lab_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6_terseLabel_en-US" xlink:label="lab_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Navi Ownership Interest Divested [Member]</link:label>
    <link:label id="lab_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6_label_en-US" xlink:label="lab_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Navi Ownership Interest Divested [Member]</link:label>
    <link:label id="lab_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6_documentation_en-US" xlink:label="lab_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Navi Ownership Interest Divested [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviOwnershipInterestDivestedMember" xlink:label="loc_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6" xlink:to="lab_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6" xlink:type="arc" />
    <link:label id="lab_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1_terseLabel_en-US" xlink:label="lab_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">China Pharmaceutical and Medical Products Distribution Business [Member]</link:label>
    <link:label id="lab_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1_label_en-US" xlink:label="lab_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">China Pharmaceutical and Medical Products Distribution Business [Member]</link:label>
    <link:label id="lab_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1_documentation_en-US" xlink:label="lab_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ChinaPharmaceuticalandMedicalProductsDistributionBusiness [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember" xlink:label="loc_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1" xlink:to="lab_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_22181AD30FA19356BD44E438CD42D1A3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_22181AD30FA19356BD44E438CD42D1A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_22181AD30FA19356BD44E438CD42D1A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_22181AD30FA19356BD44E438CD42D1A3" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_22181AD30FA19356BD44E438CD42D1A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_C974BF5C311D27320708E438CD435715_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_C974BF5C311D27320708E438CD435715" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_C974BF5C311D27320708E438CD435715_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_C974BF5C311D27320708E438CD435715" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_C974BF5C311D27320708E438CD435715" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_C974BF5C311D27320708E438CD435715" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_C974BF5C311D27320708E438CD435715" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_4591EADCD4943F8B9015E438CD4308B4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_4591EADCD4943F8B9015E438CD4308B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_4591EADCD4943F8B9015E438CD4308B4_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_4591EADCD4943F8B9015E438CD4308B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4591EADCD4943F8B9015E438CD4308B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4591EADCD4943F8B9015E438CD4308B4" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_4591EADCD4943F8B9015E438CD4308B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_6A4D96F6C076B40F401FE438CD43CBCB_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_6A4D96F6C076B40F401FE438CD43CBCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_6A4D96F6C076B40F401FE438CD43CBCB_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_6A4D96F6C076B40F401FE438CD43CBCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_6A4D96F6C076B40F401FE438CD43CBCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_6A4D96F6C076B40F401FE438CD43CBCB" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_6A4D96F6C076B40F401FE438CD43CBCB" xlink:type="arc" />
    <link:label id="lab_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106_terseLabel_en-US" xlink:label="lab_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Partnership Indirect Ownership</link:label>
    <link:label id="lab_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106_label_en-US" xlink:label="lab_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Partnership Ownership</link:label>
    <link:label id="lab_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106_documentation_en-US" xlink:label="lab_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Partnership Indirect Ownership</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_PartnershipOwnership" xlink:label="loc_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106" xlink:to="lab_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7B2D851E8940AB497F9CE438CD44F4C2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7B2D851E8940AB497F9CE438CD44F4C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7B2D851E8940AB497F9CE438CD44F4C2_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7B2D851E8940AB497F9CE438CD44F4C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7B2D851E8940AB497F9CE438CD44F4C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7B2D851E8940AB497F9CE438CD44F4C2" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7B2D851E8940AB497F9CE438CD44F4C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_1858C9D62FAA8E0968E3E438CD44B849_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_1858C9D62FAA8E0968E3E438CD44B849" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_1858C9D62FAA8E0968E3E438CD44B849_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_1858C9D62FAA8E0968E3E438CD44B849" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1858C9D62FAA8E0968E3E438CD44B849" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1858C9D62FAA8E0968E3E438CD44B849" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_1858C9D62FAA8E0968E3E438CD44B849" xlink:type="arc" />
    <link:label id="lab_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919_terseLabel_en-US" xlink:label="lab_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction and integration costs</link:label>
    <link:label id="lab_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919_label_en-US" xlink:label="lab_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Transaction and integration costs</link:label>
    <link:label id="lab_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919_documentation_en-US" xlink:label="lab_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Costs incurred during the initial evaluation of a potential acquisition that primarily relate to costs to analyze, negotiate, and consummate the transaction, as well as due diligence activities. Also includes costs related to activities required to combine the operations of an acquired enterprise into our operations and to stand-up the systems and processes needed to support a global footprint.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_BusinessCombinationTransactionandintegrationcosts" xlink:label="loc_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919" xlink:to="lab_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestments_330B61B60CC93512830BE438CD444E82_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments_330B61B60CC93512830BE438CD444E82" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_330B61B60CC93512830BE438CD444E82_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments_330B61B60CC93512830BE438CD444E82" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_330B61B60CC93512830BE438CD444E82" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments_330B61B60CC93512830BE438CD444E82" xlink:to="lab_us-gaap_EquityMethodInvestments_330B61B60CC93512830BE438CD444E82" xlink:type="arc" />
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8426AC05673F269990A6E438D27388A1_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8426AC05673F269990A6E438D27388A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8426AC05673F269990A6E438D27388A1_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8426AC05673F269990A6E438D27388A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8426AC05673F269990A6E438D27388A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8426AC05673F269990A6E438D27388A1" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8426AC05673F269990A6E438D27388A1" xlink:type="arc" />
    <link:label id="lab_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20_terseLabel_en-US" xlink:label="lab_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisional tax benefit related to transaction</link:label>
    <link:label id="lab_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20_label_en-US" xlink:label="lab_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provisional tax benefit related to transaction</link:label>
    <link:label id="lab_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20_documentation_en-US" xlink:label="lab_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Provisional tax benefit related to transaction</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_Provisionaltaxbenefitrelatedtotransaction" xlink:label="loc_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20" xlink:to="lab_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_B9D3CEA04F31DECD0CC7E438CD455DA2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_B9D3CEA04F31DECD0CC7E438CD455DA2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_B9D3CEA04F31DECD0CC7E438CD455DA2_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_B9D3CEA04F31DECD0CC7E438CD455DA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_B9D3CEA04F31DECD0CC7E438CD455DA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_B9D3CEA04F31DECD0CC7E438CD455DA2" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_B9D3CEA04F31DECD0CC7E438CD455DA2" xlink:type="arc" />
    <link:label id="lab_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492_terseLabel_en-US" xlink:label="lab_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Expense as a Result of Sale of Investment</link:label>
    <link:label id="lab_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492_label_en-US" xlink:label="lab_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Expense as a Result of Sale of Investment</link:label>
    <link:label id="lab_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492_documentation_en-US" xlink:label="lab_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Expense as a Result of Sale of Investment</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_TaxExpenseasaResultofSaleofInvestment" xlink:label="loc_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492" xlink:to="lab_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_6445D6630A03A26FE704E438CD4512CC_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments_6445D6630A03A26FE704E438CD4512CC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_6445D6630A03A26FE704E438CD4512CC_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments_6445D6630A03A26FE704E438CD4512CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6445D6630A03A26FE704E438CD4512CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6445D6630A03A26FE704E438CD4512CC" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments_6445D6630A03A26FE704E438CD4512CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6" xlink:to="lab_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_E8300C95EEA64F6B6945B5576F9D36AE_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_E8300C95EEA64F6B6945B5576F9D36AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_E8300C95EEA64F6B6945B5576F9D36AE_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_E8300C95EEA64F6B6945B5576F9D36AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_E8300C95EEA64F6B6945B5576F9D36AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue_E8300C95EEA64F6B6945B5576F9D36AE" xlink:to="lab_us-gaap_DebtInstrumentFairValue_E8300C95EEA64F6B6945B5576F9D36AE" xlink:type="arc" />
    <link:label id="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0_terseLabel_en-US" xlink:label="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying Amount of Long-Term and other Short-Term Borrowings</link:label>
    <link:label id="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0_label_en-US" xlink:label="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying Amount of Long-Term and other Short-Term Borrowings</link:label>
    <link:label id="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0_documentation_en-US" xlink:label="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying Amount of Long-Term and other Short-Term Borrowings</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:label="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0" xlink:to="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_C497C3C14099D7F076C4B5576F9D628C_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations_C497C3C14099D7F076C4B5576F9D628C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_C497C3C14099D7F076C4B5576F9D628C_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations_C497C3C14099D7F076C4B5576F9D628C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_C497C3C14099D7F076C4B5576F9D628C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_C497C3C14099D7F076C4B5576F9D628C" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations_C497C3C14099D7F076C4B5576F9D628C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7F9D007CBEE4911733E6064EB02214C0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7F9D007CBEE4911733E6064EB02214C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of outstanding options at period end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7F9D007CBEE4911733E6064EB02214C0_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7F9D007CBEE4911733E6064EB02214C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7F9D007CBEE4911733E6064EB02214C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7F9D007CBEE4911733E6064EB02214C0" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7F9D007CBEE4911733E6064EB02214C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E5FD4180E043D72F1149064EB0230D27_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E5FD4180E043D72F1149064EB0230D27" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of exercisable options at period end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E5FD4180E043D72F1149064EB0230D27_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E5FD4180E043D72F1149064EB0230D27" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E5FD4180E043D72F1149064EB0230D27" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E5FD4180E043D72F1149064EB0230D27" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E5FD4180E043D72F1149064EB0230D27" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_BB86FE2C124A1D7C4A5B064EB023EBBA_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_BB86FE2C124A1D7C4A5B064EB023EBBA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of exercised options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_BB86FE2C124A1D7C4A5B064EB023EBBA_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_BB86FE2C124A1D7C4A5B064EB023EBBA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_BB86FE2C124A1D7C4A5B064EB023EBBA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_BB86FE2C124A1D7C4A5B064EB023EBBA" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_BB86FE2C124A1D7C4A5B064EB023EBBA" xlink:type="arc" />
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_B67A31EAC03EE1C01F08064EB0232433_verboseLabel_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_B67A31EAC03EE1C01F08064EB0232433" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds/(withholding) from share-based compensation</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_B67A31EAC03EE1C01F08064EB0232433" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_B67A31EAC03EE1C01F08064EB0232433" xlink:to="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_B67A31EAC03EE1C01F08064EB0232433" xlink:type="arc" />
    <link:label id="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_9D6C02A2C01601D853CC064EB023AAC6_verboseLabel_en-US" xlink:label="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_9D6C02A2C01601D853CC064EB023AAC6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Excess tax benefits from share based compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_9D6C02A2C01601D853CC064EB023AAC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_9D6C02A2C01601D853CC064EB023AAC6" xlink:to="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_9D6C02A2C01601D853CC064EB023AAC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_DCFA7F2026EA74CBCC41064EB0236DEA_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_DCFA7F2026EA74CBCC41064EB0236DEA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_DCFA7F2026EA74CBCC41064EB0236DEA_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_DCFA7F2026EA74CBCC41064EB0236DEA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_DCFA7F2026EA74CBCC41064EB0236DEA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_DCFA7F2026EA74CBCC41064EB0236DEA" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_DCFA7F2026EA74CBCC41064EB0236DEA" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9457A4CF5283DE050DAF064EB0238FD2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9457A4CF5283DE050DAF064EB0238FD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total fair value of shares vested during the year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9457A4CF5283DE050DAF064EB0238FD2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9457A4CF5283DE050DAF064EB0238FD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9457A4CF5283DE050DAF064EB0238FD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9457A4CF5283DE050DAF064EB0238FD2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9457A4CF5283DE050DAF064EB0238FD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_B49AE6B236CC2C18C231064EB0235713_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_B49AE6B236CC2C18C231064EB0235713" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average grant date fair value per stock option (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_B49AE6B236CC2C18C231064EB0235713_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_B49AE6B236CC2C18C231064EB0235713" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_B49AE6B236CC2C18C231064EB0235713" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_B49AE6B236CC2C18C231064EB0235713" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_B49AE6B236CC2C18C231064EB0235713" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:type="arc" />
    <link:label id="lab_us-gaap_NotesPayable_82BA4D81DD123904578DC9F58ADDBEF0_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable_82BA4D81DD123904578DC9F58ADDBEF0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayable_82BA4D81DD123904578DC9F58ADDBEF0_label_en-US" xlink:label="lab_us-gaap_NotesPayable_82BA4D81DD123904578DC9F58ADDBEF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_82BA4D81DD123904578DC9F58ADDBEF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable_82BA4D81DD123904578DC9F58ADDBEF0" xlink:to="lab_us-gaap_NotesPayable_82BA4D81DD123904578DC9F58ADDBEF0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_424FAEDE087CB69F6A40C9F58ADEF9DE_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations_424FAEDE087CB69F6A40C9F58ADEF9DE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_424FAEDE087CB69F6A40C9F58ADEF9DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_424FAEDE087CB69F6A40C9F58ADEF9DE" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations_424FAEDE087CB69F6A40C9F58ADEF9DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_C4A503556652A5FCF9DFC9F58ADE0D6E_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_C4A503556652A5FCF9DFC9F58ADE0D6E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Less: current portion of long-term obligations and other short-term borrowings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_C4A503556652A5FCF9DFC9F58ADE0D6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_C4A503556652A5FCF9DFC9F58ADE0D6E" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_C4A503556652A5FCF9DFC9F58ADE0D6E" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_A348B6708E57FFD6ACDF064EB34F7FED_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_A348B6708E57FFD6ACDF064EB34F7FED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_A348B6708E57FFD6ACDF064EB34F7FED_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_A348B6708E57FFD6ACDF064EB34F7FED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_A348B6708E57FFD6ACDF064EB34F7FED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_A348B6708E57FFD6ACDF064EB34F7FED" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_A348B6708E57FFD6ACDF064EB34F7FED" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_DCB928F876FD07865D96064EB1953986_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_DCB928F876FD07865D96064EB1953986" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Income, Net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_DCB928F876FD07865D96064EB1953986_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_DCB928F876FD07865D96064EB1953986" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_DCB928F876FD07865D96064EB1953986" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_DCB928F876FD07865D96064EB1953986" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_DCB928F876FD07865D96064EB1953986" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_FCBB534680F140539CEF064EB195E21F_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_FCBB534680F140539CEF064EB195E21F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain/(loss) recognized in earnings for economic (non-designated) derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_FCBB534680F140539CEF064EB195E21F_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_FCBB534680F140539CEF064EB195E21F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_FCBB534680F140539CEF064EB195E21F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_FCBB534680F140539CEF064EB195E21F" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_FCBB534680F140539CEF064EB195E21F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7A01A915E6AB5C237E02064EAFFDFA00_netLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7A01A915E6AB5C237E02064EAFFDFA00" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7A01A915E6AB5C237E02064EAFFDFA00" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7A01A915E6AB5C237E02064EAFFDFA00" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7A01A915E6AB5C237E02064EAFFDFA00" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_48CDF4D099E39332C0D8064EAFFDF589_netLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_48CDF4D099E39332C0D8064EAFFDF589" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_48CDF4D099E39332C0D8064EAFFDF589" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_48CDF4D099E39332C0D8064EAFFDF589" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_48CDF4D099E39332C0D8064EAFFDF589" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_C2D6F04B9DC8CA6E0775064EAFFD7AA0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_C2D6F04B9DC8CA6E0775064EAFFD7AA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total fair value of shares vested during the year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_C2D6F04B9DC8CA6E0775064EAFFD7AA0_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_C2D6F04B9DC8CA6E0775064EAFFD7AA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_C2D6F04B9DC8CA6E0775064EAFFD7AA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_C2D6F04B9DC8CA6E0775064EAFFD7AA0" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_C2D6F04B9DC8CA6E0775064EAFFD7AA0" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_4D88D739035A76C72682064EB02E1AE5_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_4D88D739035A76C72682064EB02E1AE5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted Share Unit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4D88D739035A76C72682064EB02E1AE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_4D88D739035A76C72682064EB02E1AE5" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_4D88D739035A76C72682064EB02E1AE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_F293773F0CE703D0F69A064EB02FF113_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_F293773F0CE703D0F69A064EB02FF113" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_F293773F0CE703D0F69A064EB02FF113" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_F293773F0CE703D0F69A064EB02FF113" xlink:to="lab_us-gaap_EmployeeStockOptionMember_F293773F0CE703D0F69A064EB02FF113" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_4AC51A950DEB6A2BE79C064EB02FFBA8_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_4AC51A950DEB6A2BE79C064EB02FFBA8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_4AC51A950DEB6A2BE79C064EB02FFBA8_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_4AC51A950DEB6A2BE79C064EB02FFBA8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4AC51A950DEB6A2BE79C064EB02FFBA8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_4AC51A950DEB6A2BE79C064EB02FFBA8" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_4AC51A950DEB6A2BE79C064EB02FFBA8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:type="arc" />
    <link:label id="lab_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113_terseLabel_en-US" xlink:label="lab_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical Reporting Unit [Member]</link:label>
    <link:label id="lab_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113_label_en-US" xlink:label="lab_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Reporting Unit [Member]</link:label>
    <link:label id="lab_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113_documentation_en-US" xlink:label="lab_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical Reporting Unit [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalReportingUnitMember" xlink:label="loc_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113" xlink:to="lab_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis" xlink:label="loc_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9" xlink:to="lab_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F" xlink:to="lab_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_03A3BADE403A345D4547DD85E622D72C_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_03A3BADE403A345D4547DD85E622D72C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_03A3BADE403A345D4547DD85E622D72C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_03A3BADE403A345D4547DD85E622D72C" xlink:to="lab_us-gaap_Goodwill_03A3BADE403A345D4547DD85E622D72C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9FCE732D3E7BB829A585DD85E6229021_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9FCE732D3E7BB829A585DD85E6229021" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated annual amortization of intangible assets - 2020</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9FCE732D3E7BB829A585DD85E6229021_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9FCE732D3E7BB829A585DD85E6229021" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9FCE732D3E7BB829A585DD85E6229021" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9FCE732D3E7BB829A585DD85E6229021" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9FCE732D3E7BB829A585DD85E6229021" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33189D6901CC59C740A5DD85E622B752_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33189D6901CC59C740A5DD85E622B752" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated annual amortization of intangible assets - 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33189D6901CC59C740A5DD85E622B752_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33189D6901CC59C740A5DD85E622B752" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33189D6901CC59C740A5DD85E622B752" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33189D6901CC59C740A5DD85E622B752" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33189D6901CC59C740A5DD85E622B752" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_922B2ED18FD93200BC94DD85E6226159_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_922B2ED18FD93200BC94DD85E6226159" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated annual amortization of intangible assets - 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_922B2ED18FD93200BC94DD85E6226159_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_922B2ED18FD93200BC94DD85E6226159" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_922B2ED18FD93200BC94DD85E6226159" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_922B2ED18FD93200BC94DD85E6226159" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_922B2ED18FD93200BC94DD85E6226159" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1369D261D5BBFD90D1B1DD85E622A713_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1369D261D5BBFD90D1B1DD85E622A713" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated annual amortization of intangible assets - 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1369D261D5BBFD90D1B1DD85E622A713_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1369D261D5BBFD90D1B1DD85E622A713" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1369D261D5BBFD90D1B1DD85E622A713" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1369D261D5BBFD90D1B1DD85E622A713" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1369D261D5BBFD90D1B1DD85E622A713" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_11C900B8558504E06815DD85E6238B7D_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_11C900B8558504E06815DD85E6238B7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated annual amortization of intangible assets - 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_11C900B8558504E06815DD85E6238B7D_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_11C900B8558504E06815DD85E6238B7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_11C900B8558504E06815DD85E6238B7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_11C900B8558504E06815DD85E6238B7D" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_11C900B8558504E06815DD85E6238B7D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E" xlink:to="lab_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E" xlink:type="arc" />
    <link:label id="lab_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514_terseLabel_en-US" xlink:label="lab_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASC 842</link:label>
    <link:label id="lab_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514_label_en-US" xlink:label="lab_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ASC 842 [Member]</link:label>
    <link:label id="lab_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514_documentation_en-US" xlink:label="lab_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ASC 842</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ASC842Member" xlink:label="loc_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514" xlink:to="lab_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514" xlink:type="arc" />
    <link:label id="lab_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155_terseLabel_en-US" xlink:label="lab_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31)</link:label>
    <link:label id="lab_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155_label_en-US" xlink:label="lab_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">impact of adoption of new accounting standard</link:label>
    <link:label id="lab_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155_documentation_en-US" xlink:label="lab_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">impact of adoption of new accounting standard</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_Impactofadoptionofnewaccountingstandard" xlink:label="loc_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155" xlink:to="lab_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasePayments_D53ED55A89328719313FC0931EE971F0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments_D53ED55A89328719313FC0931EE971F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_D53ED55A89328719313FC0931EE971F0_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments_D53ED55A89328719313FC0931EE971F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_D53ED55A89328719313FC0931EE971F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments_D53ED55A89328719313FC0931EE971F0" xlink:to="lab_us-gaap_OperatingLeasePayments_D53ED55A89328719313FC0931EE971F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_1C7A05200977E1C4E6ACC0931EE9C3CD_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments_1C7A05200977E1C4E6ACC0931EE9C3CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_1C7A05200977E1C4E6ACC0931EE9C3CD_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments_1C7A05200977E1C4E6ACC0931EE9C3CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_1C7A05200977E1C4E6ACC0931EE9C3CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments_1C7A05200977E1C4E6ACC0931EE9C3CD" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments_1C7A05200977E1C4E6ACC0931EE9C3CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_D5E895C2102A315C9779C0931EE94602_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_D5E895C2102A315C9779C0931EE94602" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_D5E895C2102A315C9779C0931EE94602_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_D5E895C2102A315C9779C0931EE94602" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_D5E895C2102A315C9779C0931EE94602" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_D5E895C2102A315C9779C0931EE94602" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_D5E895C2102A315C9779C0931EE94602" xlink:type="arc" />
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_85E75CB8B4D08C934671C0931EE92596_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_85E75CB8B4D08C934671C0931EE92596" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_85E75CB8B4D08C934671C0931EE92596_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_85E75CB8B4D08C934671C0931EE92596" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_85E75CB8B4D08C934671C0931EE92596" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_85E75CB8B4D08C934671C0931EE92596" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_85E75CB8B4D08C934671C0931EE92596" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeveranceCosts1_9ECEFFC382CA1235BEE7064EB35D92DF_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1_9ECEFFC382CA1235BEE7064EB35D92DF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee-related costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_9ECEFFC382CA1235BEE7064EB35D92DF_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1_9ECEFFC382CA1235BEE7064EB35D92DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_9ECEFFC382CA1235BEE7064EB35D92DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1_9ECEFFC382CA1235BEE7064EB35D92DF" xlink:to="lab_us-gaap_SeveranceCosts1_9ECEFFC382CA1235BEE7064EB35D92DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_9C5A698B0B416DC22613064EB35D932A_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_9C5A698B0B416DC22613064EB35D932A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total restructuring and employee severance</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_9C5A698B0B416DC22613064EB35D932A_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges_9C5A698B0B416DC22613064EB35D932A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_9C5A698B0B416DC22613064EB35D932A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_9C5A698B0B416DC22613064EB35D932A" xlink:to="lab_us-gaap_RestructuringCharges_9C5A698B0B416DC22613064EB35D932A" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityAbstract_E0AAF15700F2E3359C5D064EB12BD9E9_label_en-US" xlink:label="lab_us-gaap_EquityAbstract_E0AAF15700F2E3359C5D064EB12BD9E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_E0AAF15700F2E3359C5D064EB12BD9E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract_E0AAF15700F2E3359C5D064EB12BD9E9" xlink:to="lab_us-gaap_EquityAbstract_E0AAF15700F2E3359C5D064EB12BD9E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3989E0DD5949351B4AC0064EB12C991B_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3989E0DD5949351B4AC0064EB12C991B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3989E0DD5949351B4AC0064EB12C991B_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3989E0DD5949351B4AC0064EB12C991B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3989E0DD5949351B4AC0064EB12C991B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3989E0DD5949351B4AC0064EB12C991B" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3989E0DD5949351B4AC0064EB12C991B" xlink:type="arc" />
    <link:label id="lab_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F_label_en-US" xlink:label="lab_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="lab_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_D18701478C033AA457D3CA0EF77096B5_terseLabel_en-US" xlink:label="lab_dei_DocumentType_D18701478C033AA457D3CA0EF77096B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_D18701478C033AA457D3CA0EF77096B5_label_en-US" xlink:label="lab_dei_DocumentType_D18701478C033AA457D3CA0EF77096B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_D18701478C033AA457D3CA0EF77096B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_D18701478C033AA457D3CA0EF77096B5" xlink:to="lab_dei_DocumentType_D18701478C033AA457D3CA0EF77096B5" xlink:type="arc" />
    <link:label id="lab_dei_DocumentAnnualReport_110FE01E858E937DCA7ECA0EF77041F4_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport_110FE01E858E937DCA7ECA0EF77041F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_110FE01E858E937DCA7ECA0EF77041F4_label_en-US" xlink:label="lab_dei_DocumentAnnualReport_110FE01E858E937DCA7ECA0EF77041F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_110FE01E858E937DCA7ECA0EF77041F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport_110FE01E858E937DCA7ECA0EF77041F4" xlink:to="lab_dei_DocumentAnnualReport_110FE01E858E937DCA7ECA0EF77041F4" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_227347DFAAB66E4E03E9CA0EF771270D_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_227347DFAAB66E4E03E9CA0EF771270D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_227347DFAAB66E4E03E9CA0EF771270D_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_227347DFAAB66E4E03E9CA0EF771270D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_227347DFAAB66E4E03E9CA0EF771270D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_227347DFAAB66E4E03E9CA0EF771270D" xlink:to="lab_dei_DocumentPeriodEndDate_227347DFAAB66E4E03E9CA0EF771270D" xlink:type="arc" />
    <link:label id="lab_dei_DocumentTransitionReport_EFE3950AA0E2BA68FF87CA0EF771F936_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport_EFE3950AA0E2BA68FF87CA0EF771F936" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_EFE3950AA0E2BA68FF87CA0EF771F936_label_en-US" xlink:label="lab_dei_DocumentTransitionReport_EFE3950AA0E2BA68FF87CA0EF771F936" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_EFE3950AA0E2BA68FF87CA0EF771F936" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_EFE3950AA0E2BA68FF87CA0EF771F936" xlink:to="lab_dei_DocumentTransitionReport_EFE3950AA0E2BA68FF87CA0EF771F936" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_4ED92DCD977E70030672CA0EF771B7B0_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_4ED92DCD977E70030672CA0EF771B7B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_4ED92DCD977E70030672CA0EF771B7B0_label_en-US" xlink:label="lab_dei_EntityFileNumber_4ED92DCD977E70030672CA0EF771B7B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_4ED92DCD977E70030672CA0EF771B7B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_4ED92DCD977E70030672CA0EF771B7B0" xlink:to="lab_dei_EntityFileNumber_4ED92DCD977E70030672CA0EF771B7B0" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_F72124530B067107F652CA0EF77181D0_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_F72124530B067107F652CA0EF77181D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_F72124530B067107F652CA0EF77181D0_label_en-US" xlink:label="lab_dei_EntityRegistrantName_F72124530B067107F652CA0EF77181D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_F72124530B067107F652CA0EF77181D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_F72124530B067107F652CA0EF77181D0" xlink:to="lab_dei_EntityRegistrantName_F72124530B067107F652CA0EF77181D0" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_3C5759F19A06F32DD2FDCA0EF7710FC0_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_3C5759F19A06F32DD2FDCA0EF7710FC0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_3C5759F19A06F32DD2FDCA0EF7710FC0_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_3C5759F19A06F32DD2FDCA0EF7710FC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3C5759F19A06F32DD2FDCA0EF7710FC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_3C5759F19A06F32DD2FDCA0EF7710FC0" xlink:to="lab_dei_EntityIncorporationStateCountryCode_3C5759F19A06F32DD2FDCA0EF7710FC0" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_37D775E1E8C8C7DA5F1DCA0EF77166E9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_37D775E1E8C8C7DA5F1DCA0EF77166E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_37D775E1E8C8C7DA5F1DCA0EF77166E9_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_37D775E1E8C8C7DA5F1DCA0EF77166E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_37D775E1E8C8C7DA5F1DCA0EF77166E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_37D775E1E8C8C7DA5F1DCA0EF77166E9" xlink:to="lab_dei_EntityTaxIdentificationNumber_37D775E1E8C8C7DA5F1DCA0EF77166E9" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_E60DCBA177304A116F8CCA0EF7726033_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_E60DCBA177304A116F8CCA0EF7726033" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_E60DCBA177304A116F8CCA0EF7726033_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_E60DCBA177304A116F8CCA0EF7726033" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_E60DCBA177304A116F8CCA0EF7726033" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_E60DCBA177304A116F8CCA0EF7726033" xlink:to="lab_dei_EntityAddressAddressLine1_E60DCBA177304A116F8CCA0EF7726033" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_5A68C5A96B142A89207FCA0EF772D326_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_5A68C5A96B142A89207FCA0EF772D326" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_5A68C5A96B142A89207FCA0EF772D326_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_5A68C5A96B142A89207FCA0EF772D326" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_5A68C5A96B142A89207FCA0EF772D326" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_5A68C5A96B142A89207FCA0EF772D326" xlink:to="lab_dei_EntityAddressCityOrTown_5A68C5A96B142A89207FCA0EF772D326" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_278B3A6EEB98A5301EC7CA0EF7720A4D_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_278B3A6EEB98A5301EC7CA0EF7720A4D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_278B3A6EEB98A5301EC7CA0EF7720A4D_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_278B3A6EEB98A5301EC7CA0EF7720A4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_278B3A6EEB98A5301EC7CA0EF7720A4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_278B3A6EEB98A5301EC7CA0EF7720A4D" xlink:to="lab_dei_EntityAddressStateOrProvince_278B3A6EEB98A5301EC7CA0EF7720A4D" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_0EAE4862207F77EAA4C3CA0EF7729F20_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_0EAE4862207F77EAA4C3CA0EF7729F20" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_0EAE4862207F77EAA4C3CA0EF7729F20_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_0EAE4862207F77EAA4C3CA0EF7729F20" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_0EAE4862207F77EAA4C3CA0EF7729F20" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_0EAE4862207F77EAA4C3CA0EF7729F20" xlink:to="lab_dei_EntityAddressPostalZipCode_0EAE4862207F77EAA4C3CA0EF7729F20" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_F10649A6FD42E4527238CA0EF772CA19_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_F10649A6FD42E4527238CA0EF772CA19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_F10649A6FD42E4527238CA0EF772CA19_label_en-US" xlink:label="lab_dei_CityAreaCode_F10649A6FD42E4527238CA0EF772CA19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_F10649A6FD42E4527238CA0EF772CA19" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_F10649A6FD42E4527238CA0EF772CA19" xlink:to="lab_dei_CityAreaCode_F10649A6FD42E4527238CA0EF772CA19" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_109E4DA2BC07E4695D93CA0EF773D958_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_109E4DA2BC07E4695D93CA0EF773D958" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_109E4DA2BC07E4695D93CA0EF773D958_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_109E4DA2BC07E4695D93CA0EF773D958" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_109E4DA2BC07E4695D93CA0EF773D958" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_109E4DA2BC07E4695D93CA0EF773D958" xlink:to="lab_dei_LocalPhoneNumber_109E4DA2BC07E4695D93CA0EF773D958" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_2189789BF885F33040B0CA0EF7734A89_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_2189789BF885F33040B0CA0EF7734A89" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_2189789BF885F33040B0CA0EF7734A89_label_en-US" xlink:label="lab_dei_Security12bTitle_2189789BF885F33040B0CA0EF7734A89" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_2189789BF885F33040B0CA0EF7734A89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_2189789BF885F33040B0CA0EF7734A89" xlink:to="lab_dei_Security12bTitle_2189789BF885F33040B0CA0EF7734A89" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_9509820AAD6216BB0F86CA0EF7782F50_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_9509820AAD6216BB0F86CA0EF7782F50" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_9509820AAD6216BB0F86CA0EF7782F50_label_en-US" xlink:label="lab_dei_TradingSymbol_9509820AAD6216BB0F86CA0EF7782F50" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_9509820AAD6216BB0F86CA0EF7782F50" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_9509820AAD6216BB0F86CA0EF7782F50" xlink:to="lab_dei_TradingSymbol_9509820AAD6216BB0F86CA0EF7782F50" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_BFF80349D235A217AC49CA0EF7780518_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_BFF80349D235A217AC49CA0EF7780518" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_BFF80349D235A217AC49CA0EF7780518_label_en-US" xlink:label="lab_dei_SecurityExchangeName_BFF80349D235A217AC49CA0EF7780518" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_BFF80349D235A217AC49CA0EF7780518" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_BFF80349D235A217AC49CA0EF7780518" xlink:to="lab_dei_SecurityExchangeName_BFF80349D235A217AC49CA0EF7780518" xlink:type="arc" />
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_8DF084B0680125EE59CECA0EF778AEED_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_8DF084B0680125EE59CECA0EF778AEED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-Known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_8DF084B0680125EE59CECA0EF778AEED_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_8DF084B0680125EE59CECA0EF778AEED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_8DF084B0680125EE59CECA0EF778AEED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_8DF084B0680125EE59CECA0EF778AEED" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_8DF084B0680125EE59CECA0EF778AEED" xlink:type="arc" />
    <link:label id="lab_dei_EntityVoluntaryFilers_80DB281496FDD47E622FCA0EF7799946_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers_80DB281496FDD47E622FCA0EF7799946" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_80DB281496FDD47E622FCA0EF7799946_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers_80DB281496FDD47E622FCA0EF7799946" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_80DB281496FDD47E622FCA0EF7799946" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_80DB281496FDD47E622FCA0EF7799946" xlink:to="lab_dei_EntityVoluntaryFilers_80DB281496FDD47E622FCA0EF7799946" xlink:type="arc" />
    <link:label id="lab_dei_EntityCurrentReportingStatus_D1A523AD94F9213DE235CA0EF779C0EC_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_D1A523AD94F9213DE235CA0EF779C0EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_D1A523AD94F9213DE235CA0EF779C0EC_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_D1A523AD94F9213DE235CA0EF779C0EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_D1A523AD94F9213DE235CA0EF779C0EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_D1A523AD94F9213DE235CA0EF779C0EC" xlink:to="lab_dei_EntityCurrentReportingStatus_D1A523AD94F9213DE235CA0EF779C0EC" xlink:type="arc" />
    <link:label id="lab_dei_EntityInteractiveDataCurrent_20C85AD22DF90899DEACCA0EF779EDB0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent_20C85AD22DF90899DEACCA0EF779EDB0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_20C85AD22DF90899DEACCA0EF779EDB0_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent_20C85AD22DF90899DEACCA0EF779EDB0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_20C85AD22DF90899DEACCA0EF779EDB0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_20C85AD22DF90899DEACCA0EF779EDB0" xlink:to="lab_dei_EntityInteractiveDataCurrent_20C85AD22DF90899DEACCA0EF779EDB0" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_2F0A3978ED1A9B3898F1CA0EF7790BC6_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory_2F0A3978ED1A9B3898F1CA0EF7790BC6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_2F0A3978ED1A9B3898F1CA0EF7790BC6_label_en-US" xlink:label="lab_dei_EntityFilerCategory_2F0A3978ED1A9B3898F1CA0EF7790BC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_2F0A3978ED1A9B3898F1CA0EF7790BC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_2F0A3978ED1A9B3898F1CA0EF7790BC6" xlink:to="lab_dei_EntityFilerCategory_2F0A3978ED1A9B3898F1CA0EF7790BC6" xlink:type="arc" />
    <link:label id="lab_dei_EntitySmallBusiness_321D769FB30C3FBF287ACA0EF77A839D_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness_321D769FB30C3FBF287ACA0EF77A839D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_321D769FB30C3FBF287ACA0EF77A839D_label_en-US" xlink:label="lab_dei_EntitySmallBusiness_321D769FB30C3FBF287ACA0EF77A839D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_321D769FB30C3FBF287ACA0EF77A839D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_321D769FB30C3FBF287ACA0EF77A839D" xlink:to="lab_dei_EntitySmallBusiness_321D769FB30C3FBF287ACA0EF77A839D" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1CB1D99B64E8EDD499B8CA0EF77A02D3_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_1CB1D99B64E8EDD499B8CA0EF77A02D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1CB1D99B64E8EDD499B8CA0EF77A02D3_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_1CB1D99B64E8EDD499B8CA0EF77A02D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_1CB1D99B64E8EDD499B8CA0EF77A02D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_1CB1D99B64E8EDD499B8CA0EF77A02D3" xlink:to="lab_dei_EntityEmergingGrowthCompany_1CB1D99B64E8EDD499B8CA0EF77A02D3" xlink:type="arc" />
    <link:label id="lab_dei_EntityShellCompany_1F233638C1F47D9EA936CA0EF77AA03C_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany_1F233638C1F47D9EA936CA0EF77AA03C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_1F233638C1F47D9EA936CA0EF77AA03C_label_en-US" xlink:label="lab_dei_EntityShellCompany_1F233638C1F47D9EA936CA0EF77AA03C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_1F233638C1F47D9EA936CA0EF77AA03C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_1F233638C1F47D9EA936CA0EF77AA03C" xlink:to="lab_dei_EntityShellCompany_1F233638C1F47D9EA936CA0EF77AA03C" xlink:type="arc" />
    <link:label id="lab_dei_EntityPublicFloat_2F368351DBD79FAFB6E5CA0EF77AA0AB_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat_2F368351DBD79FAFB6E5CA0EF77AA0AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_2F368351DBD79FAFB6E5CA0EF77AA0AB_label_en-US" xlink:label="lab_dei_EntityPublicFloat_2F368351DBD79FAFB6E5CA0EF77AA0AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_2F368351DBD79FAFB6E5CA0EF77AA0AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat_2F368351DBD79FAFB6E5CA0EF77AA0AB" xlink:to="lab_dei_EntityPublicFloat_2F368351DBD79FAFB6E5CA0EF77AA0AB" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_E0427BE992A9CCA9AE0BCA0EF77A185C_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_E0427BE992A9CCA9AE0BCA0EF77A185C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_E0427BE992A9CCA9AE0BCA0EF77A185C_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_E0427BE992A9CCA9AE0BCA0EF77A185C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_E0427BE992A9CCA9AE0BCA0EF77A185C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_E0427BE992A9CCA9AE0BCA0EF77A185C" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_E0427BE992A9CCA9AE0BCA0EF77A185C" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_EE98E0F293CA85378384CA0EF77B7291_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_EE98E0F293CA85378384CA0EF77B7291" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_EE98E0F293CA85378384CA0EF77B7291_label_en-US" xlink:label="lab_dei_AmendmentFlag_EE98E0F293CA85378384CA0EF77B7291" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_EE98E0F293CA85378384CA0EF77B7291" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_EE98E0F293CA85378384CA0EF77B7291" xlink:to="lab_dei_AmendmentFlag_EE98E0F293CA85378384CA0EF77B7291" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_EC3D76848B252357F116CA0EF77B268B_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_EC3D76848B252357F116CA0EF77B268B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_EC3D76848B252357F116CA0EF77B268B_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_EC3D76848B252357F116CA0EF77B268B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_EC3D76848B252357F116CA0EF77B268B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_EC3D76848B252357F116CA0EF77B268B" xlink:to="lab_dei_DocumentFiscalPeriodFocus_EC3D76848B252357F116CA0EF77B268B" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_90DA509928B5A431F4A6CA0EF77B14A0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_90DA509928B5A431F4A6CA0EF77B14A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_90DA509928B5A431F4A6CA0EF77B14A0_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_90DA509928B5A431F4A6CA0EF77B14A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_90DA509928B5A431F4A6CA0EF77B14A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_90DA509928B5A431F4A6CA0EF77B14A0" xlink:to="lab_dei_EntityCentralIndexKey_90DA509928B5A431F4A6CA0EF77B14A0" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9406ECF1253B106EC861CA0EF77B7CE1_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_9406ECF1253B106EC861CA0EF77B7CE1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9406ECF1253B106EC861CA0EF77B7CE1_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_9406ECF1253B106EC861CA0EF77B7CE1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_9406ECF1253B106EC861CA0EF77B7CE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_9406ECF1253B106EC861CA0EF77B7CE1" xlink:to="lab_dei_CurrentFiscalYearEndDate_9406ECF1253B106EC861CA0EF77B7CE1" xlink:type="arc" />
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_FAAE35134D25EBFB95A2CA0EF77B4642_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock_FAAE35134D25EBFB95A2CA0EF77B4642" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_FAAE35134D25EBFB95A2CA0EF77B4642_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock_FAAE35134D25EBFB95A2CA0EF77B4642" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_FAAE35134D25EBFB95A2CA0EF77B4642" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock_FAAE35134D25EBFB95A2CA0EF77B4642" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock_FAAE35134D25EBFB95A2CA0EF77B4642" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:to="lab_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommercialPaperMember_FCAB1B1FE65AB34F9A6EDD83F37C5F08_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember_FCAB1B1FE65AB34F9A6EDD83F37C5F08" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial paper</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_FCAB1B1FE65AB34F9A6EDD83F37C5F08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember_FCAB1B1FE65AB34F9A6EDD83F37C5F08" xlink:to="lab_us-gaap_CommercialPaperMember_FCAB1B1FE65AB34F9A6EDD83F37C5F08" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCredit_066111107A2AB6893E24DD83F37C6A9C_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit_066111107A2AB6893E24DD83F37C6A9C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_066111107A2AB6893E24DD83F37C6A9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit_066111107A2AB6893E24DD83F37C6A9C" xlink:to="lab_us-gaap_LineOfCredit_066111107A2AB6893E24DD83F37C6A9C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableCurrent_D2241E67D08C37E0ABCFDD83F37D7511_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_D2241E67D08C37E0ABCFDD83F37D7511" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_D2241E67D08C37E0ABCFDD83F37D7511" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_D2241E67D08C37E0ABCFDD83F37D7511" xlink:to="lab_us-gaap_AccountsPayableCurrent_D2241E67D08C37E0ABCFDD83F37D7511" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_C089ED29F4DEA9460899DD83F37EB9BE_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_C089ED29F4DEA9460899DD83F37EB9BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Amount Outstanding During Period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_C089ED29F4DEA9460899DD83F37EB9BE_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_C089ED29F4DEA9460899DD83F37EB9BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Amount Outstanding During Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_C089ED29F4DEA9460899DD83F37EB9BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_C089ED29F4DEA9460899DD83F37EB9BE" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_C089ED29F4DEA9460899DD83F37EB9BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_0A876BBE98A1BEA46240DD83F37E187C_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_0A876BBE98A1BEA46240DD83F37E187C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Average Outstanding Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:label="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_0A876BBE98A1BEA46240DD83F37E187C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_0A876BBE98A1BEA46240DD83F37E187C" xlink:to="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_0A876BBE98A1BEA46240DD83F37E187C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfNotesPayable_29387C9FD0CFBC74F43FDD83F37E8769_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfNotesPayable_29387C9FD0CFBC74F43FDD83F37E8769" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Notes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfNotesPayable_29387C9FD0CFBC74F43FDD83F37E8769" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfNotesPayable_29387C9FD0CFBC74F43FDD83F37E8769" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfNotesPayable_29387C9FD0CFBC74F43FDD83F37E8769" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AACAF2DFF9D11B55980EDD83F37EC2A6_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AACAF2DFF9D11B55980EDD83F37EC2A6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AACAF2DFF9D11B55980EDD83F37EC2A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AACAF2DFF9D11B55980EDD83F37EC2A6" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AACAF2DFF9D11B55980EDD83F37EC2A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherBorrowings_EB0D2A785D2F120D736EDD83F37E706F_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherBorrowings_EB0D2A785D2F120D736EDD83F37E706F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other Borrowings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaap_OtherBorrowings_EB0D2A785D2F120D736EDD83F37E706F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherBorrowings_EB0D2A785D2F120D736EDD83F37E706F" xlink:to="lab_us-gaap_OtherBorrowings_EB0D2A785D2F120D736EDD83F37E706F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_59AD83891776454AF4DADD83F37F3134_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_59AD83891776454AF4DADD83F37F3134" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings - 2020</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_59AD83891776454AF4DADD83F37F3134_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_59AD83891776454AF4DADD83F37F3134" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_59AD83891776454AF4DADD83F37F3134" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_59AD83891776454AF4DADD83F37F3134" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_59AD83891776454AF4DADD83F37F3134" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_AE97E5150B7F1C61402BDD83F37F4D22_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_AE97E5150B7F1C61402BDD83F37F4D22" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_AE97E5150B7F1C61402BDD83F37F4D22_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_AE97E5150B7F1C61402BDD83F37F4D22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_AE97E5150B7F1C61402BDD83F37F4D22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_AE97E5150B7F1C61402BDD83F37F4D22" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_AE97E5150B7F1C61402BDD83F37F4D22" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5120DBF8CBED70EE23C8DD83F37F62CC_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5120DBF8CBED70EE23C8DD83F37F62CC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5120DBF8CBED70EE23C8DD83F37F62CC_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5120DBF8CBED70EE23C8DD83F37F62CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5120DBF8CBED70EE23C8DD83F37F62CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5120DBF8CBED70EE23C8DD83F37F62CC" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5120DBF8CBED70EE23C8DD83F37F62CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_82C2C8A2FB3346024252DD83F37FFA34_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_82C2C8A2FB3346024252DD83F37FFA34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_82C2C8A2FB3346024252DD83F37FFA34_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_82C2C8A2FB3346024252DD83F37FFA34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_82C2C8A2FB3346024252DD83F37FFA34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_82C2C8A2FB3346024252DD83F37FFA34" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_82C2C8A2FB3346024252DD83F37FFA34" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3A2F814C308F10920620DD83F37FEB14_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3A2F814C308F10920620DD83F37FEB14" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3A2F814C308F10920620DD83F37FEB14_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3A2F814C308F10920620DD83F37FEB14" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3A2F814C308F10920620DD83F37FEB14" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3A2F814C308F10920620DD83F37FEB14" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3A2F814C308F10920620DD83F37FEB14" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0286CC014CFE45DD481ADD83F37F5256_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0286CC014CFE45DD481ADD83F37F5256" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0286CC014CFE45DD481ADD83F37F5256_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0286CC014CFE45DD481ADD83F37F5256" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0286CC014CFE45DD481ADD83F37F5256" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0286CC014CFE45DD481ADD83F37F5256" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0286CC014CFE45DD481ADD83F37F5256" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_07D52E2ED4E4D11B22B3064EB0DE5D4A_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_07D52E2ED4E4D11B22B3064EB0DE5D4A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_07D52E2ED4E4D11B22B3064EB0DE5D4A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_07D52E2ED4E4D11B22B3064EB0DE5D4A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_07D52E2ED4E4D11B22B3064EB0DE5D4A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_07D52E2ED4E4D11B22B3064EB0DE5D4A" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_07D52E2ED4E4D11B22B3064EB0DE5D4A" xlink:type="arc" />
    <link:label id="lab_cah_ScheduleIIAbstract_A034D61BAF638F358F5B064EAFE379A3_label_en-US" xlink:label="lab_cah_ScheduleIIAbstract_A034D61BAF638F358F5B064EAFE379A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule II [Abstract]</link:label>
    <link:label id="lab_cah_ScheduleIIAbstract_A034D61BAF638F358F5B064EAFE379A3_documentation_en-US" xlink:label="lab_cah_ScheduleIIAbstract_A034D61BAF638F358F5B064EAFE379A3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule II [Abstract]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_ScheduleIIAbstract" xlink:label="loc_cah_ScheduleIIAbstract_A034D61BAF638F358F5B064EAFE379A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ScheduleIIAbstract_A034D61BAF638F358F5B064EAFE379A3" xlink:to="lab_cah_ScheduleIIAbstract_A034D61BAF638F358F5B064EAFE379A3" xlink:type="arc" />
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_B53F5F33551A4FDAD388064EAFE33F93_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_B53F5F33551A4FDAD388064EAFE33F93" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_B53F5F33551A4FDAD388064EAFE33F93_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_B53F5F33551A4FDAD388064EAFE33F93" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_B53F5F33551A4FDAD388064EAFE33F93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_B53F5F33551A4FDAD388064EAFE33F93" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_B53F5F33551A4FDAD388064EAFE33F93" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1673BF2B941B1C8006F9064EB080F5D4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_1673BF2B941B1C8006F9064EB080F5D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total operating earnings</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1673BF2B941B1C8006F9064EB080F5D4_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_1673BF2B941B1C8006F9064EB080F5D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_1673BF2B941B1C8006F9064EB080F5D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_1673BF2B941B1C8006F9064EB080F5D4" xlink:to="lab_us-gaap_OperatingIncomeLoss_1673BF2B941B1C8006F9064EB080F5D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_7533967D8BCF254E6F61E457F1BC40FE_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract_7533967D8BCF254E6F61E457F1BC40FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7533967D8BCF254E6F61E457F1BC40FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7533967D8BCF254E6F61E457F1BC40FE" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract_7533967D8BCF254E6F61E457F1BC40FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:to="lab_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockMember_C9CB369BD92D9ED19984E457F1C2F2AC_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember_C9CB369BD92D9ED19984E457F1C2F2AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_C9CB369BD92D9ED19984E457F1C2F2AC_label_en-US" xlink:label="lab_us-gaap_CommonStockMember_C9CB369BD92D9ED19984E457F1C2F2AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_C9CB369BD92D9ED19984E457F1C2F2AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_C9CB369BD92D9ED19984E457F1C2F2AC" xlink:to="lab_us-gaap_CommonStockMember_C9CB369BD92D9ED19984E457F1C2F2AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsMember_7956F1A400BB6D849480E457F1C3F751_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_7956F1A400BB6D849480E457F1C3F751" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_7956F1A400BB6D849480E457F1C3F751_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_7956F1A400BB6D849480E457F1C3F751" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_7956F1A400BB6D849480E457F1C3F751" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_7956F1A400BB6D849480E457F1C3F751" xlink:to="lab_us-gaap_RetainedEarningsMember_7956F1A400BB6D849480E457F1C3F751" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockMember_2E3BCB4817923CC7D3A3E457F1C39D21_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_2E3BCB4817923CC7D3A3E457F1C39D21" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_2E3BCB4817923CC7D3A3E457F1C39D21_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_2E3BCB4817923CC7D3A3E457F1C39D21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_2E3BCB4817923CC7D3A3E457F1C39D21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember_2E3BCB4817923CC7D3A3E457F1C39D21" xlink:to="lab_us-gaap_TreasuryStockMember_2E3BCB4817923CC7D3A3E457F1C39D21" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7CC217BC102F4D5F9BE2E457F1C3464E_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7CC217BC102F4D5F9BE2E457F1C3464E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7CC217BC102F4D5F9BE2E457F1C3464E_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7CC217BC102F4D5F9BE2E457F1C3464E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7CC217BC102F4D5F9BE2E457F1C3464E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7CC217BC102F4D5F9BE2E457F1C3464E" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7CC217BC102F4D5F9BE2E457F1C3464E" xlink:type="arc" />
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_9B142BF7EF0B34A82C13E457F1C323D7_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember_9B142BF7EF0B34A82C13E457F1C323D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_9B142BF7EF0B34A82C13E457F1C323D7_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember_9B142BF7EF0B34A82C13E457F1C323D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9B142BF7EF0B34A82C13E457F1C323D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember_9B142BF7EF0B34A82C13E457F1C323D7" xlink:to="lab_us-gaap_NoncontrollingInterestMember_9B142BF7EF0B34A82C13E457F1C323D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_467DFB0A6993C5EA8A18E457F1C4A352_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_467DFB0A6993C5EA8A18E457F1C4A352" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_467DFB0A6993C5EA8A18E457F1C4A352" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_467DFB0A6993C5EA8A18E457F1C4A352" xlink:to="lab_us-gaap_CommonStockSharesIssued_467DFB0A6993C5EA8A18E457F1C4A352" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_800D1504D356630A72A2E457F1C42A4F_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_800D1504D356630A72A2E457F1C42A4F" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_800D1504D356630A72A2E457F1C42A4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_800D1504D356630A72A2E457F1C42A4F" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_800D1504D356630A72A2E457F1C42A4F" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_769844D0342F4F1CF4D4E457F1C5C6C3_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_769844D0342F4F1CF4D4E457F1C5C6C3" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury, balance at beginning of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_769844D0342F4F1CF4D4E457F1C5C6C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_769844D0342F4F1CF4D4E457F1C5C6C3" xlink:to="lab_us-gaap_TreasuryStockShares_769844D0342F4F1CF4D4E457F1C5C6C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_AC0E80F38FB51C6485BAE457F1C502B0_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_AC0E80F38FB51C6485BAE457F1C502B0" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury, balance at beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_AC0E80F38FB51C6485BAE457F1C502B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_AC0E80F38FB51C6485BAE457F1C502B0" xlink:to="lab_us-gaap_TreasuryStockValue_AC0E80F38FB51C6485BAE457F1C502B0" xlink:type="arc" />
    <link:label id="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB_terseLabel_en-US" xlink:label="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB_label_en-US" xlink:label="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB_documentation_en-US" xlink:label="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:label="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB" xlink:to="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A2BEAB627C30195BE794E457F1C51F9C_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A2BEAB627C30195BE794E457F1C51F9C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A2BEAB627C30195BE794E457F1C51F9C_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A2BEAB627C30195BE794E457F1C51F9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A2BEAB627C30195BE794E457F1C51F9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A2BEAB627C30195BE794E457F1C51F9C" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A2BEAB627C30195BE794E457F1C51F9C" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_87297F5B7109C9F38DE4E457F1C5AB90_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_87297F5B7109C9F38DE4E457F1C5AB90" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_87297F5B7109C9F38DE4E457F1C5AB90_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_87297F5B7109C9F38DE4E457F1C5AB90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_87297F5B7109C9F38DE4E457F1C5AB90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_87297F5B7109C9F38DE4E457F1C5AB90" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_87297F5B7109C9F38DE4E457F1C5AB90" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1B438BC40B223F92851FE457F1C68714_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1B438BC40B223F92851FE457F1C68714" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1B438BC40B223F92851FE457F1C68714_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1B438BC40B223F92851FE457F1C68714" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1B438BC40B223F92851FE457F1C68714" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1B438BC40B223F92851FE457F1C68714" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1B438BC40B223F92851FE457F1C68714" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_B1E875A89524AA21F814E457F1C6E4BC_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_B1E875A89524AA21F814E457F1C6E4BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_B1E875A89524AA21F814E457F1C6E4BC_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_B1E875A89524AA21F814E457F1C6E4BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_B1E875A89524AA21F814E457F1C6E4BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_B1E875A89524AA21F814E457F1C6E4BC" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_B1E875A89524AA21F814E457F1C6E4BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_F12BF709787E2DFD1B16E457F1C6C3DE_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_F12BF709787E2DFD1B16E457F1C6C3DE" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury shares acquired (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_F12BF709787E2DFD1B16E457F1C6C3DE_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_F12BF709787E2DFD1B16E457F1C6C3DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_F12BF709787E2DFD1B16E457F1C6C3DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_F12BF709787E2DFD1B16E457F1C6C3DE" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_F12BF709787E2DFD1B16E457F1C6C3DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_CE6E1D3866943017BD77E457F1C6503D_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_CE6E1D3866943017BD77E457F1C6503D" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Share repurchase program activity</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_CE6E1D3866943017BD77E457F1C6503D_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_CE6E1D3866943017BD77E457F1C6503D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_CE6E1D3866943017BD77E457F1C6503D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_CE6E1D3866943017BD77E457F1C6503D" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_CE6E1D3866943017BD77E457F1C6503D" xlink:type="arc" />
    <link:label id="lab_us-gaap_Dividends_C17FF57DBE6FF325EA6EE457F1C6513A_negatedLabel_en-US" xlink:label="lab_us-gaap_Dividends_C17FF57DBE6FF325EA6EE457F1C6513A" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_Dividends_C17FF57DBE6FF325EA6EE457F1C6513A_label_en-US" xlink:label="lab_us-gaap_Dividends_C17FF57DBE6FF325EA6EE457F1C6513A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_C17FF57DBE6FF325EA6EE457F1C6513A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends_C17FF57DBE6FF325EA6EE457F1C6513A" xlink:to="lab_us-gaap_Dividends_C17FF57DBE6FF325EA6EE457F1C6513A" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityOther_3056893B0F030C51AD62E457F1C6A1B6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther_3056893B0F030C51AD62E457F1C6A1B6" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_3056893B0F030C51AD62E457F1C6A1B6_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther_3056893B0F030C51AD62E457F1C6A1B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="loc_us-gaap_StockholdersEquityOther_3056893B0F030C51AD62E457F1C6A1B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther_3056893B0F030C51AD62E457F1C6A1B6" xlink:to="lab_us-gaap_StockholdersEquityOther_3056893B0F030C51AD62E457F1C6A1B6" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_1C990F11A9AE7A2BB835E457F1C783BB_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_1C990F11A9AE7A2BB835E457F1C783BB" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_1C990F11A9AE7A2BB835E457F1C783BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_1C990F11A9AE7A2BB835E457F1C783BB" xlink:to="lab_us-gaap_CommonStockSharesIssued_1C990F11A9AE7A2BB835E457F1C783BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6CDD3C23F00D0D21D838E457F1C71DC6_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6CDD3C23F00D0D21D838E457F1C71DC6" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6CDD3C23F00D0D21D838E457F1C71DC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6CDD3C23F00D0D21D838E457F1C71DC6" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6CDD3C23F00D0D21D838E457F1C71DC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_21CB2ABCE160215B11B6E457F1C74EF7_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_21CB2ABCE160215B11B6E457F1C74EF7" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury, balance at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_21CB2ABCE160215B11B6E457F1C74EF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_21CB2ABCE160215B11B6E457F1C74EF7" xlink:to="lab_us-gaap_TreasuryStockShares_21CB2ABCE160215B11B6E457F1C74EF7" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_4636C84BE62731035E44E457F1C7CEC3_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_4636C84BE62731035E44E457F1C7CEC3" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury, balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_4636C84BE62731035E44E457F1C7CEC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_4636C84BE62731035E44E457F1C7CEC3" xlink:to="lab_us-gaap_TreasuryStockValue_4636C84BE62731035E44E457F1C7CEC3" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_FA113901F2DA96D0EEE9077B02045EDA_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_FA113901F2DA96D0EEE9077B02045EDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_FA113901F2DA96D0EEE9077B02045EDA_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_FA113901F2DA96D0EEE9077B02045EDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_FA113901F2DA96D0EEE9077B02045EDA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_FA113901F2DA96D0EEE9077B02045EDA" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_FA113901F2DA96D0EEE9077B02045EDA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_AAF230A07E7E31550B4EB49CFBA5120C_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_AAF230A07E7E31550B4EB49CFBA5120C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation Adjustments and other</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_AAF230A07E7E31550B4EB49CFBA5120C_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_AAF230A07E7E31550B4EB49CFBA5120C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_AAF230A07E7E31550B4EB49CFBA5120C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_AAF230A07E7E31550B4EB49CFBA5120C" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_AAF230A07E7E31550B4EB49CFBA5120C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_93B0E1B81D56364692F0B49CFBA5E14F_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_93B0E1B81D56364692F0B49CFBA5E14F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Gain/(Loss) on Derivatives, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_93B0E1B81D56364692F0B49CFBA5E14F_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_93B0E1B81D56364692F0B49CFBA5E14F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_93B0E1B81D56364692F0B49CFBA5E14F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_93B0E1B81D56364692F0B49CFBA5E14F" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_93B0E1B81D56364692F0B49CFBA5E14F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_FAFABE4FF7BC7F218682B49CFBA5BBE5_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_FAFABE4FF7BC7F218682B49CFBA5BBE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_FAFABE4FF7BC7F218682B49CFBA5BBE5_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_FAFABE4FF7BC7F218682B49CFBA5BBE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_FAFABE4FF7BC7F218682B49CFBA5BBE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_FAFABE4FF7BC7F218682B49CFBA5BBE5" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_FAFABE4FF7BC7F218682B49CFBA5BBE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_90CC2DBDF286CAB8DA5BB49CFBA683AF_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax_90CC2DBDF286CAB8DA5BB49CFBA683AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_90CC2DBDF286CAB8DA5BB49CFBA683AF_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax_90CC2DBDF286CAB8DA5BB49CFBA683AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_90CC2DBDF286CAB8DA5BB49CFBA683AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_90CC2DBDF286CAB8DA5BB49CFBA683AF" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax_90CC2DBDF286CAB8DA5BB49CFBA683AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_FDB2DFB0C0DFAD3CD269B49CFBA795F0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_FDB2DFB0C0DFAD3CD269B49CFBA795F0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income/(loss), net before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_FDB2DFB0C0DFAD3CD269B49CFBA795F0_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_FDB2DFB0C0DFAD3CD269B49CFBA795F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_FDB2DFB0C0DFAD3CD269B49CFBA795F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_FDB2DFB0C0DFAD3CD269B49CFBA795F0" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_FDB2DFB0C0DFAD3CD269B49CFBA795F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A229ABA478145D0FA7ACB49CFBA7012C_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A229ABA478145D0FA7ACB49CFBA7012C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A229ABA478145D0FA7ACB49CFBA7012C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A229ABA478145D0FA7ACB49CFBA7012C" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A229ABA478145D0FA7ACB49CFBA7012C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:to="lab_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386" xlink:to="lab_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14" xlink:to="lab_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4F870BAFE50570459471C142761A9436_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4F870BAFE50570459471C142761A9436" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4F870BAFE50570459471C142761A9436" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4F870BAFE50570459471C142761A9436" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4F870BAFE50570459471C142761A9436" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_796A5D3E7D518E0FC5A8C142761A48D7_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_796A5D3E7D518E0FC5A8C142761A48D7" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_796A5D3E7D518E0FC5A8C142761A48D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_796A5D3E7D518E0FC5A8C142761A48D7" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_796A5D3E7D518E0FC5A8C142761A48D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_9CDAC9D2589202A6AAD3C142761AB326_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit_9CDAC9D2589202A6AAD3C142761AB326" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9CDAC9D2589202A6AAD3C142761AB326" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9CDAC9D2589202A6AAD3C142761AB326" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit_9CDAC9D2589202A6AAD3C142761AB326" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_D97C31181747972BF88BC142761A1739_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_D97C31181747972BF88BC142761A1739" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_D97C31181747972BF88BC142761A1739" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_D97C31181747972BF88BC142761A1739" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_D97C31181747972BF88BC142761A1739" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3AC8375A8BADB40C0404C142761AD2FF_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3AC8375A8BADB40C0404C142761AD2FF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3AC8375A8BADB40C0404C142761AD2FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3AC8375A8BADB40C0404C142761AD2FF" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3AC8375A8BADB40C0404C142761AD2FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3BD4ABB1A89EAB9F7194C142761B8491_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3BD4ABB1A89EAB9F7194C142761B8491" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3BD4ABB1A89EAB9F7194C142761B8491" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3BD4ABB1A89EAB9F7194C142761B8491" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3BD4ABB1A89EAB9F7194C142761B8491" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_71A35028291CA5B86F57C142761B3FA9_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_71A35028291CA5B86F57C142761B3FA9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_71A35028291CA5B86F57C142761B3FA9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_71A35028291CA5B86F57C142761B3FA9" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_71A35028291CA5B86F57C142761B3FA9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4DC26D65F28E335491D6C142761B22DA_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4DC26D65F28E335491D6C142761B22DA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4DC26D65F28E335491D6C142761B22DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4DC26D65F28E335491D6C142761B22DA" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4DC26D65F28E335491D6C142761B22DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_1364F251829A3AA7DA36C142761B2084_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_1364F251829A3AA7DA36C142761B2084" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of fiscal year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1364F251829A3AA7DA36C142761B2084" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_1364F251829A3AA7DA36C142761B2084" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_1364F251829A3AA7DA36C142761B2084" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DA9E9290C0CE6E53125C142761CBCC8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DA9E9290C0CE6E53125C142761CBCC8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions for tax positions of the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DA9E9290C0CE6E53125C142761CBCC8_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DA9E9290C0CE6E53125C142761CBCC8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DA9E9290C0CE6E53125C142761CBCC8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DA9E9290C0CE6E53125C142761CBCC8" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DA9E9290C0CE6E53125C142761CBCC8" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_092CA76C422A7BF7DBC5C142761CE950_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_092CA76C422A7BF7DBC5C142761CE950" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions for tax positions of prior years (1)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_092CA76C422A7BF7DBC5C142761CE950" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_092CA76C422A7BF7DBC5C142761CE950" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_092CA76C422A7BF7DBC5C142761CE950" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_E91D2CDE6DFB7B884625C142761CBC81_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_E91D2CDE6DFB7B884625C142761CBC81" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Reductions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_E91D2CDE6DFB7B884625C142761CBC81_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_E91D2CDE6DFB7B884625C142761CBC81" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_E91D2CDE6DFB7B884625C142761CBC81" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_E91D2CDE6DFB7B884625C142761CBC81" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_E91D2CDE6DFB7B884625C142761CBC81" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4E096B00601D8DDFFB42C142761CE598_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4E096B00601D8DDFFB42C142761CE598" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Settlements with tax authorities (1)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4E096B00601D8DDFFB42C142761CE598" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4E096B00601D8DDFFB42C142761CE598" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4E096B00601D8DDFFB42C142761CE598" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_CF87D39B9E8A54CBC2FBC142761CBE50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_CF87D39B9E8A54CBC2FBC142761CBE50" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Expiration of the statute of limitations (1)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_CF87D39B9E8A54CBC2FBC142761CBE50" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_CF87D39B9E8A54CBC2FBC142761CBE50" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_CF87D39B9E8A54CBC2FBC142761CBE50" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_F00B4AB5C7975DCC4801C142761D13D2_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_F00B4AB5C7975DCC4801C142761D13D2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of fiscal year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_F00B4AB5C7975DCC4801C142761D13D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_F00B4AB5C7975DCC4801C142761D13D2" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_F00B4AB5C7975DCC4801C142761D13D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_4FB36997A6E9D8EFADB0064EB2BC3EC3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_4FB36997A6E9D8EFADB0064EB2BC3EC3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_4FB36997A6E9D8EFADB0064EB2BC3EC3_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_4FB36997A6E9D8EFADB0064EB2BC3EC3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_4FB36997A6E9D8EFADB0064EB2BC3EC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_4FB36997A6E9D8EFADB0064EB2BC3EC3" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_4FB36997A6E9D8EFADB0064EB2BC3EC3" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9F17621C8F4339B36086064EB00A4167_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9F17621C8F4339B36086064EB00A4167" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9F17621C8F4339B36086064EB00A4167" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9F17621C8F4339B36086064EB00A4167" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9F17621C8F4339B36086064EB00A4167" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C247B2B75F89375D4866064EB00AE319_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C247B2B75F89375D4866064EB00AE319" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C247B2B75F89375D4866064EB00AE319" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C247B2B75F89375D4866064EB00AE319" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C247B2B75F89375D4866064EB00AE319" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_0D8145C2589A0A9C98C8064EB21ABAE0_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_0D8145C2589A0A9C98C8064EB21ABAE0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_0D8145C2589A0A9C98C8064EB21ABAE0_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_0D8145C2589A0A9C98C8064EB21ABAE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_0D8145C2589A0A9C98C8064EB21ABAE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_0D8145C2589A0A9C98C8064EB21ABAE0" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_0D8145C2589A0A9C98C8064EB21ABAE0" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="lab_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_95BA1E38FCC891493D66E2EE200DECE3_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_95BA1E38FCC891493D66E2EE200DECE3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of products sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_95BA1E38FCC891493D66E2EE200DECE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_95BA1E38FCC891493D66E2EE200DECE3" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold_95BA1E38FCC891493D66E2EE200DECE3" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_9E3BA4F9081ADC851C1CE2EE200E65C2_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_9E3BA4F9081ADC851C1CE2EE200E65C2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross margin</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_9E3BA4F9081ADC851C1CE2EE200E65C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_9E3BA4F9081ADC851C1CE2EE200E65C2" xlink:to="lab_us-gaap_GrossProfit_9E3BA4F9081ADC851C1CE2EE200E65C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A" xlink:to="lab_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_963F1E8BAD18181505D0E2EE200FC741_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_963F1E8BAD18181505D0E2EE200FC741" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and employee severance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_963F1E8BAD18181505D0E2EE200FC741" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_963F1E8BAD18181505D0E2EE200FC741" xlink:to="lab_us-gaap_RestructuringCharges_963F1E8BAD18181505D0E2EE200FC741" xlink:type="arc" />
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_D8A86B2B0F68812442F4E2EE200F5D8A_terseLabel_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts_D8A86B2B0F68812442F4E2EE200F5D8A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization and other acquisition-related costs</link:label>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_D8A86B2B0F68812442F4E2EE200F5D8A_label_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts_D8A86B2B0F68812442F4E2EE200F5D8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization and other acquisition-related costs</link:label>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_D8A86B2B0F68812442F4E2EE200F5D8A_documentation_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts_D8A86B2B0F68812442F4E2EE200F5D8A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_Amortizationandotheracquisitionrelatedcosts" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_D8A86B2B0F68812442F4E2EE200F5D8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Amortizationandotheracquisitionrelatedcosts_D8A86B2B0F68812442F4E2EE200F5D8A" xlink:to="lab_cah_Amortizationandotheracquisitionrelatedcosts_D8A86B2B0F68812442F4E2EE200F5D8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_0841BD1E7D897CE4336EE2EE2010A101_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement_0841BD1E7D897CE4336EE2EE2010A101" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Litigation (recoveries)/charges, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_0841BD1E7D897CE4336EE2EE2010A101" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement_0841BD1E7D897CE4336EE2EE2010A101" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement_0841BD1E7D897CE4336EE2EE2010A101" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_361CE081DE297D781E8EE2EE2010C500_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_361CE081DE297D781E8EE2EE2010C500" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating earnings/(loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_361CE081DE297D781E8EE2EE2010C500" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_361CE081DE297D781E8EE2EE2010C500" xlink:to="lab_us-gaap_OperatingIncomeLoss_361CE081DE297D781E8EE2EE2010C500" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_D66587F53588F6389584E2EE2010C3C6_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_D66587F53588F6389584E2EE2010C3C6" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_D66587F53588F6389584E2EE2010C3C6_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_D66587F53588F6389584E2EE2010C3C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_D66587F53588F6389584E2EE2010C3C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_D66587F53588F6389584E2EE2010C3C6" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense_D66587F53588F6389584E2EE2010C3C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpense_ED009D5BC3834890D4D1E2EE2011B14D_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense_ED009D5BC3834890D4D1E2EE2011B14D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_ED009D5BC3834890D4D1E2EE2011B14D_label_en-US" xlink:label="lab_us-gaap_InterestExpense_ED009D5BC3834890D4D1E2EE2011B14D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_ED009D5BC3834890D4D1E2EE2011B14D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_ED009D5BC3834890D4D1E2EE2011B14D" xlink:to="lab_us-gaap_InterestExpense_ED009D5BC3834890D4D1E2EE2011B14D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4D07FE12510B719A45ABE2EE2011AB07_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_4D07FE12510B719A45ABE2EE2011AB07" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Provision for/(benefit from) income taxes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4D07FE12510B719A45ABE2EE2011AB07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4D07FE12510B719A45ABE2EE2011AB07" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_4D07FE12510B719A45ABE2EE2011AB07" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_78BBA9B95D3BF5E554C2E2EE20121A42_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_78BBA9B95D3BF5E554C2E2EE20121A42" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net earnings/(loss) attributable to Cardinal Health, Inc.</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_78BBA9B95D3BF5E554C2E2EE20121A42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_78BBA9B95D3BF5E554C2E2EE20121A42" xlink:to="lab_us-gaap_NetIncomeLoss_78BBA9B95D3BF5E554C2E2EE20121A42" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00F7F43D67B584C836A9E2EE2013020A_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00F7F43D67B584C836A9E2EE2013020A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00F7F43D67B584C836A9E2EE2013020A_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00F7F43D67B584C836A9E2EE2013020A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00F7F43D67B584C836A9E2EE2013020A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00F7F43D67B584C836A9E2EE2013020A" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00F7F43D67B584C836A9E2EE2013020A" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CEF663774DA26C17971CE2EE2013D302_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CEF663774DA26C17971CE2EE2013D302" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CEF663774DA26C17971CE2EE2013D302" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CEF663774DA26C17971CE2EE2013D302" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CEF663774DA26C17971CE2EE2013D302" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B67A8121BFF7F945D1C5E2EE20148C38_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B67A8121BFF7F945D1C5E2EE20148C38" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B67A8121BFF7F945D1C5E2EE20148C38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B67A8121BFF7F945D1C5E2EE20148C38" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B67A8121BFF7F945D1C5E2EE20148C38" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncement, Early Adoption [Axis]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncement, Early Adoption [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A" xlink:to="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Principles, Early Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D_label_en-US" xlink:label="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Principles, Early Adoption [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D" xlink:to="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:type="arc" />
    <link:label id="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739_terseLabel_en-US" xlink:label="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Liabilities established as a Result of the adoption of ASC 842</link:label>
    <link:label id="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739_label_en-US" xlink:label="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Liabilities established as a Result of the adoption of ASC 842</link:label>
    <link:label id="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739_documentation_en-US" xlink:label="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Liabilities established as a Result of the adoption of ASC 842</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" xlink:label="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739" xlink:to="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6F62DDD2C2DB164DFE9A064EB12417C7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6F62DDD2C2DB164DFE9A064EB12417C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6F62DDD2C2DB164DFE9A064EB12417C7_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6F62DDD2C2DB164DFE9A064EB12417C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6F62DDD2C2DB164DFE9A064EB12417C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6F62DDD2C2DB164DFE9A064EB12417C7" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6F62DDD2C2DB164DFE9A064EB12417C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0EE745CF93FE5ECE71FFCA00752D02CD_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0EE745CF93FE5ECE71FFCA00752D02CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and local income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0EE745CF93FE5ECE71FFCA00752D02CD_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0EE745CF93FE5ECE71FFCA00752D02CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0EE745CF93FE5ECE71FFCA00752D02CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0EE745CF93FE5ECE71FFCA00752D02CD" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0EE745CF93FE5ECE71FFCA00752D02CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_A76FDBA3A20674890A05CA00752D4779_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_A76FDBA3A20674890A05CA00752D4779" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax effect of foreign operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_A76FDBA3A20674890A05CA00752D4779_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_A76FDBA3A20674890A05CA00752D4779" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_A76FDBA3A20674890A05CA00752D4779" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_A76FDBA3A20674890A05CA00752D4779" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_A76FDBA3A20674890A05CA00752D4779" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_5229F8467753BEACDE85CA00752D81C3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_5229F8467753BEACDE85CA00752D81C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nondeductible/nontaxable items</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_5229F8467753BEACDE85CA00752D81C3_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_5229F8467753BEACDE85CA00752D81C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_5229F8467753BEACDE85CA00752D81C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_5229F8467753BEACDE85CA00752D81C3" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_5229F8467753BEACDE85CA00752D81C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_E73C05E200E2FB323F9DCA00752EF765_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_E73C05E200E2FB323F9DCA00752EF765" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_E73C05E200E2FB323F9DCA00752EF765_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_E73C05E200E2FB323F9DCA00752EF765" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_E73C05E200E2FB323F9DCA00752EF765" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_E73C05E200E2FB323F9DCA00752EF765" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_E73C05E200E2FB323F9DCA00752EF765" xlink:type="arc" />
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_FDDE2374C5B88901FD4ECA00752EE088_terseLabel_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_FDDE2374C5B88901FD4ECA00752EE088" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Act</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_FDDE2374C5B88901FD4ECA00752EE088_label_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_FDDE2374C5B88901FD4ECA00752EE088" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Act 2018</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_FDDE2374C5B88901FD4ECA00752EE088_documentation_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_FDDE2374C5B88901FD4ECA00752EE088" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Act 2018</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveIncomeTaxRateReconciliationTaxAct2018" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_FDDE2374C5B88901FD4ECA00752EE088" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_FDDE2374C5B88901FD4ECA00752EE088" xlink:to="lab_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_FDDE2374C5B88901FD4ECA00752EE088" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_B27DA405F8A4E7A4F148CA00752EDC5C_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_B27DA405F8A4E7A4F148CA00752EDC5C" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowances</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_B27DA405F8A4E7A4F148CA00752EDC5C_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_B27DA405F8A4E7A4F148CA00752EDC5C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_B27DA405F8A4E7A4F148CA00752EDC5C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_B27DA405F8A4E7A4F148CA00752EDC5C" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_B27DA405F8A4E7A4F148CA00752EDC5C" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_C0A0D11DD3F6AD150F03CA00752EDF53_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_C0A0D11DD3F6AD150F03CA00752EDF53" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Foreign tax credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_C0A0D11DD3F6AD150F03CA00752EDF53_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_C0A0D11DD3F6AD150F03CA00752EDF53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_C0A0D11DD3F6AD150F03CA00752EDF53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_C0A0D11DD3F6AD150F03CA00752EDF53" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_C0A0D11DD3F6AD150F03CA00752EDF53" xlink:type="arc" />
    <link:label id="lab_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_4BF534DE9914F195B7E2CA00752E8019_negatedTerseLabel_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_4BF534DE9914F195B7E2CA00752E8019" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">China tax related to divestiture</link:label>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_4BF534DE9914F195B7E2CA00752E8019_label_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_4BF534DE9914F195B7E2CA00752E8019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Tax Rate Reconciliation, Foreign Tax Related to Divestiture</link:label>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_4BF534DE9914F195B7E2CA00752E8019_documentation_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_4BF534DE9914F195B7E2CA00752E8019" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Tax Rate Reconciliation, Foreign Tax Related to Divestiture</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture" xlink:label="loc_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_4BF534DE9914F195B7E2CA00752E8019" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_4BF534DE9914F195B7E2CA00752E8019" xlink:to="lab_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_4BF534DE9914F195B7E2CA00752E8019" xlink:type="arc" />
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_CEF416F41365756DE1ABCA00752E7514_terseLabel_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_CEF416F41365756DE1ABCA00752E7514" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_CEF416F41365756DE1ABCA00752E7514_label_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_CEF416F41365756DE1ABCA00752E7514" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_CEF416F41365756DE1ABCA00752E7514_documentation_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_CEF416F41365756DE1ABCA00752E7514" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_CEF416F41365756DE1ABCA00752E7514" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_CEF416F41365756DE1ABCA00752E7514" xlink:to="lab_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_CEF416F41365756DE1ABCA00752E7514" xlink:type="arc" />
    <link:label id="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_D216042135D184754FACCA00752F6AAB_negatedTerseLabel_en-US" xlink:label="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_D216042135D184754FACCA00752F6AAB" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Opioid Litigation</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_D216042135D184754FACCA00752F6AAB_label_en-US" xlink:label="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_D216042135D184754FACCA00752F6AAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Opioid Litigation</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_D216042135D184754FACCA00752F6AAB_documentation_en-US" xlink:label="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_D216042135D184754FACCA00752F6AAB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Opioid Litigation</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:label="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_D216042135D184754FACCA00752F6AAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_D216042135D184754FACCA00752F6AAB" xlink:to="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_D216042135D184754FACCA00752F6AAB" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_9CC8D45ACE7630CBC2D4CA00752F1766_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_9CC8D45ACE7630CBC2D4CA00752F1766" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_9CC8D45ACE7630CBC2D4CA00752F1766_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_9CC8D45ACE7630CBC2D4CA00752F1766" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_9CC8D45ACE7630CBC2D4CA00752F1766" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_9CC8D45ACE7630CBC2D4CA00752F1766" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_9CC8D45ACE7630CBC2D4CA00752F1766" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_F8FF20558018D5156A75CA00752FEE87_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_F8FF20558018D5156A75CA00752FEE87" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_F8FF20558018D5156A75CA00752FEE87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_F8FF20558018D5156A75CA00752FEE87" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_F8FF20558018D5156A75CA00752FEE87" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23" xlink:type="arc" />
    <link:label id="lab_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4_terseLabel_en-US" xlink:label="lab_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accelerated share repurchase plan</link:label>
    <link:label id="lab_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4_label_en-US" xlink:label="lab_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">accelerated share repurchase plan [Member]</link:label>
    <link:label id="lab_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4_documentation_en-US" xlink:label="lab_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">accelerated share repurchase plan [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_AcceleratedsharerepurchaseplanMember" xlink:label="loc_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4" xlink:to="lab_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Accounting Principle, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Accounting Principle, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043" xlink:to="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043" xlink:type="arc" />
    <link:label id="lab_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Accounting Principle, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Accounting Principle, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411" xlink:to="lab_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411" xlink:type="arc" />
    <link:label id="lab_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12_terseLabel_en-US" xlink:label="lab_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement of Treasury Shares [Member]</link:label>
    <link:label id="lab_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12_label_en-US" xlink:label="lab_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement of Treasury Shares [Member]</link:label>
    <link:label id="lab_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12_documentation_en-US" xlink:label="lab_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Retirement of Treasury Shares [Member]</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_RetirementofTreasurySharesMember" xlink:label="loc_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12" xlink:to="lab_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A" xlink:to="lab_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:to="lab_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonClassAMember_A131CEEB2C70491410FEDD84B209EE9C_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember_A131CEEB2C70491410FEDD84B209EE9C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_A131CEEB2C70491410FEDD84B209EE9C_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember_A131CEEB2C70491410FEDD84B209EE9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_A131CEEB2C70491410FEDD84B209EE9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember_A131CEEB2C70491410FEDD84B209EE9C" xlink:to="lab_us-gaap_CommonClassAMember_A131CEEB2C70491410FEDD84B209EE9C" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonClassBMember_DF3BF7E221CCE351C98EDD84B20A175D_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember_DF3BF7E221CCE351C98EDD84B20A175D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Class B</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_DF3BF7E221CCE351C98EDD84B20A175D_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember_DF3BF7E221CCE351C98EDD84B20A175D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_DF3BF7E221CCE351C98EDD84B20A175D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember_DF3BF7E221CCE351C98EDD84B20A175D" xlink:to="lab_us-gaap_CommonClassBMember_DF3BF7E221CCE351C98EDD84B20A175D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="lab_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5125901CD457D3DE33E1DD84B20B5BDB_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5125901CD457D3DE33E1DD84B20B5BDB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5125901CD457D3DE33E1DD84B20B5BDB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5125901CD457D3DE33E1DD84B20B5BDB" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5125901CD457D3DE33E1DD84B20B5BDB" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_8E12941CB25F2CF13979DD84B20B0D70_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_8E12941CB25F2CF13979DD84B20B0D70" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_8E12941CB25F2CF13979DD84B20B0D70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_8E12941CB25F2CF13979DD84B20B0D70" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_8E12941CB25F2CF13979DD84B20B0D70" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_24B1DC087B02D1F52716DD84B20C07CF_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_24B1DC087B02D1F52716DD84B20C07CF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_24B1DC087B02D1F52716DD84B20C07CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_24B1DC087B02D1F52716DD84B20C07CF" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_24B1DC087B02D1F52716DD84B20C07CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6DC801689C16205EEDA0DD84B20C6C21_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6DC801689C16205EEDA0DD84B20C6C21" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares acquired, average price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6DC801689C16205EEDA0DD84B20C6C21_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6DC801689C16205EEDA0DD84B20C6C21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6DC801689C16205EEDA0DD84B20C6C21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6DC801689C16205EEDA0DD84B20C6C21" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6DC801689C16205EEDA0DD84B20C6C21" xlink:type="arc" />
    <link:label id="lab_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623_terseLabel_en-US" xlink:label="lab_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock Acquired Shares</link:label>
    <link:label id="lab_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623_label_en-US" xlink:label="lab_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock Acquired Shares</link:label>
    <link:label id="lab_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623_documentation_en-US" xlink:label="lab_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Treasury Stock Acquired Shares</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_TreasuryStockAcquiredShares" xlink:label="loc_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623" xlink:to="lab_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_84E4663FFD1D2185602BDD84B20D1D0A_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_84E4663FFD1D2185602BDD84B20D1D0A" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Retained earnings decrease</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84E4663FFD1D2185602BDD84B20D1D0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84E4663FFD1D2185602BDD84B20D1D0A" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_84E4663FFD1D2185602BDD84B20D1D0A" xlink:type="arc" />
    <link:label id="lab_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6_terseLabel_en-US" xlink:label="lab_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock, Voting Rights, Votes</link:label>
    <link:label id="lab_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6_label_en-US" xlink:label="lab_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Voting Rights, Votes</link:label>
    <link:label id="lab_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6_documentation_en-US" xlink:label="lab_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Voting Rights, Votes</link:label>
    <link:loc xlink:href="cah-20200630.xsd#cah_CommonStockVotingRightsVotes" xlink:label="loc_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6" xlink:to="lab_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>cah-20200630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="cah-20200630.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:href="cah-20200630.xsd#CommitmentsContingentLiabilitiesAndLitigation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:href="cah-20200630.xsd#CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:href="cah-20200630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cah-20200630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfEarnings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:href="cah-20200630.xsd#ConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresAndAcquisitions" xlink:href="cah-20200630.xsd#DivestituresAndAcquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails" xlink:href="cah-20200630.xsd#DivestituresAndAcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresAndAcquisitionsTables" xlink:href="cah-20200630.xsd#DivestituresAndAcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DocumentAndEntityInformation" xlink:href="cah-20200630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:href="cah-20200630.xsd#EarningsPerShareAttributableToCardinalHealthInc" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:href="cah-20200630.xsd#EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:href="cah-20200630.xsd#EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:href="cah-20200630.xsd#EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:href="cah-20200630.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="cah-20200630.xsd#FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:href="cah-20200630.xsd#FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:href="cah-20200630.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:href="cah-20200630.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20200630.xsd#FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:href="cah-20200630.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="cah-20200630.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Guarantees" xlink:href="cah-20200630.xsd#Guarantees" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:href="cah-20200630.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:href="cah-20200630.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails" xlink:href="cah-20200630.xsd#IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesTables" xlink:href="cah-20200630.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Investments" xlink:href="cah-20200630.xsd#Investments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/InvestmentsDetails" xlink:href="cah-20200630.xsd#InvestmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Leases" xlink:href="cah-20200630.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesDetails" xlink:href="cah-20200630.xsd#LeasesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" xlink:href="cah-20200630.xsd#LeasesScheduleOfFutureLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails" xlink:href="cah-20200630.xsd#LeasesScheduleOfLeaseCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="cah-20200630.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:href="cah-20200630.xsd#LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesTables" xlink:href="cah-20200630.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:href="cah-20200630.xsd#LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeverance" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:href="cah-20200630.xsd#RestructuringAndEmployeeSeveranceTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccounts" xlink:href="cah-20200630.xsd#ScheduleIiValuationsAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails" xlink:href="cah-20200630.xsd#ScheduleIiValuationsAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:href="cah-20200630.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:href="cah-20200630.xsd#SegmentInformationAssetsByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails" xlink:href="cah-20200630.xsd#SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:href="cah-20200630.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails" xlink:href="cah-20200630.xsd#SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:href="cah-20200630.xsd#SegmentInformationRevenueByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:href="cah-20200630.xsd#SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:href="cah-20200630.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnaudited" xlink:href="cah-20200630.xsd#SelectedQuarterlyFinancialDataUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" xlink:href="cah-20200630.xsd#SelectedQuarterlyFinancialDataUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedTables" xlink:href="cah-20200630.xsd#SelectedQuarterlyFinancialDataUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:href="cah-20200630.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:href="cah-20200630.xsd#ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:href="cah-20200630.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:href="cah-20200630.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="cah-20200630.xsd#ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:href="cah-20200630.xsd#ShareholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:href="cah-20200630.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8C443CC866BF806DD4A0064EB3CC13E9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_F9434EF6FB04FEF5F4B3064EB3CC669E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8C443CC866BF806DD4A0064EB3CC13E9" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_F9434EF6FB04FEF5F4B3064EB3CC669E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_AB3B440F41A294266821064EB39CE54E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_AB3B440F41A294266821064EB39CE54E" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:to="loc_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_F203A95F1B933C476ED7064EB39D10C1" xlink:to="loc_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_EEEAB1F7CAB617067545064EB39DF635" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:to="loc_srt_MaximumMember_EEEAB1F7CAB617067545064EB39DF635" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_69C47B255EA92E3BF6A3064EB39DD7F3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8C3A8ECDA42500B50337064EB39D1F72" xlink:to="loc_srt_MinimumMember_69C47B255EA92E3BF6A3064EB39DD7F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_58ECC7F7847E8E4E0A30064EB39EEB48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_ECEEA1892692362A6C26064EB39E9529" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_ECEEA1892692362A6C26064EB39E9529" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_CC42FE05B275D140A1A6064EB39EB62C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_CC42FE05B275D140A1A6064EB39EB62C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_31A1AB580CB3D9003138064EB39F3667" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_31A1AB580CB3D9003138064EB39F3667" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_A1B5A8461122662AA477064EB39F69D6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_01B0A6F208F8F9B86399064EB39E4841" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_A1B5A8461122662AA477064EB39F69D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0FC8F4FFFB07D5A49D57064EB39CCB18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9541103BEE1433EA2477064EB39FE301" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9541103BEE1433EA2477064EB39FE301" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_24DC60AF119D74F9C5BC064EB39F9954" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_NumberOfOperatingSegments_24DC60AF119D74F9C5BC064EB39F9954" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_B65D516B0BF0AF25AAF2064EB39FDD5E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_B65D516B0BF0AF25AAF2064EB39FDD5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_69C143D626DEBDD76915064EB3A09ADA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_69C143D626DEBDD76915064EB3A09ADA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_FBDE385EB2EB3A1F9DA1064EB3A07B66" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_FBDE385EB2EB3A1F9DA1064EB3A07B66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_EF21E9F0F7FA500D31C5064EB3A09766" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_83AEE28BBC06388D8E9E064EB39FB34B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_EF21E9F0F7FA500D31C5064EB3A09766" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_A102EA71433E46723ABFC4ECD05367FC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_A026CFDEE36B4C0D3CEAC4ECD054B87F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_A102EA71433E46723ABFC4ECD05367FC" xlink:to="loc_us-gaap_LossContingenciesTable_A026CFDEE36B4C0D3CEAC4ECD054B87F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_BFABB8494199F2623209C4ECD05486A1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_A026CFDEE36B4C0D3CEAC4ECD054B87F" xlink:to="loc_cah_OpioidLitigationAxis_BFABB8494199F2623209C4ECD05486A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F352B98D67D7092EF0E3C4ECD0543A32" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_BFABB8494199F2623209C4ECD05486A1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F352B98D67D7092EF0E3C4ECD0543A32" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_47936590FCCE8800E6BBC4ECD0554BDF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F352B98D67D7092EF0E3C4ECD0543A32" xlink:to="loc_cah_TotalOpioidLitigationMember_47936590FCCE8800E6BBC4ECD0554BDF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_596C8DF3F04B0B7AE5D9C4ECD0555FC3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F352B98D67D7092EF0E3C4ECD0543A32" xlink:to="loc_cah_TotalOpioidLitigationnetoftaxMember_596C8DF3F04B0B7AE5D9C4ECD0555FC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_0724C8D2B09CED11ED6DC4ECD055B1C3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_A026CFDEE36B4C0D3CEAC4ECD054B87F" xlink:to="loc_us-gaap_LossContingenciesLineItems_0724C8D2B09CED11ED6DC4ECD055B1C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_9B458BF12E73BB593D2EC4ECD055996F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0724C8D2B09CED11ED6DC4ECD055B1C3" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_9B458BF12E73BB593D2EC4ECD055996F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0D5B026EF3E09D28AD8AB5FF8B4F2DAC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_079F33318E4A0C7593D8B5FF8B4F07C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0D5B026EF3E09D28AD8AB5FF8B4F2DAC" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_079F33318E4A0C7593D8B5FF8B4F07C9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_22EECC3A72F8D60F0C1BB5FF91EE713E" xlink:type="locator" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodwillAndIntangibleAssetsTable" xlink:label="loc_cah_GoodwillAndIntangibleAssetsTable_594FBE0DBDF2CE8BCE25B5FF91EEA021" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22EECC3A72F8D60F0C1BB5FF91EE713E" xlink:to="loc_cah_GoodwillAndIntangibleAssetsTable_594FBE0DBDF2CE8BCE25B5FF91EEA021" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9611934B650493242A6AB5FF91EF9B38" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_594FBE0DBDF2CE8BCE25B5FF91EEA021" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9611934B650493242A6AB5FF91EF9B38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_0DBCA902B1F7632D3D03B5FF91EF68EF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9611934B650493242A6AB5FF91EF9B38" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_0DBCA902B1F7632D3D03B5FF91EF68EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_F82F75CAC2E0DCB1A766B5FF91F01BAB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_0DBCA902B1F7632D3D03B5FF91EF68EF" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_F82F75CAC2E0DCB1A766B5FF91F01BAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_8D429DE48395183185FEB5FF91F03889" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_594FBE0DBDF2CE8BCE25B5FF91EEA021" xlink:to="loc_srt_RangeAxis_8D429DE48395183185FEB5FF91F03889" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_D02B98140C8FDA3E85ABB5FF91F5B4AD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8D429DE48395183185FEB5FF91F03889" xlink:to="loc_srt_RangeMember_D02B98140C8FDA3E85ABB5FF91F5B4AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_92D4588D769DB90694B2B5FF91F685D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_D02B98140C8FDA3E85ABB5FF91F5B4AD" xlink:to="loc_srt_MinimumMember_92D4588D769DB90694B2B5FF91F685D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_F41402059CFB23046FCFB5FF91F60941" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_D02B98140C8FDA3E85ABB5FF91F5B4AD" xlink:to="loc_srt_MaximumMember_F41402059CFB23046FCFB5FF91F60941" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodwillAndIntangibleAssetsLineItems" xlink:label="loc_cah_GoodwillAndIntangibleAssetsLineItems_1AFDA89340C0C9391EDDB5FF91F62743" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_594FBE0DBDF2CE8BCE25B5FF91EEA021" xlink:to="loc_cah_GoodwillAndIntangibleAssetsLineItems_1AFDA89340C0C9391EDDB5FF91F62743" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_5016A167D467D3FC9F90B5FF91F6AB13" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_1AFDA89340C0C9391EDDB5FF91F62743" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_5016A167D467D3FC9F90B5FF91F6AB13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_7E3032E7F71F25499228B5FF91F7680A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_1AFDA89340C0C9391EDDB5FF91F62743" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_7E3032E7F71F25499228B5FF91F7680A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DiscountRatefairvalueinputs" xlink:label="loc_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_1AFDA89340C0C9391EDDB5FF91F62743" xlink:to="loc_cah_DiscountRatefairvalueinputs_CEC21F79CF627D975265B5FF91F76915" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_BEE47AE99F308C23FBF7B5FF91F7F04F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_1AFDA89340C0C9391EDDB5FF91F62743" xlink:to="loc_us-gaap_NumberOfOperatingSegments_BEE47AE99F308C23FBF7B5FF91F7F04F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1DEBA3F7DC4FC1894D6E064EB3AABC8A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PercentageOfLIFOInventory" xlink:label="loc_us-gaap_PercentageOfLIFOInventory_D929ED28DD2207754751064EB3AAFDB3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1DEBA3F7DC4FC1894D6E064EB3AABC8A" xlink:to="loc_us-gaap_PercentageOfLIFOInventory_D929ED28DD2207754751064EB3AAFDB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReserve" xlink:label="loc_us-gaap_InventoryLIFOReserve_A2DD491DA4ED198A27CF064EB3AAD06D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1DEBA3F7DC4FC1894D6E064EB3AABC8A" xlink:to="loc_us-gaap_InventoryLIFOReserve_A2DD491DA4ED198A27CF064EB3AAD06D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaap_InventoryValuationReserves_4729B519285950342455064EB3AA63AB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1DEBA3F7DC4FC1894D6E064EB3AABC8A" xlink:to="loc_us-gaap_InventoryValuationReserves_4729B519285950342455064EB3AA63AB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:type="extended" />
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_B4992183A0DFB49CF789064EB3ADE853" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_B4992183A0DFB49CF789064EB3ADE853" xlink:to="loc_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_BC8B7317AA71C52331FC064EB3AD64D1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071" xlink:to="loc_srt_MajorCustomersAxis_BC8B7317AA71C52331FC064EB3AD64D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_740FE08DD09C2DF1187D064EB3AED872" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_BC8B7317AA71C52331FC064EB3AD64D1" xlink:to="loc_srt_NameOfMajorCustomerDomain_740FE08DD09C2DF1187D064EB3AED872" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GroupPurchasingOrganizationsMember" xlink:label="loc_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_740FE08DD09C2DF1187D064EB3AED872" xlink:to="loc_cah_GroupPurchasingOrganizationsMember_A24EF57AB26C5DA1381D064EB3AEB5E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_4EC4F062936A140A9C8B064EB3AD2071" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:label="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:to="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_34345831DEB59451A483064EB3AE9985" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_CC4AADCDF766CE3B8E10064EB3AF3AE2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_88E65A6F02A1C54C0CB7064EB3AE4710" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_CC4AADCDF766CE3B8E10064EB3AF3AE2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_224B40154C99BA2891B2064EB3A4273C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5DEA1A20F1870E4573F4064EB3A4ADC3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_224B40154C99BA2891B2064EB3A4273C" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5DEA1A20F1870E4573F4064EB3A4ADC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ADEA82A83E3111F22693064EB3A5B353" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5DEA1A20F1870E4573F4064EB3A4ADC3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ADEA82A83E3111F22693064EB3A5B353" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17381C5079B341FD3689064EB3A51586" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ADEA82A83E3111F22693064EB3A5B353" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17381C5079B341FD3689064EB3A51586" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_AB561E399CD191A39875064EB3A540EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17381C5079B341FD3689064EB3A51586" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_AB561E399CD191A39875064EB3A540EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_EEE4294E0E45C82B9287064EB3A563D3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17381C5079B341FD3689064EB3A51586" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_EEE4294E0E45C82B9287064EB3A563D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_B63CAE2C595674203A0D064EB3A6D82B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17381C5079B341FD3689064EB3A51586" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_B63CAE2C595674203A0D064EB3A6D82B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_EEF6E63D362C707C1245064EB3A694CE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5DEA1A20F1870E4573F4064EB3A4ADC3" xlink:to="loc_srt_RangeAxis_EEF6E63D362C707C1245064EB3A694CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_AAA8072C8179A2822EE3064EB3A65C28" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_EEF6E63D362C707C1245064EB3A694CE" xlink:to="loc_srt_RangeMember_AAA8072C8179A2822EE3064EB3A65C28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_ABB1A32DDB6B0C23EB6D064EB3A68C5C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_AAA8072C8179A2822EE3064EB3A65C28" xlink:to="loc_srt_MinimumMember_ABB1A32DDB6B0C23EB6D064EB3A68C5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9B31D27B43304C58248D064EB3A6C535" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_AAA8072C8179A2822EE3064EB3A65C28" xlink:to="loc_srt_MaximumMember_9B31D27B43304C58248D064EB3A6C535" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6AD952CFFC7812AEFDE0064EB3A79B03" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5DEA1A20F1870E4573F4064EB3A4ADC3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6AD952CFFC7812AEFDE0064EB3A79B03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7B4F19EA7F1631BA5BF5064EB3A741C0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6AD952CFFC7812AEFDE0064EB3A79B03" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7B4F19EA7F1631BA5BF5064EB3A741C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_FCD3F566815411FCF720064EB3A7835F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6AD952CFFC7812AEFDE0064EB3A79B03" xlink:to="loc_us-gaap_Depreciation_FCD3F566815411FCF720064EB3A7835F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_93C2DDCB4E21BDC6821D064EB3A7BAD5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_224B40154C99BA2891B2064EB3A4273C" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_93C2DDCB4E21BDC6821D064EB3A7BAD5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_353410133FF714062CBA064EB3B83EC3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_353410133FF714062CBA064EB3B83EC3" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_121C963EBFCEBCE17E01064EB3B83306" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_121C963EBFCEBCE17E01064EB3B83306" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_76062F4F8A22F148455B064EB3B821AE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_121C963EBFCEBCE17E01064EB3B83306" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_76062F4F8A22F148455B064EB3B821AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_9B9758844D9C4E6C523C064EB3B9B1E8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_76062F4F8A22F148455B064EB3B821AE" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_9B9758844D9C4E6C523C064EB3B9B1E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_29A64E1798EA2B0665AE064EB3B9DD69" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_76062F4F8A22F148455B064EB3B821AE" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_29A64E1798EA2B0665AE064EB3B9DD69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_8B46ACC3864D5B8F45C1064EB3B96165" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:to="loc_srt_RangeAxis_8B46ACC3864D5B8F45C1064EB3B96165" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_B7047A76368F3D0CF6B6064EB3B9E340" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8B46ACC3864D5B8F45C1064EB3B96165" xlink:to="loc_srt_RangeMember_B7047A76368F3D0CF6B6064EB3B9E340" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1DC9DD832B5E2817AF5E064EB3BA550E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_B7047A76368F3D0CF6B6064EB3B9E340" xlink:to="loc_srt_MinimumMember_1DC9DD832B5E2817AF5E064EB3BA550E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_C4F7CA967C40B01E84D9064EB3BA04EF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_B7047A76368F3D0CF6B6064EB3B9E340" xlink:to="loc_srt_MaximumMember_C4F7CA967C40B01E84D9064EB3BA04EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_CA4D52CF732D4D810511064EB3BA4DC6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_CA4D52CF732D4D810511064EB3BA4DC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaap_ReceivableTypeDomain_CFE29001504C3047DA21064EB3BA8830" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_CA4D52CF732D4D810511064EB3BA4DC6" xlink:to="loc_us-gaap_ReceivableTypeDomain_CFE29001504C3047DA21064EB3BA8830" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_1663D8F8735A4F7506BF064EB3B8FAC9" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_205C8E6B83881DA3DC4A064EB3BB24AB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_205C8E6B83881DA3DC4A064EB3BB24AB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ReceivableFinancingAgreementTerm" xlink:label="loc_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:to="loc_cah_ReceivableFinancingAgreementTerm_F6D13E702C7FCECB70B4064EB3BB1704" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableNet" xlink:label="loc_us-gaap_NotesReceivableNet_E494DFB69F6E5233A534064EB3BB5405" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:to="loc_us-gaap_NotesReceivableNet_E494DFB69F6E5233A534064EB3BB5405" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_68B4563223042ADD5D53064EB3BBD944" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_391BDC790E4BB76F31C2064EB3BA7E2E" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_68B4563223042ADD5D53064EB3BBD944" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2269D57960FACB86CA51DD8506122A16" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2269D57960FACB86CA51DD8506122A16" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6D204303806E79C2015FDD8506135B62" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6D204303806E79C2015FDD8506135B62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_932C1C3A0684010B2D93DD850613F3E1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6D204303806E79C2015FDD8506135B62" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_932C1C3A0684010B2D93DD850613F3E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_35FE7C4155323B696E15DD8506142434" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_35FE7C4155323B696E15DD8506142434" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_A6E3C82709E95B33D8BCDD850614188D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_35FE7C4155323B696E15DD8506142434" xlink:to="loc_us-gaap_TypeOfAdoptionMember_A6E3C82709E95B33D8BCDD850614188D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:to="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_0027B55EA9C6530054EBDD850614D48A" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_89694891D0474CA55334DD8506141F2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_DB5B4B31029D03BE48BCDD850613D24D" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_7E3AA3DE7A68D45C1771DD850615713A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_7E3AA3DE7A68D45C1771DD850615713A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" xlink:label="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA7B124DC41B536430BDD8506157405" xlink:to="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_3660376939AE306195DBDD85061AA739" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8FC81B41E243C4C88726064EB38DBE46" xlink:type="locator" />
    <link:loc xlink:href="cah-20200630.xsd#cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:label="loc_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_33664A39C1FA7B3BA564064EB38E9D39" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8FC81B41E243C4C88726064EB38DBE46" xlink:to="loc_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_33664A39C1FA7B3BA564064EB38E9D39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns" xlink:label="loc_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_C149F2EF1B3BB15A62B7064EB38E5778" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8FC81B41E243C4C88726064EB38DBE46" xlink:to="loc_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_C149F2EF1B3BB15A62B7064EB38E5778" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_D002D963AA1684A98C93064EB38A9D94" xlink:type="locator" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodsandservicessoldTable" xlink:label="loc_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_D002D963AA1684A98C93064EB38A9D94" xlink:to="loc_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:to="loc_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_509B8E351F6A220C962C064EB38A6811" xlink:to="loc_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaap_ShippingAndHandlingMember_BADD039969B7627346AF064EB38BEA05" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_E65186A0857AC4B768FD064EB38BAD8B" xlink:to="loc_us-gaap_ShippingAndHandlingMember_BADD039969B7627346AF064EB38BEA05" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodsandservicessoldLineItems" xlink:label="loc_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodsandservicessoldTable_0DD7EAADB5F09754433E064EB38ADF6E" xlink:to="loc_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_BAFC52764AA23A12BBB7064EB38B6EA5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodsandservicessoldLineItems_4E1EC903CE067E4CAFF7064EB38BD3F3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_BAFC52764AA23A12BBB7064EB38B6EA5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_DD2F5CEE5D15A3EB0A66064EB39236C0" xlink:type="locator" />
    <link:loc xlink:href="cah-20200630.xsd#cah_VendorReserves" xlink:label="loc_cah_VendorReserves_B628E9AD1C2EA94D8D79064EB392DF24" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_DD2F5CEE5D15A3EB0A66064EB39236C0" xlink:to="loc_cah_VendorReserves_B628E9AD1C2EA94D8D79064EB392DF24" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_EB53EF43BAC6A0A204BEDDA1874E2090" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_EB53EF43BAC6A0A204BEDDA1874E2090" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_5774E2F19BEE6219EC8CDDA1874FAF89" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_UseOfEstimates_5774E2F19BEE6219EC8CDDA1874FAF89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_BD2F055D2D21D7C1C853DDA1874F52B9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_BD2F055D2D21D7C1C853DDA1874F52B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_AEE055263865F0B6CEE4DDA1874F686E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_AEE055263865F0B6CEE4DDA1874F686E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_62364E0488B8B6F07D3EDDA1874FC0A9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_62364E0488B8B6F07D3EDDA1874FC0A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_6F433AEEEA47E76A486DDDA18750CD2D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_6F433AEEEA47E76A486DDDA18750CD2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_14678DCE50383D842248DDA18750FF14" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_14678DCE50383D842248DDA18750FF14" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CashDiscountsPolicyTextBlock" xlink:label="loc_cah_CashDiscountsPolicyTextBlock_8BA3A49CE126825D6888DDA187509F52" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_cah_CashDiscountsPolicyTextBlock_8BA3A49CE126825D6888DDA187509F52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0F59B88EF928803769DBDDA18750BB8A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0F59B88EF928803769DBDDA18750BB8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_9DC6375CE8583BAB2455DDA18750AC9D" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_9DC6375CE8583BAB2455DDA18750AC9D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:label="loc_cah_AssetsHeldforSalePolicyPolicyTextBlock_831FAA570F6D4E701B7FDDA18751B472" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_cah_AssetsHeldforSalePolicyPolicyTextBlock_831FAA570F6D4E701B7FDDA18751B472" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_04199747E6410ECF14D8DDA187511A71" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_04199747E6410ECF14D8DDA187511A71" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:label="loc_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5867B236276DEC3D127ADDA187517C73" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5867B236276DEC3D127ADDA187517C73" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:label="loc_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_1DF3167D5532DD5492E9DDA18751ADAF" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_1DF3167D5532DD5492E9DDA18751ADAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_DD36B48405AB8D51CEDBDDA18752545F" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_DD36B48405AB8D51CEDBDDA18752545F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_B89DD0AC72F11578C503DDA18752BE0D" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_B89DD0AC72F11578C503DDA18752BE0D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:label="loc_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_A1016052F2BB6BB2D342DDA18752C4AB" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_A1016052F2BB6BB2D342DDA18752C4AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_60339C8FCD06F51EF1FCDDA187521551" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_60339C8FCD06F51EF1FCDDA187521551" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7FCF891D2524F8664EABDDA18752025D" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7FCF891D2524F8664EABDDA18752025D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DividendsPolicyPolicyTextBlock" xlink:label="loc_cah_DividendsPolicyPolicyTextBlock_E4803F6DCFD21F7CEC0ADDA18752B7A3" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_cah_DividendsPolicyPolicyTextBlock_E4803F6DCFD21F7CEC0ADDA18752B7A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_B0CE098229AD1DDC92A7DDA187532143" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_B0CE098229AD1DDC92A7DDA187532143" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_SalesreturnsPolicyTextBlock" xlink:label="loc_cah_SalesreturnsPolicyTextBlock_E341C9E1C233D03C13AADDA187533B41" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_cah_SalesreturnsPolicyTextBlock_E341C9E1C233D03C13AADDA187533B41" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ShippingandHandlingCostsPolicyTextBlock" xlink:label="loc_cah_ShippingandHandlingCostsPolicyTextBlock_7E098F802CE8A64BB9BDDDA18753B147" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_cah_ShippingandHandlingCostsPolicyTextBlock_7E098F802CE8A64BB9BDDDA18753B147" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0E3B0ED68E6C6A21E9BBDDA18753D7C0" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0E3B0ED68E6C6A21E9BBDDA18753D7C0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:label="loc_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_7A018B16891B16F4D149DDA187539848" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_7A018B16891B16F4D149DDA187539848" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_F0A18ECF74F374652FFBDDA187538796" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_F0A18ECF74F374652FFBDDA187538796" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:label="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_0E8FB532E1648C56298DDDA187530ABA" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_0E8FB532E1648C56298DDDA187530ABA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4CE8C40A395B83B28AEBDDA187541A4C" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4CE8C40A395B83B28AEBDDA187541A4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_47BA20482B5848F0F275DDA187548A3E" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_47BA20482B5848F0F275DDA187548A3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_D0CD7F2D5884639B99D2DDA187543E5B" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6FA1000CAD9615C10232DDA1874EC30B" xlink:to="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_D0CD7F2D5884639B99D2DDA187543E5B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_94478CBADAADDD568DE9064EB3B24DBF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_94478CBADAADDD568DE9064EB3B24DBF" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_160DBEC11BAC1997CBD1064EB3B22ABA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_160DBEC11BAC1997CBD1064EB3B22ABA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_B87CEC7F240A2E55B5A5064EB3B2EA0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_160DBEC11BAC1997CBD1064EB3B22ABA" xlink:to="loc_us-gaap_SegmentDomain_B87CEC7F240A2E55B5A5064EB3B2EA0B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_43AC0EE9CE5D04C2F0C0064EB3B3FCDA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_B87CEC7F240A2E55B5A5064EB3B2EA0B" xlink:to="loc_cah_PharmaceuticalMember_43AC0EE9CE5D04C2F0C0064EB3B3FCDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:to="loc_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_7653422756353EAE86D5064EB3B3B6C9" xlink:to="loc_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CVSCaremarkCorporationMember" xlink:label="loc_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:to="loc_cah_CVSCaremarkCorporationMember_7D094FC66B042F28AB10064EB3B3F7A2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OptumRxMember" xlink:label="loc_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_D89BEF0D11A972BE97FC064EB3B32CFA" xlink:to="loc_cah_OptumRxMember_40E6D3599B6AC220F566064EB3B47967" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9F2FD21FF8F539EC09B8064EB3B27DAE" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_653E1BCC90973C8125E9064EB3B4F442" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_653E1BCC90973C8125E9064EB3B4F442" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:label="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_11D2CE93D937ED67668E064EB3B445D7" xlink:to="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_2F19386C1D37547C2B42064EB3B40035" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_13A021EC34245A1E0873064EB3BEA59C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_91E3A9D724F89FB91497064EB3BEE323" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_13A021EC34245A1E0873064EB3BEA59C" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_91E3A9D724F89FB91497064EB3BEE323" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1396FDC82E3826E79A7E064EB3BE08D1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_13A021EC34245A1E0873064EB3BEA59C" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1396FDC82E3826E79A7E064EB3BE08D1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5CAB406079FCF4625726064EB2784CFC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8CC0548D71CCB00356ED064EB278AB41" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5CAB406079FCF4625726064EB2784CFC" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8CC0548D71CCB00356ED064EB278AB41" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3879354E099AEAAD8FCCE4F266F3A891" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3879354E099AEAAD8FCCE4F266F3A891" xlink:to="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LawsuitTypeAxis" xlink:label="loc_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LawsuitTypeDomain" xlink:label="loc_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LawsuitTypeAxis_92FB47FF523AE00A9B9BE4F266F3E256" xlink:to="loc_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ClassActionLawsuitsMember" xlink:label="loc_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LawsuitTypeDomain_33122AE7A7F895B73B28E4F266F9D005" xlink:to="loc_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PlaintiffTypeAxis" xlink:label="loc_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PlaintiffTypeDomain" xlink:label="loc_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PlaintiffTypeAxis_569E13D44675D3EA6B0FE4F266F9A609" xlink:to="loc_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PrivatePartiesMember" xlink:label="loc_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PlaintiffTypeDomain_9CBC5DE5E3B4C4D99347E4F266FA8993" xlink:to="loc_cah_PrivatePartiesMember_12C43705FAFDDC35E750E4F266FA9CC4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_D2C1FBE521F533A10EDBE4F266FA47FC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_cah_OpioidLitigationAxis_D2C1FBE521F533A10EDBE4F266FA47FC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_A504A74EC1C9BF3F1499E4F266FA15CC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_D2C1FBE521F533A10EDBE4F266FA47FC" xlink:to="loc_cah_OpioidLitigationDomain_A504A74EC1C9BF3F1499E4F266FA15CC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_63817EA92916BF43C36FE4F266FB3418" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_A504A74EC1C9BF3F1499E4F266FA15CC" xlink:to="loc_cah_TotalOpioidLitigationnetoftaxMember_63817EA92916BF43C36FE4F266FB3418" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_E69840A55A12CF56F7AAE4F266FBA0FB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_A504A74EC1C9BF3F1499E4F266FA15CC" xlink:to="loc_cah_TotalOpioidLitigationMember_E69840A55A12CF56F7AAE4F266FBA0FB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GownRecallAxis" xlink:label="loc_cah_GownRecallAxis_8B5FB66D9A9B544A9841E4F266FB2391" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_cah_GownRecallAxis_8B5FB66D9A9B544A9841E4F266FB2391" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_F896145E7A29E704195DE4F266FBCB74" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GownRecallAxis_8B5FB66D9A9B544A9841E4F266FB2391" xlink:to="loc_cah_GownRecallDomain_F896145E7A29E704195DE4F266FBCB74" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_SterileSurgicalGownRecallMemberDomain" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GownRecallAxis_8B5FB66D9A9B544A9841E4F266FB2391" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_7D252F7C99DD8096EF04E4F266FC76B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_808E9655A39C7E768E11E4F266FC3C3C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_srt_RangeAxis_808E9655A39C7E768E11E4F266FC3C3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_3BC1B89A16F9A70668BBE4F266FCFAED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_808E9655A39C7E768E11E4F266FC3C3C" xlink:to="loc_srt_RangeMember_3BC1B89A16F9A70668BBE4F266FCFAED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_568429AB002BFF7986C3E4F266FCDB14" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3BC1B89A16F9A70668BBE4F266FCFAED" xlink:to="loc_srt_MinimumMember_568429AB002BFF7986C3E4F266FCDB14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_B7D8479E7DE7853D15E8E4F266FC2626" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3BC1B89A16F9A70668BBE4F266FCFAED" xlink:to="loc_srt_MaximumMember_B7D8479E7DE7853D15E8E4F266FC2626" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_0C28C07C6E11270E53E5E4F266FD7119" xlink:to="loc_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_04163EA5517BCFE4D396E4F266FD1C6C" xlink:to="loc_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LitigationTypeAxis" xlink:label="loc_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LitigationTypeDomain" xlink:label="loc_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LitigationTypeAxis_D481EDC10F212F988CB7E4F26703CED8" xlink:to="loc_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LitigationTypeDomain_8E0A0E788392E6202295E4F267031A32" xlink:to="loc_cah_ClassActionLawsuitsMember_928ABC9AC2EA33175105E4F266F93FC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_3C3B6FB2C3400F0423A3E4F267032903" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_srt_StatementGeographicalAxis_3C3B6FB2C3400F0423A3E4F267032903" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_CCC1E62FFB5378990F00E4F267043CA4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_3C3B6FB2C3400F0423A3E4F267032903" xlink:to="loc_srt_SegmentGeographicalDomain_CCC1E62FFB5378990F00E4F267043CA4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AlamedaCountyMember" xlink:label="loc_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_CCC1E62FFB5378990F00E4F267043CA4" xlink:to="loc_cah_AlamedaCountyMember_A5F7E2FAAB3C757FFFA6E4F267043706" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OtherJurisdictionsMember" xlink:label="loc_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_CCC1E62FFB5378990F00E4F267043CA4" xlink:to="loc_cah_OtherJurisdictionsMember_4E78DDD246F8E49A2EE6E4F2670458BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_EBE1D67CCA486A50B8ECE4F2670402BA" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_95F4D77CE73B579D8AA5E4F267040967" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_2FC144582B23A455E70FE4F267059E80" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_srt_MajorCustomersAxis_2FC144582B23A455E70FE4F267059E80" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_7537FCE576797D252904E4F267053B11" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_2FC144582B23A455E70FE4F267059E80" xlink:to="loc_srt_NameOfMajorCustomerDomain_7537FCE576797D252904E4F267053B11" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7537FCE576797D252904E4F267053B11" xlink:to="loc_cah_CVSHealthMember_88D02945B8404A466CD5E4F2670211D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_F3CF1C60965560F42DB9E4F26705841C" xlink:to="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:to="loc_cah_OpioidLawsuitsMember_9B9149469C0E5B21AFEDE4F2670B5DB5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLawsuitsStateDomain" xlink:label="loc_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:to="loc_cah_OpioidLawsuitsStateDomain_B69A0850E34F9C69F2CEE4F2670B3C29" xlink:type="arc" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_477CBDF41F4587C1BEAAE4F26702422B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:to="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_0101FFB65E6CBB7556AEE4F2670C8F04" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6A73AF4C4671B7CD12E4F267064F9A" xlink:to="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_1BC690DF17638C64F489E4F2670C2EA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2DEB7BA7D5125281E699E4F2670CF543" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_EA94F10A738D69BE0183E4F2670DD1D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_08FBEE3C5831189E6528E4F2670D8926" xlink:to="loc_us-gaap_SubsequentEventMember_EA94F10A738D69BE0183E4F2670DD1D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_624982F82F492F3A9077E4F266F3FDF2" xlink:to="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_B004444270C90B6B1D3CE4F2670D711E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_LitigationReserve_B004444270C90B6B1D3CE4F2670D711E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CashComponentForSettlementFrameworkTerm" xlink:label="loc_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_cah_CashComponentForSettlementFrameworkTerm_FD0F9C256201A822E4E7E4F2670E13E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRecallExpense" xlink:label="loc_us-gaap_InventoryRecallExpense_A8AAF1D270B5D0BA7AA4E4F2670EAA54" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_InventoryRecallExpense_A8AAF1D270B5D0BA7AA4E4F2670EAA54" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MaximumQuarterlyPayment" xlink:label="loc_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_cah_MaximumQuarterlyPayment_276BD20B8117C51CE18EE4F2670ED834" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_BC24CF81B273875EF0CBE4F2670E7850" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_BC24CF81B273875EF0CBE4F2670E7850" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_E84F61A0453080425FBFE4F2670FC998" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_E84F61A0453080425FBFE4F2670FC998" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2A4A50E8E0AC74FD6AD8E4F2670F78B2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2A4A50E8E0AC74FD6AD8E4F2670F78B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_845630B1D6547349B991E4F26F33B679" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_845630B1D6547349B991E4F26F33B679" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_IncomefromSettlementsofClassActionLawsuits" xlink:label="loc_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_cah_IncomefromSettlementsofClassActionLawsuits_075CD460EFB783DE74E0E4F2670F0A36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_8081B88345B6152E519AE4F267149D0B" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_8081B88345B6152E519AE4F267149D0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8C5FD0D4943FAB06E2C5E4F26714157E" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8C5FD0D4943FAB06E2C5E4F26714157E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidTotalSettlementCuyahogaandSummitCounties" xlink:label="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_93B8C20127A58C678486E4F26715C863" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_F958C6569E1677C1DA36E4F267158030" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_F958C6569E1677C1DA36E4F267158030" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LossContingencyLawsuitsNumber" xlink:label="loc_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_cah_LossContingencyLawsuitsNumber_A281745971D51483F443E4F2671536DC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:label="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_F090A94953D90FD8A20AE4F2670D7AE7" xlink:to="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_B88A314B8DD88462A51AE4F267150F49" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_F68ED68E22C824FA3C47DDA1B14CF17B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_F68ED68E22C824FA3C47DDA1B14CF17B" xlink:to="loc_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34" xlink:to="loc_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7C6AFF8514B3E5C9F119DDA1B14DD1A3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7C6AFF8514B3E5C9F119DDA1B14DD1A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_54DE0F981FF44CC43388DDA1B14DA5F0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819" xlink:to="loc_us-gaap_ReceivablesNetCurrent_54DE0F981FF44CC43388DDA1B14DA5F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_8D4374F9FDDA481A0005DDA1B14E33DC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819" xlink:to="loc_us-gaap_InventoryNet_8D4374F9FDDA481A0005DDA1B14E33DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_2EA5E843C669CF0F2F44DDA1B14EE57E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819" xlink:to="loc_us-gaap_OtherAssetsCurrent_2EA5E843C669CF0F2F44DDA1B14EE57E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_E1824EB36274E31C46DEDDA1B14E896D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0E3247C5D7E7A35C817FDDA1B14DE819" xlink:to="loc_us-gaap_AssetsCurrent_E1824EB36274E31C46DEDDA1B14E896D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_010C4F01A368DA23ADA6DDA1B14E5626" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_010C4F01A368DA23ADA6DDA1B14E5626" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_F0ECA4CDAE6706062BB4DDA1B14E42FE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_F0ECA4CDAE6706062BB4DDA1B14E42FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_305C5012468D842940BDDDA1B14F2833" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_305C5012468D842940BDDDA1B14F2833" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_990F71900491ADC40353DDA1B14FECB0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_C711E6F9E0C6DB44167FDDA1B14CBA34" xlink:to="loc_us-gaap_Assets_990F71900491ADC40353DDA1B14FECB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_F68ED68E22C824FA3C47DDA1B14CF17B" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_D33B98D501C9F248798DDDA1B14FC66F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56" xlink:to="loc_us-gaap_AccountsPayableCurrent_D33B98D501C9F248798DDDA1B14FC66F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_26151C1412A32BC03F1FDDA1B151E609" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_26151C1412A32BC03F1FDDA1B151E609" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4571A9485109560CEE72DDA1B1516D44" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4571A9485109560CEE72DDA1B1516D44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_CB6B79CE20576BBA13A8DDA1B1519893" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_262EA26118EA50A0FD1FDDA1B14F9A56" xlink:to="loc_us-gaap_LiabilitiesCurrent_CB6B79CE20576BBA13A8DDA1B1519893" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_3058F02A9956BDF16DF7DDA1B151DE16" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_3058F02A9956BDF16DF7DDA1B151DE16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_804EA0990000473440BADDA1B1512268" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_804EA0990000473440BADDA1B1512268" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D" xlink:to="loc_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_41AE489696C3A7BF0B47DDA1B1518342" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:to="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_41AE489696C3A7BF0B47DDA1B1518342" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_2383A25C5E9F4EE14DB7DDA1B1519F25" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_41AE489696C3A7BF0B47DDA1B1518342" xlink:to="loc_us-gaap_PreferredStockValue_2383A25C5E9F4EE14DB7DDA1B1519F25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_7DD2CFDA7C96C888C6D3DDA1B151AFA3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_7DD2CFDA7C96C888C6D3DDA1B151AFA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_C589590279FB79C741FFDDA1B1529CA6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_7DD2CFDA7C96C888C6D3DDA1B151AFA3" xlink:to="loc_us-gaap_CommonStockValue_C589590279FB79C741FFDDA1B1529CA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3E0F5EE17860B0F3976FDDA1B1524E2C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3E0F5EE17860B0F3976FDDA1B1524E2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_3D140956AC52D6DB6567DDA1B152401E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:to="loc_us-gaap_TreasuryStockValue_3D140956AC52D6DB6567DDA1B152401E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4EAA541681FCCE8D7866DDA1B1520B1C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4EAA541681FCCE8D7866DDA1B1520B1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_6BAF34F08D59F1926775DDA1B1529C94" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:to="loc_us-gaap_StockholdersEquity_6BAF34F08D59F1926775DDA1B1529C94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_E746029CF90BE2703139DDA1B153E773" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:to="loc_us-gaap_MinorityInterest_E746029CF90BE2703139DDA1B153E773" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_96907104661768C07984DDA1B1530AE3" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_CFF56E52F9105677CD63DDA1B1510052" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_96907104661768C07984DDA1B1530AE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_FE1099F94BBFE47B4159DDA1B1538A80" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E6E7C45411A30409D1D9DDA1B14F417D" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_FE1099F94BBFE47B4159DDA1B1538A80" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_18CDBB1659F6386FA471DDA1F606B239" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1033C8834694F1780E4FDDA1F606CBAC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_18CDBB1659F6386FA471DDA1F606B239" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1033C8834694F1780E4FDDA1F606CBAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_F5DA07283F6B4609552DDDA1F6065A2A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_18CDBB1659F6386FA471DDA1F606B239" xlink:to="loc_us-gaap_PreferredStockSharesIssued_F5DA07283F6B4609552DDDA1F6065A2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_AC05C48DECCCE37E4054DDA1F607C41F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_18CDBB1659F6386FA471DDA1F606B239" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_AC05C48DECCCE37E4054DDA1F607C41F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_5CB7E50BA0FA777C7C6CDDA1F607D449" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_18CDBB1659F6386FA471DDA1F606B239" xlink:to="loc_us-gaap_CommonStockSharesIssued_5CB7E50BA0FA777C7C6CDDA1F607D449" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_02A56F2BCE546D2BDF12DDA1F6074431" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_18CDBB1659F6386FA471DDA1F606B239" xlink:to="loc_us-gaap_TreasuryStockShares_02A56F2BCE546D2BDF12DDA1F6074431" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A3AE88F8AD7F561F2B70DE783AD65BCD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A3AE88F8AD7F561F2B70DE783AD65BCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_743EA8E916C0910DFEBCDE783AD63C55" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A3AE88F8AD7F561F2B70DE783AD65BCD" xlink:to="loc_us-gaap_ProfitLoss_743EA8E916C0910DFEBCDE783AD63C55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A3AE88F8AD7F561F2B70DE783AD65BCD" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_E33A2F78C15346563145DE783AD7F606" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_E33A2F78C15346563145DE783AD7F606" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_33B9AD2FF775B32A7AD2DE783AD76268" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:to="loc_us-gaap_LossOnSaleOfInvestments_33B9AD2FF775B32A7AD2DE783AD76268" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_6E5E731447196AFC87CFDE783AD76985" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_6E5E731447196AFC87CFDE783AD76985" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_01841B9F13BA2FEC7642DE783AD7297F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_01841B9F13BA2FEC7642DE783AD7297F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6A27E4D01BD2A66C14EBDE783AD83E1E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6A27E4D01BD2A66C14EBDE783AD83E1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_1FF0DB4901BA29324FD1DE783AD820AD" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:to="loc_us-gaap_ShareBasedCompensation_1FF0DB4901BA29324FD1DE783AD820AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_22E2AAF25B04C5096414DE783AD886B7" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_22E2AAF25B04C5096414DE783AD886B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_08F753E93DA4CDBC4EC4DE783ADD46C6" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_08F753E93DA4CDBC4EC4DE783ADD46C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E6FE367E2BB7AD8025BBDE783ADD8FE7" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E6FE367E2BB7AD8025BBDE783ADD8FE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F4055B8B7158114F81A2DE783AD65110" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_E843BCD256C4E0F64780DE783ADE9082" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_E843BCD256C4E0F64780DE783ADE9082" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_C027BB595681EF7AF942DE783ADE199C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_C027BB595681EF7AF942DE783ADE199C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_292C7AA6AA550E61380BDE783ADEDDEB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_292C7AA6AA550E61380BDE783ADEDDEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1B269A72DFE8C3CCA2DBDE783ADE1631" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78DD8CDD4F853585FF8DDE783ADE8D11" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1B269A72DFE8C3CCA2DBDE783ADE1631" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_28E0106398D675EFBB8BDE783ADF6090" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A3AE88F8AD7F561F2B70DE783AD65BCD" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_28E0106398D675EFBB8BDE783ADF6090" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_AA9C2FFE201244ED4655DE783ADF753C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_AA9C2FFE201244ED4655DE783ADF753C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0059BD1BFE376E922F72DE783ADF9566" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0059BD1BFE376E922F72DE783ADF9566" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_A4F7E263AD123A75BC25DE783ADF1E33" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:to="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_A4F7E263AD123A75BC25DE783ADF1E33" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_98FFEEDBFDB173C18ADBDE783AE06E7F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:to="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_98FFEEDBFDB173C18ADBDE783AE06E7F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" xlink:label="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_D61410D64B86462AACE5DE783AE0CC15" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:to="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_D61410D64B86462AACE5DE783AE0CC15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2E76DC30B0AD497D9B81DE783AE0D9D7" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_C5C8BFED9A4590651125DE783ADF360E" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2E76DC30B0AD497D9B81DE783AE0D9D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PaymentofContingentConsideration" xlink:label="loc_cah_PaymentofContingentConsideration_C22895BC4E679B6B7952DE783AE0F2C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:to="loc_cah_PaymentofContingentConsideration_C22895BC4E679B6B7952DE783AE0F2C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_14C584F90426B2179AB4DE783AE130A9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_14C584F90426B2179AB4DE783AE130A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_F5C035BEFA36A87E4976DF5037A810C6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_F5C035BEFA36A87E4976DF5037A810C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_4D45B23F4CDA2998D6F8DE783AE1BE05" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_4D45B23F4CDA2998D6F8DE783AE1BE05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_9EC077F0BA1DF954ED4CDE783AE6603E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_9EC077F0BA1DF954ED4CDE783AE6603E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_1162FE5A94705586C97FDE783AE6BD57" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_1162FE5A94705586C97FDE783AE6BD57" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_871D94758FBDF479534EDE783AE7DDF1" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_871D94758FBDF479534EDE783AE7DDF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_4964FF3C1BE4F8D6E3F8DE783AE77E2B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_4964FF3C1BE4F8D6E3F8DE783AE77E2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_FC2C57A19F52DC52CEBFDE783AE7A42E" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_FC2C57A19F52DC52CEBFDE783AE7A42E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_006D17C19F48FEAC951DDE783AE7FCC5" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_006D17C19F48FEAC951DDE783AE7FCC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7346B4AA501F2233DE8FDE783AE7A58F" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2DA5E7E48DD269774DE4DE783AE013B4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7346B4AA501F2233DE8FDE783AE7A58F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_A5AAB08A95EF38FA5A19DE783AE7B73A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_A5AAB08A95EF38FA5A19DE783AE7B73A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CashReclassifiedtoAssetsHeldforSale" xlink:label="loc_cah_CashReclassifiedtoAssetsHeldforSale_05D98B053BAD3EF9D4D8DE783AE83854" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:to="loc_cah_CashReclassifiedtoAssetsHeldforSale_05D98B053BAD3EF9D4D8DE783AE83854" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_D1FA0366DFB4E3197F04DF2FC817CA89" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_D1FA0366DFB4E3197F04DF2FC817CA89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_75569104994D7519E817DE783AE82537" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_75569104994D7519E817DE783AE82537" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_E33D32C636F411AFD600DE783AE8A468" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_E33D32C636F411AFD600DE783AE8A468" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_225B08A0CE00F5DAAA80DE783AE86208" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8172F3BA762D38A78FD1DE783AD69334" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_225B08A0CE00F5DAAA80DE783AE86208" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_EE3D112327F4F54FC81ADE783AE844FE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_225B08A0CE00F5DAAA80DE783AE86208" xlink:to="loc_us-gaap_InterestPaidNet_EE3D112327F4F54FC81ADE783AE844FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_58FF4821FA36AA83A7F6DE783AE9FEBD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_225B08A0CE00F5DAAA80DE783AE86208" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_58FF4821FA36AA83A7F6DE783AE9FEBD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_16B0E1ED4A9E2849CDC0A57610232439" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_3992DBA0A62A5C2705CEA57610234AD3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_16B0E1ED4A9E2849CDC0A57610232439" xlink:to="loc_us-gaap_ProfitLoss_3992DBA0A62A5C2705CEA57610234AD3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_16B0E1ED4A9E2849CDC0A57610232439" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_FF089B484F91FD3AB7A2A57610238D44" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_FF089B484F91FD3AB7A2A57610238D44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_76BFE5CA939EE1ABF540A57610241282" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_76BFE5CA939EE1ABF540A57610241282" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_F75F041699A8C9BA2035A5761024FA12" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_F75F041699A8C9BA2035A5761024FA12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5BC0998A4F6C690F515BA5761024578C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_F44E9B1B0D6ABD1F82A8A5761023BCD0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5BC0998A4F6C690F515BA5761024578C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ED0B98A23B715AA1F912A57610258518" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_16B0E1ED4A9E2849CDC0A57610232439" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ED0B98A23B715AA1F912A57610258518" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1AEC59C21939C41C39C4A57610250117" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_16B0E1ED4A9E2849CDC0A57610232439" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1AEC59C21939C41C39C4A57610250117" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_DD7ED5646E48C5BB39A9A5761025DFD2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_16B0E1ED4A9E2849CDC0A57610232439" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_DD7ED5646E48C5BB39A9A5761025DFD2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_2B56DA2F05B413F7A15CE2EE20098298" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_Revenues_2B56DA2F05B413F7A15CE2EE20098298" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_95BA1E38FCC891493D66E2EE200DECE3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_95BA1E38FCC891493D66E2EE200DECE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_9E3BA4F9081ADC851C1CE2EE200E65C2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_GrossProfit_9E3BA4F9081ADC851C1CE2EE200E65C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7B7D7573DD8756A1EEE3E2EE200E4416" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7B7D7573DD8756A1EEE3E2EE200E4416" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_963F1E8BAD18181505D0E2EE200FC741" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A" xlink:to="loc_us-gaap_RestructuringCharges_963F1E8BAD18181505D0E2EE200FC741" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Amortizationandotheracquisitionrelatedcosts" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_D8A86B2B0F68812442F4E2EE200F5D8A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A" xlink:to="loc_cah_Amortizationandotheracquisitionrelatedcosts_D8A86B2B0F68812442F4E2EE200F5D8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_30DDD3FFAD615BE6924FE2EE200FCE5D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_30DDD3FFAD615BE6924FE2EE200FCE5D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_0841BD1E7D897CE4336EE2EE2010A101" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9839F61F85FEA2D31D2CE2EE200E298A" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_0841BD1E7D897CE4336EE2EE2010A101" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_361CE081DE297D781E8EE2EE2010C500" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_OperatingIncomeLoss_361CE081DE297D781E8EE2EE2010C500" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_D66587F53588F6389584E2EE2010C3C6" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_D66587F53588F6389584E2EE2010C3C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_ED009D5BC3834890D4D1E2EE2011B14D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_InterestExpense_ED009D5BC3834890D4D1E2EE2011B14D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_F2A515F64E8CDCE5401BE2EE2011160C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_F2A515F64E8CDCE5401BE2EE2011160C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_90D69F0BD3238E583112E2EE20113567" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_90D69F0BD3238E583112E2EE20113567" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_D2F4F276243510D5599FE2EE20119A3C" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_D2F4F276243510D5599FE2EE20119A3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4D07FE12510B719A45ABE2EE2011AB07" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4D07FE12510B719A45ABE2EE2011AB07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_0D5554A6D11BFE78B995E2EE20127620" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_ProfitLoss_0D5554A6D11BFE78B995E2EE20127620" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_E2F9C6A1E44B6280C4A6E2EE2012FF5D" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_E2F9C6A1E44B6280C4A6E2EE2012FF5D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_78BBA9B95D3BF5E554C2E2EE20121A42" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_NetIncomeLoss_78BBA9B95D3BF5E554C2E2EE20121A42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_2B877EC8B09F1EAA32A4E2EE2012A550" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_2B877EC8B09F1EAA32A4E2EE2012A550" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_E493A61ABCE0680BBD1CE2EE20126B7A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_2B877EC8B09F1EAA32A4E2EE2012A550" xlink:to="loc_us-gaap_EarningsPerShareBasic_E493A61ABCE0680BBD1CE2EE20126B7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_CBA4EC92F77BBB296E7FE2EE2013B431" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_2B877EC8B09F1EAA32A4E2EE2012A550" xlink:to="loc_us-gaap_EarningsPerShareDiluted_CBA4EC92F77BBB296E7FE2EE2013B431" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00F7F43D67B584C836A9E2EE2013020A" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2A72A460356A71025D32E2EE200454D8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00F7F43D67B584C836A9E2EE2013020A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CEF663774DA26C17971CE2EE2013D302" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00F7F43D67B584C836A9E2EE2013020A" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CEF663774DA26C17971CE2EE2013D302" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B67A8121BFF7F945D1C5E2EE20148C38" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_00F7F43D67B584C836A9E2EE2013020A" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B67A8121BFF7F945D1C5E2EE20148C38" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7533967D8BCF254E6F61E457F1BC40FE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_AF24462AFA43B4C92FACE457F1C17562" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7533967D8BCF254E6F61E457F1BC40FE" xlink:to="loc_us-gaap_StatementTable_AF24462AFA43B4C92FACE457F1C17562" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_AF24462AFA43B4C92FACE457F1C17562" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3B3ABB6DB2B7D85FDDDBE457F1C2BECD" xlink:to="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_C9CB369BD92D9ED19984E457F1C2F2AC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:to="loc_us-gaap_CommonStockMember_C9CB369BD92D9ED19984E457F1C2F2AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_7956F1A400BB6D849480E457F1C3F751" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:to="loc_us-gaap_RetainedEarningsMember_7956F1A400BB6D849480E457F1C3F751" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_2E3BCB4817923CC7D3A3E457F1C39D21" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:to="loc_us-gaap_TreasuryStockMember_2E3BCB4817923CC7D3A3E457F1C39D21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7CC217BC102F4D5F9BE2E457F1C3464E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7CC217BC102F4D5F9BE2E457F1C3464E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9B142BF7EF0B34A82C13E457F1C323D7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_FA9418FE0C4AF2F6C677E457F1C2A9F4" xlink:to="loc_us-gaap_NoncontrollingInterestMember_9B142BF7EF0B34A82C13E457F1C323D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_59FA159A28AB19B1489FE457F1C4966C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_AF24462AFA43B4C92FACE457F1C17562" xlink:to="loc_us-gaap_StatementLineItems_59FA159A28AB19B1489FE457F1C4966C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_152AF61C5544993318ADE457F1C4B053" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_59FA159A28AB19B1489FE457F1C4966C" xlink:to="loc_us-gaap_NetIncomeLoss_152AF61C5544993318ADE457F1C4B053" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_59FA159A28AB19B1489FE457F1C4966C" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_467DFB0A6993C5EA8A18E457F1C4A352" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_CommonStockSharesIssued_467DFB0A6993C5EA8A18E457F1C4A352" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_800D1504D356630A72A2E457F1C42A4F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_800D1504D356630A72A2E457F1C42A4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_769844D0342F4F1CF4D4E457F1C5C6C3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_TreasuryStockShares_769844D0342F4F1CF4D4E457F1C5C6C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_AC0E80F38FB51C6485BAE457F1C502B0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_TreasuryStockValue_AC0E80F38FB51C6485BAE457F1C502B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_29FD05C31B317E1A7A42E457F1C54AFA" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_ProfitLoss_29FD05C31B317E1A7A42E457F1C54AFA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:label="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_B7C0F929A13961C84D13E457F595C8BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A2BEAB627C30195BE794E457F1C51F9C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A2BEAB627C30195BE794E457F1C51F9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_87297F5B7109C9F38DE4E457F1C5AB90" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_87297F5B7109C9F38DE4E457F1C5AB90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1B438BC40B223F92851FE457F1C68714" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1B438BC40B223F92851FE457F1C68714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_B1E875A89524AA21F814E457F1C6E4BC" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_B1E875A89524AA21F814E457F1C6E4BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_F12BF709787E2DFD1B16E457F1C6C3DE" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_F12BF709787E2DFD1B16E457F1C6C3DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_CE6E1D3866943017BD77E457F1C6503D" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_CE6E1D3866943017BD77E457F1C6503D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_C17FF57DBE6FF325EA6EE457F1C6513A" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_Dividends_C17FF57DBE6FF325EA6EE457F1C6513A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="loc_us-gaap_StockholdersEquityOther_3056893B0F030C51AD62E457F1C6A1B6" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_StockholdersEquityOther_3056893B0F030C51AD62E457F1C6A1B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_1C990F11A9AE7A2BB835E457F1C783BB" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_CommonStockSharesIssued_1C990F11A9AE7A2BB835E457F1C783BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6CDD3C23F00D0D21D838E457F1C71DC6" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6CDD3C23F00D0D21D838E457F1C71DC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_21CB2ABCE160215B11B6E457F1C74EF7" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_TreasuryStockShares_21CB2ABCE160215B11B6E457F1C74EF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_4636C84BE62731035E44E457F1C7CEC3" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_41892B49BC09B2ACDC65E457F1C4634C" xlink:to="loc_us-gaap_TreasuryStockValue_4636C84BE62731035E44E457F1C7CEC3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_5799E8AEC468239D282EE438CD3D9C03" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_5799E8AEC468239D282EE438CD3D9C03" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:to="loc_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_3D017FFBEC887BC9BAC9E438CD3DEE04" xlink:to="loc_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviOwnershipInterestDivestedMember" xlink:label="loc_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_1DE5199E80D0F6656D2EE438CD3E8568" xlink:to="loc_cah_NaviOwnershipInterestDivestedMember_FB49452FC5D07A4FBA6FE438CD3E62E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87818BAA480F8062B875E438CD3FB651" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87818BAA480F8062B875E438CD3FB651" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7AB3BE35C898214169D6E438CD3FE69C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_87818BAA480F8062B875E438CD3FB651" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7AB3BE35C898214169D6E438CD3FE69C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember" xlink:label="loc_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7AB3BE35C898214169D6E438CD3FE69C" xlink:to="loc_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_2E37CAD5F8EF9E5A3B74E438CD3FD8A1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_9E34F005ECFF422B4DEFE438CD3FCC78" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7AB3BE35C898214169D6E438CD3FE69C" xlink:to="loc_cah_NaviHealthMember_9E34F005ECFF422B4DEFE438CD3FCC78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_F881ACC08521EE1356DAE438CD40EE80" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_F881ACC08521EE1356DAE438CD40EE80" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_CECA96EE052C37AB7DB0E438CD4081A7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_F881ACC08521EE1356DAE438CD40EE80" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_CECA96EE052C37AB7DB0E438CD4081A7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_CE91806E0D86644C00FBE438CD405892" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_CECA96EE052C37AB7DB0E438CD4081A7" xlink:to="loc_cah_PatientRecoveryBusinessMember_CE91806E0D86644C00FBE438CD405892" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_84696551568311F83776E438CD41017C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:to="loc_srt_RangeAxis_84696551568311F83776E438CD41017C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_48085023287076CA58FBE438CD418AB1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_84696551568311F83776E438CD41017C" xlink:to="loc_srt_RangeMember_48085023287076CA58FBE438CD418AB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_607BC68423FE7B3C4B5DE438CD41E89E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_607BC68423FE7B3C4B5DE438CD41E89E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_607BC68423FE7B3C4B5DE438CD41E89E" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31AAFDD7ED4388584D70E438CD427FC0" xlink:to="loc_cah_PatientRecoveryBusinessMember_CE91806E0D86644C00FBE438CD405892" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_E0BA84D151AA18CC5DA0E438CD3DEB34" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_22181AD30FA19356BD44E438CD42D1A3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_22181AD30FA19356BD44E438CD42D1A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_C974BF5C311D27320708E438CD435715" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_C974BF5C311D27320708E438CD435715" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4591EADCD4943F8B9015E438CD4308B4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4591EADCD4943F8B9015E438CD4308B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_6A4D96F6C076B40F401FE438CD43CBCB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_6A4D96F6C076B40F401FE438CD43CBCB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PartnershipOwnership" xlink:label="loc_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_cah_PartnershipOwnership_1953245AF1B01B7B558CE438CD432106" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_6A1964F55350C67D5F89E438CD440716" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_cah_PreTaxGainonDivestiture_6A1964F55350C67D5F89E438CD440716" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7B2D851E8940AB497F9CE438CD44F4C2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7B2D851E8940AB497F9CE438CD44F4C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1858C9D62FAA8E0968E3E438CD44B849" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1858C9D62FAA8E0968E3E438CD44B849" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_BusinessCombinationTransactionandintegrationcosts" xlink:label="loc_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_cah_BusinessCombinationTransactionandintegrationcosts_F5B09C3199F113095990E438CD44A919" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_330B61B60CC93512830BE438CD444E82" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_EquityMethodInvestments_330B61B60CC93512830BE438CD444E82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8426AC05673F269990A6E438D27388A1" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_8426AC05673F269990A6E438D27388A1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Provisionaltaxbenefitrelatedtotransaction" xlink:label="loc_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_cah_Provisionaltaxbenefitrelatedtotransaction_81E30E43D9E98F84DFB8E438CD443C20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_B9D3CEA04F31DECD0CC7E438CD455DA2" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_B9D3CEA04F31DECD0CC7E438CD455DA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_0C3185266062ECFBD549E438CD45E4FF" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_0C3185266062ECFBD549E438CD45E4FF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TaxExpenseasaResultofSaleofInvestment" xlink:label="loc_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_cah_TaxExpenseasaResultofSaleofInvestment_536F673BCD96B051DF98E438CD452492" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6445D6630A03A26FE704E438CD4512CC" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_60C32B4559FC89F7655EE438CD42A9FA" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6445D6630A03A26FE704E438CD4512CC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_D18701478C033AA457D3CA0EF77096B5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_DocumentType_D18701478C033AA457D3CA0EF77096B5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_110FE01E858E937DCA7ECA0EF77041F4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_DocumentAnnualReport_110FE01E858E937DCA7ECA0EF77041F4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_227347DFAAB66E4E03E9CA0EF771270D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_DocumentPeriodEndDate_227347DFAAB66E4E03E9CA0EF771270D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_EFE3950AA0E2BA68FF87CA0EF771F936" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_DocumentTransitionReport_EFE3950AA0E2BA68FF87CA0EF771F936" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_4ED92DCD977E70030672CA0EF771B7B0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityFileNumber_4ED92DCD977E70030672CA0EF771B7B0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_F72124530B067107F652CA0EF77181D0" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityRegistrantName_F72124530B067107F652CA0EF77181D0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3C5759F19A06F32DD2FDCA0EF7710FC0" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3C5759F19A06F32DD2FDCA0EF7710FC0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_37D775E1E8C8C7DA5F1DCA0EF77166E9" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityTaxIdentificationNumber_37D775E1E8C8C7DA5F1DCA0EF77166E9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_E60DCBA177304A116F8CCA0EF7726033" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityAddressAddressLine1_E60DCBA177304A116F8CCA0EF7726033" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_5A68C5A96B142A89207FCA0EF772D326" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityAddressCityOrTown_5A68C5A96B142A89207FCA0EF772D326" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_278B3A6EEB98A5301EC7CA0EF7720A4D" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityAddressStateOrProvince_278B3A6EEB98A5301EC7CA0EF7720A4D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_0EAE4862207F77EAA4C3CA0EF7729F20" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityAddressPostalZipCode_0EAE4862207F77EAA4C3CA0EF7729F20" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_F10649A6FD42E4527238CA0EF772CA19" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_CityAreaCode_F10649A6FD42E4527238CA0EF772CA19" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_109E4DA2BC07E4695D93CA0EF773D958" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_LocalPhoneNumber_109E4DA2BC07E4695D93CA0EF773D958" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_2189789BF885F33040B0CA0EF7734A89" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_Security12bTitle_2189789BF885F33040B0CA0EF7734A89" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_9509820AAD6216BB0F86CA0EF7782F50" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_TradingSymbol_9509820AAD6216BB0F86CA0EF7782F50" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_BFF80349D235A217AC49CA0EF7780518" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_SecurityExchangeName_BFF80349D235A217AC49CA0EF7780518" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_8DF084B0680125EE59CECA0EF778AEED" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_8DF084B0680125EE59CECA0EF778AEED" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_80DB281496FDD47E622FCA0EF7799946" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityVoluntaryFilers_80DB281496FDD47E622FCA0EF7799946" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_D1A523AD94F9213DE235CA0EF779C0EC" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityCurrentReportingStatus_D1A523AD94F9213DE235CA0EF779C0EC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_20C85AD22DF90899DEACCA0EF779EDB0" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityInteractiveDataCurrent_20C85AD22DF90899DEACCA0EF779EDB0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_2F0A3978ED1A9B3898F1CA0EF7790BC6" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityFilerCategory_2F0A3978ED1A9B3898F1CA0EF7790BC6" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_321D769FB30C3FBF287ACA0EF77A839D" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntitySmallBusiness_321D769FB30C3FBF287ACA0EF77A839D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_1CB1D99B64E8EDD499B8CA0EF77A02D3" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityEmergingGrowthCompany_1CB1D99B64E8EDD499B8CA0EF77A02D3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_1F233638C1F47D9EA936CA0EF77AA03C" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityShellCompany_1F233638C1F47D9EA936CA0EF77AA03C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_2F368351DBD79FAFB6E5CA0EF77AA0AB" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityPublicFloat_2F368351DBD79FAFB6E5CA0EF77AA0AB" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_E0427BE992A9CCA9AE0BCA0EF77A185C" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_E0427BE992A9CCA9AE0BCA0EF77A185C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_EE98E0F293CA85378384CA0EF77B7291" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_AmendmentFlag_EE98E0F293CA85378384CA0EF77B7291" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_13782C6F79B08EF63695CA0EF77B99EA" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_DocumentFiscalYearFocus_13782C6F79B08EF63695CA0EF77B99EA" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_EC3D76848B252357F116CA0EF77B268B" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_DocumentFiscalPeriodFocus_EC3D76848B252357F116CA0EF77B268B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_90DA509928B5A431F4A6CA0EF77B14A0" xlink:type="locator" />
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_EntityCentralIndexKey_90DA509928B5A431F4A6CA0EF77B14A0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_9406ECF1253B106EC861CA0EF77B7CE1" xlink:type="locator" />
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_CurrentFiscalYearEndDate_9406ECF1253B106EC861CA0EF77B7CE1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_FAAE35134D25EBFB95A2CA0EF77B4642" xlink:type="locator" />
    <link:presentationArc order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D7E177F66A67F7FCDD4CA0EF770519F" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_FAAE35134D25EBFB95A2CA0EF77B4642" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_C76266A2B35A3E4BB3D0064EB0E5685D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_29D53F01A8CFDB78CABE064EB0E6FD5A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_C76266A2B35A3E4BB3D0064EB0E5685D" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_29D53F01A8CFDB78CABE064EB0E6FD5A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0B4E41AB36C2475CD536A678C2127BD1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_F30A4250C2272D509AEEA678C213F653" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0B4E41AB36C2475CD536A678C2127BD1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_F30A4250C2272D509AEEA678C213F653" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:label="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_545255E540EADDA21436A678C213F687" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0B4E41AB36C2475CD536A678C2127BD1" xlink:to="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_545255E540EADDA21436A678C213F687" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_129B732B0586FD0960807736CB9DAA25" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_93EEF3E3A6C1483638A77736CB9DF229" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_129B732B0586FD0960807736CB9DAA25" xlink:to="loc_us-gaap_ProfitLoss_93EEF3E3A6C1483638A77736CB9DF229" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7AD328932813074C42F57736CB9D9765" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_129B732B0586FD0960807736CB9DAA25" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7AD328932813074C42F57736CB9D9765" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1D90A24F299A9ECBF4B67736CB9EE431" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_129B732B0586FD0960807736CB9DAA25" xlink:to="loc_us-gaap_NetIncomeLoss_1D90A24F299A9ECBF4B67736CB9EE431" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C345821368C5EE2C530B7736CB9E54CB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_129B732B0586FD0960807736CB9DAA25" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C345821368C5EE2C530B7736CB9E54CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_60BF238A8ED2C097AE817736CB9EA399" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_129B732B0586FD0960807736CB9DAA25" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_60BF238A8ED2C097AE817736CB9EA399" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_75A637EFF79CB13A26AD7736CB9E86F9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_60BF238A8ED2C097AE817736CB9EA399" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_75A637EFF79CB13A26AD7736CB9E86F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E5B8AF4A617A9DB7DC307736CB9E8AAB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_129B732B0586FD0960807736CB9DAA25" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_E5B8AF4A617A9DB7DC307736CB9E8AAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_142917831E1ACD3A1CD27736CB9F0EC6" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_129B732B0586FD0960807736CB9DAA25" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_142917831E1ACD3A1CD27736CB9F0EC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_7C50A469CAD4BA1A7D347736CB9FAACA" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_129B732B0586FD0960807736CB9DAA25" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_7C50A469CAD4BA1A7D347736CB9FAACA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_72AAF0776742605367307736CB9FE2AB" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_129B732B0586FD0960807736CB9DAA25" xlink:to="loc_us-gaap_EarningsPerShareBasic_72AAF0776742605367307736CB9FE2AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_D55E22FF127D1F8ACCA77736CB9FE372" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_129B732B0586FD0960807736CB9DAA25" xlink:to="loc_us-gaap_EarningsPerShareDiluted_D55E22FF127D1F8ACCA77736CB9FE372" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_340FA0D6D75D9D803EDB064EB0DE389B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_07D52E2ED4E4D11B22B3064EB0DE5D4A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_340FA0D6D75D9D803EDB064EB0DE389B" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_07D52E2ED4E4D11B22B3064EB0DE5D4A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_E5E3E97C702C769EF469064EB22C7250" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_D20FAFBC20FCD6405B66064EB22C60CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_E5E3E97C702C769EF469064EB22C7250" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_D20FAFBC20FCD6405B66064EB22C60CB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_29EC52D5E17588F7518B064EB224A083" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_29EC52D5E17588F7518B064EB224A083" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_667940044C3814957597064EB224A0E6" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_AF5A2E06CCA03057F906064EB2253BB6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_A1BB0122CCBA1348524F064EB2259796" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_AF5A2E06CCA03057F906064EB2253BB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_EB0D2A64E23FA72E0781064EB2250AF7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_95E44859CD52A5E41833064EB2267776" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_95E44859CD52A5E41833064EB2267776" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8349386C845F16779A7C064EB226C272" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8349386C845F16779A7C064EB226C272" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_24A754A45B4FB7520981064EB2261EE4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_CB07443535EEA78E66F6064EB2251CDC" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_24A754A45B4FB7520981064EB2261EE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2F48A6A9971FDBD05123064EB22436B8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_89CE0C1F1574E1A27079064EB227006C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_89CE0C1F1574E1A27079064EB227006C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_FD05F81FE8215A9397A3064EB227FFB2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A653F8D129929231C568064EB226ABD8" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_FD05F81FE8215A9397A3064EB227FFB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_F1B1D2ACD06D92DC8A78064EB226F91A" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_E489A5D3F918DA6EF617064EB22753BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_448FA0A1215D56BC4D57064EB2271D0E" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_E489A5D3F918DA6EF617064EB22753BE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_16A0B634237085111509077B0200EB7F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_16A0B634237085111509077B0200EB7F" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_D79AB4811CA0845BA19F077B0201DDA4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_D79AB4811CA0845BA19F077B0201DDA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98E9A3A51CFC7C6FAA80077B02010601" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_D79AB4811CA0845BA19F077B0201DDA4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98E9A3A51CFC7C6FAA80077B02010601" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3B0739383EF6E5679043077B0202D81D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98E9A3A51CFC7C6FAA80077B02010601" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3B0739383EF6E5679043077B0202D81D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_D4C6B147228365F4C162077B0202AEE8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98E9A3A51CFC7C6FAA80077B02010601" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_D4C6B147228365F4C162077B0202AEE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_B43E415EB66632E21AE0077B0202FCEF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98E9A3A51CFC7C6FAA80077B02010601" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_B43E415EB66632E21AE0077B0202FCEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_09BE1DBF3D0CEA40B103077B0202C037" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_09BE1DBF3D0CEA40B103077B0202C037" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3DB1F71DE5ED53A890CC077B0202C50C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_09BE1DBF3D0CEA40B103077B0202C037" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3DB1F71DE5ED53A890CC077B0202C50C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5A90B479E72F4A4B974B077B0203F0DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3DB1F71DE5ED53A890CC077B0202C50C" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5A90B479E72F4A4B974B077B0203F0DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2D998962928CB7E44F29077B020300DC" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F23C72CD6AED2054B9A4077B0203E259" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_DCAE834A4986319753C2077B02011D63" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_58C519A3F3BD3EF8DFBD077B020478F2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_58C519A3F3BD3EF8DFBD077B020478F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_FA113901F2DA96D0EEE9077B02045EDA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_C8CA5AF6A03B60CEBF8B077B02039E06" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_FA113901F2DA96D0EEE9077B02045EDA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_72F9CAB232095F521B2C064EB22A242F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_596AED684AC2F4FD59CC064EB22AA925" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_72F9CAB232095F521B2C064EB22A242F" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_596AED684AC2F4FD59CC064EB22AA925" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2F7525616256AC5ACDBB064EB22AB54C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_72F9CAB232095F521B2C064EB22A242F" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2F7525616256AC5ACDBB064EB22AB54C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_A0D2938711916603B274064EB21A3315" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_0D8145C2589A0A9C98C8064EB21ABAE0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_A0D2938711916603B274064EB21A3315" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_0D8145C2589A0A9C98C8064EB21ABAE0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_16BAD739DE3D606E64F6DE514012D3DB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_16BAD739DE3D606E64F6DE514012D3DB" xlink:to="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:to="loc_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_8252CC0ADA5B779F06F9DE51401AA6E1" xlink:to="loc_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_B7A4B2F154845583F62BDE51401BF8EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1DF3E73D08229ACFA890DE51401A2044" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_B7A4B2F154845583F62BDE51401BF8EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1151CAB22C3E3D0C4F2CDE51401CE2C0" xlink:to="loc_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_E90CC3E563DB57D7B851DE51401C50FA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:to="loc_us-gaap_FairValueHedgingMember_E90CC3E563DB57D7B851DE51401C50FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_033D019D18C7A670A864DE51401DB617" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_DE6D4FC8852FDDB0C338DE51401C9EAF" xlink:to="loc_us-gaap_CashFlowHedgingMember_033D019D18C7A670A864DE51401DB617" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_A3E87B80A2D30B2A5ADADE51401EECE4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_B49F07B5A6F8E9725C3DDE51401E37F9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:to="loc_us-gaap_InterestRateSwapMember_B49F07B5A6F8E9725C3DDE51401E37F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_1D3219008EEBBAD58BA2DE51401E4D2A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:to="loc_us-gaap_CurrencySwapMember_1D3219008EEBBAD58BA2DE51401E4D2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2063C6DE70FC070C7CF8DE51401F32A6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_77CD51FBAC0C128179D4DE51401E3FC8" xlink:to="loc_us-gaap_ForeignExchangeContractMember_2063C6DE70FC070C7CF8DE51401F32A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:to="loc_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0205199F2C5368CE474FDE51401F9054" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_917BAC66AB5F02AB03D9DE51401F5DE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_CAE57DD31FB3A4C25D38DE514019B0EC" xlink:to="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_5964184582E648169555DE514020F598" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_5964184582E648169555DE514020F598" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_476DE8FBCE90D46DA294DE51402017F6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_476DE8FBCE90D46DA294DE51402017F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_85BD0AF9721464296371DE5149685707" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_85BD0AF9721464296371DE5149685707" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_E4C8B39E60D801A80B33DE579BD9CFC1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_E4C8B39E60D801A80B33DE579BD9CFC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_6D2962D1BA7439879AF2DE51402085FB" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_6D2962D1BA7439879AF2DE51402085FB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BF75A25CFADF5C88698ADE5140205F6D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0466F0EB8393BCC4951FDE51401F79F3" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_7E127F6E3345DB50837EDE514020F59F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_B30C280ABE3297EDE0A4C141C69B17D0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_EABBC3789B8FFAED077EC141C69BF840" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_B30C280ABE3297EDE0A4C141C69B17D0" xlink:to="loc_us-gaap_DerivativeTable_EABBC3789B8FFAED077EC141C69BF840" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_531A654D95F7ACE7392CC141C69B6286" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_EABBC3789B8FFAED077EC141C69BF840" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_531A654D95F7ACE7392CC141C69B6286" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_F9423A34AA9FA3BC2880C141C69CBE22" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_531A654D95F7ACE7392CC141C69B6286" xlink:to="loc_us-gaap_HedgingRelationshipDomain_F9423A34AA9FA3BC2880C141C69CBE22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_6CB40A27D1DD7AE8E30DC141C69C47EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_F9423A34AA9FA3BC2880C141C69CBE22" xlink:to="loc_us-gaap_FairValueHedgingMember_6CB40A27D1DD7AE8E30DC141C69C47EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_B185B1D2CAA6C1F16A03C141C69C7EE4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_F9423A34AA9FA3BC2880C141C69CBE22" xlink:to="loc_us-gaap_CashFlowHedgingMember_B185B1D2CAA6C1F16A03C141C69C7EE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_B717681E1C18744EF9F7C141C69C41A1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_EABBC3789B8FFAED077EC141C69BF840" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_B717681E1C18744EF9F7C141C69C41A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_B717681E1C18744EF9F7C141C69C41A1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_FE63B4A325D1E035A741C141C69D35F8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:to="loc_us-gaap_InterestRateSwapMember_FE63B4A325D1E035A741C141C69D35F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_EA974B5675BB49F2F923C141C69DF77D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:to="loc_us-gaap_ForeignExchangeContractMember_EA974B5675BB49F2F923C141C69DF77D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember" xlink:label="loc_us-gaap_ForwardContractsMember_6238286375496738DD5CC141C69D4A5E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:to="loc_us-gaap_ForwardContractsMember_6238286375496738DD5CC141C69D4A5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_A470C6F459CABEC28F9AC141C69E4EB3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:to="loc_us-gaap_CurrencySwapMember_A470C6F459CABEC28F9AC141C69E4EB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaap_CommodityContractMember_210BD55CA9F13F484C30C141C69E76DC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2A5EBABC2517BA60CCF2C141C69DDD1E" xlink:to="loc_us-gaap_CommodityContractMember_210BD55CA9F13F484C30C141C69E76DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_8B6572DDB9C166611BB3C141C69E4DA5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_EABBC3789B8FFAED077EC141C69BF840" xlink:to="loc_us-gaap_DerivativeLineItems_8B6572DDB9C166611BB3C141C69E4DA5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="loc_us-gaap_DerivativeNotionalAmount_39E297BF6A5F558BF4B9C144202F72A1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8B6572DDB9C166611BB3C141C69E4DA5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_39E297BF6A5F558BF4B9C144202F72A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_3ADD341D40B7AC99BED9C141C69E67AB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8B6572DDB9C166611BB3C141C69E4DA5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_3ADD341D40B7AC99BED9C141C69E67AB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8025A9AA8EC416099C11064EB20AD0F4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8025A9AA8EC416099C11064EB20AD0F4" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_A2D0D9E29BBCB207EF85064EB20AE10F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:to="loc_us-gaap_HedgingDesignationAxis_A2D0D9E29BBCB207EF85064EB20AE10F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_696EC7AC71ACF755F36C064EB20BFBE2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_A2D0D9E29BBCB207EF85064EB20AE10F" xlink:to="loc_us-gaap_HedgingDesignationDomain_696EC7AC71ACF755F36C064EB20BFBE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_419C9E6871F0E5260D5E064EB20BEBBC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_696EC7AC71ACF755F36C064EB20BFBE2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_419C9E6871F0E5260D5E064EB20BEBBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_957135AFD139D13D878F064EB20BDDA8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_957135AFD139D13D878F064EB20BDDA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_F493876053DD0F680B9B064EB20B177C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_957135AFD139D13D878F064EB20BDDA8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_F493876053DD0F680B9B064EB20B177C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_7A6CCAF6C942C3783976064EB20CB7F9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_F493876053DD0F680B9B064EB20B177C" xlink:to="loc_us-gaap_CashFlowHedgingMember_7A6CCAF6C942C3783976064EB20CB7F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_DB4101AEF3CF3986719E064EB20C5480" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_F493876053DD0F680B9B064EB20B177C" xlink:to="loc_us-gaap_FairValueHedgingMember_DB4101AEF3CF3986719E064EB20C5480" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_100730B1EDDEFA2DE625064EB20C58AD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_100730B1EDDEFA2DE625064EB20C58AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_100730B1EDDEFA2DE625064EB20C58AD" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1DA88162BFD01BF3A10D064EB20D1374" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1DA88162BFD01BF3A10D064EB20D1374" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_99CBA30FDE3005F8A972064EB20D07A6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4" xlink:to="loc_us-gaap_InterestRateSwapMember_99CBA30FDE3005F8A972064EB20D07A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_66D1C2F40240457C37B6064EB20D1945" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_66D1C2F40240457C37B6064EB20D1945" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaap_CommodityContractMember_8D4130C3737B362C3DDB064EB20D4F34" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8BB72B2493CBA362ED4B064EB20C3FA4" xlink:to="loc_us-gaap_CommodityContractMember_8D4130C3737B362C3DDB064EB20D4F34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_E5C5D4382429E3BE428E064EB20DC0F2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_B8365E7C98A6AD853FC8064EB20E0818" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:to="loc_us-gaap_OtherAssetsMember_B8365E7C98A6AD853FC8064EB20E0818" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0BC29F5AFF4BD797A28E064EB20E2B1F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0BC29F5AFF4BD797A28E064EB20E2B1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_3E86411DF0B01CFBC5AD064EB20E334A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_3E86411DF0B01CFBC5AD064EB20E334A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DeferredIncomeTaxesandOtherLiabilitiesMember" xlink:label="loc_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_FC17A700642E083DA69E064EB20DD386" xlink:to="loc_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_AB5F7EAE687B909C49D2064EB20EBA0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_C4387125311E19E45655064EB20A3337" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_D10F828DADE441D12263064EB20F3433" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_D10F828DADE441D12263064EB20F3433" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7491BF822C9A752C1C68064EB20F9222" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_535724BD8670CC7C1C92064EB20F894E" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_7491BF822C9A752C1C68064EB20F9222" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_31F6904D3211B2F8392BB5681FF6A74D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_FB3B3A723691D644C749B5681FF69B02" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_31F6904D3211B2F8392BB5681FF6A74D" xlink:to="loc_us-gaap_DerivativeTable_FB3B3A723691D644C749B5681FF69B02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_95682FA99AEDE34D9320B5681FF68A0D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_FB3B3A723691D644C749B5681FF69B02" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_95682FA99AEDE34D9320B5681FF68A0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_C7F8A74D08838B4426A3B5681FF7ACA5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_95682FA99AEDE34D9320B5681FF68A0D" xlink:to="loc_us-gaap_HedgingRelationshipDomain_C7F8A74D08838B4426A3B5681FF7ACA5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_17BC08A5BD1CBB682F85B5681FF75D06" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_C7F8A74D08838B4426A3B5681FF7ACA5" xlink:to="loc_us-gaap_CashFlowHedgingMember_17BC08A5BD1CBB682F85B5681FF75D06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8FEB151CED8E0FC5DD03B5681FF7A10D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_FB3B3A723691D644C749B5681FF69B02" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8FEB151CED8E0FC5DD03B5681FF7A10D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8FEB151CED8E0FC5DD03B5681FF7A10D" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember" xlink:label="loc_us-gaap_ForwardContractsMember_0F126400AD0335FB2B3DB56A4514F96A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66" xlink:to="loc_us-gaap_ForwardContractsMember_0F126400AD0335FB2B3DB56A4514F96A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_D8F994A5922FF2661E5FB5681FF84A4F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66" xlink:to="loc_us-gaap_InterestRateSwapMember_D8F994A5922FF2661E5FB5681FF84A4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaap_CommodityContractMember_7DAEA8DB5B526EB469EAB5681FF819F8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66" xlink:to="loc_us-gaap_CommodityContractMember_7DAEA8DB5B526EB469EAB5681FF819F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_29D7C2CFE40E878C665EB5681FF85505" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1CC0A3037E54AFD8EBFFB5681FF78C66" xlink:to="loc_us-gaap_ForeignExchangeContractMember_29D7C2CFE40E878C665EB5681FF85505" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_5F4A0D1F56718993C7CEB5681FF9729B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_FB3B3A723691D644C749B5681FF69B02" xlink:to="loc_us-gaap_DerivativeLineItems_5F4A0D1F56718993C7CEB5681FF9729B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_81930D56F9AAA2AE13B6B5681FF913D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5F4A0D1F56718993C7CEB5681FF9729B" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_81930D56F9AAA2AE13B6B5681FF913D2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_E77828DE963C3E311395DE7650229842" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_22A138D9B19C1DA11ECADE765022F2CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_E77828DE963C3E311395DE7650229842" xlink:to="loc_us-gaap_DerivativeTable_22A138D9B19C1DA11ECADE765022F2CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C5BAB4CC8342D8D0B96EDE7650237EBC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_22A138D9B19C1DA11ECADE765022F2CB" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C5BAB4CC8342D8D0B96EDE7650237EBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_FDF5F72EC5594C797A50DE7650231AA4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C5BAB4CC8342D8D0B96EDE7650237EBC" xlink:to="loc_us-gaap_HedgingRelationshipDomain_FDF5F72EC5594C797A50DE7650231AA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_C4026F83AC1BD8E92FC9DE765023FF05" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_FDF5F72EC5594C797A50DE7650231AA4" xlink:to="loc_us-gaap_CashFlowHedgingMember_C4026F83AC1BD8E92FC9DE765023FF05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3AB29C99D67285E13AFCDE765024117A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_22A138D9B19C1DA11ECADE765022F2CB" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3AB29C99D67285E13AFCDE765024117A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_163D4AFD4A452D9E6BCCDE765024C700" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3AB29C99D67285E13AFCDE765024117A" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_163D4AFD4A452D9E6BCCDE765024C700" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_EE82D8C87DEAE6E78AA6DE765024FC14" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_163D4AFD4A452D9E6BCCDE765024C700" xlink:to="loc_us-gaap_ForeignExchangeContractMember_EE82D8C87DEAE6E78AA6DE765024FC14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember" xlink:label="loc_us-gaap_ForwardContractsMember_A9C472195480FB0406D4DE765025718E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_163D4AFD4A452D9E6BCCDE765024C700" xlink:to="loc_us-gaap_ForwardContractsMember_A9C472195480FB0406D4DE765025718E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaap_CommodityContractMember_2AE824A5810EE7C67EEEDE765025520C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_163D4AFD4A452D9E6BCCDE765024C700" xlink:to="loc_us-gaap_CommodityContractMember_2AE824A5810EE7C67EEEDE765025520C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7D531114B0EC57BC7689DE765025F448" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_22A138D9B19C1DA11ECADE765022F2CB" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7D531114B0EC57BC7689DE765025F448" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7D531114B0EC57BC7689DE765025F448" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember_721101DD2BA28DCC9A0FDE765025C273" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556" xlink:to="loc_us-gaap_SalesMember_721101DD2BA28DCC9A0FDE765025C273" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_822E070734E1DF720988DE765026C3BF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556" xlink:to="loc_us-gaap_CostOfSalesMember_822E070734E1DF720988DE765026C3BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0020C039FF809F66CEE5DE7650269628" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0020C039FF809F66CEE5DE7650269628" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_A6EC90C8900595DBA420DE765026B61C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_E9899B6166DC3ADCDA6CDE7650256556" xlink:to="loc_us-gaap_InterestExpenseMember_A6EC90C8900595DBA420DE765026B61C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_A2436C6BD982E0652410DE7650269637" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_22A138D9B19C1DA11ECADE765022F2CB" xlink:to="loc_us-gaap_DerivativeLineItems_A2436C6BD982E0652410DE7650269637" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2C454ACE3FB39AAB1911DE7650262655" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_A2436C6BD982E0652410DE7650269637" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_2C454ACE3FB39AAB1911DE7650262655" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_57268196FA092CED7449064EB192B3A9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_CB5400A5DE843CE346E1064EB193A062" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_57268196FA092CED7449064EB192B3A9" xlink:to="loc_us-gaap_DerivativeTable_CB5400A5DE843CE346E1064EB193A062" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_3238C8ADF3DFDB7740DA064EB19353BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_CB5400A5DE843CE346E1064EB193A062" xlink:to="loc_us-gaap_HedgingDesignationAxis_3238C8ADF3DFDB7740DA064EB19353BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_4991457DA5C8D57FA6D3064EB1938F46" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_3238C8ADF3DFDB7740DA064EB19353BB" xlink:to="loc_us-gaap_HedgingDesignationDomain_4991457DA5C8D57FA6D3064EB1938F46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_403BA32C7DEAD389C1E9064EB1938D45" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_4991457DA5C8D57FA6D3064EB1938F46" xlink:to="loc_us-gaap_NondesignatedMember_403BA32C7DEAD389C1E9064EB1938D45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_A8E4B10ACC90908CDECE064EB19406B1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_CB5400A5DE843CE346E1064EB193A062" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_A8E4B10ACC90908CDECE064EB19406B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5E16AABAF09CD3A50E41064EB1948F41" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_A8E4B10ACC90908CDECE064EB19406B1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5E16AABAF09CD3A50E41064EB1948F41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_96A838CCB248FB70F4DA064EB1944999" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5E16AABAF09CD3A50E41064EB1948F41" xlink:to="loc_us-gaap_ForeignExchangeContractMember_96A838CCB248FB70F4DA064EB1944999" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1058EBFEDE149F8AD97A064EB194822E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_CB5400A5DE843CE346E1064EB193A062" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1058EBFEDE149F8AD97A064EB194822E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3AC7FC468C4B8AAED01F064EB1955FC6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1058EBFEDE149F8AD97A064EB194822E" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3AC7FC468C4B8AAED01F064EB1955FC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_DCB928F876FD07865D96064EB1953986" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3AC7FC468C4B8AAED01F064EB1955FC6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_DCB928F876FD07865D96064EB1953986" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_D6D52805B4ECDA47550E064EB1954BC4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_CB5400A5DE843CE346E1064EB193A062" xlink:to="loc_us-gaap_DerivativeLineItems_D6D52805B4ECDA47550E064EB1954BC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_FCBB534680F140539CEF064EB195E21F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_D6D52805B4ECDA47550E064EB1954BC4" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_FCBB534680F140539CEF064EB195E21F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6B29411A3C0EFA40A71A064EB1EF4B7A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_160F8A6A0845A03E33E6064EB1EF7A98" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6B29411A3C0EFA40A71A064EB1EF4B7A" xlink:to="loc_us-gaap_DerivativeTable_160F8A6A0845A03E33E6064EB1EF7A98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_20E5255515A450613D11064EB1EFD2DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_160F8A6A0845A03E33E6064EB1EF7A98" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_20E5255515A450613D11064EB1EFD2DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_043313DCFC0C4E2D5C8D064EB1EF4119" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_20E5255515A450613D11064EB1EFD2DD" xlink:to="loc_us-gaap_HedgingRelationshipDomain_043313DCFC0C4E2D5C8D064EB1EF4119" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_655C56BBFA2AFAD78E30064EB1F0B154" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_043313DCFC0C4E2D5C8D064EB1EF4119" xlink:to="loc_us-gaap_FairValueHedgingMember_655C56BBFA2AFAD78E30064EB1F0B154" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_E3E562C8ED86ADBB6509064EB1F0BAD6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_160F8A6A0845A03E33E6064EB1EF7A98" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_E3E562C8ED86ADBB6509064EB1F0BAD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_B51BC3B98636ECDF130E064EB1F0FC83" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_E3E562C8ED86ADBB6509064EB1F0BAD6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_B51BC3B98636ECDF130E064EB1F0FC83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_CB3C9544D03FBE2469B0064EB1F048A5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_B51BC3B98636ECDF130E064EB1F0FC83" xlink:to="loc_us-gaap_InterestRateSwapMember_CB3C9544D03FBE2469B0064EB1F048A5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FixedRateDebtMember" xlink:label="loc_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_B51BC3B98636ECDF130E064EB1F0FC83" xlink:to="loc_cah_FixedRateDebtMember_96AE325C683D358DE2C2064EB1F146D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_160F8A6A0845A03E33E6064EB1EF7A98" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_572616EA62510B8CCDEB064EB1F1E00D" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_39CF7377A649BAC47B88064EB1F10554" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_29BBAF19C05241512CE0064EB1F134FF" xlink:to="loc_us-gaap_InterestExpenseMember_39CF7377A649BAC47B88064EB1F10554" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_19B24FEF196D86DA49D0064EB1F5FC32" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_160F8A6A0845A03E33E6064EB1EF7A98" xlink:to="loc_us-gaap_DerivativeLineItems_19B24FEF196D86DA49D0064EB1F5FC32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_582B623A1A26D258A960064EB1F5604B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_19B24FEF196D86DA49D0064EB1F5FC32" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_582B623A1A26D258A960064EB1F5604B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1E61028A609FC04134AFC4ECCD2E832B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1E61028A609FC04134AFC4ECCD2E832B" xlink:to="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_9BA82437FACD745DB8EAC4ECCD2E2F21" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:to="loc_us-gaap_HedgingDesignationAxis_9BA82437FACD745DB8EAC4ECCD2E2F21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_1E09D3EE84C99C7603A1C4ECCD2FD552" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_9BA82437FACD745DB8EAC4ECCD2E2F21" xlink:to="loc_us-gaap_HedgingDesignationDomain_1E09D3EE84C99C7603A1C4ECCD2FD552" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_131014EA533B32BE8E47C4ECCD2FE8D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1E09D3EE84C99C7603A1C4ECCD2FD552" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_131014EA533B32BE8E47C4ECCD2FE8D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0B077E4E60331FA2B0A2C4ECCD2F6F51" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0B077E4E60331FA2B0A2C4ECCD2F6F51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_B073BE561CC5B73FC17EC4ECCD30CB53" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0B077E4E60331FA2B0A2C4ECCD2F6F51" xlink:to="loc_us-gaap_HedgingRelationshipDomain_B073BE561CC5B73FC17EC4ECCD30CB53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_4CB316E79A649DF627DFC4ECCD3046FB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_B073BE561CC5B73FC17EC4ECCD30CB53" xlink:to="loc_us-gaap_FairValueHedgingMember_4CB316E79A649DF627DFC4ECCD3046FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_16E5201821E3F3B8BE1EC4ECCD31B1FB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_B073BE561CC5B73FC17EC4ECCD30CB53" xlink:to="loc_us-gaap_CashFlowHedgingMember_16E5201821E3F3B8BE1EC4ECCD31B1FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_02E7F94DC80F84B0C9ABC4ECCD31E4D8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_02E7F94DC80F84B0C9ABC4ECCD31E4D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_02E7F94DC80F84B0C9ABC4ECCD31E4D8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_57AC5682CC46FEC5646AC4ECCD365656" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6" xlink:to="loc_us-gaap_InterestRateSwapMember_57AC5682CC46FEC5646AC4ECCD365656" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_8FCA73D0976F6355CDC7C4ECCD363D1A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_8FCA73D0976F6355CDC7C4ECCD363D1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaap_CommodityContractMember_66DD3C0DA01570FF61CEC4ECCD36FDDF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6" xlink:to="loc_us-gaap_CommodityContractMember_66DD3C0DA01570FF61CEC4ECCD36FDDF" xlink:type="arc" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_51E5B4B5BA68EF2E192FC4ECCD31B5A6" xlink:to="loc_us-gaap_CashFlowHedgingMember_16E5201821E3F3B8BE1EC4ECCD31B1FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_A56FD3CA5C5D5FCA6BACC4ECCD37AB86" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:to="loc_srt_RangeAxis_A56FD3CA5C5D5FCA6BACC4ECCD37AB86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_834218E75440313C2966C4ECCD375A43" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_A56FD3CA5C5D5FCA6BACC4ECCD37AB86" xlink:to="loc_srt_RangeMember_834218E75440313C2966C4ECCD375A43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_BFF73B7A12BAAAC061C7C4ECCD379D82" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_834218E75440313C2966C4ECCD375A43" xlink:to="loc_srt_MinimumMember_BFF73B7A12BAAAC061C7C4ECCD379D82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_436A1348DEB855276707C4ECCD382FF8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_834218E75440313C2966C4ECCD375A43" xlink:to="loc_srt_MaximumMember_436A1348DEB855276707C4ECCD382FF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_90DF3E8516F47846BBB9C4ECCD38908B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ED5B5D804912C37E6635C4ECCD2E229A" xlink:to="loc_us-gaap_DerivativeLineItems_90DF3E8516F47846BBB9C4ECCD38908B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_A50A80DE3D63DB48D765C4ECCD3833FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_90DF3E8516F47846BBB9C4ECCD38908B" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_A50A80DE3D63DB48D765C4ECCD3833FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_5A62F688B86A2236E717C4ECCD386F17" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_90DF3E8516F47846BBB9C4ECCD38908B" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_5A62F688B86A2236E717C4ECCD386F17" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BE141BDB859D2D3FE594C4ECCD397422" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_90DF3E8516F47846BBB9C4ECCD38908B" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_BE141BDB859D2D3FE594C4ECCD397422" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_D95F42E8D99B9AA94AE6C4ECCCE854C3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_85ABEA010DF354382525C4ECCCE96930" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_D95F42E8D99B9AA94AE6C4ECCCE854C3" xlink:to="loc_us-gaap_DerivativeTable_85ABEA010DF354382525C4ECCCE96930" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_55CB21C271343C866310C4ECCCE98640" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_85ABEA010DF354382525C4ECCCE96930" xlink:to="loc_srt_RangeAxis_55CB21C271343C866310C4ECCCE98640" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1DBE334C29D11ACD259CC4ECCCE90BB6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_55CB21C271343C866310C4ECCCE98640" xlink:to="loc_srt_RangeMember_1DBE334C29D11ACD259CC4ECCCE90BB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_C7FDA7126421D42921AAC4ECCCEA62EB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1DBE334C29D11ACD259CC4ECCCE90BB6" xlink:to="loc_srt_MinimumMember_C7FDA7126421D42921AAC4ECCCEA62EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_C77D598B6BF6A96B9838C4ECCCEAE211" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1DBE334C29D11ACD259CC4ECCCE90BB6" xlink:to="loc_srt_MaximumMember_C77D598B6BF6A96B9838C4ECCCEAE211" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_65BA34425473709EBC50C4ECCCEAC1E4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_85ABEA010DF354382525C4ECCCE96930" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_65BA34425473709EBC50C4ECCCEAC1E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_DF4D8F938F8C6A068D28C4ECCCEAE46B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_65BA34425473709EBC50C4ECCCEAC1E4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_DF4D8F938F8C6A068D28C4ECCCEAE46B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_19975C47E43D02D3E4A1C4ECCCEB3AB6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_DF4D8F938F8C6A068D28C4ECCCEAE46B" xlink:to="loc_us-gaap_ForeignExchangeContractMember_19975C47E43D02D3E4A1C4ECCCEB3AB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_37EB4E79E42020A5272DC4ECCCEBC06D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_85ABEA010DF354382525C4ECCCE96930" xlink:to="loc_us-gaap_HedgingDesignationAxis_37EB4E79E42020A5272DC4ECCCEBC06D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_728A0453B8D91734E067C4ECCCEC789D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_37EB4E79E42020A5272DC4ECCCEBC06D" xlink:to="loc_us-gaap_HedgingDesignationDomain_728A0453B8D91734E067C4ECCCEC789D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_758D8158D97AE24AF9F7C4ECCCECB5D9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_728A0453B8D91734E067C4ECCCEC789D" xlink:to="loc_us-gaap_NondesignatedMember_758D8158D97AE24AF9F7C4ECCCECB5D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_ADE28FFF219C04D56DB8C4ECCCECD7EF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_85ABEA010DF354382525C4ECCCE96930" xlink:to="loc_us-gaap_DerivativeLineItems_ADE28FFF219C04D56DB8C4ECCCECD7EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_F21ECF549D34A1C60F70C4ECCCEDE2B8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ADE28FFF219C04D56DB8C4ECCCECD7EF" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_F21ECF549D34A1C60F70C4ECCCEDE2B8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_536E6942A16AD6864DECC4ECCD5C84A3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_536E6942A16AD6864DECC4ECCD5C84A3" xlink:to="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_67CBEAE6B5EF0A385D80C4ECCD5C45E2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:to="loc_us-gaap_HedgingDesignationAxis_67CBEAE6B5EF0A385D80C4ECCD5C45E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_AA7FA9109E5439930CADC4ECCD5DB1EB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_67CBEAE6B5EF0A385D80C4ECCD5C45E2" xlink:to="loc_us-gaap_HedgingDesignationDomain_AA7FA9109E5439930CADC4ECCD5DB1EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_41D1D4A5A0FE302D26E7C4ECCD5D4F96" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_AA7FA9109E5439930CADC4ECCD5DB1EB" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_41D1D4A5A0FE302D26E7C4ECCD5D4F96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E8B88B103FC9491A31F9C4ECCD5DFBF8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E8B88B103FC9491A31F9C4ECCD5DFBF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_299842E8F230B261EDA2C4ECCD5E180D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E8B88B103FC9491A31F9C4ECCD5DFBF8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_299842E8F230B261EDA2C4ECCD5E180D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_00598A164800C8F496E1C4ECCD5E20BD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_299842E8F230B261EDA2C4ECCD5E180D" xlink:to="loc_us-gaap_FairValueHedgingMember_00598A164800C8F496E1C4ECCD5E20BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_F4C7EBCBBFA884A09750C4ECCD5ECA5F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_F4C7EBCBBFA884A09750C4ECCD5ECA5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_BEE02290A05A33FBCFB7C4ECCD5E7FE4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_F4C7EBCBBFA884A09750C4ECCD5ECA5F" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_BEE02290A05A33FBCFB7C4ECCD5E7FE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_1BE287D102C9ED2EF9E4C4ECCD64B75C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_BEE02290A05A33FBCFB7C4ECCD5E7FE4" xlink:to="loc_us-gaap_InterestRateSwapMember_1BE287D102C9ED2EF9E4C4ECCD64B75C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_E9A49621CFA2C6548D6CC4ECCD64DE30" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:to="loc_srt_RangeAxis_E9A49621CFA2C6548D6CC4ECCD64DE30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_6E77F683F42ACED8CBC4C4ECCD64CA27" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_E9A49621CFA2C6548D6CC4ECCD64DE30" xlink:to="loc_srt_RangeMember_6E77F683F42ACED8CBC4C4ECCD64CA27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_33ACC4D1E31A006B0C40C4ECCD65D3A0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6E77F683F42ACED8CBC4C4ECCD64CA27" xlink:to="loc_srt_MinimumMember_33ACC4D1E31A006B0C40C4ECCD65D3A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_20288F505E3E92FF267FC4ECCD65E1A5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0D53FAB85E285C459BC7C4ECCD5C9F55" xlink:to="loc_us-gaap_DerivativeLineItems_20288F505E3E92FF267FC4ECCD65E1A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_D9DAF4925F5251175460C4ECCD65570F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_20288F505E3E92FF267FC4ECCD65E1A5" xlink:to="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_D9DAF4925F5251175460C4ECCD65570F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_8BEEF5A366133A6CD0F2C4ECCD6502D7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_20288F505E3E92FF267FC4ECCD65E1A5" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_8BEEF5A366133A6CD0F2C4ECCD6502D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_2960AD956102F03D0D2AC4ECCD65293C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_20288F505E3E92FF267FC4ECCD65E1A5" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_2960AD956102F03D0D2AC4ECCD65293C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_FF5473DE5AC38A62A2D8B5576F99489B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_FF5473DE5AC38A62A2D8B5576F99489B" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_10C2A82FD88896AA3FDDB5576F99DB7F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_10C2A82FD88896AA3FDDB5576F99DB7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_10C2A82FD88896AA3FDDB5576F99DB7F" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_04AB712FE8F8DB4C4274B5576F9A756E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_DE8D8B529E6F552E790CB5576F993DB6" xlink:to="loc_us-gaap_InterestRateSwapMember_04AB712FE8F8DB4C4274B5576F9A756E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_B9C8ECEB6486BAA78A3DB5576F9AF766" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:to="loc_us-gaap_HedgingDesignationAxis_B9C8ECEB6486BAA78A3DB5576F9AF766" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_5681FD3850E80C99885BB5576F9A431A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_B9C8ECEB6486BAA78A3DB5576F9AF766" xlink:to="loc_us-gaap_HedgingDesignationDomain_5681FD3850E80C99885BB5576F9A431A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_608790E8F083515FDB63B5576F9AD88E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5681FD3850E80C99885BB5576F9A431A" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_608790E8F083515FDB63B5576F9AD88E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_AD70C33D31F4671FC563B5576F9B5181" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_AD70C33D31F4671FC563B5576F9B5181" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_B0354AF89C9CD9ACA4BCB5576F9BB1B5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_AD70C33D31F4671FC563B5576F9B5181" xlink:to="loc_us-gaap_HedgingRelationshipDomain_B0354AF89C9CD9ACA4BCB5576F9BB1B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_B61AF075A07A0257CFDCB5576F9B7EDD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_B0354AF89C9CD9ACA4BCB5576F9BB1B5" xlink:to="loc_us-gaap_FairValueHedgingMember_B61AF075A07A0257CFDCB5576F9B7EDD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_45CC8387C1B9791854C4B5576F9C69BD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_45CC8387C1B9791854C4B5576F9C69BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C0C501DDBE417569E37EB5576F9C7F46" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_45CC8387C1B9791854C4B5576F9C69BD" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C0C501DDBE417569E37EB5576F9C7F46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_B6261751BFAD268B0683B5576F9C451E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C0C501DDBE417569E37EB5576F9C7F46" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_B6261751BFAD268B0683B5576F9C451E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9462BC4618D056276249B5576F9DA2B5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_265333AD8214B3CE920CB5576F99A697" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9462BC4618D056276249B5576F9DA2B5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_25B789B37F62A579DAC1B5576F9D5E2C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9462BC4618D056276249B5576F9DA2B5" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount_25B789B37F62A579DAC1B5576F9D5E2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_E8300C95EEA64F6B6945B5576F9D36AE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9462BC4618D056276249B5576F9DA2B5" xlink:to="loc_us-gaap_DebtInstrumentFairValue_E8300C95EEA64F6B6945B5576F9D36AE" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:label="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9462BC4618D056276249B5576F9DA2B5" xlink:to="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_0E3CAFA6CFA02CB5C41BB55C11D773E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_C497C3C14099D7F076C4B5576F9D628C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9462BC4618D056276249B5576F9DA2B5" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_C497C3C14099D7F076C4B5576F9D628C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_361A0AEDF0C87C0D883D064EB2131399" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2246B73CFB5456618025064EB214D6AB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_361A0AEDF0C87C0D883D064EB2131399" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2246B73CFB5456618025064EB214D6AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_BD37C5AAF6BF3F876434064EB2142262" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_361A0AEDF0C87C0D883D064EB2131399" xlink:to="loc_us-gaap_DerivativeTable_BD37C5AAF6BF3F876434064EB2142262" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_67332E56EFBE78BA0383064EB214B9D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_BD37C5AAF6BF3F876434064EB2142262" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_67332E56EFBE78BA0383064EB214B9D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9EF67AC46FCE24726356064EB2144B48" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_67332E56EFBE78BA0383064EB214B9D3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9EF67AC46FCE24726356064EB2144B48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_9A8E6E26B1B8675177E3064EB215246F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9EF67AC46FCE24726356064EB2144B48" xlink:to="loc_us-gaap_FairValueHedgingMember_9A8E6E26B1B8675177E3064EB215246F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_29E47410E6379B094F57064EB215E555" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9EF67AC46FCE24726356064EB2144B48" xlink:to="loc_us-gaap_CashFlowHedgingMember_29E47410E6379B094F57064EB215E555" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_8B1AA5DE51906E563A0D064EB215FDF5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_BD37C5AAF6BF3F876434064EB2142262" xlink:to="loc_us-gaap_HedgingDesignationAxis_8B1AA5DE51906E563A0D064EB215FDF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_1E70313B31ABBB4DB077064EB215FCAD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_8B1AA5DE51906E563A0D064EB215FDF5" xlink:to="loc_us-gaap_HedgingDesignationDomain_1E70313B31ABBB4DB077064EB215FCAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_D779AB8113744D9199A7064EB215C9F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1E70313B31ABBB4DB077064EB215FCAD" xlink:to="loc_us-gaap_NondesignatedMember_D779AB8113744D9199A7064EB215C9F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_6FE1734A50DB62A0A3AF064EB2165129" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_BD37C5AAF6BF3F876434064EB2142262" xlink:to="loc_us-gaap_DerivativeLineItems_6FE1734A50DB62A0A3AF064EB2165129" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_DFC37C9D22A8F7453135064EB2165C2E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6FE1734A50DB62A0A3AF064EB2165129" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_DFC37C9D22A8F7453135064EB2165C2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_E2554AB5441990B34599064EB216DA4A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_361A0AEDF0C87C0D883D064EB2131399" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_E2554AB5441990B34599064EB216DA4A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_458D6C08D6E24783B6B9064EB2163285" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_361A0AEDF0C87C0D883D064EB2131399" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_458D6C08D6E24783B6B9064EB2163285" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_230E90E71C6C3EBE45C8064EB2170163" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_361A0AEDF0C87C0D883D064EB2131399" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_230E90E71C6C3EBE45C8064EB2170163" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2799996BE6E2C8490659064EB2176475" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_361A0AEDF0C87C0D883D064EB2131399" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2799996BE6E2C8490659064EB2176475" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6E411A653BFDBD003FE4064EB2174719" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_361A0AEDF0C87C0D883D064EB2131399" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6E411A653BFDBD003FE4064EB2174719" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:label="loc_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_B9620BED67C919FC65C3064EB217AED4" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_361A0AEDF0C87C0D883D064EB2131399" xlink:to="loc_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_B9620BED67C919FC65C3064EB217AED4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_D158DCCF0FB8F145AB72064EB34F7F3F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_A348B6708E57FFD6ACDF064EB34F7FED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_D158DCCF0FB8F145AB72064EB34F7F3F" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_A348B6708E57FFD6ACDF064EB34F7FED" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_10B0B68286D5DFABCA3CDD85E61E3EE4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_10B0B68286D5DFABCA3CDD85E61E3EE4" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6DEF9E9BF1793892B167DD85E61E0502" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6DEF9E9BF1793892B167DD85E61E0502" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5626FE57320A6714CD7DDD85E61F3698" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6DEF9E9BF1793892B167DD85E61E0502" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5626FE57320A6714CD7DDD85E61F3698" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember" xlink:label="loc_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_E126F570852817A84912DD85E61FBF8B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5626FE57320A6714CD7DDD85E61F3698" xlink:to="loc_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember_E126F570852817A84912DD85E61FBF8B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_0E4FE26D852050E4B7CFDD85E61FB47C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5626FE57320A6714CD7DDD85E61F3698" xlink:to="loc_cah_NaviHealthMember_0E4FE26D852050E4B7CFDD85E61FB47C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5D789C201AA6AD6F26D2DD85E620A34C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5D789C201AA6AD6F26D2DD85E620A34C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_37181042756ED704D137DD85E6208C69" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5D789C201AA6AD6F26D2DD85E620A34C" xlink:to="loc_us-gaap_SegmentDomain_37181042756ED704D137DD85E6208C69" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalReportingUnitMember" xlink:label="loc_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_37181042756ED704D137DD85E6208C69" xlink:to="loc_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis" xlink:label="loc_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:to="loc_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_C804E2F3146D17D1F6A5DD85E620E4E9" xlink:to="loc_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_B8B90AD395873463ED16DD85E620769F" xlink:to="loc_cah_MedicalReportingUnitMember_1C17748E5A7C3B36A6C4DD85E6206113" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E1F8E5ACF4175FB775E3DD85E61E2572" xlink:to="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DiscountRatefairvalueinputs" xlink:label="loc_cah_DiscountRatefairvalueinputs_EDC048AE80E8D4201841DD85E62124AE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_cah_DiscountRatefairvalueinputs_EDC048AE80E8D4201841DD85E62124AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_D3E27DD15F574DEC1A03DD85E621A0F5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_D3E27DD15F574DEC1A03DD85E621A0F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_03A3BADE403A345D4547DD85E622D72C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_Goodwill_03A3BADE403A345D4547DD85E622D72C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_97110EB56CE16140457BDD85E622C02B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_97110EB56CE16140457BDD85E622C02B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9FCE732D3E7BB829A585DD85E6229021" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9FCE732D3E7BB829A585DD85E6229021" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33189D6901CC59C740A5DD85E622B752" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_33189D6901CC59C740A5DD85E622B752" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_922B2ED18FD93200BC94DD85E6226159" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_922B2ED18FD93200BC94DD85E6226159" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1369D261D5BBFD90D1B1DD85E622A713" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1369D261D5BBFD90D1B1DD85E622A713" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_11C900B8558504E06815DD85E6238B7D" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_DC02D32121F2F5C9A688DD85E6217068" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_11C900B8558504E06815DD85E6238B7D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_A0D8B2FA980081536A83E412B9B631BA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_A0D8B2FA980081536A83E412B9B631BA" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_65CAF0FC34952143D44AE412B9BCB182" xlink:to="loc_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:to="loc_cah_PharmaceuticalMember_2F60F1F7B3759C907AA3E412B9BD3532" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_10AE082DA27FA413F815E412B9BCF618" xlink:to="loc_cah_MedicalMember_EC7AB95385B771418163E412B9BE5D4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_685B7A6E186D89D7BA05E412B9BAFDE2" xlink:to="loc_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers" xlink:label="loc_us-gaap_GoodwillTransfers_9F51FFEA3FBBE32EB262E412BFCE916D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:to="loc_us-gaap_GoodwillTransfers_9F51FFEA3FBBE32EB262E412BFCE916D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:to="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_A3934E12D59CAFCE9341E412B9C495B3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:to="loc_us-gaap_Goodwill_A3934E12D59CAFCE9341E412B9C495B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73D288E492E2E1163D64E412B9C8E7F6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_73D288E492E2E1163D64E412B9C8E7F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_D81A8A7C59D361C98EC1E412B9C8D00A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_D81A8A7C59D361C98EC1E412B9C8D00A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B2F7F2E518F7FC74352BE412B9C8EB2B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7019DA877586CB94E194E412B9BFDDD9" xlink:to="loc_us-gaap_Goodwill_B2F7F2E518F7FC74352BE412B9C8EB2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_656C2BB71796CA3246BAE412B9C9892B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_843913055956E68EF8DDE412B9BF777E" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_656C2BB71796CA3246BAE412B9C9892B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6D3597D3D8FAE35DEB9D064EB33EF585" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6D3597D3D8FAE35DEB9D064EB33EF585" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_005C5AA49211D96F159C064EB33E92DD" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_IPRDTrademarksandOtherMember" xlink:label="loc_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9FE29BCF92DE43E771C8064EB33FCC37" xlink:to="loc_cah_IPRDTrademarksandOtherMember_0B89FCCABE930094A72D064EB33F76C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_F65BCAED348EBFB98DCE064EB33E5CEC" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_E9ABB0E16C330B09D59C064EB33FD193" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_BC6941311993BC02FCC5064EB33F8F50" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_E9ABB0E16C330B09D59C064EB33FD193" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6D3597D3D8FAE35DEB9D064EB33EF585" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3724A519908CFBBFF12F064EB34053D4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3B318B325A3266C9810D064EB3407BCB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3B318B325A3266C9810D064EB3407BCB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TrademarksAndPatentsMember" xlink:label="loc_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:to="loc_cah_TrademarksAndPatentsMember_1C079A0DA0882FABC5D8064EB341D6A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_BAA80E6C06E7E1AEBC0D064EB341A607" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3CB66CC83AE579411A8D064EB34063DD" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_BAA80E6C06E7E1AEBC0D064EB341A607" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ABD752CD2D182478CAE5064EB340CF0E" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_DFB6EBC87AB4BF3E17F6064EB3416A99" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_DFB6EBC87AB4BF3E17F6064EB3416A99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_87E22CB079B4C5D56723064EB341B920" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_87E22CB079B4C5D56723064EB341B920" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A03798C7E0231B3DA0B064EB34267B0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1A03798C7E0231B3DA0B064EB34267B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_355EF849C74CB1B2992B064EB342EE48" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_355EF849C74CB1B2992B064EB342EE48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_F9F8D7D4374EF7AD7B99064EB342E2EC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5E0DC0D44428C8EE086A064EB3416E57" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_F9F8D7D4374EF7AD7B99064EB342E2EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_948D89A32C053B453F08064EB3423A9F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6D3597D3D8FAE35DEB9D064EB33EF585" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_948D89A32C053B453F08064EB3423A9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2859770A03BE1DE63A77064EB3428200" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6D3597D3D8FAE35DEB9D064EB33EF585" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2859770A03BE1DE63A77064EB3428200" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_18273A3E96579903070F064EB34DC1AE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_8D35D8640DB73C2FC094064EB34DF896" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_18273A3E96579903070F064EB34DC1AE" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_8D35D8640DB73C2FC094064EB34DF896" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2899107A01FBAB407B8D064EB34D8BBD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_18273A3E96579903070F064EB34DC1AE" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2899107A01FBAB407B8D064EB34D8BBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_EE6A9857E697F0AA47D4064EB34D566D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_18273A3E96579903070F064EB34DC1AE" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_EE6A9857E697F0AA47D4064EB34D566D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_D9DE50AC6280E6F193DD064EB2BB8CF5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_4FB36997A6E9D8EFADB0064EB2BC3EC3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_D9DE50AC6280E6F193DD064EB2BB8CF5" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_4FB36997A6E9D8EFADB0064EB2BC3EC3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_B276DC29BDDF7A640EAECA0072760690" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_B276DC29BDDF7A640EAECA0072760690" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_9C9B0B783AA8757C71D4CA007278FAA6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_cah_OpioidLitigationAxis_9C9B0B783AA8757C71D4CA007278FAA6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_83D1354AC2C9129D2952CA1BC505128C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_9C9B0B783AA8757C71D4CA007278FAA6" xlink:to="loc_cah_OpioidLitigationDomain_83D1354AC2C9129D2952CA1BC505128C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_AD1F08906F2F190E09B5CA1919627C13" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_83D1354AC2C9129D2952CA1BC505128C" xlink:to="loc_cah_TotalOpioidLitigationMember_AD1F08906F2F190E09B5CA1919627C13" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TaxMatterAxis" xlink:label="loc_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TaxMatterDomain" xlink:label="loc_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterAxis_DB11F4F14ADA56442430CA007277C0EC" xlink:to="loc_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:to="loc_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CareFusionMember" xlink:label="loc_cah_CareFusionMember_5789E786440FB550550ACA007278DB36" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterDomain_A6F01533B06FEEE7D7B2CA007278940A" xlink:to="loc_cah_CareFusionMember_5789E786440FB550550ACA007278DB36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_26F70DAB7E122B1CD4AACA00727F825D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_26F70DAB7E122B1CD4AACA00727F825D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82E38AD86AD772351642CA00727FCC4F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_26F70DAB7E122B1CD4AACA00727F825D" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82E38AD86AD772351642CA00727FCC4F" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82E38AD86AD772351642CA00727FCC4F" xlink:to="loc_cah_PatientRecoveryBusinessMember_EB3CBDCF5DA62F311304CA00727857C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_D73A31326D9CCFCDFA92CA0072805DCB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_D73A31326D9CCFCDFA92CA0072805DCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_D197736A810DC014D4B4CA007280EFE4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_D73A31326D9CCFCDFA92CA0072805DCB" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_D197736A810DC014D4B4CA007280EFE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3119E2EAE2A7B5A179AFCA0072804A4B" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_ACBD9D51BA1F1C388097CA0072811D78" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_ACBD9D51BA1F1C388097CA0072811D78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_9FE9497467FB50D9D863CA007281D784" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_9FE9497467FB50D9D863CA007281D784" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_414189AE5BCB1C075968CA0072816731" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_B9BDB2B1713094C16B5DCA007280CA53" xlink:to="loc_us-gaap_ForeignCountryMember_414189AE5BCB1C075968CA0072816731" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1BAE8C15670E1F820039CA0072815C76" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_srt_RangeAxis_1BAE8C15670E1F820039CA0072815C76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_EE3A96E0694FDC49419ACA00728111BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1BAE8C15670E1F820039CA0072815C76" xlink:to="loc_srt_RangeMember_EE3A96E0694FDC49419ACA00728111BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_A6F20076C004171B479BCA0072820A84" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_EE3A96E0694FDC49419ACA00728111BC" xlink:to="loc_srt_MinimumMember_A6F20076C004171B479BCA0072820A84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_403A223D3C287D2096E4CA007282A624" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_EE3A96E0694FDC49419ACA00728111BC" xlink:to="loc_srt_MaximumMember_403A223D3C287D2096E4CA007282A624" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_85EAE080C66238F12565CA0072779F6B" xlink:to="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_BF2B7E768062CD3D4A03CA0072876493" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_BF2B7E768062CD3D4A03CA0072876493" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_1BE9813F6519916B31D0CA0072889766" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_LitigationReserve_1BE9813F6519916B31D0CA0072889766" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3FAB93880BFF7C724843CA007288CAB7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3FAB93880BFF7C724843CA007288CAB7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:label="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_9DFDCAAB5494441C5712CA007288BD36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_BA1D701181C56A051845CA007288F7D9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_BA1D701181C56A051845CA007288F7D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_F21494E97DECA6BFBA0FCA0072886109" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_F21494E97DECA6BFBA0FCA0072886109" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_7E4ADA472D8F1E0E0BECCA0072888589" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_7E4ADA472D8F1E0E0BECCA0072888589" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_30DBC6DB59FF50EC762ECA0072894A2B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_30DBC6DB59FF50EC762ECA0072894A2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_DA69C0E373966F39660ACA007289A233" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_DA69C0E373966F39660ACA007289A233" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2C85A009EE8181097E9CCA0072892951" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2C85A009EE8181097E9CCA0072892951" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_98713B61E988B374098DCA00728912D4" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_98713B61E988B374098DCA00728912D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_356195757A0D6769D42ACA00728979D0" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_356195757A0D6769D42ACA00728979D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_C1DA5A00CE4D34A856EFCA00728AE932" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_C1DA5A00CE4D34A856EFCA00728AE932" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_E90814F2B01563FB9030CA00728A391E" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_E90814F2B01563FB9030CA00728A391E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8274BBF0B5BE0BF0126CCA00728A9EC7" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8274BBF0B5BE0BF0126CCA00728A9EC7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_EE0EE6364CC904886246CA00728AF60A" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_EE0EE6364CC904886246CA00728AF60A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_A60936AB3CFD6D6BC62ECA00728ADA36" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_A60936AB3CFD6D6BC62ECA00728ADA36" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_IndemnificationReceivable" xlink:label="loc_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_cah_IndemnificationReceivable_FC8709A89CD23B725619CA00728A79AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_1655E5B09BC16352B7E1CA00728BE298" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_26484A2DBC715AEED9F8CA0072870472" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_1655E5B09BC16352B7E1CA00728BE298" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_FB858867D3605914A9F2064EB2AEFE1E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_FB858867D3605914A9F2064EB2AEFE1E" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_F231C5F272FD25C2A7C0064EB2AEC321" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_F231C5F272FD25C2A7C0064EB2AEC321" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C5C6CE77F42AB205B510064EB2AFFE67" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C5C6CE77F42AB205B510064EB2AFFE67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7BE65B0A9C2A2956DB42064EB2AF2F64" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7BE65B0A9C2A2956DB42064EB2AF2F64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_E6A9A76ABFC685129E9A064EB2AFF1AA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7D31123B4C339C9810A4064EB2AE4400" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_E6A9A76ABFC685129E9A064EB2AFF1AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_FB858867D3605914A9F2064EB2AEFE1E" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_BCADBC5F7C4EF6FEC62E064EB2AFDF32" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_BCADBC5F7C4EF6FEC62E064EB2AFDF32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_D7FF5CD5A47A7EEDE550064EB2B076D7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_D7FF5CD5A47A7EEDE550064EB2B076D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1F0A963A66D7658E6896064EB2B0A285" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1F0A963A66D7658E6896064EB2B0A285" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0A7441396D5CF8BA1E69064EB2B03454" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_30FFA04E94F93B915F54064EB2AF48EE" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0A7441396D5CF8BA1E69064EB2B03454" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5552E6E9311A5D9468C1064EB2B06F0A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_FB858867D3605914A9F2064EB2AEFE1E" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5552E6E9311A5D9468C1064EB2B06F0A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2BC67305AD308CFF6464CA8A1E024EA6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_9C13A764E06669B1CA6DCA8BC0A2E80D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2BC67305AD308CFF6464CA8A1E024EA6" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_9C13A764E06669B1CA6DCA8BC0A2E80D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_6C463B092ECBFFB5B84FCA8A24074841" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2BC67305AD308CFF6464CA8A1E024EA6" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_6C463B092ECBFFB5B84FCA8A24074841" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_1DFD243CCFE4EFB9B635CA8A1E101814" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2BC67305AD308CFF6464CA8A1E024EA6" xlink:to="loc_us-gaap_DeferredTaxLiabilities_1DFD243CCFE4EFB9B635CA8A1E101814" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_CEFDF59E3084160B2605C56FB75EACF7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_CEFDF59E3084160B2605C56FB75EACF7" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_E252EF1A31BB180431B6C56FB77519A5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_E252EF1A31BB180431B6C56FB77519A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_BC574AC47A83FF7712A5C56FB77718D4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_BC574AC47A83FF7712A5C56FB77718D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_95D5A04B6969AF5AFEE2C56FB779972D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_95D5A04B6969AF5AFEE2C56FB779972D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_FB490BE471D5BFBD3E14C56FB779E2AB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_FB490BE471D5BFBD3E14C56FB779E2AB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:label="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_D62B39F4662DDFE00823C56FB77ADD24" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:to="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_D62B39F4662DDFE00823C56FB77ADD24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_2DBA479C3792727BEEA2C56FB77AF43E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_2DBA479C3792727BEEA2C56FB77AF43E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_778D7F1CB0CBE53A9FAFC56FB77B0B4E" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_778D7F1CB0CBE53A9FAFC56FB77B0B4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_35D36D1260ECC755D481C56FB77B05B7" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_35D36D1260ECC755D481C56FB77B05B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_60FC9F330F391F976BA2C56FB77BCA17" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_74C12C36ADD4B9FAB422C56FB768F879" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_60FC9F330F391F976BA2C56FB77BCA17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_CEFDF59E3084160B2605C56FB75EACF7" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_2105FC134F42EAF17674C56FB77C6891" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_2105FC134F42EAF17674C56FB77C6891" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_A93C65D22DDDEE03B931C56FB77C406C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_A93C65D22DDDEE03B931C56FB77C406C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_79DED02E4EEDCC15281CC56FB77D0585" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_79DED02E4EEDCC15281CC56FB77D0585" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_9FE7A06FF8333D0B1710C56FB77DBE9E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_54B67FDEEB7E012C9821C56FB77BF174" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_9FE7A06FF8333D0B1710C56FB77DBE9E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_230EE51B7FF7BCFC2374C56FB77D309F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_CEFDF59E3084160B2605C56FB75EACF7" xlink:to="loc_us-gaap_DeferredTaxLiabilities_230EE51B7FF7BCFC2374C56FB77D309F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7177A1906352C27D9B15CA00752D05C5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7177A1906352C27D9B15CA00752D05C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0EE745CF93FE5ECE71FFCA00752D02CD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0EE745CF93FE5ECE71FFCA00752D02CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_A76FDBA3A20674890A05CA00752D4779" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_A76FDBA3A20674890A05CA00752D4779" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_5229F8467753BEACDE85CA00752D81C3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_5229F8467753BEACDE85CA00752D81C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_E73C05E200E2FB323F9DCA00752EF765" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_E73C05E200E2FB323F9DCA00752EF765" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveIncomeTaxRateReconciliationTaxAct2018" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_FDDE2374C5B88901FD4ECA00752EE088" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018_FDDE2374C5B88901FD4ECA00752EE088" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_B27DA405F8A4E7A4F148CA00752EDC5C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_B27DA405F8A4E7A4F148CA00752EDC5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_C0A0D11DD3F6AD150F03CA00752EDF53" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_C0A0D11DD3F6AD150F03CA00752EDF53" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture" xlink:label="loc_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_4BF534DE9914F195B7E2CA00752E8019" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture_4BF534DE9914F195B7E2CA00752E8019" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_CEF416F41365756DE1ABCA00752E7514" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent_CEF416F41365756DE1ABCA00752E7514" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:label="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_D216042135D184754FACCA00752F6AAB" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_D216042135D184754FACCA00752F6AAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_9CC8D45ACE7630CBC2D4CA00752F1766" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_9CC8D45ACE7630CBC2D4CA00752F1766" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_F8FF20558018D5156A75CA00752FEE87" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_981CB77F383969E7E8B1CA00752BBD71" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_F8FF20558018D5156A75CA00752FEE87" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_F37E5580ADCFCA30BC2B064EB2B5A1FB" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_1203A2301D8D52CA13B6064EB2B58D2E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F37E5580ADCFCA30BC2B064EB2B5A1FB" xlink:to="loc_dei_DocumentFiscalYearFocus_1203A2301D8D52CA13B6064EB2B58D2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1FA796F3960EB547052D064EB2B50358" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F37E5580ADCFCA30BC2B064EB2B5A1FB" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1FA796F3960EB547052D064EB2B50358" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_33A38BDD379A3BF29051064EB2B5975F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F37E5580ADCFCA30BC2B064EB2B5A1FB" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_33A38BDD379A3BF29051064EB2B5975F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_06B868EB1C62B7452F98064EB2B5A907" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F37E5580ADCFCA30BC2B064EB2B5A1FB" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_06B868EB1C62B7452F98064EB2B5A907" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_46B9D52863A98655A73CC1427617FDA9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_46B9D52863A98655A73CC1427617FDA9" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2F228BD13C672EEFBE0EC1427618A4D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2F228BD13C672EEFBE0EC1427618A4D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_293B21C4FAB4D4EF2519C1427618B877" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2F228BD13C672EEFBE0EC1427618A4D4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_293B21C4FAB4D4EF2519C1427618B877" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_06A11252E0CCBDCA7EB8C1427618E210" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_293B21C4FAB4D4EF2519C1427618B877" xlink:to="loc_cah_PatientRecoveryBusinessMember_06A11252E0CCBDCA7EB8C1427618E210" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_C2422B9C3239CBA10CC8C1427618DAC2" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_50FCE8FF3E1A30FFBC0EC14276191DCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:to="loc_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_A5978663A4EE33C45DDCC14276191386" xlink:to="loc_us-gaap_TaxPeriodDomain_FC47DE64E99171B9612EC1427619DD14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_EED96C75B45CBDEDB830C1427617183D" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4F870BAFE50570459471C142761A9436" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4F870BAFE50570459471C142761A9436" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_796A5D3E7D518E0FC5A8C142761A48D7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_796A5D3E7D518E0FC5A8C142761A48D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9CDAC9D2589202A6AAD3C142761AB326" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9CDAC9D2589202A6AAD3C142761AB326" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_D97C31181747972BF88BC142761A1739" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_D97C31181747972BF88BC142761A1739" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3AC8375A8BADB40C0404C142761AD2FF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3AC8375A8BADB40C0404C142761AD2FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3BD4ABB1A89EAB9F7194C142761B8491" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3BD4ABB1A89EAB9F7194C142761B8491" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_71A35028291CA5B86F57C142761B3FA9" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_71A35028291CA5B86F57C142761B3FA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4DC26D65F28E335491D6C142761B22DA" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4DC26D65F28E335491D6C142761B22DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_07432BCF6C21CBD35811C142761B1250" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_07432BCF6C21CBD35811C142761B1250" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2B2B35347B5016BC9E89C142761927B6" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1364F251829A3AA7DA36C142761B2084" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1364F251829A3AA7DA36C142761B2084" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DA9E9290C0CE6E53125C142761CBCC8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DA9E9290C0CE6E53125C142761CBCC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_092CA76C422A7BF7DBC5C142761CE950" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_092CA76C422A7BF7DBC5C142761CE950" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_E91D2CDE6DFB7B884625C142761CBC81" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_E91D2CDE6DFB7B884625C142761CBC81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4E096B00601D8DDFFB42C142761CE598" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4E096B00601D8DDFFB42C142761CE598" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_CF87D39B9E8A54CBC2FBC142761CBE50" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_CF87D39B9E8A54CBC2FBC142761CBE50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_F00B4AB5C7975DCC4801C142761D13D2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_CE593D81D90F834E1E0EC142761B83DA" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_F00B4AB5C7975DCC4801C142761D13D2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6F81CB9A462860953984064EB2B8774A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_402DB2DA737E87229881064EB2B8AE77" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6F81CB9A462860953984064EB2B8774A" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_402DB2DA737E87229881064EB2B8AE77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_F2FED6BA52C4F5BF2C05064EB2B90536" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6F81CB9A462860953984064EB2B8774A" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_F2FED6BA52C4F5BF2C05064EB2B90536" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0A46EA67A0329DFA003E064EB2B91564" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6F81CB9A462860953984064EB2B8774A" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0A46EA67A0329DFA003E064EB2B91564" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_E201A3A933BB51D3B528064EB2B949A4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6F81CB9A462860953984064EB2B8774A" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_E201A3A933BB51D3B528064EB2B949A4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:label="loc_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_40955FDB6775EE8FC131064EB2B9562F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6F81CB9A462860953984064EB2B8774A" xlink:to="loc_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_40955FDB6775EE8FC131064EB2B9562F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_4D1129EFB0C88BC537D0064EB2B98E35" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6F81CB9A462860953984064EB2B8774A" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_4D1129EFB0C88BC537D0064EB2B98E35" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/Investments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_5C66418D40E204891329064EB33015D8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_6038934F725933EF18AC064EB330A425" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_5C66418D40E204891329064EB33015D8" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_6038934F725933EF18AC064EB330A425" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/InvestmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_9189A82673D1A9A339EFE42C99E48684" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9189A82673D1A9A339EFE42C99E48684" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_D63F17ED12F74D7BEBD1E42C99E4D693" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:to="loc_srt_OwnershipAxis_D63F17ED12F74D7BEBD1E42C99E4D693" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_CE501980EEEEC535E335E42C99E49E3B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_D63F17ED12F74D7BEBD1E42C99E4D693" xlink:to="loc_srt_OwnershipDomain_CE501980EEEEC535E335E42C99E49E3B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviOwnershipInterestDivestedMember" xlink:label="loc_cah_NaviOwnershipInterestDivestedMember_42AB87D5F401820DB15EE42C99E5A68F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_CE501980EEEEC535E335E42C99E49E3B" xlink:to="loc_cah_NaviOwnershipInterestDivestedMember_42AB87D5F401820DB15EE42C99E5A68F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_356D6F29EF3388A535F0E42C99E5DBAE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_356D6F29EF3388A535F0E42C99E5DBAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_BDB4EE72473BD528539DE42C99E50CFA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_356D6F29EF3388A535F0E42C99E5DBAE" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_BDB4EE72473BD528539DE42C99E50CFA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_5139899E6141FBC2F55CE42C99E5E7A0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_BDB4EE72473BD528539DE42C99E50CFA" xlink:to="loc_cah_NaviHealthMember_5139899E6141FBC2F55CE42C99E5E7A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_968997D28B0286DD031BE42C99E4FB05" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_665C4E62B645F228EAAEE42C99E6C731" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_665C4E62B645F228EAAEE42C99E6C731" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_0916593D46C777349E63E42C99E68B1F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_0916593D46C777349E63E42C99E68B1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_80CBDFB759B816D077F4E42C99E6E15B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_80CBDFB759B816D077F4E42C99E6E15B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_DB0F7C174C846D352A2EE42C99E6C1B2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_us-gaap_EquityMethodInvestments_DB0F7C174C846D352A2EE42C99E6C1B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_A3C054E4FCF2AAF17D94E42C99E7C0EB" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_A3C054E4FCF2AAF17D94E42C99E7C0EB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PartnershipOwnership" xlink:label="loc_cah_PartnershipOwnership_C21D6D4CC111A003453AE42C99E7BED7" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_cah_PartnershipOwnership_C21D6D4CC111A003453AE42C99E7BED7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_FFD9950635080300F09AE42C99E71B44" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_0E79DBF57F1AC5CAE095E42C99E6CD44" xlink:to="loc_cah_PreTaxGainonDivestiture_FFD9950635080300F09AE42C99E71B44" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/Leases" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_758DE42F16F5B0B8FEB7C0931EFFDF83" xlink:type="locator" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LeasesTextBlock" xlink:label="loc_cah_LeasesTextBlock_6A48A37B90CB14F578C6C0931EFFC794" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_758DE42F16F5B0B8FEB7C0931EFFDF83" xlink:to="loc_cah_LeasesTextBlock_6A48A37B90CB14F578C6C0931EFFC794" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_24D2BE2122E71C7B8865DA073109A692" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_8F6BF18C8B48FB170C24DA07310A6D8B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_24D2BE2122E71C7B8865DA073109A692" xlink:to="loc_us-gaap_StatementTable_8F6BF18C8B48FB170C24DA07310A6D8B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_ED931191FC71D0473A96DA07310ABF95" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8F6BF18C8B48FB170C24DA07310A6D8B" xlink:to="loc_srt_RangeAxis_ED931191FC71D0473A96DA07310ABF95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_72C311E82506DCE820B6DA07310A641C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ED931191FC71D0473A96DA07310ABF95" xlink:to="loc_srt_RangeMember_72C311E82506DCE820B6DA07310A641C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_7E7FD4C16D4A8B92C3FFDA07310BE2BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_72C311E82506DCE820B6DA07310A641C" xlink:to="loc_srt_MinimumMember_7E7FD4C16D4A8B92C3FFDA07310BE2BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_C6108ECB3D953031DB07DA07310BDB2F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_72C311E82506DCE820B6DA07310A641C" xlink:to="loc_srt_MaximumMember_C6108ECB3D953031DB07DA07310BDB2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8F6BF18C8B48FB170C24DA07310A6D8B" xlink:to="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_5BD450D9CC5C24F53CB7DA0747ED6B2D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_LeaseAndRentalExpense_5BD450D9CC5C24F53CB7DA0747ED6B2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3DC595DC5C62EBAF2917DA07310B112E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3DC595DC5C62EBAF2917DA07310B112E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_7306DF32591EBC8F2423DA07310C3A21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_68F9F17C9A1CFCD67320DA07310CCF6F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_68F9F17C9A1CFCD67320DA07310CCF6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_7B8762045FF62F7C63E7DA07310CDB4D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_7B8762045FF62F7C63E7DA07310CDB4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1702A5D7664968D481B7DA07310C0913" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1702A5D7664968D481B7DA07310C0913" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_6E34038D529ACC78CC62DA07310C894D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_6E34038D529ACC78CC62DA07310C894D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_B092BF3FB86CAEAB2453DA07310D0E7A" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_B092BF3FB86CAEAB2453DA07310D0E7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_04A5264C3326DB5EDA27DA07310D2827" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_04A5264C3326DB5EDA27DA07310D2827" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_754C441D89DA484B3CA2DA07310DF0E2" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_754C441D89DA484B3CA2DA07310DF0E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_26B8FA4C2A489F23F593DA07310DCB73" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_26B8FA4C2A489F23F593DA07310DCB73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_858EF78DEFDFAE458624DA07310D91F7" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_858EF78DEFDFAE458624DA07310D91F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_058B1CB701D23487AC4EDA07310D3AB2" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2FC66936D4D0D5536874DA07310B7581" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_058B1CB701D23487AC4EDA07310D3AB2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0E99CFD1104D40E8411BC0931ED9239F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0E99CFD1104D40E8411BC0931ED9239F" xlink:to="loc_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DE1035AD7D5C62645107C0931EDAAFF2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DE1035AD7D5C62645107C0931EDAAFF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_368287E7B197A2028685C0931EDAF385" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DE1035AD7D5C62645107C0931EDAAFF2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_368287E7B197A2028685C0931EDAF385" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OperatingLeaseMember" xlink:label="loc_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_368287E7B197A2028685C0931EDAF385" xlink:to="loc_cah_OperatingLeaseMember_6EFEB7CED5D67D026101C0931EDB52C7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FinanceLeaseMember" xlink:label="loc_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_368287E7B197A2028685C0931EDAF385" xlink:to="loc_cah_FinanceLeaseMember_F64A2304A04E3EC41C8DC0931EDB4A6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6B2023D710AF049449B1C0931EDA4893" xlink:to="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48EDC5E0F0A4630D39C5C0931EDBD417" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48EDC5E0F0A4630D39C5C0931EDBD417" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_DFCDA61FF528C3065F74C0931EDC2C48" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_DFCDA61FF528C3065F74C0931EDC2C48" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_953176C7A3A8E03043CBC0931EDC3C24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7769A8018645A9846E03C0931EDC7253" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7769A8018645A9846E03C0931EDC7253" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_76B70A8017068AEBE457C0931EDC3DA7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_76B70A8017068AEBE457C0931EDC3DA7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_19880666E81B9EF6EE79C0931EDCBCE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_001353955AA549878D6EC0931EDC7463" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_001353955AA549878D6EC0931EDC7463" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_20B6B50FAFA729CCEE59C0931EDC3610" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_20B6B50FAFA729CCEE59C0931EDC3610" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_C50CB7BB15A68D61FC2FC0931EDD6AB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0D600E7FF47D4C430799C0931EDDDDBF" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0D600E7FF47D4C430799C0931EDDDDBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_760948BECBD61079332FC0931EDD4A1E" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_760948BECBD61079332FC0931EDD4A1E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_057C5DD4BF52B09FF397C0931EDDEBFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_EAF9CB6F8E92F06BE6BFC0931EDDFE32" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_EAF9CB6F8E92F06BE6BFC0931EDDFE32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_33265FBAB7882A94105BC0931EDE818F" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_33265FBAB7882A94105BC0931EDE818F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_618C664E295DFE2B95B7C0931EDEFC52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798408633149076E3710C0931EDE4938" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_798408633149076E3710C0931EDE4938" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_DC7268E5F661418111E4C0931EDEB646" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_DC7268E5F661418111E4C0931EDEB646" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_25BA1EFD41D464F30FF3C0931EDEA759" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0CF6A7FBB13E260744BDC0931EDEA659" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0CF6A7FBB13E260744BDC0931EDEA659" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_24644C33FF0EEEE2B97BC0931EDED2AB" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_24644C33FF0EEEE2B97BC0931EDED2AB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalLeaseLiabilityPaymentsDue" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_TotalLeaseLiabilityPaymentsDue_B89C92447F580BBD3D5EC0931EDFE3BD" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_22F67AD9BBF2AE816889C0931EDFE06A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_F319B1497CEDE63678E8C0931EDFDC59" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_F684C329DFBA4C3ED2D1C0931EDFADA9" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OperatingLeaseImputedInterest" xlink:label="loc_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_OperatingLeaseImputedInterest_7192A8D8425BC39FDB64C0931EDF56E6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FinanceLeaseImputedInterest" xlink:label="loc_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_FinanceLeaseImputedInterest_3278C5FB93BAA386C4CAC0931EE0906B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_3DCAD7BA1929CA103E63C0931EE06FC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_C0790FF26CC75D9FDD96C0931EE00011" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_OperatingLeaseLiability_C0790FF26CC75D9FDD96C0931EE00011" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_3DE17E958A8931063D95C0931EE01357" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_us-gaap_FinanceLeaseLiability_3DE17E958A8931063D95C0931EE01357" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalLeaseLiability" xlink:label="loc_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_F21EF643812FF190017CC0931EDB9BFE" xlink:to="loc_cah_TotalLeaseLiability_66BC9A97D541C3FF8DD6C0931EE0B42D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_97CE9E32214B0B8FD888E42134FA5290" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_6FD066B6DB56420E346FE42134FB0D44" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97CE9E32214B0B8FD888E42134FA5290" xlink:to="loc_us-gaap_OperatingLeaseCost_6FD066B6DB56420E346FE42134FB0D44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4D31964AD828EDC81CC8E42134FC7548" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97CE9E32214B0B8FD888E42134FA5290" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4D31964AD828EDC81CC8E42134FC7548" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_5501E7F7D4C7F699C54BE42134FC05A1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97CE9E32214B0B8FD888E42134FA5290" xlink:to="loc_us-gaap_VariableLeaseCost_5501E7F7D4C7F699C54BE42134FC05A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_C9070CE34127EABDD051E42134FC7659" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97CE9E32214B0B8FD888E42134FA5290" xlink:to="loc_us-gaap_LeaseCost_C9070CE34127EABDD051E42134FC7659" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_A1DF0D6605A280423A01E2F768DE7869" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_A9EAC9A01C075FCB26ECE2F768DF511B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A1DF0D6605A280423A01E2F768DE7869" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_A9EAC9A01C075FCB26ECE2F768DF511B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_22183FAD2AA18A345E07E2F768DF9CFA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A1DF0D6605A280423A01E2F768DE7869" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_22183FAD2AA18A345E07E2F768DF9CFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6EBE7605A5FCB291805CE2F768DF8271" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A1DF0D6605A280423A01E2F768DE7869" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6EBE7605A5FCB291805CE2F768DF8271" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_F6F827C8736DD54DDB21E2F768DF6914" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A1DF0D6605A280423A01E2F768DE7869" xlink:to="loc_us-gaap_OperatingLeaseLiability_F6F827C8736DD54DDB21E2F768DF6914" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_D41FD5B8FE645D219B68E2F768DF89E0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A1DF0D6605A280423A01E2F768DE7869" xlink:to="loc_us-gaap_FinanceLeaseLiability_D41FD5B8FE645D219B68E2F768DF89E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_5441F55A04FC81DF4A6AE2F768E02A04" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A1DF0D6605A280423A01E2F768DE7869" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_5441F55A04FC81DF4A6AE2F768E02A04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_087C037B555ECFC2CEEEE2F768E01864" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A1DF0D6605A280423A01E2F768DE7869" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_087C037B555ECFC2CEEEE2F768E01864" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_E43BA21E7D27BC3E8999E2F768E0755B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A1DF0D6605A280423A01E2F768DE7869" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_E43BA21E7D27BC3E8999E2F768E0755B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_45AAE41B9BAE1C29F4D5C0931EE79331" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_661536C2ADBFC7CFCDD4C0931EE7F451" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45AAE41B9BAE1C29F4D5C0931EE79331" xlink:to="loc_us-gaap_StatementTable_661536C2ADBFC7CFCDD4C0931EE7F451" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_661536C2ADBFC7CFCDD4C0931EE7F451" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1A68D0205358538D00FCC0931EE77AE7" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ASC842Member" xlink:label="loc_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3FBEA347C88FBF717041C0931EE89A5E" xlink:to="loc_cah_ASC842Member_FA254D2D932FEEB06354C0931EE87514" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_A98C0FF6728C4EF4A752C0931EE8B11D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_661536C2ADBFC7CFCDD4C0931EE7F451" xlink:to="loc_us-gaap_StatementLineItems_A98C0FF6728C4EF4A752C0931EE8B11D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Impactofadoptionofnewaccountingstandard" xlink:label="loc_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_A98C0FF6728C4EF4A752C0931EE8B11D" xlink:to="loc_cah_Impactofadoptionofnewaccountingstandard_94D322D3092507445540C0931EE8D155" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_D53ED55A89328719313FC0931EE971F0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45AAE41B9BAE1C29F4D5C0931EE79331" xlink:to="loc_us-gaap_OperatingLeasePayments_D53ED55A89328719313FC0931EE971F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_1C7A05200977E1C4E6ACC0931EE9C3CD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45AAE41B9BAE1C29F4D5C0931EE79331" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_1C7A05200977E1C4E6ACC0931EE9C3CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_D5E895C2102A315C9779C0931EE94602" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45AAE41B9BAE1C29F4D5C0931EE79331" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_D5E895C2102A315C9779C0931EE94602" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_85E75CB8B4D08C934671C0931EE92596" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45AAE41B9BAE1C29F4D5C0931EE79331" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_85E75CB8B4D08C934671C0931EE92596" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_C07FEE0E58E9B1E1E26CC0931EFC2FE0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_AE5A669D33B81606DD57C0931EFD848F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C07FEE0E58E9B1E1E26CC0931EFC2FE0" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_AE5A669D33B81606DD57C0931EFD848F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:label="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_CE51F63359972E1CE97DC0931EFD2EE8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C07FEE0E58E9B1E1E26CC0931EFC2FE0" xlink:to="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_CE51F63359972E1CE97DC0931EFD2EE8" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_LeasePaymentsTableTextBlock" xlink:label="loc_cah_LeasePaymentsTableTextBlock_0E4DC971543366195759C0931EFDE8D7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C07FEE0E58E9B1E1E26CC0931EFC2FE0" xlink:to="loc_cah_LeasePaymentsTableTextBlock_0E4DC971543366195759C0931EFDE8D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_3E32629E1748D0DE9169C0931EFDFF4E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C07FEE0E58E9B1E1E26CC0931EFC2FE0" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_3E32629E1748D0DE9169C0931EFDFF4E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_EF1B3AA40C62E6ED903A064EB2F0405A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_6BC56C64EA2C477D87F4064EB2F12EF0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_EF1B3AA40C62E6ED903A064EB2F0405A" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_6BC56C64EA2C477D87F4064EB2F12EF0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_A843659DD46BCE5EAACDDE6EC1FAE4C2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_FC3BBA810F8F1A5D8481DE6EC1FAE151" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_A843659DD46BCE5EAACDDE6EC1FAE4C2" xlink:to="loc_us-gaap_DebtInstrumentTable_FC3BBA810F8F1A5D8481DE6EC1FAE151" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_8B595A761FF6E719E06FDE6EC1FA85CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_FC3BBA810F8F1A5D8481DE6EC1FAE151" xlink:to="loc_us-gaap_CreditFacilityAxis_8B595A761FF6E719E06FDE6EC1FA85CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_C36AC219176909051620DE6EC1FB3859" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_8B595A761FF6E719E06FDE6EC1FA85CF" xlink:to="loc_us-gaap_CreditFacilityDomain_C36AC219176909051620DE6EC1FB3859" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_76183A91EE87A99E32F6DE6EC1FBDB72" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_FC3BBA810F8F1A5D8481DE6EC1FAE151" xlink:to="loc_us-gaap_DebtInstrumentAxis_76183A91EE87A99E32F6DE6EC1FBDB72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_76183A91EE87A99E32F6DE6EC1FBDB72" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A1.948Notesdue2019Member" xlink:label="loc_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A1.948Notesdue2019Member_444C86ADF273DCC2DDD3DE6EC1FC6F92" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.616Notesdue2022Member" xlink:label="loc_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A2.616Notesdue2022Member_DFB5BCE69CAD034CDDEADE6EC1FCD208" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.079Notesdue2024Member" xlink:label="loc_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A3.079Notesdue2024Member_522E73D58C69DFECB907DE6EC1FC1637" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.41Notesdue2027Member" xlink:label="loc_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A3.41Notesdue2027Member_2AE55258A3595B8DF850DE6EC1FCED49" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.368Notesdue2047Member" xlink:label="loc_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A4.368Notesdue2047Member_7D62D234B6F29CB5D1A3DE6EC1FCA93B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_DE79098A3350FC586B2EDE6EC1FD5997" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FloatingRateNotesdue2022Member" xlink:label="loc_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_FloatingRateNotesdue2022Member_71EC13371FA56BF77D4ADE6EC1FD87A6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OnePointNineFiveNotesdue2018Member" xlink:label="loc_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_OnePointNineFiveNotesdue2018Member_1475DC7F754854CC115ADE6EC1FDB6EF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.4Notesdue2020Member" xlink:label="loc_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A2.4Notesdue2020Member_8EA048151C772D11EA09DE6EC1FDFAF6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.2Notesdue2022Member" xlink:label="loc_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A3.2Notesdue2022Member_CCF17DCD6737F5AD19AADE6EC1FD2526" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.2Notesdue2023Member" xlink:label="loc_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A3.2Notesdue2023Member_919FA289DDA575D8DA2EDE6EC1FD8F56" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.5Notesdue2025Member" xlink:label="loc_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A3.5Notesdue2025Member_F95F8194A1E0C6C8625CDE6EC1FD03F7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.75Notesdue2026Member" xlink:label="loc_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A3.75Notesdue2026Member_350036C0ADAD764FC26BDE6EC1FE3353" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.5Notesdue2044Member" xlink:label="loc_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A4.5Notesdue2044Member_3B09E33CADAC74A8A735DE6EC1FEBAA0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.6Notesdue2043Member" xlink:label="loc_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A4.6Notesdue2043Member_8537F696C28D752E1E08DE6EC1FE91D3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.625Notesdue2021Member" xlink:label="loc_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A4.625Notesdue2021Member_585575F9FF053A35D866DE6EC1FE8D5E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.9Notesdue2045Member" xlink:label="loc_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A4.9Notesdue2045Member_9400926575B02BCA6943DE6EC1FE3D35" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A7.0Debenturesduefiscal2027Member" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9C51A10B60A75E4E69B4DE6EC1FB42D1" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_38B166358E9371154A1CDE6EC1FFEB59" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_FC3BBA810F8F1A5D8481DE6EC1FAE151" xlink:to="loc_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_FF62656A497085A852AFDE6EC1FF3FB2" xlink:to="loc_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AllegianceCorporationMember" xlink:label="loc_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_654696B113F82370C4C1DE6EC1FF7B11" xlink:to="loc_cah_AllegianceCorporationMember_C15FF494F3E8C3C7279ADE6EC1FF4587" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_FC3BBA810F8F1A5D8481DE6EC1FAE151" xlink:to="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1A00D4CFC4FAB7AF41F4DE6EC2004003" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1A00D4CFC4FAB7AF41F4DE6EC2004003" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_571F81A1F9CF2A390B80DE6EC200BAA6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_AccountsPayableCurrent_571F81A1F9CF2A390B80DE6EC200BAA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfNotesPayable_90006F84DCE5913063F7DE6EC20022A9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfNotesPayable_90006F84DCE5913063F7DE6EC20022A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AB52731F2A4C89916704DE6EC2000816" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AB52731F2A4C89916704DE6EC2000816" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OfferAsPercentageOfPrincipalAmount" xlink:label="loc_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_cah_OfferAsPercentageOfPrincipalAmount_4640E709B88DC4402054DE6EC200CA5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_73F7A4B98A81F9D2FB95DE6EC201C508" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_LineOfCredit_73F7A4B98A81F9D2FB95DE6EC201C508" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2DE109C8C816F40E55FFDE6EC2013C03" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2DE109C8C816F40E55FFDE6EC2013C03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_1C592CD51FB608884FC8DE6EC201E267" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_1C592CD51FB608884FC8DE6EC201E267" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NotesPayableRepurchased" xlink:label="loc_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_EA13F813F2E5A945C223DE6EC1FF1C69" xlink:to="loc_cah_NotesPayableRepurchased_C031BE2E3B182FB4D45BDE6EC201FB6A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_F77E1F031FE7401295C3DD83F371CFAD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F77E1F031FE7401295C3DD83F371CFAD" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_A555FD2A7878974A625BDD83F3779488" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_A555FD2A7878974A625BDD83F3779488" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84DF2024C6A7F683398ADD83F377A72B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A555FD2A7878974A625BDD83F3779488" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84DF2024C6A7F683398ADD83F377A72B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_C9B622FB0F33B596ECB9DD83F378E4CD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:to="loc_us-gaap_DebtInstrumentAxis_C9B622FB0F33B596ECB9DD83F378E4CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_C9B622FB0F33B596ECB9DD83F378E4CD" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.616Notesdue2022Member" xlink:label="loc_cah_A2.616Notesdue2022Member_B0A9B918FC9D41C12A33DD83F378187C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A2.616Notesdue2022Member_B0A9B918FC9D41C12A33DD83F378187C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.2Notesdue2023Member" xlink:label="loc_cah_A3.2Notesdue2023Member_6391D432F3AAB65535CCDD83F3799A5C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A3.2Notesdue2023Member_6391D432F3AAB65535CCDD83F3799A5C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FloatingRateNotesdue2022Member" xlink:label="loc_cah_FloatingRateNotesdue2022Member_741D0635BAC46B409806DD83F379B9B4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_FloatingRateNotesdue2022Member_741D0635BAC46B409806DD83F379B9B4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.41Notesdue2027Member" xlink:label="loc_cah_A3.41Notesdue2027Member_52A199EA44CDE7CB91E8DD83F3794D78" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A3.41Notesdue2027Member_52A199EA44CDE7CB91E8DD83F3794D78" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.6Notesdue2043Member" xlink:label="loc_cah_A4.6Notesdue2043Member_D3E5F86DA085F1524A49DD83F379A08E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A4.6Notesdue2043Member_D3E5F86DA085F1524A49DD83F379A08E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.9Notesdue2045Member" xlink:label="loc_cah_A4.9Notesdue2045Member_F8867EBD60C4E834F768DD83F37A1D77" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A4.9Notesdue2045Member_F8867EBD60C4E834F768DD83F37A1D77" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.368Notesdue2047Member" xlink:label="loc_cah_A4.368Notesdue2047Member_E8E6E594309767EF74CEDD83F37AE56B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A4.368Notesdue2047Member_E8E6E594309767EF74CEDD83F37AE56B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OnePointNineFiveNotesdue2018Member" xlink:label="loc_cah_OnePointNineFiveNotesdue2018Member_8C4069C77EBC2F2C6959DD83F37AE46C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_OnePointNineFiveNotesdue2018Member_8C4069C77EBC2F2C6959DD83F37AE46C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_338F394F3093EA209C6FDD83F37AA4E5" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8C2D973C15DD153E3BE4DD83F37898E2" xlink:to="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_338F394F3093EA209C6FDD83F37AA4E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_F70AA8AF86A82FDF3602DD83F37A1256" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_145D1F6A4E4E086FB5D2DD83F37B2654" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_BC2CEB101EA7751CB129DD83F37B36B7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:to="loc_us-gaap_CreditFacilityAxis_BC2CEB101EA7751CB129DD83F37B36B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_BC2CEB101EA7751CB129DD83F37B36B7" xlink:to="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_2CBE1173C37EBC04175ADD83F37B0470" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:to="loc_us-gaap_LetterOfCreditMember_2CBE1173C37EBC04175ADD83F37B0470" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_94BD35603F9A5EBB0184DD83F37CE804" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_94BD35603F9A5EBB0184DD83F37CE804" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_23C8F7709BE856465D4BDD83F37CF220" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_23C8F7709BE856465D4BDD83F37CF220" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_FCAB1B1FE65AB34F9A6EDD83F37C5F08" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:to="loc_us-gaap_CommercialPaperMember_FCAB1B1FE65AB34F9A6EDD83F37C5F08" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_CB6FA5511D09AB671A97DD83F37C46AA" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_BCE573E11EA6BD8262B6DD83F37BF5C6" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_CB6FA5511D09AB671A97DD83F37C46AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_D7B0381F2A7367B7A6DADD83F375B58F" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_066111107A2AB6893E24DD83F37C6A9C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_LineOfCredit_066111107A2AB6893E24DD83F37C6A9C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_5474A154365EC664813DDD83F37D1713" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_dei_DocumentFiscalYearFocus_5474A154365EC664813DDD83F37D1713" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_D2241E67D08C37E0ABCFDD83F37D7511" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_AccountsPayableCurrent_D2241E67D08C37E0ABCFDD83F37D7511" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NotesPayableRepurchased" xlink:label="loc_cah_NotesPayableRepurchased_1EC4BB319D2E162A130CDD83F37D76B5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_cah_NotesPayableRepurchased_1EC4BB319D2E162A130CDD83F37D76B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_C089ED29F4DEA9460899DD83F37EB9BE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_C089ED29F4DEA9460899DD83F37EB9BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:label="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_0A876BBE98A1BEA46240DD83F37E187C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_0A876BBE98A1BEA46240DD83F37E187C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfNotesPayable_29387C9FD0CFBC74F43FDD83F37E8769" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfNotesPayable_29387C9FD0CFBC74F43FDD83F37E8769" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AACAF2DFF9D11B55980EDD83F37EC2A6" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AACAF2DFF9D11B55980EDD83F37EC2A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaap_OtherBorrowings_EB0D2A785D2F120D736EDD83F37E706F" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_OtherBorrowings_EB0D2A785D2F120D736EDD83F37E706F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_12EC5C4E4DB0C14D7378DD83F37EABA6" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_AD018C527F1D29C00B2CDD83F37C58AE" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_12EC5C4E4DB0C14D7378DD83F37EABA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_59AD83891776454AF4DADD83F37F3134" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F77E1F031FE7401295C3DD83F371CFAD" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_59AD83891776454AF4DADD83F37F3134" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_AE97E5150B7F1C61402BDD83F37F4D22" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F77E1F031FE7401295C3DD83F371CFAD" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_AE97E5150B7F1C61402BDD83F37F4D22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5120DBF8CBED70EE23C8DD83F37F62CC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F77E1F031FE7401295C3DD83F371CFAD" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5120DBF8CBED70EE23C8DD83F37F62CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_82C2C8A2FB3346024252DD83F37FFA34" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F77E1F031FE7401295C3DD83F371CFAD" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_82C2C8A2FB3346024252DD83F37FFA34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3A2F814C308F10920620DD83F37FEB14" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F77E1F031FE7401295C3DD83F371CFAD" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3A2F814C308F10920620DD83F37FEB14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0286CC014CFE45DD481ADD83F37F5256" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F77E1F031FE7401295C3DD83F371CFAD" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0286CC014CFE45DD481ADD83F37F5256" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1857DBF510521F1ADAF6064EB2BF5BFE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1857DBF510521F1ADAF6064EB2BF5BFE" xlink:to="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:to="loc_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_090BC5131667DCBFA5AE064EB2C0A1BB" xlink:to="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_39006DA89D7982E2EF27064EB2C04AF6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_39006DA89D7982E2EF27064EB2C04AF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_368D4B9C9EBDA4E70ABA064EB2C00941" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:to="loc_us-gaap_LetterOfCreditMember_368D4B9C9EBDA4E70ABA064EB2C00941" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_EDE06FE5809FFD030840064EB2C12567" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_335C603C19F403D6EE94064EB2C1D298" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_60AECC12A539F000D0AC064EB2C053F3" xlink:to="loc_us-gaap_CommercialPaperMember_335C603C19F403D6EE94064EB2C1D298" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_B2FF73E26ECFF923C6D9064EB2C12F2C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:to="loc_us-gaap_DebtInstrumentAxis_B2FF73E26ECFF923C6D9064EB2C12F2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_539F892E5749765DC63C064EB2C1BBE0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_B2FF73E26ECFF923C6D9064EB2C12F2C" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_539F892E5749765DC63C064EB2C1BBE0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_539F892E5749765DC63C064EB2C1BBE0" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_B9FE76D3017F4613D6D3064EB2C1BE86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_ECEF4DA63E91B6B1F813064EB2C2040E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:to="loc_srt_RangeAxis_ECEF4DA63E91B6B1F813064EB2C2040E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9EC47D174D3AA49C923E064EB2C2E591" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ECEF4DA63E91B6B1F813064EB2C2040E" xlink:to="loc_srt_RangeMember_9EC47D174D3AA49C923E064EB2C2E591" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3CD0BE8B1A93D106E79A064EB2BF5C18" xlink:to="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_77B984AC55F7EBDF394F064EB2C252F9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_77B984AC55F7EBDF394F064EB2C252F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_328A671E496F400F08CE064EB2C2685C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:to="loc_us-gaap_LineOfCredit_328A671E496F400F08CE064EB2C2685C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:label="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_F21BA5300ECD31413EC9064EB2C364E1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:to="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_F21BA5300ECD31413EC9064EB2C364E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaap_OtherBorrowings_6F46C8465FE9AE46D0F2064EB2C3921C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_F7EEDFE584CDA23CF538064EB2C23D28" xlink:to="loc_us-gaap_OtherBorrowings_6F46C8465FE9AE46D0F2064EB2C3921C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_E799327BFB8260DBD26FC9F58AD32D4B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_824E8F2AAB15F283FC9DC9F58AD4B5A7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_E799327BFB8260DBD26FC9F58AD32D4B" xlink:to="loc_us-gaap_DebtInstrumentTable_824E8F2AAB15F283FC9DC9F58AD4B5A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_FABDC027D29E2335851FC9F58AD47AF8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_824E8F2AAB15F283FC9DC9F58AD4B5A7" xlink:to="loc_us-gaap_DebtInstrumentAxis_FABDC027D29E2335851FC9F58AD47AF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_FABDC027D29E2335851FC9F58AD47AF8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A1.948Notesdue2019Member" xlink:label="loc_cah_A1.948Notesdue2019Member_0E49FBFCAA213597D767C9F58AD59614" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A1.948Notesdue2019Member_0E49FBFCAA213597D767C9F58AD59614" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.4Notesdue2020Member" xlink:label="loc_cah_A2.4Notesdue2020Member_5AA696BE4FE52303F364C9F58AD5CFA4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A2.4Notesdue2020Member_5AA696BE4FE52303F364C9F58AD5CFA4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.625Notesdue2021Member" xlink:label="loc_cah_A4.625Notesdue2021Member_C734C5BEDD89BCF21906C9F58AD52261" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A4.625Notesdue2021Member_C734C5BEDD89BCF21906C9F58AD52261" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2.616Notesdue2022Member" xlink:label="loc_cah_A2.616Notesdue2022Member_C9514F7CC09C6F3C7154C9F58AD62C1B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A2.616Notesdue2022Member_C9514F7CC09C6F3C7154C9F58AD62C1B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.2Notesdue2022Member" xlink:label="loc_cah_A3.2Notesdue2022Member_798CCEB80AEB53136994C9F58AD6BF45" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A3.2Notesdue2022Member_798CCEB80AEB53136994C9F58AD6BF45" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FloatingRateNotesdue2022Member" xlink:label="loc_cah_FloatingRateNotesdue2022Member_0CC469B039D26C908692C9F58AD61DC7" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_FloatingRateNotesdue2022Member_0CC469B039D26C908692C9F58AD61DC7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.2Notesdue2023Member" xlink:label="loc_cah_A3.2Notesdue2023Member_222C272F6FB60CFCFAABC9F58AD6C4D2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A3.2Notesdue2023Member_222C272F6FB60CFCFAABC9F58AD6C4D2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.079Notesdue2024Member" xlink:label="loc_cah_A3.079Notesdue2024Member_3BD2A9579E59C9810C17C9F58AD63EE3" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A3.079Notesdue2024Member_3BD2A9579E59C9810C17C9F58AD63EE3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.5Notesdue2025Member" xlink:label="loc_cah_A3.5Notesdue2025Member_55A108E32EFC5C1B67FDC9F58AD6A106" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A3.5Notesdue2025Member_55A108E32EFC5C1B67FDC9F58AD6A106" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.75Notesdue2026Member" xlink:label="loc_cah_A3.75Notesdue2026Member_988E642AB1BBFC27261EC9F58AD6D8BD" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A3.75Notesdue2026Member_988E642AB1BBFC27261EC9F58AD6D8BD" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A3.41Notesdue2027Member" xlink:label="loc_cah_A3.41Notesdue2027Member_BE07669BF049546ABDF4C9F58AD7A991" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A3.41Notesdue2027Member_BE07669BF049546ABDF4C9F58AD7A991" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.6Notesdue2043Member" xlink:label="loc_cah_A4.6Notesdue2043Member_3BBCB6B37B6B73CCB5EBC9F58AD72AD0" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A4.6Notesdue2043Member_3BBCB6B37B6B73CCB5EBC9F58AD72AD0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.5Notesdue2044Member" xlink:label="loc_cah_A4.5Notesdue2044Member_9222C23290D73B5D6029C9F58AD75415" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A4.5Notesdue2044Member_9222C23290D73B5D6029C9F58AD75415" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.9Notesdue2045Member" xlink:label="loc_cah_A4.9Notesdue2045Member_98B8ECBD92E022F9DF69C9F58AD72A4A" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A4.9Notesdue2045Member_98B8ECBD92E022F9DF69C9F58AD72A4A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A4.368Notesdue2047Member" xlink:label="loc_cah_A4.368Notesdue2047Member_B1130ACE7146A87A04F6C9F58AD7E0C3" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A4.368Notesdue2047Member_B1130ACE7146A87A04F6C9F58AD7E0C3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A7.0Debenturesduefiscal2027Member" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_F4F555E1A261038DC811C9F58ADDE0CD" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8BD43EE8FD58AB09C417C9F58AD508E5" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_F4F555E1A261038DC811C9F58ADDE0CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_824E8F2AAB15F283FC9DC9F58AD4B5A7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_2524BDB427C5D627CDF2C9F799A384D7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_AccountsPayableCurrent_2524BDB427C5D627CDF2C9F799A384D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_82BA4D81DD123904578DC9F58ADDBEF0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_NotesPayable_82BA4D81DD123904578DC9F58ADDBEF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaap_OtherBorrowings_419A41D0CA7CE7314214C9F58ADD9E98" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_OtherBorrowings_419A41D0CA7CE7314214C9F58ADD9E98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_424FAEDE087CB69F6A40C9F58ADEF9DE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_424FAEDE087CB69F6A40C9F58ADEF9DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_C4A503556652A5FCF9DFC9F58ADE0D6E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_C4A503556652A5FCF9DFC9F58ADE0D6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8C9326659FF4B1405ADBC9F58ADED039" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84863EC2FF39B2AD4F9EC9F58ADD863A" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8C9326659FF4B1405ADBC9F58ADED039" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_031D478E6F9E2AA7139A064EB2EF6145" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_27F5470913FDAB047ADF064EB2EF1509" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_031D478E6F9E2AA7139A064EB2EF6145" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_27F5470913FDAB047ADF064EB2EF1509" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_3B417D7C9E2359EF5ECC064EB3623440" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_78D293BB1E29C06C75F7064EB3627770" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_3B417D7C9E2359EF5ECC064EB3623440" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_78D293BB1E29C06C75F7064EB3627770" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_886C8BE8E5464B04A5A5064EB35DF16C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_9ECEFFC382CA1235BEE7064EB35D92DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_886C8BE8E5464B04A5A5064EB35DF16C" xlink:to="loc_us-gaap_SeveranceCosts1_9ECEFFC382CA1235BEE7064EB35D92DF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_D91BE0E276F5053C212B064EB35D2ADD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_886C8BE8E5464B04A5A5064EB35DF16C" xlink:to="loc_cah_FacilityExitAndOtherCosts_D91BE0E276F5053C212B064EB35D2ADD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_9C5A698B0B416DC22613064EB35D932A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_886C8BE8E5464B04A5A5064EB35DF16C" xlink:to="loc_us-gaap_RestructuringCharges_9C5A698B0B416DC22613064EB35D932A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_D7DBE282E1F63A01134D064EB357CAD4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_D7DBE282E1F63A01134D064EB357CAD4" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_C228D7FDFB5EF2ECCDA1064EB3588C3F" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_367C6B342013EBA36EB6064EB35830A6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:to="loc_us-gaap_EmployeeSeveranceMember_367C6B342013EBA36EB6064EB35830A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_076A494B3AC9F72537C5064EB359BBA4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_600B0D0E754AE897741B064EB3582369" xlink:to="loc_us-gaap_FacilityClosingMember_076A494B3AC9F72537C5064EB359BBA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_75B4B83C09FD09259AA6064EB35878CD" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_268786D52EF13F8029CE064EB35938AE" xlink:to="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_A11FAAB7CEF17708668C064EB359797C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:to="loc_us-gaap_RestructuringReserve_A11FAAB7CEF17708668C064EB359797C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_95A2B16C83C98DE173E4064EB35AAC35" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:to="loc_us-gaap_RestructuringCosts_95A2B16C83C98DE173E4064EB35AAC35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_73AD08C6D4D9CBB5744C064EB35A2363" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:to="loc_us-gaap_PaymentsForRestructuring_73AD08C6D4D9CBB5744C064EB35A2363" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_C106418A696A672B8FE2064EB35AFBD9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_F5E65CBBA4A7CC956769064EB35957F9" xlink:to="loc_us-gaap_RestructuringReserve_C106418A696A672B8FE2064EB35AFBD9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8881FAC34A4ED831BA62B48EFB97754E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_EF07083E094D75EA9891B48EFB98C51A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8881FAC34A4ED831BA62B48EFB97754E" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_EF07083E094D75EA9891B48EFB98C51A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_EF07083E094D75EA9891B48EFB98C51A" xlink:to="loc_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_53E9DBF24C495A8F987FB48EFB98809D" xlink:to="loc_us-gaap_RestructuringPlanDomain_35D78A72E6A7FC6C602CB48EFB981CFB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ContractTerminationAxis" xlink:label="loc_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_EF07083E094D75EA9891B48EFB98C51A" xlink:to="loc_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ContractTerminationAxis_592AF8BC320841ABFEA2B48EFB999552" xlink:to="loc_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_DistributorContractMember" xlink:label="loc_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ContractTerminationDomain_5E14394E6DADDD4C4AD8B48EFB994C7D" xlink:to="loc_cah_DistributorContractMember_4CB210F2C43B0ACB1EDAB48EFB99828E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_382B7DF65845AE3D7692B48EFB9AEE61" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_EF07083E094D75EA9891B48EFB98C51A" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_382B7DF65845AE3D7692B48EFB9AEE61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_452D6E34CF1ED220C6DEB48EFB9ADF21" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_382B7DF65845AE3D7692B48EFB9AEE61" xlink:to="loc_us-gaap_RestructuringCosts_452D6E34CF1ED220C6DEB48EFB9ADF21" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_382B7DF65845AE3D7692B48EFB9AEE61" xlink:to="loc_cah_FacilityExitAndOtherCosts_CFB505794FDB18C4048FB48EFB9A6380" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_7209AC9F75B8DA62B4B7064EB360AA8A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_9BF778FD944CB540AE7A064EB360EC66" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_7209AC9F75B8DA62B4B7064EB360AA8A" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_9BF778FD944CB540AE7A064EB360EC66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_C7CC23DDBAB9CB07AD7B064EB3608400" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_7209AC9F75B8DA62B4B7064EB360AA8A" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_C7CC23DDBAB9CB07AD7B064EB3608400" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:href="cah-20200630.xsd#cah_ScheduleIIAbstract" xlink:label="loc_cah_ScheduleIIAbstract_A034D61BAF638F358F5B064EAFE379A3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_B53F5F33551A4FDAD388064EAFE33F93" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ScheduleIIAbstract_A034D61BAF638F358F5B064EAFE379A3" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_B53F5F33551A4FDAD388064EAFE33F93" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_EA4DF5E1864307031609DE78348369A2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_EA4DF5E1864307031609DE78348369A2" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_E46CEB0DEAA4A92820B0DE7834831E3C" xlink:to="loc_us-gaap_ReceivableTypeDomain_988D1210802F0C57D26ADE7834839B90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_7EC4F9044D68E42D8DAADE783484F993" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PricingDisputesMember" xlink:label="loc_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="loc_cah_PricingDisputesMember_3C232EF21CFDB3DB88EBDE7834843E41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_175517EED0B56A00C4B6DE7834850405" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_175517EED0B56A00C4B6DE7834850405" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PriorYearRecoveriesMember" xlink:label="loc_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="loc_cah_PriorYearRecoveriesMember_712DBEBCD42A6A2CD41FDE78348536ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_C5C8EFD3035627BE1D8DDE783485117C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_C5C8EFD3035627BE1D8DDE783485117C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesReturnsAndAllowancesMember" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_3DA2CBCBBBBBF478AB2DDE7834854C78" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="loc_us-gaap_SalesReturnsAndAllowancesMember_3DA2CBCBBBBBF478AB2DDE7834854C78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_CB371EB49934956454C6DE78348579E9" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_64892347A88EED649596DE7834847F76" xlink:to="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_CB371EB49934956454C6DE78348579E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_E328EA45EE44E2673B00DE7834830027" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_2605EDC60B9C5D34A188DE783486596F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_2605EDC60B9C5D34A188DE783486596F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_382AF8651B5DFAEFF84FDE7834865F71" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_382AF8651B5DFAEFF84FDE7834865F71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5933B14FBA65BDBC0F71DE7834862444" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_5933B14FBA65BDBC0F71DE7834862444" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4775AC1450FEEC3B8E6DDE783486C9C1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4775AC1450FEEC3B8E6DDE783486C9C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_477DF9CB0679745B0682DE783487B417" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_477DF9CB0679745B0682DE783487B417" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_F66CB789A726650B8974DE7834873229" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_965F4BA9F02892A8D8AEDE7834852624" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_F66CB789A726650B8974DE7834873229" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_5D6318F8EDA21C95155B064EB0BD480C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_9B98A2518008DD151ADC064EB0BD006E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5D6318F8EDA21C95155B064EB0BD480C" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_9B98A2518008DD151ADC064EB0BD006E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_350B8A9550D9060D357F064EB05D5C25" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_589EDF1DA75A89745F43064EB05D56EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_350B8A9550D9060D357F064EB05D5C25" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_589EDF1DA75A89745F43064EB05D56EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_124454BF8EF7A82A52AA064EB05E5EA4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_589EDF1DA75A89745F43064EB05D56EA" xlink:to="loc_srt_ConsolidationItemsAxis_124454BF8EF7A82A52AA064EB05E5EA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_48EF0394F3B8D51D9400064EB05EE414" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_124454BF8EF7A82A52AA064EB05E5EA4" xlink:to="loc_srt_ConsolidationItemsDomain_48EF0394F3B8D51D9400064EB05EE414" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_36A896FE51E824723970064EB05E1F32" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_48EF0394F3B8D51D9400064EB05EE414" xlink:to="loc_us-gaap_OperatingSegmentsMember_36A896FE51E824723970064EB05E1F32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_D7F211FB1D2F5AEFF129064EB05ED9EC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_48EF0394F3B8D51D9400064EB05EE414" xlink:to="loc_us-gaap_CorporateNonSegmentMember_D7F211FB1D2F5AEFF129064EB05ED9EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9180577FB8327F495BD4064EB05FD94A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_589EDF1DA75A89745F43064EB05D56EA" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9180577FB8327F495BD4064EB05FD94A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_BACCD9FC6A6A67463002064EB05FE584" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9180577FB8327F495BD4064EB05FD94A" xlink:to="loc_us-gaap_SegmentDomain_BACCD9FC6A6A67463002064EB05FE584" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_4B000C4B7197A404EA68064EB05FF451" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_BACCD9FC6A6A67463002064EB05FE584" xlink:to="loc_cah_PharmaceuticalMember_4B000C4B7197A404EA68064EB05FF451" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_FE4CEC9CEA14CCE89815064EB05FD003" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_BACCD9FC6A6A67463002064EB05FE584" xlink:to="loc_cah_MedicalMember_FE4CEC9CEA14CCE89815064EB05FD003" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1FC6C910714C3EB2E5D5064EB0607F14" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_589EDF1DA75A89745F43064EB05D56EA" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1FC6C910714C3EB2E5D5064EB0607F14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_D8E97C4B76152619F086064EB06098D7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1FC6C910714C3EB2E5D5064EB0607F14" xlink:to="loc_us-gaap_Assets_D8E97C4B76152619F086064EB06098D7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_CADC7E7947A6B6993701064EB06C8085" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0C0A616D1FAED93DFCE2064EB06D7279" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_CADC7E7947A6B6993701064EB06C8085" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0C0A616D1FAED93DFCE2064EB06D7279" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_99CC1809621AB8118F98064EB06D92F5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0C0A616D1FAED93DFCE2064EB06D7279" xlink:to="loc_srt_ConsolidationItemsAxis_99CC1809621AB8118F98064EB06D92F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_E25E87509308628BA354064EB06D63AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_99CC1809621AB8118F98064EB06D92F5" xlink:to="loc_srt_ConsolidationItemsDomain_E25E87509308628BA354064EB06D63AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_C48465B782B0584B5345064EB06E7885" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_E25E87509308628BA354064EB06D63AA" xlink:to="loc_us-gaap_OperatingSegmentsMember_C48465B782B0584B5345064EB06E7885" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_C83070548E20E6F6AC4D064EB06E0B97" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_E25E87509308628BA354064EB06D63AA" xlink:to="loc_us-gaap_CorporateNonSegmentMember_C83070548E20E6F6AC4D064EB06E0B97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_E74F563A538841E9A7C3064EB06ECD72" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0C0A616D1FAED93DFCE2064EB06D7279" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_E74F563A538841E9A7C3064EB06ECD72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_93001C9A7245B8A2A909064EB06E1C6F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_E74F563A538841E9A7C3064EB06ECD72" xlink:to="loc_us-gaap_SegmentDomain_93001C9A7245B8A2A909064EB06E1C6F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_786A5CD8B275F04CB503064EB06E6305" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_93001C9A7245B8A2A909064EB06E1C6F" xlink:to="loc_cah_PharmaceuticalMember_786A5CD8B275F04CB503064EB06E6305" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_F97ACBBAFA6C20A6DB6E064EB06F9FBB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_93001C9A7245B8A2A909064EB06E1C6F" xlink:to="loc_cah_MedicalMember_F97ACBBAFA6C20A6DB6E064EB06F9FBB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_110FB6FEFD9BEF1F8D84064EB06FEF35" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0C0A616D1FAED93DFCE2064EB06D7279" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_110FB6FEFD9BEF1F8D84064EB06FEF35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_B2054D3E244F17FE1A9E064EB06F0B63" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_110FB6FEFD9BEF1F8D84064EB06FEF35" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_B2054D3E244F17FE1A9E064EB06F0B63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_E273D2CBE7D160F61AEC064EB06FCBD9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_110FB6FEFD9BEF1F8D84064EB06FEF35" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_E273D2CBE7D160F61AEC064EB06FCBD9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_8FA6E4A29FC3EF2B759DC5281BA61709" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8FA6E4A29FC3EF2B759DC5281BA61709" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:to="loc_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_51BD69DC5CD119BF2138C5281BA79878" xlink:to="loc_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_41FBC1C0543A8D018FADC5281BA78839" xlink:to="loc_cah_TotalOpioidLitigationMember_9F6D6C0813CAE59D5130C5281BA70717" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GownRecallAxis" xlink:label="loc_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:to="loc_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GownRecallAxis_19889F3C76AE5049DBA1C5281BA823B4" xlink:to="loc_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_SterileSurgicalGownRecallMember" xlink:label="loc_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GownRecallDomain_9A878C0647313FCDA350C5281BA8A4AE" xlink:to="loc_cah_SterileSurgicalGownRecallMember_4D0A1416424015E9A86CC5281BA8B630" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BE68D62AFF1DE13F03D9C5281BA83CC9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_CE7B6EF8E8CB02876C9FC5281BA9EA7C" xlink:to="loc_cah_NaviHealthMember_F470C89532DD3540DADDC5281BA9E920" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_174703B33BB9019F5AB9C5281BA66C66" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GainonDivestitureAfterTax" xlink:label="loc_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_cah_GainonDivestitureAfterTax_2FE2BB54E846DA7CA340C558DD1CCBF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_C731FD4880B77B650CA1C5281BA93E07" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_us-gaap_NumberOfReportableSegments_C731FD4880B77B650CA1C5281BA93E07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_8ED963C4FFD9079D270BC5281BAA1DAC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_us-gaap_NumberOfOperatingSegments_8ED963C4FFD9079D270BC5281BAA1DAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRecallExpense" xlink:label="loc_us-gaap_InventoryRecallExpense_72B2A0898268A8793A90C5281BAAEFA2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_us-gaap_InventoryRecallExpense_72B2A0898268A8793A90C5281BAAEFA2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_cah_PreTaxGainonDivestiture_7EB96FB668491BB1FE49C5281BAA9778" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_800FDEAD59F15391D9E0C5281BAA88F0" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_800FDEAD59F15391D9E0C5281BAA88F0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_49F9BF89388662A0E68CC5281BA9239B" xlink:to="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_31BA4900D6960D2A4921C5281BAAD16A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_37925F919EAF97FA5746064EB04E7976" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_37925F919EAF97FA5746064EB04E7976" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_0215FDA112570E8AB365064EB04FBEEB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328" xlink:to="loc_srt_StatementGeographicalAxis_0215FDA112570E8AB365064EB04FBEEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_C69A5F6F33D953EFE6B7064EB04F755B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0215FDA112570E8AB365064EB04FBEEB" xlink:to="loc_srt_SegmentGeographicalDomain_C69A5F6F33D953EFE6B7064EB04F755B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_country_US_7BDB4F7ADAC72A1C9752064EB04F7652" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_C69A5F6F33D953EFE6B7064EB04F755B" xlink:to="loc_country_US_7BDB4F7ADAC72A1C9752064EB04F7652" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_A9AD5F29017D326CECFE064EB04F2CFF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_C69A5F6F33D953EFE6B7064EB04F755B" xlink:to="loc_us-gaap_NonUsMember_A9AD5F29017D326CECFE064EB04F2CFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5474447B00FC0407D0B8064EB04E3328" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_B1235D0F5436BC4E4E9F064EB0500DD2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_2ED8D1AF9F0040A7F28D064EB0500E29" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_B1235D0F5436BC4E4E9F064EB0500DD2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_9BA6A1A0A0582DCEBCE3C0931BA2973C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9BA6A1A0A0582DCEBCE3C0931BA2973C" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:to="loc_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_340AC43255D26AD489A7C0931BA39659" xlink:to="loc_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_C17B9EE8A1F98BF104F4C0931BA3CB06" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:to="loc_us-gaap_OperatingSegmentsMember_C17B9EE8A1F98BF104F4C0931BA3CB06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_6534A0DCF79D7B1548C5C0931BA43E28" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_5D28FE9C1D20E45EB84BC0931BA3CFF3" xlink:to="loc_us-gaap_CorporateNonSegmentMember_6534A0DCF79D7B1548C5C0931BA43E28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_E55DE2CC4ECDA83587DAC0931BA45299" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_E55DE2CC4ECDA83587DAC0931BA45299" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_D32036E84A3999F40330C0931BA47986" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_E55DE2CC4ECDA83587DAC0931BA45299" xlink:to="loc_us-gaap_SegmentDomain_D32036E84A3999F40330C0931BA47986" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_21EFD10D2E72419B1AB2C0931BA42791" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_D32036E84A3999F40330C0931BA47986" xlink:to="loc_cah_PharmaceuticalMember_21EFD10D2E72419B1AB2C0931BA42791" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_18036A9BBFB308757EDFC0931BA55C25" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_D32036E84A3999F40330C0931BA47986" xlink:to="loc_cah_MedicalMember_18036A9BBFB308757EDFC0931BA55C25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:to="loc_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_C64E905C1EA5C4CC9D62C0931BA5D57D" xlink:to="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalDistributionandSpecialtyMember" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_16B48A8CAABCEDAA3776C0931BA5AA62" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NuclearPrecisionHealthServicesMember" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_9E733DA9E119A6E0F7E1C0931BA5EFE3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicaldistributionandproductsMember" xlink:label="loc_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:to="loc_cah_MedicaldistributionandproductsMember_853E9B017ECEE7D59B17C0931BA68784" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CardinalHealthAtHomeSolutionsMember" xlink:label="loc_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_D4322BF9A7404D379D78C0931BA56E4E" xlink:to="loc_cah_CardinalHealthAtHomeSolutionsMember_20BB5072552160C37F21C0931BA6E4D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_CCA0C09D4C690F89B320C0931BA62983" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_FBB8DABBAEE65F6A7349C0931BA6794E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:to="loc_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2C7394DEF41B507A4DE8C0931BA69251" xlink:to="loc_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_C6EEEDB7E197B8F6E6DEC0931BA72893" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:to="loc_us-gaap_NonUsMember_C6EEEDB7E197B8F6E6DEC0931BA72893" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_country_US_BE5C30E11E8EE1F32F8BC0931BA79DC3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_BB4FF6243C8160A17579C0931BA7A272" xlink:to="loc_country_US_BE5C30E11E8EE1F32F8BC0931BA79DC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_EF2AC3B615434EDFED6FC0931BA72C7D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ECD3FDC0158E626CBA5C0931BA2B0ED" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_EF2AC3B615434EDFED6FC0931BA72C7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_F286121EFF3FC668C949C0931BA77C01" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_EF2AC3B615434EDFED6FC0931BA72C7D" xlink:to="loc_us-gaap_Revenues_F286121EFF3FC668C949C0931BA77C01" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_8D85A27CF974028329BE064EB07DAB1E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8D85A27CF974028329BE064EB07DAB1E" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_9EAC3978E0E6E12BB6CC064EB07D373D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:to="loc_srt_ConsolidationItemsAxis_9EAC3978E0E6E12BB6CC064EB07D373D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_7FDA309E4A813C3C6DD0064EB07EE2EE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_9EAC3978E0E6E12BB6CC064EB07D373D" xlink:to="loc_srt_ConsolidationItemsDomain_7FDA309E4A813C3C6DD0064EB07EE2EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_2D9D35BDE71406069BF8064EB07E6741" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7FDA309E4A813C3C6DD0064EB07EE2EE" xlink:to="loc_us-gaap_OperatingSegmentsMember_2D9D35BDE71406069BF8064EB07E6741" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_6BD5B8A26C2A82DCF0D1064EB07E4BF6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7FDA309E4A813C3C6DD0064EB07EE2EE" xlink:to="loc_us-gaap_CorporateNonSegmentMember_6BD5B8A26C2A82DCF0D1064EB07E4BF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_43A5D8054B3AC85CDBDA064EB07F5956" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_43A5D8054B3AC85CDBDA064EB07F5956" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_F83A4E68BAF97A4FC90E064EB07F18BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_43A5D8054B3AC85CDBDA064EB07F5956" xlink:to="loc_us-gaap_SegmentDomain_F83A4E68BAF97A4FC90E064EB07F18BB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_B2BE9D1B828B4EE951CD064EB07FB35A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_F83A4E68BAF97A4FC90E064EB07F18BB" xlink:to="loc_cah_PharmaceuticalMember_B2BE9D1B828B4EE951CD064EB07FB35A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_FE8A7D77FD1E47CB6E30064EB07FAC37" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_F83A4E68BAF97A4FC90E064EB07F18BB" xlink:to="loc_cah_MedicalMember_FE8A7D77FD1E47CB6E30064EB07FAC37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7AA01919E69CAB1626C9064EB07DBBD5" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_1673BF2B941B1C8006F9064EB080F5D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_A0AFD74E5027772BA2C9064EB07FFF9A" xlink:to="loc_us-gaap_OperatingIncomeLoss_1673BF2B941B1C8006F9064EB080F5D4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_D0FE62241CFA56B643F1C0922AFFE3A3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_E1830F17203B36A3D059C0922B05995F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_D0FE62241CFA56B643F1C0922AFFE3A3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_E1830F17203B36A3D059C0922B05995F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_E0AD0A32BACCFA5536C4C0922B0520CA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_D0FE62241CFA56B643F1C0922AFFE3A3" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_E0AD0A32BACCFA5536C4C0922B0520CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_B08D2E1880B08247ECC6C0922B057403" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_D0FE62241CFA56B643F1C0922AFFE3A3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_B08D2E1880B08247ECC6C0922B057403" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_FD165F03CA69AB24D47FC0922B067553" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_D0FE62241CFA56B643F1C0922AFFE3A3" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_FD165F03CA69AB24D47FC0922B067553" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F327A67A746FB40ECAE7C0922B068FFF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_D0FE62241CFA56B643F1C0922AFFE3A3" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F327A67A746FB40ECAE7C0922B068FFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_3924CFFA41BE06B9480BC0922B06FC26" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_D0FE62241CFA56B643F1C0922AFFE3A3" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_3924CFFA41BE06B9480BC0922B06FC26" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_3B50FA994BB8F6D62D8DC0922B06C313" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_D0FE62241CFA56B643F1C0922AFFE3A3" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_3B50FA994BB8F6D62D8DC0922B06C313" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_8CA2C77982F571EF61A8C0922B07568B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_D0FE62241CFA56B643F1C0922AFFE3A3" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_8CA2C77982F571EF61A8C0922B07568B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_596CF52EA4C59AF4A390064EAFF984AD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_816EBB17F7AB4CD39551064EAFF974DE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_596CF52EA4C59AF4A390064EAFF984AD" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_816EBB17F7AB4CD39551064EAFF974DE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_4AA68EE936146355B22BD979690E943C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:to="loc_us-gaap_Revenues_4AA68EE936146355B22BD979690E943C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_0BD450AE1DBD21CF0F2FD979690E7268" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:to="loc_us-gaap_GrossProfit_0BD450AE1DBD21CF0F2FD979690E7268" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_AF20E8DBE1637BD78266D979690FC80A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_AF20E8DBE1637BD78266D979690FC80A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_9D38FE9E353628DD8B54D979690FE173" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:to="loc_us-gaap_ProfitLoss_9D38FE9E353628DD8B54D979690FE173" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_F5119758A83C2A0C631AD979690F8110" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_F5119758A83C2A0C631AD979690F8110" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_3013F1DE1461E03215F7D979690F3396" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:to="loc_us-gaap_NetIncomeLoss_3013F1DE1461E03215F7D979690F3396" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_63F00625FF15CFC27D6FD979690F2846" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_63F00625FF15CFC27D6FD979690F2846" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_D0FB503112D9FD084DC0D979690FC485" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_63F00625FF15CFC27D6FD979690F2846" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_D0FB503112D9FD084DC0D979690FC485" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6333C7ACD100D596149BD9796910EBD8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_63F00625FF15CFC27D6FD979690F2846" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6333C7ACD100D596149BD9796910EBD8" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodwillAndIntangibleAssetsTable" xlink:label="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_24E03BEECC3CBA3A2E74D979690D8C2E" xlink:to="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_5DE65C4D4B550DDA34BAD9796910629F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:to="loc_cah_OpioidLitigationAxis_5DE65C4D4B550DDA34BAD9796910629F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_D6FC4F369940C8AA0D09D9796911BEC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_5DE65C4D4B550DDA34BAD9796910629F" xlink:to="loc_cah_OpioidLitigationDomain_D6FC4F369940C8AA0D09D9796911BEC1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_7863A396D2B418B21886D97969103E8F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_D6FC4F369940C8AA0D09D9796911BEC1" xlink:to="loc_cah_TotalOpioidLitigationMember_7863A396D2B418B21886D97969103E8F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_5DA1CB321033F16F75B2D97C618CE8F1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_D6FC4F369940C8AA0D09D9796911BEC1" xlink:to="loc_cah_TotalOpioidLitigationnetoftaxMember_5DA1CB321033F16F75B2D97C618CE8F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_885359EE3E4F507B5C61D97969114894" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_885359EE3E4F507B5C61D97969114894" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_864D01DF175FF7F8AE0AD9796911555F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_885359EE3E4F507B5C61D97969114894" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_864D01DF175FF7F8AE0AD9796911555F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_6768A921FA020C144F30D9796911A177" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_864D01DF175FF7F8AE0AD9796911555F" xlink:to="loc_cah_NaviHealthMember_6768A921FA020C144F30D9796911A177" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_96C4996CE5882E6C5E8DD9796912197F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_96C4996CE5882E6C5E8DD9796912197F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_96C4996CE5882E6C5E8DD9796912197F" xlink:to="loc_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_0BE29DB9420FAC2D8D9CD97969120B21" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9A76C88957F050BBC128D97969123AB9" xlink:to="loc_cah_MedicalMember_0BE29DB9420FAC2D8D9CD97969120B21" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GoodwillAndIntangibleAssetsLineItems" xlink:label="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_B755DB4844AB2F5534ACD97969106DED" xlink:to="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_840E1BB30C20E9F52A9ED9796912C332" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_840E1BB30C20E9F52A9ED9796912C332" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_2318AD5D2C83F8D23948D9796913946D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_2318AD5D2C83F8D23948D9796913946D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_0A6637D0146917758FECD979691370BA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:to="loc_cah_PreTaxGainonDivestiture_0A6637D0146917758FECD979691370BA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_GainonDivestitureAfterTax" xlink:label="loc_cah_GainonDivestitureAfterTax_E1D5EA029656CCD595D5D9796913572F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:to="loc_cah_GainonDivestitureAfterTax_E1D5EA029656CCD595D5D9796913572F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_97F0328435FC79F5B702D97969132182" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_C8DB44BAA24490FF48FCD979691260F8" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_97F0328435FC79F5B702D97969132182" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_FE765CADE24EDA874459064EAFF755EC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_3F51D1EF87A174193010064EAFF7FFCE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_FE765CADE24EDA874459064EAFF755EC" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_3F51D1EF87A174193010064EAFF7FFCE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3D1E41231BBEC699FD41064EB0401F17" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_97B95FB5DCBAD98879F2064EB04046EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3D1E41231BBEC699FD41064EB0401F17" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_97B95FB5DCBAD98879F2064EB04046EA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0DD8E201165CFD2BD1BE064EAFFCD571" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68777257C7D1E3C2E5E1064EAFFC41BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0DD8E201165CFD2BD1BE064EAFFCD571" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68777257C7D1E3C2E5E1064EAFFC41BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_B9A409156C7DFBED0B14064EAFFC193C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68777257C7D1E3C2E5E1064EAFFC41BC" xlink:to="loc_us-gaap_AwardTypeAxis_B9A409156C7DFBED0B14064EAFFC193C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EDBB35EB65C95FA7FB0C064EAFFC235D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_B9A409156C7DFBED0B14064EAFFC193C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EDBB35EB65C95FA7FB0C064EAFFC235D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_8DFEFB4ED98CDA1B7EA4064EAFFD73B8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EDBB35EB65C95FA7FB0C064EAFFC235D" xlink:to="loc_us-gaap_PerformanceSharesMember_8DFEFB4ED98CDA1B7EA4064EAFFD73B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94C3CD1A31E6DB93F0C1064EAFFDBE85" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_68777257C7D1E3C2E5E1064EAFFC41BC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94C3CD1A31E6DB93F0C1064EAFFDBE85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7A01A915E6AB5C237E02064EAFFDFA00" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94C3CD1A31E6DB93F0C1064EAFFDBE85" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7A01A915E6AB5C237E02064EAFFDFA00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_48CDF4D099E39332C0D8064EAFFDF589" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94C3CD1A31E6DB93F0C1064EAFFDBE85" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_48CDF4D099E39332C0D8064EAFFDF589" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_C2D6F04B9DC8CA6E0775064EAFFD7AA0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94C3CD1A31E6DB93F0C1064EAFFDBE85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_C2D6F04B9DC8CA6E0775064EAFFD7AA0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4AD72F98AEF7E8E8D8B5064EB008643E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47983B0AF423B7D018EB064EB008486F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4AD72F98AEF7E8E8D8B5064EB008643E" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47983B0AF423B7D018EB064EB008486F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2ED30AA81B85C58BBD0F064EB0090FFF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47983B0AF423B7D018EB064EB008486F" xlink:to="loc_us-gaap_AwardTypeAxis_2ED30AA81B85C58BBD0F064EB0090FFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A9B09893428DF1D9AAFB064EB009134E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2ED30AA81B85C58BBD0F064EB0090FFF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A9B09893428DF1D9AAFB064EB009134E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5FE169E1C0D6351F2769064EB00933BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A9B09893428DF1D9AAFB064EB009134E" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5FE169E1C0D6351F2769064EB00933BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_F7FB883589F9D804E65C064EB0092A03" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A9B09893428DF1D9AAFB064EB009134E" xlink:to="loc_us-gaap_PerformanceSharesMember_F7FB883589F9D804E65C064EB0092A03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E6081F5583AC6ADEBFA064EB00A295A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47983B0AF423B7D018EB064EB008486F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E6081F5583AC6ADEBFA064EB00A295A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9F17621C8F4339B36086064EB00A4167" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E6081F5583AC6ADEBFA064EB00A295A" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9F17621C8F4339B36086064EB00A4167" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C247B2B75F89375D4866064EB00AE319" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E6081F5583AC6ADEBFA064EB00A295A" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C247B2B75F89375D4866064EB00AE319" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_31BBC975ACA8F0422A6A064EB00AF96D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E6081F5583AC6ADEBFA064EB00A295A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_31BBC975ACA8F0422A6A064EB00AF96D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_54ED85DB6FAB8DC174EEDE0D6FAD36A0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_557D9306602A1427C9E7DE0D6FADE5D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_54ED85DB6FAB8DC174EEDE0D6FAD36A0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_557D9306602A1427C9E7DE0D6FADE5D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_557D9306602A1427C9E7DE0D6FADE5D0" xlink:to="loc_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_C7A7A16CB81AAE442433DE0D6FAD0B6A" xlink:to="loc_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_A2011LtipMember" xlink:label="loc_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_06F2858BB666A513D85ADE0D6FAE88EE" xlink:to="loc_cah_A2011LtipMember_FC2D82A0F0195E08C88DDE0D6FAEB886" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_0710AB13F07E10EA83D2DE0D6FAEC89D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_557D9306602A1427C9E7DE0D6FADE5D0" xlink:to="loc_us-gaap_AwardTypeAxis_0710AB13F07E10EA83D2DE0D6FAEC89D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0710AB13F07E10EA83D2DE0D6FAEC89D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AwardsOtherThanStockOptionsMember" xlink:label="loc_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9" xlink:to="loc_cah_AwardsOtherThanStockOptionsMember_A4783928342C16AFCCECDE0D6FAF5995" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_860343C66F7C70053D9FDE0D6FAF59F9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_860343C66F7C70053D9FDE0D6FAF59F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0D8DA4EE0CB173C0E15BDE0D6FAFD217" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0D8DA4EE0CB173C0E15BDE0D6FAFD217" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_BC029B396BB38729C73FDE0D6FAF7FF9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8C8242F4BF69CD89BC5DDE0D6FAFD9E9" xlink:to="loc_us-gaap_PerformanceSharesMember_BC029B396BB38729C73FDE0D6FAF7FF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_8547CE61818AF8CAA009DE0D6FAFF24F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_557D9306602A1427C9E7DE0D6FADE5D0" xlink:to="loc_srt_RangeAxis_8547CE61818AF8CAA009DE0D6FAFF24F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_F7E4EA4987C8E97773AEDE0D6FB0FC93" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8547CE61818AF8CAA009DE0D6FAFF24F" xlink:to="loc_srt_RangeMember_F7E4EA4987C8E97773AEDE0D6FB0FC93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_46E9A8CE44DF499CA621DE0D6FB01A2C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_F7E4EA4987C8E97773AEDE0D6FB0FC93" xlink:to="loc_srt_MinimumMember_46E9A8CE44DF499CA621DE0D6FB01A2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9E1113F3DFB58E51563EDE0D6FB0E9A1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_F7E4EA4987C8E97773AEDE0D6FB0FC93" xlink:to="loc_srt_MaximumMember_9E1113F3DFB58E51563EDE0D6FB0E9A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_557D9306602A1427C9E7DE0D6FADE5D0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_VestingPeriodinyearsforShares" xlink:label="loc_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_cah_VestingPeriodinyearsforShares_305F6E5B8891F07F531EDE0D6FB17CB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C2237067A658A9C111CDE0D6FB1E346" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C2237067A658A9C111CDE0D6FB1E346" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_F4C7387D1E1F48EB1A92DE0D6FB1A2DD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_F4C7387D1E1F48EB1A92DE0D6FB1A2DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_E7CBE9C9E3FFAE1C1E8CDE0D6FB19882" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_E7CBE9C9E3FFAE1C1E8CDE0D6FB19882" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_ExercisablePeriodOfPlansInYears" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_cah_ExercisablePeriodOfPlansInYears_90E9095816ACC60A3EA2DE0D6FB16D2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_F768628F938C0BD6C893DE0D6FB14D70" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_F768628F938C0BD6C893DE0D6FB14D70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_998FA33686F69414AE6CDE0D6FB2E80A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8F93C4F6BD4108879BC4DE0D6FB0F384" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_998FA33686F69414AE6CDE0D6FB2E80A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_F1DC5224FB064D62A69C064EB021E423" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2EA1836B827C58BB9E14064EB021983C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_F1DC5224FB064D62A69C064EB021E423" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2EA1836B827C58BB9E14064EB021983C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_7A74C4762C83663D3B79064EB0215976" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2EA1836B827C58BB9E14064EB021983C" xlink:to="loc_us-gaap_AwardTypeAxis_7A74C4762C83663D3B79064EB0215976" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BA601090560F797E9CE3064EB022C006" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7A74C4762C83663D3B79064EB0215976" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BA601090560F797E9CE3064EB022C006" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_477E80E83FE5EFC56241064EB0227FFA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BA601090560F797E9CE3064EB022C006" xlink:to="loc_us-gaap_EmployeeStockOptionMember_477E80E83FE5EFC56241064EB0227FFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2EA1836B827C58BB9E14064EB021983C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7F9D007CBEE4911733E6064EB02214C0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7F9D007CBEE4911733E6064EB02214C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E5FD4180E043D72F1149064EB0230D27" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E5FD4180E043D72F1149064EB0230D27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_BB86FE2C124A1D7C4A5B064EB023EBBA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_BB86FE2C124A1D7C4A5B064EB023EBBA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_B67A31EAC03EE1C01F08064EB0232433" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_B67A31EAC03EE1C01F08064EB0232433" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_9D6C02A2C01601D853CC064EB023AAC6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_9D6C02A2C01601D853CC064EB023AAC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_DCFA7F2026EA74CBCC41064EB0236DEA" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_DCFA7F2026EA74CBCC41064EB0236DEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9457A4CF5283DE050DAF064EB0238FD2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9457A4CF5283DE050DAF064EB0238FD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_B49AE6B236CC2C18C231064EB0235713" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_99D21B6B5C48C844F25A064EB0225418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_B49AE6B236CC2C18C231064EB0235713" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52F21B113C676EEA71CA064EB0278467" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52F21B113C676EEA71CA064EB0278467" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6703C0D4DE207AFAEEC5064EB0281A73" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6703C0D4DE207AFAEEC5064EB0281A73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_E83C1D18F9AB33D5F6FD064EB028FF6D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_E83C1D18F9AB33D5F6FD064EB028FF6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC6ABD5365E8B7C81DC3064EB0281E72" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC6ABD5365E8B7C81DC3064EB0281E72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_E1BC0130A2C2B35F33F1064EB02905CE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_E1BC0130A2C2B35F33F1064EB02905CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_04C18287125088E33CA2064EB029AA6A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AF1B0AF5552EEB24F08A064EB0280622" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_04C18287125088E33CA2064EB029AA6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_608E9088F3D1E71A7EF7064EB029D56A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52F21B113C676EEA71CA064EB0278467" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_608E9088F3D1E71A7EF7064EB029D56A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52F21B113C676EEA71CA064EB0278467" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7786E48645328E6B4DBF064EB0298D7B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7786E48645328E6B4DBF064EB0298D7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_C7ABDB024C88B9FAEFCB064EB0292254" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_C7ABDB024C88B9FAEFCB064EB0292254" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9F89B5249846BE90C5C6064EB0296C78" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9F89B5249846BE90C5C6064EB0296C78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E773183CC4753EDE9926064EB02AF7DF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E773183CC4753EDE9926064EB02AF7DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_009695AF83AE21FD8E21064EB02A444D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_009695AF83AE21FD8E21064EB02A444D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_CD78816AC39418BC2745064EB02A07C7" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_A81DEB9F549DF0211E12064EB02960DE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_CD78816AC39418BC2745064EB02A07C7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4593551B539EA05DC35C064EB0014841" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4593551B539EA05DC35C064EB0014841" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216" xlink:to="loc_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_32E7FAEABE35469B8F3A064EB001BF4F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_80D47757AC837CA3BE1F064EB0029F6A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A927766910AD6CC69DD7064EB002831D" xlink:to="loc_us-gaap_PerformanceSharesMember_80D47757AC837CA3BE1F064EB0029F6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0B3D33274895DF025794064EB0013216" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_55C50C20207CF6B2DEEE064EB003D658" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_55C50C20207CF6B2DEEE064EB003D658" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_00E98CC9B2EAED295E2E064EB003DA43" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_00E98CC9B2EAED295E2E064EB003DA43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_EB4857F217D21B4A1160064EB003D6E3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_EB4857F217D21B4A1160064EB003D6E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2ACA1D091F320523594C064EB0033EEB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2ACA1D091F320523594C064EB0033EEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4F98ECDE7CA30296E3A4064EB0031535" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_02B0A54C7F70D0CF168A064EB0022680" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4F98ECDE7CA30296E3A4064EB0031535" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_814300961413DCB5681C064EB004F31A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_814300961413DCB5681C064EB004F31A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_D326C3D928BA2063894F064EB004FCA9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_D326C3D928BA2063894F064EB004FCA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1846DF5F2AB9ED40F037064EB00432A8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1846DF5F2AB9ED40F037064EB00432A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76EC03B657E934F90932064EB004D388" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76EC03B657E934F90932064EB004D388" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_CCAF181B5947865CBE7F064EB004E4B9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57011AC80CD1F5EC9B09064EB0039AC6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_CCAF181B5947865CBE7F064EB004E4B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8764D9B254F4144D3966064EB0052CE5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_E9894E7874927F03031B064EB002FE3D" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_8764D9B254F4144D3966064EB0052CE5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84F72A89C3F238913558064EB00E0B92" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3C279287E9BB5DC0CD10064EB00EA590" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84F72A89C3F238913558064EB00E0B92" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3C279287E9BB5DC0CD10064EB00EA590" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_ED41E22460C8ADAE7470064EB00EDE84" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3C279287E9BB5DC0CD10064EB00EA590" xlink:to="loc_us-gaap_AwardTypeAxis_ED41E22460C8ADAE7470064EB00EDE84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02BC78F78AF36AA6C8ED064EB00FCF4F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ED41E22460C8ADAE7470064EB00EDE84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02BC78F78AF36AA6C8ED064EB00FCF4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_A479A3A196E8BC589F4B064EB00FD222" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02BC78F78AF36AA6C8ED064EB00FCF4F" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_A479A3A196E8BC589F4B064EB00FD222" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0A2F187C25D370E09177064EB00F41BD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3C279287E9BB5DC0CD10064EB00EA590" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0A2F187C25D370E09177064EB00F41BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0A2F187C25D370E09177064EB00F41BD" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8B07469606800836B7F9064EB0109A13" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8B07469606800836B7F9064EB0109A13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27F021D61899B11B6D03064EB0104CE6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27F021D61899B11B6D03064EB0104CE6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_FC970A941820BDA59437064EB010D269" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_FC970A941820BDA59437064EB010D269" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2EF0A012B75FE9203C26064EB01074AE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2EF0A012B75FE9203C26064EB01074AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_978FBA3F5EE2FC36E02E064EB010D463" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EC22BC02D221FE3DE49D064EB00F012B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_978FBA3F5EE2FC36E02E064EB010D463" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0A2F187C25D370E09177064EB00F41BD" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_23362E45B3788F9AEC9E064EB010E404" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_23362E45B3788F9AEC9E064EB010E404" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_BFF54658551AC91CF3E7064EB01140E6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_BFF54658551AC91CF3E7064EB01140E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_FBD90DABCC4AAFCB245B064EB011B6CB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_FBD90DABCC4AAFCB245B064EB011B6CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_735E3A38AD3B7C7742AD064EB0115A72" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_735E3A38AD3B7C7742AD064EB0115A72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_66C7AB29A820A7041B23064EB011759B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_C1614D6A6E3AC326F84E064EB0106F61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_66C7AB29A820A7041B23064EB011759B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08AFF89F67E8697F2C8BDD8B84EFE118" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BF0133C2EEDDF1249639DD8B84EF4356" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08AFF89F67E8697F2C8BDD8B84EFE118" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BF0133C2EEDDF1249639DD8B84EF4356" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_36AAB2C109E9A07404EFDD8B84F09540" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BF0133C2EEDDF1249639DD8B84EF4356" xlink:to="loc_us-gaap_AwardTypeAxis_36AAB2C109E9A07404EFDD8B84F09540" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_FD3ED7642861A5E824CADD8B84F0F4BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_36AAB2C109E9A07404EFDD8B84F09540" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_FD3ED7642861A5E824CADD8B84F0F4BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_954E90C317D1CD197502DD8B84F0A0F5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_FD3ED7642861A5E824CADD8B84F0F4BC" xlink:to="loc_us-gaap_EmployeeStockOptionMember_954E90C317D1CD197502DD8B84F0A0F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_6340CE05D9D327E332BBDD8B84F11645" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BF0133C2EEDDF1249639DD8B84EF4356" xlink:to="loc_srt_RangeAxis_6340CE05D9D327E332BBDD8B84F11645" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_BC24528F003BB0FEA1A1DD8B84F1147D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6340CE05D9D327E332BBDD8B84F11645" xlink:to="loc_srt_RangeMember_BC24528F003BB0FEA1A1DD8B84F1147D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_3E7114191C57A8C0A008DD8B84F19606" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_BC24528F003BB0FEA1A1DD8B84F1147D" xlink:to="loc_srt_MinimumMember_3E7114191C57A8C0A008DD8B84F19606" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_16C739AA4BEBFDB7EF40DD8B84F1F47B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_BC24528F003BB0FEA1A1DD8B84F1147D" xlink:to="loc_srt_MaximumMember_16C739AA4BEBFDB7EF40DD8B84F1F47B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1A15565AD4C210E3101CDD8B84F26C65" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BF0133C2EEDDF1249639DD8B84EF4356" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1A15565AD4C210E3101CDD8B84F26C65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_79DC5B77D39EBDA54231DD8B84F2C5BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1A15565AD4C210E3101CDD8B84F26C65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_79DC5B77D39EBDA54231DD8B84F2C5BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_947A20F3E29B5DF3DC02DD8B84F2B277" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1A15565AD4C210E3101CDD8B84F26C65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_947A20F3E29B5DF3DC02DD8B84F2B277" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2153C91BF9CDB8204D88DD8B84F2A1BB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1A15565AD4C210E3101CDD8B84F26C65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2153C91BF9CDB8204D88DD8B84F2A1BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_DA605096AF860E4AA054DD8B84F2C128" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1A15565AD4C210E3101CDD8B84F26C65" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_DA605096AF860E4AA054DD8B84F2C128" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_C401B54158C166E72B5E064EB01C610F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DA9C9E98F31A01BA004A064EB01C1670" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_C401B54158C166E72B5E064EB01C610F" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DA9C9E98F31A01BA004A064EB01C1670" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_F96F8EB5E982DCE2DC3F064EB01C8E35" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DA9C9E98F31A01BA004A064EB01C1670" xlink:to="loc_us-gaap_AwardTypeAxis_F96F8EB5E982DCE2DC3F064EB01C8E35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0DFF94D467E3A3D04085064EB01D953D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_F96F8EB5E982DCE2DC3F064EB01C8E35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0DFF94D467E3A3D04085064EB01D953D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_C42EF881A95B51F8561C064EB01DC28E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0DFF94D467E3A3D04085064EB01D953D" xlink:to="loc_us-gaap_EmployeeStockOptionMember_C42EF881A95B51F8561C064EB01DC28E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90CDA3A25035715D0591064EB01D3094" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DA9C9E98F31A01BA004A064EB01C1670" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90CDA3A25035715D0591064EB01D3094" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_B02303C4E11F04C1379B064EB01D4270" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90CDA3A25035715D0591064EB01D3094" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_B02303C4E11F04C1379B064EB01D4270" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2AB3EA17EF3401841A4C064EB01E5566" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90CDA3A25035715D0591064EB01D3094" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2AB3EA17EF3401841A4C064EB01E5566" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_843FF8F064E86C704A6B064EB01EA4C3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90CDA3A25035715D0591064EB01D3094" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_843FF8F064E86C704A6B064EB01EA4C3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B034842A602A5A0F88E6064EB02E06D0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_FF49E821D93AC851D952064EB02E5445" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B034842A602A5A0F88E6064EB02E06D0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_FF49E821D93AC851D952064EB02E5445" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_CBFC7B05BF3D6F15585E064EB02E7932" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_FF49E821D93AC851D952064EB02E5445" xlink:to="loc_us-gaap_AwardTypeAxis_CBFC7B05BF3D6F15585E064EB02E7932" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09707CD650FFC3C1073D064EB02E0DEC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_CBFC7B05BF3D6F15585E064EB02E7932" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09707CD650FFC3C1073D064EB02E0DEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4D88D739035A76C72682064EB02E1AE5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09707CD650FFC3C1073D064EB02E0DEC" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4D88D739035A76C72682064EB02E1AE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_F293773F0CE703D0F69A064EB02FF113" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09707CD650FFC3C1073D064EB02E0DEC" xlink:to="loc_us-gaap_EmployeeStockOptionMember_F293773F0CE703D0F69A064EB02FF113" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_5C2B0D30A61607E3F02F064EB02F51AE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09707CD650FFC3C1073D064EB02E0DEC" xlink:to="loc_us-gaap_PerformanceSharesMember_5C2B0D30A61607E3F02F064EB02F51AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_657C0E67F6998B0BCE30064EB02FA9C5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_FF49E821D93AC851D952064EB02E5445" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_657C0E67F6998B0BCE30064EB02FA9C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4AC51A950DEB6A2BE79C064EB02FFBA8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_657C0E67F6998B0BCE30064EB02FA9C5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4AC51A950DEB6A2BE79C064EB02FFBA8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BAE2847E4684214D75AE064EB03CD81E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_DB19793119633BA1A11A064EB03CAED8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BAE2847E4684214D75AE064EB03CD81E" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_DB19793119633BA1A11A064EB03CAED8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_194991B5B22A084D8EAD064EB03CD32F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BAE2847E4684214D75AE064EB03CD81E" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_194991B5B22A084D8EAD064EB03CD32F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:label="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_A8F9E585769C88233CED064EB03C6C59" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BAE2847E4684214D75AE064EB03CD81E" xlink:to="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_A8F9E585769C88233CED064EB03C6C59" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_RemainingStockOptionPlanDataTableTextBlock" xlink:label="loc_cah_RemainingStockOptionPlanDataTableTextBlock_45295D34F87DDF2BC1D3064EB03C2D10" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BAE2847E4684214D75AE064EB03CD81E" xlink:to="loc_cah_RemainingStockOptionPlanDataTableTextBlock_45295D34F87DDF2BC1D3064EB03C2D10" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_275FFCCA4576396D7F3E064EB03C8B70" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BAE2847E4684214D75AE064EB03CD81E" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_275FFCCA4576396D7F3E064EB03C8B70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_643A430D66EAB26DFE37064EB03DBEDA" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BAE2847E4684214D75AE064EB03CD81E" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_643A430D66EAB26DFE37064EB03DBEDA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:label="loc_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_0A71D01001CBD9FF43F6064EB03D6CDC" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BAE2847E4684214D75AE064EB03CD81E" xlink:to="loc_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_0A71D01001CBD9FF43F6064EB03D6CDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_EE3BC24D388586F412A4064EB03D066F" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BAE2847E4684214D75AE064EB03CD81E" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_EE3BC24D388586F412A4064EB03D066F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:label="loc_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_FB289595BE8D27944373064EB03D1FE5" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BAE2847E4684214D75AE064EB03CD81E" xlink:to="loc_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_FB289595BE8D27944373064EB03D1FE5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_E0AAF15700F2E3359C5D064EB12BD9E9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3989E0DD5949351B4AC0064EB12C991B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_E0AAF15700F2E3359C5D064EB12BD9E9" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3989E0DD5949351B4AC0064EB12C991B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_FFBAC88132FF8BEB620EB49CFBA487C4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_FFBAC88132FF8BEB620EB49CFBA487C4" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_34D40CC2EFCED3DBD5D3B49CFBA4AE49" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_34D40CC2EFCED3DBD5D3B49CFBA4AE49" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_34D40CC2EFCED3DBD5D3B49CFBA4AE49" xlink:to="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_AAF230A07E7E31550B4EB49CFBA5120C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_AAF230A07E7E31550B4EB49CFBA5120C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_93B0E1B81D56364692F0B49CFBA5E14F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_93B0E1B81D56364692F0B49CFBA5E14F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_FAFABE4FF7BC7F218682B49CFBA5BBE5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_FAFABE4FF7BC7F218682B49CFBA5BBE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_35B786E77969B7F9D595B49CFBA657F5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_F83D60B8BB47C422FCD5B49CFBA436DA" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_35B786E77969B7F9D595B49CFBA657F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_945E88AB0A095C10B64BB49CFBA42025" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_90CC2DBDF286CAB8DA5BB49CFBA683AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_90CC2DBDF286CAB8DA5BB49CFBA683AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F567C313802953074A09B49CFBA61E9F" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5E66ADBEC1587E1DA25CB49CFBA601E6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5E66ADBEC1587E1DA25CB49CFBA601E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_FDB2DFB0C0DFAD3CD269B49CFBA795F0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_FDB2DFB0C0DFAD3CD269B49CFBA795F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_9D7AF11AFBC0F5BB4BA9B49CFBA77CA5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_9D7AF11AFBC0F5BB4BA9B49CFBA77CA5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A229ABA478145D0FA7ACB49CFBA7012C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A229ABA478145D0FA7ACB49CFBA7012C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3D96AC7950928502B983B49CFBA7893F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B0D036C465EC7C48D5C0B49CFBA6FC30" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3D96AC7950928502B983B49CFBA7893F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_A64BBFB1E8344D6BA6A8DD84B2077EB9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_A64BBFB1E8344D6BA6A8DD84B2077EB9" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_B5EF432A37FCF62F9A74DD84B2070F75" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_AcceleratedsharerepurchaseplanMember" xlink:label="loc_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_1E1A68CE118BF883A9A9DD84B2081B23" xlink:to="loc_cah_AcceleratedsharerepurchaseplanMember_425703C3F792FFFA294EDD84B20866B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:to="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_FBA0DB192DA48F9B02DBDD84B2082043" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_RetirementofTreasurySharesMember" xlink:label="loc_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingPrincipleMember_CC85B55F7A091611E6D9DD84B208A411" xlink:to="loc_cah_RetirementofTreasurySharesMember_14C2B78FE135E88226FADD84B209BD12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_C1847A19A3806AB6B853DD84B2098B9A" xlink:to="loc_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_A131CEEB2C70491410FEDD84B209EE9C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:to="loc_us-gaap_CommonClassAMember_A131CEEB2C70491410FEDD84B209EE9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_DF3BF7E221CCE351C98EDD84B20A175D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_989D35FD468EF6C6C773DD84B209FBA0" xlink:to="loc_us-gaap_CommonClassBMember_DF3BF7E221CCE351C98EDD84B20A175D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_C52FD2C34D9889D81EFFDD84B20A3C8C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_C52FD2C34D9889D81EFFDD84B20A3C8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_D5C5C03FD0E2FC1FA4B2DD84B20A250D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_C52FD2C34D9889D81EFFDD84B20A3C8C" xlink:to="loc_us-gaap_EquityComponentDomain_D5C5C03FD0E2FC1FA4B2DD84B20A250D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_3B09B5448F64A5B4F922DD84B20AD190" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_D5C5C03FD0E2FC1FA4B2DD84B20A250D" xlink:to="loc_us-gaap_TreasuryStockMember_3B09B5448F64A5B4F922DD84B20AD190" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_744C0EEE5311E30AD0C4DD84B2073DE5" xlink:to="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_D6A15D7DE85033904790DD84B20BA6CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_D6A15D7DE85033904790DD84B20BA6CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_5A835E5694377A71B819DD84B20B9F5C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_5A835E5694377A71B819DD84B20B9F5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5125901CD457D3DE33E1DD84B20B5BDB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_5125901CD457D3DE33E1DD84B20B5BDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_8E12941CB25F2CF13979DD84B20B0D70" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_8E12941CB25F2CF13979DD84B20B0D70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_24B1DC087B02D1F52716DD84B20C07CF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_24B1DC087B02D1F52716DD84B20C07CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6DC801689C16205EEDA0DD84B20C6C21" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_6DC801689C16205EEDA0DD84B20C6C21" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_TreasuryStockAcquiredShares" xlink:label="loc_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_cah_TreasuryStockAcquiredShares_57BF242C5376A73100BADD84B20C1623" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84E4663FFD1D2185602BDD84B20D1D0A" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_84E4663FFD1D2185602BDD84B20D1D0A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200630.xsd#cah_CommonStockVotingRightsVotes" xlink:label="loc_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_47F38931A7AFD080114DDD84B20B9CBF" xlink:to="loc_cah_CommonStockVotingRightsVotes_755191BE15DD2F18D4FADD84B20D86C6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_27A6B7DE7D8C5137B304064EB1248DBA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6F62DDD2C2DB164DFE9A064EB12417C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_27A6B7DE7D8C5137B304064EB1248DBA" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6F62DDD2C2DB164DFE9A064EB12417C7" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>chart-94d908f3201c52649e7.jpg
<TEXT>
begin 644 chart-94d908f3201c52649e7.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #I ,@# 2(  A$! Q$!_\0
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MMX_LR:%\14\>V_C7]HGP1^UY\-M7N_AM\:_V,]/TW4+K6?A_H_Q4UJ^TS4/
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M_C#\(_V?? OPT_9Y\6_&KPUI/[?WCKXI^'/%/B/4F\,^"?#7B:X\+_'WXV>
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M)NKFVEU6[^)J_9-,S';2137]V6016>'GO&<M'%*)<O\ I1_P2]_9D^''[/\
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M'PMT'XDP3D:?XEL;/6?B5XADL?"6N1W6GZO;>%M/\.W%M?6MFL#]IXH_:/\
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MGP+83?#KQ;K>EZ#K_B32;F_OM4L CV2Q?BI^T[\%)?VD/VK_ /@O]\!/ _\
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MX(W?L<R?$;Q]\4H+3XCV'BWXD_M[_!;_ (*->)KC3_%FF6]M-^T#\!Y]1OO
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M%7>95U VJ-,/UDP!G  SU]_K10!_)5^SS_P2$^-W[#7AG_@D7^U_^RU^RYX
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSZ6G_@+;_P#QNC[+:?\ /I:?^ MO_P#&Z /[GO\ A=_P9_Z*U\,O_"_\)?\
MRXH_X7?\&?\ HK7PR_\ "_\ "7_RXK^&'[+:?\^EI_X"V_\ \;H^RVG_ #Z6
MG_@+;_\ QN@#^Y[_ (7?\&?^BM?#+_PO_"7_ ,N*4?&_X,D@#XM?#(DD  >/
MO"1)).  /[8Y)/ '<U_#!]EM/^?2T_\  6W_ /C=3VMK:?:;;_1+3_CYMO\
MEU@_Y^(O^F= ']\X((!!!! ((.00>001P01T-+5:S_X];?\ ZX0?^B8ZLT %
M%%% !1110 4444 %(W0_0_RI:1NA^A_E0!^7_P <O^2L>-/^O^R_],VFUY17
MJ_QR_P"2L>-/^O\ LO\ TS:;7E% !1110 4444 %?IC^SY_R2/PG]-9_]/\
MJE?F=7Z8_L^?\DC\)_36?_3_ *I0!Z-XM_Y%;Q)_V -:_P#39=5_!G!_J(/^
MN$/_ **2O[S/%O\ R*WB3_L :U_Z;+JOX,X/]1!_UPA_]%)0!+1110 4444
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M_P"$O\(_]#?X0_\ "M\-_P#RUKVO_AR'_P $C?\ I'5^R3_X9SPU_P#&*/\
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MT+_P>:3_ /)M']MZ'_T'="_\'FD__)M?U6?\.0O^"1G_ $CK_9*_\,]X;_\
MC-'_  Y"_P""1G_2.O\ 9*_\,]X;_P#C- '\J?\ ;>A_]!W0O_!YI/\ \FU/
M;:YH8N;?.NZ$/])MNNN:3_S\1?\ 3[7]4O\ PY"_X)&?](Z_V2O_  SWAO\
M^,T?\.0O^"1G_2.O]DK_ ,,]X;_^,T ?HQI?C[P1=BPL[7QAX6N;NZ%I;VUM
M;^(]$FN+B>9(DBAA@BOVEFED=@D<<:.\CD*BL2 >WK\V_ W_  1[_P""7?PS
M\:>$OB-\/_V#?V8/!_CKP'XET3QCX-\5Z!\*?#^G:YX:\4>&]1M]7T'7M'OX
M(1-9:II.IVEM?6%W$1);W4$4J$,@K])* "BBB@ HHHH **** "BBB@ HHHH
M^+_B7^V;9^ _CT?V?/#/[.O[2OQI\3:=X<^&7BKQAXH^$7A/X=:IX$^'^B_%
MCQ-XP\->%KKQ?K'C+XK>!M5MPC> _%.LZLNC:#K@L-#TQKD-/=SP6$E,?\%
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MUZG'(R>3CIQGIQ2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
I110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>chart-148af8dedebd55ac9eb.jpg
<TEXT>
begin 644 chart-148af8dedebd55ac9eb.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #1 ,@# 2(  A$! Q$!_\0
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M;X?^2VDGX,I%\4 __"$*3HMQ%'YGV=EU-OWI\&?M'_"WQ#X=^!M[XD\9>"O
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MG5='\*:C9:OKUOI:V'U!^V?X.U2Y^)?_  57\3^.? 7C#QE^R]X/_P""U/\
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M]M__ (*0_%S]GW]HCP#^R/\ LH?L4>,OVW_VD/%'P5\0_M)^*/ VD?&/X=?
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MX>>'/^$@74=1;Q9KOB,:5\2?C[\6O&GC34=.ATA_$WB'P]9Z.T,SS6&G_LJ
M  !P , >@%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M$X!/H,T4C=#]#_*@#Y.\?_M&ZMX-\8Z[X8M_"^G7T.D7,$$=W-JEW!+,)K&U
MNRSQ1V<B(0UP4 5V!"AB<D@<?_PUGKG_ $)FD_\ @ZO_ /Y KR#XY?\ )6/&
MG_7_ &7_ *9M-KRB@#ZV_P"&L]<_Z$S2?_!U?_\ R!1_PUGKG_0F:3_X.K__
M .0*^2:* /K;_AK/7/\ H3-)_P#!U?\ _P @4?\ #6>N?]"9I/\ X.K_ /\
MD"ODFB@#ZV_X:SUS_H3-)_\ !U?_ /R!7U3\-_%L_CGP9H_BBYLH=/FU,7Q>
MS@GDN(H?LFHW=DNV:6.)WWK;+(VZ-=K,5&0 3^4%?IC^SY_R2/PG]-9_]/\
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M\VW_ %\VW_I1%0!_>W;R-+#%(V SQ1N<9 R\:L< DG&6..3Q4U5K/_CUM_\
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MKKW@']H6]\0^//$.E?"_P]J^M:'#\/?$&K:_/<6L]G\F9IGP>^'7@_\ 8[\
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MSPW_ /+2@#H*_3']GS_DD?A/Z:S_ .G_ %2ORN_X2WPE_P!#=X1_\*SPW_\
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ML;^VM%_Z#>A_^#O2?_DRI[;6M$%S;YUS0Q_I-MUUO2?^?B+_ *?* /[ZK/\
MX];?_KA!_P"B8ZLUQ.E^/?!-V+"SM?%_A>YNKI;2WMK:#Q%HLUQ//,D210PP
M1W[2S2R.P1(XT=W<A45B0#VU !1110 4444 %%%% !7Q#^T)_P $V?V"_P!J
M_P >0_%#]I']DKX$?&SXA0>']-\*P^,?B/X TGQ-X@B\.:/<ZC=Z7HL>H7RM
M*NG6-SJVI3VUL/DCDO;AAS(:^WJ* /RN_P"'('_!(W_I'9^R5_X9[P[_ /&Z
M/^'('_!(W_I'9^R5_P"&>\.__&Z_5&B@#\KO^'('_!(W_I'9^R5_X9[P[_\
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M_9GQ=U#Q_J]EI.I:!XHU:!#X"M-0O?#WA76]1AL1-'8V=^ <=_PY _X)&_\
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M?5]!U[1[^%!+9:II.IVEM?6%U'^\M[J"*5/F05^D]%% !1110 4444 %%%%
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*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>chart-262f3986bd9a95f0107.jpg
<TEXT>
begin 644 chart-262f3986bd9a95f0107.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '0 J # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;$VE:[2NTE=I7;V2ONWT6[-RBBBK&%%%,,B!Q&6&]@S*O\3*A0.P'4JA= [
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%?)WB
MOX[?$8?M&W7[.O@[X9+9?;?V<?BG\5?#'Q:\<W_V;P1K/Q%\(>(OA5X=T/P3
M8:%HD\_BS5M!T[_A9MGJOC[Q)%;:=#8[M-T'PS)K6L-K@T, ^L:*_&KP+^V+
M^W-K5YK7PWOO G[)/B7XI^)_VB/$_P !?@SXHT#Q1\=O"GPAU6;X*_#/Q!X]
M_:(\2>*YM?\ ".O^+YK'P?XMT4? _P /1^&+6X;4?B#:>+-5O%7PWX5+ZO\
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MVF?]!"Q_\#+;_P".T?VKIG_00L?_  ,MO_CM &A16?\ VMIG_00L?_ RV_\
MCM']K:9_T$+'_P #+;_X[0!H45G_ -K:9_T$+'_P,MO_ ([1_:VF?]!"Q_\
M RV_^.T :%%9_P#:VF?]!"Q_\#+;_P".T?VMIG_00L?_  ,MO_CM &A16?\
MVMIG_00L?_ RV_\ CM']K:9_T$+'_P #+;_X[0!H45G_ -K:9_T$+'_P,MO_
M ([1_:VF?]!"Q_\  RV_^.T :%%9_P#:VF?]!"Q_\#+;_P".T?VKIG_00L?_
M  ,MO_CM &A16?\ VMIG_00L?_ RV_\ CM']K:9_T$+'_P #+;_X[0!H45G_
M -K:9_T$+'_P,MO_ ([1_:VF?]!"Q_\  RV_^.T :%%9_P#:VF?]!"Q_\#+;
M_P".T?VMIG_00L?_  ,MO_CM &A16?\ VMIG_00L?_ RV_\ CM']K:9_T$+'
M_P #+;_X[0!H45G_ -K:9_T$+'_P,MO_ ([1_:VF?]!"Q_\  RV_^.T :%%9
M_P#:VF?]!"Q_\#+;_P".T?VKIG_00L?_  ,MO_CM &A16?\ VMIG_00L?_ R
MV_\ CM']K:9_T$+'_P #+;_X[0!H45G_ -K:9_T$+'_P,MO_ ([1_:VF?]!"
MQ_\  RV_^.T :%%9_P#:VF?]!"Q_\#+;_P".T?VMIG_00L?_  ,MO_CM &A1
M6?\ VMIG_00L?_ RV_\ CM']K:9_T$+'_P #+;_X[0!H45G_ -K:9_T$+'_P
M,MO_ ([1_:VF?]!"Q_\  RV_^.T :%%9_P#:VF?]!"Q_\#+;_P".T?VKIG_0
M0L?_  ,MO_CM &A16?\ VMIG_00L?_ RV_\ CM']K:9_T$+'_P #+;_X[0!H
M45G_ -K:9_T$+'_P,MO_ ([1_:VF?]!"Q_\  RV_^.T :%%9_P#:VF?]!"Q_
M\#+;_P".T?VMIG_00L?_  ,MO_CM &A16?\ VMIG_00L?_ RV_\ CM']K:9_
MT$+'_P #+;_X[0!H45G_ -K:9_T$+'_P,MO_ ([2'5=+(P=0L2/3[9;?_'?T
M[]Z /*O&/[0_P0^'_A_XH^*O&7Q1\%^'M ^"NI:1H?Q4U'4-;MDB\#^(/$.D
M>'->\/>&]>BB,MS;^)_$.E>,/"-UX?\ #44$^O:W_P )3X<@TO3KNYUO38+G
M@[;]M?\ 9,O=5^"VB6?[0GPINM4_:'T^VU3X-6EMXMT^=_'EA?W<FEZ9/I3Q
M,\5N-8UV"Y\,:+'JTFFS:SXNM+SPCI<=WXGL[K2(?RX_: _9ZO=''Q_F\!>$
MOB;X2^&ND_\ !07]G+X\^,9/@'HUY=?%7Q+X B_9^^'^B_%?XB?#6VTZTU7Q
M/XW\5:3XTU:?6_$OB'PG;Z]\3+,>&?$.H^!'E^(7ACPW!;_./@/X7?M!Z'\3
M_#_B:]T7]JV3Q%\1_$/[,VH_ 6TU[P%8S^ O$OP[^'7[6/QF\0>-=2_;ZAT_
MPU+X7\/?%BQ^ WB_1?B]XEN/BH?#'B&+XB>(W^(7PRBE_:CE\:"V /Z//&_Q
M.^'WPV/@Y?'GC#0/";_$'QQX?^&G@>/7-1AL9?%GC[Q2M[)X?\(>'XI#YFJ:
M_JL&F:E=6NG6JR3FRTW4+Z0):6-U-%Y?\,?VL_V?/C+\4?B-\&OAG\1]/\7?
M$7X37>LV'Q T+3='\41P>'[[P]XA/A/7+*37[[0;/PSJ-WI/B1)=%U"VT;6M
M2FM=0M[F"5%-K<&+\O?VRM-_:B^+WQV_9A^+GPP^$/P[^(?P2\$_'K]GH^$%
M\>>._B;\,OBW\*O$>E_&?7=.^-_Q#U;X4/\  KQ/:RZ+K7A/2?#FCZ3\0=0\
M7Z4VC?#U?$KZ5ITVC_$;4[^X[[]B'2/&'@K]HGQ/H'A6R_;&\(_"J/PW\=M2
M^/'A#]JO4EU?X;Z%\</$'QVTWQ+\+IOV;O%<^FZ=X<\1Z1XE\-:U\8/$^O7W
MP@O=7\!W'@S5OAK-XWFM/B67@D /V/HK/_M;3/\ H(6/_@9;?_':/[6TS_H(
M6/\ X&6W_P =H T**S_[6TS_ *"%C_X&6W_QVG)J>G2.L:7UF[NP1$6[MV9F
M8X55592S,3P  23P!0!>HHHH **** "BBB@ KR75?A<-3^.?@?XS?VV8/^$-
M^%/Q2^&9\.C3P_\ :)^)/C'X.>+!K1U7[8AM?[&_X5/]@_L_[!.+\:Z;@W=I
M_9HAO/6J* /SS/[$7B[PY\%_V<O"?PN^-NG^$/C?^SGKOBOQ7HGQC\3?"U?'
MWAWQ9XF^*6B>.=)^,&H>+/AB?'GA6ZNX/&VH?$+6_%]FEE\0;"_T7Q?8:%?7
MFI:]I$6MZ)KOUW\$OA7HWP.^$/PS^#WA^_U'5M'^&G@?PUX*LM8U@VYUC6D\
M/:3;:=+K>L-:16]HVKZU<03:KJC6L$%L;^\N#;PQ0[(U]1HH H:II6F:WI]U
MI6L:?8ZKIE]$8+W3M2L[:_L;N%B&,-U9W<4UM<1$JI,<T3H2H)4D"OP4_;J\
M!>!_"G_!8#_@@K_PC/@WPGX>_M+XB_\ !1*'4#H?AK0](-]%!^QCJ,L$5XVF
MV%J;J.&5VEBCN#(D<N)442*K#]^J_#+_ (*$_P#*8#_@@1_V4G_@HO\ ^L6W
M] '[>#2=,P/^)?8]!_RYVO\ \:I?[)TS_H'V/_@';?\ QJKZ]!]!_*EH S_[
M)TS_ *!]C_X!VW_QJC^R=,_Z!]C_ . =M_\ &JT** ,_^R=,_P"@?8_^ =M_
M\:KF-<TS3EUGP8HL+(!]<U ,!9VPW >%O$# ']UR-P#8/&0#C*@CMZY;7?\
MD-^"O^P[J/\ ZBGB&@#9_LG3/^@?8_\ @';?_&J/[)TS_H'V/_@';?\ QJM"
MB@#/_LG3/^@?8_\ @';?_&J/[)TS_H'V/_@';?\ QJM"B@#/_LG3/^@?8_\
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MV'A;2]7^)WQ)T&;XJOJ]I\0[[X96^K_$>?6KG7?$UM=7$OA775C^7[7X:?\
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M^)_BWJ\318>.VU;POX)6=F"_VA  7"C]G_XM?$ ^?\<_VB_&%[I\["6;X??
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M2O)ZSJ2;;>M'+<'1J1K*C[3$1NHXG$SJ8K$Q3M=1Q&)E5K0B[?!"<8+[,4A
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M^?T?^ ]Y_P#(U'_"3Z+_ ,_H_P# >\_^1JWL#W_,_P"-&![_ )G_ !H P?\
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M/]-'0?\ +O>?_(U+_P )/HO_ #^C_P ![S_Y&K= X'7H/XC_ (TN![_F?\:
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MU'XL^&=+^(VG/XN_LKXLZ%X)^)&JWWC#X?\ A_XH6/B_1/ &LS-+X.L-%BS
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M))KI)7M);QDFGJC!_P"$GT7_ )_1_P" ]Y_\C4?\)/HO_/Z/_ >\_P#D:M[
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M'EN:8:GB<J>(S&-1S488?#U(RBZ<Y0DJT\2J%#"N\7*"Q56BZL+3I*<91O\
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M_P"$FTKD#N/<4 =5129 (!(!.<#(R<=<#J<=\4@96) 921U ()';D Y'/'-
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M_EM6O]O83*_<X:P'U*K'3^W,P=+&9W)K_EY@WR+!9+JHU:,LOHRS3"R<J?\
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M_P"S_B1\:FBTCQ[XP$D$TMKJ&D>![7X<>')2I@G_ +=M#YDCS;@#..%\PQ&
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M_P#U*]%KJ:Y;QE_R!$_[#OA/_P!2O1: .IHHHH **** "BBB@ HHHH ****
M"BBB@ HHHS^OL?U]/QH **0L!D\\>BL3^  )(YZ@$4M !7X9?\%"?^4P'_!
MC_LI/_!1?_UBV_K]S:_#+_@H3_RF _X($?\ 92?^"B__ *Q;?T ?N8O0?0?R
MI:1>@^@_E2T %%%% !7+:[_R&_!7_8=U'_U%/$-=37+:[_R&_!7_ &'=1_\
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MD]Y-.7TW4[+P;X8M[Z.[^TR7,>C68EE8B4R<G\&OV?O@#^S!X8UW0O@I\-/
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MK\0_] 6Q_P#!XW_RGH^U^(?^@+8_^#QO_E/6]10!@_:_$/\ T!;'_P 'C?\
MRGKFO%MSKK:.@ETBR1/[;\+'*ZT6.X>)]',:X.DJ 'D"H7).P,7VOMV-Z'7+
M>,O^0(G_ &'?"?\ ZE>BT 6_M?B'_H"V/_@\;_Y3T?:_$/\ T!;'_P 'C?\
MRGK>HH P?M?B'_H"V/\ X/&_^4]'VOQ#_P! 6Q_\'C?_ "GK>HH P?M?B'_H
M"V/_ (/&_P#E/4D5UKK2QK-I%G'$TB"61=8,K1QE@'=8O[*C\QE7)">8FXC&
M]<YK:HH **** "BBB@ HHHH **** "BBB@ K\,O^"A/_ "F _P""!'_92?\
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ML1RMK=+4/KM>5G#+,=)/:3E@*:^<:N-A52]:=_(^G0RGH0?H0?Y4A=0"22
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M/"^A3?$P^'Y/"FF^/O%6C^%'CNO*UC5-*YSX%_M7_%'XSZK\8-.^+/[-.M_
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M_P#*8#_@@1_V4G_@HO\ ^L6W]?N;7X9?\%"?^4P'_! C_LI/_!1?_P!8MOZ
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M;67Q)TW3[::\UO2H4BM?$EE;7/B+1(HI(=7TRP_=CKTK^=#_ ()N_LT^%_\
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MA06GAJPCLO">KVLCN]MJGA73?L7A[4;=V9H+S3)H6.Y"  ?5%?AE_P %"?\
ME,!_P0(_[*3_ ,%%_P#UBV_K]M?$$&OW.C:A!X6U/1]'\02V[+I6IZ_HEYXD
MT>RNRRE9M0T/3_$'A:]U.W"!U:VM_$&E2,S*PNU"%'_ ']MC2_B_8_\ !8#_
M ((._P#"P/''PX\3&;XB_P#!0P:)_P (?\+?$O@@:?,G[&>IM?/JHUGXO_$
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M_04T;_P17W_S1T ;-%8WD>(?^@IHW_@BOO\ YHZ/(\0_]!31O_!%??\ S1T
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M'_H*:-_X(K[_ .:.ND\8V:*QO(\0_P#04T;_ ,$5]_\ -'1Y'B'_ *"FC?\
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M_P T=+Y'B'_H*:-_X(K[_P":.@#9HK&\CQ#_ -!31O\ P17W_P T='D>(?\
MH*:-_P""*^_^:.@#9HK&\CQ#_P!!31O_  17W_S1T>1XA_Z"FC?^"*^_^:.@
M#9HK&\CQ#_T%-&_\$5]_\T='D>(?^@IHW_@BOO\ YHZ -FBL;R/$/_04T;_P
M17W_ ,T='D>(?^@IHW_@BOO_ )HZ -FN6\7?\@_3?^QI\(?^I-I5:'D>(?\
MH*:-_P""*^_^:.N9\5PZZ+#3O,U+2&'_  D_A,*$T2\0ASXDTP1L2VOR HK[
M6= %+J"BR1E@Z@'?T5C>1XA_Z"FC?^"*^_\ FCH\CQ#_ -!31O\ P17W_P T
M= &S16-Y'B'_ *"FC?\ @BOO_FCH\CQ#_P!!31O_  17W_S1T ;-%8WD>(?^
M@IHW_@BOO_FCH\CQ#_T%-&_\$5]_\T= &S16-Y'B'_H*:-_X(K[_ .:.CR/$
M/_04T;_P17W_ ,T= &S16-Y'B'_H*:-_X(K[_P":.CR/$/\ T%-&_P#!%??_
M #1T ;-<MXR_Y B?]AWPG_ZE>BUH>1XA_P"@IHW_ ((K[_YHZYGQ?#KHT93)
MJ6D,O]M^%AA-$O(VW'Q1HXC.YM?D&U7VLZ[<N@9 T982* =_16-Y'B'_ *"F
MC?\ @BOO_FCH\CQ#_P!!31O_  17W_S1T ;-%8WD>(?^@IHW_@BOO_FCH\CQ
M#_T%-&_\$5]_\T= &S16-Y'B'_H*:-_X(K[_ .:.GQ0ZX)(S-J.DR1!U,J1:
M+>12/&"-ZQRMKTRQNRY"NT,JJ2&,;@;2 :U%%% !1110 4444 %%%% #=@QC
MYL>N]]W7/WMV['MG&..E.HHH *_#+_@H3_RF _X($?\ 92?^"B__ *Q;?U^Y
MM?AE_P %"?\ E,!_P0(_[*3_ ,%%_P#UBV_H _<Q>@^@_E2TB]!]!_*EH **
M** "N6UW_D-^"O\ L.ZC_P"HIXAKJ:Y;7?\ D-^"O^P[J/\ ZBGB&@#J:***
M "BBB@ HHHH **** "BBB@"G_9]B+Y]3%G:C4I+2.PDU 6\(OGL89I;B&S>[
M""X:UBGGGGBMFE,,<TTLR(LDCL>2UK2=+L[WP/':Z;IUNEMXRO;VV6&QM(EM
MKS4?#GBZ6_N[8)"HM[N^DO;QKRZ@\NXNC=W8N))!<SB3N:Y;Q'_R$/!O_8TG
M_P!1GQ+0 NN>"?!WB:U^P^(O"GAK7K(7LFH_9-9T#2-5M?M\PQ->_9]0L[F'
M[9*.)+K9Y[CAY"*W-/T^PTFQM-,TNRM-.T[3[:&SL;"PMH+.RL[2W0106UI:
M6T<5O;6\,:K'%!!''%$BA(T50 +E% !1110 4444 %%%% !1110 5R/BK_7^
M%/\ L;-._P#2'5:ZZN1\5?Z_PI_V-FG?^D.JT =:O0?0?RI:1>@^@_E2T <+
M\2_AGX#^,7@3Q1\,_B;X7TKQEX%\9:5/HOB/PYK,'GV.HV,^& .TI-;7=K,D
M5YIVHVDL&H:9?P6^H:?<VUY;PS)^?WPU^)7CS]B?QYX8_9O_ &D/$^J^,O@7
MXRU6#PS^S!^T_P")KCS[ZVOI\IHWP ^/^LN$@M?'EK @LOAS\1KTV^G_ !*T
M^WCTS4Y+;Q=;21W?Z=UPOQ+^&G@3XQ>!/$_PR^)OAC2O&7@7QEI4^C>(_#FL
MP>?8ZC8SX8 E2DUK=VLR17FG:C9RP7^F:A!;:AI]S;7EM#,GCYEEM2O4IYAE
M]2&&S;#0<*-::E[#%T.;GE@,PC!.=3"5)7E3G%.M@JTOK&'O>M1Q'Z)P9QG@
M\LP>+X2XMPF)SK@#.\3'$YAE^&E36:9!FOLXX>EQ;PE5Q$HT<)G^$HQA2Q6$
MJSIY;Q)EU-91F[AR9;F64]R"",CI_D$$'D$'@@\@\'FEK\P/ _Q'^('["_C3
MPO\  O\ :+\6ZKX]_9J\8:EI_A3]GO\ :A\4.LFN>"M<N2+71/@;^T?K V6I
MU"Z18;'X:_%^[6TL_%?E)H'BM[?Q"(KNX_3X$$9'_P!<'N".Q'>MLMS*GF$*
ML73GA<;A91I8[ 5G'V^$K.*E%2<6X5:%6/[S#8JDY4<12?-"7,IPAYW&7!F+
MX1Q."JPQF&SSAO/,/4Q_"W%66QJK*\_R^G-4ZLJ4:\(8C YGE]:2PF=9)CH4
MLRR?&KV&*I>RJ8;$8A:***](^,"BBB@ KD?%W^JT#_L;/#G_ *7BNNKD?%W^
MJT#_ +&SPY_Z7B@#K5Z#Z#^5+2+T'T'\J6@ HHHH **** "BBB@ HHHH *Y;
MQ=_R#]-_[&GPA_ZDVE5U-<MXN_Y!^F_]C3X0_P#4FTJ@#J:*** "BBB@ HHH
MH **** "BBB@ KEO&7_($3_L.^$__4KT6NIKEO&7_($3_L.^$_\ U*]%H ZF
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_#+_@H3_RF _X($?]
ME)_X*+_^L6W]?N;7X9?\%"?^4P'_  0(_P"RD_\ !1?_ -8MOZ /W,7H/H/Y
M4M(O0?0?RI: "BBB@ KEM=_Y#?@K_L.ZC_ZBGB&NIKEM=_Y#?@K_ +#NH_\
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MEU:MA\3AZ^89-F&49QF5BN1\7?ZK0/\ L;/#G_I>*ZZN1\7?ZK0/^QL\.?\
MI>*]0^&.M7H/H/Y4M(O0?0?RI: "BBB@ HHHH **** "BBB@ KEO%W_(/TW_
M +&GPA_ZDVE5U-<MXN_Y!^F_]C3X0_\ 4FTJ@#J:*** "BBB@ HHHH ****
M"BD) [\^@Y/Y#G]*\>^*'[0GP.^"L(D^*_Q9^'_@":2(S6NG>)O%.DZ=KFI*
M "$TCP^]RVNZQ.P9?+MM+TV\N)-RB.)B0*RKXBAAJ<JV)K4L/1AK.K7J0I4X
MKO*I4E&,?FT>AEF4YIG>-HY=DV6X_-LPQ#:H8#+,'B,?C*[6ZHX7"TZM>JUU
M4(2MU/6C:VOVD7QMX/M:V[6HNS#%]I6V:19FMQ<;/.$#3(DK0A_+:15<J74$
M?S\?\%'O^"F'PL_9.\5?\*;_ &9? 'PI\3?&FS\1>&M6^*VN3>%])/A7P=;>
M'?$&F>*8/!FI2Z%!87>K^.M5NM/MFNTCO,^ ;>5=5E8^*3IUG:?=7QL_:-^)
MWQT^%/CSP)^QO\-OVASXY\5^'+W3/!GQTOOAY8_"?X>^%[VY5 -=AUOX[7O@
MK6=3M6@\ZVAU;P;X/\27UCY[:IHRRZC9VBO_ !'?&GX2_$_X'?$[Q;\,OC'X
M?U7PW\0_#NIRG7[/5IY+^74'U"26\A\166M.\J>(])\1!Y-4T_Q+!/<1:TLT
MMS)-]M%Y##^,>*/'N991E^'P_#M.O&ECFX5N(Z=*<L)1:YFL)E^)<'0J8NK"
M$ISK1E*-*BG[#FK.53#?Z2?09^BCP7X@\79KFWC'BLJK8WABG'$8#P<QF.P]
M//\ ,825&G+B'BO)X8F&9X/(,#B,31PM#+*U&C5QV92@\T5#+H4<)G?]Y7[&
M'[7WP8_;:^#Q\:?#Z*STW4H2VG_%'X7ZD;&;6O!7B75TFN=1L-9MHXHX-8T;
M7G>\O-&\3);?V?XIL7GEE6'4X=7TVQ^QK>W@M((;6VABM[:WBC@MX((TBA@A
MB01Q0PQ1JL<444:JD<<:JD:*J(JJH _C%_X(K_LZ_M+^./VB=+^-WPN\2ZI\
M,?A)\/[QM(^)_C.:S-WH_P 0].D,5U??!W3M(NC'8^)KW40;>\U2_DW0?#[_
M $378;B/Q(^DV%W_ &?C( R<FOL_#WB/,^)^',/F.:X">$Q,9RH+$\L88?,X
MTHQ7UW#4^;GA&<N:%5<BH^VA-X>3A>G2_F[Z7O@WP3X(>,6;<(<!\587/\FJ
M8>EFCR55JV*S;@JMC)SFN&LYQC@\/BJU&E[/$X&I]8GF*RZOAEFM"&(Y,7CE
MHHHK[D_EP**** "BBB@ HHHH **** "FL"1@=R >2/E) ;!&""%S@@@YQBG4
M4 ?C)HOPY^,WPL\"_LL?M1Z]\$OB=\0?B-:?'7X^_'W]H_X4_#Z#P]JGQ=M]
M1_:3\#?$#PSX8ATW1/$GB[P_H^O7'PBTV]^%OPBETJ'Q%#<:'X%T>'4+66;2
M?#&I12_H7^Q_\-_%7P@_9<^ 7PS\<6L.G>,?!?PH\%Z'XHTBUOK;4[+0M?MM
M&MWU7P]I^HV1-G?Z?X=O99M"L+RT)M;JSTZ":V+0/&S?1Y52-I52O'RD#''3
MCIQVI: ,?Q!IE[K.C:AI>G>(=8\*7M[;M!;>(M AT&XUC29"RL+O3X/$^B>(
M] DN%"E%75-#U*U*NQ:V9@C)^ /[;'@;Q/X8_P""P'_!!W^VOC)\1_B'_:'Q
M%_X*&1VA\8:9\);(Z$UM^QGJ<LTNE?\ "!?"[P2)I+]'6WNQK0U>)(HHVL8K
M*<RSR_T+5^&7_!0G_E,!_P $"/\ LI/_  47_P#6+;^@#]LUTN^P/^*CUGH/
M^6'A[T_[ 5+_ &7??]#'K/\ WX\/?_**MA>@^@_E2T 8W]EWW_0QZS_WX\/?
M_**C^R[[_H8]9_[\>'O_ )15LT4 8W]EWW_0QZS_ -^/#W_RBKF=<TV\&L^#
M0=?U=R^MZ@%9H="#1$>%]?8L@71%4L0IC(D61=CL0H<(Z]_7+:[_ ,AOP5_V
M'=1_]13Q#0!H?V7??]#'K/\ WX\/?_**C^R[[_H8]9_[\>'O_E%6S10!C?V7
M??\ 0QZS_P!^/#W_ ,HJ/[+OO^ACUG_OQX>_^45;-% &-_9=]_T,>L_]^/#W
M_P HJ/[+OO\ H8]9_P"_'A[_ .45;-% &-_9=]_T,>L_]^/#W_RBH_LN^_Z&
M/6?^_'A[_P"45;-% &-_9=]_T,>L_P#?CP]_\HJ/[+OO^ACUG_OQX>_^45;-
M% &-_9=]_P!#'K/_ 'X\/?\ RBKF?$&FWBW_ (0!U_5W+>)RJEH="!C/_"-^
M(F\Q-FB("^%*8D$B;78[-X1T[^N6\1_\A#P;_P!C2?\ U&?$M &A_9=]_P!#
M'K/_ 'X\/?\ RBH_LN^_Z&/6?^_'A[_Y15LT4 8W]EWW_0QZS_WX\/?_ "BH
M_LN^_P"ACUG_ +\>'O\ Y15LT4 8W]EWW_0QZS_WX\/?_**C^R[[_H8]9_[\
M>'O_ )15LT4 8W]EWW_0QZS_ -^/#W_RBH_LN^_Z&/6?^_'A[_Y15LT4 8W]
MEWW_ $,>L_\ ?CP]_P#**C^R[[_H8]9_[\>'O_E%6S10!C?V7??]#'K/_?CP
M]_\ **N4\3Z=>+/X7!U_5I-WBG3U!>'0@8R;+5")$V:*@+J 0 X=,,V4)VE?
M1*Y'Q5_K_"G_ &-FG?\ I#JM &H-+OL#_BH]9Z#_ )8>'O\ Y14O]EWW_0QZ
MS_WX\/?_ "BK87H/H/Y4M &-_9=]_P!#'K/_ 'X\/?\ RBH_LN^_Z&/6?^_'
MA[_Y15LT4 8W]EWW_0QZS_WX\/?_ "BH_LN^_P"ACUG_ +\>'O\ Y15LT4 8
MW]EWW_0QZS_WX\/?_**C^R[[_H8]9_[\>'O_ )15LT4 <GK7A*V\1Z1J>@:_
M?W.MZ'K6GWFDZQH^K:9X7U'2]5TO4;>2TO\ 3=2L+KP]+;7MA>VTLEO=VEQ'
M)!<02/%(C*Q%?F! ?%7_  34U[3_  ]K?B+Q/KO_  3Z\1:G;:;X8\77+6VM
M:_\ L;Z_JUYY5GX6\9WE[IU_=ZG^SAJ]_=1VGACQ1(&G^$UY+;Z%K3'PO+9W
M\/ZUUF:SHVD>(](U30-?TO3];T/6]/O-)UC1]6L[?4-+U72]0MY+2_T[4;"[
MCEM;VQO;666WN[6XBD@N()'BE1D8BO*S++7C'2Q6%K+!YI@U-X+&J'/%1GRN
MKA,724H/$Y?B7""Q.&<XN\:>(P]2ABZ&'Q%+[W@KC2/#T<?D>>8"7$/ W$,L
M/'B3AN6(6&J3J8;VL<%GV0XV5+$+)>+,E5?$3R?.(8>O3=.OB\IS;"9IP_F>
M;93CJ-I;O?VMO>V/BO4KNSNX(;FUNK4>&KBVN;>XC6:"XMYX=$>*:">%TEAF
MB=XI8G22-V1U8\YXKTZ\6+0MVOZM)GQ3X>4;X="&PM? "1?+T5,NA^90VY"?
MOHXXK\ZA)XG_ ."9VL6L-S>>(/&?_!//6+V&RBNKZ2[\0^*_V*-3U"\:.TCN
M[PI/K'B/]F*\N+F.TBN;M[[6/@[)Y$<T]UX2(:W^G/VD_P!KG]G7]G_2?A1J
MWQ7^*/A[PWIWQ(\:>%8_!UU'/_:\6K:=)<6]W<>*5;2S="'P3IEG=VEYK'C&
M3_B0:;;7EG)->%KJ!).?#Y]A%0Q,LUG0RC$Y=[*.94<7B*<*.']M+DH8BEBJ
MGLJ=? 8N=U@\6E#VDE/#UJ=#&4<1A:/J9MX59_4S3):7 F&S+Q"R3B]XZ7!F
M9</Y1B\3C\V>745BLTR?'Y)A%C<5E/%>08>=.IQ#D,ZF)>#HU,/FV QF:<.9
MCD^>9E]1C2[[ _XJ/6>@_P"6'A[_ .45+_9=]_T,>L_]^/#W_P HJT+*\M-0
MM+6^L;FWO+*\MX;JTN[6:.XMKJVN(DFM[BWN(6>&>WGA=)8)XG>*:)TEC=D=
M6-FO<332::::NFM4T]FGU3/R^490E*,XN,HMQE&2<91DG9J2=FFGHTU=/<QO
M[+OO^ACUG_OQX>_^45']EWW_ $,>L_\ ?CP]_P#**MFBF(QO[+OO^ACUG_OQ
MX>_^45']EWW_ $,>L_\ ?CP]_P#**MFB@#&_LN^_Z&/6?^_'A[_Y14?V7??]
M#'K/_?CP]_\ **MFB@#&_LN^_P"ACUG_ +\>'O\ Y14?V7??]#'K/_?CP]_\
MHJV:* /QU_:O_:E^./PZ_:LT[P!X/\;^.?"7PC^$'A?]G#Q_\8/$NG_ SP+\
M2O \^D?'WXR^.? %X/C%XPU'Q!X9\5_#[P;I/A_X<7=EH&H_!_P[XP\7Z%XF
M\43?$KXC6$/PF\"ZC8ZWV7PT^(?[3%E^V'\4_@+\:OB)?>)?"TOA;PI\6/ E
MS<_"+PY\,?#%O<2_&70M*'A7X$>)XVU/6OC/X<^'O@GQ7X/L?C=K_C&"TU?P
MK\3=0\*W&E[_  YX]_X1WPO]3?&/]C?X6?&WXF^&_BAXFUGXD:/?Z=:^"]*\
M;>%O!_CB^\/^!/C1X=^&GC6Y^(WPV\+_ !@\,):W4'BK0O WC?4-8US1X;"Y
MT*\O+?7_ !%X6\17NN>"M?U;PW=_GQ^TG+^QO_P3Q\2:%XU\<?&+]H9_&7CK
MQ7I5E\+O!&F_$6Z\;W_P3^%.I?&_PA\7?C)9?##POJ5G(WA3X1^+=?\ "6CV
M/CT:O)XE\2:WX9TO3?A1\/-1TW1M*TC1-&Y,=C\%EF%JX[,<50P6#HJ+JXG$
MU(TJ4.:2A!.4FE><Y1A"*O*4I*,4Y-(^AX5X2XFXYSW \,<'Y%FG$G$.9RJQ
MP&3Y/A*N-QV)]A1J8BO*G1I1E)4Z&'I5:]>K/EI4*-.=6K.%.$I+ZOT+XG_M
M4:I\6?VT_!,!^'ES>?##P_\ ![5/V=_"]WJ36>F2V7C73/B-#<Z[\7_&-KX)
MGOQ<:KJ_A4>(;W0?"&@WD>@^%K73O#VF:GJ?B.[U/55]\_9<\2>-OB;^S/\
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MU_A3_L;-._\ 2'5:ZZN1\5?Z_P *?]C9IW_I#JM '6KT'T'\J6D7H/H/Y4M
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M6^9?+O\ PO[XJ_\ 1FO[17_A1_LQ_P#T0E'_  O[XJ_]&:_M%?\ A1_LQ_\
MT0E?4>!Z#\A1@>@_(4_J.+_Z'.8?^",J_P#G;Z_TM<_]9L@_Z-UPG_X<N//_
M *,OZN_*WRY_PO[XJ_\ 1FO[17_A1_LQ_P#T0E,D^/?Q?D1DL?V,OC\]VV!"
MNH>,/V9=.LL]6-Q>I\>;YX(U0,0R6EPS/LC$9+Y'U-@>@_(48'H/R%'U'%_]
M#G,/E1RF_P KY:UWW3Z:.VHN)\@33_XASPE*S3M+,N/7%VMI)1XTC*SM9\LH
MNS=I)V:^#/B[^TQ^U!X(^&'CSQ=X7_8<^(VM^(?#OA?5]7T?3+GXF_!C5;>X
MOK*TDFA-SI'@_P <ZSXKU>VM]IN[G2?#6F7NN:E!;R6.E1?;;B%U_A8^,7QB
M^)'Q\^(_B;XL_%CQ/>^+/'7BV]^U:KJMT#!#;PP;HK#1='TY3Y&B>']#@/V#
M1M"M%2VTRV0H1)=R7=S<?Z31 (P>G^2"".00>01R#R.:_GF_X*4?\$<HOC1X
M[T[XU?LQR>%/!/C#QMXOT73/BMX1UR=M&\':G<>)=7MM-G^)^D&RMYFT_7;.
M:[%[XQT&RMMGBZ%9=5TP6WB?[8FO?DOBKP9Q'G>7X/$97F./S>G@)RE6R>K'
M"0G4E4M!8O#1PF&PD*]>E%N$J=:%2:I2J2P\XR=2E6_T"^@7])#P:\,>+>(,
MHXXX/X6X Q7%>'HT,O\ $?!5L_Q-#!4L(O;3X?SFKQ#G.?XG*\KQ]:G#$T\;
MEM?"X:ICZ.&IYS0K4J>#QN6_F'_P26^/_P"V(?B5IG[*WP0\4>([?X:>-=5E
M\1>+M0T_PCX:\;W7P5TA5F_MOX@>&AXXNXO"GAJPU#47L8=<L=5M]5L]<U"1
M7\/^'[[Q5<RQ:C_4+'^PW\+?$C)=?'#Q=\8/VD[T31W36WQJ^)&L:CX,6Y$>
MR4P_"7P8O@SX1QP2G)^SS^";L*N%,CD%FTOV+_V+_A1^Q/\ "FU^'GP\M?[3
M\0:G]EU'XB?$34;6"'Q)\0/$D,!C.H:@8S(-/T;3Q)-;>&?#-M,^GZ!I[LB-
M=:C=:GJ>H?7]?3\$<%U<GR#"X+B*O+-L2OWD<%B:M3%9=EE.48N&"P^'JSGA
MIRHOFE.O[)VJ2=.A+V-.$I?B'TGOI*9?XB^+.>\2>#N5T> ,DJ/ZK5XER3 8
M7(>+^-L92G..(XDSC-\%A\/G6%IYA35*C0RMXZ*GA*,,5F=)YCB\52H\CX,\
M >!?ASH\7A[X?>#/"G@70(=ODZ)X-\.Z1X7TB+8I5/+T[0[.QM%VJ2!^ZR 2
M,UUH '0 ?08I:*_0X4X4H1ITX0ITX)1A"$5"$8K:,8Q2C%+HDDD?Q_BL5B<;
MB*V+QN(KXO%8B;JU\3B:M2OB*]27Q5*U:K*=2K4D]93G*4I/5MA1115F 444
M4 %%%% !7+>,O^0(G_8=\)_^I7HM=37+>,O^0(G_ &'?"?\ ZE>BT =31110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %?AE_P4)_Y3 ?\$"/^RD_\
M%%__ %BV_K]S:_#+_@H3_P I@/\ @@1_V4G_ (*+_P#K%M_0!^YB]!]!_*EI
M%Z#Z#^5+0 4444 %<MKO_(;\%?\ 8=U'_P!13Q#74URVN_\ (;\%?]AW4?\
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MM%U2YN;N34=%;3KT7MZDZ74WU&/AUX!.@^(/#!\$^$?^$;\6WNJ:GXJ\/_\
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MX ?^"GQ+_P#-/1_PX!_X(X?](^_@!_X*?$O_ ,T] 'Z]?VC8?\_MI_X%6_\
M\=KE]=U"P.M>"S]ML^-=U#K=VP)SX5\0] 906]]H.!R<"ORM_P"' /\ P1P_
MZ1]_ #_P4^)?_FGKYP^,W_!![_@E?I?Q<_9&TOPC_P $^_@^OA?Q)\9_'.F_
M%(Z1X=\97.F/X0LOV:/CKKFC0^*;BV\0RVNGZ*WQ$TOP5+:7.H-;12^([?0;
M&WN?M5W%:W8!_03_ &C8?\_MI_X%6_\ \=H_M&P_Y_;3_P "K?\ ^.U^0O\
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M".'_ $C[^ '_ (*?$O\ \T] 'Z]?VC8?\_MI_P"!5O\ _':/[1L/^?VT_P#
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M\$CD<^)\_GS3O^' /_!'#_I'W\ /_!3XE_\ FGH _7K^T;#_ )_;3_P*M_\
MX[1_:-A_S^VG_@5;_P#QVOR%_P"' /\ P1P_Z1]_ #_P4^)?_FGH_P"' /\
MP1P_Z1]_ #_P4^)?_FGH _7K^T;#_G]M/_ JW_\ CM']HV'_ #^VG_@5;_\
MQVOR%_X< _\ !'#_ *1]_ #_ ,%/B7_YIZ/^' /_  1P_P"D??P _P#!3XE_
M^:>@#]>O[1L/^?VT_P# JW_^.T?VC8?\_MI_X%6__P =K\A?^' /_!'#_I'W
M\ /_  4^)?\ YIZ/^' /_!'#_I'W\ /_  4^)?\ YIZ /UZ_M&P_Y_;3_P "
MK?\ ^.T?VC8?\_MI_P"!5O\ _':_(7_AP#_P1P_Z1]_ #_P4^)?_ )IZ/^'
M/_!'#_I'W\ /_!3XE_\ FGH _7K^T;#_ )_;3_P*M_\ X[7)>+=1L#%H/^FV
M8QXK\.'F\MESB_' S,,GT R3V!P:_++_ (< _P#!'#_I'W\ /_!3XE_^:>OF
M#]J+_@A%_P $MO#VF?!-_AO_ ,$_/A$MSJW[3GP%T#Q@WASPWXSOI3\.M8\:
M16WC9=76Q\07'V;PZVCATUN]NECL;2R9Y;J>%-LB@']# U&PP/\ 3;3H/^7J
MW_\ CM+_ &C8?\_MI_X%6_\ \=K\@T_X(!?\$<2B$_\ !/KX  E5)']D^)N"
M0"1SXG)X/J2?6G?\. ?^".'_ $C[^ '_ (*?$O\ \T] 'Z]?VC8?\_MI_P"!
M5O\ _':/[1L/^?VT_P# JW_^.U^0O_#@'_@CA_TC[^ '_@I\2_\ S3T?\. ?
M^".'_2/OX ?^"GQ+_P#-/0!^O7]HV'_/[:?^!5O_ /':/[1L/^?VT_\  JW_
M /CM?D+_ ,. ?^".'_2/OX ?^"GQ+_\ -/1_PX!_X(X?](^_@!_X*?$O_P T
M] 'Z]?VC8?\ /[:?^!5O_P#':/[1L/\ G]M/_ JW_P#CM?D+_P . ?\ @CA_
MTC[^ '_@I\2__-/1_P . ?\ @CA_TC[^ '_@I\2__-/0!^O7]HV'_/[:?^!5
MO_\ ':/[1L/^?VT_\"K?_P".U^0O_#@'_@CA_P!(^_@!_P""GQ+_ /-/1_PX
M!_X(X?\ 2/OX ?\ @I\2_P#S3T ?KU_:-A_S^VG_ (%6_P#\=KE_%NH6!T_3
MO]-LQCQ1X0/-W;+T\3:5TS*,GT49)[ U^5O_  X!_P"".'_2/OX ?^"GQ+_\
MT]?.'[4'_!![_@E?X?\ !'@*Y^''_!/OX/KK-]^T=^RSH6M/X<\.^,KZ^7P!
MK_[0_P -M'^)0NXK'Q#</%H$O@*\\0P>)KRXB^Q6'AV;4[R\FM((&NX #^@G
M^T;#_G]M/_ JW_\ CM']HV'_ #^VG_@5;_\ QVOR%'_! '_@CA@9_P""?7P
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M!_X(X?\ 2/OX ?\ @I\2_P#S3T ?KU_:-A_S^VG_ (%6_P#\=KE_&&H6!T5
M+VS&==\)_>N[91_R-6B]2TH ]LGD\#DU^5O_  X!_P"".'_2/OX ?^"GQ+_\
MT]?.'[5G_!![_@E?X<^$EIJGPS_X)]_!_P#X2C_A<_[,FFS#PUX=\97^IR>$
M=<_:6^$>A_$6&6WT[Q#/=+HL_P /-1\4P^);E5CBL?#CZK>W5S:6MO-=0@']
M!/\ :-A_S^VG_@5;_P#QVC^T;#_G]M/_  *M_P#X[7Y"C_@@#_P1P_Z1]? #
MJ?\ F$^)?7C_ )F>C_AP#_P1P_Z1]_ #_P %/B7_ .:>@#]>O[1L/^?VT_\
M JW_ /CM']HV'_/[:?\ @5;_ /QVOR%_X< _\$</^D??P _\%/B7_P":>C_A
MP#_P1P_Z1]_ #_P4^)?_ )IZ /UZ_M&P_P"?VT_\"K?_ ..TY;^R=E1+NU9F
M(556Y@9F8G  42$DD\  $D\ 5^0?_#@'_@CA_P!(^_@!_P""GQ+_ /-/78_#
MS_@B!_P2A^%'CWP5\4/AW^PW\#_"?C[X=>*_#_CCP3XITG2_$$>J>'/%GA75
M;76_#^N:=)/XBGA2^TK5;*UOK1Y898UG@C9XW4%2 ?JM11_G\Z* "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ H_S_GU_&OC/XX?M2^-O@W\3_"WA]?V
M??%GB3X/2^(?@SX5^(7QPD\6>'_#&E>&=?\ CW\3K3X2^!=.\%>$]7M9-3^*
M4^A>*-5T"]^)Z:7J6@/X3\/>)-$GT!/&WB":\\-V7F?PK_X*#6?C@>,=6\6?
M [XC^#O"DGPKO/CU\"-2T*6R^*?B+X]_!RT\7+X)BU;0_!'@>TN=;\,^.-3U
M;4_!>H:7X OWU66X\._$7P??S:_;:G'XOT7PH ?HQ17Y8^*O^"D[V_B#]C'P
MGX+^'7PK3Q1^UK\(/!/QFF\.?'#]J3P+\"->\'Z)X_O/!5AX?\(>#M*O?"7C
M:Y^-/Q(N+KQ)K\ \+^$ETNVFG\)3PVVLS-K.G[/U-!R.W4]#GC)P?Q'..QXY
MZT +1110 4444 %%%% !1110 4?Y_P ^OXU\9_M#_M2^-?@3XT\.65I^S[XN
M\;?"F"X^&D?Q2^+\?BSPUX6TGP>/BW\3;;X5^$].\$>'M:BEU/XM>*-*UNYM
M]<\<^&M'N_#\_A_PMJ.@R:3=^)_%7B+1_"5SP_PM_;RM?'/B;Q;;^)/@UXW\
M(> ;CP7\1_B9\"O'.E7UI\2+_P".7P^^$GQ$TSX7^-M2T[X?^"=/O/%OA?Q'
M=>(?$O@K6/ OA"6#Q!J/C'P=XTT35%N=)UZT\1^%]# /T$HK\I?%/_!4CP]I
M'AO]EK5=%^$5S?>)OVC?AMX.^+E[\.O%WQA^$_PO\9>%/"_C/5=,T/1_ WA.
MV\;:O9:=\8_C_K.K76M6/A?X/>"]0@/B&X\%^*K=?%NGWC^%+7Q3^K(.1G&.
M2.H/0D9R/7&?4=" <B@!:*** "BBB@ HHHH **** "C'Z<]2/Y=?H>*^+_VG
MOVJ?&W[/&JZ;>:9^SQXR^)'PQT'2=&\4_&3XH6GBWPIX/T?P)X9U[QC;>#;&
MU\&Z9XC+77Q9^(,$QOO$.I^ M'N= FM/#=M8&'6KOQ-XH\)>&=;YCX<?MRV_
MC+XD^*O#GB+X2>*/!_PUETGXZ:[\&OBC:ZS8^.IOBWI?[-'Q$TWX7?&$K\.?
M"&FWOC#POJ8\2:O8:K\,M$B3Q3J?Q'\'R3ZO%!X?UJVE\,@ ^]Z*_++XD?M^
M_&_3?V9OA)^U!\'/V1;/X@^&OB5I5@=0^'_Q"_: TSX/_%30/&OBSQSIGP^^
M&WPNTSPY;?"WXEZ7XH\>^,_%.JVWAZ33_P"W]"T[0/$,D>G7>I75F+K5K3]0
M[&6ZGL[6:]MDL[R6V@>[M(KC[7';7+Q(UQ;QW7DVXN8X9B\4=P((1.B+,(HP
M^Q0"U1110 4444 %%%% !1110 48S_/J1_+^72OC+]JS]J7QQ^SA"->T']GG
MQA\5OA_X1\&ZY\4/C1X^L?%OA;P/H?P_^'OAR_L[74HO#;>*E,?Q)^)UQ8OJ
M^OZ1\-].NM!%[HN@7GVKQ3IVL:OX3TCQ!R_@K]N*'Q'\7]=\&>(/A%XH\)_"
MR[E^/VG_  H^,0US3?%?_"RM<_9:\3KX.^-^E2_#;PQ8WWC#PK+9ZY:^))/A
MRCG7]2^(6C^#?$=\=*\-W;>'M,U\ ^]:*_)OXG?\%3M(\!? CX,?'&V^!/BN
M.'XM_P#"[=:F\'?$GQ_X$^#^N^%_#/P'\17>A^*/#TEUXKFN=-U[]H#Q0B6T
MOPX_9]TN9/$OBJ^M?%EE/KFD6?@GQ!JT/ZKZ;?)J>GV.HQPW=M'?6EM>1V]_
M:S6-] ES"DZ0WEE<JEQ9W<2R".YM9T2:VG62"55DC8  NT444 %%%% !1110
M 4444 %'^?\ /^>>]?'/[6G[3OCO]F[16\3^%?V?/%?QB\*^%? WCWXM?%SQ
M18^+O#G@'P_X ^&7PUMM.O\ Q(VGZMXHMY[+Q?\ $W5--N]0U3P9\.XYM"L]
M:T[PSXBNM:\9^%DATK^UN,\*_MT6NO\ QLU#P+J7PD\4:#\'K_7OC%X%^'/Q
MU.MZ7K=KXY^(_P"S]IDVJ_%GPQ-\-=&L[GQGX:L["'1O'-KX0UBY.I7/BS4?
MAOXPM)]#\/F;P?)XK /OFBOS0U'_ (*&:WK'PY^%WBSX4?LO_%'QQXU^)M[^
MTWK2?"OQ/X@\*?"KQ5X5^%G[*'Q#N_A[\2/%WB>3Q8\]OIOC#5-2N_!EMX/^
M%]Q#!K%QKGC6ST?Q9K/A"UT'Q/K>E??OPZ\>>'/BEX \$?$SP?=/?^$OB'X0
M\,^.?"]])$8)+WPYXNT2P\0Z'=O"2QB>YTO4K69XBS&-W:,LVW<0#LJ*** "
MBBB@ HHHH **** "C_/^?\\]Z^2/VK_VC?B!^SQX;A\1^!?V?_$OQLL=(\*_
M$#XD_$/4[3QIX6^''A?P+\./AAI6GZOXFN9_%7BZ.?3=3\?:U;:B1\/_  (5
MTRV\2#1_$M_K?BSPCHNA7.J2>,Q_\%!GNOB#K.FZ3^SW\3?$_P )FN/'_@KP
M!\2/"VI^&]4\4_$CXX?#3X-W7QQ\1_"71?A#<3:?XDTVYU#PSH_BOPIX5\1:
MKK$<&K?$SP;K_A74]*T'3I_#7B3Q  ?H[17Y</\ \% _BS%%J7P[;]D36;O]
MJ;2_B#=>%9_@3I?QR^'=]H4OA?3_ (.Z/\<M0\9P?&%M+M= #VWA+Q!H/A@^
M%[OPY::F?B5K^@Z6]U%\/]6MOB;7Z&_"_P"(?A_XN?#7X??%7PE]N_X1;XE^
M"?"OC[PW_:EJ++4QH/C'0K#Q%I*ZC9"686>H)8:C E]:>=*;6[6: R.8]Q .
MZHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _.7XZ_
M!;]K7Q]^U]\'?B+HVE?LZ>.OV9_A8GA+5M#\#_$7XB?%;PEXI\,?$ZXUG6;7
MQY\8E\*>%OA=XL\'?$CQAX;\#7MEI/P0T_Q7XHT+1?!.N3^*?$,D:^(=;T7Q
M#X3K_LH?LA_&'X,^)M._X67XW^'?B'P9\$_@/?\ [,/[.4'@K2?$FGZ_?_#3
M4?%FE^(;CQ;\6GUUY;"T\;R:1X*^&?A>71_!LEYH$MSX;\0^+&U$'Q78>&/"
MGZ144 ?DC\2_V&?V@/%OP1^#7[/.E>+/V=KGX?M^S!\)_P!FKXVZSXO^&^JZ
MK\0/!;?#Y]$EUCXF?L_^*[.""^U#7=8AM+F'PUX=\>SZ)I'@7Q;H?@GXHZ/>
M2:MIFO\ AGQ#^MJC QQU8\#'WF+?IGKU)Y/)I:* "BBB@ HHHH **** "BBB
M@#\Y_P!I3X,?M:_$C]I[X)^,?!VE_LZ>./V;/A;%X:\4K\/?BE\1/BQX)U^T
M^-5KXOO)[OXKW6A^"?AEXR\,_$:Z^'O@V+3'^"WASQ3KFB:%X:^(5[KGCC4K
M2Y\2Z=X \1>"V_LK_LD?%WX+_$70IO'OC/X=:Y\+/@/\/?BC\)/V<;+PGI/B
M6W\;:GX.^+WQ/\+?$+6=:^+4^M2MHUCXG\+:+\/O!'@'2X/!LE_I_B0P>)O&
MNJW.E3ZYIOA3P_\ HU10!^*WCK_@FC\5-4^'OPK\)>&?$7P&O]8O?V-S^P]\
M<=:^(G@_Q%XC?PW\/[[Q!9>(Y_B9\!Y[2*WNE\;Z)>2:[+8^%_%7]BZ'KNM+
MX"\2WVOZ3-\/QI7B+]I((O(ACAWO((D5 \KM)*X10H>61OFDE<#=+(WS22%G
M/+5+10 4444 %%%% !1110 4444 ?G1^UE\&OVN/BE\=?@AK?PWT_P#9W\:?
ML\?#-])\;:U\,_BY\0_BQ\/]1U;XVZ/XQM]2\,^/=7M? /PT\>:/X_T;X7Z)
MIUOK?PV\&^(M0T70[3XI7B>.M:MK_6?!W@'4O#[/V>/V1OBO\*_C)H^I^,?%
MGPZUCX-?!.U_:(LOV?;/P]8>*$^(VJQ_M,?%?1_B;X@O/BK/J[GP_87_ ,-=
M,T=O 'AI_"=QJ:^-[?5]2\8>(#X<O5M_#J?HU10!^?\ X(_9'\9:%X(_8L\!
M^(->\':IHG[-_P 3_$WQ/\>6]NFM&+Q9JL'@_P"+FD_#>#08I[.)3'X:\6_$
M?2O&%R=6%J(=2\+:?<V0EN((,??X    P   /0#@"EHH **** "BBB@ HHHH
M **** /SI_;-^#/[6_Q>^)'P6?X3Z?\ L\>,O@-X#NU\;>./A7\9OB'\5OA[
M_P )K\6-!\3:)JWPWUS7Y/AY\,OB%;>,_!'PXCTR[\3:3\/]9ETC1=7^),OA
MSQ3X@745\#Z#:T?!_P#9+^+?@CX_:5K_ (L\8?#S5/@5\(_%W[3GQ#^">GZ'
MIWBB+XH:KXL_:O\ B!>^/_%*?$VXU:2?PU:V7PR_X2;Q[X6\+WWABZO+[QSI
MOB32M5U^W\,7WAVZM?$?Z+44 ?C7\7_^"=OQ:\7?#'X8^%=#O?V<_'>I^&-)
M_:V\$:UX:^._A7QCXJ^'.@V'[3OQ2_X3S1OC3X!LM(CCU&U^,_PDTRRAT/2H
MY[?1SKFF>)_%^B:5X_\  D5T=6U#]:_ _AN?P=X,\)^$KG7M8\4W'ACPSH'A
MZX\3>(9UNM>\13Z)I%GI<NNZW<J%6XU?6)+1M2U.=5"S7UU<2 8:NIHH ***
M* "BBB@ HHHH **** /SJ_;E^"W[5_QJ\0_!S3?@YIG[//C3X*^%K_5/%OQ7
M^$WQQ^(/Q3^'EA\2_&VC:GX>O_A5;Z[?_#?X9?$9O$WPV\)7=GK7B77_ (=Z
MK%IFE>,_%D/@R3Q%+J?AKP]J/AS7ZWPP_9+^,OA3]H?2_$?B;QG\-[OX _#W
MXM?M!_M#?#?1M#TSQ,OQ2O/BG^TQ'XA?Q;H?C.]U#'A1/!_@.\^)'Q:?PQJ^
MA9U[Q19>)?"MCJVF^'6\'ZG=>,?T>HH _)#X^_L!?$SXD_!_P5X)\.W7P.U?
MQ3X<^-'[5OC-]2\?/\9M"AT?PO\ M+?$OXE>+;>]T3Q-\(?%/@SQ?K#^'M"\
M8Z;IOQ"^"OB>6Y^$7QTM$OO#7C"?3+?3/#7B2Q_2SX1_#C1?@[\*OAI\)/#;
MR2>'?A=\/_!?PZT!Y8+:VE;1? _AK3/"^E-);V44-G!(]CI4#O#:PQ6T3L8X
M(TA5%'H=% !1110 4444 %%%% !1110!^>O[>/P7_:D^.*_"?PO\%M/^ /BW
MX/Z?JWB#7OCO\+/CAX^^*/PZL/BM/IT>B2?#+PKJ.M?#/X=?$.[UCX966LKK
M?B'XC> M0M=+L/B#<Z;X1\.Z_=:GX$?QEX4\3^3WW[(G[6FC^-_%NN?#_P <
M? "S\.Z+X[^.7[5?P7T[Q/IGQ U'5+?]J_XQ_!7Q7\.++PO\1KJUMDL+WX&>
M#?&GQ"\=^/$\0>'[2/Q_K^F7_AOP>?#VAQ^'-0UKQ-^L5% 'XM_#O]C?]M;P
M5X-^'WC+3'_9:\._M-_#7QI\3]7O/%.I^/?C=\6O#GQT/QU\!:)X;^*'Q.^+
MGBG4?AS\-O%NF_%"#Q7X7\'^(?#.C>&=!NO ]CX*\(V/P?\ #J> _![^'Y?!
M?ZI_!#X86?P3^#7PG^#NGZG+K=E\*_AOX(^'=MK5Q:0V%SK47@WPUIOAX:Q<
MV5N\D%I<ZJVGMJ-Q;02/#!-<R11.Z(K'U&B@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>chart-460dfd3e426b549eabf.jpg
<TEXT>
begin 644 chart-460dfd3e426b549eabf.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #P ,@# 2(  A$! Q$!_\0
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MB@ HHHH **** $8[1GW4?]],%_3.:_FS?_@XT^'B_L1:C^V G[+WC:35]/\
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M)?\ ;OF^/?[-.L_&ZT^)_P"TQI_B3]G_ /X)H>#OCO\ %7X>_M=_#OX/^'O
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MP/\ #GP-X.U75Y':635-3\+^%=)T'4-1DD<EY'O;S3Y[EI&)9S*6)).3Z90
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5#3=*TS1K4V6D:=8Z
M79FZU"^-IIUG;6-L;W5K^YU75+PV]I%#";K4=3O;S4;^X*>=>7UU<WER\MS/
M+*]^B@ HHHH **** "J&HZ5IFL01VNK:=8:G;0WVFZG%;ZA9VU[!%J.CW]MJ
MNDW\<-U%+&E[I>IV=IJ.G7:J+BQOK6WO+62*Y@BE2_10 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !2-T/T/\ *EI&Z'Z'^5 'YD?&
M^\O(_BMXS2.\O(T6_L@J1WEU&B@Z/II(5$F5%!))(51DDGJ2:\J^WW__ #_W
M_P#X'WG_ ,?KTSXY?\E8\:?]?]E_Z9M-KRB@"W]OO_\ G_O_ /P/O/\ X_1]
MOO\ _G_O_P#P/O/_ (_52B@"W]OO_P#G_O\ _P #[S_X_1]OO_\ G_O_ /P/
MO/\ X_52B@"W]OO_ /G_ +__ ,#[S_X_7Z4_L_R22_"7PH\LDDKL-8W/+(\K
MMC7M3 W/(S.V  !EC@  8  K\RZ_3']GS_DD?A/Z:S_Z?]4H ]GHK.U>_P#[
M+TK4M3\KS_[/T^]OO)W^7YWV.VEN/*\S:^SS/*V;]C;=V[:V,'\&(_\ @N$7
MCC?_ (9I8;XT?'_"VT.-ZAL9_P"%?#.,XS@9ZX% '[\45^!/_#\ _P#1M3?^
M';3_ .=_1_P_ /\ T;4W_AVT_P#G?T ?OM17X$_\/P#_ -&U-_X=M/\ YW]'
M_#\ _P#1M3?^';3_ .=_0!^^U%?@3_P_ /\ T;4W_AVT_P#G?U)%_P %O3))
M''_PS6R^9+%'G_A;2''F2)'G'_" #.W=G&1G&,C.0 ?OE14<,GFQ1R8V^9&C
MXSG&]%?&<#.-V,]\5)0 4444 %%%% !1110 4C=#]#_*EI&Z'Z'^5 'Y?_'+
M_DK'C3_K_LO_ $S:;7E%>K_'+_DK'C3_ *_[+_TS:;7E% !1110 4444 %?I
MC^SY_P DC\)_36?_ $_ZI7YG5^F/[/G_ "2/PG]-9_\ 3_JE 'HWBW_D5O$G
M_8 UK_TV75?P9P?ZB#_KA#_Z*2O[S/%O_(K>)/\ L :U_P"FRZK^#.#_ %$'
M_7"'_P!%)0!+1110 4444 %3VO\ Q\VW_7S;?^E$505/:_\ 'S;?]?-M_P"E
M$5 '][%G_P >MO\ ]<(/_1,=6:K6?_'K;_\ 7"#_ -$QU9H **** "BBB@ H
MHHH *1NA^A_E2TC=#]#_ "H _+_XY?\ )6/&G_7_ &7_ *9M-KRBO5_CE_R5
MCQI_U_V7_IFTVO*XT,LD4095,LL<09SA$,CJ@=SV12VYSV4$X.* &45^+/@K
M_@J=\0K_ $S]OKXU>+O@?X(7]F3]D/2OBK'I.J>%/B_IEY\8[#Q[\(O$NI>"
M+7X;_&+P#J.F6\OA?7/C/J^FS:_X4OM&75++X?Z4;+3?$RZI-J]A>/\ 9W[+
M_P"U-XM^)FA?M$Z1^T'X&\'?"/XM?LH^,H?#?QHT3X?>,]2^(7@*/1-8^#_A
MKX[>&O%OA3Q%K>C>&]<NK2Z\ ^))+;5+#5=+MI;7Q%X?U:.UNI]/GM7A /MB
MBOQ7\#?\%7?&6N?LN?%G]JGQ'\&?@J?"5KIWP)N/@/X?^'G[4_A#QCK]_P"*
M_P!I'Q?8^$?AK\(_VG;:33;2Z_9_^(>EVFO^$OB!XZU![#5O"FF^"-8U>'3)
M[KQ#X6U.T;](/V6?BOXZ^-7P<T?Q_P#$30_A+I&OWVN^*]*AU+X"_&'2?CM\
M%_&^B:!K=QI6C_$'X9_$;2X;6XU#POXJ@@DG@TCQ%8:=XJT"]M;W3M<L895A
MW 'T17Z8_L^?\DC\)_36?_3_ *I7YG5^F/[/G_)(_"?TUG_T_P"J4 >C>+?^
M16\2?]@#6O\ TV75?P9P?ZB#_KA#_P"BDK^\SQ;_ ,BMXD_[ &M?^FRZK^#.
M#_40?]<(?_124 2T4=.M(2!U.,<'/&#UP<XQQS].: %HHR,9R,>O;\Z3<N,[
MA@]#D8/XT +4]K_Q\VW_ %\VW_I1%4%3VO\ Q\VW_7S;?^E$5 '][%G_ ,>M
MO_UP@_\ 1,=6:K6?_'K;_P#7"#_T3'5F@ HHHH **** "BBB@ I&Z'Z'^5+2
M-T/T/\J /R_^.7_)6/&G_7_9?^F;3:\J4J'0R)YD8=#)&&V&2,,"\8< E#(@
M*!P"4+;@#C!]5^.7_)6/&G_7_9?^F;3:\HH _GI\;?\ !+S]I#]H?XY_MJ:W
M\8M4^ W@2Q^*/P'^+WP4\._&KX5^'_$?AKQ%^T-#\4['PUJ/P>O_ (S_  ]T
MRQT[PO!#\ KOP7H4_C?4;2^\0^)O%7CB-;S2-1;3KBZ>3[<^ O[-O[4&@7/Q
MM\9_&"P_9[MO%_[:GQGM[[]J+P[X&\3_ !"US1OA[\"/#'[+=K^SYX4TWX,>
M)-3T+0KCQ;\2KW5M#L_$VK_\)=I.C>&=.T?Q-JVFVDUUJ>CVMS<_IU10!_.7
MX5_X(\_&J?X"_$7X6^+U_91\+:YX8_9Z_9F^ ?P@@\!:/XHN_ /QZUC]E;]H
M:]^/>A?&C]J/1KCPQHMQ8:_\5+%HOAEXKT73(O'&IZ-IFN^*]:?7]7@?3M*E
M_6?]B#X!>-O@%\//BG'\0]*^%_A'Q7\:?VC_ (P?M$:A\,/@D^H3_"#X/1_%
M"?P_':?#3X?WNI:+X:GU+3-)M_#BZSJVJP^&?#EAJ'B?7];FT_1[>U$<US]F
MT4 %?IC^SY_R2/PG]-9_]/\ JE?F=7Z8_L^?\DC\)_36?_3_ *I0!Z-XM_Y%
M;Q)_V -:_P#39=5_!G!_J(/^N$/_ **2O[S/%O\ R*WB3_L :U_Z;+JOX,X/
M]1!_UPA_]%)0!POQ63X@2?#'XA1_"CGXGOX-\0K\/@!8&0^+O[.G.BBV_M57
MTH7QN@HTUM41],343:/J"M9+.#^:OPY^(/B'Q?X1^!/P1\-?'/\ :'TC5?B!
M\;OB!X7^(>K^,[31-!^/7PEM?"/P8\1_%"Q\ ?\ "27.@36^K:3K^N6FE:_:
M>+X[+4%U+0YM9\-:3J;Z5#LMOU%\9>$="\?>$_$?@CQ/!=W'A[Q7I%WH>LQ:
M?J%UI.H&QO4"O)IVJV3QWFF:C;.L=UI^H6SB:SO8(+A0_EE&^8])_8U\$V7@
M.W\-7OQ ^+MSXXC\86_CM_C7:>-A:_%6/Q%9>&-2\ 6/]GZZ^D3:=9Z-!\.M
M5O\ P:=$_L22S>RU#4=0(_M>Y%]$ <S9?$#XX?%O]A#P'X]^'UKXBO/C9\0?
M /PVDGO/"<WAWPSKT-W=>+M$TGQ_XKT:X\0/!X:T*9O#MCXBUNUGO,:?8?;8
MIH[?R$C@7Y>^)?QA^)MA\*/ NE^$/'G[3Z^+?"P_:R@^(.BVVM^ /%'QQT7X
MB?!H:&=(USXC^)M&\*)X.\2?L]_#?5=3)\5S>&M.MK_Q-HFO>&(=/TG7;N&]
MLK7] ]0_9H^']YX2'@:QU?XA>'/"MAX,^&/@WPCH_ASQOJ.G6_P^;X0ZM/K?
M@KQ?X)\R&Z.F>.H=0DMFUWQ!>C4T\36VGV5EK5C<VR3)-R&K?L;?#'5?"^@^
M'D\4_%O1M4TK_A9,>N>/M!\?/I_Q!^(5E\9KZ#4OB_IOQ!U]M(N+;7;+XB7U
MI9W&K+;:7ID^DO9V8\,SZ,MLBD ^F/#.H_VOX9\-:O\ VEI>M'5O#?A_5&UG
M0PXT367U+1K&]DU?1!(!(NC:J\[:AI*RA94TZYMEE59 P'16O_'S;?\ 7S;?
M^E$59&D:3IN@Z3I6A:-90:;HVAZ7INB:1IULI6VT_2='L;?3=,L+=69F6"RL
M+6WMH0S,WEQ+O9FRQU[7_CYMO^OFV_\ 2B*@#^]BS_X];?\ ZX0?^B8ZLU6L
M_P#CUM_^N$'_ *)CJS0 4444 %%%% !1110 4C=#]#_*EI&Z'Z'^5 'Y?_'+
M_DK'C3_K_LO_ $S:;7E%>K_'+_DK'C3_ *_[+_TS:;7E% !1110 4444 %?I
MC^SY_P DC\)_36?_ $_ZI7YG5^F/[/G_ "2/PG]-9_\ 3_JE 'HWBW_D5O$G
M_8 UK_TV75?P9P?ZB#_KA#_Z*2O[S/%O_(K>)/\ L :U_P"FRZK^#.#_ %$'
M_7"'_P!%)0!+1110 4444 %3VO\ Q\VW_7S;?^E$505/:_\ 'S;?]?-M_P"E
M$5 '][%G_P >MO\ ]<(/_1,=6:K6?_'K;_\ 7"#_ -$QU9H **** "BBB@ H
MHHH *1NA^A_E2U^?O[37_!5#_@GQ^QQ\18?A'^TY^U9\*_@S\2+KPUI?C"#P
MAXRO]8MM7E\-:U<ZE9:5K*QV.BW\/V.]NM(U*&%C.)"]G,&C4!2P!P'QR_Y*
MQXT_Z_[+_P!,VFUY17PW\6?^"T7_  2HU_XB>*-9TK]NWX#W>GW]W9RVUQ%?
M>,7214TJPA?#)X.924ECDC8JS+N1MK,,$^=_\/B_^"7'_1\OP+_\#/&?_P Q
MM 'Z445^:_\ P^+_ ."7'_1\OP+_ / SQG_\QM'_  ^+_P""7'_1\OP+_P#
MSQG_ /,;0!^E%%?FO_P^+_X)<?\ 1\OP+_\  SQG_P#,;1_P^+_X)<?]'R_
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M+6=M\UO!*^ NZ2&*1L#) W.C' R<#.!D\<U8HH H_P!F:?\ \^-G_P" MO\
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MFV'_ #Y6G_@+;_\ QJF_V7IO_/A9?^ EM_\ &JOT4 4/[+TW_GPLO_ 2V_\
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M_P"&I]+TSQ2+3Q='X7 /N_\ LO3?^?"R_P# 2V_^-4?V7IO_ #X67_@);?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
3"BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>chart-785fc250b4225182a09.jpg
<TEXT>
begin 644 chart-785fc250b4225182a09.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #P ,@# 2(  A$! Q$!_\0
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MS6/A=9'X!_!#]J;]DKXP:3XE\,>/?V:/"W@_6/A[X'_9<L_@YX[U;QWX6L?
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M_BWXN^"U]JWP5\2_$_\ 8%^/2ZM\ OVI/AO\(?V<_P!GSQ-^R-\%/ /@/5?
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MX.?L[?'#X2^)?C5^SW^T=IWQ9\$?&GP-KOA;PUJ/AZ&?PC\=_P#A M+@T_\
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M_&3Q%^T-X \/>,-2TS7_  5X<\=V2^-] UGX<?$OXC^&/$'@#6O&6D:%)?\
MVS3K:ZNM-]/^'O\ P2A^-\^D?!B[\1?L]W%I96W[)_\ P5WT_P 6>#/CU\=?
M@_\ M#>-/"'[07[;'C;X7:WX"CU+QAX?\#^ O O]M_$"'0/&OB'Q:?AKX3E\
M!_#W5O%'B;0X?%VNV>J-JFJ '[P_#W]N;]G/XI?M9_%O]B[P5X]T/6?C=\&?
MA+\*?C-XIT6T\0>%[J.^\'_%PZM/HTOANULM=NM<UF7P]H\'A+Q!XRNDT>#2
M="T7XJ_"B\&HW2^-].K\\O#/_!8_QE=?'ZY\'>-_V)?'/A']F"X_X*!>*O\
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M7[47@KX.7GA'5/AK\*?$GC-O^"('_!07]E70;O2O$GA-K#P3^TK^U%\;=?\
MB3\*?@5X2UGQ!;VFL6W@;X9> /'.L?"+0/B L6G>%]+\+Z1<6,9T_2M9-C*
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MR2.2\CWMYI\]RTC$LYE+$DG)],H **** "BBB@ HHHH **** "BBB@ HHHH
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M.;E#(3+/(02HPI"] *X+_AI3XI_\_N@_^"&/_P"2Z /T<HK\X_\ AI3XI_\
M/[H/_@AC_P#DNC_AI3XI_P#/[H/_ ((8_P#Y+H _1RBOSC_X:4^*?_/[H/\
MX(8__DNC_AI3XI_\_N@_^"&/_P"2Z /T<HK\X_\ AI3XI_\ /[H/_@AC_P#D
MNOM3X2>)=5\8?#_0/$.MO;R:GJ U+[2]K;BU@;[-JU]:1;( \@3$,$8;#'<P
M9N-V  =_>WD&GV=U?73%+:RMI[NX=59V6"VB>>9@B LY6.-B%4%F(PH)(%?G
M,O\ P5A_8H=5<?$+Q,0ZJP/_  K+Q^,A@&!Q_8/&01QVK] ?%O\ R*WB3_L
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MB@ HHHH **** "OTQ_9\_P"21^$_IK/_ *?]4K\SJ_3']GS_ ))'X3^FL_\
MI_U2@#T;Q;_R*WB3_L :U_Z;+JOX,X/]1!_UPA_]%)7]YGBW_D5O$G_8 UK_
M --EU7\&<'^H@_ZX0_\ HI* ):*** "BBB@ J>U_X^;;_KYMO_2B*H*GM?\
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MG\+_  Y<>%8]*\(Z-X[\*/KUT^II%#]O_P#!+W3O%GB']C[QYX7^)'CWQ?\
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MZ^;;_P!*(J /[V+/_CUM_P#KA!_Z)CJS5:S_ ./6W_ZX0?\ HF.K- !1110
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ML,*M^T7\/ RPQ*P/_"3Y#+&H(/\ Q3?4$$4 ?7=%?)'_  WI^QM_T<7\//\
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M>(/@[9?L_:;"F@R?$_2_C%H?B:&ZTK2/"WC5]% /T1_LS3O^?&S_ / 2W_\
MC5']F:=_SXV?_@);_P#QJOS&?_@H'\68HM2^';?LB:S=?M3:7\0;KPK<? C2
M_CE\.[[0I/"^G_!W1_CEJ'C.#XPMI5KH >V\)^(-!\,'PO=^'+34S\2M?T'2
MWN8OA_JUM\3:_0WX7_$/P_\ %SX:_#[XJ^$OMW_"+?$OP3X5\?>&_P"U+466
MIC0?&.A6'B+25U&R$LPL]02PU&!+ZT\Z4VMVLT!D<Q[B =9_9FG?\^-G_P"
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>chart-b8cf9d04cd0f5e60a69.jpg
<TEXT>
begin 644 chart-b8cf9d04cd0f5e60a69.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #I ,@# 2(  A$! Q$!_\0
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MA:I\.].U[XC:UI=QX;UMO$FC:-%\0K;4-0LX[_P\MO:Z;,9-45KF/RZO@/\
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M#^(8+G1-6\/>+OBC^T%XB\2:A87L4EKJD^F:&]W TVC15S'[77_!1S_@I/\
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M_P =?VW_ (&_MJ_ME_!+]B'5_P!K&R\#:[^RW\5+[X:_"'7-4_9\T/Q/IO\
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M%VM\:_HO4[E5NFY0<?49H =1110 4444 %%%% !1110 4444 %%%% !1110
M4$9!!Z'@T44 ?C-\0/\ @G"WQ<_:*_X*:?#[XDZ3X@G_ &0_^"EWP&_9[U+Q
MQXM\&^*/#?A_Q7X.^.'PATS5O@YXU\.Z=:7T6L:C$?&?PMTGX1>*-%\0CPWJ
M6B0ZCX7\6:?JGD7MUIZ:C[7\0_\ @E+^R[\3/#/[=7A/Q'/\3ETO_@H9X?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5+2-T/T/\J /R^^.2H?BSXTRB$_;[+DHI/\ R!M-[D$UY/L3_GG'_P!^T_\
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MI#J&HQ6"))?RZ?82S)>7\5A')')?26<$\=E'(DETT*.K&W7\S'_!1^QU>/\
M:<B_:$^%]C\$/C/KNO\ BG_@EU-\ _BWH7[0'@\_&+]F1X_C_J7AK4/"GP_^
M&%G>7OB+QKX*_:ZA\2ZQ?'Q!X+O;;PGXC\.Z%X_D\875_'X7TR)OZ;KM8DN[
MQ(,"!+R[2 +]WR$N)5AV_P"SY07;UXQR>M $%?IC^SY_R2/PG]-9_P#3_JE?
MF=7Z8_L^?\DC\)_36?\ T_ZI0!Z-XM_Y%;Q)_P!@#6O_ $V75?P9P?ZB#_KA
M#_Z*2O[S/%O_ "*WB3_L :U_Z;+JOX,X/]1!_P!<(?\ T4E $M'?'?;O_P"
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M?C^/A[\8=(M;*:Z^'E_JMWIWP=/P.\/+>^%?"::=:)_PG&A2W%[+_98 TV8
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M5J+M;/PYX"U&/3UF\-Z1IPU#41I-I8&-=&_M'43HYL&U"],_O8  P!@#@ =
M/2BB@ K],?V?/^21^$_IK/\ Z?\ 5*_,ZOTQ_9\_Y)'X3^FL_P#I_P!4H ]&
M\6_\BMXD_P"P!K7_ *;+JOX,X/\ 40?]<(?_ $4E?WF>+?\ D5O$G_8 UK_T
MV75?P9P?ZB#_ *X0_P#HI* ):\33]GCX1I\9W^/B>$;1?B5)8I$^JB[U3[ ^
MLI:MI0\7OH']H_\ "//XR/AQCX9/B1M';5CHN83>>:[RM[910!\_>'_V5_@!
MX6L]=L/#_P .+#2[/Q'XB\*>*-1@@UKQ2XBU#P+XF'C/P=8Z,]QKLTGAOPQX
M<\5&77=+\&^'GTSPG%?W-X\FC2Q74L)Z/PE\!/A%X%\?>)?B=X3\%66C^-O%
MAU8ZMJT6HZY<VT)\0ZE%K/B4Z!H5_JEUX>\)_P#"4ZQ!;ZOXH_X1;2M''B#4
MH(KO4Q/(G/KU% !4]K_Q\VW_ %\VW_I1%4%3VO\ Q\VW_7S;?^E$5 '][%G_
M ,>MO_UP@_\ 1,=6:K6?_'K;_P#7"#_T3'5F@ HHHH **** "BBB@ I&Z'Z'
M^5+2-T/T/\J /R_^.7_)6/&G_7_9?^F;3:\HKU?XY?\ )6/&G_7_ &7_ *9M
M-KRB@ HHHH **** "OTQ_9\_Y)'X3^FL_P#I_P!4K\SJ_3']GS_DD?A/Z:S_
M .G_ %2@#T;Q;_R*WB3_ + &M?\ ILNJ_@S@_P!1!_UPA_\ 125_>9XM_P"1
M6\2?]@#6O_39=5_!G!_J(/\ KA#_ .BDH EHHHH **** "I[7_CYMO\ KYMO
M_2B*H*GM?^/FV_Z^;;_THBH _O8L_P#CUM_^N$'_ *)CJS5:S_X];?\ ZX0?
M^B8ZLT %%%% !1110 4444 %<WJWC#PKH=S]AUGQ)H&E7AA6<6NI:WI5A<F&
M0NL<HM[R\@F,3M&ZI($V,4<*Q*MCI*^(_P!H/_@FW^P7^U=X\A^)_P"TC^R3
M\"/C9\0K?P_IOA6#QC\1_A_H_B?Q!%X<T>XU"[TS14U&_C>9=.L;G5M2GMK8
M'9')>W##F0T ?.OQM\:>#9OBKXSEB\8^$'C:_L]K?\)7X=7.W2-.4G#:FK#D
M'@@'VKRS_A+_  C_ -#?X0_\*WPW_P#+6O:_^'(?_!(W_I'5^R3_ .&<\-?_
M !BC_AR'_P $C?\ I'5^R3_X9SPU_P#&* /%/^$O\(_]#?X0_P#"M\-__+6C
M_A+_  C_ -#?X0_\*WPW_P#+6O:_^'(?_!(W_I'5^R3_ .&<\-?_ !BC_AR'
M_P $C?\ I'5^R3_X9SPU_P#&* /%/^$O\(_]#?X0_P#"M\-__+6C_A+_  C_
M -#?X0_\*WPW_P#+6O:_^'(?_!(W_I'5^R3_ .&<\-?_ !BC_AR'_P $C?\
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M)&?](Z_V2O\ PSWAO_XS1_PY"_X)&?\ 2.O]DK_PSWAO_P",T ?RI_VWH?\
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K 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>chart-df5fa58deb025709a81.jpg
<TEXT>
begin 644 chart-df5fa58deb025709a81.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #1 ,@# 2(  A$! Q$!_\0
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M%%% !1110 4444 %!&00>AX-%% 'XS_$#_@G"WQ<_:+_ ."F?P_^).DZ_/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI&Z'Z'^5 $;7$",5>>%6
M'56D16'?D%@1QZTW[5;?\_$'_?Z/_P"*K\Q?CE_R5CQI_P!?]E_Z9M-KRB@#
M]D?M5M_S\0?]_H__ (JC[5;?\_$'_?Z/_P"*K\;J* /V1^U6W_/Q!_W^C_\
MBJ/M5M_S\0?]_H__ (JOQNHH _9'[5;?\_$'_?Z/_P"*J565U#(RNISAE(93
M@D'!!(.""#SU!%?C37Z8_L^?\DC\)_36?_3_ *I0![/16=J]^=+TK4]3$0G.
MGZ?>WPA+^6)39VLMP(C)M?8)/*V;]C[=V[:V,'\"(_\ @N#JKQQO_P ,W6 W
MQH^/^%KW1QO4-C/_  K[G&<9[^E ']!%%?S]?\/O]4_Z-NL/_#KW7_SOZ/\
MA]_JG_1MUA_X=>Z_^=_0!_0+17\_7_#[_5/^C;K#_P .O=?_ #OZ/^'W^J?]
M&W6'_AU[K_YW] '] M%?S]?\/O\ 5/\ HVZP_P##KW7_ ,[^I(O^"WFJ22QQ
M_P##-]@/,EBCS_PM:Z./,D2/./\ A7XSC=G&1G&,C.: /Z :*BAD\V*.7&WS
M(T?;G.-Z*^,X&<;L9P,XS@5+0 4444 %%%% !1110 4C=#]#_*EI&Z'Z'^5
M'Y?_ !R_Y*QXT_Z_[+_TS:;7E%>K_'+_ )*QXT_Z_P"R_P#3-IM>44 %%%%
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MP@_]$QU9H **** "BBB@ HHHH *1NA^A_E2TC=#]#_*@#\O_ (Y?\E8\:?\
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M'/K=U96-SXBO=/M+&_\ $L]A8S>(;K5)+.W:/W.B@ K],?V?/^21^$_IK/\
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M!:6MI96[/=7MQJ>K7L\MWJ$@C]IM?^/FV_Z^;;_THBJ"I[7_ (^;;_KYMO\
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; **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>a20q410k063020form10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cah="http://www.cardinal.com/20200630"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cah-20200630.xsd" xlink:type="simple"/>
    <context id="FD2020Q4YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="I2020Q1SD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2017Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandBuildingsAndImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandBuildingsAndImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationnetoftaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_MajorCustomersAxis_cah_GroupPurchasingOrganizationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_MajorCustomersAxis_cah_GroupPurchasingOrganizationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_MajorCustomersAxis_cah_GroupPurchasingOrganizationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="I2020Q1ASC842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-01</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="D2018Q1Jul29_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-29</startDate>
            <endDate>2017-07-29</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_cah_ContractTerminationAxis_cah_DistributorContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:ContractTerminationAxis">cah:DistributorContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="I2020Q4SD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-01</instant>
        </period>
    </context>
    <context id="I2018Q1navi_srt_OwnershipAxis_cah_NaviOwnershipInterestDivestedMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">cah:NaviOwnershipInterestDivestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-01</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:OperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="D2020Q1SD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="FI2020Q4_srt_RangeAxis_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_srt_RangeAxis_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="D2020Q1SD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cah_ASC842Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.4Notesdue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.4Notesdue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_dei_LegalEntityAxis_cah_AllegianceCorporationMember_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cah:AllegianceCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_CreditFacilityAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="D2020Q2NotesPayable_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.4Notesdue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="D2018Q4SD195notes_us-gaap_DebtInstrumentAxis_cah_OnePointNineFiveNotesdue2018Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:OnePointNineFiveNotesdue2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A1.948Notesdue2019Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A1.948Notesdue2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="I2020Q4_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-11</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_LitigationCaseAxis_cah_OpioidLitigationCuyahogaandSummitCountiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="I2020Q4_srt_LitigationCaseAxis_cah_OpioidLawsuitsStateDomain_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsStateDomain</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-11</instant>
        </period>
    </context>
    <context id="D2020Q4litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-28</startDate>
            <endDate>2020-07-28</endDate>
        </period>
    </context>
    <context id="D2020Q4litigation_us-gaap_LossContingenciesByNatureOfContingencyAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-28</startDate>
            <endDate>2020-07-28</endDate>
        </period>
    </context>
    <context id="D2020Q4litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:OtherJurisdictionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-28</startDate>
            <endDate>2020-07-28</endDate>
        </period>
    </context>
    <context id="I2020Q4_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-11</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_MajorCustomersAxis_cah_CVSHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:GownRecallAxis">cah:SterileSurgicalGownRecallMemberDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationlessCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationlessCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="D2020Q4litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:AlamedaCountyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-28</startDate>
            <endDate>2020-07-28</endDate>
        </period>
    </context>
    <context id="I2020Q4_cah_LawsuitTypeAxis_cah_ClassActionLawsuitsMember_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:LawsuitTypeAxis">cah:ClassActionLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-11</instant>
        </period>
    </context>
    <context id="FD2018Q4QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_cah_TaxMatterAxis_cah_CareFusionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_cah_TaxMatterAxis_cah_CareFusionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cah:DeferredIncomeTaxesandOtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cah:DeferredIncomeTaxesandOtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CrossCurrencyInterestRateContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CrossCurrencyInterestRateContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cah:DeferredIncomeTaxesandOtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cah:DeferredIncomeTaxesandOtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_cah_FixedRateDebtMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_cah_FixedRateDebtMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_cah_FixedRateDebtMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="D2018Q3SD_us-gaap_ShareRepurchaseProgramAxis_cah_AcceleratedsharerepurchaseplanMember_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cah:AcceleratedsharerepurchaseplanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-14</startDate>
            <endDate>2018-03-21</endDate>
        </period>
    </context>
    <context id="D2020Q4SD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:GownRecallAxis">cah:SterileSurgicalGownRecallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_AwardTypeAxis_cah_AwardsOtherThanStockOptionsMember_us-gaap_PlanNameAxis_cah_A2011LtipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cah:AwardsOtherThanStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2011LtipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_PlanNameAxis_cah_A2011LtipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2011LtipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_cah_A2011LtipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2011LtipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q2QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q2QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PricingDisputesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PricingDisputesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PricingDisputesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PriorYearRecoveriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PriorYearRecoveriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PriorYearRecoveriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="organization">
        <measure>cah:organization</measure>
    </unit>
    <unit id="StateAG">
        <measure>cah:StateAG</measure>
    </unit>
    <unit id="segment">
        <measure>cah:segment</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="plaintiff">
        <measure>cah:plaintiff</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="lawsuit">
        <measure>cah:lawsuit</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <cah:CommonStockVotingRightsVotes
      contextRef="FD2020Q4YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact-E16BB84E9B5409A316AC284315A96F7E-wk-Fact-E16BB84E9B5409A316AC284315A96F7E"
      unitRef="number">1</cah:CommonStockVotingRightsVotes>
    <cah:CommonStockVotingRightsVotes
      contextRef="FD2020Q4YTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact-A855C44F344869CFCFE7284315B95464-wk-Fact-A855C44F344869CFCFE7284315B95464"
      unitRef="number">0.2</cah:CommonStockVotingRightsVotes>
    <cah:PartnershipOwnership
      contextRef="I2020Q4SD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="2"
      id="Fact-D57577AEE0B557288649E01DDA4E0634-wk-Fact-D57577AEE0B557288649E01DDA4E0634"
      unitRef="number">1.00</cah:PartnershipOwnership>
    <cah:VestingPeriodinyearsforShares
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      id="Fact-EC6B57C071A328C01FDADE0DDE8A9B7F-wk-Fact-EC6B57C071A328C01FDADE0DDE8A9B7F">P3Y</cah:VestingPeriodinyearsforShares>
    <dei:AmendmentFlag
      contextRef="FD2020Q4YTD"
      id="Fact-7EE2EF7FA7123C4011BD06666A6472B1-wk-Fact-7EE2EF7FA7123C4011BD06666A6472B1">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="FD2020Q4YTD"
      id="Fact-BCB5B2A0B0B2546A6423284315E8066E-wk-Fact-BCB5B2A0B0B2546A6423284315E8066E">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="FD2020Q4YTD"
      id="Fact-E0801A484E81674D2B3D284315DF4E99-wk-Fact-E0801A484E81674D2B3D284315DF4E99">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="FD2020Q4YTD"
      id="Fact-BBDE103305CFAB43A4F6C4E57774E185-wk-Fact-BBDE103305CFAB43A4F6C4E57774E185">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentPeriodEndDate
      contextRef="FD2020Q4YTD"
      id="Fact-A938400B46946745F04E065AB29B0470-wk-Fact-A938400B46946745F04E065AB29B0470">2020-06-30</dei:DocumentPeriodEndDate>
    <dei:EntityCentralIndexKey
      contextRef="FD2020Q4YTD"
      id="Fact-4902167BFF66B25CE475284315EC4DC8-wk-Fact-4902167BFF66B25CE475284315EC4DC8">0000721371</dei:EntityCentralIndexKey>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="Fact-F18397E4069F55E1BEF2EEFDF5A8B289-wk-Fact-F18397E4069F55E1BEF2EEFDF5A8B289"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="-6"
      id="Fact-923370A2DAB955AAA46D2151A66718A7-wk-Fact-923370A2DAB955AAA46D2151A66718A7"
      unitRef="shares">755000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2019Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact-0B88AD1EAE196AB9C5E8284315A83CB2-wk-Fact-0B88AD1EAE196AB9C5E8284315A83CB2"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2019Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact-613CDB2BC19AC5C1DC9E284315B80C94-wk-Fact-613CDB2BC19AC5C1DC9E284315B80C94"
      unitRef="shares">5000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2020Q4"
      decimals="-6"
      id="Fact-A929D6785E3357D7A73F02688B24F63B-wk-Fact-A929D6785E3357D7A73F02688B24F63B"
      unitRef="shares">755000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q4"
      decimals="-6"
      id="Fact-94AC3654F08A5D1395867A7025586BC3-wk-Fact-94AC3654F08A5D1395867A7025586BC3"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2020Q4"
      decimals="-6"
      id="Fact-755B5B1B02805DBDBBF7A82ADC0764CE-wk-Fact-755B5B1B02805DBDBBF7A82ADC0764CE"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="I2020Q4SD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="2"
      id="Fact-58F11AAB82755B2B98FC98B0C750D192-wk-Fact-58F11AAB82755B2B98FC98B0C750D192"
      unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="FI2020Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="Fact-5E16D6E38F505F259D6167F261D4237A-wk-Fact-5E16D6E38F505F259D6167F261D4237A"
      unitRef="usd">334000000</us-gaap:EquityMethodInvestments>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="Fact-F492BCA4EE4466E938C9284316123E25-wk-Fact-F492BCA4EE4466E938C9284316123E25"
      unitRef="usd">1372000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="Fact-551AAB9C4149EBBA523B28431612E654-wk-Fact-551AAB9C4149EBBA523B28431612E654"
      unitRef="usd">829000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="I2018Q1navi_srt_OwnershipAxis_cah_NaviOwnershipInterestDivestedMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="2"
      id="Fact-6CB2767ACECD5E8383E5836002164E4A-wk-Fact-6CB2767ACECD5E8383E5836002164E4A"
      unitRef="number">0.98</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:NumberOfReportableSegments
      contextRef="FD2020Q4YTD"
      decimals="INF"
      id="Fact-247C9A6E30A55B969DA5C7DEFE0A5EE8-wk-Fact-247C9A6E30A55B969DA5C7DEFE0A5EE8"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="Fact-FDA3DCA53B1C9B7DF9F32843161A0750-wk-Fact-FDA3DCA53B1C9B7DF9F32843161A0750"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="Fact-62B4A22191FD5FD4276E2843161F9A82-wk-Fact-62B4A22191FD5FD4276E2843161F9A82"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="FI2019Q4"
      decimals="2"
      id="Fact-C8F54D5AD49941E92E4C28431461C297-wk-Fact-C8F54D5AD49941E92E4C28431461C297"
      unitRef="number">0.56</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="-3"
      id="Fact-889A095E4386594B95B682205A9D5F31-wk-Fact-889A095E4386594B95B682205A9D5F31"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-FD29AD63C7261C32064A284315A95422-wk-Fact-FD29AD63C7261C32064A284315A95422"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2020Q4"
      decimals="-3"
      id="Fact-68C363828CF150ACB6FC5DAC7F200062-wk-Fact-68C363828CF150ACB6FC5DAC7F200062"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="FI2019Q4"
      decimals="-3"
      id="Fact-051CC501FFCC591AB826396AA2B50926-wk-Fact-051CC501FFCC591AB826396AA2B50926"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="FI2020Q4"
      decimals="-3"
      id="Fact-623A5B55184A51C9A922D15DA7A3C6D9-wk-Fact-623A5B55184A51C9A922D15DA7A3C6D9"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:TreasuryStockShares
      contextRef="FI2019Q4"
      decimals="-6"
      id="Fact-BFB8891058D35031A6577D8BE6205F1E-wk-Fact-BFB8891058D35031A6577D8BE6205F1E"
      unitRef="shares">28000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="FI2020Q4"
      decimals="-6"
      id="Fact-94416892BB7D5C43997E6DC34F8EE5E3-wk-Fact-94416892BB7D5C43997E6DC34F8EE5E3"
      unitRef="shares">34000000</us-gaap:TreasuryStockShares>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PriorYearRecoveriesMember"
      decimals="-6"
      id="Fact-A3B3C9E4A6044F48E26C28431636DDBB-wk-Fact-A3B3C9E4A6044F48E26C28431636DDBB"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PriorYearRecoveriesMember"
      decimals="-6"
      id="Fact-1C2AF9222CEF875281FA28431639098D-wk-Fact-1C2AF9222CEF875281FA28431639098D"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock
      contextRef="FD2020Q4YTD"
      id="Fact-2255A746672A5E2ED7AA2843161E6140-wk-Fact-2255A746672A5E2ED7AA2843161E6140">&amp;lt;div style="font-family:Times New Roman;font-size:10pt;"&amp;gt;&amp;lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&amp;gt;. Investments&amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&amp;gt; &amp;lt;/font&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;In August 2018, we sold our &amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;98 percent&amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt; equity interest in naviHealth Holdings, LLC ("naviHealth") to investor entities controlled by Clayton, Dubilier &amp;amp;amp; Rice in exchange for cash proceeds of &amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;$737 million&amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt; (after adjusting for certain fees and expenses) and a &amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;40 percent&amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt; equity interest in a partnership that owns &amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;100 percent&amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt; of the equity interest of naviHealth. We also have certain call rights to reacquire naviHealth. We have accounted for this investment using the equity method of accounting and on a one-month reporting lag.&amp;lt;/font&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;During the fiscal year ended &amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;June&amp;amp;#160;30, 2019&amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;, we recognized a pre-tax gain of &amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;$508 million&amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt; related to this divestiture in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings/(loss). The carrying value of this investment was &amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;$334 million&amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt; as of &amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;June&amp;amp;#160;30, 2019&amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;. &amp;lt;/font&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;In May 2020, we sold our &amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;40 percent&amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt; equity interest in a partnership that owns &amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;100 percent&amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt; of the equity interest of naviHealth in exchange for cash proceeds of [] and recognized a gain of [] related to this disposal in gain on sale of naviHealth stock in our consolidated statements of earnings/(loss). During the three and twelve months ended &amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;June&amp;amp;#160;30, 2020&amp;lt;/font&amp;gt;&amp;lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&amp;gt;, our proportionate share of naviHealth&amp;amp;#8217;s net loss, which was recorded in other (income)/ expense, net in the consolidated statements of earnings/(loss), was immaterial.&amp;lt;/font&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock>
    <dei:DocumentType
      contextRef="FD2020Q4YTD"
      id="d9981211e2870-wk-Fact-CA2D1368291A72B449227FD1467351AF">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="FD2020Q4YTD"
      id="d9981211e2888-wk-Fact-8F565ED69BB77AAECC1B064BDDADCAFF">true</dei:DocumentAnnualReport>
    <dei:DocumentTransitionReport
      contextRef="FD2020Q4YTD"
      id="d9981211e2918-wk-Fact-FF106948A018E3CD920F064C8668447C">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="FD2020Q4YTD"
      id="d9981211e2931-wk-Fact-DE9E0385798492D3CA467FD288FE29FF">1-11373</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="FD2020Q4YTD"
      id="d9981211e2940-wk-Fact-F80AF30E4312879AC61B7FD3132110BA">Cardinal Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="FD2020Q4YTD"
      id="d9981211e2966-wk-Fact-EF5C342B9A2713FF61DD7FDC9490F16F">OH</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="FD2020Q4YTD"
      id="d9981211e2996-wk-Fact-9AF59B375EE653BD2E5D7FD661C8113B">31-0958666</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="FD2020Q4YTD"
      id="d9981211e3080-wk-Fact-1163E62A356F1F0A341C7FDE834470F3">7000 Cardinal Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="FD2020Q4YTD"
      id="d9981211e3090-wk-Fact-4F94A0EF44F975EA22597FDEC904EF04">Dublin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="FD2020Q4YTD"
      id="d9981211e3100-wk-Fact-67D42E580C70383EFC557FDF004C04CB">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="FD2020Q4YTD"
      id="d9981211e3110-wk-Fact-F6365580954346C7A6D67FDF3041895B">43017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="FD2020Q4YTD"
      id="d9981211e3207-wk-Fact-A10DA0CD4423AAA8DF977FDB85101EF0">(614)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="FD2020Q4YTD"
      id="d9981211e3217-wk-Fact-3F1E29A6893892E4B8AEA49604D23502">757-5000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="FD2020Q4YTD"
      id="d9981211e3316-wk-Fact-520761B804068BADE292A499955F3D6D">Common shares (without par value)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="FD2020Q4YTD"
      id="d9981211e3321-wk-Fact-43A52AEA7A23A86DC61DA499F4CDA4FC">CAH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="FD2020Q4YTD"
      id="d9981211e3326-wk-Fact-1C36B619C4B6F98B0BD3A49A45B97A72">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="FD2020Q4YTD"
      id="d9981211e3362-wk-Fact-2719EDFE4A379D2FB8CE800B81FED78F">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="FD2020Q4YTD"
      id="d9981211e3386-wk-Fact-A1D37D04611C3CC6DBDB800C5CD2714F">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="FD2020Q4YTD"
      id="d9981211e3396-wk-Fact-65E8A801B81091B28BC58002C357DBB8">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="FD2020Q4YTD"
      id="d9981211e3410-wk-Fact-7588CB319FE31124F557800FA6A919E9">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="FD2020Q4YTD"
      id="d9981211e3443-wk-Fact-11300E29CB57C25158107FE4EA0F4821">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="FD2020Q4YTD"
      id="d9981211e3494-wk-Fact-AD48C20809F942643BAF06518361E584">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="FD2020Q4YTD"
      id="d9981211e3524-wk-Fact-6DD83768D72B9BB3AAFB0651920A00FD">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="FD2020Q4YTD"
      id="d9981211e3603-wk-Fact-6B3AB834130D5741C1AF0777BC1D4748">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="FI2020Q2"
      decimals="0"
      id="d9981211e3626-wk-Fact-CE177E8A0E6F9C57635A284315E9690F"
      unitRef="usd">14729138108</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="I2020Q1SD"
      decimals="0"
      id="d9981211e3638-wk-Fact-37EB97E6A91357D6BA639A8F32AC563F"
      unitRef="shares">292444079</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-C968C0D54306DDF7B5360779C076D018-0-wk-Fact-BA8D36D66A1DE0F3E253077B23720715">&lt;div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:9pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;"&gt;Documents Incorporated by Reference: &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:9pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:9pt;"&gt;Portions of the registrant&#x2019;s Definitive Proxy Statement to be filed for its &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:9pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:9pt;"&gt; Annual Meeting of Shareholders are incorporated by reference into the sections of this Form 10-K addressing the requirements of Part&#160;III of Form&#160;10-K.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e2945-wk-Fact-EC673078FA4FB89EE7BA2843162A4DFB"
      unitRef="usd">152922000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e2964-wk-Fact-BD3D8FD103E378282798284316187DCD"
      unitRef="usd">145534000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e2983-wk-Fact-DB142B6DA98C5A50ADCB2843162D4777"
      unitRef="usd">136809000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e2999-wk-Fact-08D8FAD9B3F5C3D052732843162D2B32"
      unitRef="usd">146054000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3018-wk-Fact-FB042132871FCB3D9C1E28431619AA15"
      unitRef="usd">138700000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3037-wk-Fact-938179D878F2BDCAB52E2843162143E0"
      unitRef="usd">129628000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e3058-wk-Fact-7702ECF6E01FE01E12C72843162E9BF9"
      unitRef="usd">6868000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3077-wk-Fact-7A3ED88AB6960E25F46428431625A4F6"
      unitRef="usd">6834000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3096-wk-Fact-4C9A9B4C81AF004FC3DA284316183FAB"
      unitRef="usd">7181000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e3241-wk-Fact-8AB5B3C56F6B6AF3ABA72843161BFCAD"
      unitRef="usd">4572000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3260-wk-Fact-BD206D2DED90DE4C83362843162529EE"
      unitRef="usd">4480000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3279-wk-Fact-A490E01F9D9CAAD7D1FD284316409849"
      unitRef="usd">4596000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:RestructuringCharges
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e3300-wk-Fact-B1C11A87F92A34B823FC2843162C8B54"
      unitRef="usd">122000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3319-wk-Fact-3F8673AEAFD4719F9AD028431460FC93"
      unitRef="usd">125000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3338-wk-Fact-138BB9B6057862937C5C2843145D0C42"
      unitRef="usd">176000000</us-gaap:RestructuringCharges>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e3359-wk-Fact-AAAFD56F8BBBC5A01AF9284316438C07"
      unitRef="usd">524000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3378-wk-Fact-B29D1409AC87B910C1CC2843161DD8F4"
      unitRef="usd">621000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3397-wk-Fact-10BD70A944A8FF63ED792843161DD9A1"
      unitRef="usd">707000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e3418-wk-Fact-81DD573C26D385689CC62843162E7B18"
      unitRef="usd">-7000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3437-wk-Fact-7F41BBDEA2F421FA4BBB2843162FC07D"
      unitRef="usd">488000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3457-wk-Fact-6306BF99352252989396284316404B2E"
      unitRef="usd">-1417000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e3478-wk-Fact-3C0DFB838F3D17105D392843162D2A0E"
      unitRef="usd">-5741000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3497-wk-Fact-076617D8C843032BCAA828431620ECB6"
      unitRef="usd">-36000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3516-wk-Fact-4BC6C845B993548189E6284316426089"
      unitRef="usd">-159000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e3538-wk-Fact-A7B59A36E5F72A058365284316403890"
      unitRef="usd">-4098000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3558-wk-Fact-F255B30F4DA9D01D31CE2843162EC039"
      unitRef="usd">2060000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3577-wk-Fact-7CFC054F72252BD96EDA2843162CDB72"
      unitRef="usd">126000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e3660-wk-Fact-A4380AD6A9E884B496312843161E59F8"
      unitRef="usd">1000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3680-wk-Fact-40A961CF50FB552837DF28431629E64D"
      unitRef="usd">-15000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3699-wk-Fact-DD444C85DE5746491EF52843162A2860"
      unitRef="usd">-23000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e3720-wk-Fact-84F1F9CB5E981909167F28431620F264"
      unitRef="usd">238000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3739-wk-Fact-33EFFE55AA531DFAB8B32843162FAB66"
      unitRef="usd">294000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3758-wk-Fact-38B78A53A6BA2DFBA47B284316270872"
      unitRef="usd">329000000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e3779-wk-Fact-04EBBE90C0E8A84B4F0D284316412812"
      unitRef="usd">-16000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3798-wk-Fact-E27CFF974E808DDEC6EE284316279CA1"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3817-wk-Fact-9A932B4A1F36871979202843161AD9CD"
      unitRef="usd">-2000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e3840-wk-Fact-89E3224004987E7C3321A58ABB8E4B0F"
      unitRef="usd">579000000</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3860-wk-Fact-26DBFAAC3970F2B06B92E2EE19D9C158"
      unitRef="usd">0</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3879-wk-Fact-0315A7D6D42179F39666E2EE6489D3CB"
      unitRef="usd">0</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e3900-wk-Fact-8029B570251D776CB89B2843162B2728"
      unitRef="usd">-3772000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e3920-wk-Fact-5027B60DD37A44F7AA932843161E0815"
      unitRef="usd">1751000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e3939-wk-Fact-867F273B7C9665AD5CF328431621C9DA"
      unitRef="usd">-228000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e4023-wk-Fact-1F76A9CA55BDEBE5013228431626E45F"
      unitRef="usd">-79000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e4043-wk-Fact-32C8EE70D1FD77AC3B30284316197236"
      unitRef="usd">386000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e4062-wk-Fact-55DB262DD0862713240F2843161FBB12"
      unitRef="usd">-487000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e4084-wk-Fact-9AE3E593FCE6335F39752843162378C6"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e4104-wk-Fact-DA8A9DB84161C8826F8428431624E0AF"
      unitRef="usd">1365000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e4123-wk-Fact-CB17DEC5A4D0E06152A128431645C61E"
      unitRef="usd">259000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e4207-wk-Fact-59D860CFE7EAD17DA86F284314604AB7"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e4227-wk-Fact-40DF87BBE9A82CD4A06E2843164157A9"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e4247-wk-Fact-2FA51944D462B903C3502843161C2311"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e4274-wk-Fact-D376E4CF10C84B75E68E2843162F9636"
      unitRef="usd">-3696000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e4294-wk-Fact-A6793123A202F02F7DDF2843161A0AE7"
      unitRef="usd">1363000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e4313-wk-Fact-278090E7B9D1E914F887284316449146"
      unitRef="usd">256000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2020Q4YTD"
      decimals="2"
      id="d10058038e4458-wk-Fact-AA245B061237350EEC15284316290C1D"
      unitRef="usdPerShare">-12.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d10058038e4478-wk-Fact-2F9983D6B6AF648F50342843162BDF25"
      unitRef="usdPerShare">4.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d10058038e4497-wk-Fact-94E9FF2EC52DA96189682843145D91AD"
      unitRef="usdPerShare">0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2020Q4YTD"
      decimals="2"
      id="d10058038e4513-wk-Fact-DA6F10378D87161DA776284316273F14"
      unitRef="usdPerShare">-12.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d10058038e4533-wk-Fact-EAD48A09FC8087EFCA5D284316228D5C"
      unitRef="usdPerShare">4.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d10058038e4552-wk-Fact-0A9184B91DD77CD592422843162338C6"
      unitRef="usdPerShare">0.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e4697-wk-Fact-43211921D8B5D431B24928431628CAD3"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e4716-wk-Fact-F05B0CAA787082C1A64D28431622E9C2"
      unitRef="shares">300000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e4735-wk-Fact-4251EE951E11F5191C4528431624F81D"
      unitRef="shares">313000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10058038e4756-wk-Fact-8196072F7E42FDFF1191284314623FA4"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10058038e4775-wk-Fact-3EE9D56C6B63748AD0EF2843161B9246"
      unitRef="shares">301000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10058038e4794-wk-Fact-45955312A229A57570A7284316286CCF"
      unitRef="shares">315000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10060662e2943-wk-Fact-9AE3E593FCE6335F39752843162378C6"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10060662e2963-wk-Fact-DA8A9DB84161C8826F8428431624E0AF"
      unitRef="usd">1365000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10060662e2982-wk-Fact-CB17DEC5A4D0E06152A128431645C61E"
      unitRef="usd">259000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10060662e3122-wk-Fact-5316A4A73620A5AF7ECF284315D3DD68"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10060662e3141-wk-Fact-3A39C2DF5EB81751D1CC284315D4046B"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10060662e3160-wk-Fact-2D414D3CEDB2E79177EC284315C441FF"
      unitRef="usd">58000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10060662e3181-wk-Fact-85030439EC03F1534084284315CC5288"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10060662e3200-wk-Fact-E4296D3CF67F6722D94C284315CBF28C"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10060662e3219-wk-Fact-B04AA3DD5566649C483F284315CD4212"
      unitRef="usd">23000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10060662e3241-wk-Fact-54A1F40EDCA3AF5248D4284315CEC5A8"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10060662e3261-wk-Fact-AB1C3AE31F896456B19D284315C76F27"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10060662e3281-wk-Fact-A879646321F72E27A773284315D0C796"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10060662e3303-wk-Fact-A6397626AEF8DA99ACC7284315D1A7E0"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10060662e3323-wk-Fact-25A84D589EE05D58C780284315C6C941"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10060662e3342-wk-Fact-9B6DDE0F0577529DB145284315CB02AF"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10060662e3425-wk-Fact-7121B1BE87B991F317A7284315CCBB0C"
      unitRef="usd">-3718000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10060662e3445-wk-Fact-FDF73F682E589F2446E4284315CD974C"
      unitRef="usd">1378000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10060662e3464-wk-Fact-6946D48C42759534E9DC284315CB8981"
      unitRef="usd">292000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10060662e3548-wk-Fact-59D860CFE7EAD17DA86F284314604AB7"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10060662e3568-wk-Fact-40DF87BBE9A82CD4A06E2843164157A9"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10060662e3588-wk-Fact-2FA51944D462B903C3502843161C2311"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10060662e3615-wk-Fact-2DEA4357B65473DD265A284315CF337B"
      unitRef="usd">-3721000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10060662e3635-wk-Fact-B198A5E9EAA82361E700284315C925CD"
      unitRef="usd">1376000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10060662e3654-wk-Fact-4F3901E30A3C4968CCD8284315C4684A"
      unitRef="usd">289000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3039-wk-Fact-9A4D6F4B89355C9FAAA69392AD203FAB"
      unitRef="usd">2771000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3058-wk-Fact-97315FFE5C1057E198DE11BA3705027F"
      unitRef="usd">2531000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3073-wk-Fact-E1B36F938B8E51A8838E512551CAF5CA"
      unitRef="usd">8264000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3092-wk-Fact-40FF9FC6A63B586482E86B0955C58DAC"
      unitRef="usd">8448000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3112-wk-Fact-0774C5FC68CB52D4A0A2F3FB9811F7AC"
      unitRef="usd">13198000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3131-wk-Fact-FB3483C9F0A65999AA748E5902724A82"
      unitRef="usd">12822000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3151-wk-Fact-71B7A2799AF850CC9451EC25C1581E45"
      unitRef="usd">1707000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3170-wk-Fact-849FE785EBB55F7481A0567941258C90"
      unitRef="usd">1946000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3190-wk-Fact-FE16BD49BBCC5B57B33DFB2B786F7B13"
      unitRef="usd">25940000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3209-wk-Fact-2389389C28A15477ADDF98E434B9029C"
      unitRef="usd">25747000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3270-wk-Fact-022AFBD3623650148594C8C3580F78AF"
      unitRef="usd">2366000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3289-wk-Fact-65BAC2AADAAF5CD58F3560A3DA72CCD6"
      unitRef="usd">2356000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3310-wk-Fact-FAEE6BDABBFD57E9AC5917B6BC97FF27"
      unitRef="usd">11275000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3329-wk-Fact-572710A9966E5A7692E1FB9328CFF598"
      unitRef="usd">11808000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3349-wk-Fact-D25985F5AC10538786292CAF43C7D242"
      unitRef="usd">1185000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3368-wk-Fact-7A22140B18905DF0927FE02E33E1FAC1"
      unitRef="usd">1052000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3393-wk-Fact-0D1C1049F30C5252BA4FAD5427DE72B3"
      unitRef="usd">40766000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3412-wk-Fact-45315210045352E49355E81E393FAF22"
      unitRef="usd">40963000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3555-wk-Fact-76945333943153788398655228951E9B"
      unitRef="usd">21374000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3574-wk-Fact-604A1E19365D5FDFA607BE920789BA99"
      unitRef="usd">21535000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3589-wk-Fact-AEE6885C79795EC8BD6D2D94473CEAC3"
      unitRef="usd">10000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3608-wk-Fact-65E8671C68655ED487958DD7FF10BC0C"
      unitRef="usd">452000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3628-wk-Fact-5E727B9213B95603B761A4CB95A7537E"
      unitRef="usd">2231000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3647-wk-Fact-C7552CB5C5B255C3847147086BBC9F25"
      unitRef="usd">2122000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3667-wk-Fact-9A4F183F036E5452B4A40486E478ED8C"
      unitRef="usd">23615000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3686-wk-Fact-9FD3D1F2A7265466A86AF5C8D35F059B"
      unitRef="usd">24109000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3748-wk-Fact-1AC0DDF0A60D5B1AA8B9E0BB56255504"
      unitRef="usd">6765000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3767-wk-Fact-19FEF4F9B77450E896FB33A6F288C5A4"
      unitRef="usd">7579000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3787-wk-Fact-883A6A6F96ED510087CC37F98F3E57BD"
      unitRef="usd">8594000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3806-wk-Fact-A52DF61150E95F73832F36AC1129ED3C"
      unitRef="usd">2945000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:PreferredStockValue
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e3955-wk-Fact-9FD0126AA2EF554EA618B33C7C2E0FC0"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e3974-wk-Fact-C47A359CEEFC5C3EBB25B3A59D934879"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e4047-wk-Fact-D65F4D5D73615E618749D976EF4D4B7A"
      unitRef="usd">2789000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e4066-wk-Fact-2CCA681560405AB6B3E953CEB62780D4"
      unitRef="usd">2763000000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e4086-wk-Fact-B6B8CFAB9013559F936ECDA4294C99ED"
      unitRef="usd">1170000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e4105-wk-Fact-C04CBA9C6747500E83BDC09CEB5A099D"
      unitRef="usd">5434000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e4133-wk-Fact-68FCC0F9C85255D8821CC559BCC642CE"
      unitRef="usd">2066000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e4153-wk-Fact-9708B384A9A7572EB8E763C902F377DF"
      unitRef="usd">1790000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e4174-wk-Fact-7FFCFB000E8859C6A73419BF99BFA506"
      unitRef="usd">-104000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e4194-wk-Fact-8895C7DD90EF54278F4E9A7F73C5D3AA"
      unitRef="usd">-79000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e4216-wk-Fact-D6763D183153576D9EDE85F64E34DB3A"
      unitRef="usd">1789000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e4235-wk-Fact-9C18192299EC589EA09EB952F3A0B10D"
      unitRef="usd">6328000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e4255-wk-Fact-F8D041B04DEA55D58F83B33CA5318C35"
      unitRef="usd">3000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e4274-wk-Fact-658886C5E1F9554CA0F6FCC484DDEDCE"
      unitRef="usd">2000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e4294-wk-Fact-EE27D00AF623506B8D26814FF00D04C0"
      unitRef="usd">1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e4313-wk-Fact-88F8D7D7B8D15C6F9DF0260592476564"
      unitRef="usd">6330000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10065441e4338-wk-Fact-2C7A02EA1BEF5C059EA78A827965BFD6"
      unitRef="usd">40766000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10065441e4357-wk-Fact-F734184A7A235162B1FC16685EB03445"
      unitRef="usd">40963000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d10072770e3200-wk-Fact-E64CD996901E80E3033C2843148CDF69"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d10072770e3219-wk-Fact-EEF0D2681C1188CD3DC128431598EBE3"
      unitRef="usd">2697000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d10072770e3238-wk-Fact-3A445377EED55020ACE12843159D415E"
      unitRef="usd">4967000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e3253-wk-Fact-74853BF3418DBF0E562D284314764576"
      unitRef="shares">11000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e3273-wk-Fact-E6E2D01694BAA965335E28431470C2A6"
      unitRef="usd">731000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10072770e3293-wk-Fact-9B135615A0EB75B1EE512843159B846A"
      unitRef="usd">-125000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d10072770e3314-wk-Fact-12ECD40C5D2A080F219F284314890DBE"
      unitRef="usd">20000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2017Q4"
      decimals="-6"
      id="d10072770e3333-wk-Fact-58BE4933D46E97F28F6028431483A379"
      unitRef="usd">6828000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d10072770e3383-wk-Fact-E0208F68272ACC5F53622843148195B9"
      unitRef="usd">256000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d10072770e3459-wk-Fact-0E88BEFAEB209943633828431597DFA3"
      unitRef="usd">-1000000</us-gaap:ProfitLoss>
    <cah:NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10072770e3479-wk-Fact-21B6DB1FAC42C4E72E5A28431489147A"
      unitRef="usd">255000000</cah:NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10072770e3590-wk-Fact-A274C204689E9F9A0A872843146CA0F2"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10072770e3630-wk-Fact-12249A8F821549C30BD6284315961B3C"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d10072770e3762-wk-Fact-2DC758A05D1AAE5A148E28431484957F"
      unitRef="usd">19000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10072770e3782-wk-Fact-CC6909D8B3252EDD177A2843147897EB"
      unitRef="usd">19000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d10072770e3817-wk-Fact-6D466FC9259178EBE5EB2843146B4C0B"
      unitRef="usd">33000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e3857-wk-Fact-75A5AAF374A73D779E1128431474D10E"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e3871-wk-Fact-EA455C917E5AD8A31C6D2843147A759A"
      unitRef="usd">57000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10072770e3931-wk-Fact-EF7C121786857F74FD5628431477F529"
      unitRef="usd">90000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e4007-wk-Fact-9771E1CF2C5E612D2FEB28431482AAEA"
      unitRef="shares">8000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e4022-wk-Fact-C268C3032B53ABAFA8A428431599DDFC"
      unitRef="usd">550000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10072770e4083-wk-Fact-36F7F96137A9E46A0CB82843146DFDA5"
      unitRef="usd">550000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:Dividends
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d10072770e4139-wk-Fact-3748AA0E5E4DDE1D27682843146ED7BE"
      unitRef="usd">584000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10072770e4236-wk-Fact-760830E9A75D54047DBB2843148337DE"
      unitRef="usd">584000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d10072770e4292-wk-Fact-9266E704C691615915002843147D6048"
      unitRef="usd">-6000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d10072770e4368-wk-Fact-B3E6841820718F4D6B44284315A16006"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10072770e4387-wk-Fact-5E48569B3317A503A5612843159A6AA3"
      unitRef="usd">-6000000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d10072770e4407-wk-Fact-9A053AD09EA150119F5F7E802DD4D24A"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d10072770e4421-wk-Fact-5EB3015CA2EA5420B5CBB80767459469"
      unitRef="usd">2730000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d10072770e4440-wk-Fact-081F05C09EC25B78B48D8F5ABC9DAEA5"
      unitRef="usd">4645000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e4460-wk-Fact-BCB2B42D9765580C9596E554363B4C9A"
      unitRef="shares">18000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e4475-wk-Fact-56B19E5DA22F5A748539ED433809907D"
      unitRef="usd">1224000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10072770e4495-wk-Fact-D8E8AFD70315541DAB84B9798AABD625"
      unitRef="usd">-92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d10072770e4516-wk-Fact-97CFACFE7E7D5765A17ECB779F5EEC79"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10072770e4535-wk-Fact-9C91F74A71C3576D9AB14EF164472262"
      unitRef="usd">6059000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10072770e4591-wk-Fact-A6793123A202F02F7DDF2843161A0AE7"
      unitRef="usd">1363000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d10072770e4667-wk-Fact-8E9EEC27995A58BF9A8A91F7E1D73525"
      unitRef="usd">2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10072770e4686-wk-Fact-DA8A9DB84161C8826F8428431624E0AF"
      unitRef="usd">1365000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10072770e4797-wk-Fact-5098069C0A2452C487D09C0036D8B533"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10072770e4837-wk-Fact-EDC2EA4378D0553CAA139A21A4864150"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d10072770e4871-wk-Fact-22AFC1E0274F5427BFF810D80D2E8C88"
      unitRef="usd">33000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e4911-wk-Fact-D714E9EBF54C5A02A5172DD56A90CEB7"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e4925-wk-Fact-D8993BC3552F5B77A402E353B8D05265"
      unitRef="usd">34000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10072770e4985-wk-Fact-EBFED96D21A052B99CC122087818E248"
      unitRef="usd">67000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e5063-wk-Fact-DDD310F7665D5FBE90DAA36019186D6C"
      unitRef="shares">11000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e5078-wk-Fact-2760FFF59B935E778B43CBEDECAED277"
      unitRef="usd">600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10072770e5139-wk-Fact-6C4833ABCB64549088514B473B3B623B"
      unitRef="usd">600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:Dividends
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d10072770e5195-wk-Fact-39663EF132EF55F384BE6E987102ABBD"
      unitRef="usd">575000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10072770e5292-wk-Fact-BEFD301F710B59AF88490E9722414D9A"
      unitRef="usd">575000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d10072770e5348-wk-Fact-D8120BE8C13A57D99E9154065C9B6DA2"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10072770e5443-wk-Fact-429B34B7595C5A23A5D7D8BF7568AFAC"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d10072770e5463-wk-Fact-567C4336224A5237A1BBEA2E9CBFDAAE"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d10072770e5477-wk-Fact-0346FC711B445AD68D95EB0049AA6CF3"
      unitRef="usd">2763000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d10072770e5496-wk-Fact-AD803AC849C1593199D80B6BD6D0E100"
      unitRef="usd">5434000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e5516-wk-Fact-A92D2B68D2DC5A27BBFA377C2DF1D80A"
      unitRef="shares">28000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e5531-wk-Fact-CAD332DD03BC525FA0EC561ABAF7FC61"
      unitRef="usd">1790000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10072770e5551-wk-Fact-53FE35BCC48B59D8B4B22A283001343A"
      unitRef="usd">-79000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d10072770e5572-wk-Fact-75D677F3CF515C73B370A96683F6A9AC"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10072770e5591-wk-Fact-88F8D7D7B8D15C6F9DF0260592476564"
      unitRef="usd">6330000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10072770e5646-wk-Fact-D376E4CF10C84B75E68E2843162F9636"
      unitRef="usd">-3696000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d10072770e5723-wk-Fact-F4165ED7FD5857A48D79CE61364FFB17"
      unitRef="usd">3000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10072770e5742-wk-Fact-9AE3E593FCE6335F39752843162378C6"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10072770e5854-wk-Fact-FD89153856515D78A20181F5156EF4E8"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10072770e5895-wk-Fact-6FBCCE1C5FCA57F1BF127506005DDA77"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d10072770e5930-wk-Fact-7D98484CF591519996174147BB57824B"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e5970-wk-Fact-58AC83CF8F42518C853CC139AA6824EB"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e5984-wk-Fact-1FB46825630E5CCEAD5B32356133151D"
      unitRef="usd">74000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10072770e6044-wk-Fact-80EC858E39D250ADBB26172E4029FC22"
      unitRef="usd">100000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e6122-wk-Fact-D840DE3AEA4A533CB5D84C740417EC22"
      unitRef="shares">7000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e6137-wk-Fact-B56DFE89D6255492B027056E16831EE2"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10072770e6198-wk-Fact-0FFD88740F0A5843A18003D7D25D0B9D"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:Dividends
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d10072770e6255-wk-Fact-65AF2ACE299F510B9378E06634316BFD"
      unitRef="usd">570000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10072770e6352-wk-Fact-117688CB52E85103BCD2A4701D673ADC"
      unitRef="usd">570000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d10072770e6408-wk-Fact-E5F62C13DDB957DB835AF247E64BB446"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d10072770e6484-wk-Fact-8B2AF363073B58B4B39F8ED07050EA13"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10072770e6504-wk-Fact-CEDBB8E5DDE354DFA0894AF5E4E228DE"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d10072770e6524-wk-Fact-6A5599DCEFD655C3B7B90E7F5B486288"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d10072770e6543-wk-Fact-6B21B74568FA5E188A38A7498A800A13"
      unitRef="usd">2789000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d10072770e6562-wk-Fact-437ADE4D67FC53579D3FC0C3362B033E"
      unitRef="usd">1170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e6577-wk-Fact-86C13BA5B0B75AFDA6E220A4DFA83944"
      unitRef="shares">35000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10072770e6597-wk-Fact-F2B4418B5F725907B478D74139E8B580"
      unitRef="usd">2066000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10072770e6617-wk-Fact-1179AEBAD93252BAA89002DD34E515A8"
      unitRef="usd">-104000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d10072770e6638-wk-Fact-675835789CE35BBB880D42BFDE0318B3"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10072770e6657-wk-Fact-EE27D00AF623506B8D26814FF00D04C0"
      unitRef="usd">1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3015-wk-Fact-9AE3E593FCE6335F39752843162378C6"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3040-wk-Fact-DA8A9DB84161C8826F8428431624E0AF"
      unitRef="usd">1365000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3060-wk-Fact-CB17DEC5A4D0E06152A128431645C61E"
      unitRef="usd">259000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3142-wk-Fact-57EDF83A615A6AD362F8284314743364"
      unitRef="usd">913000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3166-wk-Fact-83DDAE6665350772F68628431483662C"
      unitRef="usd">1000000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3185-wk-Fact-025EC02EAF19C052A2972843148966C8"
      unitRef="usd">1032000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3206-wk-Fact-EC9F947B59F7626A70CF2843146B9E71"
      unitRef="usd">0</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3230-wk-Fact-9EA3BD11D620361DFA272843159E2BD2"
      unitRef="usd">3000000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3249-wk-Fact-9F1501F9157CD71B18A5284314690ED4"
      unitRef="usd">6000000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3270-wk-Fact-89E3224004987E7C3321A58ABB8E4B0F"
      unitRef="usd">579000000</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3294-wk-Fact-26DBFAAC3970F2B06B92E2EE19D9C158"
      unitRef="usd">0</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3313-wk-Fact-0315A7D6D42179F39666E2EE6489D3CB"
      unitRef="usd">0</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3334-wk-Fact-81DD573C26D385689CC62843162E7B18"
      unitRef="usd">-7000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3358-wk-Fact-7F41BBDEA2F421FA4BBB2843162FC07D"
      unitRef="usd">488000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3378-wk-Fact-6306BF99352252989396284316404B2E"
      unitRef="usd">-1417000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3399-wk-Fact-04EBBE90C0E8A84B4F0D284316412812"
      unitRef="usd">-16000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3423-wk-Fact-E27CFF974E808DDEC6EE284316279CA1"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3442-wk-Fact-9A932B4A1F36871979202843161AD9CD"
      unitRef="usd">-2000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3463-wk-Fact-6B97C04F43AD8F4BA5032843148C7315"
      unitRef="usd">90000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3487-wk-Fact-7FB0ECBA1306D3E53A882843146EE777"
      unitRef="usd">82000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3506-wk-Fact-AEFF1AA99AAB022A1C882843147AB65C"
      unitRef="usd">85000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3527-wk-Fact-2A3D5D1ADB9EB2D73D3C2843148BB1D8"
      unitRef="usd">-961000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3552-wk-Fact-07BADBE2FC7BA806CDA82843146F9B0B"
      unitRef="usd">-83000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3572-wk-Fact-5608F2B71E98868ABA9E2843147BAB8F"
      unitRef="usd">-1012000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3595-wk-Fact-F9CDE76EB3BE3850444D2843159F4F68"
      unitRef="usd">106000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3619-wk-Fact-AC6643F37D3C0AB3438E2843159781FA"
      unitRef="usd">88000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3638-wk-Fact-4BC0ABA7AFCE2F416134284315975397"
      unitRef="usd">74000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3659-wk-Fact-926D85D304C76ABBB48E28431598350D"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3683-wk-Fact-B6C7F21C06C789A24A94284314886CB9"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3702-wk-Fact-298610F29606204AD83A284315A430AC"
      unitRef="usd">-2000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3791-wk-Fact-C206A9FC403A31B9459528431477911F"
      unitRef="usd">-82000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3815-wk-Fact-5E44DCDE1DEE2B4D449A284314799B27"
      unitRef="usd">751000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3835-wk-Fact-F071FDA9F10B84A0C1F328431478D98A"
      unitRef="usd">871000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3857-wk-Fact-41C2E16BA36EF7107E5E284315A972BF"
      unitRef="usd">409000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3882-wk-Fact-48C8D11568AE6920F8632843159EC82E"
      unitRef="usd">551000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3902-wk-Fact-BBFEFD82C1AFF44C57EF28431476D2B6"
      unitRef="usd">1211000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3924-wk-Fact-0C572275D583D859E8C9284314820435"
      unitRef="usd">-162000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e3949-wk-Fact-7502EB01DF17E69D19C2284315A65EF7"
      unitRef="usd">1864000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e3968-wk-Fact-7D66E3030956AE7CAAA8284314643C57"
      unitRef="usd">2574000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e3989-wk-Fact-90157E909AEC8FF565E4284314874ECC"
      unitRef="usd">-6550000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4013-wk-Fact-D175EEF287E4518EFB2F28431472C825"
      unitRef="usd">-193000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4032-wk-Fact-3BDE26F7F847B4E11203284315A72C4D"
      unitRef="usd">-415000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4053-wk-Fact-571F873ECD44339BC0D028431470C631"
      unitRef="usd">1960000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4077-wk-Fact-30C76AE19077EA9AFAE028431470E2CC"
      unitRef="usd">2722000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4096-wk-Fact-2ABD408F7ADB6960BDF32843148BC49F"
      unitRef="usd">2768000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4184-wk-Fact-770DE458ED772EF50FD7284315A55B60"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4208-wk-Fact-CF15DEC65EA7E9FB846C284314794A7D"
      unitRef="usd">82000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4228-wk-Fact-EB5DCB839DF68C9EB5082843159DD461"
      unitRef="usd">6142000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4250-wk-Fact-5569821F2C7BF16C54C3284315A0F77A"
      unitRef="usd">375000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4275-wk-Fact-53BD6795C0FB005E6EB728431488D90A"
      unitRef="usd">328000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4295-wk-Fact-08E32C846E584979DCB328431474D5E4"
      unitRef="usd">384000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4318-wk-Fact-BFF3E0EF6372C222C614284315A0979F"
      unitRef="usd">20000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4343-wk-Fact-F36F20139036E1B413FD284314660A32"
      unitRef="usd">18000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4363-wk-Fact-0F3C41D083F60406D9FA284314664E6A"
      unitRef="usd">9000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4385-wk-Fact-02AAA7B2AF60BA9D64122843148C8A73"
      unitRef="usd">886000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4409-wk-Fact-1887130A343B4DAA253028431484533B"
      unitRef="usd">3000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4428-wk-Fact-9924846590D2B5D015902843159A6CEA"
      unitRef="usd">65000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4449-wk-Fact-6A96DF999DC05C1281802843159C2431"
      unitRef="usd">2000000</cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets>
    <cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4473-wk-Fact-D37085A4CB3D82F4FD8A2843147812F6"
      unitRef="usd">763000000</cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets>
    <cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4492-wk-Fact-546F76E4454FADF3C8DB28431476600E"
      unitRef="usd">862000000</cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4513-wk-Fact-0FBE0B8AD07F0424DC4C284315A45060"
      unitRef="usd">493000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4537-wk-Fact-6B403F908E603683C7F9284315A34670"
      unitRef="usd">338000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4556-wk-Fact-20DEA545AF91B94229ED2843146A0633"
      unitRef="usd">-5608000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <cah:PaymentofContingentConsideration
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4645-wk-Fact-569F036927A6BDCDF5A72843147F758A"
      unitRef="usd">0</cah:PaymentofContingentConsideration>
    <cah:PaymentofContingentConsideration
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4669-wk-Fact-F09B5682345E2C6C93FA2843148D4850"
      unitRef="usd">0</cah:PaymentofContingentConsideration>
    <cah:PaymentofContingentConsideration
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4688-wk-Fact-19B1BFB019D5B0DE8B0F2843159B8C7B"
      unitRef="usd">35000000</cah:PaymentofContingentConsideration>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4710-wk-Fact-AF0D9C803BE9CA0F690D284315A7CA64"
      unitRef="usd">-2000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4735-wk-Fact-AD00958FAA234B35B77028431479B47E"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4754-wk-Fact-21FF4CD54B0DAF8F2A5C284314891A78"
      unitRef="usd">-50000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4776-wk-Fact-0ED92021AA90104F0249284315A44151"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4800-wk-Fact-845ACBB7A62AE3CB76D82843147325C0"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4819-wk-Fact-EA086A3F2F89313B4E1E284315A6A302"
      unitRef="usd">106000000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsForProceedsFromHedgeFinancingActivities
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4841-wk-Fact-987680E5982123EFCB1528431476810F"
      unitRef="usd">-112000000</us-gaap:PaymentsForProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForProceedsFromHedgeFinancingActivities
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4865-wk-Fact-07F7075B24DD534A7E31284315A268BF"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForProceedsFromHedgeFinancingActivities
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4884-wk-Fact-4999FEB3B223F8C1A30E284315967563"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromHedgeFinancingActivities>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4905-wk-Fact-49E6320CBFFD032EF4DFA4CC94B290D3"
      unitRef="usd">0</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4929-wk-Fact-5ABC4D049B16BAE1B67CA4CC94D5F58C"
      unitRef="usd">0</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e4948-wk-Fact-942FB965171F2F36DAE6A4CC94D17533"
      unitRef="usd">3000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e4969-wk-Fact-70A6C0DC9C07CB66A7CE284314689E0A"
      unitRef="usd">1399000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e4994-wk-Fact-523D62DE7B3141125A4628431478FF09"
      unitRef="usd">1102000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e5014-wk-Fact-F06C9E17689D954643B528431597DCB0"
      unitRef="usd">954000000</us-gaap:RepaymentsOfLongTermDebt>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e5037-wk-Fact-64C7379686385DF6989728431472DBF1"
      unitRef="usd">8000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e5061-wk-Fact-5BE562853545F2035DD1284314678173"
      unitRef="usd">-14000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e5081-wk-Fact-778B23D82A70E693C5652843159D0301"
      unitRef="usd">-3000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e5103-wk-Fact-D6E3DA2146864945E79E28431489211B"
      unitRef="usd">569000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e5128-wk-Fact-6ED7CFC41F80247E31DA2843147CAE6C"
      unitRef="usd">577000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e5148-wk-Fact-C54FF9A86D54D57F463C2843146BCE98"
      unitRef="usd">581000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e5170-wk-Fact-642F443511C39C8A05F8284315A3168A"
      unitRef="usd">350000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e5195-wk-Fact-78812F29DED41077567028431482749D"
      unitRef="usd">600000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e5215-wk-Fact-EBEA51C4749354D630FF284315A0004A"
      unitRef="usd">550000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e5237-wk-Fact-896A6A76D236AB83CCF82843148A7052"
      unitRef="usd">-2200000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e5262-wk-Fact-B92070DDB4C0594BB9572843148073B9"
      unitRef="usd">-2293000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e5282-wk-Fact-69487A3B4B4E4D65CD9B2843147E58B2"
      unitRef="usd">-2276000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e5304-wk-Fact-375DF60AEFB9DF93D9B2284315961EA5"
      unitRef="usd">-13000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e5329-wk-Fact-C9D8DB1D67C5FF1F48E5284315A1DC05"
      unitRef="usd">1000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e5348-wk-Fact-D6405475ECFD56A7E1A328431483A543"
      unitRef="usd">4000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <cah:CashReclassifiedtoAssetsHeldforSale
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e5369-wk-Fact-B5A1D20BCD939F88CFEC2843146E0B68"
      unitRef="usd">0</cah:CashReclassifiedtoAssetsHeldforSale>
    <cah:CashReclassifiedtoAssetsHeldforSale
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e5393-wk-Fact-F88AF0548449C0549F612843147B440A"
      unitRef="usd">0</cah:CashReclassifiedtoAssetsHeldforSale>
    <cah:CashReclassifiedtoAssetsHeldforSale
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e5412-wk-Fact-FC26E79659256BE02BC7284314895EDF"
      unitRef="usd">-4000000</cah:CashReclassifiedtoAssetsHeldforSale>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e5434-wk-Fact-7D3ABECE6780F84C3525284314670088"
      unitRef="usd">240000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e5458-wk-Fact-B9B56A456A7CAE047A122843146D994D"
      unitRef="usd">768000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e5477-wk-Fact-B92B6E817708DCD3F2EF2843148DBAC0"
      unitRef="usd">-5116000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10082224e5499-wk-Fact-97315FFE5C1057E198DE11BA3705027F"
      unitRef="usd">2531000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10082224e5523-wk-Fact-BAD91DFF7A447392749D28431481678A"
      unitRef="usd">1763000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2017Q4"
      decimals="-6"
      id="d10082224e5542-wk-Fact-0D3D8DB6197E471A2D8A28431469E823"
      unitRef="usd">6879000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10082224e5568-wk-Fact-9A4D6F4B89355C9FAAA69392AD203FAB"
      unitRef="usd">2771000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10082224e5592-wk-Fact-97315FFE5C1057E198DE11BA3705027F"
      unitRef="usd">2531000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10082224e5612-wk-Fact-BAD91DFF7A447392749D28431481678A"
      unitRef="usd">1763000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e5699-wk-Fact-D1860AF0038635CEB7242843148677EC"
      unitRef="usd">226000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e5723-wk-Fact-6B4CD19380184837615A2843147E29F2"
      unitRef="usd">285000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e5743-wk-Fact-40C6E36DA783033D550A284315A7907B"
      unitRef="usd">320000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10082224e5759-wk-Fact-1019F891E21A3D1246CE2843146E35A3"
      unitRef="usd">368000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10082224e5783-wk-Fact-70B62F71FE6431572BD228431598C9EC"
      unitRef="usd">311000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10082224e5802-wk-Fact-4E9BDA73D620A55397822843147131E7"
      unitRef="usd">425000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-D2F85451D5D8AC126E34284316618231-0-wk-Fact-A6E21350279767F6FFA9284314853D1B">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;1. Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Cardinal Health, Inc. is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. We provide medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. References to &#x201c;we&#x201d;, &#x201c;our&#x201d; and similar pronouns in these consolidated financial statements are to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context otherwise requires.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our fiscal year ends on June&#160;30. References to fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; in these consolidated financial statements are to the fiscal years ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts could ultimately differ from these estimated amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The outbreak of the novel strain of coronavirus (&#x201c;COVID-19&#x201d;) has severely impacted, and continues to severely impact the U.S. and global economies, and beginning in the third quarter of fiscal 2020, our businesses have been impacted in a variety of ways. We cannot estimate the length or severity of the COVID-19 pandemic or the related U.S. and global economic consequences on our business and operations, including whether and when historic economic and operating conditions will resume or the extent to which the disruption may impact our business, financial position, results of operations or cash flow. Our e&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;stimates, judgments and assumptions related to COVID-19 could ultimately differ over time&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Receivables and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Trade receivables are presented net of an allowance for doubtful accounts of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$206 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$193 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. An account is considered past due on the first day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to cover potential losses, which are based primarily on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We provide financing to various customers. Such financing arrangements range from &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$104 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; (current portion &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$12 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;) and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$103 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; (current portion &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$12 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;) at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$27 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$14 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#x2019; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts.  &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;CVS Health Corporation ("CVS") and OptumRx, are our only customers that individually account for at least 10 percent of revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="15"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:34%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Percent of Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;CVS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;OptumRx&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We have entered into agreements with group purchasing organizations (&#x201c;GPOs&#x201d;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; largest GPO member relationships in terms of revenue. Sales to members of these &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; GPOs collectively accounted for &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;16 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;22 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;22 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of revenue for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;A substantial portion of our inventories (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;56 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; at both &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#x201c;distribution facilities&#x201d;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, inventories valued at LIFO cost were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$411 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$230 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; or &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our remaining inventory that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Net realizable value is defined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$155 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$171 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Cash Discounts&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#x2014;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;39 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;; machinery and equipment&#x2014;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;20 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;; and furniture and fixtures&#x2014;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;7 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. We recorded depreciation and amortization expense of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$405 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$455 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$446 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents the components of property and equipment, net at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:64%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Land, building and improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,185&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,992&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Machinery and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,008&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,038&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;138&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;138&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total property and equipment, at cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,331&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,168&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(2,965&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2,812&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,366&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,356&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term obligations, which was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;3 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. The amount of capitalized interest was immaterial for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="color:#000000;font-family:Arial Narrow;font-size:10pt;"&gt;Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We have &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#x201c;Medical Unit&#x201d;); and Cardinal Health at-Home Solutions division. Our Nuclear and Precision Health Solutions division was formerly referred to as our Nuclear Pharmacy Services division and our Cardinal Health at-Home Solutions division was formerly referred to as our Cardinal Health at Home division.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;8.5 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;10.5 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We performed annual impairment testing in fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and with the exception of our Medical Unit in fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In conjunction with the preparation of our consolidated financial statements for fiscal 2018, we completed our annual quantitative goodwill impairment test, which we perform annually in the fourth quarter. Using a combination of income and market-based approaches (using a discount rate of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;8.5 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;), the carrying value &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;exceeded the fair value and resulted in an impairment charge of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$1.4 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; related to our Medical Unit, which is included in impairments and loss on disposal of assets in our consolidated statements of earnings/(loss). Our fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The impairment was primarily driven by inventory and cost challenges within our Cordis business which furthered in the fourth quarter of fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. This impairment charge did not impact our liquidity, cash flows from operations, or compliance with debt covenants. There was no tax benefit related to the goodwill impairment charge. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The impairment test for indefinite-lived intangibles other than goodwill (primarily IPR&amp;amp;D) involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;requires the use of estimates and significant judgments and&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Assets Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We classify assets and liabilities (the &#x201c;disposal group&#x201d;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Vendor Reserves&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically refine our methodology by updating the reserve estimate percentages to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues, such as bankruptcies. Vendor reserves were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$77 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$53 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Distribution Services Agreement and Other Vendor Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#x2019; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#x2019;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Loss Contingencies and Self-Insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In connection with the opioid litigation as described further in the &lt;/span&gt;&lt;a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, we recorded a pre-tax charge of&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;(&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.14 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;after tax) during fiscal 2020. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;"&gt;Definitive terms of a settlement under the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied.  &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;"&gt;We develop and periodically update reserve estimates for the Cordis inferior vena cava ("Cordis IVC") claims, including those received to date and expected to be received in the future and related costs. To project future Cordis IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, sales data, implant and injury to report lag patterns and estimated defense costs. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We also self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The amount of ultimate loss may differ materially from these estimates.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;See &lt;/span&gt;&lt;a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding loss contingencies and product liability lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;liability being triggered under these indemnification obligations is not probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;no&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; material obligations at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amoun&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;t of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;See &lt;/span&gt;&lt;a href="#s002522EA8F5F5274B7487704BE70A9A8" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 8&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Noncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See &lt;/span&gt;&lt;a href="#sD47735F83E5151799C861160A959DEB5" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 14&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We paid cash dividends per common share of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.92&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.91&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.85&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; in fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;manufactured and sourced products, and&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Sales Returns and Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical data. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#x201c;merchantable product&#x201d;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At both &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, the accrual for estimated sales returns and allowances was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$495 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$479 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, the impact of which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.3 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.2 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.4 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Third-Party Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Shipping and Handling&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Shipping and handling costs are primarily included in SG&amp;amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$620 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$622 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$543 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Restructuring and Employee Severance&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are employee severance costs that are not incurred in connection with a restructuring activity. See &lt;/span&gt;&lt;a href="#sF72C50E68F165E22A368883CF79808D0" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 3&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding our restructuring activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Amortization and Other Acquisition-Related Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See &lt;/span&gt;&lt;a href="#s0B8CFB5481FD5F8C92CD0E2191E456DF" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 4&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding amortization of acquisition-related intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Translation of Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#x2019; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The foreign currency translation gains/(losses) included in AOCI at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; are presented in &lt;/span&gt;&lt;a href="#s3D77F43D97875956BB9F5A04AD8753DD" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 11&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Interest Rate, Currency and Commodity Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#x2019; equity through AOCI, net of tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#x2019;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments received from the cross currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;See &lt;/span&gt;&lt;a href="#s138045C0A5375688972939C6B03E89B1" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 10&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow and economic hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Level 1 -&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Observable prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Level 2 -&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Observable inputs other than quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Level 3 -&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;See &lt;/span&gt;&lt;a href="#sC842095C866F51CEAB114318376AF314" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 9&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding fair value measurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recently Adopted Financial Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;"&gt;Derivatives and Hedging &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In October 2018, the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Financial Accounting Standards Board ("FASB")&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a benchmark interest rate for hedge accounting purposes. This guidance was effective beginning the first quarter of fiscal 2020. The adoption did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and elected the transition option which allows us to apply the guidance prospectively. The initial adoption in the first quarter of fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; resulted in the recognition of lease liabilities in the amount of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$422 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. See&#160;&lt;/span&gt;&lt;a href="#s1a0a81a45f964330b5b7b44b0dd06884" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 5&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for additional information regarding leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recently Issued Financial Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This&#160;guidance will be effective for us in the first quarter of fiscal 2021. The adoption of this guidance will not have a material impact on our consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-DC06C886645E5ADEC3FA2843165E660A-0-wk-Fact-41D2489D0FDC755648A028431468FFA3">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="FD2020Q4YTD"
      id="TextSelection-BEBF39E558B1BF1F41842843165F2902-0-wk-Fact-60DA110BF97234222F5F28431488C5A7">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts could ultimately differ from these estimated amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The outbreak of the novel strain of coronavirus (&#x201c;COVID-19&#x201d;) has severely impacted, and continues to severely impact the U.S. and global economies, and beginning in the third quarter of fiscal 2020, our businesses have been impacted in a variety of ways. We cannot estimate the length or severity of the COVID-19 pandemic or the related U.S. and global economic consequences on our business and operations, including whether and when historic economic and operating conditions will resume or the extent to which the disruption may impact our business, financial position, results of operations or cash flow. Our e&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;stimates, judgments and assumptions related to COVID-19 could ultimately differ over time&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-11FDF4A20B3A08D6C1042843165E35FB-0-wk-Fact-99B46EED41FF449277F7284314725A13">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-C57247C3F98E4752B0B82843165FFDEC-0-wk-Fact-07DB15014C72C5E98C6D28431476E012">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Receivables and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Trade receivables are presented net of an allowance for doubtful accounts of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$206 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$193 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. An account is considered past due on the first day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to cover potential losses, which are based primarily on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We provide financing to various customers. Such financing arrangements range from &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$104 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; (current portion &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$12 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;) and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$103 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; (current portion &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$12 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;) at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$27 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$14 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10103707e3175-wk-Fact-F38380296049D80EEE54284315D7BE2E"
      unitRef="usd">206000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10103707e3179-wk-Fact-F77B919A29D45CF279F8284314635DD1"
      unitRef="usd">193000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <cah:ReceivableFinancingAgreementTerm
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember"
      id="d10103707e3194-wk-Fact-BA9AFE78465914E7A11928431482BA2F">P1Y</cah:ReceivableFinancingAgreementTerm>
    <cah:ReceivableFinancingAgreementTerm
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember"
      id="d10103707e3198-wk-Fact-8D0D706F7D641A3AA92F2843145F6E96">P5Y</cah:ReceivableFinancingAgreementTerm>
    <us-gaap:NotesReceivableNet
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103707e3202-wk-Fact-F7D43D7DA9D3E9EF660928431488CB90"
      unitRef="usd">104000000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103707e3206-wk-Fact-0F31C25762DA60BF5F032843146CF956"
      unitRef="usd">12000000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesReceivableNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103707e3210-wk-Fact-AF981ECDF0A7984CE4DF284314866025"
      unitRef="usd">103000000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103707e3215-wk-Fact-197BBCF35735ED553A8A284315D582B7"
      unitRef="usd">12000000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10103707e3227-wk-Fact-560ECF7266B4A2A76257A5D9FD574F9A"
      unitRef="usd">27000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10103707e3231-wk-Fact-B0FEA8F4C381D289FFAC28431479A023"
      unitRef="usd">14000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="FD2020Q4YTD"
      id="TextSelection-6A2C7D4D18DE440AB757284316600377-0-wk-Fact-BE5B003B42D683606817284314708EA5">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.&lt;/span&gt;&lt;/div&gt;Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#x2019; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts. </us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:MajorCustomersPolicyPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-A910EF4BB28FC63256BE28431660BAE1-0-wk-Fact-AC1E6CD4306E994FD3FA2843146698FF">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;CVS Health Corporation ("CVS") and OptumRx, are our only customers that individually account for at least 10 percent of revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="15"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:34%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Percent of Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;CVS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;OptumRx&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We have entered into agreements with group purchasing organizations (&#x201c;GPOs&#x201d;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; largest GPO member relationships in terms of revenue. Sales to members of these &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; GPOs collectively accounted for &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;16 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;22 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;22 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of revenue for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements</us-gaap:MajorCustomersPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-2D576EFA8CB72577A32F2843165F4768-0-wk-Fact-8D09C9B7DACB24EE37F5284314770498">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="15"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:34%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Percent of Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;CVS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;OptumRx&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2020Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="2"
      id="d10103707e3476-wk-Fact-C5F3AD6BE114A0D11E8E2843162C5A0D"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="2"
      id="d10103707e3491-wk-Fact-2360AADDAF69ADE14DD92843162E6685"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="2"
      id="d10103707e3506-wk-Fact-723CCEC70FB50E2F1CCA2843162FFD96"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <cah:GrossTradeReceivablesMajorCustomerPercentage
      contextRef="FI2020Q4_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="2"
      id="d10103707e3521-wk-Fact-3269E37177B70AD365832843162C0AB0"
      unitRef="number">0.26</cah:GrossTradeReceivablesMajorCustomerPercentage>
    <cah:GrossTradeReceivablesMajorCustomerPercentage
      contextRef="FI2019Q4_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="2"
      id="d10103707e3537-wk-Fact-F7B4ACA67A078B6A24D72843162D1CF1"
      unitRef="number">0.24</cah:GrossTradeReceivablesMajorCustomerPercentage>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2020Q4YTD_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="2"
      id="d10103707e3553-wk-Fact-52B1B312600AB8822EB22843162E040C"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="2"
      id="d10103707e3568-wk-Fact-71ECA709A0B512352D392843162C0F01"
      unitRef="number">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="2"
      id="d10103707e3583-wk-Fact-AF1EE5556E4C721C23BB2843162D6F89"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <cah:GrossTradeReceivablesMajorCustomerPercentage
      contextRef="FI2020Q4_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="2"
      id="d10103707e3598-wk-Fact-8724E6C25FEC44467F8B2843162F3CA6"
      unitRef="number">0.06</cah:GrossTradeReceivablesMajorCustomerPercentage>
    <cah:GrossTradeReceivablesMajorCustomerPercentage
      contextRef="FI2019Q4_srt_MajorCustomersAxis_cah_OptumRxMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="2"
      id="d10103707e3614-wk-Fact-08AC220879783786BEB12843162DE124"
      unitRef="number">0.04</cah:GrossTradeReceivablesMajorCustomerPercentage>
    <cah:ConcentrationRiskLargestGroupPurchasingOrganizations
      contextRef="FD2020Q4YTD"
      decimals="INF"
      id="d10103707e3631-wk-Fact-B50E8914FBA19FFFBE062843146495A2"
      unitRef="organization">2</cah:ConcentrationRiskLargestGroupPurchasingOrganizations>
    <cah:ConcentrationRiskLargestGroupPurchasingOrganizations
      contextRef="FD2020Q4YTD"
      decimals="INF"
      id="d10103707e3635-wk-Fact-B50E8914FBA19FFFBE062843146495A2"
      unitRef="organization">2</cah:ConcentrationRiskLargestGroupPurchasingOrganizations>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2020Q4YTD_srt_MajorCustomersAxis_cah_GroupPurchasingOrganizationsMember"
      decimals="2"
      id="d10103707e3639-wk-Fact-79EFF11ECDDE56FA789628431462D3E0"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_cah_GroupPurchasingOrganizationsMember"
      decimals="2"
      id="d10103707e3643-wk-Fact-D3B55CFBC0B8289DDC672843146AB4A1"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_cah_GroupPurchasingOrganizationsMember"
      decimals="2"
      id="d10103707e3647-wk-Fact-1BA8568AEF077C18BD8F284315D9107C"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-353A333F90EDCC7DCBF3284316622C51-0-wk-Fact-8DF6B1AA9F5295104BC42843148A28FB">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;A substantial portion of our inventories (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;56 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; at both &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#x201c;distribution facilities&#x201d;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, inventories valued at LIFO cost were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$411 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$230 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; or &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our remaining inventory that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Net realizable value is defined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$155 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$171 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="FI2020Q4"
      decimals="2"
      id="d10103707e3683-wk-Fact-BD683EDA0AEE5870E91B284315D8C671"
      unitRef="number">0.56</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:InventoryLIFOReserve
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103707e3706-wk-Fact-9CF1D6C21AB3DA50F852284314801D79"
      unitRef="usd">411000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReserve
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103707e3712-wk-Fact-AA4ACC711C964B3461612843147591E1"
      unitRef="usd">230000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryValuationReserves
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103707e3735-wk-Fact-629FD4D05E43FD8C8F5D2843146E5E13"
      unitRef="usd">155000000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103707e3739-wk-Fact-AD9598010FD7593F09222843148243EF"
      unitRef="usd">171000000</us-gaap:InventoryValuationReserves>
    <cah:CashDiscountsPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-A1E804E92E2ABBD6C6AF2843165FF7FD-0-wk-Fact-393768B3D8BE4F5BA8B22843145E3FFC">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Cash Discounts&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.&lt;/span&gt;&lt;/div&gt;</cah:CashDiscountsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-245A49A4CFC655C719562843165FB61E-0-wk-Fact-26C1462A401AFDEA12862843145F57C7">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#x2014;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;39 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;; machinery and equipment&#x2014;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;20 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;; and furniture and fixtures&#x2014;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;7 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. We recorded depreciation and amortization expense of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$405 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$455 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$446 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents the components of property and equipment, net at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:64%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Land, building and improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,185&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,992&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Machinery and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,008&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,038&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;138&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;138&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total property and equipment, at cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,331&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,168&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(2,965&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2,812&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,366&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,356&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term obligations, which was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;3 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. The amount of capitalized interest was immaterial for all periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"
      id="d10103707e3788-wk-Fact-DEF1BA72BAFBF304F0AB284315D6EB62">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"
      id="d10103707e3792-wk-Fact-49758C091034E482F96D2843147F7E4A">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember"
      id="d10103707e3796-wk-Fact-C47BC0FCBAC05D04BBB42843147EE4F3">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember"
      id="d10103707e3800-wk-Fact-B6CBC82046843AE018EA28431467A2B9">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      id="d10103707e3804-wk-Fact-432EC347B61AA13563972843146FECB8">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      id="d10103707e3809-wk-Fact-D97609E3BF6B6C47FFA6284314807B9B">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Depreciation
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10103707e3813-wk-Fact-23E914573FCFE351A6B62843147EA8B0"
      unitRef="usd">405000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10103707e3817-wk-Fact-B11D0A2E32E9AF10481F2843146108D1"
      unitRef="usd">455000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10103707e3821-wk-Fact-1FCDC13508AA54B84620284314660F87"
      unitRef="usd">446000000</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-E1619307AD69A5DDBE30284316606799-0-wk-Fact-A014B7BBFFC5797046C828431482756C">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents the components of property and equipment, net at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:64%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Land, building and improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,185&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,992&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Machinery and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,008&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,038&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;138&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;138&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total property and equipment, at cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,331&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,168&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(2,965&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2,812&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,366&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,356&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandBuildingsAndImprovementsMember"
      decimals="-6"
      id="d10103707e3917-wk-Fact-A9B6407D1DA8AA43C157284315F3C4FD"
      unitRef="usd">2185000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandBuildingsAndImprovementsMember"
      decimals="-6"
      id="d10103707e3936-wk-Fact-CEA6A6C112E331B9B11F2843159B0B53"
      unitRef="usd">1992000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember"
      decimals="-6"
      id="d10103707e3951-wk-Fact-190F4B5FC5FBA163F8D7284315FBF880"
      unitRef="usd">3008000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember"
      decimals="-6"
      id="d10103707e3970-wk-Fact-B33797CAC569F57F0EE1284315F60096"
      unitRef="usd">3038000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      decimals="-6"
      id="d10103707e3990-wk-Fact-8D18F5153BDF9F294C4F284315EF1A21"
      unitRef="usd">138000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      decimals="-6"
      id="d10103707e4009-wk-Fact-0927281AC0B8789107F9284314727850"
      unitRef="usd">138000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103707e4029-wk-Fact-001B380544AB8CA6924428431599F67B"
      unitRef="usd">5331000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103707e4048-wk-Fact-95892F9A964E3A0EB83C284315FB6DF3"
      unitRef="usd">5168000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103707e4068-wk-Fact-25ED03FB64CAC316DE4D2843163C5855"
      unitRef="usd">2965000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103707e4088-wk-Fact-6C5E47F4D1DDF71DA8AA284315F7D2DA"
      unitRef="usd">2812000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103707e4114-wk-Fact-022AFBD3623650148594C8C3580F78AF"
      unitRef="usd">2366000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103707e4133-wk-Fact-65BAC2AADAAF5CD58F3560A3DA72CCD6"
      unitRef="usd">2356000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="FI2020Q4"
      decimals="2"
      id="d10103707e4148-wk-Fact-25AE72DEE3E1FCEB2FB6284314738402"
      unitRef="number">0.03</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-3F21A07CBB2FC31581B7284316611B18-0-wk-Fact-24D932B3AA88B377E54728431468FFBB">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="color:#000000;font-family:Arial Narrow;font-size:10pt;"&gt;Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We have &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#x201c;Medical Unit&#x201d;); and Cardinal Health at-Home Solutions division. Our Nuclear and Precision Health Solutions division was formerly referred to as our Nuclear Pharmacy Services division and our Cardinal Health at-Home Solutions division was formerly referred to as our Cardinal Health at Home division.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;8.5 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;10.5 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We performed annual impairment testing in fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and with the exception of our Medical Unit in fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In conjunction with the preparation of our consolidated financial statements for fiscal 2018, we completed our annual quantitative goodwill impairment test, which we perform annually in the fourth quarter. Using a combination of income and market-based approaches (using a discount rate of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;8.5 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;), the carrying value &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;exceeded the fair value and resulted in an impairment charge of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$1.4 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; related to our Medical Unit, which is included in impairments and loss on disposal of assets in our consolidated statements of earnings/(loss). Our fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The impairment was primarily driven by inventory and cost challenges within our Cordis business which furthered in the fourth quarter of fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. This impairment charge did not impact our liquidity, cash flows from operations, or compliance with debt covenants. There was no tax benefit related to the goodwill impairment charge. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The impairment test for indefinite-lived intangibles other than goodwill (primarily IPR&amp;amp;D) involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;requires the use of estimates and significant judgments and&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="FD2020Q4YTD"
      decimals="0"
      id="d10103707e4196-wk-Fact-B90E114593CC51829C3D13F56F7DEC04"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <cah:DiscountRatefairvalueinputs
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember"
      decimals="3"
      id="d10103707e4203-wk-Fact-F8F58562574D4E36970C2843146D8E78"
      unitRef="number">0.085</cah:DiscountRatefairvalueinputs>
    <cah:DiscountRatefairvalueinputs
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember"
      decimals="3"
      id="d10103707e4207-wk-Fact-D759DB0E19B67115786928431462387E"
      unitRef="number">0.105</cah:DiscountRatefairvalueinputs>
    <cah:DiscountRatefairvalueinputs
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10103707e4233-wk-Fact-E6971E7F1C62A6722280284315BEE91C"
      unitRef="number">0.085</cah:DiscountRatefairvalueinputs>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10103707e4240-wk-Fact-804F9E1FB0E76481C72C2843147F8E0C"
      unitRef="usd">1400000000</us-gaap:GoodwillImpairmentLoss>
    <cah:AssetsHeldforSalePolicyPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-8DD2D08D84B5306E0AD4284316607FF4-0-wk-Fact-44439DF0BFF23ECD829828431474A61A">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Assets Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We classify assets and liabilities (the &#x201c;disposal group&#x201d;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.&lt;/span&gt;&lt;/div&gt;</cah:AssetsHeldforSalePolicyPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-E567518D0870022A33BA2843165F6999-0-wk-Fact-8069B854B6D26B8C25A7284315D8F4B5">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <cah:CostofSalesVendorReservesPolicyPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-90C13FB0AE4EF12A961628431662849E-0-wk-Fact-8317A7DEEF65F12A265A2843146A374E">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Vendor Reserves&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically refine our methodology by updating the reserve estimate percentages to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues, such as bankruptcies. Vendor reserves were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$77 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$53 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.&lt;/span&gt;&lt;/div&gt;</cah:CostofSalesVendorReservesPolicyPolicyTextBlock>
    <cah:VendorReserves
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103707e4306-wk-Fact-438805A6985F78A2D7552843147D72D9"
      unitRef="usd">77000000</cah:VendorReserves>
    <cah:VendorReserves
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103707e4310-wk-Fact-A27DD312E56DD3035D7C2843146B21B6"
      unitRef="usd">53000000</cah:VendorReserves>
    <cah:DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-86D2665D0D56DCEBBEF628431662A68B-0-wk-Fact-6ACB5E04E18B9132B112284314833F5B">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Distribution Services Agreement and Other Vendor Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#x2019; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#x2019;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.&lt;/span&gt;&lt;/div&gt;</cah:DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-D1F289BB5BABC5241B232843165FAB4A-0-wk-Fact-26E350BBDE9E574DCBEE28431483FB78">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Loss Contingencies and Self-Insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In connection with the opioid litigation as described further in the &lt;/span&gt;&lt;a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, we recorded a pre-tax charge of&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;(&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.14 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;after tax) during fiscal 2020. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;"&gt;Definitive terms of a settlement under the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied.  &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;"&gt;We develop and periodically update reserve estimates for the Cordis inferior vena cava ("Cordis IVC") claims, including those received to date and expected to be received in the future and related costs. To project future Cordis IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, sales data, implant and injury to report lag patterns and estimated defense costs. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We also self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The amount of ultimate loss may differ materially from these estimates.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;See &lt;/span&gt;&lt;a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding loss contingencies and product liability lawsuits.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-6"
      id="d10103707e4363-wk-Fact-7BEE7B16CCFA59729DF5EFBDE17CAEA0"
      unitRef="usd">-5630000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember"
      decimals="-6"
      id="d10103707e4367-wk-Fact-3BA3C56106F25C3CBCB9EB04F56E6EB3"
      unitRef="usd">-5140000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies
      contextRef="FD2020Q4YTD"
      id="TextSelection-373C08E18EE088AC0CC3B65F6C3F9410-0-wk-Fact-E2C75B9818811CD480D9B660A5780421">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;liability being triggered under these indemnification obligations is not probable.&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;no&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; material obligations at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;.</us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-3CC2F6FE5BED6001E977284316617C9A-0-wk-Fact-900A279E07625B9E25E12843145EA4E8">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amoun&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;t of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;See &lt;/span&gt;&lt;a href="#s002522EA8F5F5274B7487704BE70A9A8" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 8&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <cah:OtherAccruedLiabilitiesPolicyPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-FDB4FD894B2E12A70B72284316606C52-0-wk-Fact-316BE2B12D0EC60FA69428431487B5A2">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.&lt;/span&gt;&lt;/div&gt;</cah:OtherAccruedLiabilitiesPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-372D8F071B6A6F5D7D8C28431661ACEE-0-wk-Fact-1B7ADDC9BE32B18B55D628431479CCC5">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Noncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc. &lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="FD2020Q4YTD"
      id="TextSelection-88A4CBDE7750E2C09105284316613ECE-0-wk-Fact-CC4F9C19CFF4BB98911E2843148994E7">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See &lt;/span&gt;&lt;a href="#sD47735F83E5151799C861160A959DEB5" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 14&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding share-based compensation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <cah:DividendsPolicyPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-488A5961E3A6D68D214828431661C190-0-wk-Fact-CAD0E45E43F3CFFEE784284314738616">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We paid cash dividends per common share of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.92&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.91&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.85&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; in fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;</cah:DividendsPolicyPolicyTextBlock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="FD2020Q4YTD"
      decimals="2"
      id="d10103707e4531-wk-Fact-6B1B040B9173325E8E06B6007A5A5AF4"
      unitRef="usdPerShare">1.92</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d10103707e4535-wk-Fact-35CC992E94F54CCA9ED5B60BECD23041"
      unitRef="usdPerShare">1.91</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d10103707e4539-wk-Fact-D5C615BE5C79AC55B2E52843147BA996"
      unitRef="usdPerShare">1.85</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-172A044ECE0505509D0328431662384C-0-wk-Fact-1C763DE5C42D2F26AC1B28431465BA0D">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;manufactured and sourced products, and&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer. &lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <cah:SalesreturnsPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-888404E1830B69AD8FD92843165F2580-0-wk-Fact-DE4697F9FD1280EE343428431481587D">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Sales Returns and Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical data. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#x201c;merchantable product&#x201d;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At both &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, the accrual for estimated sales returns and allowances was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$495 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$479 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, the impact of which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.3 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.2 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.4 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Third-Party Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.&lt;/span&gt;&lt;/div&gt;</cah:SalesreturnsPolicyTextBlock>
    <cah:RevenueRecognitionReserveforSalesReturnsandAllowances
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103707e4609-wk-Fact-462A02C7F02674BE3563284315D782CC"
      unitRef="usd">495000000</cah:RevenueRecognitionReserveforSalesReturnsandAllowances>
    <cah:RevenueRecognitionReserveforSalesReturnsandAllowances
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103707e4613-wk-Fact-7F943A5A5E8BB2E68678284314616BBB"
      unitRef="usd">479000000</cah:RevenueRecognitionReserveforSalesReturnsandAllowances>
    <us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns
      contextRef="FD2020Q4YTD"
      decimals="-8"
      id="d10103707e4617-wk-Fact-4DECE9C6449C9C85435428431477268A"
      unitRef="usd">2300000000</us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns>
    <us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns
      contextRef="FD2019Q4YTD"
      decimals="-8"
      id="d10103707e4622-wk-Fact-9D21DD4838679D65AE90284314740019"
      unitRef="usd">2200000000</us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns>
    <us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns
      contextRef="FD2018Q4YTD"
      decimals="-8"
      id="d10103707e4626-wk-Fact-9291C172CB3388EABEFF2843146D70D2"
      unitRef="usd">2400000000</us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns>
    <cah:ShippingandHandlingCostsPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-2638F03ED5A82FE46A2C28431660B9AF-0-wk-Fact-A7B83BEDD3E0790147C128431473A9E8">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Shipping and Handling&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Shipping and handling costs are primarily included in SG&amp;amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$620 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$622 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$543 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. &lt;/span&gt;&lt;/div&gt;</cah:ShippingandHandlingCostsPolicyTextBlock>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2020Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember"
      decimals="-6"
      id="d10103707e4678-wk-Fact-4516DFBB47E04A95CD35284314635808"
      unitRef="usd">620000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember"
      decimals="-6"
      id="d10103707e4682-wk-Fact-2B686B6AAC7C583839D1284314617979"
      unitRef="usd">622000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember"
      decimals="-6"
      id="d10103707e4686-wk-Fact-FCC89FFD8B4930C984222843147AD541"
      unitRef="usd">543000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-E0D5A0E182B1D61F333528431661223F-0-wk-Fact-9DBED0B62F51F572454D2843147ACC84">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Restructuring and Employee Severance&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are employee severance costs that are not incurred in connection with a restructuring activity. See &lt;/span&gt;&lt;a href="#sF72C50E68F165E22A368883CF79808D0" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 3&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding our restructuring activities.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <cah:AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-5E6440FFEE24B3413D7A28431662B57D-0-wk-Fact-B2565DC47B26E1B329A928431460676B">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Amortization and Other Acquisition-Related Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See &lt;/span&gt;&lt;a href="#s0B8CFB5481FD5F8C92CD0E2191E456DF" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 4&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding amortization of acquisition-related intangible assets. &lt;/span&gt;&lt;/div&gt;</cah:AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-D8429A9C3755E52D0CD62843165EF3B6-0-wk-Fact-376E5928A1EA89F3C95F284314715155">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Translation of Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#x2019; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The foreign currency translation gains/(losses) included in AOCI at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; are presented in &lt;/span&gt;&lt;a href="#s3D77F43D97875956BB9F5A04AD8753DD" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 11&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives
      contextRef="FD2020Q4YTD"
      id="TextSelection-337EDF02C0082790FCBA284316611165-0-wk-Fact-C083ED1B5BFA04CB27E528431469D98E">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Interest Rate, Currency and Commodity Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#x2019; equity through AOCI, net of tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#x2019;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments received from the cross currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;See &lt;/span&gt;&lt;a href="#s138045C0A5375688972939C6B03E89B1" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 10&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow and economic hedges.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-9144F1271823662A0DDD284316618394-0-wk-Fact-86596244DF88938AC7A82843147EC13B">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Level 1 -&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Observable prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Level 2 -&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Observable inputs other than quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Level 3 -&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;See &lt;/span&gt;&lt;a href="#sC842095C866F51CEAB114318376AF314" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 9&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for additional information regarding fair value measurements.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-E588FA6609B98BBF617F2843165F9550-0-wk-Fact-1BAFB1FD7AC8372E533B2843147ADB7F">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recently Adopted Financial Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;"&gt;Derivatives and Hedging &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In October 2018, the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Financial Accounting Standards Board ("FASB")&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a benchmark interest rate for hedge accounting purposes. This guidance was effective beginning the first quarter of fiscal 2020. The adoption did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and elected the transition option which allows us to apply the guidance prospectively. The initial adoption in the first quarter of fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; resulted in the recognition of lease liabilities in the amount of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$422 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. See&#160;&lt;/span&gt;&lt;a href="#s1a0a81a45f964330b5b7b44b0dd06884" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 5&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for additional information regarding leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recently Issued Financial Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This&#160;guidance will be effective for us in the first quarter of fiscal 2021. The adoption of this guidance will not have a material impact on our consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842
      contextRef="I2020Q1ASC842"
      decimals="-6"
      id="d10103707e4929-wk-Fact-D0B6E47994415F8E8BF4E87CEDA52D1B"
      unitRef="usd">422000000</cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d10085457e2856-wk-Fact-138C1BF43F005E833E38A591045BA0DB"
      unitRef="usd">737000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <cah:PreTaxGainonDivestiture
      contextRef="FD2019Q4YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d10085457e2867-wk-Fact-7976D9DD094654FB9A6538D502E6B761"
      unitRef="usd">508000000</cah:PreTaxGainonDivestiture>
    <us-gaap:EquityMethodInvestments
      contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d10085457e2871-wk-Fact-B4FF5E8009214658C790A594DDDE901E"
      unitRef="usd">358000000</us-gaap:EquityMethodInvestments>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d10085457e2875-wk-Fact-F505F51AA1F48F8561EBA65873B56D1F"
      unitRef="usd">12000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <cah:Provisionaltaxbenefitrelatedtotransaction
      contextRef="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d10085457e2879-wk-Fact-686B0D1781EDAA9B07E2A65972C596C1"
      unitRef="usd">130000000</cah:Provisionaltaxbenefitrelatedtotransaction>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="FD2020Q4QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d10085457e2888-wk-Fact-A4954187376CE474EA85A65DF290D3F7"
      unitRef="usd">579000000</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10085457e2895-wk-Fact-4FC134107CD4E9624DB5A663AE0FB074"
      unitRef="usd">2000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10085457e2899-wk-Fact-1F89DB3D81D9601CA562A6647A37199C"
      unitRef="usd">10000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="FD2018Q4YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember"
      decimals="-6"
      id="d10085457e2921-wk-Fact-F755AFFA48301931E6C6A5FDF071D681"
      unitRef="usd">861000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="FD2018Q4YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember"
      decimals="-6"
      id="d10085457e2931-wk-Fact-51C1408F11F94F55A3FCA5FFA94BE15A"
      unitRef="usd">41000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10085457e2956-wk-Fact-CF15DEC65EA7E9FB846C284314794A7D"
      unitRef="usd">82000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="D2018Q1Jul29_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember"
      decimals="-8"
      id="d10085457e2971-wk-Fact-3E3F92B70752DCF3285FB47B371C7B11"
      unitRef="usd">6100000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <cah:BusinessCombinationTransactionandintegrationcosts
      contextRef="FD2020Q4YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember"
      decimals="-6"
      id="d10085457e2978-wk-Fact-92D18CDB87B5572483C2A58233E9C0BA"
      unitRef="usd">7000000</cah:BusinessCombinationTransactionandintegrationcosts>
    <cah:BusinessCombinationTransactionandintegrationcosts
      contextRef="FD2019Q4YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember"
      decimals="-6"
      id="d10085457e2982-wk-Fact-A755742BD5C20B963B54A583739B9174"
      unitRef="usd">75000000</cah:BusinessCombinationTransactionandintegrationcosts>
    <cah:BusinessCombinationTransactionandintegrationcosts
      contextRef="FD2018Q4YTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember"
      decimals="-6"
      id="d10085457e2986-wk-Fact-B386B6404E9E8BBC5E65A5839861DD77"
      unitRef="usd">109000000</cah:BusinessCombinationTransactionandintegrationcosts>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-562197F0F2B9437A7404284316644A12-0-wk-Fact-88BEA3FC66D1DE091AB0284315F4C750">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;3. Restructuring and Employee Severance&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize restructuring and employee severance costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related costs &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;66&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other costs &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;142&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total restructuring and employee severance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;122&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;176&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods. Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, vendor transition fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, restructuring costs are primarily related to implementation of certain enterprise-wide cost-savings measures.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we entered into an agreement to transition the distribution of our Medical segment's surgeon gloves in certain international markets from a third-party distribution arrangement to a direct distribution model. The costs associated with this restructuring included &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$125 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, on a pre-tax basis, in contract termination costs that were paid during fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. These costs are reflected in restructuring and employee severance in the consolidated statements of earnings/(loss) during the fiscal year ended 2018. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes activity related to liabilities associated with restructuring and employee severance:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Related Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility Exit&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;and Other Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Payments and other adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(48&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Payments and other adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-F31694C66F193D71DD8D2843166465C7-0-wk-Fact-033A3BBBE7A01409DBAA284315F74ED1">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize restructuring and employee severance costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related costs &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;66&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other costs &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;142&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total restructuring and employee severance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;122&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;176&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods. Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, vendor transition fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10089436e2996-wk-Fact-43E427D08D6EB02F90AB284315F1190A"
      unitRef="usd">66000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10089436e3015-wk-Fact-D791146DB19754C04600284315EDEE91"
      unitRef="usd">95000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10089436e3034-wk-Fact-16B20E13B90499334C2C284315EE117E"
      unitRef="usd">34000000</us-gaap:SeveranceCosts1>
    <cah:FacilityExitAndOtherCosts
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10089436e3050-wk-Fact-E7335B6128A04626E52B284315EE5B90"
      unitRef="usd">56000000</cah:FacilityExitAndOtherCosts>
    <cah:FacilityExitAndOtherCosts
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10089436e3069-wk-Fact-88B953838E9F841E7109284315F068BB"
      unitRef="usd">30000000</cah:FacilityExitAndOtherCosts>
    <cah:FacilityExitAndOtherCosts
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10089436e3088-wk-Fact-31EF1809098F2CE63C9F284315F04A13"
      unitRef="usd">142000000</cah:FacilityExitAndOtherCosts>
    <us-gaap:RestructuringCharges
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10089436e3114-wk-Fact-B1C11A87F92A34B823FC2843162C8B54"
      unitRef="usd">122000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10089436e3133-wk-Fact-3F8673AEAFD4719F9AD028431460FC93"
      unitRef="usd">125000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10089436e3152-wk-Fact-138BB9B6057862937C5C2843145D0C42"
      unitRef="usd">176000000</us-gaap:RestructuringCharges>
    <cah:FacilityExitAndOtherCosts
      contextRef="FD2018Q4YTD_cah_ContractTerminationAxis_cah_DistributorContractMember"
      decimals="-6"
      id="d10089436e3217-wk-Fact-5F1DDF755B856A4970D0284315F69F2C"
      unitRef="usd">125000000</cah:FacilityExitAndOtherCosts>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-5A1070052AB1984C57BF28431664C841-0-wk-Fact-0294BE220A66BB119B1E284315F6C321">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes activity related to liabilities associated with restructuring and employee severance:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Related Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility Exit&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;and Other Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Payments and other adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(48&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Payments and other adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d10089436e3341-wk-Fact-377EBE6DA140D145195A2843163FA8DF"
      unitRef="usd">24000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d10089436e3360-wk-Fact-F159F3A5449D769CF7BF2843163E1B49"
      unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10089436e3379-wk-Fact-3F90E746928D8C3DE9D52843163F525B"
      unitRef="usd">28000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCosts
      contextRef="FD2019Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d10089436e3395-wk-Fact-86D35A11339AAE78885E284316428015"
      unitRef="usd">84000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="FD2019Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d10089436e3414-wk-Fact-BBECBC22896BAE2B184E2843145E345A"
      unitRef="usd">8000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10089436e3433-wk-Fact-70A423E2A3F2B4DD44942843145D55C3"
      unitRef="usd">92000000</us-gaap:RestructuringCosts>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2019Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d10089436e3454-wk-Fact-FDA8B0365FF9E005E65D28431642B756"
      unitRef="usd">44000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2019Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d10089436e3474-wk-Fact-59D790580800F1796C9F2843163F3EEE"
      unitRef="usd">4000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10089436e3494-wk-Fact-D194D51A1D17C16784DA284316435680"
      unitRef="usd">48000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d10089436e3516-wk-Fact-14653DD4524D56A4B6BCC218F61E13FF"
      unitRef="usd">64000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d10089436e3535-wk-Fact-2A8D8FBFD079524FA2C907A53E8279B4"
      unitRef="usd">8000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10089436e3554-wk-Fact-AECF643BFDFD5BF2896F9A04E349E892"
      unitRef="usd">72000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCosts
      contextRef="FD2020Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d10089436e3575-wk-Fact-680925DC14F5589B99A852BF3979CFB6"
      unitRef="usd">85000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="FD2020Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d10089436e3594-wk-Fact-54EF291F4D7D546BBD78AE5116791C22"
      unitRef="usd">24000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10089436e3613-wk-Fact-71213E057E48500EADE834D9ABDA25F7"
      unitRef="usd">109000000</us-gaap:RestructuringCosts>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2020Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d10089436e3634-wk-Fact-344A568FA30B59C0B45059117B296C40"
      unitRef="usd">81000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2020Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d10089436e3654-wk-Fact-A6DAC566F6315D1693C4DD812E955855"
      unitRef="usd">4000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10089436e3674-wk-Fact-431788301B5F5042AC6391668D577B59"
      unitRef="usd">85000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d10089436e3701-wk-Fact-F13A5E509ADD53858D6DE2C0122C476E"
      unitRef="usd">68000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d10089436e3720-wk-Fact-A89463AFD4045586A4A7077C716EC500"
      unitRef="usd">28000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10089436e3739-wk-Fact-B0B291C0232D50598B30A5437E7C78A2"
      unitRef="usd">96000000</us-gaap:RestructuringReserve>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-9896D7A085152D3AB91D28431665F8DA-0-wk-Fact-CD97AD1C06572F099852284315C5ADBE">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;4. Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the carrying amount of goodwill by segment and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:42%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,621&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,695&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,663&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,715&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,378&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,657&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,700&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,357&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;, the Pharmaceutical segment accumulated goodwill impairment loss was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$829 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;, the Medical segment accumulated goodwill impairment loss was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$1.4 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize other intangible assets by class at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:22%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,554&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,828&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,726&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;673&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;332&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,604&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;767&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;837&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,936&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,895&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,854&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,936&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,918&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,045&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;295&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;377&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,602&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;616&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;986&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,836&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,858&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,430&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Total amortization of intangible assets was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$512 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$531 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$574 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. The estimated annual amortization for intangible assets for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2021&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; through &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2025&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; is as follows: &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$442 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$408 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$358 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$329 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$277 million&lt;/span&gt;&lt;/span&gt;.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-5794193DAA6F48E32CA2284316641B84-0-wk-Fact-689752128944BE8B460A284315CAAE8A">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the carrying amount of goodwill by segment and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:42%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,621&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,695&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,663&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,715&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,378&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,657&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,700&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,357&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;, the Pharmaceutical segment accumulated goodwill impairment loss was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$829 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;, the Medical segment accumulated goodwill impairment loss was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$1.4 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;. &lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="FI2018Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10103689e2973-wk-Fact-6EC83C828FDAC41140F9284315AA927F"
      unitRef="usd">2621000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2018Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10103689e2992-wk-Fact-D9174860956E0961F193284315AD9B3A"
      unitRef="usd">5695000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10103689e3011-wk-Fact-13C0F9F31849E3D5336F284315B3A619"
      unitRef="usd">8316000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTransfers
      contextRef="FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10103689e3027-wk-Fact-BE43D2F7D7542BC5290E284315A5E85F"
      unitRef="usd">45000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10103689e3046-wk-Fact-09E0D254262A56EE2932284315C1D19D"
      unitRef="usd">7000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10103689e3065-wk-Fact-E71C2F8343FBDC26BA72284315A69B0A"
      unitRef="usd">52000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10103689e3086-wk-Fact-8D2661396854D1306516284315B7A13E"
      unitRef="usd">-3000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10103689e3106-wk-Fact-1B0EEF0CF6A10818D017284315B8EC26"
      unitRef="usd">13000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10103689e3125-wk-Fact-B934E5418EF43BBD9CF7284315AB1A53"
      unitRef="usd">10000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10103689e3146-wk-Fact-5BE38993DC8E55A7AE6ABFB91134D31F"
      unitRef="usd">2663000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10103689e3165-wk-Fact-AB71997628ED5EA4AA25372BAA082898"
      unitRef="usd">5715000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103689e3184-wk-Fact-CFEC5930BF2F53CAAAC4F6E423AD054C"
      unitRef="usd">8378000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTransfers
      contextRef="FD2020Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10103689e3205-wk-Fact-0D89141EAD1957F6AC801BB1A09A3593"
      unitRef="usd">-5000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="FD2020Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10103689e3225-wk-Fact-AC7D27C5FFD258C793CD10B00B9478D2"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10103689e3244-wk-Fact-F739C8C1BD725CF99D4CF7033912F783"
      unitRef="usd">-5000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10103689e3266-wk-Fact-387A9EF0F6D450B1865361D2FE42E627"
      unitRef="usd">-1000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q4YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10103689e3286-wk-Fact-5664924CDB305D779564B5D1CF84C379"
      unitRef="usd">-15000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10103689e3306-wk-Fact-D30ACE11804454029773B456B296B4D3"
      unitRef="usd">-16000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="FI2020Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10103689e3333-wk-Fact-8AF842D9000652B99A8C49C8739EF898"
      unitRef="usd">2657000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2020Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10103689e3352-wk-Fact-E074F7A6E74F530C834DEFBDDC316B91"
      unitRef="usd">5700000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e3371-wk-Fact-DB90080FE62156838ABA5E1498FD0735"
      unitRef="usd">8357000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="FI2020Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10103689e3401-wk-Fact-A555357B33DA99105109284315C82BEA"
      unitRef="usd">829000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="FI2020Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10103689e3424-wk-Fact-82D4200A4D51B87C4DB5284315C1F341"
      unitRef="usd">1400000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-DC5E8DB9640841B311A628431664EF87-0-wk-Fact-423C709BA7A48DADCE86284315BED6CC">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize other intangible assets by class at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:22%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,554&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,828&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,726&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;673&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;332&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,604&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;767&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;837&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,936&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,895&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,854&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,936&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,918&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,045&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;295&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;377&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,602&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;616&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;986&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,836&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,858&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,430&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-50D128247EFC249417962843166431DF-0-wk-Fact-1473582E2A2E6CCAAE54284315C53BB9">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize other intangible assets by class at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:22%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,554&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,828&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,726&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;673&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;332&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,604&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;767&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;837&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,936&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,895&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,854&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,936&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,918&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,045&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;295&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;377&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,602&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;616&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;986&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,836&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,858&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,430&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember"
      decimals="-6"
      id="d10103689e3714-wk-Fact-F1ACE23082C95F0AAB5E4DE0DD7081B7"
      unitRef="usd">23000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember"
      decimals="-6"
      id="d10103689e3752-wk-Fact-F1ACE23082C95F0AAB5E4DE0DD7081B7"
      unitRef="usd">23000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e3778-wk-Fact-3DCFA1679BAB5EA382F99AF7B1F41CE2"
      unitRef="usd">23000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e3816-wk-Fact-3DCFA1679BAB5EA382F99AF7B1F41CE2"
      unitRef="usd">23000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d10103689e3919-wk-Fact-4217866368495E53A293011883C22067"
      unitRef="usd">3554000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d10103689e3938-wk-Fact-3D20FB655AE256548A2258397A7F36B1"
      unitRef="usd">1828000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d10103689e3957-wk-Fact-FA7C8FCAFB0C586C86F24425256A7B57"
      unitRef="usd">1726000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="FD2020Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      id="d10103689e3977-wk-Fact-B6505909076D54F997C2E848063CED7D">P13Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d10103689e3988-wk-Fact-E865BBF54D2F582B809BCEAFAC29373C"
      unitRef="usd">673000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d10103689e4007-wk-Fact-CB2BA626D59055D9B817EAACC763B5CC"
      unitRef="usd">341000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d10103689e4026-wk-Fact-557B190521DD53ADAFF57662C8400144"
      unitRef="usd">332000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="FD2020Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      id="d10103689e4046-wk-Fact-21FFEDA80671579688C17A5E032525B8">P13Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d10103689e4057-wk-Fact-13187A58CB3D5B8997378B1596E647C0"
      unitRef="usd">1604000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d10103689e4076-wk-Fact-3877656628E05EFA97B16B48DAE258EF"
      unitRef="usd">767000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d10103689e4095-wk-Fact-D77EE9184D8F5E8293926ABE63E77B34"
      unitRef="usd">837000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="FD2020Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      id="d10103689e4115-wk-Fact-AFAAFB11DE725513BAD67518FAB942D2">P11Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e4126-wk-Fact-4C06ACD6CDE15D738950DA8F383BD057"
      unitRef="usd">5831000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e4145-wk-Fact-9DB2FF85DF225BE89EDD1C33278E8376"
      unitRef="usd">2936000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e4164-wk-Fact-BECC0D0D87B75C19893FF47EEFD3A526"
      unitRef="usd">2895000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="FD2020Q4YTD"
      id="d10103689e4184-wk-Fact-53CC052C6E875B0CAA9EF9CA902CCD2D">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e4200-wk-Fact-400777A7ADC25350A435B9FD891BB776"
      unitRef="usd">5854000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e4219-wk-Fact-9DB2FF85DF225BE89EDD1C33278E8376"
      unitRef="usd">2936000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e4238-wk-Fact-EF222D5B5F055691AD794EDD34366343"
      unitRef="usd">2918000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember"
      decimals="-6"
      id="d10103689e4483-wk-Fact-C78B0F8AC8525A00886655D573EA3F45"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember"
      decimals="-6"
      id="d10103689e4521-wk-Fact-C78B0F8AC8525A00886655D573EA3F45"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103689e4537-wk-Fact-6B765AD6C57C5FB492FB1C40E1C1C7B3"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103689e4575-wk-Fact-6B765AD6C57C5FB492FB1C40E1C1C7B3"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d10103689e4658-wk-Fact-F0C879342C705B8FA6E1DDFD04C864B5"
      unitRef="usd">3562000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d10103689e4677-wk-Fact-C1953452B1EB5D9E9D48F755694D8490"
      unitRef="usd">1517000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d10103689e4696-wk-Fact-AB9BCE352E0C587EA93D88C44FEDCC7D"
      unitRef="usd">2045000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d10103689e4717-wk-Fact-AE3B3CCD8F7D5F298AD82A0891BEDF28"
      unitRef="usd">672000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d10103689e4736-wk-Fact-24C3653AD7175971AF1530A3723FCA69"
      unitRef="usd">295000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d10103689e4755-wk-Fact-CB14A9B6D96A5113B209A9C98BE20407"
      unitRef="usd">377000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d10103689e4776-wk-Fact-A93C982DBBBA5EB0BC55A7CF383B732D"
      unitRef="usd">1602000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d10103689e4795-wk-Fact-F054E99347D55845B057AC3A07CAB2EC"
      unitRef="usd">616000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d10103689e4814-wk-Fact-0EBE64AE59E551F4BB22D0A05C89FFB8"
      unitRef="usd">986000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103689e4835-wk-Fact-F13B95D07A7B561CA8C2536FD1B1449E"
      unitRef="usd">5836000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103689e4854-wk-Fact-E5424B236E175115A7AD8A3842FFEAB6"
      unitRef="usd">2428000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103689e4873-wk-Fact-B5C20F3553385C70A045F69A8794546A"
      unitRef="usd">3408000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103689e4899-wk-Fact-94559B23276C5319AA1C6C2270635B6B"
      unitRef="usd">5858000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103689e4918-wk-Fact-E5424B236E175115A7AD8A3842FFEAB6"
      unitRef="usd">2428000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10103689e4937-wk-Fact-03E7792CD4905F4C87900979220E9673"
      unitRef="usd">3430000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10103689e4967-wk-Fact-935B8C1D46CE99D2216A284315CFDF0C"
      unitRef="usd">512000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10103689e4971-wk-Fact-B532A228B3C06CDB4931284315C29834"
      unitRef="usd">531000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10103689e4975-wk-Fact-E13DE713EFAB2F001514284315CD3183"
      unitRef="usd">574000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e5003-wk-Fact-B77C822A66005786A96C082F6E40AD6F"
      unitRef="usd">442000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e5007-wk-Fact-53501F973DEA5E329E05872FFB2B0A7D"
      unitRef="usd">408000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e5011-wk-Fact-80109984808E553BBCC51E411A638FC9"
      unitRef="usd">358000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e5016-wk-Fact-6D16D914A74C5A5D8EB0EB242EC101CD"
      unitRef="usd">329000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10103689e5020-wk-Fact-B37C51C7EF9A5A65930406EB8E59C3B4"
      unitRef="usd">277000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <cah:LeasesTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-8AFE88E318663B6C9D17941EADD41A0D-0-wk-Fact-5892642C657792BAB173941F0289AA40">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;5. Leases&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our operating leases are primarily for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at its inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Beginning July 1, 2019, operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our consolidated balance sheet at lease commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our lease agreements contain lease components and non-lease components. For all asset classes, we have elected to account for both of these components as a single lease component.  We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the consolidated financial statements at or for the fiscal year ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in fiscal 2020 was not material. In addition, upon adoption of the new lease standard, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing 1) whether any contracts are leases or contain leases, 2) lease classification and 3) initial direct costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our leases have remaining lease terms from less than &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; up to approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;22 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the components of lease cost:       &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;134&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Variable lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;164&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Variable lease cost primarily includes payments for property taxes, maintenance and insurance. Our rental expense relating to operating leases&#160;was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$153 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$172 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; in fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes supplemental balance sheet information related to leases at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;426&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;Current portion of operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;104&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;Long-term operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;445&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Current portion of finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our consolidated balance sheet. Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables summarizes supplemental cash flow information related to leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash paid for lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Financing cash flows paid for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Non-cash right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;New operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;New finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amended lease standard adoption impact as of July 1, 2019 &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Includes the effect of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$22 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our operating leases had a weighted-average remaining lease term of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;6.4 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and a weighted-average discount rate of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2.9 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. Our finance leases had a weighted-average remaining lease term of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;4.3 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and a weighted-average discount rate of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2.4 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; . &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Future lease payments under non-cancellable leases as of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; were as follows:&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;                          &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;117&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;127&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total future lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;503&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;539&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: leases not yet commenced &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: imputed interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;445&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The future minimum rental payments for operating leases&#160;having initial or remaining non-cancelable lease terms in excess of one year at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for fiscal 2020 through 2024 and thereafter were as follows: &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$126 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$100 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$76 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$54 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$33 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$94 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;</cah:LeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="FI2020Q4_srt_RangeAxis_srt_MinimumMember"
      id="d10094005e2869-wk-Fact-1FF72909DA53581B9AF9B424323FD8C7">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="FI2020Q4_srt_RangeAxis_srt_MaximumMember"
      id="d10094005e2873-wk-Fact-C556AC05D58E563D85DE63F903B35975">P22Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-453BEB7775627F1806C6940F4687940B-0-wk-Fact-AD5B900794CC6D82D38A940FC293DB7F">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the components of lease cost:       &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;134&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Variable lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;164&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;Variable lease cost primarily includes payments for property taxes, maintenance and insurance. </us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10094005e2927-wk-Fact-D29CEE2F3D2954E2AB77E404313E4669"
      unitRef="usd">134000000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10094005e2942-wk-Fact-9E31BB57ADC850729E006DA9C6F05682"
      unitRef="usd">13000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:VariableLeaseCost
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10094005e2962-wk-Fact-CF6DF23E4032770DB578A4C556257267"
      unitRef="usd">17000000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10094005e2987-wk-Fact-A7E36D1FCBA8D33880C9E2926EBBFB8C"
      unitRef="usd">164000000</us-gaap:LeaseCost>
    <us-gaap:LeaseAndRentalExpense
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10094005e2998-wk-Fact-47894BC1F938E6572E8D28431598499D"
      unitRef="usd">153000000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10094005e3002-wk-Fact-410567B6D95CECC545292843159EC333"
      unitRef="usd">172000000</us-gaap:LeaseAndRentalExpense>
    <cah:LeasesSupplementalBalanceSheetInformationTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-E62BA2C0D9B798C266CD9410DDCC0DDA-0-wk-Fact-45075A23A46600885DA494116788D7FE">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes supplemental balance sheet information related to leases at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;426&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;Current portion of operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;104&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;Long-term operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;445&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Current portion of finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</cah:LeasesSupplementalBalanceSheetInformationTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3086-wk-Fact-F4E5D9F3F808500CA4D0602B93C115F3"
      unitRef="usd">426000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3122-wk-Fact-E15D29793650526991A5F308CE5588EF"
      unitRef="usd">104000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3142-wk-Fact-199EC984E0AC5C2FBAAABB2B996A25F0"
      unitRef="usd">341000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3163-wk-Fact-ED6DACE125C086C0FFB6E2F7634A3ACD"
      unitRef="usd">445000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3225-wk-Fact-D16A356C7DB65A83B6494BD5D33988A3"
      unitRef="usd">33000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3267-wk-Fact-75A3F16B4792529BAEC2C8523A38B257"
      unitRef="usd">9000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3287-wk-Fact-63F29DBC87915E2DA310D85D70FF8187"
      unitRef="usd">25000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3312-wk-Fact-0FED789CA64892187603E2F7B5075D76"
      unitRef="usd">34000000</us-gaap:FinanceLeaseLiability>
    <cah:LeasePaymentsTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-54D2BE6F692341EA3257941BA800778F-0-wk-Fact-8E1A7FF1DEBE1CD07D07941C1129206F">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables summarizes supplemental cash flow information related to leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash paid for lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Financing cash flows paid for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Non-cash right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;New operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;New finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amended lease standard adoption impact as of July 1, 2019 &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Includes the effect of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$22 million&lt;/span&gt;&lt;/span&gt; from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance.</cah:LeasePaymentsTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10094005e3395-wk-Fact-94519B021AD359A4B410E41819280520"
      unitRef="usd">125000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10094005e3410-wk-Fact-8953F2B9C1F55EFDAAB82AF3AACADE1F"
      unitRef="usd">7000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10094005e3451-wk-Fact-CD48E450816A56EC939BC0EF8C154364"
      unitRef="usd">150000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10094005e3471-wk-Fact-CD46892E183F5AC3AD59A7A04AE0216F"
      unitRef="usd">40000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <cah:Impactofadoptionofnewaccountingstandard
      contextRef="D2020Q1SD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cah_ASC842Member"
      decimals="-6"
      id="d10094005e3495-wk-Fact-833C0F21A7C5CBC8DE80A4C535509FC3"
      unitRef="usd">400000000</cah:Impactofadoptionofnewaccountingstandard>
    <cah:ReclassificationofdeferredrentinaccordancewithASC842
      contextRef="D2020Q1SD"
      decimals="-6"
      id="d10094005e3513-wk-Fact-70D0394C1E5C3C142E1A54B51A7F1779"
      unitRef="usd">22000000</cah:ReclassificationofdeferredrentinaccordancewithASC842>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="FI2020Q4"
      id="d10094005e3522-wk-Fact-F8F86975C6B25209B1BD88EB92071244">P6Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="FI2020Q4"
      decimals="3"
      id="d10094005e3526-wk-Fact-5F4DAF181CE35385A025110FC7F3F9E7"
      unitRef="number">0.029</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="FI2020Q4"
      id="d10094005e3530-wk-Fact-15E9E77BF9010C0994CCA5CEF4A999F4">P4Y3M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="FI2020Q4"
      decimals="3"
      id="d10094005e3534-wk-Fact-0F9927B57C4213E54940A5D00035C371"
      unitRef="number">0.024</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-BB45401D58C4CDA9270F941CBF064B34-0-wk-Fact-401820EC22D37B828D43941D29632A67">&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Future lease payments under non-cancellable leases as of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; were as follows:&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;                          &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;117&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;127&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total future lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;503&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;539&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: leases not yet commenced &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: imputed interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;445&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d10094005e3644-wk-Fact-CC6271E0296556C8AF6D1AC803361D49"
      unitRef="usd">117000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d10094005e3663-wk-Fact-1A8779ABB7AD5487A0B8B2E28020F950"
      unitRef="usd">10000000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3682-wk-Fact-9C742072AC0B54188BB8EEA3A1D343AD"
      unitRef="usd">127000000</cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d10094005e3698-wk-Fact-28413AC191E554179C124229CF6EC777"
      unitRef="usd">96000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d10094005e3717-wk-Fact-C46545D4988F5C7EB388D6240FECB85B"
      unitRef="usd">9000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <cah:LesseeLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3736-wk-Fact-38D322AF086F515899FCC8A7AD9BCE61"
      unitRef="usd">105000000</cah:LesseeLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d10094005e3757-wk-Fact-CA74593AD1935B36ABDE2CA42C40450E"
      unitRef="usd">72000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d10094005e3776-wk-Fact-CFB206162CC55548B221A19140F3F6DD"
      unitRef="usd">9000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <cah:LesseeLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3795-wk-Fact-A7BE57CAEC4652AB9BF9F6DD704B73ED"
      unitRef="usd">81000000</cah:LesseeLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d10094005e3816-wk-Fact-4818A5C54B6C5F01BAEB8E6AB351D9BD"
      unitRef="usd">51000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d10094005e3835-wk-Fact-B8CC0BABA54A53199E8057343EB8C167"
      unitRef="usd">4000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <cah:LesseeLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3854-wk-Fact-893B6F2EA2645CD7AF0359887F5E8953"
      unitRef="usd">55000000</cah:LesseeLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d10094005e3875-wk-Fact-27B91ACEAAB35C02B50B4A84D5BFAD0E"
      unitRef="usd">44000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d10094005e3894-wk-Fact-2C1CA7E33D5F595BB6192190FA41D5D8"
      unitRef="usd">2000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <cah:LesseeLeaseLiabilityPaymentsDueYearFive
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3913-wk-Fact-CC49054E4FCB5E33A10B6F527B41BDB7"
      unitRef="usd">46000000</cah:LesseeLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d10094005e3934-wk-Fact-65E559578F145C589DF193037B8B179E"
      unitRef="usd">123000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d10094005e3953-wk-Fact-7E6425FF91F85634A2D59BB030D295C8"
      unitRef="usd">2000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e3972-wk-Fact-208DF7B657AD5E7BB17FA04B4A8CAFF1"
      unitRef="usd">125000000</cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d10094005e3993-wk-Fact-1B157BD921A75D5DBEE210C43DBA4C6D"
      unitRef="usd">503000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d10094005e4012-wk-Fact-59FE7F248D55533C95AF805CCE33F98B"
      unitRef="usd">36000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <cah:TotalLeaseLiabilityPaymentsDue
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e4031-wk-Fact-42A4436E89AA5A9DB5EE4F0129069BDB"
      unitRef="usd">539000000</cah:TotalLeaseLiabilityPaymentsDue>
    <cah:LesseeOperatingLeaseLiabilityNotYetCommencedAmount
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d10094005e4056-wk-Fact-A2E7D77B7E0158B0BF8786CF2DCF7D13"
      unitRef="usd">4000000</cah:LesseeOperatingLeaseLiabilityNotYetCommencedAmount>
    <cah:LesseeFinanceLeaseLiabilityNotYetCommencedAmount
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d10094005e4075-wk-Fact-BBE57EC26B535CDBA90BE9C019ED5C40"
      unitRef="usd">0</cah:LesseeFinanceLeaseLiabilityNotYetCommencedAmount>
    <cah:TotalLeaseLiabilityNotYetCommencedAmount
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e4094-wk-Fact-428E72E3D7065F54A2C4F3305DF84431"
      unitRef="usd">4000000</cah:TotalLeaseLiabilityNotYetCommencedAmount>
    <cah:OperatingLeaseImputedInterest
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d10094005e4115-wk-Fact-27FD9A02F69C5357B20AB6AA12D22D22"
      unitRef="usd">54000000</cah:OperatingLeaseImputedInterest>
    <cah:FinanceLeaseImputedInterest
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d10094005e4134-wk-Fact-893198D2FBE352449E10424860A1F302"
      unitRef="usd">2000000</cah:FinanceLeaseImputedInterest>
    <cah:TotalLeaseLiabilityUndiscountedExcessAmount
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e4153-wk-Fact-DD76697FC7F6560F8FC746F0B78B456C"
      unitRef="usd">56000000</cah:TotalLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d10094005e4179-wk-Fact-2B273AFABE0F5A3C9ABEA5D08EC84F1A"
      unitRef="usd">445000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2020Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d10094005e4198-wk-Fact-D879A5B19B1C56BF82794EE6625CC797"
      unitRef="usd">34000000</us-gaap:FinanceLeaseLiability>
    <cah:TotalLeaseLiability
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10094005e4217-wk-Fact-AB1B09137E295A458BF3DCAE8F9A6C5A"
      unitRef="usd">479000000</cah:TotalLeaseLiability>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10094005e4243-wk-Fact-5BDFC3A1686B1ED760B054B51A7FFD9A"
      unitRef="usd">126000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10094005e4247-wk-Fact-57F12B10BCAEDFFFB8D654B51B2989E4"
      unitRef="usd">100000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10094005e4251-wk-Fact-DCE5995520BBE9E2F97954B51B22107F"
      unitRef="usd">76000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10094005e4255-wk-Fact-2E8E6B739775003C52BC54B51B0D31F1"
      unitRef="usd">54000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10094005e4260-wk-Fact-C8FB2AABFA729C12234A54B51B2413F5"
      unitRef="usd">33000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10094005e4264-wk-Fact-0E28B44946A3B30B2EAE54B51A81ADCE"
      unitRef="usd">94000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-9BE4C58C6D094B6DCE3A28431665ED32-0-wk-Fact-C2E78A137CDACF7ACBE5284316077780">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;6. Long-Term Obligations and Other Short-Term Borrowings&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes long-term obligations and other short-term borrowings at June 30:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions) (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2.4% Notes due 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;450&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.625%&#160;Notes due 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2.616% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;834&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,079&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.2% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;236&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;247&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Floating Rate Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;321&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;340&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.2% Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;576&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;551&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.079% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;809&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;781&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.5% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;413&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;402&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.75% Notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;494&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.41% Notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,215&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.6% Notes due 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;340&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;346&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.5% Notes due 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.9% Notes due 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;441&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;445&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.368% Notes due 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;560&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;594&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;7.0%&#160;Debentures due 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;124&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;124&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other Obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6,775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: current portion of long-term obligations and other short-term borrowings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;452&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#160;&#160;&#160;Long-term obligations, less current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6,765&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7,579&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)      Maturities are presented on a calendar year basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Maturities of existing long-term obligations and other short-term borrowings for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2021&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; through &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2025&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and thereafter are as follows: &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$10 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.4 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$585 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$814 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$414 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$3.6 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. The &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;7.0%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; Debentures represent unsecured obligations of Allegiance Corporation (a wholly-owned subsidiary), which Cardinal Health, Inc. has guaranteed. None of these obligations are subject to a sinking fund and the Allegiance obligations are not redeemable prior to maturity. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$21.4 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In June 2020, we redeemed &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$500 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; aggregate principle amount of 4.625% Notes due December 2020 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with the redemption, we recorded a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; loss on early extinguishment of debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;During fiscal 2020, we also early repurchased&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$247 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;of the&#160;2.616%&#160;Notes due 2022,&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$11 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;of the&#160;3.2% Notes due 2022,&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$20 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;of the&#160;Floating Rate Notes due 2022,&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$104 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;of the&#160;3.41% Notes due 2027,&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;of the&#160;4.6% Notes due 2043,&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;of the&#160;4.9% Notes due 2045, and&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$35 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;of the&#160;4.368% Notes due 2047.&#160; In connection with the early debt repurchases, we recognized a&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;loss on early extinguishment of debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In November 2019, we repaid the full principal of the 2.4% Notes due 2019 at maturity for&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$450 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The redemption and repurchases were paid for with available cash and other short-term borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In fiscal 2019, we repurchased &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$67 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of the 2.616% Notes due 2022, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of the 3.2% Notes due 2022, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of the Floating Rate Notes due 2022, and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$24 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of the 3.41% Notes due 2027 for a total of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$100 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. The repurchases were paid for with available cash. The loss on early extinguishment of debt in connection with these early repurchases was immaterial. We also paid off the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; 1.948% Notes due 2019 as they became due with available cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In June 2018, we repaid the full principal of the 1.95% Notes due 2018 at maturity for &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$550 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;If we undergo a change of control, as defined in the notes, and if the notes receive specified ratings below investment grade by each of Standard &amp;amp; Poors Ratings Services, Moody&#x2019;s Investors Services and Fitch Ratings, any holder of the notes, excluding the debentures, can require with respect to the notes owned by such holder, or we can offer, to repurchase the notes at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;101%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of the principal amount plus accrued and unpaid interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Other Financing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;commercial paper program &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;backed by a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;revolving credit facility. We also have a&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;committed receivables sales facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#x201c;CHF&#x201d;) through September 30, 2022. CHF was organized for&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;"&gt;Our revolving credit and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter through December 2020, a consolidated net leverage ratio of no more than 4.00-to-1. The maximum permitted ratio will reduce to 3.75-to-1 in March 2021 and as of the end of every quarter thereafter&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. As of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we were in compliance with this financial covenant.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, we had no amounts outstanding under the revolving credit facility; however, availability was reduced by outstanding letters of credit of  &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$24 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at  &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Under our committed receivables sales facility program, we had a maximum amount outstanding of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$700 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and an average daily amount outstanding of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$12 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; during fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. We also had no amounts outstanding under the committed receivables sales facility program; however, availability was reduced by outstanding standby letters of credit of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$29 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$30 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Under our commercial paper program we had a maximum amount outstanding of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.7 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and an average daily amount outstanding of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$183 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; during fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. We had no amounts outstanding under the commercial paper program as of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We also maintain other short-term credit facilities and an unsecured line of credit that allowed for borrowings up to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. The &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$35 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$10 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; balance of other obligations at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, consisted of short-term borrowings and finance leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-8FD28214F0771ED335CE28431665F83A-0-wk-Fact-A9AC983CE221C70B469F284316032ABF">&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes long-term obligations and other short-term borrowings at June 30:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions) (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2.4% Notes due 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;450&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.625%&#160;Notes due 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2.616% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;834&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,079&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.2% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;236&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;247&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Floating Rate Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;321&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;340&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.2% Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;576&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;551&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.079% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;809&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;781&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.5% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;413&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;402&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.75% Notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;494&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.41% Notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,215&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.6% Notes due 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;340&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;346&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.5% Notes due 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.9% Notes due 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;441&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;445&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.368% Notes due 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;560&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;594&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;7.0%&#160;Debentures due 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;124&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;124&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other Obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6,775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: current portion of long-term obligations and other short-term borrowings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;452&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#160;&#160;&#160;Long-term obligations, less current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6,765&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7,579&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)      Maturities are presented on a calendar year basis. &lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member"
      decimals="-6"
      id="d10107867e2931-wk-Fact-FA7A04C5186E5725A99D33A728378540"
      unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member"
      decimals="-6"
      id="d10107867e2950-wk-Fact-783CBE09F2735960A70552634DD6943B"
      unitRef="usd">450000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member"
      decimals="-6"
      id="d10107867e2965-wk-Fact-28841080EA3F5240B410CF9A06648B79"
      unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member"
      decimals="-6"
      id="d10107867e2984-wk-Fact-5EEC6C1340D65150BF6324267464F69E"
      unitRef="usd">508000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member"
      decimals="-6"
      id="d10107867e3004-wk-Fact-78E2DB28A5D254A3B2BA7172AB40DC2E"
      unitRef="usd">834000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member"
      decimals="-6"
      id="d10107867e3023-wk-Fact-C8B1B803E0BA54FDA54E3D19F24A66F1"
      unitRef="usd">1079000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member"
      decimals="-6"
      id="d10107867e3043-wk-Fact-134BD797E4ED503E8AE96B246002C3EC"
      unitRef="usd">236000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member"
      decimals="-6"
      id="d10107867e3062-wk-Fact-FB8328D9008C5AA7BDB0F5F48425D2E6"
      unitRef="usd">247000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member"
      decimals="-6"
      id="d10107867e3082-wk-Fact-6F8E9F26B52359C4A20BB3E9DFA87DEB"
      unitRef="usd">321000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member"
      decimals="-6"
      id="d10107867e3101-wk-Fact-CB181FE7D0735E59840BE5CD9FFD04F7"
      unitRef="usd">340000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member"
      decimals="-6"
      id="d10107867e3121-wk-Fact-A47489877A785137A6575161011B3EE2"
      unitRef="usd">576000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member"
      decimals="-6"
      id="d10107867e3140-wk-Fact-774D3727FEF4565A933647F341ADBE56"
      unitRef="usd">551000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member"
      decimals="-6"
      id="d10107867e3160-wk-Fact-53B1AF8785A05D45856192F8D114B899"
      unitRef="usd">809000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member"
      decimals="-6"
      id="d10107867e3179-wk-Fact-FF1FE4E200A05667A704A25512125CE6"
      unitRef="usd">781000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member"
      decimals="-6"
      id="d10107867e3199-wk-Fact-7CB156375A255DA083E882E6429E989D"
      unitRef="usd">413000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member"
      decimals="-6"
      id="d10107867e3218-wk-Fact-E3A9D83663A05C18B6A2DBF9E665DC3C"
      unitRef="usd">402000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member"
      decimals="-6"
      id="d10107867e3238-wk-Fact-58B86DE147825EB2BA3B6CE89E532A4F"
      unitRef="usd">529000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member"
      decimals="-6"
      id="d10107867e3257-wk-Fact-C2B2E64183915C5FB19DD45CFDC98BFD"
      unitRef="usd">494000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member"
      decimals="-6"
      id="d10107867e3277-wk-Fact-996824975C9054ED883E9A355BEA5ABC"
      unitRef="usd">1215000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member"
      decimals="-6"
      id="d10107867e3296-wk-Fact-1B6143F2BB885125811A830774EBC686"
      unitRef="usd">1318000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member"
      decimals="-6"
      id="d10107867e3317-wk-Fact-57D62AC6CDBE5714A87FFC3BB1EF2F02"
      unitRef="usd">340000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member"
      decimals="-6"
      id="d10107867e3336-wk-Fact-81761FC22E5B55A78ADFB12140FDE321"
      unitRef="usd">346000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member"
      decimals="-6"
      id="d10107867e3356-wk-Fact-9FA9B0340A9B58DD97F8CFDF9F9D293A"
      unitRef="usd">342000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member"
      decimals="-6"
      id="d10107867e3375-wk-Fact-D97433900EFD5D3EA1E722F51C3CE210"
      unitRef="usd">342000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member"
      decimals="-6"
      id="d10107867e3395-wk-Fact-78BDA8DEC9A9555F9FCBEF1FFED9DADB"
      unitRef="usd">441000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member"
      decimals="-6"
      id="d10107867e3414-wk-Fact-BD56768C53FE507D98B3B1E46442526A"
      unitRef="usd">445000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member"
      decimals="-6"
      id="d10107867e3434-wk-Fact-86263AC3CF3C531CAAB0C4116598A1DE"
      unitRef="usd">560000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member"
      decimals="-6"
      id="d10107867e3453-wk-Fact-F8439A8590B15F45AA22BF775C0DE25B"
      unitRef="usd">594000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member"
      decimals="-6"
      id="d10107867e3473-wk-Fact-8FAAD6C41FAD55A29293FE11268FC89B"
      unitRef="usd">124000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member"
      decimals="-6"
      id="d10107867e3492-wk-Fact-BFF6821DB20054EA8AD10789B45D1107"
      unitRef="usd">124000000</us-gaap:NotesPayable>
    <us-gaap:OtherBorrowings
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10107867e3512-wk-Fact-181981B23BBF57169C5A09E380550C88"
      unitRef="usd">35000000</us-gaap:OtherBorrowings>
    <us-gaap:OtherBorrowings
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10107867e3531-wk-Fact-CF6A6D11A95A520CA8CCE9E69188DD5C"
      unitRef="usd">10000000</us-gaap:OtherBorrowings>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10107867e3551-wk-Fact-9DA8E8BB8C8F5C549572884EE1EA482D"
      unitRef="usd">6775000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10107867e3570-wk-Fact-94C2B7ADE99F539DB0231B2DC19C1620"
      unitRef="usd">8031000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10107867e3590-wk-Fact-AEE6885C79795EC8BD6D2D94473CEAC3"
      unitRef="usd">10000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10107867e3609-wk-Fact-65E8671C68655ED487958DD7FF10BC0C"
      unitRef="usd">452000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10107867e3634-wk-Fact-1AC0DDF0A60D5B1AA8B9E0BB56255504"
      unitRef="usd">6765000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10107867e3653-wk-Fact-19FEF4F9B77450E896FB33A6F288C5A4"
      unitRef="usd">7579000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10107867e3679-wk-Fact-4FB450083541D7BCAA58284316088E7F"
      unitRef="usd">10000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10107867e3683-wk-Fact-6016D8E4FF39BD67BAA42843160AA9D1"
      unitRef="usd">1400000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10107867e3687-wk-Fact-87524B13B4AF9F281C44284316110452"
      unitRef="usd">585000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10107867e3692-wk-Fact-0BC639FB74B28C5FFACE2843160E7E24"
      unitRef="usd">814000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10107867e3696-wk-Fact-1301E97ECBBA91A149A22843160BF64D"
      unitRef="usd">414000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10107867e3700-wk-Fact-36C86E37DA329B627E5E284316029947"
      unitRef="usd">3600000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2020Q4_dei_LegalEntityAxis_cah_AllegianceCorporationMember_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member"
      decimals="INF"
      id="d10107867e3710-wk-Fact-8938FEE674980423E69128431609C597"
      unitRef="number">0.070</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2020Q4"
      decimals="-8"
      id="d10107867e3714-wk-Fact-29CF716DBEE25839A6737A9DA31469C4"
      unitRef="usd">21400000000</us-gaap:AccountsPayableCurrent>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member"
      decimals="-6"
      id="d10107867e3721-wk-Fact-0E01340FEA849A26B9F7B6452EE02B20"
      unitRef="usd">500000000</cah:NotesPayableRepurchased>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member"
      decimals="-6"
      id="d10107867e3725-wk-Fact-9A26BE4AD65B862A239DB6181A88D47B"
      unitRef="usd">7000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member"
      decimals="-6"
      id="d10107867e3732-wk-Fact-840A572B44E450F5859ADDB349D7BC8F"
      unitRef="usd">247000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member"
      decimals="-6"
      id="d10107867e3736-wk-Fact-60C67F50EEAE5D03B2FABA2A828B4487"
      unitRef="usd">11000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member"
      decimals="-6"
      id="d10107867e3740-wk-Fact-40BC2DDBCFED554DBDAEF5FB7B6A432F"
      unitRef="usd">20000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member"
      decimals="-6"
      id="d10107867e3744-wk-Fact-66AADD9234FC5B99B05DE9237A65B10F"
      unitRef="usd">104000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member"
      decimals="-6"
      id="d10107867e3748-wk-Fact-E7E53EE2A5445787B318D1ADFAEC52FE"
      unitRef="usd">6000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member"
      decimals="-6"
      id="d10107867e3753-wk-Fact-A18EC9E8DBFC5C54B0CE9709E694EAF1"
      unitRef="usd">5000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member"
      decimals="-6"
      id="d10107867e3757-wk-Fact-113DB8463AB75E838ED8EB31929E67DB"
      unitRef="usd">35000000</cah:NotesPayableRepurchased>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2020Q4YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember"
      decimals="-6"
      id="d10107867e3761-wk-Fact-6C1D5F13968A0EC7F5A2B619EBFA7507"
      unitRef="usd">9000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="D2020Q2NotesPayable_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member"
      decimals="-6"
      id="d10107867e3768-wk-Fact-33CAF7D006ACD940E14BB61B40B1666F"
      unitRef="usd">450000000</us-gaap:RepaymentsOfNotesPayable>
    <cah:NotesPayableRepurchased
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member"
      decimals="-6"
      id="d10107867e3778-wk-Fact-E7A7E9210E01F4547A41B61ED132FCC0"
      unitRef="usd">67000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member"
      decimals="-6"
      id="d10107867e3782-wk-Fact-633737ED3D2CB3797635B6403E1181F7"
      unitRef="usd">1000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member"
      decimals="-6"
      id="d10107867e3786-wk-Fact-AEAF04A031F1429E37E9B61F7E5966D8"
      unitRef="usd">8000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member"
      decimals="-6"
      id="d10107867e3790-wk-Fact-D506E0B80FAEBD5027F9B61FE09B321A"
      unitRef="usd">24000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10107867e3794-wk-Fact-193369BFF4FA49F61A87B639A5A02C54"
      unitRef="usd">100000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2019Q4YTD_us-gaap_DebtInstrumentAxis_cah_A1.948Notesdue2019Member"
      decimals="-6"
      id="d10107867e3799-wk-Fact-76CEA39F5722215AB74FB63D8753C624"
      unitRef="usd">1000000000.0</cah:NotesPayableRepurchased>
    <us-gaap:ProceedsFromRepaymentsOfNotesPayable
      contextRef="D2018Q4SD195notes_us-gaap_DebtInstrumentAxis_cah_OnePointNineFiveNotesdue2018Member"
      decimals="-6"
      id="d10107867e3807-wk-Fact-C5F8A24668EC8DC941B3A66E546F658D"
      unitRef="usd">550000000</us-gaap:ProceedsFromRepaymentsOfNotesPayable>
    <cah:OfferAsPercentageOfPrincipalAmount
      contextRef="FD2020Q4YTD"
      decimals="INF"
      id="d10107867e3814-wk-Fact-F898D1C7866E46DCDE6D2843160A3F70"
      unitRef="number">1.01</cah:OfferAsPercentageOfPrincipalAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember"
      decimals="-6"
      id="d10107867e3824-wk-Fact-7D45EA3096315D529AA3BF326D0BDFDC"
      unitRef="usd">2000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember"
      decimals="-6"
      id="d10107867e3831-wk-Fact-024DBDB8A5655BAFBEFBE8FB34CA5B1B"
      unitRef="usd">2000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2020Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember"
      decimals="-6"
      id="d10107867e3835-wk-Fact-74A5727D1EF6591A933CDB136522BA33"
      unitRef="usd">1000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember"
      decimals="-6"
      id="d10107867e3867-wk-Fact-6D5418BCA11D9AC5AF742843160B511A"
      unitRef="usd">1000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember"
      decimals="-6"
      id="d10107867e3871-wk-Fact-EE53C84463CDBC12C1C3A66FEA42DFC1"
      unitRef="usd">24000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod
      contextRef="FD2020Q4YTD_us-gaap_CreditFacilityAxis_cah_CommittedReceivablesSalesFacilityProgramMember"
      decimals="-6"
      id="d10107867e3887-wk-Fact-B0599BCF11243290FD3CA67185B97D85"
      unitRef="usd">700000000</us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod>
    <us-gaap:LineOfCreditFacilityAverageOutstandingAmount
      contextRef="FD2020Q4YTD_us-gaap_CreditFacilityAxis_cah_CommittedReceivablesSalesFacilityProgramMember"
      decimals="-6"
      id="d10107867e3891-wk-Fact-03CFAD8EBC60D48B6382A672C1EB38C6"
      unitRef="usd">12000000</us-gaap:LineOfCreditFacilityAverageOutstandingAmount>
    <us-gaap:LineOfCredit
      contextRef="FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember"
      decimals="-6"
      id="d10107867e3899-wk-Fact-FBF9CAAF04A45A1CC9282843160D4EF2"
      unitRef="usd">29000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember"
      decimals="-6"
      id="d10107867e3903-wk-Fact-094C8F068F4FB43203742843160FF9B1"
      unitRef="usd">30000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod
      contextRef="FD2020Q4YTD_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember"
      decimals="-6"
      id="d10107867e3919-wk-Fact-0F79EF30E1EC300872B1A6745BEBC61F"
      unitRef="usd">1700000000</us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod>
    <us-gaap:LineOfCreditFacilityAverageOutstandingAmount
      contextRef="FD2020Q4YTD_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember"
      decimals="-6"
      id="d10107867e3923-wk-Fact-3F95231F3937E6A494DFA6750F7E00C5"
      unitRef="usd">183000000</us-gaap:LineOfCreditFacilityAverageOutstandingAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2020Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember"
      decimals="-6"
      id="d10107867e3942-wk-Fact-C57AAC7F1D52FC7BF5A9284316105DF7"
      unitRef="usd">6000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember"
      decimals="-6"
      id="d10107867e3946-wk-Fact-3A1D8170067CC74F35DE2843160DCB67"
      unitRef="usd">9000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:OtherBorrowings
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10107867e3958-wk-Fact-181981B23BBF57169C5A09E380550C88"
      unitRef="usd">35000000</us-gaap:OtherBorrowings>
    <us-gaap:OtherBorrowings
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10107867e3963-wk-Fact-CF6A6D11A95A520CA8CCE9E69188DD5C"
      unitRef="usd">10000000</us-gaap:OtherBorrowings>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-EA085B351F09AB1CD3AA2843166658F5-0-wk-Fact-231F5D65E6EBC51A78B42843159B25E7">h Corporation ("CVS Health")&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Red Oak Sourcing, LLC ("Red Oak Sourcing") is a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term through June 2024. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. Due to the achievement of predetermined milestones, we are required to make quarterly payments of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$45.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; to CVS Health for the initial term.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;New York Opioid Stewardship Act&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In April 2018, the State of New York passed a budget which included the Opioid Stewardship Act (the "OSA"). The OSA created an aggregate $100 million annual assessment on all manufacturers and distributors licensed to sell or distribute opioids in New York. Under the OSA, each licensed manufacturer and distributor would be required to pay a portion of the assessment based on its share of the total morphine milligram equivalents sold or distributed in New York during the applicable calendar year, beginning in 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In December 2018, the U.S. District Court for the Southern District of New York ruled that the OSA is unconstitutional and enjoined its enforcement (the "Ruling"). In January 2019, the State filed notice of its intent to appeal the Ruling. In April 2019, the State, among other things, amended the OSA so that the assessment would only cover opioid sales in 2017 and 2018, subject to the State's pending appeal of the Ruling. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We accrue contingencies if it is probable that a liability has been incurred and the amount can be estimated. At June 30, 2020, we have no amounts accrued for the OSA because we do not believe it is probable that a liability has been incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We become involved from time to time in disputes, litigation and regulatory matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;From time to time, we determine that products we source, manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions have led to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, product liability claims and lawsuits and can lead to action by regulators. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information could directly or indirectly lead to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We may be named from time to time in &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;qui tam&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;qui tam&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;"&gt;Opioid Lawsuits and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Pharmaceutical wholesale distributors, including us, have been named as defendants in over &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;3,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; lawsuits relating to the distribution of prescription opioid pain medications. The lawsuits seek equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as public nuisance, negligence and unjust enrichment as well as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. These lawsuits also name pharmaceutical manufacturers, retail pharmacy chains and other entities as defendants.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;States &amp;amp; Political Subdivisions&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;2,800&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of these lawsuits have been filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The vast majority of these lawsuits were filed in U.S. federal court and have been transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#x201c;MDL&#x201d;).  &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In January 2020, the complaints of Cabell County and City of Huntington, West Virginia were remanded from the MDL to U.S. District Court in West Virginia.  A trial date has been set for October 2020.  In addition, the complaints of San Francisco, California and the Cherokee Nation have been remanded to their original district courts.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In addition, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; state attorneys general have filed lawsuits against distributors, including us, in various state courts.  A trial in New York for cases brought by the New York Attorney General and Nassau and Suffolk counties was scheduled to begin in March 2020, but was deferred due to the COVID-19 pandemic. A trial is scheduled to begin in Madison County, Ohio, in October 2020 for the case brought by the Ohio Attorney General. A state court trial in a case brought by &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;certain West Virginia political subdivisions is scheduled for March 2021.  Additionally, we have received requests, civil investigative demands, subpoenas or requests for information from additional state attorneys general offices and governmental authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In October 2019, we agreed in principle to a global settlement framework with a leadership group of state attorneys general that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions (the "Settlement Framework"). This Settlement Framework is subject to contingencies and uncertainties as to final terms, but is the basis for our negotiation of definitive terms and documentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The Settlement Framework includes (1) a cash &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;component&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, pursuant to which we would pay up to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.56 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; over &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;eighteen years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, (2) development and participation in a program for  distribution of opioid abuse treatment medications for a period of ten years, and (3) to-be specified industry-wide changes to controlled substance anti-diversion programs. Definitive terms for a settlement pursuant to the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. In connection with these matters, we have &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.56 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; accrued at June 30, 2020, included in deferred income taxes and other liabilities in the consolidated balance sheets, which represents the cash component. We are unable to estimate the range of possible loss associated with these matters. We are unable to reasonably estimate the liability or cost associated with the other components of the Settlement Framework, the potential distribution of treatment medications and any incremental costs for changes to our controlled substance anti-diversion program that we may agree to.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In the fiscal year ended June 30, 2020, we along with two other national distributors entered into a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$215 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; settlement with two Ohio counties, Cuyahoga and Summit, to resolve all claims in the first bellwether trial in the MDL, which had been set for trial for October 2019. In connection with this settlement, we incurred &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$66 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; within litigation (recoveries)/charges, net during the fiscal year ended June 30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In connection with these matters (including the settlement with two Ohio counties), we recorded a total pre-tax charge of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.14 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; after tax) during the fiscal year ended June 30, 2020 in litigation (recoveries)/charges, net, in the consolidated statement of earnings/(loss) for the cash component. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual. We continue to strongly dispute the allegations made in these lawsuits and reaching an agreement in principle on a global settlement framework is not an admission of liability or wrongdoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Private Plaintiffs&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The Settlement Framework does not address claims by private plaintiffs, which includes unions and other health and welfare funds, hospital systems and other healthcare providers, businesses and &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;individuals. Private plaintiffs had brought approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;400&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; lawsuits as of July 28, 2020. Of these, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;106&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs relating to the distribution of controlled substances. We are vigorously defending ourselves in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Department of Justice Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We have received federal grand jury subpoenas issued in connection with investigations being conducted by the U.S. Attorney's Office for the Eastern District of New York and the Fraud Section of the U.S. Department of Justice ("DOJ"). The subpoenas seek documents  relating to our anti-diversion policies, procedures and program, and our distribution of certain controlled substances. We are cooperating with these requests.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Product Liability Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;As of July 28, 2020, we are named as a defendant in &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;334&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;4,280&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. Another &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;31&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; lawsuits involving similar claims by approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;36&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. We continue to vigorously defend ourselves in these lawsuits and have begun to engage in preliminary resolution discussions with plaintiffs.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#5b9bd5;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At June&#160;30, 2020, we had a total of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"&gt;&lt;span&gt;$468 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, net of estimated insurance recoveries, accrued for losses and legal defense costs related to the Cordis IVC filter lawsuits which are presented on a gross basis in the consolidated balance sheets. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range to be approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"&gt;&lt;span&gt;$919 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, net of estimated insurance recoveries.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Shareholder Securities Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In August 2019, the Louisiana Sheriffs' Pension &amp;amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. The complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. In June 2020, the court appointed 1199 SEIU Health Care Employees Pension Fund as lead plaintiff. We believe that the claims asserted in this complaint are without merit and intend to vigorously defend against them. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Surgical Gown Recalls&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In January 2020, we issued a voluntary recall for &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;9.1 million&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; AAMI Level 3 surgical gowns and two voluntary field actions (a recall of some packs and a corrective action allowing overlabeling of other packs) for 2.9 million Presource Procedure Packs containing affected &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;gowns (together, the "Recalls"). These Recalls were necessary because we discovered in December 2019 that one of our FDA-registered suppliers in China had shifted production of some gowns to unapproved sites with uncontrolled manufacturing environments. Because of this, we could not assure sterility of the gowns. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In connection with these Recalls, in the fiscal year ended June 30, 2020, we recorded total charges of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$85 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, of which &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$48 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; is within cost of products sold and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$37 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; is within SG&amp;amp;A in the consolidated statements of earnings/(loss). This charge represents our best estimate of costs for the Recalls and includes inventory write-off costs and certain remediation and supply disruption costs, such as costs to replace recalled products. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Other Civil Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Generic Pharmaceutical Pricing Antitrust Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In December 2019, pharmaceutical distributors including us were added as defendants in a civil class action lawsuit filed by indirect purchasers of generic drugs, such as hospitals and retail pharmacies. The indirect purchaser case is part of a multidistrict litigation consisting of multiple individual class action matters consolidated in the Eastern District of Pennsylvania. The indirect purchaser plaintiffs allege that pharmaceutical distributors encouraged manufacturers to increase prices, provided anti-competitive pricing information to manufacturers and improperly engaged in customer allocation. We have filed a motion to dismiss the complaints and we intend to vigorously defend ourselves in this matter. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Active Pharmaceutical Ingredient Impurity Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Many participants in the pharmaceutical supply chain, including active pharmaceutical ingredient ("API") manufacturers, finished dose manufacturers, repackagers (including us), distributors (including us), and retailers have been named as defendants in lawsuits arising out of recalls of certain medications due to alleged impurities in the active pharmaceutical ingredients or finished product. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In February 2019, a Multidistrict Litigation was created in the U.S. District Court for the District of New Jersey (the &#x201c;Sartan MDL&#x201d;) alleging API impurities in certain generic blood pressure medications. We were recently named as a defendant in a Multidistrict Litigation alleging API impurities in Zantac and its generic form, ranitidine. We intend to vigorously defend ourselves in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Antitrust Litigation Proceeds&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"&gt;We received and recognized income resulting from settlements of lawsuits in which we were a class member or plaintiff of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$16 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;,&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"&gt;&lt;span&gt;$94 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"&gt;&lt;span&gt;$22 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"&gt;  during fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"&gt;,  and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"&gt;2018&lt;/span&gt;, respectively.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <cah:MaximumQuarterlyPayment
      contextRef="FD2020Q4YTD_srt_MajorCustomersAxis_cah_CVSHealthMember"
      decimals="-5"
      id="d10111338e2871-wk-Fact-133E85DA714658D4855E16F9A784C02F"
      unitRef="usd">45600000</cah:MaximumQuarterlyPayment>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q4_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d10111338e2937-wk-Fact-720FAE897D63652E4D84D9F63E69A1CA"
      unitRef="number">3000</cah:LossContingencyLawsuitsNumber>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q4_srt_LitigationCaseAxis_cah_OpioidLawsuitsStateDomain_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d10111338e2947-wk-Fact-FDA0BC7079475FD4B44FD7E0DE83BCDD"
      unitRef="number">2800</cah:LossContingencyLawsuitsNumber>
    <cah:NumberofStateAttorneysGeneralfilinglawsuits
      contextRef="I2020Q4_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d10111338e2958-wk-Fact-57FC158950C25CBB81C08952396C0849"
      unitRef="StateAG">25</cah:NumberofStateAttorneysGeneralfilinglawsuits>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember"
      decimals="-7"
      id="d10111338e2975-wk-Fact-A0BA3C98E766574492379451719F070A"
      unitRef="usd">5560000000</us-gaap:LitigationReserve>
    <cah:CashComponentForSettlementFrameworkTerm
      contextRef="FD2020Q4YTD_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember"
      id="d10111338e2979-wk-Fact-AF2082243E7C57E7ADD86F94B9E23E83">P18Y</cah:CashComponentForSettlementFrameworkTerm>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember"
      decimals="-7"
      id="d10111338e2983-wk-Fact-A0BA3C98E766574492379451719F070A"
      unitRef="usd">5560000000</us-gaap:LitigationReserve>
    <cah:OpioidTotalSettlementCuyahogaandSummitCounties
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10111338e2990-wk-Fact-224A68188626581F9A30152BDAEEC882"
      unitRef="usd">215000000</cah:OpioidTotalSettlementCuyahogaandSummitCounties>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q4YTD_srt_LitigationCaseAxis_cah_OpioidLitigationCuyahogaandSummitCountiesMember"
      decimals="-6"
      id="d10111338e2994-wk-Fact-9DF8B72E3AD55366A8818DF2C78B9655"
      unitRef="usd">-66000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-6"
      id="d10111338e3001-wk-Fact-7BEE7B16CCFA59729DF5EFBDE17CAEA0"
      unitRef="usd">-5630000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember"
      decimals="-6"
      id="d10111338e3005-wk-Fact-3BA3C56106F25C3CBCB9EB04F56E6EB3"
      unitRef="usd">-5140000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q4_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d10111338e3018-wk-Fact-D0087EAEB2735294BE2DBC7CFE363464"
      unitRef="lawsuit">400</cah:LossContingencyLawsuitsNumber>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q4_cah_LawsuitTypeAxis_cah_ClassActionLawsuitsMember_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d10111338e3022-wk-Fact-39B4B1A9302C5B5BBCB10269D42810B4"
      unitRef="lawsuit">106</cah:LossContingencyLawsuitsNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="D2020Q4litigation_us-gaap_LossContingenciesByNatureOfContingencyAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d10111338e3039-wk-Fact-F6E8E4604D74536EB840D7E9E2CCBBC3"
      unitRef="lawsuit">334</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="D2020Q4litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d10111338e3043-wk-Fact-2C3C76B47B3B591483086FAF42D4165E"
      unitRef="plaintiff">4280</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="D2020Q4litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d10111338e3047-wk-Fact-64B85656AC9D5E98984142913D64F743"
      unitRef="lawsuit">31</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="D2020Q4litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d10111338e3051-wk-Fact-24509F9E4186583A8B83AC5497ABD0E1"
      unitRef="plaintiff">36</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="FI2020Q4_srt_RangeAxis_srt_MinimumMember"
      decimals="-6"
      id="d10111338e3060-wk-Fact-F3A003C5CE3950F4B16BDDDECCEB65A8"
      unitRef="usd">468000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="FI2020Q4_srt_RangeAxis_srt_MaximumMember"
      decimals="-6"
      id="d10111338e3064-wk-Fact-9A65C6907A01594E82BE43D64A281412"
      unitRef="usd">919000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:InventoryRecallExpense
      contextRef="FD2020Q4YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain"
      decimals="-6"
      id="d10111338e3090-wk-Fact-621E6CE68D105FF193008BB558E45E0E"
      unitRef="usd">85000000</us-gaap:InventoryRecallExpense>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2020Q4YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain"
      decimals="-6"
      id="d10111338e3094-wk-Fact-8AFA4400637F516FB6BB805933517039"
      unitRef="usd">48000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2020Q4YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain"
      decimals="-6"
      id="d10111338e3098-wk-Fact-ABE67A811E1C530886BC04B4E600D3DF"
      unitRef="usd">37000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <cah:IncomefromSettlementsofClassActionLawsuits
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10111338e3127-wk-Fact-FEF658AB85BAAF779BB4D8D2A6AC7DE6"
      unitRef="usd">16000000</cah:IncomefromSettlementsofClassActionLawsuits>
    <cah:IncomefromSettlementsofClassActionLawsuits
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10111338e3131-wk-Fact-6AD77896BFBCB7B0A0F8D8D321B6E6EC"
      unitRef="usd">94000000</cah:IncomefromSettlementsofClassActionLawsuits>
    <cah:IncomefromSettlementsofClassActionLawsuits
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10111338e3135-wk-Fact-AE56D34829BE7F85D1D5D8D340210D24"
      unitRef="usd">22000000</cah:IncomefromSettlementsofClassActionLawsuits>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-FFCF7B493C2126F1B3A3284316656C68-0-wk-Fact-2576FDA57101ACE0EE21284315D24342">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;8. Income Taxes&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Earnings/(Loss) before Income Taxes and Provision for/(Benefit From) Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes earnings/(loss) before income taxes:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:53%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;U.S. operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4,056&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,478&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Non-U.S. operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;284&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;273&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(619&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Earnings/(loss) before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(3,772&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,751&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(228&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the components of provision for/(benefit from) income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Current:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;659&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;295&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;State and local&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;154&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;89&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;41&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;69&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;143&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;882&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;469&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Deferred:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(822&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1,003&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;State and local&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(127&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total deferred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(961&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1,012&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Provision for/(benefit from) income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;386&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Effective Tax Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020 (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019 (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018 (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Provision at Federal statutory rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;21.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#160;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;21.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;28.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;State and local income taxes, net of federal benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Tax effect of foreign operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(48.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nondeductible/nontaxable items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(10.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill impairment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(124.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Tax Act&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;410.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Change in valuation allowances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(76.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign tax credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;27.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;China tax related to divestiture&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(25.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Legal entity reorganization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(3.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;71.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Opioid litigation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(23.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(21.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Effective income tax rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#160;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;213.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;The effective income tax rate for fiscal 2020 and 2018 represents an income tax benefit tax rate.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;The effective income tax rate for fiscal 2019 represents an income tax expense tax rate. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The income tax benefit rate was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;2.1%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;213.8%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; in fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; compared to an income tax expense rate of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;22.1%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; in fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. Fluctuations in the effective tax rates are primarily due to the impact of opioid litigation in fiscal 2020 and the impact of the U.S. Tax Cuts and Jobs Act ("Tax Act") in fiscal 2018, both described further below, as well as the Medical Unit goodwill impairment in fiscal 2018, as described in &lt;/span&gt;&lt;a href="#sAF8B609C6A1B5242B7B172A7B9FB2416" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 1&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. There were also changes in valuation allowances related to capital losses, credit carryforwards and net operating loss carryforwards in U.S. federal, U.S. state and international jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; pre-tax charge for the opioid litigation, we recorded a tax benefit of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$488 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;in fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;,&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;which is net of unrecognized tax benefits of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$469 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the tax law; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the Tax Act. Further, it is possible that the tax authorities could challenge our interpretation of the currently enacted tax law or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See &lt;/span&gt;&lt;a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for more information regarding these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our effective tax rate has benefits from negotiated lower than statutory tax rates in select foreign jurisdictions which individually are not material to our effective tax rate but in aggregate have a favorable tax impact of approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$17 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; during fiscal 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;On December 22, 2017, the United States enacted the Tax Act. The Tax Act made broad and comp&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;lex changes to the U.S. tax code that affected fiscal 2018 and incrementally affected our fiscal year 2019 financial results in several ways. First, the U.S. statutory tax rate in fiscal 2019 was reduced to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;21.0%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. Second, the Tax Act established new tax provisions that affected us beginning July 1, 2018 including, (1) eliminating the U.S. manufacturing deduction; (2) establishing new limitations on deductible interest expense and certain executive compensation; (3) eliminating the corporate alternative minimum tax; (4) creating the base erosion anti-abuse tax; (5) creating a new provision designed to tax global intangible low-tax income (&#x201c;GILTI&#x201d;) and allow for a deduction related to foreign derived intangible income ("FDII"); (6) generally eliminating U.S. federal income taxes on dividends from foreign subsidiaries; and (7) changing rules related to uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Regarding the new GILTI tax rules, we elected to treat taxes due on future GILTI inclusions in U.S. taxable income as a current period expense when incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, foreign earnings of approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$800 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; are considered indefinitely reinvested for working capital and other offshore investment needs. The computation of tax required if those earnings are repatriated is not practicable. For amounts not &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;considered indefinitely reinvested, we have recorded an immaterial amount of income tax expense in our financial statements in fiscal 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Deferred Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities and operating loss and tax credit carryforwards for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents the components of the deferred income tax assets and liabilities at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Receivable basis difference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;607&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Loss and tax credit carryforwards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;589&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;621&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Deferred tax assets related to uncertain tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,412&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;864&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Valuation allowance for deferred income tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(470&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;942&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;322&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Inventory basis differences&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(1,083&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1,056&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Property-related&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(327&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill and other intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(751&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(808&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(2,161&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2,035&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-bottom:8px;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(1,219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1,713&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Noncurrent deferred income tax asset (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Noncurrent deferred income tax liability (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(1,258&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1,749&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(1,219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1,713&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; we had gross federal, state and international loss and credit carryforwards of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$123 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.4 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.2 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, the tax effect of which is an aggregate deferred tax asset of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$589 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. Substantially all of these carryforwards are available for at least three years. Approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$461 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of the valuation allowance at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; applies to certain federal, state and international loss carryforwards that, in our opinion, are more likely than not to expire unutilized. However, to the extent that tax benefits related&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;to these carryforwards are realized in the future, the reduction in the valuation allowance would reduce income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Unrecognized Tax Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We had &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$998 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$456 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$423 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of unrecognized tax benefits at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. The &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; balances include &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$753 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$303 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$262 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate. The remaining unrecognized tax benefits relate to tax positions for which ultimate deductibility is highly certain but for which there is uncertainty as to the timing of such deductibility. Recognition of these tax benefits would not affect our effective tax rate. We include the full amount of unrecognized tax benefits in deferred income taxes and other liabilities in the consolidated balance sheets. The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at beginning of fiscal year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;456&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;423&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;417&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions for tax positions of the current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions for tax positions of prior years (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;141&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Settlements with tax authorities (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Expiration of the statute of limitations (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at end of fiscal year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;998&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;456&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;423&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in fiscal 2018 additions for tax positions of prior years is &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$110 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; related to exposures acquired as part of the Patient Recovery Business for which we are fully indemnified. Also for fiscal 2018 are settlements of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$81 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; related to the Patient Recovery Business as well as &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$11 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; of statute expirations. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of audit issues, reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is a net decrease of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$370 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, exclusive of penalties and interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We recognize accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, we had &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$146 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$122 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$110 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, accrued for the payment of interest and penalties. These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the consolidated balance sheets. During fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; we recognized &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$16 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of expense for interest and penalties in income tax expense, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Other Tax Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We file income tax returns in the U.S. federal jurisdiction, various U.S. state and local jurisdictions, and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2008 through the current fiscal year. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), which has been acquired by Becton, Dickinson and Company. Under the tax matters agreement, &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$176 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$165 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively, and is included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition under the purchase agreement. The indemnification receivable was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$19 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$22 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, and is included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-CAF3258FE243E274D06B284316664F48-0-wk-Fact-7BFD59D23731E9571A5D284315DFA06E">&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes earnings/(loss) before income taxes:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:53%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;U.S. operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4,056&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,478&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Non-U.S. operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;284&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;273&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(619&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Earnings/(loss) before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(3,772&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,751&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(228&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e3006-wk-Fact-0248E185BA170A31AEAC28431601AA41"
      unitRef="usd">-4056000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10126096e3026-wk-Fact-7F86C4678AC49828A758952EBBCBA77B"
      unitRef="usd">1478000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e3045-wk-Fact-383DE7FE678CF8A79E1F952EBBC168E7"
      unitRef="usd">391000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e3061-wk-Fact-1D9D584817790BA4E571284316032AA3"
      unitRef="usd">284000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10126096e3080-wk-Fact-6C4D4B198110CDF3C020952EBBD5ACD1"
      unitRef="usd">273000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e3099-wk-Fact-555A2A1277094A6A03DD952EBBBC213D"
      unitRef="usd">-619000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e3126-wk-Fact-8029B570251D776CB89B2843162B2728"
      unitRef="usd">-3772000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10126096e3146-wk-Fact-5027B60DD37A44F7AA932843161E0815"
      unitRef="usd">1751000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e3165-wk-Fact-867F273B7C9665AD5CF328431621C9DA"
      unitRef="usd">-228000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-DBE1EA43A32D972D8A33284316659C15-0-wk-Fact-5F9A57BDA20510645506284315E98986">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the components of provision for/(benefit from) income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Current:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;659&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;295&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;State and local&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;154&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;89&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;41&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;69&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;143&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;882&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;469&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Deferred:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(822&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1,003&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;State and local&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(127&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total deferred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(961&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1,012&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Provision for/(benefit from) income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;386&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e3345-wk-Fact-55339C044840A183E4CA284316117276"
      unitRef="usd">659000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10126096e3364-wk-Fact-BEC86B32DF5523928C92952ECE6F9EAA"
      unitRef="usd">295000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e3383-wk-Fact-53E5608CBFD2326CCEED952ECDF8C95E"
      unitRef="usd">341000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e3399-wk-Fact-866D164EA7D1E334CFC128431608BA8B"
      unitRef="usd">154000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10126096e3418-wk-Fact-72723772EFD749252972952ECE41D150"
      unitRef="usd">89000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e3437-wk-Fact-65ED9098F57364D0959D952ECDC4B847"
      unitRef="usd">41000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e3458-wk-Fact-37CB45D9E6BCACC7043728431613EA28"
      unitRef="usd">69000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10126096e3477-wk-Fact-AF5100CC0F1D5D58B497952ECD68CB30"
      unitRef="usd">85000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e3496-wk-Fact-2C4D67578B5E21BC12EE952ECE89A9EB"
      unitRef="usd">143000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e3522-wk-Fact-185A8B9515C2D90362102843160ABB69"
      unitRef="usd">882000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10126096e3541-wk-Fact-0C152A668754C3FB6AF8952ECD075984"
      unitRef="usd">469000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e3560-wk-Fact-DA15813AA0B51A9CBF84952ECDDD7FE4"
      unitRef="usd">525000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e3705-wk-Fact-976C6AA098962A1E2DFA284316065DDF"
      unitRef="usd">-822000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10126096e3725-wk-Fact-ABD89E3D19DB63DA1E27952ECDB061D3"
      unitRef="usd">-28000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e3745-wk-Fact-267F00EB5C0F51E2BCF5952ECE27EA8F"
      unitRef="usd">-1003000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e3762-wk-Fact-19A2E169F25C7191D661284316109A72"
      unitRef="usd">-127000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10126096e3782-wk-Fact-422A9E00C16DB4AC7DF8952ECD7CBA2A"
      unitRef="usd">-37000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e3802-wk-Fact-C9FF4F1A2B7220674842952ECCF30896"
      unitRef="usd">16000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e3823-wk-Fact-5411A2D5E0C4FF15F5D728431612D0BC"
      unitRef="usd">-12000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10126096e3843-wk-Fact-29FC465E7F75F160F215952ECD219F09"
      unitRef="usd">-18000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e3863-wk-Fact-609ADB09A87073412682952ECE5A88CC"
      unitRef="usd">-25000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e3886-wk-Fact-2A3D5D1ADB9EB2D73D3C2843148BB1D8"
      unitRef="usd">-961000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10126096e3906-wk-Fact-07BADBE2FC7BA806CDA82843146F9B0B"
      unitRef="usd">-83000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e3926-wk-Fact-5608F2B71E98868ABA9E2843147BAB8F"
      unitRef="usd">-1012000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e3953-wk-Fact-1F76A9CA55BDEBE5013228431626E45F"
      unitRef="usd">-79000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10126096e3973-wk-Fact-32C8EE70D1FD77AC3B30284316197236"
      unitRef="usd">386000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e3992-wk-Fact-55DB262DD0862713240F2843161FBB12"
      unitRef="usd">-487000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-7895133F7434327CE5AF2843166544C3-0-wk-Fact-50B797CD80B14ED1D5BE284315E3F5B6">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020 (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019 (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018 (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Provision at Federal statutory rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;21.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#160;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;21.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;28.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;State and local income taxes, net of federal benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Tax effect of foreign operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(48.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nondeductible/nontaxable items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(10.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill impairment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(124.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Tax Act&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;410.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Change in valuation allowances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(76.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign tax credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;27.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;China tax related to divestiture&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(25.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Legal entity reorganization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(3.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;71.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Opioid litigation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(23.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(21.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Effective income tax rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#160;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;213.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4088-wk-Fact-9B8BF3D3579184D9F840284315E11843"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4103-wk-Fact-38DFF9B65C5B6BD2B7A4284315C65F05"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4118-wk-Fact-4F39EE8BAA91F4A4CF9B284315B9C4DA"
      unitRef="number">0.281</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4134-wk-Fact-C7B25AD2CE503E4F70C0284315C28F37"
      unitRef="number">0.025</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4148-wk-Fact-218181C31302F3522F55284315C1923F"
      unitRef="number">0.009</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4162-wk-Fact-9F26557324A6247AFD35284315B8BE7C"
      unitRef="number">-0.160</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4178-wk-Fact-CF2D098D2D4473C20EA7284315B7AADA"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4192-wk-Fact-C04F46B204C46ACA7916284315B6D42C"
      unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4207-wk-Fact-B3A819A4C81F7E9C57AA284315C45200"
      unitRef="number">-0.484</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4223-wk-Fact-1A38CB563D51606D2CF6284315B49093"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4238-wk-Fact-7AE8192BB4D3CE5D3683284315C7D7F2"
      unitRef="number">0.025</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4252-wk-Fact-5DEC7B61E65E3D1B0BD8284315BE73FA"
      unitRef="number">-0.102</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4268-wk-Fact-2B64D6DF81CC9BB72ED2284315BBF319"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4282-wk-Fact-422388AF7520A3597708284315C5BA6C"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4296-wk-Fact-84F41314A6C6FBD609E1284315C2B5F4"
      unitRef="number">1.247</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <cah:EffectiveIncomeTaxRateReconciliationTaxAct2018
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4312-wk-Fact-214716403DB3268E19D5284315BEF21E"
      unitRef="number">-0.001</cah:EffectiveIncomeTaxRateReconciliationTaxAct2018>
    <cah:EffectiveIncomeTaxRateReconciliationTaxAct2018
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4326-wk-Fact-E975813B148C6970D211284315C4E82D"
      unitRef="number">0.008</cah:EffectiveIncomeTaxRateReconciliationTaxAct2018>
    <cah:EffectiveIncomeTaxRateReconciliationTaxAct2018
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4341-wk-Fact-850AA5C58B392F438E32284315B6B7E3"
      unitRef="number">-4.109</cah:EffectiveIncomeTaxRateReconciliationTaxAct2018>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4356-wk-Fact-CA955AE8C6568F5AB77C284315BC26CF"
      unitRef="number">-0.015</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4370-wk-Fact-2831E9B8715AC1AE2534284315BF907B"
      unitRef="number">-0.045</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4384-wk-Fact-1820949393ADF9E66E3E284315C38CE5"
      unitRef="number">0.769</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4400-wk-Fact-6622C59C0394BCB78CF1284315B46084"
      unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4414-wk-Fact-E9E9542C455415AA370D284315B73637"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4429-wk-Fact-6767BB6FC39BA55A057F284315BC0E23"
      unitRef="number">-0.273</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <cah:EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4444-wk-Fact-163385C3EB2A0E27C517284315C317D0"
      unitRef="number">0</cah:EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture>
    <cah:EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4458-wk-Fact-A99E66E70A4537D9352B284315BA031B"
      unitRef="number">0</cah:EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture>
    <cah:EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4472-wk-Fact-3E6E8B3E31FF1B666066284315BB43C2"
      unitRef="number">0.258</cah:EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture>
    <cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4488-wk-Fact-767882B6A3BD49155BA6284315C34E0E"
      unitRef="number">0</cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent>
    <cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4502-wk-Fact-6098A5F4B553329E4113284315BF3B21"
      unitRef="number">-0.036</cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent>
    <cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4517-wk-Fact-1DECE176A923F3EC2B6B284315B58074"
      unitRef="number">0.714</cah:EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent>
    <cah:EffectiveIncomeTaxReconciliationOpioidLitigation
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4533-wk-Fact-6365FC22484F6DC92A35C57729EACB5E"
      unitRef="number">0.232</cah:EffectiveIncomeTaxReconciliationOpioidLitigation>
    <cah:EffectiveIncomeTaxReconciliationOpioidLitigation
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4548-wk-Fact-8C647E0B45E9B2819FDFC5785BA34367"
      unitRef="number">0</cah:EffectiveIncomeTaxReconciliationOpioidLitigation>
    <cah:EffectiveIncomeTaxReconciliationOpioidLitigation
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4562-wk-Fact-4F6A05C53D0D3D6280CDC5786D8C7614"
      unitRef="number">0</cah:EffectiveIncomeTaxReconciliationOpioidLitigation>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4577-wk-Fact-9ED7956EA513DD3F80E1284315BF3FE0"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4592-wk-Fact-5B029CD900301E71FDD7284315B662FF"
      unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4607-wk-Fact-6B0D33291A8CBC057D1C284315B55B30"
      unitRef="number">-0.219</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4623-wk-Fact-A98288A60614D42B5E15284315CCEC31"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4638-wk-Fact-7115304A0C3857B5AE7C284315D830E5"
      unitRef="number">0.221</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4653-wk-Fact-B97F7E881AFFCAFCDD6D284315D18F9E"
      unitRef="number">2.138</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4683-wk-Fact-A98288A60614D42B5E15284315CCEC31"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d10126096e4687-wk-Fact-B97F7E881AFFCAFCDD6D284315D18F9E"
      unitRef="number">2.138</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d10126096e4699-wk-Fact-7115304A0C3857B5AE7C284315D830E5"
      unitRef="number">0.221</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q3_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-7"
      id="d10126096e4717-wk-Fact-C827D709C763425D03DB54B51A88875B"
      unitRef="usd">5630000000</us-gaap:LitigationReserve>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2020Q4YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-6"
      id="d10126096e4721-wk-Fact-CE5AE3BF363D5D54B93DB630543D5E28"
      unitRef="usd">-488000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="FI2020Q4_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-6"
      id="d10126096e4735-wk-Fact-0C8F754D81135B46A8B5BB023ACA6ECE"
      unitRef="usd">469000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <cah:EffectiveTaxRateImpactFromCertainForeignJurisdictions
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e4748-wk-Fact-3E6A12D310DE121B480D284315CE2429"
      unitRef="usd">-17000000</cah:EffectiveTaxRateImpactFromCertainForeignJurisdictions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="FD2020Q4YTD"
      decimals="3"
      id="d10126096e4757-wk-Fact-9B8BF3D3579184D9F840284315E11843"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e4771-wk-Fact-FFCA1A7BE54F9FB2E89B284315D1BF8E"
      unitRef="usd">800000000</us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-8CB597CA87FAACB3F6C42843166683D0-0-wk-Fact-CCEE629D25ACAB38B4EA284315CCFD24">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents the components of the deferred income tax assets and liabilities at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Receivable basis difference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;607&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Loss and tax credit carryforwards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;589&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;621&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Deferred tax assets related to uncertain tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,412&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;864&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Valuation allowance for deferred income tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(470&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;942&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;322&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Inventory basis differences&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(1,083&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1,056&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Property-related&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(327&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill and other intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(751&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(808&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(2,161&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2,035&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="padding-bottom:8px;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(1,219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1,713&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e4903-wk-Fact-7D65AF42FAA9F7737780284315C6356E"
      unitRef="usd">39000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e4922-wk-Fact-BCB74967C3C5ABC63DC9952EDD41A400"
      unitRef="usd">35000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e4937-wk-Fact-4894D38A5EF0693E049C284315B184C2"
      unitRef="usd">607000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e4956-wk-Fact-130B7573F08AB08F0ADA952EDEA0DA2D"
      unitRef="usd">133000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e4976-wk-Fact-4D96278DA4E81B2C5307284315B6F120"
      unitRef="usd">38000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e4995-wk-Fact-95EC459A8E60F39A644E952EDD466994"
      unitRef="usd">39000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5015-wk-Fact-3511AD9B3388391AA471284315E63EDE"
      unitRef="usd">589000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5034-wk-Fact-1655DACE3DCD3F14BEA0952EDEAE9A31"
      unitRef="usd">621000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <cah:DeferredTaxAssetsRelatedtouncertaintaxpositions
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5054-wk-Fact-6C143BA513EE7388E276284315B39AE0"
      unitRef="usd">52000000</cah:DeferredTaxAssetsRelatedtouncertaintaxpositions>
    <cah:DeferredTaxAssetsRelatedtouncertaintaxpositions
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5073-wk-Fact-28B7B11F422E397814F1952EDE918EF7"
      unitRef="usd">30000000</cah:DeferredTaxAssetsRelatedtouncertaintaxpositions>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5093-wk-Fact-18269E9F1A66A46BC4B9284315B9004E"
      unitRef="usd">87000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5112-wk-Fact-4772480247B4051E8540952EDE8C317A"
      unitRef="usd">6000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5132-wk-Fact-08E1BCD50DB0DB34FF9D284315B33ED8"
      unitRef="usd">1412000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5151-wk-Fact-EDC6EE95CCAAE675D486952EDEA95B75"
      unitRef="usd">864000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5171-wk-Fact-DBAA4EDE76CFA5ED2EA6284315BA8366"
      unitRef="usd">470000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5191-wk-Fact-407B40A9B5EB9A49B112952EDEA57E4A"
      unitRef="usd">542000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5217-wk-Fact-66FFFDB89E5518A4C227284315BA0F5F"
      unitRef="usd">942000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5236-wk-Fact-D80AF8B4309618B61BDE284315BDA038"
      unitRef="usd">322000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5339-wk-Fact-37D785AA65EF8106530A284315BD360A"
      unitRef="usd">1083000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5359-wk-Fact-6E821CE7A5ED868EF8A3952EDE9BF92C"
      unitRef="usd">1056000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5375-wk-Fact-F422B5BE7BD2CEC33CF0284315B9BD64"
      unitRef="usd">327000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5395-wk-Fact-6EDD581FDF6C8E91B1B8952EDE97A649"
      unitRef="usd">171000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5416-wk-Fact-B5D6ACAAE1F22F34017F284315C1E10C"
      unitRef="usd">751000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5436-wk-Fact-68FBAE0DF6325A2B05E0952EDD4B71D6"
      unitRef="usd">808000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5464-wk-Fact-2BACE29F9D1C21E49757284315CA328C"
      unitRef="usd">2161000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5484-wk-Fact-3D88C2C626816139D7D1952EDD3C86A3"
      unitRef="usd">2035000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5505-wk-Fact-C6B8A7AE79EFC264CAE4284315F911C0"
      unitRef="usd">1219000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5525-wk-Fact-F6B12155F05213B57D56952EC2F92F17"
      unitRef="usd">1713000000</us-gaap:DeferredTaxLiabilities>
    <cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-21D3B8017C8F030B297C284316650332-0-wk-Fact-49B519DB2CE122D2BF1F284315D5176B">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Noncurrent deferred income tax asset (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Noncurrent deferred income tax liability (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(1,258&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1,749&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(1,219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1,713&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5619-wk-Fact-5BA44FD505745B13799F284315FA6D78"
      unitRef="usd">39000000</us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5638-wk-Fact-D08105063DFB4DE2A3CE952EC2C94CAE"
      unitRef="usd">36000000</us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5653-wk-Fact-B4F4111163280DABBBCB284315F876B9"
      unitRef="usd">1258000000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5673-wk-Fact-4099A83C9BCCD1CA6EB4952EC2DFCEE8"
      unitRef="usd">1749000000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxLiabilities
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5699-wk-Fact-C6B8A7AE79EFC264CAE4284315F911C0"
      unitRef="usd">1219000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5719-wk-Fact-F6B12155F05213B57D56952EC2F92F17"
      unitRef="usd">1713000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="FI2020Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember"
      decimals="-6"
      id="d10126096e5774-wk-Fact-6C10D2C3C2D86CC67ADB284315D631AE"
      unitRef="usd">123000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="FI2020Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-6"
      id="d10126096e5778-wk-Fact-327DABBA8D67B8D26EDC284315D4E7B3"
      unitRef="usd">2400000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="FI2020Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember"
      decimals="-6"
      id="d10126096e5782-wk-Fact-B1689030D322A7696D10284315E8947D"
      unitRef="usd">2200000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5786-wk-Fact-3511AD9B3388391AA471284315E63EDE"
      unitRef="usd">589000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5791-wk-Fact-500B7CF63F31BFAD6F13284315DB57F1"
      unitRef="usd">461000000</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5809-wk-Fact-D89E93BBF064CAEF2575284315E20A89"
      unitRef="usd">998000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5813-wk-Fact-822B7E99A1DB5AB0A313E733A910F08B"
      unitRef="usd">456000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10126096e5817-wk-Fact-26A1AD8EC14D0CDDC244284315CD2241"
      unitRef="usd">423000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e5846-wk-Fact-088DB6725E9B8EB1B705284315D04FE7"
      unitRef="usd">753000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5850-wk-Fact-8972CBB1C17D53EF8DE613FABD7A6962"
      unitRef="usd">303000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10126096e5855-wk-Fact-77DBA4F04BDFCC015FC0284315CCEC9F"
      unitRef="usd">262000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-12B97FD8334CE931932D284316650AEC-0-wk-Fact-FE6F70A6A9C4B66308C0284315D314A4"> sheets. The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at beginning of fiscal year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;456&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;423&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;417&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions for tax positions of the current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions for tax positions of prior years (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;141&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Settlements with tax authorities (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Expiration of the statute of limitations (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at end of fiscal year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;998&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;456&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;423&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in fiscal 2018 additions for tax positions of prior years is &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$110 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; related to exposures acquired as part of the Patient Recovery Business for which we are fully indemnified. Also for fiscal 2018 are settlements of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$81 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; related to the Patient Recovery Business as well as &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$11 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; of statute expirations. &lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e5963-wk-Fact-822B7E99A1DB5AB0A313E733A910F08B"
      unitRef="usd">456000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10126096e5982-wk-Fact-26A1AD8EC14D0CDDC244284315CD2241"
      unitRef="usd">423000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2017Q4"
      decimals="-6"
      id="d10126096e6001-wk-Fact-D376313F2A07F64C267E284315B8ED58"
      unitRef="usd">417000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e6017-wk-Fact-19FA88F5C183E0B0CF4F284315B2E0B7"
      unitRef="usd">500000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="FD2018Q4QTD"
      decimals="-6"
      id="d10126096e6036-wk-Fact-683470D6FF9F59806568284315AE6FC6"
      unitRef="usd">24000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e6055-wk-Fact-BDA0BF0D7BE0AF9E537F284315B489A6"
      unitRef="usd">15000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e6076-wk-Fact-9C26CE231C0997451AA8284315B500CB"
      unitRef="usd">78000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2018Q4QTD"
      decimals="-6"
      id="d10126096e6095-wk-Fact-1403F95CD9E8276D6C47284315B7A3C8"
      unitRef="usd">39000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e6114-wk-Fact-4925BC65CCCDDBAD0653284315B8DFB0"
      unitRef="usd">141000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e6135-wk-Fact-3E1A9E42D8D07D8793B0284315B3AB2E"
      unitRef="usd">27000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2018Q4QTD"
      decimals="-6"
      id="d10126096e6155-wk-Fact-92721D09E1774FE36DF3284315B75C58"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e6175-wk-Fact-6DB4FE2D34DF9C8E27FA284315B6F0E7"
      unitRef="usd">40000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e6197-wk-Fact-A731738A344E51369F9F284315B17F51"
      unitRef="usd">6000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="FD2018Q4QTD"
      decimals="-6"
      id="d10126096e6217-wk-Fact-91F822905754229847A0284315B1E1EE"
      unitRef="usd">25000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e6237-wk-Fact-DA6FA005CC96251E062C284315AF0F93"
      unitRef="usd">99000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e6259-wk-Fact-28C37AD50E44C26B04F4284315B04C20"
      unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="FD2018Q4QTD"
      decimals="-6"
      id="d10126096e6279-wk-Fact-8B20F719AFE7E9D49321284315B00102"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e6298-wk-Fact-73B13634DE9522FE05F2284315B58B31"
      unitRef="usd">11000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e6325-wk-Fact-D89E93BBF064CAEF2575284315E20A89"
      unitRef="usd">998000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e6344-wk-Fact-822B7E99A1DB5AB0A313E733A910F08B"
      unitRef="usd">456000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10126096e6363-wk-Fact-26A1AD8EC14D0CDDC244284315CD2241"
      unitRef="usd">423000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2018Q4YTD_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember"
      decimals="-6"
      id="d10126096e6379-wk-Fact-12DAB65A20C7E4B86EB5284315CFF3AC"
      unitRef="usd">110000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="FD2018Q4YTD_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember"
      decimals="-6"
      id="d10126096e6383-wk-Fact-7268B6BE07522BEB02A4284315E864B1"
      unitRef="usd">81000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="FD2018Q4YTD_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember"
      decimals="-6"
      id="d10126096e6387-wk-Fact-CF0B115FC3F9E1DA64BB284315E65773"
      unitRef="usd">11000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="FI2020Q4_srt_RangeAxis_srt_MinimumMember"
      decimals="-6"
      id="d10126096e6399-wk-Fact-65D42A798CC9D259CD5C284315CEC405"
      unitRef="usd">0</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="FI2020Q4_srt_RangeAxis_srt_MaximumMember"
      decimals="-6"
      id="d10126096e6403-wk-Fact-EDB83EF8173353DD843EA21548FF1761"
      unitRef="usd">370000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10126096e6422-wk-Fact-460C6E0274685B78997087EB6C0BE55C"
      unitRef="usd">146000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10126096e6426-wk-Fact-3ABE8DAC48EF7FB3E0DC284315E7DB07"
      unitRef="usd">122000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10126096e6431-wk-Fact-1AD9B44443585B6FA8707DC89F4B17C4"
      unitRef="usd">110000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10126096e6447-wk-Fact-3CAD6F80DEE9F537CE5D284315E17BD0"
      unitRef="usd">16000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="FD2018Q4QTD"
      decimals="-6"
      id="d10126096e6451-wk-Fact-638BB968C8474D0A8475284315D4386E"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10126096e6456-wk-Fact-8014A2B9BE399BC9CF2A284315E96641"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <cah:IndemnificationReceivable
      contextRef="FI2020Q4_cah_TaxMatterAxis_cah_CareFusionMember"
      decimals="-6"
      id="d10126096e6473-wk-Fact-37787FD6909A5502BFD05B7D6D97C92F"
      unitRef="usd">176000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="FI2019Q4_cah_TaxMatterAxis_cah_CareFusionMember"
      decimals="-6"
      id="d10126096e6477-wk-Fact-BAA7B8857F1D25F9DE66284315DF9546"
      unitRef="usd">165000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="FI2020Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember"
      decimals="-6"
      id="d10126096e6535-wk-Fact-E5A531A4C45D54AEAAA61C642ECA0D06"
      unitRef="usd">19000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="FI2019Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember"
      decimals="-6"
      id="d10126096e6539-wk-Fact-E20F0DD2FF17955AE8E5284315EC90E6"
      unitRef="usd">22000000</cah:IndemnificationReceivable>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-15D901CB49DCDC7AE77728431666A425-0-wk-Fact-9452A0A9983AF3E2155428431614AA72">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;9. Fair Value Measurements&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&#160;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;721&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;721&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;114&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;114&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;The fair value of interest rate swaps, foreign currency contracts, net investment hedges and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-9E3593418D6EF4EAB4F428431666C1D6-0-wk-Fact-ED1BB6F3682B36163B3A284316148B8F">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&#160;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;721&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;721&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;114&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;114&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;The</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3159-wk-Fact-478D2137315459C79FBB2BDDBBD35B17"
      unitRef="usd">721000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3178-wk-Fact-000CC1CA2134517DA056B2016A5EA65D"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3197-wk-Fact-BEE4724C85E45E7198C6EA7C6F445980"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2020Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3217-wk-Fact-FDA945F80F3650BF9857942B6ED4F990"
      unitRef="usd">721000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3232-wk-Fact-32C31CD8487C54B38D9B68E0144835ED"
      unitRef="usd">114000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3251-wk-Fact-2103811B975352B798F7B4E5829FEEE8"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3270-wk-Fact-885F2EC1EC1A5E2688705644FAE0A2B8"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3290-wk-Fact-1DA285435331501E9AFEB8D73B70B5D4"
      unitRef="usd">114000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3310-wk-Fact-14B0667DE4415F40B60DBD061D592537"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3329-wk-Fact-2C6BED4D67235C609B8FA158389990CD"
      unitRef="usd">53000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3348-wk-Fact-F32D20651D8256B2B77A8061864B29C3"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2020Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3368-wk-Fact-BDAA57BB75105940BCE79CFC2A8AAFB6"
      unitRef="usd">53000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3662-wk-Fact-FDD5F9C1E95D5A55B3F2EF71F0209857"
      unitRef="usd">297000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3681-wk-Fact-7A73469B094F5FD7AC0AA7DE4A115E0D"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3700-wk-Fact-88D34EAFBE575A82AA3B2F574E75D0BB"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3720-wk-Fact-C0C895B85F9C5B558F91F0635E3993A8"
      unitRef="usd">297000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3735-wk-Fact-1C9621A5C32F590B9268C4EE648F542C"
      unitRef="usd">118000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3754-wk-Fact-1F4133A131AA5ACE8A99C7A56A6D1C9F"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3773-wk-Fact-94AABB68AC135BB88BE04ABC6A5F6239"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3793-wk-Fact-1D3DCE01961053BE8366D7A99C7605A3"
      unitRef="usd">118000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3813-wk-Fact-38A2E1AE543D529A98D50A4F2F43B68E"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3832-wk-Fact-A92BE58186ED5B9C9C3B9072D0FE6813"
      unitRef="usd">53000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3851-wk-Fact-32CB648696335B66957F2B6B781762AF"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d10115540e3871-wk-Fact-7A9FA06361605262BCD6BD71D5BD181D"
      unitRef="usd">53000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-C3650DCD87CA370894F72843166631F6-0-wk-Fact-97A0687D102C2195C4212843161533FD"> The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-DD2CD71E9FDDD6038F3C28431668D305-0-wk-Fact-8A9B4857CCE041A248102843161C5C3C">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;10. Financial Instruments&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to current fair value through earnings at the end of each period. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are rated investment grade or better. We do not have significant exposure to any one counterparty and we believe &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;the risk of loss is remote. Additionally, we do not require collateral under these agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Interest Rate Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes in interest rates. In addition, we enter into interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Currency Exchange Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce earnings and cash flow volatility associated with foreign exchange rate changes to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Commodity Price Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pay-floating interest rate swaps (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cross-currency swap (1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;height:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;height:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;height:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;height:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pay-floating interest rate swaps (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward interest rate swaps (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Commodity contracts (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in prepaid expenses and other in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in other accrued liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Fair Value Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense, net in the consolidated statements of earnings/(loss). D&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;uring fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, there was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; gain or loss recorded to interest expense as changes in the market value of our derivative instruments offset changes in the market value of the underlying debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In May &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we unwound certain interest rate swap contracts. In connection with the unwind of these contracts, we received cash proceeds of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$112 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. The related gain will be recognized in interest expense, net in our statement of earnings/(loss) over the remaining term of the related debt agreements, which ranged from 48 months to 63 months at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the debt repayment as described in &lt;/span&gt;&lt;a href="#s90F282348F0354D781EEBCEFD3A04F7E" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 6&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, two pay-floating interest rate swaps with notional amounts of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$200 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; matured in the second quarter of fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;During fiscal&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, we terminated notional amounts of&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$163 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;of pay-floating interest rate swaps in connection with the debt repurchases in&#160;fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;described in &lt;/span&gt;&lt;a href="#s90F282348F0354D781EEBCEFD3A04F7E" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 6&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. These swaps were previously designated as fair value hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; we entered into pay-floating interest rate swaps with total notional amounts of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$1.1 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. These swaps have been designated as fair value hedges of our fixed rate debt and are included in deferred income taxes and other liabilities in the consolidated balance sheets. During fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$550 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of pay-floating interest rate swaps matured.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:26%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Mar 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nov 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Sep 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pay-floating interest rate swaps (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;106&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Fixed-rate debt (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(106&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1) Included in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive loss and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we entered into forward interest rate swaps with a total notional amount of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$200 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; to hedge probable, but not firmly committed, future transactions associated with our debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;All gains and losses currently included within accumulated other comprehensive loss associated with our cash flow hedges that are expected to be reclassified into net earnings within the next 12 months are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We enter into foreign currency contracts to protect the value of anticipated foreign currency revenues and expenses. At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, we held contracts to hedge probable, but not firmly committed, revenue and expenses. The principal currencies hedged are the Canadian dollar, Mexican peso, euro, Thai baht, Chinese renminbi, Japanese yen, Australian dollar, and British pound.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We enter into commodity contracts to manage the price risk associated with forecasted purchases of certain commodities used in our Medical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables summarize the outstanding cash flow hedges at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:40%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Jun 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;328&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Jul 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Jun 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Commodity contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Jul 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Jun 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:40%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;381&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Jul 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Jun 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Commodity contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Jul 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Jun 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:47%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Commodity contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward interest rate swaps (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Commodity contracts (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in revenue in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in cost of products sold in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in SG&amp;amp;A expenses in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(4) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In August 2019, we entered into a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;&#xa5;64 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$600 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;) cross-currency swap maturing in &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2022&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;September 2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we entered into a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;&#x20ac;200 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$233 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;) cross-currency swap maturing in &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2023&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive loss until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Pre-tax gain from net investment hedges recorded in other  foreign currency translation was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$35 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$12 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; during fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. Gain recognized in interest expense, net in the consolidated statements of earnings/(loss) for the portion of the net investment hedges excluded from the assessment of hedge effectiveness was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$17 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; during fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Economic (Non-Designated) Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. The principal currency managed through foreign currency contracts is the euro, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Canadian dollar, British pound, Japanese yen, and Chinese renminbi.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:40%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Maturity Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;325&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;July 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:40%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Maturity Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;488&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Jul 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in other income, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The carrying amounts of cash and equivalents, trade receivables, net, accounts payable, and other accrued liabilities at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; approximate fair value due to their short-term maturities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Estimated fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7,273&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,065&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Carrying amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6,775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:100%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:32%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Fair&#160;Value&lt;br/&gt;Gain/(Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Fair&#160;Value&lt;br/&gt;Gain/(Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;653&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;869&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;233&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Commodity contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-6F05C90816002F7092032843166878FA-0-wk-Fact-424FF33460EF4206E5FE28431621C906">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pay-floating interest rate swaps (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cross-currency swap (1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;height:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;height:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;height:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;height:8px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pay-floating interest rate swaps (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward interest rate swaps (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Commodity contracts (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in prepaid expenses and other in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in other accrued liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3043-wk-Fact-200A503D2BD641043332284315A62682"
      unitRef="usd">27000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3062-wk-Fact-DB8B09BAEB1FE4E6D84D284315A1FF87"
      unitRef="usd">46000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CrossCurrencyInterestRateContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3077-wk-Fact-B9893E5BEACE0A87794F284315A33582"
      unitRef="usd">47000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CrossCurrencyInterestRateContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3096-wk-Fact-E691965F46693E44600B284315A7ED4A"
      unitRef="usd">12000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3116-wk-Fact-D3AD943B2632D3A0D4F02843159FAD2D"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3135-wk-Fact-35EEF3279D45A8A3EE54284315A53CF2"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10136988e3160-wk-Fact-037C86DDD9F4CDAD320A284315A16241"
      unitRef="usd">74000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10136988e3179-wk-Fact-4A457CB25699BE0458412843159DF00B"
      unitRef="usd">64000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3281-wk-Fact-9E7C8FDF080C4B04224B284315A17C7E"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3300-wk-Fact-9212D5C8D80D902E0E252843159E1ACE"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3315-wk-Fact-5CB6BA663B4F48B39C36284315A68EA6"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3334-wk-Fact-27ECD6BB19B2ED03085F284315A0EBC4"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3354-wk-Fact-30A295E9C879654F6E5228431460ABEC"
      unitRef="usd">16000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_cah_DeferredIncomeTaxesandOtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3373-wk-Fact-C19583C9783E385BEB3628431462D925"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="FI2020Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3394-wk-Fact-9C1F60165374F4660D18284315A2C70E"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3413-wk-Fact-83E49AC604A3982F7FF2284315A513C1"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10136988e3438-wk-Fact-0581FA5F55E19F0928532843159F6F20"
      unitRef="usd">21000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10136988e3457-wk-Fact-974B58B20B1ABA8D7972284315A437A4"
      unitRef="usd">11000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10136988e3526-wk-Fact-340F0A1B46C553F8AA2D52F4211D6D27"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3537-wk-Fact-800D7B5B215EE3D6C31CB585A617A26D"
      unitRef="usd">112000000</us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge>
    <cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3553-wk-Fact-6262A45A34F655438910490228581C45"
      unitRef="usd">200000000</cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount>
    <cah:DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3568-wk-Fact-3B1696958DD2F458A9D72843162261D9"
      unitRef="usd">163000000</cah:DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3588-wk-Fact-F0597385CF13B0DDBE3D284316227163"
      unitRef="usd">1100000000</us-gaap:DerivativeAssetNotionalAmount>
    <cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount
      contextRef="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e3596-wk-Fact-1D0B89F6969E47488BFC28431624F26E"
      unitRef="usd">550000000</cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember"
      id="TextSelection-C7B6944FD4BFAAA3BF21284316677704-0-wk-Fact-8FCA07E82217C6647488284316242DFD">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:26%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Mar 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nov 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Sep 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember"
      decimals="-6"
      id="d10136988e3719-wk-Fact-8F6AFF218E0A7D4241D628431461629F"
      unitRef="usd">550000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember"
      decimals="-6"
      id="d10136988e3855-wk-Fact-0C9C89855E0A4D43225C284316213844"
      unitRef="usd">2150000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-5109584BA3C94173A5B3284316679E04-0-wk-Fact-A249B11A88C4C244DD67284316214BD4">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pay-floating interest rate swaps (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;106&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Fixed-rate debt (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(106&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1) Included in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-6"
      id="d10136988e3991-wk-Fact-C200B9F32AA14DECA3B32843159DFD2C"
      unitRef="usd">106000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-6"
      id="d10136988e4010-wk-Fact-EBEA863AF431288B0C622843159FA0C4"
      unitRef="usd">9000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-6"
      id="d10136988e4029-wk-Fact-891A8C676DE1016183F02843159F1121"
      unitRef="usd">11000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_cah_FixedRateDebtMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-6"
      id="d10136988e4045-wk-Fact-575B66D54376C587B63A284315A27E75"
      unitRef="usd">-106000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_cah_FixedRateDebtMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-6"
      id="d10136988e4065-wk-Fact-65546CC868A8D2006F0C284315A01B69"
      unitRef="usd">-9000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_cah_FixedRateDebtMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-6"
      id="d10136988e4085-wk-Fact-0E647F82F745A4E8717E284315A0856D"
      unitRef="usd">-11000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4129-wk-Fact-825D10F27F465E1EA8700FF967AA5E86"
      unitRef="usd">200000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      id="TextSelection-DE548948F8CA9045BCE028431666BE1A-0-wk-Fact-9B7A50853A9A39128FD5284316235DBE">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables summarize the outstanding cash flow hedges at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:40%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Jun 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;328&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Jul 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Jun 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Commodity contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Jul 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Jun 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:40%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;381&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Jul 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Jun 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Commodity contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Jul 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Jun 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d10136988e4270-wk-Fact-87E3DF80700DE3D26154284315AE1713"
      unitRef="usd">200000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4305-wk-Fact-838D34F076DE98A4514A284315DFEE2C"
      unitRef="usd">328000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4345-wk-Fact-66D0FBB2C3EF04AE64BE284315D9413A"
      unitRef="usd">16000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4486-wk-Fact-25195DB65F1E9216679FAB01BB4C1CB1"
      unitRef="usd">381000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4521-wk-Fact-8334FB61D99EA268C61EAB01BACEAD64"
      unitRef="usd">20000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-AB4EA973AACD973DF69D28431668B61B-0-wk-Fact-6BD4F596B55D3CAC3E84284316204DA2">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:47%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Commodity contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4663-wk-Fact-E96101B8EC06BC4640FCB569C11F1430"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4683-wk-Fact-BFA79BC4277CF35DA676B569C6A653B0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4702-wk-Fact-E4987D49B38892EDA85CB569CB43A6F1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4718-wk-Fact-5F7C94828F978958BD8E2843148C5CF0"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4737-wk-Fact-F5C79D89561257ED9F98284315A5FA19"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4757-wk-Fact-B5DF809A1BFFA5600B5EB56937D1DBB5"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4778-wk-Fact-B2AEA65500695E360BE42843159D6BCF"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4798-wk-Fact-0A3C987AB738ABC4857D2843148C1F38"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e4817-wk-Fact-57C8E77DA17C7B08A06DB5693C45448D"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-15DE37986BFFE3B9B4C528431668734C-0-wk-Fact-885EE46AAB2B9DA000632843162410B5">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward interest rate swaps (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Commodity contracts (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in revenue in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in cost of products sold in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in SG&amp;amp;A expenses in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember"
      decimals="-6"
      id="d10136988e4940-wk-Fact-0A954131919C69A44F112843160D13A1"
      unitRef="usd">7000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember"
      decimals="-6"
      id="d10136988e4959-wk-Fact-4C815D07C9874800A6322843160B2CF2"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember"
      decimals="-6"
      id="d10136988e4978-wk-Fact-6F309016821D37520F002843160F3667"
      unitRef="usd">1000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-6"
      id="d10136988e4994-wk-Fact-2FEF4FCA426C2A0907022843160D1601"
      unitRef="usd">1000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-6"
      id="d10136988e5013-wk-Fact-BC708BC4A504E7A0FF8D2843160A8F84"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-6"
      id="d10136988e5032-wk-Fact-137FB8A05FD9DDFBF3C92843160D8274"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="-6"
      id="d10136988e5053-wk-Fact-9D85849FE52D109D103D2843160E139E"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="-6"
      id="d10136988e5072-wk-Fact-B97A8EA64D62AA0501F42843160E0BD6"
      unitRef="usd">1000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="-6"
      id="d10136988e5091-wk-Fact-10A97C8F8DEEC600DD852843160D93E5"
      unitRef="usd">-2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-6"
      id="d10136988e5113-wk-Fact-45525065FEC795B66D84B56A85067C95"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-6"
      id="d10136988e5132-wk-Fact-4941A4D4A67F7FD0D51BB56A8C3242A5"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-6"
      id="d10136988e5151-wk-Fact-BBDCEBC6F615DC1CDBCEB56A930C7A2A"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="-6"
      id="d10136988e5172-wk-Fact-0F3E8D608C8641ECD16628431612934E"
      unitRef="usd">-5000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="-6"
      id="d10136988e5192-wk-Fact-876BD845FE26987C70442843160DD0B5"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="-6"
      id="d10136988e5211-wk-Fact-3D85CC1C91D93B9669672843160DBFED"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-6"
      id="d10136988e5272-wk-Fact-28327CA0E23F5099AAB45137214A079C"
      unitRef="jpy">64000000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-6"
      id="d10136988e5276-wk-Fact-9C51B897DD8952D19FA742CC2105B7D2"
      unitRef="usd">600000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-6"
      id="d10136988e5291-wk-Fact-CD0972EE3F585FD59B10B5C2B1BD64CB"
      unitRef="eur">200000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-6"
      id="d10136988e5295-wk-Fact-A0A76C80F740512FA4E0E2B74A32C8BB"
      unitRef="usd">233000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember"
      decimals="-6"
      id="d10136988e5309-wk-Fact-2C907640E605560309C6B5750BC40E64"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember"
      decimals="-6"
      id="d10136988e5313-wk-Fact-83D542563B5CFDFCADE9B58182C2621F"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember"
      decimals="-6"
      id="d10136988e5325-wk-Fact-F3C9F8154B0C8FABCC20B581CD7DB6F5"
      unitRef="usd">17000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember"
      decimals="-6"
      id="d10136988e5332-wk-Fact-AD37A13EF3042CCEF8A8B58340B26E17"
      unitRef="usd">5000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="FD2020Q4YTD_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember"
      id="TextSelection-A487D09C0A0C58647E752843166713A8-0-wk-Fact-23D2DA6DA7D549CE8600284316223FD2">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:40%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Maturity Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;325&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;July 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:40%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Notional Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Maturity Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;488&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Jul 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember"
      decimals="-6"
      id="d10136988e5471-wk-Fact-0C1B0B3AAA48A29090192843160B35D1"
      unitRef="usd">325000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember"
      decimals="-6"
      id="d10136988e5607-wk-Fact-39290C7C39E2E6BAA95E284315F039F2"
      unitRef="usd">488000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-51D544CC56D9E3A9E80A28431667E802-0-wk-Fact-20F6FE1794F029551B4A28431622D480">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Included in other income, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember"
      decimals="-6"
      id="d10136988e5743-wk-Fact-1D33DA171E8156EFB3E92BB7F8E00C7C"
      unitRef="usd">-11000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember"
      decimals="-6"
      id="d10136988e5763-wk-Fact-0EF18BAB860C55509545FDF3B280DA9B"
      unitRef="usd">-13000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember"
      decimals="-6"
      id="d10136988e5783-wk-Fact-ADC6C8E7B1DD7751F04428431608E19F"
      unitRef="usd">-5000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-D839E1E497E734116A1A28431666FD76-0-wk-Fact-0E3E6FAC4EB8D1AE033E284316237C3D">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Estimated fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7,273&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,065&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Carrying amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6,775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="FI2020Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-6"
      id="d10136988e5897-wk-Fact-264C7E2128C951DF9D9A0F0D1C876167"
      unitRef="usd">7273000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-6"
      id="d10136988e5916-wk-Fact-26B9E9CEDAB4513DBF89BA65718F4581"
      unitRef="usd">8065000000</us-gaap:DebtInstrumentFairValue>
    <cah:CarryingAmountofLongTermandotherShortTermBorrowings
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10136988e5931-wk-Fact-3DC5D901384F5A19AC7ECF33074D2088"
      unitRef="usd">6775000000</cah:CarryingAmountofLongTermandotherShortTermBorrowings>
    <cah:CarryingAmountofLongTermandotherShortTermBorrowings
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10136988e5950-wk-Fact-7D46BB0398C557D8B2BCBF1B13C9D791"
      unitRef="usd">8031000000</cah:CarryingAmountofLongTermandotherShortTermBorrowings>
    <cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-12C0EDD31AA7DFCFD0DB2843166741D8-0-wk-Fact-EB84AAF02467A07A30C228431624C25D">&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:100%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:32%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Fair&#160;Value&lt;br/&gt;Gain/(Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Fair&#160;Value&lt;br/&gt;Gain/(Loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;653&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;869&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cross-currency swap&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;233&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Commodity contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember"
      decimals="-6"
      id="d10136988e6219-wk-Fact-024078DE68EF497C4632284315D82FE1"
      unitRef="usd">550000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember"
      decimals="-6"
      id="d10136988e6238-wk-Fact-EA5C1AA4C88915DF1C13284315A885BC"
      unitRef="usd">27000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember"
      decimals="-6"
      id="d10136988e6257-wk-Fact-FCDD73E63AAB50617AB82843159C5DF6"
      unitRef="usd">2150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember"
      decimals="-6"
      id="d10136988e6277-wk-Fact-56C15295755994B4196B284315AD721E"
      unitRef="usd">40000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6292-wk-Fact-FD531D015C98CF8DD45F284315A48EDD"
      unitRef="usd">653000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6311-wk-Fact-102DCB5ADCEF25DE3D7F284315D48D8E"
      unitRef="usd">-4000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6331-wk-Fact-8EE26FC7D152C581DC67284315D53460"
      unitRef="usd">869000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6351-wk-Fact-7679F7A5C9DFBCEE90E6284315A7131E"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6371-wk-Fact-67C4D82337385D4715B3B565AFE1C0D5"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6390-wk-Fact-FE2515E22322E0AEB060B565B3165AAA"
      unitRef="usd">-16000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6410-wk-Fact-A9E74B5F26ADDE24CB48B565B689CED7"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6430-wk-Fact-30504F66B9BC256DA07EB565B9CA4ECE"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6450-wk-Fact-2B8C592D38FE3454A7B0B565BC666D34"
      unitRef="usd">833000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6469-wk-Fact-264ECF038D6464334180B565BF54D3BA"
      unitRef="usd">47000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6488-wk-Fact-67FBCCF018DE237A99D0B565C295F6AC"
      unitRef="usd">233000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6508-wk-Fact-6F491AE48C7C7F1E778CB565C5F7D426"
      unitRef="usd">12000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6528-wk-Fact-A07999AAFD668BE233E42843159C46E5"
      unitRef="usd">16000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6547-wk-Fact-7AFAE128EFF6FEE8473E2843159C9484"
      unitRef="usd">-1000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6567-wk-Fact-9C74D46BAB983F90329E284315A330F4"
      unitRef="usd">20000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CommodityContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d10136988e6587-wk-Fact-0C55E12F79572A03ADAD284315AABF67"
      unitRef="usd">-3000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-D02F0981FD28C7ED5F9E28431668D169-0-wk-Fact-1D9F4283039D37F400702843146AE2E1">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;11. Shareholders' Equity&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, authorized capital shares consisted of the following: &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;750 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; Class A common shares, without par value; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; Class B common shares, without par value; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;500 thousand&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; non-voting preferred shares, without par value. The Class A common shares and Class B common shares are collectively referred to below as &#x201c;common shares&#x201d;. Holders of common shares are entitled to share equally in any dividends declared by the Board of Directors and to participate equally in all distributions of assets upon liquidation. Generally, the holders of Class A common shares are entitled to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;one vote&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; per share, and the holders of Class B common shares are entitled to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;one-fifth of one vote&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; per share on proposals presented to shareholders for vote. Under certain circumstances, the &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;holders of Class B common shares are entitled to vote as a separate class. Only Class A common shares were outstanding at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We repurchased &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.5 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of our common shares, in the aggregate, through share repurchase programs during fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, as described below. We funded the repurchases with available cash and short term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we repurchased &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;7.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; common shares having an aggregate cost of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$350 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. The average price paid per common share was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$48.00&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. These repurchases were made under an accelerated share repurchase ("ASR") program, which began on &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;August&#160;20, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and was completed on &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;December&#160;4, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we repurchased &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;11.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; common shares having an aggregate cost of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$600 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. The average price paid per common share was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$52.32&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. These repurchases were made under ASR program, which began on &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;August&#160;16, 2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and was completed on &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;October&#160;25, 2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we repurchased &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;8.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; common shares having an aggregate cost of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$550 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. The average price paid per common share was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$65.30&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. These repurchases include&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$300 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; purchased under an ASR program, which began on &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;February&#160;14, 2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and was completed on &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;21, 2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. We repurchased&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;4.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;shares under the ASR at an average price paid per share of&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$69.26&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Adjustments and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gain/(Loss) on&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Derivatives,&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Comprehensive&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(113&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive income/(loss), net before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total other comprehensive loss attributable to Cardinal Health, Inc., net of tax of $1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive loss, before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(104&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2020Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember"
      decimals="INF"
      id="d10119396e2870-wk-Fact-E19E1ECF8D8DAE6610002843163B5D9D"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2020Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember"
      decimals="INF"
      id="d10119396e2875-wk-Fact-220E38A33B9E163CA7902843146F5F5D"
      unitRef="shares">5000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2020Q4"
      decimals="INF"
      id="d10119396e2879-wk-Fact-15921F8E736AD525E6102843146A0B3B"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="D2020Q4SD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-8"
      id="d10119396e2905-wk-Fact-854B6F5BE299DDC465202843163B4391"
      unitRef="usd">1500000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d10119396e2928-wk-Fact-B215055D30B85C1CA125EFB04AF2D1CE"
      unitRef="shares">7300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10119396e2932-wk-Fact-3936BCD4D87F534A8A416398BE9277F2"
      unitRef="usd">350000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="2"
      id="d10119396e2936-wk-Fact-B154173D9EB456EBA8E06B04DFA3CB1F"
      unitRef="usdPerShare">48.00</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <cah:TreasuryStockAcquiredShares
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d10119396e2956-wk-Fact-EA577AD26B465F41888DF858FBE664C0"
      unitRef="shares">11500000</cah:TreasuryStockAcquiredShares>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10119396e2960-wk-Fact-2760FFF59B935E778B43CBEDECAED277"
      unitRef="usd">600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="2"
      id="d10119396e2964-wk-Fact-ED2FDEB445955D35BF5C87D8D19E7913"
      unitRef="usdPerShare">52.32</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d10119396e2984-wk-Fact-43C75448B18784DE476A28431463A701"
      unitRef="shares">8400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10119396e2988-wk-Fact-C268C3032B53ABAFA8A428431599DDFC"
      unitRef="usd">550000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="2"
      id="d10119396e2992-wk-Fact-204F4B5B852B26E5CBD12843146825AC"
      unitRef="usdPerShare">65.30</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="D2018Q3SD_us-gaap_ShareRepurchaseProgramAxis_cah_AcceleratedsharerepurchaseplanMember_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d10119396e2996-wk-Fact-8072A27A17EF1439060228431462EA03"
      unitRef="usd">300000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="D2018Q3SD_us-gaap_ShareRepurchaseProgramAxis_cah_AcceleratedsharerepurchaseplanMember_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d10119396e3009-wk-Fact-917D2352F472CCA97ECA28431466F792"
      unitRef="shares">4300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="D2018Q3SD_us-gaap_ShareRepurchaseProgramAxis_cah_AcceleratedsharerepurchaseplanMember_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="2"
      id="d10119396e3013-wk-Fact-85121CC8221C6B2B683C28431467F904"
      unitRef="usdPerShare">69.26</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-CF729509B5A86AC8BD6A28431669C108-0-wk-Fact-2E894C93FF9041F4B16C284314668155">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Adjustments and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gain/(Loss) on&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Derivatives,&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Comprehensive&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(113&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive income/(loss), net before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total other comprehensive loss attributable to Cardinal Health, Inc., net of tax of $1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive loss, before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(104&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3153-wk-Fact-CB930A102123859086E92843161732C7"
      unitRef="usd">-113000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3173-wk-Fact-40627DDF112ADA9E984A28431614DA39"
      unitRef="usd">21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10119396e3192-wk-Fact-D8E8AFD70315541DAB84B9798AABD625"
      unitRef="usd">-92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3209-wk-Fact-24EC87234A8D8A3ED2952843161ADF5A"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3228-wk-Fact-67C3C8CC86EA78380877284316139317"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10119396e3247-wk-Fact-07C63015B5C7C925363B284316177F32"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3268-wk-Fact-169A10C08CAA0346D1F82843161544F6"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3287-wk-Fact-BE2B857FC0767ED81761284316228DEA"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10119396e3307-wk-Fact-EB43C3887B14E0B998BE28431616C690"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3329-wk-Fact-169839F20C352024684B2843161045F6"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3348-wk-Fact-6903EBC6F135F3EF5805284316165DFC"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10119396e3368-wk-Fact-5098069C0A2452C487D09C0036D8B533"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3389-wk-Fact-A6D0AFA11D6B5262973B842E0CCEBA87"
      unitRef="usd">-95000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3409-wk-Fact-FEB9D27E8B005BBDA69D3FB3DAA25BAC"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3428-wk-Fact-E7F2C96EB3DC5850A31A36053B97CD6A"
      unitRef="usd">-79000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3450-wk-Fact-343BD056547F52BC8AE3275F2122E5AF"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3469-wk-Fact-D84CDDF413065882A5A3430B74DE4806"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10119396e3489-wk-Fact-9651BCE6CB2D526484C5BD61BD71CE69"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3511-wk-Fact-8CC044C216A95639AF7B6F23C5795A59"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3530-wk-Fact-54FC3F572B125C07AD6C7E092A17258B"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10119396e3550-wk-Fact-9D053A10F30C501AB1419C51196C985C"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3572-wk-Fact-2DC9B07F23F53F067A9928431616BC98"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3591-wk-Fact-B234F583FBDD8979E3F52843161BC07A"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d10119396e3611-wk-Fact-FD89153856515D78A20181F5156EF4E8"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3638-wk-Fact-7638EBBE5CD856F5BF4C2378BCAC0B97"
      unitRef="usd">-92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3658-wk-Fact-A85339E44D995E78A5238B1751D2C751"
      unitRef="usd">-12000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d10119396e3678-wk-Fact-06D9310609A658858A4EC9F315B685D5"
      unitRef="usd">-104000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-0BC7E70850C47F71D10A2843166920A5-0-wk-Fact-B1D1A521756624C6BF9328431623CC67">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;12. Earnings/(Loss) Per Share Attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings/(loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(3,693&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;259&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings attributable to noncontrolling interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(3,696&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,363&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;256&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average common shares&#x2013;basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;300&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;313&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock options, restricted share units, and performance share units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-average common shares&#x2013;diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;301&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;315&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12.61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4.55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.82&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12.61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4.53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. During fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, there were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; potentially dilutive employee stock options, restricted share units and performance share units not included in the computation of diluted loss per common share attributable to Cardinal Health, Inc. because their effect would be anti-dilutive as a result of the net loss for the fiscal year.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-52C26D66429C9BB1092328431669BAA7-0-wk-Fact-AA7E17C207306814CE9C28431625DA11">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings/(loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(3,693&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;259&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings attributable to noncontrolling interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(3,696&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,363&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;256&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average common shares&#x2013;basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;300&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;313&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock options, restricted share units, and performance share units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-average common shares&#x2013;diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;301&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;315&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12.61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4.55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.82&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12.61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4.53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10130008e2975-wk-Fact-9AE3E593FCE6335F39752843162378C6"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10130008e2995-wk-Fact-DA8A9DB84161C8826F8428431624E0AF"
      unitRef="usd">1365000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10130008e3014-wk-Fact-CB17DEC5A4D0E06152A128431645C61E"
      unitRef="usd">259000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10130008e3030-wk-Fact-59D860CFE7EAD17DA86F284314604AB7"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10130008e3050-wk-Fact-40DF87BBE9A82CD4A06E2843164157A9"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10130008e3070-wk-Fact-2FA51944D462B903C3502843161C2311"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10130008e3097-wk-Fact-D376E4CF10C84B75E68E2843162F9636"
      unitRef="usd">-3696000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10130008e3117-wk-Fact-A6793123A202F02F7DDF2843161A0AE7"
      unitRef="usd">1363000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10130008e3136-wk-Fact-278090E7B9D1E914F887284316449146"
      unitRef="usd">256000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10130008e3152-wk-Fact-43211921D8B5D431B24928431628CAD3"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10130008e3171-wk-Fact-F05B0CAA787082C1A64D28431622E9C2"
      unitRef="shares">300000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10130008e3190-wk-Fact-4251EE951E11F5191C4528431624F81D"
      unitRef="shares">313000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10130008e3273-wk-Fact-4F725EA64F7161215B8677CB8530234E"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10130008e3292-wk-Fact-64785481744F008D89D4284315B047BA"
      unitRef="shares">1000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10130008e3311-wk-Fact-F4680ABA2B815576BA3E284315BB5E27"
      unitRef="shares">2000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10130008e3332-wk-Fact-8196072F7E42FDFF1191284314623FA4"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10130008e3351-wk-Fact-3EE9D56C6B63748AD0EF2843161B9246"
      unitRef="shares">301000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10130008e3370-wk-Fact-45955312A229A57570A7284316286CCF"
      unitRef="shares">315000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2020Q4YTD"
      decimals="2"
      id="d10130008e3396-wk-Fact-AA245B061237350EEC15284316290C1D"
      unitRef="usdPerShare">-12.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d10130008e3416-wk-Fact-2F9983D6B6AF648F50342843162BDF25"
      unitRef="usdPerShare">4.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d10130008e3435-wk-Fact-94E9FF2EC52DA96189682843145D91AD"
      unitRef="usdPerShare">0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2020Q4YTD"
      decimals="2"
      id="d10130008e3451-wk-Fact-DA6F10378D87161DA776284316273F14"
      unitRef="usdPerShare">-12.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d10130008e3471-wk-Fact-EAD48A09FC8087EFCA5D284316228D5C"
      unitRef="usdPerShare">4.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d10130008e3490-wk-Fact-0A9184B91DD77CD592422843162338C6"
      unitRef="usdPerShare">0.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10130008e3524-wk-Fact-A2EC6F0B0F972BF53BDE2843162BBA82"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10130008e3528-wk-Fact-83256237D1255C868538F4145DE8C92E"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10130008e3533-wk-Fact-03DCC59C9A74AB4F47D3A6787B458B32"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <cah:Sharesthatwouldbeantidilutiveasaresultofnetloss
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10130008e3541-wk-Fact-EE851B67A763B4E1786077CCF7F90B00"
      unitRef="shares">2000000</cah:Sharesthatwouldbeantidilutiveasaresultofnetloss>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-FD075778DBFAF028C5B4284316692353-0-wk-Fact-05CAEDB77BA89E601629284315FC756F">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;13. Segment Information&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our operations are principally managed on a products and services basis and are comprised of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates pharmacies, including pharmacies in community health centers, nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;this segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents revenue for each reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;137,495&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;129,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;121,241&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15,444&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,633&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,581&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,939&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;136,822&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,534&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;136,809&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:66%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;136,693&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;129,067&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;802&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;137,495&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;129,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13,429&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15,444&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,633&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,939&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,534&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services"&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents revenue by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;148,707&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;141,479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;132,539&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4,232&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4,071&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4,283&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total  segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,939&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;136,822&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,534&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;136,809&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;"&gt;Segment Profit&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general, and administrative ("SG&amp;amp;A") expenses. Segment SG&amp;amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial and customer care shared services, human resources, information technology, legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We do not allocate the following items to our segments: last-in first-out, or ("LIFO"), inventory charges/(credits); surgical gown recall costs; state opioid assessment related to prior fiscal years; restructuring and employee severance; amortization and other acquisition-related costs; impairments and (gain)/loss on disposal of assets; litigation (recoveries)/charges, net; other (income)/expense, net; interest expense, net; loss on early extinguishment of debt; gain on sale of equity interest in naviHealth and provision for/(benefit from) income taxes. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$69 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$55 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$43 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the opioid litigation as discussed further in &lt;/span&gt;&lt;a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we recognized a pre-tax charge of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; during fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; which was retained at Corporate. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the surgical gown recall as discussed further in &lt;/span&gt;&lt;a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we recognized a pre-tax charge of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$85 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; during fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; which was retained at Corporate. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the naviHealth divestiture discussed in &lt;/span&gt;&lt;a href="#s20ab24d9611f400f9fecc35ff4abdad4" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 2&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we recognized a pre-tax gain of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$508 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; during fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; which was retained at Corporate.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the sale of our remaining equity interest in a partnership that owned naviHealth as discussed in &lt;/span&gt;&lt;a href="#s20ab24d9611f400f9fecc35ff4abdad4" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 2&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we recognized a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$579 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; pre-tax gain (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$493 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; after tax) during fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which is included in gain on sale of equity interest naviHealth in the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;consolidated statements of earnings/(loss) and did not impact segment profit or operating earnings&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present segment profit by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,753&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,834&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,992&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;663&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;576&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;662&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment profit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,410&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,654&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(6,514&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(350&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2,528&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total operating earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4,098&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,060&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;126&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;135&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;147&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;156&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;243&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;288&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;278&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;535&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;598&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;913&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;86&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;127&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;242&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;199&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total additions to property and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;328&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;384&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents total assets for each reportable segment and Corporate at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22,398&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22,446&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;21,421&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;14,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,284&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;16,066&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,677&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,233&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,464&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;40,766&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;40,963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;39,951&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables present property and equipment, net by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,880&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,950&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;486&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;510&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;537&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,366&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,356&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="FD2020Q4YTD"
      decimals="0"
      id="d10148527e2863-wk-Fact-B90E114593CC51829C3D13F56F7DEC04"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-4E8A090E4A4C4F62827FB50BE49C01A2-0-wk-Fact-74D883C5AAFA9CC3D6FDB50DECC05263">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents revenue for each reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;137,495&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;129,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;121,241&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15,444&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,633&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,581&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,939&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;136,822&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,534&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;136,809&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e2983-wk-Fact-C3CDF5C17E6CE10AC8E2951AD4FE36CD"
      unitRef="usd">137495000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e3002-wk-Fact-6BDEF3281D14D51D97DB9520B43D8899"
      unitRef="usd">129917000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e3021-wk-Fact-F9D6CA3722064C40B42177CFF220537E"
      unitRef="usd">121241000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e3037-wk-Fact-8BA9924FB83D6BC37D26951AD4F6E02E"
      unitRef="usd">15444000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e3056-wk-Fact-34FE0312A02DF0B9523B9520C670168A"
      unitRef="usd">15633000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e3075-wk-Fact-B6867D55E92FEB22F69477D03ADA1622"
      unitRef="usd">15581000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d10148527e3096-wk-Fact-BBAB069DCED743CC7106951AD50F3F1A"
      unitRef="usd">152939000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d10148527e3115-wk-Fact-6D6D9868D1D895A6B1B99520CB13C2A4"
      unitRef="usd">145550000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d10148527e3134-wk-Fact-5AECB952E15DB893D65B77D074446AC1"
      unitRef="usd">136822000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e3155-wk-Fact-773AC6DE960689BFE64B951AD528B3B7"
      unitRef="usd">-17000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e3175-wk-Fact-3A18C428483A74D9BE3D9520CE0F51C2"
      unitRef="usd">-16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e3195-wk-Fact-7E80463645138BBE56E077D0A40E06C1"
      unitRef="usd">-13000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10148527e3222-wk-Fact-EC673078FA4FB89EE7BA2843162A4DFB"
      unitRef="usd">152922000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10148527e3241-wk-Fact-BD3D8FD103E378282798284316187DCD"
      unitRef="usd">145534000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10148527e3260-wk-Fact-DB142B6DA98C5A50ADCB2843162D4777"
      unitRef="usd">136809000000</us-gaap:Revenues>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-11F801B19DE243644D6028431669DCE5-0-wk-Fact-ACA56CE8637CE11FF675284315DD77A5">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:66%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;136,693&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;129,067&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;802&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;137,495&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;129,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13,429&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15,444&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,633&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,939&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,534&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services"&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-C30188B16B7D77136C042843166A12E6-0-wk-Fact-AB9B64C1F7995090DDC1284315E9D7EA">&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:66%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;136,693&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;129,067&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;802&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;137,495&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;129,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13,429&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15,444&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,633&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,939&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,534&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services"&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember"
      decimals="-6"
      id="d10148527e3367-wk-Fact-3EE08EC6A096ECD7C0AB951AD508F9A6"
      unitRef="usd">136693000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember"
      decimals="-6"
      id="d10148527e3381-wk-Fact-A0632A0EFAFD24E9D69D9520A36B85E6"
      unitRef="usd">129067000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember"
      decimals="-6"
      id="d10148527e3396-wk-Fact-C8179CCA6F45B58AEFA2951AD51B4976"
      unitRef="usd">802000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember"
      decimals="-6"
      id="d10148527e3410-wk-Fact-B70413B78D9852DB482D9520ACF3D907"
      unitRef="usd">850000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e3430-wk-Fact-C3CDF5C17E6CE10AC8E2951AD4FE36CD"
      unitRef="usd">137495000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e3444-wk-Fact-6BDEF3281D14D51D97DB9520B43D8899"
      unitRef="usd">129917000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember"
      decimals="-6"
      id="d10148527e3464-wk-Fact-97C72595945FC33A0715951AD5224F19"
      unitRef="usd">13429000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember"
      decimals="-6"
      id="d10148527e3478-wk-Fact-B8E03B5E6B87953031039520B95CFAC0"
      unitRef="usd">13833000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeSolutionsMember"
      decimals="-6"
      id="d10148527e3498-wk-Fact-37C629CCB6EEDB38B4E6951AD5141C28"
      unitRef="usd">2015000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeSolutionsMember"
      decimals="-6"
      id="d10148527e3512-wk-Fact-518318057F7EA92950609520C0329AF2"
      unitRef="usd">1800000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e3532-wk-Fact-8BA9924FB83D6BC37D26951AD4F6E02E"
      unitRef="usd">15444000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e3546-wk-Fact-34FE0312A02DF0B9523B9520C670168A"
      unitRef="usd">15633000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d10148527e3566-wk-Fact-BBAB069DCED743CC7106951AD50F3F1A"
      unitRef="usd">152939000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d10148527e3580-wk-Fact-6D6D9868D1D895A6B1B99520CB13C2A4"
      unitRef="usd">145550000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e3600-wk-Fact-773AC6DE960689BFE64B951AD528B3B7"
      unitRef="usd">-17000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e3615-wk-Fact-3A18C428483A74D9BE3D9520CE0F51C2"
      unitRef="usd">-16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10148527e3641-wk-Fact-EC673078FA4FB89EE7BA2843162A4DFB"
      unitRef="usd">152922000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10148527e3655-wk-Fact-BD3D8FD103E378282798284316187DCD"
      unitRef="usd">145534000000</us-gaap:Revenues>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-1D18CEFFA8009BB395C4284316695E85-0-wk-Fact-826F847B26F1938F3A8B284315EBC66A">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents revenue by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;148,707&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;141,479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;132,539&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4,232&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4,071&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4,283&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total  segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,939&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;136,822&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;152,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;145,534&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;136,809&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-6"
      id="d10148527e3814-wk-Fact-4ACFB677EF1D3EFF0562284316035233"
      unitRef="usd">148707000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-6"
      id="d10148527e3833-wk-Fact-5765A4CE69F83AB6DE2C284315FDC2CF"
      unitRef="usd">141479000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-6"
      id="d10148527e3852-wk-Fact-6B450C52911DA389F9B4284315FF537B"
      unitRef="usd">132539000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-6"
      id="d10148527e3868-wk-Fact-E7A5400131127CE5952D284316054BD1"
      unitRef="usd">4232000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-6"
      id="d10148527e3887-wk-Fact-1E4BC42AB3FB4AA9866F28431605CB13"
      unitRef="usd">4071000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-6"
      id="d10148527e3906-wk-Fact-DC7868D2D021593925AF284316019D4B"
      unitRef="usd">4283000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d10148527e3927-wk-Fact-BBAB069DCED743CC7106951AD50F3F1A"
      unitRef="usd">152939000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d10148527e3946-wk-Fact-6D6D9868D1D895A6B1B99520CB13C2A4"
      unitRef="usd">145550000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d10148527e3965-wk-Fact-5AECB952E15DB893D65B77D074446AC1"
      unitRef="usd">136822000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e3986-wk-Fact-773AC6DE960689BFE64B951AD528B3B7"
      unitRef="usd">-17000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e4006-wk-Fact-3A18C428483A74D9BE3D9520CE0F51C2"
      unitRef="usd">-16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e4026-wk-Fact-7E80463645138BBE56E077D0A40E06C1"
      unitRef="usd">-13000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10148527e4053-wk-Fact-EC673078FA4FB89EE7BA2843162A4DFB"
      unitRef="usd">152922000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10148527e4072-wk-Fact-BD3D8FD103E378282798284316187DCD"
      unitRef="usd">145534000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10148527e4091-wk-Fact-DB142B6DA98C5A50ADCB2843162D4777"
      unitRef="usd">136809000000</us-gaap:Revenues>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10148527e4120-wk-Fact-7A1A7490B3B257D38B13B9C6D34DB933"
      unitRef="usd">69000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10148527e4124-wk-Fact-ECFD7929BBBE59A891CD76A63E01F7D0"
      unitRef="usd">55000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10148527e4129-wk-Fact-A04483053512E1BC4D65284315F8E21F"
      unitRef="usd">43000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-6"
      id="d10148527e4154-wk-Fact-7BEE7B16CCFA59729DF5EFBDE17CAEA0"
      unitRef="usd">-5630000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:InventoryRecallExpense
      contextRef="FD2020Q4YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMember"
      decimals="-6"
      id="d10148527e4170-wk-Fact-731D1329BF8F5295AB242044B0F32C30"
      unitRef="usd">85000000</us-gaap:InventoryRecallExpense>
    <cah:PreTaxGainonDivestiture
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10148527e4186-wk-Fact-4E5C63720C372A7C7130284315F7388D"
      unitRef="usd">508000000</cah:PreTaxGainonDivestiture>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="FD2020Q4QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d10148527e4202-wk-Fact-A4954187376CE474EA85A65DF290D3F7"
      unitRef="usd">579000000</us-gaap:GainOnSaleOfInvestments>
    <cah:GainonDivestitureAfterTax
      contextRef="FD2020Q4QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d10148527e4206-wk-Fact-F43E5915F710A356B389B477FD2C18A3"
      unitRef="usd">493000000</cah:GainonDivestitureAfterTax>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-B72C5461438D05FFF94E28431669470D-0-wk-Fact-B011CB9F8B7DEF68A810284315F7A12A">&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present segment profit by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,753&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,834&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,992&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;663&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;576&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;662&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment profit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,410&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,654&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(6,514&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(350&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2,528&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total operating earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4,098&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,060&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;126&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e4365-wk-Fact-78BB278EF419BD44A0BF951ACA99DA7D"
      unitRef="usd">1753000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e4384-wk-Fact-D24F8581ED10E7D0094A951ACAB03F45"
      unitRef="usd">1834000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e4403-wk-Fact-BB3DC3CF575F73A3DDC928431600E665"
      unitRef="usd">1992000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e4419-wk-Fact-D9EF8167B4D7F596F24B951ACA8DF4F4"
      unitRef="usd">663000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e4438-wk-Fact-F8DFBE5B5F8903585277951ACA93C9F6"
      unitRef="usd">576000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e4457-wk-Fact-3BC18EBC286EA15945B8284315FA0EE3"
      unitRef="usd">662000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d10148527e4478-wk-Fact-5AD125C436A3BC5D2110951ACAAA2C60"
      unitRef="usd">2416000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d10148527e4497-wk-Fact-E9D57FA3E09FC76BE54D951ACAA5D4FD"
      unitRef="usd">2410000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d10148527e4516-wk-Fact-55EC1B93270CB1529099284315FA1D1F"
      unitRef="usd">2654000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e4537-wk-Fact-3010C5009A5F530DA628951ACA871E4B"
      unitRef="usd">-6514000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e4557-wk-Fact-DCF6276FA8829B1CCD8B951ACA8175FD"
      unitRef="usd">-350000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e4577-wk-Fact-2C6710A80E615781366E284315FEAD9B"
      unitRef="usd">-2528000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10148527e4604-wk-Fact-A7B59A36E5F72A058365284316403890"
      unitRef="usd">-4098000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10148527e4624-wk-Fact-F255B30F4DA9D01D31CE2843162EC039"
      unitRef="usd">2060000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10148527e4643-wk-Fact-7CFC054F72252BD96EDA2843162CDB72"
      unitRef="usd">126000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-61BAE07CEC5EE88710FC2843166ACF77-0-wk-Fact-1436F2F39711A5238125284315DE907D">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;135&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;147&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;156&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;243&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;288&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;278&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;535&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;598&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;913&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;86&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;127&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;242&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;199&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total additions to property and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;328&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;384&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e4760-wk-Fact-B3DDF038D48B1D32DF91284315EC7A46"
      unitRef="usd">135000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e4779-wk-Fact-35C2FAF2B5405206C16D284315F66619"
      unitRef="usd">147000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e4798-wk-Fact-8BC09ACB1EDF39D764F0284315E0DD18"
      unitRef="usd">156000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e4814-wk-Fact-F2E892895AB4DDACB181284315F40628"
      unitRef="usd">243000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e4833-wk-Fact-14127CA03D4668103C7C2843146C4894"
      unitRef="usd">288000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e4852-wk-Fact-22CF41B99E473A9CDE1D284315F33C63"
      unitRef="usd">278000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e4873-wk-Fact-2CD757E8766C91ABC040284315E9167F"
      unitRef="usd">535000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e4892-wk-Fact-378193F31A22716DED3F284315F0BA73"
      unitRef="usd">565000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e4911-wk-Fact-AC6D7E4087C79593C4BF284315F60ECD"
      unitRef="usd">598000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10148527e4937-wk-Fact-57EDF83A615A6AD362F8284314743364"
      unitRef="usd">913000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10148527e4956-wk-Fact-83DDAE6665350772F68628431483662C"
      unitRef="usd">1000000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10148527e4975-wk-Fact-025EC02EAF19C052A2972843148966C8"
      unitRef="usd">1032000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e5078-wk-Fact-A9A23B253F2D6A0AF3D728431630AEC0"
      unitRef="usd">47000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e5097-wk-Fact-D75EC5FACAD4A11E1C6A2843162E6D8F"
      unitRef="usd">35000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e5116-wk-Fact-E9B36B52E20B3A8F2A8E2843162F191D"
      unitRef="usd">58000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e5132-wk-Fact-83D82EBF49DA837E4F392843162D46A3"
      unitRef="usd">86000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e5151-wk-Fact-C36A95106E2C8FD312052843162F0D00"
      unitRef="usd">74000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e5170-wk-Fact-C7548E0FB167A43877952843162D4EE5"
      unitRef="usd">127000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e5191-wk-Fact-47CD19C57FE018295D182843162BD36B"
      unitRef="usd">242000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2019Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e5210-wk-Fact-D8A6018247D50A4A4E6A2843162E5ED9"
      unitRef="usd">219000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e5229-wk-Fact-4EF6E23E176A95FBF9252843162FA258"
      unitRef="usd">199000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10148527e5255-wk-Fact-5569821F2C7BF16C54C3284315A0F77A"
      unitRef="usd">375000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10148527e5274-wk-Fact-53BD6795C0FB005E6EB728431488D90A"
      unitRef="usd">328000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10148527e5293-wk-Fact-08E32C846E584979DCB328431474D5E4"
      unitRef="usd">384000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-FA6B32ACB13AE3269CEB28431669E41A-0-wk-Fact-58CD5D0D45E89F5813DB284315E6DFFE">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents total assets for each reportable segment and Corporate at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22,398&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22,446&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;21,421&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;14,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,284&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;16,066&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,677&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,233&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,464&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;40,766&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;40,963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;39,951&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="FI2020Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e5415-wk-Fact-FAE7C86BDC1659AB8D601372A8155930"
      unitRef="usd">22398000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e5434-wk-Fact-305835B199AD52EDBF4714879B2E1D67"
      unitRef="usd">22446000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d10148527e5453-wk-Fact-1047E59FEE41FF77BE752843146DF82F"
      unitRef="usd">21421000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2020Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e5469-wk-Fact-6E2E26B230245966A13702DAACD45126"
      unitRef="usd">14691000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e5488-wk-Fact-5042E86A83995598A18C1F623DC4236A"
      unitRef="usd">15284000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d10148527e5507-wk-Fact-44D4F4C302C687030F85284314684258"
      unitRef="usd">16066000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2020Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e5528-wk-Fact-C0849739F4185EF79795DF2E9F3D0167"
      unitRef="usd">3677000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e5547-wk-Fact-2EE07113D015563AB23B6BA07BA2D4E7"
      unitRef="usd">3233000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d10148527e5566-wk-Fact-ABCC7559ED4B4B3A85C32843147090E6"
      unitRef="usd">2464000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10148527e5592-wk-Fact-0D1C1049F30C5252BA4FAD5427DE72B3"
      unitRef="usd">40766000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10148527e5611-wk-Fact-45315210045352E49355E81E393FAF22"
      unitRef="usd">40963000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10148527e5630-wk-Fact-59FEF2AF6F38D3CD414928431471643F"
      unitRef="usd">39951000000</us-gaap:Assets>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-4723FF77A2B5913F395D2843166A6302-0-wk-Fact-86F11EA2F277DDDE0DE0284315EAB6AF">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables present property and equipment, net by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,880&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,950&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;486&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;510&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;537&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,366&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,356&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2020Q4_srt_StatementGeographicalAxis_country_US"
      decimals="-6"
      id="d10148527e5747-wk-Fact-61BE44E966CACD8EE805284315F7A755"
      unitRef="usd">1880000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2019Q4_srt_StatementGeographicalAxis_country_US"
      decimals="-6"
      id="d10148527e5766-wk-Fact-7A42B5A3DE13628584AC284315F3053C"
      unitRef="usd">1846000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2018Q4_srt_StatementGeographicalAxis_country_US"
      decimals="-6"
      id="d10148527e5785-wk-Fact-CC5B1B3B0ED37C56D41F284315EA9796"
      unitRef="usd">1950000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2020Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-6"
      id="d10148527e5801-wk-Fact-8E63A66DD5F9AE814DB3284315F4EA77"
      unitRef="usd">486000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2019Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-6"
      id="d10148527e5820-wk-Fact-B68D6FF3317AFA6E355D284315F21A4B"
      unitRef="usd">510000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2018Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-6"
      id="d10148527e5839-wk-Fact-EE82EEF39305D20F5CFD284315ECE45F"
      unitRef="usd">537000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10148527e5865-wk-Fact-022AFBD3623650148594C8C3580F78AF"
      unitRef="usd">2366000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10148527e5884-wk-Fact-65BAC2AADAAF5CD58F3560A3DA72CCD6"
      unitRef="usd">2356000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10148527e5903-wk-Fact-1EB985FB43D05687F27E284315EEA3C6"
      unitRef="usd">2487000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-0E9745B85081B8609E292843166B35F2-0-wk-Fact-02BA9C4BBD21FAC95BAB284315AD6880">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;14. Share-Based Compensation&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We maintain stock incentive plans (collectively, the &#x201c;Plans&#x201d;) for the benefit of certain of our officers, directors and employees. At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;12 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; shares remain available for future grants under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan ("2011 LTIP"). Under the 2011 LTIP's fungible share counting provisions, stock options are counted against the plan as &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;one share for every share issued&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;; awards other than stock options are counted against the plan as &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;two and one-half shares for every share issued&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. This means that only &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; shares could be issued under awards other than stock options while &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;12 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; shares could be issued under stock options. Shares are issued out of treasury shares when stock options are exercised and when restricted share units and performance share units vest. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table provides total share-based compensation expense by type of award:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:60%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Restricted share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;70&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;63&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock option expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Performance share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;90&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;82&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The total tax benefit related to share-based compensation was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$16 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$16 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$23 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Restricted share units granted under the Plans generally vest in equal annual installments over &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to restricted share units under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;71.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;50.13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;74.52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;62.32&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;42.71&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;60.21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;45.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:5px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table provides additional data related to restricted share unit activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;77&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;57&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Employee stock options granted under the Plans generally vest in equal annual installments over &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and are exercisable for a period up to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all stock option transactions under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercise Price per&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Common Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Outstanding at June 30, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;64.50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;72.54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Outstanding at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;63.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;42.36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Outstanding at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;65.15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercisable at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;65.25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table provides additional detail related to stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of outstanding options at period end&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of exercisable options at period end&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of exercised options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net proceeds/(withholding) from share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Excess tax benefits from share based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average grant date fair value per stock option&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8.26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8.34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13.50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:66%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of outstanding options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of exercisable options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average period over which stock option compensation cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Until the end of fiscal 2018, stock options were granted to our officers and certain employees. The fair values were estimated on the grant date using a lattice valuation model. We believe the lattice model provides reasonable estimates because it has the ability to take into account individual exercise patterns based on changes in our stock price and other variables, and it provides for a range of input assumptions, which are disclosed in the table below. The risk-free rate is based on the U.S. Treasury yield curve at the time of the grant. We analyzed historical data to estimate option exercise behaviors and employee terminations to be used within the lattice model. The expected life of the options granted was calculated from the option valuation model and represents the length of time in years that the options granted are expected to be outstanding. Expected volatilities are based on implied volatility from traded options on our common shares and historical volatility over a period of time commensurate with the contractual term of the option grant (up to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;). &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;There were no stock options granted to employees during fiscal year &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; or &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. The following table provides the range of assumptions used to estimate the fair value of stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.12345679012346%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2.1%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;25%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2.7%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2.8%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Expected life in years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Performance share units generally vest over a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;three&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;zero&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;240 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Performance&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Share Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;66.13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;50.96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;52.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;44.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;48.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;50.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;54.24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table provides additional data related to performance share unit activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:60%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average period over which performance share unit cost is expected to be recognized (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Employee Retirement Savings Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Substantially all of our domestic non-union employees are eligible to be enrolled in our company-sponsored contributory retirement savings plans, which include features under Section 401(k) of the Internal Revenue Code of 1986, and provide for matching and discretionary contributions by us. The total expense for our employee retirement savings plans was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$66 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$99 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$129 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="FI2020Q4_us-gaap_PlanNameAxis_cah_A2011LtipMember"
      decimals="-6"
      id="d10159911e2868-wk-Fact-413FF77BE05F667068E0284315B1899B"
      unitRef="shares">12000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="FI2020Q4_us-gaap_AwardTypeAxis_cah_AwardsOtherThanStockOptionsMember_us-gaap_PlanNameAxis_cah_A2011LtipMember"
      decimals="-6"
      id="d10159911e2880-wk-Fact-635B483F96B811A73D13284315AD3995"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_cah_A2011LtipMember"
      decimals="-6"
      id="d10159911e2885-wk-Fact-DFE567A44F49AE81C07F284315AADF32"
      unitRef="shares">12000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-E52CD5EC49FF451857672843166C8507-0-wk-Fact-93A12674EA31D3B36E4E284315F73D55">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table provides total share-based compensation expense by type of award:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:60%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Restricted share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;70&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;63&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock option expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Performance share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;90&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;82&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3005-wk-Fact-150E6B1604EC8921D76B284315B7DBC9"
      unitRef="usd">70000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3024-wk-Fact-B964489CB1C5CF7D76DF284315C0DE04"
      unitRef="usd">63000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3043-wk-Fact-53DF133EE0C38DC55C87284315CB7018"
      unitRef="usd">73000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e3059-wk-Fact-C20350B9EAC990CE8683284315BCA3C4"
      unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e3078-wk-Fact-CDF04E28835826530798284315B41AA2"
      unitRef="usd">10000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e3097-wk-Fact-F757E5A1A8A438D22623284315C63B70"
      unitRef="usd">22000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d10159911e3118-wk-Fact-930200C250DEB4034780284315B75B7E"
      unitRef="usd">17000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d10159911e3137-wk-Fact-5CC63477C4560BABEDF5284315C7F0A1"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d10159911e3156-wk-Fact-AEBF175479F690002AE1284315CFBE23"
      unitRef="usd">-10000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10159911e3183-wk-Fact-7DB978ED2CBE3D24705B284315C09EB3"
      unitRef="usd">90000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10159911e3202-wk-Fact-A36DC376E5C3914563D0284315C3FD92"
      unitRef="usd">82000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10159911e3221-wk-Fact-7C5E9A2BC2446656EC2A284315BD8E16"
      unitRef="usd">85000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10159911e3241-wk-Fact-2FAAA9E46F074CCB0570284315A8B9B7"
      unitRef="usd">16000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10159911e3245-wk-Fact-F5168AAC48A2C5A0FBB1284315AA429D"
      unitRef="usd">16000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10159911e3249-wk-Fact-9871BB0649BD6135B628284315B09CBC"
      unitRef="usd">23000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      id="d10159911e3272-wk-Fact-ABD67E191A7A536091BF27BB0A6DCE19">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-5CB15943F843B755FDAA2843166B0B06-0-wk-Fact-86E2D3537E6083207695284315A75FD8">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to restricted share units under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;71.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;50.13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;74.52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;62.32&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;42.71&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;60.21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;45.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3348-wk-Fact-75F7E839E03CC9C8C66E284316325EE7"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d10159911e3367-wk-Fact-89FA4997F35CEE3C55392843163C6AE3"
      unitRef="usdPerShare">71.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3382-wk-Fact-1862A7713002520980DC2843162CD56A"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d10159911e3396-wk-Fact-8F43E5A0495C5F7963DF284315F8110D"
      unitRef="usdPerShare">50.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3416-wk-Fact-10393C06DB042EBF5ED2284316307C72"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d10159911e3431-wk-Fact-F12B9A5EFB74AF39DB02284316195776"
      unitRef="usdPerShare">74.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3451-wk-Fact-93D3BC066EDE8284066B2843161DB56B"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d10159911e3466-wk-Fact-C6FE4E7F8C1C0C13C21E284315FA3B77"
      unitRef="usdPerShare">62.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3486-wk-Fact-C9509EDD7C4953C487EE049CC8D660BF"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d10159911e3500-wk-Fact-4725BFDBB4D752D28E860244A9AB22A1"
      unitRef="usdPerShare">51.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3520-wk-Fact-7D1041A39BB455699F468480FE79BE2C"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d10159911e3534-wk-Fact-F7CB85A6AC7C59269B18B8A99DA024B9"
      unitRef="usdPerShare">42.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3554-wk-Fact-32184EA33E675E579FC8382BD3C81533"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d10159911e3569-wk-Fact-54906FE9EBE650959B07815C86D1124B"
      unitRef="usdPerShare">60.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3589-wk-Fact-005D077437F05DC487E41EBA177AB30B"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d10159911e3603-wk-Fact-F69541D02F7D5E72A9246B119E76FF07"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3623-wk-Fact-B78A4574EF8A5ACE91538162F008C752"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d10159911e3642-wk-Fact-142CCBE7B4065DA9A51DC3AC2A769A0B"
      unitRef="usdPerShare">45.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-E5741612AFBF8CBDACA02843166CBB4A-0-wk-Fact-6B13C65EBD6C42241DA1284315A62F9E">&lt;div style="line-height:120%;padding-bottom:5px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table provides additional data related to restricted share unit activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;77&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;57&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3756-wk-Fact-5FBC12CE3E685BAF9488D69BBCCFD7DA"
      unitRef="usd">77000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3775-wk-Fact-7261A945DAAA88875B5C284315FC63D1"
      unitRef="usd">75000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3794-wk-Fact-FF4E7D68FFC9FC0033F8284315FA4416"
      unitRef="usd">78000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      id="d10159911e3810-wk-Fact-BBD672F6F87351E5A50DB36FDC15A86B">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      id="d10159911e3829-wk-Fact-64399945F2E5496E8962284315F6F14D">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      id="d10159911e3848-wk-Fact-95DFE17B6221B469CAA7284315F87828">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3874-wk-Fact-DE55300541A2EA6DD92B2843160222EA"
      unitRef="usd">57000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3893-wk-Fact-6483A927284060CFE6F0284315EF60AD"
      unitRef="usd">68000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d10159911e3912-wk-Fact-A2B7267AC2ABC31A918F284315F01E2A"
      unitRef="usd">65000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e3931-wk-Fact-737B4542D202515C8431F534FC0ABAE6">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <cah:ExercisablePeriodOfPlansInYears
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e3935-wk-Fact-FD4B81DBE0595C05A542853A316EDCD6">P10Y</cah:ExercisablePeriodOfPlansInYears>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-0E2CC69691E2DE2E422D2843166B0866-0-wk-Fact-ADEAFA84547A466DECFB284315AC4DDC">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all stock option transactions under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercise Price per&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Common Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Outstanding at June 30, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;64.50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;72.54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Outstanding at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;63.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;42.36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Outstanding at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;65.15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercisable at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;65.25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10159911e4022-wk-Fact-04FA5693206397C6AC83284315FA94C7"
      unitRef="shares">7000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="FI2018Q4"
      decimals="2"
      id="d10159911e4041-wk-Fact-93FD3E598F6B428106AC284315F461F5"
      unitRef="usdPerShare">64.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10159911e4056-wk-Fact-6B3028C20F60A3A90CFF284315F265F3"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d10159911e4070-wk-Fact-E70794C0381D918E8238284315F0C581"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10159911e4090-wk-Fact-E7C0F02D471ED9621B21284315FB01EE"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d10159911e4104-wk-Fact-4F419441803F010317FF284315F24011"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10159911e4124-wk-Fact-D8D931679DBF6900D993284315FDC222"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d10159911e4139-wk-Fact-A63A16459032782E5753284315FD157E"
      unitRef="usdPerShare">72.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10159911e4159-wk-Fact-210EAA4DEB3B59B5BDD004953B98F0F6"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="FI2019Q4"
      decimals="2"
      id="d10159911e4173-wk-Fact-596963E6C2AE5BFA88190462F822D2CC"
      unitRef="usdPerShare">63.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10159911e4193-wk-Fact-2BF2751BC7945B6C8366E9F12A437B4F"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="FD2020Q4YTD"
      decimals="2"
      id="d10159911e4207-wk-Fact-A8C77787AEE65F4FB6511C0D46B2C93B"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10159911e4227-wk-Fact-D4E723AAA1BE52A9BB93F0DAC6758EDF"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="FD2020Q4YTD"
      decimals="2"
      id="d10159911e4242-wk-Fact-54D2509E64F855AEA0021DF97EC6A76D"
      unitRef="usdPerShare">42.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10159911e4262-wk-Fact-ACA2B7F003D05E69918AAA2CA4770369"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="FD2020Q4YTD"
      decimals="2"
      id="d10159911e4276-wk-Fact-9921B5308FCE5F34AEDCF7178D0F88B0"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10159911e4296-wk-Fact-5CB45B06BC335CA699C70E942DB31484"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="FI2020Q4"
      decimals="2"
      id="d10159911e4315-wk-Fact-0968FF6934155F67ABE0E6F02D2CE9BA"
      unitRef="usdPerShare">65.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10159911e4330-wk-Fact-084C8C1418725006B340F593378FC527"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="FI2020Q4"
      decimals="2"
      id="d10159911e4349-wk-Fact-35C34FF1FB675C46A09A955ACD4185FE"
      unitRef="usdPerShare">65.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <cah:AdditionalStockOptionPlanDataTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-7E52B2F0E833E770D4152843166B4746-0-wk-Fact-BFCBA056F1CC9BEE5A79284315AF93A3">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table provides additional detail related to stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of outstanding options at period end&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of exercisable options at period end&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of exercised options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net proceeds/(withholding) from share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Excess tax benefits from share based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average grant date fair value per stock option&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8.26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8.34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;13.50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</cah:AdditionalStockOptionPlanDataTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4474-wk-Fact-F8F4ECBE2347532493DA653C07925C45"
      unitRef="usd">12000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4493-wk-Fact-68962932DD115F39B00658DC307D9DE4"
      unitRef="usd">10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4512-wk-Fact-313F156E1C2C1E9CB5B2284315B595D4"
      unitRef="usd">13000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4528-wk-Fact-2BC887C14988580CB603442FF8199396"
      unitRef="usd">12000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4547-wk-Fact-D2A211314ECC5F6D80D1D3F94F4161B8"
      unitRef="usd">10000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4566-wk-Fact-CB4D0D661C1227EA452028431633B194"
      unitRef="usd">13000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4587-wk-Fact-498891F51D1471D07042284315BE58F7"
      unitRef="usd">8000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4606-wk-Fact-292EF46C0DF6022CE9E3284315B103EB"
      unitRef="usd">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4625-wk-Fact-1B4031EF6A6B1E117E0328431630DB5E"
      unitRef="usd">14000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4646-wk-Fact-F284F4582DCDA497FAB1284315B0F219"
      unitRef="usd">26000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4665-wk-Fact-B862D3094785AD4260AF284315B0B248"
      unitRef="usd">3000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4684-wk-Fact-642AB5ED58644BD2D12628431631AE9C"
      unitRef="usd">-3000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4706-wk-Fact-8058EEC86F4C8DFEA51E284315BAE892"
      unitRef="usd">6000000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
    <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4725-wk-Fact-C36C12B512DA4F4F3879284315B3140F"
      unitRef="usd">7000000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
    <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4744-wk-Fact-9C9D76181A80B41D74B5284315AEDE35"
      unitRef="usd">10000000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4765-wk-Fact-0379BBB58BD25DA5B2B31CB19DFE7230"
      unitRef="usd">1000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4784-wk-Fact-91C4F9E14B8D6FA9AA6928431632A925"
      unitRef="usd">5000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4803-wk-Fact-B3A6FDD10E471E54DD79284316301B49"
      unitRef="usd">17000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4824-wk-Fact-55BE7AB76C15A491A1EB28431630A963"
      unitRef="usd">8000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4843-wk-Fact-DC3230356880F95B731F2843162CECE4"
      unitRef="usd">20000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d10159911e4862-wk-Fact-F35B51F08392D8EA0277284316252BED"
      unitRef="usd">19000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="d10159911e4888-wk-Fact-FAC8D718ACF686DA61E8284315ACC307"
      unitRef="usdPerShare">8.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="d10159911e4907-wk-Fact-2E8B2A8F57AACDE928D728431630FC94"
      unitRef="usdPerShare">8.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="d10159911e4926-wk-Fact-B113C6E90D581942217C28431627DE1A"
      unitRef="usdPerShare">13.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <cah:RemainingStockOptionPlanDataTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-9CFBD5538B1B821360A82843166B80D3-0-wk-Fact-BC125AF2B7E2A84A1D39284315A75D9F">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:66%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of outstanding options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of exercisable options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average period over which stock option compensation cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</cah:RemainingStockOptionPlanDataTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e4996-wk-Fact-681EAA3CCC7A597084D5940F78374968">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e5006-wk-Fact-C978030C8276581FA810CFA857D4CCC9">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e5016-wk-Fact-B04CC475EAC8FF6CC5BC284316323567">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e5027-wk-Fact-2B882F85D49258838C0B4715F4396E2E">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e5037-wk-Fact-AEB7914FB9A45387A1B51068393668DF">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e5047-wk-Fact-BA221B7A81B19EEB30E528431631A140">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e5058-wk-Fact-320CDF4B825F58B8A586B112DD375363">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e5068-wk-Fact-49E3C4B7CD3BFF574F1A28431632C84E">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e5078-wk-Fact-C46435AF8B3E34A078C128431630B0ED">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <cah:ExercisablePeriodOfPlansInYears
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e5095-wk-Fact-C505AA130D680F117B00284315A4D4E5">P10Y</cah:ExercisablePeriodOfPlansInYears>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-37106044D6F99D0222372843166C9265-0-wk-Fact-A729FA8FDA20E4C55329284315AB7F2A">The following table provides the range of assumptions used to estimate the fair value of stock options:&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.12345679012346%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:4%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2.1%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;25%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2.7%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2.8%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Expected life in years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="3"
      id="d10159911e5186-wk-Fact-F6FBE752F5E655A22802284315B4BF56"
      unitRef="number">0.021</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="d10159911e5207-wk-Fact-0301073A2E1D6184062B284315C2BCF1"
      unitRef="number">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="3"
      id="d10159911e5228-wk-Fact-59C6F6BAAEE2D98E696D284315BBA094"
      unitRef="number">0.027</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="3"
      id="d10159911e5238-wk-Fact-B0667923EA120693BBE6284314606962"
      unitRef="number">0.028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d10159911e5249-wk-Fact-6C8A338B2A34529740D3284315AEFB22">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d10159911e5314-wk-Fact-9C08A77BDF7C543A90547D25A6115F5E"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="FD2020Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d10159911e5318-wk-Fact-1458231810045FE9BF79B7E5A1A8891D"
      unitRef="number">2.40</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-458A5D6795BEA9FED75E2843166B4257-0-wk-Fact-D48FE830EF3A6FB70285284315A66172">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Performance&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Share Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;66.13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;50.96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;52.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;44.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;48.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;50.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at June 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;54.24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d10159911e5420-wk-Fact-6C4748E5D23E7546507C284315C417AB"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d10159911e5439-wk-Fact-D129CF2F36899B379ABE284315D4AEC4"
      unitRef="usdPerShare">66.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d10159911e5454-wk-Fact-58AB46548D125763BAE9284315C4300E"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d10159911e5468-wk-Fact-9947D4B3FA37690D44E0284315D33103"
      unitRef="usdPerShare">50.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d10159911e5488-wk-Fact-F36426B17F3930B3FA4A284315C5AAA6"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d10159911e5502-wk-Fact-3D55CB364E0559E6BC2D284315D96A99"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d10159911e5522-wk-Fact-279712A35FE5C2DC9067284315D4F15B"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d10159911e5537-wk-Fact-A7CCFC69D837024E06CC284315CD861A"
      unitRef="usdPerShare">52.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d10159911e5557-wk-Fact-3F35DCDC64F75101B99DF7951E8F1401"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d10159911e5571-wk-Fact-7116820D176758BEBEA8981C89AB130B"
      unitRef="usdPerShare">51.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d10159911e5591-wk-Fact-EFE975B0095159F7B7A203A26E3765E0"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d10159911e5605-wk-Fact-CF021A229C9D58ABAF258CCAAA1AD015"
      unitRef="usdPerShare">44.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d10159911e5625-wk-Fact-BDE8A9A3DABC5812913BC664C4F3A995"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d10159911e5640-wk-Fact-4B74E52F9C9C5DB9B8E48DFB53F196A0"
      unitRef="usdPerShare">48.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d10159911e5660-wk-Fact-48D0DA9A9C015FBE9282755F3A595DFD"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d10159911e5675-wk-Fact-A6135A848EEB5DD6BABEE20FEAF2713A"
      unitRef="usdPerShare">50.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d10159911e5695-wk-Fact-8AA3D43BF6D4563FA7D9FB69C0B6F024"
      unitRef="shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d10159911e5714-wk-Fact-768171E09C535230907B059EED38413A"
      unitRef="usdPerShare">54.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <cah:AdditionalPerformanceShareUnitsDataTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-035483CD28D067EDEDB52843166B5B03-0-wk-Fact-D2EBDFBC76C29E5C31F0284315A4C0AD">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table provides additional data related to performance share unit activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:60%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average period over which performance share unit cost is expected to be recognized (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</cah:AdditionalPerformanceShareUnitsDataTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d10159911e5851-wk-Fact-3DF7DD887BFD502EA5D9D540E7E92D50"
      unitRef="usd">29000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d10159911e5870-wk-Fact-5EBF16AAECC38C0375D7284315EC14F6"
      unitRef="usd">12000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d10159911e5889-wk-Fact-B73CCC31C12F848DF70D284315F1CA4F"
      unitRef="usd">1000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      id="d10159911e5905-wk-Fact-53CD132D9DB85DB3BB1878D432E4903B">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      id="d10159911e5924-wk-Fact-87145B08C4722A640446284315EF63FF">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      id="d10159911e5943-wk-Fact-FFB1BD5F6DA8E5AF7F16284315F2C5DA">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d10159911e5969-wk-Fact-CCCFBB6F6AA748441264284315EDCFDA"
      unitRef="usd">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d10159911e5988-wk-Fact-3D5D3182F33E61C6300C284315EC954D"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d10159911e6007-wk-Fact-EE5A8BA232F3F98A6881284315F22588"
      unitRef="usd">14000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10159911e6026-wk-Fact-D847A36CDF8CC991F1C1284315A92F13"
      unitRef="usd">66000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10159911e6030-wk-Fact-278F4D25D7DA6B08912A284315A8B60A"
      unitRef="usd">99000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10159911e6034-wk-Fact-D7BF134819BB98F4F23E284315A3482B"
      unitRef="usd">129000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-FD211B76A9FB756DF2322843166C04F5-0-wk-Fact-15D310389967ACB4E64428431638D0B3">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ff0000;font-weight:bold;"&gt;15. Selected Quarterly Financial Data (Unaudited)&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ff0000;font-weight:bold;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following is selected quarterly financial data for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. The sum of the quarters may not equal year-to-date due to rounding.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:40%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per common share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;First&lt;br/&gt;Quarter (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Second&lt;br/&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Third&lt;br/&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Fourth&lt;br/&gt;Quarter (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;37,341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;39,735&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;39,157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;36,689&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross margin&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,679&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,714&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,885&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,590&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Distribution, selling, general and administrative expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,163&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,165&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,137&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings/(loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(4,921&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;220&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;351&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;657&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: Net earnings attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(4,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;220&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;350&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;656&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2.25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1.19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2.23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Includes a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; pre-tax charge for the opioid litigation (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$5.14 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; after tax). &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Includes a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$579 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; pre-tax gain (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$493 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; after tax) in connection with the sale of our remaining equity interest in a partnership that owned naviHealth.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per common share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;First&lt;br/&gt;Quarter (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Second&lt;br/&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Third&lt;br/&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Fourth&lt;br/&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Fiscal 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35,213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;37,740&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35,228&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;37,353&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross margin&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,667&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,730&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,764&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Distribution, selling, general and administrative expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,064&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,097&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,168&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings/(loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;594&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;281&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: Net earnings attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;593&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;280&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1.95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Diluted (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1.94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.93&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Includes a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$508 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; gain (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$378 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; after tax) related to the naviHealth divestiture.&lt;/span&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-73E2EB373AB1C5FB8A552843166C1630-0-wk-Fact-8FDA74F56F5598CE02D528431631BBC9">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following is selected quarterly financial data for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. The sum of the quarters may not equal year-to-date due to rounding.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:40%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per common share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;First&lt;br/&gt;Quarter (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Second&lt;br/&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Third&lt;br/&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Fourth&lt;br/&gt;Quarter (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;37,341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;39,735&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;39,157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;36,689&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross margin&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,679&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,714&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,885&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,590&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Distribution, selling, general and administrative expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,163&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,165&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,137&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings/(loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(4,921&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;220&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;351&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;657&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: Net earnings attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(4,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;220&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;350&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;656&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2.25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(16.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1.19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2.23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Includes a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; pre-tax charge for the opioid litigation (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$5.14 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; after tax). &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Includes a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$579 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; pre-tax gain (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$493 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; after tax) in connection with the sale of our remaining equity interest in a partnership that owned naviHealth.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per common share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;First&lt;br/&gt;Quarter (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Second&lt;br/&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Third&lt;br/&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Fourth&lt;br/&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Fiscal 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35,213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;37,740&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35,228&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;37,353&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross margin&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,667&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,730&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,764&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Distribution, selling, general and administrative expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,064&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,097&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,168&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings/(loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;594&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;281&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: Net earnings attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;593&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;280&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1.95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Diluted (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1.94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.93&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Includes a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$508 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; gain (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$378 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; after tax) related to the naviHealth divestiture.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD"
      decimals="-6"
      id="d10148526e3074-wk-Fact-9F333D5389E65F858DA8284314721358"
      unitRef="usd">37341000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q2QTD"
      decimals="-6"
      id="d10148526e3093-wk-Fact-779FF2039DE032B70B0E284315B0C4E9"
      unitRef="usd">39735000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d10148526e3112-wk-Fact-85B1CB06276AC43C7F94284316096427"
      unitRef="usd">39157000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q4QTD"
      decimals="-6"
      id="d10148526e3132-wk-Fact-926A0DAC21B65AD3AFA151E8E1850C4C"
      unitRef="usd">36689000000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="FD2020Q1QTD"
      decimals="-6"
      id="d10148526e3147-wk-Fact-84FA1AB96E2F559DD2A8284316024978"
      unitRef="usd">1679000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2020Q2QTD"
      decimals="-6"
      id="d10148526e3166-wk-Fact-A2772F7C28D77EB27FC7284314645298"
      unitRef="usd">1714000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d10148526e3185-wk-Fact-924020C06DAB730BA1DE284315FCA9C3"
      unitRef="usd">1885000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2020Q4QTD"
      decimals="-6"
      id="d10148526e3205-wk-Fact-65A256B3A08F5E61991D35C9124C0EF4"
      unitRef="usd">1590000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2020Q1QTD"
      decimals="-6"
      id="d10148526e3225-wk-Fact-9DDD113631F5915A066F2843160870FF"
      unitRef="usd">1107000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2020Q2QTD"
      decimals="-6"
      id="d10148526e3244-wk-Fact-FD941D4856399AB4C3CF284316005DA5"
      unitRef="usd">1163000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d10148526e3263-wk-Fact-BDFE552D487CA424261928431476A913"
      unitRef="usd">1165000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2020Q4QTD"
      decimals="-6"
      id="d10148526e3283-wk-Fact-35E870AF90A55A1C83376EE7FE7B821F"
      unitRef="usd">1137000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q1QTD"
      decimals="-6"
      id="d10148526e3303-wk-Fact-42B6A32CF1D251009E7B2843160DF85C"
      unitRef="usd">-4921000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q2QTD"
      decimals="-6"
      id="d10148526e3323-wk-Fact-7144DB4988456ED6C419284316067884"
      unitRef="usd">220000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d10148526e3342-wk-Fact-B1B38AA9932E76ABD0E32843160D3B25"
      unitRef="usd">351000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q4QTD"
      decimals="-6"
      id="d10148526e3362-wk-Fact-1FFCB5FB71275D0F854F493A060AC8C4"
      unitRef="usd">657000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q1QTD"
      decimals="-6"
      id="d10148526e3382-wk-Fact-A909CF9ECCA08491B00328431600D12D"
      unitRef="usd">-1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q2QTD"
      decimals="-6"
      id="d10148526e3402-wk-Fact-6F3378926DD61B1402B228431477FC70"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d10148526e3421-wk-Fact-3809AC150355D1E7B05C28431601A1D5"
      unitRef="usd">-1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q4QTD"
      decimals="-6"
      id="d10148526e3442-wk-Fact-575D921A1C0955A3957261704DC9345C"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q1QTD"
      decimals="-6"
      id="d10148526e3463-wk-Fact-4C1788D14931EE035A12284315FB99EA"
      unitRef="usd">-4922000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q2QTD"
      decimals="-6"
      id="d10148526e3483-wk-Fact-D8E7EB0A28B7F1ACD4B8284316118CC5"
      unitRef="usd">220000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d10148526e3502-wk-Fact-ACB834C6B87307952470284315F930CD"
      unitRef="usd">350000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q4QTD"
      decimals="-6"
      id="d10148526e3522-wk-Fact-518C75E08EC4558E9B768F1132044091"
      unitRef="usd">656000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="FD2020Q1QTD"
      decimals="2"
      id="d10148526e3711-wk-Fact-6F68CA0AEB4307E338EF284315F11DCE"
      unitRef="usdPerShare">-16.65</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="FD2020Q2QTD"
      decimals="2"
      id="d10148526e3731-wk-Fact-0E31400111E08726AA0F284315B22D87"
      unitRef="usdPerShare">0.75</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="FD2020Q3QTD"
      decimals="2"
      id="d10148526e3750-wk-Fact-21598021607A7FB6BB7E284315FDA46C"
      unitRef="usdPerShare">1.20</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="FD2020Q4QTD"
      decimals="2"
      id="d10148526e3770-wk-Fact-B37E75F1F7FDA5B08788A67A746CA411"
      unitRef="usdPerShare">2.25</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="FD2020Q1QTD"
      decimals="2"
      id="d10148526e3786-wk-Fact-BFEA375997F21A7AC9B12843147389C7"
      unitRef="usdPerShare">-16.65</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="FD2020Q2QTD"
      decimals="2"
      id="d10148526e3806-wk-Fact-7AC138190F9644A2F69A284316038C0C"
      unitRef="usdPerShare">0.75</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="FD2020Q3QTD"
      decimals="2"
      id="d10148526e3825-wk-Fact-039801FAAB67D89E384D284315FADFCE"
      unitRef="usdPerShare">1.19</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="FD2020Q4QTD"
      decimals="2"
      id="d10148526e3845-wk-Fact-92888785DC2936E0946BA67A7537FB13"
      unitRef="usdPerShare">2.23</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-6"
      id="d10148526e3865-wk-Fact-7BEE7B16CCFA59729DF5EFBDE17CAEA0"
      unitRef="usd">-5630000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember"
      decimals="-6"
      id="d10148526e3869-wk-Fact-3BA3C56106F25C3CBCB9EB04F56E6EB3"
      unitRef="usd">-5140000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="FD2020Q4QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d10148526e3880-wk-Fact-A4954187376CE474EA85A65DF290D3F7"
      unitRef="usd">579000000</us-gaap:GainOnSaleOfInvestments>
    <cah:GainonDivestitureAfterTax
      contextRef="FD2020Q4QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d10148526e3884-wk-Fact-F43E5915F710A356B389B477FD2C18A3"
      unitRef="usd">493000000</cah:GainonDivestitureAfterTax>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d10148526e4090-wk-Fact-A9D13AFEC9B2FB77D5F828431628505B"
      unitRef="usd">35213000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q2QTD"
      decimals="-6"
      id="d10148526e4109-wk-Fact-A614E4BD35E45AE2029328431634C20B"
      unitRef="usd">37740000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d10148526e4128-wk-Fact-9DF0D77000B43DFFCC3E2843163855DA"
      unitRef="usd">35228000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q4QTD"
      decimals="-6"
      id="d10148526e4148-wk-Fact-E7294A8D52405715BC70284314825C7E"
      unitRef="usd">37353000000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d10148526e4163-wk-Fact-7F1B9B03859768714CAF28431634E21F"
      unitRef="usd">1667000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q2QTD"
      decimals="-6"
      id="d10148526e4182-wk-Fact-9B1A59E0CBC1A3FAFDCC28431631E17C"
      unitRef="usd">1730000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d10148526e4201-wk-Fact-34D1D7F926C08E5D0A0F284316310380"
      unitRef="usd">1764000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q4QTD"
      decimals="-6"
      id="d10148526e4221-wk-Fact-41DFD00F86411243B76B284316333117"
      unitRef="usd">1674000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d10148526e4241-wk-Fact-D9158987ADD5433149D12843163468C9"
      unitRef="usd">1155000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2019Q2QTD"
      decimals="-6"
      id="d10148526e4260-wk-Fact-6AD1C589EA74ADC36B4B28431631AC25"
      unitRef="usd">1064000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d10148526e4279-wk-Fact-A9AABF28B8463E1F5E3A28431633900A"
      unitRef="usd">1097000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2019Q4QTD"
      decimals="-6"
      id="d10148526e4299-wk-Fact-67F296DAB6FA545946C4284315CFAB1E"
      unitRef="usd">1168000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d10148526e4319-wk-Fact-9DD5337DE48CE56B1363284316308657"
      unitRef="usd">594000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q2QTD"
      decimals="-6"
      id="d10148526e4338-wk-Fact-7AE3D5F2DF0C880EF1A8284316363393"
      unitRef="usd">281000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d10148526e4357-wk-Fact-1F757B849937A3FA5D94284316373E3F"
      unitRef="usd">296000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q4QTD"
      decimals="-6"
      id="d10148526e4377-wk-Fact-6B98451C47F4F9B39EAA284316362BFE"
      unitRef="usd">194000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d10148526e4397-wk-Fact-D56EF4E6221F6D57BC4F2843163BB234"
      unitRef="usd">-1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q2QTD"
      decimals="-6"
      id="d10148526e4417-wk-Fact-22551189A97AA637189B284315DC0631"
      unitRef="usd">-1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d10148526e4437-wk-Fact-4FE20A66245B6CE8C573284316332567"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q4QTD"
      decimals="-6"
      id="d10148526e4457-wk-Fact-6B9AD00563D22853B00A284315D06831"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d10148526e4477-wk-Fact-BD087FF9909400CF599328431636D82B"
      unitRef="usd">593000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q2QTD"
      decimals="-6"
      id="d10148526e4496-wk-Fact-2EB20EEB4539A2656022284316370ADD"
      unitRef="usd">280000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d10148526e4515-wk-Fact-1685DCCF87FEC6E8AD4928431637A84E"
      unitRef="usd">296000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4QTD"
      decimals="-6"
      id="d10148526e4535-wk-Fact-9D64CB9F433201288F302843163477C1"
      unitRef="usd">194000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="FD2019Q1QTD"
      decimals="2"
      id="d10148526e4724-wk-Fact-38FA669F0541645B7D8728431631E615"
      unitRef="usdPerShare">1.95</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="FD2019Q2QTD"
      decimals="2"
      id="d10148526e4743-wk-Fact-01E5621503272C101959284316330D85"
      unitRef="usdPerShare">0.94</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="FD2019Q3QTD"
      decimals="2"
      id="d10148526e4762-wk-Fact-50E546EA701EF4115DA3284315D8232A"
      unitRef="usdPerShare">0.99</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="FD2019Q4QTD"
      decimals="2"
      id="d10148526e4782-wk-Fact-A91D9FFF296CF4DB81C628431633AB21"
      unitRef="usdPerShare">0.65</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="FD2019Q1QTD"
      decimals="2"
      id="d10148526e4798-wk-Fact-1323B6C40D2E49A606DE28431635CB9C"
      unitRef="usdPerShare">1.94</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="FD2019Q2QTD"
      decimals="2"
      id="d10148526e4817-wk-Fact-266B724350EE75B8A54328431632878F"
      unitRef="usdPerShare">0.93</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="FD2019Q3QTD"
      decimals="2"
      id="d10148526e4836-wk-Fact-F0F09B7D1ED9406C230B28431632F348"
      unitRef="usdPerShare">0.99</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="FD2019Q4QTD"
      decimals="2"
      id="d10148526e4856-wk-Fact-87A943E4F63ACBE6032928431638B8FA"
      unitRef="usdPerShare">0.65</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <cah:PreTaxGainonDivestiture
      contextRef="FD2019Q1QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d10148526e4874-wk-Fact-E1DE1AFCDED5C394D1942843163CB78A"
      unitRef="usd">508000000</cah:PreTaxGainonDivestiture>
    <cah:GainonDivestitureAfterTax
      contextRef="FD2019Q1QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d10148526e4878-wk-Fact-B8CA76FE5068617C65522843163254B4"
      unitRef="usd">378000000</cah:GainonDivestitureAfterTax>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="FD2020Q4YTD"
      id="TextSelection-91371D9B7EF18E5DA1512843166C0C7C-0-wk-Fact-72699077A983AECC94BD284315FEDA40">&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:14pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;"&gt;Cardinal Health, Inc. and Subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ff0000;font-weight:bold;"&gt;Schedule&#160;II - Valuation and Qualifying Accounts &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="20"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:29%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance&#160;at&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Beginning of Period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Charged&#160;to Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;and Expenses (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Charged&#160;to&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Other Accounts&#160;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Deductions&#160;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance&#160;at&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;End of Period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;193&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;139&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(127&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;206&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance notes receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Sales returns and allowances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,253&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(2,237&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;495&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;687&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,407&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(2,366&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;729&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Fiscal 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;139&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;140&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;193&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance notes receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Sales returns and allowances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,205&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2,205&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;626&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,353&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;687&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Fiscal 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;137&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;113&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(111&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;139&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance notes receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Sales returns and allowances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;347&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,402&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2,270&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;494&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,513&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2,381&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;626&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; include &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$49 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$60 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$37 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;, respectively, for reserves related to service charges and customer pricing disputes, excluded from provision for bad debts on the consolidated statements of cash flows and classified as a reduction in revenue in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Recoveries of amounts provided for or written off in prior years was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; in each fiscal year &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Write-off of uncollectible accounts or actual sales returns.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;The sum of the components may not equal the total due to rounding.</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e3113-wk-Fact-F77B919A29D45CF279F8284314635DD1"
      unitRef="usd">193000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e3132-wk-Fact-AFB8CEEAD599B76D323D284315DF579B"
      unitRef="usd">139000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e3151-wk-Fact-4088C845BB43D141593F284315EBCD9F"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e3171-wk-Fact-CF67913C27010DC1EFD628431461472F"
      unitRef="usd">127000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e3191-wk-Fact-F38380296049D80EEE54284315D7BE2E"
      unitRef="usd">206000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e3206-wk-Fact-B0FEA8F4C381D289FFAC28431479A023"
      unitRef="usd">14000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e3225-wk-Fact-C39DCA928D715F12DA93284315DC94D0"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e3244-wk-Fact-9DAD7279BAE1F1CE14D52843162BBF7B"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e3264-wk-Fact-F94C4A1F2DE49CC7AC3928431600B72F"
      unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e3284-wk-Fact-560ECF7266B4A2A76257A5D9FD574F9A"
      unitRef="usd">27000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e3304-wk-Fact-BEC461849D59104D167E284315E052AF"
      unitRef="usd">479000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e3323-wk-Fact-D83C3E160B892EA8A121284315EBB733"
      unitRef="usd">2253000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e3342-wk-Fact-43964B0893A450C82EA528431623ACC7"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e3362-wk-Fact-4491094BD68EE9CDF032284315E514F9"
      unitRef="usd">2237000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e3382-wk-Fact-2E309E3F3DD5685386D7284315FFF7EA"
      unitRef="usd">495000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e3402-wk-Fact-31FE6D702B1FBE19D9262843161A5A69"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e3421-wk-Fact-28B8C061BCB2383A1F15284315EC1B4F"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e3440-wk-Fact-B24ADF0176D341156E07284315E91603"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e3460-wk-Fact-C39FE1F174389A15B034284316178175"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2020Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e3479-wk-Fact-FAA95DFBDAD40473FCA2284315D2EF19"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10161388e3504-wk-Fact-46831EDF60EF5DDA9D9A2843161C2BB3"
      unitRef="usd">687000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10161388e3523-wk-Fact-6AA5D952C48C05E9296F28431621B2D4"
      unitRef="usd">2407000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10161388e3542-wk-Fact-ACA38F6BA1AEAAFBC095284315DD7C67"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2020Q4YTD"
      decimals="-6"
      id="d10161388e3562-wk-Fact-4156B603948078D3560228431623F100"
      unitRef="usd">2366000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2020Q4"
      decimals="-6"
      id="d10161388e3582-wk-Fact-768F2B010B148561326728431621C191"
      unitRef="usd">729000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e3806-wk-Fact-2DCB09F6D4C2F3A216F82843162AD6DC"
      unitRef="usd">139000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e3825-wk-Fact-64F6A80CE4C195DF9A47284315D1DC5A"
      unitRef="usd">140000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e3844-wk-Fact-D83321AA5B3FB94586A12843160AD4C4"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e3864-wk-Fact-BD085E701D2D9D98368A28431603833E"
      unitRef="usd">87000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e3884-wk-Fact-F77B919A29D45CF279F8284314635DD1"
      unitRef="usd">193000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e3899-wk-Fact-CE711DF92741B13D379C28431629855F"
      unitRef="usd">7000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e3918-wk-Fact-202D8A23CBEFFA79F1562843162B030E"
      unitRef="usd">8000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e3937-wk-Fact-2D790080FF4701D5C121284315EEBAA9"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e3957-wk-Fact-8CD9EE34C55518C60F2B284315DEB78C"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e3977-wk-Fact-B0FEA8F4C381D289FFAC28431479A023"
      unitRef="usd">14000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e3998-wk-Fact-022084EAC061078ABF7B2843162ACF35"
      unitRef="usd">479000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e4017-wk-Fact-4E465F78B4EEB0D8564B284315CDB0BC"
      unitRef="usd">2205000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e4036-wk-Fact-309CBB863A5D99D6E3A52843161E77EF"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e4056-wk-Fact-5F5A07B27AB522AD829F284315E5E8C3"
      unitRef="usd">2205000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e4076-wk-Fact-BEC461849D59104D167E284315E052AF"
      unitRef="usd">479000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e4096-wk-Fact-C2F1C1BF2968A3CEBD702843161EC354"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e4115-wk-Fact-2AC5B86AF1D632A0708A284315F5B487"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e4134-wk-Fact-742B1623FDD6FBABCE0928431624775A"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e4154-wk-Fact-E0D94B245766B5545E48284316040B34"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e4173-wk-Fact-31FE6D702B1FBE19D9262843161A5A69"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10161388e4198-wk-Fact-74E83E48928278AD4FF628431619DE74"
      unitRef="usd">626000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10161388e4217-wk-Fact-4F90DFB0A3F3BCC5E5D3284315E11589"
      unitRef="usd">2353000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10161388e4236-wk-Fact-82905ED475C09D718D32284314633167"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2019Q4YTD"
      decimals="-6"
      id="d10161388e4256-wk-Fact-FC869AAEFDAC48574905284315D08358"
      unitRef="usd">2293000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4"
      decimals="-6"
      id="d10161388e4276-wk-Fact-46831EDF60EF5DDA9D9A2843161C2BB3"
      unitRef="usd">687000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e4500-wk-Fact-58350DE1E6285ECE1F76284315F8981A"
      unitRef="usd">137000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e4519-wk-Fact-BFF5EF877CD544AB7887284315F9DECA"
      unitRef="usd">113000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e4538-wk-Fact-CF3ACCF5B07B2F1AD18928431618C270"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e4558-wk-Fact-5514592FB1CAFF278ADC2843161D0DDD"
      unitRef="usd">111000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember"
      decimals="-6"
      id="d10161388e4578-wk-Fact-2DCB09F6D4C2F3A216F82843162AD6DC"
      unitRef="usd">139000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e4593-wk-Fact-CEEE9711EE585694D3BD284315DE3392"
      unitRef="usd">9000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e4612-wk-Fact-3391634CA8E227C1E2A62843160782DB"
      unitRef="usd">-2000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e4632-wk-Fact-8DF2BD4E92C2D27DFAC2284315F2B76B"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e4652-wk-Fact-2717026EE586038A5C10284315E388C3"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLossesOnFinanceReceivablesMember"
      decimals="-6"
      id="d10161388e4671-wk-Fact-CE711DF92741B13D379C28431629855F"
      unitRef="usd">7000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e4691-wk-Fact-CC02F4DFDDB20B714901284315D6DDCF"
      unitRef="usd">347000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e4710-wk-Fact-5780789841126AD0B394284315E60A55"
      unitRef="usd">2402000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e4729-wk-Fact-66AC025BA37F49ED429C284315EC919F"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e4749-wk-Fact-B9A7838D43E7A92F4890284315EF2C70"
      unitRef="usd">2270000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_SalesReturnsAndAllowancesMember"
      decimals="-6"
      id="d10161388e4769-wk-Fact-022084EAC061078ABF7B2843162ACF35"
      unitRef="usd">479000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e4789-wk-Fact-047FC05B62074A188FA22843160E80DD"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e4808-wk-Fact-33DED8A28EB733EB6834284315EA4391"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e4827-wk-Fact-DE415946A73BB291B79928431617F5FD"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e4847-wk-Fact-07DA0F0D2D9E48DF5DF1284315E7B303"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForLoanAndLeaseLossesMember"
      decimals="-6"
      id="d10161388e4866-wk-Fact-C2F1C1BF2968A3CEBD702843161EC354"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2017Q4"
      decimals="-6"
      id="d10161388e4891-wk-Fact-1E6F492F070DE6B213BE284315E9654E"
      unitRef="usd">494000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10161388e4910-wk-Fact-C70BE7C8CB07DDF08C9B2843160EBA70"
      unitRef="usd">2513000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10161388e4929-wk-Fact-0BD01C429C3000A35914284315D5A228"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2018Q4YTD"
      decimals="-6"
      id="d10161388e4949-wk-Fact-14E78EFF785842D8DC49284315D80BA3"
      unitRef="usd">2381000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4"
      decimals="-6"
      id="d10161388e4969-wk-Fact-74E83E48928278AD4FF628431619DE74"
      unitRef="usd">626000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PricingDisputesMember"
      decimals="-6"
      id="d10161388e4997-wk-Fact-BC42DF7DEDEF0A0745E2284315FDBDB3"
      unitRef="usd">49000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PricingDisputesMember"
      decimals="-6"
      id="d10161388e5001-wk-Fact-C6AFE77CA22B6BE89FD3284315F44528"
      unitRef="usd">60000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PricingDisputesMember"
      decimals="-6"
      id="d10161388e5006-wk-Fact-C85076BA4FEB9A7CA944284315EF00F8"
      unitRef="usd">37000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="FD2020Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_cah_PriorYearRecoveriesMember"
      decimals="-6"
      id="d10161388e5019-wk-Fact-AB40FC6AFB8AE36D164D284315F30170"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesRecoveries>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971049240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cardinal Health, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">OH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-0958666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Cardinal Place<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">43017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(614)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">757-5000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares (without par value)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CAH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-Known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,729,138,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,444,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000721371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Documents Incorporated by Reference: </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Portions of the registrant&#8217;s Definitive Proxy Statement to be filed for its </span><span style="font-family:Arial Narrow;font-size:9pt;">2020</span><span style="font-family:Arial Narrow;font-size:9pt;"> Annual Meeting of Shareholders are incorporated by reference into the sections of this Form 10-K addressing the requirements of Part&#160;III of Form&#160;10-K.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 20-F, 40-F<br> -Number 240<br> -Section 15<br> -Subsection d-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970911288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Earnings - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 152,922<span></span>
</td>
<td class="nump">$ 145,534<span></span>
</td>
<td class="nump">$ 136,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">146,054<span></span>
</td>
<td class="nump">138,700<span></span>
</td>
<td class="nump">129,628<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">6,868<span></span>
</td>
<td class="nump">6,834<span></span>
</td>
<td class="nump">7,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="nump">4,572<span></span>
</td>
<td class="nump">4,480<span></span>
</td>
<td class="nump">4,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and employee severance</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Amortizationandotheracquisitionrelatedcosts', window );">Amortization and other acquisition-related costs</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">621<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairments and (gain)/loss on disposal of assets, net</a></td>
<td class="nump">7<span></span>
</td>
<td class="num">(488)<span></span>
</td>
<td class="nump">1,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation (recoveries)/charges, net</a></td>
<td class="nump">5,741<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating earnings/(loss)</a></td>
<td class="num">(4,098)<span></span>
</td>
<td class="nump">2,060<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="num">(579)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings/(loss) before income taxes</a></td>
<td class="num">(3,772)<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for/(benefit from) income taxes</a></td>
<td class="num">(79)<span></span>
</td>
<td class="nump">386<span></span>
</td>
<td class="num">(487)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="num">(3,693)<span></span>
</td>
<td class="nump">1,365<span></span>
</td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to noncontrolling interests</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings/(loss) attributable to Cardinal Health, Inc.</a></td>
<td class="num">$ (3,696)<span></span>
</td>
<td class="nump">$ 1,363<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Earnings/(loss) per common share attributable to Cardinal Health, Inc.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings Per Share, Basic</a></td>
<td class="num">$ (12.61)<span></span>
</td>
<td class="nump">$ 4.55<span></span>
</td>
<td class="nump">$ 0.82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="num">$ (12.61)<span></span>
</td>
<td class="nump">$ 4.53<span></span>
</td>
<td class="nump">$ 0.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted-average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">301<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Amortizationandotheracquisitionrelatedcosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Amortizationandotheracquisitionrelatedcosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972965672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="num">$ (3,693)<span></span>
</td>
<td class="nump">$ 1,365<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax', window );">Net unrealized gain/(loss) on derivative instruments, net of tax</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="num">(25)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income/(loss)</a></td>
<td class="num">(3,718)<span></span>
</td>
<td class="nump">1,378<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to Cardinal Health, Inc.</a></td>
<td class="num">$ (3,721)<span></span>
</td>
<td class="nump">$ 1,376<span></span>
</td>
<td class="nump">$ 289<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971002088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents</a></td>
<td class="nump">$ 2,771<span></span>
</td>
<td class="nump">$ 2,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">8,264<span></span>
</td>
<td class="nump">8,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">13,198<span></span>
</td>
<td class="nump">12,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">1,707<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">25,940<span></span>
</td>
<td class="nump">25,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,366<span></span>
</td>
<td class="nump">2,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Goodwill and other intangibles, net</a></td>
<td class="nump">11,275<span></span>
</td>
<td class="nump">11,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,185<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">40,766<span></span>
</td>
<td class="nump">40,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">21,374<span></span>
</td>
<td class="nump">21,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term obligations and other short-term borrowings</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">2,231<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">23,615<span></span>
</td>
<td class="nump">24,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term obligations, less current portion</a></td>
<td class="nump">6,765<span></span>
</td>
<td class="nump">7,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred income taxes and other liabilities</a></td>
<td class="nump">8,594<span></span>
</td>
<td class="nump">2,945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred shares, without par value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Authorized&#8212;500 thousand shares, Issued&#8212;none</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common shares, without par value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Authorized&#8212;755 million shares, Issued&#8212;327 million shares at June 30, 2020 and 2019, respectively</a></td>
<td class="nump">2,789<span></span>
</td>
<td class="nump">2,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">5,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Common shares in treasury, at cost: 34 million shares and 28 million shares at June 30, 2020 and 2019, respectively</a></td>
<td class="num">(2,066)<span></span>
</td>
<td class="num">(1,790)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(104)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Cardinal Health, Inc. shareholders' equity</a></td>
<td class="nump">1,789<span></span>
</td>
<td class="nump">6,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">1,792<span></span>
</td>
<td class="nump">6,330<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 40,766<span></span>
</td>
<td class="nump">$ 40,963<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404077901352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, authorized</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="nump">755,000,000<span></span>
</td>
<td class="nump">755,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, issued</a></td>
<td class="nump">327,000,000<span></span>
</td>
<td class="nump">327,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Common shares in treasury</a></td>
<td class="nump">34,000,000<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971326360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Shares</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Shares</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">$ 256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period (in shares) at Jun. 30, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Jun. 30, 2017</a></td>
<td class="nump">6,828<span></span>
</td>
<td class="nump">$ 2,697<span></span>
</td>
<td class="nump">4,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (125)<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at beginning of period (in shares) at Jun. 30, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at beginning of period at Jun. 30, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (731)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</a></td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of noncontrolling interests</a></td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program activity</a></td>
<td class="num">(550)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (550)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2018</a></td>
<td class="nump">6,059<span></span>
</td>
<td class="nump">$ 2,730<span></span>
</td>
<td class="nump">4,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,224)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period (in shares) at Jun. 30, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Jun. 30, 2017</a></td>
<td class="nump">$ 6,828<span></span>
</td>
<td class="nump">$ 2,697<span></span>
</td>
<td class="nump">4,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at beginning of period (in shares) at Jun. 30, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at beginning of period at Jun. 30, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (731)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="nump">327.0<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="nump">$ 1,792<span></span>
</td>
<td class="nump">$ 2,789<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="num">(34.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Jun. 30, 2020</a></td>
<td class="num">$ (2,066)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,066)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">1,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period (in shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Jun. 30, 2018</a></td>
<td class="nump">6,059<span></span>
</td>
<td class="nump">$ 2,730<span></span>
</td>
<td class="nump">4,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at beginning of period (in shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at beginning of period at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,224)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">1,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program activity</a></td>
<td class="num">(600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Jun. 30, 2019</a></td>
<td class="nump">327.0<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2019</a></td>
<td class="nump">$ 6,330<span></span>
</td>
<td class="nump">$ 2,763<span></span>
</td>
<td class="nump">5,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Jun. 30, 2019</a></td>
<td class="num">(28.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Jun. 30, 2019</a></td>
<td class="num">$ (1,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="num">(3,696)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="num">(3,693)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program activity</a></td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="nump">327.0<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="nump">$ 1,792<span></span>
</td>
<td class="nump">$ 2,789<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (104)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="num">(34.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Jun. 30, 2020</a></td>
<td class="num">$ (2,066)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,066)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972020856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="num">$ (3,693)<span></span>
</td>
<td class="nump">$ 1,365<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">913<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on Sale of Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="num">(579)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairments and (gain)/loss on disposal of assets, net</a></td>
<td class="nump">7<span></span>
</td>
<td class="num">(488)<span></span>
</td>
<td class="nump">1,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Provision for/(benefit from) deferred income taxes</a></td>
<td class="num">(961)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="num">(1,012)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for bad debts</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Decrease/(increase) in trade receivables</a></td>
<td class="nump">82<span></span>
</td>
<td class="num">(751)<span></span>
</td>
<td class="num">(871)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(409)<span></span>
</td>
<td class="num">(551)<span></span>
</td>
<td class="num">(1,211)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase/(decrease) in accounts payable</a></td>
<td class="num">(162)<span></span>
</td>
<td class="nump">1,864<span></span>
</td>
<td class="nump">2,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other accrued liabilities and operating items, net</a></td>
<td class="nump">6,550<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">415<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,960<span></span>
</td>
<td class="nump">2,722<span></span>
</td>
<td class="nump">2,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of subsidiaries, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="num">(6,142)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property and equipment</a></td>
<td class="num">(375)<span></span>
</td>
<td class="num">(328)<span></span>
</td>
<td class="num">(384)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Purchaseofavailableforsalesecuritiesandotherinvestments', window );">Purchase of other investments</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments', window );">Proceeds from sale of investments and available-for-sale securities</a></td>
<td class="nump">886<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets', window );">Proceeds from divestitures, net of cash sold, and disposal of property and equipment</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="nump">862<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by/(used in) investing activities</a></td>
<td class="nump">493<span></span>
</td>
<td class="nump">338<span></span>
</td>
<td class="num">(5,608)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PaymentofContingentConsideration', window );">Payment of contingent consideration obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net change in short-term borrowings</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Payments to Acquire Businesses and Interest in Affiliates</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Reduction of long-term obligations</a></td>
<td class="num">(1,399)<span></span>
</td>
<td class="num">(1,102)<span></span>
</td>
<td class="num">(954)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities', window );">Proceeds from interest rate swap terminations</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from long-term obligations, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation', window );">Net tax proceeds/(withholding) from share-based compensation</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends on common shares</a></td>
<td class="num">(569)<span></span>
</td>
<td class="num">(577)<span></span>
</td>
<td class="num">(581)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury shares</a></td>
<td class="num">(350)<span></span>
</td>
<td class="num">(600)<span></span>
</td>
<td class="num">(550)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(2,200)<span></span>
</td>
<td class="num">(2,293)<span></span>
</td>
<td class="num">(2,276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rates changes on cash and equivalents</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CashReclassifiedtoAssetsHeldforSale', window );">Cash reclassified to assets held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">768<span></span>
</td>
<td class="num">(5,116)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents at beginning of period</a></td>
<td class="nump">2,531<span></span>
</td>
<td class="nump">1,763<span></span>
</td>
<td class="nump">6,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents at end of period</a></td>
<td class="nump">2,771<span></span>
</td>
<td class="nump">2,531<span></span>
</td>
<td class="nump">1,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash payments for interest</a></td>
<td class="nump">226<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash payments for income taxes</a></td>
<td class="nump">$ 368<span></span>
</td>
<td class="nump">$ 311<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CashReclassifiedtoAssetsHeldforSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CashReclassifiedtoAssetsHeldforSale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CashReclassifiedtoAssetsHeldforSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Netproceedstaxwithholdingsfromsharebasedcompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PaymentofContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from a settlement payment of contingent consideration assumed in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PaymentofContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from divestitures and disposal of property and equipment and held for sale assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of available-for-sale securities and other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Purchaseofavailableforsalesecuritiesandotherinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from purchases of available-for-sale securities and other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Purchaseofavailableforsalesecuritiesandotherinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975154328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">1. Basis of Presentation and Summary of Significant Accounting Policies</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc. is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. We provide medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. References to &#8220;we&#8221;, &#8220;our&#8221; and similar pronouns in these consolidated financial statements are to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context otherwise requires.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our fiscal year ends on June&#160;30. References to fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;"> in these consolidated financial statements are to the fiscal years ended </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis of Presentation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts could ultimately differ from these estimated amounts.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The outbreak of the novel strain of coronavirus (&#8220;COVID-19&#8221;) has severely impacted, and continues to severely impact the U.S. and global economies, and beginning in the third quarter of fiscal 2020, our businesses have been impacted in a variety of ways. We cannot estimate the length or severity of the COVID-19 pandemic or the related U.S. and global economic consequences on our business and operations, including whether and when historic economic and operating conditions will resume or the extent to which the disruption may impact our business, financial position, results of operations or cash flow. Our e</span><span style="font-family:Arial Narrow;font-size:10pt;">stimates, judgments and assumptions related to COVID-19 could ultimately differ over time</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash Equivalents</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Receivables and Allowance for Doubtful Accounts</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Trade receivables are presented net of an allowance for doubtful accounts of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$206 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$193 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. An account is considered past due on the first day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to cover potential losses, which are based primarily on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We provide financing to various customers. Such financing arrangements range from </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>1 year</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>5 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$104 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> (current portion </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$12 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">) and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$103 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> (current portion </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$12 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">) at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$27 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$14 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Concentrations of Credit Risk</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#8217; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts.  </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Major Customers</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">CVS Health Corporation ("CVS") and OptumRx, are our only customers that individually account for at least 10 percent of revenue </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:34%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Percent of Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">CVS</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">OptumRx</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have entered into agreements with group purchasing organizations (&#8220;GPOs&#8221;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>two</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> largest GPO member relationships in terms of revenue. Sales to members of these </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>two</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> GPOs collectively accounted for </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>16 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>22 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>22 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of revenue for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Inventories</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">A substantial portion of our inventories (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>56 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at both </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#8220;distribution facilities&#8221;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, inventories valued at LIFO cost were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$411 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$230 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> or </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our remaining inventory that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Net realizable value is defined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$155 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$171 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash Discounts</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Property and Equipment</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#8212;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>3</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>39 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">; machinery and equipment&#8212;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>3</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>20 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">; and furniture and fixtures&#8212;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>3</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>7 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. We recorded depreciation and amortization expense of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$405 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$455 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$446 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents the components of property and equipment, net at June&#160;30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Land, building and improvements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,185</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,992</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Machinery and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,008</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,038</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Furniture and fixtures</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>138</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>138</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total property and equipment, at cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,331</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,168</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(2,965</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2,812</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Property and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,366</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,356</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term obligations, which was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>3 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">. The amount of capitalized interest was immaterial for all periods presented.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Goodwill and Other Intangible Assets</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>two</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#8220;Medical Unit&#8221;); and Cardinal Health at-Home Solutions division. Our Nuclear and Precision Health Solutions division was formerly referred to as our Nuclear Pharmacy Services division and our Cardinal Health at-Home Solutions division was formerly referred to as our Cardinal Health at Home division.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>8.5 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>10.5 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We performed annual impairment testing in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;"> and with the exception of our Medical Unit in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In conjunction with the preparation of our consolidated financial statements for fiscal 2018, we completed our annual quantitative goodwill impairment test, which we perform annually in the fourth quarter. Using a combination of income and market-based approaches (using a discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>8.5 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">), the carrying value </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">exceeded the fair value and resulted in an impairment charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$1.4 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> related to our Medical Unit, which is included in impairments and loss on disposal of assets in our consolidated statements of earnings/(loss). Our fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The impairment was primarily driven by inventory and cost challenges within our Cordis business which furthered in the fourth quarter of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. This impairment charge did not impact our liquidity, cash flows from operations, or compliance with debt covenants. There was no tax benefit related to the goodwill impairment charge. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The impairment test for indefinite-lived intangibles other than goodwill (primarily IPR&amp;D) involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation </span><span style="font-family:Arial Narrow;font-size:10pt;">requires the use of estimates and significant judgments and</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Assets Held for Sale</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We classify assets and liabilities (the &#8220;disposal group&#8221;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Investments</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Vendor Reserves</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically refine our methodology by updating the reserve estimate percentages to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues, such as bankruptcies. Vendor reserves were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$77 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$53 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Distribution Services Agreement and Other Vendor Fees</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#8217; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#8217;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Loss Contingencies and Self-Insurance</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with the opioid litigation as described further in the </span><a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;">, we recorded a pre-tax charge of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;(</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.14 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;after tax) during fiscal 2020. </span><span style="font-family:Arial Narrow;">Definitive terms of a settlement under the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied.  </span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">We develop and periodically update reserve estimates for the Cordis inferior vena cava ("Cordis IVC") claims, including those received to date and expected to be received in the future and related costs. To project future Cordis IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, sales data, implant and injury to report lag patterns and estimated defense costs. </span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We also self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The amount of ultimate loss may differ materially from these estimates.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). </span><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding loss contingencies and product liability lawsuits.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Guarantees</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">liability being triggered under these indemnification obligations is not probable.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were </span><span style="font-family:Arial Narrow;font-size:10pt;">no</span><span style="font-family:Arial Narrow;font-size:10pt;"> material obligations at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amoun</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">t of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a href="#s002522EA8F5F5274B7487704BE70A9A8" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding income taxes.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Accrued Liabilities</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Noncontrolling Interests</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Noncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Share-Based Compensation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See </span><a href="#sD47735F83E5151799C861160A959DEB5" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 14</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding share-based compensation.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Dividends</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We paid cash dividends per common share of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.92</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.91</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.85</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Revenue Recognition</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both </span><span style="font-family:Arial Narrow;font-size:10pt;">manufactured and sourced products, and</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Sales Returns and Allowances</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical data. </span><span style="font-family:Arial Narrow;font-size:10pt;">Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#8220;merchantable product&#8221;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At both </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, the accrual for estimated sales returns and allowances was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$495 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$479 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, the impact of which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.3 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.2 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.4 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Third-Party Returns</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Shipping and Handling</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Shipping and handling costs are primarily included in SG&amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$620 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$622 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$543 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Restructuring and Employee Severance</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are employee severance costs that are not incurred in connection with a restructuring activity. See </span><a href="#sF72C50E68F165E22A368883CF79808D0" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 3</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding our restructuring activities.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Amortization and Other Acquisition-Related Costs</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See </span><a href="#s0B8CFB5481FD5F8C92CD0E2191E456DF" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 4</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding amortization of acquisition-related intangible assets. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Translation of Foreign Currencies</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#8217; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The foreign currency translation gains/(losses) included in AOCI at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> are presented in </span><a href="#s3D77F43D97875956BB9F5A04AD8753DD" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 11</span></a><span style="font-family:Arial Narrow;font-size:10pt;">. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Interest Rate, Currency and Commodity Risk</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#8217; equity through AOCI, net of tax.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#8217;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments received from the cross currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a href="#s138045C0A5375688972939C6B03E89B1" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 10</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow and economic hedges.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value Measurements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">Level 1 -</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Observable prices in active markets for identical assets and liabilities.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">Level 2 -</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Observable inputs other than quoted prices in active markets for identical assets and liabilities.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">Level 3 -</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a href="#sC842095C866F51CEAB114318376AF314" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 9</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding fair value measurements.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Adopted Financial Accounting Standards</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Derivatives and Hedging </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2018, the </span><span style="font-family:Arial Narrow;font-size:10pt;">Financial Accounting Standards Board ("FASB")</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a benchmark interest rate for hedge accounting purposes. This guidance was effective beginning the first quarter of fiscal 2020. The adoption did not have a material impact on our consolidated financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Leases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and elected the transition option which allows us to apply the guidance prospectively. The initial adoption in the first quarter of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> resulted in the recognition of lease liabilities in the amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$422 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. See&#160;</span><a href="#s1a0a81a45f964330b5b7b44b0dd06884" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 5</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for additional information regarding leases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Issued Financial Accounting Standards Not Yet Adopted</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This&#160;guidance will be effective for us in the first quarter of fiscal 2021. The adoption of this guidance will not have a material impact on our consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975156520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasesTextBlock', window );">Leases</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">5. Leases</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operating leases are primarily for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at its inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Beginning July 1, 2019, operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our consolidated balance sheet at lease commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our lease agreements contain lease components and non-lease components. For all asset classes, we have elected to account for both of these components as a single lease component.  We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the consolidated financial statements at or for the fiscal year ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in fiscal 2020 was not material. In addition, upon adoption of the new lease standard, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing 1) whether any contracts are leases or contain leases, 2) lease classification and 3) initial direct costs. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our leases have remaining lease terms from less than </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>1 year</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> up to approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>22 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the components of lease cost:       </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>134</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Variable lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>164</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Variable lease cost primarily includes payments for property taxes, maintenance and insurance. Our rental expense relating to operating leases&#160;was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$153 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$172 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes supplemental balance sheet information related to leases at June&#160;30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>426</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Current portion of operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>104</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Long-term operating lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>341</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>445</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease right-of-use assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>33</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Current portion of finance lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term finance lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>25</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our consolidated balance sheet. Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our consolidated balance sheet. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarizes supplemental cash flow information related to leases:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash paid for lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating cash flows paid for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>125</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Financing cash flows paid for finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>150</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>40</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amended lease standard adoption impact as of July 1, 2019 </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>400</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes the effect of </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$22 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operating leases had a weighted-average remaining lease term of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>6.4 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and a weighted-average discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>2.9 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Our finance leases had a weighted-average remaining lease term of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>4.3 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and a weighted-average discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>2.4 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> . </span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Future lease payments under non-cancellable leases as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> were as follows:</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">                          </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:51%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>117</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>127</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>96</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>105</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>72</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>81</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>55</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2025</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>46</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>123</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>125</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>503</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>539</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: leases not yet commenced </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>54</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>56</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>445</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>479</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">As of </span><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the consolidated balance sheet. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The future minimum rental payments for operating leases&#160;having initial or remaining non-cancelable lease terms in excess of one year at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> for fiscal 2020 through 2024 and thereafter were as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$126 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$100 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$76 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$54 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$33 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$94 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975071272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Employee Severance</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">3. Restructuring and Employee Severance</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize restructuring and employee severance costs:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:57%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>66</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>56</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>142</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>122</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>125</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>176</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods. Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, vendor transition fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, restructuring costs are primarily related to implementation of certain enterprise-wide cost-savings measures.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered into an agreement to transition the distribution of our Medical segment's surgeon gloves in certain international markets from a third-party distribution arrangement to a direct distribution model. The costs associated with this restructuring included </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$125 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, on a pre-tax basis, in contract termination costs that were paid during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These costs are reflected in restructuring and employee severance in the consolidated statements of earnings/(loss) during the fiscal year ended 2018. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Related Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility Exit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">and Other Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>28</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>84</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>92</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(44</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(48</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>72</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>85</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>109</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(81</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(85</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>68</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>96</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404068778824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">4. Goodwill and Other Intangible Assets</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Goodwill</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:42%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,621</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,695</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,316</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>45</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>52</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,663</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,715</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,378</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(16</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,657</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,700</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,357</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">At </span><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;">, the Pharmaceutical segment accumulated goodwill impairment loss was </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$829 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;">.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">At </span><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;">, the Medical segment accumulated goodwill impairment loss was </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$1.4 billion</span></span><span style="font-family:Arial Narrow;font-size:8pt;">. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Intangible Assets</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at June&#160;30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:22%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:22%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted- Average Remaining Amortization Period (Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,554</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,828</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,726</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>673</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>341</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>332</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,604</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>767</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>837</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,831</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,936</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,895</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,854</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,936</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,918</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,562</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,517</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,045</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>672</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>295</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>377</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,602</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>616</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>986</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,836</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,408</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Total amortization of intangible assets was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$512 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$531 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$574 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. The estimated annual amortization for intangible assets for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2021</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> through </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2025</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> is as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$442 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$408 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$358 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$329 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$277 million</span></span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404068778824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock', window );">Investments</a></td>
<td class="text">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;. Investments&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In August 2018, we sold our &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;98 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; equity interest in naviHealth Holdings, LLC ("naviHealth") to investor entities controlled by Clayton, Dubilier &amp;amp; Rice in exchange for cash proceeds of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$737 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (after adjusting for certain fees and expenses) and a &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;40 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; equity interest in a partnership that owns &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;100 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of the equity interest of naviHealth. We also have certain call rights to reacquire naviHealth. We have accounted for this investment using the equity method of accounting and on a one-month reporting lag.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the fiscal year ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2019&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we recognized a pre-tax gain of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$508 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; related to this divestiture in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings/(loss). The carrying value of this investment was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$334 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; as of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2019&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In May 2020, we sold our &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;40 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; equity interest in a partnership that owns &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;100 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of the equity interest of naviHealth in exchange for cash proceeds of [] and recognized a gain of [] related to this disposal in gain on sale of naviHealth stock in our consolidated statements of earnings/(loss). During the three and twelve months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2020&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, our proportionate share of naviHealth&amp;#8217;s net loss, which was recorded in other (income)/ expense, net in the consolidated statements of earnings/(loss), was immaterial.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment holdings.  This includes the information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970082200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Obligations and Other Short-Term Borrowings</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">6. Long-Term Obligations and Other Short-Term Borrowings</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes long-term obligations and other short-term borrowings at June 30:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions) (1)</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.4% Notes due 2019</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>450</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.625%&#160;Notes due 2020</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>508</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.616% Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>834</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,079</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2% Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>236</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>247</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Floating Rate Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>321</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>340</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2% Notes due 2023</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>576</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>551</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.079% Notes due 2024</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>809</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>781</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.5% Notes due 2024</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>413</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>402</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.75% Notes due 2025</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>529</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>494</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.41% Notes due 2027</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,215</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,318</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.6% Notes due 2043</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>340</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>346</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.5% Notes due 2044</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>342</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>342</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.9% Notes due 2045</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>441</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>445</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.368% Notes due 2047</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>560</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>594</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7.0%&#160;Debentures due 2026</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>124</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>124</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other Obligations</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6,775</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,031</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: current portion of long-term obligations and other short-term borrowings</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>452</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;&#160;&#160;Long-term obligations, less current portion</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6,765</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7,579</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)      Maturities are presented on a calendar year basis. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Maturities of existing long-term obligations and other short-term borrowings for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2021</span><span style="font-family:Arial Narrow;font-size:10pt;"> through </span><span style="font-family:Arial Narrow;font-size:10pt;">2025</span><span style="font-family:Arial Narrow;font-size:10pt;"> and thereafter are as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$10 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.4 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$585 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$814 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$414 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$3.6 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Long-Term Debt</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. The </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>7.0%</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> Debentures represent unsecured obligations of Allegiance Corporation (a wholly-owned subsidiary), which Cardinal Health, Inc. has guaranteed. None of these obligations are subject to a sinking fund and the Allegiance obligations are not redeemable prior to maturity. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$21.4 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In June 2020, we redeemed </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$500 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> aggregate principle amount of 4.625% Notes due December 2020 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with the redemption, we recorded a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$7 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> loss on early extinguishment of debt. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">During fiscal 2020, we also early repurchased&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$247 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;2.616%&#160;Notes due 2022,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$11 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;3.2% Notes due 2022,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$20 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;Floating Rate Notes due 2022,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$104 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;3.41% Notes due 2027,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$6 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;4.6% Notes due 2043,&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;4.9% Notes due 2045, and&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$35 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of the&#160;4.368% Notes due 2047.&#160; In connection with the early debt repurchases, we recognized a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$9 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;loss on early extinguishment of debt. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In November 2019, we repaid the full principal of the 2.4% Notes due 2019 at maturity for&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$450 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The redemption and repurchases were paid for with available cash and other short-term borrowings.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In fiscal 2019, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$67 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the 2.616% Notes due 2022, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the 3.2% Notes due 2022, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>8 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the Floating Rate Notes due 2022, and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$24 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the 3.41% Notes due 2027 for a total of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$100 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. The repurchases were paid for with available cash. The loss on early extinguishment of debt in connection with these early repurchases was immaterial. We also paid off the </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> 1.948% Notes due 2019 as they became due with available cash.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In June 2018, we repaid the full principal of the 1.95% Notes due 2018 at maturity for </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$550 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">If we undergo a change of control, as defined in the notes, and if the notes receive specified ratings below investment grade by each of Standard &amp; Poors Ratings Services, Moody&#8217;s Investors Services and Fitch Ratings, any holder of the notes, excluding the debentures, can require with respect to the notes owned by such holder, or we can offer, to repurchase the notes at </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>101%</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the principal amount plus accrued and unpaid interest.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Financing Arrangements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;commercial paper program </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">backed by a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;revolving credit facility. We also have a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;committed receivables sales facility.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through September 30, 2022. CHF was organized for</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">Our revolving credit and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter through December 2020, a consolidated net leverage ratio of no more than 4.00-to-1. The maximum permitted ratio will reduce to 3.75-to-1 in March 2021 and as of the end of every quarter thereafter</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. As of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we were in compliance with this financial covenant.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had no amounts outstanding under the revolving credit facility; however, availability was reduced by outstanding letters of credit of  </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$24 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at  </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Under our committed receivables sales facility program, we had a maximum amount outstanding of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$700 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and an average daily amount outstanding of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$12 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">. We also had no amounts outstanding under the committed receivables sales facility program; however, availability was reduced by outstanding standby letters of credit of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$29 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$30 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Under our commercial paper program we had a maximum amount outstanding of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.7 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and an average daily amount outstanding of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$183 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">. We had no amounts outstanding under the commercial paper program as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We also maintain other short-term credit facilities and an unsecured line of credit that allowed for borrowings up to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$6 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$9 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. The </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$35 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$10 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> balance of other obligations at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, consisted of short-term borrowings and finance leases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970895320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">8. Income Taxes</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Earnings/(Loss) before Income Taxes and Provision for/(Benefit From) Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes earnings/(loss) before income taxes:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:53%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">U.S. operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4,056</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,478</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>391</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-U.S. operations</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>284</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>273</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(619</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings/(loss) before income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(3,772</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,751</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(228</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the components of provision for/(benefit from) income taxes:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Current:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>659</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>295</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>341</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State and local</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>154</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>89</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-U.S.</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>69</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>85</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>143</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total current</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>882</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>469</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>525</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Deferred:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(822</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(28</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1,003</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State and local</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(127</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(37</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-U.S.</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(18</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total deferred</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(961</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(83</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1,012</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Provision for/(benefit from) income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(79</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>386</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(487</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Effective Tax Rate</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:54%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020 (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019 (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018 (1)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Provision at Federal statutory rate</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>21.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>21.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>28.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State and local income taxes, net of federal benefit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Tax effect of foreign operations</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(48.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nondeductible/nontaxable items</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(10.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill impairment</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(124.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Tax Act</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>410.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Change in valuation allowances</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(76.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign tax credits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>27.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">China tax related to divestiture</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(25.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Legal entity reorganization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(3.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>71.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Opioid litigation</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(23.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(21.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effective income tax rate</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>213.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1) </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The effective income tax rate for fiscal 2020 and 2018 represents an income tax benefit tax rate.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2) </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The effective income tax rate for fiscal 2019 represents an income tax expense tax rate. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The income tax benefit rate was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>2.1%</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>213.8%</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;"> compared to an income tax expense rate of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>22.1%</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. Fluctuations in the effective tax rates are primarily due to the impact of opioid litigation in fiscal 2020 and the impact of the U.S. Tax Cuts and Jobs Act ("Tax Act") in fiscal 2018, both described further below, as well as the Medical Unit goodwill impairment in fiscal 2018, as described in </span><a href="#sAF8B609C6A1B5242B7B172A7B9FB2416" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 1</span></a><span style="font-family:Arial Narrow;font-size:10pt;">. There were also changes in valuation allowances related to capital losses, credit carryforwards and net operating loss carryforwards in U.S. federal, U.S. state and international jurisdictions.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax charge for the opioid litigation, we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$488 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">,</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$469 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the tax law; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the Tax Act. Further, it is possible that the tax authorities could challenge our interpretation of the currently enacted tax law or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our effective tax rate has benefits from negotiated lower than statutory tax rates in select foreign jurisdictions which individually are not material to our effective tax rate but in aggregate have a favorable tax impact of approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$17 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> during fiscal 2020.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">On December 22, 2017, the United States enacted the Tax Act. The Tax Act made broad and comp</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">lex changes to the U.S. tax code that affected fiscal 2018 and incrementally affected our fiscal year 2019 financial results in several ways. First, the U.S. statutory tax rate in fiscal 2019 was reduced to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>21.0%</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Second, the Tax Act established new tax provisions that affected us beginning July 1, 2018 including, (1) eliminating the U.S. manufacturing deduction; (2) establishing new limitations on deductible interest expense and certain executive compensation; (3) eliminating the corporate alternative minimum tax; (4) creating the base erosion anti-abuse tax; (5) creating a new provision designed to tax global intangible low-tax income (&#8220;GILTI&#8221;) and allow for a deduction related to foreign derived intangible income ("FDII"); (6) generally eliminating U.S. federal income taxes on dividends from foreign subsidiaries; and (7) changing rules related to uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Regarding the new GILTI tax rules, we elected to treat taxes due on future GILTI inclusions in U.S. taxable income as a current period expense when incurred.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, foreign earnings of approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$800 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> are considered indefinitely reinvested for working capital and other offshore investment needs. The computation of tax required if those earnings are repatriated is not practicable. For amounts not </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">considered indefinitely reinvested, we have recorded an immaterial amount of income tax expense in our financial statements in fiscal 2020. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Deferred Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities and operating loss and tax credit carryforwards for tax purposes. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents the components of the deferred income tax assets and liabilities at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Deferred income tax assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Receivable basis difference</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>607</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>133</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss and tax credit carryforwards</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>589</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>621</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Deferred tax assets related to uncertain tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>52</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>87</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total deferred income tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,412</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>864</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Valuation allowance for deferred income tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(470</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(542</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net deferred income tax assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>942</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>322</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Deferred income tax liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inventory basis differences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(1,083</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1,056</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Property-related</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(327</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(171</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill and other intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(751</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(808</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total deferred income tax liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(2,161</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2,035</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net deferred income tax liability</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(1,219</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1,713</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Noncurrent deferred income tax asset (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Noncurrent deferred income tax liability (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(1,258</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1,749</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net deferred income tax liability</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(1,219</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1,713</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in other assets in the consolidated balance sheets.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> we had gross federal, state and international loss and credit carryforwards of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$123 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.4 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.2 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, the tax effect of which is an aggregate deferred tax asset of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$589 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. Substantially all of these carryforwards are available for at least three years. Approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$461 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the valuation allowance at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> applies to certain federal, state and international loss carryforwards that, in our opinion, are more likely than not to expire unutilized. However, to the extent that tax benefits related</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">to these carryforwards are realized in the future, the reduction in the valuation allowance would reduce income tax expense.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Unrecognized Tax Benefits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We had </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$998 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$456 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$423 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of unrecognized tax benefits at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. The </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;"> balances include </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$753 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$303 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$262 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate. The remaining unrecognized tax benefits relate to tax positions for which ultimate deductibility is highly certain but for which there is uncertainty as to the timing of such deductibility. Recognition of these tax benefits would not affect our effective tax rate. We include the full amount of unrecognized tax benefits in deferred income taxes and other liabilities in the consolidated balance sheets. The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at beginning of fiscal year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>456</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>423</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>417</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions for tax positions of the current year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>500</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions for tax positions of prior years (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>78</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>141</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Reductions for tax positions of prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(27</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(40</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Settlements with tax authorities (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(99</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Expiration of the statute of limitations (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at end of fiscal year</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>998</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>456</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>423</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in fiscal 2018 additions for tax positions of prior years is </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$110 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> related to exposures acquired as part of the Patient Recovery Business for which we are fully indemnified. Also for fiscal 2018 are settlements of </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$81 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> related to the Patient Recovery Business as well as </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$11 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> of statute expirations. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of audit issues, reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations.</span><span style="font-family:Arial Narrow;font-size:10pt;"> We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is a net decrease of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$0 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$370 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, exclusive of penalties and interest.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$146 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$122 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$110 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, accrued for the payment of interest and penalties. These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the consolidated balance sheets. During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;"> we recognized </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$16 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$8 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$8 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of expense for interest and penalties in income tax expense, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Tax Matters</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state and local jurisdictions, and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2008 through the current fiscal year. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), which has been acquired by Becton, Dickinson and Company. Under the tax matters agreement, </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$176 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$165 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, and is included in other assets in the consolidated balance sheets.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition under the purchase agreement. The indemnification receivable was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$19 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$22 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and is included in other assets in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404069446312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingent Liabilities and Litigation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments, Contingent Liabilities and Litigation</a></td>
<td class="text">h Corporation ("CVS Health")<div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Red Oak Sourcing, LLC ("Red Oak Sourcing") is a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term through June 2024. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. Due to the achievement of predetermined milestones, we are required to make quarterly payments of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$45.6 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to CVS Health for the initial term.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Contingencies</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">New York Opioid Stewardship Act</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In April 2018, the State of New York passed a budget which included the Opioid Stewardship Act (the "OSA"). The OSA created an aggregate $100 million annual assessment on all manufacturers and distributors licensed to sell or distribute opioids in New York. Under the OSA, each licensed manufacturer and distributor would be required to pay a portion of the assessment based on its share of the total morphine milligram equivalents sold or distributed in New York during the applicable calendar year, beginning in 2017.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In December 2018, the U.S. District Court for the Southern District of New York ruled that the OSA is unconstitutional and enjoined its enforcement (the "Ruling"). In January 2019, the State filed notice of its intent to appeal the Ruling. In April 2019, the State, among other things, amended the OSA so that the assessment would only cover opioid sales in 2017 and 2018, subject to the State's pending appeal of the Ruling. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We accrue contingencies if it is probable that a liability has been incurred and the amount can be estimated. At June 30, 2020, we have no amounts accrued for the OSA because we do not believe it is probable that a liability has been incurred. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Legal Proceedings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We become involved from time to time in disputes, litigation and regulatory matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we determine that products we source, manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions have led to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, product liability claims and lawsuits and can lead to action by regulators. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information could directly or indirectly lead to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We may be named from time to time in </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">a </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our consolidated statements of earnings/(loss).</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Opioid Lawsuits and Investigations</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Pharmaceutical wholesale distributors, including us, have been named as defendants in over </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>3,000</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits relating to the distribution of prescription opioid pain medications. The lawsuits seek equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as public nuisance, negligence and unjust enrichment as well as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. These lawsuits also name pharmaceutical manufacturers, retail pharmacy chains and other entities as defendants.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">States &amp; Political Subdivisions</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>2,800</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of these lawsuits have been filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The vast majority of these lawsuits were filed in U.S. federal court and have been transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#8220;MDL&#8221;).  </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In January 2020, the complaints of Cabell County and City of Huntington, West Virginia were remanded from the MDL to U.S. District Court in West Virginia.  A trial date has been set for October 2020.  In addition, the complaints of San Francisco, California and the Cherokee Nation have been remanded to their original district courts.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>25</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> state attorneys general have filed lawsuits against distributors, including us, in various state courts.  A trial in New York for cases brought by the New York Attorney General and Nassau and Suffolk counties was scheduled to begin in March 2020, but was deferred due to the COVID-19 pandemic. A trial is scheduled to begin in Madison County, Ohio, in October 2020 for the case brought by the Ohio Attorney General. A state court trial in a case brought by </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">certain West Virginia political subdivisions is scheduled for March 2021.  Additionally, we have received requests, civil investigative demands, subpoenas or requests for information from additional state attorneys general offices and governmental authorities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In October 2019, we agreed in principle to a global settlement framework with a leadership group of state attorneys general that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions (the "Settlement Framework"). This Settlement Framework is subject to contingencies and uncertainties as to final terms, but is the basis for our negotiation of definitive terms and documentation.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Settlement Framework includes (1) a cash </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">component</span><span style="font-family:Arial Narrow;font-size:10pt;">, pursuant to which we would pay up to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.56 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> over </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>eighteen years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, (2) development and participation in a program for  distribution of opioid abuse treatment medications for a period of ten years, and (3) to-be specified industry-wide changes to controlled substance anti-diversion programs. Definitive terms for a settlement pursuant to the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. In connection with these matters, we have </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.56 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> accrued at June 30, 2020, included in deferred income taxes and other liabilities in the consolidated balance sheets, which represents the cash component. We are unable to estimate the range of possible loss associated with these matters. We are unable to reasonably estimate the liability or cost associated with the other components of the Settlement Framework, the potential distribution of treatment medications and any incremental costs for changes to our controlled substance anti-diversion program that we may agree to.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the fiscal year ended June 30, 2020, we along with two other national distributors entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$215 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> settlement with two Ohio counties, Cuyahoga and Summit, to resolve all claims in the first bellwether trial in the MDL, which had been set for trial for October 2019. In connection with this settlement, we incurred </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$66 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> within litigation (recoveries)/charges, net during the fiscal year ended June 30, 2020. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with these matters (including the settlement with two Ohio counties), we recorded a total pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.14 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> after tax) during the fiscal year ended June 30, 2020 in litigation (recoveries)/charges, net, in the consolidated statement of earnings/(loss) for the cash component. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual. We continue to strongly dispute the allegations made in these lawsuits and reaching an agreement in principle on a global settlement framework is not an admission of liability or wrongdoing.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Private Plaintiffs</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Settlement Framework does not address claims by private plaintiffs, which includes unions and other health and welfare funds, hospital systems and other healthcare providers, businesses and </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">individuals. Private plaintiffs had brought approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>400</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits as of July 28, 2020. Of these, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>106</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs relating to the distribution of controlled substances. We are vigorously defending ourselves in these matters.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Department of Justice Investigations</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have received federal grand jury subpoenas issued in connection with investigations being conducted by the U.S. Attorney's Office for the Eastern District of New York and the Fraud Section of the U.S. Department of Justice ("DOJ"). The subpoenas seek documents  relating to our anti-diversion policies, procedures and program, and our distribution of certain controlled substances. We are cooperating with these requests.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Product Liability Lawsuits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As of July 28, 2020, we are named as a defendant in </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>334</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>4,280</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. Another </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>31</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits involving similar claims by approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>36</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. We continue to vigorously defend ourselves in these lawsuits and have begun to engage in preliminary resolution discussions with plaintiffs.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#5b9bd5;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At June&#160;30, 2020, we had a total of </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"><span>$468 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, net of estimated insurance recoveries, accrued for losses and legal defense costs related to the Cordis IVC filter lawsuits which are presented on a gross basis in the consolidated balance sheets. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range to be approximately </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"><span>$919 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, net of estimated insurance recoveries.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Shareholder Securities Litigation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In August 2019, the Louisiana Sheriffs' Pension &amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. The complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. In June 2020, the court appointed 1199 SEIU Health Care Employees Pension Fund as lead plaintiff. We believe that the claims asserted in this complaint are without merit and intend to vigorously defend against them. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Surgical Gown Recalls</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In January 2020, we issued a voluntary recall for </span><span style="font-family:Arial Narrow;font-size:10pt;">9.1 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> AAMI Level 3 surgical gowns and two voluntary field actions (a recall of some packs and a corrective action allowing overlabeling of other packs) for 2.9 million Presource Procedure Packs containing affected </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">gowns (together, the "Recalls"). These Recalls were necessary because we discovered in December 2019 that one of our FDA-registered suppliers in China had shifted production of some gowns to unapproved sites with uncontrolled manufacturing environments. Because of this, we could not assure sterility of the gowns. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with these Recalls, in the fiscal year ended June 30, 2020, we recorded total charges of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$85 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, of which </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$48 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> is within cost of products sold and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$37 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> is within SG&amp;A in the consolidated statements of earnings/(loss). This charge represents our best estimate of costs for the Recalls and includes inventory write-off costs and certain remediation and supply disruption costs, such as costs to replace recalled products. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Civil Litigation </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Generic Pharmaceutical Pricing Antitrust Litigation </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In December 2019, pharmaceutical distributors including us were added as defendants in a civil class action lawsuit filed by indirect purchasers of generic drugs, such as hospitals and retail pharmacies. The indirect purchaser case is part of a multidistrict litigation consisting of multiple individual class action matters consolidated in the Eastern District of Pennsylvania. The indirect purchaser plaintiffs allege that pharmaceutical distributors encouraged manufacturers to increase prices, provided anti-competitive pricing information to manufacturers and improperly engaged in customer allocation. We have filed a motion to dismiss the complaints and we intend to vigorously defend ourselves in this matter. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Active Pharmaceutical Ingredient Impurity Litigation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Many participants in the pharmaceutical supply chain, including active pharmaceutical ingredient ("API") manufacturers, finished dose manufacturers, repackagers (including us), distributors (including us), and retailers have been named as defendants in lawsuits arising out of recalls of certain medications due to alleged impurities in the active pharmaceutical ingredients or finished product. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In February 2019, a Multidistrict Litigation was created in the U.S. District Court for the District of New Jersey (the &#8220;Sartan MDL&#8221;) alleging API impurities in certain generic blood pressure medications. We were recently named as a defendant in a Multidistrict Litigation alleging API impurities in Zantac and its generic form, ranitidine. We intend to vigorously defend ourselves in these matters.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Antitrust Litigation Proceeds</span></div><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">We received and recognized income resulting from settlements of lawsuits in which we were a class member or plaintiff of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$16 million</span></span><span style="font-family:inherit;font-size:10pt;">,</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"><span>$94 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;"><span>$22 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">  during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">, </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">,  and </span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:normal;">2018</span>, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404070177640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">9. Fair Value Measurements</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>721</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>721</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>114</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>114</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div>The fair value of interest rate swaps, foreign currency contracts, net investment hedges and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971642328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">10. Financial Instruments</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to current fair value through earnings at the end of each period. </span><span style="font-family:Arial Narrow;font-size:10pt;">We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are rated investment grade or better. We do not have significant exposure to any one counterparty and we believe </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">the risk of loss is remote. Additionally, we do not require collateral under these agreements.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Interest Rate Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes in interest rates. In addition, we enter into interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Currency Exchange Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce earnings and cash flow volatility associated with foreign exchange rate changes to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commodity Price Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>27</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cross-currency swap (1) </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>74</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps (3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (4)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps (3)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>16</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in other assets in the consolidated balance sheets.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in prepaid expenses and other in the consolidated balance sheets.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in other accrued liabilities in the consolidated balance sheets.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense, net in the consolidated statements of earnings/(loss). D</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">uring fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, there was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>no</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> gain or loss recorded to interest expense as changes in the market value of our derivative instruments offset changes in the market value of the underlying debt.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In May </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we unwound certain interest rate swap contracts. In connection with the unwind of these contracts, we received cash proceeds of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$112 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The related gain will be recognized in interest expense, net in our statement of earnings/(loss) over the remaining term of the related debt agreements, which ranged from 48 months to 63 months at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the debt repayment as described in </span><a href="#s90F282348F0354D781EEBCEFD3A04F7E" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 6</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, two pay-floating interest rate swaps with notional amounts of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$200 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> matured in the second quarter of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">During fiscal&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we terminated notional amounts of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$163 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;of pay-floating interest rate swaps in connection with the debt repurchases in&#160;fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;described in </span><a href="#s90F282348F0354D781EEBCEFD3A04F7E" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 6</span></a><span style="font-family:Arial Narrow;font-size:10pt;">. These swaps were previously designated as fair value hedges.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> we entered into pay-floating interest rate swaps with total notional amounts of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$1.1 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These swaps have been designated as fair value hedges of our fixed rate debt and are included in deferred income taxes and other liabilities in the consolidated balance sheets. During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$550 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of pay-floating interest rate swaps matured.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:26%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:11%;"/><td style="width:4%;"/><td style="width:12%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Maturity&#160;Date</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>550</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Mar 2023</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:11%;"/><td style="width:4%;"/><td style="width:12%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Maturity&#160;Date</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,150</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nov 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">-</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Sep 2025</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>106</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fixed-rate debt (1)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(106</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1) Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash Flow Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive loss and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered into forward interest rate swaps with a total notional amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$200 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to hedge probable, but not firmly committed, future transactions associated with our debt.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">All gains and losses currently included within accumulated other comprehensive loss associated with our cash flow hedges that are expected to be reclassified into net earnings within the next 12 months are immaterial.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We enter into foreign currency contracts to protect the value of anticipated foreign currency revenues and expenses. At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we held contracts to hedge probable, but not firmly committed, revenue and expenses. The principal currencies hedged are the Canadian dollar, Mexican peso, euro, Thai baht, Chinese renminbi, Japanese yen, Australian dollar, and British pound.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We enter into commodity contracts to manage the price risk associated with forecasted purchases of certain commodities used in our Medical segment.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarize the outstanding cash flow hedges at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:14%;"/><td style="width:4%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Maturity&#160;Date</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>200</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jun 2022</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>328</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jul 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">-</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jun 2021</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jul 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">-</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jun 2021</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:14%;"/><td style="width:4%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Maturity&#160;Date</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>381</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jul 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">-</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jun 2020</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jul 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">-</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jun 2020</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(16</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (3)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps (4)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts (3)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in revenue in the consolidated statements of earnings/(loss).</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in cost of products sold in the consolidated statements of earnings/(loss).</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in SG&amp;A expenses in the consolidated statements of earnings/(loss).</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4) </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Net Investment Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In August 2019, we entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>&#165;64 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$600 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">) cross-currency swap maturing in </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2022</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In </span><span style="font-family:Arial Narrow;font-size:10pt;">September 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>&#8364;200 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$233 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">) cross-currency swap maturing in </span><span style="font-family:Arial Narrow;font-size:10pt;">2023</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive loss until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Pre-tax gain from net investment hedges recorded in other  foreign currency translation was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$35 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$12 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. Gain recognized in interest expense, net in the consolidated statements of earnings/(loss) for the portion of the net investment hedges excluded from the assessment of hedge effectiveness was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$17 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$5 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Economic (Non-Designated) Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. The principal currency managed through foreign currency contracts is the euro, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Canadian dollar, British pound, Japanese yen, and Chinese renminbi.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:14%;"/><td style="width:4%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Maturity Date</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>325</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">July 2020</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:14%;"/><td style="width:4%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Maturity Date</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>488</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jul 2019</span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (1)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(11</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in other income, net in the consolidated statements of earnings/(loss).</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value of Financial Instruments</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The carrying amounts of cash and equivalents, trade receivables, net, accounts payable, and other accrued liabilities at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> approximate fair value due to their short-term maturities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Estimated fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7,273</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Carrying amount</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6,775</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,031</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:</span></div><div style="line-height:100%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:32%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Notional<br/>Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fair&#160;Value<br/>Gain/(Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Notional<br/>Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fair&#160;Value<br/>Gain/(Loss)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>550</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,150</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>40</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>653</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>869</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>200</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(16</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cross-currency swap</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>833</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>47</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>233</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404064464360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">11. Shareholders' Equity</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, authorized capital shares consisted of the following: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>750 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> Class A common shares, without par value; </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>5 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> Class B common shares, without par value; and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>500 thousand</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> non-voting preferred shares, without par value. The Class A common shares and Class B common shares are collectively referred to below as &#8220;common shares&#8221;. Holders of common shares are entitled to share equally in any dividends declared by the Board of Directors and to participate equally in all distributions of assets upon liquidation. Generally, the holders of Class A common shares are entitled to </span><span style="font-family:Arial Narrow;font-size:10pt;">one vote</span><span style="font-family:Arial Narrow;font-size:10pt;"> per share, and the holders of Class B common shares are entitled to </span><span style="font-family:Arial Narrow;font-size:10pt;">one-fifth of one vote</span><span style="font-family:Arial Narrow;font-size:10pt;"> per share on proposals presented to shareholders for vote. Under certain circumstances, the </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">holders of Class B common shares are entitled to vote as a separate class. Only Class A common shares were outstanding at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.5 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of our common shares, in the aggregate, through share repurchase programs during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, as described below. We funded the repurchases with available cash and short term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>7.3 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$350 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$48.00</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These repurchases were made under an accelerated share repurchase ("ASR") program, which began on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">August&#160;20, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and was completed on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">December&#160;4, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>11.5 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$600 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$52.32</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These repurchases were made under ASR program, which began on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">August&#160;16, 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and was completed on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">October&#160;25, 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>8.4 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$550 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$65.30</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These repurchases include&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$300 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> purchased under an ASR program, which began on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">February&#160;14, 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and was completed on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;21, 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We repurchased&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>4.3 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;shares under the ASR at an average price paid per share of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$69.26</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Accumulated Other Comprehensive Loss</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:38%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Currency</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Translation</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Adjustments and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain/(Loss) on</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Derivatives,</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Comprehensive</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Loss</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(113</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(92</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), net before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total other comprehensive loss attributable to Cardinal Health, Inc., net of tax of $1 million</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(95</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(79</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(20</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(25</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(92</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(104</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404068823960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc.<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share Attributable to Cardinal Health, Inc.</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">12. Earnings/(Loss) Per Share Attributable to Cardinal Health, Inc.</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:61%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(3,693</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,365</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>259</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings attributable to noncontrolling interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(3,696</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,363</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>256</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>293</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>300</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>313</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units, and performance share units</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>293</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>301</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>315</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12.61</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4.55</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.82</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12.61</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4.53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.81</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>6 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>7 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>6 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. During fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, there were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>2 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> potentially dilutive employee stock options, restricted share units and performance share units not included in the computation of diluted loss per common share attributable to Cardinal Health, Inc. because their effect would be anti-dilutive as a result of the net loss for the fiscal year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403964554616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">13. Segment Information</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operations are principally managed on a products and services basis and are comprised of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>two</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Revenue</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates pharmacies, including pharmacies in community health centers, nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">this segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue for each reportable segment and Corporate:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>137,495</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>129,917</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>121,241</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15,444</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,633</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,581</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,939</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,550</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>136,822</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,922</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,534</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>136,809</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:66%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>136,693</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>129,067</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>802</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>850</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>137,495</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>129,917</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (3)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13,429</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13,833</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,015</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,800</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15,444</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,633</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,939</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,550</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,922</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,534</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services"</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue by geographic area:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>148,707</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>141,479</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>132,539</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4,232</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4,071</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4,283</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total  segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,939</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,550</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>136,822</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,922</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,534</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>136,809</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Segment Profit</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general, and administrative ("SG&amp;A") expenses. Segment SG&amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial and customer care shared services, human resources, information technology, legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We do not allocate the following items to our segments: last-in first-out, or ("LIFO"), inventory charges/(credits); surgical gown recall costs; state opioid assessment related to prior fiscal years; restructuring and employee severance; amortization and other acquisition-related costs; impairments and (gain)/loss on disposal of assets; litigation (recoveries)/charges, net; other (income)/expense, net; interest expense, net; loss on early extinguishment of debt; gain on sale of equity interest in naviHealth and provision for/(benefit from) income taxes. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$69 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$55 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$43 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the opioid litigation as discussed further in </span><a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> which was retained at Corporate. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the surgical gown recall as discussed further in </span><a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$85 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> which was retained at Corporate. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the naviHealth divestiture discussed in </span><a href="#s20ab24d9611f400f9fecc35ff4abdad4" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 2</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$508 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> which was retained at Corporate.</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the sale of our remaining equity interest in a partnership that owned naviHealth as discussed in </span><a href="#s20ab24d9611f400f9fecc35ff4abdad4" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 2</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$579 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax gain (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$493 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> after tax) during fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is included in gain on sale of equity interest naviHealth in the </span><span style="font-family:Arial Narrow;font-size:10pt;">consolidated statements of earnings/(loss) and did not impact segment profit or operating earnings</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present segment profit by reportable segment and Corporate:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,753</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,834</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,992</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>663</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>576</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>662</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,416</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,410</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,654</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(6,514</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(350</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2,528</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4,098</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,060</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>126</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>135</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>147</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>156</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>243</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>288</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>278</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>535</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>565</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>598</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total depreciation and amortization</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>913</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,032</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>58</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>86</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>74</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>127</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>242</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>219</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>199</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total additions to property and equipment</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>375</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>328</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>384</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents total assets for each reportable segment and Corporate at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22,398</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22,446</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>21,421</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>14,691</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,284</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>16,066</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,677</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,233</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,464</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>40,766</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>40,963</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>39,951</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables present property and equipment, net by geographic area:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,880</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,846</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,950</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>486</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>510</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>537</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Property and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,366</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,356</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,487</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403964427224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">14. Share-Based Compensation</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We maintain stock incentive plans (collectively, the &#8220;Plans&#8221;) for the benefit of certain of our officers, directors and employees. At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>12 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> shares remain available for future grants under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan ("2011 LTIP"). Under the 2011 LTIP's fungible share counting provisions, stock options are counted against the plan as </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">one share for every share issued</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">; awards other than stock options are counted against the plan as </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">two and one-half shares for every share issued</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. This means that only </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>5 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> shares could be issued under awards other than stock options while </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>12 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> shares could be issued under stock options. Shares are issued out of treasury shares when stock options are exercised and when restricted share units and performance share units vest. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides total share-based compensation expense by type of award:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:60%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>70</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>73</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation expense</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>90</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>82</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>85</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The total tax benefit related to share-based compensation was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$16 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$16 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$23 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Restricted Share Units</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Restricted share units granted under the Plans generally vest in equal annual installments over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>three years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:52%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Restricted Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>71.58</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>50.13</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>74.52</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>62.32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51.65</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>42.71</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>60.21</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>45.92</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:5px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table provides additional data related to restricted share unit activity:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>77</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>75</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>78</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total fair value of shares vested during the year</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>57</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Stock Options</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Employee stock options granted under the Plans generally vest in equal annual installments over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>three years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and are exercisable for a period up to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>ten years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all stock option transactions under the Plans:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:57%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Stock</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercise Price per</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Common Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>64.50</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Exercised</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>72.54</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>63.78</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Exercised</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>42.36</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Outstanding at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>65.15</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercisable at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>65.25</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides additional detail related to stock options:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of outstanding options at period end</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercisable options at period end</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercised options</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net proceeds/(withholding) from share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>26</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Excess tax benefits from share based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total fair value of shares vested during the year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average grant date fair value per stock option</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8.26</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8.34</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13.50</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:66%;"/><td style="width:10%;"/><td style="width:2%;"/><td style="width:10%;"/><td style="width:2%;"/><td style="width:10%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in years)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of outstanding options</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of exercisable options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average period over which stock option compensation cost is expected to be recognized</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Until the end of fiscal 2018, stock options were granted to our officers and certain employees. The fair values were estimated on the grant date using a lattice valuation model. We believe the lattice model provides reasonable estimates because it has the ability to take into account individual exercise patterns based on changes in our stock price and other variables, and it provides for a range of input assumptions, which are disclosed in the table below. The risk-free rate is based on the U.S. Treasury yield curve at the time of the grant. We analyzed historical data to estimate option exercise behaviors and employee terminations to be used within the lattice model. The expected life of the options granted was calculated from the option valuation model and represents the length of time in years that the options granted are expected to be outstanding. Expected volatilities are based on implied volatility from traded options on our common shares and historical volatility over a period of time commensurate with the contractual term of the option grant (up to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>ten years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">). </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">There were no stock options granted to employees during fiscal year </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> or </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. The following table provides the range of assumptions used to estimate the fair value of stock options:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.12345679012346%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:76%;"/><td style="width:10%;"/><td style="width:4%;"/><td style="width:10%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Risk-free interest rate</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2.1%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Expected volatility</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>25%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividend yield</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2.7%</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">-</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2.8%</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Expected life in years</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7</span></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Performance Share Units</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Performance share units generally vest over a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">three</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>zero</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>240 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:51%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Performance</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>66.13</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>50.96</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>52.20</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51.45</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>44.03</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>48.40</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>50.92</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>54.24</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table provides additional data related to performance share unit activity:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:60%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total fair value of shares vested during the year</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Employee Retirement Savings Plans</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Substantially all of our domestic non-union employees are eligible to be enrolled in our company-sponsored contributory retirement savings plans, which include features under Section 401(k) of the Internal Revenue Code of 1986, and provide for matching and discretionary contributions by us. The total expense for our employee retirement savings plans was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$66 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$99 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$129 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403964554616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected Quarterly Financial Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Selected Quarterly Financial Data (Unaudited)</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ff0000;font-weight:bold;">15. Selected Quarterly Financial Data (Unaudited)</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ff0000;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following is selected quarterly financial data for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. The sum of the quarters may not equal year-to-date due to rounding.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">First<br/>Quarter (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Second<br/>Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Third<br/>Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fourth<br/>Quarter (2)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fiscal 2020</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>37,341</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>39,735</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>39,157</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>36,689</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross margin</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,679</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,714</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,885</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,590</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Distribution, selling, general and administrative expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,107</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,163</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,165</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,137</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(4,921</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>220</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>351</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>657</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(4,922</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>220</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>350</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>656</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16.65</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.75</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1.20</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2.25</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16.65</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.75</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1.19</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2.23</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes a </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> pre-tax charge for the opioid litigation (</span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$5.14 billion</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax). </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes a </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$579 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> pre-tax gain (</span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$493 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax) in connection with the sale of our remaining equity interest in a partnership that owned naviHealth.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">First<br/>Quarter (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Second<br/>Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Third<br/>Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fourth<br/>Quarter</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fiscal 2019</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35,213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>37,740</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35,228</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>37,353</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross margin</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,667</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,730</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,764</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,674</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Distribution, selling, general and administrative expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,155</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,064</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,097</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,168</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>594</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>281</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>194</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>593</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>280</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>194</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1.95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.99</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.65</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted (3)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1.94</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.93</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.99</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.65</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes a </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$508 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> gain (</span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$378 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax) related to the naviHealth divestiture.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403965858664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuations and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ScheduleIIAbstract', window );"><strong>Schedule II [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Cardinal Health, Inc. and Subsidiaries</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ff0000;font-weight:bold;">Schedule&#160;II - Valuation and Qualifying Accounts </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance&#160;at</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Beginning of Period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Charged&#160;to Costs</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">and Expenses (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Charged&#160;to</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Other Accounts&#160;(2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Deductions&#160;(3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance&#160;at</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">End of Period</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fiscal 2020</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>193</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>139</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(127</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>206</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance notes receivable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Sales returns and allowances</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>479</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,253</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(2,237</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>495</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>687</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,407</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(2,366</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>729</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fiscal 2019</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>139</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>140</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(87</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>193</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance notes receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Sales returns and allowances</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>479</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,205</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2,205</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>479</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>626</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,353</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2,293</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>687</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fiscal 2018</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>137</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>113</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(111</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>139</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance notes receivable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Sales returns and allowances</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>347</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,402</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2,270</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>479</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>494</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,513</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2,381</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>626</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fiscal </span><span style="font-family:Arial Narrow;font-size:8pt;">2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, </span><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">2018</span><span style="font-family:Arial Narrow;font-size:8pt;"> include </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$49 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;">, </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$60 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$37 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;">, respectively, for reserves related to service charges and customer pricing disputes, excluded from provision for bad debts on the consolidated statements of cash flows and classified as a reduction in revenue in the consolidated statements of earnings/(loss).</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Recoveries of amounts provided for or written off in prior years was </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$1 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> in each fiscal year </span><span style="font-family:Arial Narrow;font-size:8pt;">2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, </span><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">2018</span><span style="font-family:Arial Narrow;font-size:8pt;">.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Write-off of uncollectible accounts or actual sales returns.</span></div></td></tr></table>The sum of the components may not equal the total due to rounding.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ScheduleIIAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule II [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ScheduleIIAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971631768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis of Presentation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts could ultimately differ from these estimated amounts.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The outbreak of the novel strain of coronavirus (&#8220;COVID-19&#8221;) has severely impacted, and continues to severely impact the U.S. and global economies, and beginning in the third quarter of fiscal 2020, our businesses have been impacted in a variety of ways. We cannot estimate the length or severity of the COVID-19 pandemic or the related U.S. and global economic consequences on our business and operations, including whether and when historic economic and operating conditions will resume or the extent to which the disruption may impact our business, financial position, results of operations or cash flow. Our e</span><span style="font-family:Arial Narrow;font-size:10pt;">stimates, judgments and assumptions related to COVID-19 could ultimately differ over time</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash Equivalents</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivables</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Receivables and Allowance for Doubtful Accounts</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Trade receivables are presented net of an allowance for doubtful accounts of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$206 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$193 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. An account is considered past due on the first day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to cover potential losses, which are based primarily on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We provide financing to various customers. Such financing arrangements range from </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>1 year</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>5 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$104 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> (current portion </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$12 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">) and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$103 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> (current portion </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$12 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">) at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$27 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$14 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the credit worthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Concentrations of Credit Risk</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.</span></div>Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#8217; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts. <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersPolicyPolicyTextBlock', window );">Major Customers</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Major Customers</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">CVS Health Corporation ("CVS") and OptumRx, are our only customers that individually account for at least 10 percent of revenue </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:34%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Percent of Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">CVS</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">OptumRx</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:Arial Narrow;font-size:10pt;">We have entered into agreements with group purchasing organizations (&#8220;GPOs&#8221;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>two</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> largest GPO member relationships in terms of revenue. Sales to members of these </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>two</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> GPOs collectively accounted for </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>16 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>22 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>22 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of revenue for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span>, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Inventories</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">A substantial portion of our inventories (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>56 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at both </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#8220;distribution facilities&#8221;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, inventories valued at LIFO cost were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$411 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$230 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> or </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our remaining inventory that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Net realizable value is defined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$155 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$171 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CashDiscountsPolicyTextBlock', window );">Cash Discounts</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash Discounts</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Property and Equipment</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#8212;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>3</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>39 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">; machinery and equipment&#8212;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>3</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>20 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">; and furniture and fixtures&#8212;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>3</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>7 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. We recorded depreciation and amortization expense of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$405 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$455 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$446 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents the components of property and equipment, net at June&#160;30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Land, building and improvements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,185</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,992</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Machinery and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,008</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,038</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Furniture and fixtures</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>138</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>138</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total property and equipment, at cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,331</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,168</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(2,965</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2,812</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Property and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,366</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,356</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term obligations, which was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>3 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">. The amount of capitalized interest was immaterial for all periods presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Goodwill and Other Intangible Assets</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>two</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#8220;Medical Unit&#8221;); and Cardinal Health at-Home Solutions division. Our Nuclear and Precision Health Solutions division was formerly referred to as our Nuclear Pharmacy Services division and our Cardinal Health at-Home Solutions division was formerly referred to as our Cardinal Health at Home division.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>8.5 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>10.5 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;">. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We performed annual impairment testing in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;"> and with the exception of our Medical Unit in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In conjunction with the preparation of our consolidated financial statements for fiscal 2018, we completed our annual quantitative goodwill impairment test, which we perform annually in the fourth quarter. Using a combination of income and market-based approaches (using a discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>8.5 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">), the carrying value </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">exceeded the fair value and resulted in an impairment charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$1.4 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> related to our Medical Unit, which is included in impairments and loss on disposal of assets in our consolidated statements of earnings/(loss). Our fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The impairment was primarily driven by inventory and cost challenges within our Cordis business which furthered in the fourth quarter of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. This impairment charge did not impact our liquidity, cash flows from operations, or compliance with debt covenants. There was no tax benefit related to the goodwill impairment charge. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The impairment test for indefinite-lived intangibles other than goodwill (primarily IPR&amp;D) involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation </span><span style="font-family:Arial Narrow;font-size:10pt;">requires the use of estimates and significant judgments and</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AssetsHeldforSalePolicyPolicyTextBlock', window );">Assets Held for Sale, Policy [Policy Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Assets Held for Sale</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We classify assets and liabilities (the &#8220;disposal group&#8221;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Investments</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CostofSalesVendorReservesPolicyPolicyTextBlock', window );">Vendor Reserves</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Vendor Reserves</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically refine our methodology by updating the reserve estimate percentages to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues, such as bankruptcies. Vendor reserves were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$77 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$53 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock', window );">Distribution Service Agreement and Other Vendor Fees</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Distribution Services Agreement and Other Vendor Fees</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#8217; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#8217;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Loss Contingencies</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Loss Contingencies and Self-Insurance</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with the opioid litigation as described further in the </span><a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;">, we recorded a pre-tax charge of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;(</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.14 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;after tax) during fiscal 2020. </span><span style="font-family:Arial Narrow;">Definitive terms of a settlement under the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied.  </span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">We develop and periodically update reserve estimates for the Cordis inferior vena cava ("Cordis IVC") claims, including those received to date and expected to be received in the future and related costs. To project future Cordis IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, sales data, implant and injury to report lag patterns and estimated defense costs. </span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We also self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The amount of ultimate loss may differ materially from these estimates.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). </span><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a href="#sD2716397D81358C69DCBB2A8D6E9CCCE" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding loss contingencies and product liability lawsuits.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amoun</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">t of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a href="#s002522EA8F5F5274B7487704BE70A9A8" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding income taxes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock', window );">Other Accrued Liabilities, Policy [Policy Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Accrued Liabilities</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Noncontrolling Interests and Redeemable Noncontrolling Interests</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Noncontrolling Interests</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Noncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc. </span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Share-Based Compensation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See </span><a href="#sD47735F83E5151799C861160A959DEB5" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 14</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding share-based compensation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DividendsPolicyPolicyTextBlock', window );">Dividends, Policy [Policy Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Dividends</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We paid cash dividends per common share of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.92</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.91</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.85</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Revenue Recognition</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both </span><span style="font-family:Arial Narrow;font-size:10pt;">manufactured and sourced products, and</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SalesreturnsPolicyTextBlock', window );">Sales Returns and Allowances</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Sales Returns and Allowances</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical data. </span><span style="font-family:Arial Narrow;font-size:10pt;">Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#8220;merchantable product&#8221;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At both </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, the accrual for estimated sales returns and allowances was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$495 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$479 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, the impact of which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.3 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.2 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.4 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Third-Party Returns</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ShippingandHandlingCostsPolicyTextBlock', window );">Shipping and Handling</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Shipping and Handling</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Shipping and handling costs are primarily included in SG&amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$620 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$622 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$543 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Restructuring and Employee Severance</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Restructuring and Employee Severance</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are employee severance costs that are not incurred in connection with a restructuring activity. See </span><a href="#sF72C50E68F165E22A368883CF79808D0" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 3</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding our restructuring activities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock', window );">Amortization and Other Acquisition-Related Costs</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Amortization and Other Acquisition-Related Costs</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See </span><a href="#s0B8CFB5481FD5F8C92CD0E2191E456DF" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 4</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding amortization of acquisition-related intangible assets. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Translation of Foreign Currencies</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Translation of Foreign Currencies</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#8217; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The foreign currency translation gains/(losses) included in AOCI at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> are presented in </span><a href="#s3D77F43D97875956BB9F5A04AD8753DD" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 11</span></a><span style="font-family:Arial Narrow;font-size:10pt;">. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives', window );">Interest Rate, Currency and Commodity Risk</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Interest Rate, Currency and Commodity Risk</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#8217; equity through AOCI, net of tax.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#8217;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments received from the cross currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a href="#s138045C0A5375688972939C6B03E89B1" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 10</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow and economic hedges.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value Measurements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">Level 1 -</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Observable prices in active markets for identical assets and liabilities.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">Level 2 -</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Observable inputs other than quoted prices in active markets for identical assets and liabilities.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:10pt;">Level 3 -</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See </span><a href="#sC842095C866F51CEAB114318376AF314" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 9</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding fair value measurements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Financial Accounting Standards</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Adopted Financial Accounting Standards</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Derivatives and Hedging </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2018, the </span><span style="font-family:Arial Narrow;font-size:10pt;">Financial Accounting Standards Board ("FASB")</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a benchmark interest rate for hedge accounting purposes. This guidance was effective beginning the first quarter of fiscal 2020. The adoption did not have a material impact on our consolidated financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Leases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and elected the transition option which allows us to apply the guidance prospectively. The initial adoption in the first quarter of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> resulted in the recognition of lease liabilities in the amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$422 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. See&#160;</span><a href="#s1a0a81a45f964330b5b7b44b0dd06884" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 5</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for additional information regarding leases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Issued Financial Accounting Standards Not Yet Adopted</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This&#160;guidance will be effective for us in the first quarter of fiscal 2021. The adoption of this guidance will not have a material impact on our consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies', window );">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Guarantees</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">liability being triggered under these indemnification obligations is not probable.</span></div><span style="font-family:Arial Narrow;font-size:10pt;">From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were </span><span style="font-family:Arial Narrow;font-size:10pt;">no</span><span style="font-family:Arial Narrow;font-size:10pt;"> material obligations at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the costs incurred during and relating to an acquisition. These costs specifically include transaction and integration costs; changes in fair value of contingent consideration obligations and amortization of acquisition-related intangible assets, and are recorded within amortization and other acquisition-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AssetsHeldforSalePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets Held for Sale, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AssetsHeldforSalePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CashDiscountsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Discounts [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CashDiscountsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CostofSalesVendorReservesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for allowances received from a vendor. The disclosure differentiates between those allowances that are recorded as a reduction in the price of the vendors' products or services (that is, the entity's inventory) and which ultimately will be recorded as a reduction in the entity's cost of sales and those that are not.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CostofSalesVendorReservesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes an entity's accounting policy for fees received from distribution service agreements and other fees received from vendors related to the purchase or distribution of the vendor's inventory. Such fees are recognized as a reduction of inventory when those fees have been earned and the entity is entitled to payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DividendsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DividendsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Accrued Liabilities, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_SalesreturnsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>sales returns [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_SalesreturnsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ShippingandHandlingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ShippingandHandlingCosts [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ShippingandHandlingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for derivatives used in hedging relationships, which may include how gains or losses are recognized and presented in the financial statements, and amortization policies for deferred amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EEEE<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109999725-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975189800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Costs</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the components of lease cost:       </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>134</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Variable lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>164</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div>Variable lease cost primarily includes payments for property taxes, maintenance and insurance. <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock', window );">Leases Supplemental Balance Sheet Information</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes supplemental balance sheet information related to leases at June&#160;30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>426</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Current portion of operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>104</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Long-term operating lease liabilities</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>341</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>445</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease right-of-use assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>33</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Current portion of finance lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term finance lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>25</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasePaymentsTableTextBlock', window );">Leases Supplemental Cash Flow Information</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarizes supplemental cash flow information related to leases:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash paid for lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating cash flows paid for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>125</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Financing cash flows paid for finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>150</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>40</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amended lease standard adoption impact as of July 1, 2019 </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>400</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><span style="font-family:Arial Narrow;font-size:8pt;">Includes the effect of </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$22 million</span></span> from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Lease Payments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Future lease payments under non-cancellable leases as of </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> were as follows:</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">                          </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:51%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2021</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>117</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>127</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>96</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>105</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>72</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>81</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>55</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2025</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>46</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>123</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>125</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>503</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>539</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: leases not yet commenced </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>54</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>56</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>445</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>479</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">As of </span><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the consolidated balance sheet. </span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasePaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Lease Payments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasePaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasesSupplementalBalanceSheetInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403965785752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule of Revenue and Gross Trade Receivables Percentage by Major Customers</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes historical percent of revenue and gross trade receivables from CVS and OptumRx:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:34%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Percent of Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">CVS</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">OptumRx</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Components of Property and Equipment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents the components of property and equipment, net at June&#160;30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Land, building and improvements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,185</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,992</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Machinery and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,008</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,038</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Furniture and fixtures</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>138</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>138</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total property and equipment, at cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,331</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,168</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(2,965</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2,812</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Property and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,366</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,356</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975245304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Summary of Restructuring and Employee Severance</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize restructuring and employee severance costs:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:57%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>66</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>56</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>142</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>122</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>125</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>176</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods. Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, vendor transition fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Related Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility Exit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">and Other Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>28</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>84</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>92</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(44</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(48</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>72</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>85</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>109</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(81</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(85</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>68</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>96</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403966057560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill by Reportable Segment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:42%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,621</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,695</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,316</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>45</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>52</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,663</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,715</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,378</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(16</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,657</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,700</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,357</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">At </span><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;">, the Pharmaceutical segment accumulated goodwill impairment loss was </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$829 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;">.</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">At </span><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;">, the Medical segment accumulated goodwill impairment loss was </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$1.4 billion</span></span><span style="font-family:Arial Narrow;font-size:8pt;">. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at June&#160;30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:22%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:22%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted- Average Remaining Amortization Period (Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,554</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,828</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,726</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>673</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>341</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>332</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,604</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>767</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>837</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,831</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,936</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,895</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,854</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,936</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,918</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,562</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,517</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,045</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>672</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>295</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>377</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,602</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>616</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>986</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,836</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,408</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at June&#160;30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:22%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:22%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted- Average Remaining Amortization Period (Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,554</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,828</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,726</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>673</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>341</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>332</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,604</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>767</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>837</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,831</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,936</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,895</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,854</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,936</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,918</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,562</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,517</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,045</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>672</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>295</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>377</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,602</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>616</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>986</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,836</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,408</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404075854808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes long-term obligations and other short-term borrowings at June 30:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions) (1)</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.4% Notes due 2019</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>450</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.625%&#160;Notes due 2020</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>508</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.616% Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>834</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,079</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2% Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>236</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>247</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Floating Rate Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>321</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>340</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2% Notes due 2023</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>576</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>551</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.079% Notes due 2024</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>809</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>781</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.5% Notes due 2024</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>413</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>402</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.75% Notes due 2025</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>529</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>494</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.41% Notes due 2027</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,215</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,318</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.6% Notes due 2043</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>340</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>346</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.5% Notes due 2044</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>342</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>342</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.9% Notes due 2045</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>441</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>445</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.368% Notes due 2047</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>560</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>594</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7.0%&#160;Debentures due 2026</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>124</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>124</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other Obligations</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6,775</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,031</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: current portion of long-term obligations and other short-term borrowings</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>452</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;&#160;&#160;Long-term obligations, less current portion</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6,765</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7,579</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)      Maturities are presented on a calendar year basis. </span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975165128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income Before Income Tax, Domestic and Foreign</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes earnings/(loss) before income taxes:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:53%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">U.S. operations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4,056</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,478</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>391</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-U.S. operations</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>284</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>273</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(619</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings/(loss) before income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(3,772</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,751</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(228</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit), Current and Deferred</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the components of provision for/(benefit from) income taxes:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Current:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>659</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>295</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>341</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State and local</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>154</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>89</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-U.S.</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>69</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>85</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>143</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total current</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>882</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>469</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>525</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Deferred:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(822</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(28</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1,003</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State and local</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(127</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(37</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-U.S.</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(18</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total deferred</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(961</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(83</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1,012</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Provision for/(benefit from) income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(79</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>386</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(487</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:54%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020 (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019 (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018 (1)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Provision at Federal statutory rate</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>21.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>21.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>28.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State and local income taxes, net of federal benefit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Tax effect of foreign operations</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(48.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nondeductible/nontaxable items</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(10.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill impairment</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(124.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Tax Act</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>410.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Change in valuation allowances</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(76.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign tax credits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>27.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">China tax related to divestiture</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(25.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Legal entity reorganization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(3.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>71.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Opioid litigation</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(23.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(21.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effective income tax rate</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>213.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents the components of the deferred income tax assets and liabilities at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Deferred income tax assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Receivable basis difference</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>607</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>133</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss and tax credit carryforwards</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>589</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>621</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Deferred tax assets related to uncertain tax positions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>52</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>87</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total deferred income tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,412</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>864</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Valuation allowance for deferred income tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(470</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(542</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net deferred income tax assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>942</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>322</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Deferred income tax liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inventory basis differences</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(1,083</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1,056</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Property-related</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(327</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(171</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill and other intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(751</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(808</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total deferred income tax liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(2,161</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2,035</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net deferred income tax liability</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(1,219</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1,713</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities after Netting by Tax Jurisdiction</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Noncurrent deferred income tax asset (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Noncurrent deferred income tax liability (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(1,258</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1,749</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net deferred income tax liability</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(1,219</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1,713</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in other assets in the consolidated balance sheets.</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text"> sheets. The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:<div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at beginning of fiscal year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>456</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>423</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>417</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions for tax positions of the current year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>500</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions for tax positions of prior years (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>78</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>141</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Reductions for tax positions of prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(27</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(40</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Settlements with tax authorities (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(99</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Expiration of the statute of limitations (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at end of fiscal year</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>998</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>456</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>423</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in fiscal 2018 additions for tax positions of prior years is </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$110 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> related to exposures acquired as part of the Patient Recovery Business for which we are fully indemnified. Also for fiscal 2018 are settlements of </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$81 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> related to the Patient Recovery Business as well as </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$11 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> of statute expirations. </span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971632040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>721</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>721</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>114</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>114</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div>The<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"> The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404060047544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:70%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>27</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cross-currency swap (1) </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>74</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps (3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (4)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps (3)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>16</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in other assets in the consolidated balance sheets.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in prepaid expenses and other in the consolidated balance sheets.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in other accrued liabilities in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(16</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>106</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fixed-rate debt (1)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(106</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:12px;text-indent:-12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1) Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (3)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps (4)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts (3)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in revenue in the consolidated statements of earnings/(loss).</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in cost of products sold in the consolidated statements of earnings/(loss).</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in SG&amp;A expenses in the consolidated statements of earnings/(loss).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Gain/(Loss) Recognized in Earnings for Economic (Non-designated) Derivative Instruments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts (1)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(11</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Included in other income, net in the consolidated statements of earnings/(loss).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Estimated fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7,273</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Carrying amount</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6,775</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,031</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock', window );">Schedule of Fair Value Gain/(Loss) Derivative Instrument</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:</span></div><div style="line-height:100%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:32%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Notional<br/>Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fair&#160;Value<br/>Gain/(Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Notional<br/>Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fair&#160;Value<br/>Gain/(Loss)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>550</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,150</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>40</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>653</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>869</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>200</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(16</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cross-currency swap</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>833</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>47</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>233</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Outstanding Instruments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:14%;"/><td style="width:4%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Maturity Date</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>325</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">July 2020</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:14%;"/><td style="width:4%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Maturity Date</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>488</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jul 2019</span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Outstanding Instruments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:26%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:11%;"/><td style="width:4%;"/><td style="width:12%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Maturity&#160;Date</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>550</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Mar 2023</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:11%;"/><td style="width:4%;"/><td style="width:12%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Maturity&#160;Date</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pay-floating interest rate swaps</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,150</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nov 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">-</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Sep 2025</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Outstanding Instruments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarize the outstanding cash flow hedges at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:14%;"/><td style="width:4%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Maturity&#160;Date</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward interest rate swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>200</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jun 2022</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>328</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jul 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">-</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jun 2021</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jul 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">-</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Jun 2021</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:14%;"/><td style="width:4%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Maturity&#160;Date</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>381</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jul 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">-</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jun 2020</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Commodity contracts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jul 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">-</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Jun 2020</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summarizes the fair value and notional amounts of derivative instruments held as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404097725080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:38%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Currency</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Translation</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Adjustments and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain/(Loss) on</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Derivatives,</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Comprehensive</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Loss</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(113</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(92</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), net before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total other comprehensive loss attributable to Cardinal Health, Inc., net of tax of $1 million</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(95</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(79</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(20</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(25</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(92</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(104</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403965901448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:61%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(3,693</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,365</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>259</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings attributable to noncontrolling interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(3,696</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,363</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>256</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>293</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>300</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>313</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units, and performance share units</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>293</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>301</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>315</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12.61</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4.55</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.82</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12.61</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4.53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.81</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970956984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment [Table Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue for each reportable segment and Corporate:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>137,495</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>129,917</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>121,241</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15,444</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,633</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,581</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,939</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,550</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>136,822</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,922</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,534</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>136,809</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Revenue by Reportable Segment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:66%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>136,693</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>129,067</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>802</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>850</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>137,495</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>129,917</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (3)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13,429</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13,833</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,015</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,800</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15,444</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,633</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,939</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,550</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,922</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,534</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services"</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:66%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>136,693</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>129,067</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>802</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>850</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>137,495</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>129,917</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (3)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13,429</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13,833</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,015</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,800</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15,444</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,633</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,939</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,550</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,922</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,534</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services"</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas [Table Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue by geographic area:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>148,707</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>141,479</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>132,539</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4,232</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4,071</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4,283</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total  segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,939</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,550</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>136,822</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>152,922</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>145,534</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>136,809</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Segment Profit by Reportable Segment</a></td>
<td class="text"><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present segment profit by reportable segment and Corporate:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,753</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,834</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,992</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>663</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>576</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>662</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,416</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,410</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,654</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(6,514</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(350</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2,528</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4,098</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,060</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>126</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock', window );">Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>135</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>147</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>156</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>243</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>288</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>278</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>535</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>565</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>598</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total depreciation and amortization</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>913</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,032</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>58</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>86</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>74</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>127</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>242</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>219</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>199</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total additions to property and equipment</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>375</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>328</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>384</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Assets by Reportable Segment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents total assets for each reportable segment and Corporate at June 30:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22,398</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22,446</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>21,421</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>14,691</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,284</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>16,066</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,677</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,233</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,464</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>40,766</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>40,963</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>39,951</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Property and Equipment, Net by Geographic Area</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables present property and equipment, net by geographic area:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,880</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,846</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,950</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>486</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>510</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>537</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Property and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,366</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,356</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,487</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971066200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Total Share-based Compensation Expense by Type of Award</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides total share-based compensation expense by type of award:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:60%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>70</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>73</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation expense</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>90</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>82</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>85</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Transactions Under the Plans</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all stock option transactions under the Plans:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:57%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Stock</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercise Price per</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Common Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>64.50</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Exercised</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>72.54</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>63.78</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Exercised</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>42.36</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Outstanding at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>65.15</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercisable at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>65.25</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AdditionalStockOptionPlanDataTableTextBlock', window );">Schedule of Additional Data Related to Stock Option Activity</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides additional detail related to stock options:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of outstanding options at period end</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercisable options at period end</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercised options</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net proceeds/(withholding) from share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>26</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Excess tax benefits from share based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total fair value of shares vested during the year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average grant date fair value per stock option</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8.26</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8.34</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>13.50</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_RemainingStockOptionPlanDataTableTextBlock', window );">Schedule of Remaining Stock Option Plan Data</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:66%;"/><td style="width:10%;"/><td style="width:2%;"/><td style="width:10%;"/><td style="width:2%;"/><td style="width:10%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in years)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of outstanding options</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of exercisable options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average period over which stock option compensation cost is expected to be recognized</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Range of Assumptions Used to Estimate Fair Value of Stock Options</a></td>
<td class="text">The following table provides the range of assumptions used to estimate the fair value of stock options:<div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.12345679012346%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:76%;"/><td style="width:10%;"/><td style="width:4%;"/><td style="width:10%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Risk-free interest rate</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2.1%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Expected volatility</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>25%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividend yield</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2.7%</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">-</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2.8%</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Expected life in years</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7</span></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Transactions Related to Restricted Share Units Under the Plans</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:52%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Restricted Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>71.58</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>50.13</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>74.52</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>62.32</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51.65</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>42.71</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>60.21</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>45.92</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock', window );">Additional Restricted Shares and Restricted Share Units Activity</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:5px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table provides additional data related to restricted share unit activity:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>77</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>75</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>78</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total fair value of shares vested during the year</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>57</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of Transactions Related to Performance Share Units Under the Plans</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:51%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Performance</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>66.13</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>50.96</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>52.20</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51.45</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>44.03</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>48.40</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>50.92</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at June 30, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>54.24</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AdditionalPerformanceShareUnitsDataTableTextBlock', window );">Additional Data Related to Performance Share Units Activity</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table provides additional data related to performance share unit activity:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:60%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total fair value of shares vested during the year</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AdditionalPerformanceShareUnitsDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Performance Share Units Data [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AdditionalPerformanceShareUnitsDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Restricted Shares And Restricted Share Units Data [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AdditionalStockOptionPlanDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A disclosure of additional data related to all stock option activity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AdditionalStockOptionPlanDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_RemainingStockOptionPlanDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Remaining Stock Option Plan Data [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_RemainingStockOptionPlanDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403964402808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected Quarterly Financial Data (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of Selected Quarterly Financial Data</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following is selected quarterly financial data for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. The sum of the quarters may not equal year-to-date due to rounding.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">First<br/>Quarter (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Second<br/>Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Third<br/>Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fourth<br/>Quarter (2)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fiscal 2020</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>37,341</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>39,735</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>39,157</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>36,689</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross margin</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,679</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,714</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,885</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,590</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Distribution, selling, general and administrative expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,107</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,163</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,165</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,137</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(4,921</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>220</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>351</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>657</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(4,922</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>220</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>350</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>656</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16.65</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.75</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1.20</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2.25</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(16.65</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.75</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1.19</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2.23</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes a </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> pre-tax charge for the opioid litigation (</span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$5.14 billion</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax). </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes a </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$579 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> pre-tax gain (</span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$493 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax) in connection with the sale of our remaining equity interest in a partnership that owned naviHealth.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">First<br/>Quarter (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Second<br/>Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Third<br/>Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fourth<br/>Quarter</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Fiscal 2019</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35,213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>37,740</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35,228</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>37,353</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross margin</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,667</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,730</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,764</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,674</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Distribution, selling, general and administrative expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,155</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,064</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,097</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,168</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>594</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>281</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>194</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>593</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>280</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>194</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1.95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.99</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.65</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted (3)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1.94</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.93</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.99</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.65</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes a </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$508 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> gain (</span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$378 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> after tax) related to the naviHealth divestiture.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404060074776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReclassificationofdeferredrentinaccordancewithASC842', window );">Reclassification of deferred rent in accordance with ASC 842</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Operating Leases, Future Minimum Payments Due, Next Twelve Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Future minimum rental payments for operating leases - 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">Future minimum rental payments for operating leases - 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">Operating Leases, Future Minimum Payments, Due in Four Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">Operating Leases, Future Minimum Payments, Due in Five Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Operating Leases, Future Minimum Payments, Due Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">22 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ReclassificationofdeferredrentinaccordancewithASC842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of deferred rent in accordance with ASC 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ReclassificationofdeferredrentinaccordancewithASC842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403963127368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 729<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Finance notes and related accrued interest, net, total</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Finance notes and related accrued interest, net, current</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReceivableFinancingAgreementTerm', window );">Receivable financing agreement term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReceivableFinancingAgreementTerm', window );">Receivable financing agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember', window );">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ReceivableFinancingAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivable Financing Agreement Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ReceivableFinancingAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975198184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Schedule of Lease Costs (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 164<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404069371704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details) - Pharmaceutical<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">CVS Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percent of Revenue</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GrossTradeReceivablesMajorCustomerPercentage', window );">Percent of Gross Trade Receivables</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">OptumRx [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percent of Revenue</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GrossTradeReceivablesMajorCustomerPercentage', window );">Percent of Gross Trade Receivables</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GrossTradeReceivablesMajorCustomerPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross Trade Receivables, Major Customer Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GrossTradeReceivablesMajorCustomerPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cah_CVSCaremarkCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cah_CVSCaremarkCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cah_OptumRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cah_OptumRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970569096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Supplemental Balance Sheet Information (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">445<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</a></td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970576216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details) - organization<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ConcentrationRiskLargestGroupPurchasingOrganizations', window );">Largest group purchasing organizations</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cah_GroupPurchasingOrganizationsMember', window );">Group Purchasing Organizations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue, major customer, percentage</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ConcentrationRiskLargestGroupPurchasingOrganizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Largest Group Purchasing Organizations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ConcentrationRiskLargestGroupPurchasingOrganizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cah_GroupPurchasingOrganizationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cah_GroupPurchasingOrganizationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970985464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance Lease, Principal Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member', window );">ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Impactofadoptionofnewaccountingstandard', window );">New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31)</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Impactofadoptionofnewaccountingstandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>impact of adoption of new accounting standard</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Impactofadoptionofnewaccountingstandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975237000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PercentageOfLIFOInventory', window );">Portion of inventories held at LIFO, percentage</a></td>
<td class="nump">56.00%<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">Inventories valued at LIFO amount higher than average cost value</a></td>
<td class="nump">$ 411<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Reserves for excess and obsolete inventory</a></td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 171<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfLIFOInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfLIFOInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971862296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Schedule of Future Lease Payments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">$ 127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityNotYetCommencedAmount', window );">Less: leases not yet commenced (1)</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiability', window );">Total Lease Liability</a></td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_OperatingLeaseMember', window );">Operating Leases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount', window );">Less: leases not yet commenced (1)</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OperatingLeaseImputedInterest', window );">Less: imputed interest</a></td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">445<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_FinanceLeaseMember', window );">Finance Leases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount', window );">Less: leases not yet commenced (1)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FinanceLeaseImputedInterest', window );">Less: imputed interest</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FinanceLeaseImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Imputed Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FinanceLeaseImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Finance Lease Liability Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Remainder Of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Liability Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OperatingLeaseImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Imputed Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OperatingLeaseImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total undiscounted Lease Liability Payments Due for both operating and financing leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_OperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_OperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970833112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 405<span></span>
</td>
<td class="nump">$ 455<span></span>
</td>
<td class="nump">$ 446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Interest rate on long-term projects (approximates weighted-average on long-term obligations)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972149272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term Debt, Weighted Average Interest Rate, at Point in Time</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">$ 5,331<span></span>
</td>
<td class="nump">$ 5,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(2,965)<span></span>
</td>
<td class="num">(2,812)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,366<span></span>
</td>
<td class="nump">2,356<span></span>
</td>
<td class="nump">$ 2,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember', window );">Land, building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">2,185<span></span>
</td>
<td class="nump">1,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">3,008<span></span>
</td>
<td class="nump">3,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">$ 138<span></span>
</td>
<td class="nump">$ 138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building and Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building and Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970271240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 729<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DiscountRatefairvalueinputs', window );">Discount Rate, fair value inputs</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DiscountRatefairvalueinputs', window );">Discount Rate, fair value inputs</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DiscountRatefairvalueinputs', window );">Discount Rate, fair value inputs</a></td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember', window );">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DiscountRatefairvalueinputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, fair value inputs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DiscountRatefairvalueinputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GoodwillAndIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill and Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GoodwillAndIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403966035224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_VendorReserves', window );">Vendor reserves</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_VendorReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of reserves, relating to vendor disputes or deductions, that are netted against vendor liabilities in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_VendorReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975261800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividends per common share (in usd per share)</a></td>
<td class="nump">$ 1.92<span></span>
</td>
<td class="nump">$ 1.91<span></span>
</td>
<td class="nump">$ 1.85<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975245304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_RevenueRecognitionReserveforSalesReturnsandAllowances', window );">Accrual for estimated sales returns and allowances</a></td>
<td class="nump">$ 495<span></span>
</td>
<td class="nump">$ 479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns', window );">Revenue Recognition, Sales Returns, Reserve for Sales Returns</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_RevenueRecognitionReserveforSalesReturnsandAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Recognition, Reserve for Sales Returns and Allowances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_RevenueRecognitionReserveforSalesReturnsandAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of estimated sales returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970682248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodsandservicessoldLineItems', window );"><strong>goods and services sold [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="nump">$ 146,054<span></span>
</td>
<td class="nump">$ 138,700<span></span>
</td>
<td class="nump">$ 129,628<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodsandservicessoldLineItems', window );"><strong>goods and services sold [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="nump">$ 620<span></span>
</td>
<td class="nump">$ 622<span></span>
</td>
<td class="nump">$ 543<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GoodsandservicessoldLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for goods and services sold [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GoodsandservicessoldLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975179016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842', window );">Lease Liabilities established as a Result of the adoption of ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities established as a Result of the adoption of ASC 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975140072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="num">$ (5,630)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember', window );">Total Opioid Litigation, net of tax [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="num">$ (5,140)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972501000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures and Acquisitions (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 29, 2017</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Aug. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 6,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (Loss) from Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_PatientRecoveryBusinessMember', window );">Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">$ 6,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_BusinessCombinationTransactionandintegrationcosts', window );">Transaction and integration costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember', window );">China Pharmaceutical and Medical Products Distribution Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from Divestiture of Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember', window );">naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from Divestiture of Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PartnershipOwnership', window );">Partnership Indirect Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Provisionaltaxbenefitrelatedtotransaction', window );">Provisional tax benefit related to transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=cah_NaviOwnershipInterestDivestedMember', window );">Navi Ownership Interest Divested [Member] | naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling Interest, Ownership Percentage by Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_BusinessCombinationTransactionandintegrationcosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred during the initial evaluation of a potential acquisition that primarily relate to costs to analyze, negotiate, and consummate the transaction, as well as due diligence activities. Also includes costs related to activities required to combine the operations of an acquired enterprise into our operations and to stand-up the systems and processes needed to support a global footprint.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_BusinessCombinationTransactionandintegrationcosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PartnershipOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Partnership Indirect Ownership</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PartnershipOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PreTaxGainonDivestiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Tax Gain on Divestiture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PreTaxGainonDivestiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Provisionaltaxbenefitrelatedtotransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provisional tax benefit related to transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Provisionaltaxbenefitrelatedtotransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_PatientRecoveryBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_PatientRecoveryBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=cah_NaviOwnershipInterestDivestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=cah_NaviOwnershipInterestDivestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403969553464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee-related costs</a></td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total restructuring and employee severance</a></td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 176<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FacilityExitAndOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FacilityExitAndOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970703048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">$ 72<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(85)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee- Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility Exit and Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970727816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring Costs</a></td>
<td class="nump">$ 109<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="nump">$ 56<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ContractTerminationAxis=cah_DistributorContractMember', window );">Distributor Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FacilityExitAndOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FacilityExitAndOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ContractTerminationAxis=cah_DistributorContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ContractTerminationAxis=cah_DistributorContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403976556200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">8,378<span></span>
</td>
<td class="nump">8,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">8,357<span></span>
</td>
<td class="nump">8,378<span></span>
</td>
<td class="nump">8,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,663<span></span>
</td>
<td class="nump">2,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,657<span></span>
</td>
<td class="nump">2,663<span></span>
</td>
<td class="nump">2,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment loss</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">5,715<span></span>
</td>
<td class="nump">5,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">5,700<span></span>
</td>
<td class="nump">5,715<span></span>
</td>
<td class="nump">$ 5,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment loss</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">$ 1,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972310808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">512<span></span>
</td>
<td class="nump">531<span></span>
</td>
<td class="nump">$ 574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">5,831<span></span>
</td>
<td class="nump">5,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,936<span></span>
</td>
<td class="nump">2,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 2,895<span></span>
</td>
<td class="nump">3,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Intangible, Total other intangible assets</a></td>
<td class="nump">$ 5,854<span></span>
</td>
<td class="nump">5,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Intangible, Total other intangible assets</a></td>
<td class="nump">2,918<span></span>
</td>
<td class="nump">3,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember', window );">IPR&amp;D, trademarks and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">3,554<span></span>
</td>
<td class="nump">3,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,828<span></span>
</td>
<td class="nump">1,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 1,726<span></span>
</td>
<td class="nump">2,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember', window );">Trademarks, trade names and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">$ 673<span></span>
</td>
<td class="nump">672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 332<span></span>
</td>
<td class="nump">377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">$ 1,604<span></span>
</td>
<td class="nump">1,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">767<span></span>
</td>
<td class="nump">616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 837<span></span>
</td>
<td class="nump">$ 986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970272488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DiscountRatefairvalueinputs', window );">Discount Rate, fair value inputs</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 8,357<span></span>
</td>
<td class="nump">$ 8,378<span></span>
</td>
<td class="nump">8,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">512<span></span>
</td>
<td class="nump">$ 531<span></span>
</td>
<td class="nump">$ 574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Estimated annual amortization of intangible assets - 2020</a></td>
<td class="nump">442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization of intangible assets - 2021</a></td>
<td class="nump">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization of intangible assets - 2022</a></td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization of intangible assets - 2023</a></td>
<td class="nump">329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated annual amortization of intangible assets - 2024</a></td>
<td class="nump">$ 277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DiscountRatefairvalueinputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, fair value inputs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DiscountRatefairvalueinputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971890536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Aug. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (Loss) from Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember', window );">naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from Divestiture of Businesses</a></td>
<td class="nump">$ 737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PartnershipOwnership', window );">Partnership Indirect Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=cah_NaviOwnershipInterestDivestedMember', window );">Navi Ownership Interest Divested [Member] | naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling Interest, Ownership Percentage by Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PartnershipOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Partnership Indirect Ownership</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PartnershipOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PreTaxGainonDivestiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Tax Gain on Divestiture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PreTaxGainonDivestiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=cah_NaviOwnershipInterestDivestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=cah_NaviOwnershipInterestDivestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970556952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 21,374<span></span>
</td>
<td class="nump">$ 21,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Other obligations</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total</a></td>
<td class="nump">6,775<span></span>
</td>
<td class="nump">8,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: current portion of long-term obligations and other short-term borrowings</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term obligations, less current portion</a></td>
<td class="nump">6,765<span></span>
</td>
<td class="nump">7,579<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.4Notesdue2020Member', window );">2.4% Notes due 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member', window );">4.625% Notes due 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member', window );">2.616% Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">834<span></span>
</td>
<td class="nump">1,079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member', window );">3.2% Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member', window );">Floating Rate Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member', window );">3.2% Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">576<span></span>
</td>
<td class="nump">551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.079Notesdue2024Member', window );">3.079% Notes due fiscal 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">809<span></span>
</td>
<td class="nump">781<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.5Notesdue2025Member', window );">3.5% Notes due fiscal 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.75Notesdue2026Member', window );">3.75% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">529<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member', window );">3.41% Notes due fiscal 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">1,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member', window );">4.6% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.5Notesdue2044Member', window );">4.5% Notes due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member', window );">4.9% Notes due 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">441<span></span>
</td>
<td class="nump">445<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member', window );">4.368% Notes due fiscal 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">560<span></span>
</td>
<td class="nump">594<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member', window );">7.0% Debentures due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.4Notesdue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.4Notesdue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.079Notesdue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.079Notesdue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.5Notesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.5Notesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.75Notesdue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.75Notesdue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.5Notesdue2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.5Notesdue2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972548104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,374<span></span>
</td>
<td class="nump">$ 21,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Other Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Maturities of existing long-term obligations and other short-term borrowings - 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Maturities of existing long-term obligations and other short-term borrowings-2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Maturities of existing long-term obligations and other short-term borrowings-2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Maturities of existing long-term obligations and other short-term borrowings-2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">Maturities of existing long-term obligations and other short-term borrowings-2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Maturities of existing long-term obligations and other short-term borrowings-Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember', window );">Committed Receivables Sales Facility Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod', window );">Line of Credit Facility, Maximum Amount Outstanding During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAverageOutstandingAmount', window );">Line of Credit Facility, Average Outstanding Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod', window );">Line of Credit Facility, Maximum Amount Outstanding During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAverageOutstandingAmount', window );">Line of Credit Facility, Average Outstanding Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember', window );">Short Term Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member', window );">2.616% Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member', window );">3.2% Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member', window );">Floating Rate Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member', window );">3.41% Notes due fiscal 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member', window );">4.6% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member', window );">4.9% Notes due 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member', window );">4.368% Notes due fiscal 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_OnePointNineFiveNotesdue2018Member', window );">1.95% Notes due 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable', window );">Proceeds from (Repayments of) Notes Payable</a></td>
<td class="num">$ (550)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember', window );">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NotesPayableRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal Amount of Notes Payable Repurchased during the year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NotesPayableRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAverageOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average amount borrowed under the credit facility during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAverageOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum amount borrowed under the credit facility at any time during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_OnePointNineFiveNotesdue2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_OnePointNineFiveNotesdue2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972210712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,374<span></span>
</td>
<td class="nump">$ 21,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OfferAsPercentageOfPrincipalAmount', window );">Offer as percentage of principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A1.948Notesdue2019Member', window );">1.948% Notes due 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member', window );">2.616% Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member', window );">3.41% Notes due fiscal 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member', window );">4.368% Notes due fiscal 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember', window );">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member', window );">Floating Rate Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_OnePointNineFiveNotesdue2018Member', window );">1.95% Notes due 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable', window );">Proceeds from (Repayments of) Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.4Notesdue2020Member', window );">2.4% Notes due 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of Notes Payable</a></td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member', window );">3.2% Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member', window );">3.2% Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member', window );">4.6% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member', window );">4.625% Notes due 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member', window );">4.9% Notes due 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member', window );">7.0% Debentures due 2026 | Allegiance Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NotesPayableRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal Amount of Notes Payable Repurchased during the year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NotesPayableRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OfferAsPercentageOfPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount that the company is required to offer to purchase certain notes, under certain circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OfferAsPercentageOfPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A1.948Notesdue2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A1.948Notesdue2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_OnePointNineFiveNotesdue2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_OnePointNineFiveNotesdue2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.4Notesdue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.4Notesdue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cah_AllegianceCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cah_AllegianceCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403974587736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Other obligations</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Committed Receivables Sales Facility Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember', window );">Short Term Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember', window );">Short Term Credit Facilities | Committed Receivables Sales Facility Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAverageOutstandingAmount', window );">Average amount outstanding</a></td>
<td class="nump">$ 183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAverageOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average amount borrowed under the credit facility during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAverageOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403964694040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S. operations</a></td>
<td class="num">$ (4,056)<span></span>
</td>
<td class="nump">$ 1,478<span></span>
</td>
<td class="nump">$ 391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Non-U.S. operations</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="num">(619)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings/(loss) before income taxes</a></td>
<td class="num">$ (3,772)<span></span>
</td>
<td class="nump">$ 1,751<span></span>
</td>
<td class="num">$ (228)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972739864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 659<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">$ 341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Non-U.S.</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">882<span></span>
</td>
<td class="nump">469<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(822)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(1,003)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="num">(127)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Non-U.S.</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(961)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="num">(1,012)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for/(benefit from) income taxes</a></td>
<td class="num">$ (79)<span></span>
</td>
<td class="nump">$ 386<span></span>
</td>
<td class="num">$ (487)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403969737560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Provision at Federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">28.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes, net of federal benefit</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="num">(16.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Tax effect of foreign operations</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="num">(48.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Nondeductible/nontaxable items</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="num">(10.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses', window );">Goodwill impairment</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(124.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018', window );">Tax Act</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="num">(410.90%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowances</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="num">(76.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign', window );">Foreign tax credits</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="nump">27.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture', window );">China tax related to divestiture</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(25.80%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent', window );">Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(3.60%)<span></span>
</td>
<td class="nump">71.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveIncomeTaxReconciliationOpioidLitigation', window );">Effective Income Tax Reconciliation, Opioid Litigation</a></td>
<td class="num">(23.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="num">(21.90%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">22.10%<span></span>
</td>
<td class="nump">213.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveIncomeTaxRateReconciliationTaxAct2018">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Act 2018</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveIncomeTaxRateReconciliationTaxAct2018</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveIncomeTaxReconciliationOpioidLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Opioid Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveIncomeTaxReconciliationOpioidLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Tax Rate Reconciliation, Foreign Tax Related to Divestiture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972780408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">22.10%<span></span>
</td>
<td class="nump">213.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (79)<span></span>
</td>
<td class="nump">$ 386<span></span>
</td>
<td class="num">$ (487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions', window );">Effective Tax Rate Impact From Certain Foreign Jurisdictions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Provision at Federal statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">28.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 822<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 1,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Deferred tax assets on tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(589)<span></span>
</td>
<td class="num">(621)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Valuation allowance on operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">$ 262<span></span>
</td>
<td class="nump">753<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">998<span></span>
</td>
<td class="nump">456<span></span>
</td>
<td class="nump">423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits, interest and penalties accrued</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized tax benefits, interest and penalties</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense', window );">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated range of decrease in unrecognized tax benefits within the next 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated range of decrease in unrecognized tax benefits within the next 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember', window );">Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember', window );">Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IndemnificationReceivable', window );">Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TaxMatterAxis=cah_CareFusionMember', window );">CareFusion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IndemnificationReceivable', window );">Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Tax Rate Impact From Certain Foreign Jurisdictions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_IndemnificationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_IndemnificationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TaxMatterAxis=cah_CareFusionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TaxMatterAxis=cah_CareFusionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972344552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Receivable basis difference</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">607<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Loss and tax credit carryforwards</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">621<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions', window );">Deferred tax assets related to uncertain tax positions</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred income tax assets</a></td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred income tax assets</a></td>
<td class="num">(470)<span></span>
</td>
<td class="num">(542)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred income tax assets</a></td>
<td class="nump">942<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts', window );">Inventory basis differences</a></td>
<td class="num">(1,083)<span></span>
</td>
<td class="num">(1,056)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property-related</a></td>
<td class="num">(327)<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Goodwill and other intangibles</a></td>
<td class="num">(751)<span></span>
</td>
<td class="num">(808)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(2,161)<span></span>
</td>
<td class="num">(2,035)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liability</a></td>
<td class="num">$ (1,219)<span></span>
</td>
<td class="num">$ (1,713)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets related to uncertain tax positions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DeferredTaxAssetsRelatedtouncertaintaxpositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975065224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent', window );">Deferred Income Taxes and Other Assets, Noncurrent</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent', window );">Deferred Income Taxes and Other Tax Liabilities, Noncurrent</a></td>
<td class="nump">1,258<span></span>
</td>
<td class="nump">1,749<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liability</a></td>
<td class="num">$ (1,219)<span></span>
</td>
<td class="num">$ (1,713)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972516968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current Federal Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 659<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">$ 341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current State and Local Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current Foreign Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">882<span></span>
</td>
<td class="nump">469<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred Federal Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(822)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(1,003)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred State and Local Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred Foreign Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(961)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="num">(1,012)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">386<span></span>
</td>
<td class="num">(487)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of fiscal year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">456<span></span>
</td>
<td class="nump">423<span></span>
</td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions for tax positions of the current year</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions of prior years (1)</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions for tax positions of prior years</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements with tax authorities (1)</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(99)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Expiration of the statute of limitations (1)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of fiscal year</a></td>
<td class="nump">$ 423<span></span>
</td>
<td class="nump">$ 998<span></span>
</td>
<td class="nump">$ 456<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember', window );">Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions of prior years (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements with tax authorities (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Expiration of the statute of limitations (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970397176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingent Liabilities and Litigation (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 28, 2020 </div>
<div>plaintiff </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 11, 2020 </div>
<div>StateAG </div>
<div>lawsuit</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IncomefromSettlementsofClassActionLawsuits', window );">Income from Settlements of Class Action Lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.0<span></span>
</td>
<td class="nump">$ 94.0<span></span>
</td>
<td class="nump">$ 22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,054.0<span></span>
</td>
<td class="nump">138,700.0<span></span>
</td>
<td class="nump">129,628.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,137.0<span></span>
</td>
<td class="nump">$ 1,165.0<span></span>
</td>
<td class="nump">$ 1,163.0<span></span>
</td>
<td class="nump">$ 1,107.0<span></span>
</td>
<td class="nump">$ 1,168.0<span></span>
</td>
<td class="nump">$ 1,097.0<span></span>
</td>
<td class="nump">$ 1,064.0<span></span>
</td>
<td class="nump">$ 1,155.0<span></span>
</td>
<td class="nump">4,572.0<span></span>
</td>
<td class="nump">4,480.0<span></span>
</td>
<td class="nump">4,596.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidTotalSettlementCuyahogaandSummitCounties', window );">Opioid Total Settlement, Cuyahoga and Summit Counties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,741.0)<span></span>
</td>
<td class="num">$ (36.0)<span></span>
</td>
<td class="num">$ (159.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsMember', window );">Opioid Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NumberofStateAttorneysGeneralfilinglawsuits', window );">Number of State Attorneys General filing lawsuits | StateAG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsStateDomain', window );">Opioid Lawsuits State [Domain] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember', window );">Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of lawsuits filed | lawsuit</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLitigationlessCuyahogaandSummitCountiesMember', window );">Opioid Litigation, less Cuyahoga and Summit Counties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,560.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CashComponentForSettlementFrameworkTerm', window );">Cash Component For Settlement Framework, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLitigationCuyahogaandSummitCountiesMember', window );">Opioid Litigation, Cuyahoga and Summit Counties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (66.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cah_CVSHealthMember', window );">CVS Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_MaximumQuarterlyPayment', window );">Maximum quarterly payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cah_AlamedaCountyMember', window );">Alameda County [Member] | Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">4,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember', window );">Other Jurisdictions [Member] | Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember', window );">Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of lawsuits filed | lawsuit</a></td>
<td class="nump">334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">468.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">468.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss Contingency, Estimate of Possible Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 919.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">919.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain', window );">Sterile Surgical Gown Recall [Member] [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRecallExpense', window );">Inventory Recall Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember', window );">Total Opioid Litigation, net of tax [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,140.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,630.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,630.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PlaintiffTypeAxis=cah_PrivatePartiesMember', window );">Private Parties [Member] | Opioid Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember', window );">Class Action Lawsuits [Member] | Private Parties [Member] | Opioid Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CashComponentForSettlementFrameworkTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Component For Settlement Framework, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CashComponentForSettlementFrameworkTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_IncomefromSettlementsofClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income from Settlements of Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_IncomefromSettlementsofClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LossContingencyLawsuitsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Lawsuits, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LossContingencyLawsuitsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_MaximumQuarterlyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_MaximumQuarterlyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NumberofStateAttorneysGeneralfilinglawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of State Attorneys General filing lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NumberofStateAttorneysGeneralfilinglawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidTotalSettlementCuyahogaandSummitCounties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Opioid Total Settlement, Cuyahoga and Summit Counties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidTotalSettlementCuyahogaandSummitCounties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRecallExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRecallExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsStateDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLawsuitsStateDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLitigationlessCuyahogaandSummitCountiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLitigationCuyahogaandSummitCountiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLitigationCuyahogaandSummitCountiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cah_CVSHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cah_CVSHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cah_AlamedaCountyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cah_AlamedaCountyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PlaintiffTypeAxis=cah_PrivatePartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PlaintiffTypeAxis=cah_PrivatePartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972123672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 721<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">721<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=117331979&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975102280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=117331979&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972975176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liabilities</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Foreign Currency Contracts | Prepaid Expenses and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Foreign Currency Contracts | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liabilities</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swaps | Deferred Income Taxes and Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liabilities</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Commodity Contracts | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Interest Rate Swaps | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Interest Rate Swaps | Deferred Income Taxes and Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Cross Currency Interest Rate Contract [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cah_DeferredIncomeTaxesandOtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cah_DeferredIncomeTaxesandOtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971688744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Narrative) (Details)<br> &#8364; in Millions, &#165; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 64,000<span></span>
</td>
<td class="nump">$ 233<span></span>
</td>
<td class="nump">&#8364; 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest Income (Expense), Nonoperating, Net</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">550<span></span>
</td>
<td class="nump">2,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount', window );">Derivatives, terminated notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount', window );">Derivatives, matured notional amounts</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403966150584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details) - Fair Value Hedging - Interest Rate Swaps - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 550<span></span>
</td>
<td class="nump">$ 2,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge', window );">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount', window );">Derivatives, matured notional amounts</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the unamortized adjustment to the carrying value of an interest-bearing hedged item made under an effective interest rate fair value hedge that is amortized upon discontinuation of the interest rate fair value hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 35<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121561968&amp;loc=d3e75592-113984<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970717848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details) - Fair Value Hedging - Interest Expense, Net - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain/(loss) on derivative</a></td>
<td class="nump">$ 106<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fixed-Rate Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain/(loss) on derivative</a></td>
<td class="num">$ (106)<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=cah_FixedRateDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=cah_FixedRateDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971237688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">550<span></span>
</td>
<td class="nump">$ 2,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Commodity Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount', window );">Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403964332760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details) - Cash Flow Hedging - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Gain/(loss) included in AOCI for derivative instruments designated as cash flow hedges</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Commodity Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Gain/(loss) included in AOCI for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Gain/(loss) included in AOCI for derivative instruments designated as cash flow hedges</a></td>
<td class="num">$ (8)<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970247544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details) - Cash Flow Hedging - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Currency Contracts | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Currency Contracts | Cost of Products Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Currency Contracts | SG&amp;A Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Forward Contracts [Member] | Interest Expense, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Commodity Contracts | SG&amp;A Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971383048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contracts | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 325<span></span>
</td>
<td class="nump">$ 488<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403964569000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign Currency Contracts | Other Income, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gain/(loss) recognized in earnings for economic (non-designated) derivative instruments</a></td>
<td class="num">$ (11)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971637960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CarryingAmountofLongTermandotherShortTermBorrowings', window );">Carrying Amount of Long-Term and other Short-Term Borrowings</a></td>
<td class="nump">$ 6,775<span></span>
</td>
<td class="nump">$ 8,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Carrying amount</a></td>
<td class="nump">6,775<span></span>
</td>
<td class="nump">8,031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="nump">$ 7,273<span></span>
</td>
<td class="nump">8,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swaps | Designated as Hedging Instrument | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount', window );">Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CarryingAmountofLongTermandotherShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying Amount of Long-Term and other Short-Term Borrowings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CarryingAmountofLongTermandotherShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403963065960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 550<span></span>
</td>
<td class="nump">$ 2,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Gain/(Loss)</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">653<span></span>
</td>
<td class="nump">869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Gain/(Loss)</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Gain/(Loss)</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Currency Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">833<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Gain/(Loss)</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Commodity Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Gain/(Loss)</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404059764872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Narrative) (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 21, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755,000,000<span></span>
</td>
<td class="nump">755,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury shares acquired | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings decrease | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,170)<span></span>
</td>
<td class="num">(5,434)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,170)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury shares acquired | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,300,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="nump">8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury shares acquired, average price per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48.00<span></span>
</td>
<td class="nump">$ 52.32<span></span>
</td>
<td class="nump">$ 65.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TreasuryStockAcquiredShares', window );">Treasury Stock Acquired Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CommonStockVotingRightsVotes', window );">Common Stock, Voting Rights, Votes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CommonStockVotingRightsVotes', window );">Common Stock, Voting Rights, Votes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cah_AcceleratedsharerepurchaseplanMember', window );">Accelerated share repurchase plan | Treasury Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock | $</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury shares acquired, average price per share (in usd per share) | $ / shares</a></td>
<td class="nump">$ 69.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CommonStockVotingRightsVotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Votes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CommonStockVotingRightsVotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TreasuryStockAcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Acquired Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TreasuryStockAcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cah_AcceleratedsharerepurchaseplanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cah_AcceleratedsharerepurchaseplanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971379512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Other Comprehensive Income (Loss), Tax</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">6,330<span></span>
</td>
<td class="nump">6,059<span></span>
</td>
<td class="nump">$ 6,828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(25)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">1,792<span></span>
</td>
<td class="nump">6,330<span></span>
</td>
<td class="nump">6,059<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(95)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income/(loss), net before reclassifications</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(92)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gain/(Loss) on Derivatives, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income/(loss), net before reclassifications</a></td>
<td class="num">(23)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(104)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income/(loss), net before reclassifications</a></td>
<td class="num">(20)<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(25)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">$ (104)<span></span>
</td>
<td class="num">$ (79)<span></span>
</td>
<td class="num">$ (92)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972114840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">$ 657<span></span>
</td>
<td class="nump">$ 351<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
<td class="num">$ (4,921)<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
<td class="nump">$ 296<span></span>
</td>
<td class="nump">$ 281<span></span>
</td>
<td class="nump">$ 594<span></span>
</td>
<td class="num">$ (3,693)<span></span>
</td>
<td class="nump">$ 1,365<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings attributable to noncontrolling interest</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">$ 656<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
<td class="num">$ (4,922)<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
<td class="nump">$ 296<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
<td class="nump">$ 593<span></span>
</td>
<td class="num">$ (3,696)<span></span>
</td>
<td class="nump">$ 1,363<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares&#8211;basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Employee stock options, restricted share units, and performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares&#8211;diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">301<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings per common share attributable to Cardinal Health, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings Per Share, Basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12.61)<span></span>
</td>
<td class="nump">$ 4.55<span></span>
</td>
<td class="nump">$ 0.82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12.61)<span></span>
</td>
<td class="nump">$ 4.53<span></span>
</td>
<td class="nump">$ 0.81<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975111976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss', window );">shares that would be antidilutive as a result of net loss</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>shares that would be antidilutive as a result of net loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Sharesthatwouldbeantidilutiveasaresultofnetloss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972759976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,741)<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="num">$ (159)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ProjectCostsOnInvestmentAndOtherSpending', window );">Project costs on investment and other spending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember', window );">naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GainonDivestitureAfterTax', window );">Gain on Divestiture After Tax</a></td>
<td class="nump">$ 493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GownRecallAxis=cah_SterileSurgicalGownRecallMember', window );">Sterile Surgical Gown Recall [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRecallExpense', window );">Inventory Recall Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,630)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GainonDivestitureAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on Divestiture After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GainonDivestitureAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PreTaxGainonDivestiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Tax Gain on Divestiture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PreTaxGainonDivestiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ProjectCostsOnInvestmentAndOtherSpending">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ProjectCostsOnInvestmentAndOtherSpending</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRecallExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRecallExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GownRecallAxis=cah_SterileSurgicalGownRecallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GownRecallAxis=cah_SterileSurgicalGownRecallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403968684856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Revenue by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 36,689<span></span>
</td>
<td class="nump">$ 39,157<span></span>
</td>
<td class="nump">$ 39,735<span></span>
</td>
<td class="nump">$ 37,341<span></span>
</td>
<td class="nump">$ 37,353<span></span>
</td>
<td class="nump">$ 35,228<span></span>
</td>
<td class="nump">$ 37,740<span></span>
</td>
<td class="nump">$ 35,213<span></span>
</td>
<td class="nump">$ 152,922<span></span>
</td>
<td class="nump">$ 145,534<span></span>
</td>
<td class="nump">$ 136,809<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,232<span></span>
</td>
<td class="nump">4,071<span></span>
</td>
<td class="nump">4,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148,707<span></span>
</td>
<td class="nump">141,479<span></span>
</td>
<td class="nump">132,539<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152,939<span></span>
</td>
<td class="nump">145,550<span></span>
</td>
<td class="nump">136,822<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,495<span></span>
</td>
<td class="nump">129,917<span></span>
</td>
<td class="nump">121,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical | Pharmaceutical Distribution and Specialty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,693<span></span>
</td>
<td class="nump">129,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical | Nuclear Precision Health Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">802<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,444<span></span>
</td>
<td class="nump">15,633<span></span>
</td>
<td class="nump">15,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical | Medical distribution and products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,429<span></span>
</td>
<td class="nump">13,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical | Cardinal Health At Home Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,015<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972826552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Segment Profit by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="num">$ (4,098)<span></span>
</td>
<td class="nump">$ 2,060<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">2,416<span></span>
</td>
<td class="nump">2,410<span></span>
</td>
<td class="nump">2,654<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">1,753<span></span>
</td>
<td class="nump">1,834<span></span>
</td>
<td class="nump">1,992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">663<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="num">$ (6,514)<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
<td class="num">$ (2,528)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404186745560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">$ 913<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total additions to property and equipment</a></td>
<td class="nump">375<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="nump">384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total additions to property and equipment</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="nump">278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total additions to property and equipment</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">535<span></span>
</td>
<td class="nump">565<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total additions to property and equipment</a></td>
<td class="nump">$ 242<span></span>
</td>
<td class="nump">$ 219<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404065084520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information (Assets by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 40,766<span></span>
</td>
<td class="nump">$ 40,963<span></span>
</td>
<td class="nump">$ 39,951<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">22,398<span></span>
</td>
<td class="nump">22,446<span></span>
</td>
<td class="nump">21,421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">14,691<span></span>
</td>
<td class="nump">15,284<span></span>
</td>
<td class="nump">16,066<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 3,677<span></span>
</td>
<td class="nump">$ 3,233<span></span>
</td>
<td class="nump">$ 2,464<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970971224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information  Property and Equipment, net by Geographic Area) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="nump">$ 2,356<span></span>
</td>
<td class="nump">$ 2,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,880<span></span>
</td>
<td class="nump">1,846<span></span>
</td>
<td class="nump">1,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 486<span></span>
</td>
<td class="nump">$ 510<span></span>
</td>
<td class="nump">$ 537<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972527560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Narrative) (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit related to share-based compensation</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total expense on employee retirement savings plans</a></td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ExercisablePeriodOfPlansInYears', window );">Exercisable period of plans (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ExercisablePeriodOfPlansInYears', window );">Exercisable period of plans (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_VestingPeriodinyearsforShares', window );">Vesting Period in years for Shares</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="nump">240.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cah_A2011LtipMember', window );">2011 LTIP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cah_A2011LtipMember', window );">2011 LTIP | Awards Other than Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cah_A2011LtipMember', window );">2011 LTIP | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ExercisablePeriodOfPlansInYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The instrument's contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ExercisablePeriodOfPlansInYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_VestingPeriodinyearsforShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vesting Period in years for Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_VestingPeriodinyearsforShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cah_A2011LtipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cah_A2011LtipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cah_AwardsOtherThanStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cah_AwardsOtherThanStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404091791480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971545768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Canceled and forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period (in shares)</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (in usd per share)</a></td>
<td class="nump">$ 63.78<span></span>
</td>
<td class="nump">$ 64.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share)</a></td>
<td class="nump">42.36<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled and forfeited (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">72.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in usd per share)</a></td>
<td class="nump">65.15<span></span>
</td>
<td class="nump">$ 63.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period (in usd per share)</a></td>
<td class="nump">$ 65.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403971780600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation', window );">Net proceeds/(withholding) from share-based compensation</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of outstanding options at period end</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of exercisable options at period end</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of exercised options</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation', window );">Net proceeds/(withholding) from share-based compensation</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities', window );">Excess tax benefits from share based compensation</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of shares vested during the year</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per stock option (in usd per share)</a></td>
<td class="nump">$ 8.26<span></span>
</td>
<td class="nump">$ 8.34<span></span>
</td>
<td class="nump">$ 13.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Netproceedstaxwithholdingsfromsharebasedcompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11374-113907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403975217928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details) - Stock Options<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual life of outstanding options</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual life of exercisable options</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which stock option compensation cost is expected to be recognized</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403970954136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of the Range of Assumptions Used to Estimate the Fair Value of Stock Options) (Details) - Stock Options<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate (minimum)</a></td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life in years</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">2.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">2.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404190927560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details) - Restricted Share Units - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share)</a></td>
<td class="nump">$ 51.65<span></span>
</td>
<td class="nump">$ 71.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share)</a></td>
<td class="nump">42.71<span></span>
</td>
<td class="nump">50.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share)</a></td>
<td class="nump">60.21<span></span>
</td>
<td class="nump">74.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">62.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share)</a></td>
<td class="nump">$ 45.92<span></span>
</td>
<td class="nump">$ 51.65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403963216056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested during the year</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested during the year</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140404107761496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details) - Performance Share Units - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Performance Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares)</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares)</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares)</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share)</a></td>
<td class="nump">$ 51.45<span></span>
</td>
<td class="nump">$ 66.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share)</a></td>
<td class="nump">44.03<span></span>
</td>
<td class="nump">50.96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share)</a></td>
<td class="nump">48.40<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in usd per share)</a></td>
<td class="nump">50.92<span></span>
</td>
<td class="nump">52.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share)</a></td>
<td class="nump">$ 54.24<span></span>
</td>
<td class="nump">$ 51.45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403964621000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details) - Performance Share Units - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested during the year</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972933512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected Quarterly Financial Data (Unaudited) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 36,689<span></span>
</td>
<td class="nump">$ 39,157<span></span>
</td>
<td class="nump">$ 39,735<span></span>
</td>
<td class="nump">$ 37,341<span></span>
</td>
<td class="nump">$ 37,353<span></span>
</td>
<td class="nump">$ 35,228<span></span>
</td>
<td class="nump">$ 37,740<span></span>
</td>
<td class="nump">$ 35,213<span></span>
</td>
<td class="nump">$ 152,922<span></span>
</td>
<td class="nump">$ 145,534<span></span>
</td>
<td class="nump">$ 136,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">1,590<span></span>
</td>
<td class="nump">1,885<span></span>
</td>
<td class="nump">1,714<span></span>
</td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">1,674<span></span>
</td>
<td class="nump">1,764<span></span>
</td>
<td class="nump">1,730<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="nump">6,868<span></span>
</td>
<td class="nump">6,834<span></span>
</td>
<td class="nump">7,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="nump">1,137<span></span>
</td>
<td class="nump">1,165<span></span>
</td>
<td class="nump">1,163<span></span>
</td>
<td class="nump">1,107<span></span>
</td>
<td class="nump">1,168<span></span>
</td>
<td class="nump">1,097<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
<td class="nump">4,572<span></span>
</td>
<td class="nump">4,480<span></span>
</td>
<td class="nump">4,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">657<span></span>
</td>
<td class="nump">351<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="num">(4,921)<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="num">(3,693)<span></span>
</td>
<td class="nump">1,365<span></span>
</td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Cardinal Health, Inc.</a></td>
<td class="nump">$ 656<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
<td class="num">$ (4,922)<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
<td class="nump">$ 296<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
<td class="nump">$ 593<span></span>
</td>
<td class="num">(3,696)<span></span>
</td>
<td class="nump">1,363<span></span>
</td>
<td class="nump">256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="num">$ (16.65)<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="nump">$ 0.99<span></span>
</td>
<td class="nump">$ 0.94<span></span>
</td>
<td class="nump">$ 1.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 2.23<span></span>
</td>
<td class="nump">$ 1.19<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="num">$ (16.65)<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="nump">$ 0.99<span></span>
</td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 1.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,741)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="num">(159)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember', window );">naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="nump">$ 579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GainonDivestitureAfterTax', window );">Gain on Divestiture After Tax</a></td>
<td class="nump">$ 493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,630)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember', window );">Total Opioid Litigation, net of tax [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GainonDivestitureAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on Divestiture After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GainonDivestitureAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GoodwillAndIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill and Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GoodwillAndIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PreTaxGainonDivestiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Tax Gain on Divestiture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PreTaxGainonDivestiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140403972434632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuations and Qualifying Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 729<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">2,407<span></span>
</td>
<td class="nump">2,353<span></span>
</td>
<td class="nump">2,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">2,366<span></span>
</td>
<td class="nump">2,293<span></span>
</td>
<td class="nump">2,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PricingDisputesMember', window );">Pricing Disputes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PriorYearRecoveriesMember', window );">Prior Year Recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesRecoveries', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember', window );">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember', window );">Sales Returns and Allowances [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">495<span></span>
</td>
<td class="nump">479<span></span>
</td>
<td class="nump">479<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">2,253<span></span>
</td>
<td class="nump">2,205<span></span>
</td>
<td class="nump">2,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">2,237<span></span>
</td>
<td class="nump">2,205<span></span>
</td>
<td class="nump">2,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLoanAndLeaseLossesMember', window );">SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PricingDisputesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PricingDisputesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PriorYearRecoveriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PriorYearRecoveriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLoanAndLeaseLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLoanAndLeaseLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>131
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MF:=M2-[S)S+S(>#"5>CE"G_8Q0V0+NTZ9Z>CP6" ,6050]:&X=CWE=#Z>'=
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MX# C]@&XOY+2[$[L"\HO)I?_ E!+ P04    " "%4 U1HO^6W4L&  "6&
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MM8*YQ1TGF1G0#E&<FQ'@LC1-W2LX[5FG;^Q%@( HW@J]BAJ-U9N*OS &X(_
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M\/H!R^%[\R9#<2?^XMY&AFXB=T]P-L/$KL3$3JVV*+(.55PB/)9MAJI.WCI
M:(/A30R[\#HP;%$4FB7<)=IKE#N,8._ MF;PZJ0/OB4X=-NH[J"SO]L?KE^W
M1\K&_1M\/NN.R <SW8G]E_8<2:**+<%D>)9!L(KN$+R[4'S3'@O/N5*\;K^N
M&2V8T +X?<FY>KW0#^C_%''U'U!+ P04    " "%4 U1S-N/X;L#  !'#
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MVR%XI,JIM5P8N7-SW$H:F K=:P:3/E46 -\W4IJ7A350_W>8_0=02P,$%
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M*5YWCP6C0%T#X/<MY^KQ15_N]9>YZW\ 4$L#!!0    ( (50#5%O>*6J<0(
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MF*<' -8PH.;I85LY4D*BR4I.2%9X^ A 5F+T908:.7)RHO%+CHQ?1P\ _.*
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MQ>C@]_;5/VS\%A?+)"M1*IZ47W >J0:*W?] ["YDOJE_@O^82YFOZ[<K$:O
MJS)0WS_EN7RYJ'[5O_]/E*M_ 5!+ P04    " "%4 U11OA&<2L)  !2*
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M=0@G/]M&KD7RHZEH=3K!2*W]0 #O"=SCZ(R_[9IO23J^2O 8CX$%S3\]',V
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MALSK;P&@-/7.-R13BG$HMEL!@J=?BNTKUI"F_$)LMV( Q\7 (_G8%]?_9UF
M_>SMQ8JSD 4 &:8!MTFM!D@_H0$.M8%8MUP.)>6;9-ER-5FH YKZ&7OHN@&
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ML'5?9+LU5[J6K93MQGQ<4Z**=0U0_[]J6[G_HE]PN$9X^S]02P,$%     @
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M+$%.M6QBE]PP>6Q7V6-^I(DVYI=B* O'-G-/9%US-0OM&8%0Y8(<=M6ISUI
M3RADJZ5I#NP':4$=O"YL\A$5DHVS=4#P1LN&:DJOZ2HS'GS-5G-@FUT&2L;)
M3E4?I):?I(C!9-#Y@*F,!K>.PB"R.UH*ZG),..>UI[UP(J$=.;R.J@4U\9R#
M3M$_^"1^I72Q,G1RDH0@GB',P/!)]%-/IX@1R:#"3[M 0'#&@I6../;A"G_V
MA*';J6MXE)ASEL_,4ATK !0'-$B? \42D>VO@S;+C2ZQE,4F:BAJK5S@W&M5
MDY'8F88HOD2K37%%;D"0<'\&9:H$[\6#ICAT:&, 5F#2]2:VQI_>MH#C3^*L
M*=&))YC5?W5W*E:;.!!/GR5R0DBG\H;NG<Q6)SPM6RWY1A2W5AUHV8IR4&0G
MCJJ9!J0*V UZ3W'/?%P3V82'/4>_OYAZUV7?TP;/:%HKN0@+M?QG8EAJC0"<
MM*<GCXMS=<*Z*I0Y"MF&S+*6/:I@2BX!0]#(HG@@77%5J2B;G*0[/T:@'G'3
M^. >AKFO);!Y39GR2:6& V["A,:V.T=@C<W2NMV-@Z4,CUS%IZK8SQ"]Q2,_
M[C:4R,3<YGH6MU70UG,R105IT$+V3:-@[(NE76U0/!6B3PI\C?AHS-5.LH\J
M"'+T<HI.DQHOHEB 5<<#1VAQ;5>W)%F]G"SL5& 68+[*BDT"HH\ZUYI4X7S@
MZ@RB+]T*L(42@6L4X9$BV885DGTRHK#0/4!% M_>=K)/2"*?YK0\;EC"9N=F
MU%Q9=HVDL>_E4WC[[OV_E]O=BS?WLU_'NPQ!'G\=<"W^U_V(*E2N@]R*(F]U
M+KY=%;%C@H:$G+ D\9I%)R&X9"8K!C<99[?#MN]'X^O_<0!(D-\U/J^_JQ]H
M=207&'GGO3C1X(-;AMGCRV!UW^:BHV5=ZW!C/BM&1T/PTN1,LN*_]MH6)X])
M.=^%3-E"VZ(O,)H3GO@JQ/^'Z'+8\>^=_@O'I5)R]B2E\86HT9!"=+>D";;E
MUIH[E%!?HCA>LGTRA.6F[9IN?256;@HII,#,3-Y- [A:"TUG(?TN1!%W1J+H
M+COQ6\_950KJIN@L;>[A&+#&*&%C7A<FF81(9K$)!#O@$C@<-)^BF,9$7(*:
ML<-YY)MM5:#'N8N5PRWYY@!V326T"-*E%E4D<COD1)_-:A1.>G%R"XMOP"G;
M8WO(@Q+S44BUIX2Y!ZO<LM-@+?J_S3#7F-=/E@R!)%NN8VUHMGIU98?(^H46
MCW,Z* #*:9&B;S!H.1LRSG(L.*BU+=MR;8EBVZT:4&6Q:\K6<BDLY\^-ROK.
MD()Y.8%"L'S "$B,2ME>+@.Q;A,M8@8F<@VH^%I8LV93":]##C&&$35:]^46
MHS0=HV%)NL45W8."="G[YI+>0;UM2<[1D^<,3,);V1((5\:TI+40X7*Q(;XC
MDVR2_ZMDH5CF]XQTX!VM3\_-15(.[.7\9%A?9]&7,SGVHY.$JYS)801W8Y1;
MTL6L\ME_KL&TVV-7) 7Z&J[V_0\^?7M,#A0O1_1)3;(3^C"UTE(M9TT<;JP3
MO%.M'\S0/8CMM#CUM6)MU4Q9+''F:DAY*P?UX&1OFW#4WP1MW"[Y_"??"X++
MBJ]\D$U\G-E8<]JZD(W/4NHK]HY/NK-(8%6U (Y&],GEDFO<#=\X7E7'.,(V
M^Z'SM\3L([X4#WKX3$86$J2G?6)6S2AIN[2KFH6JG68F6ZA'<>B\K>2.2P\T
MYJE63K*7PBSW+6'$/;$=[S_0/ K)QCB$(+?841]#JMFV3%=_$H[$V*DGO(?=
M,ZHX<^63FO_93Z,:JJEHHNRD<V!J51XWZ=9@_JF4?W92_"%E'N\M-?/M'3)+
ML1(I#S'1$Y%,1DBO68 $;OD)^K66=^[**]VBP;HM:>T;?=\"FT""O79CLO%2
M;9%]U\.*M,O+C?)8^@HKI%*]9MRE:O]6$KE2[$0>R\H]IUS#W;IFPQ)AA86Z
M8Z1<98#:H95UR*^GX[<B<OIE':+EM/*X"9C1..!$DSU8D<]T!5G%N(,*2ZL
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MO*V$*I49^EY"DMEY8$B8BYFU<UFGM?F_PP*KL+/W,K FF-OPFE^&6)Z^O&+
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MB&L52K&2N31!+!(A11"7>8[9ZJ),03@16!YPAX)^-JK&X YP6]M\SPCX?<=
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MEPICOJ4-6)\;=-SVA@1T'UI?_!=02P,$%     @ A5 -4282(WH[$0  R3$
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M%15@L@2'#+R^;*$H9Q]D/)4A93FW)$9=0+3= -Y7;7<VEU:%R\KLD19\779
MF-4[NZT1DK)RZOTR\(BZ8C0&J6!H4TIMH0'DUY8%<N1$(YD;03P:#8$/C$6/
M/:D/VRF;Y*8<[%O;;-AAAYT[K)%Z&(#R5CP&16S\N046ZQ*Y@<'J\.4C ],C
M.[++H&(UX+"I-1#$CBMJ#-=*83YO(%@>=%*Q4%2>R,F\G*<PMN9L47&ZE^LU
MR52Z^)9B)1]RP[%-2YL:)7<(@T?6$PZZBJ9U%DK %102)#6H(T-'LE3;!02,
M8VK?HVG/^CE"$+(STBT:?PH]^6OSATTX"Y-+&RE4Z$6J'NN"X\IO'3W+/'$N
M+UEFU08*MBR@Y'"@L\K\,M*36WI $VR1 3(&"AAI$LBF2DMGE0<&X'MY@.7O
M-%)6K^'BU)3'<(.BV)#W6[^E%N"%(-]#04IZH2[(-6$+76P4U<.]]>PF';4%
MK<C7UCKCQ/%]!>&BGA6[SF4]!H\JU5N=V;I:\XT47:THWDR0=_+L-0/!F@_Z
MCA@A"J7#2^0#=>-@4PC6U]"+[>8B4SVJ9<6.2);$U]*=,3SE"K5DE[/^9.H*
M.54@Y/!MM25-8-OHFO!#LX<*CE FM\T78/Q+N:@L\L3J<;!:LAA-?PB<@Q"S
M%B$MK]-\P1T8RM&:!4.X,AAPZ+)+R#X>O/[3_0]?[_ES]/K:YC_"/9P_9*/'
M,%/Y>$;%@$A)>(@GWKG[>'_?N0;3DVNQ1@8Q[*VACD+LTVZJ21Q*"BI+7-;Q
M)Q;5HM")!GQ5Q6MFMCN]ML%$)$V5ML$:=&=S>LO>J^>Q&>O9@D;2&454Z)UR
M!8LV*6)H'77:%Y_#!,LF8OW:6"+N&&IQ6G2VHH.<W(3':>9@"XS=R*Y?>%SO
M\X0,="UI?. A"&32>5+[[GZCN)V@;P&#WK/PWU>9JH>2 &%>N7YT=B9=S@:#
M.E]2DD:DPP[*L(8<,*&%()11ETII"_Y#T(%TX3$S R8&^/EJ56QL=:+UC#8R
MI1)7-RFZJJ"(<R?,* D'4A7-*4X\O\01FC=9&EN8"(NBBNQH) HX!5WUJ>VN
M81U]^;P$;"FN*@TNA#*W=7%JJOJ9A@W&LAG9)V#&]5ON+ML0NE\/O]J#SOII
M*S;@^J!NJ[_:4H(Q'AXH;E46JMP31@M3/Y;9I)$E3I?^"24<:W  G-+'BF14
MHUWL' 6*)W*V\>$6@Y)\A>17*&?.BW.OTP&F0[K'DE_DK_3N?'F@>4:1CMPK
MQ.M2Z0=F"JJ XS2JY"DO_1BCE"U-I=HG3P93$0V'X@MZ*_72=@IA41##&>W_
MX5F5C6=S,8FCALU W&^ A^,8PKOQS&PJ)L<3SE,=1KU1%(O99"3^<MKKL@6?
MV-P=36E,U1V/:!#T$_+H$XNOQ'Q$<]YA')^U0J#/5W#^!S@! 8]C2Q1N]LM#
M6ON1Q_&?#+EF>7CIU=0=VCEP-(W"\5Z3=II*!4EHTDZCW\'L="Y\GDF>1?<B
M'AGSQ\%P_(06_,Z#93J.YI[_:42B7';,$S]W,QT$#E!7'4@]5XA0SFPT,VBC
M3R'4MN,FF/6""_4X@;H3FE!%TF[-DRACYJE.6-/ %NPM?%7W;6'X4Y[Y*G71
M91C>^;B;/+>ET2]A/-+P>&;'^-/1_%^P"S%QSY#3(@#K.\XRSVO#SAY# F>8
M\+F529^Q])/TWY='19PK52+6AK)-/4^Z-$JJT_C9?$13FB@>!E.:J[@_JF=*
MM \/XOH!37&*G>W/TD.O;G&;&7X](9)APY:<Y#L^FM*A/QI-!0!?24#8-CL(
MYKK3/IJXT2CO0>J4<SF#UQ*=EBQH>&#0%C.$@^K:P&:$6/:GN>IS9@ 8^+=3
M./!1JFW_YF/JV]3>YIH:H)['"OD.((1&-R0+M^ZI_HVXY!:;0 M. [Z@65&5
MH0U):<36%W^N!TNVF52/I?)3L-;\+:@FEU0(-,I4ZW3 6-0:U=2]@/ORG*;V
M/)6Q[>$97-1' QV,!ZE/O/7L_6J=^&H^GX7.-T*NWX;.-PJ<\\EYXXG5>C83
MU=<);=>U6.7I'2X2"]>2 B1,QZU0&0Z&;6[C2=P:>(:A\B3WSC=6HEG0<^JU
MLXZL'F]<&OA;B8RBUUDHI5\^S+J&;QX;=,$HGL.W2NV4Z6CPA:C>Z/4&7NKC
M@"8SS;:2)^U851<?;)+UX*.D?I!GI46UW+1I4S?%W :SO$*U^;;ZH-B0+MV<
M'1?Q!-B;S/IU&@+XRXKY#V3O/W03'/2>.%C9$;-O:)Z2X)F+_EO'G"R#(^C>
M-1@E70F*0?Q$X.%G-!7ODR1PD+;+M(>NEL(8_6,\$M'XN9T[M*_&M=M4AJ<,
MHJ-1!%]PV>=;=EH8..;;88*KS4R[<'<E1\-D.JL[J=\2Z,[Y7I-R;<L*=CC&
M-W'A1(%W#X-;TVY$$#'0K2)O.=8J);I0M\>XHS7Y^W:](=BNHJAIV(.TCRS,
MKPS!SY:NG48L[J2IA].?(!*9C4(/1>4@;JM"9S3[;F(::(-J!<70@;OG+=U;
M\("!+M/:]ZHS7EL$!J J/XO.L?<T \%M(.0+2X WBZH-1C=D?(]07_8<3J\4
M>)!!^6-!D^-E?8\?7"4]F1O(D]SR#$57H*O:VO?'W,TJOZ1G'2R\)KVWL""%
MC&AY*KIR,0]Z26.S^\]?.M=T+6%3BT/S@:?V&C&"6R!JX*N$;TZ*BA:1V.$=
MFGK41?ET"?!W(2VG=YHMCCR>\ZF_=VBN: QKT+^[XOEL%/M'5$FPD>=UB:*A
M7,'TKQKOAIJOAM-!4&/5(X_,'G@E4(=,ZU&&'^XR_S4OL)/M[^O9+ZUM=K:Z
M\"<*1?N-'0J#L&*<@>VG>,0!^:MH- E1113';501QO<QJO#2^.O>G3QX-S@O
M()<DNKORX(8BUO82]4VH?7%-9H<CB$7S8E/7UO](M_/QY(+&*Z[7J&X?V)/T
MTU)?B"=9?;,P>_B1G37860_0YU[*.$:/=@9#D/9'>ZU&3K;2:?O-$P5 W335
MK2%XV+3W@*Z1TZOB^*T ^V95ZRK-"N77G[UM@\-3V5NI/86'VKE]+I,7U>)O
M!)XH97$::08)89$,$KNM-/%@,*/V*J_6FU;1#U9QJ'%WQG7FP(>P*MSE(UI"
M]&?LH5R:/V#Q'8^\Q0=WA<(O)G6:+SK7_K4#>T&ILJ:>@?5;R$(:_*B7OVDX
MEHV9#_2237:@#L1?=9_EHA=R@.R3+U)Z3<+&OZ]V!V$U+<*)2E!=:>"';%A(
MVS#9$+!%VMUI-A5R( IT?B_SU8J\L3G<OV;DZNO27^'6$\L]5\+I47L43<;-
M@Y.^U<;+_#1I9#PWU__*V..]A:]TT5B_D4%F*4($?[G ]^@%G]+DF5Z*7;K\
M]^H^R.'VCB0PQS&CS;L0N\J@>M$EH/>.;S3*_*@)C/\[)CGW/OA-\'K]5IDU
M_Q,!OTZ1E?9-^_II_7\*[^WK^<UR^T\./TJ#EJ$0J5IAZZ _'7>$L?\X8/\H
M\QV_K+_(RS+?\L>-DM N+<#WJSPO_1]T0/W?&^_^ 5!+ P04    " "%4 U1
MUYUN-U$8  #]1   &0   'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6S57%MS
M&[>2_BLHK>M$JJ*IJQW[Q'&5(MN)7':LLD[BVMW:!W &)&$/!\Q@AK3.K]^O
MNP$,9D1)=M7F85\2DQP C;Y^?1F]V+KFBU\:TZJOJZKV/^\MVW;]S\-#7RS-
M2ONI6YL:O\Q=L](M/C:+0[]NC"YYT:HZ/#DZ>GJXTK;>>_F"O[MJ7KYP75O9
MVEPURG>KE6YN?C&5V_Z\=[P7O_AH%\N6OCA\^6*M%^;:M'^LKQI\.DR[E'9E
M:F]=K1HS_WGO_/B?OYS1\_S G]9L??9O13>9.?>%/ER6/^\=$4&F,D5+.VC\
M;V,N3%711B#CK[#G7CJ2%N;_CKN_X;OC+C/MS86K/MFR7?Z\]VQ/E6:NNZK]
MZ+:_F7"?)[1?X2K/_U5;>?;)R9XJ.M^Z55@,"E:VEO_KKX$/V8)G1W<L. D+
M3IAN.8BI?*5;_?)%X[:JH:>Q&_V#K\JK09RM22C7;8-?+=:U+R_<:F5;<+GU
M$W7AZM;6"WQ0[ZR>V<JVUGBEZQ*?6[O0Q,@7ARW.I=6'13CC%SGCY(XSCD_4
M>^R\].IU79IRN,$A"$Y4GT2J?SFY=\>W73U5IT<3=7)T<G3/?J>)"Z>\W^G#
M7.#;)D84=/]7UA>5\UUCU'^?SWS;0)7^YYY3S]*I9WSJV=_*^_O/6&+C9NT:
M7J[V]R[^O%:_&5VUR[T#]=&4ZH/^HJY=UQ0X?*+>O;O 0^/O\:@%*>J/Z?7T
M,=E J4"H:6RAUDL-VRA,U]I"5\J'%6J#BQ##MK8%">E0!3>".RE;XTYXOC7-
M2K7+QG6+I8)4#4GT;'J+,E6;A<.*%BRYZ^ANO:YN5 $^DH"\PGUG9JFKN7)S
M9?'%6C=XU*XU&#Y5KSJC6H?##5S#TIJ-(4G0L_!NI2'*P,L21E<9F&%M(*0M
MGL6E&O-79_$0K5_I+T;]U6%KT^#XM;X1-<(^C\Z>3)_2^HIXCV='?*"C<T9,
M1WKW.WS:?\*GJ0]KZVRIKENSU0W\KEVK\Z)5E[4Z7S>V L^.GTUXN^L6+**S
MT]JU]B0OK69=N8"3WRYML<2Q1=65= ,LNF/[??IM[\/U^=[!5/V+GKL^5P4\
M?TO[P:$N%HU9T'F/CH^.TCUU77>X$!WKO; 47U85.%5W<T@&:M&(8I<6QF1G
M7>OP164+^'IA*KQVI<"A] #NQ$1Z4)[N-E5_P)\('T';1!D(LM\G/V]\'&)%
M5Y70CX$L(3PP"M;"Q@(NLG+T%Q'5QT^D37Y)JA >:EV+.Z]@:DLHC?!BT>B5
MHMTWNF*5\ Y'#FY5YM=19=>0JO.AT&5H]:PRJJ#5I6[4C='-!"0O;%W3<U@*
MP?\X)3UX90JSFN&>O2J0L9+KPE$0Y@4,J4U:![/"_YJZ_SU7F::K6#-T&UE+
MYM_5,"W?VK8C[I"$P5)3?W9L)<014V/_0LQ(E.=C5['[8!K?0AZ(^T3B\UQ;
MYY:.JV'>A8FF:NN6=H%,P E#]H''9;?I0._SG29*KQP8X^AN^!H/>_K.U$G3
M<17O^JMELA6%<#6[D W6B\(I#_;[R&N^L[#8=[//0!;1A3 !/\#'X# 23B [
MJ$>D_!/YFJ*!YRD&EF[IUL3D=>-F+'4F44.9)13<J*7VD+TAUUET3<,F*)?"
MI3M<H-#D[Q1\E5V1B4[5>2LN-09*]E]+O3%@=ECE SUE4@UBT<P4NO.&'B\=
M20;?5.0AOY_*J7H''U&IJ\85QA!K/'$!)[@5>;^-JS9T>N,0!X#VF)^6?R([
M6<-((,,J14"^-=Q.5VF8\0V,O(7KA#M_,]Z!;YO\N) *PLN.8@-^XE"%IS(W
M0<8):/H%;C+<>T6X& \JOS:%G<,DB0A0E)$0/$B(X]ABW<TJ"T@&Y6DUF6X)
M^CXMP94M'Z'SU9ITX$;9$LOM7/P/Z3X%!805YBK69"NL]YW<#NPC<;,/9FV@
M6 3-:QS,@[XL'&3 N)?AKP-JNN[@(^6#%V6H@O,3WN D>)P*-RF<!Z?P2V/6
MVC9"Q;I"Q%5Z/L>V6!<9"BLT*X(91!]LMVFZM1P!.<:=V90FZ6.O-46E[4I"
M0J6WOK,!AI%*5\@TV \(BI_=]*P 5U\#9R@]\V3!!"N$B]8,= 2$1TXR[UA&
M@]LR-\6 6"\SX_XF:N]2O["=WE*HB# 'C*K<C2%6,*O8EW8E71J$B?-BJ&(8
M1:R=]Y8#@<-"JVOP/V@]>2&2II??D(+)'G N!?;UN!U8P#&%&%B0Q3/,Z\]-
M7PIP<B3XN:UQ"BD@Y$W!D)8PA?RO1*2!BR7D%:@1!>D/S.AE%$C,2@0O&085
MQ)=Y@[V9G7H&KX.C0-!C4EW1(389^FJ&H&D@3]JH-Z@!C\$O/N%>IHTL)S(#
MGO];C0@12)?$#U=/;OLN/@%+#"V!*JV=J75@SU^=(:LB;VMKR:GIBKS'1C?6
M=?@1\+/1#( \1T@=XT3.7O)*X!=\F^>]0R#JOYK#ET@&:9J)P&-KFEY\MB[Q
M:W,SPL6743=Z'HG+^[:;%!Q'2TLLJ]CV<$[\%(TYQMX$M()-A1@$H<&;%@F0
M5QQ"UED(T0LHNV]5%XCQ2,+)U7A(FLGE6+L"GD-(K $![@@Q\-P0^"HY1('C
MY-G@:"#_#;$?:MZ4T219^#YSH@) XK/1<-<=95UM\%S#7.26?!<$..H00*"(
M9A'BU5Q7",.!.>RL.;A"$D@<VQ"U0\I!%!,E_6:LSL2#J(L$V@GB$][ H_#I
MT9<UI*A% ;V9=Q60P[PES#RXE01W 6MZQ+C)^.05-&M@9&,>W0 K\>&"S%.8
MWBZ-H#<G=@G_SH)*EAG<E&*,1KOVV("S%&^2,.7J5)D">*5$P1,D0P)4F5OT
M8FM/@O:)EK#EY7S\;&D*RK+]@,;;6G##Y]=('/%+118IF$_23N@'1:+A!4A-
MB 0(E7C@MG74H^3#1ZHT(BU'F',)!!G*9.\AP?X[H-7_"3@-I%:.V"! %8FD
M1QXQ@UO(,.LO 7JV+,E( NFGK<$37!+/=S6EZ$A;F!HZJJOG>@/X09]+ -7*
MK4,:SM[!59VH!)WM"M X"=@_1KX,B\/2[&*)8P(*$,LI(\[SZC,RZ5 KFB&1
M4O..P:.AFH<X'N$BU0,:LZ'2Y/ ($L MC2=_SJ*#S8?S1%QE*C\)(W0)0O"+
M).4]@^$"F8O"95*^T@*G-<'S,4,CIR.9A5O4]M_$7 ZB\4G5<Q,7Y)_(#?>J
ML@W!-WJ6X-!=(<ZST'[)81L\;L=G)6D'=1BPAK46<8&,]F'5I*]STGNR>Z&/
M*!_NNT]DP7QP],%A@8Q^(<D>"8/275?9DDEE1YTJ.\C$*07WA_MT!:2WH83R
M+D>OEX/XJ:Z&Y:KMTL$I:-+7K HR"9494LL.GWJ?+T%,DW^:4SV@;H50<H.G
MDZ.CHQXZYRB!!),."-R \?BBL0%<">5K8OB*C$J'^$G*E;;TQGSA6D8;N LH
M,9?X0@Z.8'^I5YJXEXHDF@&-H?PEAG!0XQHVLG3+"'HHYF,13@Q!J0>WG$\5
MJNXLA7>XVMHL*DL:$XW_,X4;4S>V6$K@HPROHB*4VEA7!0D0SI#H03$,UDWI
M62&W%/_]41=(_@Q8>EG/JXY.*$-!F-&H^M L-)0X;$A5,OHUWD%P%:E*QR8F
MX:A/:2KO6([CTN6@,D:Y)=2_B@\AX5@2V.&3 O"&Q4AU.%>'J10AO/J'7JU_
M4E>.])RVO^YFI=U8+S03LOW*!@CW=#)Y!LT1[YR3VNN=!/P9544H4:"0L>IJ
MAHM2HD:BV)>JU^E0GQ\*W1J!VXE8U"2[54$EJJ!X&^TI*'^&MHC^C.C;FB86
MCK WE[HBJN)M>-O^$FVC:P]7V 3(-#!MF,-CV,<(81+F4._)ISY.1;*^$)\]
M2D\^5&_['2'\5KWMP](ZJ9/]XS^>G9P<_?3^U3O^U_%/XX(9U6X",$YIWEQ=
MZ!DI^04)1G*7B\"MWR2G:PF9?8(34G_:9@%LJX5Q!(JX)I;\/8XF;['K#KC>
M8 N@0R7L(O;UH1^>GN_[H6B=5")/CD:9TNTK7",>OVDHV_2%F^!&E<4>1&@$
M$!?@F_MBP$-A?"_4= MQ<URAL""1*(M7B#HU(./D2<RK6OC<VMR$G@(6\NZB
M5[W9AESC/C^=*;AL'0^.O,KKO*R!\))@'%<$$G1/3YP'PM2O@2[BQN^(IKKC
M?UYW\[FKOB2;5%M(@1JV91>J.5PFIE/?ZP9>5%0(M/.3Y#/8%LJ^!W+QX<_+
M5X^/GR,2@*DK6V2TW[TW> *9B 9.6*.9%[D.)".@*X]OS#8POBV=G'&QYZ"^
MM4>$"D,EO\L+Y?<@JA)OCG%D4 ^J _2%TH!ORI3ODK?;V$%RO"'(2:KXS3DR
MFYU.!]ZIC6X^MT7PK#W*YW)1NR37&//1GM]4$*<NU:(QXAN1DL"ZUA4+6JM%
M!0Q?D;&VE>37\P81B5KG4J71G*0C#E$;: %.K[FH<@>%G EPTN3MHA;U8.A%
MF!F^*97#<8, DP/@&!;Z) V%0+V$L'MBB706KOL+O(D7D#X5J-GU(TN_+^L-
M4:>@B*!,,;+BJ3E[$T+J7JS'>BFR:&]%K 048V\RP"M8%Y<1"!;32LEP7=&Q
M\%*B>@>5TIC#-8\/1-^7[#*!LO#<1/)&+:T1:>5!VM*[H.X5I(4?'CV9/GFJ
M9J$AQQ"1IQ/(:U(7R6.C_9.#/%,2CL="4$3*5 %PW,>:YWVK<-$@2:[:P4B-
M;B67[E&DM'NA!7"-)8?Q2($$_OW3 ]#[&-E@J*^SSDI9ZO'6EH:P3[V0E&DG
M=N/"()0#"AO",I%+[=VQ%(243/%S5K9WR2//V:F4%-O0Y21&*$I-/7=4/'(T
M)BKUEVI#)14=:VSDJ"W!4K).L<=,63+2^ &I?C7];K>22%W?9(_RUL1*\-X3
M*]DU8%$=)F#8O@>)=>_HABH3FT+Z5@<I-8ZI/Q/#2$C!6OW5Y#"URN88 D@:
M "\X(F873Z\0+:S/C:'\A#.M$#4R"Y "!UC>U5*)<"F=Y*<;TI9!U9QSS"PU
MO<V$'7ONJ$V$4DVL>#"(].VNG1.<#33[6/W8I6"A;I1:/F,;VVU67"ROJ=52
M2..)<6\,-9G-A#SV6^U&=&TKE=.HI:Q&7!0 2,-!9+]*>JJWVXNZH@ZLL&+K
M BNDEI;?CAK^AFIGK#UL"8].CI^D(8+,%M)>C!7Z+.2BN]%+M] !$-$HS60<
M?D)<L9'^QG,KL]J&(F,$%@$"1Q5<ZG*(:>7!(;H]?GZ'?5&@2>2';D.HBCUZ
MVL^#T-,/%R,HV6WSR8 'A/"PS:O]'KK2A@^R^B#V,UQ3<NU7AATX;=)?E1#*
M\RY/ID]/DP_9I\_'9[U/X9HR5AQ\QW6^H5S#')KL=#"I:+.C9I/#TH&#B17(
M'<6IOZ,,.1I#^%NJCR+_"+QZ=D:->*@>R=-?WUMUI"_);$!&2#.MCQLRF7EH
MA5N WZAN8F%:V$*=$!UK^:4),AZ45)@S-+_%(#.+A@/HR]6H^Z O1W!N(>MR
M9;U/=</,WV^)Q-+Q(,=5*/1?<2J+"_N[(5WI3-B]+!ON R2TF_H%:9O)<$"+
MQFZ2QQ=G*IU3_F)KJCEW4#M./I;.KRV9IK_QT/O;B[C="E>_L24'_]@K-+&2
M2BB[I )T?\.>-'&+(??2@S+265Y^U!SPWG947GH6O=*'4,*9J..CIVQ(H;-A
M&/U3C"ZRPB.;H/0PP_0N=PNE$B4ZD!'&[2L+QZI#&]1Y,U@1*HC9DH=JI+N"
M9H\4-G;AP A/"LOU-]H)!N,-(H_O]30AC%>& &!T16\!<&G8:50A_C1..F-)
M"Z$9XOG<-3=9@LFC#(S#QNY^V+A%) M-#IIC2!R46D],O7_PD! EF\DMOM:^
MO7-"+!9GWG#K_CH<'F".%)%V7GA_[]6'MW&<L+\*5Y=CAG2[RSW&*O#OA0V3
M) 72^28FC )B0DVQNYVPQ&K!_<(MG$/"(A1DX3-F\V0:,A+R+GF'5/<_OZW[
M:6HT5?!U7[0E\9V>GNV8,DGF!'*:DMJ1(NSSBK;1L>IWW7%RU?3%NJR&)N-5
M+/WD<D:&.SEY=I3;A;3VI 6-G;V320#HGF3%M]$NQ4HJ1A*5T*)U^YIJ-"2"
M?S5ZS1]L/1<B$:,HI]UHM7_YY\4!5=H(%,0I(NAC+?[J]+AG0'^+:.-WW>;T
MZ=@KQ/H#=4IX8[J(IYB=?(T?MSD&?0N"UZ4UPX)?W6>KX_;'K<AVRU7L\A.#
M>!8JG(N.9X9-O<"^$LY,9:DQS3-GJ;U%[<'.2VV$A=*SX,X1P![%\9CRTV<)
ME0K>)+B4NG2VCGEMC[XF@[E!"OW!!J7/PS>ER07.2;*^,U<:15.@ %'^?5F?
M8Y]$*<X!8R=IT1"ZD+++PZGD5$8,960QI>BZSPZ'+4@3&(<CU_U(9^Z^(R9,
M<Y,1O?<Y)Q\P,[0@SQD)42!1$^6[8VV?A4>FTD^0M%UUJ[@H7\#W&R2FA!D5
M*]<\HTEJ%D,;>?3\^/GW2GNJKFG8>>DJFJ* N^^D]I@W1&@HMUM0'ZZ?RGWG
M.NNMALU?X_JDD3^HJ_!"CS2I/DHC\4U']<$P6K(;&/2-@U20O]#L&*LX4\^5
MQ.CB*>$*92TJO!*@Y0 7NL9I""^U;VI+1X86VO?,37.RE(BFF:=\0H.KH%V#
M9,7SC-P\Y.3<[>09<HK0[9;2S5B/1B),-+[7/"S]+$"B_O[LGGU?&,I:PM+N
M-"DH>^"M_=E!&%S>UP=],2))D7Y[_56J!MS3Q"/'SQ&59M1I_T(N#Y@XU66R
M&H0+6/F6C=-<S*+1.2P(9I_FTP1Q4M;"8[!UF=[@H'8G#YM4!&(S:QEM(8&>
M?'884Y7![=P]QZ8TBWS<OHY2%7[2FQX^:_,/[B?]N/!^2FK&<:-QO7:6'=7Q
M\?/GZOKUY1]1'R_(D;U.BA8UGY4=,("'X9*S'OFL6/(+\UD1RS(CK,^5(;QD
M0ZD@M-RV@;$M>8.=\2>:#_9?T3QPL^ B^Z\T;O11AG]O=Q^IBB& $^$1H:=N
M)0S1X\S(Y]/CY%;.S]]?JG>4_ZI32#4<L, !PE8J,?2;0%!5F8:V]G7<E=H.
M5%9<Z^)+*'G=GL4DX;DMPV_(OJ*.*'^8IT%:+)9D_V3:.[XK"J T_RV#Z80A
MU16?0[$;_.%\,DXY"^7[K5MP:BSBWPN\"G 6T2$RCWNL?>DWGZ:G-N<F5+T&
M+VT\%YD#3407\>;5^6-D\M9+E2S.;[+#NH!%:([C?FGGV2!VL#?FFU -%>AJ
M#@&447C;QFC'[W-$&-Q/(-#%3;VQ2'974E&(P8_MV$K-6*8\.:GU_&(<41DR
MY3B5M@UFL[L:]3&.F=MO+RZF&I1@ESBO0QCFV9,LJ.$+01*/SGID8Y,KX<(M
MS\&$MP'XQ1Q2L$>G/^YX_OI7#E;G]]>8=@\&<3\JE,BRRC8/[U+/,D5QSCEC
M!9=G48(VA1DGJ0;T#G,+4S>/$=/"LCSX"6CM)Z>"8X7VQ9%J7I./C_>C_CS@
M+R:8#?C_OZ^+?6!W<,'-VPRV_!I>)AQ-9UWA.[*$<YJT:0C5#*'.P'0GXWF>
M09D['Q00UZ#+<M<HEPZMY0'J"="X'\.)T]0C4!%?BBR;;I$)-I:$8J4L'RRR
M841IQY;29[?RRJ1,DJ^HT)?F*K(B(ED#O@Y>EQ^CDEM?3!I>*-8<!T84#&M7
MS0%1L_8WU4;SZ,D=Y.997S8^?9]8H+HP0KT8O2@8IGKI-4?/\[Q%*#10S:R,
MKR:LUJ:5IMTZ*$K>WN>W0L?O.MH5O5' [XA*2B>EFS"?SV&L",WA6 >*@'CE
MXK:X 2&2\2"-U +O#?JCI-/Z((@I 3ZZR,@ +NL%V3"9WN5JW?$85F8"[RFI
MR=\;B"*\XZ5<@G1Y"BTOXX^?MOVA^WOG5Y=[!^/1.&J6\IM5I>/\;#0W1]$>
MK!TV.3KJ8 QD/_ZQMPU:^N#,99^M-]9+Y:^56H%X[*S2E#?MPK!-1)M6V)HU
M1Q]B"KO+Q('@F3G$OC&S)GNW,@RNE3OFUFC\)[[#^PV#:^/JWULPR-P,IM:N
MH05PV]GPFER1W>?5Y>B>D3'17\TJYW@$3V#$8 +UDXGC:H4$EKLJ:/?<]QY2
M_@NK=2'&V?:OE9,=3RB!MK1C+<GV=YC6H'"P,WZ$=R%]&(N66J_H8)B13BUU
M>;.%Z.<>2M^[8"W+2F39, B'F.!T5Q*E7.8B&2X=/\W@TJ/G9]G;VT!!)R?I
M<VC5!73&+;F)X-5)>AEVUY]".,S^) 7\VX+_\(:7GJ+\=8KT;?K;'N?R)RWZ
MQ^4/@R K7M#\:V7F6'HT_?')GFKDCVW(A]:M^0]<S%P+9\K_7/(,$SV W^?.
MM?$#'9#^XLG+_P502P,$%     @ A5 -4:VRA*)C P  [ <  !D   !X;"]W
M;W)K<VAE971S+W-H965T,38N>&ULK55M;]0X$/XKHQPZM1)L7G9+MV5WI;8<
MND-45,!Q'TY\\":3C57'WOJE*?QZ9IPT; 7;$SJ^)+9GYIEY/"]>=,9>NP;1
MPUVKM%LFC??;TS1U98.M<!.S14V2VMA6>-K:3>JV%D45C5J5%EGV/&V%U,EJ
M$<^N[&IA@E=2XY4%%]I6V,_GJ$RW3/+D_N"=W#2>#]+58BLV^![]W]LK2[MT
M1*EDB]I)H\%BO4S.\M/S&>M'A8\2.[>S!F:R-N::-W]5RR3C@%!AZ1E!T.\6
M+U I!J(P;@;,9'3)AKOK>_17D3MQ60N'%T;](RO?+)-Y A76(BC_SG1_XL#G
MB/%*HUS\0M?K3F<)E,%YTP[&%$$K=?\7=\,][!C,LST&Q6!0Q+A[1S'*E\*+
MU<*:#BQK$QHO(M5H3<%)S4EY[RU))=GYU2LA+7P4*B!<HG#!(MVX=XO4$SBK
MI.4 =-X#%7N \@(NC?:-@S]TA=5#@)2B&D,K[D,[+QY%?!WT!*;94RBR(GL$
M;SI2G4:\Z7]3?2E=J0RS=?#OV=IY2]7QZ1$?L]''+/J8_?_K?!SH9 )[L.!#
M@U ;1>TD]0:\6"MB01WI2 J>A6QXRX:.%"T(YY#LA*[@0$FQEDIZB>X0VAZV
M FX/:K$R6,N85.:2]#U0"I!2<!I3  =24PDJ1=U$QF_P%A7DP[\8_E/X8+Q0
M<!9]GL*%< W@39 43XS^"1P7.7U__VU>Y,6+!RN6O"4&%J2^1>=[O@?Y(>3Y
M;-2[__,9=68G; 4EE1[GD+2+PU'C:+J[+++\Y%=Q*$Z.]W!@R3X.\Q]PF/\4
M!\;A_)OO/*R%$KI$.BM5J"CSNT(F'7P@3G70E7L*72/+!H1%"([R[PV8NB:V
M4*M0DB)/S&A& PXMETAI6GH(7)3 3A5-.!Z'#_ 'WVS/]<A7YS^#X_J*-N0L
MX@G-FT[Z!M;$")2P&XQUZEJA%,TY>TTQE6(K*1_R2^^<Y0T-VV<WY)"!:WE'
M 1)QTR(%O/8[KB9]NXP=P:Y]#/C!_3BR\VAIP!)2<-P$-\%XV@PQ;*TL&8U2
M\Z,QD>Y,X!:)!;\SCD@&[?MA/)Z.3]E9/\&_J??OX"5=@J3+5UB3:38Y/DK
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M,0TMOF*7FQQ3I=*'&"VC Z<D4:>DLF34/S!_=XBH)XXO+_N/4KFWQ$Y\G=4
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MW'-H]7#W--\[:>=4829JAJG]\ZO+(VB/GY!S'W*SXJ?2@$ARL^0_%PHAU-(
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MU8<.K'U</P_0/2 G=X'\-(3)QA]/]KYFLU$66%C?LO]/.:A)&%QN,!0J:P-
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M$?N\)!Z$CB7E!?G##<)HJV5,OO->* MI/5170KM"!IQT[JTQA9Q$(<M0J @
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MPM]N\E69+_-%6K;)Q6)1=66;EZOD4U7DB]PUR3/]Z_C;YRT A4,_7P@ [QB
MV1X IK/DYZILUTWRCS)S63S <UB-7]),E_1N-CKB?W;E:7)^-DEF9[.SD?'.
M/8K.:;SS/>,-K?B_+^9-6P-)_<_(!"_\!"]H@A=/V8,A3'[!,,G'KDX65=D
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M\D>7K61Q2&\-R)\MTU^[3MLD72YAYWC#A18!EJINGT(_-/)"B!R14U8P]VE
M_Q@8B/.N"=,9'..C0&6+HFJZ&H]"03"TU02!A0<J>*%. ,<;/'T%R%A"SA)/
M1=7-VV57^/,\@0EN 8(*F/IM6G2!U2._J&\1RE5597<YG&#\6@8'3E*N\GGA
M$&K0$W)895[C6B8) -80.P!H7<G"@(\?DTB5=8#<(D_G>0$LA(8%D;P\R4M8
M$<$*X-5=6C3'S#[@[6H#C"B]1P1>+%KXS>\,+*3($F 'A%6@MRR'[:O]^6W"
MSGO6P@0&"LD<M);/>KC+"LYJ@CP\)XH#NJK*]#:ONT"FEQ]_NWI_,GVKI I,
MJ@'H;UV-4R,:%C /@\TXZ!R18.\9/@FG-Z?TY*JHYK D!V]4&\\UYVZ5ER4B
M3:B@7>=UEOS9I4")-9^)9@'OH5";P')JRPT#]U2HZ+3 -@-?;DF&WZ4/@(K?
M@9K3$JC3XXDF*URY@N,$5$.@Y_P*_J(X2("R,[?)%_A0NPZTN&=="SHU<#*!
M*@! /-8&9":OK>,33Y2I-'.W=D1V^ 3\72;K')2@&@;T(YN7X07X-LOY)!'E
MHKP  A(PW7T+A(J;<K?.%VOFWWE3=W3X@%GX3;+P3<PQ!Q9/PT^L) JPDSQ,
MFW6RA,-W2FS6)8<<^W"8 Y+WT3<0*RP'M.%D3+J\\M+EU:ALN$1P_P%,$[@
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MF=B'\3OR"'E=T11,O7L%?O5IE,!6,X?,0!B%_P$9,YRE?!ML4$I811VR(]M
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MAWV$" 4@,5IT8^ZQDU/3+L]8V+ZO V]B2+#F' RL;>$$(E-/YQUL&J$K72]
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ML-9GUM)H@3(")5"*9"S.]61&)(^K,L\]DT 1]D5_SK+QBW(GT(P1R4L&BMB
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M@0A)X&5L1#X6:W)SV-.LS8YMA/&;PX1QU,Y^['*3T%MM-MX=C7UU%](5]J?
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MCQM.VM!]#!L\O.H?\EQ.3M&!<_@2K:CKM]Z.$]V IGF5\70[:R3%(E6-R);
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M+RFSB%P0*=$(S6W[!U$[ZA>YP"ERP&EMQ***;8XT)5*?\I(AA0_\#^:N&XG
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MW^PVCZ=9?#.\B<>7UQ>Z\P3Y(7%)JIWV+660B:^9N'"Z#"^(A7;T'@G3G!Z
M:+P ?5]J[78+#] \*:?_ 5!+ P04    " "%4 U1JP'$O]<$  !^$0  &0
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M9 B7\; >$%V8^<BL  4 Z_A#($D,Q365X59 =UPB7HDX%B'7FS N\7,#ZJ$
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M^V41@>T?DWY!I@T-?&>(GX,PK?G]1>LO\'EE#!T7WL'XHF_^ 5!+ P04
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M10Q\I]=OLOE\;K-AK)60UAPZ7K@V8?/8-,QOXV>_XF=_;WZ.DD10*K%0:*O
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MD-; ?%\+T^/BP08H-^3QOU!+ P04    " "%4 U149<LUF,"  #0!0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6R%5$UOVS ,_2N"T4,+M+7C? V%
M8R!I-VQ#BQ7-VAV&'928CH7*DB?12;=?/TI.O'1-O(LM2N1[CY3(9*/-LRT
MD+V44ME)4"!65V%HEP64W%[J"A2=Y-J4',DTJ]!6!GCF@TH9QE$T"DLN5) F
M?N_>I(FN40H%]X;9NBRY^34#J3>3H!?L-A[$JD"W$:9)Q5<P!WRL[@U988N2
MB1*4%5HQ _DDF/:N9F/G[QV>!&SLWIJY3!9:/SOC4S8)(B<()"S1(7#ZK>$:
MI'1 )./G%C-H*5W@_GJ'_L'G3KDLN(5K+;^)#(M)\"Y@&>2\EOB@-Q]AF\_0
MX2VUM/[+-HWO<!BP96U1E]M@4E *U?SYR[8.>P%Q[TA O V(O>Z&R*N\X<C3
MQ.@-,\Z;T-S"I^JC29Q0[E+F:.A44!RFMT I63:GR\YJ"4SGS&^Q:VW1LM,;
M0"ZD/6,G3"AV)Z2D6MHD1.)V".%RRS-K>.(C/+V8W6F%A67O50;9:X"01+?*
MXYWR6=R)^+E6EZP?G;,XBJ/'^0T[/3GK@.VW!>E[V'YW0;Y/%Q8-O9D?'9B#
M%G/@,0=',+]48#@*M6IJ>^Z+>ZB&#<S0P[AV6J>]_B )UP>XARWWL)-[6FJ#
MXC?W/4"W:]PSO=#Y14V7S*T%/'B;#>CHE9+#0D:MD%&GD"=N!%_0$Y/^?2V/
ME&#TEGA\F'C<$H\[B;]JY/(_K..WA1_]6_APK\M*,"L_2RQ!U@J;AFMWVW$U
M;;KTKWLSZ^ZX60EE251.H='EF)A-,S\: W7E>W:AD2: 7Q8T<L$X!SK/M<:=
MX0C:(9[^ 5!+ P04    " "%4 U10!-Q[^L"  #Z"0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970T,2YX;6RU5EUOVC 4_2M6I$F=U)$//DHK0"JPK:V&AF#K
M'JH]F.22>'5L9CNE_?>SG9#2CB1H6E^([?B<ZW/O(;Z#+1?W,@%0Z#&E3 Z=
M1*G-A>O*,($4RQ;? --OUERD6.FIB%VY$8 C"TJI&WA>STTQ8<YH8-?F8C3@
MF:*$P5P@F:4I%D]CH'P[='QGM[ @<:+,@CL:;' ,2U#?-W.A9V[)$I$4F"2<
M(0'KH7/I7TQ]SP#LCEL"6[DW1D;*BO-[,[F.AHYG3@040F4HL'X\P 0H-4SZ
M'+\+4J>,:8#[XQW[)RM>BUEA"1-.?Y!()4.G[Z (UCBC:L&W5U (ZAJ^D%-I
M?]&VV.LY*,RDXFD!UB=("<N?^+%(Q![ [U4 @@(0O 9T*@#M M ^%M I !V;
MF5R*S<,4*SP:"+Y%PNS6;&9@DVG16CYAINY+)?1;HG%J-,:22,37:"Y  E,X
MKP:+T#)W@GFW)#$C:Q)BIM!E&/*,*<)B-.>4A 0D.EG  [ ,+.ZSX%*B;P)'
M@!80 GG *ZHWS4&$)D ,:/6$9O@7%VAB!8*0[]')%!0F5(\^H'F"=4E#R)2.
M20>NTD+-<=VP$#7.1045HOP S3A3B40?60312P)79ZA,4[!+TSBH9;S)6 NU
MO5,4>(%WX$"3H^'^^0'X]'AXOT9-NRQZV_)U*O@FMTMT!9BJI(:L4Y)U+%F[
M@JRH_>FKDJ*[+WHCNE:0RI\U8;IEF&[MF0O[&#L6$0_YHIXCZ+4\[]VA\OTC
M;MJ Z_Z->R&^5XKO'2N^XN]U*!GUG-7):,!U&D2=E:+.:HF^;E26+A[1W0S2
M%8@ZD_1+ROY;>O&\#'/^'[Q8S^$?2&.>_@9<N\J+#3B_H6R^]WQE>&_@Q@;2
M2C<VX"K=Z.Y=BMH#L6TN)+*W5_[A+U?+!N;27MNOUL>FL;&7[3--WA7-L(@)
MDXC"6E-ZK3/].1!YHY%/%-_8JW?%E3:B'2:Z.0-A-NCW:\[5;F("E.W>Z ]0
M2P,$%     @ A5 -43+U; JJ @  Q@<  !D   !X;"]W;W)K<VAE971S+W-H
M965T-#(N>&ULG95;3]LP%,>_BA7M :1"KKVA-%(+0F."#=&Q/4Q[<-.3UL*Q
M,]NAL$\_VPE>MZ85\)+X=O[G=XZ/[73#Q8-< RCT5%(F)]Y:J>K,]V6^AA++
M4UX!TS,%%R56NBM6OJP$X*4U*JD?!<' +S%A7I;:L5N1I;Q6E#"X%4C698G%
M\PPHWTR\T'L9N".KM3(#?I96> 5S4/?5K= ]WZDL20E,$LZ0@&+B3<.S61@8
M [OB&X&-W&HC$\J"\P?3N5I.O, 0 85<&0FL?X]P#I0:)<WQJQ7UG$]CN-U^
M4;^TP>M@%EC".:??R5*M)][(0TLH<$W5'=]\A#:@OM'+.97VBS;-VF'@H;R6
MBI>ML28H"6O^^*E-Q)9!%.XQB%J#R'(WCBSE!58X2P7?(&%6:S73L*%::PU'
MF-F5N1)ZEF@[E5V##DFB>5U5%'2V%:9HABEF.:"Y+8LKUNR]R>'1!2A,J#Q&
M'Q!AZ(90JH=EZBN-8@3]O'4[:]Q&>]Q^JMDIBH,>BH(HN)]?H*,/Q_^J^#H0
M%TWDHHFL;'PXFA_3A51";_C/ YJQTXRM9K)'\TL%0D?/5LBJ]] UP0M"B7KN
MH<^<Y;40.FU=*6AT^U;7G(['+$["U'_L@$D<3/)NF//])(WH8(LD#))NDKXC
MZ;^-Q![H$UZ<W$M 4RFADZ2_0Y)$@VZ2@2,9'"3YRDW1<L=##0^B;6((=);G
M8)<CZ7=S#!W'\!4<!6'V\+R*8KA#$>_9EI&#&!V$N&S=[]V4'L*% H&F>5Z7
M-<4*EFA:<J'(;WO&NS!'NYAQ-^;888[?@OFZ*A[O8(R[*<+@[^T7O)/C\-%N
M9;?/=O1_^?A;M[)YX6ZP6!$F=644VB@X'6IKT3P:34?QRE[4"Z[TM6^;:_W0
M@C +]'S!N7KIF+O?/=W9'U!+ P04    " "%4 U1J-XB';D"  !Z!P  &0
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M5-"?(%S5W;:>&%FZAK62!MN?&^9X05%E _!_)J5YF]@>V%YYLS]02P,$%
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M(JYX20MUY\"KG$AU6AUC45:4[)N@/(M1DLSCG+ BVJZ;:P_5=LUKF;&"/E1
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MO31V4KU9V;<$E0NP^X64YN2X<1U>I_0/4$L#!!0    ( (50#5%"O%UX<P(
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MN?N"O9Y+QY?)6OLO['K?,("LU4;R'FPSX$QT?_K<U^$ $%V= ,0]('X-F)P
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M6N<"[1)HY[4OBI57>LPL&_2TVH%VUN3-+?)VY305F$LGK-AJ.N7$V<$=,]R
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M1 7U#N&Z&.C%QJIU/H#FRM(XRY<K^@:B=@9TOE#*?FS<3*N^JH._4$L#!!0
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M&8X.1SI=2_53+P$,>8XCH<]:2V-6G]MM'2PA9OI$KD#@G;E4,3-XJA9MO5+
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MKH_*ON1E)T:NTF\V,VF,C-/#)3"<;JT!WI]+:;8G]C-0\3UU_"]02P,$%
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M-GUM:F<ML'RL]6D]5X:NG3;.1V;>E./A/TTYK)Y,L3.A"8>%H0RN;XQ'JAP
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MDGCQ*J XD>R0;XXW3*JM=GZX)S@D/ M0][>,R=-)]H#JA<SR/U!+ P04
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M3*I.Q-S.57>)N0Y0SZ>,R?5 +U#WJ_U_4$L#!!0    ( (50#5&B2&:?JP,
M #T-   9    >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;*U7;6_:.A3^*T?1
MKM1)6Q/G!6@%2&WI.J:QB]:[>S],^V#(@5A+;&8[T$K[\7->"&F7!.[4+Q [
M?AX_/F\^&>Z$_*XB1 T/2<S5R(JTWES:MEI&F%!U+C;(S9N5D G59BC7MMI(
MI&$.2F+;=9R>G5#&K?$PGYO+\5"D.F8<YQ)4FB14/EYC+'8CBUC[B<]L'>EL
MPAX/-W2-]ZB_;.;2C.R*)60)<L4$!XFKD75%+N](D 'R%?\RW*G:,V1'60CQ
M/1M,PY'E9(HPQJ7.**CYV^(-QG'&9'3\*$FM:L\,6'_>L[_+#V\.LZ *;T3\
M'PMU-+(&%H2XHFFL/XO=>RP/E M<BECEO[ KUO9\"Y:ITB(IP49!PGCQ3Q]*
M0]0 AJ<9X)8 ]U2 5P*\YX!>"\ O ?YS0-L9@A(0/ =X+8!>">B=ND._!/1S
M9Q76S5TSH9J.AU+L0&:K#5OVD/LW1QN/,)Z%XKV6YBTS.#V>\BTJ;6)+*SB;
MH*8L5J_A+7RYG\#9J]?P"AB'&8MC$S=J:&NS90:TER7]=4'OMM 3F FN(P6W
M/,2P 7_3C?>.X2=']G<["&QCJ\I@[MY@UVXGXU6Z/@>/O '7(8.F W7#[W%C
MX$XK?-(-_Y#R/=QU&N"W)\/)10/\73=\1A_!(:V;WYU@.:?1<D\\X56AZ^5\
MW@FA^_6C>0E3C8GZUD'M5]1^3NVW4B]%@G#V42B3#2LI$KC]D3+]"#/4D0BA
MMG>3$POV(&?/+H/MV!W:V[J??E]!G&K)$\U!I3GHU#R7^/8?^@!WYOX!4^0G
M+)/(="JQ26)!UJL)")Q!LX)>I:#7J8#3+7N/--81?)UALD#9Y8M^Q=I_:3</
M*NK!$9.))6*H"@_7# 9B!=>I,LN5PL:R-_C-?WVOWVR^BTK-1:>:M@A[ W_O
M.$H5L0W,42[-E&D2FK*WF]]WSAWGKPZS$>=P:3A_)+4Q&4JNNJT\SW^:#W=-
MBX*6>"2URXUT.YA*O3?=E(=,F@;H8,TF$QXA),Y1([H'<>X+)NQ-R1:T9&Q1
M5HXL>JKT4&B)UZGTDTGL6A!.N49II):*,:S2'7["_RL"Y%"1B?_298 <2B?I
MKIV?A"GX7$MA^AR^K@[8G'FP> 036&;0= <>V>EBT!8_=JV)2U"N\_Y<P5*D
M7!?M235;?0-<Y9WOL_D)N;PM.OD#3?%A,:-RS;B"&%>&TCGO&ZVRZ-6+@1:;
MO%5<"&T:S_PQ,M\W*+,%YOU*"+T?9!M47TSC7U!+ P04    " "%4 U1M?1E
M+3@%  "'&P  &0   'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6RUF6UOFT@0
MQ[_*RFJE5FJ!?0([<BPUB:K+*;U&27OWXG0OL+VV48'U+>NX_?:W"Y3%L*Q[
MLGB3@#TSS/R]^V,&YD<NOA4[QB3XGJ5Y<3W92;F_\OUBM6-97'A\SW+US8:+
M+);J5&S]8B]8O"Z=LM1'01#Z69SDD\6\_.Q1+.;\(-,D9X\"%(<LB\6/&Y;R
MX_4$3GY^\)1L=U)_X"_F^WC+GIG\NG\4ZLQOHJR3C.5%PG,@V.9Z\@%>W5*D
M'4J+/Q-V+%K'0)>RY/R;/KE?7T\"G1%+V4KJ$+'Z]\)N69KJ2"J/?^N@D^::
MVK%]_#/ZQ[)X5<PR+M@M3_]*UG)W/9E.P)IMXD,JG_CQ-U871'6\%4^+\B\X
MUK;!!*P.A>19[:PRR)*\^A]_KX5H.4 RX(!J!_2K#KAVP&6A569E67>QC!=S
MP8] :&L531^4VI3>JIHDUS_CLQ3JVT3YR<4#S[?OOS"1@<_+--G&6ML"Q/D:
M?)8[)L#SC@M9&=QPH8(G^;8 S]6/#O@&W+&E!&_NF(R3M'@+WH.OSW?@S:NW
MX!5(<O I25,=<>Y+E:R^I+^J$[NI$D,#B?U^R#V @W< !2BPN-_^LCN<G;K[
MJHI&)]3HA,IX>"!>6>9]7DAQ4(M8@K\?E &XERPK_G&$QTUX7(8G ^$_K%;\
MD,L"[.,?\3)E-KVJ"+2,H'?GRP)!')&Y_]*6Q69%,6VL3M(C37K$F5ZU%KA9
M(;;\JA!AZ\JMRU;)]4U@8,^,-IE19V9?N(Q36S:T=ZDPBKKY](VF 8;VC,(F
MH]"9T0,KBBNU=870ZV2OMH_&E=HIJ=YJ4N\DWMEJO)2W*+=::;!LMIJMM-"E
M8E58WX109*\K:NJ*W'79TG\'4E5NMUI;TI'E]PB[OT??**+1S)[WM,E[ZLP;
M>>0U^(-+5H#U@9WCP:R).AN#!S P7 Z<:5<9/P[CH/9OB]5=!1830@<V'&S=
M,: S,^*%B)Y*VB7T:63#6#@*9*&A+'1C]KRH^+RH?1,:3 =$-8"%;L(B+X1A
M6]1-4JSB5&N+7*4;3D(ZBK8&>]#-O?/:]J$TQ=W;E\4(!D,(@(9=T TO[*'.
MBG6J:M@"IZ.H:C #9Q>J.NL)AG#85=5B1"*[J,@@"KD1]3'EZBZ0;\%3+-G_
M7KK(  ?!,41&K=X.729R[7_2VR#8$=EF1 9HBPRRD!M9_96+734;X" RBJ@&
M.,C=F9T7M=]]T:B[<FU&=*!#0X95R,TJ["FFV&E+7,4;WJ!H%'4->)"[JSFO
M[M32V\ZZZO:-HNF0NH99R,TL[%&[MM0U*1GLX&"44<SP!KL;G+/:UOXG?17$
MW4',8A0,].#8H J[486]J-M[.55M#:!X%%4-<+"[PSFO:G\ZI*B[8BU&9$8&
M5#6LPFY688] ^Y*-7+4;WN!P%'$-;["[OSDO;G^T@@AVYR^;%88#S2TVL,)N
M6*F)X73-$M<]#!O0X%&&,&)00RX<PDA_PFK?\^NG'C:C<.")C*$4.3>&=4!
M7+<N8@A#1AG"B"$-N7 ((_T)"Q/4%=5M=)I;ZSF7&U+$FW5$==&5&,"04:8O
M8@A#+IR^B.61$.FVL%:CH6>'!D[$#2?BX7!JQ2MQX948OI!1IC!B0$,NG,)(
M?\"B88\#%J.A>Q<UC*)N1D5>\%H_A5>%'X3I"D)'X=1 AHXR>E%#&WKAZ%7[
MTY,;5_>IP1FC*C>_]99$OZ+Z%(MMDA<@91OE%:C&:@)$]=:G.I%\7[XX67(I
M>58>[EB\9D(;J.\W7"5?G^AW,<V[M\5_4$L#!!0    ( (50#5'#U(BZF 8
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M&+.\=EV=+FA.=$<NJ<";F50Y,;A5<U<O%259"<JY&WA>S\T)$\YH4)X]J=%
M%H8S09\4Z"+/B?H[IERNAH[OK ^>V7QA[($[&BS)G$ZH>5D^*=RY#4O&<BHT
MDP(4G0V=&_\ZB:U]:?"=T97>6(-5,I7RU6X>LJ'CV8 HIZFQ# 3_WN@MY=P2
M81A_:DZG<6F!F^LU^WVI';5,B::WDO]@F5D,G;X#&9V1@IMGN?I,:SU=RY=*
MKLM?6-6VG@-IH8W,:S!&D#-1_9/W.@\; +]W!!#4@& 7$!T!A#4@/!<0U8"H
MS$PEI<Q#0@P9#91<@;+6R&8793)+-,IGPI9]8A3>,L29T8-(94[A&WFG&EH3
M?%59P2G(&=0W4XIOB\*'W24DN-*&I4!$!IA]S*VX@%9"#6%<7T ;7B8)M#Y=
MP"=@ AX9YUAB/7 -!FS=NFD=W+@*+C@2G!_ HQ1FH>%.9#3;)G!1:2,W6,L=
M!R<9OQ2B Z%W"8$7> <"NCT;[E\=@"?GP_LGU(1-\<*2+_QO\2!A.N52%UBJ
M7S=3;11^4+]/N(@:%U'I(CKB(I%I@5^Y@7MT0#C\I$1AS?%E'BKG::[]G&^%
MU&U"ZIZD>>E,.H!]3Q%S[%E5!-V2P#:^MU$[\KJ]@?NV6>M]*S^*^]M&R;Y1
M>.4W-EL">HV WDD!7Z5HGR&B(NEM> [ZT8Z$ S9QN*-@WZ;=LZ_WD(2XD1"?
ME'!'E&!BKMT6/CK\Y.LNP:H':6PW.20IWJ]+&,?!CJA]*S_N^CNJ#E %07]'
ME;O1&'.JYN6 T9#*0IBJ:32GS0R[*5OWSOD89ULUBCYHJL'X2-2<"0V<SI#2
MZ\08DJJ&3;4Q<EFVWZDTV,S+Y0+G,U76 .]G4IKUQCIH)O[H'U!+ P04
M" "%4 U1E*WOFGX#   5#   &0   'AL+W=O<FMS:&5E=',O<VAE970V.2YX
M;6RE5VUOFSH8_2L6VH=$6@.8EY JB;2$37>3>E4UZ]UG-Y@$#>Q<VVFZ?S_;
M$)(8@ZKM2X/AG.-S'MOP='ZB["??8RS 6U42OG#V0ASN79=O][A"?$(/F,@G
M.645$G+(=BX_,(PR3:I*%WI>[%:H(,YRKN\]LN6<'D59$/S( #]6%6*_5KBD
MIX7C.^<;3\5N+]0-=SD_H!W>8/%\>&1RY+8J65%AP@M* ,/YPOGDWZ=^H @:
M\5^!3_SJ&J@H+Y3^5(.OV<+QE"-<XJU0$DC^O.(U+DNE)'W\WX@Z[9R*>'U]
M5O^BP\LP+XCC-2U_%)G8+YS$ 1G.T;$43_3T#VX"14IO2TNN_X)3@_4<L#UR
M0:N&+!U4!:E_T5M3B"N"'_<08$. )B'L(00-(7@O(6P(H:Y,'477(44"+>>,
MG@!3:*FF+G0Q-5O&+XA:]XU@\FDA>6+YE6QIA<%W](8Y&&WDMLJ.)08T!VM:
M'2C!1' UNN# YS>YZ3@&HQ4F."_$^"-8'QF32(!(!E*<8SG*QF"48H&*DH_!
M'7C>I&#T80P^@(* AZ(LY:+SN2MD!&7$W39V5[5=V&/7A^"!$K'GX#/)<'8K
MX,KL;0'@N0 K.*CX[4@F(/ ^ NA!SV)H_6ZZ/[/0T_?3DX$T0;N<@=8+>O2:
MA;@?D I;J5!+A3U27W"&&2IM:U03(TU4+Y;791S)\*_79>MBX"RZQ:1=3!#Z
M+>;&==2ZC@9=;P026._#DF[M[FN!^&I6/PH-]UU,8@1,NY ^[W'K/1[T_B\E
M=\^3S<1F.N[,%IL5[T(2L^!=B!\&=M/3UO1TT/1W*E IWU1ZW]F<3[NV$FA8
M[V)",U[:Q40PLGM/6N_)X&DYOZJ&CLNLU9K]Z7&9=9S?)= L@04$$Z,$%HSO
M>3T+Z'N73X#WMV>F4;B=&DZ-##948(!2"\B/>R)<?<7\/SXZ#=7P;EJW@<SZ
MVT!]>]"'%^_P'2<H:_:B-0'LSCN+?3."!94$9@0+R/>NRG$;XO+=\8/!$(^,
MOA:Z&92]J#MZJ5L#D#-:C>4G7S</0C49UGQ!YT-P-S5?;Q90D,1F/(M2F$R-
M=.Y5OU1AMM-])P=;>B2B[AS:NVUO^TEW=,;]E>IY=1]VD:D;Y@?$=@7AH,2Y
ME/0F4VF)U3UH/1#TH+NR%RIDCZ<O][)OQTP!Y/.<4G$>J G:_P26OP%02P,$
M%     @ A5 -4<B/W8MS!   PQ(  !D   !X;"]W;W)K<VAE971S+W-H965T
M-S N>&ULG5A=;^,H%/TK*-)*J539QG:3=)1&:IMV=T8S.U6['P^K?2#V38(&
M0Q9PT^ZO7\"NTP^,NWU);,PYEWNX7"[,]T+^4%L C1XJQM79:*OU[E,<JV(+
M%5&1V $W7]9"5D2;5[F)U4X"*1VH8G&:)).X(I2/%G/7=B,7<U%K1CG<2*3J
MJB+R\0*8V)^-\.BIX99NMMHVQ(OYCFS@#O3ONQMIWN*.I:05<$4%1Q+69Z-S
M_&F))Q;@>OQ!8:^>/2/KRDJ('_;E<WDV2NR(@$&A+04Q?_=P"8Q9)C..?UK2
M46?3 I\_/[%?.^>-,RNBX%*P/VFIMV>CV0B5L"8UT[=B_PNT#IU8OD(PY7[1
MONV;C%!1*RVJ%FQ&4%'>_).'5HAG ..H'Y"V@/0U(.\!9"T@>R\@;P&Y4Z9Q
MQ>FP))HLYE+LD;2]#9M]<&(ZM'&?<COO=UJ:K]3@].(S+T0%Z#?R  J-[TQ8
ME34#)-;H:KT&-RGHT ?=$@WH%@K!"\HHL5-WA,9+T(0R=32/M1F2)8Z+UOQ%
M8S[M,8]3]$UPO57HBI=0OB2(C2^=0^F30Q=ID/%+S2.4)<<H3=+$,Z#+=\/Q
MJ0>^?#]\%O FZZ8G<WS9X/2@)54%$ZJ6@/XZ7RDMS9+Y.V B[TSDSD3>8^)&
MBGOJEC'1Z!I*D(0AI8FNM9"/2)H9]\UKF#3%49+\Y)/_@[CE &X6X=>X%VJ<
M=&J<!(GNM(UPPDO$1&&$H,T$:+L^CA$WB=@LC76KT@HXK*GVR1.VDD8G?G7"
ML"0Z]8L3AHWQQ*IZ%)!GTLDS"5+90 27&)P.0IJ\RI'9A:3+!<HG19@QZ0N4
M,&R<1-,W+C5B# #S692'Q9AV8DR#5+\*F[-JDR17#&)N\AAY(.8140V55XHP
MG_$)^WVZ# /[PFDY8 \G41J68M9),0M2_2Q$N:?,K)=J1Z@TA8%W581)>D/A
M8[!E&#;&:>Z)H1?NGW;NGPXNB_/"ZW(8&)CR,#")9GZG!^SEV"61D-,X.=0.
M29#M<DOXQH0[1_>$U:0IY)@I)0DOP+L !@AQ7UX<P.5]"V  -YY.!M5X5DGA
M(-EUFPU-%D"%A))JOP1AEJ17@C!NC#TYOA4AC$RG41;<.W%ZD" =" C*B1-
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M;H&84Y#M8+ZOA=!/+]9 =V^U^ ]02P,$%     @ A5 -4</NY!YJ!P  T"(
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M/\WA.)L@/HE[A<YC?82^2)J5>%^<">CD<#_.TSR!/CFO&?",R@Q.1=E'&F.
ML^N/VQ$$77MD^53H)U0W/.-IGOI&>$MO<'"(R1%;2H+]E&2F-$^+I$%*EP4^
MS)_1%6:)O).Q&'P% ;UB*&./&H48I<4#"^>CA39OZ$@KMJP!^UG##6#["VFU
M+1@?9"#'MGGA%T;R_R:M[8Y#1EV)M2T'^UN.<VS9M641&P\/DE@+>-@/>%]>
M,89@!VCACND(6TC"?D@RG905>'0M8G^:+$3@R2'21"Q.$/\8])HTD?:L@Z,N
MV",668@?62H0]H5CSSK!!\G/U@,X/^=^57[:'!CCSOQ8B"!^B+@%"@9,M7A&
M]\#D$[K(%8C =/K;#4OOF?S=%ZD]S61PD-39(TU>0<+^A6EM1E[!E(@%#O(*
MIO1OCA,SXN!!'=276-0A?M3YS^> &7$\7.H*PP(=\7.A?U3TD86_Z" T*;)@
M%OG![#P5.;@]I9)=Y<4#3JY0PHN4YAGTRZ*+0\<'S@UD=2E943>H:N7LP5S0
MTDB: RF_9VA-.31_40CHLK)H55E/SB?T;1(5-A^J.61PQ_.9R*)OY&=:6U'O
MLTL6A*/#_ RR]3N('U+_%[O4YF3AJ#DQ5D([9VLXZ-@G"_61G[A]$9HFZ)<U
M%^#R->#3LGP2NL^F6?B/#L+H(@O,D1^8+57><OD:-HTG[A1?1>UY=3 D'1TB
MLA ;^2'VM3\51>UI\5TT[AAY(PN1D1\B#_Z0>%HMN/-\;MA\,M7?^ET]97)9
MO#*A4&P.0_DC<WVW?BWCO'@9H7%_&KZ?E2]76#/ENQXW5"YY!B>2+<!D<#P"
MCV3Y^D1YH<6Z^/7^7F@MTN+CBE$XMT8 OE\(H9\OS +U2RQG?P-02P,$%
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M9$4C)2 _7W,N#@_JQS_%+P+/_@=02P,$%     @ A5 -49/Q1L93 P  <@X
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ME"> 'H&J1(+9(ZW06>6!F*,;I<#<I?$,/3 Z89QI!FK;,D-V0] S3!,I6;Q
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M.QL$O0 RG+!"V'NUO,+2G[;C&RMA_"\L2]LH@'%AK,I+,"G(N5S]LY<R#C5
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M;W)K<VAE971S+W-H965T.#4N>&ULC53?3]LP$/Y73A$/(+$F3<K&4!H)VB%
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MW-:#MG.K5]SJ.[E=XP(%Q#OL:E29&E_Q;4HK>NE.H6_=8>*(+AS134ZD:R]
M&J?)!R?2#4XTZIN=.*D(GNPD>"6I!:&QT">6,%BRN8%_T$/#I]+S9@8N<3QU
M%7IK@12RTNW*YSO*=5JQ.?V*;M:BMW$0[2Q7#S5?,#=:S:'7C=#C9J2DY3*G
M2>&.75.@L>'','6/]>H=EKUE8R^.UMZ$6B/YX'&X,M#<U\0-TW2% 8$30D5'
M*<%U,:"+C55S/^.&RM+$],L9?=2@=@'T?**4?=VXL5E])K7_ U!+ P04
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M1A:M#M\+AX&1N^S(_2B-/<!GEUO[C07*!=CG:RG-\\"=XHNOMOE?4$L#!!0
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M96I9N>U9G@BZ+;;IGJD0-"T.(X)#PI2!_']-Y6.J3]0-JLWGV3]02P,$%
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M$%A"]LSME>;VG/,X_32[!%.E1#S?*#)/*% <7.L28>H$?*391&I[P9<;GB1
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M&(#^?<&Y>GPQ Y373I-_ 5!+ P04    " "%4 U1,V)D)B$%  #,%   &0
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M\(A@*K978$;B+KCXBF)*8IQBJ)8378,)S3+YI*1P\,)1HN@TV^T% G>0XQA
MDH I3N5  NZ7SY?@8HH$Q"F_!!_!R_,47'RX!!^  W@A!1/P0K#@5[6!SSA-
MI4HY]J'^.G*$=$ANEA.7QM\5QOLGC _ 9TK$EH-[DJ#$PI\W\SV_08 C(U&%
MPS^$X\YOE#C?DRX(W"O@N[YKF="DF?X9,DGW3M*GS?0IB@]T;VBAWS?3G]'N
M,'DK_:&U[5;ZI]:V6^F/[6T?6.BS]K;;Z//?B_O3[[ENT9X^:,CBH"HJ@9(7
MM"\J_]RNN&!RS_VW07ZODM]3\GLGY'^1W8DL0C1#X&)!.;]4-2G=RS*U 4O*
M5$'2R]@76:WD8F545@L)FQ&!9#T1MJI1: ^5]KR->1U'87_DO-87HHD)0N\8
M,S4Q?A[=.N;>Q'SL#7U-TH.)\H:]8\PGB[9A=(QYM& &FJZ9B0EU77/+K(-H
M&!RCGBRS#J+P&+2P3"D<5IBC_ BK_ C/Y@<ZY"#4\H <YP%NR(-"2U2W4G/6
MQ(3H26 B]!0X*^/AK(Q/9Q&/9[7,SB+F%H?H,;= ?"WBC5*. AY5 8]^K2 8
MJW\IBQ"Q!CFR+'9MV4Q,3!!J_IV:&'.QFYA\L6O^>3!1YF*W:#,6NP4ST&8T
M,S&AOHSGEEG+Q:YI>[+,.H@T40O+E&K./HI]OXI]OS'VW]1!"R4?X2MB\N (
MXJ(-+?K%/_\8^)[WUTHUGQ?X,'QIVZ+[1E[Z1DDS,8&K^71AP7@G$GQ0&3EH
MWE'7:WELS9OL)&^>Y<$5<!3O&188\>N&+758*1@V>O$^VZ7T)Y)B!8V_ [H3
M18>=ET:&X[Q=5YX#^Z(;S_OX'6+J&H#$J/[QG)N'YTK5DXG0"M'"1/AV!WON
M^T'(_?T\2LJCRQD32U7-J60!!:YNJ WDA2=LK1WZO,9T.IS JDU2AO+(7F/7
MM!X"FQ+/\]\GXS>GGM$M7A6'1:MG"UG]HSW9[T:>[EP3U^N&>N]A0;G=P:E4
M>F]_O>"7+2I=;K4I:&F3B9,VZ276@I(V>6[]S],L=&H7"!EB&W4MQF5&[(DH
MVOYJM+IZNU47$-KXG7<]\RSC\_RJ3EU8O(LO[OGDL6V#"0<I6DM5;K<O-P=6
M7)T5+X+NU/7%B@I!,_6X13!!+ ?([VM*Q>$E5U!=8([_!U!+ P04    " "%
M4 U1A;V1%+T"  #5!@  &0   'AL+W=O<FMS:&5E=',O<VAE970Y,BYX;6R-
M5=MNXC 0_951GEJI2T*XM%L!$I>NVI6Z0JUV]V&U#R89B%7'SMJ3TOY];2=D
M@0+BA?@RY_C,C'T8K)5^,1DBP5LNI!D&&5%Q&X8FR3!GIJ4*E'9GJ73.R$[U
M*C2%1I9Z4"[".(KZ8<ZX#$8#OS;7HX$J27")<PVFS'.FWR<HU'H8M(/-PA-?
M9>06PM&@8"M\1OI9S+6=A0U+RG.4ABL)&I?#8-R^G?5<O _XQ7%MML;@,EDH
M]>(F#^DPB)P@%)B08V#V\XI3%,(161G_:LZ@.=(!M\<;]F\^=YO+@AF<*O&;
MIY0-@YL 4ERR4M"36M]CG8\7F"AA_"^LZ]@H@*0TI/(:;!7D7%9?]E;780O0
M[A\!Q#4@W@=TCP Z-:!S+J!; [J^,E4JO@XS1FPTT&H-VD5;-C?PQ?1HFSZ7
MKNW/I.TNMS@:W3$MN5P9F*.&YXQIA#&1YHN2V$(@D((ITRF73, ],D'9%3S(
MI 47/YC6S#7M$BYF2(P+<PE?P#@.L_EP"8]<"-MA,PC)ZG6GADFM;5)IBX]H
M:\?PJ"1E!NYDBNDN06@3;;*--]E.XI.,WTO9@DYT!7$41P<$3<^&M[\>@,_.
MA]^<R*;3]*[C^3KG]^[/>&%(V\?T]P1_M^'O>O[N$?ZY(I3$F1#OD')1NF8#
MYH50[XA@KV;R JIPS]=<60NP!_.$,*UZ#Z7D9(#)% K4WI]D@CM[E#&"-=HY
ML\<T)US82U-=G\M#=Z;2W/>:G:F]COJ#\'6[B9\CKG<C9J<X=DK5:TK5.UFJ
M^KI7&:E2I+#8RXK96K@B63\"M01I'5TH<_!5]#ZIB_?4A5L//D>]\L9I(%&E
MI.HU-*N--X^])>VM3ZQG5Q;[GZ8R_$>F5UP:$+BTE%'KVJK2E8E6$U*%MY6%
M(FM2?IC9_QW4+L#N+Y6]/O7$'=#\DXT^ %!+ P04    " "%4 U1=H^/(  $
M  #R#@  &0   'AL+W=O<FMS:&5E=',O<VAE970Y,RYX;6R]5UUOVS84_2N$
MT(<$6")1LCX<V :2V$U3)&T0M]M#L0?:HFVN$JF1=)P"^_&[E&3Y2U(T;.N+
M+5'WGGO.Y>4E.=@(^5VM*-7H-4VX&EHKK;,KVU;S%4V)NA09Y?!E(61*-+S*
MI:TR24F<.Z6)[3I.8*>$<6LTR,>>Y&@@UCIAG#Y)I-9I2N2/&YJ(S=#"UG;@
MF2U7V@S8HT%&EG1*]=?L2<*;7:'$+*5<,<&1I(NA=8VO[G!D''*+7QG=J+UG
M9*3,A/AN7N[CH>481C2A<VT@"/R]T%N:) 8)>/Q9@EI53..X_[Q%?Y^+!S$S
MHNBM2'YCL5X-K<A",5V0=:*?Q>8#+07Y!F\N$I7_HDUAZP<6FJ^5%FGI# Q2
MQHM_\EHF8L_!Q0T.;NG@=G7P2@>OJT.O=.@=.T0-#G[IX'>-$)0.05>'L'0(
M\\DJLIM/S9AH,AI(L4'26 .:><CG-_>&&6'<E.)42_C*P$^/IG0)A:71/2_*
MVI3'V2<B)3$E<H[.QE03EJAS] XQCAY9DH")&M@:@AL(>UX&NBD"N0V!//0H
MN%XI-.$QC6O\)^W^V&T!L$%U)=W=2K]Q6Q$_KODE\IQ?D.NXSM?I&)V].Z_A
M==N.,J79%@7WFU'&W5&B9I3)/U>DB@FN 7O?&:Q-V%UWE'IA!W/G567KY;#>
M&V7[3#,A->/+@P+^]@#FZ%[35/W>$JQ7!>OEP7H-P3ZMTQF52"S*<&264%0R
M4.@OU)SB20$<Y,!F5W@9N0/[I8:+7W'Q.W+YG%&S2$%Z-RI^5RI!125HI?(D
MZ<47\HKN8,-#D/4Q- REF5Y+6A>_ //WXOM.5,\@K!B$K0SRR&</0D%[>J8)
MT31&6J 'IMFRJ 382G5"FU(2GJ3DP@][N")5+)/PA/B%%QS:W-788+]?KRZJ
MU$5OY%?\ 1LVF@L%<PMB&#<)SNN>\!@)O8)*4' HB:$*ZO1%)_J"_I&X4Q/?
M/](6G6CK>?7*^I6R?JLR3E[8!TH2O4+?'JDIZ+9EBIW=7N;\_UT![VV=^.WR
M.RQ\=+W0,"FP+&IW2'R:RKYWF.YQC9$7-BP4[.ZXNO_A8AV7:$VKM:B=-XP.
MF>XZ._9:F4XA@<PTV+5<LCE)T)W8<)A2>$PZE<NNK>/>3RB77>?&[:W['I8O
MUT+^V(J9O,+:5;7-LH3:3VWD-V1VUZ]Q>\/^(C2D\W/&!(OWFV27I.Y:,@Y_
M0E)W/1*W-\E_N07<XM/N=N$'GG.4:WOOA)U2N<PO3PI:\YKKXM12C587M.O\
M6G(T?H.OQKAF?&(N=/F)?@=?W 8?":P#KE!"%Q#*N0R!JRPN6,6+%EE^OI\)
M#;>%_'$%EU(JC0%\7PBAMR\F0'7-'?T-4$L#!!0    ( (50#5'%K.EZ1P4
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MRK<:Y0VGZ^)D>4$YITEQN2)^2%@.$+\_4\JW-WD'];NET?]02P,$%     @
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M0JZPG%.N@)&9D0S..B8F6=[KRXX62W?3G0IM[LVNN3!O(2*M@9F?":$W';M
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M1'V5J0>*5_9PO^)*7Q7LXU9?_X@P /U^S;DZ#$R ]D(Y^P=02P,$%     @
MA5 -41#X2^#4 @  P0D  !D   !X;"]W;W)K<VAE971S+W-H965T.3<N>&UL
MM5;=;MHP&'T5*^I%*VU-XH1 *D!J0=,ZK1HJZW8Q[<*$#[#JQ)EMH)7V\+.=
M- UIH$Q5;XCMG//]G$-L][=<W,L5@$(/*<ODP%DIE5^XKDQ6D!)YSG/(])L%
M%RE1>BJ6KLP%D+DEI<S%GA>Y*:&9,^S;M8D8]OE:,9K!1""Y3E,B'J^ \>W
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M+P$\G5B5'=EE=T.<B'\NTS,4^!\1\8G?0.CVX' \: @?'QY^X<@FJ+0*<KS
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M$>.S8@ZU,'3C8K^5(O;M:\$_?(*@?]$]W;!DF;BP:Z\<?!R3!1-+B?Q/FK0
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MX RN+7(%;EC##3OAYIBG4" S!/E&4.+7A/:(XO!F%-L2#5].2$<UZ>@MNY(
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MKRCMJNJEU<3(W'67E334J]PPH<\/5-: ]M=2FMW$'M!\T(Q_ U!+ P04
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MI'97@-W$R)4[%,^EH2.V&Z9T;4)E ^CY0DJSG]@75!>QT;]02P,$%     @
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MZWSZSE^B<^M_85O;1@$DI25=U&".H)"J^A?/-0\M0&=P A#7@'@?T#L!Z-:
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M=/.1 S+5L*PVI-=^?"PT\3#RRXR_+] X WZ^U)I>-NZ"YHME_ M02P,$%
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M*M*R*AL]9JG<"'27KM@*X,^[^9AT"!@J$QWL1/9VNB6=$N>[]!S9UADB%K&
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M"&9K)7,!@7!;-X3K01>_,^GF6\PW0I4=LQ=EU5?5Z^0;@OJ=.3;G,%>?1!\
MD-ZZ=T*:6ZFG.=P]SGWD[,-O]"O:;VD<Y5N)Y(Y#]S;S2EKC.+."ED74XP/N
MGA_V(:H.C61+(YY;$N41!-V=5;*:EQQ6FR'J%A=W][@I?8W*HPM]>63),^.=
MZ5"W4#C\ >E'ZK.:6/]C;-Y6TMR6V&PNHCZ@2?<!_>^B:E9):XNJZLJU&]1<
M:7U<D>[C"E@ANGE1PPM2ZP<-1HQE.$8I!T"VW[;6NI(3NW.MOV52]5>_;*,L
M6AW7TQ[Q2NKR39P?$:]U+24]:NE_/R[N*O&-EM_U[)9Z0.K"2+H+8XNQSU"J
MFF&55U*%=Q_#UT60^#_"\'7!(]T%[[L-'P"&QXYN^.'16\J$\77Q[EVHH6"7
MRO(5QN'IX?W^3?&64WM^BR]F&'@^QQ>+\NU]+;[\8X+'XBI:H)B]*%5Y+SA
MO'P_7WZ1V;9X1_J<29DEQ<<-HRO&<X#Z_4N6R?V77,'AKR2N_P%02P,$%
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M+7P='^,$E50M.V< >_DSCDG)+KNH6W,0350O?S+;<Q=UP?Z?1/@'4$L#!!0
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M;KK=-%EV:HY]*2Y+D>Y_<&?_8T$?_@502P,$%     @ A5 -43J;0#48 P
MF4   !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<\W;2T[<0!2%X:V@
M7@"N6^^*@%$F3",VT&K,0_1+;4>!W:<% SBE##)!_D=6V?+U&7VR[#I7O\;M
M>GX^[*>GY^-T\;K;[J?KU=,\'W\,P[1Y&G?KZ?)P'/?G*P^'TVX]GY>GQ^&X
MWKRL'\?!.Y>'T]<9JYNKKS,O[MZ.X_],/#P\/&_&GX?-[]VXG_\Q>/AS.+U,
M3^,XKR[NUJ?'<;Y>#:_;S]/3\'ZPR_/DU<7M_?7J='MOJV'I0%X"^>4#!0D4
ME@\4)5!</E"20&GY0%D"Y>4#%0E4E@]4)5!=/E"30&WY0.941@>(U&$-T-J4
M:P-X;0JV <0V)=L 9INB;0"U3=DV@-NF<!M ;E.Z#6"W*=X&T-NKWAZ@MU>]
M/4!OW[UL _3VJK<'Z.U5;P_0VZO>'J"W5[T]0&^O>GN WE[U]@"]O>KM 7H'
MU3L ] ZJ=P#H'53O - [=!]+ 'H'U3L ] ZJ=P#H'53O - [J-X!H'=0O0-
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MIGHW@-Y-]6X O9OJW0!Z-]6[ ?1NJG<#Z-U4[P;0NZG>#:!W4[T;0._6E74
M>IOKZSH O\UUA1T'$-Q<5]EQ ,/-=:4=!U#<7%?;<0#'S77%'0>0W%Q7W7$
MR\UUY1T'T-Q<5]]Q ,_-=04>1Q"]+V!^:P-SFM^VX_29Z&/=!?A.O>?SO>/G
M\]^7'R?[TN<[U\/7&-/-7U!+ P04    " "%4 U1QX65K'H"   G/@  $P
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " "%4 U1F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M (50#5%6V#:_.@8  #T9   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " "%4 U1HO^6W4L&  "6&   &
M            @(%]#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#
M%     @ A5 -4<S;C^&[ P  1PP  !@              ("!_A0  'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( (50#5%2>"+8B04  -@5
M   8              " @>\8  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q0
M2P$"% ,4    " "%4 U1;WBEJG$"   D!P  &               @(&N'@
M>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ A5 -44?>^&E>
M"   E3(  !@              ("!52$  'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;%!+ 0(4 Q0    ( (50#5%&^$9Q*PD  %(H   8              "
M@>DI  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "%4 U1
MV /JIULJ  !#A0  &               @(%*,P  >&PO=V]R:W-H965T<R]S
M:&5E=#@N>&UL4$L! A0#%     @ A5 -4?99$(=E"0  9AD  !@
M     ("!VUT  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (
M (50#5$6F!1S^P0  #H,   9              " @79G  !X;"]W;W)K<VAE
M971S+W-H965T,3 N>&UL4$L! A0#%     @ A5 -48VKG<SH!   4@T  !D
M             ("!J&P  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"
M% ,4    " "%4 U1CI1NEA@%  !A%P  &0              @(''<0  >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( (50#5'TQZ12@0H
M '0=   9              " @19W  !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&UL4$L! A0#%     @ A5 -4282(WH[$0  R3$  !D              ("!
MSH$  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "%4 U1
MUYUN-U$8  #]1   &0              @(% DP  >&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;%!+ 0(4 Q0    ( (50#5&MLH2B8P,  .P'   9
M      " @<BK  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%
M  @ A5 -42@/DJ?B#P  LC@  !D              ("!8J\  'AL+W=O<FMS
M:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " "%4 U1C?NPBCP&  # $
M&0              @(%[OP  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+
M 0(4 Q0    ( (50#5$I+B<;R ,  !\*   9              " @>[%  !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ A5 -4:>42B[/
M"P  XR(  !D              ("![<D  'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6Q02P$"% ,4    " "%4 U1U*[(H P+  "G(0  &0
M@('SU0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( (50
M#5$S?KM[C00  &$+   9              " @3;A  !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&UL4$L! A0#%     @ A5 -412)2K];!   <@H  !D
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M=#(W+GAM;%!+ 0(4 Q0    ( (50#5&K <2_UP0  'X1   9
M  " @;<J 0!X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @
MA5 -46ISMC2! P  O0<  !D              ("!Q2\! 'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6Q02P$"% ,4    " "%4 U1M)I)R?L'  !O%@  &0
M            @(%],P$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4
M Q0    ( (50#5'WL3Q\* 0  !L*   9              " @:\[ 0!X;"]W
M;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ A5 -49;+3YF#!P
MW1X  !D              ("!#D ! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6Q02P$"% ,4    " "%4 U1&BNT)EH#    "   &0              @('(
M1P$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( (50#5&B
M<&?&10,  -T'   9              " @5E+ 0!X;"]W;W)K<VAE971S+W-H
M965T,S0N>&UL4$L! A0#%     @ A5 -4<HL'QI:!@  W!@  !D
M     ("!U4X! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (50#5%1ERS68P(  - %   9              "
M@7AI 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ A5 -
M44 3<>_K @  ^@D  !D              ("!$FP! 'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6Q02P$"% ,4    " "%4 U1,O5L"JH"  #&!P  &0
M        @($T;P$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0
M   ( (50#5&HWB(=N0(  'H'   9              " @15R 0!X;"]W;W)K
M<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ A5 -442,A!J\ @  _@8
M !D              ("!!74! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q0
M2P$"% ,4    " "%4 U1'/WYU)T"  !O!@  &0              @('X=P$
M>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( (50#5&469TR
M!00  *$2   9              " @<QZ 0!X;"]W;W)K<VAE971S+W-H965T
M-#8N>&UL4$L! A0#%     @ A5 -45=;PG[# P  G \  !D
M ("!"'\! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " "%
M4 U1DR/V[:X$   Q%@  &0              @($"@P$ >&PO=V]R:W-H965T
M<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( (50#5&^!>D]Q0,  $$-   9
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M970U,RYX;6Q02P$"% ,4    " "%4 U12__2=^0"  !A!P  &0
M    @('+E@$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (
M (50#5& %T FAP(  '\&   9              " @>:9 0!X;"]W;W)K<VAE
M971S+W-H965T-34N>&UL4$L! A0#%     @ A5 -4:2Y7V]-!0  6Q4  !D
M             ("!I)P! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"
M% ,4    " "%4 U1*]SR>;X"  "1!P  &0              @($HH@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( (50#5%8Z6;]DP,
M +D-   9              " @1VE 0!X;"]W;W)K<VAE971S+W-H965T-3@N
M>&UL4$L! A0#%     @ A5 -40G"1GRK @  N0<  !D              ("!
MYZ@! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " "%4 U1
MRA[P0#<$  "<$0  &0              @(')JP$ >&PO=V]R:W-H965T<R]S
M:&5E=#8P+GAM;%!+ 0(4 Q0    ( (50#5$T!]8O]@0  ,$6   9
M      " @3>P 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%
M  @ A5 -41UG7O\L P  NPH  !D              ("!9+4! 'AL+W=O<FMS
M:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    " "%4 U1HDAFGZL#   ]#0
M&0              @(''N $ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+
M 0(4 Q0    ( (50#5&U]&4M. 4  (<;   9              " @:F\ 0!X
M;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ A5 -4</4B+J8
M!@  L2(  !D              ("!&,(! 'AL+W=O<FMS:&5E=',O<VAE970V
M-2YX;6Q02P$"% ,4    " "%4 U1D>!]&I4%  #$&P  &0
M@('GR $ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( (50
M#5$"P=3#I@,  ,T-   9              " @;/. 0!X;"]W;W)K<VAE971S
M+W-H965T-C<N>&UL4$L! A0#%     @ A5 -44F(S_GA @  _0<  !D
M         ("!D-(! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4
M    " "%4 U1E*WOFGX#   5#   &0              @(&HU0$ >&PO=V]R
M:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( (50#5'(C]V+<P0  ,,2
M   9              " @5W9 0!X;"]W;W)K<VAE971S+W-H965T-S N>&UL
M4$L! A0#%     @ A5 -4</NY!YJ!P  T"(  !D              ("!!]X!
M 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " "%4 U1Z:H2
MSN #  "R#0  &0              @(&HY0$ >&PO=V]R:W-H965T<R]S:&5E
M=#<R+GAM;%!+ 0(4 Q0    ( (50#5'0[T9"@P(  $4&   9
M  " @;_I 0!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @
MA5 -40<M=XQ7!0  #1<  !D              ("!>>P! 'AL+W=O<FMS:&5E
M=',O<VAE970W-"YX;6Q02P$"% ,4    " "%4 U1%=8+6H\'   =*   &0
M            @($'\@$ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4
M Q0    ( (50#5&3\4;&4P,  '(.   9              " @<WY 0!X;"]W
M;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ A5 -42P:"A+! @
MRPD  !D              ("!5_T! 'AL+W=O<FMS:&5E=',O<VAE970W-RYX
M;6Q02P$"% ,4    " "%4 U18^WP<>,#  !N$0  &0              @(%/
M  ( >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( (50#5'6
M+!J^L 0  (D2   9              " @6D$ @!X;"]W;W)K<VAE971S+W-H
M965T-SDN>&UL4$L! A0#%     @ A5 -476'/9+( @  P0<  !D
M     ("!4 D" 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (50#5%OFF/H3P(  !,%   9              "
M@4D: @!X;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @ A5 -
M48)^RN7' @  U@8  !D              ("!SQP" 'AL+W=O<FMS:&5E=',O
M<VAE970X-BYX;6Q02P$"% ,4    " "%4 U1B#IC6"D#   R"0  &0
M        @('-'P( >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0
M   ( (50#5&*^F%H? ,  ,$-   9              " @2TC @!X;"]W;W)K
M<VAE971S+W-H965T.#@N>&UL4$L! A0#%     @ A5 -4=BI0';A!   B!8
M !D              ("!X"8" 'AL+W=O<FMS:&5E=',O<VAE970X.2YX;6Q0
M2P$"% ,4    " "%4 U1G.E@!( %  ""&@  &0              @('X*P(
M>&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;%!+ 0(4 Q0    ( (50#5$S8F0F
M(04  ,P4   9              " @:\Q @!X;"]W;W)K<VAE971S+W-H965T
M.3$N>&UL4$L! A0#%     @ A5 -486]D12] @  U08  !D
M ("!!S<" 'AL+W=O<FMS:&5E=',O<VAE970Y,BYX;6Q02P$"% ,4    " "%
M4 U1=H^/(  $  #R#@  &0              @('[.0( >&PO=V]R:W-H965T
M<R]S:&5E=#DS+GAM;%!+ 0(4 Q0    ( (50#5'%K.EZ1P4  &<:   9
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M970Y."YX;6Q02P$"% ,4    " "%4 U1IGKCXWH$  !M%0  &0
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M,3 S+GAM;%!+ 0(4 Q0    ( (50#5%IU"^JVP(  .X(   :
M  " @61D @!X;"]W;W)K<VAE971S+W-H965T,3 T+GAM;%!+ 0(4 Q0    (
M (50#5']%6GYA ,  "8,   :              " @7=G @!X;"]W;W)K<VAE
M971S+W-H965T,3 U+GAM;%!+ 0(4 Q0    ( (50#5&2Q :2L ,  )0-   :
M              " @3-K @!X;"]W;W)K<VAE971S+W-H965T,3 V+GAM;%!+
M 0(4 Q0    ( (50#5$AV724C@,  #D,   :              " @1MO @!X
M;"]W;W)K<VAE971S+W-H965T,3 W+GAM;%!+ 0(4 Q0    ( (50#5%,K@?1
M.@,  +T(   :              " @>%R @!X;"]W;W)K<VAE971S+W-H965T
M,3 X+GAM;%!+ 0(4 Q0    ( (50#5$R L<D*@<  #$A   :
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( (50#5$ZFT U& ,  )E    :
M          "  8:. @!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( (50#5''A96L>@(  "<^   3              "  =:1 @!;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@    !V '8 ?"   (&4 @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>421</ContextCount>
  <ElementCount>564</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>128</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Consolidated Statements of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings</Role>
      <ShortName>Consolidated Statements of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002000 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003000 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003501 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1013000 - Statement - Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1014000 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Restructuring and Employee Severance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeverance</Role>
      <ShortName>Restructuring and Employee Severance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2105100 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2110100 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2111100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - Commitments, Contingent Liabilities and Litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation</Role>
      <ShortName>Commitments, Contingent Liabilities and Litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2114100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2115100 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2117100 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2118100 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc.</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2119100 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2120100 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2121100 - Disclosure - Selected Quarterly Financial Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnaudited</Role>
      <ShortName>Selected Quarterly Financial Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2123100 - Schedule - Schedule II - Valuations and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccounts</Role>
      <ShortName>Schedule II - Valuations and Qualifying Accounts</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2201201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2301301 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/Leases</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2301302 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Restructuring and Employee Severance (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</Role>
      <ShortName>Restructuring and Employee Severance (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeverance</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2310301 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2311301 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2314301 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurements</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2315301 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstruments</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2317301 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquity</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2318301 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2319301 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2320301 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2321301 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedTables</Role>
      <ShortName>Selected Quarterly Financial Data (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnaudited</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2401402 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LeasesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2401403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2401403 - Disclosure - Leases Schedule of Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails</Role>
      <ShortName>Leases Schedule of Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2401404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2401404 - Disclosure - Leases Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2401405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2401405 - Disclosure - Leases Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2401406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2401406 - Disclosure - Leases Schedule of Future Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails</Role>
      <ShortName>Leases Schedule of Future Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2401407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2401408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2401409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2401411 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2401412 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2401413 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2401414 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2401415 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2401416 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2402402 - Disclosure - Divestitures and Acquisitions (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails</Role>
      <ShortName>Divestitures and Acquisitions (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails</Role>
      <ShortName>Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2403403 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails</Role>
      <ShortName>Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2403404 - Disclosure - Restructuring and Employee Severance Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails</Role>
      <ShortName>Restructuring and Employee Severance Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2405403 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2405404 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2408401 - Disclosure - Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/InvestmentsDetails</Role>
      <ShortName>Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/Investments</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2410402 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2411402 - Disclosure - Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails</Role>
      <ShortName>Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2411403 - Disclosure - Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails</Role>
      <ShortName>Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2411406 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2411407 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails</Role>
      <ShortName>Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2411408 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails</Role>
      <ShortName>Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2412401 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails</Role>
      <ShortName>Commitments, Contingent Liabilities and Litigation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2414402 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2414403 - Disclosure - Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details</Role>
      <ShortName>Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2415402 - Disclosure - Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails</Role>
      <ShortName>Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2415403 - Disclosure - Financial Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2415404 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2415405 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2415408 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2415410 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails</Role>
      <ShortName>Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2415411 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails</Role>
      <ShortName>Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2415412 - Disclosure - Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails</Role>
      <ShortName>Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2417402 - Disclosure - Shareholders' Equity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>Shareholders' Equity (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquityTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2417403 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquityTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>2418402 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>2418403 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>2419402 - Disclosure - Segment Information (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>2419403 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Revenue by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>2419404 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Segment Profit by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>2419405 - Disclosure - Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>2419406 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Assets by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>2419407 - Disclosure - Segment Information  Property and Equipment, net by Geographic Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails</Role>
      <ShortName>Segment Information  Property and Equipment, net by Geographic Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>2420402 - Disclosure - Share-Based Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>2420403 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>2420404 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>2420405 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>2420406 - Disclosure - Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails</Role>
      <ShortName>Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>2420407 - Disclosure - Share-Based Compensation (Schedule of the Range of Assumptions Used to Estimate the Fair Value of Stock Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of the Range of Assumptions Used to Estimate the Fair Value of Stock Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>2420408 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails</Role>
      <ShortName>Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails</Role>
      <ShortName>Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>2421402 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails</Role>
      <ShortName>Selected Quarterly Financial Data (Unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="a20q410k063020form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>2423401 - Schedule - Schedule II - Valuations and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails</Role>
      <ShortName>Schedule II - Valuations and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="a20q410k063020form10-k.htm">a20q410k063020form10-k.htm</File>
    <File>a20q410k63020exhibit211.htm</File>
    <File>a20q410k63020exhibit231.htm</File>
    <File>a20q410k63020exhibit311.htm</File>
    <File>a20q410k63020exhibit312.htm</File>
    <File>a20q410k63020exhibit321.htm</File>
    <File>a20q410k63020exhibit991.htm</File>
    <File>cah-20200630.xsd</File>
    <File>cah-20200630_cal.xml</File>
    <File>cah-20200630_def.xml</File>
    <File>cah-20200630_lab.xml</File>
    <File>cah-20200630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>chart-148af8dedebd55ac9eb.jpg</File>
    <File>chart-262f3986bd9a95f0107.jpg</File>
    <File>chart-460dfd3e426b549eabf.jpg</File>
    <File>chart-785fc250b4225182a09.jpg</File>
    <File>chart-94d908f3201c52649e7.jpg</File>
    <File>chart-b8cf9d04cd0f5e60a69.jpg</File>
    <File>chart-df5fa58deb025709a81.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>137
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "a20q410k063020form10-k.htm": {
   "axisCustom": 6,
   "axisStandard": 35,
   "contextCount": 421,
   "dts": {
    "calculationLink": {
     "local": [
      "cah-20200630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cah-20200630_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "a20q410k063020form10-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cah-20200630_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cah-20200630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cah-20200630.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 855,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 26,
    "http://www.cardinal.com/20200630": 4,
    "http://xbrl.sec.gov/dei/2019-01-31": 6,
    "total": 36
   },
   "keyCustom": 79,
   "keyStandard": 485,
   "memberCustom": 62,
   "memberStandard": 61,
   "nsprefix": "cah",
   "nsuri": "http://www.cardinal.com/20200630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Document and Entity Information",
     "role": "http://www.cardinal.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103100 - Disclosure - Restructuring and Employee Severance",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeverance",
     "shortName": "Restructuring and Employee Severance",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420403 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails",
     "shortName": "Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420404 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:Netproceedstaxwithholdingsfromsharebasedcompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420405 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
     "shortName": "Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:AdditionalStockOptionPlanDataTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:RemainingStockOptionPlanDataTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420406 - Disclosure - Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails",
     "shortName": "Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:RemainingStockOptionPlanDataTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420407 - Disclosure - Share-Based Compensation (Schedule of the Range of Assumptions Used to Estimate the Fair Value of Stock Options) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails",
     "shortName": "Share-Based Compensation (Schedule of the Range of Assumptions Used to Estimate the Fair Value of Stock Options) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420408 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails",
     "shortName": "Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:AdditionalPerformanceShareUnitsDataTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails",
     "shortName": "Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421402 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Details)",
     "role": "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails",
     "shortName": "Selected Quarterly Financial Data (Unaudited) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4QTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105100 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "2423401 - Schedule - Schedule II - Valuations and Qualifying Accounts (Details)",
     "role": "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails",
     "shortName": "Schedule II - Valuations and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108100 - Disclosure - Investments",
     "role": "http://www.cardinal.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110100 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings",
     "role": "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111100 - Disclosure - Income Taxes",
     "role": "http://www.cardinal.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112100 - Disclosure - Commitments, Contingent Liabilities and Litigation",
     "role": "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation",
     "shortName": "Commitments, Contingent Liabilities and Litigation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114100 - Disclosure - Fair Value Measurements",
     "role": "http://www.cardinal.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115100 - Disclosure - Financial Instruments",
     "role": "http://www.cardinal.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117100 - Disclosure - Shareholders' Equity",
     "role": "http://www.cardinal.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118100 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc.",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001000 - Statement - Consolidated Statements of Earnings",
     "role": "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
     "shortName": "Consolidated Statements of Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "lang": null,
      "name": "cah:Amortizationandotheracquisitionrelatedcosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119100 - Disclosure - Segment Information",
     "role": "http://www.cardinal.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120100 - Disclosure - Share-Based Compensation",
     "role": "http://www.cardinal.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121100 - Disclosure - Selected Quarterly Financial Data (Unaudited)",
     "role": "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnaudited",
     "shortName": "Selected Quarterly Financial Data (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "2123100 - Schedule - Schedule II - Valuations and Qualifying Accounts",
     "role": "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccounts",
     "shortName": "Schedule II - Valuations and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2201201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "cah:LeasesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2301301 - Disclosure - Leases (Tables)",
     "role": "http://www.cardinal.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "cah:LeasesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2301302 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Restructuring and Employee Severance (Tables)",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables",
     "shortName": "Restructuring and Employee Severance (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310301 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)",
     "role": "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002000 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311301 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.cardinal.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314301 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315301 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317301 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318301 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319301 - Disclosure - Segment Information (Tables)",
     "role": "http://www.cardinal.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320301 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321301 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables)",
     "role": "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedTables",
     "shortName": "Selected Quarterly Financial Data (Unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401402 - Disclosure - Leases (Details)",
     "role": "http://www.cardinal.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:ReceivablesPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:NotesReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003000 - Statement - Consolidated Balance Sheets",
     "role": "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "cah:LeasesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401403 - Disclosure - Leases Schedule of Lease Costs (Details)",
     "role": "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails",
     "shortName": "Leases Schedule of Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "cah:LeasesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_srt_MajorCustomersAxis_cah_CVSCaremarkCorporationMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:LeasesSupplementalBalanceSheetInformationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401404 - Disclosure - Leases Supplemental Balance Sheet Information (Details)",
     "role": "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:LeasesSupplementalBalanceSheetInformationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cah:ConcentrationRiskLargestGroupPurchasingOrganizations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "organization",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cah:ConcentrationRiskLargestGroupPurchasingOrganizations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "organization",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:LeasePaymentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401405 - Disclosure - Leases Supplemental Cash Flow Information (Details)",
     "role": "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:LeasePaymentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:PercentageOfLIFOInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:PercentageOfLIFOInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401406 - Disclosure - Leases Schedule of Future Lease Payments (Details)",
     "role": "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails",
     "shortName": "Leases Schedule of Future Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongtermDebtWeightedAverageInterestRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_srt_RangeAxis_srt_MinimumMember",
      "decimals": "3",
      "lang": null,
      "name": "cah:DiscountRatefairvalueinputs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003501 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "cah:CostofSalesVendorReservesPolicyPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:VendorReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401411 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "cah:CostofSalesVendorReservesPolicyPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:VendorReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "cah:DividendsPolicyPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401412 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "cah:DividendsPolicyPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:RevenueRecognitionReserveforSalesReturnsandAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401413 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:RevenueRecognitionReserveforSalesReturnsandAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401414 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "cah:ShippingandHandlingCostsPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401415 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "I2020Q1ASC842",
      "decimals": "-6",
      "lang": null,
      "name": "cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:GainLossRelatedToLitigationSettlement",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401416 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402402 - Disclosure - Divestitures and Acquisitions (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
     "shortName": "Divestitures and Acquisitions (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "D2018Q1Jul29_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_PatientRecoveryBusinessMember",
      "decimals": "-8",
      "lang": null,
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403402 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails",
     "shortName": "Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403403 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails",
     "shortName": "Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403404 - Disclosure - Restructuring and Employee Severance Narrative (Details)",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails",
     "shortName": "Restructuring and Employee Severance Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2018Q4YTD_cah_ContractTerminationAxis_cah_DistributorContractMember",
      "decimals": "-6",
      "lang": null,
      "name": "cah:FacilityExitAndOtherCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2018Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1013000 - Statement - Consolidated Statements of Shareholders' Equity",
     "role": "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
     "shortName": "Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:GoodwillTransfers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:GoodwillTransfers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405403 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "cah:DiscountRatefairvalueinputs",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405404 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Other Intangible Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408401 - Disclosure - Investments (Details)",
     "role": "http://www.cardinal.com/role/InvestmentsDetails",
     "shortName": "Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410402 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:NotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "INF",
      "lang": null,
      "name": "cah:OfferAsPercentageOfPrincipalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411402 - Disclosure - Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails",
     "shortName": "Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411403 - Disclosure - Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails",
     "shortName": "Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1014000 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:LossOnSaleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411404 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
     "shortName": "Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "3",
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Income Taxes (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "lang": null,
      "name": "cah:EffectiveTaxRateImpactFromCertainForeignJurisdictions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411406 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails",
     "shortName": "Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411407 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails",
     "shortName": "Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411408 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails",
     "shortName": "Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2018Q4QTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:IncomefromSettlementsofClassActionLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412401 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)",
     "role": "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
     "shortName": "Commitments, Contingent Liabilities and Litigation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:IncomefromSettlementsofClassActionLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414402 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
     "shortName": "Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414403 - Disclosure - Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details",
     "shortName": "Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415402 - Disclosure - Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
     "shortName": "Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415403 - Disclosure - Financial Instruments (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
     "shortName": "Financial Instruments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415404 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415405 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeLiabilityNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeLiabilityNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415408 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SalesMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415410 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails",
     "shortName": "Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:CarryingAmountofLongTermandotherShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415411 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails",
     "shortName": "Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:CarryingAmountofLongTermandotherShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415412 - Disclosure - Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
     "shortName": "Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417402 - Disclosure - Shareholders' Equity (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails",
     "shortName": "Shareholders' Equity (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:PaymentsForRepurchaseOfCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cah:LeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101100 - Disclosure - Leases",
     "role": "http://www.cardinal.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cah:LeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417403 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418402 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418403 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419402 - Disclosure - Segment Information (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "lang": null,
      "name": "cah:ProjectCostsOnInvestmentAndOtherSpending",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419403 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
     "shortName": "Segment Information (Revenue by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419404 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails",
     "shortName": "Segment Information (Segment Profit by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419405 - Disclosure - Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails",
     "shortName": "Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419406 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
     "shortName": "Segment Information (Assets by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419407 - Disclosure - Segment Information  Property and Equipment, net by Geographic Area) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails",
     "shortName": "Segment Information  Property and Equipment, net by Geographic Area) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FI2020Q4_srt_StatementGeographicalAxis_country_US",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420402 - Disclosure - Share-Based Compensation (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q410k063020form10-k.htm",
      "contextRef": "FD2020Q4YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 128,
   "tag": {
    "cah_A1.948Notesdue2019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.948% Notes due 2019",
        "label": "1.948% Notes due 2019 [Member]",
        "terseLabel": "1.948% Notes due 2019"
       }
      }
     },
     "localname": "A1.948Notesdue2019Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A2.4Notesdue2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.4% Notes due 2020",
        "label": "2.4% Notes due 2020 [Member]",
        "terseLabel": "2.4% Notes due 2019"
       }
      }
     },
     "localname": "A2.4Notesdue2020Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]",
        "label": "2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]",
        "terseLabel": "2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]"
       }
      }
     },
     "localname": "A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A2.616Notesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.616% Notes due 2022",
        "label": "2.616% Notes due 2022 [Member]",
        "terseLabel": "2.616% Notes due fiscal 2022"
       }
      }
     },
     "localname": "A2.616Notesdue2022Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A2011LtipMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2011 LTIP [Member]",
        "label": "2011 LTIP [Member]",
        "terseLabel": "2011 LTIP"
       }
      }
     },
     "localname": "A2011LtipMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.079Notesdue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.079% Notes due 2024",
        "label": "3.079% Notes due 2024 [Member]",
        "terseLabel": "3.079% Notes due fiscal 2024"
       }
      }
     },
     "localname": "A3.079Notesdue2024Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.2Notesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.2% Notes due 2022",
        "label": "3.2% Notes due 2022 [Member]",
        "terseLabel": "3.2% Notes due 2022"
       }
      }
     },
     "localname": "A3.2Notesdue2022Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.2Notesdue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.2% Notes due 2023",
        "label": "3.2% Notes due 2023 [Member]",
        "terseLabel": "3.2% Notes due 2023"
       }
      }
     },
     "localname": "A3.2Notesdue2023Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.41Notesdue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.41% Notes due 2027",
        "label": "3.41% Notes due 2027 [Member]",
        "terseLabel": "3.41% Notes due fiscal 2027"
       }
      }
     },
     "localname": "A3.41Notesdue2027Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.5Notesdue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.5% Notes due 2025",
        "label": "3.5% Notes due 2025 [Member]",
        "terseLabel": "3.5% Notes due fiscal 2025"
       }
      }
     },
     "localname": "A3.5Notesdue2025Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.75Notesdue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.75% Notes due 2026",
        "label": "3.75% Notes due 2026 [Member]",
        "terseLabel": "3.75% Notes due 2025"
       }
      }
     },
     "localname": "A3.75Notesdue2026Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.368Notesdue2047Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.368% Notes due 2047",
        "label": "4.368% Notes due 2047 [Member]",
        "terseLabel": "4.368% Notes due fiscal 2047"
       }
      }
     },
     "localname": "A4.368Notesdue2047Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.5Notesdue2044Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.5% Notes due 2044",
        "label": "4.5% Notes due 2044 [Member]",
        "terseLabel": "4.5% Notes due 2044"
       }
      }
     },
     "localname": "A4.5Notesdue2044Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.625Notesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.625% Notes due 2021",
        "label": "4.625% Notes due 2021 [Member]",
        "terseLabel": "4.625% Notes due 2020"
       }
      }
     },
     "localname": "A4.625Notesdue2021Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.6Notesdue2043Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.6% Notes due 2043",
        "label": "4.6% Notes due 2043 [Member]",
        "terseLabel": "4.6% Notes due 2043"
       }
      }
     },
     "localname": "A4.6Notesdue2043Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.9Notesdue2045Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.9% Notes due 2045",
        "label": "4.9% Notes due 2045 [Member]",
        "terseLabel": "4.9% Notes due 2045"
       }
      }
     },
     "localname": "A4.9Notesdue2045Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A7.0Debenturesduefiscal2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "7.0% Debentures due fiscal 2027",
        "label": "7.0% Debentures due fiscal 2027 [Member]",
        "terseLabel": "7.0% Debentures due 2026"
       }
      }
     },
     "localname": "A7.0Debenturesduefiscal2027Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_ASC842Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASC 842",
        "label": "ASC 842 [Member]",
        "terseLabel": "ASC 842"
       }
      }
     },
     "localname": "ASC842Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_AcceleratedsharerepurchaseplanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "accelerated share repurchase plan [Member]",
        "label": "accelerated share repurchase plan [Member]",
        "terseLabel": "Accelerated share repurchase plan"
       }
      }
     },
     "localname": "AcceleratedsharerepurchaseplanMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_AdditionalPerformanceShareUnitsDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional Performance Share Units Data [Table Text Block]",
        "label": "Additional Performance Share Units Data [Table Text Block]",
        "terseLabel": "Additional Data Related to Performance Share Units Activity"
       }
      }
     },
     "localname": "AdditionalPerformanceShareUnitsDataTableTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional Restricted Shares And Restricted Share Units Data [Table Text Block]",
        "label": "Additional Restricted Shares And Restricted Share Units Data [Table Text Block]",
        "terseLabel": "Additional Restricted Shares and Restricted Share Units Activity"
       }
      }
     },
     "localname": "AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AdditionalStockOptionPlanDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A disclosure of additional data related to all stock option activity",
        "label": "Additional Stock Option Plan Data [Table Text Block]",
        "terseLabel": "Schedule of Additional Data Related to Stock Option Activity"
       }
      }
     },
     "localname": "AdditionalStockOptionPlanDataTableTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AlamedaCountyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Alameda County [Member]",
        "label": "Alameda County [Member]",
        "terseLabel": "Alameda County [Member]"
       }
      }
     },
     "localname": "AlamedaCountyMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_AllegianceCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Allegiance Corporation [Member]",
        "label": "Allegiance Corporation [Member]",
        "terseLabel": "Allegiance Corporation"
       }
      }
     },
     "localname": "AllegianceCorporationMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the costs incurred during and relating to an acquisition. These costs specifically include transaction and integration costs; changes in fair value of contingent consideration obligations and amortization of acquisition-related intangible assets, and are recorded within amortization and other acquisition-related costs.",
        "label": "Amortization and Other Acquisition Related Costs Policy [Policy Text Block]",
        "terseLabel": "Amortization and Other Acquisition-Related Costs"
       }
      }
     },
     "localname": "AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_Amortizationandotheracquisitionrelatedcosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Amortization and other acquisition-related costs",
        "terseLabel": "Amortization and other acquisition-related costs"
       }
      }
     },
     "localname": "Amortizationandotheracquisitionrelatedcosts",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_AssetsHeldforSalePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assets Held for Sale, Policy [Policy Text Block]",
        "label": "Assets Held for Sale, Policy [Policy Text Block]",
        "terseLabel": "Assets Held for Sale, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "AssetsHeldforSalePolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AwardsOtherThanStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Awards Other than Stock Options [Member]",
        "label": "Awards Other than Stock Options [Member]",
        "terseLabel": "Awards Other than Stock Options"
       }
      }
     },
     "localname": "AwardsOtherThanStockOptionsMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_BusinessCombinationTransactionandintegrationcosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Costs incurred during the initial evaluation of a potential acquisition that primarily relate to costs to analyze, negotiate, and consummate the transaction, as well as due diligence activities. Also includes costs related to activities required to combine the operations of an acquired enterprise into our operations and to stand-up the systems and processes needed to support a global footprint.",
        "label": "Business Combination, Transaction and integration costs",
        "terseLabel": "Transaction and integration costs"
       }
      }
     },
     "localname": "BusinessCombinationTransactionandintegrationcosts",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_CVSCaremarkCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CVS Caremark Corporation [Member]",
        "label": "CVS Caremark Corporation [Member]",
        "terseLabel": "CVS Health"
       }
      }
     },
     "localname": "CVSCaremarkCorporationMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CVSHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CVS Health [Member]",
        "label": "CVS Health [Member]",
        "terseLabel": "CVS Health"
       }
      }
     },
     "localname": "CVSHealthMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CardinalHealthAtHomeSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cardinal Health At Home Solutions [Member]",
        "label": "Cardinal Health At Home Solutions [Member]",
        "terseLabel": "Cardinal Health At Home Solutions [Member]"
       }
      }
     },
     "localname": "CardinalHealthAtHomeSolutionsMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CareFusionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CareFusion [Member]",
        "label": "CareFusion [Member]",
        "terseLabel": "CareFusion [Member]"
       }
      }
     },
     "localname": "CareFusionMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CarryingAmountofLongTermandotherShortTermBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying Amount of Long-Term and other Short-Term Borrowings",
        "label": "Carrying Amount of Long-Term and other Short-Term Borrowings",
        "terseLabel": "Carrying Amount of Long-Term and other Short-Term Borrowings"
       }
      }
     },
     "localname": "CarryingAmountofLongTermandotherShortTermBorrowings",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_CashComponentForSettlementFrameworkTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash Component For Settlement Framework, Term",
        "label": "Cash Component For Settlement Framework, Term",
        "terseLabel": "Cash Component For Settlement Framework, Term"
       }
      }
     },
     "localname": "CashComponentForSettlementFrameworkTerm",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cah_CashDiscountsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash Discounts [Policy Text Block]",
        "label": "Cash Discounts [Policy Text Block]",
        "terseLabel": "Cash Discounts"
       }
      }
     },
     "localname": "CashDiscountsPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_CashReclassifiedtoAssetsHeldforSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CashReclassifiedtoAssetsHeldforSale",
        "label": "CashReclassifiedtoAssetsHeldforSale",
        "terseLabel": "Cash reclassified to assets held for sale"
       }
      }
     },
     "localname": "CashReclassifiedtoAssetsHeldforSale",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ChinaPharmaceuticalandMedicalProductsDistributionBusiness [Member]",
        "label": "China Pharmaceutical and Medical Products Distribution Business [Member]",
        "terseLabel": "China Pharmaceutical and Medical Products Distribution Business [Member]"
       }
      }
     },
     "localname": "ChinaPharmaceuticalandMedicalProductsDistributionBusinessMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_ClassActionLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class Action Lawsuits [Member]",
        "label": "Class Action Lawsuits [Member]",
        "terseLabel": "Class Action Lawsuits [Member]"
       }
      }
     },
     "localname": "ClassActionLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CommittedReceivablesSalesFacilityProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Committed receivables sales facility program that exists largely to provide liquidity by selling interests in trade receivables.",
        "label": "Committed Receivables Sales Facility Program [Member]",
        "terseLabel": "Committed Receivables Sales Facility Program"
       }
      }
     },
     "localname": "CommittedReceivablesSalesFacilityProgramMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CommonStockVotingRightsVotes": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Votes",
        "label": "Common Stock, Voting Rights, Votes",
        "terseLabel": "Common Stock, Voting Rights, Votes"
       }
      }
     },
     "localname": "CommonStockVotingRightsVotes",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "cah_ConcentrationRiskLargestGroupPurchasingOrganizations": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Concentration Risk, Largest Group Purchasing Organizations",
        "label": "Concentration Risk, Largest Group Purchasing Organizations",
        "terseLabel": "Largest group purchasing organizations"
       }
      }
     },
     "localname": "ConcentrationRiskLargestGroupPurchasingOrganizations",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_ContractTerminationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract Termination [Axis]",
        "label": "Contract Termination [Axis]",
        "terseLabel": "Contract Termination [Axis]"
       }
      }
     },
     "localname": "ContractTerminationAxis",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_ContractTerminationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Contract Termination [Axis]",
        "label": "Contract Termination [Domain]",
        "terseLabel": "Contract Termination [Domain]"
       }
      }
     },
     "localname": "ContractTerminationDomain",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CostofSalesVendorReservesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for allowances received from a vendor. The disclosure differentiates between those allowances that are recorded as a reduction in the price of the vendors' products or services (that is, the entity's inventory) and which ultimately will be recorded as a reduction in the entity's cost of sales and those that are not.",
        "label": "Cost of Sales, Vendor Reserves, Policy [Policy Text Block]",
        "terseLabel": "Vendor Reserves"
       }
      }
     },
     "localname": "CostofSalesVendorReservesPolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_DeferredIncomeTaxesandOtherLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Income Taxes and Other Liabilities [Member]",
        "label": "Deferred Income Taxes and Other Liabilities [Member]",
        "terseLabel": "Deferred Income Taxes and Other Liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxesandOtherLiabilitiesMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_DeferredTaxAssetsRelatedtouncertaintaxpositions": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred tax assets related to uncertain tax positions",
        "label": "Deferred Tax Assets, Related to uncertain tax positions",
        "terseLabel": "Deferred tax assets related to uncertain tax positions"
       }
      }
     },
     "localname": "DeferredTaxAssetsRelatedtouncertaintaxpositions",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount",
        "label": "Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount",
        "terseLabel": "Derivatives, matured notional amounts"
       }
      }
     },
     "localname": "DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount",
        "label": "Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount",
        "terseLabel": "Derivatives, terminated notional amounts",
        "verboseLabel": "Derivatives, Hedge Discontinuances, Termination of Hedging Instrument, Amount"
       }
      }
     },
     "localname": "DerivativesHedgeDiscontinuancesTerminationofHedgingInstrumentAmount",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DiscountRatefairvalueinputs": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discount Rate, fair value inputs",
        "label": "Discount Rate, fair value inputs",
        "terseLabel": "Discount Rate, fair value inputs"
       }
      }
     },
     "localname": "DiscountRatefairvalueinputs",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Describes an entity's accounting policy for fees received from distribution service agreements and other fees received from vendors related to the purchase or distribution of the vendor's inventory. Such fees are recognized as a reduction of inventory when those fees have been earned and the entity is entitled to payment.",
        "label": "Distribution Service Agreement And Other Vendor Fees [Policy Text Block]",
        "terseLabel": "Distribution Service Agreement and Other Vendor Fees"
       }
      }
     },
     "localname": "DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_DistributorContractMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Distributor Contract [Member]",
        "label": "Distributor Contract [Member]",
        "terseLabel": "Distributor Contract [Member]"
       }
      }
     },
     "localname": "DistributorContractMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_DividendsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Dividends, Policy [Policy Text Block]",
        "label": "Dividends, Policy [Policy Text Block]",
        "terseLabel": "Dividends, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "DividendsPolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent",
        "label": "Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveIncomeTaxRateReconciliationTaxAct2018": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Act 2018",
        "label": "Effective Income Tax Rate Reconciliation, Tax Act 2018",
        "terseLabel": "Tax Act"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxAct2018",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveIncomeTaxReconciliationOpioidLitigation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Opioid Litigation",
        "label": "Effective Income Tax Reconciliation, Opioid Litigation",
        "negatedTerseLabel": "Effective Income Tax Reconciliation, Opioid Litigation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationOpioidLitigation",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Tax Rate Impact From Certain Foreign Jurisdictions",
        "label": "Effective Tax Rate Impact From Certain Foreign Jurisdictions",
        "negatedTerseLabel": "Effective Tax Rate Impact From Certain Foreign Jurisdictions"
       }
      }
     },
     "localname": "EffectiveTaxRateImpactFromCertainForeignJurisdictions",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Tax Rate Reconciliation, Foreign Tax Related to Divestiture",
        "label": "Effective Tax Rate Reconciliation, Foreign Tax Related to Divestiture",
        "negatedTerseLabel": "China tax related to divestiture"
       }
      }
     },
     "localname": "EffectiveTaxRateReconciliationForeignTaxRelatedtoDivestiture",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_ExercisablePeriodOfPlansInYears": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The instrument's contractual term.",
        "label": "Exercisable period of plans, in years",
        "terseLabel": "Exercisable period of plans (in years)"
       }
      }
     },
     "localname": "ExercisablePeriodOfPlansInYears",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cah_FacilityExitAndOtherCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.",
        "label": "Facility Exit and Other Costs",
        "terseLabel": "Facility Exit and Other Costs"
       }
      }
     },
     "localname": "FacilityExitAndOtherCosts",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_FinanceLeaseImputedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finance Lease Imputed Interest",
        "label": "Finance Lease Imputed Interest",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseImputedInterest",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_FinanceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finance Lease",
        "label": "Finance Lease [Member]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_FixedRateDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fixed Rate Debt [Member]",
        "label": "Fixed Rate Debt [Member]",
        "terseLabel": "Fixed-Rate Debt"
       }
      }
     },
     "localname": "FixedRateDebtMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_FloatingRateNotesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Floating Rate Notes due 2022",
        "label": "Floating Rate Notes due 2022 [Member]",
        "terseLabel": "Floating Rate Notes due fiscal 2022"
       }
      }
     },
     "localname": "FloatingRateNotesdue2022Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_GainonDivestitureAfterTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gain on Divestiture After Tax",
        "label": "Gain on Divestiture After Tax",
        "terseLabel": "Gain on Divestiture After Tax"
       }
      }
     },
     "localname": "GainonDivestitureAfterTax",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_GoodsandservicessoldLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for goods and services sold [Table]",
        "label": "goods and services sold [Line Items]",
        "terseLabel": "goods and services sold [Line Items]"
       }
      }
     },
     "localname": "GoodsandservicessoldLineItems",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GoodsandservicessoldTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "goods and services sold [Table]",
        "label": "goods and services sold [Table]",
        "terseLabel": "goods and services sold [Table]"
       }
      }
     },
     "localname": "GoodsandservicessoldTable",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GoodwillAndIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Goodwill and Intangible Assets [Line Items]",
        "label": "Goodwill and Intangible Assets [Line Items]",
        "terseLabel": "Goodwill and Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsLineItems",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GoodwillAndIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Goodwill and Intangible Assets [Table]",
        "label": "Goodwill and Intangible Assets [Table]",
        "terseLabel": "Goodwill and Intangible Assets [Table]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsTable",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GownRecallAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gown Recall [Axis]",
        "label": "Gown Recall [Axis]",
        "terseLabel": "Gown Recall [Axis]"
       }
      }
     },
     "localname": "GownRecallAxis",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GownRecallDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Gown Recall [Axis]",
        "label": "Gown Recall [Domain]",
        "terseLabel": "Gown Recall [Domain]"
       }
      }
     },
     "localname": "GownRecallDomain",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_GrossTradeReceivablesMajorCustomerPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross Trade Receivables, Major Customer Percentage",
        "label": "Gross Trade Receivables, Major Customer Percentage",
        "terseLabel": "Percent of Gross Trade Receivables"
       }
      }
     },
     "localname": "GrossTradeReceivablesMajorCustomerPercentage",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_GroupPurchasingOrganizationsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Group Purchasing Organizations [Member]",
        "label": "Group Purchasing Organizations [Member]",
        "terseLabel": "Group Purchasing Organizations"
       }
      }
     },
     "localname": "GroupPurchasingOrganizationsMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_IPRDTrademarksandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Includes in process investigation of new knowledge useful in developing new product or service or new process or techniques or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for the improvements to existing product or process and rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "IPR&amp;D,TrademarksandOther [Member]",
        "terseLabel": "IPR&amp;D, trademarks and other"
       }
      }
     },
     "localname": "IPRDTrademarksandOtherMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Impactofadoptionofnewaccountingstandard": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "impact of adoption of new accounting standard",
        "label": "impact of adoption of new accounting standard",
        "terseLabel": "New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31)"
       }
      }
     },
     "localname": "Impactofadoptionofnewaccountingstandard",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_IncomefromSettlementsofClassActionLawsuits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income from Settlements of Class Action Lawsuits",
        "label": "Income from Settlements of Class Action Lawsuits",
        "terseLabel": "Income from Settlements of Class Action Lawsuits"
       }
      }
     },
     "localname": "IncomefromSettlementsofClassActionLawsuits",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_IndemnificationReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.",
        "label": "Indemnification Receivable",
        "terseLabel": "Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority"
       }
      }
     },
     "localname": "IndemnificationReceivable",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LawsuitTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lawsuit Type [Axis]",
        "label": "Lawsuit Type [Axis]",
        "terseLabel": "Lawsuit Type [Axis]"
       }
      }
     },
     "localname": "LawsuitTypeAxis",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_LawsuitTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Lawsuit Type [Axis]",
        "label": "Lawsuit Type [Domain]",
        "terseLabel": "Lawsuit Type [Domain]"
       }
      }
     },
     "localname": "LawsuitTypeDomain",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease Liabilities established as a Result of the adoption of ASC 842",
        "label": "Lease Liabilities established as a Result of the adoption of ASC 842",
        "terseLabel": "Lease Liabilities established as a Result of the adoption of ASC 842"
       }
      }
     },
     "localname": "LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LeasePaymentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Table Text Block] for Lease Payments [Table]",
        "label": "Lease Payments [Table Text Block]",
        "terseLabel": "Leases Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "LeasePaymentsTableTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LeasesSupplementalBalanceSheetInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]",
        "label": "LeasesSupplementalBalanceSheetInformation [Table Text Block]",
        "terseLabel": "Leases Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "LeasesSupplementalBalanceSheetInformationTableTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LeasesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Leases [Text Block]",
        "label": "Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LeasesTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Finance Lease Liability Not Yet Commenced, Amount",
        "label": "Lessee Finance Lease Liability Not Yet Commenced, Amount",
        "terseLabel": "Less: leases not yet commenced (1)"
       }
      }
     },
     "localname": "LesseeFinanceLeaseLiabilityNotYetCommencedAmount",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due After Year Five",
        "label": "Lessee Lease Liability Payments Due After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Five",
        "label": "Lessee Lease Liability Payments Due Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Four",
        "label": "Lessee Lease Liability Payments Due Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Three",
        "label": "Lessee Lease Liability Payments Due Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Two",
        "label": "Lessee Lease Liability Payments Due Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Remainder Of Fiscal Year",
        "label": "Lessee Lease Liability Payments Remainder Of Fiscal Year",
        "terseLabel": "Remainder of 2020"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Operating Lease Liability Not Yet Commenced, Amount",
        "label": "Lessee Operating Lease Liability Not Yet Commenced, Amount",
        "terseLabel": "Less: leases not yet commenced (1)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityNotYetCommencedAmount",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LitigationTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation Type [Axis]",
        "label": "Litigation Type [Axis]",
        "terseLabel": "Litigation Type [Axis]"
       }
      }
     },
     "localname": "LitigationTypeAxis",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_LitigationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Litigation Type [Axis]",
        "label": "Litigation Type [Domain]",
        "terseLabel": "Litigation Type [Domain]"
       }
      }
     },
     "localname": "LitigationTypeDomain",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_LossContingencyLawsuitsNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Lawsuits, Number",
        "label": "Loss Contingency, Lawsuits, Number",
        "terseLabel": "Loss Contingency, Lawsuits, Number"
       }
      }
     },
     "localname": "LossContingencyLawsuitsNumber",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_MaximumQuarterlyPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved.",
        "label": "Maximum Quarterly Payment",
        "terseLabel": "Maximum quarterly payment"
       }
      }
     },
     "localname": "MaximumQuarterlyPayment",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_MedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical [Member]",
        "label": "Medical Member",
        "terseLabel": "Medical"
       }
      }
     },
     "localname": "MedicalMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_MedicalReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical Reporting Unit [Member]",
        "label": "Medical Reporting Unit [Member]",
        "terseLabel": "Medical Reporting Unit [Member]"
       }
      }
     },
     "localname": "MedicalReportingUnitMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_MedicaldistributionandproductsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical distribution and products [Member]",
        "label": "Medical distribution and products [Member]",
        "terseLabel": "Medical distribution and products [Member]"
       }
      }
     },
     "localname": "MedicaldistributionandproductsMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NaviHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "naviHealth [Member]",
        "label": "naviHealth [Member]",
        "terseLabel": "naviHealth [Member]"
       }
      }
     },
     "localname": "NaviHealthMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NaviOwnershipInterestDivestedMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Navi Ownership Interest Divested [Member]",
        "label": "Navi Ownership Interest Divested [Member]",
        "terseLabel": "Navi Ownership Interest Divested [Member]"
       }
      }
     },
     "localname": "NaviOwnershipInterestDivestedMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest",
        "label": "Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_Netproceedstaxwithholdingsfromsharebasedcompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.",
        "label": "Net proceeds/(tax withholdings) from share-based compensation",
        "terseLabel": "Net tax proceeds/(withholding) from share-based compensation",
        "verboseLabel": "Net proceeds/(withholding) from share-based compensation"
       }
      }
     },
     "localname": "Netproceedstaxwithholdingsfromsharebasedcompensation",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_NotesPayableRepurchased": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Principal Amount of Notes Payable Repurchased during the year",
        "label": "Notes Payable Repurchased",
        "terseLabel": "Notes Payable Repurchased"
       }
      }
     },
     "localname": "NotesPayableRepurchased",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_NuclearPrecisionHealthServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nuclear Precision Health Services [Member]",
        "label": "Nuclear Precision Health Services [Member]",
        "terseLabel": "Nuclear Precision Health Services [Member]"
       }
      }
     },
     "localname": "NuclearPrecisionHealthServicesMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NumberofStateAttorneysGeneralfilinglawsuits": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of State Attorneys General filing lawsuits",
        "label": "Number of State Attorneys General filing lawsuits",
        "terseLabel": "Number of State Attorneys General filing lawsuits"
       }
      }
     },
     "localname": "NumberofStateAttorneysGeneralfilinglawsuits",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_OfferAsPercentageOfPrincipalAmount": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of principal amount that the company is required to offer to purchase certain notes, under certain circumstances.",
        "label": "Offer As Percentage Of Principal Amount",
        "terseLabel": "Offer as percentage of principal amount"
       }
      }
     },
     "localname": "OfferAsPercentageOfPrincipalAmount",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_OnePointNineFiveNotesdue2018Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "One Point Nine Five % Notes due 2018 [Member]",
        "label": "One Point Nine Five % Notes due 2018 [Member]",
        "terseLabel": "1.95% Notes due 2018"
       }
      }
     },
     "localname": "OnePointNineFiveNotesdue2018Member",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OperatingLeaseImputedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease Imputed Interest",
        "label": "Operating Lease Imputed Interest",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "OperatingLeaseImputedInterest",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_OperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease",
        "label": "Operating Lease [Member]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Lawsuits [Member]",
        "label": "Opioid Lawsuits [Member]",
        "terseLabel": "Opioid Lawsuits"
       }
      }
     },
     "localname": "OpioidLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLawsuitsStateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Lawsuits State and Political Subdivisions [Domain]",
        "label": "Opioid Lawsuits State [Domain]",
        "terseLabel": "Opioid Lawsuits State [Domain]"
       }
      }
     },
     "localname": "OpioidLawsuitsStateDomain",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLitigationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Litigation",
        "label": "Opioid Litigation [Axis]",
        "terseLabel": "Opioid Litigation [Axis]"
       }
      }
     },
     "localname": "OpioidLitigationAxis",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_OpioidLitigationCuyahogaandSummitCountiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Litigation, Cuyahoga and Summit Counties",
        "label": "Opioid Litigation, Cuyahoga and Summit Counties [Member]",
        "terseLabel": "Opioid Litigation, Cuyahoga and Summit Counties [Member]"
       }
      }
     },
     "localname": "OpioidLitigationCuyahogaandSummitCountiesMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLitigationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Litigation [Domain]",
        "label": "Opioid Litigation [Domain]",
        "terseLabel": "Opioid Litigation [Domain]"
       }
      }
     },
     "localname": "OpioidLitigationDomain",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLitigationlessCuyahogaandSummitCountiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Litigation, less Cuyahoga and Summit Counties",
        "label": "Opioid Litigation, less Cuyahoga and Summit Counties [Member]",
        "terseLabel": "Opioid Litigation, less Cuyahoga and Summit Counties [Member]"
       }
      }
     },
     "localname": "OpioidLitigationlessCuyahogaandSummitCountiesMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidTotalSettlementCuyahogaandSummitCounties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Total Settlement, Cuyahoga and Summit Counties",
        "label": "Opioid Total Settlement, Cuyahoga and Summit Counties",
        "terseLabel": "Opioid Total Settlement, Cuyahoga and Summit Counties"
       }
      }
     },
     "localname": "OpioidTotalSettlementCuyahogaandSummitCounties",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_OptumRxMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "OptumRx [Member]",
        "label": "OptumRx [Member]",
        "terseLabel": "OptumRx [Member]"
       }
      }
     },
     "localname": "OptumRxMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Accrued Liabilities, Policy [Policy Text Block]",
        "label": "Other Accrued Liabilities, Policy [Policy Text Block]",
        "terseLabel": "Other Accrued Liabilities, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesPolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_OtherJurisdictionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Jurisdictions [Member]",
        "label": "Other Jurisdictions [Member]",
        "terseLabel": "Other Jurisdictions [Member]"
       }
      }
     },
     "localname": "OtherJurisdictionsMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PartnershipOwnership": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Partnership Indirect Ownership",
        "label": "Partnership Ownership",
        "terseLabel": "Partnership Indirect Ownership"
       }
      }
     },
     "localname": "PartnershipOwnership",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_PatientRecoveryBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Patient Recovery Business [Member]",
        "label": "Patient Recovery Business [Member]",
        "terseLabel": "Patient Recovery Business [Member]"
       }
      }
     },
     "localname": "PatientRecoveryBusinessMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PaymentofContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow from a settlement payment of contingent consideration assumed in a business combination.",
        "label": "Payment of Contingent Consideration",
        "negatedTerseLabel": "Payment of contingent consideration obligation"
       }
      }
     },
     "localname": "PaymentofContingentConsideration",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_PharmaceuticalDistributionandSpecialtyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmaceutical Distribution and Specialty [Member]",
        "label": "Pharmaceutical Distribution and Specialty [Member]",
        "terseLabel": "Pharmaceutical Distribution and Specialty [Member]"
       }
      }
     },
     "localname": "PharmaceuticalDistributionandSpecialtyMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PharmaceuticalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmaceutical [Member]",
        "label": "Pharmaceutical Member",
        "terseLabel": "Pharmaceutical"
       }
      }
     },
     "localname": "PharmaceuticalMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PlaintiffTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plaintiff Type [Axis]",
        "label": "Plaintiff Type [Axis]",
        "terseLabel": "Plaintiff Type [Axis]"
       }
      }
     },
     "localname": "PlaintiffTypeAxis",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_PlaintiffTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Plaintiff Type [Axis]",
        "label": "Plaintiff Type [Domain]",
        "terseLabel": "Plaintiff Type [Domain]"
       }
      }
     },
     "localname": "PlaintiffTypeDomain",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PreTaxGainonDivestiture": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pre-Tax Gain on Divestiture",
        "label": "Pre-Tax Gain on Divestiture",
        "terseLabel": "Pre-Tax Gain on Divestiture"
       }
      }
     },
     "localname": "PreTaxGainonDivestiture",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_PricingDisputesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expense related to pricing disputes, excluded from provision for bad debts in the consolidated statements of cash flows and recorded as a reduction in gross margin  in the consolidated statements of earnings.",
        "label": "Pricing Disputes [Member]",
        "terseLabel": "Pricing Disputes [Member]"
       }
      }
     },
     "localname": "PricingDisputesMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PriorYearRecoveriesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Prior Year Recoveries [Member]",
        "label": "Prior Year Recoveries [Member]",
        "terseLabel": "Prior Year Recoveries"
       }
      }
     },
     "localname": "PriorYearRecoveriesMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PrivatePartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Private Parties [Member]",
        "label": "Private Parties [Member]",
        "terseLabel": "Private Parties [Member]"
       }
      }
     },
     "localname": "PrivatePartiesMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from divestitures and disposal of property and equipment and held for sale assets",
        "label": "Proceeds from divestitures and disposal of property and equipment and held for sale assets",
        "terseLabel": "Proceeds from divestitures, net of cash sold, and disposal of property and equipment"
       }
      }
     },
     "localname": "Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from sales of available-for-sale securities and other investments.",
        "label": "Proceeds from sale of available-for-sale securities and other investments",
        "terseLabel": "Proceeds from sale of investments and available-for-sale securities"
       }
      }
     },
     "localname": "Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ProductLiabilityLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Liability Lawsuits [Member]",
        "label": "Product Liability Lawsuits [Member]",
        "terseLabel": "Product Liability Lawsuits"
       }
      }
     },
     "localname": "ProductLiabilityLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_ProjectCostsOnInvestmentAndOtherSpending": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.",
        "label": "Project Costs On Investment And Other Spending",
        "terseLabel": "Project costs on investment and other spending"
       }
      }
     },
     "localname": "ProjectCostsOnInvestmentAndOtherSpending",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_Provisionaltaxbenefitrelatedtotransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Provisional tax benefit related to transaction",
        "label": "Provisional tax benefit related to transaction",
        "terseLabel": "Provisional tax benefit related to transaction"
       }
      }
     },
     "localname": "Provisionaltaxbenefitrelatedtotransaction",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_Purchaseofavailableforsalesecuritiesandotherinvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow from purchases of available-for-sale securities and other investments.",
        "label": "Purchase of available-for-sale securities and other investments",
        "negatedLabel": "Purchase of other investments"
       }
      }
     },
     "localname": "Purchaseofavailableforsalesecuritiesandotherinvestments",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ReceivableFinancingAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Receivable Financing Agreement Term",
        "label": "Receivable Financing Agreement Term",
        "terseLabel": "Receivable financing agreement term"
       }
      }
     },
     "localname": "ReceivableFinancingAgreementTerm",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cah_ReclassificationofdeferredrentinaccordancewithASC842": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reclassification of deferred rent in accordance with ASC 842",
        "label": "Reclassification of deferred rent in accordance with ASC 842",
        "terseLabel": "Reclassification of deferred rent in accordance with ASC 842"
       }
      }
     },
     "localname": "ReclassificationofdeferredrentinaccordancewithASC842",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_RemainingStockOptionPlanDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Table Text Block] for Remaining Stock Option Plan Data [Table]",
        "label": "Remaining Stock Option Plan Data [Table Text Block]",
        "terseLabel": "Schedule of Remaining Stock Option Plan Data"
       }
      }
     },
     "localname": "RemainingStockOptionPlanDataTableTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_RetirementofTreasurySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Retirement of Treasury Shares [Member]",
        "label": "Retirement of Treasury Shares [Member]",
        "terseLabel": "Retirement of Treasury Shares [Member]"
       }
      }
     },
     "localname": "RetirementofTreasurySharesMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_RevenueRecognitionReserveforSalesReturnsandAllowances": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue Recognition, Reserve for Sales Returns and Allowances",
        "label": "Revenue Recognition, Reserve for Sales Returns and Allowances",
        "terseLabel": "Accrual for estimated sales returns and allowances"
       }
      }
     },
     "localname": "RevenueRecognitionReserveforSalesReturnsandAllowances",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_SalesreturnsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "sales returns [Policy Text Block]",
        "label": "sales returns [Policy Text Block]",
        "terseLabel": "Sales Returns and Allowances"
       }
      }
     },
     "localname": "SalesreturnsPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_ScheduleIIAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule II [Abstract]",
        "label": "Schedule II [Abstract]"
       }
      }
     },
     "localname": "ScheduleIIAbstract",
     "nsuri": "http://www.cardinal.com/20200630",
     "xbrltype": "stringItemType"
    },
    "cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]",
        "label": "Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities after Netting by Tax Jurisdiction"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarizes the fair value and notional amounts of derivative instruments held as of the balance sheet date.",
        "label": "Schedule Of Fair Value Gain Loss Derivative Instrument [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Gain/(Loss) Derivative Instrument"
       }
      }
     },
     "localname": "ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_Sharesthatwouldbeantidilutiveasaresultofnetloss": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "shares that would be antidilutive as a result of net loss",
        "label": "shares that would be antidilutive as a result of net loss",
        "terseLabel": "shares that would be antidilutive as a result of net loss"
       }
      }
     },
     "localname": "Sharesthatwouldbeantidilutiveasaresultofnetloss",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cah_ShippingandHandlingCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ShippingandHandlingCosts [Policy Text Block]",
        "label": "ShippingandHandlingCosts [Policy Text Block]",
        "terseLabel": "Shipping and Handling"
       }
      }
     },
     "localname": "ShippingandHandlingCostsPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_ShortTermCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other short-term credit facilities and an unsecured line of credit",
        "label": "Short Term Credit Facilities Member",
        "terseLabel": "Short Term Credit Facilities"
       }
      }
     },
     "localname": "ShortTermCreditFacilitiesMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_SterileSurgicalGownRecallMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sterile Surgical Gown Recall [Member]",
        "label": "Sterile Surgical Gown Recall [Member]",
        "terseLabel": "Sterile Surgical Gown Recall [Member]"
       }
      }
     },
     "localname": "SterileSurgicalGownRecallMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_SterileSurgicalGownRecallMemberDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sterile Surgical Gown Recall [Member] [Domain]",
        "label": "Sterile Surgical Gown Recall [Member] [Domain]",
        "terseLabel": "Sterile Surgical Gown Recall [Member] [Domain]"
       }
      }
     },
     "localname": "SterileSurgicalGownRecallMemberDomain",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TaxExpenseasaResultofSaleofInvestment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax Expense as a Result of Sale of Investment",
        "label": "Tax Expense as a Result of Sale of Investment",
        "terseLabel": "Tax Expense as a Result of Sale of Investment"
       }
      }
     },
     "localname": "TaxExpenseasaResultofSaleofInvestment",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TaxMatterAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax Matter [Axis]",
        "label": "Tax Matter [Axis]",
        "terseLabel": "Tax Matter [Axis]"
       }
      }
     },
     "localname": "TaxMatterAxis",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_TaxMatterDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Tax Matter [Axis]",
        "label": "Tax Matter [Domain]",
        "terseLabel": "Tax Matter [Domain]"
       }
      }
     },
     "localname": "TaxMatterDomain",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TotalLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Lease Liability",
        "label": "Total Lease Liability",
        "terseLabel": "Total Lease Liability"
       }
      }
     },
     "localname": "TotalLeaseLiability",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Lease Liability Not Yet Commenced, Amount",
        "label": "Total Lease Liability Not Yet Commenced, Amount",
        "terseLabel": "Less: leases not yet commenced (1)"
       }
      }
     },
     "localname": "TotalLeaseLiabilityNotYetCommencedAmount",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total undiscounted Lease Liability Payments Due for both operating and financing leases",
        "label": "Total Lease Liability Payments Due",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "TotalLeaseLiabilityPaymentsDue",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Lease Liability Undiscounted Excess Amount",
        "label": "Total Lease Liability Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "TotalLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalOpioidLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Opioid Litigation",
        "label": "Total Opioid Litigation [Member]",
        "terseLabel": "Total Opioid Litigation [Member]"
       }
      }
     },
     "localname": "TotalOpioidLitigationMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TotalOpioidLitigationnetoftaxMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Opioid Litigation, net of tax",
        "label": "Total Opioid Litigation, net of tax [Member]",
        "terseLabel": "Total Opioid Litigation, net of tax [Member]"
       }
      }
     },
     "localname": "TotalOpioidLitigationnetoftaxMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TrademarksAndPatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Trademarks And Patents Member",
        "terseLabel": "Trademarks, trade names and patents"
       }
      }
     },
     "localname": "TrademarksAndPatentsMember",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TreasuryStockAcquiredShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Treasury Stock Acquired Shares",
        "label": "Treasury Stock Acquired Shares",
        "terseLabel": "Treasury Stock Acquired Shares"
       }
      }
     },
     "localname": "TreasuryStockAcquiredShares",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cah_VendorReserves": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of reserves, relating to vendor disputes or deductions, that are netted against vendor liabilities in the ordinary course of business.",
        "label": "Vendor Reserves",
        "terseLabel": "Vendor reserves"
       }
      }
     },
     "localname": "VendorReserves",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeVendorReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_VestingPeriodinyearsforShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vesting Period in years for Shares",
        "label": "Vesting Period in years for Shares",
        "terseLabel": "Vesting Period in years for Shares"
       }
      }
     },
     "localname": "VestingPeriodinyearsforShares",
     "nsuri": "http://www.cardinal.com/20200630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r667"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r666"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-Known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r187",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r207",
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r187",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r207",
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case Type"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r220",
      "r334",
      "r337",
      "r631"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r349",
      "r351",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r576",
      "r628",
      "r632"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r349",
      "r351",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r576",
      "r628",
      "r632"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r220",
      "r334",
      "r337",
      "r631"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r214",
      "r334",
      "r335",
      "r577",
      "r627",
      "r629"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r214",
      "r334",
      "r335",
      "r577",
      "r627",
      "r629"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r338",
      "r349",
      "r351",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r576",
      "r628",
      "r632"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r338",
      "r349",
      "r351",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r576",
      "r628",
      "r632"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r128",
      "r672"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r215",
      "r216",
      "r334",
      "r336",
      "r630",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r215",
      "r216",
      "r334",
      "r336",
      "r630",
      "r648",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r670",
      "r671"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r128",
      "r672"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "verboseLabel": "Accounts Payable, Current"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r35",
      "r275"
     ],
     "calculation": {
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r57",
      "r63",
      "r64",
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments and other"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r58",
      "r63",
      "r64",
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gain/(Loss) on Derivatives, net of tax"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r26",
      "r60",
      "r62",
      "r63",
      "r610",
      "r640",
      "r644"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r59",
      "r63",
      "r64",
      "r130",
      "r131",
      "r132",
      "r471",
      "r635",
      "r636"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of change in accounting principle. Excludes change from amendment to accounting standards.",
        "label": "Change in Accounting Principle, Type [Axis]",
        "terseLabel": "Change in Accounting Principle, Type [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForChangeInAccountingPrincipleAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r432",
      "r433",
      "r434",
      "r435",
      "r579",
      "r580",
      "r581",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r353",
      "r383",
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForLoanAndLeaseLossesMember": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Allowance for portion expected to be uncollectible of receivable from loan and lease portfolio.",
        "label": "SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]"
       }
      }
     },
     "localname": "AllowanceForLoanAndLeaseLossesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForLossesOnFinanceReceivablesMember": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Allowance for portion expected to be uncollectible of investment in contractual right to receive money on demand or on fixed or determinable date recognized as asset in creditor's statement of financial position.",
        "label": "SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]",
        "verboseLabel": "SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]"
       }
      }
     },
     "localname": "AllowanceForLossesOnFinanceReceivablesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r103",
      "r258",
      "r266"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r59",
      "r63",
      "r64",
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r113",
      "r195",
      "r202",
      "r209",
      "r232",
      "r464",
      "r472",
      "r530",
      "r584",
      "r608"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r53",
      "r113",
      "r232",
      "r464",
      "r472",
      "r530"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r355",
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r487",
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and Improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r348",
      "r350"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "verboseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r348",
      "r350",
      "r450",
      "r451"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "verboseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r454",
      "r455",
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r102",
      "r457"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent consideration obligation"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r31",
      "r105"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and equivalents at end of period",
        "periodStartLabel": "Cash and equivalents at beginning of period",
        "terseLabel": "Cash and equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r12",
      "r106",
      "r108"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r99",
      "r531"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleMember": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change in accounting principle. Excludes change from amendment to accounting standards.",
        "label": "Change in Accounting Principle, Type [Domain]",
        "terseLabel": "Change in Accounting Principle, Type [Domain]"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": {
     "auth_ref": [
      "r513"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments",
        "terseLabel": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r111",
      "r113",
      "r149",
      "r150",
      "r151",
      "r153",
      "r155",
      "r167",
      "r168",
      "r169",
      "r232",
      "r530"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper",
        "verboseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r294",
      "r295",
      "r296",
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments, Contingent Liabilities and Litigation"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r108",
      "r310",
      "r649",
      "r650"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommodityContractMember": {
     "auth_ref": [
      "r339",
      "r503"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.",
        "label": "Commodity Contract [Member]",
        "terseLabel": "Commodity Contracts"
       }
      }
     },
     "localname": "CommodityContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Common Class B"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Cash dividends per common share (in usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r130",
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Common shares, without par value:"
       }
      }
     },
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common shares, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "terseLabel": "Common shares, issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Authorized\u2014755 million shares, Issued\u2014327 million shares at June 30, 2020 and 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r67",
      "r69",
      "r70",
      "r80",
      "r599",
      "r622"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r67",
      "r69",
      "r79",
      "r460",
      "r476",
      "r598",
      "r621"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income/(loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r172",
      "r605"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r176",
      "r177",
      "r220",
      "r527",
      "r528"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Revenue, major customer, percentage",
        "verboseLabel": "Percent of Revenue"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r178",
      "r527",
      "r529"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r108",
      "r466"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Noncontrolling Interests and Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r211",
      "r213"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r86",
      "r577"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of Goods and Services Sold",
        "verboseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Products Sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r108",
      "r285",
      "r286",
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Restructuring and Employee Severance"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r339",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross Currency Interest Rate Contract [Member]"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap [Member]"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r114",
      "r428",
      "r438"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "verboseLabel": "Current Federal Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r117",
      "r428"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Non-U.S.",
        "verboseLabel": "Current Foreign Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r114",
      "r428",
      "r438",
      "r440"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r114",
      "r428",
      "r438"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State and local",
        "verboseLabel": "Current State and Local Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r591",
      "r616"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "totalLabel": "Total",
        "verboseLabel": "Carrying amount"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Obligations and Other Short-Term Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r15",
      "r16",
      "r17",
      "r585",
      "r587",
      "r607"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r42",
      "r115",
      "r324",
      "r327",
      "r328",
      "r329",
      "r542",
      "r543",
      "r545",
      "r604"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r406"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Estimated range of decrease in unrecognized tax benefits within the next 12 months"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r114",
      "r429",
      "r438"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Federal",
        "terseLabel": "Federal",
        "verboseLabel": "Deferred Federal Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r114",
      "r429",
      "r438"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Non-U.S.",
        "verboseLabel": "Deferred Foreign Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge": {
     "auth_ref": [
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the unamortized adjustment to the carrying value of an interest-bearing hedged item made under an effective interest rate fair value hedge that is amortized upon discontinuation of the interest rate fair value hedge.",
        "label": "Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge",
        "terseLabel": "Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge"
       }
      }
     },
     "localname": "DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r103",
      "r114",
      "r429",
      "r438",
      "r439",
      "r440"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Provision for/(benefit from) deferred income taxes",
        "totalLabel": "Total deferred",
        "verboseLabel": "Deferred Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r18",
      "r19",
      "r418",
      "r586",
      "r606"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Assets, Noncurrent",
        "terseLabel": "Deferred Income Taxes and Other Assets, Noncurrent"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent",
        "terseLabel": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r114",
      "r429",
      "r438"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State and local",
        "verboseLabel": "Deferred State and Local Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.",
        "label": "Deferred Tax and Other Liabilities, Noncurrent",
        "terseLabel": "Deferred income taxes and other liabilities"
       }
      }
     },
     "localname": "DeferredTaxAndOtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r424",
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "negatedLabel": "Deferred tax assets on tax credit carryforwards",
        "terseLabel": "Loss and tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts",
        "terseLabel": "Receivable basis difference"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance for deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r401",
      "r421"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred income tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.",
        "label": "Deferred Tax Liabilities, Inventory",
        "negatedLabel": "Inventory basis differences"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "Goodwill and other intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property-related"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r347"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Total expense on employee retirement savings plans"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r103",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r103",
      "r190"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Total depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r479",
      "r480",
      "r482"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional Amount",
        "verboseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": {
     "auth_ref": [
      "r477"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.",
        "label": "Derivative Assets (Liabilities), at Fair Value, Net",
        "terseLabel": "Forward contracts"
       }
      }
     },
     "localname": "DerivativeAssetsLiabilitiesAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]",
        "verboseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r54",
      "r55",
      "r490",
      "r575"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Total assets"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r54",
      "r55",
      "r490",
      "r575"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Total liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r526"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Fair Value Gain/(Loss)"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r489"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Gain/(loss) on derivative"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r488",
      "r491",
      "r497",
      "r506"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r485",
      "r488",
      "r497"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r495",
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r496",
      "r498"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Gain/(loss) recognized in earnings for economic (non-designated) derivative instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r479",
      "r480",
      "r482"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "Derivative Liability, Notional Amount"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r480",
      "r482"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r478",
      "r481",
      "r482",
      "r485",
      "r486",
      "r493",
      "r497",
      "r509",
      "r510",
      "r514"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for derivatives used in hedging relationships, which may include how gains or losses are recognized and presented in the financial statements, and amortization policies for deferred amounts.",
        "label": "Derivatives, Methods of Accounting, Hedging Derivatives [Policy Text Block]",
        "terseLabel": "Interest Rate, Currency and Commodity Risk"
       }
      }
     },
     "localname": "DerivativesMethodsOfAccountingHedgingDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "verboseLabel": "Developed technology and other"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r103",
      "r272",
      "r277"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "terseLabel": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r348",
      "r350"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r330",
      "r603"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r81",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r147",
      "r149",
      "r153",
      "r154",
      "r155",
      "r160",
      "r161",
      "r600",
      "r623"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings Per Share, Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Earnings/(loss) per common share attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r81",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r149",
      "r153",
      "r154",
      "r155",
      "r160",
      "r161",
      "r600",
      "r623"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings Per Share, Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted earnings per common share attributable to Cardinal Health, Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r156",
      "r158",
      "r159",
      "r162"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share Attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r531"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rates changes on cash and equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r403",
      "r442"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Provision at Federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r403",
      "r442"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "negatedTerseLabel": "Change in valuation allowances"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r403",
      "r442"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Tax effect of foreign operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r403",
      "r442"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "terseLabel": "Nondeductible/nontaxable items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": {
     "auth_ref": [
      "r403",
      "r442"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent",
        "negatedLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r403",
      "r442"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State and local income taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign": {
     "auth_ref": [
      "r403",
      "r442"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent",
        "negatedTerseLabel": "Foreign tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "netLabel": "Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax",
        "terseLabel": "Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax",
        "verboseLabel": "Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "netLabel": "Weighted-average period over which performance share unit cost is expected to be recognized (in years)",
        "terseLabel": "Weighted-average period over which stock option compensation cost is expected to be recognized",
        "verboseLabel": "Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Tax benefit related to share-based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee- Related Costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options",
        "verboseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r135",
      "r144",
      "r146",
      "r166",
      "r236",
      "r323",
      "r330",
      "r390",
      "r391",
      "r392",
      "r434",
      "r435",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r538",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity Method Investment, Ownership Percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r32",
      "r196",
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities": {
     "auth_ref": [
      "r396"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.",
        "label": "Excess Tax Benefit from Share-based Compensation, Financing Activities",
        "terseLabel": "Excess tax benefits from share-based compensation",
        "verboseLabel": "Excess tax benefits from share based compensation"
       }
      }
     },
     "localname": "ExcessTaxBenefitFromShareBasedCompensationFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Facility Exit and Other Costs"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r516",
      "r517",
      "r518",
      "r523"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r521",
      "r523"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r517",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r522",
      "r523"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r516",
      "r517",
      "r519",
      "r520",
      "r524"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r339",
      "r340",
      "r345",
      "r346",
      "r517",
      "r566"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r339",
      "r340",
      "r345",
      "r346",
      "r517",
      "r567"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r517",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r521",
      "r523"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r522",
      "r524"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r487",
      "r493",
      "r511"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r550",
      "r563"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "totalLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance Lease, Liability, Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2020"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r552",
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Finance Lease, Principal Payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r551",
      "r555",
      "r564"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetailsCalc2": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r561",
      "r564"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r560",
      "r564"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Estimated annual amortization of intangible assets - 2020"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated annual amortization of intangible assets - 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization of intangible assets - 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization of intangible assets - 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization of intangible assets - 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r259",
      "r261",
      "r265",
      "r269",
      "r578",
      "r582"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r265",
      "r582"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Intangible"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r259",
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "verboseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r265",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Net Intangible"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r108",
      "r540"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Translation of Foreign Currencies"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r339",
      "r502"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Currency Contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward Contracts [Member]"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "verboseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "negatedTerseLabel": "Impairments and (gain)/loss on disposal of assets, net"
       }
      }
     },
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r297"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Litigation (recoveries)/charges, net",
        "terseLabel": "Gain (Loss) Related to Litigation Settlement"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainOnSaleOfInvestments": {
     "auth_ref": [
      "r83",
      "r84",
      "r103",
      "r594",
      "r624"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.",
        "label": "Gain on Sale of Investments",
        "negatedTerseLabel": "Gain on Sale of Investments",
        "terseLabel": "Gain on Sale of Investments"
       }
      }
     },
     "localname": "GainOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r103",
      "r313",
      "r314"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt",
        "terseLabel": "Gain (Loss) on Extinguishment of Debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r245",
      "r247",
      "r583"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r108",
      "r253",
      "r262"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r250"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency translation adjustments and other"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r248",
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated goodwill impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r103",
      "r246",
      "r249",
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Goodwill, Transfers"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r85",
      "r113",
      "r195",
      "r201",
      "r205",
      "r208",
      "r211",
      "r232",
      "r530"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross margin",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": {
     "auth_ref": [
      "r108",
      "r310"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.",
        "label": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]",
        "terseLabel": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]"
       }
      }
     },
     "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r485",
      "r507"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r116",
      "r441"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r116",
      "r441"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Non-U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r116",
      "r195",
      "r201",
      "r205",
      "r208",
      "r211"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Earnings/(loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r73",
      "r81",
      "r134",
      "r139",
      "r140",
      "r141",
      "r142",
      "r149",
      "r153",
      "r154",
      "r592",
      "r595",
      "r600",
      "r618"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "verboseLabel": "Basic (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r73",
      "r81",
      "r134",
      "r139",
      "r140",
      "r141",
      "r142",
      "r149",
      "r153",
      "r154",
      "r155",
      "r600",
      "r618",
      "r620",
      "r623"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "verboseLabel": "Diluted (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r76",
      "r103",
      "r192",
      "r229",
      "r593",
      "r617"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Income (Loss) from Equity Method Investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r348",
      "r350"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r408",
      "r415",
      "r417",
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r404",
      "r416",
      "r423",
      "r436",
      "r443",
      "r447",
      "r448",
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r114",
      "r145",
      "r146",
      "r193",
      "r402",
      "r437",
      "r445",
      "r626"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income Tax Expense (Benefit)",
        "totalLabel": "Provision for/(benefit from) income taxes",
        "verboseLabel": "Provision for/(benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitCurrentAndDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r71",
      "r108",
      "r399",
      "r400",
      "r416",
      "r417",
      "r422",
      "r430",
      "r651"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash payments for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Increase/(decrease) in accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Increase in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other accrued liabilities and operating items, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedTerseLabel": "Decrease/(increase) in trade receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Shareholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r260",
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Net Intangible"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r260",
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Gross Intangible, Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r257",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Net Intangible, Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "terseLabel": "Goodwill and other intangibles, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r74",
      "r189",
      "r541",
      "r544",
      "r601"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense, Net"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "terseLabel": "Interest Income (Expense), Nonoperating, Net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r96",
      "r100",
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash payments for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swaps",
        "verboseLabel": "Interest Rate Swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForInterestRateContractsDesignatedAsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryLIFOReserve": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.",
        "label": "Inventory, LIFO Reserve",
        "terseLabel": "Inventories valued at LIFO amount higher than average cost value"
       }
      }
     },
     "localname": "InventoryLIFOReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r49"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r11",
      "r50",
      "r108",
      "r163",
      "r241",
      "r242",
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRecallExpense": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.",
        "label": "Inventory Recall Expense",
        "terseLabel": "Inventory Recall Expense"
       }
      }
     },
     "localname": "InventoryRecallExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r49",
      "r128",
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Reserves for excess and obsolete inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for investment holdings.  This includes the information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.",
        "label": "Investment Holdings, Schedule of Investments [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r231",
      "r625"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandBuildingsAndImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Real estate held and additions or improvements to real estate held and structures used in the conduct of business.",
        "label": "Land, Buildings and Improvements [Member]",
        "terseLabel": "Land, building and improvements"
       }
      }
     },
     "localname": "LandBuildingsAndImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Operating Leases, Rent Expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r562",
      "r564"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2020"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r29",
      "r113",
      "r232",
      "r530",
      "r589",
      "r613"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r40",
      "r113",
      "r232",
      "r465",
      "r472",
      "r473",
      "r530"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r17",
      "r587",
      "r607"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Long-term Line of Credit",
        "verboseLabel": "Line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAverageOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Average amount borrowed under the credit facility during the period.",
        "label": "Line of Credit Facility, Average Outstanding Amount",
        "terseLabel": "Average amount outstanding",
        "verboseLabel": "Line of Credit Facility, Average Outstanding Amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityAverageOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r38",
      "r115"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum amount borrowed under the credit facility at any time during the period.",
        "label": "Line of Credit Facility, Maximum Amount Outstanding During Period",
        "terseLabel": "Line of Credit Facility, Maximum Amount Outstanding During Period"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity",
        "verboseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r38",
      "r115"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r43",
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated Litigation Liability"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Property and Equipment, Net by Geographic Area"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term obligations, less current portion"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Current portion of long-term obligations and other short-term borrowings",
        "verboseLabel": "Less: current portion of long-term obligations and other short-term borrowings"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r119",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r119",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings - 2020"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r119",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r119",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r119",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r119",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "verboseLabel": "Interest rate on long-term projects (approximates weighted-average on long-term obligations)"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r302",
      "r303",
      "r304",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r302",
      "r303",
      "r304",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss Contingency Accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r301",
      "r305",
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Loss Contingency, Estimate of Possible Loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r302",
      "r303",
      "r304",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of lawsuits filed"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossOnSaleOfInvestments": {
     "auth_ref": [
      "r83",
      "r84",
      "r103",
      "r594",
      "r624"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.",
        "label": "Loss on Sale of Investments",
        "terseLabel": "Loss on Sale of Investments"
       }
      }
     },
     "localname": "LossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "verboseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MajorCustomersPolicyPolicyTextBlock": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.",
        "label": "Major Customers, Policy [Policy Text Block]",
        "terseLabel": "Major Customers"
       }
      }
     },
     "localname": "MajorCustomersPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r48",
      "r113",
      "r232",
      "r530",
      "r588",
      "r612"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r330",
      "r462",
      "r463"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedLabel": "Purchase of noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Noncontrolling Interest, Ownership Percentage by Parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by/(used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r99",
      "r101",
      "r104"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r65",
      "r68",
      "r77",
      "r104",
      "r113",
      "r134",
      "r139",
      "r140",
      "r141",
      "r142",
      "r145",
      "r146",
      "r152",
      "r195",
      "r201",
      "r205",
      "r208",
      "r211",
      "r232",
      "r530",
      "r596",
      "r619"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net earnings attributable to Cardinal Health, Inc.",
        "totalLabel": "Net earnings/(loss) attributable to Cardinal Health, Inc.",
        "verboseLabel": "Net Income (Loss) Attributable to Parent"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r65",
      "r68",
      "r145",
      "r146",
      "r468",
      "r475"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net earnings attributable to noncontrolling interest",
        "negatedTerseLabel": "Less: Net earnings attributable to noncontrolling interests",
        "terseLabel": "Net Income (Loss) Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPrinciplesEarlyAdoptionMember": {
     "auth_ref": [
      "r138",
      "r141"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents a group of guidance that has been adopted early.",
        "label": "New Accounting Principles, Early Adoption [Domain]",
        "terseLabel": "New Accounting Principles, Early Adoption [Domain]"
       }
      }
     },
     "localname": "NewAccountingPrinciplesEarlyAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementEarlyAdoptionAxis": {
     "auth_ref": [
      "r138",
      "r141"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The financial statement line items and the effect of the guidance on financial statement line items by guidance implemented if the entity elects earlier application.",
        "label": "New Accounting Pronouncement, Early Adoption [Axis]",
        "terseLabel": "New Accounting Pronouncement, Early Adoption [Axis]"
       }
      }
     },
     "localname": "NewAccountingPronouncementEarlyAdoptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r141",
      "r160",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r432",
      "r433",
      "r434",
      "r435",
      "r579",
      "r580",
      "r581",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Financial Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International",
        "verboseLabel": "Non-US [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r330",
      "r458"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r23",
      "r222",
      "r223",
      "r590"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Finance notes and related accrued interest, net, current"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r17",
      "r587",
      "r609"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableNet": {
     "auth_ref": [
      "r24",
      "r222",
      "r240"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.",
        "label": "Financing Receivable, after Allowance for Credit Loss",
        "terseLabel": "Finance notes and related accrued interest, net, total"
       }
      }
     },
     "localname": "NotesReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of Operating Segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r195",
      "r201",
      "r205",
      "r208",
      "r211"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating earnings",
        "totalLabel": "Operating earnings/(loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r556",
      "r564"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetailsCalc2": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r553",
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r561",
      "r564"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r560",
      "r564"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r546",
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months",
        "terseLabel": "Operating Leases, Future Minimum Payments Due, Next Twelve Months"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r546",
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Five Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Five Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r546",
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Four Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r546",
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "Future minimum rental payments for operating leases - 2021"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r546",
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "Future minimum rental payments for operating leases - 2020"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": {
     "auth_ref": [
      "r546",
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due Thereafter",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due Thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Operating Loss Carryforwards, Valuation Allowance",
        "terseLabel": "Valuation allowance on operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r39"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r487",
      "r511"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherBorrowings": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.",
        "label": "Other Borrowings",
        "terseLabel": "Other obligations",
        "verboseLabel": "Other Borrowings"
       }
      }
     },
     "localname": "OtherBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r63",
      "r72",
      "r532",
      "r534",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "verboseLabel": "Other comprehensive income/(loss), net before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax",
        "terseLabel": "Net unrealized gain/(loss) on derivative instruments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r66",
      "r69",
      "r72",
      "r78",
      "r323",
      "r532",
      "r537",
      "r538",
      "r597",
      "r620"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive income/(loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income/(loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r66",
      "r69",
      "r460",
      "r461",
      "r470"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income, net of tax",
        "verboseLabel": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r61",
      "r78",
      "r402",
      "r444",
      "r446",
      "r532",
      "r535",
      "r538",
      "r597",
      "r620"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r58",
      "r60",
      "r515"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "Gain/(loss) included in AOCI for derivative instruments designated as cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossIncludedInAociForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Income, Net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossRecognizedInEarningsForDerivativesNotDesignatedAsHedgingInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromHedgeFinancingActivities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net cash outflow or inflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for (Proceeds from) Hedge, Financing Activities",
        "negatedTerseLabel": "Proceeds from interest rate swap terminations"
       }
      }
     },
     "localname": "PaymentsForProceedsFromHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchase of treasury shares",
        "terseLabel": "Payments for Repurchase of Common Stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r97",
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Payments and other adjustments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends on common shares"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of subsidiaries, net of cash acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "terseLabel": "Payments to Acquire Businesses and Interest in Affiliates"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property and equipment",
        "terseLabel": "Total additions to property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PercentageOfLIFOInventory": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.",
        "label": "Percentage of LIFO Inventory",
        "terseLabel": "Portion of inventories held at LIFO, percentage"
       }
      }
     },
     "localname": "PercentageOfLIFOInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Share Units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r355",
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Preferred shares, without par value:"
       }
      }
     },
     "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred shares, issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Authorized\u2014500 thousand shares, Issued\u2014none"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfFairValueOfAssetsAndLiabilitiesRelatedToDerivativesDesignatedAsHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from long-term obligations, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from Divestiture of Businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfNotesPayable": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.",
        "label": "Proceeds from (Repayments of) Notes Payable",
        "negatedTerseLabel": "Proceeds from (Repayments of) Notes Payable",
        "terseLabel": "Proceeds from (Repayments of) Notes Payable"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Net change in short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from Sale of Equity Method Investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r65",
      "r68",
      "r98",
      "r113",
      "r134",
      "r145",
      "r146",
      "r195",
      "r201",
      "r205",
      "r208",
      "r211",
      "r232",
      "r460",
      "r467",
      "r469",
      "r475",
      "r476",
      "r530",
      "r602"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings",
        "verboseLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r35",
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r34",
      "r274"
     ],
     "calculation": {
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total property and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r13",
      "r14",
      "r276",
      "r615"
     ],
     "calculation": {
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r33",
      "r108",
      "r276",
      "r652",
      "r653"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r13",
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Components of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r13",
      "r274"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, Plant and Equipment, Useful Life",
        "verboseLabel": "Useful life of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r82",
      "r239"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for bad debts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Selected Quarterly Financial Data (Unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r24",
      "r30",
      "r614",
      "r645"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r108",
      "r224",
      "r226",
      "r227",
      "r228"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r63",
      "r64",
      "r72",
      "r532",
      "r536",
      "r538"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified to earnings"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r202",
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Assets by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r201",
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r201",
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Segment Profit by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r203",
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.",
        "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r200",
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Revenue by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable Noncontrolling Interest, Equity, Carrying Amount"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Reduction of long-term obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayments of Notes Payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r254",
      "r255"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Share Units",
        "verboseLabel": "Restricted Share Unit"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Employee Severance"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeverance"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r103",
      "r280",
      "r285",
      "r290"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "totalLabel": "Total restructuring and employee severance",
        "verboseLabel": "Restructuring and employee severance"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Additions",
        "verboseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r281",
      "r287"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r25",
      "r330",
      "r393",
      "r611",
      "r639",
      "r644"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Retained earnings decrease",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r135",
      "r144",
      "r146",
      "r236",
      "r390",
      "r391",
      "r392",
      "r434",
      "r435",
      "r635",
      "r637"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas [Table Text Block]"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r110"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of estimated sales returns.",
        "label": "Revenue Recognition, Sales Returns, Reserve for Sales Returns",
        "terseLabel": "Revenue Recognition, Sales Returns, Reserve for Sales Returns"
       }
      }
     },
     "localname": "RevenueRecognitionSalesReturnsReserveForSalesReturns",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeSalesReturnsAndAllowancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r75",
      "r113",
      "r186",
      "r187",
      "r200",
      "r206",
      "r207",
      "r214",
      "r215",
      "r220",
      "r232",
      "r530",
      "r602"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r559",
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r559",
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesReturnsAndAllowancesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A revision in the estimated reserve needed for product returns and price or other concessions granted to customers.",
        "label": "Sales Returns and Allowances [Member]",
        "terseLabel": "Sales Returns and Allowances [Member]"
       }
      }
     },
     "localname": "SalesReturnsAndAllowancesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r63",
      "r537",
      "r538"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r450",
      "r451"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresAndAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of Total Share-based Compensation Expense by Type of Award"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit), Current and Deferred"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.",
        "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r488",
      "r497",
      "r507"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r478",
      "r481",
      "r482",
      "r485",
      "r486",
      "r493",
      "r497",
      "r509",
      "r510"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Outstanding Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r516",
      "r517"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r259",
      "r264",
      "r578"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r259",
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of Future Lease Payments"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r253",
      "r256"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]",
        "verboseLabel": "Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r253",
      "r256"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income Before Income Tax, Domestic and Foreign"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r268",
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r268",
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r646"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Transactions Related to Performance Share Units Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r496",
      "r498"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Schedule of Gain/(Loss) Recognized in Earnings for Economic (Non-designated) Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r35",
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesComponentsOfPropertyAndEquipmentDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativePropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Schedule of Selected Quarterly Financial Data"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r283",
      "r284",
      "r288"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r283",
      "r284",
      "r288"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Summary of Restructuring and Employee Severance"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r281",
      "r289"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "terseLabel": "Schedule of Revenue and Gross Trade Receivables Percentage by Major Customers"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r75",
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationPropertyAndEquipmentNetByGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r195",
      "r198",
      "r204",
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r195",
      "r198",
      "r204",
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r355",
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Transactions Related to Restricted Share Units Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r360",
      "r372",
      "r375"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Transactions Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Range of Assumptions Used to Estimate Fair Value of Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r44",
      "r111",
      "r167",
      "r168",
      "r316",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r415",
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r182",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r220",
      "r627"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r182",
      "r184",
      "r185",
      "r195",
      "r199",
      "r205",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r219",
      "r220",
      "r221"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Distribution, selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "SG&amp;A Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleOfGainLossReclassifiedFromAociIntoEarningsForDerivativeInstrumentsDesignatedAsCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r103",
      "r280",
      "r285",
      "r290"
     ],
     "calculation": {
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "verboseLabel": "Employee-related costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Canceled and forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (in shares)",
        "periodStartLabel": "Nonvested at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Restricted Share Units",
        "verboseLabel": "Performance Share Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (in usd per share)",
        "periodStartLabel": "Nonvested at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value per Share",
        "verboseLabel": "Weighted-Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested during the year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate (minimum)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable at end of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of exercised options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled and forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value per stock option (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of outstanding options at period end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r362",
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period (in usd per share)",
        "periodStartLabel": "Outstanding at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price per Common Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r352",
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedToRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r108",
      "r355",
      "r358"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Target performance goal (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r378",
      "r394"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRangeOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of exercisable options at period end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual life of exercisable options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted-average remaining contractual life of outstanding options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfRemainingStockOptionPlanDataDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested during the year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]",
        "terseLabel": "Shipping and Handling [Member]"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeShippingAndHandlingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r182",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r220",
      "r253",
      "r279",
      "r282",
      "r291",
      "r627"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Operating and Reportable Segment"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesRevenueAndGrossTradeReceivablesPercentageByMajorCustomersDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationAndAmortizationAndAdditionsToPropertyAndEquipmentByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails",
      "http://www.cardinal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r111",
      "r113",
      "r149",
      "r150",
      "r151",
      "r153",
      "r155",
      "r167",
      "r168",
      "r169",
      "r232",
      "r323",
      "r530"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r46",
      "r130",
      "r131",
      "r132",
      "r135",
      "r144",
      "r146",
      "r166",
      "r236",
      "r323",
      "r330",
      "r390",
      "r391",
      "r392",
      "r434",
      "r435",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r538",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r166",
      "r577"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r21",
      "r22",
      "r323",
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r21",
      "r22",
      "r323",
      "r330",
      "r364"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r21",
      "r22",
      "r330",
      "r354",
      "r373"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r22",
      "r27",
      "r28",
      "r113",
      "r225",
      "r232",
      "r530"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Cardinal Health, Inc. shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r113",
      "r130",
      "r131",
      "r132",
      "r135",
      "r144",
      "r232",
      "r236",
      "r330",
      "r390",
      "r391",
      "r392",
      "r434",
      "r435",
      "r458",
      "r459",
      "r474",
      "r530",
      "r532",
      "r533",
      "r538",
      "r636",
      "r637"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r330",
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Axis]",
        "terseLabel": "Subsegments Consolidation Items [Axis]"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Domain]",
        "terseLabel": "Subsegments Consolidation Items [Domain]"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r539",
      "r565"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r539",
      "r565"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r539",
      "r565"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "TaxCreditCarryforwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense": {
     "auth_ref": [
      "r430"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense",
        "terseLabel": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury shares acquired, average price per share (in usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r45",
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Shares"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r45",
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Treasury, balance at end of period (in shares)",
        "negatedPeriodStartLabel": "Treasury, balance at beginning of period (in shares)",
        "terseLabel": "Common shares in treasury"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r22",
      "r323",
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedLabel": "Treasury shares acquired (in shares)",
        "terseLabel": "Treasury Stock, Shares, Acquired"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r45",
      "r331",
      "r332"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Common shares in treasury, at cost: 34 million shares and 28 million shares at June 30, 2020 and 2019, respectively",
        "negatedPeriodEndLabel": "Treasury, balance at end of period",
        "negatedPeriodStartLabel": "Treasury, balance at beginning of period"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r323",
      "r330",
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Share repurchase program activity",
        "terseLabel": "Treasury shares acquired"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r432",
      "r433",
      "r434",
      "r435",
      "r579",
      "r580",
      "r581",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r398",
      "r409"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of fiscal year",
        "periodStartLabel": "Balance at beginning of fiscal year",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Reductions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Settlements with tax authorities (1)",
        "terseLabel": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized tax benefits, interest and penalties accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Unrecognized tax benefits, interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r411"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions for tax positions of the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions of prior years (1)",
        "verboseLabel": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r413"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Expiration of the statute of limitations (1)",
        "terseLabel": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleOfUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r170",
      "r171",
      "r173",
      "r174",
      "r179",
      "r180",
      "r181"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r120",
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails",
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r125",
      "r126"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesRecoveries": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r125",
      "r126"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeGoodwillAndOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIiValuationsAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r557",
      "r564"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetailsCalc2": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Employee stock options, restricted share units, and performance share units (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r148",
      "r155"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted-average common shares\u2013diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r147",
      "r155"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average common shares\u2013basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted-average number of common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(ColumnA))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11374-113907"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e39076-109324"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4616395-111683"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EEEE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109999725-113959"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121561968&loc=d3e75592-113984"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611133-123010"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r663": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r664": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r665": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r666": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r667": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r668": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r669": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r670": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r671": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r672": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>138
<FILENAME>0000721371-20-000089-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000721371-20-000089-xbrl.zip
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M7&[AC@/F3QP*;D:F9>7!%RL/X\N77XU/W'WOV]?[[]RW7^\??C6^?.>^?^7
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MEV?9@;[&&WV)[\F2(&HMW>BH0AO80A(D&,JWC66VN"=/3H@B%^$!P@?,$E
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MXV\ $#Y$Q\.3.)_T9=@=,Z0SH=,UPXC3^>0-MCD)#^$/Y!I/J$I/,S1>  >
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M4C5GGWARY0[#-?:("4!FW$EZ.\S?_\<UUXF# -E@\:Z&#].3WX!X=AK2^:G
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M&M4=1>A1+&==.T'^4-#Q!#):E@&V\3<_0%G'(Z)!Y"(4 CPIRC.?G?0PE5_
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M1BF /@9;A(A[)&8UOW^\EQM;I?4""5J7QV:I_)B PD77]J'H]+_J0LN6*DH
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MB2<19%21H\*HJ) 1B@(9P6E!S?UWC/%&4KE2',-J$8H'$_I@5!2K2&20)++
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MMPZH$X,JU(FR\Y[./@_UU-=RRWPP91Q.KO"#T!*+A9IW3#,XU/@*QTLD)$W
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MVV:(U"SSL9S0DF$(9,<%K@M71-:C$]T_52&>5Q".]4/W<"$RP(^E!>3T_BS
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M)M#:NHQ#.&@8<II<I:0P/@R*'>^G[KZ^Y;\UI-(R=/EF G[+#_QW\@/_K/S
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MQF=A\VN'NGE&,@ =)Q)JV_BRN8=[ 91HWPO7E=X=4$"(T%033!"H*S]TU.$
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MJB- 4FA)SA*S;Z+*)'PB6%C\X(<7N?[-";];OPA/<*IXX9-/]CYO)J8Z$U5
M3L-!PD?0?]-*(PX)V^ND*628Y,3XI%"D/Z>L%SPS=VCYL?+#.)!)IBE*;AI
MHQH&UC)+8O\0IW#,#K CK%8!\":;IK\ M-PX*?@GGH.PQY>WK@=^\"B">?8Z
M=JXE?S@A]TCPB* EW)"JN,HN*\)0JBMWU<4Y&&+])B6M>O9_8^S?@W56#]SO
M\O]2OP_^^S4P1I>P(+0N9GX<86K1=QE92"!GR5PIHTY6HX1X-6RM^T N_G;V
M7^'%[>1RU)E>C2ZZE\/>H'<YONR.>Q?CR^GM96_0'16^//0B6^E<7%$\W&X4
MUI<X:+<_Z0R&5YV+87\\'*%%VYOVX=R7G?[-9'K9+7G03@4G54'>__-?DUY/
MQ_$ +Z_,G+:TA.9;4M]&+W0_D:QQO 5R7\(4S%((DG25F NNTP0L)ZW!(2"#
MA>(\$"IF6L=N8GEK@Q:S#$XSLDT)]M**IWI7.&E;\)I:9)625DWU4E.]=$+5
M2\^@>PDU-,>!\Y5[7.<UK*ZK00&6[%<[\C/I0.(ND-P;+$TTP[[7N0?375"X
MEB?$7&C4(S$)%WB7A]EA<1"B_D&M%KEMH+0>_=B=8]<2*U[A+WX:MH<C;?I:
MB,,6P41*CT<44L=O8:D*;M)C<)NT&0?SNH5]C[7<&^,(5R)0'=5Q7>P'0<T>
MN&N'CXH2&H7P G;4"9-^WUC=;2=]R9,R RYNV-64'+\W R5Q!9N99Z8I=B<?
M\1!JOB 5Y]C"H_+TI/7["G/9X9N/]])3A>])&Y,E@@+6OJ-4]:<F$6*C\MB-
M=*.!&>;D8<,+!"A SUDL)"6/PA-ZW&$+RT]P+Y@CZ+JL-E995E+A,-.2_HF-
M'NV&TG)*AJ_6)FZ,!DSUY$^;F'25TSI*=>BM8SW4=DN-BIMU5=V/D!U(U;83
M&U>2-[1W4.ZK[QF6_84K'N[JKFOJ6,P9R*(D8%ZS-J.O2<74UJT415@<SV3T
MB%K$3P.CAR9BCYEMS+W2Z'G0>98BP,J\3;LVDO:]!Q^Y8P\Z_"H0:,K:"!4]
M6"7? &W*BEXIHZYU@\-Z$DR536:KES.DPE(80)7_8:)DTC&28CVX]XH[CDY[
ME5+O2JHVG2UJQZ3[\E?<'+R+W[$-ATHE>Z>@4PW[#Y]]KD[/W?= $*QP75O=
M;DL52:!'_-)'[SF@P+432&Z;28W5'BB(N8WL^.A/G?9@,IR:^ 1\'?%UD/Z,
M)HSA_SQTC&/,?"9")VP9?>Z)GGPL$X,/=(>\+909M, ]\#(94+$=ERREC[9*
M=O]Z>\!?Q'>PJ#7< ^C!I"4_H)_Z'5X&R^3IJL%9?UGXC3#TMS3.6T^9^)9M
MV$OWGBEK/E3!BW7>2)*'4:T]LZ<A# "YDK"O])@5M0K?--1:.@A+(2:/&5-(
MGCN<^BCGJEC5R+W8D6V1EV>1];&5B"[VK\?CVT'_>CJ>C(?3X>CR<GH[O.@,
M+J[A[_WKZY+1Q2KBJ"JZ>/;RN.+9YBQ%TT]7S]9 E5(8]@.HE$:F@_Y^6$$<
M 7*3NI3;5-\JV6Q$8G^6M+N2H-)DZ@Y4WX;QA]82]%@VUWGSS>VQSG#W[D\O
M,/^"\L&G2@1?6%KXKN6#;YDRWQ3Z%2_TJR+QO<[5?L8]L<.YFFO* 65W4"R%
M9/\RZC75?$4*$X7ES/]V%@Y&P^O+3F]T/;FX&4YN+BZ'-V-0YJ\Z5]>CSN3F
MYHQU[F+29$,6GE;5^K3=ZT[V7[/>&Q:L&BPB=)JJP:9J<!<KI>[W!P*46M0&
MUEN:[*Y9?-%NTP_UBJ%9;X<J5"S3R.<Z!^PR]X+VD#5($#V!CI/LU4PO9D>K
M21ER%N$\34/$4KS9.DD;I&0ARM1W@:;#OQ8OUYR<L,)2VD#N=9ZWD)]02+J[
M?S4M]%:Q;W4[S<>J^-A3OZN)NV.W:C0IQ&KQK4T!1!YC9 &PWKGC:?=W^"%?
M4S(4_X):D_**O[7[I#C$L@EW)]1GZ(2ONX?Q-_AO73J -=?^)M<^4-<^;*[]
M9*[]=QSX\#$S\:&Y]2._]1SOT.^8[+O+._(BU^.6:]&F?PY&,U0C*B@!)^G.
MD#\IX;R[0SVLG%9V0C6_T#=)N=@_L'XJXDI\#D>>@D2A V^&I\J<&-L8='M%
M8J7[O<5*?8N57.,!2X.&@H^8@KNMZ6C<T&]#OPW]'BC]]GJ]AGX;^FWH]R#I
MM]\:#AOZ;>CW&.@WQX=R:@2= X)1:SPH$BLZ, H_NK H-OA231-]SQ@OBHZP
M9]RFO6?<ID5 \";2J-<;%<#4VDJ5(Q >AX]3@VX1[M?@5(-33VC-_89/-3A5
MM2=E-&XX58-5>S8'>JW1(*^"J[9H=DKA;FZI("V7^V6EV=W6>>^Y],?G4+12
M\+P-1^Q4:;;6ED\>L^_IF+%STF!G@YUUQ<XB]DF#G UROHV;KT'.!CGKB9PY
M%E,A7T_]T/4( R1?5Q)KQKR[/(.I7]9@JBF&@N;9+9(Q5UL^>4KLL+XX-2IB
MSC0XU>#4;IR:%BE::U"J0:DGV%2A^M<&IQJ<>H7"/^P<%)*=4H#D5]6?.*/J
MIX/1DW8WYX/2X9)G2DL/S; ]^SPJQ#L+PZ&V3+?QRQPE>@\FA;)<&_1NT/L0
MT+M7+!K>H'>#WH> WL6<[ UV-]A=?^S.,3&[K?[P-/AYP4;9O:=[^70+DT E
MU4OC]K 0-O![.?A O7YVM7:USH<?K/-1D08WKP+J"V%Z)%5^+X3,817[3<?E
MY>@V+.I9\?<>N%^*G]2I[K=A#*?%&/JMSJ!(.*YA#0UK:%C#4;.&;FLRFC:L
MH6$-#6MH6,-&)+S5GQ0I%FQ80\,:&M9PU*RAVVWUQJ?#&W:.)'O5$**-JTVF
M?NV82V1M;R]WGN& _=@*_"]VO *(L_#<FO64Q8(,":L93(6"/:]LU@W[_/3,
M1I\< U8F+O6;7 4RI)RBI8ABP!D'KLA?T"BN;%.F'3E)^?W*Y0\]K&NQL^9[
M+D,[<&9R;LTD</FV]4W*9%"7>.U1K/M +OYV]E_AM'/;F_3Z@\EMIS\<7(\G
MW9N;RZN;V^O^16=P.[XI"JI_^)&T4O>C*+@, A< 9V%O[U[G$ZX:XA",*P )
M\@*::\:%\KC*MPA^0$E?]$+W$\VS7\0! =_Q%C@_#.'9?HZJ&THN0,F[VA+4
MFY(=SUG&RR=(CV?I :(].M&]8[9?RSZE)_*EF#D3+JT9WDO) PLT+J;D#.^5
M)^.NZ(A)5PR&B^EHT.]W9L/9>#88S#KS>6<TF0Q*D?'P_<BXK>BX(=<]D.NN
MHKB#(%?_B7*_38)EV2ML.XCAAZXC9H[+LAM)<BX7,@B($FU_*:U(_)"FS#:?
M;XB\(?+#(O)=N>_U(_(+:[6=T&\YJ/J"; ;<$4B5EK@+).$-XE;RQIWOST$5
M!PU;!@^.C9AW+R)\VY5WPG77ED3MSY:$0S0Z:"5M9T%,P'6M$,X#?[,%K@NB
M/3-"=^'\@,_#XB^S!5/H_3D9 6H9,X[_G#A6-A_GA]A4?_TD9/:F#+:]!CMF
M(Q>]*,V"_QT#M)@OPE7,9'(;\T\,LE;*K0/K0<":"/Q5 /<#__8?G!#9]2>Z
M#K&"G_R@2<56Y"P1[(J?1('P0F&3VF[]?B]ST40L_9A&&SNA[?HA8LO,?Y!6
MH"5',@<YU.LFBA]L[O'>L>^M1\",(%D6UX"-T1: 6ZAQR<C*^6E;A/<@#2)T
MNH5P6X!%OFW'0=M*"U/0>\&R1,01V'[.?Y2(,G&7,=5[\%W8L.<#[$"U!%&T
M="+"\T7@+RWIJ**6(%K3+MEHA$W2KW&7?&)"Q;;U!6 "2(!?:R6Y1(HJ ,OQ
MNF+/<>&8 9&'C3+,53(3=X%4 ,R:H+N0>!;^%5P30 *>B/ :MW>"\C&B#*:<
M>R);5ZXB CKMF>XMN>KM;YHWE3[,Y$Z'60(V9Y#/FH-E#NB#;P;RWS%@623U
M?OD2S2MZNG9(N*&O]8D0,3Z /0*XD@=@,XD?L%BIPK ]TF-M2RW$X% X3 ='
MI0813:RMJW]^L_Y;"A<N\,H/5FJ\KG5^!K\X^X!(#3CB2:(RON??X.6OXKOU
M#2X4A2M!A[ <@ W/KUP!\-3W&,BE@%LB9@E(N)8B2 @MX=A5.2VN>^/NJ#\=
M7T^Z_>'D:C2]OKJ\[%U,KD<WTZNKJW).BW$]G!::>.&!W7Z+1B,JH!$-#T8C
M2@<>&C9(RPICD#Z@#,5>(&T?]);_()V+'T"8'JA*$3R2V#2;Q@P^EEGL7@"Y
MSJ3TGA8HP%0EXC#^F/SE*)AB$!E!!'0/(DGA/,_K7A/_A4^M_-!AW@HH/9.V
MB)'E+M0RO(TUKAN $0?(/D-%30EJ+7F5*B"\=5;D5L5-.IW>L->[N9C<#F^'
MO?'@<CR8C,>=P>7-N',QO9B4XB:3RKC)V<OYR%G&[8DJ41RBJH5+F49NXP7=
M!W]Y76[V>_*7IQ/-YSXJ35KY234>UKI IP ]8"GF,D]Y0(3U5X[OH+LE4DNV
MD&GE^D:^&=;7M7R0KK_B;\'O;@%]86>E5*->I]<IIULA!_T=F!YHG:$Z*.PM
MN@<#\Y?K_R.6JT\7^$PV8GZT&@X?\_6,J7UF?0%.SA8]X,6#H1RBK0Y2P+Y'
MNY$,]'CV!X":-5BD&6?%2NML#1LF2PX?6_F(88@B\ *0$1N5+52$Y8\5+J P
M-[$124;1UK_)*'+YZ[>!6,I'/_BN;-D0[$:!UE_@QW>,T-W)1]1K$QOB7Q*M
M)J01L/I0(*)= $+7@6\^WDM$#[!$4\)9(DG#VG>.QR=TZ- @(T,'^2P1%GQH
M3=05NRP&W930,,4#H><L%BR #;NTA1(6]P)K@$'7J-JE5>UGO3TO]LF\W"6S
M[<JIAM/G93(8_Z9_"<N9_^TLG(+>,QCUAE>CB_&PW^M.;^'?@V%W?#6XN>[V
M\,;QNC9]5[M!8)S8S&[)'J[W3([&CM/1:ZJX3<K>N#=0O\05_NKA7;K;"2L$
M^#GHSFP%PW.>A(]_72P^7BIG_C=RYE\$@?#N&&.RT'OEP9\4X<_EI^PXNWH-
MN- ],"K/S_@PSWPXS$9DPCC,&;")K*PJ]O'_B3W)Z_0[+:N$F%7KD8K ?!#-
M'L/Y2](6[N7FR@IB=TMW-3'X EC!:#*XO9W>3(?]Z>!B<#&\O.E<3:;#R][H
M9G2\&/R;M$F6)0SOPK91YJ$)!;S/FXM@7EM$+BJP^/5$8EW<3BY'G2FPK^[E
ML#?H78XON^/>Q?AR>GO9&W1'A?='(JM;0F2I=:J161MF7< WOTA>$^G-A_KF
M\VB&!4/Z]^+X@!N000XZ&$MN65GTO@,*F<=_-[^ID-\DN:ZRS%YEF#YEA6[L
M=BD"T,YX>R*.?/T#SLBEG[!9.AVW!X!E_?'P3SI)$8C8%:M0_E7_X=-F2F)J
MXB;E[_VSW18M?ZD_^)-A_V[\KO^RW]6TW6\Y?E%>?FVQU;//W2)U<7N&VD["
M*@:W*V %#BJ[*AY0!H(Y@BL+S_]7:GD<@D/6/VH6UBWP ZO;^?C_U>2*WC+C
M?F?*,?_[/D@Y[)W\. /;]?M'L0"T^:MP'\4Z1$YP'V3UI*ONQ?7-X+8S[$[Z
MP][US?2V=S6\[/2G%]/I]<W-<%-/*B,<]IB277)3SXJD@Q9H2EI-VYWN<#R8
M=/K=P734&>U;:/5&NP73L+?[=[U> :&ULP^*''07_6%.'Q3UB\.1=FK?"_HG
MC\]J)V25;60.#DHY<+D*E'/0L(1^A>/9.OOOF_1"]D0:3]SH7)$# 6>-)%&.
M4?$:[EPO>[I2['D%)";[M;238QE&XBHY5B"5XSKOM^2;.7<^,'I@(A$%D$7&
M^>0L06;1I'),!DIM4MOWV--*L MD&+N<0:.2>74.SKFC/Z#26#BTS*%CVU^N
M7/G##!$@_-/TKADE <4K^,Q*A!%% 0)'HB,,WP$A*=@+AO9T=_PIM/Z(YW><
MG_*5LW^DO\(LP=6*(]E)<%HFC^I8>"B6TEI0:A4N;CN!'2_1X,841 "?B_G%
M%- RW/;)7MO6I8J)I]M'^.L(N[M.8^PM2\7H--PP2,!K4K87Q:)4;(JB'SK"
MQOLTKB>]:CB@P[ZU52!7@M*FMO*;T_L+$U>$#@)J4&)1D@/GU.@CK:4/H)_+
ME215"''!."+FPX5AO%S1G;=1L]\1KL[#0?1_.+"14.=WFT?G7(>%Z=3/6:,%
MCS?>I@)9V75Q%RH.GU2"8E[HU==_?KG^V)T"V0/2+1T;>!/B!0A'C*(Q5]+1
M18QZ.U[,P-AXA@#VO^UO;7KRSO5GL \0#IZ_5(R_Q6$\2GA3GFE PF"N,P01
MZHO4=&T15<WB$$ 6AK!$FG6C=X7+"$J2E9Q-@U:;&6/,I,6XTKL#TYWRG1]0
M@"<).-M 2#+T7+KK'>>RB>B!W4IB78IWZRTS525<VDR.?KR77%Z!Z8$8]609
MFZYKO J/)S) I<PB-ULFF9Z +HJY<HXM_@P80A 3IR"6IX6+L;N6P:-TQE%K
MAWR!#U$6T8***+_"*K*<AT)SM58B&[887 )[)32V[X@EA1'R9<;.$5^,\E;@
MI$EH9=L-_)+4DTT]?52,>$=;&RJNGEVX<(D4X4*1<.W'LV@1)\I:98&.DW)L
M=SN=<LZ![K/. ?K$.[FF\QL**$/A::-*7=XPUR7T!O:542<"+''E"ER=T&KF
M^O9W73!"T,U4C/S9J#UY?57)VP3_4'Z+##G/-3DK]2U,T_#OI(=5"V89CXWL
M7@8/DF7F7'(I@20Y\=S"LS6\_>#(1TISUS_%D)KSP/5"0"IW*/3F<.Q@;464
M"=:R0%$%V,@@HR,'+)M)R<!LH(@#<+0"**J1'Y#M]0AH(3_ZBX5:C9.95*H2
M/[>FLP3R+G8%%AW(!^'&J +<^X^6?8_1?$J1,T6X$JZFA";!JA_1XG.'MM B
M&2M ^,!#:ON!$WXOD6U[,AKS,ST'M$Y%-LB:GOHM03&^_F<$VBL$]]M2[X5U
MOUYA@CF[%3KM+F:E440:T##@ EW,^51_5BJS(EDJ[-,O@$%)%Q!@PEM@PB<J
M&4JJ/E?ED;0VUC-)?_=V'G<FYMP7!+T1'GLRRGW^ITG)JB&U#O$89;YG;@4+
M>M#QH.K@U,:)+Z(0)8ME42HY-U<[+7\QY(.@>L(5/!?)XF33>4L3]B)B1P:J
M^RU=QT49G8]4E<@E$,(3[IK)#(3.G/K'H$VC)9$#9H?VT^%KKO,=[0G@7R[E
ML_H;OKI%',7D<<J2YG,B,X=D081*,*@W2@]QL;(AX*>RF:Q+'_Y3)0(F;D&Q
M1.?5W/0?W<7 _Q$J!%_EG0PM:=3!+@&,"%$E/%V?#/Z\W,OWJA-^#^0&V<<L
M/2U%,ID[&O)886B=<<ZVG)OP.[.6_ERZJG@5Q+!#9;6&,I7Z>%LZ&=OT-+"[
M.7'BAO%JY0=L:@%Z2UN$J%["/9+>@^YDQ/HXU-2P<((PRO?M=-N612F8Z(-6
M^AD7#:>:EIC[JX@U,?B(!S9:@D>X,WHWT5@I+9Q<(TC[RKN.7@&"=M:U_KR?
MU@]T233@9,CUTPL?B9M+M+@@6_76,)45T#HI3^3N11HT^RFP-AL][A'H>E+#
MB$I!_[K_4,@!&>-56=J]9TWMT1,)8MW=OYH6>NN)N/Y!?:NFV7+%\_\WW6=<
MI.F0#^T<6)S2(\%H5-7YJ6 /GQN=V2\YO^>M<^<J[7MIZJHGE(QVFO>/U]TM
MTAN]N>Z#O>[)+@?MB8Q8OLC5^QA34ELP,J*AH.YR0>(;$<I.(!])O^CG<.C
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M::GV4O0+$2+K;'%+IX]^'%GG9S]_N?UZ]L%:RNA>#=(%#O9=1M0N*>1&;*O
M@1_"EN"Q 'MO IW(#/:H3X/0@*?O!;!A6\;<J0V>C0)G%A/B+8#7NMPN3/6O
M1SS\-?M&*'G,P+GJ0KEC!=5R\@,W=L)S&!VB>#=&ARBS+]3"DB+ BOWP+^?8
M8^N#:M9/K;\WM@\\/\89!W& PQ$"Q^;V>M)V5&-+3(1>N"+MOT]C'Y+V3Q\Q
MM4:#:FVY.! !)S13BV^<(8$#CJ7 W2QB%]NP>PN7&I'/L3=K$AJ:Q32.82;O
MQ8.#0P"62SEWN&$V;D<B4\G[>-OZ[Z17F+MN\1EXD, L$-3D+7MDU:%=-9K%
M_GG<"@XU'KAWW5S<X?;O9M]'&H8>4MNO5>!C=GB(DF".QY7XB/EQ6M^QMSZ>
M_2Y^%901Y**;'\[TF,S];M.W=0]]6PU%,%?Q->3C>W3VV[,\_5_BILAL6I9#
M,,<&DN$&-F[2.W?OXSYY2;>^3;K+X2XMW904FZRFA$$=\F9RXZ.JFV4N)6#/
M2KQ'^*,,C.W!SN^E2Z)#*,&![[<1<4!-"R5RC-+G%/DG3>CZZ4-F&4SI4]X#
MZB3'?&8L>'4#8IO>?:^:^_K4;-<7SH1]UT3>0\^Y>D4LZ: GM)93P?E*ZCRF
M]0F_9IEKR@%E-R\5^4U\?Y5FJ,U?/U&V^%F:P;#-8-AF,&QA+M0,AFT&P]9$
M!RL\&/8(7<Z9D1K*,0@688!I0&2VL:\1K;?41./N\>AQ (ONP<%)1\)L6T\C
M+7XXVBNA0G5)MWLV!@,)H+39/Z073L9DHC-SAR>Q;5V  1G;]VR*DBM13P+!
MH10TB(\'F-IXN.@1IQ>>BP_&=S:=K[0(;TR[5'F^ZVSC+=XT3Q*U>7!HT@T_
M]=V^'(!PF+I-BZF%OYS<ARL><4!>#<-]G3K0TVM[1(]'R3$U@VZWFD$U",'G
M5MC)M<J>HM?O5'0*Y7L!MN!M8S5= D\P\RGLSL-V,A>% []^V#B4,R'WE'(,
M,L81P"!><!5N21*OZ(/TC<WPU]I:!/XRNYG(-U"A=N.7D*>\-SW5=B 7SC4-
M)$YPRDH"$D8X@\2/=D7,\I@VCE>.R'_^7'R-PVK9 )L15_,DHC2<^3\DT12Z
M_R/GI_C-N5SP^*E:SL_9\Q72U#ZE;H)F"08?PE@%C]1<&I_\1'"OH* &/%0L
MG8GK(HM(U >*D,T=6]F3U$@PF:;.?G94P_Q0S56, N&%-"6'!:H1\M #8W@$
MV%:4<29<*K0/[Z6,>" X7CLQ*Q[12#$4Q<,H7#B#MT'BFRH+Q0:KD#_=X; Z
M^5-Z,^/*A&'M^'']%!PU/I.56)H:G^ 7HUQHDS;+["N=3S\3(> QJ,<[)DP9
M/Z:AG8'_!\^L N+!F*.:#JI'DZJ>8;#T'=./J;2V+)2WJJ6GP_EFUIRV@2+:
M^XBI!J:V#'_+Q.,#"?_UDLGVF_&<^C"T+PL+]PQ/F).Y<$0=\H&%>/ #XDVD
M&='0J72"=BN9*(<SL!)@) P%LQ1G4@]DFQ>7RR\>-U4,!CO=K<>6*OEWWY]3
M]!+Q]2N%U+]X),]1$_T9R',./XB$=^?@G5^$H2PYL/L)^#1)EDV299-DN5_.
M]FN,67$H-^],TG=2&A=$X^2,PDG:BA=8KH,,'.4 R#R:8TB972OA!&35"L^+
M*1D"?OQX+S$3 M18 ?R?!6GZI/SAH &<L![C5[BTLH1\E[Y'FJ\(G#!UI:7:
M]@+>2^UDL+$Q9Q1>CV''E%.DLC64IF'9 !1*31-+]!3KU#8EE4!QP&0B]&5%
M#A@YI&PXQ!,%#I5T'52R'VAF,/P59XGRWQ%B88@':%<Z8O?_&M]$/0)!B1?
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M=<>?PHWXMY'AS5Y:AB)[>U?"H:BY$\EE<M1,44/:[BLM;R@>8^[L$XG8];D
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MZ^GA>NJMG8XN%XD2I?BE]K!JEPQ^,'+0_9,':#6F/)ECH29XDVKI6;N;NK7
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MS<0!>.8 !MAQ0#FZ_P%8::2LI>.>^IS:]\G-MM=T%M^[\_&"].60+U%OZGD
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MQ4Q!S.) %4!JEHT+[+IMYF,&#V.=#>"&H7&*'2O%*4RCYVF"X*;X5DEYP/,
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MS-D/O_7H;C1 D!(?DD"RLWL362*![NJJZGK^:DT=5#""5U8X+RO76^X[7<R
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MI?0-W =""=+TFP7OUOE,>PT3\6_$GE[X[N(<$1QC1RG<O &PJ& X\Z-U*2'
MZCR0)-W.Q=VJKE ILHG T3/X.!4E74OO<OJ;>H)Y#X1[CRGB8CJ**CR%!WPM
MJ> OYLSJ/"5TZODAWVZQ.M3DM/% 1HI+UR6T?<CM:SI/.T\^J*R<9[N\C(+@
M=.@^Z]#MVUU?\6[7* L6$O/V<RU6X89&VIR?*K+ *M/5.J871Y<**Y.&I1@.
M8%902%S=5#F% (@QC0AXWB#0$ZB$ G(F=6T]29M'U%RB*:0LO61%4P\U1KJ
M['D?DZU+-&2M'BV0D#F8JC&">5D]MT&?*MV0F\[5(-PVU*^U[9BGA>2EW0OH
M9H][T&OC[T]%&JN@ OX5_@<XSJK?UV,<P-;'&W#+-N53DE7/&DY=5T*^JH$K
M"NP;#U0*N(-T*P-UV <^Y?%I1F)#%5#1C+AT*5?!=QLH7 :B9>!E!FBD<(3J
MD<@JJ3JQ1*,[,_R&68TY<GL>QW&"G<G6U%#Z)+5+,-*RNC)CN(\9#QV?@D.S
M<E&F;?,;8FDA!Y U@]<@78%I9%_'!>B+YE8G;#TGT- &*!85(;ZW:@H5D&#M
M-5\])^!$Q9K_!A^#8R4&M$#)-TLV_80,IA^;E"$GJ* PEX0>=G_>^P9>2^/2
M]%'7IP\X4TN7TW!.OU ]:K>VF#_T9I6_7Q]7^AE.I7@,)O:;-U5J_;RB7_53
MQ2-^/$;[^T1=[OB7X_9)H4/]QV/5GW[2\(X[)\4>V$)K,/S][$0UELTUM"WO
M9X.OGI_@83S:" &?[)X4*WJ?4-0-W[HXL>NZZ$O'Z!^<_+BX((ZKPXXO3ZPQ
MCMYQ7@-S\J-= ;/1=;F)-GLY'M1L _(WY&%9VM:0JW-CF0<KGNGX<@%?/I4G
MX9-7)Z;DDX.X"Z*X_.KK$^,U/RFV<P!,CS:087QM?&F;JU3IT<"1+:O1!$7!
M?H46AR>]R0G(,PC(-N6CP4:S&CX+2DW=*>W6R4*WX'5ODQ?TK99>-7.CZ+89
M]?@IG^^*#MV/Q]HCPTC&2?$.8F^>_>.E4K:BV#NA7"24V^W!6_58ZJD/MAKS
M([>*/:SC939=D?<9RR&&+84$)HN!CY/70J"LI]8:^ &%T@Q1<7Q6,J9.LW4M
MA_5U7+B^"6.SB-X4[UD.3@6JCY'DC24(^Z9G;=6$&YXU5K+E0D6]N/D<B5V/
M>-HI@KU?K[7^Z^=;?HV7MN.4=<O?:/EN\%IQM6[PVJY4#C_3X+5.NWY]'3O=
M?^,&K[U$W?):@]>N+MK=RW>7UY>WMYWN^_=7-[<7[]Z?G=U<=RXO+]^?M_ [
M;O!:S6\LUPCC&F%<(XQKA'G%P6OUGG=BZFZ,?!1%9VM33@[*_]D8(J!S_KCG
MTUU\C[07_^EBK6]=KO6M)7]:;_'U?^!ZY%WO6Z^T^)JZRU=K*=.K1XJIC_W0
M@^\'#*@GO_?EE$K&$*=I@ID;#M SN--)]4UJ&8[U\I37)UF%"?;15(B],^4(
MV +X&%$Z!TD43]5(?K:RTX?(-66RW'(F\0-G$K_:U6&'2)Y/Q5*#6U5J\)Y*
M#1R15 I5IHMTSG9>\'^2;+J ?M@2M*2%J3M-CW[&H&DV_?F0]>".'=%VUL3>
MY=,5_5YSP#M3E(5M8H=^[;U5=1'O/GVIEQPT.TY9U?9P7DM)'1*48,[B"Q70
M!!82R+4VJV)"%*S*@Z:F;.E5V%TE$?\7)Q%A)G$M!E T61@75EO<E9! !9DP
M.+I*I/P9*;(>%STG<7YX1LILG1!E),BM4N+XO-&ZOGI&<N1BL).<LB <M",R
M]*RL\UOSU^8V<W%J,UOA@:V"C.[6F3N]^2)Z\ZQQ>=EQ>G,_]::3H1>1H<MK
M)T!.@)P ;7 )75Q?.!G:3QERQOOA&>_/>N:=YDK]$(>E*_ZTTWSC[ML7N6_;
MG>:%DR%WW[K[=NE]^_3\RURO1Y_^LZ7$RRM+R-'/7RI 3Y+B].U5,];/0;G7
MEI>CGZ^ZZPC'(AK44RI6*4AX9L&H2<K:\?A!\OA^'F]GI6R .]X=.]Z+,W>\
M[H9R1-A[06\UG28_$"Y_LI^Z*W6 X'&N Z.YH0)8ASHO(LKK7-D[(9&[+GB.
MNVK)776G^#IP7H[B&SFU>T?Q0]*@A[37NDM2J]G:/_6U)PQ6EWS52S@(GY\
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MO6X+;W7X^S3RN>X8@V%S(D=.[F9VQ#^R4++..VLUJ'AG4[ND:(2!6Q5+# <
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M0?RZT@GDFV64"[-!(E(L>XQWC ^;)_1$(,*&%_@3RLPCV#36%.438?B9B*&
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MZAF3G];>[I,G@>S07;>EB^SB\8NLO22=L62*<6?-[[67I$\N:I+F7V8WK3\
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M(H\<MEE % 1G"*2LCV464]7QCH0JO =^P@@D62VSDH>TR+K!HLV%9@L-SM4
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M7LXL\6E=[\VYW.ES40B9YACSUL&&&L*J1N8QD"/*SE#)#C%+PP8KQ^9H3)@
MJ65H"*+&+R\B"8W58F)(#5W<#ZCFCAKF1(R %U0;"/] "-?A3$&<#LVB;.K0
MNFH*^E!A,OPNN1NXAS13G8RE08JJ[3>4(Z$0[FV&9XD91<A5<R2N*1V4,N^T
M.]W.-5;.2JF'SALT/'6\"G]"#2WET>@KRMI:0D9X=2\C:DTM:A5J1<])\"=3
M!@%!O,)0]8FGIIZVF@P&2(_$+.:!BZA/"Y-A-55+KRJ6&F,4OW11U!4=O,Q<
M7\<\U96S&SE^#[4"%V?(?_KT+@?O07Q%"T ZF.68V+JCUQ))IIK4DU*Q-M34
M)B?%:>I#*Y9#VC510L^!\+F'5LZIA@<B!&;A<6T<S(D0N+K\7$H*]XN P;6E
MNLK-V?/V*]=I"L0)<$@_"4GHJVF=1%--DB+VA?HM?J."M 09)56>88C@F-R^
MK$J7Q\ VE*!*U#+LE^-4#4O_S:>S&C:>EZ:2@B3-C1AS6C2IO'C*E%T#"N:*
MF.[W[RF%^(E*"D#<F!=)UL=9N,,L* %VTL #M%+P8;$O$7T<;%*%K)X(C6UE
M]H&&9U9CZ/VR<+U?!+-B@?"8/!:;$@0_!_Q-EB>LD+D^E@28B*2FMG==/@],
M810;67VLU_,!V'V$7@D4-#N! 0UE3'A80[83"'X5$><M>"Z>7*K8R^*]/ F&
M0Q]4!T$B82O(-6 G B_K,;-^R28<JEQH49KTFP81_!<G@3'G1:DP7V-U& KA
MC!D_M%#_";P?)\LD*$4XRX)F)E<REO!&P%@X$EJS&-*(F4QW21C)*0BZ#3D9
M%BUBEH*F=V.T!O:WY.OAA@<#\0$$"-%\UIC=:J)'@JAO>-]: %U%\"B:]4J/
MT9,+T&BGR0$&"Q._H:9D#\5]%.N1K5EMQ>7HYT\18H;W440"4.Q!:1"R1G?
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MT0H^JNG=2%92'IB&T\]C(!BKT<;'D6ZV.T*.-,$Y-4^,;6EBQ!R6'>.0P:Q
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MJEH S&QV-*"P7VZ&Q?'32(;8F)S0V?CS70B(7II09S,Q"Q^DFL>5VU/DBMW
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M:.FU.E68\^=F2)FQ*,!QJ%E]DNP.11NHRR@>]SV"RCCJ#S)X\$0*#@)D)'
M<1@3AX%0LY*(05;,B6\H*RSE;13DKF-7:3TK:A_&P594*3[,(O#14'W$28*@
M/Z[0,[,U+]V,!;>4U%(J=9$0G]&$#-W7^EF&-'1?Z[!&9J@_';JOG:#[FGDY
MY4M#O>Q0+SO4RP[ULI?G"USZ_,_4X%QWO>P&GF>O\-H#1;05 !F%L D-,=%
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MK_TXMC+!5A7?\9JS/A9L2C+#P-%\06-U37G%(D/RR#NRC! \)$\=P2\EA!3
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M1[&([:/2Y^NZ$FWDS$XF?9T%N(V+D+[K"7J\^9,[)\,GGFN1C&=Q6:;3-)E
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MS._),DZS9"(E<9&E ZO1SA(IU)D1&;3]R/4<6=$,PXD<S0S]P-551_<=)]P
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M[#8Q!Y>OI)F$I@#%R@+I%*0 0NFIYTX 9"VQB*PEH35*%A8I:$4._CT0ORM
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M60&P,H)( ZG$4,KPAF;:,@M<^$F'26!_L:X7I-4:?#T3=)$)3A;]3\7P4-B
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MF.MY*10&N:*8*4Z@I1II##EU &K&)"1.:,B% <;$WPQ:DB;/QMQSYF#WQWI
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M\YJ6W#EY;HX=:=L"B[&Z<A^V5CG&&,44<(X\B[7^([ $9@RM-P[>"5AM.DD
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M%Q1M.O?JN^YCIT]7]G84C-MBCS=*0F$.!%7$:&P%\L1;437U$A!Y=D#LM=@
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MK5O,DXM7!V- K01E0CD/.#=0:"M\V70KJ#'\A<>D6_@I3V;Q&D6#(GU>%>5
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M75W.9_A:]?)=8U*K\+'[\;6CY?Q;.IB_^0M>5W_;,+T"N1Q@(67M.B>24V&
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M:7;,5,G-72$' ?'3.Z!@7HQ'[L6:RYMVJ(V@-5O16:DMM[<NYIB"N:$?IV<
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MC&K[!L3QI9* I1Y;<P;TK0!9#Z7Y?MQ-U36EDKS.&BM]K2MF!C>EU PS=8.
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M,Z@65U>0/(4^\OR' 3E6QZCN933M1."6*N!V^$&NP?=\9HOYJJ;]Z:I)?<!
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MZU6C;$SH7V.#SIS)U07NE:/QEVK_E]*0#73/BDEEM$]C3AETU0O-)J$SB<M
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M80(A/T@B)!CU8\\//!-U3),T%6NU#X\JJ/:JI,1Z+JQ74+V"ZA74ZU=0Q&_
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M%)C#"<+6X1]T[N+S ,"3Z2VPA:MLDHUP=:-B>FN><I-^R>Q:KO 0[O&MP[P
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MVZ5:AIH/<C1<D27.ZCZCD;8X'? K^K9F-\C!0-$;5!(&X,7>.FCE(W)5>MD
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MV58Y=5ME"VNJBV\[<9>>1)3ZZ/C!(:JN=_:'GHNPU\0VI<VHJ(AXF@DO]*/
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MFHXFV5TZ& #]HP92(]XJ][+,BWR*_EFQQ7_J(8;,C $*#! DDUX^XF,!3UT
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M<TAJW)'^6!/=(B(&$/I!HESBAJX"B1AJ$<8)UTJI9(/^VMZ3'JB/7[(S]0&
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M$N@XD#$HT4P0,&(WY.ISM.=DNCCR9!?1)?$>K2#]EN3E*Z=,UDC!0(:A&^A
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M0I--P$O$<>B%A'$W\@01;I!XC'+J^=SCB;<Y@J4#T=@AH6WT5):G0&G?EL_
M(]ZJUX#2%U+GJ9<\5W3,7)>W5-R81@&56D14<,T"&FB?^%0'0-DA?28=[VA<
M ^A:=$P[HV/9;?7-T2FYW[)]?;)4O"O1TM; 0AF00+HL=@,M>!+!/S&+"-BI
M7'O>9BI6)W9I7T1++MQNRU6.CFQ/T#9EE[1CX7NDU+FWC&VE=X.6'$2^\F,>
M1P*H5NI8>0'EGNO2D,5A#S(6X-,+L=).1PD<K2#]EN3ED1+>KG3F-2,]DD R
M*B/ENC(46OM!%+B)2+CD%+3;V.M!+/9&9]P_!3K[EBS29#RU55:_I?/L;)CN
M)31E0\Q>(F-0:+U 4"94R#56@;!818F6?A0_,_:RB]"L 8CPZX6H&24GK>>>
MS=,3I.4=21?^:LS3@$B2Q'[D^DS$0DGN!K$((Y4D$:;+=R^'^R==?@Z?OGH3
ME9VFIKROM"6T(5G-?2Z5]'WM2T&8KSWA"^+!Q02$;DQ[-U%9=\&<+:67KU!U
M/INH1T]XN](9;V44^3QB/O63..'"$UHQYG$_89SH"&1D_R9JAW0FNM1FCU_R
MG8")RBY=7ZT)1?Z-Z;-[2\M6];5@ =$XE4UH5T1<2.$111,9$<(#J?K(,C*@
M:]$Q[RYHZIYV].5LE9X@%>]*M*U>R4D"-BF/J>L"T7H>:+HNUQ2D&"54A#UY
MA_LB6E^>MBOI).U1T;'H/5+:W%O"JH98_3 @PF.^0 J-M"M9+"6-/4Y5K*3:
M*%3O1,*VDPM%=YGW9+/AR2O4D\_VZ-$3WHYT1DG3CSMF6D62>1X#H1@2&7B:
M1D&B8L\34<B>F9JPHU#LB<[<+J<B';_D.PE[U%^7B>(;4V3W%9:4-40L9""]
M*";<EU3$F,'+ B^,I8H%HYIO],GK1%CZ;2KVNO,JT;,U>K9&7QD1[TJSPF]U
MY@I0G262*2)"D01$11$781*%2@;),Q7<'05O3S3+M_20.R6:/4ECE),UR>N?
MIE*\MX#U&V)5RI.4*U^$RA4\CB28HTHS(7#:E@[Z2>#EI$6L?H?I]I1T.4_K
M:"7IMR0PCY3V=B4UY36Y\H%'.$MH$$@I"!62$"V9Z_L\#D)/]N.E[8W4&#D7
MEKXRFY1?KI65\I>F#;TV;79?B<E(NX]^Y%$=>B%F-?B$:^DG2<B"@,0)3=P^
M\HD < T5\^[R'$X]]>]LD9X@#>]*LJR1O)+X'DE"2F,1"*%]J2.P2BGA;A+%
MC/915-H?R78Z&/OH2/8$#5*^'AWEY^CH*JF*AE15HE7@@F""_Q$RBI2?R#")
M$I6HB"JV,2^H$^G:\AWQ[A(9&#^)J,W9&#UZPMN5SORFFQ@0%F=,N6Z<1")B
ML2:Q3VDB2(A]Z\DS.X_N*!+/=':V1"N1N):KR\_!T1UI6(E6@Z,@TC**0Z65
M$ )D9!C$"4F2.%*1CGJH(P4:;B7]\0XS'/AI)_V=+=$3I.$=29:3IB=9$ G/
M]V0H6!(+UX^4#%A 8NYQ3@7UGJG>[BAV^R+9+F,MQT>R)VF),D^N"=YS;'25
M6%E#K-*C'M.@$"<,"):$6@=NR GQA)*:1'TT$#00:I%K=Q$;X77IZSU:0?HM
MR<LC);U=*4TT;<02R9G24B@W("+A0FM*@\3W1>A&,15]=*/OD=(ZS1DZ?OEW
M O:H?^E6W>@!70!-%D63/.1]8UKMWI+3;^A9)EI''LC*1$=":*JH H67$.K)
M))2J#\L40-C #D WRI%8NTUZH*>=#'@V4D^0G'>E7M7T)PN2Q).41 %U,2=0
M2QWA92K@(B+P5P_2^$R]9WMU$W/M&.+6<.+35)CWE;B"-#1+)%&2!)0%02)\
MXJE0:%?%3+I"N*&4&U/:\6B;J<[;A6X7P9ES0NZ)"< C):)=::8U?3%,/.V!
M1--*:$'=4,LPC%7L*2)E%(F-W/<G:09%71>2ZB0\-1W;CV1OLJI&ZIIQX1OS
M= \AQCY/Y^GXF-3._4[D" 2>:(A715K&,@AD*!,1"JZ$CQ/2XIC$FDNZ466&
MFJ>>#,-TE@,T?L[2,FLI%KW)/^_"]P\2)^D$RT_-I'S&H1RKN#TIPM^5SOVF
M(9GB(0U\'<5*)8*I*' I STW"HD*B4<W$I6>2^<=R6QYX;*#I# <)YV?H/'Y
M<U:6/SB#15%DD[DSFQ8&4Z<C9SS%Y6;%K3-M$,M))T-G:NS5\@:NM1=<+97%
MEW(!"_7J4#8!?Z1*^=Z"7C4,0,>Q)Z4(?>4K$8<RB+R(1HISGX6Q#MDZ _@9
MP/,9#O]Q1A!:N/8F]SO5X9^"_O&*]Q[0]K7:S:^4A'>D6,]M.IQY(H;O"-:T
M"A%'7 +A@D'M)PEQ@]#=L*M?2+$=27 NNDPC/EJ2W=TL7]D!W=C!\:CN?<C_
M+9++<H'VOS]OTP0NG#%H#NN*PW-0:$< [&4 ]*I6=GK<_];#D3V)LT=L.^VK
M2WFMC#:B0S>*$E=[;B0"HK4,5.P&@?"H$,+E^W'F/ITG7J?.DWW1XSB-KMZV
M>^K.ES/;7=YUYK+[J;NMY$6B<.1%H@+?Y\*-I?*2@#'M)53BL,;.F&I'>JY_
M(;H=2GQ:3-7HQW^>8RY+_7T7SVYM9IQ/LG<W5I 3ZGZW3@8<R*"UX7\MRGD^
MNN\(N[\G;QWSWR_I? &+S[/228O,F159">IJ-G0 V5,'$6DR3 OG/H-_KM(R
M+R^=M=.R&/3KXA8.8;#EL[VJWGU]*,WG+H^D/OC6,U?XM%L_()^ ?+&?VR^=
M(+V,5Q@4<:V!;5#!&63C<?7KO[]QWYC/<!J#^O,6.'S.;^%P?\WNG-^FM^F&
M4+O+A_,;^!-V6U$"D,<XG979#_4?/Z[C_9NEZ;9T.[ W#QMV]A6,???CFPUB
MKG[CC_S6NN]IJ_%T,B$.OK\6E =(@\4S=O@ L5>WA6D!;X8+_B-+Q_.;)07O
M\[2*>6<9]2G?9HW\STN>7H,D,8E_F'?M.@D0I4/<=_]Y?'!:5SA> J8M1^EM
M:\RU13)U+ULZE:?FWYNBX<C7V;NK(DM_?Y>. ,U_2,=WZ7V)/.:F>+%0Z%$Q
MZ'Q19S&U*6ZH][ H$O3AWRC=0TP]Z)[-.!DQL45IK7XX;/SR)6RE6O?(_+>-
MR=@RT/G424!$3 ;XI$_S=)YA9O8#\<H7G>FIJP:GOO]7*G^VV![5@_\TS,O9
M.,6'FG5?C:>#WW]T6ASO3RN7CW 4LR71ZB*NS#5@^:"QGD\6Z=)9\!EV^2D;
M9\:\?J>"F(="AE[D*AYX41@S325GQ/-$'#'ZCEA['QZ1#?7\V;?3-X<%P^.J
M7,NVG(Z<[(^\Q G6^R5.H"O#L>4@+U)?W_P$.B5YV1.<^0W(A.N7Z=%F(>*%
M"\%#PS/+C")E+/@4CVH,O*#\X87KLQZP?WO*!=8:0,>3@ O7E4QP$OE!J+60
M%C]=*6-_8TQ'VP76(,MOV2R]-]+GP^ACD8-(FJ7C]Y-? 5$_WV7C+]DOL-*;
M_L(-6W(V'#BN<3M\]Y)SO3@,7&3CFO1<XD4RYDG"5!!Y?J UK^"BM8HV&E\^
M"R[_E:7%Y[OI"\"A'@?'Y6;!EG/U"N'1] Z6OJ \("S@.E$)E23D%3P(<;G8
MZ!W\?'C<%-D#%;1=5+;+S6C<:Z205JVC&X0>4TG@\X#*4"2)#N.*0F(_IH\Z
M[W>"2#)=%+T!1)(M)/(: =+JDL]<$BL_#H- *Z()5YI6  D2CV_D]3\?(/F7
M_BB$]PT0(_D/ 1/?;5(PF1=*+V9^I!E5@4?]6-1$0I7B&P7!SX")1OVE [ \
M+DK8Y6;7Y$Y%R>7>#B-WS1!T'W<@T?WT<MHX!*H F_T1GU![E39<!&89<(;3
MPJCJ>'H9)D:C&H_@=1"^_86Y7F:#Z/$8-61G8KP<158%N "7RFRP*##0U3)"
MP$Q9\Y5?..\G@TM#;D4Z^=W)_GN1CL?W3CYQC#&.MU3X#,;@_,:!7_$[8/>-
MQ8-WCQ98U-YZ+WX)GQ;H+X 78LP-W7U7\,<D*\M+YS,LNPL2?XK"24/A4C&9
MQ+'G<R5=3AD60584KD*A-BA\M8[_/08MLG+^&VS&N)"&'[,"0QGI]4/M/(99
M_L^?L^MT'(/1.[]O.@&,Q]EUGDX&63@M9A7FV1X 7381 /Y@OFAXR?M?DR4S
M 7/ZT0CZY::A\%TWW+W5?F8'E&T.RVF=EO-]ZMS=@"EX_VYZ-X&[ -7*?)BG
MQ?W;"_@E']P\@.PW8$->+U+ ]WF6#2^=7X'@\3U 1V6V:K0#1L-C_Y4-YNA!
M3)TRG_R.&#]:3(:U==I>W_K-0):PPV&6W1J_]:S(P<R')]U:<7%_Z=1(Y>0E
M$%H^=&:+HES TO R?#HZ"LIJ>>WG&P(J:\K'EV6C$3I2OF1 ORMT5SUIG*<@
M#)8."R3AY9G!=Q= GX/Q IF7,R_288:$C\LV5Q]$&+=:2%(5)CZ8=4$<4R&9
MTI[/?##F-"/<4^&&QJH'@^D"A&[5H&/?P@>YHZBEO9MM^\O:GD7.^XGSU\7$
M-(UR@="R"L&S RELM"F.=6.7,.XFL9:H/WN!2OS  P,SCET:-$5SP#97NK>
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MB.;[KXD.JN5R9&&BL:0G]-R(R\!CD@(Z (./ R9#;Q=TT'9?+41X(MQV="A
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M7]8]L>&A3;<@0$/4@_$6LT+SUW*1&2@NZ&"O5F/QMGGA>B<BA.%RP3<FB##
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MG5<,:)QG(VNJH4Z(WL]A>ILB@UG&8U/C0,G0C5N[#& UT\)([27NUDX6]#'
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M\69:SO#@G/*^!+ZQ>9/IG00F\9=\:%Q:=>.?RKOQJKN/B)>%J[VC"E=C_R,
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M8ILPT!WH>MF[Z:B^K1W2LVE2S?C:*EP$2@&.2;0A0M.GMY[A:!]A(D.@U]F
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MTF1$9YG!VDJQN_1 /W5L/4VX.65TV1I,2 4FV@N4&]( NX$G:&#@I,A!\Y#
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MX^S!@+HBF'Q_U@WV6L7;;1+,I\:^6TOL6HJJCUC$A$<0\YG0OI8NR/.<747
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MG0]4G6F$^*L%%^AN:V@=,D?9!GFNKNB&-F(P*OT8^UW(D%X#--'0LV"UY[/
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M+NLR;:&HK>F45SUQ=FSH4%S I)GFBC)%UTX]YVNWZSG/B?,0]YU[,YS8N4M
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MSO$(2':4S+^%>69X_5MX!5 I%X7UHG"ON<3L/[D?K?J\.Q8N-2T\P5[G@'O
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M^@@:(1R462J93WXQ^L]JX*UK4!4I9IN#C3,]M);;9)8%.")YM R=9]7 (2]
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M)OQ78-KI+9592A7W49JWS>) ]&BFIU1;4K_SL0TBD4IN,\EL'J7*L?GQ&P&
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M<;D:C^]R*R$X^\G@V:O<(!ETLN!$Y4>9E.<^X=>D[W^01N.'-"S_WFH8AR#
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ME2@'T/$/_L$?TS6WF#R,AM-O#YE5N*A%R>3=O_DSH\_S00A&T]C_M6 @[>>
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MT+PFVKB[8W :;%BF<[LY;&BAH(6"S5 @*V9"+ !AF!$*L= ZIBP&P2-0!,2
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MOR(+LFC!?%(<P^B.UEN?>%DX=H/T9!\'V<Y/QFG7OTW.I+W],%92D<5<40(
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M^1R8/D_24:^??B[$I_Q%;0PTXK1^0(M(#4&D2A#./[GW;WJ3Z2BM %(]0(1
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M29';:X+4VT/070&3E^0WF!KDE$.:$D 18 8R6V2+,<;@TO;5?H!Y%=R#A+>
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MY>)/N+%0&LI=[/4:26JA*'!#6^_[G\F"/V9='B+'2S6\A+J\MIBW+>;=U^1
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M&K?:1MM5G6ZMPV>]^,,IM?[\]G+]45=J2#L:YF@K;;6M2'8X+K*Q!\7J0 E
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M?J@^=MMQ?1TMFUWER;XPP%? .O.HXP!?Y)D7'%/HJ*+ :LR\-9 JL<@,N#,
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MUX^]-7U3'Y0BT6!*-$)P XD4@@I@- .8$.2]@%)BN9RY^/-J#/F\NCCX*8;
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ML*=*J?9Z^U9"1+%+W3KL8Y''=3J]C2>+0!#]M ]CO[-&P"F'2-9/KYTF)E"
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M=C];:(Q,TKOQ0[ &5LT06]DF\R2, Q?".#M>TZLL0FE+IIT?3*:S/$+SUX>
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MSGL5#F!(635T'&#P1F_C$%'?/>BOZ/6WU]\.Z2_FC3PSEP (X#V)(0-JZK&
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MM7]<BPJ-ASNR>#BB\E&/=26\U1*\1<4Q6<F0>581=4Y5'9W/8V!LE=TVYOX
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M+O+$%1UU>)$V%=NIJ=@L--.,PCAF[J<QGSB@Z87VVJ+SW[^DVUJQ.@R;/X0
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M#6U3Q5*J\I;<M7%&NC6BJF0Z_ON_BC>/8?_UU__]?R^&R7CTZ_\'4$L#!!0
M   ( (50#5'#&D%F-1$  (N9 0 ;    83(P<30Q,&LV,S R,&5X:&EB:70R
M,3$N:'1M[9UM=],X%L=?SWP*;3@,,V?)DYM":4O/2=,"A0+9I@R[^TZQE5B+
M+'DEN6GX]'ME)YTD#1TV:1G)5CFD=?P@7>E_?[J6)?GP;R<?>Y?_ZI^B6"<,
M]3\=GY_U4*W>;'[>Z36;)Y<GZ,WE^W/4:;3:Z%)BKJBF@F/6;)Y^J*%:K'6Z
MWVQ.)I/&9*<AY+AY>=$TE^HTF1"*-"(=U8Y^/C1?'?W\TV%,< 2_?SK\6[V.
M3D28)81K%$J"-8E0IB@?H\\145]0&]7K-T?V1#J5=!QK%+2"%OHLY!=ZA>='
M:*H9.3J]CNF0ZL-FL0F)-6>I'0Y%-#TZC.@54GK*R,O:2'!='^&$LNG^)4V(
M0A_(!%V(!/.#?)^B7\E^NY7J Y-[.//H$"..$SA7'7>#SE[[6:<3O#K>?=4]
M>1&\>+Y[LO>JT^MUVYW.<>WHL(GA?W[6_&.>,J.<U&-B;-EO!ZW'!YI<ZSIF
M=,SW<PMOIW]HOEF7\ZZDF*$/6$HQ63TMWYP4Z0P%B^ ZLP)"0;O1/FR: Q8R
M^<W\?7]V*(^)I.L,&,JCY007RB;?]Z>Y2'$4@3;J0Z&U2/;WTNO%@@M!1$0N
M)AQL5G+!^I(;9$-%(XHE!:6($=(Q01=D3)4&C]#?7Y8K5G26K?A/IC0=3>])
M +6C<\@?.-60,#%!6!*4X/\(J*!I74PX[% K5O6PA-S!!=\0S'3\%)WQL(%P
MOF]NXV8Y>9MQ\LNC]K/6P4[K:>["VUVO@=!2E9#KD&41F#22(LEKAX'M,\LG
M(F,1XD(_1:$ ?D5$PI&4Y\?A\5B2,<#'V(F1X0\C?Y3,M#@'B)*90] OC_:"
MH'6@H+KHB(;89/[FV'QG^^#.HM0QU@BTFB"J4$1&E!=YN<@@V7:]%?PZ^<U<
M8'#:,PK+&#:X18/Z/QO?DMF3B*J48>-_N>"&3(1?#M"$1CJ& @/9/5DZ?,0$
MUON,C/3\H,[>RC%W4BH_\[9&%\Z>R]P<N=^:BYSR"-PTWUZ\/!<RP>S&-;1(
MS26OS24U'D*IA(2QV=Z7M58MWU8I#N?;_S_2"ZMWVL\AF:&0((AZ*!C#J2+[
M\S]N66SR ZC2$2C"I,]?UG8,Z75D/N3-WEEVBC2"8*\P)3]L=>_N'?OV.@L[
MUUS_BD@- F2S+!9$F5LSXTL[O49*,!JA1ZW\YV"(PR]C*3(>&8N%W'^$0_/O
M8*G* DAZL3X6MV>77OPJ;[;R;Y9E<!>@]S8"V]Z?X'D*IR1DI:E9+ET'RDU
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MH7D:ZY<PMM=PFQ]B.>P()#+FH+X4419JA<YX!/%/7](KK(EO 4K1 N1UZEN
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M5&PEUM61/+),R/WU)_D!Q@1"0KA"CQD(:*5]:7^K71;OW>!K?_3]; A"/HO
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MUZ;5/VMPOE,NLO\ [WK9OZ9[_P)02P,$%     @ A5 -4=5U?F!/"   N#,
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M^'32_AX^'='7^T.H*Z9A6,"5#6D>!GT=HZV YGK[+ACVC!@ N)C)!5(R5S
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MGP[_I4^9GY4%^^\FSP?V_V#.?P=02P,$%     @ A5 -4?8TU E"!0  SB
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M-I:?DU^!\50FF2K)?=C.Q-V.J^RV,\E.KG6<2>U'B 0EN"F" 4BIE5^_[P!
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MGXP5_)2HV90RS8K.J)A1\3VHN#*NU2BO%_T.L6YI3=\2-NW?R0PN8]5=L>I
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MRH#B\$,C7N)"^&,_+=V. _IL3YLW1U)*_5JY&3S";!SVAN_J#'OY4N'/_91
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M+%>VQ$;@4^?&^UW]7E9&5#C*4E)PR734+I?MGL9BT<=8UQM"P"F'0<2#8HJ
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MK>T_J.=P<0<DQ.-V+)Z9@TJH#3<.M9 Q*^:L!UE3%;_D_HU:^S@.!T/X;S/
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M/*;B)-YK3?#1K%MPYVTV)VYVUE0KYY:V<A9!\L:CMQP:ZIIY%,-4VKWF[[.
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M>;,6-A=]I\_CLBU>ZK<6HC[[&8S_0[3/5@T,1G%[*=]2[47JC)J8,#HP)S[
MW\OB@90(J7X65+D?,P?[KCT^7>MO"%J'Q[\G/Q"_(G]2FD<#MB2YR>?D5:V;
M[$OS&ETI=?MK&,E?W616K[YIQA8E>)D>ZM^77^<KFL(V-'MR3+HB:J*TF_SQ
M%R @;U,MUYY19K,498QIY"DWB.*,H]0YI4Q"4F'Q8X8G(1U662V'ZT@<-P&)
M#^&YJ9@G/DF521FRB59(*N41)50C+A.<I=1(D;@V7*^)Z4EEWI053, __@*
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M\VJ38V%LDEJ/#*$IPI@P)(+;'TZ%%%AGF-'16_7#JBU#X1A+DM;CNB\=]-8
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M',+")HA1[9$F(,%*&&9P*Z5BF%$)+M+ X>>J#(_<[=N[$#KM_?33K0M/]D(
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M-:@+F')K 4OI$<?* [Y$A2V"$0KJ:>H['*D>5_'O2XKBXGNH.%6E<<[6 9U
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M](6[4<44+(PUN@*J81Z.@+POY4Q--A=:QHM]>_<%Z +L([T)WDQ,I-WXNIR
MU->+5^5Q>UN$JZS?3\$4G=_,FYFY/+.Y 1/I&I"X#T(3WJ;'&HI'1$;?TQ[U
MOE,(EH=3X3\:).A/__;_ 5!+ P04    " "%4 U11,OOI*[#  "Q/PH %
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MU!<"\_D3(CX'5WL9;U)OEG\LIDGV<1ZW!D'U-_6'P5-R3JXZ7<#2PLL'1NK
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MU UH?2G-AW4.W-7-58 GWMP_OHU!G3I".3HF0L0:!I2'4%I.O#0T1W/+HPP
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MSXY8/P4U]6GV/<Y.)0E5G"D*'XY$FDAM@-3!V+6&T0(/ALF(FJ1WH!K=@C6
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M+:C?W*][<W?0K:H3>'NKPTZRL%3F"6E;#)\PHU9[=CXDI_2K]!R1(T(J:G&
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M2&D91X(&]TIYL^.40,CKGYGW'&%MT]:H"<Y%Q\\8MOGY$E&$(BL=TV;/J>$
M7)Y=45V(E0)IM?!ZRQIR,6;$L(KQEH[:G1/!RC*"V[R4RG&A%"MX]09>6G>L
MTJ*K=IEK)9 N+>2NI"$<09EW'_4:$, LV7%'.13U+W,=*.Q:7P6:HW-Y85>D
M@G(3104$SG'#N'.%NT4I O4/J@8*N]:4?COP])=QD<=DKE?Q:G/$^KY<QZ,3
MHR)N\^8^D&@0W"^N#6>B\):H)Z3/Z/L@/D1[V RL V<MQ)/C(B>%E)I!QJS!
MRAJK6/']Y$V?1IZFV8H4RVE&([S>MHZ,THT8GVH,HQ+7\;Q$6Y(G3T7!^H$
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MB((W0,=X0M22K$IU":B&3O^^WZ%+?\JF.1P9&U&!-$-8086"642%DFP?.&2
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M6EHTKEI[BC20WF/9F5[6:3^@.D[-?M'Q$*KR6)E_+66RI$<%I[PTFGGA)/*
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M]9AO>1&0KO&F)P%LUJ^7#V98\V@M7?;FGWM,,-0(YRT&F#+$M8/Q:.R0@'!
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M28R0'((FB#HB*CE(9L(OF1&2MR9=*L3Q*].UEQHY+##SPHA C:-$@&*ADJ<
M@:_HB#@*/T2'PON5E#%S#2P(I8($QBV52H$VP>F=Y )#?8:@\]D+N^%^ACI\
MIOC'K[C76&ID 3@37'&.C=/8 0V568$9^D6=*R-7X6XY,'X]OL92([!>(V]2
M5QMCP%G"JA9UR=_FFD?BQNS@&;D>=\N!\>OQE94:41Z91Y5)W>"=E(P87TF/
M&]D\;63,CJ61:W"'!!B\%N,VH7/ST2R7CP^;V?ZQ3+488;F:/NQ/[.;C7L^:
MUV*,$UX=;##G@AO/'(EF%,4(.^^550R(<*)64=1K,48ZU"),J2,A> ^8,"VH
MWN 8@%%^35U>:E.FLV*,\\"^PF*,E.%HB<-(!VV09"A.?"L"I#GKL_1GH&*,
MVA0XWN7E+!RS.<*.(*,=/ U>"D:4P(8'19@S%;+ K!M3,49MEO21VMX,V%?J
MMH?P"(HQ1L7889BZZ_S\PU@X68AQ\)DB@AHT<A1+'P]#6$N.2#5'@Z#YW0+C
M*L*H+>I#;;@O!+8A>9:+U1YQXO^>DR;^J%@;H =.:4]^7PC*D N(>^TID8%2
M8NUVS!@+UIP,YP<Y1G(ZNP2_SF5^<%EX]HG".L(X48 0M19!,-%2VHV;R4P[
MVS7$_KGD+L)@/#+,:O/O5W3]B>SO$;Z'QX>C0GORF8(&&<>(-79<&N7BUH!4
M-?943)'/_ML8]7D[<^]4;I-OI^6V_YD""R>I-H;98,%;&;<'5(T=F&P>1VP]
M'Z 5N5TP]VPLN$,[_\X!O^>BOYTN_P6+LGPS6Y6+<KFZG:S*+7F[<&N?.81"
M:N^XE=)3'5*2.R.TDB&)OVB>7)U?0ED+[ML\I3)*O0C?OI2IY/S/^7W\FOOI
MZGL"H"^5>/GMA6;2$ 0T$&VY!^K=SM0BEDB9SUI\;=K0BD!&K0A^^G7ZH9Q]
M&$(-]M]=$,RIT]B"=MXJ@IA7U6&*&&RO*;$I4R6X0!S9WX=Z;-[OR\4#/L7]
M3EY:>",01UH84 (%9@SB;+?C8G)-UPZW1/H<Y#!\2DZ99#6=?=ISVR:'L)^L
M)J]Y-\?9IY'SAAK"$>42<X^XQMOL*T^1KE7+\IIW4T:5T4X'K5*O&82M08AM
M.\UAAX6\IDM0:U.FL[R;\\"^PKP;T )4L#QB0+P+\0^%"@ 5:)]AOH$B.[4I
M<#3OYCP<L[%L1I"\@#R 9IX)F9)[/6)(\6J1T)QF&H.ZD"6]7"G9"-A7ZK:'
M<%:AMRM@[#7DW3A& BB%C>:68U!<5.T'L7=$C=&#WZFH:^?=G =L]HZ7;37(
MS>-JN9K,HIW[Z5F!S,Z6=?%0NIC<K1XG]\DH)Z=6P7Y'4UA$***.!8P!,8>I
MU%71G6>D5WNG/U=-8\LG>P&-17'"MVAL3)?)!*B)1">NS.:C*8BQ-!@L U"&
ML&+85.W><>!<7-/- \,K3O<"ZOVX4BZ^3N_*EV6RJQ]=8[!\/U]-[O=_[^;+
MU=OYZI_EZK:\FW^:3?\345M76<-\L?U1^MPQG>EW((5B%$"M#Z]*.!FM?%$M
M8R$*IOE5PCG'P9JJ2]:R&3Q,L)[IRQ]*X8_9LK3?T['VYN,:F=?(P7&2"BX=
M"D*"T%I99%V@VT8;!(QVKQ6[-3V9 $P'1:*!1(U3/!E*VU:;)'!V099^?I&#
MVI3I+')P'MA7&#EP%IRTB%N@7@#F7/%0 2 U[;-+RT"1@]H4.!HY. _'5_?K
M&3XD+9%T7G $X*C#2%)?(8M\&%7%;FV6].*';03L*W7;0W@$D8-1,788IG;3
M/FV=42BICB:?D=&:(D+MMB5L+N@*/K((0EV1G]4^[3QPQQF" J*IE!20"Q)%
MT.(AVU2':\ 7-%T:SK'8)X': K8O\KPK%Q_GBX?);.OG69ZDSH$G"NZ(19XB
M([! ,L2)$JCFQ_$%K1V&<['U29QV8.V+-N9^+<"X3!YSA!TS)VM]0<&,XREH
M&Y&SPA ;#P]NIS36-$_ESCD^V-2_T0FF _E;UT;V(:_I=CR7O_;S_#ZR8;FY
MB;+7E[G/B0_+-S-S=_?X\'B?Q+:^_S*!$#^;3MU?RS>S^!7E;_/EX!<_WI9W
M]Y/E<OIQ>K<A](?_?5RN$GEO'E<W'^O,HH8_N<6W%,"%=!13A8CF-#6F0=HR
M[2+%!0ZZ5A/J?K"L.[=3SN2+OK?0C >EC$41)Q[W+2N8W>+%XD2R<2 /PI&?
MS(3^D,[:>_S[*DXWO6V[JL4ISV?IY'3"FWSTN8(RSY!S)( +GGKKN:<50":P
MYOWV.O8N]T2+YSZ3%K'LS69].M23?K87/U^ HEX@JR),TC%"P'E>S8T*;_+V
M\;8DM^<&:(M(71<;LG2;YD2"@4S)'^LCS!?E]-/,/2X6Y>SN^X^=/2Z3]X\I
M;_'=?+$6SFJUF/[UN$KKYOOYV_DL[8$1^3BX3]4='"<=&=V^N# &2#3;H\T>
MK7;,.;+1Q-J@S3%!O7KQZYFN%[+FN36:$[P#D/EMN?I;Q"\9;Q"A=I/E9[B?
M__M_R@]KNZ];0G?T\D)3BP*V"GLNJ&!"$T 5Z@&S6D95O][ASDB=!\2]$7M^
M-^V&M!=]<0$&C T,0%HG@6 E%*G0LO:">%=G7N>6"=DG? .LHH=,IG,6P^/?
M45!NI1)!2BVTE: ]UQ7T@LL++CON[+J0SM:T5I'JBRW'W*;O)]^.<.3$DRF!
MVI%XZ@:BA#-6^:04V_DJ:IKO=IT=X7)PCK6+:F]KSHU[\W3A?#>)I]55W.9O
M/L9AUVOM?<:W%!9Y1(5C@@<7%59Y[JJ-7H"CS6O?.CM+Y<"N[A#N+44MI08\
M"08UV<"/.E?;>$'!@Q#&V^ P5S)@;PAW%7H(7]#<MK/5KQ-N_.1M'0#<'+92
M6WZ,9OSS)6!98=MPFSWQK05X2SQ8Y) 'XZGS1%3+A-0<,EPD^R!A?XCVEPWY
M=+S)I*ZQGVQ<2JM-85D-*K;YFD)[:0!C ]8A2&<8:W9(2F<RM#W[X.: $.>P
M3%9#?W$SV*#=<*FL\<V%(42;:.])A1GW"(PTU;8B$2;-G<Z=V;)#+Y?MH]I/
MQM23(\C;R6(1E>UK.72:D$NJOVU9^UN-A)\7/U\P"51IBB/.X)%"&#/OO6*6
M(*N='3!U9Z]^+ W9?E]/X(PJS^=/%9(QAT((G&(<*#(>.;:=JZ2^UX3]HVDW
M%TKJ<"GFA8CDG1Z3-/6V_/*XN/L\69;O%O-/B\G#J=R8@P\5EJ>&4\10"0X$
M 6WD#AH$<@P7-C87]TNE0FW U&MIVD\#KE=B=N"Q @=LA'(!8V5!*6JTT=N9
M*FP)S3P#I@41UF+%16A=,S_RS(G)C!;GTN%N\GDM8R0H6DLX_B!%6<K[<I%,
MH&4:S&(WF"_WD\,%6W4?+1CA$E%'06H" (9H%JI)"&%KW< ]0*7$Q3*9=XI3
M;]&'G2=]&8V=37' NC9@_CA;)=?B8CJ[FWZY/WE+PSG?4T3[!7F+-?&&*= 6
MI;#,%@N"6)^U?H,?)[I$KB\6'1GUR7CYR6<+YQ2WG(,T2&,1T15^IY*&89SW
M6:,C^<[[0?'78%"6IY&Q$*>54\IMN9HNUH;R_./[13E9/BZ^GZ@+KO-8@9DC
M5BH(F*8B!T($F.W@M?6XS_N":IY.6A3(O#.@^@M9;[/4][U =4M\GC]3.*R8
M-%@;JI P5EC%:35'977S1/WSXR:#'SO:0JFW#6)OF"=-TY\_7&BE/>7@F5 !
MA!-.RMVLTMJ9]R&B!6D]7_?;@NA:")#E&2 +N0\D[_G#PWRV'JXY?03\Z<.%
MP12[$"Q)-[MJS#""RM[6(>@,RV N$<US*5^*QP!2MN=(>?OAP@.U( ,AV+E
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M4N<WKMTH'/>SEI?*C><X>7'8B+R\6A?E_3;[5 T^5KGZ]P5A)*41 FD8ID(
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MUN6=_E&,&85O6V3^0O#0%AD<?$=L#/=A]YDKYCOXSN/MT(9R%FE';#!_,79
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M*-<7#_5Z]#O0G33"&4D?O9WG(?[CN_WT-O8I>!^<#S</GZH(2*)"E2B*PE!
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MW9G)R(N?-AD(CU%HCPF6W>2;3;VF?KFL_N#*\+"!/D]F@N&4'#N5F$86-+1
MFYMY"8 ^[!.CWM!OTZ%>"4J6WVSX_7:;;:Z^-]G*NBE>]7OS%PD449K*F$0R
MD@!@*'"G-3R5B;*Y -6A=:TA,?B*TPYH<-4A#78'J,%R]5_WY:Y="Z[WZ!2[
MS[I53A_-8:8Y8S7!P+E/WP ]SN (Z/&QI6GTZV42-13.84O,2P-=.G9")9US
M9ZJCKV_OEOFV>4VN-B920%.:<$0$Q("35/)>M%,1AG2 9AI:&D<?#P/U "]X
M<^X:=Z=LFDF>#P8'RILN:UY5["$O&HIE2>2\U,G6B1-*-(@3XXD:BU2B(HE
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M;1^M/+;M#Q&M?/IO%JV\MX1YM.++\K-:%U];L>LS_M>;HZ5D@]@:P5"24":
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MV+L2-+[83CM':5+3&>C<6M-^,CJL42=/F)PVB=8L=<RFGT>8F,CWDW/7\5O
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M9WW7)E9+S=TWT]RTVX.')Y7:%YMZYYGR(E^]R7?Y3?MF47TH'@$F,!$<<0$
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M?='6HV_%&%W60\%&W&<UA$]?BT628$+3$*0X1I2D,:Z@]"B2"!GM.7)MVW.
MJD83\%"-,2'780G&$Z]^ZRXUXJ""/,,ZRX'/H<45BY:91W+OS3N;,HHUBTYJ
M)\?6,4O"VGP2XI1*)F.4['5;4*.ZMBN;LU-*9V0ZJ(9XXM%'"60:/=1DS[;.
M8<'_//3/N5<F%0UKUH:6,8X, Y*F(<98IH 1J;"4">D-,RZ!B]J%@;G9J)Q+
M"H<5)CRQY[8:48%\6=F\$>RF[."):#^U!BW"A]87S@8&#W3.NY)@XY!F^<":
M*R\U@ZJW9(LP!!!!@A"E*"9ID@HL]QEXC/U5#;2L^X\3D<>Z@1[!'BH'SKD=
MHW90@YYQ]:"&YZI^8-0^\\B@/?HWI(9@P:33*D)C/PH99BA45-$D(IQ+B?9:
M#C$(G=<1M*S.3CL=$NJPEN"<2W_5A/$54IO!H14%HU:8AR)Z\,NFJF#!G*NZ
M0F.:HY"SA#& **Z$%R@>J<ZTP)1IB9]3@[/1/;<TNJDN.&?05WWAK-9YI-EM
MC<$YW;ZK#"8AQKK.<")@>"'UQZ@UF+ED6&VPX,M'O4%5O7,1"AR&,E$J3D3,
M8Q@FI ]4U?^8\E5NT#+N/W) ?]4&/7K=%QN<,SM"K:'&/-]20XW.4:7!J''F
MD5;[<V] G<&"1Y=EAL9\@D,2ITQR5LEW91O"@X+'%!B=]W5F=':2Z8Y.=S4&
MYTQZ*S&,+XRZ_ TL,!@UP3R$T+U;%N4%"]X<51=:R44)1Y41IE#$0J(4)/U^
M"2&9X@Z+"UKV9B-W3DET4EIPSI^GRL)9B?/'L=.Z@G.N/9<53,**;57A1)#P
MP>@/45,P\\BLI&#!EI>*0OXE6TBJ"&=8I9)$*L1,8K8/3DK"R%M%0<>X_W@1
M>ZPH:-'KH:+@FMDQ*@H5YAE7%"ITKBH*)HTSCT3:GWM#*@KF/#JM*-3FJSP>
M(\4H2](THB0&(>K/K<D4I$;%6&=&9R>9[NAT6%%PS:2_BL+HPJC+W]"*@DD3
MS$,(W;ME4U$PY\U51:&VC$'*,8YE1% EL1$CB/59JU0<::6++NW-1NZ<DNBF
MHN":/U\5A7,2YX]CMQ4%UUS[KB@8A!7KBL+S0<('HS]&1<'((\.*@CE;KBL*
M]+K2USV6A*1QF&((04S"!$M8/U3588D)-+I,S0\"SY'CT^=LFRUK1'XJ#(9T
MNRTS^&/:;ZVA:8^Y5QP>D.N@[&#76/-(N3W[:%F &,*HJRK$0PSU=0\XE4AA
M#&*0 @!D?[^;9#C&+DL19I9G*K..Z753FO#'K(_ZQ*1B:D3E@%*%79/,0SP]
M^698M!C"H(/*Q4/S$6(42"5B(&(<*Q@JU5^8(VF"B*/RA9G1F4FD>U('ES/\
M\>F^ID$U9=$SY\[*&_ZX]U?CT&T#!Y6.EP*--X9G7_.P=$N_\#&$-]?5CT7(
M%::)8@Q &>$PB6,F]N:Q7F1Q;M1W9*G?V ZN[W?WVRQ8-P/RKD/GI^CQ,LMN
MZQQ."?99VIAG)<-!\4*[!>:1<KMWR[)$8<B;JZK$(JJT-^80*A7*ZG\1(\E^
M95)$E+DL1+QH[$>1O^&LNJD_."745<FAPW=1)W;SJC$,*"MH,ST/67/GCF'Q
MP) GG7I!,VI/&V0IX22*XT2A-&1,0('ZRW"4A$S[Q=R!9N8N72Z8?+DL,"*)
M9G+5\G=N#CH>C?HS_1'IM)O;M[3>;U9Y>57<;W;9ZOP\_[K8!I?%[G-0[+/D
MY6857#>J4O^NZ=JGN[3._/\\:2=F_(Z8GGZ.[\J1PGDO-*T0G\B9WQ:[_\QV
MO+BM %QE*WI;][M%%"F<4$$84Q&5*<!I2O8@0DS-ZL1.37N.##7BOW;C)M@4
MN^![M@NN>HS!3^#/IA5-M\3KUI(GX]RJHOQHEG^D=Q7@H$(<["%?!"WH:9O!
MM+P\67,,*C*[;!;]6K,)5V<KSEY(GSXF^73N2?79(X?ZL>O9:=+S$!0$A(&8
M)+R:(6&(DU2F/03!35<X'1K^X>*62])UH]9$?%O%K <E&Q\1RV4#F,:KB1IB
M4+1RUR#ZL4J?I[.1R@/=<XE3/EQ[$J6\\6=943MA&J<QAQ$1BM'J%U)$ O2F
MJ:#:L<F9P1\H)KDCV:KLYI]?%P4X!Z'''<^#ZG+^^1Y2H1LGPNC2HE^#&\;J
M]!'%O4OGZW(N^-*)( \G6:]O[^YWV>KUII+<K-PM$D BFHHTCA#CD"C!<+]G
M5"$LM3:W#[<R2JS(6U!!WJ'2UZV!%+X<%,9CSRP2/*[1=,B"UV-3J*_WXU%I
M)_+6E.JH^EGG3TBY&\*FUV]'?A2NNY*^4A]/-!Y;@U&2<J08@8Q2F&(><]I:
MDR$)L=;>GZ$V9J[2@^A[6:/'8LY,H1_6)>SU>1!Y^NH\%HEVVFQ)IHXRGW'\
MA"Z[H&IZ57;B1>&V PVJOOQVM(%"?KNJ-*O+W*'@5"2,5F&!< I"*#'LK6/%
MM5XK=&USYHKME%ZKTLLHS+JHOAP##5JD+LHO]G0/JL",0KO+(HP%_995F%/4
MZ!=B!I,[?=3PXM7Y<HPCUG0W^Y]8^E[P,"&A4A'F/$&BFE4(@GMK80BT'D,?
M:F.4_;'MQMAU!RH_LY'0+7_GP\28U TJQ1QMXQ]WX_X)9IZ1)U=<SF.;_F O
M"K<]S,'9HDK:)$@D02E-*P-59!($];8 1,G@ T4O6O@1I,:2.SVA\4_;@'K"
M9"+S+"MG)&88B_,0F($^Z!S^,63$<H:\P)AQ0DDB4 PX5"H58B]A+(Z&'/-Y
M\=NC",JCV<&@&=C+;%E-;)T2Y6 "ZYFC0;-1IUPYG'6ZGEKJ3R&U&9GE5%$?
M_?DIH2$+>EN.Z_U*G[)O.U8Y\/<%IG%*8<)(R!F(%4I2WEE0BB<DUM]1;/9=
M[X7!LT?#AM/RLB;Z9,1,#ULDP>\UEJ !\W\\,F.R&=<?0[9[;?69TMM&^\##
M$_IGR\/TVF>-O!C>"\SFGQ^KGI#5'>+==9N9YLOU^Z+,Z^Y!+\O==GFU6X"4
M"\8 1D1AF&)%XP0(08'"(681U+V QHDM?W*PAQ<4U\$>8- C#'[O,6KW?3=S
M+AW:SDS!G+(^CQF96Y<*C[W4;#"^KWI-MMUFJX^[:L1__+RL>BN]WWTNMOD_
MLM4"A!#R-(4Q)K$"21K*6/5&.:-:#ULZ,N4Y3=FC"\H&V46PW&,SJQ$-I51/
MV49DTTS3#D0VR"Z"%EM 7Z;3BY:=)^J,BCEB>![ZY<J9PDLO'*Y9K\OROC*H
MD*!A$J5081;CD" 4B=X@HI'6?0(.S(RN57F#:[A.Z=)HKU$>&'2C3Z_/4SB:
M-K4X#'7)D-7Y:I*I(QIZ9,6-KA;59S:*S?/J1WF(>)P*R3F7,)%QB.+.8L)C
M8/1NX1 [GM6HA38X;1K$I)X>C46BF2!U_,TC6SI#T1E)<D'L/#3)B2>%^VXW
M4)4Z#42<)1*%C(:*)DG"$XYY;TW$L='ER;8VQE4CF\3(FCU+%?) W' %NI@D
M(3K!C8GT&+(Y4]DQ]>(ER;%B15=N/FVS97F__7YD;Q%&%&$5,2Y1C$7$A )1
M;RF.H='F19OOCRDS0;X)=AU&,ZFQ8DY/9GR39B8Q/9J'(C.NN#S#R!EA&<+?
M/$1ED >%N]YDN#UQF6__MES?9Z7(MOF7Y2[_DI5LN:ZW,'W\G&6[-S6M>;%A
MWP\_P(M-4R7_5)EBW_\]6]WDFQN1E?G-IOG93\O+=;;@,4P3$"$(@ 1$Q@@C
M%.)8LBBD$$*S/8[3P?0L;;5G0>M:<.3;1=!Y%S3N!;U_%\'E]Z.?"WH?@]K)
MX/?&)<U%[AEPJ[M5\\=H?3.-'K7A_>P5]=8L9P+%#/K"/.+-'(AXO/5U!I#,
M9N[;HBSY_7:;;:Z^]Z=9/RQW>U"_9K>7V7:!L0 \4G$8Q6&,$@X3ACOK I 8
M&<WD'=GTG7+7,(,>Y_XH=E C/8C/[RU8PXCCC';-$L $C!N6!-R0[:=(H,?>
MN:*!8_[GH;_.O7I<5/#"FJXR/J?:]%M>+B3B2%1B',41D9#).$IE;XZ'*C*1
M0FLCGK7O^0PL^+W&9BAU]CSJ:=LH%)J)F1U[7K3K%#MGQ&HPH?-0I^%N%(X[
MVG#]$<7M,M\L% <)3<+*1B3#% J*R=Z@@*G1J_ #S$RD02TZ!RJDRZ:]#GD@
MTHT2O<3A:%K4 C%4(T-:YZM'IHYH*)(5-]HW1^P^9UM:EMFN['(OED*,9,))
M2C$5*8**IYV=RBY(C>Z,,/ZZ9P5J  4M(LN)G@5C>G+CERPSE3'CR<_5$(_I
M.",I]M3-0TD&X']\$<1 )@QVT-XM\Y7\=I=MRJRDFU5CN9W;[1X "!F/B$)4
MJ9B)A"3TD$S)B)EM8G-HUO\.VQIIT$-MGKMKP!KOL75&M)X.3<2QF4"=IK<K
M.>VF52]]$L_OTW7=$O/0.Q^./=W'ZX<[786D5U?;^VSUYG!13&<.RA3'  @5
MLA!PQ3BBHC<'86QTPL#:R#AY5HLN>&-[68X]AWI2-PI]9L+V#&<32=@I<LX(
MUF ^YR%/P]TH'/<S_3LA1'=\X?7FJKC-/BV_9>6RT[ZGYBE#*I%4XK0^HDUX
M3$34FV<TU+X'W*E1S]+48PU:L$&#]BA],!8K]ZR?%Z])"3<3,P.N#6?C[DG7
MO^IB,O+M[L%PV@@Z%V68\/-,,/%&\?17;/AQJ_#<-<WRWJ-M,ON],V_R3?9Z
ME]V6"P11$E5I=HJ3D/.$ TYZFRHEL31)?H=9\AYFCK:_'?;%!;_7"(,&HF'A
M<2"Q>AGQ>)R:1I(!='I)C\\R=29'=L/P/!)E1[X4/OJ@K6KM3;Z[/OS'IEZP
M$* R$:6""AG'0( HJL)>9QK&4.M1!J<&/6M8>X_@LJF5V&K5$#I-)6LD)FV5
MJZU('LO71?!+LTNN^8.IY.LT:UHJYH#TN8F9"Y=.:IHSOAQ)V^&"RB0F@%4
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M#^_7N^)ZD^W6U9QB@6(4(211'$HJ!(U O ^ %8)4ZWH&'W8]AY+N#IE6\6O
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MBO1"M3=VS$:U-C%>@O4Q"6>BM157\PC7=M +!WW%3@6Z64&(592BE#&,,44
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M9/79P*M=MFHLUFM.Y8>/OW4V0Y$*&DL9<@82R$,)$.MMB@@D)G(TS))G23J
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MTP.URH*J$)T?05-5W)*2567>1)7U[^SC>6G&N\T5(-5Z3:OZS[Q>+?S8\Q*
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M"WTC_7C['[N\9EJS?NYO:\W7[S:W5?W0@FMOS#X\$>)1'Z0@HU&(08A [+G
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M-S,07&T7*H-M14)PO5]9OGQD"O6F? @SINI^1((XI1E)8C<<3(' "X4%5]6
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M[@NVXAR>4#B+@9C':[8V'*NL-V(Y:<3+9;7;;)M/^3-_39SLZIK96_@AH!'
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M S2GPS915GV%JPN9M2F6YY%=&_.FLM,6C:VQOM^7:/F9FS)K""$8D2C+W"C
M@^D@\Z5.WQDQ..VFE'H=JAFVM5=.[1!M=!-JNAI3$=[45D7E:9^'XIEU27S]
M4Y4O4>W##U6]+?_53F'X#1,OK2]2F@1,9:,0)RBA7@9"&NR-XECHE11#IBSK
MW3&Z[FZ65]U13N5T>173MQ$IE5,V=3:MZ-EEGBXHF2&"YZ%AIIRIK#1"8SG;
M;W75-(LHS" D"9OS)HA-=?T@A-Y@-HFAU%DB;6.6M:L%H5R]KD^E=C)FGD6S
M^]8MOMFD8"T:M?1+CNAYR)8Y=\33+A6>#$@77BYW#[MUSJ]:/%+5!<"N%\81
M"3,7>B#Q4NPF/1 8A(DI,5,U;SLU.\!RCG$9DSEEVK6%;PS&S4JA=##&5L<S
ME*KII6Y\9J^@V@Z*:ZH9+@VH[(=BN_!\/Z,1BDF(2 (2&,=P;S3+4&1(445,
M659/G8.-NB1JZZ-I_LQJ(4,W&]EC6-0D3H;BV<N9E#/BTB7/D0&9VC]]<:R6
MW;7:8$%C&J5ABKP0933$:9C$\1X-E+O#VA8&R\*V?P'BQ%,[+]:?^DO[?_KO
M(J^;\T>*QXV/MC2.%AJSFGDQ1K-1TTODJLFLD7#-7G_->"DNS 99%;]5X\12
MP=MSZ#&*TBC&'B2N[R7(]Z@[E-M #\=4[BX-(R9'7H6\<=J'(OI2MO(@!;G"
M?HHIUL5D=P+"Y53VW!KE+"[1$.'N@H@:)G\>FFG:J3?79%C@3%416;;\UC2,
M_#@,73;73S*09H&'V7>]Z8@QJJ.'2@9'G79;U4(UOM64T#K5VCK(B9^?"I[B
M34(#M6B?IP+JN71%_PSP)?4J])LGL]Z^?9E<?]_Z<[5>TZKF_[C %"0NIK[O
MPRQ+(&)*W97[N)!)-H32#S^/#]&RPGYIGW?\J/Q,\P0Q$]/<'R!<<BIM\K'E
M(^><W[E[3N_?V#<;60G2A2%AXE8QCT%D:A).O7L\=4PF&*@^[-IR_"!T/5Z2
MFF;0#3'%6=9?6\IP AQZB^[ V)=M7F]''ZD$,<JHWFMWA 7P6+1R)G7%7;EI
MUT"KV^%0W4_EQFFX:[(KU!.$=?1AS$(L9S&"L=G*[N*)W+D/71W\<48MR4;P
MEQNP9/VW-U8I16*L8>HW?@BZ>=?O G2%?%GD$9""B,8X\;S4IP%-!Z24!E+/
M44Z!S_K*?7=N?+(Q2"EFXXQ"ML,UW3C4><9?R>E\FZ3,V4)X+(Y&.HWAKS$>
M:3%@>$32CX;PF,27FMXUS:Y8I;N:C8"=R19=T_YC#RG[7M3+DL%=9"3 2>I[
M@9]%24@BD!)O/SAF(5QLBCM>"OE58N0QCT)(J>).J=X %E:M/1Z-$<9"! 0'
MD(E8GWQ\&/PY&B)&'ANDF;\D_?;".!-EM^C@:^&VS>58<P5:U;=%N=TQV'BS
MRKX_EMUE3OM!99&!A+C <S$D,/%\ZGD4]+ACUR>9BHQ/#GH<U2<Y:[=K)C#\
M_IO;#O24DPP#P1YGRC%2@"<?8([\;-O(D:>3#3FV0V=Q<F*NV<QD0)L/'X8G
M+J8C-=T.D(L(B& 4 NB[491Y'L%PP(EQ@/L=H&RSFFK_YQI"^?V?P1G5W9]B
MLY+<]YFEU$V["R :UK^&E&GX;WT70"X28TE5/_/@#QL-NQ5NE,4,(?52-N$
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M,_+0VJWB']_3ZNXNW^_X?D-]Q>8N+I+KN$QVV_R>/[?<; T%OD48!#>@(:'
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M1$V:,C'QTLF6G$@=BS9R*%=\K:U==</Q0UJUETN[#UT9GQ[JXM +'N1Z0=V
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M2$*?8,<\HD HE'D'0;5M*067?\A :%UDUPJ#ZI61\0&9M#8R2RRTKHZT'JQ
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M:A50H5G-PM@AK;ONI^HN*8P38J.!+">3*BD7$\J%V):3RF=$OZ)X/5HI3N:
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M"H_.:9\RMJ15[2V[)+^/TVR#K# T+=O&.$26 P+7!K2US## <:HVP=XRJM:
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MK%X7\QF;O<0YDR)_9/,TEGKNJ_C'=9(E-VG5SI"JO#?AV@16Y/#$D\ (!C0
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MZM+ MVS[6-'(MS 1;PU]:XC-7/.]%G!2OL\^UXK\+6>3U1?#=A@&'HUL;-D
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M7JU$\VJ'_WE?;RJP*-*048)!EL$PQ@"D/*>#K2@-H=*K4786IA&> =+5^(=
M@@L^;K0+)2,2547'-W]&@J-/G3O!>860LV)C0^!<A,;*AQ<B8\^(ML!0\<>/
MVZ_-'YM%@M.<)ABE!,01SE$D1H6C)08CY64AT^]/+"X2F1PO2&R&PJ)#GJ:L
M>.+-3E24*',N*(]4J,B) 7$S$Q,3#TY)B3$;VD+2#<T^;C]MFV^U\'<193F!
M."T*@G*<P! 4=%R"BD(<*V],L3(RL:0<YB!&@(:ZHLVEIKCXI-%.8=09="XS
MSTA1T1I3'F<F.,9NG%(=.UZTI>=3T^[*]?^I'[HIH;# 19RGD=2W+"LPCNFX
M/3="/-*<8S8R,;'L]. "@<YH.MF,14W)\4>@G>"H<N=<;IX0HB(V9@S.3&H,
MG3@E-#:<*)T7DZ:V5=E]GH,PC1%..8NC(DZB+(+Y^'F*@?+<K]9'/4M)5]%+
M,)K*H4?,VUKAC1,]=5"DP\DANB./3Z2_$2F73W@SV(UE8U!/ZO>"F_6GNV8S
M;I@!(2IBAB-"PZR(4R0OF!A,0(:27#6QM3_L.;D[/$$'2'OE1I^DMY/<*S]Z
MB:Y!C8MD?^[YB80W)NCR26\.O7'00-23_TNUW&^%OH#H^FN]6XNQ"<A1EB/"
M\SSA$(9Q2,+11(QSY5Y=^\.>D[\#(1^D =$OUW\*1GCJ"J#/U-L*X)4D/070
MY<>%##QW_X0,&+-T>1DPA]XX:"7J,O!U6Z[JS>V7'_?7S7J!DA#E48@Q2R.0
M$A+R/!V^GT<\49XRT/NJ;P'HP00]&O6\UZ3F[:3WQXIFQJL1XB+1G[A\(LO-
M:+E\BAOB;FP;A'X?/]YWVVUX)9SG(8P1BV""(Y!A&H_GZ_(P <I%OM''/:?Z
MB.GQZFB][>IFA*EW]]ZXTA, 39I<]OC'#+S1ZQN1=7E9L(/_2N]OP8/Z"L+?
MJO7ZWS;-'YLO5=DV\I;LMMV+@4?.>)C')$SS$$1)422(CL?W<UP4FJN7IE:F
M64>0Z'[MX 4COJ 'J+N28,RFZF+"%$0:K2=T'/Y=BT-W*PHG6#F[J&#+Y.4%
MQY$?+Y86W#"C+D%_;=;[S:[<=D?XMNTB#QF)<A"CE#,69T4:1>,^#810K+D-
M2_?KTTC. 570P](5&FW.5 7&)UU&PJ+,E#LY><;!61DQY6LN\F&,_X5LV#&A
M+A=TO]U6FUU_T%^.HG;E;M\N&,!)!#%#,4<1@*P0A=)HCH8%U5,-0R/3B,<
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M?JENNTF$KPUM-FVSKE?="=WN'*5\HAP@@(H4R4L7TRBEJ*\^,T8(2W3&[!/
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MO9@@*N#NI[]>2["BFNI>HPOP=BO^8G=3ROC$(6^V-U6]VVL_6.8A2FJ">^$
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MI,FB7TUZP9&**)D3.S-5LG#DE"S9<F.G2\-]9TG(:9%S#@N 8<@YH6$QF$2
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M&]5,^M=MT[:?MDUWJVH!"8XY"G. &<T30 $=+!1I(A]IE>,&M<31^:Y6!7V
MH)PG'93@OMS>UIMIT^.(A#/Y8$+5/!+ "'ECWU#TFOC'ATKN*MK<#K?&M(?.
M">40\13P/.$%CAB4&UQ'>Q'*M2Y@,;?B>0!Y -;-A$ED_TMO^&C!GUIY.@UU
M>@7J(VLCJ(N5J"?I.:,I]I3.0V$<^-&X;FRZMTC)\>1RM]\*F_1.]$)5NT I
MY*"0U[2"7/PG"1,6#J8XS6+-6U*-3'@O3Y^@ZB;GJV&J,F@K.;TO&L#4E^B\
MY.E,#EG1.H_TL7/AQ04SUGR\E33+\FZ![YOMKO[O;EY:M)IF=R?:RO*_]G5_
M$&584I>K.^V"Y3A/241"GN8YB.(XXO%H/6%J';AKFYZ[\V.H759U8(,CM+^.
MNPXZO&I]O7/BS_?\E^1<KP[X2>A>-<MNSK+[VBQI?X)0?=_-7164M[?;[DS!
M6, &RTY\5N+?E/6FW055N97W);5RB;=<=Z);]5>R#%,DG8/RSM!: -C<UM=K
M\=FVK79M%U/QO8T0,[G,+/_635EO@V_E>M\=/%B.C^+))>5-6Z^J\8S"];J^
M[3=T_U/P]:X6WUJW3;"M'H1#W8K"R58B+'6WQ72+TM7-3;7<!65PO6_K327&
MJLOF_KK>]%;ZQ>[^;]V5WZK@NJHV(Q.K8-5WKQ)VOU;^3\&7_>$O"#/K_4IX
M5&\$[']L@YNJ:O\Y*%??ZK;9_K@*UH+8]94 NI27@8DO776.=Z:OCMK[@QB@
M"62RS:Q%M]4Q,1Y<[3XI^.D>*BA7]_6FEA75KO[6!Z"]&G",0'ML@EKY)NIX
MZUZYD<&IMM+ $6]ML*H>RNU.-IU_[@#=ES\.?AV^)!J(,%H=2HVZ;??RSZOJ
M>M?7'N*+NQ^B\A"\=X>(_DFU]A!)TQ4480K#KIS0S*)7*@Q?>7C9HL.;5XU?
M]=*<,!/M]7W3MI][4U^;]\)R+P./Y]8681X#PD"1L1QEM(@A3(O>-@@Q"('!
MN2\WAI4DV_HDUR.TX!>YX4:4^R+E_O1;+]QMMVURXJDX%?;.3=(Y97\>HP/'
M/CV?V// F/:47[\L)6$LH#P<&N: B<%\QK)<C%H.EF@2ACJSVR;?]SS+?33-
M-U1#O_VR%K@FWMOV"C,JTU0&/,XCAZP\.#4U9<R&<G[(?O-#LVF>6ARFQ!8L
M39,\XPE,\IRG,$=)'A^,0IKJ7:-@:<R@Q]+,G*["_:7N4/WIMZ&T/M]'>6%5
M<;9\ CK-ILP['H^1C4\T_#* FUJ+SC)U3I;<4#P3A7+DS'.Q<LF1^CXI,<:K
MVMUHI6 B]5E"*,QAG*.0Q:*4Z*T  F*F=R!3[]N>Y_E&.(&Y'FFSI29 /HG2
M4YP#1P.4J;>./>'A[)8Q,\;F(2#&Z%]L$;-A0?L ]XLW8L*,%R!*0$@R@'"<
M8#):PR34/.IH:L7[JMNG;?.MEO-T\B#B;[]<][BZV^7^%/0ECKSWZ<RY;K^'
MD95?1K)E>"ZY8^G%J=/'5JRHYM*':G<T%,ER0C B*&&0\*1(DI@.6SE!!'"L
MM3U,[\N>A\X"S/-!<U#N=MOZ>K^35[C(27I:;E>UG)O^WU6YWMUU-XDK3R&[
MR:$GG)W)'#-NYY$OAM@;%ZU++S?&HXJX/ZGX87]_76T_WG3GK]J/^UV[*S=R
MQ8/5Z[WXM<>S!.]VU?WCII,PY!F/(4LS(BIDFL,4HP$<%,U :PO:1) \%[XO
MSH!N.C_ZI;C[>]&S=8<\VZ!Y]$AS1]M4L5.KIV<8-KTR?'0@&#P(/APBUCL1
M''D1/'NHZU*[ZMRP?D:&)P[K//1[:J>;BZ:2GQZ#E&V]7-""IRG,LICA**4@
M0]FX%QI )E#XZ!C4+'O6_PY$=S:_U_F))PVUN'*0_GJ<_UQ9KNF;83*;,&B9
MLX-^O("R(&F&<U%6$BX4!,4) S094,0YA5H/9[FV[3EO!URSR]Q3?.GGKC7S
ML\Y>>^_4\M<1B^IS&'_@P^ZV3]MF(_ZX["^7_KBEW<:_=YOCWZA%<?JPKK[*
MD?^"D83$!((P0BR$I(AS0AG+DS"55TSJ+3#X1>)[V_$!ESRTO5EU5Y3]Y6$E
M=UK*_74]?KF#\N@W#RX$OW=.:+ZJ[#ET:J.S^41-;U#F.6">9K@LN#X[(S9%
M#.>A[A/Y^F+&;3J&[96_*+?K'WC5/,@9"/R];L6(+Q)CO:3 B*8)#,,D+LB
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M8/W198LQC 9_^L,8/]39C6146/,^FCD0HSB@T2=R)NIBY\.988TI(ZH:<Y@
MEL;DG?T57O[7OMY6*]JTNS]7N[MFM4A E* 04!8G&8.L@+  H^F$,*(C.4X,
M>E:@PVI&VZ]FE /":1-)A:DS>>64Z'FDF5N7&H\-TR()^Z68T?8B+T"$8D!)
ME/"(<@!1-BZXDY!E6G.5-G:F2KD.V]6PCG@5X,NGWE.B5#/.D-X9)IJI)^?R
MRXH=U;3Z5/X8M^\]GH3Y>-/7[QV,1103P&B89W+#'N!)E(%T,$S#C&H5TP[,
M>4ZR$6%PTVR/3X")JG$8DG8PI\VUMVD[DW(..9]'YKETJ/'6/BVZMS'G\;=J
M6]Y6LF_]5&T[/5BDC(JZ-LT1!6D4)D7!<#B:3VFDM9G5F=$+U9I70=F##1ZV
M]5+\=[4=SN+\4F^"?;MZ_,F?](;%[L*A-E*^2"3T!L]/JX]#T2'*CR$&$J>\
M-ZVO2RY8C)SA3[4R<1&">8BE>[?.U2SN>%/9%ONJZ;YL6B09X5$<T01F*<X@
M"$,R;M"2]I4.2]G:F'0\<,C(85R@OFO3BL;S^C8E@T[D;%KRU'>[3D6BV497
M0S)5-KB><?P5,7=%U>6WM3KQHG';@/1*VL_5KJPWU:HHMYMZ<RM&LJ)I[;O'
M@5AU4R_KW2*/BSA-(><,L CD21I&XXDP\9,0C_??JY6S#@PJI<K3"^_U-'O$
M&%0#R&!5+65H)BZ8WN;J3*GDD.AY%$DN'6J\-4KUPNAHO/K71AY1^ES?WNU:
M\6>1[5F2  1( 1+&(@YR%A^VKK,\I4K7<UL;F6:#Q3!1VL,+>GS=/^KT\'9D
MOET?3<:CT0:,&5"H7B5-1J59F61!J4JI=,[[$[62$\(N7RRY<:-QW)">Z_5Q
M<-^+/_W+/XP_$?]U+4J ?_F'_P=02P,$%     @ A5 -42%/$N[>#P$ $C@.
M !0   !C86@M,C R,# V,S!?<')E+GAM;.R]:9?;.+(F_'U^1;T]GZL+^W+/
M],S!6NTYKK*O[>Z>;SRTQ,QDMU+,2TDN9__Z%Y!$Y2J)XB:F?.]23J<),.*)
MAT @$ C\K__S_7;VT[>L7.3%_"]_@G\&?_HIFT^*:3Z__LN?_O;Y9_79O'OW
MI__SO__'__K_?O[Y_^E/[W^RQ61UF\V7/YDR2Y?9]*<_\N7-3_^89HM__715
M%K<__:,H_Y5_2W_^>=/HI_4/LWS^K_^(__F:+K*?OB_R_UA,;K+;]'TQ29?K
M=]\LEW?_\<LO?_SQQY^_?RUG?R[*ZU\0 /B77:N]3\2__5P]]G/\U<\0_8SA
MG[\OIG_Z*6@X7ZS?7>,EU>/?7SS_!UX_#:64OZS_=??H(G_MP= M_.7__?;^
M\UK/G_/Y8IG.)]F?_O?_^.FG#1QE,<L^95<_Q3__]NG=DTXF:1ELD,[^/"EN
M?XD/_*+31;[X</6QS!8!_35H:C[]O+J]3<O[#U>?\^MY?I5/TOE232;%:KX,
M)OQ8S/))GBV"J.LWWI39U5_^-$EO DA!/H9!A.A_=M'U\OXN^\N?%OGMW2R
M^,LYM#3%[5TQ#\W6'11W6;F\#XW=?ZWRN\A8FRW3?-8G&"=*, +,WA>+(/7Z
M5^&[#[_H'Z1CKQP!*K^G91E:?,ML_BV?9O/I + <?>>8</FU**9_Y+-9:/EA
M>9.5[T)/\^O\ZRQ3BT6V'!*N$T49$XKOYM]"XZ(<Y+.K\=:Q8;-8QD%S:&Q>
M?^N8L/DM_6=1FM5B6=P&SVU > Z^>$P(G6?Z/^7U8T+K4S;)@L<>ALPAR;3_
MK6/#9K[TH>?@JZ2SAR<_AVEF&MXY-&0G"3,F)#^GP=*?LN6JG"]":S6;%7_$
M%=&0 -:5852XW>1W=^$?0LN_!BL',:Z'1.SHV\>$U=^#WUR4GT(7Y;=!B77P
MQ2- :(!(P @C I^RX.JNLO#\KV58=7XIT^GC:>=C5L;Q-+W.]/W0/E57HHT
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M;QA(YR_%,IV]_E"5+GK_)8@2;%@_8ZO?E_:*3#VGO4;3+J4\I>95[[6M7K[
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M " K6?!](1-$26&J*RZ$DE;6VDJI-5']6A33.(Q% N5A$%L4L^F^?(J#SR?
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M./(04BX,!;C24#O0:J'W8\3".X*VX12Y'C.#5N4J8/QPT/\4-^N4+I* $62
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MYM_6A1@6OV7+FV+ZY(3K7[/I];HJX.ZA [0\M:LP6PBOPTK)04:$H0Q)L7.
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M[,:[BL5T-=EE:M[72A(YW"@A/%;-\01Z0@4/([G;!L<X0 2A"RLGU(D)BY[
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M7CZ<(*>H$P0;QJ3QP*/ ]THKURYF/\) 1[?T: WG65S=NBYNXF!P^IW&#/'
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MJPR9@-X8)VSXAEB%!]"M;H<=X1G\'CC6+^#GBZ.=%#]+F%8>$P^$I=)#B0*
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MDSFU:91X:A7@2&#/=/ $):7(5EI2A50+/HUR8V1@/C5"^0P;("<,4 =:)<H
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MKQ_A_>%IVJ6-!LLJC#%LG09<8HYU-E\<6]6\WB"!W@.KB0SJ*20Q(@_A-8&
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MPG^VT&!51?G=_//J:_AR\K3<E,%55U?Y+ _#Q<$$\0;=)9X:@*EV7F&F1#"
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MEBX6^56>39?%IKK>7S<I.+'BWIXE<(V6":!6"@UH@,IBYZ4EMG)2!1:T35K
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M,Z[-AN#).R]#7'/=-5TZ@W8H OU:!N]FLV%Y@#&/GDJDPUK%"E<QN\4$G]O
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MK ROJ8A#TGH_NJ/&%A#LU.S_KWPV^]_SZ*K^F4]6<5>ZW=P:??IL\<B83+F
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M"\7 DL""X]KN\01=[2;-*]RVDZAUM %M_PJYPGVZ5AO5%G\N(T%RP@46\7_
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MJTO90D@ZC1@@I5K0<:48<#U4KSD&3,$0;;5V0A+%HX\!P>XD91C+E$#,%<2
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MYHFTU% !PK+R@P7&(ZO*;JBL10=0]K4R_/*E9W:5-\]F5B'F2:"8"8>EPT$
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M&3!0; Q6B,5_BBVJDF,-*>>0 V1ORTRKT+FI5_4,G/3;0JS:5E;23V3&<LG
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MCT?'D;/26IP+F?ET '8$=H/QPM@2OER'YW9?VV$+=,>X(>;(FX[VP_RJB+Q
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MX*G(#AF9"Z!-PU8S2HZ6"&(<%/75[?W-J6K"35\100AGI=)&YH*WR*J$0XT
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MZ-(Q#SQ3"EF95N]TUMN?]#4-:").Z+W2J'.4A^;23T$8#:CTTS-1!:\%=0S
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M&$F9KL<M]80/3Z4\.(=AK;"^CI@CXB35S =@.*_7)OU8K_]"$UYBI!UC8/Y
M3BQ=X7T=@4;6,@!!&'4J[?4&2R[K>2$-*2I=.J(UJ".Y-@HT.@_1\0:>.!%"
M\#8=&K6T"D00/M3C($I/IAA81](\$GIR'I(C"#VS@3N* L9!A8"!$E"UVT4Z
M9+B)F&2Z%7QK^ :^_^\U<V8 8ARU G-&6? 0O( ]TUW19=(8\[D,>8KJ'OZA
M8]R.D*MN$H$H@?.].5!P0BBG]VJZE FT::@C_0CU0*39F9A>**9G]YNWJ^7'
M^6;BD3W**YZV$ =:,D04)=KN0E%E.J+B1N?^OJ;JS7)Q,[][J%KZ)._A@UQR
M?JD<IU9[17U8/IZWJ]M3@3[E+X_2&(1SOA*A74(JKY^Z1LY:/\UJZ04$^FE)
M&%@"8P\#TB$MK5JJ@(((F%@KG*M'0R6=6!S9D.(_'15T'O;7$!4DP1N*=& F
MUU"C3GB/=B,*@82)V'.[$&F3J*#ST+R^J"#BM:?<^B Q0P*)G+>O'I^0;"*J
M;C<B;A@5=!ZD5QH5E%99JTQ:>(G)0;^ /*['R"R4..2/S#;3.6VZ O6ZHX(8
M-=PKQ)FEQBGNO/5F-U;@FD^$0!?4>?H0P[B#A$!1PX)0-J>1- P2/O5Y!+"R
M$\E6U[%<CP8)G8?HA8*$++%!>VP549:%H#EVONZDI;PD__(8Q=Y.0*>"A,X#
M<; @(0C*2"_35HL#D\Z*0.L]%I*2/\UR- 6R+4'O4C= ^[UQ\2FK5[!<'=\=
M?]P<VUP:=?3%:) !+UG@B$@IB35DOR4#@"Y9>4;H%7Q)'684 AS\</]0VC./
MI<G!_K%UQ$)2"\1JABUV*DUZV(U+(>"^Q%U]O%OBY=AQR"[06B(7NOW:3M)I
M7&YY!$$0PK #PX45C$)V'B>Y@&V@II'O2$^C/.^Z/N%O4T?^?0R$=F^, 2N*
M $N2:V@*0SWB>HN133]H7I+3]PI6B?.I4I:^KB7LP[E'_+B[[^[MC^SH#9C9
M_J4Q(..1H6G5=5DNG K':I0(<B6ZU7@U_^[(.1CR0_'3S]>S3Y]6U:<?![3=
MLII0L='S,6W'GJ0)JE#ZB3 9G!/UV"5#)2Z'(]3H.V=='R /[!_V8@+DYV6;
MUHUI5_#6F([M@@.BS@AM+&&>2=CA)&2:EP5D'&,P6/=+X%#07VJ//N\$WF*_
M;O>!")1((Z213(!E*#@39(V>@J)B$6.,".I[[QY$"A?C\+:VW_S38OYQ?C/+
M,/YP>.^:T.5?BU03Y@!,.LD')-*)/NUC-:[@2,G-Y1B]RWMG]^ BN135'THG
M'#0\M>%STU=&:CD"HS6S.?3'"^*5KQ%R%)?H$E=0I+1STO:$^U#,?%;-H[UZ
M>]Z+HG*&."FU(L E#B"P43LT)!>JY(9>_058V"O: ]F<[ZJ;-$'^S_ULE01P
M]QW2OR]R-BD_V\S^N9C=W\[3/U_,!/USOY[8\M+I]N9NN;Y?50TLTV>^*7(M
M'' 2#'-<&\B9(;=WM8D26C'3R ?\ I@T622:O2 J+(*U6((TECE/->>X1D R
M/Q&_Y=[YL1P _#&M%9<.R;K<DD%80-2&X!QUUE!#0I*4EEIHY)4C%PW@:AYK
MR8P1*@1-!6:"<F[3_K0;1="L68&IZ4[[QC(^%'9Y'KQ#*:"_KI;K]8,YXPA'
MGK2*R'K&D0G86T^2XH2 0#T.2<1$RE ,39/V" _G+7:730&_5HMJ-;LSBUMS
M^V6^R#D%$Q;?JO#GUVJQ/EK8K=$+H@&"@O(V8$&E]5(1(7:C!Z?0Q'RYAN)7
M+^ /1;U'<^L1>CTVBMK37"8F4$X%4=XKRVN0(& YL?N:H2C4&N#!<AI5FT='
M+[-Y2':Z/8DO7R_3/RPV"=6M.7.1\*K6QW:\L]\5@6.L)5=&44<,<H)B4V.B
M,$:#W+7H!](M\L5OMGY-A7M]B^,B%&U*OT@1IH!]2(HC3O@1S$'68Z%43^RB
MXR*<.A/CH?@29JM%8O7Z;;5Z_SFA9V?K^4W:O?W\[CY-\ 9GV89OB(("0H)P
M ,P=."*]J)5.((J5<&R$]Q)#<:P?](=BW^/TR!<L+JVR\\5]&L[N'GRYR./:
M#FD[N",L//--V3!O.:(8$Z_!(\6\0WL]E*E!$[OTF6RP-YXLA\1_5'S<0=8)
M(Y^^*V%/J9/&>8R0YUI@IG<&'(R"+4HO?[;AXR_#R0()M(R-_'6YO/UC?I?/
MR$F9G"T^S9.:^7#/=RBC59/'HI6<>\L48\82X+GNJ*L[+WQ1C?H17KGVO<'V
M 'E+OKSY.E_.;U_--_,'9]L#R1@.-8W<!\$=\\QRCKPWE%FS[R31$PG^Z%9>
MRTXQ[4CP!Y,D'&X<<^Y&!E1HS9!3QB"/]*ZCV 8WD:0_Y7(Z(O!62+84^8?E
M9G;WO -'H^B//!&E$M2DHZ4GEF%E"59*U*.G04UHYI?*;-D'H%UR8%%MEA\W
MLS_/Y\*/3Z898;"SE*0.4\ ")+=)!9=.8.72"$H6A!'=K@W!B2)@ASW1/&:0
MF=TE9:EZ_[FJ-ML[FMMY'LJV\-].8UK;[^DO7Y?KV=VOJ^7]UW5ZQ=W];=*;
M<YL');JZ?=2A3^2&&J8#42E.N0Z!!@8<2<L3[K54F=(E<? CHW7G2LZH)35@
MT&'S<;R>?:E.9JQJ^<:H!/,(>\ R'7@E*).C-'?X<#ZU6.VQD>[G,,<!A-A2
M47@]^S9_**MWO"CJLV912*&,)AA,>J/#+.V&J.Z<P;(DU=((&=:[")>=03V8
MITTO>1ZU<$RG/P)7B@3A>%!^-U:"M2Q9N$;D5]/K%MPEP ,G^3HS@Z,V4CBE
M-)> .++68:+JL5!C]=3N7SJ2[-$<CN=AVG+3.3^S'[*!:&\U(PB,RV%1NIX,
M!*4S]+2VFY8B.9C9[SSTNK^2>'4DZU[31Z-3:35DUAC"F$8 3,%^$ +!1 HG
M]V:"[@'CP=R_TRS(-W#OJKNMP]CRT7[ROMIL[K9KXC''\";/1\50P-92Y @*
M&C@Q.M1C=Y1.I*AD]U1X[B/> ]A#$NW-XOTL9^GZ;?&M6F^VV^L):KWP1"04
M*^.Y)TY14)Y0S>HU._TH2NY1K\>4U V9RN%MN:&]754?9G_F+N3+X/SQ^>;^
M17>-(ZTC,D)0F4Z!+'5.2JX@U$.G$MF)1 KTQH3NH&VKUCS_K/F88$S].:3+
M'&H? _8\I#.\%EPXY[GFB<&[[G))2LZVUZ/ E#&A*W 'VU!V0/SVY>MLOLIK
MUPF7ZI<?B.GXABA1C')P,FV75B)2CXY@5:*;C"A%4O_;21?HCBF:^<(I>"\7
MS Q!"NZ,#X0%;Y1DC.M= 'HZ&X5&8< ]F;+V>5Z/Q](WS9G2ZGV1 L<>!U#2
M8,FPI@C7\?\2P/W%LR,T9L_!'+[]R6*8Y67G*EO=NN67'%2Y?<?%UI%'$;WY
M^+1#NS.D6ZXWZVV7?\]=?CO[_F#U/+VLE+TXTEP) Z?#AK7!":W!LUV%+88P
MX$:77!=&S#X=6,/,MR5O3INIU1PL]RY[R2F5-E128\9$&+2^SA!&^:$H]O.E
M\H!BNN"B].3Z/FD^>ZO2VVJU76^W%_WIN7\NYAMSLYE_FV^^7SK'RUB7,^2]
M"@1AG#8_\,1Z_%"!.6U$Z<0D&UVB]*TT'2#!:I6. EO3X=I^_XG7YH]$IE.5
MO#O[1A0J%_C@TLDT>:DC@8<Z^Y%CV$XL!\U0I#M<+V%0<0UE&GCH8/KD"7^)
M']I%JPU#&G.1!@,V>&1ST=B'L23-<F+4NP 'EMVA/YCS1&ML'D>WN'U[-ULT
M\DGLXW,Q>&LI#S8M$DDM,1(L<C6RA/*)U;1OR:KG*^3E!3%8;IUGVM[I N8'
MGHC*0P";COU:.6^PE<'48'M);8D7P0B)=EF*/$_-TXE(1K.J'D+N59,2D\4O
MCYHYZCPV% ?AK:: 7+VC>1N*D@^,Z(9Y/)K X"(;+'O+EZ]WR^]5];Y:?9OO
MIN9/XWR]W-Z^5P_KPGH;R_3TW_,IX/5R\Z]JFY#_TV+^OX]IF5_*]]+7-Z,T
M")NTF09A+$_+D0R(U!B#024)KIJO[_L$5YO+KNX=4O)YRIB1"/#J)TG:%.?+
M6UBN=K_*[? E9LZ+'8DL;<G /-(Z4$TI<<BKO32X*G&Q;K[+_#V=+BK5T6M<
MX7_NYYOOORW6F]7]5@/8%HGY\'FV>/-U&Y'S7UO8?EL\H+$%#F;SU7_-[NZ/
M6@POTJ'HB!> F-7>*6=$0%+RO3YL3,D6-B*/L1',NJN0[_BN7MZEP:WF-W7"
MH[]O7DX;P9GQDH!6)H ,*JB<B_;AM@TIP>@%<^]?U\T+DUI1BPPP0FWV_%0)
MPAV.3(F)Q34/1;K>;E[.$]>X;UY(\!09H[!5W'%EK4>P&TMV09P8]2[ @:,W
M+^>A/QJ-]0IN7HRV2"M-&5$>L-?&0"T?C2F;F*=@2U8-<?-RGB"&HO@396^S
MO/EW5O;6[][_\^3]R]'G(H> A0XX'3P%Y1B(%+H>*Z6VI++?"$EW6;K\5.JG
M.\%<W_4?2+!*4:XT:*\0RYG]ZO$1\[R8_-7?FHR)>-V(9#1;^X6O_T@02&'@
M7%'CA/'!@MFA9HCF)6ZV8R3RQ=71P45V]3<;%[G^TX"E(-@I8)1J2Q/BHL:8
M83%H6JI!4L(,2,O!K@#/$^+53Y217P$ZPJ0E5G)(F[[D/JV2>VD$BH>Y OQ[
M2EU<LJ/7O"9V#9A#@IR6W#BC #%"C-B3"'11"I%I7@.VG757(=\+7@.^GJT>
MZF_^?;OW\D4+9\$K[JT 8Y5W6+(0?$ ^_=U3T>S"_N_;O2IR+KVF*&U"Q&!&
MI--!UC@&[H?QW;N6V[W&I.OM=N\\<0UF*]Q9JTY<[CUM%ITTTF#AK,+&!,9(
M.G?4(T%6#!JS?$W&E,8,>&X*; _^T#0Z>2GWS#J*!!"5KY*$$(9CFN:HV8TF
M*!4F=IW63I 'V- *P999O4R.2'VUF7\]FH/V6:L(.7<J,0@0UCP@Y93R==>L
M4B7E1T<LW'/ELNP*P'$[A"")D;&8 I(!HV 4]:0>BU-Z(BD>Q[-IE* _&MO%
M%3B$I$E)& %F06CGE;:.UW,4O Z#9E4?VB&D,:N&< @Y3Q!M-\*M$7%ON-CZ
M!.RL%\>WQE//1<.DHIHHRHC#PH!SP=7=YUH/6AUY!/:K7AFP[$\P@U^O/';X
MI)?'P6>B$H@RZH0 Z21"G.8*T?LQPJ"7%G\1\G4ME.OV<$->><-"0,YB21T*
MF-L]>J19ZK@)6>^')&"7@KD^#S?K$-&6:F$M59)H)^E^DDDH6OE&E&5ZE,3K
M1B0M*;=>;9[0+?WM.=72K^*[#,N!4^X/_QX59](%@156!I0S!B%=]QD(FT@A
MKLN?;DM0[YTI!Q>A9RTBR,""85I)IX*64E*SNXRP")PN<:L=D:[?4E;/)=T*
MLSYE_8_Y8O[E_LM1:?_0)C(1M%$N,.:!:>V,(+CN.S9D(FGH6DMLV0UNO<I\
M]N=IF3]M$W7 &%.@'BQ7@6,NZ'[T:503*?K=B<P+<!N-I?+"_NT*-'4,A,WY
MD'-Z8NO8'G>J2FIQCU&-O;AU?7"1M;179I>J^>+3@T?5?/&]FJW62>E^T+</
MV"J//A,IXB "MTII#$@"I[B>GU@Z.Y&Z;Y>0\[(?$8Q^B7Q]GQ?^W5Q>FV^S
M^5V>F[!<_9J>/>:(UM<GHW"$4(F$-((KHUW:DER-<*"LY.9Z1)OW!4D^,@F.
M*BCBP^Q/6RVJC_,-)%$]_9?P9_[QF'=A-Q^(P)RD*J=\Q,!4L-AH4J-GB/_;
MF;HK_E]$7J/?$;9__+ ''@OPZ?(S,:0--.BD!E( $[##0>W7#:V*2L>-49&^
MPI6_7&HM=>GP9[6ZF:_S-O/PW3<?LR5\_=OB7UD_.Z!-GW@JZG2J19HK+(QS
M AD:S'[J"E]4YG)$M0HOK$]W*X1!U\_?3X/U^[$I\F[^Z?-FG49]DQGRZ63D
M5M??BR"%$B1+33EDO7!*TQI;YF5)F(+XF^ C$]]04\,G;6B1![K8K.:_W^>!
MY@F=HT :A=0W>CYJK<!0F@  H1EF)HAZ6R%!H9) !_DW=7L6QP5# !_MDP=R
M@CYU,_L[3/#EB"W WG%"V#9=CA?$"+U+=$-P8*31)>G?88)5),%@18551&Z3
MMNGP4"\GXZC5U&I@#46ZWL($SQ/7N&,^I)',,2F(2R,2U%,K=3T6KN7$ H N
MP(&C,1_GH3\:H] 5Q'Q8(Q!&&G&!0&H9M MTARQQ"$V,URU9-43,QWF"N$[?
M?"9E4FZ#HA!X ,<%J4L>$R(!IA9M?5&:-/;-/T\HHUE;+UV$37N"K;#<,>44
M8T"XJ5'C#)=4$QSCM>K%]8'!139ZHN_.W&_N-^O-;)$.\Y]^RR:'Q7I^TUM>
MJU/?C!*T1RA?802F,9:4!E%CC)F;6"*7(4G9U7SH6(2COT#8C??)M<F/XSUY
M'=O+1V/@X)-X44",YF(=&+-:]Z3(DY(HL3'N'Q>>*&.0X;5L*+L!5^L?LM<-
MMK<T^7RT5@D(Q&'"#/;2,?/_VKNVYK9Q+/V^OP;WR\M6 0? ;%?U=+HRF=G:
M)Y;:9A+M.%)6DGN2^?4+2J(B.[9$"B()TGIH5]H6*>"<[QR<.[BM*>^M37$D
MIEG4,]0QTP$W+RQY^*W<?%TM[\KR/IY[W_XUWWS^O'RHCK]U1?#U007<'>WS
ME3J(2UY56"&K:^H,(.JK6Q9P0*K>9#4OJ<]JG)$,TVT+VIYXTUOLY=M=N5X_
MK9A[F:IAOI@M[N(F][?QS5\LB+_*>POM!"!B2*220-@I3J%.*U!C("5@V+K(
M9Z(X'H)1694-C^;2 0?!R!"W*GP52[8 A]@9%<ZGV"'3+ BZ6!0R8>%8W-VG
M\Z</HZ>[='9?^\I",RX-@\")JLJM.'(FU!16P:74(4^S]&@H5_=*'!R+H[OM
MKCDX)O]=5N6"47=$HV+VJ=S^T<TV9:?W!%RVDL(R;;RP44$!1+=) :$'G<4E
M3O$EU$VB1L/8/,H"'QZ.<HH?XI[6L[OMYO^^B(C:UJ;?Z@)?+M'B)$188DQ!
M2.&C_8&AAJ54K-F=57GJUJ/TPOOEPT-8KJH_]I.2.OK"P@1<7?G&.2?>6\*B
M8U]3.'KX9&(MWGW!L;M<U.6\&XO5<;397>-O/T*Q^ZY"2$0!.>8\0=($XSWP
MFJ;8R%['-7W='HI_V\Q6FSSMARO!LSMIN8BI8Q&4I[;37U;+=2<E/:]_6^$5
M!>RP"MI82AT/(KB:KB$DW<,UI1QMGF*2SM#>!*4RGW]9KQ_+>_>X.K0";W>W
M/FZOJ9-I)^VHUB\K/ AC':>">V4E*.R 'M2'ERDV4O-DJM[!?%%^VK85O3FT
M=\VVL6C]2,B/Y7SS6$U"6=S[;U_GJ^T;#I+<X1EP]KL+CRT@3)$A0"SE@=)0
M^^<:<4BYXZ=Y$O>MBTIF7!Z+9 WK>" &6!$E,>%(*4\I&%+3U)BDB]9:IXUW
MCH=?W-_$IC^6CD5,CNK].A>3G[ZK$$AY':D9J(MG>'3>?) U31U/$I,,78Z1
MQJM2V38643@2^6>IB]H*_7TUORLK[?2QSP!OP\44)MK$WNK F78!$8P]/B@H
M@5R*M99AE>A(A:ESODY,VH87L4)*)3Q3@G%*E!>6.5N7 VCEI+T%D?N%^3 2
MV1(&V8CAJPV*37+V5Q/%ZZVBNGW7NDAT!DI%N!@?H"Z?UU5YP[1LQBD)XF @
M&(TP_M0_,I0\MEI(H8/2EA.FH^5DHV< ',0!,2!3NL,SM#S?DDAVB8-LI#(U
M@CJ0_9JTKL)+2;&B $SRZIX6K4G-*Q.D2YE>.Z5QR1G*;$:P&(L(C\?91$@+
MS4U0U'B"@U/Q9TU_QEA*$<;T$P>YBV8W(!B+$![%D0<2PH8K*,!)M9TH3C7#
MR@*1K*XP,TA"RK2**?6YC4\ NP% +HT)Q]T(AX'%S^_JW=X2?>M5.)<?8%Q3
MSK'E5'N#N /*]^W$"#/%&ET"V9$:'M4,8V2IHS3*C]*\$G4N-:OI2 F>V,#-
MOD#7V0SC=NS*>X8Q)5X&XXWUE#.AK0K4U'NQ(>EF[PRA-P &3LXP;D?];&S8
M$<PP-II(*83&R#@!(+1S^^H+1!3%*2YBAKB^$%5]S#!NQXB^(/[<X%N?G6#\
MRA.%0HY)R:4!1248:CT.]?YT2*K.RA!HPT)DV05+LM&J T\O]EIIYJ62++(C
M((HHMC75@J=3ZVP:W!+HG679 ]W_W^-\\_V7133T'[>$?[?Y7*X^?)XM]I&)
MPS"?COO'+UI(@8A%AC.002*'(&!15V$C0H3J=<[Q2*:@-0;PM62G#\Y.2,ZZ
MJW9ONX:"<^ (*E)(",(2Y[W?\X ZP5/*)Z978-@QS/N7QHM ,'Y!?%KL-8@<
M/EU"@5#4V0#:$F^\(YI[\H,#AJ4,B\C12GSK IC$_?'+W]/I=X/(W],E%-XR
MQ64@6%;3RYC!6* ?&M"GR-\$&_.G(H9)(!B_&.ZKM0:6Q)]641 #!CND<: $
M<4*Y9G4JBE+O4YI>)MCZ/Q5A3,7!^.4Q1_^0!:T\.%\%?*L"&4]-'8:CF%-^
MJPF<G""F06!"8GAVB&PV\=(V*RVX1!@;4 @<#MQ'MP/IFI\Z[5J)UK[F+:":
M,>O?DBAG+K^%PHQ6I=F88>K <J%P;0NQ0'&O^? )Q6F[D9X,M4!+ (U?]#.X
M<N#::RP<)0*HTT39:OX3C8=2./ 0C+Y%B=^6^'>+G_'K@*?QO3QU0,LU%E@Q
MX0(/Q%CM'4/1&JVKNA@EYM;O_L9T0+?X&;\..&I)SE,!M%E@(84'1*W@TFO*
M@D::DII[CJH4Z9]2Y_R;D?X.P3-^T9^.]P]@ E;8<LVD$ARLEP?#S3.;8OB_
MW2C\R$6_,_CT*OA_G"?-'\])L_U1V3W5O.9J[^MH_-Q5V/YT5I*O_7V%DH(Y
M;0EG@6$6]:@6^Z$EB!/P*0FR*=GC5XJE#\R^K+OMW\<MKN9W\=_;-]R:[1OU
M/2L69'1[--! J-*8<KZ_D!YY9'6C*UENS?9E08%(350T+:WE#JISLBZ>\H;K
M7MLTLF^V;PRZSIKMV[$K[V9[[QCVA#"!0!EGO&3RL!?G5<I4U@RA-P &3C;;
MMZ-^-E[E")KM$;$@59#*!"J,$:#\_@XU%&!R0R0N1%4?S?;M&-$7Q(_LO>K6
MLJV]]_YO?S_;<G_RN<(PJ0TU6 NO+'"E ZO-\^#(U*[Q'18NR^X8DXV>';C]
M'AD2L)) N*,R&E<:RSK=$1T^>VN_O[)MT#O+L@?ZR-OO/9"HSA")*@97X1G/
M]$&9(4QZO8$D@_/@BO =MOF^'5\G)&49-5<HBR036B"A$%)46!GV206,M,&W
M*^)[A/E@[17M0#!^0<RO^;Y*0Q#L!%9:6XRM<(C6'&#@>VV(R/B(FXH )G%_
M_/*77_-] "V1J:9=$V1=]"Y879*&D2,BI;KAUGR?K1@F@6#\8IAM\[T/R%2(
MD#QX31"%^A(6'.T4DW*3ZZWY/EMA3,7!^.4Q1_]02Q6LH8%[3P)0X5$]%RCJ
M1"92_,.W6_:7MR"F06!"8CC1YGO  C,G3#5% 2@10;$#/T40C>[V> .^YBC"
MJ1TR_BT)<N;26Q!*!?&,6RJ5"MIXT ?.>89Z+2^:4)2V&^G)4 NT!-#X17^*
MK?<V!,X$5YQC QI#H+X.3V"&;C'BMR;^W>)G_#I@BJWWP3J-G+$ S)@ ED25
M7O/0"D@IA9A2J\^;T0'=XF?\.F!BK?>41^1191RU$J1DQ+B:>]S(E,+86^O]
M"*6_0_",7_2GX_T+ =)8HHTBR$C$L"5U>0"67*<<^F\W!C]RT>\,/EGT%[^O
MZ//NHUFO'[_L]OOW==5?[->;^9?CS;W[N.U3V!/EUF#\<J\G4B8$I8.07@DM
M P%EG5,VHCAXC!N-[+DU&%<>-,*4 O'>N8 )TX+JFHZ,\MMMWA>!KK,&XW;L
MRKO!N.KBL@0PTEX;)!F*>]CM)2#-V<1ZVP? P.G;O%M1/QO;>00-QL%1[Z1@
M1 ELN%>$@:DI&YB%:>'Z0E3UT6#<CA%]0=Q_^?JP_%Z61U;>V>;B5Y\I(E&]
M1D"Q=!@<UI(C4N_1H) R*"E#L T+DV4W3+D0>.O5Y@AT\?^> R[^JMAZ':^<
MRD_^7@C*$'C$G7:42$\IL7O;)F L6 J0<DS%#78:IU"]<Z2\JHB>?:*P0!@G
M*D3*6XN"-]C@P[J93&D STCM7,BKYYR^B&9=\OJO\\7\R^.7D]Q^\IF">AG7
MB#4&+HV"J,60JM=>-=E-C-]M.;:\#MTZY?GLVWF>'W^FP (DU<8PZVUP5D9]
MANJU!R938K09G0A7X7D"W;+QK 8>*1+)S+G@QC$@&'F*432==E0C L34)GX.
M'@WHG679 _T0@3^*T;^?K_\95F7YRR)BHEQOWL\VY5[#=R$.+9=02.V 6RD=
MU;YJ[V.$ULJ*Q#^DM)5E="P/ =EK24NW'!VE3/EO7\MJ'-<_E@_Q-0_SS?>*
M 'V)T\O?7F@F#4&!>J(M=X$Z.+CLQ!(IIV'L3$V2KL+,40N1F_\YOR\7]T.(
MT/%W%P1S"AK;H,%911!SJO9TB,'V5L:9M0 EL#+[BPU.[?M#N?J"S\E-)U]:
M.",01UJ8H 3RS!C$V>&DQ^1VZ=!5!28''N91AU1628_YXM-1VJ)*B+C99G8K
M-GJY[@,8PI8SS!5@(;PDEM>U<B P:C0R^E9L5$9QT:"]5M7-N)&B!B%F:CIB
M(2=6\=$7Z#HK-FK'KKR+C8(60?E(0JV( Q__HZ'>B_)T:GGR_C%PLMBH'?6S
M<<A&4&R$7 B:.29DU0GA$$.*[RGK-*<32<0FHJJ7VPQ:,6*<Q4; B ]*8:.Y
MY3@H+NK;[K$#HMY:N+E3F#0N-FK'E&QTZ\#I1HW &6H(1Y1+S!WB&M=4HTBG
MC!_),=X[N#W0.\NR#TOM&WS>/6[6F]DB>O&?GO4]'3QU6"ZV+L'C[*$*.Y!S
MDM'O:@J+"$44F,<X( :82ETW8#M&^O7JXEK_6 Y]+EP1RM<*9?7&WK&(G?]6
MKN[FZTJG-:1$)V'BRU=3$&.I-UCZ0!G"BF'#ZG/?<RYNLW-R$;KNF=N[-U&N
M_IS?E2_SY-#&NZ7!^L-R,WLX_GL5]_IMN?F?<O.^O%M^6LS_':FV;<$.R]7^
M5]7G3LE;OPLI%*,AJ*UOJ03(:/*(6@7ZR)B4B;'3S&U>*FI9\S6+],UVMR]_
MJ$I-+=:E_5YYGN\^;JESR^B\'%RWB#+%B!&(&&Y0])_]?@YW-0C8-;)9;QF=
ML@B!::\(=IH:4+R*89":CIPE=0UE&!'J"W2=973:L2OOC [8 -(B;@-U(F#.
M59T?(UYJ.K4K5?O'P,F,3COJ9Q-U'$-&1TLDP0F.0@ *&$GJ#EK"^4FWCS=&
M52\9G5:,Z OBW=Q/O2WQDU1'>]W(: H3H0Y* 1O?ZSF>10RO4\"TNJ&Z'6O&
MF5@,1%,I:4#@)8I$"T+OLPHD!)QT96?K6-:;@]^UV-(7]*(O_W&Y^C);[ ,$
MZ[/ >^6)@@.QR%%D!!9(^KA1$NK]<9QT*]<8XSI]@NXZ+,G&KAPXFRVX!.2%
MC *JE446/$4UU8R&V_".*_M"O;.L-U?\80N.:(F<"C&>\M$;O:!@!GA5L1)5
MA!6&V&C=P^%DL2:E^2%#)Z=/N#SWVKO@QX"1\*W<WN+9/X46C2>*2<^$8@0S
M)[G9.\X4G,*-+)FNX]G/<S1AN?H9]4>J>P_=^.G7%/V6*O9[99)L<?$A(L'&
MA_[9*/;=XWH*9[&6FF*L!:6VFBF"3<T?X]W$]%U?8'XU3IXO:WNS6,_82,<S
MILW=9O[G?//] AFZ].4%UDQK;+DEQ"#%G/+UZ/[(8TH:M52-QV(=7"!ZXM-Y
M=-_-/F\ABP1%6\#&7Q3F_GZ;D9\]O-"4>!:5+=]0&!6TYXI+H4$I0BGXPY8$
M<)T O0R]_IZAURTS+L37J9[71O!J_H*"<:*YHRPHZ5P@%JJ*E_V&B,,IU; 9
MMG4/@*[.>#'DT7SL]!UKY:K]? >#'RWH2<?TY5]4$,E# # L"BO5PLE #\Q2
M-JG.N_6=+9-#=A8\R\4X?2DAM@M$7]M2;?E-A6#4,(J<$-Y8(ESP='_A)'76
M.Y,@ ^(F UDP+=F&/5K>-K-A%O?/?K5=\06V[<5O+I"1V"&,$ ;K= B,!E&3
M0(!+*2J1;QZWPS"I?V5]*+P^2MYMA7,G@9?KYDM>7'A/JUF]CBK%E0@,$\-J
M:B$A4B((ZLU#>A >)6O>YTGE2_5LP_<4P1*EN>;6*T>D9HS*VK]P."153>DW
M#\$^6-)?(NOS\B'R=;V[!'&P]-7NZQNDHYY^L/#(F("Y1"@03RG7P'=1&DSB
M2>4;A<PZ.ITJ"_ )<7];;LH?4&UT$#5]1T&UTAXYQS73E&/+#* ]': *DTXK
MC7,I")Z?(1V1=R#AA<]5VFC]R\+<W3U^>=SJONU5II5.C)^-:G'^9_G+(KZB
M_'6Y'OP&STMEOLK[@U*8DA"4]580Y"W3$'_-E(1&$S*Z*H&^>YBMU_./\WW.
M[G'S[F,#;IQKBTIZ;Z$9]TH9BPS2'#"R@MF:7G$C$VN%NA0L/Y4^]T?RWARF
MR+]M6GFO+^+JEXNM*72ZO>GD<P5ECB$ X@-X1YUUW-%ZK\:SE*Q5AO#J"1<_
MG537XT!OA?A/EWJV9^G%SQ=!42>059%,45H)">!XO3<JDN*:&:+K2GQ^7D=_
M!<KV5N?Y0Y3"<E7./RW@,3)H<??=W/_OXWI3$2=*U,-C-2KF]^5JR]/-9C7_
MXW&S=;B6ORVCP"TVD>IQ<9_JJRS.EN)W^\5%M% )C6(OO?04<XXLJ\\AC@F:
M6/-<(N*>EXKFQ)H!!.&W<O.72+_*9@^1U#!;?PX/RW_]5WF_-?>[%8:.OKS0
MU"*/K<*."RJ8T"2@FNH>LXG5674F$'FPIS>A6-[-NP%\THN+8(*QGH4@+<A
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MCEKBS<54J:V[%'_#=K+"]6ND&?]Z(!'V38BX0UGJNJ,@P#WH 27M !Y_?'"
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M)16P\\2@,7!MZXKQ;OG-S#?-^^R[4OTVY,]+_?_?\)K^_P)02P,$%     @
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M)=4R2-=14/_! %N2KF5C<M.,@L\5U4[F^JD0O\6G?"1*M3ABTDYW[?A\0VU
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M7C*>8(+>[!5-([Z^,G203L)W4Q@@$$*Z%6#AV(PN-*LP)=JWDAF@OBH&*/'
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M!H)%;/VG1)O&G!N$NH1/'1_"84$+_N]7?R,Y26G?,O7CPPF1#:T9/*NA:Z/
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M1>4!#8HA'&TUIJ0A#1- ^:79T8^+H3-7>&6V,8M21C AJLNDUYG;5[?T4#R
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M3QW.K>X2]$U[LL[62*-PXV3[TS=_F7L#Q@[>R9T_Q;7>6N@>?JUS1L)>>(8
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MC>D]H(];W+JQ,3\Q7'#9ZZ 2U8 P<-B >D2_E4HZM,PW@3LUU) G.31FG>8
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MWL9&*5=K=K(!11UP#I #8"S]M*<)VZ&"*1^+:*<I,W0X]V,OM9')F<^>LR<
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MYA719@^"JBGO6-,]/,_O4YNOX*E27#]\[0QYH6;$__,O+P+B-8(@[.C3TUW
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MG7%9UC?C#BPN?%RDO"H1V_U>PR)=-,-8V>8T_\%?N)?C949S^*FBCONAWZN
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M842U3+UIT$Y2@T)A*0IF!+) 'T0(@SU.@$W!SCGT2;#I>40_GH7N2+OU?<<
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M?]ATEWM)(X_8\$(KRIC(G^V: 3PY_885\[0 E&59G7A!]Z'Q/V!PHP4F-@?
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M@8-?>*A*8,=(YKG5U9NC9Y^L9\H8=7IHB[\:ZKJ6 %84O:)-K-H!K9VXDRT
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MO-J/K]$N-/%*DX$AZW/'Y*>4RG.+S*'&ILI5U,JKSZ?FMW+'S6=PLF@_T 5
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MA3*-YDI?) PT!6 4WPX3V:]:!RBQ=QL<?70"J 4"GA/!N-.TM225_;I]%>!
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M'O*6:_?7H#H%._L>FE[U$]K\R:=EK].6 [ARO'G[HV@I7^T=T@."7MA_LOB
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M*IBZ&J[%Q;0 "P"-C3S?6$F:;'L##7\$U4\K6 JDF8[.$#E-&=]Z6JU,2[Z
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M&'Q44=BGBOHC/2??]9;8!7JX-EAS?Q-PL#)*G7DA=-_FCAA_).="W"6 [Z)
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M;S%"Q$*>/@!/QB5D?3UVY>LQU,GO4(XT.V8]Z GXT[*6(NCXHYB/4S62"1(
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M1]MWF\\(,>ZTD)_-.XTK1U(W_2+A39#Z]Z\6[Q)>^92G"$+YF@MSF?ZZ>JM
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MI?D<#(=N$^T%\EK0B7KJPGNVW_=^:2*^9*\6' =LEQW:.9GTO< Z+M0Z+N_
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M7U!'0^,<0SW#'TPU:E&$[QMLHOQ&+;(JF6%+5O**=Y=0.C@L+R*]GJ0BZL+
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M3=LBCR"W%^?7JWSX=.G5N)F2X_L'ACU$/]W=\Y?P#H]739\% #'LO6K4F-'
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MNCSJN[<"$7-9?38BLAA_H09Z "3P!]L,N]#8(4]^8QM1V3XRF#>RG6X#S1R
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MGS60"W/,H-NH2[EM;%/^5^9E_V" *I*1#QZ_/J[KVTI>0]>']K7<PAO3H 5
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MS:OVFM".FA.5.#.2X)R=47QF^A;N-1$X&=P$)3R>:G+YM 1:L<0PZ>_;3<D
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M !EG>;F)XY^8#C+>$L:FQ#9XVOVLZ&)D$UQ\BCV/$17T&-;/.N65PWO!U=4
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M[DCB+"-,GR 4^>8]/6WZP@CK7L<GD/2B:[B3TQ/GQNUE<6'[[PW]'M; [M
MB!-]H@J^IKP()_%=-("Q$_04,[2$%K3+ZG-=:?1,.WG!!?)1CH0TK#]IXLZ[
M'6=KC(Q#[<I<V**RA.89D%)+7\!/E'%M&3$MDB+.Q9HAJB_$N;3N5*>%\\^%
M:UET*=CBH %.?&K>C'5X=@K'*5D:H$;(D5,&- !F<&MXZK(&,&?98F)P 49
MSCVC6I*_U0!+XEAKX8(LUGH^["BC"$BYQ*6N3TD+#\6237TLXC2 /I$?-I6#
M)L;+:=2+.;=(V9RVTP"Q>X)81Y_(283UA42#>%X<86 .S*829DRHVV$1_Z?F
M+QAZE&5(P!Y( UR8X=B,*R-60K_01.'=ZT^1]/!-9>O8?[OI47I-T>*O^A--
M_"9>Q29UZ"^.PKG07)V2&+SWZZY3O,%0Y;X^MV2:$+-$:"6C#7315+IXMH'+
M1N/O\!\P_%KFXFNY67_DSPI\'+L?K&Q\53,8?35YA_N:$[;1QS+_M(:JMS^!
MQ9,E$%6)EY/E1!_L)P]MH>=RH(C J69G)ADIBKF+==MZW5"F(=&J;4.CLYP:
M:FOEWF<^%C!G0E6*T$524W0#Q D3-SLRTD)?-28JG(FM8H[)C$E4J\7N\47J
M>PHZ8I<T:4I^UD3G^YBJBYL7AS,P,N(@11<1E:>AM_ES4ZWJC6-BQ?L)OBIH
M" U6ET[$-P8:!A]38E9UKVHWH2=Z2KELNFO'^G[1GC[2_15!WQ%&+U,E@\JP
M3'F @)Y6S>KBZ40B55!:BYBZ$%N+NA7(RU.C8"F?K7T@%HZ3L"]YTV4A_1FU
M,K;):.'^MN**BK&YIJ+*_.ME8U;Q:K2NOS#W4C6J@'F8895*'UV(V,$)B@[1
MY HH1QYZP6<^4B+CIK)6'D3MD5N05"@19S(/PO3#W=-DG1%)C?L;Y[J>Z>NU
M#KTG$C^][7,SVEH'U6<RPRM3O".6]JW(A*HQ&V?509%J#S9HI>1"-T3%3MW>
MH7(061L@I _,*@RQ?JF!*R6E8$XTV0;=D-,O, G#@;R8*N@JF+L(];M,S+*(
MT(9G9MG8&@24[4RC#1-,&"K^V;*:^!IP?NQ9O&S)PU?!FA[6RV9W*#2%',/-
M*+Q< P[G@]!V:EH^"ZB"R:T=^A2X?M))985U^ZQ!*N'JEJDS27\@R8GG>/,B
M F23!#DYRY2YB1M<N?XGR6!LU=A*@""1#E*4$%P_,96H6HUO_41U4>9D.KQ8
MV0)/93<NA;BM<_K"3AW4OHMTW-L.HK>1E]42S=H4&L!BU/-]^H/IIVQM)""D
M]Q1/*O&KN%FG,G_[YY"D99/*"V=!B@:((>10=1OM8)*"F.7MHK)GC!]&BN#P
MX1/UT%Z%5,#)+/3(K:'F4N>QUN-M18?EP-#9RGLDOO,*6Q%<@FX3-SJ6'(QK
M-N+LKNT%9:[0U1KWI(87(4%R3CU[8H.\<S!)!$)?(XF@/L)_QC/ %J)AR!7%
M%#N?:(*Y#:$V2#I4[P_K3]R"'5N:%W<QURAXZ1'V^)[,*CM'R))(,YAV]\OY
MP=2)N<S,EZ5FE]XL?MITM8*++G9ID1J"-)RS5K%*(?UA#9 Y31I(4GHA_JIS
MHW-I<2P'ZN+Q9G.D0K5UC*=5RS5"ZB>)"Q.I"Y%Q8;$+?((KDV:%"9\J[MV;
M# VM[RV[^OY@WRW/W)\3@.3-<#MF&*VR8EH@4:H(Q@<2WG;UL)6,&\JUR$GY
ME"U*0X*'V3E40BWI(F;-@X9*!58Q*3.YNHGB)]!LCG>X0JL,]7RUSNUN?"'5
MAN9)SXC>WW_"[B'(]EZ#TT<]XB?3 .DL:Z1)M6N$:(#I,LA"=W+5*=LE_4QK
MU2'4$'E?,F;KH'[D'0\[\:V8'N*YS1H@[0'3:YB:SB(BYT[BG"9=A/J7CTKT
M2F7AI(L)R$Z;HY3TB+5NGUQ*P<^J)7XR87B9M/K$4Y4[\PLH6#I1KP'F:0"\
M^Q5A'2P;9*J4N1>A51X"6_Q\G%ABJT4'F39B^K1_ZF";K7;WA'=DF809BZ14
MHM\U5_>YTB]UQQ84+[W\KK];)2@?I;")T-<\24APC()Z";54N2#Z\HR\,G_\
M%:MA*I]Z81>C?%B:68F""2H]9@12JB!)8F0?TC2 P85\S @*[A!E>,>JKT0F
MRP-K>,:,NO;#?1/+"_;6<O;T? #(=U^_W;[;/K<_\.W^4Z>^>3[R;&/#HZM+
M#P9&?Q,8O3PMC7+7.:>VT<1>KT^R>F R9]N[H>MF-;JWG(V6;-]@D57H4KVA
MZJNR\IO:V:O_Z3 \FZ[.SXLZ4S'F$:(,8W%HFR=G)GLK=&N+\NY03B8E)7B7
M1F6_Z7^S*:8PX)L*LQ."\R:L6'0!'KE\A"2O0&+D7"LDO)6LS3)A[E7G5>(*
M<5)?'M!&8DL-IC=3*5!H#LOC($I" O1XD!#3 %_#9=?*F#N@!TW#4\M\%163
M&D!F\"IQRGQ4:O@@D3:UY PE4<F=) S'Q\C!9^1<CDGCII/FW(L^RU$[I& X
MV7#L#/.G^!F.)</Q,/0AS_O1Y:C+SGY[ZI-^^#[;:$$>>@,95RY0W^&=(+W^
M.,R[Y*.#DB&<&KSD4\@*TH1(97V#M! 9;(U8VEB/?,*[]2-$7T'.DAI[^Y72
MZJ\$EVF 5A)>D!FV/CTS@QV^ED%LZJL/C<Y.(&U'G4!GKAVAJ+8P%R*?9,$T
MH0;0]EG/=$'Z9&0";6[VP@S;%%T'BS,:S]P<?>,$O91.\DRD<=C2WD0OZV#:
MSH_.;Y\\+(Y^?%GRX26TK;\^I"?HTQ/H&F9D"I$4]1,;N%@?S^@$BX!D*BSQ
MZHA)UL=Y"]< 1]HU@.3:L"B],1:2= I^RRTY1C1C)LN?3EKSJ<:3W)! 7$]'
M>/:XVJP:>%>7@5EO?U!94C# .T(?N"8$M7$;0D;6D+,?,,UE/'W417T3/$9,
M9Y$1IVC9=713;/D8RQJ:FDB&7&24+'HI].[\2HKQ(9Z ,@\I[*?%[_BM^^/>
M/\%ZXX1!*C_1XV.DC(+8>Z!FQ /J2Z>F!J;VJG_ %C(MX,YG4XB#XZ2;RN$U
M4M_"LVHV'^M0'4"_59?C&FXA_.Y*^=B?L?F%\>*,FJETF.D&K^(I@A/DM@_F
M<!_21C+[O7V8UD3S??(8U@%8JF"<&HP0NHPK$;51#::G!MYT#XH\,R?;;K):
M&Z8$X\&TUKD3Y7*C7\%(K\[!A)VPL/ITL7E.R--7-4/KGS,W9_(;BNN_K'T*
M(CNB^E=49=44SI%EY:@90<GH9]FPVJUFA9TY1"URC ;(!FL+4AM=Y/0,GA[J
MIPI B?")"GEPN,"]_\4;6R1!/K4 26%N@D\;Q>_X(-WV$":GF&#I<I,=[WX3
M!Q2?NS$>?@;T:-RNTL%Z<+=9CENZNF+CKK?0@ELXAH@N7ES.X=V-,;*+'XX@
M&V)Q4OBA#T_I*/J59.^8SJ[+:I;;4(NL2R8^3Z-_(Q($Q:@O5#+)[K4$Q+YS
M4GH;>VD%3JB)$T\ACOS=T\]A:?F"%\E[G2D S;UC85#65(!Z3<FI$P,5Z#9<
MNPT*+4)"0\(>-"DX>F\.H5NZL?5(")AJE3Y[\01&0FR[I7L?55<5!,'[+^K/
M!/)JQ1/W-8#EJ<[S&[ NO*$Y(']4QF'V$)8'L4C9S?,+Y-%8T_"D3T\(O#,S
M?OCB3!F\K%"84DJ5C(4]N([K[N,31RWW^+Z]?[E8!R9CAI&JM8QP&6'2%(Z2
MD=LXZ9R:B^IK1[IKR1*G%JINLQ-";'NS 0D?OD<W?SU*-67NE6^V\^]U.W=C
MC0^1$4):PFB(7ZDT<N'^.IQ+Y[N'I3]X>-6:_D**G!9- CQ;;W\X!C./27W7
M]T$###=*"6"\$<DFB(O,9S2_5P9#XHG<FZ@##[:7-$:[Y3W!PS&VF66!T-\-
MC@GB&IKO19>4EI4XM(F>V2Y6_\"C45]W*G$%FYK7 ML-;R7K:8"CX9V((U5$
M&;@ALVSE+F$>19Q5NVEG12)Z3K-C+],.BI+-3G!@>JO4&%VJ\HTE/L*JSB@"
M:\X1<:2)'TH4%DB:?,HDX,[HHD.C29*\5_K*:/I)W=\7_CX89*:<-;WSBF*<
MY>K2LC9K1>'2J*.7 \NRKAZXLVTMC%/Z_(I[+S CQ&,OD@1ERNCGW2JWSQ1%
M/=, "Y@FPWA7OB(YZ!9,:<7,NT_9^.V^&N#P]MQ@A\^Y_"M9,1OS[:]=&_T1
MV.UO]K\=^TT\=O2XTO9&WXGM]SQ\O:&7E%M6%!,?=9R>2%,5A>YK=%=>\3-H
MP.EJL&,;-EQ>="8Y,>',]W_^WKF.R_K[EY:U&26EL84"4\F8)#&C/-Y$>:.B
MC7[WX&!$BT5)B70PKB$8_6[(?UWLN=*QTZ<++Q>=_F7].GIE_)3SD>QW\TN#
MIG=I^9O]OQV!0X17&F!MV+815N:G7?KO H2J]N>8$Z/#KK$QUP)[OC;@3*+5
M:D^?PL!]V_/,%FU?L>_(U;-7:;\U2T$-0)[%=1;QC 80C??X; )_/0"7J\$!
M</1&,'?U32.0SM, ')4&0 F-&D QG=R,FSEP2@- /A\U +MOQVIMZ2 ^?8]]
MUA\Z4V1$3?SK+3-[LH%Z)3[]I 'P$\]4G1B96DJN1J\&006M['57=TRXY7:N
M8SO5N4U^;=)IYU(' -&7 > ;P.GC>M[78$SG)WO6XCD:>0[L6ZTS,')_,D(#
MJ$@[>FO)3IU89\\4O;$(HQ8IO6)/>'-=:!,?O2MO*-V'!NOJO@#U[/#](+.\
M[(%WP-C(9E<FV#KHESMFO127:$R72XHOEXZG;"'RS$*'*2@97W]7K0=F4X.C
M 0/^8;Z%V-S[KUZU!]=.NDT;MR\#H8[CS4>J CA(>.#)=X%7WA.A\\:30S\?
MB5GR_.46_:D\\V4;SU0%K'+_=*5$L4DX'2K\SB7W=2=SWU_WPAX/OVGR;_E7
M&HBWL'U:GT!<T>X0Y9+',;RQ?BV)/^-_EB<B?7*R==4 7!5)[1);^\??;PX=
M94_@F;!GMX+!>+>@S)6R8O[[,>"L1P[X-@1V5)]WXZK=#X=",?IS%\GC%\AS
M:YQ4+V ZFOW&7@,\U*O5 &7MOV#&N$;?K:_^+E,#^#L 0?]9F'LE>%EUU*N9
M@^#HUOVZ%%S2$]VE,Q_C-4"IZ2[]V2K\;;9U&F"FE:!>;'/PEWX0'J=K@$/+
M\?!MZ"O\RP?1-=:WYHA_!/U'K0,H#_E# SA$"3DS&B :7T6\>^/M)JJB ,UC
M6X%B=0%VO4;RY^-7[?:[]?9O;%_F^[-LX?.QE-^5_LY/.J/G#<O/+_5GK4.<
M,,,BV!"/F[JYV8WQ=!A,M50>4?\PS<VN&O4L3_<AC19PEDQXGX-R! T%J<XL
M:_1;:$%)67B[+#E!X<,MZ^ B>U3;#N]IEV$_'J^1+EY?X<Z-9.!JAX4GH]8C
MA[7J&+5FYQ65+V+=(IV/.;-^\]F8R0>M7"F9;UQZFU<P##<O/H"09=S+;ZQ@
M>KJW?^7(&VOQ^LKUC3KR[<ZU02:A077Y8D$$L:^DMH%#*>Z3 :IOL]%0R ,U
M3Q*&O9]X L<H*V!B"R>UO#6D(>G9#?9YC(B<4>U%_(2>:EP.:(!8HN5K)$#&
M;25+3DN"W;O'E2"262JA88N0%$6E[X0;W3"V>7Z_&^/4KQ\:_63Q.[MX@>1H
M3C;FB?1!"0&P!A $$V3KKW"EM&:G[EN]S=IH9#?+BVD)-V?=I"59A; _?Z,5
MQ*^W#L_U:\76IAHXI@7"YAE%\DIM9?_L3O&ZR+S(W[6F_5D_89V</P-1Q^E^
M<%H#_!+Z+O$?#^W2+V'48_[T1>!KG3 -T!/=!^I]!]Y-PQ[[:8#;5WF-G18:
MX'FEG*(":-2YXPW<X9>$F86@>#XXO6?7O)K=/94KEB=^*=+W_F:FY>4&$7GG
M,:UC)79+GXNX])?7OE=X91#\KJ0AK[1[E3SX<QE2W:5SN\U]_U*H^[34$P?Q
M>25/_1TN7+>*0N)J.>C900T@GD^>_CKQZ'G#U;?_/O[&NGNZ_[8ISY-)V%\Y
M=.V>6Z^>%Q^)?/7KDOB,0+XVG G\N''YZF7:N^J&%WR1'/H/!9L-8&>9^+KF
M-:KOD(^!E\&ZLGHX9Q]B,AQ$S"9K822F&30EY.).$29F-/JK_/S@G2)^&+ME
M7 -<T@"$4^TV7JV0'V0XU7+6#//HC2<U^LGIY@RY6V.WFT7/@_7%E'H?;:R#
M5ZN7D@#7"\$EZ\@Q3^F6F(2S='**%T=:@%@+-,#"V@YKV=0SMC&K_32O^GVZ
MJS3-UKYWVME0T<9;Q$V,7] ID/!0!\G.7%F15P#L7EDF"4ZL&%'6>Y#+]^W2
M_U@@HR)VG<(*3!OU1\+E,^H?F<X/&%'*L^KKS5KH\K1G8>3L]:@./'Y G<<[
M1I.RSUH*V1+VML>0,.=D)!?=5W6L>2F#Z]^S$A:6E\063F7/E(MG&,2=W:7J
M&/5%'RW&X+ EOS/[).K7W6R)!+2!5N Q/ +$FFVW(/[PM;'%Z')D,['- "7;
ME/,IF;,-^3FRBAEGE^WUD'S<L^X>(8.Y*?(N@T/M?]<S?>[<[F5B\M&N+;K_
MMRM4WP@^Z+-\.R22FX&&FY!BS 0V1'V  TL).;SJ<L_5=5A?:'<ZW&#HVM]G
M.BWH#2X9,^P/^I)<R%O 6HYDMF&FR&(H@$]=AKN@9+O]2 K\5*Z?CJT8PUQJ
MNER);*I!_&=9)P#-UC&U<$?N\#+%K;GRSOC<'V5Y7 FCV<O9-]%Y07P,/VQG
MV=P^+V?>;F:TS,9(]&8Q3$SUIN@.B3(;0^\<'CG[(HQU*_'.F)YP1KNQ\/2]
M(_";V,+<ZOM)^.'C<IK7Z^6/=V$'MWUB;U?G,A='#WN!)A'H%N1I@N(B&DE7
MU"/B6$4D#0XAFQYD1.V!=-E*5L/<5DEB<:X^OS($5_WE6S'!U8Z)6I. 77:J
MB+?4K5HO!IA;$!E,5RZ$B&P6,0S)_JB($1 !U/WJN4Z##IG4>/S5T!#CZ=9N
M)BAOLE(("/H9-6MN\.M\5O9/QC0*.9'*UV67I<\#AZD%S0YH)'(C$BIYUD"]
MX'U&1>'F,->1::M]EH_42:3GO7?#(G\D"SIV+"90[&.'W-@&W69X"3C54GYR
MZ%['M@0&;6<=#W;/XC*^M2%O%Y^0-3VJ5>OTDH^R,V>+%]GJ5?5A*Q@)K76V
MQDC4L'3^"+8,;BXI#T=]Z!<\:^:DJ8W48<Y&ZY(RQIC-5T%'Q4S?LVZNL%L=
M)SJZ\L#O@_:_>JRXQQ)*C1.I1B,^MA0S-+RK-M@)L_CZ['MV#9'HPX'UY>8%
M0MJ(&REGCBZP2:[)R8D_W2YWF"DM$MZODT1<][FJ/!W%=QEI/YZ]Q><GZ&6)
MFBOCF,3AQCHLHB:1;H* ^^)C_!:X!D?/.%L)E<'4K8NT5HY([KV49%Q]E)[G
M.GXC.B]DR[-3(?\K"QZ)M=IYX^:H9TAZR4'?LA&);4'92.&VHN.E\35JQX"J
M^IY3[4:)1X\>6'??.7[REO&+-X>"FJX_$D6(,9]XWO@[G!]WK+Q)F/JV$]N,
M/W/\ G%NE6?U?MR0*?JEV&-??'=$W7/]_TKF/Y4,E<.K$:/F?I@!K%K&],^4
M$2<WJ4*83H@+O'*<'T:]M!S*O,2=R8F/H)K00CWS\O/NWS_MZ8R2HYH:NMU6
M1T9]^4/3SRTEN\P>ZFO]M\ Q/7!O:?3YH]U=,;:247*PFW=">G[V;+)ZZ.<Z
ML2F5T=;M'[RVU9+OF'9]^_:HJ^YK7SR]4E=MO/@]""$\Q$&D)I*>\5!CF*,!
M-M1HS>WV9^&0^7+<J!80IYD\;=P!N A!5(C;;$(.KK(/@5U_HD:XON_$Q?5'
MZRW$4K/0=SS4AX09G-0  >T0";<'WGB47L03__D;J&7DZO?H5;*!VHVC)H_E
MH3W@/WF?>(BJ]]DMDZ% D@GS2^A#SCU,R@,J$XTV5*AOZ_>B>]A$SOTXRPUZ
MVYEKEIVOV2A$;\[[8OD/OLN)=<W.&N!*N("C!/IYTP.)U):?B6-X@AXLU  C
M=[BC7@(J1*4@=I7*E,J!%ERSZR! S--N-Z]COGW,G0G.;9<@X09B>M'+P[V1
MIC]-[S_ZC"SZG5S/F3CQL+52Y8]Z&S\4W">@]I^,J^[BCVWSZ%WH#R0G^3.O
M: "3494UV-6&>FN =ASP]0:RK(D<19_[DI?)^92 1\QC"S&\BVH/\L_BS#!]
M$B20_WRO =Z=8"-TRNM![#))]AX[A'NJCE?Z_3.;N2A>B.*.>NQ'?RK^JG^\
MJ;1>W<2+VEJL1Y>XR%[O+];[%I0Y/MM?[/XM*+\Q8K8H.1T [^3^1=/P5F-6
M8,L)/+0_4LW0^&%J.H= /D%-P9SQ)F,D>&,-D5(;27?&6"N2*8+B=;!/2<PM
M!NC7$_48^J.1GGPO3IQ?YY[E^K"$XDVS$QK8S22@V+Z_VO4S\<XQ\1_#6YR&
MUX^NR-[V[%>=A))EQC\;#Q^!.P[</K]: QR-Q2.AP(OD/+Z5T#CV1(<7QCR.
MIWZ15 /D[A];K<U6'BW2 #[N(&* ;R_A7>Q%#^^]L%,#:.&Y1?J8;C!!689,
M1JEVQ4FKQ2W<@<YG&F#1*;H>PVY8G(NM0'UA[J1-#)0_OJT:X<O966=MB@HR
MO!>P%B'**:&EI^T-B!_:]Z (9P."*/GDN<@[X1>EG4WL:UW@\*U^SYE);LHT
M/=5V,TP0D8W'-$#-9IZ(D-)LT7MJDB[D&=20!@:#B\\-G;9S*"N*5^@A_%\8
M:<.3!1/JLM9"8\[B:=ZE,&+6K8;N&K81HV]Z%Z&+^%>,N]77R\'.7 ZF':X!
MX%]0(8BL)K;]=+NWV:9^(NO^$*M70A58<PU_9\[OQC8QO9I?W8&:.5!2 /+'
M7<9+PB7GTK 1K<E&1[F)/E^_=9:UK*:W4U )^G:_>4?*G*NM%TC4)@@5)O U
M@*6/%>J#W).1ZL%69YC4XF,.SV;@IL79/[_,E;AD),1V97?H[D>+7JR;F?>P
M]YN@<8KG7MKIZBU'$FSE6OW@T5CIOZ<J_W.J"E0>%-SU.U%0W7J<\/>?S@9*
MU3<B\52%<!"CSZFJX V<I:/(07#8 ;_"ZM[T+EW"1),'QES'@Q8-_@UZ09D&
MZ$POP+&#\"^-.\E?D#?JSW#;Z2:L(7(--YNY >;('^2HEAX+FVJ1IC=DBL8/
MZXVW\FI>7I<3<HFFR]4<; VC1":LMV!#AUD+#OJ7CV.K,EM\5O4S762?6,NE
MOR:>L<V2#=!#/A[T.+V<6 [^94DE*E(PCL&(A,ZK^XSAT\=*7*D$^%B3^!R)
MHR*4S]-%GBI(+>P4(L%[C=S&#B^!R +!]\Q()$U.USJ$[GV,T*#9@+J>G]9%
MF$-ZY9 J%&8+3,"]W>@*&9Y/JZ$1"3H7+T[QCEU5P)6#@S='B%;.J'XL1!=X
M=K9V$F@\P-L 3E <B=@ U165,3<CUU24H=$P>BO!>+39J/>"[0I8F+>^5,[1
M&F0,"B3)+_,(&7:X0<LH[Y[N-,NA6 ;(OB,\U0"/IJ6?H$<X&P?1,;< 9<0-
M/!$65,0 ;U?"7Z!-P'1G5.^Y94>.G/+N?J7K__#1MM"@H/W1*_+R);K1WWP_
M/W+)\K3GRU,)R_L:_OG_60@9;J37=!GQ,GB<O835Q[-LMD"7($658>AF=1'J
M 5'"X<SSTZ 9TQ>AR,&TXG5(C[PC)@+J;^+&6E)D[$D;BES_0JV-U7M^$B1=
M52$;S&EOF5<W=Z3233PQ!7OA[(NKZ'@>FS/_ 6O1 +I/?=/'!"5"G-9[4Q:C
M8<^J:I$T**&5;'&JTV0(/?RTZU1_WPRHZRLGVAZ;W2 Y5BT=RRD)&[?XH?1^
M]:">*B,;0 \A22IK3/+&$*+SIY;&<E7KD"3E#82FH&3--;W/3B3;HO%(M:SS
M<J:">[Z&8H+N0HK@A#;/3#XGXXUS#VNUKYQGA) %/DN[&EUN#C%L12T1IE6X
M=>^%B&E2_I\(:29H.)-O1$X%]9H7HS8],YL2GY+201/4%/HP&/:X)J/U?5A.
M2[-5#]/;+>>&4])5HZ"B_37*WA/.-Z_(4FG75V8-F1Z8R_T[85XXPEH+KB1,
M<S/ (V0\VHX3OV'KX3^9SL@&NNHK1"6WG-21DZW1$Q#U_'0N2?2&!(G:I!)]
M(<_2-5E?\,;C6N C.*)>:4((@2Y?OQ\>9UE@0;K'.*%S+.9154\9,:%K"RZO
M7=3L1&XF]2%=0!]P#&Z"5EWG(OQ67JU[3EF<K6T/W94W[_48F<B,QX-1N'^R
M([VNB';VR@#G8CY)OJWN8>P#-Z/D'33_)P2=]K=42[Q_<(KMD7NJ8%S(7&?Y
M+&!G-MO0!T14N.Q!%S/D(7+KI)PP4" DP#JM5MZV%EV-H3%0@-R\N51^;_,R
M1I(\5, U/(0&(&XR%=?V6+/^M=WT)<=FWQBJPV^?7VBL54Q)Z'%\(OKRU\GB
M-<=N_]6(_PN#K!GX-U!+ P04    " "%4 U1X"ITH-XH  !)+P  '0   &-H
M87)T+3<X-69C,C4P8C0R,C4Q.#)A,#DN:G!G[7II5%-9F^Y!YLD (B@(47%6
M2"E3R70*$=&BJ#B"@! 592Q,64PI#3D(2D"$E%I*"05Q E2&B$P60P($DK(4
M(X,@H213*3+)B4(XDI/D'KM[]7>__KKO[=7=]]\-:V?!SL[>^WF'YWW>L]"\
MTH@!LZ]W[=D%:&D!@!;V VA& #_LK__>Z_,F_]T]M#3M@+D!  ._:VNM!A:9
M:VF;:VFZ #QV3]U_7@#\RTMKD;:.KIZ^@:&1,;:@P0Q8I*6MO4A'6U=71P?[
M-!W['- QU[58M=57;\F^8_JK3UMN.W?YEH'#CMJ.I?M[X37.QW_(-#2RLEZV
MW&;MNO4;-FYR<75S_W*[A]]._UT!N_=\?>#@H>"0PZ%A42=.1L?$QL4G):>D
MIE%^/)-U_D(V/2?WXI6K/U^[7OC+C:+;=^Z6E5?<N__@45U]0V/3X]^:.[E=
MW3S^[T_^Z.L?>#DX]&I8*)'*_GKS=NS=^(3\P\?9.<4\\FGA,RXM0/M?H?^[
MN,PQ7(MT=+1U]#_CTEJ4]GF!N8[NJJUZ%K[[](^=7K)ZVSD#RQV7;]5V&#HX
M[X>7'O^AU\AJC8MDK?PSM']"]I\#EOE?0O:OP/Z&2PB8:&MASM,V!T! K=YP
M^R+P7QGHD.HQYQ3Y$EA'X.&&SXKQ[?AA_$%5M7J+NK\YAI\/[8)[&'P<@)HT
MP2*Z&AC7 (M="9;QUA[S74'K-,#.@?>$1+7#X>KL4H++$Z^1Y0>?;.IIQOVJ
M-M  '<G@2?)%^RW(QG+4[^INU8U6<WFAXO@@>WL8HE1D(W?$./K@&?TNCI&Z
M7\B?JI RAZ5O!0=:,KFA\M)".8YKO^EQXU RV8Q8$7]F%]UUUN:[8/+:-TTQ
M&D 7VSZ3%B]J')K.4@+(U:Y4VI=TL7X':$@;WDJ-D..Y^ (: 5DB>^T0B11+
ML,5ND(E+CSL)2922C:C^ [,D\]=(0'<P>W7M"]>=_=='!_N5Z=\XA]Y'N(J'
MV/(=$X4^:Y'78M9P@N(,DE"!&O:#XFRP/FUJN](]UKIY)CN"NEWI1_T**;F/
MU'6>6?N3O$=QBQ57&-9ES1QI%G0G1NT5.;5X=ZL;I/HOWY2^R0"3R!H@@3"<
M%8B,E]&>>11.F\+!7$7>X.PQJ2E>?'*L2Z0_@H8.S$;WOQET&-A"U5Y7PU[S
M.#/=?G0LM.G#[,>USQEQ:0]& IQ*$KV?T4ZF8%98@=T4&J:D'92GB*8;E!M&
M*"&[<*H[TCUL$"4P=C1= 7$4<O>5\/Q#K=]LB6XAFE+XG46RX1&!JW"\=$VO
MD]#<OB+V)!H@YT^MQ;;3E3>AEN'B@*Z>*$G*940?]E.4JZZPOXCS60OS&5 T
MPY@"'D;.BJ'A'P3BL8(YLAT2QF__B=8K6JH!8CDZB&R_W!(/7Z?T2^_#>DSX
M!U$ /,,EF$S:7"DK:4878[<-1&-AJ)V(K,%Q(6O4"(E;.S-U1[F9]CK24G73
MY6QUC&2TLN(=<P7-"UT.:X"LUB7WOZHMSG?G%96VU>#-7\7;;^K_]FZ1=\.S
M)NOYI[I=26:XT03<2)+BRY=44)[6742:/J3TF(BT0K3UKJ7(.5U%$ ^B%S;K
M=P9&I/82Z@.9.44]K)R3_:T.Y*IP=O)O<\7%AQL,]X>'[RIZO_'H-R4'%)]4
M.2[@^4@#!,N"(69=<#[L)PUN9-O ^MUM(;(8;ING9.@2==<I)\?H%]3MTDF!
MF=_M"6'/SXJTWHDS)\O^+"S:TS^G_< ONM$]"/?Q=066",X:X!24A=>:K0;%
MK'9.=J[L*1Y9,X1:,!3?R<$+5:<T0/2D,A^2-4V]40901J2XZ0#]"UO8FV/9
MFQ#G-'GAUW!:#C^'9HD>1RHD3#/*4O8:MT*I;BMGH#ZGK%%*LX$ZMD-D<D81
MR"5?/%,X=4A,&C'N"M/OT@#(IF^OLF@"R-8'I.J]=&KPUE;,OJ3I(_WM>!MJ
ME*QXQ@!)DQ1>=/J.))G/42^GO4BUMX=9YU'?I-L4>E@+DB1^?<#OLHOJB/;"
MQ0%.W,PP-P#I$&N X?E@9 Y.^@:9E.MS!5+1(NH*#G)-/$G*'=T*=W:G?.^J
M 4PHJQ./>?G7Q&T+CULH>=GVON38:=V7Y=<J(\+J!Q<BT$9UDMQ=\5YUU<<*
M-9?CIG4KT13DI!1'#R-TXO.8*UPJ.7J4CQWLU1SY#%<#G.L+.TS=/<!>$<YE
M=23(UL/S.7-!QAV%S.%"7E\_C[8&'LMFS6R9<XS^8R.D0T0M^(J;1&1CR'FU
M(](B;E!4PR%=G"4:X"B)$5A)7:2Z[V.+KE+]J@%B!$MHOXMTO;3%WB'M114=
M+&OJ4GD GYPC)%_P"H>5>XF90CQW.J&C=+&<S&7EA*AMY&_+Q,9Y$:DSH1^8
M62+X&P*R <M& ^I6Y3;J'E4I55M",J0)1 _34"MMQ6Z8V#7)R,?CJ/ONH#'R
MIND\&98M C$C/]'+O#S ITX,Z1SA2I2NZ[MN$RUCV2O[4^+F>HS]ZFOA][=8
M &V!:HOESB6J-<**DJ^7NJK;8$X[OHYQ#HQA#@\I+C8@<BDHU!=/CUX&+[ ]
M7U&_:N'0>6J;/J^ E'OHYH>PW5#FDET:X'Q=]WPO$L,_\_IM0SFR;6%!UM&\
MP!]GK\1V/T?CVEO"N$[F1=HZ%4:!T4':$@[?<[+$62PJF&,6@(M=1 8HD5W;
M7, _T B[YSBA?E8WI-M=$G?$)JO2E&[2E!<IAK=K!VUX$SMS.4QW;,]XM;#Y
ML^-R(IV)PRU<'YO!*K8=U&&"1MQ4/UW@=(/G_78@;5("LMZ]FY1'<T8^*3V1
MO"X;RP41=]I&T-UH\_[" R2!-/@=J?T,/]?5<9WCM\=TF3E.6Y+ 4Z1766JC
M$.5>=$D]',*%7K'$8U,RB2 ?KX]EV_1F'MX0<RQVMN@1/1.-@^>E9!['^EV8
M@'L#C&5<*G5!3LI&6$LISM*"_+N1DR)[U$ZY;L)G.9.O :Q/PE*D6.I(SW;A
MRWV*M%0XJK6JQH6<Q['@)!+H8QW"0OHJ53Z-$ L:-52G*8-<);(+@S0MU 61
MK\])KE[-_::IM:^O/PC)L\\L\@NL/"**B LZ2_[!2KUY,W09.BI -@JZ6"/.
M(3 QA^JO7$89P2X_+>=*"+DT5RQ9ZU-+Y#$=6(*:UB#AW# &_1:S$[33 ))%
M?>)^#!;^4E@!71I(M!@'<5X!4H)%67?C59F=1>(9W!**YY$^\11TG#/<)&-U
M@EA4=NSPVB=M,<;1Y\%ZL!O*8KLB_M5[[E'.\GX([98P7B4H4A'"_?@%7M[=
MB:OMCY $*93A%1"S[G)ZVJ+)5.&.T5"BT^7[PR0!\AO,41NF*!,0;I?(=E;E
MKCB$'-( .A_D^MV,5YX*KJH$C!?DD@S8/N,+0U.3RN_5O:3EZA7#%&L)CL=9
M1.N!%K_W;^JH=N_T<2*;H0=>M@96(8$=D3[]TU[$-+%Q0L0/R_#[?M5>V-X/
MDO&OBL,0;ZD&$"[9I:H!HWO"Q2$9KN->CC+&)8\8GH >H@%,O=9*#S;7UY%P
M2![O.GM5H6]?2F5Q?D!0 3^PM>WB_%Z;\AMKS[MOC;<B;Z,T*695.:WZXA%\
M3JFSBL6))ALCN$-7N[\?]W$>HFVGNO53"94"<0292[.5W[79]=MIJ4M_0SC#
M<%+]!5R>)_W293+O1G+B@:XBN_P%W]/WA^]RGL3D0%&L7%(M<VI<3!2>55Q!
MXO0[6,NHKJI&#2!F>LP)N(P1!\5+!)3C)*1IPT2E%_H%\AIN\H5;2T$D2.F#
M,2QSBB_N,5)*IX2,#@$>C6._G)X9DLR<=T"8('?R*<$DKC"R0HFG==- U4,?
M XHM9I3S;#/42@YRST9C9?+2+-[87T(R1P+#$-^[B$CQ&!&)T[7%+DSME CR
MGA>KL85V\7A=ZLX77G9R@A\\>NTV5XRL'!C+VU4[]%WB,NV%PH>J!C!*%=))
M6N9UMDP]P*P;K1 SAQ7O/7$%D4[][*U4D T/=6X>%A></4O,67A3PW&[(3'.
MN_:3?Z)50U+L4$B<:_[#(H5AM:Q;'C ]HS1#UDO&SK,=*5Q%JZJ(NA7F\]G+
MF+Q2?;FZ3=XB>5XHP2U#OAZ*[&UU3),2C1/F::OROI7KY<5(R>:QD?9M R[W
MWXOK!N?2P<#F6/*I_3;JT]0D+-C.JUBW$>O[2))DANN]N7-!D*T!3HJ0555;
M$6=)89?H H1+$>5"F"0Y2K9&3\BMITW%.!R%N[\?JTBZE"1^:J L73L4.2TG
M2,%L+U^Q:0(O;-<%3 "-N$PF5%:[]ZOML9S90',7W*4N:Y%;3\V?CCN9J%R/
M34;,:@ KBK-LB$_*T@#U[OE>JY2^M!%[-R2B&C'R#N39XV$PH]58U21?9*?-
M8Z^2QR$)DNU4?7@^6!Z06_\E-:)F>"+_07P&OA7$0:?(PP)IX72,G*QP@D,8
MR=XQLK0.YGF.$<V94N%?+]>_\/X.&X:ZN97$.X&2EG#'U,DC@R=A!4/_?*NO
M;//=7G%?LJ.UE-69UW'O-2%_=@+]  M0*Y 70L+74.UDT*M"OH^YZA<G4'PS
M<A-&R*<H9 6KC^U&W29/J;FCW#$.FJ6PLNV719P5_QH<1NC"%*)?]^BVONGZ
M7] =5Q/<FEV$9<41#5T[]ZPE(.M$4V2Y4A&I*J^?L4"#$)SD::(V#P]_C8F,
M]:3V&7-J?"]6+04'V' ,GS$,<B/=X+1N_(4P-C/Q"^2<5%MF3%Y.2=C?WWKZ
MUMJQ3/(L*_M,2G;UO9Z41,G9B.W@\1ED#9$K,L8TP)QRKWH *Y<!-2@)0C9P
MID.4W] $PN#[<A$?DT1^$N9BI%\:D..*.P]:S4+GA,1+D(3XCFEY L[FG-TX
MV  9'*$,[1AP.M'\^''CH$.VU S7&Q2@-K)3ZL?YF,@971$!BJ>JPFHO;7C^
M$'P]2\:P"93W2SCH:K;E$/KCR;3[%(+O4,,;N6%_\G1:MP>-"4&W8H>LC>]/
M! >'I*4.LLB)7I?1<\I]4$>$V@XU5]VAK:#UB(QF\><AV]8@&32,EP5,7_NQ
M9D+40.^8R6S6 8W9*RCN!^0!YX["D?=E:[$>Q#X>6LIYU. 8]ERIC.%B$I/5
MV6/<+5J68D?>"Q>>=Q74T5*H3I_]1GO)K N9JL;"OTR^CJYTI-C*!-W@JTJI
M]31)2F: C[Q "_42)!+,#2N<7I\H#_1[X;/^'<D,C6J1?-LFF[DP+O7V4/>K
M+9Z^&B,;4UJZA:F,RO#)U-3!IA7$<QA3%9 :K#/9BR,I 0>1!+BBJ]29C*S6
M1RVM%8=>G)IE65""JKR6*+]6#Y!LL<XC%S2BZ5("0^6Z;>6UB6)R=B0@?UX+
MYWV%9-3&C5KWH82[1P[SDE6;0]VV9=#FU,\@>"_N'-1@W<VZQ &HME5QC1P;
M,(9E@MH,JITH;B*>O:'\H$W$6+<&H M#&,%#G<*F"PVJ/6C$;<KVADJ<(<+H
M5BPD9I\?W9+65__I5*1;O/(Z9RDD+A8]"N%A:K184:%ZT.HGQXL+Z;,$/?0$
M0E N?HTDR*QRI4RZ\-=^Y*EX9JI'3,C4 )9JJXD%IQN;D+>;E40;)/R _ =*
M]N%37G:LT"/#HV&DIU4]7G'*0U_I6N[[AV%R96>NS9[E^\P#/6N-[F5=3XM>
MN6EUYO,NR:% >UW:<:H1YJU?44^$FR;!+4'H.^"T#LZY4F]$2TH6.G#Q5NIU
MZ!GDD$3Y"5T,Q2U7ZU#7#S2 %Q9*;Y4C(WO@,1X.]R>%)'7".H1?PCN:7467
M7 C9:<T-HOSUA_]2+4:R)$J.%<6:1[-ZV!QH.V-!.=!U1O?:U(7.T->388Z*
MPH3DMZXQAF3O/W^H]8\V.I^QNQNR^0!U^'#B\2/&"CQ"2(*3).PLJ?%NS.=T
MT2+HJ&G"-W)"/G6M)&^2+ Q1T%2-/J:1U"@DCC4>-OW7@7$8@8*0[7(+.^*^
M@7W)O)?)][T\'4J"WZP\BIN42<!I+=A/-G;!E66+&F#R0" CGF_U9DV.6@QZ
M!<!U_$A,*&=54%A<SUU-DLII$M>CH.)87-7XZ,G60K<ESYK,1R*&1PV$@^]'
MXR!O'YW/%.NCH^YEUN)S.?&871B=03$R7"84C4?B"':T)YB":>ITM.:)%CNR
MO$"H)C9R.5(F2Z=]W W/=TXZ'A;Z);@78/7KG3W^1=^'S3VG/#< H=Z>BEVJ
M&UXQ,$&!L7;F5>3!6$>D+0QQ,<VL.(>$R+#)QLCE3.[U(EJ%A+-8S1=I^U@B
MUQ=(BV,7K8&[GZ([86)N=73C0%4UP15<K_R>[]V NA^ /$D&H/@JV-2KNNI(
MTT$8BCV(/^S' [4QXS*@QK&ITQ64E@[2<MJRA"NT0:8M)^&)VFZ2MK2O(;7/
MT6628S+.-"6@2ZL2(K?+<5T1$;.5S-S1+:W-\*&W=9(GI]"=7X&40K71M=M,
MACG5F)SE\<L 7C$ <Z:B1U<1\>\>C5=6(5<5>H6*<7M/?\8.MX^Q@T7) 9(G
MM8S]6R..?"'_V4,X?B(N8-0+D\2ZVJJ2MTB TA%1RF:Z&1G,.D:^!H@7&5&B
MPI$4^&DW5 ]U:( E8 [55VKKN;$,YG,%*][9KV1T<JQD#]D#W[G<HP:)0\GU
M=F$?-, W><3'/S9X&L2@[0V8^:CJ@=.T@>ND):(.CPTP%80/X.BB^I\+93SU
M4F?&>:$^:LXC#VL?&-(K=<4U-DR!=G94ER(SNO)X^I<:H#-PZ:T76AQ6%NJ'
M,5REJMG+4^E&L19/,Z>NPDDR5B[; XL,6[8N]N[:&B'%+T>/(@EWFJ8\Y3&2
MP3JYQTP7WE)V-;2OX3>O!/C#!]+%,&+7(I'>^Q2FK4"^6;*>?H<1Y.9^YMNV
MNP#T[<+8]':E':5.NHGVS'X5,H/U'%>E%7DS*%&R%;8.07+AC^'RIAQ7HN'A
MT FU(_P,DYGD%,^VD+T#+MY."L'^P>3P:OO O/"-^]\GD#?:R6 F)LT[ L 3
M(!W2\?%&?1&\?#/6(O-[UBL\Z7Z%,DP#9C"7^. GU:L1;U@9)/=AWD;F(U^V
MNDLJ>W;&PJ@[?,G>21ZBT&D\0PWKA=WJ)(D>"D%POOKIIVNWH8YM4&RB@W1*
M9/:>9D\Y$"'7K4"M"1+"=(IUMVD@"3:0C[8I-R%XA0O,Z4@/YRT4L"SIH1$!
M>Y%S,=*-IVBV#<_.=*230U\ZNM0EWGN2DH+5%@UP@B <4CBK?L%BM>Q[ZF[$
M'-?!&;[^46TX).]71&.!7,G#+V<;TP;"1FOE(]*9W#F\ ;H,25>N1\/A)BZH
M1WL1%C#%J8JD]#G:\R4QTW9G[R'=[)5("W??N,?.0H\(15FRENI&^)^^:3HA
M;GW=IQ-/VP3IP+]?]?.RN'=E^>WK;K%_78R]L3:W]V+KJ2I#G8,OWT*ZJ.U]
MC#W]X*9VF\&["\]KQ1#=1P].K:S\?7I+47F%!#(:]UA\Z]X3ARL?O*??,KV?
M[NZJNQ%HL>?)[!__UX>=F[)+RN**=A[H*(L;]#AA[;Y04)FTF!F3>-)RH;0V
MW:>B,MXY(,%RCZ.BXM[K(Z()ZRN;CXR._DE,2=G29/'$@70[PVC#OXQ;]\;#
MHFMU4IL;2X[='_%++Y\X'3YAE3KTT/_>NWF%L.8JM,)]7Z!-Y/B9DI+R.Q41
M#_+R;"?#SSX-7?U;YL;]*DM@G___Y%@E7O+.%'!<*O_\P*> 8T9UE,U8(-#N
MYEY9?_+3EMA$B[& P!O7UO97U1S9L_TWOU7;!*MT[G7^U ;4&*MM#DB9J/H=
MB*QB:( K[[1G?[B(8HR8_3-2H0' 9IS:($H#_-4,2LI\-FH P?O/%+I, WQR
MR@ #-K">@T@<\2+T47D3BZ-L4!UXYS^[H?* 9'UN"FD9%7SAY5?=UEI4>M.5
M4-]6_;CA'+NGDA3F_PCXH-/UQ2Y;D[0OHF6I@#YT]D<]9DQ*>G*W8U5U1<OC
ME.#4PXZW?WQ[-,=X^V'9\:6^T0Y&ABM#QK9AR7@8.DX_=%INW-7E48FQL=%3
MOFQ5QM'3JBR>[XI4U@N\E0;XO5I*5 ()I(7OFEGBY[@Y,VC( )K=OU=_KE@#
MX$BJB]"[6Q3L5]-"#,8GOP#4&U)@!KA]04I&W2)!#?#&%%HWBRV__#^P_%LB
MLFELZI##;4(788E5VLZ]M.4(LNCYQ$5##S/M+>TG?EU<<8[TI)J8H 'P;J*Y
MCXD:H,Q\K_X\N^#1ZM_IFR9J*G1.AOII9_W^^TIIR:$J#2 ;%*D?^V+G1U6Z
M_%VT['?WFP7_N'ZY&7]+?5#K$R1_JOZ:GP].JI]BI"Y,_-'_#(=/^+39WD4#
ML)0$E7-<PYN_?3EDG#'U20.L871"03$:@+A01HOYQSG@C'L>]%>P?+TJPY6E
M<HL(@6/T%W+ R?/@PL;-RF=R,GIQ=(T&>*B'58[RIP_4)AA7[M-7?4_7 /YK
M@4!_R[U:G\<!X6<*;5)11Z#QG8=T_P%[+7::/=9ESW7B5$OL0A\,0O))L@8X
MLE(#]&Y]6?1WJ;_1]M8"_DW@[M>X%QI@$X!RD#<:8&T4CSF'-8_8+1+=6F^W
MD62%Z#6&#32D*E3?J!=^^-O7-\_R%50LF ,D8'F=!JA0[><X5_[#7(:W;3?G
MPV;*576[S9"ZV*D2<<Y2[<3/=>)5EM=4;RE-:G^R!?1*.TP#])]\">E]#]W+
M4C_&2M[M*QEK;U_< 'P>]Z<AV=L1-3N1,WM[4V8%9B)&,7GA$X:S+^>>MO(5
M=A0C'%J0Z*MS"ZI>)H#(7),&J#&#WOTRT0-8[O/_V\A_H<)]*+M[BOX.N@;0
M2.@/V&5K9<0%#? (NX!;<>2^2-:_]?Z1<.JK-%Y?18D5$N)93MR:UOEX++GR
MEX$"OR\<?MVK<S3S\*)M+>XFF2'/2-N\VU=4W+ _P?C>_L31UK,_654\\OBI
MJJ"J8_FAR]=NG !X?U1IG;R\.W;8=_%=RS5F"9\F506):@>*ON*]JHJZ5"JR
M17>"]1Q^'B'_S% [,=^#V6TL*F#6$G@BW+NP3@JKHZG4 4F_FY#Z ?&3@E.?
MQ*\3.H5KF9T:8/$12C#6^GNX%Z ;%N;Z)^(L0<SQ'83D&2L*7>$C'[N@7D.9
MQWH)2Z\ _+2_,H7J(W?O\M[_/AW?S5X?B!<ND5IGU;@.,'<]-I9X*G]?^CZY
MF+Q8$'=2$IB;>!2>&8YZ6+=):^&'P:'=![VK_[!.K*4WW3#)5PV89+1 CVXR
MXZ/X:X(>'?XK%U[\)(HBTK\EE(3KKUAQ5,$:.\ %Z_CY,SZZ4,<WU$#E9NI!
MI"(J039ST8,X%:YT'Z%^KWI(6_OD[G"<2,]G X70(;)G;QIG6K+74PJ[K&F6
M<GH7(V<;U1^.R5P+/R,):V/51GTND,EX<WF;-.\Q ?HLW(N%C8(LTA+U\GB:
MF1Q_KC5-":K[-, RMCZZ_X6KJ(!CK@'B[+ZD*#OS)$%ALH,PL9N3MV\$_6JP
M%5=%(7?1EK/[DAGFK^**Z-D-^H/)+24>0LG)N*] WX3_YX&^*5[8>.WF>%AI
M2\U$JHU3[NWQ^:+&VJKXIGV'Q\]\6U@1_B3M7GQ8_M340^'A5T*N8\_+KBJ+
M#5%IVWFXGRGA"CKB*"->:)[A,4U1OQ<I^&R:5=.@$W6?-"7A\7&X[YTYW^>^
M7DMYSW?-[.)TTX;N:Z_93.\,]H!CBN.F1(_1J?C4'8F$@B*([DK&.L&ER8)E
MH92ZO7"9!LA _1.DGB2MN,D'R*MW?:\>LW^#RW_AG[I5,UZK_>#5\*,_G.R[
M>(GOY].O0\]^B8;R10^A:3_]O'5]-,=8SN)Z@M6$R,1GX[O/K8\1QS*E&)_M
M7CC8/)3;ZDE6V)*645HDSYL>L'\2=M0UO\!'UO>=<NGQ& J%?W6,UEIHDXKL
M*>[M-+,!KW09:!%'6PZ?*HR*N4]"Z"'7 \\:GPWRG;[=_\38LO# D?@EH\/"
M5X?#PXGW(D<C?&,2$AP'[IM_K Y7_*)BUA,,* 2^4,##:<>Q39'<)&]F9JM_
MRH.O&^U7EOY!KILX/KS_Y?OIXR_>ZP^C 4D/PEZ%(=$R*_5*YC<W>FVQW(H'
M;6/'Q+,^)G4#KMZ$+AJN374-/2ME6 HI:4=>KD'<);:BG#/.K]#O,D<W&[H(
M+/ZDZ"D[TQ9*!/3E<YO/4FY;EV[I*_YJ6T#2!S7&-H:'U3SV:E@#Y*80S>)L
M^-W&'.'3;Y T>2,AVR.[G+FB.@6TG["9>YW_[B(O(J;#AC&=9#H;'-RL=XY\
M2QC?G%+VODS\M-JQOMIH="7NU:G%!BLSM73,_O#]:^G)M:&[WX3N"=99NL8L
M_BP)^<R1K&*R:L/%WXAZ05"26*3_9WS1(N3 06:GCU7Q?OC!LWEC2?HN$FY<
MD"ZY]OBG^JLL>DU1Q/+H:T6ANCD_AM[=PJ_\?\FW^ZO^^./=LX)+-05W*QUN
MF11<^N+0M8R31WV#@4P#5O"_4Y$R?-P01Z6NN@</8&T%477'9SG%+!8RHZT+
M3"=<3V&8C2()[?G2L_=<&;E^$OZ%!KOX>2[-!+_4ZT!,E!2R8>!B%TC"F6J'
MAPT?7'Y<5WNUC^JN=$)Q,!U=Z< MQ37W%4H8?# 'JB_,<LCJ+B5\,2Y:3ML<
M))UDV%-J%,M=>7F1#4/KY4.Y8_;60U?WP^7%;K<LFX/S3JXK*6^K>&&Y5[^G
M2?0(/S5]7RU0KU85IA#H5D6,]IFE\9$;AUQ9>J*$TK6/2TEF"%?J=D>>=ECN
MRKR(/ZP!SK.^EKN0EK@&,FUCSZ@+J\/B2VV'HAX]?E'S7=3#^FRG$3'4SKJ@
M >J87"4QFV2 >I^68"JNHYI"[YJOOC^)*8,\ZAXI:(6T'"@,DY,N4:-D^*43
M'OR+7B3IC,7$E8:W#5*"67RA,'_RKMFG6F&8<,1W\N>]6J1RL&X,O0(:JER9
M*G#BVJ>2?S/SL]:[44<-<#F\BZD !CFSPRFDCE_Q$RL_^UP#O+O+FG'^#ZGO
M9RT/9X?*.]L\MC5[6-04G-_F\7!EY6;@C_;,NXL,5E>&"D?B%(.*5#-^3%QL
MU?5&A9B_])%7WY_;OLJ0NL:]+3INK=US/4#YO$O@#WSI6>/64F-LWG#C^\-+
MCW^QR_C^IK_2WZP-7RG]><^F*T^W/."?.KQ;4O#LNZ=Z^O,4>Q*X3N_9T0,;
M;B[Z>\'PP*AT2.V3R)E\.Z(!OEY]$S=S7*#VQ@34Y'G\PCJ/NO^O%/\CI4AB
M<NJ'T*5^:D.Y<@75GR[!3V]7!E,W(\[RU9/<,-*EE3#]$FLN+S&29)H0XG'M
M^K6JJE0/1Q2,:FON<]UP+.K+G]I^[;BSU_*AOM8_&([J+H]1&_MK )U[0^K5
ME#NA?9Q3HHSY,^FJU[\V#IF3*-U]_D&;.JVYZ[-N[-D3=<5MT[.6RXUU)DO&
M(!CA(&OY*CRAG8.:R)D:8&N]UL(^?QH&F2O%I$$A?I;*6:0!8&<>A/)ZL5XC
M#^O7CD"]'U!C#= N6*X!/MI^A2^S#'G+07T(:L/3&B#@*4S0 -I>F)6>)>+_
M_1/^;>*@_="_<][0:Y(>-MD*PKL)IM0OX?=YE6H1!ZA.,=YZ7W5;?P#=S\ S
MJ^*MM^KMH6Y<D5&_C8?>U/EBY4^^*_&-[/]CVHU[=I%@$A%QJ%:<JQ[N^/P\
M"P%B6OI</6-]7U*_37+LO@3SMN(OE#R/&#AF_LOLH>AVD/\GV,2<.O6PLUKI
MCWJ9/.RJPJ%K/IG4WL.V[78?,/,'TM/\J5@_9CJNM(5ZNU$O#? 4 WP#:W;;
MP"CRPI<<.O-3$F8Q]Z_PX;VD-1#W#(TGFCT-X< /8QK@[2D&0B:^&E$7$"1C
MZB,: .UYH3\XY\U"L4 <ZFE2_^Q/PH[ZMU\J:U*U<:)VENJ1A<Z25X=*]8Y#
MDO7MATK=CD/2XG>6%ND7 .AN/A,]@^7LD $X^TU*-&>#V@;J.(69]F>2)9HH
M)EU@XL!3I'-J1^0<UN2.VL*$S%;"W0G:JG1B5^D6N<^=F%L4R*\_ZC'\II6<
M7AD_=+W1+=?EX1VB5X(#S]!A+@E5'_R[9#_T8Z)C3.+'\([-8J?Q51=WM3_1
M3KJSPN17$_$)><_AVQD;-$!T'&8)&18D&5@JH?&,J1Y/-?4[S/46(@V0?VAB
MPR*&(KI$ _BX08@AEEZ\>^IG_9PQGD #:&&^15Y27>4X13DR':7<&R^J&^I@
M#0O:-8!%,EF/XB >RE>O0GWEK&F[&/CZY*XZK&0P<L_8E11F>RVF62"*&9ZU
MAWTQS UY65."L0&.GW[Z[+&[X3DB01OC:B\DOC7H,3?-.C=+SK3WEN/XH,F$
M!JCWYO!QY]A6 \G39!['L)XP/!)4>O9UJL/:\I)$F1["?4#)$D\73JG*.XM,
MF$MF.9?"\+FWFOOJ&<:4E[-[<;WXO\>X3W6C A+D,]6+PC6 _ '*@Y -^.Y?
M;@^P[9JF<JM>TP:$I"Y;EM&?5(,^]7:J)_O%79C-A-,"D#?W*,]QEQS+PMYI
M3;>NEYKJ<_4[YVDKZ@<$7=60;]_H6P)]H:&I2Z@R14AR'%<#6/O8H#Y(I830
M!'4ZR@D=/DOE\]D:H,'1_WJY"W[9NV#[U7TA^QY9/-LRI_-PX&C@)-'C0$)J
MW5<GDNRE6H-0=)SHGUUU_;.K"I7N1 W W$Q$=3'Q(CN4>A$H4Q4?PUP5S$2,
M/[OJ/F?X#!E%0B'Q6FR%3>7L7EW<5)N[FKJ% UN,_!/TPG(-(+A0B&&'Y ]:
MOP6_ +?IS[&>DDUIK\%ZUD7J5CE36I.G7!X;-M,ANM!,YT]&Z$UV<NJ?WY#B
M\O'F*U5,]4;*'0FOR8H!1] 6A_I73*K7T3M\U@U2G26?:"M%3U)^M,^5#).#
M/X:ZIZ[$5T!_=Z4[2D(0AL&8@.HT?L;PZ6/UYX>N/K8$+E.X7A;"Y>@B+3)"
M!^,<'N>U46KG@(7 L<*N'ZC'D"PI6>L(>N QD@#/!S3V_[(E<BFL5P$K0^2,
M+E/H0!^Z2H+YT^;U.R&ZD#ATSBMN72%+"HW<?(>W<43UXV!REX>@4X!+X !>
MAO(DV8G(K7!C23G5&[FJ)+X>#R-WXDS&V<8#Y^U7R7G7G,JD3*T1RDB7,/WY
M-5RV@UP#9%?TS0HL\XC6 9+O<2V8')P5?8(Q3=@>2%:[!B@BBS%'6)$00ZQ<
M\1[ VX%90=3 V14G3B1[];W0]7_X:%=(8."ADZNN71?JGCSZ@\&Q92NS?E^9
MB5OYLADK^!?_<>"R70FOR!)\ ?0=8QGM)<>:;84N0TJJPU!O50GJ#A/#Y?2,
M6<B2ZHL0I5!6Z1:D7]H3$PD/MK'BK(D2QK0=4:I_OL'.9HR;!HO6W9>,Y#WM
MT&E<.%'M.C0U(_?$V-=* R1R&$R#&IK%,'I0==/'%,7#S,[*&:OQL/;:!B0+
M3NH$K9(%IJ_1B);>Y,&7<Y"NKQ1O'SN_51A;)YK(NQ,V:?53657=B)XR^R*
M'D'2E+9JX:@13.;.+(]C*;<@:8IB)$%&S%UH&[N(]0AH(E(G$1309:R,>J(I
MNA<ID2=U>]"YS.Q1QW[:!E\IQQ@!NWR6][8ZWWQ-L>=W1)K7(J!D ,9GB;@?
M$,)<H)C.-08S(3WV$M2N?VY[2@OA F2*FL/O1\(>UV=WCH7E=;!M^JE>KGG%
MF].N& >6'*I7#)QRO'E9DIEP8W7N:_/#"_E_(\SS)VB;H-6X658V= +$K+U^
MZ@^UD_P#U1'92E;N0)12ZVEM*6B+GH))&;/Y!/XH >9WBX3Z/(ZU2[I^UZC[
MU=V/Y)%-"E-<,%QPHRH\WKK0BE!).:4=&_.HMK\<G]3[%1Y G56,%!:=])#<
M11Y>']0&K[O!0KB=G :WO/)X>_M^L@M'Y]4$B*<F8L8H.C3=<Z&Q).',Y6%F
MSG6"=%?CP[@:5^/TKQ/\?\-I/_V+9/WY/U)*UR"5RB!,R-R@^2QFT-EVY&$^
M25Y>TTL-?HC<.BW%#1?R<'+M3ALO>ZO>UI 8.$"ZE%TFK?1>04F3AG2QC(Z@
M 8BK1,FRCV7K7]U'7A8[/VJD"K^=86:B54I,ZE__&__+)].E&V/_M\?E_\4!
M:H;_%U!+ P04    " "%4 U1F#;+SHPW  #</0  '0   &-H87)T+3DT9#DP
M.&8S,C Q8S4R-C0Y93<N:G!GU7MY5!/GW^\@(BI"V%$0HH+BGEH$%"$C4D6D
M&'<4"JDBLHFI521*R"@@81%2M4J%2D1$5(2(;(J0  '2EB([D5#)9F67&<4P
M)9/)'=^[_M[S_G'/O>?>>VXXSR&9///-\WV^R^?SR4QT;W1RP'3/+K]=@)X>
M .@1?X!N$/ A7OWO/;X8^=^UH:=K ,SF Z/ ;_IZ*X Y9GKZ9GJZ9H!,K-/@
M/T\ _LM#;X[^7(-YAO,7+#0B)E29 G/T]/7GS-4W,)@[EW@WD7@?F&MF8+Y\
MD_<\B_W'#5><M?SZRO6"^8X[RANM#G3!3BXG?DQ:L-#:9O$2VY6KG%>O6;O9
MU<U]RU8/GV]V[O+=[;?GX*'#1P*/'@L*.QE^*B(R*OK<^;@+\<R+EY)3KJ9R
MTM(S;MS\^=;MG%_NY-XO?%#TL/C1XR?/*RJKJFM>O*QM$C6WM(I_^_V/[I[>
MOG[)FP&I0JEZ]_?[X9'1,>3CI^G/ZAGTG]DO?ND!^O_-]?_0+S/"KSESY^K/
M-?SBE]Z<^"\3S.8:+-\TS]Q[O^'QLQ8KOKXRWW+']8+RQ@6.+@=@JQ,_=BVT
M=MJL6(E\<>W?//N?<RSI?\FS_^;8?_=+"BS2UR."IV\&@ ".K[Z? ?ROCG4?
M.>H>'9!T _-&K1!-(Z]<!TQ<UY!1E7I,^[3.#VZ=4N6D4Y<PZ4KHLF ATT41
MW_B+IX]S2N74$I8O6H48GZGS*I Q^<W5,[.!R9Y?W3X@&[\1E=/==O8$]Z'O
M8YP?^&F-)IP5#.L S*(07QBK\<.[A)5%.J!%EDI^+IQ4:(Q86U%G!22=4I!%
M],78MW7:?+87RZ8/@XI:%/4')(UL"Z2U2!$;%DH8X:ZOBR/^!?>R7!^/2'GI
MTY&E#\M?5G6[OGQZ&3RF \+XZ&JH22CEJA.Y*M^LZ0!?=3#BSL&7L[Y%W1&Z
MPEE<>DXDL$$H(C!3!\Q3U=>AM^2#=T^IIP*Z/ -B[HU<<&%6DTU'_MQPQG.%
M4S]_<O/-XR5!4;)C(=@/Z*;CI4Q]48[0&E]R#.4HZU-L^4V3"\?%0^8U_6RG
MJ!PWY.W@&%6O^WV_N0YH/>(2%&#UIWN^74WO9%'-[:TG;G7U<9%PF-'(LQ3&
MZ@!]=F.H@[;\I+8(C-0! SI 3(9#P"Q]^9%Z33BZ*L!126JAO7DEHI>#&64L
M_<?HL.BG$>K22JHAPL\\#UKN?!04,J+V<'A1(ZV_=OO<L9"_I&X09NFBX$VH
MY% &#S["NP(NU@$1H&6,K(;66JG-]=RF ^:&U<*\1F@Q,[EY 3S32#9D.S"#
MY;)4X4ERFL/BSHW3W*3;Q"P!)<K!48!6S<M1\H %IU6YP\<X1ZLBDK:3)O/V
MH;_#7#^4\P!S[*.NQCQZV&O'U<9/1NC&%(RA2 #3//IO9Z[[_7$4U>AEWPED
M8U%QZ[,_.BZ&%W6<*;&\=G+0[E8P[1JT@(([TC%R.5H ?_BD;+U5O+'\"6M3
M%2*\^H&Z?+361[RT:ZP&7\ Y#%D,C#[?N?['E9];;]E7[!I=EA-60E;:J(N2
M1;+Y.D#^U"7&'20)R'B7K*HF&XRFOXEH9CMI[[*I[!:AU?F.[-#E2/Q5; WL
MWU0[/*FG =A_0895_E<8L)W(N)#.[*'#.<T:'4!B&HEJBU-8L0]07F/HLJ3W
M=HFT8C0\%IY2N&/6&EHG=0G+#8Z?U$/"6GGP0>&UH:^189$.R.*5BUO(*<(:
M[L3O!:R=-(=!5*).AWTG+\*#@:_06(2O=NF9?KMC_!@*%6*'^OF5[3X-U)6=
ME7<I#;6G:B(<*AY>AG:1X8,T=.WP54B>RP:UUSQ7*G5 \NQP\UTC=3E:\QC;
M)O$,*6362D3/,#NX_^H3UK:>JJDT:7_.645];)U?8607:T=UKZO1EBG,LUI=
M>[HU8'_0>W C__*7'<JW0I-U@$$,6D.$]ED7FQ2S:DIAT[1.F#8K%HM4V[9Z
M;GW$S/0G*JL),A_/!RK@$VCXF1N:;WK8%)2A\3W,L/IM6:WYCMF@I^6_4><2
M'0-G=\S*)EV0&K4INJTP4II=<%;%'9C!%TXIVK]6=S=]'!O\!BD53_A8E\+=
MLQ_>S\_?MN8^>J4 O12[I=VUKL;F0IO5 U[4(%<L'##Z#BU6@C;"R0[$46Z3
M1G5D!6GYH#R'!Q^3255B:.[F%N3"U415HD\SW99JRP)AY\8VLEFD]6Q@1N5+
MS!ON4,2G5FIMQT6[!EM^B)1>"W2PJHH-TU#?-H OR29XIPX L) "5-2,6Z*#
M<&;SD!V:P#PO<T")#++P-"N-S%_0>V37U6D=8!,M/?4JKAB-_F?5D?32N%=Y
M2YHS?J_X\9F%'T+LXZ&OHMP/LB)0FE5UO>K5U%6I?;/0#%O\4PQHL;GM\?HX
M"N?2H=+2M,]D^Z.A(M>[4RGK<R%3:8C/AOK6NY:__0:^SMF=V82O09<3L0#[
M!0;,>,4O:"(2B,^_!>?/BG9H[^B $_QT'?"<WG@(39=#THC=W9XQ<L:B49XI
M!3NH[)#JM\H6\)JMV;9(L5AHAG*/(!&9GP=+M.!^4ZAIZPH?3;KF./L/7GGQ
M1($F!F^S]16#;VJ.HC<U\]]"C9[X5YBCEL<R@GO4%Q%&*]\X"JR9R1:L0<^U
M4!U[\T34!; DO<R3@LRH(BX_/9_'F(^%2%Y??R16>IFKOGN!G/E%:CR<[NFI
MIR6_9?>>K1$SYC#U=\"R%$]O>%N+4$_@B$7UZH H.TJ6;%&/"'=X =ND3QN;
M4TQVRL,>^2EI9I&Y#_,>CTG?%R'.>U[I@)1M3;PW$7OZAX/?[M(GO60&*F5-
MPJ7CLY*K+"MD70-U(P)R-K\U/(:0.)Z;5!1C-#FT\SS7\DW+$V;8H?[*1,>#
M=;WG2[<U7SH-C]D:?]96U9>5AZV/OW1>XO;1*0MSP'^W7?42TFQA-\\<L74K
M@.;RX-,$%%GI[\F("5DU]EX:<F1*&:V]^>V?%[IWNFH'3IH=4PS716Q8>B#]
M1QU01(;]90,W%>()': )U &-=I['89%B50X\V"Q<(I1SV*Y].B"2;LZ$FJ84
MDX%*6O/B,N%)GL7&"B1X7VJ_$=\,[?:*::Y%,F9:7$)BK*NO2T>MVQE%([GA
M66F&8S:3[D0F;-$6X;9LZ9"3-D,'A/-0Y\ ,\#3/"G66NXL@[I KXI"NH;%L
MT24.R0INNL-72'SRYO'=E;S,2W&WJLOC&8_1 ]OGW5&N^>"LB;[S='ULJ?0#
MO1@,IZ.K91-: F]_8QMHG[%VEAYCOPY=B%#KE<(YS)R=J%;)7< T^=0 6M09
MJNBF+$\D_G)5>\+AOHDZEXN/!]!BD4>1((=Z]]&+_J<[J_YRZ_]4WW*K6,&;
M%&H6XYU@%1^S^J1NJ]3^"D5SI3[JW:A0 :(KN0W&P0KP&GLA4PKIH: 8- M6
M&;;^4@?*^9DU/XW:V$@ER>%UJ:[,\QO.>??5@7%LUC<Y[M??5-^)^T<'J,!,
MJ,*Z6&,#-:["3>GLW\@F@GG,,SW!V@JV.6N_!(KB#12JQ),Z0 <LFB1@\G2D
M&]T4MXRB5PSQE%[N :A0X\/NH7H@*V<RV38$JR'BLR @]<K#T'36NN*0\<P2
MZ2A ?F.3#IX1#LR(H"IN(_AF"+*2#F%!Z"<XN55H5V>I#BKFV(E^9#HWV>:D
M5N8YKBJFOC3N+WS*5(XW_TB3Q[J(I.QG<?44D6!E7VY"S 8/YU>SE":A%<&3
MQD,1Z&J=%6+1,$1!W$63>[S(8H$]+,S$MBGMXQL]ZOZ8,KFEU#KZ]O+CR(O&
M#CPX@[P9O]#O?F#MIJ/9_6*8KS%$;9J&[!$^9EHL!LT]#<(*L=-(#F;AJ&[5
M_BJ8@ZJ4)-&&'V<.=4.G::GD)92G[/GH'AUPJ YN_\3T:9$9GP_N6"I2W*4U
M$Z3BR)!U]\K^@LK>V!6U5\*G^:A[FZ+^*;TJ9^+MQILJ&0FEJW@-T$ ,4>W"
M6$H*G224\V0VU(7H)]P<LAK/7ZRA<W3 &9*4VTHW^U"W#8E1N>4A_M]4(I#(
MZT?R0GHHFN-+MVX_'ELP^N/@RLN&,^X[+??I_=?AO6R.7\/2&Y?TQB*?4BS&
M?T!C1+53:67+;RN-#7W[7!]/RM>NRM^PHFEX_XW%F3\E^=WH;<U+"_GSZ^WO
M+V^UCU#Y-NH $V:8V,$5,6RA<VQMD@6+QVIJR<T\ZQB'+;#@CH+/J>W/L[Y+
M+7S 5(76]WW?7>?\^(UWR:C+T.BL=HAW,=:ZN-BS\UY]U:>#"O=6'H&!#IBC
M83/IBLR*NA0+@U?V]:K=AC:CQU30(FP[_&"FO\3B[=$6)6EA]*7JGR75F9ZK
MQCHF=[S_R]\LU\E\U90J6=YQI9(NM6ODP6><&WE2ME0DIL\5GNE((]=P)V6:
M #2A>>44RQY1J>_W8YO*V)UDH_/D]*_V[N(I@^V\(I2!:2?+X=LO[?MY)8/,
M8!H\V5+UN32W05N<\84%&A,]VM.'Z G/^J&3.N"-N!5Z1A;S.;+G-2**=(6H
M(;<FG6W,K% ?0?)S%/2,V>$F$@=<0K5GS4>CBD2%&-A/=1KY."9AKZQXT5_Z
MH*XJJ3E:L*2[*O,8A=( 5ER*65&SG_?.M]#DFM<OIJ1E$;GX><] ) 9?6%&*
MG=;F0?)\ 5E;PM;'J-H'^'K,")W2_$"@<5&>FOX< :^RC.$V$>X%.R>S;?'7
M9".V132^Y5D/:^>YATRNV' 7PFFF6<7$.ZSE-06=IRY+>NUU_'W&)P6-:&QP
M(!==+;X&A<O>]*CZ[_*CA,^YHKN,)G+E# >*IDL#"=X:KN(.ABDNW-+LP]LA
M6S[59(#IV,)>TOE9B.X1&+,[0 L"HA>A''$Y]FW/--V664AS]U>$F/0<KN^L
MVI6BK[%=.&]3OLFYE^G@E/F/0X,5V9LZ VT0DM)9Q$\9,NO#EV%'$%DR>PEJ
M(1J/G)W)8B]CEOC ])3SAX2"ZI[UP8&(<SIENMTF@("CCQU[JV/:WACT_=U7
M]>LIOX>IJ_ @\ P774N>;(/;FF45\<T="W BOM2Y^.^"K[4_4>=A,=U0=("A
M>AWZ2G,0;Q62!5O05M6!'&7@%=R)%0(_+ !;Z -<A5?J'4-.%4V?SN7D"*@O
MNCX/CNL ,]<'TN\Z!Q*_]#:#62[!3$#Y3Z!5+*-L^FY\$]V,NH(M<K.9J74=
M%72Y\A8Q9>H_M+].,#YL+MWE8A<2=2D_\^E>M4V7Y<6G'Y:_S+H^L!O0GI4(
MO+ %< 7VE8,SV@7S1%RD]GU3A_R/<:&YIWTA+S,^]T'0(6ELL<BJU_55F&H\
M:X\]XYO;?\B:PH[<4'O1_6]8WHHS<LOK;RK[T47BM=>E8W&'MX3QUO GO??"
MU[8SS1Z$SB%QR?!N6:K N6_*-5@'H$[TR02-*;L1_ZI\_:F776P7M U?N!\I
MEL//ZOV<5L<E< <&B1V*YP^*MQZ#*C!Z^*:=V;O?,=YV)-$)5BV5$3(NZ1%K
M'NJ?J-F.VJB3M;\0;5]JH:Y&%^/V:+#&@;4;=F_H2!Z61R2Q5Z(UC?WT1<)8
MAL-=?=S65UGU<[[!LVY\\U$T6"2M$;TU/)#3?&'(H2]_6^+:DP!>G&98QNSX
MT=!QZ>4?H*6J1^]?DFV8,PWY0*;H$W.J56 )'Z*N0XYPY*"1OU)F$>5@QVW.
M=T.^^1C,9#3.SLUM_WQCG+H6,?[SP.!(*+F'D$5]$=F[*\>WI9O]#*V4+0#E
M!1!\6 >DZ8!RSD0Y(B! K:,A@"2FPP=D@S9$1RMWGYC\@0V,1A6QVSWB.?A*
MO/LV:$;0")+UX'?HM0'6,:3C&FLEG-HM;@2-AV,-F]QL?AK-1MZ.V6:7+.]&
MIB:+-$&_EQUC.6H??X!.05*C%IZ>4"[O0)T9$XD*@L.2+MM:%:>*DUE1<G ^
M^H2>D6\%Y]>7HM4,CFS)NWK)!T_:PYA^JF-_%7@57]47ET@2V;:\OG4\;!F
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MZ/]P.OL7O(/W<3?F/-T/3>N )X'OX_[]H7V&A<P:?"?#''JC'T08".^#YOT
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ML;ASRG+UD7@\!6@(5PFH/>Q@$F@6DV*#!BM^REQ+BT#JO-EE\WWZE=UX#36
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M$MC/^6/T?SJ71]@!1Z!I0^9*X.$"/!I%K0\P;9$2\%97_)RL!-S7@!=S_U=
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M2J"*-9X)F4E#&JU  H[?\<WDQ1CQ$V8)JP6OZ/ALK_7<UMUK!^9X\_R8\9U
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M4,+%=ZI?.7%!Z[7NF(5Q;8G,49N.K3KST4T=5NG/6Z3QLQV'^CY-SHA&;F<
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MNQ(B,P!D5!8]E2\G7)$8XMPX+.#7=K3;][FNMQP5Y-[OH:P>;Q0EH8?.RJ_
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M;=\>LO%)36\1O(*?@I(>,)P95.C*./^DV@:OXB5L:Y:CNIJU+4+*%>]5*(_
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M4N-_4[K-W@?)EF?K8P/UX@V9ZF<GREW?\V&]@TAQ,>NK"#0X_K[$>V45$IL
M?6KQ6-T0=S^UN<"XUX6V9+C^EV+F&<F^ZD_4+&*5J%UBS>[C$.Y"DE0TL!"O
MT@U/5=8L'X0OWZ:G<$\Z+TSQ*$VC?C=C&8C(S9'+T-/]T*V9M@I?>211GTEK
MYA/>(\<5?NXRPE4R];Y;"=S@>QN7--%)%60_E;LW\,6KQ7%S6]Y]]_%LW]59
M^>V,]4#1__^AK1GZ'U!+ 0(4 Q0    ( (50#5'8_=\0ZQT$ )EW-@ :
M          "  0    !A,C!Q-#$P:S V,S R,&9O<FTQ,"UK+FAT;5!+ 0(4
M Q0    ( (50#5'#&D%F-1$  (N9 0 ;              "  2,>! !A,C!Q
M-#$P:S8S,#(P97AH:6)I=#(Q,2YH=&U02P$"% ,4    " "%4 U1P@QTFR %
M  #U'@  &P              @ &1+P0 83(P<30Q,&LV,S R,&5X:&EB:70R
M,S$N:'1M4$L! A0#%     @ A5 -4=5U?F!/"   N#,  !L
M ( !ZC0$ &$R,'$T,3!K-C,P,C!E>&AI8FET,S$Q+FAT;5!+ 0(4 Q0    (
M (50#5$6(2.A3 @  &(S   ;              "  7(]! !A,C!Q-#$P:S8S
M,#(P97AH:6)I=#,Q,BYH=&U02P$"% ,4    " "%4 U1]C34"4(%  #.(
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M &-A:"TR,#(P,#8S,%]C86PN>&UL4$L! A0#%     @ A5 -443+[Z2NPP
ML3\* !0              ( !2;,$ &-A:"TR,#(P,#8S,%]D968N>&UL4$L!
M A0#%     @ A5 -41N&,\2B:P$ Y!P3 !0              ( !*7<% &-A
M:"TR,#(P,#8S,%]L86(N>&UL4$L! A0#%     @ A5 -42%/$N[>#P$ $C@.
M !0              ( !_>(& &-A:"TR,#(P,#8S,%]P<F4N>&UL4$L! A0#
M%     @ A5 -4;?N2(]?)@  2"L  !T              ( !#?,' &-H87)T
M+3$T.&%F.&1E9&5B9#4U86,Y96(N:G!G4$L! A0#%     @ A5 -48W+:/\Q
M_0  \RT! !T              ( !IQD( &-H87)T+3(V,F8S.3@V8F0Y83DU
M9C Q,#<N:G!G4$L! A0#%     @ A5 -49P=&L)-)   %BH  !T
M     ( !$Q<) &-H87)T+30V,&1F9#-E-#(V8C4T.65A8F8N:G!G4$L! A0#
M%     @ A5 -4> J=*#>*   22\  !T              ( !FSL) &-H87)T
M+3<X-69C,C4P8C0R,C4Q.#)A,#DN:G!G4$L! A0#%     @ A5 -49@VR\Z,
M-P  W#T  !T              ( !M&0) &-H87)T+3DT9#DP.&8S,C Q8S4R
M-C0Y93<N:G!G4$L! A0#%     @ A5 -4:0 -DX3(P  QB@  !T
M     ( !>YP) &-H87)T+6(X8V8Y9# T8V0P9C5E-C!A-CDN:G!G4$L! A0#
M%     @ A5 -468)X"0R*P  GS   !T              ( !R;\) &-H87)T
M+61F-69A-3AD96(P,C4W,#EA.#$N:G!G4$L%!@     3 !, 404  #;K"0
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
